Citrus Sinensis ID: 011326
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 488 | 2.2.26 [Sep-21-2011] | |||||||
| Q39008 | 608 | Mitogen-activated protein | yes | no | 0.534 | 0.429 | 0.679 | 1e-101 | |
| Q9SZ67 | 1895 | Probable WRKY transcripti | no | no | 0.540 | 0.139 | 0.597 | 4e-86 | |
| O22040 | 666 | Mitogen-activated protein | no | no | 0.518 | 0.379 | 0.484 | 3e-63 | |
| Q9FZ36 | 651 | Mitogen-activated protein | no | no | 0.516 | 0.387 | 0.471 | 1e-62 | |
| Q54R82 | 942 | Mitogen-activated protein | yes | no | 0.516 | 0.267 | 0.450 | 5e-60 | |
| Q56UN5 | 1328 | Mitogen-activated protein | yes | no | 0.520 | 0.191 | 0.432 | 4e-57 | |
| E9Q3S4 | 1311 | Mitogen-activated protein | yes | no | 0.520 | 0.193 | 0.444 | 9e-57 | |
| O22042 | 651 | Mitogen-activated protein | no | no | 0.516 | 0.387 | 0.437 | 9e-57 | |
| P28829 | 659 | Protein kinase byr2 OS=Sc | yes | no | 0.516 | 0.382 | 0.434 | 3e-56 | |
| Q10407 | 1116 | MAP kinase kinase kinase | no | no | 0.543 | 0.237 | 0.406 | 2e-53 |
| >sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 368 bits (945), Expect = e-101, Method: Compositional matrix adjust.
Identities = 178/262 (67%), Positives = 212/262 (80%), Gaps = 1/262 (0%)
Query: 224 ITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF 283
ITSWQKG+LLG GS+G VYEG++ DG FFAVKEVSL D+G + ++ I QLE EI LL Q
Sbjct: 330 ITSWQKGQLLGRGSFGSVYEGISGDGDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQL 389
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHE 343
+H NIV+Y GT +D L IFLELVT+GSL LYQ+Y L DS VS YTRQIL+GLKYLH+
Sbjct: 390 QHQNIVRYRGTAKDGSNLYIFLELVTQGSLLKLYQRYQLRDSVVSLYTRQILDGLKYLHD 449
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLK-KDGY 402
+ +HRDIKCANILVDA+G+VKLADFGLAK + ND+KSCKGT FWMAPEV+N K DGY
Sbjct: 450 KGFIHRDIKCANILVDANGAVKLADFGLAKVSKFNDIKSCKGTPFWMAPEVINRKDSDGY 509
Query: 403 GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQ 462
G ADIWSLGCTVLEM T + PYS LE QA+F+IG G LP VP++LS DA+ FILKCL+
Sbjct: 510 GSPADIWSLGCTVLEMCTGQIPYSDLEPVQALFRIGRGTLPEVPDTLSLDARLFILKCLK 569
Query: 463 VNPNDRPTAAQLMEHPFIKRPL 484
VNP +RPTAA+L+ HPF++RPL
Sbjct: 570 VNPEERPTAAELLNHPFVRRPL 591
|
Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5 |
| >sp|Q9SZ67|WRK19_ARATH Probable WRKY transcription factor 19 OS=Arabidopsis thaliana GN=WRKY19 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 319 bits (817), Expect = 4e-86, Method: Compositional matrix adjust.
Identities = 168/281 (59%), Positives = 204/281 (72%), Gaps = 17/281 (6%)
Query: 212 NNVSP----NGKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGK 267
+N SP G F IT WQKG+LLG GS G VYEG++ DG FFA KEVSL D+G +
Sbjct: 1610 SNTSPIYASEGSF---ITCWQKGQLLGRGSLGSVYEGISADGDFFAFKEVSLLDQGSQAH 1666
Query: 268 QSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQV 327
+ I Q+E I+LL Q +H NIV+Y GT +DE L IFLELVT+GSL LYQ+ L DS V
Sbjct: 1667 EWIQQVEGGIALLSQLQHQNIVRYRGTTKDESNLYIFLELVTQGSLRKLYQRNQLGDSVV 1726
Query: 328 SSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTA 387
S YTRQIL+GLKYLH++ +HR+IKCAN+LVDA+G+VKLADFGLAK V S T
Sbjct: 1727 SLYTRQILDGLKYLHDKGFIHRNIKCANVLVDANGTVKLADFGLAK------VMSLWRTP 1780
Query: 388 F--WMAPEVVNLKK--DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP 443
+ WMAPEV+ K DGYG ADIWSLGCTVLEMLT + PYS LE G A++ IG G+LP
Sbjct: 1781 YWNWMAPEVILNPKDYDGYGTPADIWSLGCTVLEMLTGQIPYSDLEIGTALYNIGTGKLP 1840
Query: 444 PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484
+P+ LS DA+DFIL CL+VNP +RPTAA+L+ HPF+ PL
Sbjct: 1841 KIPDILSLDARDFILTCLKVNPEERPTAAELLNHPFVNMPL 1881
|
Transcription factor. Interacts specifically with the W box (5'-(T)TGAC[CT]-3'), a frequently occurring elicitor-responsive cis-acting element. May act also as a disease resistance protein with a serine/threonine-protein kinase activity. Arabidopsis thaliana (taxid: 3702) |
| >sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 243 bits (619), Expect = 3e-63, Method: Compositional matrix adjust.
Identities = 129/266 (48%), Positives = 181/266 (68%), Gaps = 13/266 (4%)
Query: 226 SWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQD---EGPRGKQSILQLEQEISLLG 281
SW+KG+L+G G++G VY G+ D G AVK+V + + + I +LE+E+ LL
Sbjct: 68 SWRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLK 127
Query: 282 QFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKY 340
H NIV+YLGT R++ L I LE V GS++SL +K+ +S V +YTRQ+L GL+Y
Sbjct: 128 NLSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGLEY 187
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFG----LAKATTMNDVKSCKGTAFWMAPEVVN 396
LH ++HRDIK ANILVD G +KLADFG +A+ TM KS KGT +WMAPEV+
Sbjct: 188 LHNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEVI- 246
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTRRHPYS-HLEGGQAMFKIGGGEL-PPVPNSLSRDAQ 454
+ G+ +ADIWS+GCTV+EM+T + P+S + A+F IG + PP+P++LS DA+
Sbjct: 247 -LQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTLSSDAK 305
Query: 455 DFILKCLQVNPNDRPTAAQLMEHPFI 480
DF+LKCLQ PN RPTA++L++HPF+
Sbjct: 306 DFLLKCLQEVPNLRPTASELLKHPFV 331
|
May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 240 bits (613), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 125/265 (47%), Positives = 181/265 (68%), Gaps = 13/265 (4%)
Query: 227 WQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQS---ILQLEQEISLLGQ 282
W+KG+L+G G++G VY G+ D G AVK+V + +++ I +LE+E+ LL
Sbjct: 68 WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKLLKN 127
Query: 283 FEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYL 341
H NIV+YLGT R+++ L I LE V GS++SL +K+ +S V +YT Q+L GL+YL
Sbjct: 128 LSHPNIVRYLGTVREDETLNILLEFVPGGSISSLLEKFGAFPESVVRTYTNQLLLGLEYL 187
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFG----LAKATTMNDVKSCKGTAFWMAPEVVNL 397
H ++HRDIK ANILVD G +KLADFG +A+ T++ KS KGT +WMAPEV+
Sbjct: 188 HNHAIMHRDIKGANILVDNQGCIKLADFGASKQVAELATISGAKSMKGTPYWMAPEVI-- 245
Query: 398 KKDGYGLTADIWSLGCTVLEMLTRRHPYS-HLEGGQAMFKIGGGEL-PPVPNSLSRDAQD 455
+ G+ +ADIWS+GCTV+EM+T + P+S + A+F IG + PP+P+++S DA D
Sbjct: 246 LQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEIAAIFHIGTTKSHPPIPDNISSDAND 305
Query: 456 FILKCLQVNPNDRPTAAQLMEHPFI 480
F+LKCLQ PN RPTA++L++HPF+
Sbjct: 306 FLLKCLQQEPNLRPTASELLKHPFV 330
|
Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2 | Back alignment and function description |
|---|
Score = 232 bits (591), Expect = 5e-60, Method: Compositional matrix adjust.
Identities = 118/262 (45%), Positives = 175/262 (66%), Gaps = 10/262 (3%)
Query: 227 WQKGELLGSGSYGFVYEGLTDD-GFFFAVKEVSLQD--EGPRGKQSILQLEQEISLLGQF 283
WQKG++LG G YG VY GL D G FAVK++ + D P+ K IL +EI ++
Sbjct: 170 WQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRSL 229
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLH 342
HDNIV+YLGT D+ L +FLE + GS++SL K+ S++ + YT+QIL GL +LH
Sbjct: 230 RHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGLSFLH 289
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDVKSCKGTAFWMAPEVVNLKKD 400
+++HRDIK ANIL+D G VKL+DFG +K+ + ++ KS +GT +WMAPEV+ K+
Sbjct: 290 ANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVI--KQT 347
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPYSHL-EGGQAMFKIGGG-ELPPVPNSLSRDAQDFIL 458
G+G ++DIWSLGC ++EM T + P+S++ E M+ I +P +P+ +S++A DF+
Sbjct: 348 GHGRSSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQEAFDFLN 407
Query: 459 KCLQVNPNDRPTAAQLMEHPFI 480
C + +P +RP A QL++HPFI
Sbjct: 408 LCFKRDPKERPDANQLLKHPFI 429
|
Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q56UN5|M3K19_HUMAN Mitogen-activated protein kinase kinase kinase 19 OS=Homo sapiens GN=MAP3K19 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 222 bits (566), Expect = 4e-57, Method: Compositional matrix adjust.
Identities = 116/268 (43%), Positives = 167/268 (62%), Gaps = 14/268 (5%)
Query: 227 WQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGP-RGKQSILQLEQEISLLGQFEH 285
W KGE+LG G+YG VY GLT G AVK+V+L ++ +L++E+ LL +H
Sbjct: 1061 WTKGEILGKGAYGTVYCGLTSQGQLIAVKQVALDTSNKLAAEKEYRKLQEEVDLLKALKH 1120
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQ 344
NIV YLGT E + IF+E V GS++S+ ++ L + YT+QIL G+ YLHE
Sbjct: 1121 VNIVAYLGTCLQENTVSIFMEFVPGGSISSIINRFGPLPEMVFCKYTKQILQGVAYLHEN 1180
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAK--------ATTMNDVKSCKGTAFWMAPEVVN 396
VVHRDIK N+++ +G +KL DFG A+ T + +KS GT +WMAPEV+N
Sbjct: 1181 CVVHRDIKGNNVMLMPTGIIKLIDFGCARRLAWAGLNGTHSDMLKSMHGTPYWMAPEVIN 1240
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG--GELPPVPNSLSRDAQ 454
+ GYG +DIWS+GCTV EM T + P + ++ AMF IG G +PP+P+ S +A
Sbjct: 1241 --ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRMAAMFYIGAHRGLMPPLPDHFSENAA 1298
Query: 455 DFILKCLQVNPNDRPTAAQLMEHPFIKR 482
DF+ CL + ++RP+A QL++H F++R
Sbjct: 1299 DFVRMCLTRDQHERPSALQLLKHSFLER 1326
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|E9Q3S4|M3K19_MOUSE Mitogen-activated protein kinase kinase kinase 19 OS=Mus musculus GN=Map3k19 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (563), Expect = 9e-57, Method: Compositional matrix adjust.
Identities = 119/268 (44%), Positives = 167/268 (62%), Gaps = 14/268 (5%)
Query: 227 WQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRG-KQSILQLEQEISLLGQFEH 285
W KGE+LG G+YG VY GLT G AVK+V+L ++ +L++E+ LL +H
Sbjct: 1044 WTKGEILGRGAYGTVYCGLTSLGQLIAVKQVALDTSDKLATEKEYRKLQEEVDLLKALKH 1103
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQ 344
NIV YLGT +E L IF+E V GS++S+ ++ L + YTRQIL G+ YLH+
Sbjct: 1104 VNIVAYLGTCLEENTLSIFMEFVPGGSISSIINRFGPLPEMVFCKYTRQILQGVAYLHDN 1163
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAK--------ATTMNDVKSCKGTAFWMAPEVVN 396
VVHRDIK N+++ +G +KL DFG AK T + +KS +GT +WMAPEV+N
Sbjct: 1164 CVVHRDIKGNNVMLMPTGIIKLIDFGCAKRLAWAGLNGTHSDMLKSMRGTPYWMAPEVIN 1223
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG--GELPPVPNSLSRDAQ 454
+ GYG +DIWS+GCTV EM T + P + ++ AMF IG G +PP+P S A
Sbjct: 1224 --ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRMAAMFYIGAHRGLMPPLPARFSEPAA 1281
Query: 455 DFILKCLQVNPNDRPTAAQLMEHPFIKR 482
DF+ CL + ++RP+A QL++H F+KR
Sbjct: 1282 DFVRLCLTRDQHERPSALQLLKHSFLKR 1309
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (563), Expect = 9e-57, Method: Compositional matrix adjust.
Identities = 116/265 (43%), Positives = 171/265 (64%), Gaps = 13/265 (4%)
Query: 227 WQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQS---ILQLEQEISLLGQ 282
W+KGEL+G G++G VY G+ D G A+K+V + +++ I +LE+E+ LL
Sbjct: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAIKQVLIAPSSASKEKTQGHIRELEEEVQLLKN 127
Query: 283 FEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYL 341
H NIV+YLGT R+ L I +E V GS++SL +K+ + + YT+Q+L GL+YL
Sbjct: 128 LSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLLEKFGSFPEPVIIMYTKQLLLGLEYL 187
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKA----TTMNDVKSCKGTAFWMAPEVVNL 397
H ++HRDIK ANILVD G ++LADFG +K T+N KS KGT +WMAPEV+
Sbjct: 188 HNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYWMAPEVI-- 245
Query: 398 KKDGYGLTADIWSLGCTVLEMLTRRHPYS-HLEGGQAMFKIGGGEL-PPVPNSLSRDAQD 455
+ G+ +ADIWS+GCTV+EM T + P+S + A+ IG + PP+P LS +A+D
Sbjct: 246 LQTGHSFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPPIPEDLSPEAKD 305
Query: 456 FILKCLQVNPNDRPTAAQLMEHPFI 480
F++KCL P+ R +A +L++HPF+
Sbjct: 306 FLMKCLHKEPSLRLSATELLQHPFV 330
|
Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|P28829|BYR2_SCHPO Protein kinase byr2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=byr2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 219 bits (558), Expect = 3e-56, Method: Compositional matrix adjust.
Identities = 116/267 (43%), Positives = 168/267 (62%), Gaps = 15/267 (5%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEV---SLQDEGPRGKQSILQLEQEISLLGQ 282
W +G L+GSGS+G VY G+ G AVK+V S+ + R + + L EI+LL +
Sbjct: 394 WIRGALIGSGSFGQVYLGMNASSGELMAVKQVILDSVSESKDRHAKLLDALAGEIALLQE 453
Query: 283 FEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYL 341
H++IVQYLG++ + L IFLE V GS+A L Y ++ V ++ +Q L GL+YL
Sbjct: 454 LSHEHIVQYLGSNLNSDHLNIFLEYVPGGSVAGLLTMYGSFEETLVKNFIKQTLKGLEYL 513
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--------SCKGTAFWMAPE 393
H + +VHRDIK ANILVD G +K++DFG++K +N S +G++FWMAPE
Sbjct: 514 HSRGIVHRDIKGANILVDNKGKIKISDFGISKKLELNSTSTKTGGARPSFQGSSFWMAPE 573
Query: 394 VVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDA 453
VV K+ + DIWSLGC V+EMLT +HPY + + QA+F+IG LP P+++S A
Sbjct: 574 VV--KQTMHTEKTDIWSLGCLVIEMLTSKHPYPNCDQMQAIFRIGENILPEFPSNISSSA 631
Query: 454 QDFILKCLQVNPNDRPTAAQLMEHPFI 480
DF+ K ++ N RPTA++L+ HPF+
Sbjct: 632 IDFLEKTFAIDCNLRPTASELLSHPFV 658
|
Serine/threonine protein kinase involved in conjugation and sporulation. It is thought that it phosphorylates the byr1 protein kinase which itself phosphorylate the spk1 kinase. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q10407|MKH1_SCHPO MAP kinase kinase kinase mkh1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=mkh1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 210 bits (535), Expect = 2e-53, Method: Compositional matrix adjust.
Identities = 117/288 (40%), Positives = 172/288 (59%), Gaps = 23/288 (7%)
Query: 211 GNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQS 269
G+ VS N F+ W KGEL+G+G+YG V+ + + G AVK+V + + G+
Sbjct: 814 GSVVSQNATFK-----WMKGELIGNGTYGKVFLAMNINTGELIAVKQVEIP-QTINGRHD 867
Query: 270 ILQ------LEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLS 323
L+ + EIS++ +H NIVQYLG ++ E + IFLE V+ GS+ + Y
Sbjct: 868 QLRKDIVDSINAEISMIADLDHLNIVQYLGFEKTETDISIFLEYVSGGSIGRCLRNYGPF 927
Query: 324 DSQVSSY-TRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM---ND 379
+ Q+ + +RQ+L GL YLH + ++HRD+K N+L+D G K++DFG++K + ND
Sbjct: 928 EEQLVRFVSRQVLYGLSYLHSKGIIHRDLKADNLLIDFDGVCKISDFGISKHSDNVYDND 987
Query: 380 VK-SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIG 438
S +G+ FWMAPEV++ GY D+WSLGC VLEML R P+S E QAMFK+G
Sbjct: 988 ANLSMQGSIFWMAPEVIHNDHQGYSAKVDVWSLGCVVLEMLAGRRPWSTDEAIQAMFKLG 1047
Query: 439 G-GELPPVPNSL----SRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
+ PP+P+ L S +A F+ C VN + RPTA +L+ HPF+K
Sbjct: 1048 TEKKAPPIPSELVSQVSPEAIQFLNACFTVNADVRPTAEELLNHPFMK 1095
|
May regulate cell morphology, cell wall integrity, salt resistance, cell cycle reentry from stationary-phase arrest, and filamentous growth in response to stress. Activates the MAP kinase kinase skh1/pek1 by phosphorylation. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 488 | ||||||
| 359486016 | 559 | PREDICTED: mitogen-activated protein kin | 0.600 | 0.524 | 0.758 | 1e-129 | |
| 298204644 | 719 | unnamed protein product [Vitis vinifera] | 0.600 | 0.407 | 0.758 | 1e-128 | |
| 255587684 | 451 | Mitogen-activated protein kinase kinase | 0.563 | 0.609 | 0.789 | 1e-127 | |
| 224082218 | 548 | predicted protein [Populus trichocarpa] | 0.620 | 0.552 | 0.700 | 1e-124 | |
| 224066881 | 558 | predicted protein [Populus trichocarpa] | 0.573 | 0.501 | 0.764 | 1e-124 | |
| 255545546 | 555 | Mitogen-activated protein kinase kinase | 0.602 | 0.529 | 0.719 | 1e-123 | |
| 356509460 | 566 | PREDICTED: mitogen-activated protein kin | 0.600 | 0.517 | 0.73 | 1e-122 | |
| 356557517 | 440 | PREDICTED: mitogen-activated protein kin | 0.551 | 0.611 | 0.767 | 1e-121 | |
| 225459451 | 567 | PREDICTED: mitogen-activated protein kin | 0.604 | 0.520 | 0.709 | 1e-120 | |
| 402169211 | 564 | protein kinase [Nicotiana benthamiana] | 0.567 | 0.491 | 0.744 | 1e-118 |
| >gi|359486016|ref|XP_002264549.2| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 468 bits (1204), Expect = e-129, Method: Compositional matrix adjust.
Identities = 226/298 (75%), Positives = 254/298 (85%), Gaps = 5/298 (1%)
Query: 191 VSYHDDDDSKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGLTDDGF 250
S +D+DS S +EP +SPNG+F+R I SWQ+GELLGSGS+G VYEG TDDGF
Sbjct: 255 TSNDEDEDS-----SMTLEPIYGISPNGQFKRTINSWQRGELLGSGSFGTVYEGYTDDGF 309
Query: 251 FFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTK 310
FFAVKEVSL D+G +GKQSI QLEQEISLL QFEH+NIV+Y GTD+D+ +L IFLELVTK
Sbjct: 310 FFAVKEVSLLDQGSQGKQSIYQLEQEISLLSQFEHENIVRYYGTDKDDSKLYIFLELVTK 369
Query: 311 GSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFG 370
GSL SLYQKY L +SQ S+YTRQILNGLKYLHEQNVVHRDIKCANILVD +GSVKLADFG
Sbjct: 370 GSLLSLYQKYDLRESQASAYTRQILNGLKYLHEQNVVHRDIKCANILVDVNGSVKLADFG 429
Query: 371 LAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG 430
LAKAT +NDVKSCKGT FWMAPEVVN K GYGL ADIWSLGCTVLE+LTRR PYSHLEG
Sbjct: 430 LAKATKLNDVKSCKGTVFWMAPEVVNRKNKGYGLAADIWSLGCTVLEILTRRPPYSHLEG 489
Query: 431 GQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
QA+F+IG GE PPV NSLS DA++FILKCLQVNP+DRPTA QL++HPF+KRPL T S
Sbjct: 490 MQALFRIGKGEPPPVSNSLSSDARNFILKCLQVNPSDRPTAGQLLDHPFVKRPLHTFS 547
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|298204644|emb|CBI23919.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 466 bits (1199), Expect = e-128, Method: Compositional matrix adjust.
Identities = 226/298 (75%), Positives = 254/298 (85%), Gaps = 5/298 (1%)
Query: 191 VSYHDDDDSKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGLTDDGF 250
S +D+DS S +EP +SPNG+F+R I SWQ+GELLGSGS+G VYEG TDDGF
Sbjct: 415 TSNDEDEDS-----SMTLEPIYGISPNGQFKRTINSWQRGELLGSGSFGTVYEGYTDDGF 469
Query: 251 FFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTK 310
FFAVKEVSL D+G +GKQSI QLEQEISLL QFEH+NIV+Y GTD+D+ +L IFLELVTK
Sbjct: 470 FFAVKEVSLLDQGSQGKQSIYQLEQEISLLSQFEHENIVRYYGTDKDDSKLYIFLELVTK 529
Query: 311 GSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFG 370
GSL SLYQKY L +SQ S+YTRQILNGLKYLHEQNVVHRDIKCANILVD +GSVKLADFG
Sbjct: 530 GSLLSLYQKYDLRESQASAYTRQILNGLKYLHEQNVVHRDIKCANILVDVNGSVKLADFG 589
Query: 371 LAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG 430
LAKAT +NDVKSCKGT FWMAPEVVN K GYGL ADIWSLGCTVLE+LTRR PYSHLEG
Sbjct: 590 LAKATKLNDVKSCKGTVFWMAPEVVNRKNKGYGLAADIWSLGCTVLEILTRRPPYSHLEG 649
Query: 431 GQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
QA+F+IG GE PPV NSLS DA++FILKCLQVNP+DRPTA QL++HPF+KRPL T S
Sbjct: 650 MQALFRIGKGEPPPVSNSLSSDARNFILKCLQVNPSDRPTAGQLLDHPFVKRPLHTFS 707
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255587684|ref|XP_002534356.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis] gi|223525440|gb|EEF28029.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 460 bits (1183), Expect = e-127, Method: Compositional matrix adjust.
Identities = 217/275 (78%), Positives = 245/275 (89%)
Query: 214 VSPNGKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQL 273
+PNGK RR I SW KG++LGSGS+G VYEGLTDDGFFFA+KEVSL D+G +GKQSILQL
Sbjct: 165 AAPNGKVRRSIFSWIKGDVLGSGSFGTVYEGLTDDGFFFAIKEVSLLDQGSQGKQSILQL 224
Query: 274 EQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQ 333
EQEISLL FEH+NIV+YLGT++DE +L IFLEL TKGSLA LYQKYHL DS VS+YTRQ
Sbjct: 225 EQEISLLRAFEHENIVRYLGTEKDEAKLYIFLELATKGSLARLYQKYHLRDSHVSAYTRQ 284
Query: 334 ILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPE 393
ILNGLKYLH++NVVHRDIKCANILVDA+GSVKLADFGLAKATTMNDVKSCKGT FWMAPE
Sbjct: 285 ILNGLKYLHDRNVVHRDIKCANILVDANGSVKLADFGLAKATTMNDVKSCKGTVFWMAPE 344
Query: 394 VVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDA 453
VVNLK GYGL ADIWSLGCTVLE+LT R PYSHLEG QA+F+IG GE PP+ +SLS DA
Sbjct: 345 VVNLKNRGYGLAADIWSLGCTVLELLTGRPPYSHLEGMQALFRIGKGEPPPIADSLSTDA 404
Query: 454 QDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
+DFIL+CLQVNP +RPTAAQL++HPF+KRP +T S
Sbjct: 405 RDFILRCLQVNPTNRPTAAQLLDHPFVKRPHETFS 439
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224082218|ref|XP_002306607.1| predicted protein [Populus trichocarpa] gi|222856056|gb|EEE93603.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 452 bits (1163), Expect = e-124, Method: Compositional matrix adjust.
Identities = 225/321 (70%), Positives = 257/321 (80%), Gaps = 18/321 (5%)
Query: 186 NNVEYVSYHDDDDSKGHP------------------ISEIMEPGNNVSPNGKFRRRITSW 227
NN E+ S DDD + P S EP +N+SPN +FRR IT W
Sbjct: 217 NNKEFSSGDDDDGRERRPQVIDAASCSFTTSNDDDSSSSTTEPMSNISPNLRFRRSITDW 276
Query: 228 QKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
+KGELLG GS+G VYEG++DDGFFFAVKEVSL D+G +GKQSI QLEQEI+LL +FEH+N
Sbjct: 277 EKGELLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQGKQSIYQLEQEIALLSRFEHEN 336
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
IVQY GTD+DE +L IFLELVTKGSL LYQ+Y+L DSQVS+YTRQIL+GLKYLH+QNVV
Sbjct: 337 IVQYYGTDKDESKLYIFLELVTKGSLLKLYQRYNLRDSQVSAYTRQILHGLKYLHDQNVV 396
Query: 348 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTAD 407
HRDIKCAN+LVDA+GSVKLADFGLAKAT NDVKSCKGTAFWMAPEVVN K GYGL AD
Sbjct: 397 HRDIKCANLLVDANGSVKLADFGLAKATKFNDVKSCKGTAFWMAPEVVNNKNQGYGLPAD 456
Query: 408 IWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPND 467
IWSLGCTVLEMLTR+ PYS LE QA+F+IG G P VP+SLS DA+DFIL+CLQVNPND
Sbjct: 457 IWSLGCTVLEMLTRQIPYSELESMQALFRIGRGVPPLVPDSLSNDARDFILQCLQVNPND 516
Query: 468 RPTAAQLMEHPFIKRPLQTSS 488
RPTAA L++HPF+KRPL T S
Sbjct: 517 RPTAAVLLDHPFMKRPLPTFS 537
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224066881|ref|XP_002302260.1| predicted protein [Populus trichocarpa] gi|222843986|gb|EEE81533.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 450 bits (1157), Expect = e-124, Method: Compositional matrix adjust.
Identities = 214/280 (76%), Positives = 247/280 (88%)
Query: 209 EPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQ 268
EP +N+SPN +FRR IT W+KGELLG GS+G VYEG++DDGFFFAVKEVSL D+G +GKQ
Sbjct: 268 EPMSNISPNVRFRRAITYWEKGELLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSKGKQ 327
Query: 269 SILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVS 328
SI QLEQEI+LL +FEH+NIVQY GTD+DE +L IFLELVTKGSL LYQ+Y+L DSQVS
Sbjct: 328 SIYQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLQKLYQRYNLRDSQVS 387
Query: 329 SYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF 388
SYTRQIL+GLKYLH+QNVVHRDIKCAN+LVDA+GSVKLADFGLAKAT +NDVKSCKGTAF
Sbjct: 388 SYTRQILHGLKYLHDQNVVHRDIKCANLLVDANGSVKLADFGLAKATKLNDVKSCKGTAF 447
Query: 389 WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNS 448
WMAPEVVN K GYGL ADIWSLGCTVLEMLTR+ PYS LE QA+F+IG G P VP+S
Sbjct: 448 WMAPEVVNNKNQGYGLPADIWSLGCTVLEMLTRQIPYSELESMQALFRIGRGVPPLVPDS 507
Query: 449 LSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
LS DA++FIL+C+QVNPNDRPTAA L++HPF+K+ L TSS
Sbjct: 508 LSNDAREFILQCIQVNPNDRPTAAVLLDHPFVKKLLPTSS 547
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545546|ref|XP_002513833.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis] gi|223546919|gb|EEF48416.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 447 bits (1151), Expect = e-123, Method: Compositional matrix adjust.
Identities = 215/299 (71%), Positives = 255/299 (85%), Gaps = 5/299 (1%)
Query: 190 YVSYHDDDDSKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGLTDDG 249
+ + +DDD S +E+M +N+SP+ +FRR I+ W+KG+LLG GS+G VYEG+ DG
Sbjct: 251 FTTSNDDDSSST--TTELM---SNISPHERFRRMISDWEKGDLLGRGSFGSVYEGIAHDG 305
Query: 250 FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVT 309
FFFA+KEVSL D+G +GKQSI QLEQEI+LL QFEH+NIV+Y GTD+D+ L IFLELVT
Sbjct: 306 FFFAIKEVSLLDQGSQGKQSIYQLEQEIALLSQFEHENIVRYYGTDKDDSNLYIFLELVT 365
Query: 310 KGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADF 369
+GSL +LYQ+YHL DSQVS+YTRQIL+GLKYLH++NVVHRDIKCANILVDASGSVKLADF
Sbjct: 366 QGSLMNLYQRYHLRDSQVSAYTRQILHGLKYLHDRNVVHRDIKCANILVDASGSVKLADF 425
Query: 370 GLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE 429
GLAKAT +NDVKSCKGTAFWMAPEVVN K GYGL ADIWSLGCTVLEMLTR+ PYSHLE
Sbjct: 426 GLAKATKLNDVKSCKGTAFWMAPEVVNRKTHGYGLPADIWSLGCTVLEMLTRQVPYSHLE 485
Query: 430 GGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
QA+F+IG G PPVP+SLS DA+DFIL+CLQVNPN RPTAAQL+EH F+++PL SS
Sbjct: 486 CMQALFRIGKGVPPPVPDSLSNDARDFILQCLQVNPNGRPTAAQLLEHSFVRQPLPMSS 544
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356509460|ref|XP_003523467.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 443 bits (1140), Expect = e-122, Method: Compositional matrix adjust.
Identities = 219/300 (73%), Positives = 250/300 (83%), Gaps = 7/300 (2%)
Query: 192 SYHDDDDSKGHPISEIMEP-GNNVSPNGKFRRRIT--SWQKGELLGSGSYGFVYEGLTDD 248
S ++DDS S +P NN+SP G+ +R IT SWQKGE LG GS+G VYEG++DD
Sbjct: 259 STSNEDDSS----SSTTDPRSNNISPQGRIKRIITAGSWQKGEFLGGGSFGSVYEGISDD 314
Query: 249 GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELV 308
GFFFAVKEVSL D+G +GKQS+ QLEQEI+LL QFEHDNIVQY GT+ D+ +L IFLELV
Sbjct: 315 GFFFAVKEVSLLDQGTQGKQSVYQLEQEIALLSQFEHDNIVQYYGTEMDQSKLYIFLELV 374
Query: 309 TKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLAD 368
TKGSL SLYQKY L DSQVS+YTRQIL+GLKYLH++NVVHRDIKCANILVDASGSVKLAD
Sbjct: 375 TKGSLRSLYQKYTLRDSQVSAYTRQILHGLKYLHDRNVVHRDIKCANILVDASGSVKLAD 434
Query: 369 FGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHL 428
FGLAKAT +NDVKS KGTAFWMAPEVV K GYGL AD+WSLGCTVLEMLT + PY L
Sbjct: 435 FGLAKATKLNDVKSMKGTAFWMAPEVVKGKNKGYGLPADMWSLGCTVLEMLTGQLPYRDL 494
Query: 429 EGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
E QA+F+IG GE PP+P+SLSRDAQDFIL+CLQVNPNDRPTAAQL+ H F++RPL SS
Sbjct: 495 ECMQALFRIGKGERPPIPDSLSRDAQDFILQCLQVNPNDRPTAAQLLNHSFVQRPLSQSS 554
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356557517|ref|XP_003547062.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 440 bits (1132), Expect = e-121, Method: Compositional matrix adjust.
Identities = 211/275 (76%), Positives = 242/275 (88%), Gaps = 6/275 (2%)
Query: 212 NNVSPNGK--FRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQS 269
+N+SPNG FR SWQKG++LG GS+G VYEG TDDG FFAVKEVSL D+G +GKQS
Sbjct: 154 HNLSPNGSGYFR----SWQKGDILGKGSFGTVYEGFTDDGNFFAVKEVSLLDDGSQGKQS 209
Query: 270 ILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSS 329
+ QL+QEISLL QF HDNIV+YLGTD+D+ +L IFLELVTKGSLASLYQKY L DSQVS+
Sbjct: 210 LFQLQQEISLLSQFRHDNIVRYLGTDKDDDKLYIFLELVTKGSLASLYQKYRLRDSQVSA 269
Query: 330 YTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFW 389
YTRQIL+GLKYLH++NVVHRDIKCANILVDA+GSVKLADFGLAKAT +NDVKS KG+ +W
Sbjct: 270 YTRQILSGLKYLHDRNVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSSKGSPYW 329
Query: 390 MAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSL 449
MAPEVVNL+ GYGL ADIWSLGCTVLEMLTR+ PYSHLEG QA+F+IG G+ PPVP SL
Sbjct: 330 MAPEVVNLRNRGYGLAADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGRGQPPPVPESL 389
Query: 450 SRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484
S DA+DFILKCLQVNPN RPTAA+L++HPF+KRPL
Sbjct: 390 STDARDFILKCLQVNPNKRPTAARLLDHPFVKRPL 424
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225459451|ref|XP_002284356.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 439 bits (1130), Expect = e-120, Method: Compositional matrix adjust.
Identities = 212/299 (70%), Positives = 245/299 (81%), Gaps = 4/299 (1%)
Query: 190 YVSYHDDDDSKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGLTDDG 249
+ + +DDDS S EP +N+SPNG R T+W KG LGSGS+G VYEG+++DG
Sbjct: 261 FTTTSNDDDSS----STTTEPMSNISPNGSLRPSFTNWMKGAFLGSGSFGTVYEGMSEDG 316
Query: 250 FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVT 309
FFAVKEVSL D+G +GKQS+ QLEQEI LL QF+H+NIVQY GT +DE +L IFLELVT
Sbjct: 317 IFFAVKEVSLLDQGSQGKQSLYQLEQEIDLLSQFQHENIVQYHGTAKDESKLYIFLELVT 376
Query: 310 KGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADF 369
KGSLASLYQ+Y+L DSQ S+YTRQIL+GL YLHE+NV+HRDIKCANILV A+GSVKL+DF
Sbjct: 377 KGSLASLYQRYNLGDSQASAYTRQILHGLNYLHERNVIHRDIKCANILVGANGSVKLSDF 436
Query: 370 GLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE 429
GLAKAT +ND KSCKGT FWMAPEVVN K GYGL ADIWSLGCTVLEMLTR PYSHLE
Sbjct: 437 GLAKATQLNDAKSCKGTPFWMAPEVVNGKGQGYGLAADIWSLGCTVLEMLTREVPYSHLE 496
Query: 430 GGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
QA+F+IG GE PPVP+SLS DA+DFILKCLQV P+DRPTAAQL+ H F+KRP TSS
Sbjct: 497 SMQALFRIGKGEPPPVPDSLSPDARDFILKCLQVIPDDRPTAAQLLNHQFVKRPPPTSS 555
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|402169211|dbj|BAM36967.1| protein kinase [Nicotiana benthamiana] | Back alignment and taxonomy information |
|---|
Score = 432 bits (1112), Expect = e-118, Method: Compositional matrix adjust.
Identities = 207/278 (74%), Positives = 242/278 (87%), Gaps = 1/278 (0%)
Query: 212 NNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSIL 271
+++SPNG+F R IT W KG+LLG GS+G VYEG++DDGFFFAVKEVSL D+G G+QS+
Sbjct: 275 SSISPNGRFARYITYWDKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGDGGRQSLY 334
Query: 272 QLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYT 331
QLEQEI LL QFEH+NIV+Y GTD+D+ +L IFLELVT+GSL SLYQKYHL DSQVS YT
Sbjct: 335 QLEQEIELLSQFEHENIVRYYGTDKDDSKLYIFLELVTQGSLLSLYQKYHLRDSQVSVYT 394
Query: 332 RQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMA 391
RQIL+GLKYLH++NVVHRDIKCANILVDA+GSVKLADFGLAKAT +NDVKSCKGTA WMA
Sbjct: 395 RQILHGLKYLHDRNVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCKGTALWMA 454
Query: 392 PEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-QAMFKIGGGELPPVPNSLS 450
PEVVN K GYG ADIWSLGCTVLEMLTR+ PYSHLE QA+F+IG GE PPVPN+LS
Sbjct: 455 PEVVNRKNQGYGQAADIWSLGCTVLEMLTRQFPYSHLENQMQALFRIGKGEPPPVPNTLS 514
Query: 451 RDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
DA++FI +CLQV+P+ RPTA+QL+EHPF+KR L +SS
Sbjct: 515 IDARNFINQCLQVDPSARPTASQLLEHPFVKRTLPSSS 552
|
Source: Nicotiana benthamiana Species: Nicotiana benthamiana Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 488 | ||||||
| TAIR|locus:2133559 | 608 | MEKK1 "MAPK/ERK kinase kinase | 0.534 | 0.429 | 0.679 | 2.7e-93 | |
| TAIR|locus:2133539 | 773 | MAPKKK9 "mitogen-activated pro | 0.538 | 0.340 | 0.625 | 6e-87 | |
| TAIR|locus:2133529 | 560 | MEKK3 "MAPK/ERK kinase kinase | 0.594 | 0.517 | 0.586 | 5.4e-86 | |
| TAIR|locus:2118116 | 1895 | WRKY19 [Arabidopsis thaliana ( | 0.547 | 0.140 | 0.598 | 2.6e-79 | |
| TAIR|locus:2026674 | 883 | YDA "YODA" [Arabidopsis thalia | 0.520 | 0.287 | 0.517 | 7.4e-66 | |
| TAIR|locus:2024832 | 609 | MAP3KA "mitogen-activated prot | 0.557 | 0.446 | 0.482 | 2.5e-65 | |
| TAIR|locus:2174969 | 716 | MAPKKK5 "mitogen-activated pro | 0.536 | 0.365 | 0.470 | 3.9e-60 | |
| TAIR|locus:2035989 | 666 | NP1 "NPK1-related protein kina | 0.518 | 0.379 | 0.484 | 1.3e-59 | |
| UNIPROTKB|Q40541 | 690 | Q40541 "Protein kinase" [Nicot | 0.516 | 0.365 | 0.460 | 1.4e-57 | |
| DICTYBASE|DDB_G0283265 | 1267 | mkkA "octicosapeptide/Phox/Bem | 0.676 | 0.260 | 0.373 | 5.5e-57 |
| TAIR|locus:2133559 MEKK1 "MAPK/ERK kinase kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 929 (332.1 bits), Expect = 2.7e-93, P = 2.7e-93
Identities = 178/262 (67%), Positives = 212/262 (80%)
Query: 224 ITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF 283
ITSWQKG+LLG GS+G VYEG++ DG FFAVKEVSL D+G + ++ I QLE EI LL Q
Sbjct: 330 ITSWQKGQLLGRGSFGSVYEGISGDGDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQL 389
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHE 343
+H NIV+Y GT +D L IFLELVT+GSL LYQ+Y L DS VS YTRQIL+GLKYLH+
Sbjct: 390 QHQNIVRYRGTAKDGSNLYIFLELVTQGSLLKLYQRYQLRDSVVSLYTRQILDGLKYLHD 449
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLK-KDGY 402
+ +HRDIKCANILVDA+G+VKLADFGLAK + ND+KSCKGT FWMAPEV+N K DGY
Sbjct: 450 KGFIHRDIKCANILVDANGAVKLADFGLAKVSKFNDIKSCKGTPFWMAPEVINRKDSDGY 509
Query: 403 GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQ 462
G ADIWSLGCTVLEM T + PYS LE QA+F+IG G LP VP++LS DA+ FILKCL+
Sbjct: 510 GSPADIWSLGCTVLEMCTGQIPYSDLEPVQALFRIGRGTLPEVPDTLSLDARLFILKCLK 569
Query: 463 VNPNDRPTAAQLMEHPFIKRPL 484
VNP +RPTAA+L+ HPF++RPL
Sbjct: 570 VNPEERPTAAELLNHPFVRRPL 591
|
|
| TAIR|locus:2133539 MAPKKK9 "mitogen-activated protein kinase kinase kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 869 (311.0 bits), Expect = 6.0e-87, P = 6.0e-87
Identities = 165/264 (62%), Positives = 208/264 (78%)
Query: 225 TSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE 284
TSWQKG+LL GS+G VYE +++DG FFAVKEVSL D+G + ++ I QLE EI+LL Q E
Sbjct: 499 TSWQKGQLLRQGSFGSVYEAISEDGDFFAVKEVSLLDQGSQAQECIQQLEGEIALLSQLE 558
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQ 344
H NI++Y GTD+D L IFLELVT+GSL LY++Y + DS +S YT+QIL+GLKYLH +
Sbjct: 559 HQNILRYRGTDKDGSNLYIFLELVTQGSLLELYRRYQIRDSLISLYTKQILDGLKYLHHK 618
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLK-KDGYG 403
+HRDIKCA ILVDA+G+VKLADFGLAK + +ND+KS K T FWMAPEV+N K DGY
Sbjct: 619 GFIHRDIKCATILVDANGTVKLADFGLAKVSKLNDIKSRKETLFWMAPEVINRKDNDGYR 678
Query: 404 LTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQV 463
ADIWSLGCTVLEM T + PYS LE +A+F+I G LP VP++LS DA+ FILKCL++
Sbjct: 679 SPADIWSLGCTVLEMCTGQIPYSDLEPVEALFRIRRGTLPEVPDTLSLDARHFILKCLKL 738
Query: 464 NPNDRPTAAQLMEHPFIKRPLQTS 487
NP +RPTA +L+ HPF++RPL +S
Sbjct: 739 NPEERPTATELLNHPFVRRPLPSS 762
|
|
| TAIR|locus:2133529 MEKK3 "MAPK/ERK kinase kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 860 (307.8 bits), Expect = 5.4e-86, P = 5.4e-86
Identities = 173/295 (58%), Positives = 216/295 (73%)
Query: 191 VSYHDDDDSKGHPISEIMEPG----NNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGLT 246
+S+ D S+ P + E N + N + ITSW KG+LLG GSY VYE ++
Sbjct: 263 ISFRKRDFSEEGPSGRVKEKRKLMRNKLIENFRKPEDITSWLKGQLLGRGSYASVYEAIS 322
Query: 247 DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLE 306
+DG FFAVKEVSL D+G + ++ I QLE EI+LL Q +H NIV+Y GT +D +L IFLE
Sbjct: 323 EDGDFFAVKEVSLLDKGIQAQECIQQLEGEIALLSQLQHQNIVRYRGTAKDVSKLYIFLE 382
Query: 307 LVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKL 366
LVT+GS+ LY++Y LS + VS YTRQIL GL YLH++ VHRDIKCAN+LVDA+G+VKL
Sbjct: 383 LVTQGSVQKLYERYQLSYTVVSLYTRQILAGLNYLHDKGFVHRDIKCANMLVDANGTVKL 442
Query: 367 ADFGLAKATTMNDVKSCKGTAFWMAPEVVNLK-KDGYGLTADIWSLGCTVLEMLTRRHPY 425
ADFGLA+A+ ND+ SCKGT FWMAPEV+N K DG G ADIWSLGCTVLEM T + PY
Sbjct: 443 ADFGLAEASKFNDIMSCKGTLFWMAPEVINRKDSDGNGSPADIWSLGCTVLEMCTGQIPY 502
Query: 426 SHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480
S L+ QA FKIG G LP VP++LS DA+ FIL CL+VNP +RPTAA+L+ HPF+
Sbjct: 503 SDLKPIQAAFKIGRGTLPDVPDTLSLDARHFILTCLKVNPEERPTAAELLHHPFV 557
|
|
| TAIR|locus:2118116 WRKY19 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 810 (290.2 bits), Expect = 2.6e-79, P = 2.6e-79
Identities = 170/284 (59%), Positives = 207/284 (72%)
Query: 212 NNVSP----NGKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGK 267
+N SP G F IT WQKG+LLG GS G VYEG++ DG FFA KEVSL D+G +
Sbjct: 1610 SNTSPIYASEGSF---ITCWQKGQLLGRGSLGSVYEGISADGDFFAFKEVSLLDQGSQAH 1666
Query: 268 QSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQV 327
+ I Q+E I+LL Q +H NIV+Y GT +DE L IFLELVT+GSL LYQ+ L DS V
Sbjct: 1667 EWIQQVEGGIALLSQLQHQNIVRYRGTTKDESNLYIFLELVTQGSLRKLYQRNQLGDSVV 1726
Query: 328 SSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTA 387
S YTRQIL+GLKYLH++ +HR+IKCAN+LVDA+G+VKLADFGLAK V S T
Sbjct: 1727 SLYTRQILDGLKYLHDKGFIHRNIKCANVLVDANGTVKLADFGLAK------VMSLWRTP 1780
Query: 388 FW--MAPEVV-NLKK-DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP 443
+W MAPEV+ N K DGYG ADIWSLGCTVLEMLT + PYS LE G A++ IG G+LP
Sbjct: 1781 YWNWMAPEVILNPKDYDGYGTPADIWSLGCTVLEMLTGQIPYSDLEIGTALYNIGTGKLP 1840
Query: 444 PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTS 487
+P+ LS DA+DFIL CL+VNP +RPTAA+L+ HPF+ PL +S
Sbjct: 1841 KIPDILSLDARDFILTCLKVNPEERPTAAELLNHPFVNMPLPSS 1884
|
|
| TAIR|locus:2026674 YDA "YODA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 670 (240.9 bits), Expect = 7.4e-66, P = 7.4e-66
Identities = 134/259 (51%), Positives = 180/259 (69%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
W+KG LLG GS+G VY G ++ G A+KEV+L + P+ ++S QL QEIS+L + H
Sbjct: 400 WKKGRLLGMGSFGHVYLGFNSESGEMCAMKEVTLCSDDPKSRESAQQLGQEISVLSRLRH 459
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQ 344
NIVQY G++ + +L I+LE V+ GS+ L Q+Y ++ + +YT+QIL+GL YLH +
Sbjct: 460 QNIVQYYGSETVDDKLYIYLEYVSGGSIYKLLQEYGQFGENAIRNYTQQILSGLAYLHAK 519
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAK-ATTMNDVKSCKGTAFWMAPEVVNLKKDGYG 403
N VHRDIK ANILVD G VK+ADFG+AK T + S KG+ +WMAPEV+ +G
Sbjct: 520 NTVHRDIKGANILVDPHGRVKVADFGMAKHITAQSGPLSFKGSPYWMAPEVIK-NSNGSN 578
Query: 404 LTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG-ELPPVPNSLSRDAQDFILKCLQ 462
L DIWSLGCTVLEM T + P+S EG AMFKIG ELP +P+ LS + +DF+ KCLQ
Sbjct: 579 LAVDIWSLGCTVLEMATTKPPWSQYEGVPAMFKIGNSKELPDIPDHLSEEGKDFVRKCLQ 638
Query: 463 VNPNDRPTAAQLMEHPFIK 481
NP +RPTAAQL++H F++
Sbjct: 639 RNPANRPTAAQLLDHAFVR 657
|
|
| TAIR|locus:2024832 MAP3KA "mitogen-activated protein kinase kinase kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 665 (239.2 bits), Expect = 2.5e-65, P = 2.5e-65
Identities = 136/282 (48%), Positives = 188/282 (66%)
Query: 211 GNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGLTDD-GFFFAVKEVSLQDEGPRGKQS 269
G SP+G ++W+KG+ LGSG++G VY G + G A+KEV + + K+
Sbjct: 203 GYETSPSG-----FSTWKKGKFLGSGTFGQVYLGFNSEKGKMCAIKEVKVISDDQTSKEC 257
Query: 270 ILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVS 328
+ QL QEI+LL Q H NIVQY G++ E+ L ++LE V+ GS+ L + Y ++ +
Sbjct: 258 LKQLNQEINLLNQLCHPNIVQYYGSELSEETLSVYLEYVSGGSIHKLLKDYGSFTEPVIQ 317
Query: 329 SYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK-ATTMNDVKSCKGTA 387
+YTRQIL GL YLH +N VHRDIK ANILVD +G +KLADFG+AK T + + S KG+
Sbjct: 318 NYTRQILAGLAYLHGRNTVHRDIKGANILVDPNGEIKLADFGMAKHVTAFSTMLSFKGSP 377
Query: 388 FWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG-ELPPVP 446
+WMAPEVV + ++GY DIWSLGCT+LEM T + P+S EG A+FKIG + P +P
Sbjct: 378 YWMAPEVV-MSQNGYTHAVDIWSLGCTILEMATSKPPWSQFEGVAAIFKIGNSKDTPEIP 436
Query: 447 NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
+ LS DA++FI CLQ NP RPTA+QL+EHPF++ + +S
Sbjct: 437 DHLSNDAKNFIRLCLQRNPTVRPTASQLLEHPFLRNTTRVAS 478
|
|
| TAIR|locus:2174969 MAPKKK5 "mitogen-activated protein kinase kinase kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 616 (221.9 bits), Expect = 3.9e-60, P = 3.9e-60
Identities = 129/274 (47%), Positives = 178/274 (64%)
Query: 225 TSWQKGELLGSGSYGFVYEGLTDD-GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF 283
+ W+KG+L+G G++G VY + G A+KEV L + P+ + I QLEQEI LL
Sbjct: 344 SQWKKGKLIGRGTFGSVYVASNSETGALCAMKEVELFPDDPKSAECIKQLEQEIKLLSNL 403
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILNGLKY 340
+H NIVQY G++ E R I+LE V GS+ + Y + H +++S V ++TR IL+GL Y
Sbjct: 404 QHPNIVQYFGSETVEDRFFIYLEYVHPGSI-NKYIRDHCGTMTESVVRNFTRHILSGLAY 462
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK-SCKGTAFWMAPEVVN--L 397
LH + VHRDIK AN+LVDASG VKLADFG+AK T S KG+ +WMAPE++ +
Sbjct: 463 LHNKKTVHRDIKGANLLVDASGVVKLADFGMAKHLTGQRADLSLKGSPYWMAPELMQAVM 522
Query: 398 KKDG---YGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQ 454
+KD DIWSLGCT++EM T + P+S EG AMFK+ + PP+P S+S + +
Sbjct: 523 QKDSNPDLAFAVDIWSLGCTIIEMFTGKPPWSEFEGAAAMFKVMR-DSPPIPESMSPEGK 581
Query: 455 DFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
DF+ C Q NP +RPTA+ L+EH F+K LQ +S
Sbjct: 582 DFLRLCFQRNPAERPTASMLLEHRFLKNSLQPTS 615
|
|
| TAIR|locus:2035989 NP1 "NPK1-related protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 611 (220.1 bits), Expect = 1.3e-59, P = 1.3e-59
Identities = 129/266 (48%), Positives = 182/266 (68%)
Query: 226 SWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQS---ILQLEQEISLLG 281
SW+KG+L+G G++G VY G+ D G AVK+V + +++ I +LE+E+ LL
Sbjct: 68 SWRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLK 127
Query: 282 QFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKY 340
H NIV+YLGT R++ L I LE V GS++SL +K+ +S V +YTRQ+L GL+Y
Sbjct: 128 NLSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGLEY 187
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFG----LAKATTMNDVKSCKGTAFWMAPEVVN 396
LH ++HRDIK ANILVD G +KLADFG +A+ TM KS KGT +WMAPEV+
Sbjct: 188 LHNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEVI- 246
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTRRHPYSH-LEGGQAMFKIGGGEL-PPVPNSLSRDAQ 454
+ G+ +ADIWS+GCTV+EM+T + P+S + A+F IG + PP+P++LS DA+
Sbjct: 247 -LQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTLSSDAK 305
Query: 455 DFILKCLQVNPNDRPTAAQLMEHPFI 480
DF+LKCLQ PN RPTA++L++HPF+
Sbjct: 306 DFLLKCLQEVPNLRPTASELLKHPFV 331
|
|
| UNIPROTKB|Q40541 Q40541 "Protein kinase" [Nicotiana tabacum (taxid:4097)] | Back alignment and assigned GO terms |
|---|
Score = 592 (213.5 bits), Expect = 1.4e-57, P = 1.4e-57
Identities = 122/265 (46%), Positives = 175/265 (66%)
Query: 227 WQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGP---RGKQSILQLEQEISLLGQ 282
W+KGE++G G++G VY G+ D G A+KEVS+ G R + + +LE+E++LL
Sbjct: 80 WRKGEMIGCGAFGRVYMGMNVDSGELLAIKEVSIAMNGASRERAQAHVRELEEEVNLLKN 139
Query: 283 FEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYL 341
H NIV+YLGT R+ L I LE V GS++SL K+ +S + YT+Q+L GL+YL
Sbjct: 140 LSHPNIVRYLGTAREAGSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 199
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKAT----TMNDVKSCKGTAFWMAPEVVNL 397
H+ ++HRDIK ANILVD G +KLADFG +K TM KS KGT +WMAPEV+
Sbjct: 200 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATMTGAKSMKGTPYWMAPEVI-- 257
Query: 398 KKDGYGLTADIWSLGCTVLEMLTRRHPYSH-LEGGQAMFKIGGGEL-PPVPNSLSRDAQD 455
+ G+ +ADIWS+GCT++EM T + P+S + A+F IG + PP+P LS +++D
Sbjct: 258 LQTGHSFSADIWSVGCTIIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPEHLSAESKD 317
Query: 456 FILKCLQVNPNDRPTAAQLMEHPFI 480
F+LKCLQ P+ R +A+ L++HPF+
Sbjct: 318 FLLKCLQKEPHLRHSASNLLQHPFV 342
|
|
| DICTYBASE|DDB_G0283265 mkkA "octicosapeptide/Phox/Bem1p domain-containing protein" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 597 (215.2 bits), Expect = 5.5e-57, P = 5.5e-57
Identities = 129/345 (37%), Positives = 208/345 (60%)
Query: 145 NIFSNLLLGVEFVRHKFQYYMSLCNYIVTEAAKVRRRQDCPNNVEYVSYHDDDDSKGHPI 204
N F N G++ R ++++ N I+ + + + NN + ++++++ + I
Sbjct: 416 NSFENG--GIKLPRPLSPTFLNINNNIIN--SNLNNNNNNNNNNNNNNNNNNNNNNNNII 471
Query: 205 SEIMEPGNNVSPNGKF-RRRITSWQKGELLGSGSYGFVYEGLTDD-GFFFAVKEVSLQD- 261
P ++ + + WQKG++LG G YG VY GL D G FAVK++ + D
Sbjct: 472 QHTDFPSLIINEHEELISNHNIKWQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDI 531
Query: 262 -EGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY 320
P+ K IL +EI ++ HDNIV+YLGT D+ L +FLE + GS++SL K+
Sbjct: 532 NSDPKLKNMILSFSKEIEVMRSLRHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKF 591
Query: 321 H-LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--M 377
S++ + YT+QIL GL +LH +++HRDIK ANIL+D G VKL+DFG +K+ + +
Sbjct: 592 GAFSENVIKVYTKQILQGLSFLHANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIV 651
Query: 378 NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHL-EGGQAMFK 436
+ KS +GT +WMAPEV+ K+ G+G ++DIWSLGC ++EM T + P+S++ E M+
Sbjct: 652 SQFKSMQGTPYWMAPEVI--KQTGHGRSSDIWSLGCVIVEMATAQPPWSNITELAAVMYH 709
Query: 437 IGGGE-LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480
I +P +P+ +S++A DF+ C + +P +RP A QL++HPFI
Sbjct: 710 IASSNSIPNIPSHMSQEAFDFLNLCFKRDPKERPDANQLLKHPFI 754
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 488 | |||
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-138 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-116 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-96 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-92 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-83 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-83 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-82 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-81 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-80 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-79 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-76 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-70 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-69 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-66 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-66 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-65 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-64 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-64 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-63 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-63 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-63 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-61 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-60 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-60 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-55 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-54 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-53 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-53 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-51 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-51 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-50 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-50 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-49 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-48 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-48 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-48 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-47 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-45 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-45 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-45 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-45 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-45 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-45 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-44 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-44 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-44 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-43 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-43 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-42 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-42 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-42 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-41 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-41 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-41 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-41 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-40 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-40 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-40 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-40 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-40 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-40 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-39 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-39 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-38 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-37 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-37 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-37 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-37 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-36 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-36 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-36 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-35 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-35 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-35 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-35 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-35 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-35 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-35 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-34 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-34 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-34 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-34 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-33 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-33 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-33 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-33 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-33 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-33 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-32 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-32 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-32 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-32 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-32 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-31 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-31 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-31 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-31 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-30 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-30 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-30 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-30 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-30 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-30 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-30 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-30 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-30 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-29 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-29 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-29 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-29 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-28 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-28 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-28 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-28 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-28 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-28 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-28 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-27 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-27 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-27 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-27 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-27 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-27 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-27 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-26 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-26 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-26 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-26 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-26 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-25 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-25 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-25 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-25 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-25 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-25 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-25 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-25 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-24 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-24 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-24 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-24 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-24 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-24 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-24 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-24 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-24 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-24 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-24 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-23 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-23 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-23 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-23 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-23 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-23 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-23 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-23 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-23 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-23 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-22 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-22 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-22 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-22 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-22 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-22 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-22 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-22 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-22 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-21 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-21 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-21 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-21 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-21 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-21 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-21 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-21 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-20 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-20 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-20 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-19 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-19 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-19 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-19 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-19 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-19 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-18 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-18 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-18 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-18 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-18 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-18 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-18 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-17 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-17 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-17 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-17 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-17 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-17 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-17 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-16 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-16 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-16 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-16 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-16 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-16 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-16 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-16 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-16 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-16 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-15 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-15 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-15 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-15 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-15 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-15 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-15 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-14 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-14 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-13 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-13 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-13 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-13 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-13 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-13 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-12 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 6e-12 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-10 | |
| pfam12515 | 47 | pfam12515, CaATP_NAI, Ca2+-ATPase N terminal autoi | 1e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-08 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 397 bits (1023), Expect = e-138
Identities = 163/259 (62%), Positives = 200/259 (77%), Gaps = 5/259 (1%)
Query: 226 SWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE 284
W+KGELLGSGS+G VYEGL DDG FFAVKEVSL D+G G++++ QLEQEI+LL + +
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHE 343
H NIVQYLGT+R+E L IFLELV GSLA L +KY + + YTRQIL GL+YLH+
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VKSCKGTAFWMAPEVVNLKKDGY 402
+N VHRDIK ANILVD +G VKLADFG+AK KS KG+ +WMAPEV+ ++ GY
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA-QQGGY 179
Query: 403 GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIG-GGELPPVPNSLSRDAQDFILKCL 461
GL ADIWSLGCTVLEM T + P+S LEG A+FKIG ELPP+P+ LS +A+DFILKCL
Sbjct: 180 GLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL 239
Query: 462 QVNPNDRPTAAQLMEHPFI 480
Q +P+ RPTAA+L+EHPF+
Sbjct: 240 QRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 343 bits (882), Expect = e-116
Identities = 132/265 (49%), Positives = 170/265 (64%), Gaps = 15/265 (5%)
Query: 226 SWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE 284
W +GELLG GS+G VY L D G AVK V L + + + LE+EI +L +
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSE---EELEALEREIRILSSLQ 57
Query: 285 HDNIVQYLGTDRDE--KRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYL 341
H NIV+Y G++RDE L IFLE V+ GSL+SL +K+ L + + YTRQIL GL YL
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAK----ATTMNDVKSCKGTAFWMAPEVVNL 397
H +VHRDIK ANILVD+ G VKLADFG AK T S +GT +WMAPEV+
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR- 176
Query: 398 KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG-GQAMFKIG-GGELPPVPNSLSRDAQD 455
+ YG ADIWSLGCTV+EM T + P+S L A++KIG GE P +P LS +A+D
Sbjct: 177 -GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKD 235
Query: 456 FILKCLQVNPNDRPTAAQLMEHPFI 480
F+ KCL+ +P RPTA +L++HPF+
Sbjct: 236 FLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 291 bits (747), Expect = 2e-96
Identities = 117/259 (45%), Positives = 165/259 (63%), Gaps = 13/259 (5%)
Query: 228 QKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286
Q G+L+G G++G VY+GL + G F A+K++SL+ ++++ + QEI LL +H
Sbjct: 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK---EEALKSIMQEIDLLKNLKHP 59
Query: 287 NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQN 345
NIV+Y+G+ L I LE GSL + +K+ +S V+ Y Q+L GL YLHEQ
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDV----KSCKGTAFWMAPEVVNLKKDG 401
V+HRDIK ANIL G VKLADFG+A T +NDV S GT +WMAPEV+ + G
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEM--SG 175
Query: 402 YGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCL 461
+DIWSLGCTV+E+LT PY L A+F+I + PP+P +S + +DF+++C
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCF 235
Query: 462 QVNPNDRPTAAQLMEHPFI 480
Q +PN RPTA QL++HP+I
Sbjct: 236 QKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 280 bits (719), Expect = 3e-92
Identities = 97/260 (37%), Positives = 140/260 (53%), Gaps = 12/260 (4%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++ E LG GS+G VY G A+K + + K+ ++ +EI +L + +H
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI----KKDRERILREIKILKKLKH 56
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQ 344
NIV+ DE +L + +E G L L +K LS+ + Y RQIL+ L+YLH +
Sbjct: 57 PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK 116
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-KSCKGTAFWMAPEVVNLKKDGYG 403
+VHRD+K NIL+D G VKLADFGLA+ + + GT +MAPEV L GYG
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEV--LLGKGYG 174
Query: 404 LTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVP---NSLSRDAQDFILKC 460
DIWSLG + E+LT + P+ + +FK G PP P +S +A+D I K
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 461 LQVNPNDRPTAAQLMEHPFI 480
L +P R TA + ++HPF
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 258 bits (661), Expect = 2e-83
Identities = 121/270 (44%), Positives = 158/270 (58%), Gaps = 16/270 (5%)
Query: 227 WQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSL-----QDEGPRGKQSILQLEQEISLL 280
W KGEL+G G+YG VY L G AVK+V L R K + L EI L
Sbjct: 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 281 GQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQ-VSSYTRQILNGLK 339
+H NIVQYLG + E+ L IFLE V GS+ S + Y + Q V +T Q+L GL
Sbjct: 63 KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA 122
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT---MNDVK-SCKGTAFWMAPEVV 395
YLH + ++HRD+K N+LVDA G K++DFG++K + ND S +G+ FWMAPEV+
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG-GELPPVP----NSLS 450
+ GY DIWSLGC VLEM R P+S E AMFK+G PP+P +LS
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS 242
Query: 451 RDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480
A DF+ C +NP++RPTA +L++HPFI
Sbjct: 243 PVALDFLNACFTINPDNRPTARELLQHPFI 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 257 bits (658), Expect = 5e-83
Identities = 113/266 (42%), Positives = 165/266 (62%), Gaps = 15/266 (5%)
Query: 227 WQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
WQ+G +G G++G VY + D G AVKE+ +QD P+ +I ++ E+ +L +H
Sbjct: 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPK---TIKEIADEMKVLELLKH 58
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQV-SSYTRQILNGLKYLHEQ 344
N+V+Y G + +++ IF+E + G+L L + + D V YT Q+L GL YLH
Sbjct: 59 PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 345 NVVHRDIKCANILVDASGSVKLADFG----LAKATTM--NDVKSCKGTAFWMAPEVVNL- 397
+VHRDIK ANI +D +G +KL DFG L TT +V+S GT +MAPEV+
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 398 KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-QAMFKIGGGELPPVPNS--LSRDAQ 454
K G+G ADIWSLGC VLEM T + P+S L+ Q MF +G G PP+P+S LS + +
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK 238
Query: 455 DFILKCLQVNPNDRPTAAQLMEHPFI 480
DF+ +CL+ +P RPTA++L++HPF+
Sbjct: 239 DFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 255 bits (652), Expect = 4e-82
Identities = 124/268 (46%), Positives = 171/268 (63%), Gaps = 16/268 (5%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRG---KQSILQ-LEQEISLLG 281
W KG L+GSGS+G VY G+ G AVK+V L K+S+L L +EI+LL
Sbjct: 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 282 QFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKY 340
+ +H+NIVQYLG+ D L IFLE V GS+A+L Y ++ V ++ RQIL GL Y
Sbjct: 62 ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNY 121
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--------SCKGTAFWMAP 392
LH + ++HRDIK ANILVD G +K++DFG++K N + S +G+ FWMAP
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 393 EVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRD 452
EVV K+ Y ADIWSLGC V+EMLT +HP+ QA+FKIG P +P+++S +
Sbjct: 182 EVV--KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239
Query: 453 AQDFILKCLQVNPNDRPTAAQLMEHPFI 480
A DF+ K +++ N RPTAA+L++HPF+
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 253 bits (648), Expect = 1e-81
Identities = 95/264 (35%), Positives = 143/264 (54%), Gaps = 14/264 (5%)
Query: 227 WQKGELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++ LGSGS+G VY+ G AVK + + E + Q+ + EI +L + H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR---EIRILRRLSH 57
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQ 344
NIV+ + D+ L + +E G L + LS+ + QIL GL+YLH
Sbjct: 58 PNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC--KGTAFWMAPEVVNLKKDGY 402
++HRD+K NIL+D +G VK+ADFGLAK + GT ++MAPEV+ L +GY
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVL-LGGNGY 176
Query: 403 GLTADIWSLGCTVLEMLTRRHPYSHLEGG---QAMFKIGGGELP---PVPNSLSRDAQDF 456
G D+WSLG + E+LT + P+S Q + +I G L P +S S +A+D
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDL 236
Query: 457 ILKCLQVNPNDRPTAAQLMEHPFI 480
I KCL +P+ RPTA ++++HP+
Sbjct: 237 IKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 249 bits (639), Expect = 3e-80
Identities = 105/261 (40%), Positives = 153/261 (58%), Gaps = 17/261 (6%)
Query: 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++ E +G G +G VY+ G A+K + L E K+ I+ EI +L + +H
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL--ESKEKKEKIIN---EIQILKKCKH 56
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHE 343
NIV+Y G+ + L I +E + GSL L + + L++SQ++ +++L GL+YLH
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTAFWMAPEVVNLKKD 400
++HRDIK ANIL+ + G VKL DFGL + ++D K+ GT +WMAPEV+N K
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGL--SAQLSDTKARNTMVGTPYWMAPEVINGK-- 172
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNS--LSRDAQDFIL 458
Y ADIWSLG T +E+ + PYS L +A+FKI P + N S + +DF+
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLK 232
Query: 459 KCLQVNPNDRPTAAQLMEHPF 479
KCLQ NP RPTA QL++HPF
Sbjct: 233 KCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 248 bits (635), Expect = 1e-79
Identities = 112/264 (42%), Positives = 165/264 (62%), Gaps = 10/264 (3%)
Query: 225 TSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF 283
T+W++G+LLG G++G VY D G AVK+V + P K+ + LE EI LL
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLH 342
+H+ IVQY G RD++ L IF+E + GS+ + Y L+++ YTRQIL G++YLH
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH 121
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAK-----ATTMNDVKSCKGTAFWMAPEVVNL 397
+VHRDIK ANIL D++G+VKL DFG +K ++ +KS GT +WM+PEV++
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS- 180
Query: 398 KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV-PNSLSRDAQDF 456
+GYG AD+WS+GCTV+EMLT + P++ E A+FKI P P+ +S DA++F
Sbjct: 181 -GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF 239
Query: 457 ILKCLQVNPNDRPTAAQLMEHPFI 480
+ + N RP+A +L+ H F+
Sbjct: 240 LRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 240 bits (614), Expect = 2e-76
Identities = 114/269 (42%), Positives = 163/269 (60%), Gaps = 20/269 (7%)
Query: 227 WQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSL----QDEGPRGKQSILQLEQEISLLGQ 282
W KGE+LG G+YG VY GLT+ G AVK+V L + + +L++E+ LL
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYE---KLQEEVDLLKS 58
Query: 283 FEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYL 341
+H NIVQYLGT D+ + IF+E V GS++S+ ++ L + YT+QIL+G+ YL
Sbjct: 59 LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYL 118
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--------NDVKSCKGTAFWMAPE 393
H VVHRDIK N+++ +G +KL DFG A+ N +KS GT +WMAPE
Sbjct: 119 HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 394 VVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE--LPPVPNSLSR 451
V+N + GYG +DIWS+GCTV EM T + P + ++ AMF IG +P +P+S S
Sbjct: 179 VIN--ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236
Query: 452 DAQDFILKCLQVNPNDRPTAAQLMEHPFI 480
A DF+ CL + ++RP+A QL+ H F+
Sbjct: 237 AAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 5e-70
Identities = 95/259 (36%), Positives = 141/259 (54%), Gaps = 10/259 (3%)
Query: 228 QKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286
E +G GS+G VY+ + A+K + L++ + I ++QEI L Q
Sbjct: 4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE----AEDEIEDIQQEIQFLSQCRSP 59
Query: 287 NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNV 346
I +Y G+ +L I +E GS L + L ++ ++ R++L GL+YLHE+
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGK 119
Query: 347 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTAFWMAPEVVNLKKDGYGL 404
+HRDIK ANIL+ G VKLADFG++ T K + GT FWMAPEV+ K+ GY
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI--KQSGYDE 177
Query: 405 TADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVP-NSLSRDAQDFILKCLQV 463
ADIWSLG T +E+ P S L + +F I P + N S+ +DF+ CL
Sbjct: 178 KADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNK 237
Query: 464 NPNDRPTAAQLMEHPFIKR 482
+P +RP+A +L++H FIK+
Sbjct: 238 DPKERPSAKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 220 bits (564), Expect = 5e-69
Identities = 98/259 (37%), Positives = 146/259 (56%), Gaps = 20/259 (7%)
Query: 231 ELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
E LG GSYG VY+ + + G A+K V + ++ + ++ +EIS+L Q + IV
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPV-------EEDLQEIIKEISILKQCDSPYIV 61
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
+Y G+ L I +E GS++ + + L++ ++++ Q L GL+YLH +
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI 121
Query: 348 HRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLT 405
HRDIK NIL++ G KLADFG++ TM + GT FWMAPEV +++ GY
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEV--IQEIGYNNK 179
Query: 406 ADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP----VPNSLSRDAQDFILKCL 461
ADIWSLG T +EM + PYS + +A+F I PP P S + DF+ KCL
Sbjct: 180 ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--PNKPPPTLSDPEKWSPEFNDFVKKCL 237
Query: 462 QVNPNDRPTAAQLMEHPFI 480
+P +RP+A QL++HPFI
Sbjct: 238 VKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 214 bits (548), Expect = 1e-66
Identities = 93/263 (35%), Positives = 146/263 (55%), Gaps = 15/263 (5%)
Query: 228 QKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286
++ ++LG GS G VY+ G +A+K++ + + KQ L +E+ L E
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQ----LLRELKTLRSCESP 59
Query: 287 NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQ- 344
+V+ G E + I LE + GSLA L +K + + ++ RQIL GL YLH +
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTAFWMAPEVVNLKKDGY 402
+++HRDIK +N+L+++ G VK+ADFG++K T++ + GT +M+PE + + Y
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSY 179
Query: 403 GLTADIWSLGCTVLEMLTRRHPYSHLEGG---QAMFKIGGGELPPVP-NSLSRDAQDFIL 458
ADIWSLG T+LE + P+ + M I G P +P S + +DFI
Sbjct: 180 --AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS 237
Query: 459 KCLQVNPNDRPTAAQLMEHPFIK 481
CLQ +P RP+AA+L++HPFIK
Sbjct: 238 ACLQKDPKKRPSAAELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 2e-66
Identities = 116/264 (43%), Positives = 161/264 (60%), Gaps = 13/264 (4%)
Query: 226 SWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE 284
+W++G+LLG G++G VY D G A K+V E P + + LE EI LL +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 285 HDNIVQYLGT--DRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYL 341
H+ IVQY G DR EK L IF+E + GS+ + Y L++S YTRQIL G+ YL
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYL 122
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAK-----ATTMNDVKSCKGTAFWMAPEVVN 396
H +VHRDIK ANIL D++G+VKL DFG +K + ++S GT +WM+PEV++
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL-PPVPNSLSRDAQD 455
+GYG AD+WSLGCTV+EMLT + P++ E A+FKI P +P+ +S A+D
Sbjct: 183 --GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240
Query: 456 FILKCLQVNPNDRPTAAQLMEHPF 479
F L C+ V RP+A +L+ HPF
Sbjct: 241 F-LGCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 1e-65
Identities = 107/259 (41%), Positives = 159/259 (61%), Gaps = 15/259 (5%)
Query: 232 LLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQ 290
+LG G+YG VY A+KE+ +D + + L +EI+L +H NIVQ
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-----RYVQPLHEEIALHSYLKHRNIVQ 69
Query: 291 YLGTDRDEKRLCIFLELVTKGSLASLYQK----YHLSDSQVSSYTRQILNGLKYLHEQNV 346
YLG+D + IF+E V GSL++L + ++ + YT+QIL GLKYLH+ +
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129
Query: 347 VHRDIKCANILVDA-SGSVKLADFGLAKATT-MNDV-KSCKGTAFWMAPEVVNLKKDGYG 403
VHRDIK N+LV+ SG VK++DFG +K +N ++ GT +MAPEV++ GYG
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYG 189
Query: 404 LTADIWSLGCTVLEMLTRRHPYSHLEGGQ-AMFKIGGGEL-PPVPNSLSRDAQDFILKCL 461
ADIWSLGCT++EM T + P+ L Q AMFK+G ++ P +P SLS +A++FIL+C
Sbjct: 190 APADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCF 249
Query: 462 QVNPNDRPTAAQLMEHPFI 480
+ +P+ R +A L++ PF+
Sbjct: 250 EPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 209 bits (534), Expect = 1e-64
Identities = 84/260 (32%), Positives = 146/260 (56%), Gaps = 17/260 (6%)
Query: 231 ELLGSGSYGFVYEGL---TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
+ +G GS+G VY L DG + +KE+ L + + ++ L E+ +L + H N
Sbjct: 6 KQIGKGSFGKVY--LVRRKSDGKLYVLKEIDLSNMSEKEREDALN---EVKILKKLNHPN 60
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-----HLSDSQVSSYTRQILNGLKYLH 342
I++Y + ++ +LCI +E G L+ +K + Q+ + Q+ LKYLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTAFWMAPEVVNLKKD 400
+ ++HRDIK NI + ++G VKL DFG++K +T++ K+ GT ++++PE+ K
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP- 179
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460
Y +DIWSLGC + E+ T +HP+ + KI G+ PP+P+ S + ++ +
Sbjct: 180 -YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSL 238
Query: 461 LQVNPNDRPTAAQLMEHPFI 480
LQ +P +RP+ AQ+++ PFI
Sbjct: 239 LQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 208 bits (531), Expect = 4e-64
Identities = 102/257 (39%), Positives = 137/257 (53%), Gaps = 15/257 (5%)
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291
+GSG+YG VY+ G A+K + L+ ++QEIS+L + H NIV Y
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEP-----GDDFEIIQQEISMLKECRHPNIVAY 65
Query: 292 LGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHR 349
G+ +L I +E GSL +YQ LS+ Q++ R+ L GL YLHE +HR
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHR 125
Query: 350 DIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTAFWMAPEVV-NLKKDGYGLTA 406
DIK ANIL+ G VKLADFG++ T+ KS GT +WMAPEV +K GY
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKC 185
Query: 407 DIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV----PNSLSRDAQDFILKCLQ 462
DIW+LG T +E+ + P L +A+F I PP S DFI KCL
Sbjct: 186 DIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLT 245
Query: 463 VNPNDRPTAAQLMEHPF 479
+P RPTA +L++HPF
Sbjct: 246 KDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 3e-63
Identities = 84/252 (33%), Positives = 124/252 (49%), Gaps = 43/252 (17%)
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291
LG G +G VY G A+K + +D + +L +EI +L + H NIV+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS----SSLLEELLREIEILKKLNHPNIVKL 56
Query: 292 LGTDRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHEQNVVHR 349
G DE L + +E GSL L ++ LS+ ++ QIL GL+YLH ++HR
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116
Query: 350 DIKCANILVDA-SGSVKLADFGLAKATTMND--VKSCKGTAFWMAPEVVNLKKDGYGLTA 406
D+K NIL+D+ +G VKLADFGL+K T + +K+ GT +MAPEV+ K Y +
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKG-YYSEKS 175
Query: 407 DIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPN 466
DIWSLG + E+ + +D I K LQ +P
Sbjct: 176 DIWSLGVILYEL--------------------------------PELKDLIRKMLQKDPE 203
Query: 467 DRPTAAQLMEHP 478
RP+A +++EH
Sbjct: 204 KRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 206 bits (525), Expect = 3e-63
Identities = 90/266 (33%), Positives = 151/266 (56%), Gaps = 16/266 (6%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQ-LEQEISLLGQFE 284
W KG+ LG+G++ Y+ G AVK+V+ ++ +++ L +EI L+ +
Sbjct: 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHE 343
H +I++ LG ++ +F+E + GS++ L KY ++ + +YT Q+L GL YLHE
Sbjct: 62 HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121
Query: 344 QNVVHRDIKCANILVDASGS-VKLADFGLAK--ATTMNDVKSCK----GTAFWMAPEVVN 396
++HRD+K AN+L+D++G +++ADFG A A + GT +MAPEV
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV-- 179
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTRRHPY---SHLEGGQAMFKIGGG-ELPPVPNSLSRD 452
L+ + YG + D+WS+GC ++EM T + P+ H +FKI P +P LS
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239
Query: 453 AQDFILKCLQVNPNDRPTAAQLMEHP 478
+D L+CL++ P DRP + +L++HP
Sbjct: 240 LRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 205 bits (522), Expect = 6e-63
Identities = 116/266 (43%), Positives = 158/266 (59%), Gaps = 13/266 (4%)
Query: 225 TSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF 283
T+W+ G+LLG G++G VY D G AVK+V E P + + LE EI LL
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 284 EHDNIVQYLGTDRD--EKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKY 340
H+ IVQY G RD E+ L IF+E + GS+ + Y L+++ YTRQIL G+ Y
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGLAK-----ATTMNDVKSCKGTAFWMAPEVV 395
LH +VHRDIK ANIL D+ G+VKL DFG +K + +KS GT +WM+PEV+
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV-PNSLSRDAQ 454
+ +GYG ADIWS+GCTV+EMLT + P++ E A+FKI PV P +S +
Sbjct: 182 S--GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCR 239
Query: 455 DFILKCLQVNPNDRPTAAQLMEHPFI 480
DF LK + V RP+A +L+ H F+
Sbjct: 240 DF-LKRIFVEAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 201 bits (512), Expect = 2e-61
Identities = 114/265 (43%), Positives = 158/265 (59%), Gaps = 13/265 (4%)
Query: 226 SWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE 284
+W+ G+LLG G++G VY D G AVK+V + + + LE EI LL
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 285 HDNIVQYLGTDRD--EKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYL 341
HD IVQY G RD EK+L IF+E + GS+ + Y L+++ YTRQIL G+ YL
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAK-----ATTMNDVKSCKGTAFWMAPEVVN 396
H +VHRDIK ANIL D++G+VKL DFG +K + +KS GT +WM+PEV++
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP-VPNSLSRDAQD 455
+GYG AD+WS+ CTV+EMLT + P++ E A+FKI P +P+ +S +D
Sbjct: 183 --GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240
Query: 456 FILKCLQVNPNDRPTAAQLMEHPFI 480
F LK + V RPTA L+ HPF+
Sbjct: 241 F-LKQIFVEEKRRPTAEFLLRHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 199 bits (509), Expect = 1e-60
Identities = 98/272 (36%), Positives = 144/272 (52%), Gaps = 21/272 (7%)
Query: 224 ITSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQ---EISL 279
W+ LG G++G VY+ + G F A K + ++ E +LE EI +
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE--------ELEDFMVEIDI 55
Query: 280 LGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNG 337
L + +H NIV E +L I +E G+L S+ + L++ Q+ RQ+L
Sbjct: 56 LSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEA 115
Query: 338 LKYLHEQNVVHRDIKCANILVDASGSVKLADFGL-AK-ATTMNDVKSCKGTAFWMAPEVV 395
L +LH V+HRD+K NIL+ G VKLADFG+ AK +T+ + GT +WMAPEVV
Sbjct: 116 LNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVV 175
Query: 396 ---NLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV--PNSLS 450
K + Y ADIWSLG T++E+ P+ L + + KI E P + P+ S
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWS 235
Query: 451 RDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
DF+ CL +P+DRPTAA+L++HPF+
Sbjct: 236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 2e-60
Identities = 98/270 (36%), Positives = 147/270 (54%), Gaps = 30/270 (11%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+K +G G+ G VY+ G A+K++ L+ KQ+ + EI ++ +H
Sbjct: 24 LEK---IGEGASGEVYKATDRATGKEVAIKKMRLR------KQNKELIINEILIMKDCKH 74
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHE 343
NIV Y + L + +E + GSL + + +++ Q++ R++L GL+YLH
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLA--------KATTMNDVKSCKGTAFWMAPEVV 395
QNV+HRDIK NIL+ GSVKLADFG A K ++ V GT +WMAPEV+
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV--V----GTPYWMAPEVI 188
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV--PNSLSRDA 453
+KD YG DIWSLG +EM PY +A+F I +PP+ P S +
Sbjct: 189 -KRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEF 246
Query: 454 QDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483
+DF+ KCL +P RP+A +L++HPF+K+
Sbjct: 247 KDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 5e-55
Identities = 78/260 (30%), Positives = 130/260 (50%), Gaps = 17/260 (6%)
Query: 228 QKGELLGSGSYGFVYEGLTDDGFFF-----AVKEVSLQDEGPRGKQSILQLEQEISLLGQ 282
G+ LG G++G VY+G AVK +L+++ Q I + +E ++ +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVK--TLKEDASE--QQIEEFLREARIMRK 57
Query: 283 FEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKY 340
+H N+V+ LG +E+ L I +E + G L S +K LS S + S+ QI G++Y
Sbjct: 58 LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKA---TTMNDVKSCKGTAFWMAPEVVNL 397
L +N +HRD+ N LV + VK++DFGL++ + K WMAPE +
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 398 KKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDF 456
K + +D+WS G + E+ T PY + + + + G P P + + D
Sbjct: 178 GK--FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDL 235
Query: 457 ILKCLQVNPNDRPTAAQLME 476
+L+C +P DRPT ++L+E
Sbjct: 236 MLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 1e-54
Identities = 95/262 (36%), Positives = 146/262 (55%), Gaps = 12/262 (4%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+Q+ EL+G G+YG VY G G A+K ++L + +++E++LL Q
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQREVALLSQLRQ 58
Query: 286 D---NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLH 342
NI +Y G+ RL I +E GS+ +L + +++ +S R++L LKY+H
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIH 118
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTAFWMAPEVVNLKKD 400
+ V+HRDIK ANILV +G+VKL DFG+A N K + GT +WMAPEV+ +
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVI-TEGK 177
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVP-NSLSRDAQDFILK 459
Y ADIWSLG T+ EM T PYS ++ +AM I + P + N S+ ++F+
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237
Query: 460 CLQVNPNDRPTAAQLMEHPFIK 481
CL P +R +A +L++ +IK
Sbjct: 238 CLDEEPKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 1e-53
Identities = 81/260 (31%), Positives = 131/260 (50%), Gaps = 18/260 (6%)
Query: 229 KGELLGSGSYGFVYEG-LTDDGFFF----AVKEVSLQDEGPRGKQSILQLEQEISLLGQF 283
G+ LG G++G VY+G L G AVK +L+++ Q I + +E ++ +
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVK--TLKEDASE--QQIEEFLREARIMRKL 58
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILNGLKY 340
+H NIV+ LG +E+ L I +E + G L +K LS S + S+ QI G++Y
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKA---TTMNDVKSCKGTAFWMAPEVVNL 397
L +N +HRD+ N LV + VK++DFGL++ VK K WMAPE +
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 398 KKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDF 456
K + +D+WS G + E+ T PY + + + + G P P + +
Sbjct: 179 GK--FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKL 236
Query: 457 ILKCLQVNPNDRPTAAQLME 476
+L+C +P DRPT ++L+E
Sbjct: 237 MLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 9e-53
Identities = 87/268 (32%), Positives = 132/268 (49%), Gaps = 26/268 (9%)
Query: 231 ELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
E +G GS+G V + DG KE+ + + KQ QL E+++L + +H NIV
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQ---QLVSEVNILRELKHPNIV 62
Query: 290 QYLG--TDRDEKRLCIFLELVTKGSLASLYQKY-----HLSDSQVSSYTRQILNGLKYLH 342
+Y DR + L I +E G LA L QK ++ + + Q+L L H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 343 -----EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKGTAFWMAPEVV 395
V+HRD+K ANI +DA+ +VKL DFGLAK + K+ GT ++M+PE +
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTRRHP---YSHLEGGQAMFKIGGGELPPVPNSLSRD 452
N Y +DIWSLGC + E+ P + L+ KI G+ +P S +
Sbjct: 183 N--HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLAS---KIKEGKFRRIPYRYSSE 237
Query: 453 AQDFILKCLQVNPNDRPTAAQLMEHPFI 480
+ I L V+P+ RP+ +L++ P I
Sbjct: 238 LNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 1e-51
Identities = 77/262 (29%), Positives = 128/262 (48%), Gaps = 18/262 (6%)
Query: 228 QKGELLGSGSYGFVYEG-LTDDGFFF----AVKEVSLQDEGPRGKQSILQLEQEISLLGQ 282
+ G+ LG G++G VY+G L DG AVK +L++ ++ + +E S++ +
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVK--TLKEGA--SEEEREEFLEEASIMKK 57
Query: 283 FEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKY 340
H NIV+ LG + L I E + G L +K+ L+ + QI G++Y
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV----KSCKGTAFWMAPEVVN 396
L +N VHRD+ N LV + VK++DFGL++ +D K WMAPE +
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455
K + +D+WS G + E+ T PY + + + + G P P + + +
Sbjct: 178 DGK--FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYE 235
Query: 456 FILKCLQVNPNDRPTAAQLMEH 477
+L+C +P DRPT ++L+E
Sbjct: 236 LMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 3e-51
Identities = 91/253 (35%), Positives = 131/253 (51%), Gaps = 11/253 (4%)
Query: 232 LLGSGSYGFVYE-GLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQ 290
LG GSYG VY+ D F+A+KEV L + ++ + EI +L H NI+
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN---EIRILASVNHPNIIS 63
Query: 291 YLGTDRDEKRLCIFLELVTKGSLASLYQKYH-----LSDSQVSSYTRQILNGLKYLHEQN 345
Y D +LCI +E G L+ K + + ++ Q+L GL+ LHEQ
Sbjct: 64 YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK 123
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLT 405
++HRD+K ANIL+ A+ VK+ D G++K N K+ GT +MAPEV K Y
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEV--WKGRPYSYK 181
Query: 406 ADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465
+DIWSLGC + EM T P+ +K+ G+ PP+P S+D Q+FI LQV P
Sbjct: 182 SDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKP 241
Query: 466 NDRPTAAQLMEHP 478
RP +++ P
Sbjct: 242 KLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 2e-50
Identities = 84/261 (32%), Positives = 140/261 (53%), Gaps = 18/261 (6%)
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEVSL-QDEGPRGKQSILQLEQEISLLGQFEHDNIVQ 290
LG+G+ G V + L G AVK + L +E Q+ +E+ +L + IV
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-----AIQKQILRELDILHKCNSPYIVG 63
Query: 291 YLGTDRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHEQ-NVV 347
+ G + + I +E + GSL + ++ + + + +L GL YLHE+ ++
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123
Query: 348 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTAD 407
HRD+K +NILV++ G +KL DFG++ + K+ GT+ +MAPE ++ + Y + +D
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPE--RIQGNDYSVKSD 181
Query: 408 IWSLGCTVLEMLTRRHPY-SHLEGGQAMF----KIGGGELPPVPNS-LSRDAQDFILKCL 461
IWSLG +++E+ T R PY + +F I P +P+ S D QDF+ CL
Sbjct: 182 IWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCL 241
Query: 462 QVNPNDRPTAAQLMEHPFIKR 482
+P +RP+ +L+EHPFIK+
Sbjct: 242 IKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 8e-50
Identities = 88/276 (31%), Positives = 139/276 (50%), Gaps = 30/276 (10%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-E 284
++ E++G G+YG VY+ G A+K + D ++ I ++E ++L ++
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIK---IMDIIEDEEEEI---KEEYNILRKYSN 61
Query: 285 HDNIVQYLG--------TDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVS----SYT- 331
H NI + G + D+ L +EL GS+ L + ++ +Y
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLV--MELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119
Query: 332 RQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTAFW 389
R+ L GL YLHE V+HRDIK NIL+ + VKL DFG++ +T+ + GT +W
Sbjct: 120 RETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYW 179
Query: 390 MAPEVVNLKKD---GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV- 445
MAPEV+ + Y +D+WSLG T +E+ + P + +A+FKI P +
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLK 239
Query: 446 -PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480
P + S+ DFI +CL N RP +L+EHPFI
Sbjct: 240 SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 5e-49
Identities = 96/265 (36%), Positives = 148/265 (55%), Gaps = 9/265 (3%)
Query: 227 WQKGELLGSGSYGFVYEGLTDDGF-FFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+ K E +G GS+G VY+G+ + A+K + L++ + I ++QEI++L Q +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDS 61
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQN 345
I +Y G+ +L I +E + GS L + L ++ +++ R+IL GL YLH +
Sbjct: 62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER 121
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTAFWMAPEVVNLKKDGYG 403
+HRDIK AN+L+ G VKLADFG+A T +K + GT FWMAPEV+ K+ Y
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--KQSAYD 179
Query: 404 LTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQV 463
ADIWSLG T +E+ P S L + +F I P + S+ ++F+ CL
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNK 239
Query: 464 NPNDRPTAAQLMEHPFIKRPLQTSS 488
+P RPTA +L++H FI R + +S
Sbjct: 240 DPRFRPTAKELLKHKFITRYTKKTS 264
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 2e-48
Identities = 76/254 (29%), Positives = 128/254 (50%), Gaps = 11/254 (4%)
Query: 231 ELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
+G GS+G V++ + D +A+K++ L R ++ + E +L + + I+
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID---EARVLAKLDSSYII 62
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILNGLKYLHEQNV 346
+Y + D+ +L I +E G L L + L + QV + QIL GL +LH + +
Sbjct: 63 RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKI 122
Query: 347 VHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKGTAFWMAPEVVNLKKDGYGL 404
+HRDIK N+ +DA +VK+ D G+AK + N + GT ++++PE+ K Y
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP--YNE 180
Query: 405 TADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVN 464
+D+W+LG + E T +HP+ G + KI G PPV S+ I +CL +
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKD 240
Query: 465 PNDRPTAAQLMEHP 478
RP QL+ +P
Sbjct: 241 YRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 2e-48
Identities = 95/265 (35%), Positives = 151/265 (56%), Gaps = 9/265 (3%)
Query: 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+ K E +G GS+G V++G+ + A+K + L++ + I ++QEI++L Q +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDS 61
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQN 345
+ +Y G+ + +L I +E + GS L + L ++Q+++ R+IL GL YLH +
Sbjct: 62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTAFWMAPEVVNLKKDGYG 403
+HRDIK AN+L+ G VKLADFG+A T +K GT FWMAPEV+ K+ Y
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--KQSAYD 179
Query: 404 LTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQV 463
ADIWSLG T +E+ P+S L + +F I P + + S+ ++F+ CL
Sbjct: 180 SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 239
Query: 464 NPNDRPTAAQLMEHPFIKRPLQTSS 488
P+ RPTA +L++H FI R + +S
Sbjct: 240 EPSFRPTAKELLKHKFIVRFAKKTS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 4e-48
Identities = 91/289 (31%), Positives = 140/289 (48%), Gaps = 44/289 (15%)
Query: 228 QKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSL--QDEG-PRGKQSILQLEQEISLLGQF 283
+K E LG G+YG VY+ G A+K++ L ++EG P ++ +EISLL +
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP--STAL----REISLLKEL 55
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYL 341
+H NIV+ L E++L + E L K LS + + S Q+L GL Y
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG--TAFWMAPEVVNLKK 399
H ++HRD+K NIL++ G +KLADFGLA+A + T ++ APE++ L
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEIL-LGS 173
Query: 400 DGYGLTADIWSLGCTVLEMLTRRHPY---SHLEGGQAMFKIGG----------GELP--- 443
Y DIWS+GC EM+T + + S ++ +F+I G +LP
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233
Query: 444 ---PV--PNSLSR-------DAQDFILKCLQVNPNDRPTAAQLMEHPFI 480
P P L + + D + K LQ NP R +A + ++HP+
Sbjct: 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 167 bits (422), Expect = 5e-47
Identities = 89/290 (30%), Positives = 134/290 (46%), Gaps = 31/290 (10%)
Query: 226 SWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-E 284
S++ LG GS+G VY D A+K ++ + E + + + +EI +L
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESK--SKEVERFLREIQILASLNH 56
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH----LSDSQVSSYTRQILNGLKY 340
NIV+ +DE L + +E V GSL L +K LS+S+ QIL+ L+Y
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 341 LHEQNVVHRDIKCANILVDASGS-VKLADFGLAKATTMNDV--------KSCKGTAFWMA 391
LH + ++HRDIK NIL+D G VKL DFGLAK + GT +MA
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 392 PEVVNLKKDGYGLTA-DIWSLGCTVLEMLTRRHPY----SHLEGGQAMFKIGGGELPPVP 446
PEV+ Y ++ DIWSLG T+ E+LT P+ + Q + I P +
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 447 NSLSRD--------AQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
+ LS A D + K L +P +R +++ + H + S
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES 286
|
Length = 384 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 9e-47
Identities = 75/263 (28%), Positives = 123/263 (46%), Gaps = 25/263 (9%)
Query: 231 ELLGSGSYGFVYEGLTDDGFFF----AVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286
+ LG G++G VY+G AVK +L+++ ++ +E ++ + H
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVK--TLKEDASEEERK--DFLKEARVMKKLGHP 56
Query: 287 NIVQYLGTDRDEKRLCIFLELVTKGSL----------ASLYQKYHLSDSQVSSYTRQILN 336
N+V+ LG +E+ L + LE + G L +K LS + S+ QI
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 337 GLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-KSCKGTAF---WMAP 392
G++YL + VHRD+ N LV VK++DFGL++ +D + G WMAP
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 393 EVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSR 451
E LK + +D+WS G + E+ T PY L + + + G P P
Sbjct: 177 ES--LKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD 234
Query: 452 DAQDFILKCLQVNPNDRPTAAQL 474
+ + +L C Q++P DRPT ++L
Sbjct: 235 ELYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-45
Identities = 91/265 (34%), Positives = 148/265 (55%), Gaps = 9/265 (3%)
Query: 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+ K E +G GS+G V++G+ + A+K + L++ + I ++QEI++L Q +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDS 61
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQN 345
+ +Y G+ +L I +E + GS L + + Q+++ ++IL GL YLH +
Sbjct: 62 PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTAFWMAPEVVNLKKDGYG 403
+HRDIK AN+L+ G VKLADFG+A T +K + GT FWMAPEV+ ++ Y
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--QQSAYD 179
Query: 404 LTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQV 463
ADIWSLG T +E+ P S + + +F I P + S+ ++FI CL
Sbjct: 180 SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNK 239
Query: 464 NPNDRPTAAQLMEHPFIKRPLQTSS 488
+P+ RPTA +L++H FI + + +S
Sbjct: 240 DPSFRPTAKELLKHKFIVKNAKKTS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-45
Identities = 91/264 (34%), Positives = 143/264 (54%), Gaps = 24/264 (9%)
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEV-SLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQ 290
+GSG+ G VY+ + G +A+K + ++ R Q+ +EI +L H N+V+
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR-----RQICREIEILRDVNHPNVVK 136
Query: 291 YLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDS-QVSSYTRQILNGLKYLHEQNVVHR 349
+ + LE + GSL + H++D ++ RQIL+G+ YLH +++VHR
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSL----EGTHIADEQFLADVARQILSGIAYLHRRHIVHR 192
Query: 350 DIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTAFWMAPEVVNL-----KKDGY 402
DIK +N+L++++ +VK+ADFG+++ A TM+ S GT +M+PE +N DGY
Sbjct: 193 DIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGY 252
Query: 403 GLTADIWSLGCTVLEMLTRRHPYSHLEGGQ---AMFKIGGGELPPVPNSLSRDAQDFILK 459
DIWSLG ++LE R P+ G M I + P P + SR+ + FI
Sbjct: 253 A--GDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISC 310
Query: 460 CLQVNPNDRPTAAQLMEHPFIKRP 483
CLQ P R +A QL++HPFI R
Sbjct: 311 CLQREPAKRWSAMQLLQHPFILRA 334
|
Length = 353 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 3e-45
Identities = 81/266 (30%), Positives = 135/266 (50%), Gaps = 21/266 (7%)
Query: 231 ELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
E++G G+ VY + + A+K + L+ S+ +L +E+ + Q H N+V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT----SVDELRKEVQAMSQCNHPNVV 62
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASL----YQKYHLSDSQVSSYTRQILNGLKYLHEQN 345
+Y + L + + ++ GSL + Y + L ++ +++ +++L GL+YLH
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK------GTAFWMAPEVVNLKK 399
+HRDIK NIL+ GSVK+ADFG++ + ++ K GT WMAPEV+ +
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME-QV 181
Query: 400 DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNS-----LSRDAQ 454
GY ADIWS G T +E+ T PYS + + + P + S+ +
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFR 241
Query: 455 DFILKCLQVNPNDRPTAAQLMEHPFI 480
I CLQ +P+ RPTA +L++H F
Sbjct: 242 KMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 4e-45
Identities = 75/255 (29%), Positives = 127/255 (49%), Gaps = 13/255 (5%)
Query: 233 LGSGSYG--FVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQ 290
LG G++G +Y T+D KEV+L + ++ L EI +L +H NI+
Sbjct: 8 LGKGAFGEATLYRR-TEDDSLVVWKEVNLTRLSEKERRDALN---EIVILSLLQHPNIIA 63
Query: 291 YLGTDRDEKRLCIFLELVTKGSLASLY---QKYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
Y D+ L I +E G+L + + V Y QI++ + Y+H+ ++
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGIL 123
Query: 348 HRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLT 405
HRDIK NI + +G +KL DFG++K + + ++ GT ++M+PE+ K Y
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK--YNFK 181
Query: 406 ADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465
+DIW+LGC + E+LT + + + KI G PV + S + + LQ +P
Sbjct: 182 SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDP 241
Query: 466 NDRPTAAQLMEHPFI 480
RPTA ++++ P +
Sbjct: 242 EKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 5e-45
Identities = 88/264 (33%), Positives = 131/264 (49%), Gaps = 32/264 (12%)
Query: 233 LGSGSYGFVYEGL---TDDGFFFAVKEVSLQDEGPRGKQSILQLEQ------EISLLGQF 283
LG GS+G V L D G +A+K + K+ I++ ++ E ++L +
Sbjct: 1 LGKGSFGKVL--LVRKKDTGKLYAMKVLK--------KKKIIKRKEVEHTLTERNILSRI 50
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLH 342
H IV+ + E++L + LE G L S K S+ + Y +I+ L+YLH
Sbjct: 51 NHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLH 110
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTAFWMAPEVVNLKK 399
+++RD+K NIL+DA G +KL DFGLAK ++ GT ++APEV L
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEV--LLG 167
Query: 400 DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGELPPVPNSLSRDAQDFIL 458
GYG D WSLG + EMLT + P+ E + ++ KI L P LS +A+D I
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKDPL-RFPEFLSPEARDLIS 225
Query: 459 KCLQVNPNDRPT---AAQLMEHPF 479
LQ +P R A ++ HPF
Sbjct: 226 GLLQKDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 5e-45
Identities = 98/288 (34%), Positives = 157/288 (54%), Gaps = 17/288 (5%)
Query: 206 EIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGP 264
EI+E + G +++ T ++K +G G+ G VY + G A+K+++LQ + P
Sbjct: 3 EILEKLRTIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-P 58
Query: 265 RGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSD 324
+ K+ I+ EI ++ + +H NIV YL + L + +E + GSL + + + +
Sbjct: 59 K-KELIIN---EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE 114
Query: 325 SQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--S 382
Q+++ R+ L L++LH V+HRDIK NIL+ GSVKL DFG T K +
Sbjct: 115 GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174
Query: 383 CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL 442
GT +WMAPEVV K YG DIWSLG +EM+ PY + +A++ I
Sbjct: 175 MVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT 232
Query: 443 P--PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK--RPLQT 486
P P LS +DF+ +CL+++ R +A +L++HPF+K +PL +
Sbjct: 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 2e-44
Identities = 94/269 (34%), Positives = 141/269 (52%), Gaps = 21/269 (7%)
Query: 227 WQKGELLGSGSYGFVYEGLTDD-GFFFAVKEVSLQDEGPRGKQSILQLEQ---EISLLGQ 282
W+ LG G++G VY+ + G A K + + E +LE EI +L
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE--------ELEDYMVEIEILAT 65
Query: 283 FEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKY 340
H IV+ LG + +L I +E G++ ++ + L++ Q+ RQ+L L+Y
Sbjct: 66 CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQY 125
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGL-AKAT-TMNDVKSCKGTAFWMAPEVV--- 395
LH ++HRD+K N+L+ G +KLADFG+ AK T+ S GT +WMAPEVV
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV--PNSLSRDA 453
+K Y ADIWSLG T++EM P+ L + + KI E P + P+ S +
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF 245
Query: 454 QDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
+DF+ L +P RP+AAQL+EHPF+
Sbjct: 246 RDFLKTALDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 6e-44
Identities = 86/259 (33%), Positives = 135/259 (52%), Gaps = 16/259 (6%)
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLE---QEISLLGQFEHDNI 288
+G GS+G VY A+K++S GKQS + + +E+ L Q H N
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYS-----GKQSNEKWQDIIKEVRFLQQLRHPNT 77
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQNV 346
++Y G E + +E GS + + + K L + ++++ L GL YLH
Sbjct: 78 IEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 347 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDG-YGLT 405
+HRDIK NIL+ G+VKLADFG A+ ++ S GT +WMAPEV+ +G Y
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFG--SASLVSPANSFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 406 ADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV-PNSLSRDAQDFILKCLQVN 464
D+WSLG T +E+ R+ P ++ A++ I + P + N S ++F+ CLQ
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKI 254
Query: 465 PNDRPTAAQLMEHPFIKRP 483
P DRP++ +L++H F+ R
Sbjct: 255 PQDRPSSEELLKHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 6e-44
Identities = 94/283 (33%), Positives = 146/283 (51%), Gaps = 22/283 (7%)
Query: 214 VSPNGKFRRRITSWQKGELLGSGSYGFV---YEGLTDDGFFFAVKEVSLQDEGPRGKQSI 270
V P G R + ++ K +G GS G V + T G AVK++ L R +Q
Sbjct: 12 VDP-GDPRSYLDNFVK---IGEGSTGIVCIATDKST--GRQVAVKKMDL-----RKQQRR 60
Query: 271 LQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSY 330
L E+ ++ ++H NIV+ + L + +E + G+L + +++ Q+++
Sbjct: 61 ELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATV 120
Query: 331 TRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV---KSCKGTA 387
+L L +LH Q V+HRDIK +IL+ + G VKL+DFG A +V KS GT
Sbjct: 121 CLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFC-AQVSKEVPRRKSLVGTP 179
Query: 388 FWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPN 447
+WMAPEV++ + YG DIWSLG V+EM+ PY + QAM +I P + N
Sbjct: 180 YWMAPEVIS--RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKN 237
Query: 448 S--LSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
+S + F+ + L +P R TAA+L+ HPF+ + SS
Sbjct: 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 3e-43
Identities = 82/268 (30%), Positives = 134/268 (50%), Gaps = 26/268 (9%)
Query: 233 LGSGSYGFVY---EGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
+ G+YG V+ + T D +A+K + D K + Q+ E +L Q + +V
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADM--IRKNQVDQVLTERDILSQAQSPYVV 56
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVH 348
+ + + +K L + +E + G LASL + L + Y +I+ L+YLH ++H
Sbjct: 57 KLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116
Query: 349 RDIKCANILVDASGSVKLADFGLAKATTMN--------DVKSCK--GTAFWMAPEVVNLK 398
RD+K NIL+D++G +KL DFGL+K + + + + GT ++APEV+ +
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 399 KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGELP-PVPNSLSRDAQDF 456
G+ T D WSLGC + E L P+ H E + +F I G++ P +S +A D
Sbjct: 177 --GHSKTVDWWSLGCILYEFLVGIPPF-HGETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233
Query: 457 ILKCLQVNPNDRPTAA---QLMEHPFIK 481
I K L +P R A ++ HPF K
Sbjct: 234 ISKLLVPDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 4e-43
Identities = 82/282 (29%), Positives = 129/282 (45%), Gaps = 40/282 (14%)
Query: 230 GELLGSGSYGFVYEG-LTDDGFFFAVKEVS---LQDEGPRGKQSILQLEQEI-SLLGQFE 284
G+++G GS+ V + +A+K + L E K +++E+E+ + L
Sbjct: 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEK---KVKYVKIEKEVLTRLNG-- 60
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHE 343
H I++ T +DE+ L LE G L +KY L + Y +IL L+YLH
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCK------------- 384
+ ++HRD+K NIL+D +K+ DFG AK N +
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 385 ---GTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE 441
GTA +++PE++N K G +D+W+LGC + +MLT + P+ KI E
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKS--SDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238
Query: 442 LPPVPNSLSRDAQDFILKCLQVNPNDRPTA----AQLMEHPF 479
P + DA+D I K L ++P DR +L HPF
Sbjct: 239 Y-SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 2e-42
Identities = 91/272 (33%), Positives = 138/272 (50%), Gaps = 33/272 (12%)
Query: 233 LGSGSYGFVYE-GLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291
LG G+ G V + L + G FA+K + D P ++ IL+ E+ + + IV+Y
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILR---ELEINKSCKSPYIVKY 64
Query: 292 LGTDRDEK--RLCIFLELVTKGSLASLYQKYHLSDSQVSSY-----TRQILNGLKYLHEQ 344
G DE + I +E GSL S+Y+K ++ +L GL YLH +
Sbjct: 65 YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGL 404
++HRDIK +NIL+ G VKL DFG++ + + GT+F+MAPE ++ Y +
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPE--RIQGKPYSI 182
Query: 405 TADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL------PPVPN---------SL 449
T+D+WSLG T+LE+ R P+ EG + I EL P P
Sbjct: 183 TSDVWSLGLTLLEVAQNRFPFPP-EGEPPLGPI---ELLSYIVNMPNPELKDEPGNGIKW 238
Query: 450 SRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
S + +DFI +CL+ +P RPT ++EHP+IK
Sbjct: 239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 4e-42
Identities = 93/264 (35%), Positives = 138/264 (52%), Gaps = 15/264 (5%)
Query: 227 WQKGELLGSGSYGFVYEGLTDD-GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
W+ LG G++G VY+ + G A K + + E + + EI +L +H
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE-----EELEDYMVEIDILASCDH 61
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHE 343
NIV+ L E L I +E G++ ++ + L++ Q+ +Q L L YLHE
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGL-AKAT-TMNDVKSCKGTAFWMAPEVV---NLK 398
++HRD+K NIL G +KLADFG+ AK T T+ S GT +WMAPEVV K
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 399 KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV--PNSLSRDAQDF 456
Y AD+WSLG T++EM P+ L + + KI E P + P+ S + +DF
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241
Query: 457 ILKCLQVNPNDRPTAAQLMEHPFI 480
+ KCL+ N + R T QL++HPF+
Sbjct: 242 LKKCLEKNVDARWTTTQLLQHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 151 bits (381), Expect = 6e-42
Identities = 97/288 (33%), Positives = 159/288 (55%), Gaps = 17/288 (5%)
Query: 206 EIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGP 264
EI+E ++ G +++ T ++K +G G+ G VY + G A+K+++LQ + P
Sbjct: 3 EILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-P 58
Query: 265 RGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSD 324
+ K+ I+ EI ++ + ++ NIV YL + L + +E + GSL + + + +
Sbjct: 59 K-KELIIN---EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE 114
Query: 325 SQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--S 382
Q+++ R+ L L +LH V+HRDIK NIL+ GSVKL DFG T K +
Sbjct: 115 GQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174
Query: 383 CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL 442
GT +WMAPEVV K YG DIWSLG +EM+ PY + +A++ I
Sbjct: 175 MVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT 232
Query: 443 PPV--PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK--RPLQT 486
P + P LS +DF+ +CL+++ + R +A +L++HPF+K +PL +
Sbjct: 233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 1e-41
Identities = 96/289 (33%), Positives = 159/289 (55%), Gaps = 19/289 (6%)
Query: 206 EIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGLTDD--GFFFAVKEVSLQDEG 263
EIME + G +++ T ++K +G G+ G V+ D G A+K+++LQ +
Sbjct: 3 EIMEKLRTIVSIGDPKKKYTRYEK---IGQGASGTVFTA-IDVATGQEVAIKQINLQKQ- 57
Query: 264 PRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLS 323
P+ K+ I+ EI ++ + ++ NIV +L + L + +E + GSL + + +
Sbjct: 58 PK-KELIIN---EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMD 113
Query: 324 DSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK-- 381
++Q+++ R+ L L++LH V+HRDIK N+L+ GSVKL DFG T K
Sbjct: 114 EAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173
Query: 382 SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE 441
+ GT +WMAPEVV K YG DIWSLG +EM+ PY + +A++ I
Sbjct: 174 TMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG 231
Query: 442 LPPV--PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK--RPLQT 486
P + P LS +DF+ +CL+++ R +A +L++HPF+K +PL +
Sbjct: 232 TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 3e-41
Identities = 96/257 (37%), Positives = 140/257 (54%), Gaps = 16/257 (6%)
Query: 233 LGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291
+GSG+YG VY+ + G A+K + L+ P +++Q QEI ++ +H NIV Y
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLE---PGEDFAVVQ--QEIIMMKDCKHSNIVAY 71
Query: 292 LGTDRDEKRLCIFLELVTKGSLASLYQ-KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRD 350
G+ +L I +E GSL +Y LS+SQ++ +R+ L GL YLH + +HRD
Sbjct: 72 FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRD 131
Query: 351 IKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTAFWMAPEVVNL-KKDGYGLTAD 407
IK ANIL+ +G VKLADFG++ T+ KS GT +WMAPEV + +K GY D
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCD 191
Query: 408 IWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPN-----SLSRDAQDFILKCLQ 462
IW++G T +E+ + P L +A+F + P P S F+ L
Sbjct: 192 IWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP-PKLKDKMKWSNSFHHFVKMALT 250
Query: 463 VNPNDRPTAAQLMEHPF 479
NP RPTA +L++HPF
Sbjct: 251 KNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 4e-41
Identities = 81/257 (31%), Positives = 138/257 (53%), Gaps = 12/257 (4%)
Query: 231 ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
+ +G GS+G +Y D +KE+ L + K++ ++E+ LL + +H NIV
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS---KKEVILLAKMKHPNIV 62
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILNGLKYLHEQNV 346
+ + ++ RL I +E G L + S+ Q+ S+ QI GLK++H++ +
Sbjct: 63 TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKI 122
Query: 347 VHRDIKCANILVDASGSV-KLADFGLAKA--TTMNDVKSCKGTAFWMAPEVVNLKKDGYG 403
+HRDIK NI + +G V KL DFG+A+ +M +C GT ++++PE+ + Y
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP--YN 180
Query: 404 LTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQV 463
DIWSLGC + E+ T +HP+ Q + KI G P+ + SRD + I + +V
Sbjct: 181 NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKV 240
Query: 464 NPNDRPTAAQLMEHPFI 480
+P DRP+ +++ PF+
Sbjct: 241 SPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 7e-41
Identities = 96/256 (37%), Positives = 138/256 (53%), Gaps = 14/256 (5%)
Query: 233 LGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291
+GSG+YG VY+ G AVK + L+ P S++Q QEI ++ + +H NIV Y
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE---PGDDFSLIQ--QEIFMVKECKHCNIVAY 71
Query: 292 LGTDRDEKRLCIFLELVTKGSLASLYQ-KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRD 350
G+ ++L I +E GSL +Y LS+ Q++ R+ L GL YLH + +HRD
Sbjct: 72 FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRD 131
Query: 351 IKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTAFWMAPEVVNLKKD-GYGLTAD 407
IK ANIL+ +G VKLADFG+A T+ KS GT +WMAPEV ++K+ GY D
Sbjct: 132 IKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCD 191
Query: 408 IWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV----PNSLSRDAQDFILKCLQV 463
IW++G T +E+ + P L +A+F + P S +F+ L
Sbjct: 192 IWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTK 251
Query: 464 NPNDRPTAAQLMEHPF 479
NP RPTA +L+ H F
Sbjct: 252 NPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 1e-40
Identities = 94/266 (35%), Positives = 145/266 (54%), Gaps = 23/266 (8%)
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291
LG G+YG VY+ L G A+KE+ L+ + + Q I++L+ +L + IV +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELD----ILHKAVSPYIVDF 64
Query: 292 LGTDRDEKRLCIFLELVTKGSLASLY----QKYHLSDSQVSSYTRQILNGLKYLHEQ-NV 346
G E + + +E + GSL LY + + + T ++ GLK+L E+ N+
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124
Query: 347 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDG----- 401
+HRD+K N+LV+ +G VKL DFG++ + K+ G +MAPE +K G
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPE--RIKSGGPNQNP 182
Query: 402 -YGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFK----IGGGELPPVPNSLSRDAQDF 456
Y + +D+WSLG ++LEM R+PY E +F I G+ P +P+ S DAQDF
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPYPP-ETYANIFAQLSAIVDGDPPTLPSGYSDDAQDF 241
Query: 457 ILKCLQVNPNDRPTAAQLMEHPFIKR 482
+ KCL PN RPT AQL+EHP++ +
Sbjct: 242 VAKCLNKIPNRRPTYAQLLEHPWLVK 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 1e-40
Identities = 80/261 (30%), Positives = 137/261 (52%), Gaps = 27/261 (10%)
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEVSLQD-EGPRGKQSILQLEQEISLLGQFEHDNIVQ 290
+G G + VY+ + DG A+K+V + + + +Q L+ EI LL Q +H N+++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK---EIDLLKQLDHPNVIK 66
Query: 291 YLGTDRDEKRLCIFLELVTKGSLASLY-----QKYHLSDSQVSSYTRQILNGLKYLHEQN 345
YL + + L I LEL G L+ + QK + + + Y Q+ + L+++H +
Sbjct: 67 YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAK---ATTMNDVKSCKGTAFWMAPEVVNLKKDGY 402
++HRDIK AN+ + A+G VKL D GL + + T S GT ++M+PE + ++GY
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERI--HENGY 183
Query: 403 GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF------KIGGGELPPVPNS-LSRDAQD 455
+DIWSLGC + EM + P+ G M KI + PP+P S + +D
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFY----GDKMNLYSLCKKIEKCDYPPLPADHYSEELRD 239
Query: 456 FILKCLQVNPNDRPTAAQLME 476
+ +C+ +P RP + +++
Sbjct: 240 LVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-40
Identities = 83/294 (28%), Positives = 136/294 (46%), Gaps = 59/294 (20%)
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEVSLQDE---GPRGKQSILQLEQEISLLGQFEHDNI 288
+G G+YG VY+ G A+K++ +++E P +I +EI LL + H NI
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPI--TAI----REIKLLQKLRHPNI 60
Query: 289 VQYLGTDRDEKRLCIFL-------ELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYL 341
V+ + + I++ +L G L S + ++SQ+ Y +Q+L GL+YL
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDL--TGLLDS--PEVKFTESQIKCYMKQLLEGLQYL 116
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT----AFWM-APEVVN 396
H ++HRDIK +NIL++ G +KLADFGLA+ S T W PE++
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLAR--PYTKRNSADYTNRVITLWYRPPELL- 173
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTRRHPY---SHLEGGQAMFKIGGG----------ELP 443
L YG D+WS+GC + E+ + + + LE + +F++ G +LP
Sbjct: 174 LGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233
Query: 444 ---------PVPNSL--------SRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480
P L A D + K L ++P R +A Q ++H +
Sbjct: 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 3e-40
Identities = 97/298 (32%), Positives = 142/298 (47%), Gaps = 57/298 (19%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKE--VSLQDEG-PRGKQSILQLEQEISLLGQ 282
+++ +G G+YG VY+ + G F A+K+ V L +EG P S L+ EI+LL Q
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP---LSTLR---EIALLKQ 54
Query: 283 ---FEHDNIVQYLG---TDRDEKRLCIFL--ELVTKGSLASLYQKYH---LSDSQVSSYT 331
FEH NIV+ L R ++ L + L E V + LA+ K L +
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLM 113
Query: 332 RQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DVKSCKGTAFWM 390
RQ+L G+ +LH +VHRD+K NILV + G VK+ADFGLA+ + + S T ++
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYR 173
Query: 391 APEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHP----YSHLEGGQAMFKIGGGELP--- 443
APEV L + Y D+WS+GC E+ RR P S + +F + G LP
Sbjct: 174 APEV--LLQSSYATPVDMWSVGCIFAELFRRR-PLFRGTSEADQLDKIFDVIG--LPSEE 228
Query: 444 --PVPNSLSRD--------------------AQDFILKCLQVNPNDRPTAAQLMEHPF 479
P SL R D + K L NP+ R +A + ++HP+
Sbjct: 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 3e-40
Identities = 95/288 (32%), Positives = 156/288 (54%), Gaps = 17/288 (5%)
Query: 206 EIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGP 264
EI+E ++ G +++ T ++K +G G+ G VY + G A+++++LQ + P
Sbjct: 4 EILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-P 59
Query: 265 RGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSD 324
+ K+ I+ EI ++ + ++ NIV YL + L + +E + GSL + + + +
Sbjct: 60 K-KELIIN---EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE 115
Query: 325 SQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK 384
Q+++ R+ L L++LH V+HRDIK NIL+ GSVKL DFG T K
Sbjct: 116 GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175
Query: 385 --GTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL 442
GT +WMAPEVV K YG DIWSLG +EM+ PY + +A++ I
Sbjct: 176 MVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 233
Query: 443 PPV--PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK--RPLQT 486
P + P LS +DF+ +CL ++ R +A +L++H F+K +PL +
Sbjct: 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSS 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 8e-40
Identities = 77/263 (29%), Positives = 142/263 (53%), Gaps = 17/263 (6%)
Query: 227 WQKGELLGSGSYG-FVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+ K + +G GS+G + +DG + +KE+++ P+ ++ + +E+++L +H
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKH 58
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH------LSDSQVSSYTRQILNGLK 339
NIVQY + + L I ++ G L Y+K + + Q+ + QI LK
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDL---YKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTAFWMAPEVVNL 397
++H++ ++HRDIK NI + G++KL DFG+A+ +T+ ++C GT ++++PE+
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN 175
Query: 398 KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFI 457
+ Y +DIW+LGC + EM T +H + + KI G PPV + S D ++ +
Sbjct: 176 RP--YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLV 233
Query: 458 LKCLQVNPNDRPTAAQLMEHPFI 480
+ + NP DRP+ ++E FI
Sbjct: 234 SQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 2e-39
Identities = 84/294 (28%), Positives = 136/294 (46%), Gaps = 51/294 (17%)
Query: 227 WQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+QK +G G+YG VY+ G A+K++ L+ E ++ L+ EI LL + H
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR---EIKLLKELNH 57
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQ-----KYHLSDSQVSSYTRQILNGLKY 340
NI++ L R + L + E + LY+ + L +S + SY Q+L GL +
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAF 113
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKA-----TTMNDVKSCKGTAFWMAPEVV 395
H ++HRD+K N+L++ G +KLADFGLA++ T ++ APE++
Sbjct: 114 CHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV---TRWYRAPELL 170
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTRRHPY---SHLEGGQAMFKIGGG------------ 440
L GY DIWS+GC E+L+RR + S ++ +F+ G
Sbjct: 171 -LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL 229
Query: 441 --------------ELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480
LP + + S A D + + L +P+ R TA Q + HP+
Sbjct: 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 5e-39
Identities = 82/264 (31%), Positives = 128/264 (48%), Gaps = 25/264 (9%)
Query: 231 ELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQ------EISLLGQF 283
+ LG+GS+G V G ++A+K +S K I++L+Q E +L
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILS--------KAKIVKLKQVEHVLNEKRILQSI 58
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSS-YTRQILNGLKYLH 342
H +V G+ +D+ L + +E V G L S +K V+ Y Q++ L+YLH
Sbjct: 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH 118
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGY 402
++V+RD+K N+L+D+ G +K+ DFG AK C GT ++APE++ K GY
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC-GTPEYLAPEIILSK--GY 175
Query: 403 GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQ 462
G D W+LG + EML P+ Q KI G++ P+ S DA+D I LQ
Sbjct: 176 GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV-RFPSFFSPDAKDLIRNLLQ 234
Query: 463 VNP-----NDRPTAAQLMEHPFIK 481
V+ N + + HP+
Sbjct: 235 VDLTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 5e-38
Identities = 79/274 (28%), Positives = 120/274 (43%), Gaps = 37/274 (13%)
Query: 233 LGSGSYGFVYEG---LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
LG G +G V D V SL G +Q E+EI +L +H+NIV
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG--EEQHRSDFEREIEILRTLDHENIV 69
Query: 290 QYLG--TDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQN 345
+Y G + L + +E + GSL Q++ ++ ++ ++ QI G+ YL Q
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGT-AFWMAPEVVNLKKD 400
+HRD+ NILV++ VK++DFGLAK + VK + FW APE L+
Sbjct: 130 YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC--LRTS 187
Query: 401 GYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIG-----------------GGEL 442
+ +D+WS G T+ E+ T S + + IG G L
Sbjct: 188 KFSSASDVWSFGVTLYELFTYGDPSQSPP--AEFLRMIGIAQGQMIVTRLLELLKEGERL 245
Query: 443 PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476
P P S + D + C + P DRP+ A L+
Sbjct: 246 PR-PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 89/258 (34%), Positives = 138/258 (53%), Gaps = 16/258 (6%)
Query: 233 LGSGSYGFVY---EGLTDDGFFFAVKEVSLQDEGPRGK-QSILQLEQEISLLGQFEHDNI 288
+G GS+G VY T++ AVK++S + K Q I++ E+ L Q +H N
Sbjct: 29 IGHGSFGAVYFATNSHTNE--VVAVKKMSYSGKQTNEKWQDIIK---EVKFLQQLKHPNT 83
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQNV 346
++Y G E + +E GS + L + K L + ++++ T L GL YLH N+
Sbjct: 84 IEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142
Query: 347 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDG-YGLT 405
+HRDIK NIL+ G VKLADFG A+ + S GT +WMAPEV+ +G Y
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFG--SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGK 200
Query: 406 ADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV-PNSLSRDAQDFILKCLQVN 464
D+WSLG T +E+ R+ P ++ A++ I + P + N + + F+ CLQ
Sbjct: 201 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKI 260
Query: 465 PNDRPTAAQLMEHPFIKR 482
P +RP +A+L+ H F++R
Sbjct: 261 PQERPASAELLRHDFVRR 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 3e-37
Identities = 84/292 (28%), Positives = 136/292 (46%), Gaps = 47/292 (16%)
Query: 232 LLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQ 290
+GSG+YG V + G A+K++S + + IL+ EI LL H+NI+
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR---EIKLLRHLRHENIIG 63
Query: 291 YLGTDRDEKRLCIF--LELVTKGSLASLYQ----KYHLSDSQVSSYTRQILNGLKYLHEQ 344
L R F + +VT+ L++ L+D + + QIL GLKYLH
Sbjct: 64 LLDILRPPSPED-FNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA 122
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF----WM-APEVVNLKK 399
NV+HRD+K +NILV+++ +K+ DFGLA+ ++ + T + W APE++ L
Sbjct: 123 NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELL-LSS 181
Query: 400 DGYGLTADIWSLGCTVLEMLTRRHPY---SHLEGGQAMFKIGG----------------- 439
Y DIWS+GC E+LTR+ + +++ + ++ G
Sbjct: 182 SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARN 241
Query: 440 -----GELPPVPNS-----LSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
+ P P S S +A D + K L +P R TA + + HP++
Sbjct: 242 YLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLA 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 4e-37
Identities = 82/285 (28%), Positives = 130/285 (45%), Gaps = 40/285 (14%)
Query: 231 ELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
++G G+YG V + G A+K+ ++ K++ L+ E+ +L Q H+NIV
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR---EVKVLRQLRHENIV 63
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASL-YQKYHLSDSQVSSYTRQILNGLKYLHEQNVVH 348
R + RL + E V + L L L V SY Q+L + Y H N++H
Sbjct: 64 NLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIH 123
Query: 349 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTAFWMAPEVVNLKKDGYGLT 405
RDIK NILV SG +KL DFG A+A T ++ APE++ + YG
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELL-VGDTNYGKP 182
Query: 406 ADIWSLGCTVLEMLTRRHPY---SHLE---------GG-----QAMF----KIGGGELPP 444
D+W++GC + E+L + S ++ G Q +F + G P
Sbjct: 183 VDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPE 242
Query: 445 V----------PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
P +S A DF+ CL+++P +R T +L++HP+
Sbjct: 243 PSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 6e-37
Identities = 91/260 (35%), Positives = 141/260 (54%), Gaps = 20/260 (7%)
Query: 233 LGSGSYGFVY---EGLTDDGFFFAVKEVSLQDEGPRGKQSILQLE---QEISLLGQFEHD 286
+G GS+G VY + T++ A+K++S GKQS + + +E+ L + +H
Sbjct: 33 IGHGSFGAVYFARDVRTNE--VVAIKKMSYS-----GKQSNEKWQDIIKEVKFLQRIKHP 85
Query: 287 NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQ 344
N ++Y G E + +E GS + L + K L + ++++ T L GL YLH
Sbjct: 86 NSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDG-YG 403
N++HRDIK NIL+ G VKLADFG A+ + S GT +WMAPEV+ +G Y
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFG--SASIASPANSFVGTPYWMAPEVILAMDEGQYD 202
Query: 404 LTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV-PNSLSRDAQDFILKCLQ 462
D+WSLG T +E+ R+ P ++ A++ I E P + N S ++F+ CLQ
Sbjct: 203 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQ 262
Query: 463 VNPNDRPTAAQLMEHPFIKR 482
P DRPT+ +L++H F+ R
Sbjct: 263 KIPQDRPTSEELLKHMFVLR 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 90/262 (34%), Positives = 137/262 (52%), Gaps = 17/262 (6%)
Query: 233 LGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291
+G GS G V G AVK + L R +Q L E+ ++ ++H N+V+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDL-----RKQQRRELLFNEVVIMRDYQHQNVVEM 83
Query: 292 LGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDI 351
+ + L + +E + G+L + + L++ Q+++ +L L YLH Q V+HRDI
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDI 143
Query: 352 KCANILVDASGSVKLADFGLAKATTMNDV---KSCKGTAFWMAPEVVNLKKDGYGLTADI 408
K +IL+ G VKL+DFG A DV KS GT +WMAPEV++ + YG DI
Sbjct: 144 KSDSILLTLDGRVKLSDFGFC-AQISKDVPKRKSLVGTPYWMAPEVIS--RTPYGTEVDI 200
Query: 409 WSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNS--LSRDAQDFILKCLQVNPN 466
WSLG V+EM+ PY QAM ++ P + N+ +S +DF+ + L P
Sbjct: 201 WSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQ 260
Query: 467 DRPTAAQLMEHPFIKRPLQTSS 488
+R TA +L++HPF+ LQT
Sbjct: 261 ERATAQELLDHPFL---LQTGL 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 85/255 (33%), Positives = 131/255 (51%), Gaps = 10/255 (3%)
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291
+G GS+G VY + A+K++S G + + + +E+ L + H N +QY
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 292 LGTDRDEKRLCIFLELVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQNVVHR 349
G E + +E GS + L + K L + ++++ T L GL YLH N++HR
Sbjct: 81 RGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 350 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDG-YGLTADI 408
D+K NIL+ G VKL DFG A+ M GT +WMAPEV+ +G Y D+
Sbjct: 140 DVKAGNILLSEPGLVKLGDFG--SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDV 197
Query: 409 WSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV-PNSLSRDAQDFILKCLQVNPND 467
WSLG T +E+ R+ P ++ A++ I E P + S ++F+ CLQ P D
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257
Query: 468 RPTAAQLMEHPFIKR 482
RPT+ L++H F+ R
Sbjct: 258 RPTSEVLLKHRFVLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-36
Identities = 83/277 (29%), Positives = 136/277 (49%), Gaps = 22/277 (7%)
Query: 225 TSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF 283
+ E LG G+YG V + G AVK + K+ ++ L+ IS+
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLD--ISMRSV- 57
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQV-----SSYTRQILNGL 338
+ V + G E + I +E V SL Y+K + + I+ L
Sbjct: 58 DCPYTVTFYGALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKAL 116
Query: 339 KYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK-GTAFWMAPEVVN 396
+YLH + +V+HRD+K +N+L++ +G VKL DFG++ + K+ G +MAPE +N
Sbjct: 117 EYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERIN 176
Query: 397 --LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF----KIGGGELPPVPN-SL 449
L + GY + +D+WSLG T++E+ T R PY + + F ++ P +P
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIELATGRFPY---DSWKTPFQQLKQVVEEPSPQLPAEKF 233
Query: 450 SRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486
S + QDF+ KCL+ N +RP +L++HPF + L
Sbjct: 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 86/295 (29%), Positives = 129/295 (43%), Gaps = 67/295 (22%)
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEV-----SLQDEGPRGKQSILQLEQEISLLGQFEHD 286
LG G++G VY + G A+K++ S ++ + L + SL EH
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE--------CMNLREVKSLRKLNEHP 58
Query: 287 NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY------HLSDSQVSSYTRQILNGLKY 340
NIV+ R+ L E + +LYQ S+S + S QIL GL +
Sbjct: 59 NIVKLKEVFRENDELYFVFEYMEG----NLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK------GTAFWMAPEV 394
+H+ HRD+K N+LV VK+ADFGLA+ +++S T ++ APE+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYVSTRWYRAPEI 169
Query: 395 VNLKKDGYGLTADIWSLGCTVLEMLTRR--------------------HPYSHL--EGGQ 432
+ L+ Y DIW+LGC + E+ T R P EG +
Sbjct: 170 L-LRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228
Query: 433 AMFKIGGGELPPV-PNSL-------SRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
K+ G P P SL S +A D I L+ +P RPTA+Q ++HP+
Sbjct: 229 LASKL-GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 97/295 (32%), Positives = 140/295 (47%), Gaps = 55/295 (18%)
Query: 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSL--QDEG-PRGKQSILQLEQEISLLGQ 282
+QK E +G G+YG VY+ G A+K++ L +DEG P +I +EISLL +
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVP--STAI----REISLLKE 54
Query: 283 FEHDNIVQYLGTDRDEKRLCI---FLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLK 339
H NIV+ L E +L + FL+L K + S L + SY Q+L G+
Sbjct: 55 LNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIA 113
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTAFWMAPE 393
Y H V+HRD+K N+L+D G++KLADFGLA+A T ++V T ++ APE
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYRAPE 169
Query: 394 VVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKI-------------GGG 440
++ L Y DIWS+GC EM+ RR + +F+I G
Sbjct: 170 IL-LGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT 228
Query: 441 ELP----------------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
LP VPN L D D + K L +P R +A ++HP+
Sbjct: 229 SLPDYKPTFPKWARQDLSKVVPN-LDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 91/284 (32%), Positives = 137/284 (48%), Gaps = 40/284 (14%)
Query: 231 ELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
L+G GSYG V + + G A+K+ ++ K+ ++ EI +L Q H+N+V
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR---EIRMLKQLRHENLV 63
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQNVVH 348
+ R +KRL + E V L L + + L +S+V Y QIL G+++ H N++H
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIH 123
Query: 349 RDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTA 406
RDIK NILV SG VKL DFG A+ A T ++ APE++ + YG
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELL-VGDTKYGRAV 182
Query: 407 DIWSLGCTVLEMLTRRHPY------------------SHLEGGQAMFK----IGGGELPP 444
DIW++GC V EMLT P + + Q +F+ G LP
Sbjct: 183 DIWAVGCLVTEMLT-GEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPE 241
Query: 445 VPN---------SLSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
V LS D +CL+++P+DRP+++QL+ H F
Sbjct: 242 VKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 2e-35
Identities = 89/292 (30%), Positives = 134/292 (45%), Gaps = 47/292 (16%)
Query: 226 SWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE 284
++QK E +G G+YG VY+ G A+K++ L E + ++ EISLL +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELN 57
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKG--SLASLYQKYHLSDSQVSSYTRQILNGLKYLH 342
H NIV+ L E +L + E + + + + SY Q+L GL + H
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTAFWMAPEVVN 396
V+HRD+K N+L++ G++KLADFGLA+A T ++V T ++ APE++
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL- 172
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKI-------------GGGELP 443
L Y DIWSLGC EM+TRR + +F+I G LP
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232
Query: 444 P----------------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
VP L D +D + + L +PN R +A + HPF
Sbjct: 233 DYKPSFPKWARQDFSKVVPP-LDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 3e-35
Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 16/257 (6%)
Query: 233 LGSGSYGFV-YEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291
+G GSYG V DG + +K+++L++ R +++ EQE LL Q +H NIV Y
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAA---EQEAQLLSQLKHPNIVAY 64
Query: 292 LGTDRDEKRLCIFLELVTKGSLASLYQKYH------LSDSQVSSYTRQILNGLKYLHEQN 345
+ E L + +G LY K L ++QV + QI L+YLHE++
Sbjct: 65 RESWEGEDGLLYIVMGFCEG--GDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAKA-TTMNDVKSCK-GTAFWMAPEVVNLKKDGYG 403
++HRD+K N+ + + +K+ D G+A+ D+ S GT ++M+PE+ + K Y
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP--YN 180
Query: 404 LTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQV 463
+D+W+LGC V EM T +H ++ + +++I G+LPP+P S + + I L
Sbjct: 181 YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSK 240
Query: 464 NPNDRPTAAQLMEHPFI 480
P RP+ ++ P+I
Sbjct: 241 RPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 3e-35
Identities = 88/267 (32%), Positives = 138/267 (51%), Gaps = 23/267 (8%)
Query: 231 ELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD-NI 288
EL+G+G+YG VY+G G A+K + + + +++QEI++L ++ H NI
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE------EIKQEINMLKKYSHHRNI 65
Query: 289 VQYLGT------DRDEKRLCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILNGLK 339
Y G + +L + +E GS+ L + L + ++ R+IL GL
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTAFWMAPEVVNL 397
+LH+ V+HRDIK N+L+ + VKL DFG++ T+ + GT +WMAPEV+
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 398 KKD---GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPN-SLSRDA 453
++ Y +D+WSLG T +EM P + +A+F I P + + S+
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKF 245
Query: 454 QDFILKCLQVNPNDRPTAAQLMEHPFI 480
Q FI CL N + RPT QLM+HPFI
Sbjct: 246 QSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 6e-35
Identities = 88/297 (29%), Positives = 143/297 (48%), Gaps = 43/297 (14%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQD--EGPRG-KQSILQLEQEISLLGQ 282
++KG+ LG G+Y VY+ + G A+K++ L + E G + L+ EI LL +
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR---EIKLLQE 58
Query: 283 FEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKY 340
+H NI+ L + + + E + + L + + L+ + + SY L GL+Y
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT-TMNDVKSCKGTAFWM-APEVVNLK 398
LH ++HRD+K N+L+ + G +KLADFGLA++ + N + + W APE++
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELL-FG 176
Query: 399 KDGYGLTADIWSLGCTVLEMLTRRHPY----SHLEGGQAMFKIGG--------------- 439
YG+ D+WS+GC E+L R P+ S ++ +F+ G
Sbjct: 177 ARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235
Query: 440 ----GELPPVP-----NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK-RPLQT 486
PP P + S DA D + + L +NPN R TA Q +EHP+ P T
Sbjct: 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 77/261 (29%), Positives = 128/261 (49%), Gaps = 27/261 (10%)
Query: 236 GSYGFVY---EGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYL 292
G++G VY + T D +FA+K + D + + + ++ E+ I ++ Q E + +
Sbjct: 7 GAFGSVYLAKKRSTGD--YFAIKVLKKSDMIAKNQVTNVKAERAI-MMIQGESPYVAKLY 63
Query: 293 GTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDI 351
+ + + L + +E + G ASL + L + Y +++ G++ LH++ ++HRDI
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 352 KCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTA--DIW 409
K N+L+D +G +KL DFGL++ N K GT ++APE + G G D W
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSRNGLEN--KKFVGTPDYLAPETIL----GVGDDKMSDWW 177
Query: 410 SLGCTVLEMLTRRHPYSHLEGGQAMFK------IGGGELPPVPNSLSRDAQDFILKCLQV 463
SLGC + E L P+ H E A+F I E V S +A D I + L +
Sbjct: 178 SLGCVIFEFLFGYPPF-HAETPDAVFDNILSRRINWPE--EVKEFCSPEAVDLINRLLCM 234
Query: 464 NPNDRPTA---AQLMEHPFIK 481
+P R A ++ HPF K
Sbjct: 235 DPAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 4e-34
Identities = 73/244 (29%), Positives = 120/244 (49%), Gaps = 14/244 (5%)
Query: 233 LGSGSYGFVYE-GLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291
LG G +G V + FA+K V + G+Q + E+EI L + H IV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEI--LEECNHPFIVKL 58
Query: 292 LGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRD 350
T +D+K + + +E G L + L + + Y ++ +YLH + +++RD
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRD 118
Query: 351 IKCANILVDASGSVKLADFGLAK-ATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIW 409
+K N+L+D++G VKL DFG AK + + GT ++APE++ K GY + D W
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNK--GYDFSVDYW 176
Query: 410 SLGCTVLEMLTRRHPYSHLEGGQAMFKI-----GGGELPPVPNSLSRDAQDFILKCLQVN 464
SLG + E+LT R P+ + +I G PN + + A+D I + L+ N
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDP--MEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234
Query: 465 PNDR 468
P +R
Sbjct: 235 PEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 5e-34
Identities = 89/277 (32%), Positives = 141/277 (50%), Gaps = 31/277 (11%)
Query: 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVK---EVSLQDEGPRGKQSILQLEQEISLLG 281
+W+ E +G G+YG V++ L +G AVK + DE ++E E ++L
Sbjct: 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE---------EIEAEYNILK 69
Query: 282 QF-EHDNIVQYLGT--DRDEK---RLCIFLELVTKGSLASLYQKY-----HLSDSQVSSY 330
+H N+V++ G +D K +L + LEL GS+ L + + + + ++
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 331 TRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTAF 388
+ L GL++LH +HRD+K NIL+ G VKL DFG++ T ++ + GT F
Sbjct: 130 LHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF 189
Query: 389 WMAPEVVNLKKD---GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV 445
WMAPEV+ ++ Y D+WSLG T +E+ P + L +A+FKI P +
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTL 249
Query: 446 --PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480
P S + DFI KCL + RPT + L++H FI
Sbjct: 250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 8e-34
Identities = 80/260 (30%), Positives = 125/260 (48%), Gaps = 23/260 (8%)
Query: 234 GSGSYGFVYE-GLTDDGFFFAVKEVSLQDEGPRGK-QSILQLEQEISLLGQFEHDNIVQY 291
G G++G V D FA+K ++ Q +G +++L E +L + H +V
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN---ERRILQELNHPFLVNL 65
Query: 292 LGTDRDEKRLCIFLELVTKGSLA-SLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRD 350
+ +DE+ + + ++L+ G L L QK S+ QV + +I+ L+YLH + ++HRD
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRD 125
Query: 351 IKCANILVDASGSVKLADFGLA---KATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTAD 407
IK NIL+D G V + DF +A T+ S GT +MAPEV L + GY + D
Sbjct: 126 IKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGYMAPEV--LCRQGYSVAVD 181
Query: 408 IWSLGCTVLEMLTRRHPY-----SHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQ 462
WSLG T E L + PY + + +A + P + S +A D I K L+
Sbjct: 182 WWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE---TADVLYPATWSTEAIDAINKLLE 238
Query: 463 VNPNDR--PTAAQLMEHPFI 480
+P R L HP+
Sbjct: 239 RDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 1e-33
Identities = 91/273 (33%), Positives = 141/273 (51%), Gaps = 16/273 (5%)
Query: 214 VSPNGKFRRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQ 272
VSP G R + S+ K +G GS G V G AVK++ L R +Q
Sbjct: 15 VSP-GDPREYLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQRREL 65
Query: 273 LEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTR 332
L E+ ++ + H+N+V + L + +E + G+L + +++ Q+++
Sbjct: 66 LFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCL 125
Query: 333 QILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDVKSCKGTAFWM 390
+L L YLH Q V+HRDIK +IL+ + G +KL+DFG + + KS GT +WM
Sbjct: 126 SVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWM 185
Query: 391 APEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNS-- 448
APEV++ + YG DIWSLG V+EM+ PY + QAM +I P V +S
Sbjct: 186 APEVIS--RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHK 243
Query: 449 LSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
+S + F+ L P+ R TA +L++HPF+K
Sbjct: 244 VSSVLRGFLDLMLVREPSQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 71/255 (27%), Positives = 122/255 (47%), Gaps = 22/255 (8%)
Query: 233 LGSGSYGFVYEG--LTDDGFFFAVKEVSL----QDEGPRGKQSILQLEQEISLLGQFEHD 286
LG G++G V +G L G EV++ Q+ GK+ L+ E S++ Q +H
Sbjct: 3 LGHGNFGSVVKGVYLMKSG---KEVEVAVKTLKQEHIAAGKKEFLR---EASVMAQLDHP 56
Query: 287 NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQN 345
IV+ +G + E L + +EL G L +K + S + Q+ G+ YL ++
Sbjct: 57 CIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH 115
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTAF---WMAPEVVNLKKD 400
VHRD+ N+L+ K++DFG+++A ++ + W APE +N K
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK- 174
Query: 401 GYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILK 459
+ +D+WS G T+ E + PY ++G + + + GE P P ++ +L
Sbjct: 175 -FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLS 233
Query: 460 CLQVNPNDRPTAAQL 474
C + P DRPT ++L
Sbjct: 234 CWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 4e-33
Identities = 87/276 (31%), Positives = 139/276 (50%), Gaps = 40/276 (14%)
Query: 233 LGSGSYGFVY----EGLTDDGFFFAVKEVS----LQD----EGPRGKQSILQLEQE---- 276
LG+G+YG V+ G D G +A+K + +Q E R ++ +L+ +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 277 ISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQIL 335
++L F+ D +L + L+ V G L + LYQ+ H ++S+V Y +I+
Sbjct: 68 VTLHYAFQTDT------------KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIV 115
Query: 336 NGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK---ATTMNDVKSCKGTAFWMAP 392
L +LH+ +++RDIK NIL+D+ G V L DFGL+K A S GT +MAP
Sbjct: 116 LALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 393 EVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ----AMFKIGGGELPPVPNS 448
EV+ G+ D WSLG E+LT P++ ++G Q + + PP P +
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT-VDGEQNSQSEISRRILKSKPPFPKT 234
Query: 449 LSRDAQDFILKCLQVNPNDR---PTAAQLMEHPFIK 481
+S +A+DFI K L+ +P R A ++ HPF +
Sbjct: 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 5e-33
Identities = 90/278 (32%), Positives = 136/278 (48%), Gaps = 31/278 (11%)
Query: 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVK---EVSLQDEGPRGKQSILQLEQEISLLG 281
+W+ E +G G+YG VY+ DG AVK +S DE ++E E ++L
Sbjct: 23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE---------EIEAEYNILQ 73
Query: 282 QF-EHDNIVQYLGT--DRDE---KRLCIFLELVTKGSLASLYQKY-----HLSDSQVSSY 330
H N+V++ G D+ +L + LEL GS+ L + L ++ +S
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 331 TRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTAF 388
L GL++LH ++HRD+K NIL+ G VKL DFG++ T ++ + GT F
Sbjct: 134 LYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF 193
Query: 389 WMAPEVVNLKKD---GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV 445
WMAPEV+ ++ Y D+WSLG T +E+ P + + +FKI P +
Sbjct: 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL 253
Query: 446 --PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
P R FI +CL + RP+ L+EHPFIK
Sbjct: 254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 6e-33
Identities = 84/257 (32%), Positives = 137/257 (53%), Gaps = 16/257 (6%)
Query: 233 LGSGSYGFV-YEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291
+G GS G V + G AVK++ L R +Q L E+ ++ ++H+N+V+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 82
Query: 292 LGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDI 351
+ L + +E + G+L + +++ Q+++ +L L LH Q V+HRDI
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDI 142
Query: 352 KCANILVDASGSVKLADFGLAKATTMNDV---KSCKGTAFWMAPEVVNLKKDGYGLTADI 408
K +IL+ G VKL+DFG A +V KS GT +WMAPE+++ + YG DI
Sbjct: 143 KSDSILLTHDGRVKLSDFGFC-AQVSKEVPRRKSLVGTPYWMAPELIS--RLPYGPEVDI 199
Query: 409 WSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDA---QDFILKCLQVNP 465
WSLG V+EM+ PY + +AM K+ LPP +L + + + F+ + L +P
Sbjct: 200 WSLGIMVIEMVDGEPPYFNEPPLKAM-KMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDP 258
Query: 466 NDRPTAAQLMEHPFIKR 482
R TAA+L++HPF+ +
Sbjct: 259 AQRATAAELLKHPFLAK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 6e-33
Identities = 87/312 (27%), Positives = 140/312 (44%), Gaps = 62/312 (19%)
Query: 223 RITSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLG 281
++ ++ LG G++G VY+ G A+K++ + +E + I L +EI +L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE--KDGFPITAL-REIKILK 62
Query: 282 QFEHDNIVQYL------GTDRDEKRLCIFLELVT---KGSLASLY--QKYHLSDSQVSSY 330
+ +H N+V + KR +++ VT L+ L L++SQ+ Y
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYM--VTPYMDHDLSGLLENPSVKLTESQIKCY 120
Query: 331 TRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK-----------ATTMND 379
Q+L G+ YLHE +++HRDIK ANIL+D G +K+ADFGLA+
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180
Query: 380 VK--SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY----SHLEGGQA 433
K + T ++ PE++ L + Y DIW +GC EM TRR P S ++
Sbjct: 181 RKYTNLVVTRWYRPPELL-LGERRYTTAVDIWGIGCVFAEMFTRR-PILQGKSDIDQLHL 238
Query: 434 MFKIGGG----------ELPPVPN----------------SLSRDAQDFILKCLQVNPND 467
+FK+ G LP L + D + K L ++P
Sbjct: 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYK 298
Query: 468 RPTAAQLMEHPF 479
R TA+ +EHP+
Sbjct: 299 RLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 2e-32
Identities = 85/267 (31%), Positives = 136/267 (50%), Gaps = 23/267 (8%)
Query: 231 ELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD-NI 288
E++G+G+YG VY+G G A+K + + ++ +++ EI++L ++ H NI
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE------EIKLEINMLKKYSHHRNI 75
Query: 289 VQYLGT------DRDEKRLCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILNGLK 339
Y G + +L + +E GS+ L + L + ++ R+IL GL
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTAFWMAPEVVNL 397
+LH V+HRDIK N+L+ + VKL DFG++ T+ + GT +WMAPEV+
Sbjct: 136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 398 KKD---GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPN-SLSRDA 453
++ Y +DIWSLG T +EM P + +A+F I P + + S+
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKF 255
Query: 454 QDFILKCLQVNPNDRPTAAQLMEHPFI 480
DFI CL N RP+ QL++HPFI
Sbjct: 256 IDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 76/260 (29%), Positives = 118/260 (45%), Gaps = 21/260 (8%)
Query: 231 ELLGSGSYGFVYEG--LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
+ LG GS+G V G T G V L+ + +E +++ +H+N+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMD--DFLKEAAIMHSLDHENL 58
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSS---YTRQILNGLKYLHEQN 345
++ G + + EL GSL +K L +S+ Y QI NG++YL +
Sbjct: 59 IRLYGVVLTHPLMMVT-ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF-------WMAPEVVNLK 398
+HRD+ NIL+ + VK+ DFGL +A N+ W APE + +
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNE--DHYVMEEHLKVPFAWCAPESLRTR 175
Query: 399 KDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKI-GGGELPPVPNSLSRDAQDF 456
+ +D+W G T+ EM T P++ L G Q + KI GE P + +D +
Sbjct: 176 T--FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNV 233
Query: 457 ILKCLQVNPNDRPTAAQLME 476
+L+C NP DRPT A L E
Sbjct: 234 MLQCWAHNPADRPTFAALRE 253
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 5e-32
Identities = 94/290 (32%), Positives = 136/290 (46%), Gaps = 48/290 (16%)
Query: 229 KGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
K E +G G+YG VY+G G A+K++ L+ E G S +EISLL + +H N
Sbjct: 4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAI--REISLLKELQHPN 60
Query: 288 IVQYLGTDRDEKRLCIFLELVT---KGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQ 344
IV E RL + E ++ K L SL + ++ V SY QIL G+ + H +
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKA-------TTMNDVKSCKGTAFWMAPEVVNL 397
V+HRD+K N+L+D G +KLADFGLA+A T V T ++ APEV+ L
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-----TLWYRAPEVL-L 174
Query: 398 KKDGYGLTADIWSLGCTVLEMLTRR---HPYSHLEGGQAMFKIGGG----------ELPP 444
Y DIWS+G EM T++ H S ++ +F+I G LP
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234
Query: 445 VPNS---------------LSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
N+ L D D + K L +P R +A + + HP+
Sbjct: 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 6e-32
Identities = 62/161 (38%), Positives = 92/161 (57%), Gaps = 17/161 (10%)
Query: 334 ILNGLKYLHE-QNVVHRDIKCANILVDASGSVKLADFGLA------KATTMNDVKSCKGT 386
I+ L YL E V+HRD+K +NIL+DASG+VKL DFG++ KA T +S G
Sbjct: 123 IVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT----RS-AGC 177
Query: 387 AFWMAPEVVNLK--KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-QAMFKIGGGELP 443
A +MAPE ++ Y + AD+WSLG +++E+ T + PY + + + + KI E P
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237
Query: 444 PVPN--SLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
+P S D F+ CL + RP +L++HPFI+R
Sbjct: 238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 8e-32
Identities = 76/255 (29%), Positives = 127/255 (49%), Gaps = 18/255 (7%)
Query: 231 ELLGSGSYGFVYEGLTDDG--FFFAVKEVSLQD----EGPRGK-QSILQLEQEISLLG-Q 282
E LGSG++G VY+ + A+KE+++ + + R + +SI + E++++ Q
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 283 FEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLY-----QKYHLSDSQVSSYTRQILNG 337
H NIV+Y T + RL I ++L+ L + +K ++ ++ + Q++
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 338 LKYLH-EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VKSCKGTAFWMAPEVV 395
L+YLH E+ +VHRD+ NI++ V + DFGLAK + S GT + PE+V
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIV 185
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSL-SRDAQ 454
K + YG AD+W+ GC + +M T + P+ KI P+P + S D
Sbjct: 186 --KNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVT 243
Query: 455 DFILKCLQVNPNDRP 469
D I CL + RP
Sbjct: 244 DVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 78/264 (29%), Positives = 123/264 (46%), Gaps = 20/264 (7%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEG----LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQE 276
R IT G +G G +G VY+G ++ AVK ++ LQ E
Sbjct: 5 REDITL---GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSV-REKFLQ---E 57
Query: 277 ISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQ--KYHLSDSQVSSYTRQI 334
++ QF+H +IV+ +G + + I +EL G L S Q KY L + + Y+ Q+
Sbjct: 58 AYIMRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQL 116
Query: 335 LNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-KSCKGT--AFWMA 391
L YL + VHRDI N+LV + VKL DFGL++ K+ KG WMA
Sbjct: 117 STALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMA 176
Query: 392 PEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLS 450
PE +N ++ + +D+W G + E+L P+ ++ + +I GE P+P +
Sbjct: 177 PESINFRR--FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCP 234
Query: 451 RDAQDFILKCLQVNPNDRPTAAQL 474
+ KC +P+ RP +L
Sbjct: 235 PTLYSLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 81/264 (30%), Positives = 131/264 (49%), Gaps = 27/264 (10%)
Query: 233 LGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGK---QSILQLEQEISLLGQFEHDNIV 289
LG GS+G VY L D A + + + E P G+ +Q QE LL + +H IV
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-----LSDSQVSSYTRQILNGLKYLHEQ 344
++ + + CI E L ++ LS++QV + Q+L G+ Y+H++
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAK--------ATTMNDVKSCKGTAFWMAPEVVN 396
++HRD+K NI + + +K+ DFG+++ ATT GT ++M+PE
Sbjct: 126 RILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFT------GTPYYMSPEA-- 176
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDF 456
LK GY +DIWSLGC + EM H + + +I G P +P + SR
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236
Query: 457 ILKCLQVNPNDRPTAAQLMEHPFI 480
+ L +P+ RP+AA+++ +PFI
Sbjct: 237 MQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 4e-31
Identities = 82/262 (31%), Positives = 132/262 (50%), Gaps = 18/262 (6%)
Query: 228 QKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286
Q E+LG G+ G VY+ AVK + L D ++ I+ E+ +L + +
Sbjct: 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPL-DITVELQKQIMS---ELEILYKCDSP 59
Query: 287 NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNV 346
I+ + G E R+ I E + GSL +Y+K + + + ++ GL YL +
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSL-DVYRK--IPEHVLGRIAVAVVKGLTYLWSLKI 116
Query: 347 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTA 406
+HRD+K +N+LV+ G VKL DFG++ + K+ GT +MAPE + + YG+ +
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPE--RISGEQYGIHS 174
Query: 407 DIWSLGCTVLEMLTRRHPYSHLEGGQA------MFKIGGGELPPV-PNSL-SRDAQDFIL 458
D+WSLG + +E+ R PY ++ Q + + E PPV P S FI
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFIT 234
Query: 459 KCLQVNPNDRPTAAQLMEHPFI 480
+C++ P +RP LM+HPFI
Sbjct: 235 QCMRKQPKERPAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 5e-31
Identities = 70/245 (28%), Positives = 117/245 (47%), Gaps = 15/245 (6%)
Query: 233 LGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYL 292
LG+G +G V+EGL ++ AVK + G E ++ + H ++Q
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK------PGTMDPKDFLAEAQIMKKLRHPKLIQLY 67
Query: 293 GTDRDEKRLCIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQNVVHR 349
E+ + I EL+ GSL Q L Q+ Q+ +G+ YL QN +HR
Sbjct: 68 AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHR 127
Query: 350 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKKDGYGLTA 406
D+ N+LV + K+ADFGLA+ + ++ +G F W APE + + + +
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR--FSIKS 185
Query: 407 DIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465
D+WS G + E++T R PY + + + ++ G P P ++ D +L C + +P
Sbjct: 186 DVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDP 245
Query: 466 NDRPT 470
+DRPT
Sbjct: 246 DDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 78/292 (26%), Positives = 127/292 (43%), Gaps = 47/292 (16%)
Query: 226 SWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE 284
++K E +G G+YG V++ + A+K V L D+ S L+ EI LL + +
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELK 57
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY------HLSDSQVSSYTRQILNGL 338
H NIV+ +K+L + E + +KY + V S+ Q+L GL
Sbjct: 58 HKNIVRLYDVLHSDKKLTLVFEYCDQD-----LKKYFDSCNGDIDPEIVKSFMFQLLKGL 112
Query: 339 KYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTAFWMAPEVVN 396
+ H NV+HRD+K N+L++ +G +KLADFGLA+A + V+ S + W P V
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI-PVRCYSAEVVTLWYRPPDVL 171
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTRRHP----YSHLEGGQAMFKIGGG------------ 440
Y + D+WS GC E+ P + + +F++ G
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231
Query: 441 ----ELPPVPN---------SLSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
P P L+ +D + L NP R +A + ++HP+
Sbjct: 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 78/253 (30%), Positives = 129/253 (50%), Gaps = 25/253 (9%)
Query: 233 LGSGSYGFVYEG-LTDDGFFFAVKEVSLQD-EGPRGKQSILQLEQEISLLGQFEHDNIVQ 290
+G G + VY DG A+K+V + D + + ++ EI LL Q H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQLNHPNVIK 66
Query: 291 YLGTDRDEKRLCIFLELVTKGSLASLY-----QKYHLSDSQVSSYTRQILNGLKYLHEQN 345
Y + ++ L I LEL G L+ + QK + + V Y Q+ + L+++H +
Sbjct: 67 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTAFWMAPEVVNLKKDGYG 403
V+HRDIK AN+ + A+G VKL D GL + ++ S GT ++M+PE ++ ++GY
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH--ENGYN 184
Query: 404 LTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF------KIGGGELPPVP-NSLSRDAQDF 456
+DIWSLGC + EM + P+ G M KI + PP+P + S + +
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFY----GDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 240
Query: 457 ILKCLQVNPNDRP 469
+ C+ +P RP
Sbjct: 241 VNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-30
Identities = 88/294 (29%), Positives = 137/294 (46%), Gaps = 51/294 (17%)
Query: 226 SWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE 284
++++ E LG G+Y VY+G G A+KE+ L E +I +EISL+ + +
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI----REISLMKELK 56
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-----LSDSQVSSYTRQILNGLK 339
H+NIV+ E +L + E + K Y H L + V S+T Q+L G+
Sbjct: 57 HENIVRLHDVIHTENKLMLVFEYMDKD--LKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTAFWMAPE 393
+ HE V+HRD+K N+L++ G +KLADFGLA+A T N+V T ++ AP+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV----TLWYRAPD 170
Query: 394 VVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAM---FKIGG----------- 439
V+ L Y + DIWS+GC + EM+T R + + F+I G
Sbjct: 171 VL-LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229
Query: 440 ------GELPPVPN--------SLSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
P P D + + LQ+NP R +A ++HP+
Sbjct: 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 82/293 (27%), Positives = 136/293 (46%), Gaps = 45/293 (15%)
Query: 231 ELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
E +GSG+YG V + T G A+K++ + P + L+ E+ +L F+HDNI+
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR---ELKILRHFKHDNII 67
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKYH----LSDSQVSSYTRQILNGLKYLHEQN 345
R + +V + L+ H L++ + + Q+L GLKY+H N
Sbjct: 68 AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN 127
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK------GTAFWMAPEVVNLKK 399
V+HRD+K +N+LV+ +++ DFG+A+ + + + T ++ APE++ L
Sbjct: 128 VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL-LSL 186
Query: 400 DGYGLTADIWSLGCTVLEMLTRRH--P---YSH----------LEGGQAMFKIGG----- 439
Y D+WS+GC EML RR P Y H + + +IG
Sbjct: 187 PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRK 246
Query: 440 -----GELPPVPNS-----LSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
PVP S S +A D + + LQ +P +R T Q ++HPF+ +
Sbjct: 247 YIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 68/209 (32%), Positives = 112/209 (53%), Gaps = 20/209 (9%)
Query: 275 QEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLY-----QKYHLSDSQVSS 329
+EI LL Q H N+++YL + ++ L I LEL G L+ + QK + + V
Sbjct: 51 KEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWK 110
Query: 330 YTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTA 387
Y Q+ + ++++H + V+HRDIK AN+ + A+G VKL D GL + ++ S GT
Sbjct: 111 YFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP 170
Query: 388 FWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAM------FKIGGGE 441
++M+PE ++ ++GY +DIWSLGC + EM + P+ G M KI +
Sbjct: 171 YYMSPERIH--ENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLFSLCQKIEQCD 224
Query: 442 LPPVPNS-LSRDAQDFILKCLQVNPNDRP 469
PP+P S ++ + C+ +P+ RP
Sbjct: 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 73/263 (27%), Positives = 130/263 (49%), Gaps = 20/263 (7%)
Query: 233 LGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYL 292
LG+G+ G V + K+V ++ IL+ E+ ++ + IV +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILR---ELQIMHECRSPYIVSFY 69
Query: 293 GTDRDEKRLCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLH-EQNVVHRD 350
G +E +C+ +E + GSL +Y+K + + ++ GL YL+ ++HRD
Sbjct: 70 GAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRD 129
Query: 351 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWS 410
IK +NILV++ G +KL DFG++ + + GT+ +M+PE ++ Y + +D+WS
Sbjct: 130 IKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPE--RIQGGKYTVKSDVWS 187
Query: 411 LGCTVLEMLTRRHPYSHLEG---GQA--------MFKIGGGELPPVPNS-LSRDAQDFIL 458
LG +++E+ + P++ GQ + +I P +P+S D +DF+
Sbjct: 188 LGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVD 247
Query: 459 KCLQVNPNDRPTAAQLME-HPFI 480
CL +P +RPT QL PFI
Sbjct: 248 ACLLKDPTERPTPQQLCAMPPFI 270
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-30
Identities = 81/270 (30%), Positives = 132/270 (48%), Gaps = 35/270 (12%)
Query: 232 LLGSGSYGFV----YEGLTDDGFFFAVK----EVSLQD---EGPRGKQSILQLEQEISLL 280
+LG GS+G V +G TD+ +AVK +V LQD E ++ +L L
Sbjct: 2 VLGKGSFGKVLLAELKG-TDE--LYAVKVLKKDVILQDDDVECTMTEKRVLAL------- 51
Query: 281 GQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLK 339
+H + Q + + RL +E V G L Q+ + + Y +I+ GL+
Sbjct: 52 -AGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQ 110
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTAFWMAPEVVN 396
+LHE+ +++RD+K N+L+D+ G +K+ADFG+ K + V + C GT ++APE+
Sbjct: 111 FLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYIAPEI-- 167
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDF 456
L YG D W+LG + EML + P+ + +F+ + P LS++A+
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSPF-EGDDEDELFQSILEDEVRYPRWLSKEAKSI 226
Query: 457 ILKCLQVNPNDR----PTAAQ-LMEHPFIK 481
+ L NP R PT Q + HPF +
Sbjct: 227 LKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-30
Identities = 70/260 (26%), Positives = 129/260 (49%), Gaps = 11/260 (4%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++K ++G G++G V+ D +K++ ++ + + + E +L H
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAA---QNECQVLKLLSH 58
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLH 342
NI++Y ++K L I +E G+LA QK L + + + QIL L ++H
Sbjct: 59 PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118
Query: 343 EQNVVHRDIKCANILVDASGSV-KLADFGLAKA-TTMNDVKSCKGTAFWMAPEVVNLKKD 400
+ ++HRD+K NIL+D V K+ DFG++K ++ + + GT +++PE+ K
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKP- 177
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460
Y +DIW+LGC + E+ + + + + KI G P+ + S D + IL
Sbjct: 178 -YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSM 236
Query: 461 LQVNPNDRPTAAQLMEHPFI 480
L ++P+ RP +Q+M P
Sbjct: 237 LNLDPSKRPQLSQIMAQPIC 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 9e-30
Identities = 82/292 (28%), Positives = 138/292 (47%), Gaps = 48/292 (16%)
Query: 233 LGSGSYGFVYEGLTDD-GFFFAVKEVSLQDEGPRGKQSI-LQLEQEISLLGQFEHDNIVQ 290
+G G+YG VY+ D G A+K+V L +E K+ + +EI +L Q H NIV
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNE----KEGFPITAIREIKILRQLNHRNIVN 70
Query: 291 Y--LGTD--------RDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLK 339
+ TD +D+ + E + + L H S+ + S+ +Q+L GL
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLN 130
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTAFWMAPEVVNL 397
Y H++N +HRDIKC+NIL++ G +KLADFGLA+ + + + K W P + L
Sbjct: 131 YCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLL 190
Query: 398 KKDGYGLTADIWSLGCTVLEMLTRRHPY-SHLEGGQ--AMFKIGGGELPPV-PNS----- 448
++ YG D+WS GC + E+ T++ + ++ E Q + ++ G P V P+
Sbjct: 191 GEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPY 250
Query: 449 --------------------LSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480
+ A D + L ++P+ R TA + + P++
Sbjct: 251 FNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 78/298 (26%), Positives = 131/298 (43%), Gaps = 60/298 (20%)
Query: 227 WQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++K +G GSYG V++ + G A+K+ ++ P K+ L+ EI +L Q +H
Sbjct: 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR---EIRMLKQLKH 59
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQ 344
N+V + R +++L + E L L + + + + Q L + + H+
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTAFWMAPEVVNLKKD-G 401
N +HRD+K NIL+ G +KL DFG A+ +D T ++ APE+ L D
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPEL--LVGDTQ 177
Query: 402 YGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-------------KIGGGELP----- 443
YG D+W++GC E+LT GQ ++ K G +P
Sbjct: 178 YGPPVDVWAIGCVFAELLT----------GQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227
Query: 444 ------------PVPNS----------LSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
P P + +S A F+ CLQ++P +R + +L+EHP+
Sbjct: 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 90/301 (29%), Positives = 127/301 (42%), Gaps = 63/301 (20%)
Query: 226 SWQKGELLGSGSYGFVYEG---LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQ 282
+++K + LG GSY VY+G LT A+KE+ L+ E +I +E SLL
Sbjct: 6 TYKKLDKLGEGSYATVYKGRSKLTGQ--LVALKEIRLEHEEGAPFTAI----REASLLKD 59
Query: 283 FEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILNGLK 339
+H NIV +K L + E + Y LS V + Q+L GL
Sbjct: 60 LKHANIVTLHDIIHTKKTLTLVFEYLDTD--LKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTAFWMAPE 393
Y H++ V+HRD+K N+L+ G +KLADFGLA+A T N+V W P
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEV-----VTLWYRPP 172
Query: 394 VVNLKKDGYGLTADIWSLGCTVLEMLTRR-------HPYSHLEGGQAMFKIGG------- 439
V L Y + D+W +GC EM T R L +F++ G
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLH---KIFRVLGTPTEETW 229
Query: 440 --------------GELPPVP-----NSLSR--DAQDFILKCLQVNPNDRPTAAQLMEHP 478
PP P L R ++ LK LQ P R +AA+ M+HP
Sbjct: 230 PGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP 289
Query: 479 F 479
+
Sbjct: 290 Y 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 75/253 (29%), Positives = 128/253 (50%), Gaps = 18/253 (7%)
Query: 232 LLGSGSYG---FVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
++G GS+G V +D +A+KE+ L P+ ++ +E LL + +H NI
Sbjct: 7 VVGEGSFGRALLVQHVNSDQ--KYAMKEIRL----PKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLASLY--QKYHL-SDSQVSSYTRQILNGLKYLHEQN 345
V + + + L I +E G L Q+ L + + + Q+ G++++HE+
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTAFWMAPEV-VNLKKDGY 402
V+HRDIK NI + +G VKL DFG A+ T +C GT +++ PE+ N+ Y
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP---Y 177
Query: 403 GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQ 462
+DIWSLGC + E+ T +HP+ + K+ G P+P+ S + + I + +
Sbjct: 178 NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFK 237
Query: 463 VNPNDRPTAAQLM 475
NP RP+A ++
Sbjct: 238 RNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 78/262 (29%), Positives = 116/262 (44%), Gaps = 32/262 (12%)
Query: 228 QKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
+ G +G G +G V G G AVK L+D+ Q+ L E S++ H N
Sbjct: 9 KLGATIGKGEFGDVMLG-DYRGQKVAVK--CLKDDS-TAAQAFLA---EASVMTTLRHPN 61
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQ---KYHLSDSQVSSYTRQILNGLKYLHEQ 344
+VQ LG L I E + KGSL + + ++ +Q + + G++YL E+
Sbjct: 62 LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGL 404
N VHRD+ N+LV K++DFGLAK + S K W APE + KK +
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-QDSGKLPVKWTAPEALREKK--FST 178
Query: 405 TADIWSLGCTVLEMLT-RRHPY---------SHLEGGQAMFKIGGGELPPVPNSLSRDAQ 454
+D+WS G + E+ + R PY H+E G M P +
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM---------EAPEGCPPEVY 229
Query: 455 DFILKCLQVNPNDRPTAAQLME 476
+ C +++P RPT QL E
Sbjct: 230 KVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 78/276 (28%), Positives = 128/276 (46%), Gaps = 33/276 (11%)
Query: 228 QKGELLGSGSYGFV----YEGLTDD-GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQ 282
+K +LG G +G V Y+ D G AVK + ++ G + ++EI++L
Sbjct: 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK-RECGQQNTSG---WKKEINILKT 62
Query: 283 FEHDNIVQYLG--TDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKY 340
H+NIV+Y G +++ K L + +E V GSL K+ L+ +Q+ + +QI G+ Y
Sbjct: 63 LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAY 122
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTAFWMAPEVV 395
LH Q+ +HRD+ N+L+D VK+ DFGLAKA + FW A E
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC- 181
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTRRHPY-SHLEGGQAMFKIGGGELP----------- 443
LK++ + +D+WS G T+ E+LT S + + M G++
Sbjct: 182 -LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240
Query: 444 ---PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476
P P + ++ + C + RPT L+
Sbjct: 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 74/293 (25%), Positives = 128/293 (43%), Gaps = 62/293 (21%)
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSI-LQLEQEISLLGQFEHDNIVQ 290
+G G++G V++ + G A+K+V+L R + I Q +EI L +H +V+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVAL----RRLEGGIPNQALREIKALQACQHPYVVK 63
Query: 291 YLGTDRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHEQNVVH 348
L + +E + L+ + + L ++QV SY R +L G+ Y+H ++H
Sbjct: 64 LLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMH 122
Query: 349 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTAFWMAPEVVNLKKDGYGLT 405
RD+K AN+L+ A G +K+ADFGLA+ + + + T ++ APE++ Y
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL-YGARKYDPG 181
Query: 406 ADIWSLGCTVLEMLTRRHPYSHLEGGQAMF------------------------------ 435
D+W++GC E+L G +F
Sbjct: 182 VDLWAVGCIFAELL----------NGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231
Query: 436 ----KIGGGELPPVP-----NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
KI E P+P S +A D + L +P+ R +AA+ + HP+
Sbjct: 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 80/269 (29%), Positives = 123/269 (45%), Gaps = 34/269 (12%)
Query: 233 LGSGSYGFVYEGL-----TDDGFF-FAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286
LG GS+G VYEGL + A+K V+ ++ R + L E S++ +F
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN-ENASMRERIEFLN---EASVMKEFNCH 69
Query: 287 NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQ----VSSYTR--------QI 334
++V+ LG + + +EL+ KG L S Y + +++ + T +I
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKS-YLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 335 LNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKGT--AFWM 390
+G+ YL + VHRD+ N +V +VK+ DFG+ + D K KG WM
Sbjct: 129 ADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 391 APEVVNLKKDGYGLTA-DIWSLGCTVLEMLT-RRHPYSHLEGGQAM-FKIGGGELPPVPN 447
APE + KDG T D+WS G + EM T PY L + + F I GG L P
Sbjct: 189 APESL---KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDL-PE 244
Query: 448 SLSRDAQDFILKCLQVNPNDRPTAAQLME 476
+ + + C Q NP RPT +++
Sbjct: 245 NCPDKLLELMRMCWQYNPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 74/256 (28%), Positives = 123/256 (48%), Gaps = 15/256 (5%)
Query: 226 SWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
S + LG+G +G V+ G + AVK + G ++ LQ E ++ + H
Sbjct: 7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLK---PGTMSPEAFLQ---EAQIMKKLRH 60
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLH 342
D +VQ +E+ + I E ++KGSL + L Q+ QI G+ YL
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKK 399
+N +HRD+ NILV + K+ADFGLA+ ++ + +G F W APE N +
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGR 180
Query: 400 DGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFIL 458
+ + +D+WS G + E++T R PY + + + ++ G P P + + D +L
Sbjct: 181 --FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLML 238
Query: 459 KCLQVNPNDRPTAAQL 474
+C +P +RPT L
Sbjct: 239 QCWDKDPEERPTFEYL 254
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 71/205 (34%), Positives = 109/205 (53%), Gaps = 10/205 (4%)
Query: 222 RRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLL 280
R +T ++K +G G+YG VY T G A+K+V + +E R I L +EI+LL
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE--RDGIPISSL-REITLL 60
Query: 281 GQFEHDNIVQYLGTDRDEKRLCIFLEL-VTKGSLASLYQ--KYHLSDSQVSSYTRQILNG 337
H NIV+ + IFL + + LASL S+SQV Q+L G
Sbjct: 61 LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRG 120
Query: 338 LKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKGTAFWMAPEVV 395
L+YLHE ++HRD+K +N+L+ G +K+ADFGLA+ + + T ++ APE++
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELL 180
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLT 420
L Y D+W++GC + E+L
Sbjct: 181 -LGCTTYTTAIDMWAVGCILAELLA 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 74/265 (27%), Positives = 130/265 (49%), Gaps = 21/265 (7%)
Query: 225 TSWQKGELLGSGSYGFVYEGL-TDDG----FFFAVKEVSLQDEGPRGKQSILQLEQEISL 279
T +K ++LGSG++G VY+G+ +G A+K + ++ P+ + IL E +
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-REETSPKANKEILD---EAYV 62
Query: 280 LGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILN 336
+ +H ++V+ LG ++ + +L+ G L Y + H + + ++ QI
Sbjct: 63 MASVDHPHVVRLLGICLSS-QVQLITQLMPLGCLLD-YVRNHKDNIGSQYLLNWCVQIAK 120
Query: 337 GLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAP 392
G+ YL E+ +VHRD+ N+LV VK+ DFGLAK +++ + K WMA
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180
Query: 393 EVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSR 451
E + + Y +D+WS G TV E++T PY + + + GE P P +
Sbjct: 181 ESILHRI--YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTI 238
Query: 452 DAQDFILKCLQVNPNDRPTAAQLME 476
D ++KC ++ RPT +L+
Sbjct: 239 DVYMVLVKCWMIDAESRPTFKELIN 263
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 80/275 (29%), Positives = 132/275 (48%), Gaps = 35/275 (12%)
Query: 231 ELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
+G G++G V + L G AVK + + K+ ++ L+ + + IV
Sbjct: 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMR---SSDCPYIV 66
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLY------QKYHLSDSQVSSYTRQILNGLKYLHE 343
++ G E I +EL+ SL Y K + + + + L YL E
Sbjct: 67 KFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE 125
Query: 344 Q-NVVHRDIKCANILVDASGSVKLADFGLAK------ATTMNDVKSCKGTAFWMAPEVVN 396
+ ++HRD+K +NIL+D +G++KL DFG++ A T + C+ +MAPE ++
Sbjct: 126 ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD--AGCRP---YMAPERID 180
Query: 397 L-KKDGYGLTADIWSLGCTVLEMLTRRHPY----SHLEGGQAMFKIGGGELPPVPNSL-- 449
+DGY + +D+WSLG T+ E+ T + PY S + + K G+ P + NS
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK---GDPPILSNSEER 237
Query: 450 --SRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
S +FI CL + + RP +L+EHPFIK
Sbjct: 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 85/277 (30%), Positives = 146/277 (52%), Gaps = 37/277 (13%)
Query: 231 ELLGSGSYGFVY----EGLTDDGFFFAVK--------EVSLQDEGPRGKQSILQLEQEIS 278
++LG+G+YG V+ D G +A+K + + E R ++++L+ ++
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 279 LLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNG 337
L + + E +L + L+ V+ G + + LYQ+ + S+ +V Y+ +I+
Sbjct: 66 FLVTLHY--------AFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA 117
Query: 338 LKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK---SCKGTAFWMAPEV 394
L++LH+ +V+RDIK NIL+D+ G V L DFGL+K + + S GT +MAPE+
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 395 VNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG-----GQAMFKIGGGELPPVPNSL 449
+ K G+G D WSLG + E+LT P++ LEG + +I + PP P+ +
Sbjct: 178 IR-GKGGHGKAVDWWSLGILIFELLTGASPFT-LEGERNTQSEVSRRILKCD-PPFPSFI 234
Query: 450 SRDAQDFILKCLQVNPNDR-----PTAAQLMEHPFIK 481
+AQD + K L+ +P R A+++ EHPF K
Sbjct: 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 86/291 (29%), Positives = 141/291 (48%), Gaps = 48/291 (16%)
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSIL-QLEQEISLLGQFEHDNIVQ 290
LG+G+ G V + L G A K + L+ K +I Q+ +E+ +L + IV
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEI-----KPAIRNQIIRELKVLHECNSPYIVG 63
Query: 291 YLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQ-NVVH 348
+ G + + I +E + GSL + +K + ++ + + +L GL YL E+ ++H
Sbjct: 64 FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMH 123
Query: 349 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADI 408
RD+K +NILV++ G +KL DFG++ + S GT +M+PE L+ Y + +DI
Sbjct: 124 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYTVQSDI 181
Query: 409 WSLGCTVLEMLTRRHPY----------------SHLEGGQAMFKIGGG------------ 440
WSLG +++EM R+P S E ++ + G
Sbjct: 182 WSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFE 241
Query: 441 -------ELPP-VPNS-LSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
E PP +P+ S + QDF+ KCL+ NP +R +L +HPFIKR
Sbjct: 242 LLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 73/257 (28%), Positives = 113/257 (43%), Gaps = 62/257 (24%)
Query: 276 EISLLGQF-EHDNIVQYLGTDRDEKRLCIFL--ELVTKGSLASLYQKYHLSDSQVSSYTR 332
EI L + +H NIV+ L + E I+L E + + L ++ + L D
Sbjct: 56 EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-ETDLHAVIRANILEDVHKRYIMY 114
Query: 333 QILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA-TTMNDVKSCK------G 385
Q+L LKY+H NV+HRD+K +NIL+++ VKLADFGLA++ + + +
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 386 TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF---------- 435
T ++ APE++ L Y D+WS+GC + EML G+ +F
Sbjct: 175 TRWYRAPEIL-LGSTRYTKGVDMWSVGCILGEMLL----------GKPLFPGTSTLNQLE 223
Query: 436 ---------------KIGGGELPPVPNSL---------------SRDAQDFILKCLQVNP 465
I + +SL S DA D + K L NP
Sbjct: 224 KIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNP 283
Query: 466 NDRPTAAQLMEHPFIKR 482
N R TA + +EHP++ +
Sbjct: 284 NKRLTAEEALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 79/260 (30%), Positives = 133/260 (51%), Gaps = 17/260 (6%)
Query: 231 ELLGSGSYGFVYEG-LTDDGFFFAVK----EVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++LG GS+G V+ L FFA+K +V L D+ +E+ + L +EH
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDD----DVECTMVEKRVLSLA-WEH 55
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSD-SQVSSYTRQILNGLKYLHEQ 344
+ T + ++ L +E + G L Q H D + + Y +I+ GL++LH +
Sbjct: 56 PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTAFWMAPEVVNLKKDGY 402
+V+RD+K NIL+D G +K+ADFG+ K + D K+C GT ++APE++ +K Y
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK--Y 173
Query: 403 GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQ 462
+ D WS G + EML + P+ H + +F+ + P P L+R+A+D ++K
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPF-HGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFV 232
Query: 463 VNPNDR-PTAAQLMEHPFIK 481
P R + +HPF +
Sbjct: 233 REPERRLGVKGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 75/254 (29%), Positives = 111/254 (43%), Gaps = 15/254 (5%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
LGSG +G V+EGL + A+K + D KQ Q E + L + H +++
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL---KQQDFQKE--VQALKRLRHKHLI 65
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSS---YTRQILNGLKYLHEQNV 346
+ + I EL+ KGSL + + V+S Q+ G+ YL EQN
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS 125
Query: 347 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKKDGYG 403
+HRD+ NILV K+ADFGLA+ DV W APE + +
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAASHGT--FS 182
Query: 404 LTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQ 462
+D+WS G + EM T + PY + + +I G P P ++ +L+C
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWA 242
Query: 463 VNPNDRPTAAQLME 476
P DRP+ L E
Sbjct: 243 AEPEDRPSFKALRE 256
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 87/302 (28%), Positives = 142/302 (47%), Gaps = 61/302 (20%)
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291
LG GS G V+ + +D AVK++ L D QS+ +EI ++ + +HDNIV+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-----PQSVKHALREIKIIRRLDHDNIVKV 67
Query: 292 L------GTDRDE--------KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNG 337
G+D E + I E + + LA++ ++ LS+ + Q+L G
Sbjct: 68 YEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLFMYQLLRG 126
Query: 338 LKYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVKSCKG-------TAFW 389
LKY+H NV+HRD+K AN+ ++ V K+ DFGLA+ ++ S KG T ++
Sbjct: 127 LKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLAR--IVDPHYSHKGYLSEGLVTKWY 184
Query: 390 MAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRR--HPYSH-LEGGQAMFK---------- 436
+P ++ L + Y D+W+ GC EMLT + +H LE Q + +
Sbjct: 185 RSPRLL-LSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243
Query: 437 ------------IGGGE----LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480
GGE L + ++ +A DF+ + L NP DR TA + + HP++
Sbjct: 244 NELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303
Query: 481 KR 482
Sbjct: 304 SC 305
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 77/267 (28%), Positives = 120/267 (44%), Gaps = 30/267 (11%)
Query: 233 LGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQ------EISLLGQFEH 285
+G G YG V+ D G A+K + K + +L + E +L +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMK--------KSLLFKLNEVRHVLTERDILTTTKS 60
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLY-QKYHLSDSQVSSYTRQILNGLKYLHEQ 344
+ +V+ L +D++ L + +E V G +L LS+ Y ++ + LHE
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGL 404
+HRD+K N L+DASG +KL DFGL+K + S G+ +MAPEV+ K GY
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKG-IVTYANSVVGSPDYMAPEVLRGK--GYDF 177
Query: 405 TADIWSLGCTVLEMLTRRHPYS---------HLEGGQAMFKIGGGELPPVPNSLSRDAQD 455
T D WSLGC + E L P+S +L+ + + + P +LS +A D
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRF--NLSDEAWD 235
Query: 456 FILKCLQVNPNDRPTAAQLMEHPFIKR 482
I K + + + HPF K
Sbjct: 236 LITKLINDPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 86/296 (29%), Positives = 132/296 (44%), Gaps = 57/296 (19%)
Query: 231 ELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLE-QEISLLGQFEHDNI 288
+G G+YG V G A+K++S P Q+ Q +EI +L +F+H+NI
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKIS-----PFEHQTFCQRTLREIKILRRFKHENI 65
Query: 289 VQYLGT----DRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQ 344
+ L + ++ + + L L + HLS+ + + QIL GLKY+H
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSA 125
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF----WM-APEVVNLKK 399
NV+HRD+K +N+L++ + +K+ DFGLA+ + T + W APE++ L
Sbjct: 126 NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM-LNS 184
Query: 400 DGYGLTADIWSLGCTVLEMLTRRHP------YSHLEGGQAM--FKIGGG----------- 440
GY DIWS+GC + EML+ R P Y H Q + G
Sbjct: 185 KGYTKAIDIWSVGCILAEMLSNR-PLFPGKDYLH----QLNLILGVLGTPSQEDLNCIIS 239
Query: 441 --------ELP---PVP-NSL----SRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480
LP VP N L A D + K L NP+ R T + + HP++
Sbjct: 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYL 295
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 79/294 (26%), Positives = 131/294 (44%), Gaps = 48/294 (16%)
Query: 230 GELLGSGSYGFVY----EGLTD----DGFFFAVKEVSLQ--------DEGPRGKQSILQL 273
E LG G +G V+ +GL D + + D ++
Sbjct: 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED---F 66
Query: 274 EQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTR- 332
+E+ +L + NI + LG + LC+ +E + G L QK+ S ++ ++
Sbjct: 67 LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126
Query: 333 -----------QILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK 381
QI +G++YL N VHRD+ N LV + ++K+ADFG+++ +D
Sbjct: 127 LSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY 186
Query: 382 SCKGTAF----WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT--RRHPYSHL------E 429
+G A WMA E V L K + +D+W+ G T+ E+LT R PY HL E
Sbjct: 187 RVQGRAPLPIRWMAWESVLLGK--FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIE 244
Query: 430 GGQAMFKIGGG-ELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
F+ G P P + +D + +L+C + + DRPT ++ H F++R
Sbjct: 245 NAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI--HLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 4e-27
Identities = 86/285 (30%), Positives = 127/285 (44%), Gaps = 42/285 (14%)
Query: 233 LGSGSYGFVYEG--LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQ 290
+G G+YG V++ L + G F A+K V +Q S ++ + L FEH N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 291 YLG------TDRDEKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYL 341
TDR E +L + E V + L + K + + Q+L GL +L
Sbjct: 69 LFDVCTVSRTDR-ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWM-APEVVNLKKD 400
H VVHRD+K NILV +SG +KLADFGLA+ + + W APEV L +
Sbjct: 127 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV--LLQS 184
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPY---SHLEGGQAMFKIGGGELPP-------VPNSL- 449
Y D+WS+GC EM R+ + S ++ + + G +P
Sbjct: 185 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 244
Query: 450 -SRDAQ--------------DFILKCLQVNPNDRPTAAQLMEHPF 479
S+ AQ D +LKCL NP R +A + HP+
Sbjct: 245 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 84/263 (31%), Positives = 136/263 (51%), Gaps = 18/263 (6%)
Query: 232 LLGSGSYGFVYEGL----TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
+LG G YG V++ D G FA+K V + R ++ + E ++L +H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNV 346
IV + + +L + LE ++ G L L ++ + Y +I L++LH+Q +
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 347 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTAFWMAPEVVNLKKDGYG 403
++RD+K NIL+DA G VKL DFGL K + + C GT +MAPE+ L + G+G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMAPEI--LMRSGHG 178
Query: 404 LTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQV 463
D WSLG + +MLT P++ + + KI G+L +P L+ +A+D + K L+
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL-NLPPYLTPEARDLLKKLLKR 237
Query: 464 NPNDR-----PTAAQLMEHPFIK 481
NP+ R AA++ HPF +
Sbjct: 238 NPSSRLGAGPGDAAEVQSHPFFR 260
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 94/305 (30%), Positives = 143/305 (46%), Gaps = 70/305 (22%)
Query: 227 WQKGELLGSGSYGFVYEG---LTDDGFFFAVKEVSL--QDEG-PRGKQSILQLEQEISLL 280
++K E +G G+YG VY+ +T++ A+K++ L +DEG P +I +EISLL
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNE--TIALKKIRLEQEDEGVP--STAI----REISLL 55
Query: 281 GQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQ--------VSSYTR 332
+ +H NIV+ EKRL + E + L K H+ S + +Y
Sbjct: 56 KEMQHGNIVRLQDVVHSEKRLYLVFEYL------DLDLKKHMDSSPDFAKNPRLIKTYLY 109
Query: 333 QILNGLKYLHEQNVVHRDIKCANILVDAS-GSVKLADFGLAKA------TTMNDVKSCKG 385
QIL G+ Y H V+HRD+K N+L+D ++KLADFGLA+A T ++V
Sbjct: 110 QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV---- 165
Query: 386 TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKI-------- 437
T ++ APE++ L Y DIWS+GC EM+ ++ + +FKI
Sbjct: 166 TLWYRAPEIL-LGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN 224
Query: 438 -----GGGELPP----------------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476
G LP VP L D + K L+++P+ R TA +E
Sbjct: 225 EETWPGVTSLPDYKSAFPKWPPKDLATVVPT-LEPAGVDLLSKMLRLDPSKRITARAALE 283
Query: 477 HPFIK 481
H + K
Sbjct: 284 HEYFK 288
|
Length = 294 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 71/253 (28%), Positives = 120/253 (47%), Gaps = 13/253 (5%)
Query: 231 ELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQ 290
E +G G++G VY+G+ AVK P K+ LQ E EI L Q++H NIV+
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP-PDLKRKFLQ-EAEI--LKQYDHPNIVK 56
Query: 291 YLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVH 348
+G ++ + I +ELV GSL + +K L+ ++ + G++YL +N +H
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIH 116
Query: 349 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTA----FWMAPEVVNLKKDGYGL 404
RD+ N LV + +K++DFG+++ G W APE +N + Y
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR--YTS 174
Query: 405 TADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQV 463
+D+WS G + E + PY + Q +I G P P + +L+C
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAY 234
Query: 464 NPNDRPTAAQLME 476
+P +RP+ +++
Sbjct: 235 DPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-26
Identities = 67/245 (27%), Positives = 115/245 (46%), Gaps = 15/245 (6%)
Query: 233 LGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYL 292
LG+G +G V+ G ++ AVK + G S+ +E +L+ +HD +V+
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK------PGTMSVQAFLEEANLMKTLQHDKLVRLY 67
Query: 293 GTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSS---YTRQILNGLKYLHEQNVVHR 349
E+ + I E + KGSL + + ++ QI G+ Y+ +N +HR
Sbjct: 68 AVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 127
Query: 350 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKKDGYGLTA 406
D++ AN+LV S K+ADFGLA+ N+ + +G F W APE +N + + +
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF--GSFTIKS 185
Query: 407 DIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465
D+WS G + E++T + PY + M + G P + + D + C +
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKA 245
Query: 466 NDRPT 470
+RPT
Sbjct: 246 EERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 95/298 (31%), Positives = 136/298 (45%), Gaps = 67/298 (22%)
Query: 233 LGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSI-LQLEQEISLLG---QFEHDN 287
+G G+YG VY+ G F A+K V +Q + + L +E++LL F+H N
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQT----NEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 288 IVQYLG------TDRDEKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGL 338
IV+ + TDR+ K +F E V + L + K L + RQ L GL
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVF-EHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 339 KYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG-------TAFWMA 391
+LH +VHRD+K NILV + G VKLADFGLA+ + SC+ T ++ A
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR------IYSCQMALTPVVVTLWYRA 175
Query: 392 PEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY--SHLEGGQ--AMFKIGGGELP---- 443
PEV L + Y D+WS+GC EM RR P + E Q +F + G LP
Sbjct: 176 PEV--LLQSTYATPVDMWSVGCIFAEMF-RRKPLFCGNSEADQLGKIFDLIG--LPPEDD 230
Query: 444 -PVPNSLSRDA--------------------QDFILKCLQVNPNDRPTAAQLMEHPFI 480
P +L R A +L+ L NP+ R +A + ++HPF
Sbjct: 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 75/260 (28%), Positives = 130/260 (50%), Gaps = 19/260 (7%)
Query: 232 LLGSGSYGFVYEG-LTDDGFFFAVK----EVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286
+LG GS+G V L FFA+K +V L+D+ +E+ + L +EH
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDD----DVECTMVERRVLALA-WEHP 56
Query: 287 NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQN 345
+ T + ++ L +E + G L Q +++ Y +I+ GL++LH++
Sbjct: 57 FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTAFWMAPEVVNLKKDGY 402
+++RD+K N+L+D G +K+ADFG+ K + K+ C GT ++APE+ LK Y
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEI--LKGQKY 173
Query: 403 GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQ 462
+ D WS G + EML + P+ H E +F + P P +S++A+D + K +
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPF-HGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFE 232
Query: 463 VNPNDR-PTAAQLMEHPFIK 481
+P R + +HPF +
Sbjct: 233 RDPTKRLGVDGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 75/254 (29%), Positives = 126/254 (49%), Gaps = 20/254 (7%)
Query: 223 RITSWQKGELLGSGSYGFV-YEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQ------ 275
+++ ++ GE LG+GS+G V G ++A+K + K+ IL+++Q
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLK--------KREILKMKQVQHVAQ 67
Query: 276 EISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSS-YTRQI 334
E S+L + H IV + + +DE R+ LE V G L + +K + V+ Y ++
Sbjct: 68 EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAEL 127
Query: 335 LNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEV 394
+ +YLH +++++RD+K N+L+D G VK+ DFG AK C GT ++APEV
Sbjct: 128 VLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC-GTPEYLAPEV 186
Query: 395 VNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQ 454
+ K G+G D W++G + E + P+ + KI G L PN A+
Sbjct: 187 IQSK--GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL-KFPNWFDGRAR 243
Query: 455 DFILKCLQVNPNDR 468
D + LQ + R
Sbjct: 244 DLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 68/245 (27%), Positives = 122/245 (49%), Gaps = 16/245 (6%)
Query: 233 LGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYL 292
LG+G +G V+ + AVK + G S+ E +++ +HD +V+ L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK------PGSMSVEAFLAEANVMKTLQHDKLVK-L 66
Query: 293 GTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSS---YTRQILNGLKYLHEQNVVHR 349
++ + I E + KGSL + S + ++ QI G+ ++ ++N +HR
Sbjct: 67 HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 126
Query: 350 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKKDGYGLTA 406
D++ ANILV AS K+ADFGLA+ N+ + +G F W APE +N + + +
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF--GSFTIKS 184
Query: 407 DIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465
D+WS G ++E++T R PY + + + + G P P + + + +++C + P
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRP 244
Query: 466 NDRPT 470
+RPT
Sbjct: 245 EERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 61/253 (24%), Positives = 106/253 (41%), Gaps = 14/253 (5%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
+ LGSG +G V+ G A+K + EG + ++ E ++ + H N+V
Sbjct: 9 LKELGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIE---EAKVMMKLSHPNLV 62
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
Q G ++ + I E + G L + + K L + + ++YL +
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 348 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKKDGYGL 404
HRD+ N LV VK++DFGLA+ + S +GT F W PEV + + +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSR--FSS 180
Query: 405 TADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQV 463
+D+WS G + E+ + + PY + + + G P + + C
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHE 240
Query: 464 NPNDRPTAAQLME 476
P DRP +L+
Sbjct: 241 KPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 66/247 (26%), Positives = 118/247 (47%), Gaps = 16/247 (6%)
Query: 231 ELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQ 290
+ LG+G +G V+ G + A+K + +G S E +L+ Q +H +V+
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLK------QGSMSPEAFLAEANLMKQLQHPRLVR 65
Query: 291 YLGTDRDEKRLCIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQNVV 347
E + I E + GSL + L+ +++ QI G+ ++ +N +
Sbjct: 66 LYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124
Query: 348 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKKDGYGL 404
HRD++ ANILV + K+ADFGLA+ N+ + +G F W APE +N + +
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTI 182
Query: 405 TADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQV 463
+D+WS G + E++T R PY + + + + G P P++ + + + C +
Sbjct: 183 KSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKE 242
Query: 464 NPNDRPT 470
P +RPT
Sbjct: 243 KPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 37/272 (13%)
Query: 233 LGSGSYGFVYE-GLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291
LG G +G V + G +A K++ + R + + E++I L + IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKI--LEKVSSRFIVSL 58
Query: 292 LGTDRDEKRLCIFLELVTKGSLASLYQKYHL--------SDSQVSSYTRQILNGLKYLHE 343
+ LC+ + L+ G L KYH+ +++ Y QI+ GL++LH+
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDL-----KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ 113
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLA-KATTMNDVKSCKGTAFWMAPEVVNLKKDGY 402
+ +V+RD+K N+L+D G+V+++D GLA + +K GT +MAPEV L+ + Y
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEV--LQGEVY 171
Query: 403 GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP------PV--PNSLSRDAQ 454
+ D ++LGCT+ EM+ R P+ Q K+ EL V P+ S +A+
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFR-----QRKEKVEKEELKRRTLEMAVEYPDKFSPEAK 226
Query: 455 DFILKCLQVNPNDR-----PTAAQLMEHPFIK 481
D LQ +P R +A ++ EHP K
Sbjct: 227 DLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 82/282 (29%), Positives = 139/282 (49%), Gaps = 44/282 (15%)
Query: 231 ELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH----- 285
++LG+G+YG V F V++VS D G +L+ + EH
Sbjct: 6 KVLGTGAYGKV----------FLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTER 55
Query: 286 ---DNIVQ--YLGT----DRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQIL 335
++I Q +L T + + +L + L+ + G L + L Q+ + +V Y+ +I+
Sbjct: 56 QVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIV 115
Query: 336 NGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK---SCKGTAFWMAP 392
L++LH+ +++RDIK NIL+D++G V L DFGL+K ++V+ S GT +MAP
Sbjct: 116 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 393 EVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY-------SHLEGGQAMFKIGGGELPPV 445
++V G+ D WS+G + E+LT P+ S E + + K PP
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK----SEPPY 231
Query: 446 PNSLSRDAQDFILKCLQVNPNDR----PTAAQ-LMEHPFIKR 482
P +S A+D I + L +P R P+ A + +HPF ++
Sbjct: 232 PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 83/304 (27%), Positives = 124/304 (40%), Gaps = 86/304 (28%)
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQ-----EISLLGQFE-H 285
+G G++ V + G ++A+K K+ LEQ EI L + H
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIK---------CMKKHFKSLEQVNNLREIQALRRLSPH 57
Query: 286 DNIVQYLGT--DRDEKRLCIFLELVTKGSLASLY-----QKYHLSDSQVSSYTRQILNGL 338
NI++ + DR RL + EL+ +LY +K L + +V SY Q+L L
Sbjct: 58 PNILRLIEVLFDRKTGRLALVFELMD----MNLYELIKGRKRPLPEKRVKSYMYQLLKSL 113
Query: 339 KYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG------------T 386
++H + HRDIK NIL+ +KLADFG SC+G T
Sbjct: 114 DHMHRNGIFHRDIKPENILIK-DDILKLADFG-----------SCRGIYSKPPYTEYIST 161
Query: 387 AFWMAPEVVNLKKDG-YGLTADIWSLGCTVLEMLT------------------------- 420
++ APE L DG YG DIW++GC E+L+
Sbjct: 162 RWYRAPEC--LLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPD 219
Query: 421 -----RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLM 475
+ H+ K G G +PN S + D + K L +P++R TA Q +
Sbjct: 220 AEVLKKFRKSRHMNYNFP-SKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQAL 277
Query: 476 EHPF 479
HP+
Sbjct: 278 RHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 77/268 (28%), Positives = 135/268 (50%), Gaps = 23/268 (8%)
Query: 232 LLGSGSYGFV-YEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQ 290
+LGSG+ G V DG FAVK V ++ + + E+ L + +IV+
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE---ADKNRAQAEVCCLLNCDFFSIVK 95
Query: 291 ----YLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTR---------QILNG 337
+ D + + LV + A ++ S ++ + R Q+L
Sbjct: 96 CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA 155
Query: 338 LKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK---ATTMNDV-KSCKGTAFWMAPE 393
+ ++H ++++HRDIK ANIL+ ++G VKL DFG +K AT +DV ++ GT +++APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 394 VVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDA 453
+ ++ Y AD++SLG + E+LT + P+ + M K G P+P S+S +
Sbjct: 216 I--WRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEM 273
Query: 454 QDFILKCLQVNPNDRPTAAQLMEHPFIK 481
Q+ + L +P RP++++L+ P K
Sbjct: 274 QEIVTALLSSDPKRRPSSSKLLNMPICK 301
|
Length = 496 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 85/317 (26%), Positives = 140/317 (44%), Gaps = 81/317 (25%)
Query: 234 GSGSYGFVYEGLTDDGF---FFAVKEVSLQDEGPRGKQSILQLE--QEISLLGQFEHDNI 288
G G+YG VY+ +G +A+K+ +G + + + + +EI+LL + +H+N+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKF----KGDKEQYTGISQSACREIALLRELKHENV 64
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLASLYQ--KYH-------LSDSQVSSYTRQILNGLK 339
V + + ++L + + L+Q K+H + S V S QILNG+
Sbjct: 65 VSLVEVFLEHADKSVYL--LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 340 YLHEQNVVHRDIKCANILV----DASGSVKLADFGLAK-----ATTMNDVKSCKGTAFWM 390
YLH V+HRD+K ANILV G VK+ D GLA+ + D+ T ++
Sbjct: 123 YLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYR 182
Query: 391 APEVVNLKKDGYGLTADIWSLGCTVLEMLT-------------RRHPYSHLEGGQAMFKI 437
APE++ L Y DIW++GC E+LT + +P+ + + +F++
Sbjct: 183 APELL-LGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF-QRDQLERIFEV 240
Query: 438 GGGELPPV-------------------------PNSLS--------RDAQDFIL--KCLQ 462
G P NSL+ D+Q F L K L+
Sbjct: 241 LG--TPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLE 298
Query: 463 VNPNDRPTAAQLMEHPF 479
+P R TA + +EHP+
Sbjct: 299 YDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 83/297 (27%), Positives = 130/297 (43%), Gaps = 44/297 (14%)
Query: 225 TSWQKGELLGSGSYGFVY-EGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF 283
++K +LLG G G V+ L G FA+K + ++ R K + EQEI L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI--LATL 58
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKY 340
+H + + + E LC+ ++ G L L Q+ LS+ Y ++L L+Y
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT----------------TMNDVK--- 381
LH +V+RD+K NIL+ SG + L+DF L+K + +
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 382 ------------SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE 429
S GT ++APEV+ DG+G D W+LG + EML P+
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVI--SGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236
Query: 430 GGQAMFKIGGGELP-PVPNSLSRDAQDFILKCLQVNPNDR----PTAAQLMEHPFIK 481
+ I E+ P +S A+D I K L +P+ R AA++ +HPF +
Sbjct: 237 RDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 76/262 (29%), Positives = 128/262 (48%), Gaps = 25/262 (9%)
Query: 231 ELLGSGSYGFVYEGL----TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286
+++G G +G V G A+K +L+ G KQ + L E S++GQF+H
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIK--TLKA-GSSDKQRLDFL-TEASIMGQFDHP 65
Query: 287 NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQ 344
NI++ G + + I E + GSL ++ + Q+ R I +G+KYL E
Sbjct: 66 NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM 125
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKD 400
N VHRD+ NILV+++ K++DFGL++ ++ K K W APE + +K
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK- 184
Query: 401 GYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGG-ELPP---VPNSLSRDAQD 455
+ +D+WS G + E+++ PY + + + G LPP P++L + D
Sbjct: 185 -FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLD 243
Query: 456 FILKCLQVNPNDRPTAAQLMEH 477
C Q + N+RPT +Q++
Sbjct: 244 ----CWQKDRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 78/241 (32%), Positives = 120/241 (49%), Gaps = 12/241 (4%)
Query: 232 LLGSGSYGFVYEGLTDD---GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
+G+G++G V+ L D ++A+K +++ + R KQ + E +L + H I
Sbjct: 8 TVGTGTFGRVH--LVRDRISEHYYALKVMAIPEV-IRLKQ-EQHVHNEKRVLKEVSHPFI 63
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
++ T+ D++ L + +E V G L S L S+S Y +I+ L+YLH + +V
Sbjct: 64 IRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIV 123
Query: 348 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTAD 407
+RD+K NIL+D G +KL DFG AK C GT ++APEV+ K G+ D
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC-GTPEYLAPEVIQSK--GHNKAVD 180
Query: 408 IWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPND 467
W+LG + EML P+ KI G+L P L A+D I K L V+
Sbjct: 181 WWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL-EFPRHLDLYAKDLIKKLLVVDRTR 239
Query: 468 R 468
R
Sbjct: 240 R 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 69/251 (27%), Positives = 119/251 (47%), Gaps = 14/251 (5%)
Query: 231 ELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQ 290
ELLG G++G V++G D AVK + +++ P+ + ++ E +L Q++H NIV+
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVK--TCKEDLPQELK--IKFLSEARILKQYDHPNIVK 56
Query: 291 YLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVH 348
+G + + I +ELV G S +K L Q+ + G+ YL +N +H
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 349 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTA----FWMAPEVVNLKKDGYGL 404
RD+ N LV + +K++DFG+++ + + S G W APE +N + Y
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQED-DGIYSSSGLKQIPIKWTAPEALNYGR--YSS 173
Query: 405 TADIWSLGCTVLEMLTRRH-PYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQV 463
+D+WS G + E + PY + QA ++ G P D + +C
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDY 233
Query: 464 NPNDRPTAAQL 474
P +RP ++L
Sbjct: 234 KPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 72/246 (29%), Positives = 116/246 (47%), Gaps = 18/246 (7%)
Query: 233 LGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYL 292
LG G +G V+ G + V+++ P G S QE ++ + H+ +VQ
Sbjct: 14 LGQGCFGEVWMGTWN-----GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLY 67
Query: 293 GTDRDEKRLCIFLELVTKGSLASL----YQKYHLSDSQVSSYTRQILNGLKYLHEQNVVH 348
+E + I E ++KGSL KY L Q+ QI +G+ Y+ N VH
Sbjct: 68 AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVH 125
Query: 349 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKKDGYGLT 405
RD++ ANILV + K+ADFGLA+ N+ + +G F W APE + + +
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIK 183
Query: 406 ADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVN 464
+D+WS G + E+ T+ R PY + + + ++ G P P D + +C +
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKE 243
Query: 465 PNDRPT 470
P +RPT
Sbjct: 244 PEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 87/297 (29%), Positives = 133/297 (44%), Gaps = 52/297 (17%)
Query: 223 RITSWQKGELLGSGSYGFVYEG---LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISL 279
++ ++ K + LG G+Y VY+G LTD+ A+KE+ L+ E +I +E+SL
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLTDN--LVALKEIRLEHEEGAPCTAI----REVSL 57
Query: 280 LGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDS-------QVSSYTR 332
L +H NIV EK L + E + K K +L D V +
Sbjct: 58 LKDLKHANIVTLHDIIHTEKSLTLVFEYLDKD------LKQYLDDCGNSINMHNVKLFLF 111
Query: 333 QILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTAFWMA 391
Q+L GL Y H + V+HRD+K N+L++ G +KLADFGLA+A ++ S + W
Sbjct: 112 QLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYR 171
Query: 392 PEVVNLKKDGYGLTADIWSLGCTVLEMLTRR--HPYSHLEGG-QAMFKIGGGEL----PP 444
P + L Y D+W +GC EM T R P S +E +F+I G P
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231
Query: 445 VPNS----------------------LSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
+ ++ L D + + K LQ R +A + M+HP+
Sbjct: 232 ILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 74/262 (28%), Positives = 112/262 (42%), Gaps = 27/262 (10%)
Query: 232 LLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQ----LEQEISLLGQFEHDN 287
LGSG++G VYEG D + + + R K + Q +E L+ F H N
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR-KGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH--------LSDSQVSSYTRQILNGLK 339
IV+ LG + I +EL+ G L S + L+ ++ + G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 340 YLHEQNVVHRDIKCANILV-----DASGSVKLADFGLAKATTMNDVKSCKGTAF----WM 390
YL + + +HRD+ N LV DA VK+ DFGLA+ +D +G WM
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180
Query: 391 APEVVNLKKDGYGLTADIWSLGCTVLEMLTRRH-PYSHLEGGQAM-FKIGGGELPPVPNS 448
APE +L + +D+WS G + E+LT PY L + + GG L P +
Sbjct: 181 APE--SLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQK-PEN 237
Query: 449 LSRDAQDFILKCLQVNPNDRPT 470
+ C +P++RPT
Sbjct: 238 CPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 82/320 (25%), Positives = 136/320 (42%), Gaps = 80/320 (25%)
Query: 228 QKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLE----------QE 276
QKG LG G+YG V + T G A+K+V + E QL +E
Sbjct: 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKI-IEISNDVTKDRQLVGMCGIHFTTLRE 70
Query: 277 ISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQ-KYHLSDSQVSSYTRQIL 335
+ ++ + +H+NI+ + + + + ++++ L + K L++SQV QIL
Sbjct: 71 LKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQIL 129
Query: 336 NGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA--------TTMNDVKSCKG-- 385
NGL LH+ +HRD+ ANI +++ G K+ADFGLA+ T D +
Sbjct: 130 NGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 386 ------TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG 439
T ++ APE++ + + Y D+WS+GC E+LT G+ +F G
Sbjct: 190 MTSKVVTLWYRAPELL-MGAEKYHFAVDMWSVGCIFAELLT----------GKPLFP-GE 237
Query: 440 GEL-------------------------------PPVPNSL-------SRDAQDFILKCL 461
E+ P P L S DA D + L
Sbjct: 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLL 297
Query: 462 QVNPNDRPTAAQLMEHPFIK 481
++NP +R +A + ++H + K
Sbjct: 298 KLNPLERISAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 84/292 (28%), Positives = 139/292 (47%), Gaps = 47/292 (16%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQ---EISLLGQ 282
+Q +GSG+YG V T G AVK++S R QSI+ ++ E+ LL
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 72
Query: 283 FEHDNIVQYLGTDRDEKRLCIF--LELVTK---GSLASLYQKYHLSDSQVSSYTRQILNG 337
+H+N++ L + L F + LVT L ++ + L+D V QIL G
Sbjct: 73 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 338 LKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNL 397
LKY+H +++HRD+K +N+ V+ +K+ DFGLA+ T +++ T ++ APE++ L
Sbjct: 133 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-L 190
Query: 398 KKDGYGLTADIWSLGCTVLEMLTRRHPY---SHLEGGQAMFKIGG--------------- 439
Y T DIWS+GC + E+LT R + H++ + + ++ G
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 250
Query: 440 ----GELPPVPNSLSRD--------AQDFILKCLQVNPNDRPTAAQLMEHPF 479
L +P + A D + K L ++ + R TAAQ + H +
Sbjct: 251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 82/296 (27%), Positives = 132/296 (44%), Gaps = 52/296 (17%)
Query: 228 QKGELLGSGSYGFVYEGLT---DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE 284
+ +++G G++G V+ L D G +A+K + D R + + ++ E++I +
Sbjct: 4 EVIKVIGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILA----D 57
Query: 285 HDN--IVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYL 341
D+ IV+ + +DE+ L + +E + G L +L + + Y +++ L +
Sbjct: 58 ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKA--------------------------- 374
H+ +HRDIK NIL+DA G +KLADFGL K
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 375 ----TTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG 430
S GT ++APEV L+ YGL D WSLG + EML P+
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEV--LRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235
Query: 431 GQAMFKIGGGE----LPPVPNSLSRDAQDFILKCLQVNPNDRPTAA-QLMEHPFIK 481
+ KI + PP P +S +A D I + L +P DR + ++ HPF K
Sbjct: 236 QETYNKIINWKESLRFPPDP-PVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 81/265 (30%), Positives = 133/265 (50%), Gaps = 28/265 (10%)
Query: 231 ELLGSGSYG---FVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
+LLG G++G V E T G ++A+K L+ E K + E +L H
Sbjct: 1 KLLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPF 56
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSS------YTRQILNGLKYL 341
+ + RLC +E G L +HLS +V + Y +I++ L+YL
Sbjct: 57 LTALKYAFQTHDRLCFVMEYANGGELF-----FHLSRERVFTEERARFYGAEIVSALEYL 111
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTAFWMAPEVVNLKK 399
H ++VV+RDIK N+++D G +K+ DFGL K + +K+ GT ++APEV L+
Sbjct: 112 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV--LED 169
Query: 400 DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILK 459
+ YG D W LG + EM+ R P+ + + + +F++ E P +LS +A+ +
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 228
Query: 460 CLQVNPNDR----PTAAQ-LMEHPF 479
L+ +P R P+ A+ +MEH F
Sbjct: 229 LLKKDPKQRLGGGPSDAKEVMEHRF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 71/252 (28%), Positives = 120/252 (47%), Gaps = 16/252 (6%)
Query: 226 SWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
S Q + LG+G +G V+ G + AVK + G +S L+ E ++ + H
Sbjct: 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLK---PGTMSPESFLE---EAQIMKKLRH 60
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLH 342
D +VQ E+ + I E ++KGSL + L + Q+ G+ Y+
Sbjct: 61 DKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKK 399
N +HRD++ ANILV K+ADFGLA+ N+ + +G F W APE +
Sbjct: 120 RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 400 DGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFIL 458
+ + +D+WS G + E++T+ R PY + + + ++ G P P + +L
Sbjct: 180 --FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELML 237
Query: 459 KCLQVNPNDRPT 470
+C + +P +RPT
Sbjct: 238 QCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 68/245 (27%), Positives = 118/245 (48%), Gaps = 16/245 (6%)
Query: 233 LGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYL 292
LG G +G V+ G + A+K + G ++ LQ E ++ + HD +V
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK---PGTMMPEAFLQ---EAQIMKKLRHDKLVPLY 67
Query: 293 GTDRDEKRLCIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQNVVHR 349
+E + I E + KGSL ++ +L Q+ QI +G+ Y+ N +HR
Sbjct: 68 AVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126
Query: 350 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKKDGYGLTA 406
D++ ANILV + K+ADFGLA+ N+ + +G F W APE + + + +
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 184
Query: 407 DIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465
D+WS G + E++T+ R PY + + + ++ G P P + + C + +P
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDP 244
Query: 466 NDRPT 470
++RPT
Sbjct: 245 DERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 79/268 (29%), Positives = 130/268 (48%), Gaps = 32/268 (11%)
Query: 231 ELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQ-----------LEQEISL 279
++LG GS+G V F V++++ D G +L+ + E +
Sbjct: 2 KVLGQGSFGKV----------FLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDI 51
Query: 280 LGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQVSSYTRQILNGL 338
L + H IV+ + E +L + L+ + G L L ++ ++ V Y ++ L
Sbjct: 52 LAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL 111
Query: 339 KYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTAFWMAPEVVN 396
+LH +++RD+K NIL+D G +KL DFGL+K + ++ K S GT +MAPEVVN
Sbjct: 112 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDF 456
+ G+ +AD WS G + EMLT P+ + + M I +L +P LS +AQ
Sbjct: 172 --RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSL 228
Query: 457 ILKCLQVNPNDRPTAA-----QLMEHPF 479
+ + NP +R A ++ HPF
Sbjct: 229 LRALFKRNPANRLGAGPDGVEEIKRHPF 256
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 5e-24
Identities = 81/265 (30%), Positives = 130/265 (49%), Gaps = 28/265 (10%)
Query: 231 ELLGSGSYG---FVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
+LLG G++G V E + G ++A+K L+ E K + E +L H
Sbjct: 1 KLLGKGTFGKVILVREKAS--GKYYAMK--ILKKEVIIAKDEVAHTLTESRVLKNTRHPF 56
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSS------YTRQILNGLKYL 341
+ + + + RLC +E V G L +HLS +V S Y +I++ L YL
Sbjct: 57 LTSLKYSFQTKDRLCFVMEYVNGGELF-----FHLSRERVFSEDRTRFYGAEIVSALDYL 111
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTAFWMAPEVVNLKK 399
H +V+RD+K N+++D G +K+ DFGL K T +K+ GT ++APEV L+
Sbjct: 112 HSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEV--LED 169
Query: 400 DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILK 459
+ YG D W LG + EM+ R P+ + + + +F++ E P +LS DA+ +
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEDIKFPRTLSADAKSLLSG 228
Query: 460 CLQVNPNDR-----PTAAQLMEHPF 479
L +PN R A ++M H F
Sbjct: 229 LLIKDPNKRLGGGPDDAKEIMRHSF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 86/280 (30%), Positives = 127/280 (45%), Gaps = 49/280 (17%)
Query: 233 LGSGSYGFV----YEGLTDD-GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
LG G +G V Y+ D+ G AVK SL+ E G I L++EI +L H+N
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVK--SLKPES--GGNHIADLKKEIEILRNLYHEN 67
Query: 288 IVQYLG--TDRDEKRLCIFLELVTKGSLASLY--QKYHLSDSQVSSYTRQILNGLKYLHE 343
IV+Y G T+ + + +E + GSL K ++ Q Y QI G+ YL
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAKA--------TTMNDVKSCKGTAFWMAPEVV 395
+ VHRD+ N+LV++ VK+ DFGL KA T +D+ S FW APE
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDS---PVFWYAPEC- 183
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-QAMF-KIGG-------------- 439
L + + + +D+WS G T+ E+LT Y E +F K+ G
Sbjct: 184 -LIQSKFYIASDVWSFGVTLYELLT----YCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238
Query: 440 ---GELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476
G+ P P + + + KC + P+ R T L+E
Sbjct: 239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 61/160 (38%), Positives = 90/160 (56%), Gaps = 11/160 (6%)
Query: 330 YTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT-TMNDVKS--CKGT 386
Y +++ L++LH+ ++V+RD+K NIL+DA+G + L DFGL+KA T N + C GT
Sbjct: 101 YIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-GT 159
Query: 387 AFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFK-IGGGELPPV 445
++APEV+ L + GY D WSLG V EM P+ + E Q M++ I G++
Sbjct: 160 TEYLAPEVL-LDEKGYTKHVDFWSLGVLVFEMCCGWSPF-YAEDTQQMYRNIAFGKVRFP 217
Query: 446 PNSLSRDAQDFILKCLQVNPNDR----PTAAQLMEHPFIK 481
N LS + + F+ L NP R A +L EHPF
Sbjct: 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFA 257
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 69/264 (26%), Positives = 112/264 (42%), Gaps = 32/264 (12%)
Query: 231 ELLGSGSYGFVYEG------LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE 284
LG G++G V+ G +D AVK +L++ + E+E LL F+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVK--TLKETASNDAR--KDFEREAELLTNFQ 66
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQ---------------KYHLSDSQVSS 329
H+NIV++ G + + E + G L + L+ SQ+
Sbjct: 67 HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 330 YTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF- 388
QI +G+ YL Q+ VHRD+ N LV VK+ DFG+++ D G
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 389 ---WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPP 444
WM PE + +K + +D+WS G + E+ T + P+ L + + I G L
Sbjct: 187 PIRWMPPESIMYRK--FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQ 244
Query: 445 VPNSLSRDAQDFILKCLQVNPNDR 468
P + + D +L C + +P R
Sbjct: 245 RPRTCPSEVYDIMLGCWKRDPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 88/292 (30%), Positives = 131/292 (44%), Gaps = 43/292 (14%)
Query: 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF 283
TS+ E LG GSY VY+G++ +G A+K +S++ E +I +E SLL
Sbjct: 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI----REASLLKGL 60
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILNGLKY 340
+H NIV ++ L E + LA Y H L V + Q+L GL Y
Sbjct: 61 KHANIVLLHDIIHTKETLTFVFEYM-HTDLAQ-YMIQHPGGLHPYNVRLFMFQLLRGLAY 118
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTAFWMAPEVVNLKK 399
+H Q+++HRD+K N+L+ G +KLADFGLA+A ++ + S + W P V L
Sbjct: 119 IHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGA 178
Query: 400 DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-QAMFKI-------------GGGELP-- 443
Y DIW GC +EML + + + + + KI G +LP
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238
Query: 444 -------PVP-------NSLSR--DAQDFILKCLQVNPNDRPTAAQLMEHPF 479
P LSR A+D + L + P DR +A + HP+
Sbjct: 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 80/308 (25%), Positives = 145/308 (47%), Gaps = 65/308 (21%)
Query: 222 RRITSWQKGELLGSGSYGFVY---EGLTDDGFFFAVKEVSLQDEG---PRGKQSILQLEQ 275
R + ++K + G+YG VY + T + A+K++ ++ E P I L +
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGE--IVALKKLKMEKEKEGFP-----ITSL-R 53
Query: 276 EISLLGQFEHDNIVQY----LGTDRDEKRLCI-FLELVTKGSLASLYQKYHLSDSQVSSY 330
EI++L + +H NIV +G++ D+ + + ++E K + ++ K S+V
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETM--KQPFLQSEVKCL 111
Query: 331 TRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLA-------KATTMNDVKSC 383
Q+L+G+ +LH+ ++HRD+K +N+L++ G +K+ DFGLA K T V
Sbjct: 112 MLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--- 168
Query: 384 KGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY---SHLEGGQAMFKIGGG 440
T ++ APE++ L Y D+WS+GC E+LT++ + S ++ +FK+ G
Sbjct: 169 --TLWYRAPELL-LGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGT 225
Query: 441 ----------ELPPV------------------PNSLSRDAQDFILKCLQVNPNDRPTAA 472
ELP SLS + D + + L +P R +A
Sbjct: 226 PTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAE 285
Query: 473 QLMEHPFI 480
++HP+
Sbjct: 286 DALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 1e-23
Identities = 70/250 (28%), Positives = 115/250 (46%), Gaps = 14/250 (5%)
Query: 233 LGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYL 292
LGSG +G V+ G A+K + +EG ++ ++ E ++ + H +VQ
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAI---NEGAMSEEDFIE---EAKVMMKLSHPKLVQLY 65
Query: 293 GTDRDEKRLCIFLELVTKGSLAS-LYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRD 350
G +K L I E + G L + L Q+ LS + S + + G++YL + +HRD
Sbjct: 66 GVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRD 125
Query: 351 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKKDGYGLTAD 407
+ N LV ++G VK++DFG+ + ++ S G F W PEV N K Y +D
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK--YSSKSD 183
Query: 408 IWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPN 466
+WS G + E+ T + P+ + + I G P S + + C P
Sbjct: 184 VWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPE 243
Query: 467 DRPTAAQLME 476
RPT A+L+
Sbjct: 244 GRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 59/302 (19%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
G+ + + AVK+++L K+ + L+QEI Q +H NI+
Sbjct: 7 GKCFEDLMIVHLAKH-KPTNTLVAVKKINLDSCS---KEDLKLLQQEIITSRQLQHPNIL 62
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASL---YQKYHLSDSQVSSYTRQILNGLKYLHEQNV 346
Y+ + + L + L+ GS L + L + ++ + +LN L Y+H +
Sbjct: 63 PYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGF 122
Query: 347 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF-------------WMAPE 393
+HR +K ++IL+ G V L+ GL + +M +K K W++PE
Sbjct: 123 IHRSVKASHILLSGDGKVVLS--GLRYSVSM--IKHGKRQRVVHDFPKSSVKNLPWLSPE 178
Query: 394 VVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF--KIGG------------ 439
V+ GY +DI+S+G T E+ P+ + Q M K+ G
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKVRGTVPCLLDKSTYP 237
Query: 440 ---GELP----PVPNSLSRDAQD-------------FILKCLQVNPNDRPTAAQLMEHPF 479
+ + +RD+ D F+ CLQ +P RP+A+QL+ H F
Sbjct: 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297
Query: 480 IK 481
K
Sbjct: 298 FK 299
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-23
Identities = 78/268 (29%), Positives = 131/268 (48%), Gaps = 27/268 (10%)
Query: 223 RITSWQKGELLGSGSYGFVYEGL---TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISL 279
+ T +K +LLGSG +G V++G+ D V ++QD G+Q+ ++ +
Sbjct: 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLA 62
Query: 280 LGQFEHDNIVQYLGTDRDEKRLC--IFLELVTK----GSLASLYQKYH--LSDSQVSSYT 331
+G +H IV+ LG +C L+LVT+ GSL +++ L ++ ++
Sbjct: 63 MGSLDHAYIVRLLG-------ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC 115
Query: 332 RQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK----SCKGTA 387
QI G+ YL E +VHR++ NIL+ + V++ADFG+A +D K K
Sbjct: 116 VQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175
Query: 388 FWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVP 446
WMA E + + Y +D+WS G TV EM++ PY+ + + + GE P
Sbjct: 176 KWMALESILFGR--YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQP 233
Query: 447 NSLSRDAQDFILKCLQVNPNDRPTAAQL 474
+ D ++KC ++ N RPT +L
Sbjct: 234 QICTIDVYMVMVKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 88/294 (29%), Positives = 136/294 (46%), Gaps = 55/294 (18%)
Query: 231 ELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLE---QEISLLGQFEHD 286
+GSG+YG V T G A+K++S R QS + + +E+ LL +H+
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLS------RPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 287 NIVQYLGTDRDEKRLCIFLE--LVTKGSLASLY-----QKYHLSDSQVSSYTRQILNGLK 339
N++ L L F + LVT A L QK LSD + QIL GLK
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK--LSDDHIQFLVYQILRGLK 132
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTAFWMAPEVVNL 397
Y+H ++HRD+K +NI V+ +K+ DFGLA+ D + T ++ APE++ L
Sbjct: 133 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-L 188
Query: 398 KKDGYGLTADIWSLGCTVLEMLTRR--HPYS-HLEGGQAMFKIGGG-------------- 440
Y T DIWS+GC + E+LT + P S H++ + + + G
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248
Query: 441 -----ELPPVPNS--------LSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
LP +P + A D + K L ++P+ R TAA+ + HP++
Sbjct: 249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 85/323 (26%), Positives = 137/323 (42%), Gaps = 73/323 (22%)
Query: 215 SPNGKFRRRITSWQKGELLGSGSYGFVYEG---LTDDGFFFAVKEVSLQDEGPRGKQ--S 269
F ++ ++K +G G++G V++ T A+K+V +++E K+
Sbjct: 2 QYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQ--IVALKKVLMENE----KEGFP 55
Query: 270 ILQLEQEISLLGQFEHDNIVQYL------GTDRDEKRLCIFLEL-VTKGSLASL--YQKY 320
I L +EI +L +H+N+V + T + + +L + LA L +
Sbjct: 56 ITAL-REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV 114
Query: 321 HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--N 378
+ S++ + +LNGL Y+H ++HRD+K ANIL+ G +KLADFGLA+A ++ N
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174
Query: 379 DVKSCKG----TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY--------- 425
+ T ++ PE++ L + YG D+W GC + EM T R P
Sbjct: 175 SKPNRYTNRVVTLWYRPPELL-LGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQHQ 232
Query: 426 ----SHLEGG---------------QAMFKIGGGELPP-----VPNSL-----SRDAQDF 456
S L G + M ELP V L A D
Sbjct: 233 LTLISQLCGSITPEVWPGVDKLELFKKM------ELPQGQKRKVKERLKPYVKDPHALDL 286
Query: 457 ILKCLQVNPNDRPTAAQLMEHPF 479
I K L ++P R A + H F
Sbjct: 287 IDKLLVLDPAKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-23
Identities = 68/213 (31%), Positives = 106/213 (49%), Gaps = 27/213 (12%)
Query: 223 RITSWQKGELLGSGSYGFVYEG---LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISL 279
++ ++ K E LG G+Y V++G LT++ A+KE+ L+ E +I +E+SL
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTEN--LVALKEIRLEHEEGAPCTAI----REVSL 57
Query: 280 LGQFEHDNIVQYLGTDRDEKRLCIFLELVTK---------GSLASLYQKYHLSDSQVSSY 330
L +H NIV +K L + E + K G++ S++ V +
Sbjct: 58 LKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHN--------VKIF 109
Query: 331 TRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTAFW 389
QIL GL Y H + V+HRD+K N+L++ G +KLADFGLA+A ++ S + W
Sbjct: 110 LYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLW 169
Query: 390 MAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRR 422
P V L Y D+W +GC EM + R
Sbjct: 170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 3e-23
Identities = 80/265 (30%), Positives = 130/265 (49%), Gaps = 28/265 (10%)
Query: 231 ELLGSGSYG---FVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
+LLG G++G V E T G ++A+K L+ E K + E +L H
Sbjct: 1 KLLGKGTFGKVILVREKAT--GKYYAMK--ILKKEVIIAKDEVAHTLTESRVLQNTRHPF 56
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSS------YTRQILNGLKYL 341
+ + + RLC +E G L +HLS +V S Y +I++ L YL
Sbjct: 57 LTALKYSFQTHDRLCFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSALGYL 111
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTAFWMAPEVVNLKK 399
H +VV+RD+K N+++D G +K+ DFGL K + +K+ GT ++APEV L+
Sbjct: 112 HSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV--LED 169
Query: 400 DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILK 459
+ YG D W LG + EM+ R P+ + + + +F++ E P +LS +A+ +
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIRFPRTLSPEAKSLLAG 228
Query: 460 CLQVNPNDR-----PTAAQLMEHPF 479
L+ +P R A ++MEH F
Sbjct: 229 LLKKDPKQRLGGGPEDAKEIMEHRF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 3e-23
Identities = 83/270 (30%), Positives = 114/270 (42%), Gaps = 34/270 (12%)
Query: 233 LGSGSYGFVYEGL----TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
LG G++G VYEGL D V +L + +S +E I + +F H NI
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI--MSKFNHQNI 71
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYT--------RQILNGLKY 340
V+ +G + I LEL+ G L S ++ + SS T R + G KY
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 341 LHEQNVVHRDIKCANILVDASGS---VKLADFGLAKATTMNDVKSCKGTAF----WMAPE 393
L E + +HRDI N L+ G K+ADFG+A+ G A WM PE
Sbjct: 132 LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPE 191
Query: 394 VVNLKKDG-YGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAM-FKIGGGELPP---VPN 447
DG + D+WS G + E+ + PY + M F GGG L P P
Sbjct: 192 AF---LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPG 248
Query: 448 SLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
+ R D C Q P DRP A ++E
Sbjct: 249 PVYRIMTD----CWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 5e-23
Identities = 78/313 (24%), Positives = 137/313 (43%), Gaps = 74/313 (23%)
Query: 227 WQKGELLGSGSYGFVYEGL---TDDGFFFAVKEVS-LQDEGPRGKQSILQLEQEISLLGQ 282
++ + LG G+YG V T + A+K+++ + + K+++ +E+ LL
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL----RELKLLRH 57
Query: 283 F-EHDNIVQYLGTDRDEKRLCIF-LELVTKGSLASLY---------------QKYHLSDS 325
F H NI C++ +++V G+ LY L+D+
Sbjct: 58 FRGHKNIT------------CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDA 105
Query: 326 QVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK- 384
S+ QIL GLKY+H NV+HRD+K N+LV+A +K+ DFGLA+ + N ++
Sbjct: 106 HFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165
Query: 385 -----GTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYS------------H 427
T ++ APE++ L Y D+WS+GC + E+L R+ +
Sbjct: 166 MTEYVATRWYRAPEIM-LSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ 224
Query: 428 LEGG---QAMFKIGG----------GELPPVPNS-----LSRDAQDFILKCLQVNPNDRP 469
+ G + + +IG +P P + A D + K L +P R
Sbjct: 225 VLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRI 284
Query: 470 TAAQLMEHPFIKR 482
+ + +EHP++
Sbjct: 285 SVEEALEHPYLAI 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 7e-23
Identities = 83/304 (27%), Positives = 136/304 (44%), Gaps = 54/304 (17%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++K LG+G+ G V++ G A K + L+ + P + I++ E+ +L +
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK-PAIRNQIIR---ELQVLHECNS 62
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQ 344
IV + G + + I +E + GSL + +K + + + + ++ GL YL E+
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122
Query: 345 N-VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYG 403
+ ++HRD+K +NILV++ G +KL DFG++ + S GT +M+PE L+ Y
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYS 180
Query: 404 LTADIWSLGCTVLEMLTRRHPY-----SHLE---GGQAMFKIGGGELPPVPNSLSR---- 451
+ +DIWS+G +++EM R+P LE G E P P R
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSS 240
Query: 452 ---------------------------------DAQDFILKCLQVNPNDRPTAAQLMEHP 478
+ QDF+ KCL NP +R QLM H
Sbjct: 241 YGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA 300
Query: 479 FIKR 482
FIKR
Sbjct: 301 FIKR 304
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 7e-23
Identities = 78/275 (28%), Positives = 126/275 (45%), Gaps = 39/275 (14%)
Query: 231 ELLGSGSYGFV----YEGLTDD-GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+ LG G++G V Y+ L D+ G AVK+ LQ + + E+EI +L +H
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKK--LQ---HSTAEHLRDFEREIEILKSLQH 64
Query: 286 DNIVQYLGT--DRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYL 341
DNIV+Y G + L + +E + GSL QK+ L ++ Y QI G++YL
Sbjct: 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL 124
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKS-CKGTAFWMAPEVVN 396
+ VHRD+ NILV++ VK+ DFGL K + V+ + FW APE +
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184
Query: 397 LKKDGYGLTADIWSLGCTVLEMLT-----RRHPYSHLE-------GGQAMFKI-----GG 439
K + + +D+WS G + E+ T P + G ++ +
Sbjct: 185 ESK--FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN 242
Query: 440 GELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQL 474
G L P P + + +C +P+ RP+ ++L
Sbjct: 243 GRL-PAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 8e-23
Identities = 64/249 (25%), Positives = 110/249 (44%), Gaps = 14/249 (5%)
Query: 233 LGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYL 292
+GSG +G V+ G + A+K + G S +E ++ + H +VQ
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR------EGAMSEEDFIEEAQVMMKLSHPKLVQLY 65
Query: 293 GTDRDEKRLCIFLELVTKGSLASLY--QKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRD 350
G + +C+ E + G L+ Q+ S + + G+ YL NV+HRD
Sbjct: 66 GVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRD 125
Query: 351 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKKDGYGLTAD 407
+ N LV + VK++DFG+ + + S GT F W +PEV + K Y +D
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK--YSSKSD 183
Query: 408 IWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPN 466
+WS G + E+ + + PY + + + I G P S+ + + C + P
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPE 243
Query: 467 DRPTAAQLM 475
DRP+ + L+
Sbjct: 244 DRPSFSLLL 252
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 76/259 (29%), Positives = 114/259 (44%), Gaps = 14/259 (5%)
Query: 233 LGSGSYGFV-YEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQ 290
LG G +G V G +A+K + D R + L E+ I E H +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 291 YLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRD 350
+ E +C +E G L S+ + Y ++ GL+YLHE +V+RD
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRD 126
Query: 351 IKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTAFWMAPEVVNLKKDGYGLTAD 407
+K N+L+D G VK+ADFGL K ++ C GT ++APEV L + Y D
Sbjct: 127 LKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-GTPEFLAPEV--LTETSYTRAVD 183
Query: 408 IWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPND 467
W LG + EML P+ + + I E P LSR+A + + L+ NP
Sbjct: 184 WWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE-VRYPRFLSREAISIMRRLLRRNPER 242
Query: 468 R----PTAAQ-LMEHPFIK 481
R A+ + + PF +
Sbjct: 243 RLGSGEKDAEDVKKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-22
Identities = 69/247 (27%), Positives = 115/247 (46%), Gaps = 16/247 (6%)
Query: 233 LGSGSYGFVYEG---LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
LGSG++G V +G + AVK + + P K +L+ E +++ Q ++ IV
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR---EANVMQQLDNPYIV 59
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVH 348
+ +G E + +EL G L QK H+++ ++ Q+ G+KYL E N VH
Sbjct: 60 RMIGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118
Query: 349 RDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTAFWMAPEVVNLKKDGYG 403
RD+ N+L+ K++DFGL+KA ++ K W APE +N K +
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK--FS 176
Query: 404 LTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQ 462
+D+WS G + E + + PY ++G + I GE P + D + C
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWT 236
Query: 463 VNPNDRP 469
++RP
Sbjct: 237 YGVDERP 243
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-22
Identities = 67/198 (33%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE 284
S++K E LG GSY VY+G + +G A+K + LQ+E +I +E SLL +
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI----REASLLKGLK 61
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLH 342
H NIV ++ L + E V L K+ L V + Q+L GL Y+H
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH 120
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTAFWMAPEVVNLKKDG 401
++ ++HRD+K N+L+ +G +KLADFGLA+A ++ + S + W P V L
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 402 YGLTADIWSLGCTVLEML 419
Y D+W +GC +EM+
Sbjct: 181 YSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 81/266 (30%), Positives = 132/266 (49%), Gaps = 29/266 (10%)
Query: 231 ELLGSGSYG---FVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
+LLG G++G V E T G ++A+K L+ E K + E +L H
Sbjct: 1 KLLGKGTFGKVILVKEKAT--GRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPF 56
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSS------YTRQILNGLKYL 341
+ + + RLC +E G L +HLS +V S Y +I++ L YL
Sbjct: 57 LTALKYSFQTHDRLCFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSALDYL 111
Query: 342 H-EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGTAFWMAPEVVNLK 398
H E+NVV+RD+K N+++D G +K+ DFGL K + +K+ GT ++APEV L+
Sbjct: 112 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV--LE 169
Query: 399 KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFIL 458
+ YG D W LG + EM+ R P+ + + + +F++ E P +LS +A+ +
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLSPEAKSLLS 228
Query: 459 KCLQVNPNDR-----PTAAQLMEHPF 479
L+ +P R A ++M+H F
Sbjct: 229 GLLKKDPKQRLGGGPDDAKEIMQHKF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 79/284 (27%), Positives = 127/284 (44%), Gaps = 52/284 (18%)
Query: 232 LLGSGSYGFVY-----EGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286
L+ +G+YG VY E FA+K+++ Q+ R + I Q+ E +L E+
Sbjct: 8 LISNGAYGAVYLVRHKETRQR----FAMKKINKQNLILRNQ--IQQVFVERDILTFAENP 61
Query: 287 NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQN 345
+V + ++ LC+ +E V G A+L + L Y + + L+YLH
Sbjct: 62 FVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG 121
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAKATTMN------------------DVKSCKGTA 387
+VHRD+K N+L+ + G +KL DFGL+K M+ D + C GT
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC-GTP 180
Query: 388 FWMAPEVVNLKKDGYGLTADIWSLGCTVLEML---------TRRHPYSHLEGGQAMFKIG 438
++APEV+ + GYG D W++G + E L T + + + G
Sbjct: 181 EYIAPEVI--LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEG 238
Query: 439 GGELPPVPNSLSRDAQDFILKCLQVNPNDR---PTAAQLMEHPF 479
LP DAQD I + L+ NP +R A ++ +H F
Sbjct: 239 DEALPA-------DAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 4e-22
Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 11/215 (5%)
Query: 276 EISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSL-----ASLYQKYHLSDSQVSSY 330
E+ L +H IV++ + + +L + +E + G L L + + +V
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174
Query: 331 TRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK----ATTMNDVKSCKGT 386
QI+ L +H + ++HRD+K ANI + +G +KL DFG +K + +++ S GT
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGT 234
Query: 387 AFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVP 446
+++APE+ K+ Y AD+WSLG + E+LT P+ + M ++ G+ P P
Sbjct: 235 PYYLAPELWERKR--YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFP 292
Query: 447 NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
+S + + L NP RPT QL+ F+K
Sbjct: 293 CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 5e-22
Identities = 72/260 (27%), Positives = 119/260 (45%), Gaps = 51/260 (19%)
Query: 272 QLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSY 330
Q+ +E+ +L + IV + G + + I +E + GSL L + + + +
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKV 108
Query: 331 TRQILNGLKYLHEQN-VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFW 389
+ +L GL YL E++ ++HRD+K +NILV++ G +KL DFG++ + S GT +
Sbjct: 109 SIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 168
Query: 390 MAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY-----SHLEG--GQAMFKIGGGE- 441
M+PE L+ Y + +DIWS+G +++E+ R+P LE G+ + GE
Sbjct: 169 MSPE--RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEP 226
Query: 442 --------------------------------------LPPVPNSL-SRDAQDFILKCLQ 462
P +PN + + D Q+F+ KCL
Sbjct: 227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLI 286
Query: 463 VNPNDRPTAAQLMEHPFIKR 482
NP +R LM H FIKR
Sbjct: 287 KNPAERADLKMLMNHTFIKR 306
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 5e-22
Identities = 82/298 (27%), Positives = 135/298 (45%), Gaps = 50/298 (16%)
Query: 226 SWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE 284
+++K E +G G+YG VY+ + G A+K+ L+ + + L+ EISLL
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR---EISLLQMLS 58
Query: 285 HDN-IVQYLG---TDRDEKRLCI-----FLELVTKGSLASLYQKYH--LSDSQVSSYTRQ 333
IV+ L + + + +L+ K + S + L + S+ Q
Sbjct: 59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 334 ILNGLKYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVKSCKG---TAFW 389
+L G+ + H+ V+HRD+K N+LVD + K+AD GL +A ++ VKS T ++
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIVTLWY 177
Query: 390 MAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY---SHLEGGQAMFKIGGG------ 440
APEV+ L Y DIWS+GC EM ++ + S L+ +FK+ G
Sbjct: 178 RAPEVL-LGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236
Query: 441 ----------ELP---------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
E P VP+ LS + D + K L+ +P R +A + HP+
Sbjct: 237 PGVSKLRDWHEFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-22
Identities = 73/267 (27%), Positives = 120/267 (44%), Gaps = 27/267 (10%)
Query: 232 LLGSGSYGFVY---EGLTDDGFFFAV--KEVSLQD---EGPRGKQSILQLEQEISLLGQF 283
+LG GS+G V TD+ + + K+V +QD E ++ +L L + L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFL--- 63
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLH 342
Q + RL +E V G L Q+ + Y +I GL +LH
Sbjct: 64 -----TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTAFWMAPEVVNLKKD 400
+ +++RD+K N+++DA G +K+ADFG+ K + GT ++APE++ +
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQP- 177
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460
YG + D W+ G + EML + P+ E +F+ P SLS++A
Sbjct: 178 -YGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNVSYPKSLSKEAVSICKGL 235
Query: 461 LQVNPNDR----PTAAQ-LMEHPFIKR 482
L +P R PT + + EH F +R
Sbjct: 236 LTKHPAKRLGCGPTGERDIREHAFFRR 262
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 9e-22
Identities = 66/213 (30%), Positives = 107/213 (50%), Gaps = 27/213 (12%)
Query: 223 RITSWQKGELLGSGSYGFVYEG---LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISL 279
++ ++ K + LG G+Y V++G LT++ A+KE+ L+ E +I +E+SL
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGRSKLTEN--LVALKEIRLEHEEGAPCTAI----REVSL 56
Query: 280 LGQFEHDNIVQYLGTDRDEKRLCIFLELVTK---------GSLASLYQKYHLSDSQVSSY 330
L +H NIV E+ L + E + G+L S++ V +
Sbjct: 57 LKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHN--------VKIF 108
Query: 331 TRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTAFW 389
Q+L GL Y H++ ++HRD+K N+L++ G +KLADFGLA+A ++ S + W
Sbjct: 109 MFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLW 168
Query: 390 MAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRR 422
P V L Y D+W +GC + EM T R
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 1e-21
Identities = 83/295 (28%), Positives = 139/295 (47%), Gaps = 58/295 (19%)
Query: 233 LGSGSYGFVYEGLTD--DGFFFAVKEVSLQDEGPRGKQSILQLEQ---EISLLGQFEHDN 287
+G G++G V+ +TD DG K V+L+ + P Q+++ ++ E+ +L F+HDN
Sbjct: 8 IGYGAFGVVW-SVTDPRDG-----KRVALK-KMPNVFQNLVSCKRVFRELKMLCFFKHDN 60
Query: 288 IVQYLGTDRDEKRLCIFLEL--VTKGSLASLYQ----KYHLSDSQVSSYTRQILNGLKYL 341
++ L + + F E+ VT+ + L++ LS V + QIL GLKYL
Sbjct: 61 VLSALDILQ-PPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYL 119
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTA-----FWMAPEVVN 396
H ++HRDIK N+LV+++ +K+ DFGLA+ ++ S T ++ APE++
Sbjct: 120 HSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE--SKHMTQEVVTQYYRAPEIL- 176
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTRR------HPYSHLE---------GGQAMFKIG--- 438
+ Y DIWS+GC E+L RR P L+ +AM
Sbjct: 177 MGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236
Query: 439 ------GGELPPVPNSL-------SRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480
G PP L + +A + + L +P+ R +AA + HP++
Sbjct: 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 1e-21
Identities = 82/268 (30%), Positives = 128/268 (47%), Gaps = 27/268 (10%)
Query: 232 LLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQ-SILQLEQEI--SLLGQFEHDN 287
++G G +G VY D G +A+K L + + KQ L L + I SL+ +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK--CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSS------YTRQILNGLKYL 341
IV +L L+L+ G L YHLS V S Y +I+ GL+++
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDL-----HYHLSQHGVFSEAEMRFYAAEIILGLEHM 113
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDG 401
H + VV+RD+K ANIL+D G V+++D GLA + + GT +MAPEV+ K
Sbjct: 114 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGVA 172
Query: 402 YGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL---PPVPNSLSRDAQDFIL 458
Y +AD +SLGC + ++L P+ + +I L +P+S S + + +
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELRSLLE 231
Query: 459 KCLQVNPNDR-----PTAAQLMEHPFIK 481
LQ + N R A ++ EHPF +
Sbjct: 232 GLLQRDVNRRLGCLGRGAQEVKEHPFFR 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 81/268 (30%), Positives = 125/268 (46%), Gaps = 28/268 (10%)
Query: 231 ELLGSGSYGFVYEG-LTDDGFFFAVK----EVSLQD---EGPRGKQSILQLEQEISLLGQ 282
+LG GS+G V L + G +AVK +V LQD E ++ IL L +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN------ 54
Query: 283 FEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSD-SQVSSYTRQILNGLKYL 341
H + Q + RL +E V G L QK D ++ Y +I + L +L
Sbjct: 55 --HPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFL 112
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTAFWMAPEVVNLKK 399
H++ +++RD+K N+L+D G KLADFG+ K N + GT ++APE+ L++
Sbjct: 113 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEI--LQE 170
Query: 400 DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILK 459
YG + D W++G + EML P+ E +F+ + P LS+DA D +
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDILKA 229
Query: 460 CLQVNPNDRPTAAQL------MEHPFIK 481
+ NP R + L + HPF K
Sbjct: 230 FMTKNPTMRLGSLTLGGEEAILRHPFFK 257
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 71/265 (26%), Positives = 131/265 (49%), Gaps = 27/265 (10%)
Query: 231 ELLGSGSYGFVYEG-LTDDGFFFAVK----EVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++LG GS+G V L G +FAVK +V L D+ +E+ + L +E+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDD----DVECTMVEKRVLALA-WEN 55
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDS------QVSSYTRQILNGLK 339
+ T + ++ L +E + G L +H+ D + + Y +I+ GL+
Sbjct: 56 PFLTHLYCTFQTKEHLFFVMEFLNGGDLM-----FHIQDKGRFDLYRATFYAAEIVCGLQ 110
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTAFWMAPEVVNL 397
+LH + +++RD+K N+++D G +K+ADFG+ K D ++ GT ++APE++
Sbjct: 111 FLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170
Query: 398 KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFI 457
K Y + D WS G + EML + P+ H + +F+ + P P ++++++D +
Sbjct: 171 LK--YTFSVDWWSFGVLLYEMLIGQSPF-HGDDEDELFESIRVDTPHYPRWITKESKDIL 227
Query: 458 LKCLQVNPNDR-PTAAQLMEHPFIK 481
K + +P R + HPF K
Sbjct: 228 EKLFERDPTRRLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 3e-21
Identities = 72/251 (28%), Positives = 115/251 (45%), Gaps = 14/251 (5%)
Query: 229 KGELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
K +++G+G +G V+ G L G + G KQ L E S++GQF H N
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFL-SEASIMGQFSHHN 67
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQN 345
I++ G K I E + G+L + + S Q+ R I G+KYL + N
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN 127
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTA------FWMAPEVVNLKK 399
VHRD+ NILV+++ K++DFGL++ +D + T+ W APE + +K
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 400 DGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFIL 458
+ +D+WS G + E+++ PY + + M I G P P +L
Sbjct: 187 --FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLML 244
Query: 459 KCLQVNPNDRP 469
+C Q + RP
Sbjct: 245 QCWQQDRARRP 255
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 3e-21
Identities = 72/251 (28%), Positives = 120/251 (47%), Gaps = 16/251 (6%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
GE++G G +G V +G G AVK + Q+ L+ E +++ + H N+V
Sbjct: 11 GEIIGEGEFGAVLQG-EYTGQKVAVKNIKCDVTA----QAFLE---ETAVMTKLHHKNLV 62
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQ---KYHLSDSQVSSYTRQILNGLKYLHEQNV 346
+ LG L I +EL++KG+L + + + +S Q+ ++ + G++YL + +
Sbjct: 63 RLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL 121
Query: 347 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTA 406
VHRD+ NILV G K++DFGLA+ +M V + K W APE LK + +
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMG-VDNSKLPVKWTAPEA--LKHKKFSSKS 178
Query: 407 DIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465
D+WS G + E+ + R PY + + + G P D + C + P
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEP 238
Query: 466 NDRPTAAQLME 476
RP+ +L E
Sbjct: 239 KKRPSFHKLRE 249
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 4e-21
Identities = 79/300 (26%), Positives = 133/300 (44%), Gaps = 51/300 (17%)
Query: 221 RRRITSWQKGELLGSGSYGFVY----EGL---TDDGFFFAVKEVS--------LQDEGPR 265
R+R+T +K LG G +G V+ EG+ D F V L+++ +
Sbjct: 4 RKRLTFKEK---LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60
Query: 266 GKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHL--- 322
++ +EI ++ + + NI++ L LC+ E + G L ++
Sbjct: 61 NARN--DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEA 118
Query: 323 ---SDSQVSSYTR------QILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 373
+D SY+ QI +G+KYL N VHRD+ N LV + ++K+ADFG+++
Sbjct: 119 AEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 374 ATTMNDVKSCKGTAF----WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT--RRHPYSH 427
D +G A WM+ E + L K + +D+W+ G T+ E+LT + PYS
Sbjct: 179 NLYSGDYYRIQGRAVLPIRWMSWESILLGK--FTTASDVWAFGVTLWEILTLCKEQPYSQ 236
Query: 428 LEGGQAM------FKIGGGEL-PPVPNSLSRDAQDFILKCLQVNPNDRPT----AAQLME 476
L Q + F+ G ++ P P +L C + N +RP+ A L+E
Sbjct: 237 LSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 4e-21
Identities = 73/261 (27%), Positives = 124/261 (47%), Gaps = 25/261 (9%)
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQ---EISLLGQFEHDNI 288
LG G YG VYEG+ AVK + K+ +++E+ E +++ + +H N+
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTMEVEEFLKEAAVMKEIKHPNL 64
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLASLYQ---KYHLSDSQVSSYTRQILNGLKYLHEQN 345
VQ LG E I E +T G+L + + ++ + QI + ++YL ++N
Sbjct: 65 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 124
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKKDGY 402
+HRD+ N LV + VK+ADFGL++ T + + G F W APE +L + +
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE--SLAYNKF 182
Query: 403 GLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCL 461
+ +D+W+ G + E+ T PY ++ Q + G P + + C
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACW 242
Query: 462 QVNPNDRPTAAQL---MEHPF 479
Q NP+DRP+ A++ E F
Sbjct: 243 QWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 5e-21
Identities = 70/252 (27%), Positives = 112/252 (44%), Gaps = 58/252 (23%)
Query: 276 EISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSD---------SQ 326
EI LL +H+N++ +D + + + +Y Y L D SQ
Sbjct: 54 EIKLLRHLDHENVIAI----KD------IMPPPHREAFNDVYIVYELMDTDLHQIIRSSQ 103
Query: 327 VSS------YTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND- 379
S + Q+L GLKY+H NV+HRD+K +N+L++A+ +K+ DFGLA+ T+
Sbjct: 104 TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163
Query: 380 -VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRR-----HPYSH------ 427
+ T ++ APE++ L Y D+WS+GC E+L R+ Y H
Sbjct: 164 FMTEYVVTRWYRAPELL-LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLIT 222
Query: 428 -LEGGQAMFKIGG----------GELPPVPN-SLSR-------DAQDFILKCLQVNPNDR 468
L G + +G LP P S +R A D + K L +P+ R
Sbjct: 223 ELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKR 282
Query: 469 PTAAQLMEHPFI 480
T + + HP++
Sbjct: 283 ITVEEALAHPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 6e-21
Identities = 63/264 (23%), Positives = 110/264 (41%), Gaps = 27/264 (10%)
Query: 232 LLGSGSYGFVYEG------LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
LG G +G V+ VK + + + + +E+ + + H
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD----ENLQSEFRRELDMFRKLSH 67
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQ----------KYHLSDSQVSSYTRQIL 335
N+V+ LG R+ + + LE G L + LS Q + QI
Sbjct: 68 KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 336 NGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAP 392
G+ +L VHRD+ N LV + VK++ L+K ++ + W+AP
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187
Query: 393 EVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELP-PVPNSLS 450
E V ++D + +D+WS G + E+ T+ P+ L + + ++ G+L PVP
Sbjct: 188 EAV--QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCP 245
Query: 451 RDAQDFILKCLQVNPNDRPTAAQL 474
+ +C VNP DRP+ ++L
Sbjct: 246 SRLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 7e-21
Identities = 74/269 (27%), Positives = 132/269 (49%), Gaps = 31/269 (11%)
Query: 225 TSWQKGELLGSGSYGFVYEGL-TDDG----FFFAVKEVSLQDEGPRGKQSILQLEQEISL 279
T ++K ++LGSG++G VY+GL +G A+KE+ + P+ + IL E +
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILD---EAYV 62
Query: 280 LGQFEHDNIVQYLGTDRDEKRLCIF--LELVTK----GSLASLYQ--KYHLSDSQVSSYT 331
+ ++ ++ + LG +C+ ++L+T+ G L + K ++ + ++
Sbjct: 63 MASVDNPHVCRLLG-------ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 115
Query: 332 RQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTA 387
QI G+ YL E+ +VHRD+ N+LV VK+ DFGLAK ++ + K
Sbjct: 116 VQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175
Query: 388 FWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVP 446
WMA E ++ Y +D+WS G TV E++T PY + + + GE P P
Sbjct: 176 KWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 233
Query: 447 NSLSRDAQDFILKCLQVNPNDRPTAAQLM 475
+ D ++KC ++ + RP +L+
Sbjct: 234 PICTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 7e-21
Identities = 76/264 (28%), Positives = 115/264 (43%), Gaps = 22/264 (8%)
Query: 232 LLGSGSYG---FVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
L+G G +G V E T D +A+K ++ ++++ E+E +L I
Sbjct: 8 LVGRGHFGEVQVVREKATGD--IYAMK--VMKKSVLLAQETVSFFEEERDILSISNSPWI 63
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHEQNV 346
Q +D+ L + +E G L SL +Y + Y +++ + +H+
Sbjct: 64 PQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY 123
Query: 347 VHRDIKCANILVDASGSVKLADFGLAKATTMNDV---KSCKGTAFWMAPEVVNL----KK 399
VHRDIK N+L+D +G +KLADFG A T N + K GT ++APEV+ K
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 400 DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE----LPPVPNSLSRDAQD 455
YG+ D WSLG EM+ R P+ + I + P P +S D D
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK-VSSDFLD 242
Query: 456 FILKCLQVNPNDRPTAAQLMEHPF 479
I L +R L HPF
Sbjct: 243 LIQSLL-CGQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 9e-21
Identities = 76/268 (28%), Positives = 122/268 (45%), Gaps = 32/268 (11%)
Query: 233 LGSGSYGFVYEGLTDD------GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286
LG GS+G VYEG D AVK V +E ++ I + E S++ F
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTV---NESASLRERI-EFLNEASVMKGFTCH 69
Query: 287 NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQ------------VSSYTRQI 334
++V+ LG + + +EL+ G L S Y + +++ + +I
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKS-YLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 335 LNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKG--TAFWM 390
+G+ YL+ + VHRD+ N +V +VK+ DFG+ + D K KG WM
Sbjct: 129 ADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 391 APEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAM-FKIGGGELPPVPNS 448
APE +LK + ++D+WS G + E+ + PY L Q + F + GG L P++
Sbjct: 189 APE--SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PDN 245
Query: 449 LSRDAQDFILKCLQVNPNDRPTAAQLME 476
D + C Q NP RPT +++
Sbjct: 246 CPERVTDLMRMCWQFNPKMRPTFLEIVN 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 12/209 (5%)
Query: 276 EISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQ 333
E S++GQF+H NI+ G K + I E + GSL + +K+ + Q+ R
Sbjct: 55 EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRG 114
Query: 334 ILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTA------ 387
I +G+KYL + VHRD+ NILV+++ K++DFGL++ +D ++ T
Sbjct: 115 IASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPI 173
Query: 388 FWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVP 446
W APE + +K + +D+WS G + E+++ PY + + I G P P
Sbjct: 174 RWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAP 231
Query: 447 NSLSRDAQDFILKCLQVNPNDRPTAAQLM 475
+L C Q + N+RP Q++
Sbjct: 232 MDCPAALHQLMLDCWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 69/274 (25%), Positives = 119/274 (43%), Gaps = 36/274 (13%)
Query: 233 LGSGSYGFVYE----GLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
+G G++G V++ GL F V L++E Q+ ++E +L+ +F+H NI
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA--DFQREAALMAEFDHPNI 70
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLA------SLYQKYHLSDSQVS-------------- 328
V+ LG K +C+ E + G L S + LS S S
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 329 ---SYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG 385
+Q+ G+ YL E+ VHRD+ N LV + VK+ADFGL++ D
Sbjct: 131 EQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASE 190
Query: 386 TAF----WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGG 440
WM PE + + Y +D+W+ G + E+ + PY + + ++ + G
Sbjct: 191 NDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDG 248
Query: 441 ELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQL 474
+ P++ + + + C P+DRP+ A +
Sbjct: 249 NVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-20
Identities = 62/249 (24%), Positives = 113/249 (45%), Gaps = 14/249 (5%)
Query: 233 LGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYL 292
LG+G +G V G + A+K + G S + +E ++ + H+ +VQ
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK------EGSMSEDEFIEEAKVMMKLSHEKLVQLY 65
Query: 293 GTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRD 350
G ++ + I E ++ G L + +++ SQ+ + + G+ YL + +HRD
Sbjct: 66 GVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRD 125
Query: 351 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKKDGYGLTAD 407
+ N LVD G VK++DFGL++ ++ S G+ F W PEV+ K + +D
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK--FSSKSD 183
Query: 408 IWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPN 466
+W+ G + E+ + + PY + + K+ G P+ S + C
Sbjct: 184 VWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAE 243
Query: 467 DRPTAAQLM 475
+RPT QL+
Sbjct: 244 ERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 73/260 (28%), Positives = 120/260 (46%), Gaps = 22/260 (8%)
Query: 231 ELLGSGSYGFVYEG-LTDDG---FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286
E++G+G +G V G L G F A+K + + ++ E S++GQF+H
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTL----KSGYTEKQRRDFLSEASIMGQFDHP 65
Query: 287 NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQ 344
NI+ G + + I E + G+L S ++ + Q+ R I G+KYL E
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAK-------ATTMNDVKSCKGTAFWMAPEVVNL 397
N VHRD+ NILV+++ K++DFGL++ T K W APE +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 398 KKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGG-ELPPVPNSLSRDAQD 455
+K + +D+WS G + E+++ PY + + I LPP + + Q
Sbjct: 186 RK--FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQ- 242
Query: 456 FILKCLQVNPNDRPTAAQLM 475
+L C Q + N RP Q++
Sbjct: 243 LMLDCWQKDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-20
Identities = 66/248 (26%), Positives = 112/248 (45%), Gaps = 14/248 (5%)
Query: 231 ELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
E +G G++G V+ G L D AVK S ++ P ++ + QE +L Q+ H NIV
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVK--SCRETLPPDLKA--KFLQEARILKQYSHPNIV 56
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVV 347
+ +G ++ + I +ELV G + + L ++ G++YL ++ +
Sbjct: 57 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCI 116
Query: 348 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT----AFWMAPEVVNLKKDGYG 403
HRD+ N LV +K++DFG+++ S G W APE +N + Y
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR--YS 174
Query: 404 LTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQ 462
+D+WS G + E + PY++L Q I G P P + +C +
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWE 234
Query: 463 VNPNDRPT 470
+P RP+
Sbjct: 235 YDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-20
Identities = 75/286 (26%), Positives = 124/286 (43%), Gaps = 57/286 (19%)
Query: 231 ELLGSGSYGFVY----EGL-----------TDDGFFFAVKEVSLQDEGPRGKQSILQLEQ 275
E LG G +G V+ EGL AVK + D + L+
Sbjct: 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR-ADVTKTARNDFLK--- 66
Query: 276 EISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSL------ASLYQKYHLSDSQVSS 329
EI ++ + ++ NI++ LG + LC+ E + G L + + +++ + S
Sbjct: 67 EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN-IPS 125
Query: 330 YTR--------QILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK 381
+ QI +G+KYL N VHRD+ N LV ++K+ADFG+++ D
Sbjct: 126 VSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 382 SCKGTAF----WMAPEVVNLKKDGYGLTADIWSLGCTVLEM--LTRRHPYSHLEGGQAM- 434
+G A WMA E + L K + +D+W+ G T+ EM L + PYS L Q +
Sbjct: 186 RIQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE 243
Query: 435 -----FKIGGGEL-----PPVPNSLSRDAQDFILKCLQVNPNDRPT 470
F+ G ++ P P+ + +++C + DRPT
Sbjct: 244 NTGEFFRNQGRQIYLSQTPLCPSPVF----KLMMRCWSRDIKDRPT 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 74/249 (29%), Positives = 106/249 (42%), Gaps = 56/249 (22%)
Query: 275 QEISLLGQFEHDNIVQYLGTDRDEKRLC-IFLE------LVTK---GSLASLYQKYHLSD 324
+E+ LL H+NI+ L IF+ VT+ L L L
Sbjct: 58 RELKLLKHLRHENIIS----------LSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEK 107
Query: 325 SQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKS 382
+ + QIL GLKY+H VVHRD+K +NIL++ + +K+ DFGLA+ M S
Sbjct: 108 QFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS 167
Query: 383 CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRR---------HPYS---HLEG 430
T ++ APE++ L Y + DIWS GC EML + + +S L G
Sbjct: 168 ---TRYYRAPEIM-LTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLG 223
Query: 431 GQAMFKIGG----------GELP---PVPNS-----LSRDAQDFILKCLQVNPNDRPTAA 472
I LP PVP S A D + K L +P R +AA
Sbjct: 224 TPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAA 283
Query: 473 QLMEHPFIK 481
+ + HP++
Sbjct: 284 EALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 81/267 (30%), Positives = 130/267 (48%), Gaps = 33/267 (12%)
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSIL---QLEQEISLLGQFEHDNI 288
+GSG+YG V L G A+K++ R QS L + +E+ LL +H+N+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLY------RPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 289 VQYLGTDRDEKRLCIF----LELVTKGS-LASLYQKYHLSDSQVSSYTRQILNGLKYLHE 343
+ L + L F L + G+ L L + LS+ ++ Q+L GLKY+H
Sbjct: 77 IGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHA 136
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYG 403
++HRD+K N+ V+ +K+ DFGLA+ T +++ T ++ APEV+ L Y
Sbjct: 137 AGIIHRDLKPGNLAVNEDCELKILDFGLARQTD-SEMTGYVVTRWYRAPEVI-LNWMHYT 194
Query: 404 LTADIWSLGCTVLEMLTRRHPYS---HLEGGQAMFKIGGGELPP---VPNSLSRDAQDFI 457
T DIWS+GC + EMLT + + HL+ + K+ G P V S DA++++
Sbjct: 195 QTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTG--TPSKEFVQKLQSEDAKNYV 252
Query: 458 LKCLQVN--------PNDRPTAAQLME 476
K + PN P A ++E
Sbjct: 253 KKLPRFRKKDFRSLLPNANPLAVNVLE 279
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 6e-20
Identities = 70/264 (26%), Positives = 113/264 (42%), Gaps = 35/264 (13%)
Query: 233 LGSGSYGFVYEGL------TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286
LG G++G V+ T D AVK +L+D ++ ++E LL +H+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARKD---FQREAELLTNLQHE 67
Query: 287 NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-----------------HLSDSQVSS 329
+IV++ G D L + E + G L + + L SQ+
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 330 YTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF- 388
QI +G+ YL Q+ VHRD+ N LV A+ VK+ DFG+++ D G
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 389 ---WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPP 444
WM PE + +K + +D+WS G + E+ T + P+ L + + I G +
Sbjct: 188 PIRWMPPESIMYRK--FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLE 245
Query: 445 VPNSLSRDAQDFILKCLQVNPNDR 468
P ++ D +L C Q P R
Sbjct: 246 RPRVCPKEVYDIMLGCWQREPQQR 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 83/296 (28%), Positives = 123/296 (41%), Gaps = 52/296 (17%)
Query: 231 ELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
E++G GSYG V + T G A+K+++ E IL+ EI LL H +IV
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR---EIKLLRLLRHPDIV 62
Query: 290 QYLG-----TDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQ 344
+ + R+ K + + EL+ + L+ + Q+L LKY+H
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA 122
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWM---------APEVV 395
NV HRD+K NIL +A +K+ DFGLA+ ND FW APE+
Sbjct: 123 NVFHRDLKPKNILANADCKLKICDFGLARVAF-NDT---PTAIFWTDYVATRWYRAPELC 178
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTRRHPY------------SHLEGGQAMFKIGG---- 439
Y DIWS+GC E+LT + + + L G + I
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238
Query: 440 ------GEL---PPVPNSLS-RDAQDFILKCLQ----VNPNDRPTAAQLMEHPFIK 481
+ PVP S +A L+ L+ +P DRPTA + + P+ K
Sbjct: 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 7e-20
Identities = 71/278 (25%), Positives = 125/278 (44%), Gaps = 33/278 (11%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEGLT------DDGFFFAVKEVSLQDEGPRGKQSILQLE 274
R +IT ++ LG GS+G VYEG+ + A+K V +E ++ I +
Sbjct: 5 REKITMSRE---LGQGSFGMVYEGIAKGVVKDEPETRVAIKTV---NEAASMRERI-EFL 57
Query: 275 QEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSS----- 329
E S++ +F ++V+ LG + + +EL+T+G L S Y + + + +
Sbjct: 58 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS-YLRSLRPEMENNPVQAPP 116
Query: 330 -------YTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS 382
+I +G+ YL+ VHRD+ N +V +VK+ DFG+ + D
Sbjct: 117 SLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 176
Query: 383 CKGTAF----WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKI 437
G WM+PE +LK + +D+WS G + E+ T PY + Q + +
Sbjct: 177 KGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234
Query: 438 GGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLM 475
G L P++ + + C Q NP RP+ +++
Sbjct: 235 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 17/202 (8%)
Query: 233 LGSGSYGFVYE-GLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291
LG G +G V + + G +A K++ + + + + LE+EI L + IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 292 LGTDRDEKRLCIFLELVTKGSLASLYQKYHLSD-----SQVSSYTRQILNGLKYLHEQNV 346
+ LC+ + L+ G L Y Y++ + +V Y+ QI G+ +LH ++
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116
Query: 347 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTAFWMAPEVVNLKKDGYG 403
V+RD+K N+L+D G+ +L+D GL A + D K+ GT +MAPE+ LK++ Y
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGL--AVELKDGKTITQRAGTNGYMAPEI--LKEEPYS 172
Query: 404 LTADIWSLGCTVLEMLTRRHPY 425
D +++GC++ EM+ R P+
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 68/248 (27%), Positives = 117/248 (47%), Gaps = 18/248 (7%)
Query: 233 LGSGSYGFVYEG---LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
LGSG++G V +G + A+K + ++E K ++ +E ++ Q ++ IV
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE----KSVRDEMMREAEIMHQLDNPYIV 58
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLY--QKYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
+ +G E L + +E+ + G L +K ++ S V Q+ G+KYL +N V
Sbjct: 59 RMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 348 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTA-----FWMAPEVVNLKKDGY 402
HRD+ N+L+ K++DFGL+KA +D +A W APE +N +K +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK--F 175
Query: 403 GLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCL 461
+D+WS G T+ E + + PY ++G + M I G+ P + + C
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCW 235
Query: 462 QVNPNDRP 469
DRP
Sbjct: 236 IYKWEDRP 243
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 82/254 (32%), Positives = 116/254 (45%), Gaps = 38/254 (14%)
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEIS-LLGQFEHDNIVQ 290
+G GS+G V DG F+AVK LQ + K+ + E + LL +H +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVK--VLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 291 YLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHR 349
+ + +L L+ V G L L ++ + + Y +I + L YLH N+++R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 350 DIKCANILVDASGSVKLADFGLAK-ATTMNDVKS--CKGTAFWMAPEVVNLKKDGYGLTA 406
D+K NIL+D+ G V L DFGL K + S C GT ++APEV L+K Y T
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPEV--LRKQPYDRTV 177
Query: 407 DIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQ---DFIL-KCLQ 462
D W LG + EML LPP SRD D IL K L+
Sbjct: 178 DWWCLGAVLYEMLY--------------------GLPPF---YSRDTAEMYDNILNKPLR 214
Query: 463 VNPNDRPTAAQLME 476
+ PN +A L+E
Sbjct: 215 LKPNISVSARHLLE 228
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 34/203 (16%)
Query: 301 LCIFLELVTKGSLASLYQKYHL--------SDSQVSSYTRQILNGLKYLHEQNVVHRDIK 352
LC+ L L+ G L K+H+ + + Y +I GL+ LH + +V+RD+K
Sbjct: 75 LCLVLTLMNGGDL-----KFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLK 129
Query: 353 CANILVDASGSVKLADFGLAKATTMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSL 411
NIL+D G ++++D GLA + ++ GT +MAPEVV ++ Y + D W L
Sbjct: 130 PENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNER--YTFSPDWWGL 187
Query: 412 GCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL--------PPVPNSLSRDAQDFILKCLQV 463
GC + EM+ + P+ Q K+ E+ S A+ + L
Sbjct: 188 GCLIYEMIEGKSPFR-----QRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTK 242
Query: 464 NPNDR-----PTAAQLMEHPFIK 481
+P R A ++ HPF +
Sbjct: 243 DPGFRLGCRGEGAEEVKAHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 68/261 (26%), Positives = 114/261 (43%), Gaps = 32/261 (12%)
Query: 233 LGSGSYGFVYEGLT------DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286
LG G++G V+ D AVK +L+D ++ +E LL +H+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVK--TLKDASDNARKD---FHREAELLTNLQHE 67
Query: 287 NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--------------HLSDSQVSSYTR 332
+IV++ G + L + E + G L + + L+ SQ+ +
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 333 QILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---- 388
QI G+ YL Q+ VHRD+ N LV + VK+ DFG+++ D G
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 389 WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPN 447
WM PE + +K + +D+WSLG + E+ T + P+ L + + I G + P
Sbjct: 188 WMPPESIMYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPR 245
Query: 448 SLSRDAQDFILKCLQVNPNDR 468
+ ++ D +L C Q P+ R
Sbjct: 246 TCPKEVYDLMLGCWQREPHMR 266
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 2e-19
Identities = 73/271 (26%), Positives = 120/271 (44%), Gaps = 29/271 (10%)
Query: 230 GELLGSGSYGFVYEGL--TDDGFF--FAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
G++LG G +G V EG DDG AVK + L + L E + + F+H
Sbjct: 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLS---EAACMKDFDH 60
Query: 286 DNIVQYLG---TDRDEKRL---CIFLELVTKGSLAS--LY-----QKYHLSDSQVSSYTR 332
N+++ +G +++ + L + G L S LY L + +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 333 QILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV----KSCKGTAF 388
I G++YL +N +HRD+ N ++ +V +ADFGL+K D + K
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180
Query: 389 WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAM-FKIGGGELPPVP 446
W+A E +L Y +D+W+ G T+ E+ TR + PY +E + + G L
Sbjct: 181 WIAIE--SLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238
Query: 447 NSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
+ L + D + C + +P DRPT +L E
Sbjct: 239 DCLD-ELYDLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 19/210 (9%)
Query: 226 SWQKGELLGSGSYGFVYE-GLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE 284
++++ +LG G +G V + G +A K + + R +S+ E++I L +
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQI--LEKVN 58
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHL--------SDSQVSSYTRQILN 336
+V + LC+ L ++ G L K+H+ + + Y +IL
Sbjct: 59 SQFVVNLAYAYETKDALCLVLTIMNGGDL-----KFHIYNMGNPGFEEERALFYAAEILC 113
Query: 337 GLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLA-KATTMNDVKSCKGTAFWMAPEVV 395
GL+ LH +N V+RD+K NIL+D G ++++D GLA K ++ GT +MAPEV+
Sbjct: 114 GLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL 173
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTRRHPY 425
N ++ Y L+ D W LGC + EM+ + P+
Sbjct: 174 NNQR--YTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 82/287 (28%), Positives = 132/287 (45%), Gaps = 48/287 (16%)
Query: 232 LLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSIL---QLEQEISLLGQFEHDN 287
+GSG+YG V + G A+K++S R QS + + +E++LL +H+N
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLS------RPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 288 IVQYLGTDRDEKRLCIFLE--LVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLH 342
++ L F + LV L QK + LS+ +V Q+L GLKY+H
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDL-QKIMGHPLSEDKVQYLVYQMLCGLKYIH 134
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGY 402
++HRD+K N+ V+ +K+ DFGLA+ ++ T ++ APEV+ L Y
Sbjct: 135 SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-EMTGYVVTRWYRAPEVI-LNWMHY 192
Query: 403 GLTADIWSLGCTVLEMLTRRHPYS---HLEGGQAMFKIGG-------------------G 440
T DIWS+GC + EMLT + + +L+ + K+ G
Sbjct: 193 NQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIK 252
Query: 441 ELPPVPN--------SLSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
LP P S A D + K L+++ + R TA + +EHP+
Sbjct: 253 SLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 69/211 (32%), Positives = 106/211 (50%), Gaps = 11/211 (5%)
Query: 276 EISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSD-SQVSSYTRQI 334
E ++L Q IV + + ++L + L + G L Q+ D S+ YT ++
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL 102
Query: 335 LNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTAFWMA 391
L L+ LH+ NV++RD+K NIL+D G + L DFGL K +D K+ C GT ++A
Sbjct: 103 LCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLA 161
Query: 392 PEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSR 451
PE+ L GY D W+LG + EMLT P+ + E M++ E P+ R
Sbjct: 162 PEL--LLGHGYTKAVDWWTLGVLLYEMLTGLPPF-YDENVNEMYRKILQEPLRFPDGFDR 218
Query: 452 DAQDFILKCLQVNPNDR---PTAAQLMEHPF 479
DA+D ++ L +P R A ++ HPF
Sbjct: 219 DAKDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-19
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 10/207 (4%)
Query: 276 EISLLGQFEHDNIVQYLGTDRDEK-RLCIFLELVTKGSLASLYQ---KYHLSDSQVSSYT 331
E S++ Q H N+VQ LG +EK L I E + KGSL + + L + ++
Sbjct: 49 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 108
Query: 332 RQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK-ATTMNDVKSCKGTAFWM 390
+ ++YL N VHRD+ N+LV K++DFGL K A++ D + K W
Sbjct: 109 LDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWT 166
Query: 391 APEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSL 449
APE + KK + +D+WS G + E+ + R PY + + ++ G P+
Sbjct: 167 APEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC 224
Query: 450 SRDAQDFILKCLQVNPNDRPTAAQLME 476
D + +C ++ RP+ QL E
Sbjct: 225 PPVVYDVMKQCWHLDAATRPSFLQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 79/267 (29%), Positives = 126/267 (47%), Gaps = 23/267 (8%)
Query: 231 ELLGSGSYGFVYEGL---TDDGFFFAV--KEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++LG GS+G V TD+ + V K+V LQD+ E+ I L +H
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDD----DVDCTMTEKRILALAA-KH 55
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSD-SQVSSYTRQILNGLKYLHEQ 344
+ + + RL +E V G L Q+ D + Y ++ L +LH
Sbjct: 56 PFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH 115
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTAFWMAPEVVNLKKDGY 402
V++RD+K NIL+DA G KLADFG+ K +N V + GT ++APE+ L++ Y
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEI--LQELEY 173
Query: 403 GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQ 462
G + D W+LG + EM+ + P+ + +F+ + P LS++A + +
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMT 232
Query: 463 VNPNDR--PTAAQ-----LMEHPFIKR 482
NPN R A+Q + +HPF K
Sbjct: 233 KNPNKRLGCVASQGGEDAIKQHPFFKE 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 5e-19
Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 37/206 (17%)
Query: 301 LCIFLELVTKGSLASLYQKYH----------LSDSQVSSYTRQILNGLKYLHEQNVVHRD 350
LC+ + ++ G L +YH + + YT QI++GL++LH++ +++RD
Sbjct: 68 LCLVMTIMNGGDL-----RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRD 122
Query: 351 IKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADI 408
+K N+L+D G+V+++D GLA + K GT +MAPE+ L+ + Y + D
Sbjct: 123 LKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPEL--LQGEEYDFSVDY 180
Query: 409 WSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP------PV--PNSLSRDAQDFILKC 460
++LG T+ EM+ R P+ G+ K+ EL V P+ S ++ F
Sbjct: 181 FALGVTLYEMIAARGPFR--ARGE---KVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235
Query: 461 LQVNPNDR-----PTAAQLMEHPFIK 481
L +P R L HP +
Sbjct: 236 LAKDPEKRLGFRDGNCDGLRTHPLFR 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 7e-19
Identities = 67/243 (27%), Positives = 111/243 (45%), Gaps = 45/243 (18%)
Query: 275 QEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQ-------- 326
+E+ +L + + NI++ LG DE LC+ E + G L +HL D +
Sbjct: 68 KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127
Query: 327 ------VSSYTR------QILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 374
SY+ QI +G+KYL N VHRD+ N LV + ++K+ADFG+++
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRN 187
Query: 375 TTMNDVKSCKGTAF----WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT--RRHPYSHL 428
D +G A WMA E + + K + +D+W+ G T+ E+L + PY L
Sbjct: 188 LYAGDYYRIQGRAVLPIRWMAWECILMGK--FTTASDVWAFGVTLWEILMLCKEQPYGEL 245
Query: 429 ------EGGQAMFKIGGGEL-----PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
E F+ G ++ PP P L + +L+C + +RP+ + + H
Sbjct: 246 TDEQVIENAGEFFRDQGRQVYLFRPPPCPQGL----YELMLQCWSRDCRERPSFSDI--H 299
Query: 478 PFI 480
F+
Sbjct: 300 AFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 74/275 (26%), Positives = 128/275 (46%), Gaps = 27/275 (9%)
Query: 226 SWQKGELLGSGSYGFVYE-GLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE 284
++++ +LG G +G V + G +A K++ + R +S+ E++I L +
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQI--LEKVN 58
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDS-----QVSSYTRQILNGLK 339
+V + LC+ L L+ G L + YH+ ++ + Y +I GL+
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLK--FHIYHMGEAGFEEGRAVFYAAEICCGLE 116
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLA-KATTMNDVKSCKGTAFWMAPEVVNLK 398
LH++ +V+RD+K NIL+D G ++++D GLA +K GT +MAPEVV K
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--K 174
Query: 399 KDGYGLTADIWSLGCTVLEMLTRRHPYSH------LEGGQAMFKIGGGELPPVPNSLSRD 452
+ Y + D W+LGC + EM+ + P+ E + + K E S D
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEY---SEKFSPD 231
Query: 453 AQDFILKCLQVNPNDR-----PTAAQLMEHPFIKR 482
A+ L +P +R A ++ EHP K+
Sbjct: 232 ARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 69/204 (33%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 232 LLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQ-SILQLEQEI--SLLGQFEHDN 287
++G G +G VY D G +A+K L + + KQ L L + I SL+ +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK--CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSS------YTRQILNGLKYL 341
IV +LC L+L+ G L YHLS V S Y +I+ GL+++
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDL-----HYHLSQHGVFSEKEMRFYATEIILGLEHM 113
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDG 401
H + VV+RD+K ANIL+D G V+++D GLA + + GT +MAPEV+ K
Sbjct: 114 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGTA 172
Query: 402 YGLTADIWSLGCTVLEMLTRRHPY 425
Y +AD +SLGC + ++L P+
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-18
Identities = 67/262 (25%), Positives = 129/262 (49%), Gaps = 19/262 (7%)
Query: 225 TSWQKGELLGSGSYGFVYEGL-TDDG----FFFAVKEVSLQDEGPRGKQSILQLEQEISL 279
T ++ ++LGSG++G VY+G+ +G A+K ++ + GP+ ++ E +
Sbjct: 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKAN---VEFMDEALI 62
Query: 280 LGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNG 337
+ +H ++V+ LG + + +L+ G L ++ ++ + ++ QI G
Sbjct: 63 MASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKG 121
Query: 338 LKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPE 393
+ YL E+ +VHRD+ N+LV + VK+ DFGLA+ ++ K WMA E
Sbjct: 122 MMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181
Query: 394 VVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRD 452
++ +K + +D+WS G T+ E++T PY + + + GE P P + D
Sbjct: 182 CIHYRK--FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTID 239
Query: 453 AQDFILKCLQVNPNDRPTAAQL 474
++KC ++ + RP +L
Sbjct: 240 VYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 8/205 (3%)
Query: 276 EISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQ 333
E LGQF+H NIV+ G + I E ++ G+L S +K+ L Q+
Sbjct: 56 EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPG 115
Query: 334 ILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC---KGTAFWM 390
+ +G+KYL E VH+ + +LV++ K++ F + + + K W
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWA 175
Query: 391 APEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSL 449
APE + + +D+WS G + E+++ PY + G + + G P P +
Sbjct: 176 APEAIQYHH--FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNC 233
Query: 450 SRDAQDFILKCLQVNPNDRPTAAQL 474
+L C Q +RP +Q+
Sbjct: 234 PNLLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 71/266 (26%), Positives = 127/266 (47%), Gaps = 25/266 (9%)
Query: 230 GELLGSGSYGFVYEGL--TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
G +LG G +G V E ++DG F V L+ + I + +E + + +F+H N
Sbjct: 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD-IFSSSDIEEFLREAACMKEFDHPN 62
Query: 288 IVQYLGTD---RDEKRLCI---FLELVTKGSLASLY-------QKYHLSDSQVSSYTRQI 334
+++ +G R + RL I L + G L + + + L + + I
Sbjct: 63 VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122
Query: 335 LNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSC--KGTAFWM 390
+G++YL +N +HRD+ N +++ + +V +ADFGL+K D + C K W+
Sbjct: 123 ASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 391 APEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAM-FKIGGGELPPVPNS 448
A E +L + Y +D+W+ G T+ E++TR + PY+ +E + + I G L P+
Sbjct: 183 ALE--SLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDC 240
Query: 449 LSRDAQDFILKCLQVNPNDRPTAAQL 474
L D + + +C P RP+ L
Sbjct: 241 LE-DVYELMCQCWSPEPKCRPSFQHL 265
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 18/200 (9%)
Query: 296 RDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKC 353
+DE L + ++ G L +L K+ L + Y +++ + +H+ VHRDIK
Sbjct: 71 QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKP 130
Query: 354 ANILVDASGSVKLADFG-----LAKATTMNDVKSCKGTAFWMAPEVVNLKKDG---YGLT 405
N+L+D +G ++LADFG LA T ++V GT +++PE++ +DG YG
Sbjct: 131 DNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV--GTPDYISPEILQAMEDGKGRYGPE 188
Query: 406 ADIWSLGCTVLEMLTRRHPY---SHLEG-GQAMFKIGGGELPPVPNSLSRDAQDFILK-- 459
D WSLG + EML P+ S +E G+ M + PP +S +A+D I +
Sbjct: 189 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLI 248
Query: 460 CLQVNPNDRPTAAQLMEHPF 479
C R +HPF
Sbjct: 249 CSPETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 73/270 (27%), Positives = 129/270 (47%), Gaps = 31/270 (11%)
Query: 225 TSWQKGELLGSGSYGFVYEGL-TDDG----FFFAVKEVSLQDEGPRGKQSILQLEQEISL 279
T +K ++LGSG++G VY+G+ DG A+K V ++ P+ + IL E +
Sbjct: 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIK-VLRENTSPKANKEILD---EAYV 62
Query: 280 LGQFEHDNIVQYLGTDRDEKRLCIF--LELVTK----GSLASLYQ--KYHLSDSQVSSYT 331
+ + + LG +C+ ++LVT+ G L + K + + ++
Sbjct: 63 MAGVGSPYVCRLLG-------ICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWC 115
Query: 332 RQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK----SCKGTA 387
QI G+ YL E +VHRD+ N+LV + VK+ DFGLA+ +++ + K
Sbjct: 116 VQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI 175
Query: 388 FWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVP 446
WMA E + ++ + +D+WS G TV E++T PY + + + GE P P
Sbjct: 176 KWMALESILHRR--FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQP 233
Query: 447 NSLSRDAQDFILKCLQVNPNDRPTAAQLME 476
+ D ++KC ++ RP +L++
Sbjct: 234 PICTIDVYMIMVKCWMIDSECRPRFRELVD 263
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.3 bits (218), Expect = 2e-18
Identities = 74/295 (25%), Positives = 140/295 (47%), Gaps = 42/295 (14%)
Query: 223 RITSWQKGELLGSGSYGFVY---EGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISL 279
R+ ++ + +G+G +G V+ T + FF K +S + R K QL E+++
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQE--FFCWKAISYRGLKEREKS---QLVIEVNV 65
Query: 280 LGQFEHDNIVQYLGT--DRDEKRLCIFLELVTKGSLASLYQKYH-----LSDSQVSSYTR 332
+ + +H NIV+Y+ ++ ++L I +E G L+ QK + + + + TR
Sbjct: 66 MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR 125
Query: 333 QILNGLKYLHE-------QNVVHRDIKCANILVDAS----GSV-------------KLAD 368
Q+L+ L Y H + V+HRD+K NI + G + K+ D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 369 FGLAKATTMNDV-KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSH 427
FGL+K + + SC GT ++ +PE++ + Y +D+W+LGC + E+ + + P+
Sbjct: 186 FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
Query: 428 LEG-GQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
Q + ++ G P+ S++ I L ++ +RP+A Q + + IK
Sbjct: 246 ANNFSQLISELKRGPDLPIKGK-SKELNILIKNLLNLSAKERPSALQCLGYQIIK 299
|
Length = 1021 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 7/206 (3%)
Query: 231 ELLGSGSYGFVY-EGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
+++G GS+G V DG F+AVK + + + +Q+ + E+ + LL +H +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLV 59
Query: 290 QYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVH 348
+ + ++L L+ V G L L ++ + + Y ++ + + YLH N+++
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119
Query: 349 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTAFWMAPEVVNLKKDGYGLTA 406
RD+K NIL+D+ G V L DFGL K + + GT ++APEV L+K+ Y T
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEV--LRKEPYDRTV 177
Query: 407 DIWSLGCTVLEMLTRRHPYSHLEGGQ 432
D W LG + EML P+ + Q
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQ 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 21/202 (10%)
Query: 298 EKRLCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANI 356
E RL +E V G L Q+ L + Y+ +I L YLHE+ +++RD+K N+
Sbjct: 68 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 127
Query: 357 LVDASGSVKLADFGLAK-ATTMNDVKS--CKGTAFWMAPEVVNLKKDGYGLTADIWSLGC 413
L+D+ G +KL D+G+ K D S C GT ++APE+ L+ + YG + D W+LG
Sbjct: 128 LLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEI--LRGEDYGFSVDWWALGV 184
Query: 414 TVLEMLTRRHPYSHLEGGQA--------MFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465
+ EM+ R P+ + +F++ + +P SLS A + L +P
Sbjct: 185 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDP 244
Query: 466 NDR----PTA--AQLMEHPFIK 481
+R P A + HPF +
Sbjct: 245 KERLGCHPQTGFADIQGHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 23/203 (11%)
Query: 298 EKRLCIFLELVTKGSLA-SLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANI 356
E RL +E V+ G L + ++ L + Y+ +I L +LHE+ +++RD+K N+
Sbjct: 68 ESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNV 127
Query: 357 LVDASGSVKLADFGLAK-ATTMNDVKS--CKGTAFWMAPEVVNLKKDGYGLTADIWSLGC 413
L+DA G +KL D+G+ K D S C GT ++APE+ L+ + YG + D W+LG
Sbjct: 128 LLDAEGHIKLTDYGMCKEGIRPGDTTSTFC-GTPNYIAPEI--LRGEDYGFSVDWWALGV 184
Query: 414 TVLEMLTRRHPYSHLEGGQA---------MFKIGGGELPPVPNSLSRDAQDFILKCLQVN 464
+ EM+ R P+ + G +F++ + +P SLS A + L +
Sbjct: 185 LMFEMMAGRSPFD-IVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKD 243
Query: 465 PNDR------PTAAQLMEHPFIK 481
P +R + HPF +
Sbjct: 244 PKERLGCHPQTGFRDIKSHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 76/262 (29%), Positives = 118/262 (45%), Gaps = 20/262 (7%)
Query: 228 QKGELLGSGSYGFVYE----GLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEI-SLLGQ 282
G+ LG+G++G V E GL+ V L+ ++ L E +I S LG
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN 97
Query: 283 FEHDNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYH--LSDSQVSSYTRQILNGLK 339
H+NIV LG + + E G L + L +K L+ + S++ Q+ G+
Sbjct: 98 --HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS-CKGTAF----WMAPEV 394
+L +N +HRD+ N+L+ VK+ DFGLA+ MND KG A WMAPE
Sbjct: 156 FLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVVKGNARLPVKWMAPE- 213
Query: 395 VNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFK-IGGGELPPVPNSLSRD 452
++ Y +D+WS G + E+ + +PY + +K I G P +
Sbjct: 214 -SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAE 272
Query: 453 AQDFILKCLQVNPNDRPTAAQL 474
D + C +P RPT Q+
Sbjct: 273 IYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 65/252 (25%), Positives = 95/252 (37%), Gaps = 55/252 (21%)
Query: 276 EISLLGQFEHDNIVQYLGTDRDEKRLCIFL-----ELVTKGSLASLYQKYHLSDSQVSSY 330
E LL H ++++ T C+ L +L T + S L Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS----RPLPIDQALII 162
Query: 331 TRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DVKSCKGTAFW 389
+QIL GL+YLH Q ++HRD+K NI ++ V + D G A+ + GT
Sbjct: 163 EKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET 222
Query: 390 MAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHP----------------YSHLEGGQA 433
APEV L +D Y ADIWS G + EML +SHL +
Sbjct: 223 NAPEV--LARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS 280
Query: 434 MFKIGGGELPPVPNS---------------------------LSRDAQDFILKCLQVNPN 466
K+ E P P S L D + + K L +
Sbjct: 281 TLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAA 340
Query: 467 DRPTAAQLMEHP 478
RP+A +++ +P
Sbjct: 341 MRPSAEEILNYP 352
|
Length = 357 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 85/303 (28%), Positives = 139/303 (45%), Gaps = 56/303 (18%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVS--LQDEGPRGKQSILQLEQEISLLGQF 283
+Q+ + +GSG+ G V T G AVK++S Q++ K++ +E+ LL
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ-THAKRAY----RELVLLKCV 77
Query: 284 EHDNIVQYLGTDRDEKRLCIF--LELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLK 339
H NI+ L +K L F + LV + A+L Q H L ++S Q+L G+K
Sbjct: 78 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIK 137
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK-GTAFWMAPEVVNLK 398
+LH ++HRD+K +NI+V + ++K+ DFGLA+ N + + T ++ APEV+
Sbjct: 138 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI--L 195
Query: 399 KDGYGLTADIWSLGCTV------------------------------LEMLTRRHPY--S 426
GY DIWS+GC + E + R P +
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN 255
Query: 427 HLEGGQAMFKIGGGELPP---VPNSLSRD------AQDFILKCLQVNPNDRPTAAQLMEH 477
++E I EL P P+ RD A+D + K L ++P+ R + + + H
Sbjct: 256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315
Query: 478 PFI 480
P+I
Sbjct: 316 PYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 52/180 (28%), Positives = 88/180 (48%), Gaps = 11/180 (6%)
Query: 298 EKRLCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANI 356
RL + +E V G L Q+ L + Y +I L +LHE+ +++RD+K N+
Sbjct: 68 TSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNV 127
Query: 357 LVDASGSVKLADFGLAKATTM--NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCT 414
L+DA G +KL D+G+ K + + GT ++APE+ L+ + YG + D W+LG
Sbjct: 128 LLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEI--LRGEEYGFSVDWWALGVL 185
Query: 415 VLEMLTRRHPYSHLEGGQAM------FKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDR 468
+ EM+ R P+ + M F++ + +P LS A + L +P +R
Sbjct: 186 MFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 76/288 (26%), Positives = 135/288 (46%), Gaps = 51/288 (17%)
Query: 233 LGSGSYGFV---YEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQ---EISLLGQFEHD 286
+GSG+YG V Y+ AVK++S R QS++ + E+ LL +H+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKV--AVKKLS------RPFQSLIHARRTYRELRLLKHMKHE 74
Query: 287 NIVQYLGTDRDEKRLCIFLE--LVTK---GSLASLYQKYHLSDSQVSSYTRQILNGLKYL 341
N++ L + F E LVT L ++ + LSD V Q+L GLKY+
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDG 401
H ++HRD+K +N+ V+ +++ DFGLA+ +++ T ++ APE++ L
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD-DEMTGYVATRWYRAPEIM-LNWMH 192
Query: 402 YGLTADIWSLGCTVLEMLTRRHPY---SHLEGGQAMFKIGGG------------------ 440
Y T DIWS+GC + E+L + + +++ + + ++ G
Sbjct: 193 YNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYI 252
Query: 441 -ELPPVPN----SLSRDAQ----DFILKCLQVNPNDRPTAAQLMEHPF 479
LP +P + R A D + K L ++ + R +A++ + HP+
Sbjct: 253 QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 69/267 (25%), Positives = 110/267 (41%), Gaps = 34/267 (12%)
Query: 231 ELLGSGSYGFVYEGL-----TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
E LG ++G +Y+G D A+K +L+D Q + +QE SL+ + H
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIK--TLKDIN--NPQQWGEFQQEASLMAELHH 66
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSS--------------- 329
NIV LG E+ +C+ E + +G L L + SD SS
Sbjct: 67 PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 330 --YTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTA 387
QI G++YL VH+D+ NIL+ VK++D GL++ D + +
Sbjct: 127 LHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 388 F----WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGEL 442
WM PE + K + +DIWS G + E+ + PY + + + +L
Sbjct: 187 LLPIRWMPPEAIMYGK--FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL 244
Query: 443 PPVPNSLSRDAQDFILKCLQVNPNDRP 469
P + +C Q P+ RP
Sbjct: 245 LPCSEDCPPRMYSLMTECWQEGPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 231 ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
+++G GS+G V DG +AVK + + R +Q + E+ + LL +H +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLV 59
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQNVVH 348
+ + ++L L+ V G L Q+ + + Y +I + L YLH N+V+
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVY 119
Query: 349 RDIKCANILVDASGSVKLADFGLAK-ATTMNDVKS--CKGTAFWMAPEVVNLKKDGYGLT 405
RD+K NIL+D+ G V L DFGL K +D + C GT ++APEV ++K Y T
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC-GTPEYLAPEV--IRKQPYDNT 176
Query: 406 ADIWSLGCTVLEMLTRRHPY 425
D W LG + EML P+
Sbjct: 177 VDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 4/211 (1%)
Query: 216 PNGKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQ 275
P K + + + LG+GS+G V + F V + ++ + +
Sbjct: 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS 80
Query: 276 EISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSS-YTRQI 334
E +L H V G+ +DE L + LE V G + ++ + V Y QI
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140
Query: 335 LNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEV 394
+ +YL N+V+RD+K N+L+D G +K+ DFG AK C GT ++APE+
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC-GTPEYIAPEI 199
Query: 395 VNLKKDGYGLTADIWSLGCTVLEMLTRRHPY 425
L G+G AD W+LG + E+L P+
Sbjct: 200 --LLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 8e-17
Identities = 71/267 (26%), Positives = 124/267 (46%), Gaps = 27/267 (10%)
Query: 232 LLGSGSYGFVY-EGLTDDGFFFAVK----EVSLQD---EGPRGKQSILQLEQEISLLGQF 283
+LG GS+G V +A+K +V +QD E ++ +L L+ + L Q
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLH 342
+ Q + RL +E V G L Q+ + Q Y +I GL +LH
Sbjct: 67 H--SCFQTV------DRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH 118
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKGTAFWMAPEVVNLKKD 400
+ +++RD+K N+++D+ G +K+ADFG+ K ++ V ++ GT ++APE++ +
Sbjct: 119 RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP- 177
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460
YG + D W+ G + EML + P+ E +F+ P SLS++A
Sbjct: 178 -YGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNVSYPKSLSKEAVSICKGL 235
Query: 461 LQVNPNDRPTAAQ-----LMEHPFIKR 482
+ +P+ R + EH F +R
Sbjct: 236 MTKHPSKRLGCGPEGERDIREHAFFRR 262
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 8e-17
Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 16/208 (7%)
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
IVQ +D+K L + +E + G L +L Y + + YT +++ L +H +
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFI 164
Query: 348 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTAFWMAPEVVNLKKDG--- 401
HRD+K N+L+D SG +KLADFG N + C GT +++PEV LK G
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEV--LKSQGGDG 222
Query: 402 -YGLTADIWSLGCTVLEMLTRRHPY--SHLEG--GQAMFKIGGGELPPVPNSLSRDAQDF 456
YG D WS+G + EML P+ L G + M P +S+ A+D
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI-EISKQAKDL 281
Query: 457 ILKCLQVNPN--DRPTAAQLMEHPFIKR 482
I L R ++ HPF K
Sbjct: 282 ICAFLTDREVRLGRNGVDEIKSHPFFKN 309
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 74/256 (28%), Positives = 117/256 (45%), Gaps = 38/256 (14%)
Query: 231 ELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
+++G GS+G V + F+AVK + + + ++ + E+ + LL +H +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLV 59
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLS------DSQVSSYTRQILNGLKYLHE 343
+ + +L L+ + G L YHL + + Y +I + L YLH
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELF-----YHLQRERCFLEPRARFYAAEIASALGYLHS 114
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTAFWMAPEVVNLKKDG 401
N+V+RD+K NIL+D+ G + L DFGL K ++ + GT ++APEV L K
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV--LHKQP 172
Query: 402 YGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFIL-KC 460
Y T D W LG + EML LPP + + + D IL K
Sbjct: 173 YDRTVDWWCLGAVLYEMLY--------------------GLPPFYSRNTAEMYDNILNKP 212
Query: 461 LQVNPNDRPTAAQLME 476
LQ+ PN +A L+E
Sbjct: 213 LQLKPNITNSARHLLE 228
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 70/289 (24%), Positives = 117/289 (40%), Gaps = 64/289 (22%)
Query: 247 DDGFFFAVKEVSLQDEGPRGKQSILQLEQ------EISLLGQFEHDNIVQYLGTDRDEKR 300
D G +A+K++ K +L+ EQ E +L + ++ +V+ + +DE
Sbjct: 24 DTGHIYAMKKLR--------KSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY 75
Query: 301 LCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVD 359
L + +E + G + +L K ++ + Y + + + +H+ +HRDIK N+L+D
Sbjct: 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD 135
Query: 360 ASGSVKLADFGLAK--------------------------ATTMNDVK------------ 381
A G +KL+DFGL + M+ +
Sbjct: 136 AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRAL 195
Query: 382 --SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKI-G 438
S GT ++APEV + GY D WSLG + EML P+ + KI
Sbjct: 196 AYSTVGTPDYIAPEV--FLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIIN 253
Query: 439 GGELPPVPNS--LSRDAQDFILKCLQVNPNDR---PTAAQLMEHPFIKR 482
E P+ LS +A+D I + L R ++ HPF K
Sbjct: 254 WKETLQFPDEVPLSPEAKDLIKR-LCCEAERRLGNNGVNEIKSHPFFKG 301
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 50/148 (33%), Positives = 69/148 (46%), Gaps = 5/148 (3%)
Query: 276 EISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQIL 335
E +L H +I+Q GT K C+ L L K +++ + + R +L
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVL 192
Query: 336 NGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLA---KATTMNDVKSCKGTAFWMAP 392
++YLHE ++HRDIK NI ++ G V L DFG A N GT AP
Sbjct: 193 RAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAP 252
Query: 393 EVVNLKKDGYGLTADIWSLGCTVLEMLT 420
E+ L +D YG DIWS G + EM T
Sbjct: 253 EL--LARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 2e-16
Identities = 54/174 (31%), Positives = 87/174 (50%), Gaps = 25/174 (14%)
Query: 321 HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVD-ASGSVKLADFGLAKATTMND 379
LS+++V RQ++ L LH+ N++H DIK N+L D A + L D+GL K
Sbjct: 105 KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII---G 161
Query: 380 VKSC-KGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY----------SHL 428
SC GT + +PE +K Y ++ D W++G E+LT +HP+ L
Sbjct: 162 TPSCYDGTLDYFSPE--KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL 219
Query: 429 EGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDR-PTAAQLMEHPFIK 481
Q K+ P ++S++A DF+ L+ N N R ++++HPF+K
Sbjct: 220 LKRQQ-KKL------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266
|
Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 80/280 (28%), Positives = 123/280 (43%), Gaps = 41/280 (14%)
Query: 230 GELLGSGSYGFVY--EGLTDD------GFFFAVKEVSLQDEGPRGKQSILQLEQEI-SLL 280
G+ LG G +G V E L D AVK L+D+ S L E E+ ++
Sbjct: 20 GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMI 77
Query: 281 GQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASL------------YQKYHLSDSQVS 328
G+ H NI+ LG + L + +E +KG+L Y + D Q++
Sbjct: 78 GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135
Query: 329 -----SYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC 383
S T Q+ G++YL Q +HRD+ N+LV + +K+ADFGLA+ +N++
Sbjct: 136 FKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DVNNIDYY 193
Query: 384 KGTAF------WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFK 436
K T WMAPE L Y +D+WS G + E+ T PY + +
Sbjct: 194 KKTTNGRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251
Query: 437 IGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476
+ G P + + + + C P+ RPT QL+E
Sbjct: 252 LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 48/145 (33%), Positives = 74/145 (51%), Gaps = 9/145 (6%)
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
+VQ +D+K L + +E + G L +L Y + + YT +++ L +H ++
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLI 164
Query: 348 HRDIKCANILVDASGSVKLADFGLA---KATTMNDVKSCKGTAFWMAPEVVNLKKDG--- 401
HRD+K N+L+D G +KLADFG T M + GT +++PEV LK G
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV--LKSQGGDG 222
Query: 402 -YGLTADIWSLGCTVLEMLTRRHPY 425
YG D WS+G + EML P+
Sbjct: 223 YYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-16
Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 29/211 (13%)
Query: 226 SWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE 284
S++ G ++G+GS+G VYE + D A+K+V LQD P+ K +E+ ++
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV-LQD--PQYKN------RELLIMKNLN 117
Query: 285 HDNIV---QYLGTD---RDEKRLCIFLELVTKGSLASL--YQKYHLSDSQ------VSSY 330
H NI+ Y T+ ++EK IFL +V + ++ Y K++ ++ V Y
Sbjct: 118 HINIIFLKDYYYTECFKKNEKN--IFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLY 175
Query: 331 TRQILNGLKYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMNDVK-SCKGTAF 388
+ Q+ L Y+H + + HRD+K N+L+D + ++KL DFG AK S + F
Sbjct: 176 SYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235
Query: 389 WMAPEVVNLKKDGYGLTADIWSLGCTVLEML 419
+ APE++ L Y D+WSLGC + EM+
Sbjct: 236 YRAPELM-LGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 70/276 (25%), Positives = 112/276 (40%), Gaps = 39/276 (14%)
Query: 221 RRRIT-SWQKGELLGSGSYGFVYEG-----LTD-DGFFFAVKEVSLQDEGPRGKQSILQL 273
RR I W+ LG G++G V+ L + D AVK + E R
Sbjct: 4 RRDIVLKWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR-----QDF 54
Query: 274 EQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY------------- 320
++E LL +H +IV++ G + + L + E + G L + +
Sbjct: 55 QREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDV 114
Query: 321 ---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377
L+ Q+ + QI +G+ YL + VHRD+ N LV VK+ DFG+++
Sbjct: 115 APGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 174
Query: 378 NDVKSCKGTAF----WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQ 432
D G WM PE + +K + +DIWS G + E+ T + P+ L +
Sbjct: 175 TDYYRVGGRTMLPIRWMPPESILYRK--FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE 232
Query: 433 AMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDR 468
A+ I G P + + + C Q P R
Sbjct: 233 AIECITQGRELERPRTCPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 35/205 (17%)
Query: 233 LGSGSYGFV---YEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQ---EISLLGQFEHD 286
+GSG+ G V Y+ +T A+K++S R Q++ ++ E+ L+ H
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNV--AIKKLS------RPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 287 NIVQYLGTDRDEKRLCIFLE--LVTKGSLASLYQKYHLS-DSQVSSY-TRQILNGLKYLH 342
NI+ L +K L F + LV + A+L Q + D + SY Q+L G+K+LH
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 135
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVN------ 396
++HRD+K +NI+V + ++K+ DFGLA+ GT+F M P VV
Sbjct: 136 SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---------AGTSFMMTPYVVTRYYRAP 186
Query: 397 --LKKDGYGLTADIWSLGCTVLEML 419
+ GY DIWS+GC + EM+
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 41/283 (14%)
Query: 232 LLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQ 290
++G G+YG V + + A+K+ +E K++ L+ E+ +L + +NIV+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR---ELKMLRTLKQENIVE 64
Query: 291 YLGTDRDEKRLCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQNVVHR 349
R +L + E V K L L + + + +V SY Q++ + + H+ ++VHR
Sbjct: 65 LKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHR 124
Query: 350 DIKCANILVDASGSVKLADFGLAKATTM-NDVKSCK--GTAFWMAPEVVNLKKDGYGLTA 406
DIK N+L+ + +KL DFG A+ + ++ + T ++ +PE+ L YG
Sbjct: 125 DIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPEL--LLGAPYGKAV 182
Query: 407 DIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG--GELPPV------------------- 445
D+WS+GC + E+ + + +F I G LP
Sbjct: 183 DMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAV 242
Query: 446 --PNSLSRDAQ--------DFILKCLQVNPNDRPTAAQLMEHP 478
P SL R D + L++NP DR Q + HP
Sbjct: 243 NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 66/266 (24%), Positives = 113/266 (42%), Gaps = 22/266 (8%)
Query: 230 GELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
G+ LG G +G V EG L D V V + + E + +F+H N+
Sbjct: 4 GKTLGEGEFGSVMEGQLNQDDSILKVA-VKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62
Query: 289 VQYLG-----TDRDE-KRLCIFLELVTKGSLAS--LYQKY-----HLSDSQVSSYTRQIL 335
++ +G + + + L + G L S LY + +L + + I
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 336 NGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV----KSCKGTAFWMA 391
+G++YL ++ +HRD+ N +++ + +V +ADFGL+K D + K W+A
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 392 PEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLS 450
E +L Y +D+WS G T+ E+ TR + PY +E + + G P
Sbjct: 183 IE--SLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCL 240
Query: 451 RDAQDFILKCLQVNPNDRPTAAQLME 476
+ C +NP DRP+ L
Sbjct: 241 DGLYSLMSSCWLLNPKDRPSFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 46/285 (16%)
Query: 228 QKGELLGSGSYGFVYEGLTDDGFFFAVK--------EVSLQDEGPRGKQSILQLEQEISL 279
G+ LG G +G V + F +K V + E + + L E +L
Sbjct: 3 VLGKTLGEGEFGKVVKA-----TAFRLKGRAGYTTVAVKMLKENASSSE-LRDLLSEFNL 56
Query: 280 LGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH------------------ 321
L Q H ++++ G + L + +E GSL S ++
Sbjct: 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116
Query: 322 -------LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 374
L+ + S+ QI G++YL E +VHRD+ N+LV +K++DFGL++
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176
Query: 375 TTMND--VKSCKG--TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLE 429
D VK KG WMA E +L Y +D+WS G + E++T +PY +
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIE--SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234
Query: 430 GGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQL 474
+ + G P + S + + +L C + P+ RPT A +
Sbjct: 235 PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 69/266 (25%), Positives = 107/266 (40%), Gaps = 30/266 (11%)
Query: 231 ELLGSGSYGFVYEG----LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286
E LG G++G VY+G + +V +L++ Q + QE L+ +H
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ--EFRQEAELMSDLQHP 68
Query: 287 NIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTR------------- 332
NIV LG E+ C+ E + G L L + SD S
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 333 ---QILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF- 388
QI G++YL + VHRD+ N LV +VK++DFGL++ D + +
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 389 ---WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPP 444
WM PE + K + +DIWS G + E+ + PY + + I +L P
Sbjct: 189 PVRWMPPEAILYGK--FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP 246
Query: 445 VPNSLSRDAQDFILKCLQVNPNDRPT 470
P +++C P RP
Sbjct: 247 CPEDCPARVYALMIECWNEIPARRPR 272
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
+VQ +D++ L + +E + G L +L Y + + YT +++ L +H +
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 164
Query: 348 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTAFWMAPEVVNLKKDG--- 401
HRD+K N+L+D SG +KLADFG + C GT +++PEV LK G
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV--LKSQGGDG 222
Query: 402 -YGLTADIWSLGCTVLEMLTRRHPY--SHLEGGQAMFKIGGGELP-PVPNSLSRDAQDFI 457
YG D WS+G + EML P+ L G + L P N +S++A++ I
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 282
Query: 458 LKCLQVNPND----RPTAAQLMEHPFIK 481
C + + R ++ H F K
Sbjct: 283 --CAFLTDREVRLGRNGVEEIKRHLFFK 308
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 9e-16
Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 23/201 (11%)
Query: 273 LEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTR 332
+EI +L H I+ + R + +C+ + + + L Q + R
Sbjct: 133 PGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQR 192
Query: 333 QILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK-SCKGTAFWM- 390
++L L YLH + ++HRD+K NI +D + L DFG A + C G + +
Sbjct: 193 RLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLE 252
Query: 391 --APEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNS 448
+PE++ L D Y DIWS G + EM + L G Q V +S
Sbjct: 253 TNSPELLAL--DPYCAKTDIWSAGLVLFEMSVKNVT---LFGKQ------------VKSS 295
Query: 449 LSRDAQDFILKCLQVNPNDRP 469
S+ I++C+QV+P + P
Sbjct: 296 SSQLRS--IIRCMQVHPLEFP 314
|
Length = 392 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 73/303 (24%), Positives = 131/303 (43%), Gaps = 60/303 (19%)
Query: 233 LGSGSYGFVY-EGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291
+G G++G V D +A+K + D R + + ++ E++I L + +++ +V+
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDI--LAEADNEWVVKL 66
Query: 292 LGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSS-YTRQILNGLKYLHEQNVVHRD 350
+ +D+ L ++ + G + SL + + + ++ Y ++ ++ +H+ +HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126
Query: 351 IKCANILVDASGSVKLADFGL------------------AKATTMN------DVKSCK-- 384
IK NIL+D G +KL DFGL + +M ++ C+
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186
Query: 385 -------------------GTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY 425
GT ++APEV L + GY D WS+G + EML + P+
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEV--LLRTGYTQLCDWWSVGVILYEMLVGQPPF 244
Query: 426 SHLEGGQAMFKIGGGE----LPPVPNSLSRDAQDFILKCLQVNPNDR---PTAAQLMEHP 478
+ K+ E +P LSR+A D IL+ L DR A ++ HP
Sbjct: 245 LADTPAETQLKVINWETTLHIPSQAK-LSREASDLILR-LCCGAEDRLGKNGADEIKAHP 302
Query: 479 FIK 481
F K
Sbjct: 303 FFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 73/213 (34%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 229 KGELLGSGSYGFVYEGLTDDGFFFAVKEVSL-QDEGPRGKQSILQLEQEISLLGQFEHDN 287
+G +G G+YG VY+ DG KE +L Q EG S + EI+LL + +H N
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACR---EIALLRELKHPN 59
Query: 288 IV---QYLGTDRDEKRLCIF------LELVTKGSLASLYQK--YHLSDSQVSSYTRQILN 336
++ + + D K +F L + K AS K L S V S QIL+
Sbjct: 60 VIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 337 GLKYLHEQNVVHRDIKCANILVDAS----GSVKLADFGLAK-----ATTMNDVKSCKGTA 387
G+ YLH V+HRD+K ANILV G VK+AD G A+ + D+ T
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 388 FWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT 420
++ APE++ L Y DIW++GC E+LT
Sbjct: 180 WYRAPELL-LGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 64/265 (24%), Positives = 111/265 (41%), Gaps = 25/265 (9%)
Query: 231 ELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
+++G G++G V + DG +++ + E E+ L H NI+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNII 59
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-----------------LSDSQVSSYTR 332
LG L + +E G+L +K LS Q+ +
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 333 QILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG--TAFWM 390
+ G+ YL ++ +HRD+ NILV + K+ADFGL++ + VK G WM
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWM 178
Query: 391 APEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSL 449
A E +N Y +D+WS G + E+++ PY + + K+ G P +
Sbjct: 179 AIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC 236
Query: 450 SRDAQDFILKCLQVNPNDRPTAAQL 474
+ D + +C + P +RP+ AQ+
Sbjct: 237 DDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 68/268 (25%), Positives = 119/268 (44%), Gaps = 27/268 (10%)
Query: 232 LLGSGSYGFVYE-GLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQ 290
+LG G +G V + G +A K++ + R +++ E+ I L + +V
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRI--LEKVNSRFVVS 64
Query: 291 YLGTDRDEKRLCIFLELVTKGSLASLYQKYHL--------SDSQVSSYTRQILNGLKYLH 342
+ LC+ L ++ G L K+H+ + + Y ++ GL+ L
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDL-----KFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VKSCKGTAFWMAPEVVNLKKDG 401
+ +V+RD+K NIL+D G ++++D GLA + V+ GT +MAPEV+N +K
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEK-- 177
Query: 402 YGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIG---GGELPPVPNSLSRDAQDFIL 458
Y + D W LGC + EM+ + P+ + ++ + S DA+
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237
Query: 459 KCLQVNPNDR-----PTAAQLMEHPFIK 481
L NP +R AA + +HP K
Sbjct: 238 MLLTKNPKERLGCRGNGAAGVKQHPIFK 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 72/266 (27%), Positives = 128/266 (48%), Gaps = 21/266 (7%)
Query: 231 ELLGSGSYGFV-YEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
+++G G++G V L + FA+K ++ + R + + + E+++ + G + +
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHEQNVV 347
Y +DE L + ++ G L +L K+ L + Y +++ + +H+ + V
Sbjct: 67 HY--AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYV 124
Query: 348 HRDIKCANILVDASGSVKLADFG-----LAKATTMNDVKSCKGTAFWMAPEVVNLKKDG- 401
HRDIK NIL+D +G ++LADFG + T + V GT +++PE++ +DG
Sbjct: 125 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV--GTPDYISPEILQAMEDGK 182
Query: 402 --YGLTADIWSLGCTVLEMLTRRHPY---SHLEG-GQAMFKIGGGELPPVPNSLSRDAQD 455
YG D WSLG + EML P+ S +E G+ M + P +S DA+D
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKD 242
Query: 456 FI--LKCLQVNPNDRPTAAQLMEHPF 479
I L C + + + +HPF
Sbjct: 243 LIRRLICSREHRLGQNGIEDFKQHPF 268
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 65/258 (25%), Positives = 117/258 (45%), Gaps = 20/258 (7%)
Query: 231 ELLGSGSYGFVYEG--LTDDG--FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286
++G G +G VY G + DG AVK ++ + + + Q +E ++ F H
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD----LEEVEQFLKEGIIMKDFSHP 56
Query: 287 NIVQYLGTD-RDEKRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHE 343
N++ LG E + L + G L + + ++ + + + Q+ G++YL
Sbjct: 57 NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS 116
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDVKSCKGTAFWMAPEVVNL 397
+ VHRD+ N ++D S +VK+ADFGLA+ ++++ K WMA E +L
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE--SL 174
Query: 398 KKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDF 456
+ + +D+WS G + E++TR PY ++ + G P +
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEV 234
Query: 457 ILKCLQVNPNDRPTAAQL 474
+L C P RPT ++L
Sbjct: 235 MLSCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 66/273 (24%), Positives = 106/273 (38%), Gaps = 63/273 (23%)
Query: 269 SILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH---LSDS 325
+ LQ E +S L F H NIV Y T + L + + GS L + +S+
Sbjct: 44 TFLQGELHVSKL--FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSEL 101
Query: 326 QVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM-------- 377
++ + +L L Y+H VHR +K ++IL+ G V L+ GL +M
Sbjct: 102 AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLR 159
Query: 378 --NDV-KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAM 434
+D K W++PEV+ GY +DI+S+G T E+ P+ + Q +
Sbjct: 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 219
Query: 435 FKIGGGELP---------------------------------------------PVPNSL 449
+ G +P P +
Sbjct: 220 LEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTF 279
Query: 450 SRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
S F+ +CLQ NP+ RP+A+ L+ H F K+
Sbjct: 280 SPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 53/176 (30%), Positives = 88/176 (50%), Gaps = 16/176 (9%)
Query: 296 RDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKC 353
+DE L + ++ G L +L K+ L + Y +++ + +H+ + VHRDIK
Sbjct: 71 QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKP 130
Query: 354 ANILVDASGSVKLADFGLAKATTMNDVKSCK-----GTAFWMAPEVVNLKKDG---YGLT 405
N+L+D +G ++LADFG MN + + GT +++PE++ +DG YG
Sbjct: 131 DNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPE 188
Query: 406 ADIWSLGCTVLEMLTRRHPY---SHLEG-GQAMFKIGGGELPPVPNSLSRDAQDFI 457
D WSLG + EML P+ S +E G+ M + P +S +A+D I
Sbjct: 189 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLI 244
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 64/267 (23%), Positives = 106/267 (39%), Gaps = 58/267 (21%)
Query: 273 LEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH---LSDSQVSS 329
L+ E+ L F H NI+ L + + GS SL + Y +S++ + +
Sbjct: 46 LQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGN 105
Query: 330 YTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF- 388
L GL YLH+ +HR+IK ++IL+ G V L+ + N K+ F
Sbjct: 106 ILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFP 165
Query: 389 --------WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY----------SHLEG 430
W++PE++ GY + +DI+S+G T E+ T R P+ L+G
Sbjct: 166 QFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKG 225
Query: 431 -----------------------------GQAMFKIGGGEL-------PPVPNSLSRDAQ 454
G+++ G + P + S Q
Sbjct: 226 PPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQ 285
Query: 455 DFILKCLQVNPNDRPTAAQLMEHPFIK 481
+ + CLQ +P RP+A+ L+ H F K
Sbjct: 286 NLVELCLQQDPEKRPSASSLLSHAFFK 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 4e-15
Identities = 67/216 (31%), Positives = 108/216 (50%), Gaps = 33/216 (15%)
Query: 224 ITSWQKGELLGSGSYGFV---YEGLTDDGFFFAVKEVSLQDEGPRGKQS-ILQLEQEISL 279
+ +Q + +GSG+ G V Y+ + D A+K++S P Q+ + +E+ L
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSR----PFQNQTHAKRAYRELVL 69
Query: 280 LGQFEHDNIVQYLGTDRDEKRLCIFLE--LVTKGSLASLYQ--KYHLSDSQVSSYTRQIL 335
+ H NI+ L +K L F + LV + A+L Q + L ++S Q+L
Sbjct: 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 129
Query: 336 NGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVV 395
G+K+LH ++HRD+K +NI+V + ++K+ DFGLA+ GT+F M P VV
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPYVV 180
Query: 396 N--------LKKDGYGLTADIWSLGCTVLEMLTRRH 423
+ GY DIWS+GC + EM+ RH
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMV--RH 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 78/287 (27%), Positives = 123/287 (42%), Gaps = 40/287 (13%)
Query: 221 RRRITSWQKGELLGSGSYGFVY--------EGLTDDGFFFAVKEVSLQDEGPRGKQSILQ 272
R R+T G+ LG G +G V + + AVK L+D+ S L
Sbjct: 11 RTRLTL---GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVK--MLKDDATDKDLSDLV 65
Query: 273 LEQEI-SLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASL------------YQK 319
E E+ ++G+ H NI+ LG + L + +E +KG+L +
Sbjct: 66 SEMEMMKMIGK--HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDT 123
Query: 320 YHLSDSQVS-----SYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 374
L + Q++ S Q+ G++YL Q +HRD+ N+LV +K+ADFGLA+
Sbjct: 124 CKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183
Query: 375 TTMNDV--KSCKG--TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLE 429
D K+ G WMAPE L Y +D+WS G + E+ T PY +
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241
Query: 430 GGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476
+ + G P + + + + +C P+ RPT QL+E
Sbjct: 242 VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 70/279 (25%), Positives = 118/279 (42%), Gaps = 39/279 (13%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEV---SLQDEGPRGKQSILQLE--- 274
R R+T +LL G++G ++ G+ D +EV +++D S +Q+
Sbjct: 5 RDRVTL---SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-----SEIQVTLLL 56
Query: 275 QEISLLGQFEHDNIVQYLGT---DRDEKRLC----------IFLELVTKGSLASLYQKYH 321
QE LL H NI+ L D + + +FL + L
Sbjct: 57 QESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL---QQCRLGEANNPQA 113
Query: 322 LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK 381
LS Q+ QI G+ YLH++ V+H+DI N ++D VK+ D L++ D
Sbjct: 114 LSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY- 172
Query: 382 SCKGT-----AFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMF 435
C G WMA E +L Y +D+WS G + E++T + PY ++ +
Sbjct: 173 HCLGDNENRPVKWMALE--SLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA 230
Query: 436 KIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQL 474
+ G P + + + C ++P +RP+ +QL
Sbjct: 231 YLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQL 269
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 68/215 (31%), Positives = 102/215 (47%), Gaps = 31/215 (14%)
Query: 229 KGELLGSGSYGFVYEGLTDDGFF---FAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+G +G G+YG VY+ DG +A+K++ G + +EI+LL + +H
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI-------EGTGISMSACREIALLRELKH 57
Query: 286 DNIV---QYLGTDRDEKRLCIF------LELVTKGSLASLYQK--YHLSDSQVSSYTRQI 334
N++ + + D K +F L + K AS K L V S QI
Sbjct: 58 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 117
Query: 335 LNGLKYLHEQNVVHRDIKCANILVDAS----GSVKLADFGLAK-----ATTMNDVKSCKG 385
L+G+ YLH V+HRD+K ANILV G VK+AD G A+ + D+
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 386 TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT 420
T ++ APE++ L Y DIW++GC E+LT
Sbjct: 178 TFWYRAPELL-LGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 6e-15
Identities = 51/157 (32%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 275 QEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSL--ASLYQ--KYHLSDSQVSSY 330
+E+ L+ H NI+ L +K L F ++ L A+L Q + L ++S
Sbjct: 72 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 331 TRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWM 390
Q+L G+K+LH ++HRD+K +NI+V + ++K+ DFGLA+ GT+F M
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMM 182
Query: 391 APEVVN--------LKKDGYGLTADIWSLGCTVLEML 419
P VV + GY DIWS+GC + EM+
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-15
Identities = 49/163 (30%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 322 LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK 381
L+ + S+T Q+ G+++L +N VHRD+ N+L+ VK+ DFGLA+ +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY 293
Query: 382 SCKGTAF----WMAPEVV--NLKKDGYGLTADIWSLGCTVLEMLTRRH-PYSHLEGGQAM 434
KG+ F WMAPE + NL Y +D+WS G + E+ + PY +
Sbjct: 294 VSKGSTFLPVKWMAPESIFDNL----YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349
Query: 435 F-KIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476
+ KI G P+ +++ D ++KC P RP+ L +
Sbjct: 350 YNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 65/233 (27%), Positives = 112/233 (48%), Gaps = 22/233 (9%)
Query: 232 LLGSGSYGFVY---EGLTDDGFFFAV--KEVSLQD---EGPRGKQSILQLEQEISLLGQF 283
+LG GS+G V TD+ + + K+V +QD E ++ +L L + L Q
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLH 342
+ Q + RL +E V G L Q+ + Y +I GL +LH
Sbjct: 67 H--SCFQTM------DRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH 118
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKGTAFWMAPEVVNLKKD 400
+ +++RD+K N+++D+ G +K+ADFG+ K + V K+ GT ++APE++ +
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQP- 177
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDA 453
YG + D W+ G + EML + P+ E +F+ P S+S++A
Sbjct: 178 -YGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEA 228
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 24/215 (11%)
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASL------------YQKYHLSDSQVS--- 328
+H NI+ LG + L + +E +KG+L Y + + Q+S
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 329 --SYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCK 384
S Q+ G++YL + +HRD+ N+LV +K+ADFGLA+ D K+
Sbjct: 142 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 385 G--TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGE 441
G WMAPE L Y +D+WS G + E+ T PY + + + G
Sbjct: 202 GRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 259
Query: 442 LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476
P++ + + + C P+ RPT QL+E
Sbjct: 260 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 58/224 (25%), Positives = 92/224 (41%), Gaps = 42/224 (18%)
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLY-------QKYHLSDSQVS-------- 328
+H NI+ LG E L + +E G+L + D +
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 329 --SYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCK 384
S+ Q+ G+++L + +HRD+ N+LV +K+ADFGLA+ D K+
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 385 G--TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT---RRHP-------YSHLEGGQ 432
G WMAPE L Y +D+WS G + E+ T +P + L+ G
Sbjct: 194 GRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGY 251
Query: 433 AMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476
M K P + +++ + C P+ RPT QL+E
Sbjct: 252 RMEK---------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 76/312 (24%), Positives = 133/312 (42%), Gaps = 62/312 (19%)
Query: 227 WQKGELLGSGSYGFV-YEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+ K + LG G++G V D +A+K + +D R + + ++ E++I L + ++
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDI--LAEADN 60
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHL-SDSQVSSYTRQILNGLKYLHEQ 344
+ +V+ + +D+ L ++ + G + SL + + + Y ++ ++ +H+
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLA------------------KATTMN------DV 380
+HRDIK NIL+D G +KL DFGL + +M+ D
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 381 KSCK-------------------------GTAFWMAPEVVNLKKDGYGLTADIWSLGCTV 415
+C+ GT ++APEV L + GY D WS+G +
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEV--LLRTGYTQLCDWWSVGVIL 238
Query: 416 LEMLTRRHPY---SHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDR---P 469
EML + P+ + LE + P LS +A D I+K L P DR
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKN 297
Query: 470 TAAQLMEHPFIK 481
A ++ HPF K
Sbjct: 298 GADEIKAHPFFK 309
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 65/266 (24%), Positives = 113/266 (42%), Gaps = 27/266 (10%)
Query: 231 ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEI-SLLGQFEHDNI 288
+++G G++G V + DG L++ E E+ LG H NI
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH--HPNI 65
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-----------------LSDSQVSSYT 331
+ LG + L I +E G+L +K L+ Q+ +
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 332 RQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG--TAFW 389
+ G++YL E+ +HRD+ N+LV + + K+ADFGL++ + VK G W
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY-VKKTMGRLPVRW 184
Query: 390 MAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNS 448
MA E +N Y +D+WS G + E+++ PY + + K+ G P +
Sbjct: 185 MAIESLNYSV--YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRN 242
Query: 449 LSRDAQDFILKCLQVNPNDRPTAAQL 474
+ + + +C + P +RP AQ+
Sbjct: 243 CDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 67/272 (24%), Positives = 117/272 (43%), Gaps = 37/272 (13%)
Query: 231 ELLGSGSYGFVY------EGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF- 283
+++G G++G V +GL D +KE + +D+ E+ +L +
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR-------DFAGELEVLCKLG 65
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-----------------LSDSQ 326
H NI+ LG L + +E G+L +K LS Q
Sbjct: 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 327 VSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG- 385
+ + + G+ YL ++ +HRD+ NILV + K+ADFGL++ + VK G
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGR 184
Query: 386 -TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELP 443
WMA E +N Y +D+WS G + E+++ PY + + K+ G
Sbjct: 185 LPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 242
Query: 444 PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLM 475
P + + D + +C + P +RP+ AQ++
Sbjct: 243 EKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 76/280 (27%), Positives = 119/280 (42%), Gaps = 41/280 (14%)
Query: 230 GELLGSGSYGFVYEGLT--------DDGFFFAVKEVSLQDEGPRGKQSILQLEQEI-SLL 280
G+ LG G +G V D AVK L+D + L E E+ L+
Sbjct: 17 GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK--MLKDNATDKDLADLISEMELMKLI 74
Query: 281 GQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASL------------YQKYHLSDSQVS 328
G+ H NI+ LG E L + +E KG+L + + + Q+S
Sbjct: 75 GK--HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS 132
Query: 329 -----SYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC 383
S Q+ G++YL + +HRD+ N+LV +K+ADFGLA+ ++D+
Sbjct: 133 FKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARG--VHDIDYY 190
Query: 384 KGTAF------WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFK 436
K T+ WMAPE L Y +D+WS G + E+ T PY + +
Sbjct: 191 KKTSNGRLPVKWMAPEA--LFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248
Query: 437 IGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476
+ G P++ + + + +C P RPT QL+E
Sbjct: 249 LREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 266 GKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLY-----QKY 320
G ++ +QLE EI LG+ H+NI++ R E ++T+ LY + +
Sbjct: 203 GSRAAIQLENEILALGRLNHENILKIEEILRSEA----NTYMITQKYDFDLYSFMYDEAF 258
Query: 321 HLSDSQVSSYTR----QILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376
D + TR Q+L ++Y+H++ ++HRDIK NI ++ G + L DFG A
Sbjct: 259 DWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG--TAMP 316
Query: 377 MNDVKSCK-----GTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG 431
+ GT +PE+ L DGY DIWS G +L+ML+ H + + G
Sbjct: 317 FEKEREAFDYGWVGTVATNSPEI--LAGDGYCEITDIWSCGLILLDMLS--HDFCPIGDG 372
Query: 432 QAMFKIGGGELPPVPNSLSRDAQDF 456
G +L + +SLS ++F
Sbjct: 373 G---GKPGKQLLKIIDSLSVCDEEF 394
|
Length = 501 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-13
Identities = 59/242 (24%), Positives = 95/242 (39%), Gaps = 29/242 (11%)
Query: 259 LQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE---KRLCIFLELVTKGSLAS 315
L+ + P + + +E +L + H NIV L D E L E V +L
Sbjct: 11 LRTDAPEEEHQRARFRRETALCARLYHPNIVALL--DSGEAPPGLLFAVFEYVPGRTLRE 68
Query: 316 LYQ-KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG---SVKLADFGL 371
+ L + Q+L+ L H Q +VHRD+K NI+V +G K+ DFG+
Sbjct: 69 VLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGI 128
Query: 372 ---------AKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRR 422
A T+ GT + APE L+ + +D+++ G LE LT +
Sbjct: 129 GTLLPGVRDADVATLTRTTEVLGTPTYCAPE--QLRGEPVTPNSDLYAWGLIFLECLTGQ 186
Query: 423 HPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQ-----DFILKCLQVNPNDRPTAAQLMEH 477
+ +++ +L PV SL + K L +P R +A +
Sbjct: 187 RVVQGASVAEILYQ----QLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAASAPALAE 242
Query: 478 PF 479
F
Sbjct: 243 RF 244
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 48/168 (28%), Positives = 85/168 (50%), Gaps = 9/168 (5%)
Query: 316 LYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375
LY+K L+ + Y+ Q+ G+++L + +HRD+ NIL+ + VK+ DFGLA+
Sbjct: 171 LYKKV-LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229
Query: 376 TMNDVKSCKGTAF----WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEG 430
+ KG A WMAPE + + Y + +D+WS G + E+ + PY ++
Sbjct: 230 YKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKI 287
Query: 431 GQAMF-KIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
+ ++ G P+ + + +L C P+ RPT ++L+EH
Sbjct: 288 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 63/267 (23%), Positives = 106/267 (39%), Gaps = 34/267 (12%)
Query: 231 ELLGSGSYGFVYEGLT------DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE 284
E LG +G VY+G + A+K + + EGP ++ + E + + +
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREE----FKHEAMMRSRLQ 66
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQ-----------------KYHLSDSQV 327
H NIV LG E+ L + + L K L +
Sbjct: 67 HPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF 126
Query: 328 SSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTA 387
QI G+++L +VVH+D+ N+LV +VK++D GL + D G +
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 388 F----WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGEL 442
WM+PE + K + + +DIWS G + E+ + PY + I ++
Sbjct: 187 LLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV 244
Query: 443 PPVPNSLSRDAQDFILKCLQVNPNDRP 469
P P+ +L+C P+ RP
Sbjct: 245 LPCPDDCPAWVYTLMLECWNEFPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 4e-13
Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 36/210 (17%)
Query: 287 NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQN 345
N+V E + + L+ G L S K+ ++ + V + +++ L LH +
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG 105
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK-SCKGTA---FWMAPEVVNLKKDG 401
+V RD+ NIL+D G ++L F ++V+ SC G A + APEV + +
Sbjct: 106 IVCRDLNPNNILLDDRGHIQLTYFS-----RWSEVEDSCDGEAVENMYCAPEVGGISE-- 158
Query: 402 YGLTA--DIWSLGCTVLEMLT-----RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQ 454
T D WSLG + E+LT HP I +P +S +A+
Sbjct: 159 --ETEACDWWSLGAILFELLTGKTLVECHPSG----------INTHTTLNIPEWVSEEAR 206
Query: 455 DFILKCLQVNPNDRPTAA-----QLMEHPF 479
+ + LQ NP +R A + HPF
Sbjct: 207 SLLQQLLQFNPTERLGAGVAGVEDIKSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 74/307 (24%), Positives = 129/307 (42%), Gaps = 60/307 (19%)
Query: 229 KGELLGSGSYGFV-YEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
K + LG G++G V D +A+K + +D R + + ++ E++I L + +++
Sbjct: 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDI--LAEADNEW 62
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSS-YTRQILNGLKYLHEQNV 346
+V+ + +D+ L ++ + G + SL + + ++ Y ++ ++ +H+
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 347 VHRDIKCANILVDASGSVKLADFGLA------------------KATTM------NDVKS 382
+HRDIK NIL+D G +KL DFGL + +M +DV +
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 383 CK-------------------------GTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLE 417
C+ GT ++APEV L + GY D WS+G + E
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEV--LLRKGYTQLCDWWSVGVILFE 240
Query: 418 MLTRRHPYSHLEGGQAMFKIGGGELP---PVPNSLSRDAQDFILK--CLQVNPNDRPTAA 472
ML + P+ + K+ E P LS +A D I K C R A
Sbjct: 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300
Query: 473 QLMEHPF 479
+ HPF
Sbjct: 301 DIKAHPF 307
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 75/297 (25%), Positives = 125/297 (42%), Gaps = 52/297 (17%)
Query: 231 ELLGSGSYGFV-YEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
+++G G++G V D G +A+K + D K+ + + E +L + + +V
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM--LEKEQVAHIRAERDILVEADGAWVV 64
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQNVVH 348
+ + +D++ L + +E + G + +L K LS+ Y + + + +H+ +H
Sbjct: 65 KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH 124
Query: 349 RDIKCANILVDASGSVKLADFGLAKA-----------------------TTMNDVK---- 381
RDIK N+L+DA G VKL+DFGL MN +
Sbjct: 125 RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184
Query: 382 ----------SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG 431
S GT ++APEV + GY D WSLG + EML P+
Sbjct: 185 WKKNRRQLAYSTVGTPDYIAPEV--FMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 432 QAMFKIGGGE----LPP-VPNSLSRDAQDFILK-CLQV-NPNDRPTAAQLMEHPFIK 481
+ K+ + PP VP +S A+D IL+ C N ++ HPF +
Sbjct: 243 ETYRKVMNWKETLVFPPEVP--ISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFE 297
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 6e-13
Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 25/222 (11%)
Query: 233 LGSGSYGFVYEGLTDDGFFFA---VKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
+G+G +G V G G A VKE L+ +Q L QE+ + H N++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKE--LRASATPDEQ--LLFLQEVQPYRELNHPNVL 58
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQ------ILNGLKYLHE 343
Q LG + + LE G L + + +Q++ + +GL +LH+
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---VKSCKGTAF-WMAPEVVNLKK 399
+ +H D+ N + A SVK+ D+GLA D K C W+APE+V ++
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 400 DGYGLTAD------IWSLGCTVLEMLTR-RHPYSHLEGGQAM 434
L D IWSLG T+ E+ T PY L Q +
Sbjct: 179 QDL-LPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL 219
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 18/168 (10%)
Query: 322 LSDSQVSSY------TRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375
+++S SY + Q+ NG+++L +N VHRD+ N+L+ VK+ DFGLA+
Sbjct: 230 INESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDI 289
Query: 376 TMNDVKSCKGTAF----WMAPEVV--NLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHL 428
+ KG+ F WMAPE + NL Y +D+WS G + E+ T PY L
Sbjct: 290 MRDSNYISKGSTFLPLKWMAPESIFNNL----YTTLSDVWSFGILLWEIFTLGGTPYPEL 345
Query: 429 EGGQAMFK-IGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLM 475
+ + I G P S + + + KC + RP +QL+
Sbjct: 346 PMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 9e-13
Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 8/155 (5%)
Query: 329 SYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF 388
SY+ Q+ G+++L + +HRD+ NIL+ + VK+ DFGLA+ + KG A
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 389 ----WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMF-KIGGGEL 442
WMAPE + K Y +D+WS G + E+ + PY ++ + ++ G
Sbjct: 237 LPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR 294
Query: 443 PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
P + + +L C NP DRPT ++L+E
Sbjct: 295 MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 29/160 (18%)
Query: 322 LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK 381
L +QV++ RQ+L+ + Y+H + ++HRDIK N+LV+ + L DFG A +
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACF-----AR 311
Query: 382 SCKGTAFWM---------APEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ 432
T F APEV L D Y + DIWS G + E H S +
Sbjct: 312 GSWSTPFHYGIAGTVDTNAPEV--LAGDPYTPSVDIWSAGLVIFE--AAVHTASLFSASR 367
Query: 433 AMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAA 472
G E P + R I++ QV+ ++ P A
Sbjct: 368 ------GDERRPYDAQILR-----IIRQAQVHVDEFPQHA 396
|
Length = 461 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 45/153 (29%), Positives = 78/153 (50%), Gaps = 8/153 (5%)
Query: 330 YTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF- 388
Y+ Q+ G+++L + +HRD+ NIL+ + VK+ DFGLA+ + KG+A
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 389 ---WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFK-IGGGELP 443
WMAPE + K Y +D+WS G + E+ + PY ++ + + + G
Sbjct: 239 PLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296
Query: 444 PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476
P + + + +L C Q +P +RPT + L+E
Sbjct: 297 RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 6e-12
Identities = 45/187 (24%), Positives = 69/187 (36%), Gaps = 30/187 (16%)
Query: 311 GSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLAD 368
SLA + + L++ ++ + Q L L+ LH Q + + L+ GSV
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSV---- 56
Query: 369 FGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHL 428
K + ++MAPEV ++ Y ADI+SLG T+ E L PY+
Sbjct: 57 --AFKTPEQSRP-----DPYFMAPEV--IQGQSYTEKADIYSLGITLYEALDYELPYNEE 107
Query: 429 EGGQAMFKIGGGELPPVPNSLSRDAQ------------DFILKCLQVNPNDRPTAAQLME 476
A+ +I L +P RD DF+ C P R A +
Sbjct: 108 RELSAILEI---LLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLA 164
Query: 477 HPFIKRP 483
H
Sbjct: 165 HCRALFA 171
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 73/307 (23%), Positives = 124/307 (40%), Gaps = 60/307 (19%)
Query: 231 ELLGSGSYGFV-YEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
+++G G++G V D G +A+K +L K + ++ E +L + + +V
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMK--TLLKSEMFKKDQLAHVKAERDVLAESDSPWVV 64
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSS-YTRQILNGLKYLHEQNVVH 348
+ +D + L + +E + G L ++ KY V+ Y + + ++ +H+ +H
Sbjct: 65 SLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIH 124
Query: 349 RDIKCANILVDASGSVKLADFGLA-----------------------KATTMNDVK---- 381
RDIK NIL+D G +KL+DFGL+ + N V
Sbjct: 125 RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSI 184
Query: 382 ----------------------SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEML 419
S GT ++APE+ + GYG D WSLG + E L
Sbjct: 185 NLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEI--FLQQGYGQECDWWSLGAIMFECL 242
Query: 420 TRRHPYSHLEGGQAMFKI-GGGELPPVPN--SLSRDAQDFILKCLQVNPN--DRPTAAQL 474
P+ + KI E P+ LS +A+D I + + N R A ++
Sbjct: 243 IGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEI 302
Query: 475 MEHPFIK 481
HPF +
Sbjct: 303 KSHPFFR 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 68/273 (24%), Positives = 117/273 (42%), Gaps = 50/273 (18%)
Query: 231 ELLGSGSYGFV-YEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
+++G G++G V D G +A+K + D K+ + + E +L + + +V
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM--LEKEQVGHIRAERDILVEADSLWVV 64
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQNVVH 348
+ + +D+ L + +E + G + +L K L++ + Y + + + +H+ +H
Sbjct: 65 KMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIH 124
Query: 349 RDIKCANILVDASGSVKLADFGLAKA-----------------------TTMNDVK---- 381
RDIK N+L+D+ G VKL+DFGL MN +
Sbjct: 125 RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184
Query: 382 ----------SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG 431
S GT ++APEV + GY D WSLG + EML P+
Sbjct: 185 WKRNRRQLAFSTVGTPDYIAPEV--FMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 432 QAMFKIGGGE----LPP-VPNSLSRDAQDFILK 459
+ K+ + PP VP +S A+D IL+
Sbjct: 243 ETYKKVMNWKETLIFPPEVP--ISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 32/167 (19%)
Query: 333 QILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM----------NDVKS 382
+I ++Y+H + V+HRD+K NIL+ G V + D+G A + ++
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 383 CK----------GTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ 432
C GT +MAPE L + DI++LG + +MLT PY +G +
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPE--RLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238
Query: 433 AMFK---IGGGELPP---VPNSLSRDAQDFILKCLQVNPNDRPTAAQ 473
++ + E+ P +P LS+ A +K L V+P +R ++ Q
Sbjct: 239 ISYRDVILSPIEVAPYREIPPFLSQIA----MKALAVDPAERYSSVQ 281
|
Length = 932 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 10/153 (6%)
Query: 329 SYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK-SCKGTA 387
++ Q+ G+ +L +N +HRD+ N+L+ K+ DFGLA+ MND KG A
Sbjct: 216 RFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-DIMNDSNYVVKGNA 274
Query: 388 F----WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFK-IGGGE 441
WMAPE ++ Y + +D+WS G + E+ + + PY + +K + G
Sbjct: 275 RLPVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY 332
Query: 442 LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQL 474
P+ + + C + P +RPT +Q+
Sbjct: 333 QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 44/154 (28%), Positives = 71/154 (46%), Gaps = 8/154 (5%)
Query: 329 SYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF 388
S++ Q+ G+ +L +N +HRD+ NIL+ K+ DFGLA+ + KG A
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR 277
Query: 389 ----WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFK-IGGGEL 442
WMAPE ++ Y +D+WS G + E+ + PY + +K I G
Sbjct: 278 LPVKWMAPE--SIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335
Query: 443 PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476
P + D + C +P RPT Q+++
Sbjct: 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 62/253 (24%), Positives = 107/253 (42%), Gaps = 22/253 (8%)
Query: 233 LGSGSYGFVYEGL----TDDGFFFAVKEVSLQDEGPRGKQSI-LQLEQEISLLGQFEHDN 287
LG G++ +Y+G+ +D +EVS+ + L + SL+ Q H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 288 IVQYLG-TDRDEKRLCIFLELVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQ 344
+V+ G RDE + E V G L K ++S +Q+ + L YL ++
Sbjct: 63 LVKLYGVCVRDENI--MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK 120
Query: 345 NVVHRDIKCANILV-----DASGS--VKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNL 397
+VH ++ NILV + +KL+D G+ T+ + W+APE +
Sbjct: 121 KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI--PITVLSREERVERIPWIAPECIRN 178
Query: 398 KKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDF 456
+ + AD WS G T+LE+ + P S L + P+P+ + +
Sbjct: 179 GQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPD--CAELANL 236
Query: 457 ILKCLQVNPNDRP 469
I +C +P RP
Sbjct: 237 INQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 64/265 (24%), Positives = 111/265 (41%), Gaps = 27/265 (10%)
Query: 233 LGSGSYGFVYEGLTDDGFFFA---VKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
+G+G +G V G + G+ A VKE+ + Q ++ +E +H N++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVS----ASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTR------QILNGLKYLHE 343
Q LG + + +E G L + ++ T +I GL +LH+
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF----WMAPEVV---- 395
N +H D+ N L+ A +VK+ D+GL+ D + W+APE+V
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 396 -NLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAM-FKIGGGELPPVPNSLSRD 452
NL +++WSLG T+ E+ PY HL Q + + + +L L
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238
Query: 453 AQDFILKCLQ---VNPNDRPTAAQL 474
D + +Q + P RP+A ++
Sbjct: 239 LSDRWYEVMQFCWLQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 9e-10
Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 22/214 (10%)
Query: 233 LGSGSYGFVY--EGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQ 290
+G+G +G V E TD G V + + + + LQ +L +H NI+Q
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL---QHPNILQ 59
Query: 291 YLGTDRDEKRLCIFLELVTKGSLASLY--QKYHLSDSQVSSYTR---QILNGLKYLHEQN 345
LG + + E G L S +++H +SQ+ R +I G+ ++H+ N
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN 119
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF----WMAPEVVNLKKDG 401
+H D+ N + + +VK+ D+G+ + D + W+APE+V G
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179
Query: 402 YGLTAD------IWSLGCTVLEML-TRRHPYSHL 428
+TA+ +W+LG T+ E+ PYSHL
Sbjct: 180 L-ITAEQTKPSNVWALGVTLWELFENAAQPYSHL 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|204949 pfam12515, CaATP_NAI, Ca2+-ATPase N terminal autoinhibitory domain | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-08
Identities = 16/47 (34%), Positives = 25/47 (53%), Gaps = 3/47 (6%)
Query: 6 ELFGVAPWISGQPPEDTLKRWKSACNIVNNRRRKFRMVANLANQAET 52
+ F + E+ L+RW+ A +V N RR+FR A+LA + E
Sbjct: 4 DPFDIPA---KNSSEEALRRWRQAVGLVKNARRRFRYTADLAKRCEA 47
|
This domain family is found in eukaryotes, and is approximately 50 amino acids in length. The family is found in association with pfam00689, pfam00122, pfam00702, pfam00690. There is a conserved RRFR sequence motif. There are two completely conserved residues (F and W) that may be functionally important. This family is the N terminal autoinhibitory domain of an endosomal Ca2+-ATPase. Length = 47 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 26/77 (33%), Positives = 43/77 (55%), Gaps = 1/77 (1%)
Query: 305 LELVTKGSLASLYQKYHLSDSQVS-SYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS 363
+E + G + SL Y D +++ Y ++ L YLH ++HRD+K N+L+ G
Sbjct: 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGH 142
Query: 364 VKLADFGLAKATTMNDV 380
+KL DFGL+K T ++
Sbjct: 143 IKLTDFGLSKVTLNREL 159
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 27/62 (43%), Positives = 33/62 (53%), Gaps = 7/62 (11%)
Query: 327 VSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT 386
+ RQ+L GL+ LH +VHRDIK N+LV G VK+ DFG A V C G
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA-------VDMCTGI 363
Query: 387 AF 388
F
Sbjct: 364 NF 365
|
Length = 507 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 43/217 (19%)
Query: 278 SLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLY--QKYHLSDSQVSSYTRQIL 335
SL+ Q H ++ G + E V G L +K + + + +Q+
Sbjct: 68 SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLA 127
Query: 336 NGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF------- 388
+ L YL ++N+VH ++ NIL LA GLA+ T+ S G +F
Sbjct: 128 SALSYLEDKNLVHGNVCAKNIL--------LARLGLAEGTSPFIKLSDPGVSFTALSREE 179
Query: 389 ------WMAPEVVNLKKDGYGLT--ADIWSLGCTVLEM-------LTRRHPYSHLEGGQA 433
W+APE V G L+ AD WS G T+LE+ L R P +
Sbjct: 180 RVERIPWIAPECV---PGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEK 236
Query: 434 MFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPT 470
++ P ++ I +CL P RP+
Sbjct: 237 KHRL--------PEPSCKELATLISQCLTYEPTQRPS 265
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 217 NGKFRRRIT------SWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQS 269
+ K + IT S ++ ++ G G Y+G + +G F VKE++ + P
Sbjct: 676 DSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----- 730
Query: 270 ILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSS 329
EI+ +G+ +H NIV+ +G R EK + E + +L+ + + +LS +
Sbjct: 731 ----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR--NLSWERRRK 784
Query: 330 YTRQILNGLKYLH---EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT 386
I L++LH VV ++ I++D L L D K C +
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-DTK-CFIS 841
Query: 387 AFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHP 424
+ ++APE K +DI+ G ++E+LT + P
Sbjct: 842 SAYVAPETRETKD--ITEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 8e-06
Identities = 65/260 (25%), Positives = 111/260 (42%), Gaps = 29/260 (11%)
Query: 231 ELLGSGSYGFVYEGL-------TDDGFFFAVK-EVSLQDEGPRGKQSILQLEQEISLLGQ 282
E LG G+ +Y G+ DDG+ + + +V L+ P + L + S++ Q
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 283 FEHDNIVQYLGT-DRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLK 339
H +IV G RD + + + E V G L + L+ +Q+ + L
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMV-EEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALS 119
Query: 340 YLHEQNVVHRDIKCANILVDASG-------SVKLADFGLAKATTMNDVKSCKGTAFWMAP 392
YL ++++VH ++ NIL+ G +KL+D G+ T+ + C W+AP
Sbjct: 120 YLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI--PITVLSRQECVERIPWIAP 177
Query: 393 EVVNLKKDGYGLT--ADIWSLGCTVLEM-LTRRHPYSHLEGGQAMFKIGGGELPPVPNSL 449
E V +D L+ AD WS G T+ E+ P + G + P+
Sbjct: 178 ECV---EDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPS-- 232
Query: 450 SRDAQDFILKCLQVNPNDRP 469
++ D + C+ +PN RP
Sbjct: 233 CKELADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 21/47 (44%), Positives = 27/47 (57%), Gaps = 1/47 (2%)
Query: 327 VSSYTRQILNGLKYLHEQNVVHRDIKCANILVD-ASGSVKLADFGLA 372
+ + RQIL L LH +VHRD+K NI+ SGS K+ D G A
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 53/254 (20%), Positives = 106/254 (41%), Gaps = 19/254 (7%)
Query: 231 ELLGSGSYGFVYEGLTD---DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
E LG G++ +++G+ D EV L+ + + S++ Q H +
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHEQN 345
+V G + E V GSL + +K ++ S +Q+ L +L ++
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 346 VVHRDIKCANILV-----DASGS---VKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNL 397
+ H ++ N+L+ +G+ +KL+D G++ ++ + W+ PE +
Sbjct: 121 LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP--WVPPECIEN 178
Query: 398 KKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDF 456
++ L AD WS G T+ E+ + P S L+ + + P P + +
Sbjct: 179 PQN-LSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWT--ELANL 235
Query: 457 ILKCLQVNPNDRPT 470
I +C+ P+ RP+
Sbjct: 236 INQCMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 20/217 (9%)
Query: 267 KQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK----RLCIFLELVTKGSLASLYQKYHL 322
K I E EI L + + +NI++ G D RL + LE T+G L + K
Sbjct: 59 KVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK--- 115
Query: 323 SDSQVSSYTR-----QILNGLKYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKATT 376
+ +S T+ GL L++ N ++++ + LV + +K+ GL K +
Sbjct: 116 -EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174
Query: 377 MNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHL---EGGQA 433
K+ + + +++N Y + DI+SLG + E+ T + P+ +L E
Sbjct: 175 SPPFKNVNFMVY-FSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL 233
Query: 434 MFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPT 470
+ +P + + + C + RP
Sbjct: 234 IINKNNSL--KLPLDCPLEIKCIVEACTSHDSIKRPN 268
|
Length = 283 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 24/115 (20%), Positives = 48/115 (41%), Gaps = 7/115 (6%)
Query: 327 VSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCK 384
+ + + +L L+Y+HE + H DIK NI+VD + + D+G+A ++ ++ K
Sbjct: 128 IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSK 187
Query: 385 GTAFWMAPEVVNLKKDGYGLT-----ADIWSLGCTVLEMLTRRHPYSHLEGGQAM 434
+ D + D+ SLG +L+ + P+ +
Sbjct: 188 EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242
|
Length = 294 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 31/101 (30%), Positives = 47/101 (46%), Gaps = 12/101 (11%)
Query: 385 GTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFK------IG 438
GT ++APE+ L +G D W+LG + E LT P++ E Q +F+ I
Sbjct: 542 GTPDYLAPEL--LLGKPHGPAVDWWALGVCLFEFLTGIPPFND-ETPQQVFQNILNRDI- 597
Query: 439 GGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
P LS +AQ+ I L ++P R +L +HP
Sbjct: 598 --PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 488 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| PF12515 | 47 | CaATP_NAI: Ca2+-ATPase N terminal autoinhibitory d | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.52 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.5 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.44 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.39 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.39 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.37 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.23 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.2 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.13 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.11 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.07 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.03 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.02 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.94 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.77 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.77 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.72 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.7 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.56 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.5 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.46 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.39 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.3 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.17 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.16 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.15 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.14 | |
| KOG0204 | 1034 | consensus Calcium transporting ATPase [Inorganic i | 98.11 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.04 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.95 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.91 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.84 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.77 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.74 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.67 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.66 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.64 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.64 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.62 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.57 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.56 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.5 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.41 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.1 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.99 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.98 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.91 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.87 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.69 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.64 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.6 | |
| PLN02236 | 344 | choline kinase | 96.58 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.49 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.4 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.34 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.09 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.62 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.5 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.35 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.12 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.73 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 94.19 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=421.90 Aligned_cols=262 Identities=30% Similarity=0.418 Sum_probs=226.5
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcc--hhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRG--KQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
....|.+.+.||+|+||.|-+|..+ +|+.||||.+.+....... ......+.+|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3567899999999999999999875 8999999999877644322 222345679999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC---CcEEEeecCCcccc
Q 011326 300 RLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS---GSVKLADFGLAKAT 375 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~---~~vkL~DFGla~~~ 375 (488)
..||||||+.||.|.+.+-.+ .+.+..-..++.|++.|+.|||++||+||||||+|||+..+ ..+||+|||+|+..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999998877554 58888889999999999999999999999999999999765 78999999999988
Q ss_pred cCCC-cccCCCCCcccCchhhccccCCCCh-hhhHHHHHHHHHHHHcCCCCCCCCchhh-hHHHhcCCCCC---CCCCcc
Q 011326 376 TMND-VKSCKGTAFWMAPEVVNLKKDGYGL-TADIWSLGCTVLEMLTRRHPYSHLEGGQ-AMFKIGGGELP---PVPNSL 449 (488)
Q Consensus 376 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~-k~DvwSlGvlL~eLltG~~Pf~~~~~~~-~~~~i~~~~~~---~~~~~~ 449 (488)
.... ..+.+|||.|.|||++...+..+.. ++|+||+||+||-+++|.+||....... ...++..+.+. +....+
T Consensus 330 g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~I 409 (475)
T KOG0615|consen 330 GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRI 409 (475)
T ss_pred ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhh
Confidence 6544 5688999999999998655554444 8999999999999999999998876665 67777777764 445679
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
+++..+||.+||..||++|||++|+|+||||+.+-
T Consensus 410 seea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 410 SEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 99999999999999999999999999999998543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-52 Score=428.20 Aligned_cols=257 Identities=34% Similarity=0.599 Sum_probs=235.4
Q ss_pred CceeeeeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
.+|+.+++||+|||+.||.+++ .+|..||+|++.+..... ....+.+.+|++|.++|+|||||+++++|++.+.+||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k--~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK--PKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC--cchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence 5699999999999999999999 789999999998765432 3445678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--Cc
Q 011326 304 FLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DV 380 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~ 380 (488)
|.|+|+.++|.+++++. .++|.++..++.||+.||.|||+++|+|||||..|+|++++.++||+|||+|...... ..
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK 175 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence 99999999999999754 5999999999999999999999999999999999999999999999999999877644 35
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHh
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~c 460 (488)
.+.+|||.|.|||++ .+.+.+..+||||+||+||-||+|++||...+-.+++..|....+ .+|..++.++++||.++
T Consensus 176 ~TlCGTPNYIAPEVl--~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y-~~P~~ls~~A~dLI~~l 252 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVL--NKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY-SMPSHLSAEAKDLIRKL 252 (592)
T ss_pred ceecCCCcccChhHh--ccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc-ccccccCHHHHHHHHHH
Confidence 678999999999998 466789999999999999999999999999999999999988877 56789999999999999
Q ss_pred hhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 461 LQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 461 L~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
|++||.+|||+++|+.|+||++..-+
T Consensus 253 L~~~P~~Rpsl~~vL~h~Ff~~g~~p 278 (592)
T KOG0575|consen 253 LRPNPSERPSLDEVLDHPFFKSGFTP 278 (592)
T ss_pred hcCCcccCCCHHHHhcCHhhhCCCcC
Confidence 99999999999999999999766543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-51 Score=403.18 Aligned_cols=258 Identities=30% Similarity=0.506 Sum_probs=234.6
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
....++|++.++||+|+||.||.++.+ +++.+|+|++.+...... .......+|..+|.+++||+||+++..|++.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~--~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~ 98 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK--KEVRHTKAERNILSKIKHPFIVKLIYSFQTEE 98 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh--hhHHHHHHHHHHHHhCCCCcEeeeEEecccCC
Confidence 345789999999999999999999875 799999999988765433 34567889999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 300 RLCIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
.+|+|+||+.||.|..+|++ ..+++..+..++.+|+.||.|||++||+||||||+|||+|.+|+++|+|||+++.....
T Consensus 99 kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 99999999999999998875 46999999999999999999999999999999999999999999999999999854333
Q ss_pred --CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHH
Q 011326 379 --DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDF 456 (488)
Q Consensus 379 --~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L 456 (488)
...+.+||+.|||||++ .+.+|+.++|+||||+++|||++|.+||...+..++...+..+..+..+..++.+++++
T Consensus 179 ~~~t~tfcGT~eYmAPEil--~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardl 256 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEIL--LGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDL 256 (357)
T ss_pred CCccccccCCccccChHHH--hcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHH
Confidence 34567999999999997 55679999999999999999999999999999999999999998777788899999999
Q ss_pred HHHhhhhCCCCCC----CHHHHHhCccCCC
Q 011326 457 ILKCLQVNPNDRP----TAAQLMEHPFIKR 482 (488)
Q Consensus 457 i~~cL~~dP~~Rp----s~~eil~hp~f~~ 482 (488)
++++|+.||++|. ++.+|.+||||..
T Consensus 257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred HHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 9999999999995 6999999999975
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-51 Score=402.94 Aligned_cols=258 Identities=31% Similarity=0.560 Sum_probs=233.7
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC-
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK- 299 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~- 299 (488)
....+.+.++.||+|..|+||++.++ ++..+|+|++... ......+++.+|+++++..+||+||.+||.|..+.
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~----~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN----IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE 151 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc----CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence 44568888999999999999999986 7999999999543 33556678999999999999999999999999988
Q ss_pred ceEEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHH-CCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 300 RLCIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
.+.|+||||.+|+|+.++.. .+++|..+..++.++++||.|||+ .+|+||||||+|||++..|.+||||||.++.+..
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 59999999999999999876 459999999999999999999995 8999999999999999999999999999998877
Q ss_pred CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCC-----chhhhHHHhcCCCCCCCCCc-ccH
Q 011326 378 NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHL-----EGGQAMFKIGGGELPPVPNS-LSR 451 (488)
Q Consensus 378 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~-~s~ 451 (488)
....+..||..|||||.+ .+..|+.++||||||+.++|+++|+.||... ...+.+..|..+..|..|.. +|+
T Consensus 232 S~a~tfvGT~~YMsPERi--~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ 309 (364)
T KOG0581|consen 232 SIANTFVGTSAYMSPERI--SGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSP 309 (364)
T ss_pred hhcccccccccccChhhh--cCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCH
Confidence 777889999999999998 4567999999999999999999999999764 45577788888888888886 999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
+++++|..||++||.+|||+.|+++|||+++...
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 9999999999999999999999999999987654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=375.93 Aligned_cols=254 Identities=30% Similarity=0.496 Sum_probs=232.3
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
.+.+|++.+.||.|+||.|.+++.+ +|..+|+|++.+.... .....+...+|..+|+.+.||+++++++.+.+.+.+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vV--klKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l 119 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVV--KLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL 119 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHH--HHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence 4789999999999999999999886 7999999999865432 234456678899999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCc
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV 380 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 380 (488)
|+||||++||.|..++++. ++++..+..++.||+.||+|||.++|++|||||+|||+|.+|.+||+|||+|+..... .
T Consensus 120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-T 198 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-T 198 (355)
T ss_pred EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-E
Confidence 9999999999999999765 6999999999999999999999999999999999999999999999999999887755 5
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHh
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~c 460 (488)
.+.+|||.|+|||+++ ..+++.++|+|+||+++|||+.|.+||...+...+..+|..+.. .+|...++++++|+.++
T Consensus 199 ~TlCGTPeYLAPEii~--sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v-~fP~~fs~~~kdLl~~L 275 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQ--SKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV-KFPSYFSSDAKDLLKKL 275 (355)
T ss_pred EEecCCccccChHHhh--cCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc-cCCcccCHHHHHHHHHH
Confidence 6788999999999984 55699999999999999999999999999999999999998887 67889999999999999
Q ss_pred hhhCCCCC-----CCHHHHHhCccCCC
Q 011326 461 LQVNPNDR-----PTAAQLMEHPFIKR 482 (488)
Q Consensus 461 L~~dP~~R-----ps~~eil~hp~f~~ 482 (488)
|+.|-.+| ....+|.+||||+.
T Consensus 276 L~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 276 LQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HhhhhHhhhcCcCCCccccccCccccc
Confidence 99999999 45789999999985
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=383.37 Aligned_cols=257 Identities=29% Similarity=0.565 Sum_probs=229.3
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 300 (488)
...++|.+.+.||.|+||+||+|+.+ ++..||||.+.+... .....+-+..|+.+|+.++|||||.+++++.+++.
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l---~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~ 83 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL---NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF 83 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc---CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence 45788999999999999999999985 789999999987642 45566678899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC------CcEEEeecCCcc
Q 011326 301 LCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS------GSVKLADFGLAK 373 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~------~~vkL~DFGla~ 373 (488)
+|+|||||.||+|.++++.. .+++..+..++.||+.||++||+++|+||||||+|||++.+ -.+||+|||+|+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999999999876 69999999999999999999999999999999999999864 469999999999
Q ss_pred cccCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC--CCCCCCccc
Q 011326 374 ATTMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE--LPPVPNSLS 450 (488)
Q Consensus 374 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~s 450 (488)
.+.... ..+.+|+|.|||||++ ....|+.|+|+||+|++||+|++|++||...+..+....+..+. .+..+..++
T Consensus 164 ~L~~~~~a~tlcGSplYMAPEV~--~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s 241 (429)
T KOG0595|consen 164 FLQPGSMAETLCGSPLYMAPEVI--MSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELS 241 (429)
T ss_pred hCCchhHHHHhhCCccccCHHHH--HhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhcc
Confidence 887654 4578899999999998 45669999999999999999999999999888888877666544 345566788
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 451 RDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 451 ~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
+.+.+|+...++.+|..|.++.+-+.|+++...
T Consensus 242 ~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 242 NPLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred CchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 888999999999999999999999999998654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=397.74 Aligned_cols=295 Identities=26% Similarity=0.425 Sum_probs=254.0
Q ss_pred ehhhHHHHHHHHHHHHHHHHHhhhhcCCCCCcccccccCCCCCCCCCCccccCCCCCCCCCcccccccCceeeeeeeccc
Q 011326 157 VRHKFQYYMSLCNYIVTEAAKVRRRQDCPNNVEYVSYHDDDDSKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSG 236 (488)
Q Consensus 157 ~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G 236 (488)
-...|+.++.++.++..++...+.+...|+..... ..+.+.-...+.|......+.+.+.||+|
T Consensus 154 ~~~~F~~l~~lv~~~~~~~~gl~~~l~~p~~~~~~----------------~~p~~~~~~~d~wei~r~~l~l~~~LG~G 217 (468)
T KOG0197|consen 154 ERELFSSLQQLVNYYSKNADGLCTRLRDPCSKQGH----------------TKPQTPDLARDPWEIPREELKLIRELGSG 217 (468)
T ss_pred HHHhhhhHHHHHhhhhccCcchhhcccCchhccCC----------------CCCCCCccccCCeeecHHHHHHHHHhcCC
Confidence 35678999999999999999988887777653210 00111111145667777778889999999
Q ss_pred CceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeeccCCChHHH
Q 011326 237 SYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASL 316 (488)
Q Consensus 237 ~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~ 316 (488)
-||.|+.|.++....||+|.+.... .....|.+|+++|++|+|+|||+++++|..++.+|||||||+.|+|.++
T Consensus 218 ~FG~V~~g~~~~~~~vavk~ik~~~------m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~y 291 (468)
T KOG0197|consen 218 QFGEVWLGKWNGSTKVAVKTIKEGS------MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDY 291 (468)
T ss_pred ccceEEEEEEcCCCcccceEEeccc------cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHH
Confidence 9999999999988899999998543 2335788999999999999999999999999999999999999999999
Q ss_pred Hhh---hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCcccCCC---CCccc
Q 011326 317 YQK---YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG---TAFWM 390 (488)
Q Consensus 317 l~~---~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~g---t~~y~ 390 (488)
++. ..++..+.+.++.|||+||+||+++++|||||...|||+++++.+||+|||+|+....+......| ...|.
T Consensus 292 Lr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWt 371 (468)
T KOG0197|consen 292 LRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWT 371 (468)
T ss_pred hhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceec
Confidence 976 358999999999999999999999999999999999999999999999999999555444333323 33599
Q ss_pred CchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCC
Q 011326 391 APEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRP 469 (488)
Q Consensus 391 aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rp 469 (488)
|||.+ ....++.++||||||++||||+| |+.||.++++.+++..+..+.+.+.|..||+++.+++..||..+|++||
T Consensus 372 APEa~--~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RP 449 (468)
T KOG0197|consen 372 APEAL--NYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRP 449 (468)
T ss_pred CHHHH--hhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCC
Confidence 99998 45559999999999999999999 9999999999999999999999999999999999999999999999999
Q ss_pred CHHHHH
Q 011326 470 TAAQLM 475 (488)
Q Consensus 470 s~~eil 475 (488)
||+.+.
T Consensus 450 tF~~L~ 455 (468)
T KOG0197|consen 450 TFETLR 455 (468)
T ss_pred CHHHHH
Confidence 999765
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=397.28 Aligned_cols=257 Identities=32% Similarity=0.533 Sum_probs=229.6
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDE 298 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 298 (488)
.+...+|.+++.||+|+|++|++|+.. ++..||||++.+.-... +.-.+.+..|-.+|.+| +||.|++|+..|+++
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik--e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~ 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK--EKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE 146 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh--hcccchhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence 456789999999999999999999885 79999999997654321 22234566788889999 899999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhhc-cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 299 KRLCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~~-ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
..+|+|+||+++|+|.++|++.+ +++..+..++.||+.||+|||++|||||||||+|||+|.|++++|+|||.|+.+..
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999999999998765 99999999999999999999999999999999999999999999999999976543
Q ss_pred CC---------------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC
Q 011326 378 ND---------------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL 442 (488)
Q Consensus 378 ~~---------------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~ 442 (488)
.. ..+.+||..|.+||++ .....+..+|+|+|||+||+|+.|.+||...+...+..+|....+
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL--~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y 304 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELL--NDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY 304 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHh--cCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc
Confidence 21 1347899999999997 556688999999999999999999999999999999999988777
Q ss_pred CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 443 PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 443 ~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
.+++..++.+.+||+++|..||.+|+|.+||.+||||..
T Consensus 305 -~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 305 -EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred -cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 678899999999999999999999999999999999975
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=393.16 Aligned_cols=260 Identities=31% Similarity=0.505 Sum_probs=228.2
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCCC
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDEK 299 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~ 299 (488)
...+.|.+++.||+|+||.|+.|... ++..||+|.+...............+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 45678999999999999999999875 7899999977654222111233456678999999999 999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC-CcEEEeecCCccccc-
Q 011326 300 RLCIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS-GSVKLADFGLAKATT- 376 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~-~~vkL~DFGla~~~~- 376 (488)
.+++||||+.||+|.+.+.. .++.|..+..+++|+++|++|||++||+||||||+|||++.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 99999999999999998876 579999999999999999999999999999999999999999 999999999998773
Q ss_pred -CCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcc-cHHHH
Q 011326 377 -MNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSL-SRDAQ 454 (488)
Q Consensus 377 -~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-s~~l~ 454 (488)
.....+.+||+.|+|||++......-+.++||||+|++||.|++|..||...+.......+..+.. .+|..+ +++++
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~-~~p~~~~S~~~~ 252 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF-KIPSYLLSPEAR 252 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc-cCCCCcCCHHHH
Confidence 334678899999999999853332346899999999999999999999999888888888777665 567777 99999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
.|+.+||..||.+|+|+.+|++||||+.
T Consensus 253 ~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 253 SLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 9999999999999999999999999997
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-49 Score=371.72 Aligned_cols=246 Identities=34% Similarity=0.590 Sum_probs=220.9
Q ss_pred ccccCceeeeeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeec-cccCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLG-TDRDE 298 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~-~~~~~ 298 (488)
...+.+|+++++||.|+||.||++.. .+|..+|.|.+.... -......++..|+.+|++|+|||||++++ .+.++
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~---md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~ 91 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM---MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIED 91 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh---ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhcc
Confidence 34567899999999999999999987 589999999998544 34566678899999999999999999999 44444
Q ss_pred Cc-eEEEEeeccCCChHHHHhhh-----ccChhhhhHHHHHHHHHHHHHHH--CC--CccccCCcccEEECCCCcEEEee
Q 011326 299 KR-LCIFLELVTKGSLASLYQKY-----HLSDSQVSSYTRQILNGLKYLHE--QN--VVHRDIKCANILVDASGSVKLAD 368 (488)
Q Consensus 299 ~~-~~lV~E~~~~gsL~~~l~~~-----~ls~~~~~~i~~qi~~aL~yLH~--~g--iiHrDLkp~NILl~~~~~vkL~D 368 (488)
.. ++||||||.+|+|.++++.. .+++..+|+++.|++.||+++|. .. |+||||||.||+++.+|.+||+|
T Consensus 92 ~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGD 171 (375)
T KOG0591|consen 92 NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGD 171 (375)
T ss_pred chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeecc
Confidence 44 99999999999999999643 49999999999999999999998 44 99999999999999999999999
Q ss_pred cCCcccccCCC--cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCC
Q 011326 369 FGLAKATTMND--VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVP 446 (488)
Q Consensus 369 FGla~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 446 (488)
||+++...... ..+.+|||.||+||.+ ...+|+.++||||+||++|||+.-.+||.+.+-.+...+|.++..+++|
T Consensus 172 fGL~r~l~s~~tfA~S~VGTPyYMSPE~i--~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 172 FGLGRFLSSKTTFAHSLVGTPYYMSPERI--HESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP 249 (375)
T ss_pred chhHhHhcchhHHHHhhcCCCcccCHHHH--hcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc
Confidence 99999877654 4678999999999998 5677999999999999999999999999999888999999999999999
Q ss_pred -CcccHHHHHHHHHhhhhCCCCCCCH
Q 011326 447 -NSLSRDAQDFILKCLQVNPNDRPTA 471 (488)
Q Consensus 447 -~~~s~~l~~Li~~cL~~dP~~Rps~ 471 (488)
..+|.++..||..|+..||+.||+.
T Consensus 250 ~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 250 DEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHhhhHHHHHHHHHccCCcccCCCc
Confidence 7899999999999999999999984
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=387.84 Aligned_cols=256 Identities=34% Similarity=0.546 Sum_probs=224.5
Q ss_pred cccccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 218 GKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 218 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
..+.....+..+.+.||.|+||+||+|.+++...||+|.+........ ....|.+|+.+|.+++|||||+++|+|.+
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~---~~~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDE---SRKAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChH---HHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 344555667777788999999999999998666699999986654322 26799999999999999999999999999
Q ss_pred CC-ceEEEEeeccCCChHHHHhh---hccChhhhhHHHHHHHHHHHHHHHCC-CccccCCcccEEECCCC-cEEEeecCC
Q 011326 298 EK-RLCIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQN-VVHRDIKCANILVDASG-SVKLADFGL 371 (488)
Q Consensus 298 ~~-~~~lV~E~~~~gsL~~~l~~---~~ls~~~~~~i~~qi~~aL~yLH~~g-iiHrDLkp~NILl~~~~-~vkL~DFGl 371 (488)
.. .++|||||+++|+|.+++.. ..++...+..++.||+.||.|||+++ ||||||||+|||++.++ ++||+|||+
T Consensus 111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGL 190 (362)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence 88 79999999999999999965 46999999999999999999999999 99999999999999998 999999999
Q ss_pred cccccC--CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhc-CCCCCCCCCc
Q 011326 372 AKATTM--NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIG-GGELPPVPNS 448 (488)
Q Consensus 372 a~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~-~~~~~~~~~~ 448 (488)
++.... ...+...||+.|||||++......++.++||||||++||||+||+.||...........+. .+.++.++..
T Consensus 191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~ 270 (362)
T KOG0192|consen 191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKE 270 (362)
T ss_pred ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence 986655 3344578999999999984225679999999999999999999999999988866666554 6777788888
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 449 LSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 449 ~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+++.+..|+.+||..||.+||++.+|+.
T Consensus 271 ~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 271 CPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 9999999999999999999999999874
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-48 Score=368.17 Aligned_cols=254 Identities=29% Similarity=0.545 Sum_probs=216.5
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
++.|+.+.++|+|+||+||+|+++ +|+.||||.+.-+. ......+-.++|+.+|++++|+|+|.++++|.....++
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese---dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklh 77 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE---DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLH 77 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC---ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeE
Confidence 357888999999999999999986 79999999997544 33444456689999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC-C-
Q 011326 303 IFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM-N- 378 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~-~- 378 (488)
+|+|||+..-| +-++. ++++...+..++.|++.|+.|+|+++++||||||+||||+.+|.+||||||+|+.+.. +
T Consensus 78 LVFE~~dhTvL-~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 78 LVFEYCDHTVL-HELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred EEeeecchHHH-HHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence 99999998444 44443 4699999999999999999999999999999999999999999999999999998763 2
Q ss_pred CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC--CCCC-------------
Q 011326 379 DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG--GELP------------- 443 (488)
Q Consensus 379 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~--~~~~------------- 443 (488)
..+.++.|.+|+|||.+ .+...|+..+|||++||++.||++|.+.|.+.++.+.+..|.. +.+.
T Consensus 157 ~YTDYVATRWYRaPELL-vGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELL-VGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred hhhhhhhhhhccChhhh-cccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 35678899999999998 4567899999999999999999999999999888776555432 1100
Q ss_pred -----CCC----------CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 444 -----PVP----------NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 444 -----~~~----------~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
+.+ ..++.-+.+|++.||+.||++|++-+|++.||||..
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 111 235667889999999999999999999999999953
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-48 Score=387.81 Aligned_cols=258 Identities=28% Similarity=0.456 Sum_probs=223.1
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCCC-
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDEK- 299 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~- 299 (488)
.+++|.+.+.||.|+||.||+|... +|..||||.++..-.. . ...--++|+..|++|+ ||||+++.+++.+.+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s---~-ee~~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS---W-EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc---H-HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 3578999999999999999999875 7999999999765422 1 2223468999999998 999999999999888
Q ss_pred ceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 300 RLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
.+|+|||||+. +|.++++.+ .+++..+..|+.||++||+|+|++|++|||+||+|||+..+..+||+|||+|+....
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 99999999988 899999654 499999999999999999999999999999999999999999999999999997765
Q ss_pred CC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC---------------
Q 011326 378 ND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE--------------- 441 (488)
Q Consensus 378 ~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~--------------- 441 (488)
.+ .+.++.|.+|+|||++ +....|+.+.|||++||+++|+.+-++.|.+.+..+.+.+|..-.
T Consensus 163 kpPYTeYVSTRWYRAPEvL-Lrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVL-LRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred CCCcchhhhcccccchHHh-hhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 54 6678899999999998 677889999999999999999999999999988877766653211
Q ss_pred ------CCC--------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 442 ------LPP--------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 442 ------~~~--------~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
++. +-..++.++.+||.+|+++||.+|||+.|+++||||+.+...
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 111 113478999999999999999999999999999999987653
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=378.68 Aligned_cols=256 Identities=48% Similarity=0.814 Sum_probs=218.7
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC--c
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK--R 300 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--~ 300 (488)
..+|..++.||+|+||.||++.+. +|...|||.+..... .....+.+|+.+|.+++|||||+.+|...... .
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~-----~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS-----PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc-----hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence 456888899999999999999886 599999999986521 11567889999999999999999999855444 6
Q ss_pred eEEEEeeccCCChHHHHhhhc--cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC-CCcEEEeecCCcccccC
Q 011326 301 LCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAKATTM 377 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~~--ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~-~~~vkL~DFGla~~~~~ 377 (488)
++|+|||+++|+|.+++.+.+ +++..+..+++|+++||+|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999999999998775 899999999999999999999999999999999999999 79999999999976652
Q ss_pred -----CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCC-CchhhhHHHhc-CCCCCCCCCccc
Q 011326 378 -----NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSH-LEGGQAMFKIG-GGELPPVPNSLS 450 (488)
Q Consensus 378 -----~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~-~~~~~~~~~i~-~~~~~~~~~~~s 450 (488)
.......||+.|||||++.. +.....++|||||||++.||+||+.||.. .........+. ....|.+|..+|
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~-g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls 249 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRN-GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLS 249 (313)
T ss_pred ccccccccccccCCccccCchhhcC-CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccC
Confidence 22346789999999999843 32234599999999999999999999987 34444444444 344678899999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 451 RDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 451 ~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
+++++++.+|++.||++|||++++|+|||.+....
T Consensus 250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 250 DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999999999999999999999977543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=386.59 Aligned_cols=257 Identities=28% Similarity=0.471 Sum_probs=223.6
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
+..+++|+++++||+|+||.||+|+.+ +|..+|+|++.+..... ...+..++.|-.+|...++|.||+|+..|++.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~--~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLK--KNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHh--hhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 446789999999999999999999875 79999999999877643 344567889999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC-
Q 011326 300 RLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM- 377 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~- 377 (488)
.+||||||++||++..+|.+. .+++..+..++.+++.|++.||+.|+|||||||+|+|||..|++||+|||++..+..
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 999999999999999988665 599999999999999999999999999999999999999999999999999842110
Q ss_pred ------------------------C---C---------------------cccCCCCCcccCchhhccccCCCChhhhHH
Q 011326 378 ------------------------N---D---------------------VKSCKGTAFWMAPEVVNLKKDGYGLTADIW 409 (488)
Q Consensus 378 ------------------------~---~---------------------~~~~~gt~~y~aPE~~~~~~~~~s~k~Dvw 409 (488)
. . ....+|||.|+|||++ .+.+|+..+|+|
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl--l~kgY~~~cDwW 372 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL--LGKGYGKECDWW 372 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH--hcCCCCccccHH
Confidence 0 0 0134599999999998 556699999999
Q ss_pred HHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC---CCCCCCcccHHHHHHHHHhhhhCCCCCC---CHHHHHhCccCCC
Q 011326 410 SLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE---LPPVPNSLSRDAQDFILKCLQVNPNDRP---TAAQLMEHPFIKR 482 (488)
Q Consensus 410 SlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~l~~Li~~cL~~dP~~Rp---s~~eil~hp~f~~ 482 (488)
|||||+||||.|.+||...+..++..++..-. .-+....+++++.+||.+||. ||++|. +++||..||||+.
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 99999999999999999999988888775432 123345688999999999999 999996 5999999999985
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=394.40 Aligned_cols=257 Identities=30% Similarity=0.536 Sum_probs=230.9
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
.++-|++++.||.|+.|.|-+|++. +|+.+|||.+.+.... .......+.+|+.+|+.+.|||++++++++++...+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~--s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l 87 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSEL--SSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL 87 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeecccccc--ccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence 3566899999999999999999885 8999999999876432 223345688999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHH-hhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC-C
Q 011326 302 CIFLELVTKGSLASLY-QKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-D 379 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l-~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~ 379 (488)
|+|.||++||.|.+++ .++++++.++.+++.||+.|+.|||..+|+||||||+|+|+|..+++||+|||+|.....+ -
T Consensus 88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 9999999999998876 5667999999999999999999999999999999999999999999999999999765444 3
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILK 459 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~ 459 (488)
..+.+|+|+|.+||++. +....+.++||||+|++||.||+|+.||+..+-...+.++..+.+ .+|..+|.++.+||.+
T Consensus 168 LeTSCGSPHYA~PEIV~-G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f-~MPs~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVS-GRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF-EMPSNISSEAQDLLRR 245 (786)
T ss_pred ccccCCCcccCCchhhc-CCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc-cCCCcCCHHHHHHHHH
Confidence 56889999999999983 444458899999999999999999999998888888889988887 6789999999999999
Q ss_pred hhhhCCCCCCCHHHHHhCccCCCC
Q 011326 460 CLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 460 cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
||..||++|.|++||++|||++.-
T Consensus 246 ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 246 MLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred HhccCccccccHHHHhhCchhhcC
Confidence 999999999999999999999764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=391.59 Aligned_cols=257 Identities=27% Similarity=0.456 Sum_probs=231.5
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDE 298 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 298 (488)
...+.+|.+.++||+|+||.|+++..+ +++.+|||++++...-. ...++....|..|+... +||.+++++.+|++.
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~--~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~ 441 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ--RDEVESLMCEKRIFELANRHPFLVNLFSCFQTK 441 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec--cccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence 456889999999999999999999986 68899999999876543 34456667787777766 599999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC-
Q 011326 299 KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM- 377 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~- 377 (488)
+++|+||||+.||++..+.+...+++..+..++..|+.||.|||++||||||||.+|||+|.+|++||+|||+++....
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred CeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 9999999999999977777777899999999999999999999999999999999999999999999999999986542
Q ss_pred -CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHH
Q 011326 378 -NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDF 456 (488)
Q Consensus 378 -~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L 456 (488)
+...+.+|||.|+|||++ .+..|+.++|+|||||+|||||.|..||.+.+.++....|..... .+|..+|.++.++
T Consensus 522 g~~TsTfCGTpey~aPEil--~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~-~yP~~ls~ea~~i 598 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVL--TEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSKEAIAI 598 (694)
T ss_pred CCccccccCChhhcChhhh--ccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCcccHHHHHH
Confidence 335688999999999997 677799999999999999999999999999999999999987664 7899999999999
Q ss_pred HHHhhhhCCCCCCC-----HHHHHhCccCCC
Q 011326 457 ILKCLQVNPNDRPT-----AAQLMEHPFIKR 482 (488)
Q Consensus 457 i~~cL~~dP~~Rps-----~~eil~hp~f~~ 482 (488)
++++|.++|++|.. +++|..||||+.
T Consensus 599 l~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 599 MRRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred HHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 99999999999975 589999999986
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=350.62 Aligned_cols=258 Identities=30% Similarity=0.495 Sum_probs=235.3
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
...+++|++++.||+|-||.||.|..+ ++..||+|++.++.. .......++.+|++|-+.|+||||++++++|.++.
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi--~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQI--LKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHH--HHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 446889999999999999999999875 789999999987653 33445568899999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 300 RLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
..|+++||.+.|+|...+... ++++...+.++.|++.|+.|+|.++++||||||+|+|++.+|.+||+|||.+-..+
T Consensus 96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999999988732 49999999999999999999999999999999999999999999999999998777
Q ss_pred CCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHH
Q 011326 377 MNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDF 456 (488)
Q Consensus 377 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L 456 (488)
.+...+.+||..|.+||.+ .+...+..+|+|++|++.||++.|.+||...+..+++..|..... .+|..++.++.+|
T Consensus 176 ~~kR~tlcgt~dyl~pEmv--~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~-~~p~~is~~a~dl 252 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMV--EGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL-KFPSTISGGAADL 252 (281)
T ss_pred CCCceeeecccccCCHhhc--CCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc-cCCcccChhHHHH
Confidence 6667788999999999997 556689999999999999999999999999888899998887665 5678999999999
Q ss_pred HHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 457 ILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 457 i~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
|.+||.++|.+|.+..|++.|||+...
T Consensus 253 I~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHhccCccccccHHHHhhhHHHHhc
Confidence 999999999999999999999999765
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=382.95 Aligned_cols=254 Identities=31% Similarity=0.547 Sum_probs=231.2
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
+++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+.. +.+...+.+.+|++|++.++||||+.++++|++...++
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g---r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~ 77 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG---RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLW 77 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcC---CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEE
Confidence 367888999999999999999886 78999999998765 45667788999999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 303 IFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
+|+||+.| +|..++... .++|+.+..++.++++||.|||+++|.|||+||.|||++..|.+|+||||+|+....+.
T Consensus 78 vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred EEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 99999988 999999765 59999999999999999999999999999999999999999999999999999876654
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILK 459 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~ 459 (488)
.+...|||.|||||.+ .+..|+..+|+||+||++|||++|++||....-.+....|..... ..|...+..+.+++..
T Consensus 157 ltsikGtPlYmAPElv--~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v-~~p~~~S~~f~nfl~g 233 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELV--EEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV-KPPSTASSSFVNFLQG 233 (808)
T ss_pred eeeccCcccccCHHHH--cCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC-CCcccccHHHHHHHHH
Confidence 4677899999999998 578899999999999999999999999998777777777776554 4566899999999999
Q ss_pred hhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 460 CLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 460 cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
+|++||.+|.+-.+++.|||.++.+
T Consensus 234 LL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 234 LLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred HhhcChhhcccHHHHhcChHHhhhh
Confidence 9999999999999999999998764
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=374.93 Aligned_cols=256 Identities=28% Similarity=0.475 Sum_probs=222.8
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
...+.+|++.+.||+|+||.||+|.+. +++.||+|.+...... .......+.+|+.++++++||||+++++++.+++
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 91 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL--KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN 91 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh--hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence 345789999999999999999999886 6899999999754221 1233456889999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 300 RLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
..++||||+++|+|.+.+... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999999999888654 5899999999999999999999999999999999999999999999999999765433
Q ss_pred CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHH
Q 011326 379 DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFIL 458 (488)
Q Consensus 379 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~ 458 (488)
.....||+.|+|||++ ....++.++|||||||++|+|++|..||.+.+..+....+..+. ...+..++.++.+||.
T Consensus 172 -~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~ 247 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVI--QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRARDLVK 247 (329)
T ss_pred -cceecCChhhcCHHHH--cCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-cCCCCCCCHHHHHHHH
Confidence 2345799999999997 44557899999999999999999999998877777666666554 3567778999999999
Q ss_pred HhhhhCCCCCCC-----HHHHHhCccCCC
Q 011326 459 KCLQVNPNDRPT-----AAQLMEHPFIKR 482 (488)
Q Consensus 459 ~cL~~dP~~Rps-----~~eil~hp~f~~ 482 (488)
+||+.||.+||+ ++++++||||++
T Consensus 248 ~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 248 GLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 999999999986 899999999976
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=366.58 Aligned_cols=252 Identities=29% Similarity=0.438 Sum_probs=219.5
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||+|.+. +|..||+|.+...... .......+.+|+.++++++||||+++++++.+++..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI--RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh--hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence 36889999999999999999886 7899999999754221 12234567899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCccc
Q 011326 304 FLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS 382 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 382 (488)
||||+++|+|.+++... .+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++...... ...
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-~~~ 157 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-TWT 157 (291)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-ccc
Confidence 99999999999988654 5899999999999999999999999999999999999999999999999998765432 334
Q ss_pred CCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhh
Q 011326 383 CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQ 462 (488)
Q Consensus 383 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~ 462 (488)
..||+.|+|||++ .+..++.++||||||+++|+|++|+.||.+.+..+....+..+.. ..+..+++.+.+||.+||+
T Consensus 158 ~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 158 LCGTPEYLAPEVI--QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL-EFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccCChhhcCHHHH--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-CCCccCCHHHHHHHHHHcC
Confidence 5699999999997 445678999999999999999999999998877776666665543 5667789999999999999
Q ss_pred hCCCCCCC-----HHHHHhCccCCC
Q 011326 463 VNPNDRPT-----AAQLMEHPFIKR 482 (488)
Q Consensus 463 ~dP~~Rps-----~~eil~hp~f~~ 482 (488)
.||.+||+ ++++++||||+.
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccC
Confidence 99999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=382.79 Aligned_cols=254 Identities=34% Similarity=0.602 Sum_probs=228.4
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
...|.....||+|+.|.||.+... +++.||||++...... ..+-+.+|+.+|+..+|+|||++++.+...+.++
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-----~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-----KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELW 346 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-----chhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence 345777888999999999999874 7899999999875543 2345789999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--c
Q 011326 303 IFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--V 380 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~ 380 (488)
+|||||+||+|.+++....++|.++..|.++++.||+|||.+||+|||||.+|||++.+|.+||+|||++....... .
T Consensus 347 VVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred EEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999987665443 4
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCC--CCcccHHHHHHHH
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV--PNSLSRDAQDFIL 458 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~Li~ 458 (488)
.+.+|||+|||||++ ....|+++.||||||++.+||+-|++||-..+....+..|.....+.+ +..+|+++++++.
T Consensus 427 ~TmVGTPYWMAPEVv--trk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~ 504 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVV--TRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLD 504 (550)
T ss_pred ccccCCCCccchhhh--hhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHH
Confidence 578899999999998 556699999999999999999999999998888888888777666544 5679999999999
Q ss_pred HhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 459 KCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 459 ~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
+||+.|+++|+++.|+|+||||+.+-
T Consensus 505 ~cL~~dv~~RasA~eLL~HpFl~~a~ 530 (550)
T KOG0578|consen 505 RCLVVDVEQRASAKELLEHPFLKMAK 530 (550)
T ss_pred HHhhcchhcCCCHHHHhcChhhhhcC
Confidence 99999999999999999999997654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=346.57 Aligned_cols=253 Identities=30% Similarity=0.494 Sum_probs=218.2
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
.+|...+.||+|.||.||+|++. +|+.||||.+.......... ....+|+..|+.++|+||+.++++|...+.+.|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~---~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGIN---RTALREIKLLQELKHPNIIELIDVFPHKSNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCcc---HHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence 46888899999999999999884 89999999998875433222 356799999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCc-
Q 011326 304 FLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV- 380 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~- 380 (488)
|+||++. +|...++.. .++...+..++.++++||+|||++.|.||||||.|+|++.+|.+||+|||+|+.....+.
T Consensus 79 VfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 79 VFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred EEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9999988 999998765 489999999999999999999999999999999999999999999999999998765542
Q ss_pred -ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC-------CC---------
Q 011326 381 -KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE-------LP--------- 443 (488)
Q Consensus 381 -~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~-------~~--------- 443 (488)
...+-|.+|+|||.+ .+...|+..+||||.||++.||+.|.+-|.+.++.+.+..+-... +|
T Consensus 158 ~~~~V~TRWYRAPELL-fGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELL-FGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred cccceeeeeccChHHh-ccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 334789999999998 567779999999999999999999999898888777665543211 00
Q ss_pred -----------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 444 -----------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 444 -----------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
.+....++++.+|+.+||..||.+|+++.|+++|+||++
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 011346778899999999999999999999999999986
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=364.58 Aligned_cols=262 Identities=30% Similarity=0.563 Sum_probs=228.6
Q ss_pred cccccCceeeeeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 220 FRRRITSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 220 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
+-....+|++..+||.|..++||+|+. ..+..||||++..... ......+.+|+..|+.++||||++.+..|..+
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc----~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC----NNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh----hhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 334567899999999999999999986 4789999999987643 33467899999999999999999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 299 KRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
..+++||.||.+|++.++++.. +++|..+..|++++++||.|||++|.||||||+.||||+.+|.|||+|||.+..+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 9999999999999999999654 6999999999999999999999999999999999999999999999999976433
Q ss_pred cCCC------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCC----
Q 011326 376 TMND------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV---- 445 (488)
Q Consensus 376 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~---- 445 (488)
.... .....||+.|||||++.....+|+.|+||||||++..||.+|..||....+-+++....++..+..
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~ 256 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG 256 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence 3221 145679999999999656677899999999999999999999999999888887777666665421
Q ss_pred -----CCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 446 -----PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 446 -----~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
....+..++.++..||++||.+|||++++++|+||++...
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 1346778999999999999999999999999999998643
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=370.43 Aligned_cols=258 Identities=27% Similarity=0.380 Sum_probs=222.6
Q ss_pred ccccccCceeeeeeecccCceEEEEEEec-C-CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecccc
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLTD-D-GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR 296 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~-g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 296 (488)
......++|++.+.||+|+||.||+|.+. + +..||+|.+...... .......+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII--KQKQVDHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 34456789999999999999999999864 3 468999998754321 1233456788999999999999999999999
Q ss_pred CCCceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 297 DEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 297 ~~~~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
+++..++||||+++|+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999999999999988654 5899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHH
Q 011326 376 TMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455 (488)
Q Consensus 376 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~ 455 (488)
.. ......||+.|+|||++ .+..++.++|+|||||++|||++|..||...+.......+..+.. ..+..+++++.+
T Consensus 182 ~~-~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~ 257 (340)
T PTZ00426 182 DT-RTYTLCGTPEYIAPEIL--LNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII-YFPKFLDNNCKH 257 (340)
T ss_pred CC-CcceecCChhhcCHHHH--hCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHH
Confidence 43 23456799999999997 445678999999999999999999999998777766666665543 567788999999
Q ss_pred HHHHhhhhCCCCCC-----CHHHHHhCccCCC
Q 011326 456 FILKCLQVNPNDRP-----TAAQLMEHPFIKR 482 (488)
Q Consensus 456 Li~~cL~~dP~~Rp-----s~~eil~hp~f~~ 482 (488)
+|++||+.||++|+ +++++++||||+.
T Consensus 258 li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 99999999999995 8999999999975
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=368.65 Aligned_cols=247 Identities=29% Similarity=0.480 Sum_probs=213.3
Q ss_pred eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeecc
Q 011326 231 ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVT 309 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 309 (488)
+.||+|+||.||++.+. +|..||+|++..... ........+.+|+.++++++||||+++++++..++..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI--IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence 36999999999999875 799999999975332 122334567789999999999999999999999999999999999
Q ss_pred CCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--CcccCCCC
Q 011326 310 KGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGT 386 (488)
Q Consensus 310 ~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~gt 386 (488)
+|+|.+.+... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ......||
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence 99998888654 5899999999999999999999999999999999999999999999999998753222 23346699
Q ss_pred CcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCC
Q 011326 387 AFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPN 466 (488)
Q Consensus 387 ~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~ 466 (488)
+.|+|||++ .+..++.++||||+||++|||++|..||...+.......+.... ..++..+++++.+||.+||+.||+
T Consensus 159 ~~y~aPE~~--~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05571 159 PEYLAPEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred ccccChhhh--cCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccCCHH
Confidence 999999997 45568999999999999999999999998877666666555443 356778999999999999999999
Q ss_pred CCC-----CHHHHHhCccCCC
Q 011326 467 DRP-----TAAQLMEHPFIKR 482 (488)
Q Consensus 467 ~Rp-----s~~eil~hp~f~~ 482 (488)
+|| ++.++++||||+.
T Consensus 236 ~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 236 QRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred HcCCCCCCCHHHHHcCCCcCC
Confidence 999 8999999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=373.05 Aligned_cols=256 Identities=30% Similarity=0.537 Sum_probs=221.4
Q ss_pred ccccCceeeeeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC-
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE- 298 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~- 298 (488)
....+.|+.++.||+|+||.||+|++ .+|+.||+|.+....+.... .....+|+.||++|+||||++|.+...+.
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~---~~t~~REI~ILr~l~HpNIikL~eivt~~~ 189 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGF---PITAIREIKILRRLDHPNIIKLEEIVTSKL 189 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcc---hHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence 44567899999999999999999988 48999999999987654333 34567999999999999999999987665
Q ss_pred -CceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 299 -KRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 299 -~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
..+|+|+|||+. +|.-++... .|++.++..++.||+.||+|||.+||.|||||..|||||.+|.+||+|||+|+.+
T Consensus 190 ~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 190 SGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred CceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 689999999998 888888765 6999999999999999999999999999999999999999999999999999966
Q ss_pred cCCC---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC------------
Q 011326 376 TMND---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG------------ 440 (488)
Q Consensus 376 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~------------ 440 (488)
.... .++.+-|.+|+|||.+ ++...|+.++|+||.||||.||+.|++.|.+.+..+.+..|-..
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELL-LG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELL-LGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCCCcccccceEEeeccChHHh-cCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 5443 6678899999999998 67788999999999999999999999999998877766655321
Q ss_pred CCC---------C-------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCC
Q 011326 441 ELP---------P-------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481 (488)
Q Consensus 441 ~~~---------~-------~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~ 481 (488)
.++ + ....+++.+.+|+..||..||.+|.|+.++|+|+||.
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 111 0 0124678899999999999999999999999999994
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=349.88 Aligned_cols=254 Identities=30% Similarity=0.499 Sum_probs=225.4
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.+.|++-++||+|.|+.||++... +|+.+|+|.+....... ...+++.+|+.|-+.|+||||+++.+...++...|
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~---~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA---RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc---ccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 346888899999999999999774 89999999997655432 25578889999999999999999999999999999
Q ss_pred EEEeeccCCChH-HHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC---CCcEEEeecCCcccccCC
Q 011326 303 IFLELVTKGSLA-SLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA---SGSVKLADFGLAKATTMN 378 (488)
Q Consensus 303 lV~E~~~~gsL~-~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~---~~~vkL~DFGla~~~~~~ 378 (488)
+|+|+|.|++|. +++.+.-+++..+-.+++||++||.|+|.+||+|||+||+|+++.. .--+||+|||+|......
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 999999999995 5666777999999999999999999999999999999999999953 346999999999877643
Q ss_pred C-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC---CCCCcccHHHH
Q 011326 379 D-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP---PVPNSLSRDAQ 454 (488)
Q Consensus 379 ~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l~ 454 (488)
. +....|||.|||||++ .+..|+..+|||+.|++||-|+.|.+||.+.+.......|..+.+. +....++++++
T Consensus 167 ~~~~G~~GtP~fmaPEvv--rkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVL--KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAK 244 (355)
T ss_pred cccccccCCCcccCHHHh--hcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHH
Confidence 2 5678899999999997 6778999999999999999999999999998888888888877653 34568999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
+|+++||..||.+|.|+.|.|+|||+.+
T Consensus 245 ~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 245 SLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred HHHHHHhccChhhhccHHHHhCCchhcc
Confidence 9999999999999999999999999975
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=359.81 Aligned_cols=256 Identities=29% Similarity=0.460 Sum_probs=222.0
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
.+.+|++++.||.|..|+||++..+ ++..+|+|++.+..... ..-..+...|-+||+.++||.++.||..++.++..
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~--rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS--RKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh--hhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 4668999999999999999999987 57899999998766543 33445667788899999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC-
Q 011326 302 CIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM- 377 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~- 377 (488)
|++||||+||+|..+.++. .+++..+..++.+++.||+|||..|||+|||||+||||.++|++.|+||.++.....
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999999988765 399999999999999999999999999999999999999999999999998631100
Q ss_pred --------------------------------C-C------------------------cccCCCCCcccCchhhccccC
Q 011326 378 --------------------------------N-D------------------------VKSCKGTAFWMAPEVVNLKKD 400 (488)
Q Consensus 378 --------------------------------~-~------------------------~~~~~gt~~y~aPE~~~~~~~ 400 (488)
. . ..+++||-.|+|||++ .+.
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI--~G~ 310 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI--RGE 310 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee--ecC
Confidence 0 0 1134588999999998 566
Q ss_pred CCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC-CCCcccHHHHHHHHHhhhhCCCCCCC----HHHHH
Q 011326 401 GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP-VPNSLSRDAQDFILKCLQVNPNDRPT----AAQLM 475 (488)
Q Consensus 401 ~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~l~~Li~~cL~~dP~~Rps----~~eil 475 (488)
+.+.++|+|+||++||||++|.+||.+.++.++...+....... -...++..+++||+++|.+||.+|.. +.||.
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 68999999999999999999999999999999999988765421 11267899999999999999999998 99999
Q ss_pred hCccCCC
Q 011326 476 EHPFIKR 482 (488)
Q Consensus 476 ~hp~f~~ 482 (488)
+||||+.
T Consensus 391 ~HpFF~g 397 (459)
T KOG0610|consen 391 RHPFFEG 397 (459)
T ss_pred cCccccC
Confidence 9999975
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=356.30 Aligned_cols=253 Identities=25% Similarity=0.422 Sum_probs=212.7
Q ss_pred eeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEE
Q 011326 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFL 305 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 305 (488)
|+..+.||+|+||.||++.+. +|..||+|.+...... .......+.+|+.++.+++|+||+++++++.+++..++||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh--hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence 778899999999999999874 7999999998754322 1222345778999999999999999999999999999999
Q ss_pred eeccCCChHHHHhh---hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-cc
Q 011326 306 ELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VK 381 (488)
Q Consensus 306 E~~~~gsL~~~l~~---~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~ 381 (488)
||+++|+|...+.. ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++....... ..
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR 159 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeec
Confidence 99999999877743 258999999999999999999999999999999999999999999999999987654322 34
Q ss_pred cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhh---HHHhcCCCCCCCCCcccHHHHHHHH
Q 011326 382 SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQA---MFKIGGGELPPVPNSLSRDAQDFIL 458 (488)
Q Consensus 382 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~s~~l~~Li~ 458 (488)
...||+.|+|||++ .+..++.++|||||||++|+|++|+.||...+.... ............+..+++++.+|+.
T Consensus 160 ~~~g~~~y~aPE~~--~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 160 GRVGTVGYMAPEVI--NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred CCCCCCCccCHhhh--cCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence 55799999999997 455689999999999999999999999987554322 2222222333566778999999999
Q ss_pred HhhhhCCCCCCC-----HHHHHhCccCCCC
Q 011326 459 KCLQVNPNDRPT-----AAQLMEHPFIKRP 483 (488)
Q Consensus 459 ~cL~~dP~~Rps-----~~eil~hp~f~~~ 483 (488)
+||+.||.+||+ ++++++||||+..
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 999999999997 9999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=355.75 Aligned_cols=252 Identities=27% Similarity=0.465 Sum_probs=208.4
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
.+++|++.+.||+|+||.||+|.+. ++..||+|.+...... .....+.+|+.++++++||||+++++++.+++..
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE----GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCL 78 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC----CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 3678999999999999999999886 7899999998754321 1123567899999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC-
Q 011326 302 CIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN- 378 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~- 378 (488)
++||||+++ +|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred EEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 999999986 888877543 3788999999999999999999999999999999999999999999999998754332
Q ss_pred -CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC-----------------
Q 011326 379 -DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG----------------- 440 (488)
Q Consensus 379 -~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~----------------- 440 (488)
......+|+.|+|||.+. ....++.++||||+|+++|+|++|+.||.+.+..+....+...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLL-GSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred ccccCceecccccChHHhc-CCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 233456899999999873 3456889999999999999999999999876654443322110
Q ss_pred ----CCC--------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 441 ----ELP--------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 441 ----~~~--------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
..+ .....+++++.+||.+||++||.+|||++|+++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 000 0113468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=364.77 Aligned_cols=263 Identities=29% Similarity=0.494 Sum_probs=222.7
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCc---------chhHHHHHHHHHHHHhcCCCCCcce
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPR---------GKQSILQLEQEISLLGQFEHDNIVQ 290 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~---------~~~~~~~~~~Ei~iL~~l~HpnIv~ 290 (488)
+..+++|++++.||+|.||.|-+|++. +++.||||++.+...... .....++..+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 567899999999999999999999986 799999999976542211 1123457899999999999999999
Q ss_pred eeccccC--CCceEEEEeeccCCChHHHHhhhc-cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEe
Q 011326 291 YLGTDRD--EKRLCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLA 367 (488)
Q Consensus 291 l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~-ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~ 367 (488)
|+++-.+ .+.+|||+|||..|.+...-.... +++.+++.+++.++.||+|||.+|||||||||.|+|++.+|++||+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 9999765 568999999999998865544444 8999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccCC-------CcccCCCCCcccCchhhcccc--CCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhc
Q 011326 368 DFGLAKATTMN-------DVKSCKGTAFWMAPEVVNLKK--DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIG 438 (488)
Q Consensus 368 DFGla~~~~~~-------~~~~~~gt~~y~aPE~~~~~~--~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~ 438 (488)
|||.+...... ......|||.|+|||.+.... ...+.+.||||+|++||.|+.|+.||.+....+...+|.
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 99988644221 134577999999999984322 234788999999999999999999999988888999888
Q ss_pred CCCCCCCC--CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 439 GGELPPVP--NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 439 ~~~~~~~~--~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
...+ .+| ..+.+++++||.+||.+||++|.++.+|..|||.....
T Consensus 333 n~pL-~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 333 NDPL-EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred cCcc-cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 7655 233 34789999999999999999999999999999997764
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=353.69 Aligned_cols=251 Identities=25% Similarity=0.437 Sum_probs=207.9
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||+|.+. ++..||+|++...... ......+.+|+.+++.++||||+++++++..++..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN---EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL 77 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc---ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence 46899999999999999999986 6889999999765322 2234567789999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC---
Q 011326 304 FLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--- 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--- 379 (488)
||||++++++..+... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 9999999877665543 358999999999999999999999999999999999999999999999999987654322
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC-------------------
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG------------------- 440 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~------------------- 440 (488)
.....||+.|+|||++ .+..++.++|+||+||++|||++|+.||...+..+....+...
T Consensus 158 ~~~~~~~~~y~aPE~~--~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 158 YTEYVATRWYRSPELL--LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccCCcHHH--cCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 2345689999999997 3455889999999999999999999999876544332221110
Q ss_pred --CCCC----------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 441 --ELPP----------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 441 --~~~~----------~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
..+. ....+|.++.+|+.+||++||++|||++|+++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000 112368889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=363.18 Aligned_cols=254 Identities=29% Similarity=0.440 Sum_probs=216.5
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||+|.+. ++..||+|++...... .......+.+|+.++..++||||+++++++.+++..|+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF--KLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh--hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence 46899999999999999999986 6899999999754321 12334567889999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCccc
Q 011326 304 FLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS 382 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 382 (488)
||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-~~~~ 157 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-YANS 157 (333)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-ccCC
Confidence 99999999999998654 589999999999999999999999999999999999999999999999999875543 3345
Q ss_pred CCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC----CCCCC---CcccHHHHH
Q 011326 383 CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE----LPPVP---NSLSRDAQD 455 (488)
Q Consensus 383 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~----~~~~~---~~~s~~l~~ 455 (488)
..||+.|+|||++ .+..++.++|||||||++|||++|..||...+..+....+.... .+... ..+++++.+
T Consensus 158 ~~gt~~y~aPE~~--~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~ 235 (333)
T cd05600 158 VVGSPDYMAPEVL--RGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235 (333)
T ss_pred cccCccccChhHh--cCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence 6799999999997 34578999999999999999999999998877666554443211 11111 256899999
Q ss_pred HHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 456 FILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
|+.+||+.+|.+||++.++++||||+..
T Consensus 236 li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 236 LITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 9999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=360.16 Aligned_cols=246 Identities=28% Similarity=0.445 Sum_probs=212.1
Q ss_pred ecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeeccCC
Q 011326 233 LGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKG 311 (488)
Q Consensus 233 LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 311 (488)
||+|+||.||+|.+. ++..||+|.+..... ........+.+|+.++.+++||||+++++++.+++..++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI--VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence 699999999999886 688999999875322 12234456788999999999999999999999999999999999999
Q ss_pred ChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--CcccCCCCCc
Q 011326 312 SLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGTAF 388 (488)
Q Consensus 312 sL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~gt~~ 388 (488)
+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++..... ......||+.
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 158 (312)
T cd05585 79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPE 158 (312)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcc
Confidence 999888554 5899999999999999999999999999999999999999999999999998753322 2334569999
Q ss_pred ccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCC
Q 011326 389 WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDR 468 (488)
Q Consensus 389 y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~R 468 (488)
|+|||++ .+..++.++||||+||++|+|++|..||...+..+....+.... ...+..+++++.+|+.+||+.||.+|
T Consensus 159 y~aPE~~--~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R 235 (312)
T cd05585 159 YLAPELL--LGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP-LRFPDGFDRDAKDLLIGLLSRDPTRR 235 (312)
T ss_pred cCCHHHH--cCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC-CCCCCcCCHHHHHHHHHHcCCCHHHc
Confidence 9999997 45568999999999999999999999998877776666665543 35677899999999999999999999
Q ss_pred C---CHHHHHhCccCCCC
Q 011326 469 P---TAAQLMEHPFIKRP 483 (488)
Q Consensus 469 p---s~~eil~hp~f~~~ 483 (488)
| ++.++++||||.+.
T Consensus 236 ~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 236 LGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCCCHHHHHcCCCcCCC
Confidence 7 57999999999863
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=361.30 Aligned_cols=248 Identities=29% Similarity=0.486 Sum_probs=213.1
Q ss_pred eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeecc
Q 011326 231 ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVT 309 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 309 (488)
+.||+|+||.||++.+. +|..||+|.+..... ........+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence 36999999999999875 799999999975422 122344567789999999999999999999999999999999999
Q ss_pred CCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--CcccCCCC
Q 011326 310 KGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGT 386 (488)
Q Consensus 310 ~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~gt 386 (488)
+|+|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......||
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence 99998888654 5899999999999999999999999999999999999999999999999998653222 23346799
Q ss_pred CcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCC
Q 011326 387 AFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPN 466 (488)
Q Consensus 387 ~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~ 466 (488)
+.|+|||++ .+..++.++|||||||++|||++|+.||...+.......+..... ..+..+++++.+||.+||+.||.
T Consensus 159 ~~y~aPE~~--~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05595 159 PEYLAPEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred cCcCCcccc--cCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHHccCCHH
Confidence 999999997 455689999999999999999999999988776666665554433 46778999999999999999999
Q ss_pred CCC-----CHHHHHhCccCCCC
Q 011326 467 DRP-----TAAQLMEHPFIKRP 483 (488)
Q Consensus 467 ~Rp-----s~~eil~hp~f~~~ 483 (488)
+|| ++.++++||||.+.
T Consensus 236 ~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 236 QRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred HhCCCCCCCHHHHHcCCCcCCC
Confidence 998 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=361.79 Aligned_cols=247 Identities=29% Similarity=0.486 Sum_probs=212.9
Q ss_pred eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeecc
Q 011326 231 ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVT 309 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 309 (488)
+.||+|+||.||++.+. +|..||+|++..... ........+.+|+.+++.++||||+++++++..++.+++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI--IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence 36999999999999875 799999999975432 123345677889999999999999999999999999999999999
Q ss_pred CCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--CcccCCCC
Q 011326 310 KGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGT 386 (488)
Q Consensus 310 ~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~gt 386 (488)
+|+|...+... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ......||
T Consensus 79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence 99998887654 5899999999999999999999999999999999999999999999999998753222 23345699
Q ss_pred CcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCC
Q 011326 387 AFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPN 466 (488)
Q Consensus 387 ~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~ 466 (488)
+.|+|||.+ .+..++.++|||||||++|+|++|+.||...+..+....+.... ..++..+++++.+||.+||++||.
T Consensus 159 ~~y~aPE~~--~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~ 235 (328)
T cd05593 159 PEYLAPEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED-IKFPRTLSADAKSLLSGLLIKDPN 235 (328)
T ss_pred cCccChhhh--cCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC-ccCCCCCCHHHHHHHHHHcCCCHH
Confidence 999999997 44568999999999999999999999998877666665555443 356778999999999999999999
Q ss_pred CCC-----CHHHHHhCccCCC
Q 011326 467 DRP-----TAAQLMEHPFIKR 482 (488)
Q Consensus 467 ~Rp-----s~~eil~hp~f~~ 482 (488)
+|+ ++.|+++||||..
T Consensus 236 ~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 236 KRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred HcCCCCCCCHHHHhcCCCcCC
Confidence 997 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=359.43 Aligned_cols=252 Identities=28% Similarity=0.456 Sum_probs=214.9
Q ss_pred eeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHH---HhcCCCCCcceeeccccCCCceE
Q 011326 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISL---LGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~i---L~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
|++.+.||+|+||.||+|.+. ++..||+|.+...... .......+.+|..+ ++.++||||+++++++.+.+..|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII--ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence 678899999999999999875 7899999999754321 11223455556554 45678999999999999999999
Q ss_pred EEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--Cc
Q 011326 303 IFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DV 380 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~ 380 (488)
+||||+++++|...+....+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++..... ..
T Consensus 79 lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05589 79 FVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT 158 (324)
T ss_pred EEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998643222 23
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHh
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~c 460 (488)
....||+.|+|||.+ .+..++.++|+||||+++|+|++|+.||.+.+..+....+..... ..+..+++++.++|.+|
T Consensus 159 ~~~~g~~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~ 235 (324)
T cd05589 159 STFCGTPEFLAPEVL--TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSREAISIMRRL 235 (324)
T ss_pred cccccCccccCHhHh--cCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHH
Confidence 356799999999997 455688999999999999999999999998877777666655443 46678899999999999
Q ss_pred hhhCCCCCC-----CHHHHHhCccCCCC
Q 011326 461 LQVNPNDRP-----TAAQLMEHPFIKRP 483 (488)
Q Consensus 461 L~~dP~~Rp-----s~~eil~hp~f~~~ 483 (488)
|+.||.+|| ++.++++||||+..
T Consensus 236 L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 236 LRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred hhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 999999999 69999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=357.75 Aligned_cols=255 Identities=29% Similarity=0.483 Sum_probs=214.6
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||++.+. +|..+|+|.+.... .......+.+|+.++++++||||+++++++..++..+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 468999999999999999999886 78899999987532 2334567899999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHC-CCccccCCcccEEECCCCcEEEeecCCcccccCCCc
Q 011326 303 IFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV 380 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 380 (488)
+||||+++++|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++........
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 159 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccccc
Confidence 999999999999998654 589999999999999999999986 699999999999999999999999999876654445
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhc----------------------
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIG---------------------- 438 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~---------------------- 438 (488)
....||+.|+|||++ .+..++.++|+||||+++|||++|+.||...+..+....+.
T Consensus 160 ~~~~g~~~y~aPE~~--~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 160 NSFVGTRSYMSPERL--QGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred ccCCCCcCcCCHhHh--cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence 566799999999997 44568999999999999999999999997654433221111
Q ss_pred ------------------------CCCCCCC-CCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 439 ------------------------GGELPPV-PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 439 ------------------------~~~~~~~-~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
....+.. ...+++++.+||.+||++||++|||+.|+++||||++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 1111111 124688999999999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=356.79 Aligned_cols=253 Identities=27% Similarity=0.492 Sum_probs=229.6
Q ss_pred cCceeeeeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
..+|++.+.||+|.||.|-+++. ..|+.||||.+.+... ..++.+..+.+|++||+.|+||||++++.+|++.+.+.
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI--kdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI--KDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhc--ccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 45799999999999999999987 5899999999987765 45667788999999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-c
Q 011326 303 IFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-V 380 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~ 380 (488)
|||||..+|.|.+++.+. .+++.++.++++||++|+.|+|.++++|||||.+|||+|.++++||+|||++..+.... .
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFL 209 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHH
Confidence 999999999999999765 59999999999999999999999999999999999999999999999999998776655 5
Q ss_pred ccCCCCCcccCchhhccccCCC-ChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHH
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGY-GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILK 459 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~-s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~ 459 (488)
++++|+|.|.+||+++ +..| ++.+|-||||++||-|+.|..||++.+....+.+|..+.+.. +.-+.++.-||++
T Consensus 210 qTFCGSPLYASPEIvN--G~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE--P~~PSdA~gLIRw 285 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVN--GTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE--PETPSDASGLIRW 285 (668)
T ss_pred HHhcCCcccCCccccC--CCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC--CCCCchHHHHHHH
Confidence 6899999999999984 3334 788999999999999999999999999999999998887632 3457788899999
Q ss_pred hhhhCCCCCCCHHHHHhCccCCC
Q 011326 460 CLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 460 cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
||-.||++|.|+++|..|.|+.=
T Consensus 286 mLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 286 MLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred HHhcCcccchhHHHHhhhheeec
Confidence 99999999999999999999853
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=348.83 Aligned_cols=260 Identities=28% Similarity=0.418 Sum_probs=221.0
Q ss_pred ccccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc--
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD-- 295 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-- 295 (488)
.-.+.+++|+.++.|++|+||.||+|.++ +++.||+|.++...+...... .-.+|+.+|.+.+|||||.+-.+.
T Consensus 70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPI---tsLREIniLl~~~H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPI---TSLREINILLKARHPNIVEVKEVVVG 146 (419)
T ss_pred cCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcc---hhHHHHHHHHhcCCCCeeeeEEEEec
Confidence 34566889999999999999999999985 799999999988775544332 346899999999999999988864
Q ss_pred cCCCceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 296 RDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 296 ~~~~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
.+-+.+|||||||+. +|..++... +++..++..++.|+++|++|||.+.|+||||||+|+|+++.|.+||+|||+|+
T Consensus 147 ~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 147 SNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAR 225 (419)
T ss_pred cccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhh
Confidence 445679999999998 888888654 59999999999999999999999999999999999999999999999999999
Q ss_pred cccCC--CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC----------
Q 011326 374 ATTMN--DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE---------- 441 (488)
Q Consensus 374 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~---------- 441 (488)
.++.. ..+..+-|.+|+|||.+ +....|++++||||+||++.||+++++.|.+....+.+.+|-...
T Consensus 226 ~ygsp~k~~T~lVVTLWYRaPELL-LG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 226 EYGSPLKPYTPLVVTLWYRAPELL-LGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred hhcCCcccCcceEEEeeecCHHHh-cCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence 87754 35677899999999998 677789999999999999999999999998877766655542110
Q ss_pred -----------CCC---------CCC-cccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 442 -----------LPP---------VPN-SLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 442 -----------~~~---------~~~-~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
++. ++. .+++...+|+..+|..||.+|.|++|.|+|+||.+.
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 000 111 156889999999999999999999999999999873
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=363.74 Aligned_cols=253 Identities=30% Similarity=0.463 Sum_probs=216.3
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||+|.+. +|..||+|++...... .......+.+|+.++..++||||+++++++.+++..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI--KRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh--hccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence 47899999999999999999986 7999999999754321 12334568889999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC---
Q 011326 304 FLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--- 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--- 379 (488)
||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 99999999999988665 69999999999999999999999999999999999999999999999999987544332
Q ss_pred ----------------------------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh
Q 011326 380 ----------------------------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG 431 (488)
Q Consensus 380 ----------------------------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~ 431 (488)
.....||+.|+|||++ .+..++.++|||||||++|||++|+.||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL--RGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHH--cCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 2345699999999997 4456899999999999999999999999887766
Q ss_pred hhHHHhcC--CC-CCCCCCcccHHHHHHHHHhhhhCCCCCCC-HHHHHhCccCCC
Q 011326 432 QAMFKIGG--GE-LPPVPNSLSRDAQDFILKCLQVNPNDRPT-AAQLMEHPFIKR 482 (488)
Q Consensus 432 ~~~~~i~~--~~-~~~~~~~~s~~l~~Li~~cL~~dP~~Rps-~~eil~hp~f~~ 482 (488)
+....+.. .. ..+....+++++.+||.+||+ ||.+||+ +.++++||||+.
T Consensus 237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 65555544 11 112223479999999999998 9999999 999999999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=362.90 Aligned_cols=255 Identities=25% Similarity=0.409 Sum_probs=211.3
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||++.+. ++..||+|++...... .......+.+|+.++.+++||||+++++.+.++..+|+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML--EKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH--HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence 47899999999999999999875 6899999999753321 12334567889999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC---
Q 011326 304 FLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--- 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--- 379 (488)
||||+++|+|.+++.+ ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 9999999999998865 468999999999999999999999999999999999999999999999999986432110
Q ss_pred ----------------------------------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCC
Q 011326 380 ----------------------------------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY 425 (488)
Q Consensus 380 ----------------------------------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf 425 (488)
.....||+.|+|||++ .+..++.++|||||||++|||++|..||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~--~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVF--MQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHH--cCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 1234699999999997 4556899999999999999999999999
Q ss_pred CCCchhhhHHHhcCCC-CCCCC--CcccHHHHHHHHHhhh--hCCCCCCCHHHHHhCccCCCC
Q 011326 426 SHLEGGQAMFKIGGGE-LPPVP--NSLSRDAQDFILKCLQ--VNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 426 ~~~~~~~~~~~i~~~~-~~~~~--~~~s~~l~~Li~~cL~--~dP~~Rps~~eil~hp~f~~~ 483 (488)
...+..+....+.... ...++ ..++++++++|.+|+. .++..||+++||++||||+..
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCC
Confidence 8877776666655422 11222 2478999999999765 233356899999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=353.47 Aligned_cols=254 Identities=31% Similarity=0.508 Sum_probs=205.5
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||+|.+. ++..||+|.+...... .....+.+|+.+++.++||||+++++++.+++..+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE----GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc----ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEE
Confidence 468999999999999999999986 7899999998754321 11235678999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--
Q 011326 303 IFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-- 378 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-- 378 (488)
+||||+++ +|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 80 LVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred EEEECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 99999965 77766654 35899999999999999999999999999999999999999999999999998654322
Q ss_pred CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhh-hHHHhc---CC-C---C------CC
Q 011326 379 DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ-AMFKIG---GG-E---L------PP 444 (488)
Q Consensus 379 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~-~~~~i~---~~-~---~------~~ 444 (488)
......||+.|+|||++. ....++.++||||+||++|+|++|..||.+..+.. ....+. .. . . +.
T Consensus 159 ~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLL-GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred cCCCCcccCCCCChHHHc-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 234466899999999873 34457889999999999999999999998754321 111110 00 0 0 00
Q ss_pred ---------CC---------CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 445 ---------VP---------NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 445 ---------~~---------~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
.+ ...++++.+|+.+||+.||.+|||+.|+++||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00 1245788999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=366.06 Aligned_cols=260 Identities=26% Similarity=0.392 Sum_probs=220.3
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
.....+|++.+.||+|+||.||++.+. ++..||+|.+...... .......+.+|+.+++.++||||+++++++.+++
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI--KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 345678999999999999999999885 7899999999753211 1223345778999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 300 RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
..++||||+++|+|.+++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999987654322
Q ss_pred ---cccCCCCCcccCchhhccc--cCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC-CCCC--CcccH
Q 011326 380 ---VKSCKGTAFWMAPEVVNLK--KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL-PPVP--NSLSR 451 (488)
Q Consensus 380 ---~~~~~gt~~y~aPE~~~~~--~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~~~--~~~s~ 451 (488)
.....||+.|+|||++... ...++.++|+|||||++|||++|+.||...+.......+..... ...+ ..++.
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISK 276 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCH
Confidence 2345799999999997432 23478999999999999999999999998777666666654321 1223 35799
Q ss_pred HHHHHHHHhhhhCCCC--CCCHHHHHhCccCCC
Q 011326 452 DAQDFILKCLQVNPND--RPTAAQLMEHPFIKR 482 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~--Rps~~eil~hp~f~~ 482 (488)
++.+||.+||+.+|.+ |++++++++||||+.
T Consensus 277 ~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 277 QAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 9999999999999987 999999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=354.98 Aligned_cols=251 Identities=29% Similarity=0.474 Sum_probs=212.1
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC----
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE---- 298 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~---- 298 (488)
.-.|+..+++|.|+||.||+|... ++..||||.+....... -+|+.+|+.++|||||+|..+|...
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---------nrEl~im~~l~HpNIV~L~~~f~~~~~~d 93 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---------NRELQIMRKLDHPNIVRLLYFFSSSTESD 93 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---------cHHHHHHHhcCCcCeeeEEEEEEecCCCc
Confidence 345788899999999999999875 68999999997654322 2689999999999999999887432
Q ss_pred -CceEEEEeeccCCChHHHHh-----hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC-CcEEEeecCC
Q 011326 299 -KRLCIFLELVTKGSLASLYQ-----KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS-GSVKLADFGL 371 (488)
Q Consensus 299 -~~~~lV~E~~~~gsL~~~l~-----~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~-~~vkL~DFGl 371 (488)
-...+||||||. +|.+.++ +.+++...++-++.||++||.|||+.||+||||||.|+|+|.+ |.+||||||.
T Consensus 94 ~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 94 EVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred hhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCc
Confidence 246789999998 9999887 3469999999999999999999999999999999999999975 9999999999
Q ss_pred cccccCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC---------
Q 011326 372 AKATTMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE--------- 441 (488)
Q Consensus 372 a~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~--------- 441 (488)
|+.+..+. ..++..|..|+|||.+ .+...|+.+.||||.||++.||+.|++-|.+.+..+.+..+....
T Consensus 173 AK~L~~~epniSYicSRyYRaPELi-fga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 173 AKVLVKGEPNISYICSRYYRAPELI-FGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred ceeeccCCCceeEEEeccccCHHHH-cCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 99876654 4577899999999998 577789999999999999999999999999987766555443210
Q ss_pred ----------CC--------C-CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 442 ----------LP--------P-VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 442 ----------~~--------~-~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
.+ . .....++++.+|+.++|+++|.+|.++.|++.||||.+...
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 00 0 23457899999999999999999999999999999987654
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=364.09 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=213.6
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||+|.+. +|..||||++...... .......+.+|+.+++.++||||+++++++.+++.+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML--EKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence 47899999999999999999885 6899999999754321 12334567889999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC---
Q 011326 304 FLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--- 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--- 379 (488)
||||+++|+|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 99999999999988654 58999999999999999999999999999999999999999999999999986432110
Q ss_pred -------------------------------------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCC
Q 011326 380 -------------------------------------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRR 422 (488)
Q Consensus 380 -------------------------------------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~ 422 (488)
.....||+.|+|||++ ....++.++|||||||++|||++|.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVF--LQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHH--cCCCCCCeeeeecchhHHHHhhcCC
Confidence 0124599999999997 4556899999999999999999999
Q ss_pred CCCCCCchhhhHHHhcCCCC-CCC--CCcccHHHHHHHHHhhhhCCCCCCC---HHHHHhCccCCCC
Q 011326 423 HPYSHLEGGQAMFKIGGGEL-PPV--PNSLSRDAQDFILKCLQVNPNDRPT---AAQLMEHPFIKRP 483 (488)
Q Consensus 423 ~Pf~~~~~~~~~~~i~~~~~-~~~--~~~~s~~l~~Li~~cL~~dP~~Rps---~~eil~hp~f~~~ 483 (488)
.||...+..+....+..... ... ...+++++.+||.+||. +|.+|++ +.|++.||||+..
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 99988776666555543221 122 23578999999999997 9999998 9999999999763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=356.60 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=215.7
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCC-CcceeeccccCCCceEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD-NIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp-nIv~l~~~~~~~~~~~l 303 (488)
+|++.+.||+|+||.||+|.+. ++..||+|++...... .......+..|..++..++|+ +|+.+++++.+.+.+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII--QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence 5889999999999999999886 6889999999754321 123345677899999998765 58889999999999999
Q ss_pred EEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc--CCCc
Q 011326 304 FLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDV 380 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~--~~~~ 380 (488)
||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.... ....
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT 158 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence 99999999999888654 58999999999999999999999999999999999999999999999999986432 2223
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHh
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~c 460 (488)
....||+.|+|||++ .+..++.++||||+||++|+|++|+.||.+.+..+....+.... ...+..+++++.+++.+|
T Consensus 159 ~~~~gt~~y~aPE~~--~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~ 235 (324)
T cd05587 159 RTFCGTPDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGL 235 (324)
T ss_pred eeecCCccccChhhh--cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHH
Confidence 455699999999997 44568899999999999999999999999887777776666544 356778999999999999
Q ss_pred hhhCCCCCCCH-----HHHHhCccCCCC
Q 011326 461 LQVNPNDRPTA-----AQLMEHPFIKRP 483 (488)
Q Consensus 461 L~~dP~~Rps~-----~eil~hp~f~~~ 483 (488)
|+.||.+|++. +++++||||+..
T Consensus 236 l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 236 LTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred hhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999999976 899999999763
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=357.95 Aligned_cols=249 Identities=32% Similarity=0.514 Sum_probs=212.6
Q ss_pred eeecccCceEEEEEEe----cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEe
Q 011326 231 ELLGSGSYGFVYEGLT----DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLE 306 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 306 (488)
+.||+|+||.||++.. .++..||+|++...... ........+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHH-hhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 5799999999999975 35889999999753221 112233467789999999999999999999999999999999
Q ss_pred eccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--CcccC
Q 011326 307 LVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSC 383 (488)
Q Consensus 307 ~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~ 383 (488)
|+++++|.+.+... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 99999999988655 4788899999999999999999999999999999999999999999999998643222 23345
Q ss_pred CCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhh
Q 011326 384 KGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQV 463 (488)
Q Consensus 384 ~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~ 463 (488)
.||+.|+|||++ .+..++.++||||||+++|||++|+.||...+.......+..+.. ..+..+++++.+||.+||+.
T Consensus 161 ~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 161 CGTIEYMAPEIL--MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL-NLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred CCCccccChhhc--cCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHccc
Confidence 699999999997 345578999999999999999999999998877776666665543 56778899999999999999
Q ss_pred CCCCCC-----CHHHHHhCccCCCC
Q 011326 464 NPNDRP-----TAAQLMEHPFIKRP 483 (488)
Q Consensus 464 dP~~Rp-----s~~eil~hp~f~~~ 483 (488)
||++|| +++++++||||+..
T Consensus 238 ~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999 89999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=350.00 Aligned_cols=255 Identities=29% Similarity=0.459 Sum_probs=217.1
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC-----C
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD-----E 298 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-----~ 298 (488)
..|...+.||+|+||.|..+.+. +|..||||.+...- .+....++..+|+.+|+.++|+||+.+.+++.. -
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F---~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF---ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh---hchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34555788999999999999885 79999999997432 344556788899999999999999999998765 3
Q ss_pred CceEEEEeeccCCChHHHHhhhc-cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc-
Q 011326 299 KRLCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT- 376 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~~-ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~- 376 (488)
..+|+|+|+|+. +|.++++.+. +++..+..++.|++.||.|+|+.|++||||||.|+|++.++.+||||||+|+...
T Consensus 99 ~DvYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 99 NDVYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred ceeEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 468999999955 9999998887 9999999999999999999999999999999999999999999999999999875
Q ss_pred ---CCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC--------------
Q 011326 377 ---MNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG-------------- 439 (488)
Q Consensus 377 ---~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~-------------- 439 (488)
....+..+.|.+|+|||++ +....|+.+.||||+||++.||++|++.|.+.+..+.+..+..
T Consensus 178 ~~~~~~mTeYVaTRWYRAPEll-l~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELL-LNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred cCcccchhcceeeeeecCHHHH-hccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 3345778899999999998 6788899999999999999999999999988765444333221
Q ss_pred -----------CCCCC-----CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 440 -----------GELPP-----VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 440 -----------~~~~~-----~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
...+. ..+..++.+.+|+.+||..||.+|+|++|+|.|||+..-.
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 01111 1246889999999999999999999999999999997643
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=357.80 Aligned_cols=255 Identities=31% Similarity=0.483 Sum_probs=211.2
Q ss_pred ceeeeeeecccCceEEEEEEe----cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCc
Q 011326 226 SWQKGELLGSGSYGFVYEGLT----DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 300 (488)
+|++.+.||+|+||.||++.. .++..||+|++...... ........+..|+.++..+ +||||+++++++..++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV-QKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence 488999999999999999876 36889999999753221 1223345678899999999 59999999999999999
Q ss_pred eEEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 301 LCIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
+++||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 9999999999999888754 458999999999999999999999999999999999999999999999999987543222
Q ss_pred ---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh----hhHHHhcCCCCCCCCCcccHH
Q 011326 380 ---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG----QAMFKIGGGELPPVPNSLSRD 452 (488)
Q Consensus 380 ---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~s~~ 452 (488)
.....||+.|+|||++. ....++.++|||||||++|||++|..||...... .....+. ...+..+..+++.
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIR-GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL-KCDPPFPSFIGPE 237 (332)
T ss_pred CCccccccCCccccCHHHhc-CCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCHH
Confidence 23456999999999973 3345788999999999999999999999643221 2222222 2334567789999
Q ss_pred HHHHHHHhhhhCCCCCC-----CHHHHHhCccCCCC
Q 011326 453 AQDFILKCLQVNPNDRP-----TAAQLMEHPFIKRP 483 (488)
Q Consensus 453 l~~Li~~cL~~dP~~Rp-----s~~eil~hp~f~~~ 483 (488)
+.+++.+||+.||++|| +++++++||||+..
T Consensus 238 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999999999999999 88999999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=364.31 Aligned_cols=254 Identities=25% Similarity=0.409 Sum_probs=210.2
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
.|++++.||+|+||.||+|.+. ++..||+|.+..... ........+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV--LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence 5889999999999999999875 789999999975432 1233456788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC-----
Q 011326 305 LELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----- 378 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~----- 378 (488)
|||+++|+|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 9999999999988654 5899999999999999999999999999999999999999999999999987532100
Q ss_pred --------------------------------------------CcccCCCCCcccCchhhccccCCCChhhhHHHHHHH
Q 011326 379 --------------------------------------------DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCT 414 (488)
Q Consensus 379 --------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvl 414 (488)
......||+.|+|||++ .+..++.++|||||||+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~--~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL--LRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHH--cCCCCCCccceeehhhH
Confidence 01234699999999997 44568999999999999
Q ss_pred HHHHHcCCCCCCCCchhhhHHHhcCC-CCCCC--CCcccHHHHHHHHHhh--hhCCCCCCCHHHHHhCccCCCC
Q 011326 415 VLEMLTRRHPYSHLEGGQAMFKIGGG-ELPPV--PNSLSRDAQDFILKCL--QVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 415 L~eLltG~~Pf~~~~~~~~~~~i~~~-~~~~~--~~~~s~~l~~Li~~cL--~~dP~~Rps~~eil~hp~f~~~ 483 (488)
+|||++|..||...+..+....+... ..... ...+++++.+||.+|+ ..+|..||++.+++.||||++.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 99999999999877665554444321 11122 2358999999999955 5566669999999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=360.78 Aligned_cols=259 Identities=33% Similarity=0.495 Sum_probs=229.2
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCCCc
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDEKR 300 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~ 300 (488)
....|++.+.||.|.||.||++..+ +|..+|+|.+.+..... ......+.+|+.+|+++. |||||.+++++++.+.
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~--~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG--KEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc--cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 3457999999999999999999986 59999999998766532 234567899999999998 9999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC----CcEEEeecCCccccc
Q 011326 301 LCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS----GSVKLADFGLAKATT 376 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~----~~vkL~DFGla~~~~ 376 (488)
+++|||++.||.|.+.+....+++..+..++.|++.++.|||+.|++||||||+|+|+... +.++++|||++....
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999887765469999999999999999999999999999999999999643 479999999998776
Q ss_pred CC-CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC---CCCCcccHH
Q 011326 377 MN-DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP---PVPNSLSRD 452 (488)
Q Consensus 377 ~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~ 452 (488)
.. .....+||+.|+|||++ ....|+..+||||+|+++|.|++|.+||.+.+.......+..+.+. +....++..
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl--~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVL--GGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred CCceEeeecCCccccCchhh--cCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 53 35678899999999997 4567999999999999999999999999999888888888777652 344578999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 453 AQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 453 l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
++++|+.||..||.+|+|+.++|+|||++..-+
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~ 301 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE 301 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence 999999999999999999999999999997633
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=356.94 Aligned_cols=247 Identities=29% Similarity=0.461 Sum_probs=211.2
Q ss_pred eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCceEEEEeec
Q 011326 231 ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
+.||+|+||.||+|.+. ++..||+|.+...... .......+..|..++..+ +||||+++++++.+.+.+++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL--QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh--hccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence 36999999999999886 6899999998753211 122345567788888776 6999999999999999999999999
Q ss_pred cCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--CcccCCC
Q 011326 309 TKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKG 385 (488)
Q Consensus 309 ~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~g 385 (488)
++|+|..++... .+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||+++..... ......|
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence 999999888654 6899999999999999999999999999999999999999999999999998653222 2334569
Q ss_pred CCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCC
Q 011326 386 TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465 (488)
Q Consensus 386 t~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP 465 (488)
|+.|+|||++ .+..++.++||||||+++|+|++|+.||...+..+....+..... ..+..+++++.+|+.+||+.||
T Consensus 159 t~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP 235 (320)
T cd05590 159 TPDYIAPEIL--QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLSQDAVDILKAFMTKNP 235 (320)
T ss_pred CccccCHHHH--cCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHHcccCH
Confidence 9999999997 455688999999999999999999999998887777777665443 5567789999999999999999
Q ss_pred CCCCCH------HHHHhCccCCC
Q 011326 466 NDRPTA------AQLMEHPFIKR 482 (488)
Q Consensus 466 ~~Rps~------~eil~hp~f~~ 482 (488)
.+||++ +++++||||+.
T Consensus 236 ~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 236 TMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred HHCCCCCCCCCHHHHHcCCCcCC
Confidence 999998 99999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=347.02 Aligned_cols=250 Identities=31% Similarity=0.515 Sum_probs=201.3
Q ss_pred CceeeeeeecccCceEEEEEEec--CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC---CCCCcceeecccc---
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD--DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF---EHDNIVQYLGTDR--- 296 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~--- 296 (488)
.+|++.+.||+|+||.||+|.+. ++..||+|.+......... ...+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc---hHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence 36889999999999999999873 4788999998765432221 22344566666554 7999999999874
Q ss_pred --CCCceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCC
Q 011326 297 --DEKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGL 371 (488)
Q Consensus 297 --~~~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGl 371 (488)
....+++||||+++ +|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 78 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 78 TDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCCCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 34568999999975 888887543 489999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC-------
Q 011326 372 AKATTMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP------- 443 (488)
Q Consensus 372 a~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~------- 443 (488)
+....... .....||+.|+|||.+ ....++.++||||||+++|||++|++||.+.+..+....+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCCcccccccccccccChHHH--hCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 97654432 3355689999999997 3456889999999999999999999999887665554443211100
Q ss_pred -------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 444 -------------------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 444 -------------------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
.....+++.+.+|+.+||+.||++|||+.|+++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0113467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=355.49 Aligned_cols=255 Identities=27% Similarity=0.414 Sum_probs=204.7
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC-----C
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE-----K 299 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~ 299 (488)
+|++.+.||+|+||.||+|.+. +|..||+|.+..... .......+.+|+.++++++||||+++++++... .
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 77 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE---HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc---cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence 5889999999999999999875 789999999864322 122335678999999999999999999987533 3
Q ss_pred ceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 300 RLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
..|+||||+. ++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 78 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 78 DIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred eEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 4899999996 5888877654 5899999999999999999999999999999999999999999999999998754322
Q ss_pred C-----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHh----------------
Q 011326 379 D-----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKI---------------- 437 (488)
Q Consensus 379 ~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i---------------- 437 (488)
. .....||+.|+|||++......++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 2345799999999997433356899999999999999999999999765432221110
Q ss_pred -----------cCCCCC---CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 438 -----------GGGELP---PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 438 -----------~~~~~~---~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
...... .....+++++.+++.+||+.||++|||++|+++||||+..-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 000000 01124678899999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=364.12 Aligned_cols=252 Identities=27% Similarity=0.444 Sum_probs=211.2
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
.|++++.||+|+||.||+|.+. ++..||+|.+..... ........+.+|+.++++++||||+++++.+.+++.+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV--LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh--hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence 5889999999999999999885 789999999875322 1233456788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC-----
Q 011326 305 LELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----- 378 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~----- 378 (488)
|||+++|+|.+++.+. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 9999999999988654 5889999999999999999999999999999999999999999999999987422100
Q ss_pred --------------------------------------------CcccCCCCCcccCchhhccccCCCChhhhHHHHHHH
Q 011326 379 --------------------------------------------DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCT 414 (488)
Q Consensus 379 --------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvl 414 (488)
......||+.|+|||++ .+..++.++|||||||+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~--~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHh--cCCCCCCeeeEEechHH
Confidence 01134689999999997 45568999999999999
Q ss_pred HHHHHcCCCCCCCCchhhhHHHhcCCCC---CCCCCcccHHHHHHHHHhhhhCCCCCCC---HHHHHhCccCCC
Q 011326 415 VLEMLTRRHPYSHLEGGQAMFKIGGGEL---PPVPNSLSRDAQDFILKCLQVNPNDRPT---AAQLMEHPFIKR 482 (488)
Q Consensus 415 L~eLltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~l~~Li~~cL~~dP~~Rps---~~eil~hp~f~~ 482 (488)
+|||++|+.||...+..+....+..... .+....+++++.++|.+|+ .+|.+|++ ++++++||||+.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 9999999999988776665555543221 1223468999999999986 59999987 999999999976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=358.55 Aligned_cols=248 Identities=29% Similarity=0.475 Sum_probs=212.2
Q ss_pred eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeecc
Q 011326 231 ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVT 309 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 309 (488)
+.||+|+||.||++.+. +|..||+|.+..... ........+.+|+.++..++||||+++++++..++..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 36999999999999875 799999999975432 122334567789999999999999999999999999999999999
Q ss_pred CCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHH-CCCccccCCcccEEECCCCcEEEeecCCcccccC--CCcccCCC
Q 011326 310 KGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKG 385 (488)
Q Consensus 310 ~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~--~~~~~~~g 385 (488)
+|+|..++... .+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++.... .......|
T Consensus 79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence 99998888654 58999999999999999999997 7999999999999999999999999999864322 22334569
Q ss_pred CCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCC
Q 011326 386 TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465 (488)
Q Consensus 386 t~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP 465 (488)
|+.|+|||++ .+..++.++||||||+++|+|++|..||...+..+....+.... ..++..+++++.+|+.+||+.||
T Consensus 159 t~~y~aPE~~--~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP 235 (325)
T cd05594 159 TPEYLAPEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLSGLLKKDP 235 (325)
T ss_pred CcccCCHHHH--ccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHhhcCH
Confidence 9999999997 44568999999999999999999999998877666655554433 35677899999999999999999
Q ss_pred CCCC-----CHHHHHhCccCCCC
Q 011326 466 NDRP-----TAAQLMEHPFIKRP 483 (488)
Q Consensus 466 ~~Rp-----s~~eil~hp~f~~~ 483 (488)
.+|+ ++.++++||||...
T Consensus 236 ~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 236 KQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred HHhCCCCCCCHHHHhcCCCcCCC
Confidence 9996 99999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=356.65 Aligned_cols=248 Identities=27% Similarity=0.473 Sum_probs=206.5
Q ss_pred eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCceEEEEeec
Q 011326 231 ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
++||+|+||.||++.+. ++..||+|.+..... ........+..|..++..+ +||||+++++++.+.+.+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV--NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 36999999999999885 789999999975432 1223345678899999888 7999999999999999999999999
Q ss_pred cCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc--CCCcccCCC
Q 011326 309 TKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDVKSCKG 385 (488)
Q Consensus 309 ~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~--~~~~~~~~g 385 (488)
++|+|..++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++... ........|
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence 99999888754 469999999999999999999999999999999999999999999999999986422 122345679
Q ss_pred CCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCc--------hhhhHHHhcCCCCCCCCCcccHHHHHHH
Q 011326 386 TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE--------GGQAMFKIGGGELPPVPNSLSRDAQDFI 457 (488)
Q Consensus 386 t~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~--------~~~~~~~i~~~~~~~~~~~~s~~l~~Li 457 (488)
|+.|+|||++ .+..++.++|+||||+++|+|++|+.||.... ..+.............|..++.++.++|
T Consensus 159 t~~y~aPE~~--~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li 236 (329)
T cd05588 159 TPNYIAPEIL--RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVL 236 (329)
T ss_pred CccccCHHHH--cCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 9999999997 45568899999999999999999999996321 1112222222333456778999999999
Q ss_pred HHhhhhCCCCCCC------HHHHHhCccCCC
Q 011326 458 LKCLQVNPNDRPT------AAQLMEHPFIKR 482 (488)
Q Consensus 458 ~~cL~~dP~~Rps------~~eil~hp~f~~ 482 (488)
.+||+.||.+|++ +.++++||||..
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 237 KGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9999999999987 899999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=363.36 Aligned_cols=258 Identities=24% Similarity=0.380 Sum_probs=217.0
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
...+|++.+.||+|+||.||++.+. ++..+|+|.+.+.... .......+.+|+.+++.++||||+++++++.+++.+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI--KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 4568999999999999999999886 6889999998753221 122334577899999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 302 CIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
|+||||+++|+|.+++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 999999999999999988889999999999999999999999999999999999999999999999999997654332
Q ss_pred -cccCCCCCcccCchhhcccc--CCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC-CCCC--CcccHHH
Q 011326 380 -VKSCKGTAFWMAPEVVNLKK--DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL-PPVP--NSLSRDA 453 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~~--~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~~~--~~~s~~l 453 (488)
.....||+.|+|||++.... ..++.++|+||+||++|+|++|..||...+.......+..... ...+ ..++..+
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 278 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHA 278 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHH
Confidence 23567999999999984322 2378899999999999999999999988777666666554321 2223 3579999
Q ss_pred HHHHHHhhhhCCCC--CCCHHHHHhCccCCC
Q 011326 454 QDFILKCLQVNPND--RPTAAQLMEHPFIKR 482 (488)
Q Consensus 454 ~~Li~~cL~~dP~~--Rps~~eil~hp~f~~ 482 (488)
++++.+||+.++.+ |+++.|+++||||+.
T Consensus 279 ~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 279 KNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred HHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 99999999855543 899999999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=354.41 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=215.3
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCceEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 303 (488)
+|++.+.||+|+||.||+|.+. ++..||+|.+.+.... .......+..|..++..+ +|++|+++++++.+.+.+++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI--QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence 5888999999999999999886 6889999999754321 122334566777887776 58999999999999999999
Q ss_pred EEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--Cc
Q 011326 304 FLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DV 380 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~ 380 (488)
||||+++|+|...+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT 158 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence 9999999999888755 45899999999999999999999999999999999999999999999999998754322 23
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHh
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~c 460 (488)
....||+.|+|||++ ....++.++|||||||++|||++|+.||...+..+....+..... ..+..++.++.+++.+|
T Consensus 159 ~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~ 235 (323)
T cd05616 159 KTFCGTPDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEAVAICKGL 235 (323)
T ss_pred ccCCCChhhcCHHHh--cCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCcCCHHHHHHHHHH
Confidence 456799999999997 455689999999999999999999999998887777776665443 56778999999999999
Q ss_pred hhhCCCCCCC-----HHHHHhCccCCC
Q 011326 461 LQVNPNDRPT-----AAQLMEHPFIKR 482 (488)
Q Consensus 461 L~~dP~~Rps-----~~eil~hp~f~~ 482 (488)
|+.||.+|++ ..++++||||+.
T Consensus 236 l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 236 MTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred cccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 9999999997 589999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=355.19 Aligned_cols=247 Identities=27% Similarity=0.428 Sum_probs=211.0
Q ss_pred eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCceEEEEeec
Q 011326 231 ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
+.||+|+||.||+|.+. ++..||+|++...... .......+..|..++..+ +||||+++++++.+++.+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL--QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh--hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence 35999999999999886 6889999999753221 123344566788888765 7999999999999999999999999
Q ss_pred cCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--CcccCCC
Q 011326 309 TKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKG 385 (488)
Q Consensus 309 ~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~g 385 (488)
++|+|...+... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... ......|
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence 999998877544 5899999999999999999999999999999999999999999999999998653222 2334569
Q ss_pred CCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCC
Q 011326 386 TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465 (488)
Q Consensus 386 t~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP 465 (488)
|+.|+|||++ .+..++.++||||||+++|+|++|+.||...+..+....+..... ..+..++.++.+++.+||+.||
T Consensus 159 t~~y~aPE~~--~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~ll~~~L~~dp 235 (321)
T cd05591 159 TPDYIAPEIL--QELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV-LYPVWLSKEAVSILKAFMTKNP 235 (321)
T ss_pred CccccCHHHH--cCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhccCH
Confidence 9999999997 455689999999999999999999999998887777777665543 4566789999999999999999
Q ss_pred CCCC-------CHHHHHhCccCCC
Q 011326 466 NDRP-------TAAQLMEHPFIKR 482 (488)
Q Consensus 466 ~~Rp-------s~~eil~hp~f~~ 482 (488)
++|| ++.++++||||..
T Consensus 236 ~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 236 NKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred HHcCCCCCCCCCHHHHhcCCccCC
Confidence 9999 9999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=361.23 Aligned_cols=253 Identities=39% Similarity=0.663 Sum_probs=230.8
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
.|...++||+|+||.||+|.+. +++.||+|++.... ....++++.+|+.+|.+++++||.+.|+.+..+..++++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~----~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE----AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhh----cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 4666688999999999999985 79999999998753 345667889999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhhcc-ChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--cc
Q 011326 305 LELVTKGSLASLYQKYHL-SDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VK 381 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~~l-s~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~~ 381 (488)
||||.||++.++++..++ ++..+..++++++.|+.|||.++.+|||||+.|||+..+|.+||+|||.+-...... ..
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 999999999999988776 999999999999999999999999999999999999999999999999986655443 35
Q ss_pred cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhh
Q 011326 382 SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCL 461 (488)
Q Consensus 382 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL 461 (488)
+.+|||.|||||++. ..+|+.++||||||++.+||++|.+|+....+...+..|.....|.+...+++.+++++..||
T Consensus 170 tfvGTPfwMAPEVI~--~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIK--QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred cccccccccchhhhc--cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHh
Confidence 788999999999984 667999999999999999999999999999888888888888888888899999999999999
Q ss_pred hhCCCCCCCHHHHHhCccCCCCC
Q 011326 462 QVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 462 ~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
.+||+.||++.++++|+|++.+-
T Consensus 248 ~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 248 DKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred hcCcccCcCHHHHhhhHHHHhcC
Confidence 99999999999999999999844
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=362.78 Aligned_cols=253 Identities=27% Similarity=0.459 Sum_probs=210.3
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||++.+. ++..||+|.+..... ........+.+|+.++++++||||+++++++.+++.+|+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM--FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH--HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence 36899999999999999999875 799999999865322 122345678889999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC---
Q 011326 304 FLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--- 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--- 379 (488)
||||+++|+|.+++... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||+++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 99999999999988654 58999999999999999999999999999999999999999999999999985321100
Q ss_pred ----------------------------------------------cccCCCCCcccCchhhccccCCCChhhhHHHHHH
Q 011326 380 ----------------------------------------------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGC 413 (488)
Q Consensus 380 ----------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGv 413 (488)
.....||+.|+|||++ .+..++.++|||||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGv 236 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF--LQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHH--ccCCCCCceeeEecch
Confidence 0124699999999997 4556899999999999
Q ss_pred HHHHHHcCCCCCCCCchhhhHHHhcCC-CCCCCC--CcccHHHHHHHHHhhhhCCCCC---CCHHHHHhCccCCC
Q 011326 414 TVLEMLTRRHPYSHLEGGQAMFKIGGG-ELPPVP--NSLSRDAQDFILKCLQVNPNDR---PTAAQLMEHPFIKR 482 (488)
Q Consensus 414 lL~eLltG~~Pf~~~~~~~~~~~i~~~-~~~~~~--~~~s~~l~~Li~~cL~~dP~~R---ps~~eil~hp~f~~ 482 (488)
++|||++|..||...+..+....+... .....+ ..++.++.+||.+||+ +|.+| +++.|++.||||+.
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999999887766655554432 112223 3578999999999998 67765 59999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=363.69 Aligned_cols=253 Identities=27% Similarity=0.438 Sum_probs=210.8
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||++.+. ++..||+|.+...... .......+.+|+.+|+.++||||+++++.+.+++.+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL--MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH--hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence 47999999999999999999875 6899999998643211 12234567889999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC----
Q 011326 304 FLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN---- 378 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~---- 378 (488)
||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 79 v~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 99999999999998665 4788999999999999999999999999999999999999999999999987422100
Q ss_pred -----------------------------------------CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHH
Q 011326 379 -----------------------------------------DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLE 417 (488)
Q Consensus 379 -----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~e 417 (488)
......||+.|+|||++ .+..++.++|||||||++||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHH--cCCCCCcceeeeeccceeee
Confidence 01134699999999997 45568999999999999999
Q ss_pred HHcCCCCCCCCchhhhHHHhcCCC---CCCCCCcccHHHHHHHHHhhhhCCCCCC---CHHHHHhCccCCC
Q 011326 418 MLTRRHPYSHLEGGQAMFKIGGGE---LPPVPNSLSRDAQDFILKCLQVNPNDRP---TAAQLMEHPFIKR 482 (488)
Q Consensus 418 LltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~l~~Li~~cL~~dP~~Rp---s~~eil~hp~f~~ 482 (488)
|++|+.||...+..+....+.... ..+....+++++.++|.+|+ .+|.+|+ ++.++++||||+.
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 999999998877665554443221 11223468999999999977 5999999 9999999999985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=355.70 Aligned_cols=256 Identities=32% Similarity=0.540 Sum_probs=212.1
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 300 (488)
....+|+..+.||+|+||.||+|.+. +++.||+|.+.... .......+.+|+.+++.++|+||+++++++.+++.
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 146 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH----EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE 146 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC----cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe
Confidence 34678999999999999999999875 78999999986432 23345678899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--
Q 011326 301 LCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-- 378 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-- 378 (488)
+++||||+++|+|... ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 147 ~~lv~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 147 IQVLLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred EEEEEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999999999998643 23567788899999999999999999999999999999999999999999998765432
Q ss_pred CcccCCCCCcccCchhhcc---ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhh---HHHhcCCCCCCCCCcccHH
Q 011326 379 DVKSCKGTAFWMAPEVVNL---KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQA---MFKIGGGELPPVPNSLSRD 452 (488)
Q Consensus 379 ~~~~~~gt~~y~aPE~~~~---~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~s~~ 452 (488)
......||..|+|||.+.. .+...+.++|||||||++|||++|+.||......+. ...+.....+..+..++.+
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE 303 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence 2235579999999998732 122345689999999999999999999974333222 2222333344556778999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 453 AQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 453 l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
+.+||.+||+.||++|||+.|+++||||.+..
T Consensus 304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 304 FRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 99999999999999999999999999998873
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=336.67 Aligned_cols=254 Identities=44% Similarity=0.789 Sum_probs=216.4
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
+.|++.+.||+|++|.||.+.+. ++..+|+|.+...............+.+|+.++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999875 78999999987654333333445678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCc--
Q 011326 304 FLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-- 380 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-- 380 (488)
+|||+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999999988654 588999999999999999999999999999999999999999999999999865432211
Q ss_pred ---ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhc-CCCCCCCCCcccHHHHHH
Q 011326 381 ---KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIG-GGELPPVPNSLSRDAQDF 456 (488)
Q Consensus 381 ---~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~l~~L 456 (488)
....++..|+|||.+. +..++.++||||+|+++|+|++|+.||...+......... .......+..++.++.++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVIS--GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF 239 (263)
T ss_pred ccccCCCcCccccCcceec--cCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHH
Confidence 2345788999999973 4558899999999999999999999998765554443333 233445677899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHhCccC
Q 011326 457 ILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 457 i~~cL~~dP~~Rps~~eil~hp~f 480 (488)
+.+||..+|.+|||+.++++||||
T Consensus 240 i~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 240 LRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHhhcCcccCCCHHHHhhCCCC
Confidence 999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=356.44 Aligned_cols=255 Identities=29% Similarity=0.417 Sum_probs=216.3
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||++.+. +|..||+|.+..... ........+.+|+.+++.++||||+++++++.+.+..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL--LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence 36899999999999999999885 799999999975432 122345668889999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 304 FLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
||||+++|+|.+++... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999999999998764 58999999999999999999999999999999999999999999999999997654332
Q ss_pred -cccCCCCCcccCchhhccc----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC-C--CCCCcccH
Q 011326 380 -VKSCKGTAFWMAPEVVNLK----KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL-P--PVPNSLSR 451 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~----~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~-~--~~~~~~s~ 451 (488)
.....||+.|+|||++... ...++.++||||||+++|+|++|..||...+.......+..... . +....+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence 2234689999999997421 34578899999999999999999999988776666555543221 1 22235799
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
++.+|+.+||+ +|.+|||+++++.||||++
T Consensus 239 ~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 239 DFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred HHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 99999999998 9999999999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=343.87 Aligned_cols=246 Identities=25% Similarity=0.429 Sum_probs=205.1
Q ss_pred ecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeeccCC
Q 011326 233 LGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKG 311 (488)
Q Consensus 233 LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 311 (488)
||+|+||+||++.+. +|..||+|.+...... .......+..|+.+++.++||||+++.+++..+...++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK--KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh--hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence 699999999999875 7899999998754321 2223456778999999999999999999999999999999999999
Q ss_pred ChHHHHhh-----hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--cccCC
Q 011326 312 SLASLYQK-----YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCK 384 (488)
Q Consensus 312 sL~~~l~~-----~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~ 384 (488)
+|...+.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... .....
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 99877632 348999999999999999999999999999999999999999999999999987554332 23457
Q ss_pred CCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh----hhHHHhcCCCCCCCCCcccHHHHHHHHHh
Q 011326 385 GTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG----QAMFKIGGGELPPVPNSLSRDAQDFILKC 460 (488)
Q Consensus 385 gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~s~~l~~Li~~c 460 (488)
||+.|+|||.+ .+..++.++|+||||+++|+|++|+.||...... .....+... ....+..+++++.+++.+|
T Consensus 159 g~~~y~aPE~~--~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~ 235 (280)
T cd05608 159 GTPGFMAPELL--QGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-SVTYPDKFSPASKSFCEAL 235 (280)
T ss_pred CCcCccCHHHh--cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-CCCCcccCCHHHHHHHHHH
Confidence 89999999997 3456889999999999999999999999764322 222222222 2345667899999999999
Q ss_pred hhhCCCCCC-----CHHHHHhCccCCCC
Q 011326 461 LQVNPNDRP-----TAAQLMEHPFIKRP 483 (488)
Q Consensus 461 L~~dP~~Rp-----s~~eil~hp~f~~~ 483 (488)
|+.||++|| +++++++||||+..
T Consensus 236 l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 236 LAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred hcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 999999999 88999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=351.66 Aligned_cols=248 Identities=27% Similarity=0.456 Sum_probs=212.0
Q ss_pred eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCceEEEEeec
Q 011326 231 ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
+.||+|+||.||++.+. ++..||+|.+...... .......+..|..++..+ +||||+++++++.+.+.+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL--QDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh--hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 36999999999999886 6889999999754321 122345567888888877 6999999999999999999999999
Q ss_pred cCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC--CCcccCCC
Q 011326 309 TKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKG 385 (488)
Q Consensus 309 ~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~--~~~~~~~g 385 (488)
++|+|...+... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... .......|
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence 999999888665 699999999999999999999999999999999999999999999999999864322 22334568
Q ss_pred CCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCC
Q 011326 386 TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465 (488)
Q Consensus 386 t~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP 465 (488)
|+.|+|||++ .+..++.++|+|||||++|+|++|+.||...+..+....+.... ...+..+++++.+||.+||+.||
T Consensus 159 ~~~y~aPE~~--~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dP 235 (318)
T cd05570 159 TPDYIAPEIL--SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE-VRYPRWLSKEAKSILKSFLTKNP 235 (318)
T ss_pred CccccCHHHh--cCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCcCCHHHHHHHHHHccCCH
Confidence 9999999997 45568999999999999999999999998877776666665443 35667889999999999999999
Q ss_pred CCCCCH-----HHHHhCccCCCC
Q 011326 466 NDRPTA-----AQLMEHPFIKRP 483 (488)
Q Consensus 466 ~~Rps~-----~eil~hp~f~~~ 483 (488)
.+||++ .+++.||||+..
T Consensus 236 ~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 236 EKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred HHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999 999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=355.10 Aligned_cols=246 Identities=30% Similarity=0.482 Sum_probs=212.0
Q ss_pred eeecccCceEEEEEEe----cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEe
Q 011326 231 ELLGSGSYGFVYEGLT----DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLE 306 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 306 (488)
+.||+|+||.||++.+ .+|..+|+|++...... ......+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK---VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence 5699999999999875 36899999999754321 1223456789999999999999999999999999999999
Q ss_pred eccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--CcccC
Q 011326 307 LVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSC 383 (488)
Q Consensus 307 ~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~ 383 (488)
|+++|+|.+.+.+. .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... .....
T Consensus 79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 99999999888654 5899999999999999999999999999999999999999999999999998754333 23356
Q ss_pred CCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhh
Q 011326 384 KGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQV 463 (488)
Q Consensus 384 ~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~ 463 (488)
.||+.|+|||.+ ....++.++||||||+++|||++|+.||...+..+....+..... ..+..+++++.+|+.+||+.
T Consensus 159 ~g~~~y~aPE~~--~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~l~~ 235 (318)
T cd05582 159 CGTVEYMAPEVV--NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSLLRALFKR 235 (318)
T ss_pred cCChhhcCHHHH--cCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhhc
Confidence 799999999997 345678999999999999999999999988777776666655443 56778899999999999999
Q ss_pred CCCCCCC-----HHHHHhCccCCC
Q 011326 464 NPNDRPT-----AAQLMEHPFIKR 482 (488)
Q Consensus 464 dP~~Rps-----~~eil~hp~f~~ 482 (488)
||++||+ +.+++.||||+.
T Consensus 236 ~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 236 NPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred CHhHcCCCCCCCHHHHhCCCCcCC
Confidence 9999999 788999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=351.77 Aligned_cols=255 Identities=30% Similarity=0.506 Sum_probs=212.2
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||++.+. ++..+|+|.+.... .......+.+|+.++++++||||+++++++.+++..+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 468999999999999999999886 68899999887532 2334467889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHC-CCccccCCcccEEECCCCcEEEeecCCcccccCCCc
Q 011326 303 IFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV 380 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 380 (488)
+||||+++++|.+++... .+++..+..++.|++.||.|||+. +++|+||||+|||++.++.+||+|||++........
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~ 159 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcc
Confidence 999999999999988654 488899999999999999999975 799999999999999999999999999876544444
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHH------------------------
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFK------------------------ 436 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~------------------------ 436 (488)
....||..|+|||.+ .+..++.++|+|||||++|+|++|+.||......+....
T Consensus 160 ~~~~~~~~y~aPE~~--~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (333)
T cd06650 160 NSFVGTRSYMSPERL--QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP 237 (333)
T ss_pred ccCCCCccccCHHHh--cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence 456799999999997 445688999999999999999999999975443222111
Q ss_pred --------------------hcCCCCCCCC-CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 437 --------------------IGGGELPPVP-NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 437 --------------------i~~~~~~~~~-~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
+.....+..+ ...+.++.+|+.+||++||++|||+.|++.||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 1111111111 13578899999999999999999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=359.30 Aligned_cols=260 Identities=25% Similarity=0.372 Sum_probs=217.8
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
+...++|++.+.||+|+||.||++.+. ++..+|+|.+...... .......+.+|+.+++.++||||+++++++.+++
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~--~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI--KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh--hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 345679999999999999999999886 7899999998653221 1223345778999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 300 RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
..++||||+++|+|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999997654322
Q ss_pred ---cccCCCCCcccCchhhcccc--CCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC-C--CCCCcccH
Q 011326 380 ---VKSCKGTAFWMAPEVVNLKK--DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL-P--PVPNSLSR 451 (488)
Q Consensus 380 ---~~~~~gt~~y~aPE~~~~~~--~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~-~--~~~~~~s~ 451 (488)
.....||+.|+|||++.... ..++.++|||||||++|||++|..||...+.......+..... . +....++.
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 276 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCH
Confidence 23566999999999984322 2378999999999999999999999998777666666554321 1 22346899
Q ss_pred HHHHHHHHhhhhCCCC--CCCHHHHHhCccCCC
Q 011326 452 DAQDFILKCLQVNPND--RPTAAQLMEHPFIKR 482 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~--Rps~~eil~hp~f~~ 482 (488)
+++++|.+||+.++.+ |++++++++||||+.
T Consensus 277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 277 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred HHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 9999999999844433 789999999999976
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=353.69 Aligned_cols=249 Identities=28% Similarity=0.478 Sum_probs=206.0
Q ss_pred eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCceEEEEeec
Q 011326 231 ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
+.||+|+||.||++.+. ++..||+|.+.+.... .......+.+|+.++.++ +||||+++++++.+++..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc--chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence 36999999999999875 6889999999864321 223445677888888776 8999999999999999999999999
Q ss_pred cCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC--CCcccCCC
Q 011326 309 TKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKG 385 (488)
Q Consensus 309 ~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~--~~~~~~~g 385 (488)
++|+|..++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.... .......|
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence 99999887754 4699999999999999999999999999999999999999999999999999864322 22334679
Q ss_pred CCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCc--------hhhhHHHhcCCCCCCCCCcccHHHHHHH
Q 011326 386 TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE--------GGQAMFKIGGGELPPVPNSLSRDAQDFI 457 (488)
Q Consensus 386 t~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~--------~~~~~~~i~~~~~~~~~~~~s~~l~~Li 457 (488)
|+.|+|||++ .+..++.++|+||||+++|+|++|+.||.... ...............+|..++.++.+||
T Consensus 159 t~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll 236 (329)
T cd05618 159 TPNYIAPEIL--RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 236 (329)
T ss_pred CccccCHHHH--cCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 9999999997 45568899999999999999999999995311 1112222222333457788999999999
Q ss_pred HHhhhhCCCCCCC------HHHHHhCccCCCC
Q 011326 458 LKCLQVNPNDRPT------AAQLMEHPFIKRP 483 (488)
Q Consensus 458 ~~cL~~dP~~Rps------~~eil~hp~f~~~ 483 (488)
.+||+.||.+||+ +.++++||||+..
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 237 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 9999999999998 6899999999763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=338.15 Aligned_cols=261 Identities=28% Similarity=0.465 Sum_probs=228.0
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcc---hhHHHHHHHHHHHHhcC-CCCCcceeeccccCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRG---KQSILQLEQEISLLGQF-EHDNIVQYLGTDRDE 298 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 298 (488)
...|+..+.||.|..++|-++..+ +|..+|+|++......... ....+.-.+|+.||+++ .||||+.+.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 456777788999999999998765 8999999999876544332 23445667899999998 699999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 299 KRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
..+++|+|.|+.|.|.+++... .+++.....|++|+++|++|||..+|+||||||+|||++++.+++|+|||+|..+..
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 9999999999999999999765 599999999999999999999999999999999999999999999999999988776
Q ss_pred CC-cccCCCCCcccCchhhc----cccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC---CCCCcc
Q 011326 378 ND-VKSCKGTAFWMAPEVVN----LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP---PVPNSL 449 (488)
Q Consensus 378 ~~-~~~~~gt~~y~aPE~~~----~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~ 449 (488)
.. .+..+|||+|+|||.+. ....+|+..+|+|++|++||-|+.|.+||.....--++..|..+.+. +...++
T Consensus 176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadi 255 (411)
T KOG0599|consen 176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADI 255 (411)
T ss_pred chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhc
Confidence 54 67889999999999973 24556899999999999999999999999887777777777777663 445678
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
+...++||.+||+.||.+|.|++|+|.||||.+.+
T Consensus 256 s~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 256 SATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred cccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 99999999999999999999999999999995443
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=351.10 Aligned_cols=248 Identities=26% Similarity=0.449 Sum_probs=208.8
Q ss_pred eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhc-CCCCCcceeeccccCCCceEEEEeec
Q 011326 231 ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQ-FEHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
+.||+|+||.||+|.+. +|..||+|.+...... .......+..|..++.. .+||||+++++++.+++..|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL--IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence 46999999999999886 6899999999754221 11223445667777765 48999999999999999999999999
Q ss_pred cCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc--CCCcccCCC
Q 011326 309 TKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDVKSCKG 385 (488)
Q Consensus 309 ~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~--~~~~~~~~g 385 (488)
++|+|..++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||+++... ........|
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCC
Confidence 999998888654 68999999999999999999999999999999999999999999999999986432 222345679
Q ss_pred CCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCC
Q 011326 386 TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465 (488)
Q Consensus 386 t~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP 465 (488)
|+.|+|||++ .+..++.++||||+|+++|||++|..||...+..+....+... .+..+..++.++.+|+.+||+.||
T Consensus 159 t~~y~aPE~~--~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP 235 (316)
T cd05620 159 TPDYIAPEIL--QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-TPHYPRWITKESKDILEKLFERDP 235 (316)
T ss_pred CcCccCHHHH--cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHHccCCH
Confidence 9999999997 4556899999999999999999999999887766666555433 345677789999999999999999
Q ss_pred CCCCCH-HHHHhCccCCCC
Q 011326 466 NDRPTA-AQLMEHPFIKRP 483 (488)
Q Consensus 466 ~~Rps~-~eil~hp~f~~~ 483 (488)
++||++ +++++||||+..
T Consensus 236 ~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 236 TRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred HHcCCChHHHHcCCCcCCC
Confidence 999997 589999999774
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=350.66 Aligned_cols=248 Identities=27% Similarity=0.478 Sum_probs=208.2
Q ss_pred eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhc-CCCCCcceeeccccCCCceEEEEeec
Q 011326 231 ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQ-FEHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
+.||+|+||.||+|.+. ++..||+|.+...... .......+..|..++.. .+||||+++++++..++..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL--EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 36999999999999875 6889999999754321 11223344556666664 48999999999999999999999999
Q ss_pred cCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--CcccCCC
Q 011326 309 TKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKG 385 (488)
Q Consensus 309 ~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~g 385 (488)
++|+|..++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..... ......|
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence 999999888654 5899999999999999999999999999999999999999999999999998754322 2334569
Q ss_pred CCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCC
Q 011326 386 TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465 (488)
Q Consensus 386 t~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP 465 (488)
|+.|+|||.+ .+..++.++|||||||++|||++|..||.+.+..+....+.. ..+..+..++.++.+|+.+||+.||
T Consensus 159 t~~y~aPE~~--~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~ll~~~l~~~P 235 (316)
T cd05592 159 TPDYIAPEIL--KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-DRPHFPRWISKEAKDCLSKLFERDP 235 (316)
T ss_pred CccccCHHHH--cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCHHHHHHHHHHccCCH
Confidence 9999999997 445688999999999999999999999998877776666554 3456777899999999999999999
Q ss_pred CCCCCH-HHHHhCccCCCC
Q 011326 466 NDRPTA-AQLMEHPFIKRP 483 (488)
Q Consensus 466 ~~Rps~-~eil~hp~f~~~ 483 (488)
.+||++ .++++||||++.
T Consensus 236 ~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 236 TKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred HHcCCChHHHHcCcccCCC
Confidence 999986 589999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=343.06 Aligned_cols=253 Identities=25% Similarity=0.433 Sum_probs=212.6
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
.|++.+.||+|+||.||++.+. ++..||+|.+...... .......+.+|+.+++.++||||+++++.+.+++..++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh--hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 3788999999999999999875 7899999999754321 122334567899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhh---hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-c
Q 011326 305 LELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-V 380 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~---~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~ 380 (488)
|||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI 158 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence 999999999887743 248999999999999999999999999999999999999999999999999987654332 2
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHh---cCCCCCCCCCcccHHHHHHH
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKI---GGGELPPVPNSLSRDAQDFI 457 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i---~~~~~~~~~~~~s~~l~~Li 457 (488)
....|++.|+|||.+ .+..++.++|+||+|+++|||++|..||.+.+.......+ ........+..++..+.+|+
T Consensus 159 ~~~~~~~~y~aPE~~--~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 159 RGRVGTVGYMAPEVV--KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred ccccCCCCccCcHHh--cCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 345689999999997 4456889999999999999999999999876543322211 22233345667899999999
Q ss_pred HHhhhhCCCCCC-----CHHHHHhCccCCC
Q 011326 458 LKCLQVNPNDRP-----TAAQLMEHPFIKR 482 (488)
Q Consensus 458 ~~cL~~dP~~Rp-----s~~eil~hp~f~~ 482 (488)
.+||+.||.+|| +++++++||||.+
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 8999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=358.53 Aligned_cols=253 Identities=27% Similarity=0.451 Sum_probs=212.1
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||++.+. ++..||+|.+..... ........+.+|+.++..++||||+++++.+.+++.+++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM--LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 36889999999999999999885 689999999975322 122344577889999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC---
Q 011326 304 FLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--- 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--- 379 (488)
||||+++|+|.+++.+ ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 9999999999998865 468999999999999999999999999999999999999999999999999986432110
Q ss_pred ----------------------------------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCC
Q 011326 380 ----------------------------------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY 425 (488)
Q Consensus 380 ----------------------------------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf 425 (488)
.....||+.|+|||++ .+..++.++|||||||++|||++|+.||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~--~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVF--MQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHH--cCCCCCCcceeccccceeeecccCCCCC
Confidence 1134699999999997 4566899999999999999999999999
Q ss_pred CCCchhhhHHHhcCCC-CCCCC--CcccHHHHHHHHHhhhhCCCCCC---CHHHHHhCccCCC
Q 011326 426 SHLEGGQAMFKIGGGE-LPPVP--NSLSRDAQDFILKCLQVNPNDRP---TAAQLMEHPFIKR 482 (488)
Q Consensus 426 ~~~~~~~~~~~i~~~~-~~~~~--~~~s~~l~~Li~~cL~~dP~~Rp---s~~eil~hp~f~~ 482 (488)
...+..+....+.... ....+ ..+++++++||.+|+. ||.+|+ ++.++++||||+.
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 8877776666554321 11222 2478999999999874 999998 5899999999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=367.23 Aligned_cols=256 Identities=27% Similarity=0.439 Sum_probs=221.8
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC--
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK-- 299 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-- 299 (488)
...+|++.+.||+|+||.||+|.+. +|..||+|.+..... .......+.+|+.++..++|+||++++..+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM---SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC---CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3468999999999999999999875 799999999976542 2344567889999999999999999887764332
Q ss_pred ------ceEEEEeeccCCChHHHHhhh-----ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEee
Q 011326 300 ------RLCIFLELVTKGSLASLYQKY-----HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLAD 368 (488)
Q Consensus 300 ------~~~lV~E~~~~gsL~~~l~~~-----~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~D 368 (488)
.+++||||+++|+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 378999999999999988542 488999999999999999999999999999999999999999999999
Q ss_pred cCCcccccCC----CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC
Q 011326 369 FGLAKATTMN----DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP 444 (488)
Q Consensus 369 FGla~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~ 444 (488)
||+++..... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||...+..+....+..+...+
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~--~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~ 264 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIW--RRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHh--CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 9998754322 12346799999999997 45568999999999999999999999999888877777777777777
Q ss_pred CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 445 VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 445 ~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
.+..+++++.+|+.+||+.||.+||++.++++|||++..
T Consensus 265 ~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 888999999999999999999999999999999998753
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=331.34 Aligned_cols=250 Identities=30% Similarity=0.549 Sum_probs=220.6
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|++.+.||+|++|.||++.+. ++..|++|.+..... .......+.+|+.++++++||||+++++++.+++..+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM---NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC---CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence 4788899999999999999885 789999999875432 234456788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 305 LELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
|||+++++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999998654 58899999999999999999999999999999999999999999999999987654332
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILK 459 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~ 459 (488)
.....|++.|+|||++ ....++.++|+||||+++++|++|+.||...+.......+..+..++.+..++.++.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08529 158 ANTIVGTPYYLSPELC--EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQ 235 (256)
T ss_pred hhccccCccccCHHHh--cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHH
Confidence 2344688999999997 34557899999999999999999999998888777777777777777777899999999999
Q ss_pred hhhhCCCCCCCHHHHHhCccC
Q 011326 460 CLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 460 cL~~dP~~Rps~~eil~hp~f 480 (488)
||+.+|++||++.++++|||+
T Consensus 236 ~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 236 CLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=351.88 Aligned_cols=247 Identities=29% Similarity=0.435 Sum_probs=207.4
Q ss_pred eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHH-HHhcCCCCCcceeeccccCCCceEEEEeec
Q 011326 231 ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEIS-LLGQFEHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
+.||+|+||.||+|.+. +|..||+|.+...... .......+..|.. +++.++||||+++++++.+.+..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL--KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh--hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence 36999999999999985 7999999999754321 1122234445544 567899999999999999999999999999
Q ss_pred cCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--CcccCCC
Q 011326 309 TKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKG 385 (488)
Q Consensus 309 ~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~g 385 (488)
++|+|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......|
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccC
Confidence 999998888654 5899999999999999999999999999999999999999999999999998653222 2334569
Q ss_pred CCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCC
Q 011326 386 TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465 (488)
Q Consensus 386 t~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP 465 (488)
|+.|+|||++ .+..++.++||||||+++|+|++|..||...+..+....+..... ..+..+++++.++|.+||+.||
T Consensus 159 t~~y~aPE~~--~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~~p 235 (323)
T cd05575 159 TPEYLAPEVL--RKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL-RLKPNISVSARHLLEGLLQKDR 235 (323)
T ss_pred ChhhcChhhh--cCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhhcCH
Confidence 9999999997 455689999999999999999999999998777776666655443 4556789999999999999999
Q ss_pred CCCCCH----HHHHhCccCCC
Q 011326 466 NDRPTA----AQLMEHPFIKR 482 (488)
Q Consensus 466 ~~Rps~----~eil~hp~f~~ 482 (488)
.+||++ .++++||||..
T Consensus 236 ~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 236 TKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred HhCCCCCCCHHHHHcCCCcCC
Confidence 999986 69999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=348.97 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=214.6
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCCCceEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~l 303 (488)
+|+..+.||+|+||.||+|.+. +|..||+|.+...... .......+..|..++..+. |++|+++++++.+.+.+|+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI--QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence 4778899999999999999875 7899999998753221 1223455677888888875 5778889999999999999
Q ss_pred EEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--Cc
Q 011326 304 FLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DV 380 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~ 380 (488)
||||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++..... ..
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence 9999999999998865 45899999999999999999999999999999999999999999999999998754322 23
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHh
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~c 460 (488)
....||+.|+|||++ ....++.++|+||+|+++|+|++|..||...+.......+..... ..+..++.++.+++.+|
T Consensus 159 ~~~~gt~~y~aPE~~--~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~ 235 (323)
T cd05615 159 RTFCGTPDYIAPEII--AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-SYPKSLSKEAVSICKGL 235 (323)
T ss_pred cCccCCccccCHHHH--cCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHHH
Confidence 345699999999997 445689999999999999999999999998877776666665443 56778899999999999
Q ss_pred hhhCCCCCCC-----HHHHHhCccCCCC
Q 011326 461 LQVNPNDRPT-----AAQLMEHPFIKRP 483 (488)
Q Consensus 461 L~~dP~~Rps-----~~eil~hp~f~~~ 483 (488)
|+.+|.+|++ ..++++||||+..
T Consensus 236 l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 236 MTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred cccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 9999999997 5799999999863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=349.50 Aligned_cols=248 Identities=27% Similarity=0.478 Sum_probs=209.1
Q ss_pred eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhc-CCCCCcceeeccccCCCceEEEEeec
Q 011326 231 ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQ-FEHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
+.||+|+||.||+|.+. ++..||+|.+...... .......+..|..++.. ++||||+++++++.+.+.+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 36999999999999886 6889999999754211 11223445667777775 58999999999999999999999999
Q ss_pred cCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC--CCcccCCC
Q 011326 309 TKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKG 385 (488)
Q Consensus 309 ~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~--~~~~~~~g 385 (488)
++|+|..++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..... .......|
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecC
Confidence 999999988654 689999999999999999999999999999999999999999999999999864322 22345569
Q ss_pred CCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCC
Q 011326 386 TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465 (488)
Q Consensus 386 t~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP 465 (488)
|+.|+|||++ .+..++.++|+||+||++|||++|..||...+..+....+.... +..+..++.++.+++.+||+.||
T Consensus 159 t~~y~aPE~~--~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~P 235 (316)
T cd05619 159 TPDYIAPEIL--LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-PCYPRWLTREAKDILVKLFVREP 235 (316)
T ss_pred CccccCHHHH--cCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHhccCH
Confidence 9999999997 44568999999999999999999999998877776666655433 34566789999999999999999
Q ss_pred CCCCCHH-HHHhCccCCCC
Q 011326 466 NDRPTAA-QLMEHPFIKRP 483 (488)
Q Consensus 466 ~~Rps~~-eil~hp~f~~~ 483 (488)
.+||++. +++.||||+..
T Consensus 236 ~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 236 ERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred hhcCCChHHHHcCcccCCC
Confidence 9999996 99999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=367.36 Aligned_cols=252 Identities=26% Similarity=0.415 Sum_probs=219.5
Q ss_pred cCceeeeeeecccCceEEEEEEec-C-CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-D-GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~-g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
...|.+.+.||+|+||.||.|... + +..||+|.+... .......+.+|+.+|+.++||||+++++++..++..
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-----DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL 140 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE
Confidence 345999999999999999999874 4 678899876532 223345677899999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhh-----hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 302 CIFLELVTKGSLASLYQK-----YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~-----~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
++||||+++|+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 999999999999887753 248899999999999999999999999999999999999999999999999997654
Q ss_pred CCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHH
Q 011326 377 MND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRD 452 (488)
Q Consensus 377 ~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 452 (488)
... .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||...+..+....+..+...+.+..++.+
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~ 298 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELW--ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSG 298 (478)
T ss_pred CccccccccccCCCccccCHhHh--CCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHH
Confidence 332 2345699999999997 4566899999999999999999999999988777777777777777777889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 453 AQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 453 l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
+.++|.+||+.||++||++.+++.|||++.
T Consensus 299 ~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 299 MKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 999999999999999999999999999864
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=345.51 Aligned_cols=255 Identities=29% Similarity=0.473 Sum_probs=209.0
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
+++|++.+.||+|+||.||+|.+. ++..||+|.+....... ....+.+|+.++++++||||+++++++..++..+
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT 80 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC----cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence 568999999999999999999886 68899999987543221 1235668999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-
Q 011326 303 IFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND- 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~- 379 (488)
+||||+++ +|.+.+... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred EEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 99999986 787776543 37889999999999999999999999999999999999999999999999986543322
Q ss_pred -cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC------------------
Q 011326 380 -VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG------------------ 440 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~------------------ 440 (488)
.....+|+.|+|||.+. ....++.++||||||+++|+|++|+.||...+..+....+...
T Consensus 160 ~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLL-GSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred ccccccccccccCCHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 23456889999999873 3445789999999999999999999999876544332222100
Q ss_pred ---CCC--------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 441 ---ELP--------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 441 ---~~~--------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
..+ .....+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 000 01134788999999999999999999999999999998744
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=359.20 Aligned_cols=256 Identities=32% Similarity=0.581 Sum_probs=234.3
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc-e
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR-L 301 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~-~ 301 (488)
+.+|+.++.+|+|+||.++.+..+ ++..+++|.+........ ......+|+.++++++|||||.+.+.+..++. .
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~---~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l 79 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP---ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLL 79 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch---hhHHHHHHHHHHHhccCCCeeeeccchhcCCceE
Confidence 568999999999999999998875 688999999987764433 23367899999999999999999999999988 9
Q ss_pred EEEEeeccCCChHHHHhhhc---cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 302 CIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~~---ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
+|||+||+||+|.+.+.+.+ ++++.+..|+.|++.|+.|||+++|.|||||+.||+++.++.++|+|||+|+.....
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999999986543 999999999999999999999999999999999999999999999999999988766
Q ss_pred C--cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHH
Q 011326 379 D--VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDF 456 (488)
Q Consensus 379 ~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L 456 (488)
. ..+..||+.|+.||++ .+..|+.++|||||||++|||++-+++|...+....+.++......+++..++.+++.|
T Consensus 160 ~~~a~tvvGTp~YmcPEil--~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEIL--SDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL 237 (426)
T ss_pred hhhhheecCCCcccCHHHh--CCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence 4 5678899999999997 66779999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 457 ILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 457 i~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
|..||+.+|..||++.++|.+|..+..+
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 9999999999999999999999887544
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=363.46 Aligned_cols=250 Identities=26% Similarity=0.433 Sum_probs=201.6
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC----
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD---- 297 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~---- 297 (488)
...+|++++.||+|+||.||+|.+. ++..||||.+.... ....+|+.+++.++||||+++++++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---------QYKNRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---------chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 3467999999999999999999885 68999999885422 123479999999999999999886532
Q ss_pred ----CCceEEEEeeccCCChHHHHh-----hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC-cEEEe
Q 011326 298 ----EKRLCIFLELVTKGSLASLYQ-----KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG-SVKLA 367 (488)
Q Consensus 298 ----~~~~~lV~E~~~~gsL~~~l~-----~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~-~vkL~ 367 (488)
...+++||||+++ +|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 135 ~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred cCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeee
Confidence 2247799999986 6766553 23589999999999999999999999999999999999998665 79999
Q ss_pred ecCCcccccCC-CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC------
Q 011326 368 DFGLAKATTMN-DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG------ 440 (488)
Q Consensus 368 DFGla~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~------ 440 (488)
|||+++..... ......||+.|+|||++. ....++.++|||||||++|||++|.+||.+.+..+....+...
T Consensus 214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 214 DFGSAKNLLAGQRSVSYICSRFYRAPELML-GATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccccchhccCCCCcccCCCCcCccCHHHhc-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99999765433 234567899999999872 3446899999999999999999999999877655443332210
Q ss_pred -------------CCC---------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 441 -------------ELP---------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 441 -------------~~~---------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
..+ .++...++++.+||.+||++||.+|||+.|++.||||+..
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 001 1234578899999999999999999999999999999754
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=336.65 Aligned_cols=260 Identities=27% Similarity=0.459 Sum_probs=230.5
Q ss_pred cccccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecccc
Q 011326 218 GKFRRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR 296 (488)
Q Consensus 218 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 296 (488)
.+-+..+++|..+++||+|.||.|.+++.+ +|+.+|+|++++... ........-+.|-.+|...+||.+..+...|+
T Consensus 161 ~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevi--iakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ 238 (516)
T KOG0690|consen 161 RKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVI--IAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ 238 (516)
T ss_pred ccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhhe--eehHHhhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence 344557899999999999999999999875 899999999987654 33444556678899999999999999999999
Q ss_pred CCCceEEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 297 DEKRLCIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 297 ~~~~~~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
..+++|+||||..||.|.-.+.+ ..+++.....+...|++||.|||+++|++||||.+|+|+|.+|++||+|||+++..
T Consensus 239 t~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 239 TQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred cCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence 99999999999999999877754 46999999999999999999999999999999999999999999999999999753
Q ss_pred cC--CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHH
Q 011326 376 TM--NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDA 453 (488)
Q Consensus 376 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l 453 (488)
-. ....+.+|||.|+|||++ ....|+.++|+|.+|+++|||++|+.||.+.+.+.....|..... .+|..+++++
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVl--eDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~-kFPr~ls~eA 395 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVL--EDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL-KFPRTLSPEA 395 (516)
T ss_pred ccccceeccccCChhhcCchhh--ccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc-cCCccCCHHH
Confidence 32 235688999999999997 567799999999999999999999999999888888777776665 6789999999
Q ss_pred HHHHHHhhhhCCCCCCC-----HHHHHhCccCCC
Q 011326 454 QDFILKCLQVNPNDRPT-----AAQLMEHPFIKR 482 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps-----~~eil~hp~f~~ 482 (488)
+.|+..+|.+||.+|.. +.||..|+||..
T Consensus 396 ktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 396 KTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred HHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 99999999999999954 899999999975
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=349.69 Aligned_cols=251 Identities=26% Similarity=0.454 Sum_probs=205.0
Q ss_pred cccccCceeeeeeecccCceEEEEEEe------cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceee
Q 011326 220 FRRRITSWQKGELLGSGSYGFVYEGLT------DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYL 292 (488)
Q Consensus 220 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~ 292 (488)
|+...++|++.+.||+|+||.||+|.+ .++..||+|.+.... .......+.+|+.++.++ +||||++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~ 77 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA----TASEHKALMSELKILIHIGNHLNVVNLL 77 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc----chHHHHHHHHHHHHHHHhccCcceeeEE
Confidence 344556899999999999999999974 245789999986432 223445788999999999 899999999
Q ss_pred ccccCC-CceEEEEeeccCCChHHHHhhh---------------------------------------------------
Q 011326 293 GTDRDE-KRLCIFLELVTKGSLASLYQKY--------------------------------------------------- 320 (488)
Q Consensus 293 ~~~~~~-~~~~lV~E~~~~gsL~~~l~~~--------------------------------------------------- 320 (488)
+++... ..++++|||+++|+|.+++...
T Consensus 78 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (338)
T cd05102 78 GACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGST 157 (338)
T ss_pred eEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccc
Confidence 987654 4689999999999999888542
Q ss_pred ------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC----cccCC
Q 011326 321 ------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCK 384 (488)
Q Consensus 321 ------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~ 384 (488)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus 158 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 237 (338)
T cd05102 158 NPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237 (338)
T ss_pred ccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCC
Confidence 26677888999999999999999999999999999999999999999999997543221 12334
Q ss_pred CCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhh-hHHHhcCCCCCCCCCcccHHHHHHHHHhhh
Q 011326 385 GTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQ-AMFKIGGGELPPVPNSLSRDAQDFILKCLQ 462 (488)
Q Consensus 385 gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~ 462 (488)
++..|+|||++ ....++.++||||||+++|||++ |..||......+ ....+..+.....+..+++++.+|+.+||+
T Consensus 238 ~~~~y~aPE~~--~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 315 (338)
T cd05102 238 LPLKWMAPESI--FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQ 315 (338)
T ss_pred CCccccCcHHh--hcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 56789999987 44568999999999999999997 999998755433 333444444455667889999999999999
Q ss_pred hCCCCCCCHHHHHh
Q 011326 463 VNPNDRPTAAQLME 476 (488)
Q Consensus 463 ~dP~~Rps~~eil~ 476 (488)
.||.+|||+.|+++
T Consensus 316 ~dp~~RPs~~el~~ 329 (338)
T cd05102 316 GDPKERPTFSALVE 329 (338)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=333.67 Aligned_cols=253 Identities=48% Similarity=0.860 Sum_probs=217.6
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCc----chhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPR----GKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~----~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 300 (488)
+|.+++.||+|++|.||+|.+. ++..+|+|.+........ .......+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4678889999999999999875 688999999876543222 22334678899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 301 LCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
.+++|||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999998664 58899999999999999999999999999999999999999999999999987554211
Q ss_pred --------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccH
Q 011326 380 --------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSR 451 (488)
Q Consensus 380 --------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 451 (488)
.....|+..|+|||.+ .+..++.++|+||+|+++|+|++|+.||...+.......+.....+..+..++.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVV--KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISS 238 (267)
T ss_pred ccCCccccccccCCCcCccChhHh--ccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCH
Confidence 1234578899999987 345678899999999999999999999988776666666655556677788999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
++.++|.+||+.||.+||++.++++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 239 EAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 99999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=354.47 Aligned_cols=253 Identities=28% Similarity=0.473 Sum_probs=207.2
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC-----
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK----- 299 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----- 299 (488)
+|++.+.||+|+||.||++.+. +|..||+|.+.... ........+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 77 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF---QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE 77 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc---cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence 4778899999999999999875 79999999986432 12234467889999999999999999999988776
Q ss_pred ceEEEEeeccCCChHHHHh-hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 300 RLCIFLELVTKGSLASLYQ-KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~-~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
..|+||||+.+ +|.+.+. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 78 EIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred eEEEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 78999999975 6776664 446899999999999999999999999999999999999999999999999998754332
Q ss_pred C---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC----------------
Q 011326 379 D---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG---------------- 439 (488)
Q Consensus 379 ~---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~---------------- 439 (488)
. .....+|+.|+|||.+. ....++.++||||+||++|||++|+.||.+.+..+....+..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILM-GSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHc-CCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 2 23456889999999873 334578999999999999999999999987665443332211
Q ss_pred --------CCCC-------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 440 --------GELP-------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 440 --------~~~~-------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
...+ ......++++.+||.+||+.||.+|||+.|+++||||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 0000 1223468899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=350.63 Aligned_cols=253 Identities=27% Similarity=0.451 Sum_probs=204.5
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC--
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK-- 299 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-- 299 (488)
...+|++.+.||+|+||.||++.+. +|..||+|.+..... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ---NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc---chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 4678999999999999999999885 689999999865432 2233456778999999999999999999876443
Q ss_pred ----ceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 300 ----RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 300 ----~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
..|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 57999999987 5655553 35889999999999999999999999999999999999999999999999998754
Q ss_pred cCC-CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC---------------
Q 011326 376 TMN-DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG--------------- 439 (488)
Q Consensus 376 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~--------------- 439 (488)
... ......||+.|+|||.+ .+..++.++||||||+++|+|++|+.||.+.+..+....+..
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred ccCccCCCCcccCCCCCchhc--cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 332 23456789999999997 455688999999999999999999999987654332211100
Q ss_pred ---------CCCC-----------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 440 ---------GELP-----------------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 440 ---------~~~~-----------------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
...+ ......++++.+||.+||+.||++|||+.|+++||||+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 0000 011234678999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=349.18 Aligned_cols=249 Identities=26% Similarity=0.449 Sum_probs=207.7
Q ss_pred eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCceEEEEeec
Q 011326 231 ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
+.||+|+||.||++.+. ++..||+|++..... ........+.+|+.++.++ +||||+++++++.+.+.+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV--HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence 36999999999999875 688999999975432 1223445678899998888 6999999999999999999999999
Q ss_pred cCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC--CCcccCCC
Q 011326 309 TKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKG 385 (488)
Q Consensus 309 ~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~--~~~~~~~g 385 (488)
++|+|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......|
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence 99999887754 4699999999999999999999999999999999999999999999999999864322 22345679
Q ss_pred CCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCc------hhhhHHHhcCCCCCCCCCcccHHHHHHHHH
Q 011326 386 TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE------GGQAMFKIGGGELPPVPNSLSRDAQDFILK 459 (488)
Q Consensus 386 t~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~------~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~ 459 (488)
|+.|+|||++ .+..++.++|+||||+++|+|++|..||.... ..+.............|..++..+.+++.+
T Consensus 159 t~~y~aPE~~--~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 159 TPNYIAPEIL--RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKG 236 (327)
T ss_pred CcccCCHHHH--CCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999997 45668999999999999999999999996422 222223333333345777899999999999
Q ss_pred hhhhCCCCCCC------HHHHHhCccCCCC
Q 011326 460 CLQVNPNDRPT------AAQLMEHPFIKRP 483 (488)
Q Consensus 460 cL~~dP~~Rps------~~eil~hp~f~~~ 483 (488)
||+.||.+|++ ++++++||||+..
T Consensus 237 ~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 237 FLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 99999999987 6799999999863
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=328.76 Aligned_cols=250 Identities=30% Similarity=0.565 Sum_probs=215.3
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC-CCceEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD-EKRLCI 303 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~~l 303 (488)
+|++.+.||.|++|.||.+.+. ++..+|+|.+..... .......+.+|+.++++++|+|++++++.+.. +..+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA---SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc---CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence 4889999999999999999875 688999999875432 23344567889999999999999999988764 446899
Q ss_pred EEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--
Q 011326 304 FLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-- 378 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-- 378 (488)
+|||+++++|.+++... .+++.++..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999999988653 4899999999999999999999999999999999999999999999999998755432
Q ss_pred CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHH
Q 011326 379 DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFIL 458 (488)
Q Consensus 379 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~ 458 (488)
......+++.|+|||.+ ....++.++|+||+|+++++|++|+.||...+.......+..+..+..+...++++.+++.
T Consensus 158 ~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd08223 158 MASTLIGTPYYMSPELF--SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIA 235 (257)
T ss_pred ccccccCCcCccChhHh--cCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHH
Confidence 22345688999999997 4456788999999999999999999999877766666666666666677789999999999
Q ss_pred HhhhhCCCCCCCHHHHHhCccC
Q 011326 459 KCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 459 ~cL~~dP~~Rps~~eil~hp~f 480 (488)
+||+.||++||++.++++||||
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 236 TMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=328.91 Aligned_cols=254 Identities=64% Similarity=1.059 Sum_probs=219.2
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|+..+.||+|++|.||+|.+. ++..|++|.+...............+.+|+.+++.++|+||+++++++.++...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999986 799999999987554434455667889999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhhc-cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-ccc
Q 011326 305 LELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VKS 382 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~~-ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~ 382 (488)
|||+++++|.+++.... +++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+....... ...
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 160 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS 160 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence 99999999999987655 8999999999999999999999999999999999999999999999999987654333 345
Q ss_pred CCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC-CCCCCCCCcccHHHHHHHHHhh
Q 011326 383 CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG-GELPPVPNSLSRDAQDFILKCL 461 (488)
Q Consensus 383 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l~~Li~~cL 461 (488)
..|+..|++||.+.. ...++.++|+||||+++|+|++|+.||...........+.. ...+..+..+++++.+++.+||
T Consensus 161 ~~~~~~y~~pe~~~~-~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 239 (258)
T cd06632 161 FKGSPYWMAPEVIAQ-QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL 239 (258)
T ss_pred cCCCcceeCHHHhcC-CCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHh
Confidence 668899999999732 22378999999999999999999999977665554444443 4455667788999999999999
Q ss_pred hhCCCCCCCHHHHHhCccC
Q 011326 462 QVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 462 ~~dP~~Rps~~eil~hp~f 480 (488)
+.+|.+||++.+++.|||+
T Consensus 240 ~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 240 QRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred hcCcccCcCHHHHhcCCCC
Confidence 9999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=347.61 Aligned_cols=256 Identities=25% Similarity=0.389 Sum_probs=211.6
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||++... ++..||+|.+.+... ........+.+|+.++..++|+||+++++++.+++.+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM--LKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence 47899999999999999999875 689999999975321 112234567889999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCc-
Q 011326 304 FLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV- 380 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~- 380 (488)
||||+++|+|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999999999999865 3589999999999999999999999999999999999999999999999999865433221
Q ss_pred --ccCCCCCcccCchhhccc---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC----CCCCCCcccH
Q 011326 381 --KSCKGTAFWMAPEVVNLK---KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE----LPPVPNSLSR 451 (488)
Q Consensus 381 --~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~s~ 451 (488)
....||+.|+|||++... ...++.++||||+||++|+|++|+.||...+..+....+.... .+.....+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 234699999999998421 2447889999999999999999999998776666555554321 2233345899
Q ss_pred HHHHHHHHhhhhCCCC--CCCHHHHHhCccCCC
Q 011326 452 DAQDFILKCLQVNPND--RPTAAQLMEHPFIKR 482 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~--Rps~~eil~hp~f~~ 482 (488)
++++++.+||..++.+ |+++.++++||||..
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 9999999988764443 789999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=335.59 Aligned_cols=256 Identities=37% Similarity=0.643 Sum_probs=222.9
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||.|++|.||+|.+. ++..+|+|.+.... .......+.+|+.+++.++|+||+++++++.++...++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE----AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI 76 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc----cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence 36888899999999999999886 68999999987542 12334567899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--Ccc
Q 011326 304 FLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVK 381 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~ 381 (488)
|+||+++++|.+++....+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 77 IMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred EEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence 999999999999998878999999999999999999999999999999999999999999999999998765543 233
Q ss_pred cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCc-ccHHHHHHHHHh
Q 011326 382 SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNS-LSRDAQDFILKC 460 (488)
Q Consensus 382 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~s~~l~~Li~~c 460 (488)
...+++.|+|||.+ .+..++.++||||||+++|+|++|..||...+.......+.....+..+.. +++++.+++.+|
T Consensus 157 ~~~~~~~y~~PE~~--~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 157 TFVGTPFWMAPEVI--KQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred cccCCccccChhhh--ccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHH
Confidence 45688899999997 344489999999999999999999999987776666666555555555555 899999999999
Q ss_pred hhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 461 LQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 461 L~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
|..+|++|||++++++||||++.-+.
T Consensus 235 l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 235 LNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred hhCChhhCcCHHHHhhChhhcCCCcc
Confidence 99999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=336.71 Aligned_cols=250 Identities=35% Similarity=0.560 Sum_probs=207.7
Q ss_pred eeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEE
Q 011326 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFL 305 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 305 (488)
|++++.||+|+||+||++.+. ++..+|+|.+..... .........+|+.++++++||||+++++++.+....+++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI---EEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH---HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc---cccccchhhhhhhccccccccccccccccccccccccccc
Confidence 789999999999999999986 577999999986542 2222233456999999999999999999999999999999
Q ss_pred eeccCCChHHHHh-hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc--cCCCccc
Q 011326 306 ELVTKGSLASLYQ-KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT--TMNDVKS 382 (488)
Q Consensus 306 E~~~~gsL~~~l~-~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~--~~~~~~~ 382 (488)
|++++++|.+++. ...+++..+..++.|+++||++||++|++|+||||+||+++.++.++|+|||.+... .......
T Consensus 78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999997 567999999999999999999999999999999999999999999999999998753 2233456
Q ss_pred CCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhh---hHHHhcCCCCC---CCCCcccHHHHHH
Q 011326 383 CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ---AMFKIGGGELP---PVPNSLSRDAQDF 456 (488)
Q Consensus 383 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~---~~~~i~~~~~~---~~~~~~s~~l~~L 456 (488)
..++..|+|||.+. ....++.++|+||+|+++|+|++|..||...+..+ ........... ......+.++.++
T Consensus 158 ~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQ-QGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDL 236 (260)
T ss_dssp SSSSGGGSCHHHHT-TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred cccccccccccccc-ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHH
Confidence 77899999999973 25668999999999999999999999998773222 22222111110 1111234899999
Q ss_pred HHHhhhhCCCCCCCHHHHHhCccC
Q 011326 457 ILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 457 i~~cL~~dP~~Rps~~eil~hp~f 480 (488)
+.+||+.||++|||+.++++||||
T Consensus 237 i~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 237 IKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHccCChhHCcCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=339.18 Aligned_cols=258 Identities=34% Similarity=0.575 Sum_probs=215.8
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCC-cceeeccccCCC--
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN-IVQYLGTDRDEK-- 299 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~-- 299 (488)
+..|+..+.||+|+||+||+|+.. +|+.||+|.+.......... ....+|+.+|+.++|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P---~taiREisllk~L~~~~~iv~L~dv~~~~~~~ 86 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVP---STAIREISLLKRLSHANHIVRLHDVIHTSNNH 86 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCC---chhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence 556778888999999999999985 79999999998765432211 34568999999999999 999999998877
Q ss_pred ----ceEEEEeeccCCChHHHHhhh-----ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecC
Q 011326 300 ----RLCIFLELVTKGSLASLYQKY-----HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFG 370 (488)
Q Consensus 300 ----~~~lV~E~~~~gsL~~~l~~~-----~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFG 370 (488)
.+++|+||+.. +|..++... +++...++.++.||+.||+|||+++|+||||||+||||+++|.+||+|||
T Consensus 87 ~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 87 RGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred cccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccc
Confidence 89999999987 898888653 47778899999999999999999999999999999999999999999999
Q ss_pred CcccccC--CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC-------C
Q 011326 371 LAKATTM--NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG-------E 441 (488)
Q Consensus 371 la~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~-------~ 441 (488)
+|+.... ...++..+|.+|+|||++ ++...|+...||||+||+++||++++.-|.+....+....|-.. .
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvL-lGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVL-LGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHh-cCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 9986542 346778899999999998 56667999999999999999999999999888776655544210 0
Q ss_pred CC----------CC-----C-------CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 442 LP----------PV-----P-------NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 442 ~~----------~~-----~-------~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
+| ++ + +..+++..+++.+||+.+|.+|.|+..++.||||++.-.+
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence 00 00 0 1234588999999999999999999999999999987544
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=337.01 Aligned_cols=249 Identities=31% Similarity=0.541 Sum_probs=199.4
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC---CCCCcceeeccccC----
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF---EHDNIVQYLGTDRD---- 297 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~---- 297 (488)
+|++.+.||+|+||.||+|.+. ++..||+|.+.......... ..+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~---~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLP---LSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCc---hHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence 5889999999999999999886 78999999987643222111 2344566666554 79999999998754
Q ss_pred -CCceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 298 -EKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 298 -~~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
....+++|||+++ +|..++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus 78 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 78 RETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred CCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 3458999999986 888877543 48999999999999999999999999999999999999999999999999987
Q ss_pred cccCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC------------
Q 011326 374 ATTMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG------------ 440 (488)
Q Consensus 374 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~------------ 440 (488)
...... .....||..|+|||++ .+..++.++||||+||++|+|++|.+||...+..+....+...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCcccCCCccccccccCchHh--hCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 654332 3345689999999997 4456899999999999999999999999776554433332110
Q ss_pred ------CCC--------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 441 ------ELP--------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 441 ------~~~--------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
... .....+++++.+|+.+||++||++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 000 1123567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=332.02 Aligned_cols=253 Identities=45% Similarity=0.825 Sum_probs=214.7
Q ss_pred ceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCC-CcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEG-PRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|++++.||+|+||.||+|...++..+|+|.+...... .........+.+|+.++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47888999999999999998888999999998754322 12233446788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC------
Q 011326 305 LELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM------ 377 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~------ 377 (488)
|||+++++|.+++.+ ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT 160 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccc
Confidence 999999999999866 4589999999999999999999999999999999999999999999999998864321
Q ss_pred --CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC--CCCCCCCCcccHHH
Q 011326 378 --NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG--GELPPVPNSLSRDA 453 (488)
Q Consensus 378 --~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~s~~l 453 (488)
.......|+..|+|||.+ ....++.++|+||||+++|+|++|..||...+.......+.. ...+..+..++.++
T Consensus 161 ~~~~~~~~~~~~~~~~pe~~--~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 161 HSNMLKSMHGTPYWMAPEVI--NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred ccccccccCCCccccChhhh--cCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 112345688999999997 445578999999999999999999999987665544333322 23455677889999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 454 QDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
.+++.+||+.+|.+||++.++++||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=352.06 Aligned_cols=248 Identities=30% Similarity=0.452 Sum_probs=206.7
Q ss_pred ecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC---CCCCcceeeccccCCCceEEEEeec
Q 011326 233 LGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF---EHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 233 LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
||+|+||.||+|.+. ++..||+|++...... ..........|..++... +||||+.+++++.+.+..++||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV--AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh--hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence 699999999999885 6999999998753221 122233455566666655 6999999999999999999999999
Q ss_pred cCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--CcccCCC
Q 011326 309 TKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKG 385 (488)
Q Consensus 309 ~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~g 385 (488)
++|+|...+... .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++...... ......|
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g 158 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCG 158 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccC
Confidence 999998887554 5899999999999999999999999999999999999999999999999998653222 2345679
Q ss_pred CCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCC
Q 011326 386 TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465 (488)
Q Consensus 386 t~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP 465 (488)
|+.|+|||++. ....++.++|||||||++|+|++|..||...+..+....+..+........+++++.+|+.+||+.||
T Consensus 159 t~~y~aPE~~~-~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P 237 (330)
T cd05586 159 TTEYLAPEVLL-DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237 (330)
T ss_pred CccccCHHHHc-CCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCH
Confidence 99999999873 33457899999999999999999999998877777666666555433334579999999999999999
Q ss_pred CCCC----CHHHHHhCccCCCC
Q 011326 466 NDRP----TAAQLMEHPFIKRP 483 (488)
Q Consensus 466 ~~Rp----s~~eil~hp~f~~~ 483 (488)
.+|| ++.++++||||+..
T Consensus 238 ~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 238 QHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred HHCCCCCCCHHHHhcCccccCC
Confidence 9998 79999999999753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=349.17 Aligned_cols=256 Identities=26% Similarity=0.413 Sum_probs=208.5
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC----
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE---- 298 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~---- 298 (488)
.++|++.+.||+|+||.||+|.+. ++..||+|.+..... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ---SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh---hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 467999999999999999999875 788999999865321 122345677899999999999999999987543
Q ss_pred --CceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 299 --KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 299 --~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
...++++|++ +++|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 3578999988 6799998887789999999999999999999999999999999999999999999999999997654
Q ss_pred CCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC----------------
Q 011326 377 MNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG---------------- 440 (488)
Q Consensus 377 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~---------------- 440 (488)
. ......||+.|+|||++. ....++.++|||||||++|+|++|+.||...+..+....+...
T Consensus 170 ~-~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 170 D-EMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred C-CcCCccccccccCchHhc-CCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence 3 334567899999999973 3346889999999999999999999999765543332222110
Q ss_pred ------CCCC--------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 441 ------ELPP--------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 441 ------~~~~--------~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
..+. .....++.+.+|+.+||+.||.+|||+.|+++||||.+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 0000 11235677899999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=338.48 Aligned_cols=253 Identities=26% Similarity=0.446 Sum_probs=211.0
Q ss_pred eeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEE
Q 011326 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFL 305 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 305 (488)
|+..+.||+|+||.||++.+. +++.||+|.+...... .......+.+|+.++++++|+||+++++.+.+++..++||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc--chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 677889999999999999885 7899999998754322 2223345678999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-cc
Q 011326 306 ELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VK 381 (488)
Q Consensus 306 E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~ 381 (488)
||+++++|.+++... ++++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 159 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcccc
Confidence 999999999887533 48999999999999999999999999999999999999999999999999986544322 23
Q ss_pred cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh---hhHHHhcCCCCCCCCCcccHHHHHHHH
Q 011326 382 SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG---QAMFKIGGGELPPVPNSLSRDAQDFIL 458 (488)
Q Consensus 382 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~s~~l~~Li~ 458 (488)
...|+..|+|||.+ .+..++.++|+||+|+++|+|++|+.||...... +.............+..+++++.+|+.
T Consensus 160 ~~~g~~~y~aPE~~--~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05630 160 GRVGTVGYMAPEVV--KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCK 237 (285)
T ss_pred CCCCCccccChHHH--cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHH
Confidence 45789999999997 4456899999999999999999999999764432 122222222223455678999999999
Q ss_pred HhhhhCCCCCCC-----HHHHHhCccCCCC
Q 011326 459 KCLQVNPNDRPT-----AAQLMEHPFIKRP 483 (488)
Q Consensus 459 ~cL~~dP~~Rps-----~~eil~hp~f~~~ 483 (488)
+||+.||++||| ++|+++||||++.
T Consensus 238 ~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 238 MLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 999999999999 9999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=349.12 Aligned_cols=247 Identities=29% Similarity=0.426 Sum_probs=207.0
Q ss_pred eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHH-HHhcCCCCCcceeeccccCCCceEEEEeec
Q 011326 231 ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEIS-LLGQFEHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
+.||+|+||.||+|.+. +|..+|+|++...... .......+..|.. +++.++||||+++++++..++..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL--NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence 35999999999999875 7999999999754221 1222334455554 467799999999999999999999999999
Q ss_pred cCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC--CCcccCCC
Q 011326 309 TKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKG 385 (488)
Q Consensus 309 ~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~--~~~~~~~g 385 (488)
++|+|...+... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.... .......|
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccC
Confidence 999998877554 589999999999999999999999999999999999999999999999999864322 22345679
Q ss_pred CCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCC
Q 011326 386 TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465 (488)
Q Consensus 386 t~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP 465 (488)
|+.|+|||++ .+..++.++|||||||++|+|++|..||...+..+....+..... ..+...+.++.+++.+||+.+|
T Consensus 159 t~~y~aPE~~--~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~ll~~~p 235 (325)
T cd05604 159 TPEYLAPEVI--RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL-VLRPGASLTAWSILEELLEKDR 235 (325)
T ss_pred ChhhCCHHHH--cCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc-cCCCCCCHHHHHHHHHHhccCH
Confidence 9999999997 455688999999999999999999999988777776666655443 3455689999999999999999
Q ss_pred CCCCCH----HHHHhCccCCC
Q 011326 466 NDRPTA----AQLMEHPFIKR 482 (488)
Q Consensus 466 ~~Rps~----~eil~hp~f~~ 482 (488)
.+||++ .++++||||..
T Consensus 236 ~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 236 QRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred HhcCCCCCCHHHHhcCCCcCC
Confidence 999875 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=339.17 Aligned_cols=257 Identities=33% Similarity=0.584 Sum_probs=218.1
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
..+|++.+.||+|+||.||++.+. ++..||+|.+..... .....+.+|+.+++.++||||+++++++..++..+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence 467999999999999999999874 799999999875432 12355788999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--c
Q 011326 303 IFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--V 380 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~ 380 (488)
+||||+++++|.+++.+..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....... .
T Consensus 93 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 172 (297)
T cd06656 93 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (297)
T ss_pred EeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999986544332 2
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC--CCCCcccHHHHHHHH
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP--PVPNSLSRDAQDFIL 458 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~Li~ 458 (488)
....+++.|+|||.+ .+..++.++|+||||+++|+|++|..||...+.......+.....+ ..+..++..+.+++.
T Consensus 173 ~~~~~~~~y~aPE~~--~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (297)
T cd06656 173 STMVGTPYWMAPEVV--TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN 250 (297)
T ss_pred CcccCCccccCHHHH--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence 345688999999997 4456789999999999999999999999776554433322222222 234567889999999
Q ss_pred HhhhhCCCCCCCHHHHHhCccCCCCCCCC
Q 011326 459 KCLQVNPNDRPTAAQLMEHPFIKRPLQTS 487 (488)
Q Consensus 459 ~cL~~dP~~Rps~~eil~hp~f~~~~~~~ 487 (488)
+||+.+|++||++.++++||||+.+.+.+
T Consensus 251 ~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 279 (297)
T cd06656 251 RCLEMDVDRRGSAKELLQHPFLKLAKPLS 279 (297)
T ss_pred HHccCChhhCcCHHHHhcCchhccccccc
Confidence 99999999999999999999998776543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=348.65 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=206.0
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC---
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE--- 298 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--- 298 (488)
..++|++.+.||+|+||.||++.+. ++..||||.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc---CchhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence 3678999999999999999999885 688999999875432 223345677899999999999999999987543
Q ss_pred ---CceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 299 ---KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 299 ---~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
...|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 99 ~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 99 EEFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred cccCeEEEEEeCCCC-CHHHHHH-hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 357999999976 6766664 35888999999999999999999999999999999999999999999999999765
Q ss_pred cCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC------------
Q 011326 376 TMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL------------ 442 (488)
Q Consensus 376 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~------------ 442 (488)
.... .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred CCCCcccCCcccCCcCCHHHH--hCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 4332 3456789999999997 455689999999999999999999999987665544333221100
Q ss_pred ---------C--------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 443 ---------P--------------------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 443 ---------~--------------------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
+ ......+.++++||.+||+.||.+|||+.|+++||||..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0 001123567899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=337.96 Aligned_cols=257 Identities=29% Similarity=0.479 Sum_probs=210.5
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
.+++|++.+.||+|+||.||+|.+. ++..||+|.+....... ....+.+|+.+++.++||||+++++++..++..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 79 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIIHTEKSL 79 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC----chhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence 4678999999999999999999886 68999999987543221 123566899999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 302 CIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
++||||+++ +|..++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 80 TLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred EEEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 999999985 888877543 48899999999999999999999999999999999999999999999999986543222
Q ss_pred --cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC------------------
Q 011326 380 --VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG------------------ 439 (488)
Q Consensus 380 --~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~------------------ 439 (488)
.....+++.|+|||.+. ....++.++||||||+++|+|++|+.||...+..+....+..
T Consensus 159 ~~~~~~~~~~~y~~PE~~~-~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILL-GSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CcccccceeecccCcHHHh-CCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 23445788999999873 344578899999999999999999999987655433222110
Q ss_pred ---CCCC--------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 440 ---GELP--------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 440 ---~~~~--------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
...+ .....+++++.+||.+||+.||.+|||+.|+++||||+..-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 0001 012357889999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=336.23 Aligned_cols=256 Identities=35% Similarity=0.567 Sum_probs=217.4
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||++.+. ++..||+|.+.... .......+.+|+.++++++||||+++++.+..++..++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL----DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM 76 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence 36888999999999999999886 79999999986432 22334678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh----ccChhhhhHHHHHHHHHHHHHHH-CCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 304 FLELVTKGSLASLYQKY----HLSDSQVSSYTRQILNGLKYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~----~ls~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
||||+++++|..++... .+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++......
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999999988764 68999999999999999999997 59999999999999999999999999998765444
Q ss_pred CcccCCCCCcccCchhhcccc----CCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhh---HHHhcCCCCCCCCCcccH
Q 011326 379 DVKSCKGTAFWMAPEVVNLKK----DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQA---MFKIGGGELPPVPNSLSR 451 (488)
Q Consensus 379 ~~~~~~gt~~y~aPE~~~~~~----~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~s~ 451 (488)
......+++.|+|||.+.... ..++.++|+||+|+++|+|++|+.||........ ...+.....+..+..+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCH
Confidence 445566888999999873221 2358899999999999999999999976544332 223444555567777999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
++.++|.+||+.+|.+||++.++++||||.+..
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred HHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=334.01 Aligned_cols=252 Identities=30% Similarity=0.525 Sum_probs=210.5
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|++.++||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.++.+++||||+++++.+..++..++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI----TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC 77 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC----ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence 6788899999999999999874 78999999987532 233445788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCcccCC
Q 011326 305 LELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK 384 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 384 (488)
|||+++++|..+ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++............
T Consensus 78 ~e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (279)
T cd06619 78 TEFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV 154 (279)
T ss_pred EecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCC
Confidence 999999999654 34788899999999999999999999999999999999999999999999999766555555667
Q ss_pred CCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh-------hhHHHhcCCCCCCC-CCcccHHHHHH
Q 011326 385 GTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-------QAMFKIGGGELPPV-PNSLSRDAQDF 456 (488)
Q Consensus 385 gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~-------~~~~~i~~~~~~~~-~~~~s~~l~~L 456 (488)
||..|+|||.+ .+..++.++|+||||+++|+|++|+.||...... .....+.....+.. ....++++.++
T Consensus 155 ~~~~y~aPE~~--~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (279)
T cd06619 155 GTNAYMAPERI--SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF 232 (279)
T ss_pred CChhhcCceee--cCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence 99999999987 3456889999999999999999999999653221 11222222222222 23578899999
Q ss_pred HHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 457 ILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 457 i~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
+.+||+.+|++||++++++.||||+..-.+
T Consensus 233 i~~~l~~~P~~Rp~~~eil~~~~~~~~~~~ 262 (279)
T cd06619 233 ITQCMRKQPKERPAPENLMDHPFIVQYNDG 262 (279)
T ss_pred HHHHhhCChhhCCCHHHHhcCcccccccCc
Confidence 999999999999999999999999876443
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=346.85 Aligned_cols=247 Identities=28% Similarity=0.412 Sum_probs=205.6
Q ss_pred eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHH-HHHhcCCCCCcceeeccccCCCceEEEEeec
Q 011326 231 ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEI-SLLGQFEHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei-~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
+.||+|+||.||+|.+. ++..||+|++...... .......+..|. .+++.++||||+++++++.+++..++||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL--KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHH--hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence 36999999999999886 6889999999753221 111223344444 4567899999999999999999999999999
Q ss_pred cCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--CcccCCC
Q 011326 309 TKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKG 385 (488)
Q Consensus 309 ~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~g 385 (488)
++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++..... ......|
T Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence 999999988654 5889999999999999999999999999999999999999999999999998653222 2345679
Q ss_pred CCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCC
Q 011326 386 TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465 (488)
Q Consensus 386 t~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP 465 (488)
|+.|+|||++ .+..++.++|||||||++|+|++|..||...+..+....+..... ..+..+++++.+++.+||+.||
T Consensus 159 t~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~~p 235 (325)
T cd05602 159 TPEYLAPEVL--HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QLKPNITNSARHLLEGLLQKDR 235 (325)
T ss_pred CccccCHHHH--cCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc-CCCCCCCHHHHHHHHHHcccCH
Confidence 9999999997 455688999999999999999999999988777776666554433 4556789999999999999999
Q ss_pred CCCCCHH----HHHhCccCCC
Q 011326 466 NDRPTAA----QLMEHPFIKR 482 (488)
Q Consensus 466 ~~Rps~~----eil~hp~f~~ 482 (488)
.+||++. ++++|+||..
T Consensus 236 ~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 236 TKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred HHCCCCCCCHHHHhcCcccCC
Confidence 9999855 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=345.63 Aligned_cols=247 Identities=28% Similarity=0.430 Sum_probs=206.4
Q ss_pred eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHH-HHhcCCCCCcceeeccccCCCceEEEEeec
Q 011326 231 ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEIS-LLGQFEHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
++||+|+||.||+|.+. ++..||+|.+...... .......+..|.. +++.++||||+++++++.+.+..++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL--KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH--HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence 36999999999999985 6899999998753221 1122334445544 578899999999999999999999999999
Q ss_pred cCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC--CCcccCCC
Q 011326 309 TKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKG 385 (488)
Q Consensus 309 ~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~--~~~~~~~g 385 (488)
++|+|...+.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.... .......|
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence 99999887754 4589999999999999999999999999999999999999999999999999865322 22334569
Q ss_pred CCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCC
Q 011326 386 TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465 (488)
Q Consensus 386 t~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP 465 (488)
|+.|+|||.+ .+..++.++|||||||++|||++|..||...+.......+.... ...+...+.++.+++.+||+.||
T Consensus 159 t~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p 235 (321)
T cd05603 159 TPEYLAPEVL--RKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP-LQLPGGKTVAACDLLVGLLHKDQ 235 (321)
T ss_pred CcccCCHHHh--cCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccCCH
Confidence 9999999997 45568899999999999999999999998877766666665543 35667789999999999999999
Q ss_pred CCCCCH----HHHHhCccCCC
Q 011326 466 NDRPTA----AQLMEHPFIKR 482 (488)
Q Consensus 466 ~~Rps~----~eil~hp~f~~ 482 (488)
.+||+. .++++||||..
T Consensus 236 ~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 236 RRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred hhcCCCCCCHHHHhCCCCcCC
Confidence 999864 59999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=336.18 Aligned_cols=246 Identities=26% Similarity=0.408 Sum_probs=202.1
Q ss_pred ecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeeccCC
Q 011326 233 LGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKG 311 (488)
Q Consensus 233 LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 311 (488)
||+|+||.||++... +|..||+|.+....... ......+..|++++++++||||+++++++.++...++||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK--KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc--chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence 699999999999875 69999999986533211 112234556999999999999999999999999999999999999
Q ss_pred ChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-cccCCCCC
Q 011326 312 SLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VKSCKGTA 387 (488)
Q Consensus 312 sL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~gt~ 387 (488)
+|..++... ++++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++....... .....|+.
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN 158 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCC
Confidence 998877433 48888999999999999999999999999999999999999999999999986554332 23456899
Q ss_pred cccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh----hhHHHhcCCCCCCCCCcccHHHHHHHHHhhhh
Q 011326 388 FWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG----QAMFKIGGGELPPVPNSLSRDAQDFILKCLQV 463 (488)
Q Consensus 388 ~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~ 463 (488)
.|+|||++ ....++.++|+||+||++|||++|+.||...... +................+++++.+|+.+||++
T Consensus 159 ~y~aPE~~--~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 159 GYMAPEIL--KEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CccCHHHH--ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 99999997 3445899999999999999999999999764332 22233333333223346899999999999999
Q ss_pred CCCCCCCH----HHHHhCccCCC
Q 011326 464 NPNDRPTA----AQLMEHPFIKR 482 (488)
Q Consensus 464 dP~~Rps~----~eil~hp~f~~ 482 (488)
||++||++ ++++.||||+.
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcC
Confidence 99999999 77889999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=327.01 Aligned_cols=250 Identities=29% Similarity=0.565 Sum_probs=219.5
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|++.+.||+|+||.||.+... +|..||+|.+..... .......+.+|+.++++++||||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM---SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC---ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence 5889999999999999999875 789999999875432 123345788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 305 LELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
|||+++++|.+.+... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 9999999999888653 47889999999999999999999999999999999999999999999999987554332
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILK 459 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~ 459 (488)
.....|++.|+|||.+ .+..++.++|+||||+++++|++|..||...+..+....+..+..++.+..++.++.++|.+
T Consensus 158 ~~~~~~~~~~~~pe~~--~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08218 158 ARTCIGTPYYLSPEIC--ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQ 235 (256)
T ss_pred hhhccCCccccCHHHh--CCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHH
Confidence 2234588899999997 34557889999999999999999999998877777777777777777788899999999999
Q ss_pred hhhhCCCCCCCHHHHHhCccC
Q 011326 460 CLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 460 cL~~dP~~Rps~~eil~hp~f 480 (488)
||+.+|.+||++.++++||||
T Consensus 236 ~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 236 LFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=351.66 Aligned_cols=249 Identities=27% Similarity=0.396 Sum_probs=201.4
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
...+|++.+.||+|+||.||+|.+. +++.||+|.... ..+.+|+.++++++||||+++++++..+...
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----------GGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 4568999999999999999999885 789999996431 2456899999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC---
Q 011326 302 CIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--- 377 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~--- 377 (488)
++|||++. ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 159 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 159 CLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 99999996 478776644 4689999999999999999999999999999999999999999999999999864322
Q ss_pred CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCch-------hhhHHHhc------------
Q 011326 378 NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG-------GQAMFKIG------------ 438 (488)
Q Consensus 378 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~-------~~~~~~i~------------ 438 (488)
.......||+.|+|||++ .+..++.++|||||||++|||++|..||..... ...+..+.
T Consensus 238 ~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 238 NKYYGWAGTIATNAPELL--ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccCccCCCChhhh--cCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 123345799999999997 445689999999999999999999988743221 00000000
Q ss_pred --------------CC-CC-C-CCC-----CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 439 --------------GG-EL-P-PVP-----NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 439 --------------~~-~~-~-~~~-----~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
.. .. + ..+ ..++.++.+||.+||+.||.+|||+.|+++||||++.-.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 384 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD 384 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence 00 00 0 000 134678999999999999999999999999999987543
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=347.02 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=205.3
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC---
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE--- 298 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--- 298 (488)
...+|++.+.||+|+||.||++.+. ++..||+|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc---ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 4678999999999999999999875 689999999865432 233445677899999999999999999987543
Q ss_pred ---CceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 299 ---KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 299 ---~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 357999999976 56665543 5889999999999999999999999999999999999999999999999999765
Q ss_pred cCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC--------------
Q 011326 376 TMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG-------------- 440 (488)
Q Consensus 376 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~-------------- 440 (488)
.... .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred CCccccCCccccCCccCHHHH--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 4332 3456789999999997 4556899999999999999999999999876543322111000
Q ss_pred ----------C--------------C---CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 441 ----------E--------------L---PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 441 ----------~--------------~---~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
. . ...+...+.++++||.+||+.||++|||+.|+++||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 0 0 001122456889999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=345.66 Aligned_cols=256 Identities=25% Similarity=0.373 Sum_probs=212.8
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||++... ++..+|+|.+.+... ........+.+|+.++..++|+||+++++++.+++.+++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM--LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH--HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence 37899999999999999999876 688999999864321 112233457889999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 304 FLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
||||+++|+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999999999999976 358999999999999999999999999999999999999999999999999986543222
Q ss_pred -cccCCCCCcccCchhhcc---ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC----CCCCCCcccH
Q 011326 380 -VKSCKGTAFWMAPEVVNL---KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE----LPPVPNSLSR 451 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~---~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~s~ 451 (488)
.....||+.|+|||++.. ....++.++|||||||++|||++|+.||...+..+....+.... .+.....+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence 223569999999999742 23457889999999999999999999998877777666665432 2233346799
Q ss_pred HHHHHHHHhhhhCCCC--CCCHHHHHhCccCCC
Q 011326 452 DAQDFILKCLQVNPND--RPTAAQLMEHPFIKR 482 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~--Rps~~eil~hp~f~~ 482 (488)
++.+|+.+||..++.+ |+++.++++||||+.
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 9999999999765444 689999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=333.93 Aligned_cols=255 Identities=35% Similarity=0.630 Sum_probs=222.0
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
.|+..+.||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.++++++||||+++++++.++...++|
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc----cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 5677888999999999999885 68899999987532 234456788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--ccc
Q 011326 305 LELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKS 382 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~~~ 382 (488)
|||+++++|.+++....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence 999999999999988889999999999999999999999999999999999999999999999999986554332 223
Q ss_pred CCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhh
Q 011326 383 CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQ 462 (488)
Q Consensus 383 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~ 462 (488)
..++..|+|||.+ ....++.++|+||||+++|||++|..||...+.......+.....+..+..++.++.+++.+||+
T Consensus 161 ~~~~~~y~apE~~--~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06640 161 FVGTPFWMAPEVI--QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLN 238 (277)
T ss_pred ccCcccccCHhHh--ccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcc
Confidence 4578899999987 34558899999999999999999999998877666665555555566667788999999999999
Q ss_pred hCCCCCCCHHHHHhCccCCCCCCC
Q 011326 463 VNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 463 ~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
.+|++||++.+++.||||.+...+
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 239 KDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred cCcccCcCHHHHHhChHhhhcchh
Confidence 999999999999999999877654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=343.84 Aligned_cols=253 Identities=26% Similarity=0.446 Sum_probs=203.6
Q ss_pred eeeeeccc--CceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEE
Q 011326 229 KGELLGSG--SYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFL 305 (488)
Q Consensus 229 ~~~~LG~G--~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 305 (488)
++++||+| +|++||++.+. +|..||+|.+..... .......+.+|+.+++.++||||+++++++..++..++||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC---TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc---cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence 45779999 78999999875 799999999865432 1233456778999999999999999999999999999999
Q ss_pred eeccCCChHHHHhh---hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC---
Q 011326 306 ELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--- 379 (488)
Q Consensus 306 E~~~~gsL~~~l~~---~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--- 379 (488)
||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++++||+.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 99999999999864 248999999999999999999999999999999999999999999999998653221110
Q ss_pred ------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC----------
Q 011326 380 ------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP---------- 443 (488)
Q Consensus 380 ------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---------- 443 (488)
.....++..|+|||++......++.++|||||||++|||++|+.||..............+..+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 1223467779999998433356899999999999999999999999765544332222211110
Q ss_pred -----------------------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 444 -----------------------------------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 444 -----------------------------------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
+....+++++.+|+.+||+.||++|||++|+++||||++.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 11224577899999999999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=335.37 Aligned_cols=256 Identities=32% Similarity=0.571 Sum_probs=219.0
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
..+|++.+.||.|++|.||+|.+. +++.|++|.+..... .....+.+|+.+++.++||||+++++++..++..+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-----PKKELIINEILVMKELKNPNIVNFLDSFLVGDELF 92 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-----chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence 356999999999999999999874 799999999875332 22356788999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--c
Q 011326 303 IFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--V 380 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~ 380 (488)
+|+||+++++|..++....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 93 lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 172 (296)
T cd06655 93 VVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR 172 (296)
T ss_pred EEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccC
Confidence 99999999999999988889999999999999999999999999999999999999999999999999987544332 2
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC--CCCCCcccHHHHHHHH
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL--PPVPNSLSRDAQDFIL 458 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~l~~Li~ 458 (488)
....++..|+|||.+ ....++.++|+||||+++|+|++|+.||...+.......+..... ...+..+++.+.++|.
T Consensus 173 ~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (296)
T cd06655 173 STMVGTPYWMAPEVV--TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLN 250 (296)
T ss_pred CCcCCCccccCcchh--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHH
Confidence 345688999999987 345578999999999999999999999988766554444432222 2345568899999999
Q ss_pred HhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 459 KCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 459 ~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
+||..||.+||++.+++.||||+.....
T Consensus 251 ~~l~~dp~~Rpt~~~il~~~~~~~~~~~ 278 (296)
T cd06655 251 RCLEMDVEKRGSAKELLQHPFLKLAKPL 278 (296)
T ss_pred HHhhcChhhCCCHHHHhhChHhhhcccc
Confidence 9999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=335.27 Aligned_cols=254 Identities=33% Similarity=0.580 Sum_probs=216.1
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
..+|++.+.||+|+||.||+|.+. ++..+++|.+..... .....+.+|+.+++.++||||+++++.+..+...+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence 457999999999999999999875 789999999875432 22356788999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--c
Q 011326 303 IFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--V 380 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~ 380 (488)
+||||+++++|.+++....+++.++..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++....... .
T Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 173 (296)
T cd06654 94 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (296)
T ss_pred EeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccccc
Confidence 99999999999999987789999999999999999999999999999999999999999999999999886543322 2
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC--CCCCcccHHHHHHHH
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP--PVPNSLSRDAQDFIL 458 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~Li~ 458 (488)
....+++.|+|||.+ ....++.++|+||||+++|+|++|+.||...+.......+.....+ ..+..++..+.+++.
T Consensus 174 ~~~~~~~~y~aPE~~--~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (296)
T cd06654 174 STMVGTPYWMAPEVV--TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (296)
T ss_pred CcccCCccccCHHHH--cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence 345688999999987 3455789999999999999999999999876654433333222221 234568899999999
Q ss_pred HhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 459 KCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 459 ~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
+||..+|++||++.+++.||||..+.
T Consensus 252 ~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 252 RCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred HHCcCCcccCcCHHHHhhChhhhccC
Confidence 99999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=332.71 Aligned_cols=250 Identities=33% Similarity=0.520 Sum_probs=204.1
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|++.+.||+|++|.||+|... ++..||+|.+...... ......+.+|+.++++++||||+++++++.+++..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE---EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc---CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence 5888999999999999999885 7999999998654322 22234677899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhh----hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-
Q 011326 305 LELVTKGSLASLYQK----YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND- 379 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~----~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~- 379 (488)
|||++ ++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 99998 488877753 348999999999999999999999999999999999999999999999999986543221
Q ss_pred -cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC-------------------
Q 011326 380 -VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG------------------- 439 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~------------------- 439 (488)
.....+++.|+|||.+. ....++.++|+||||+++|+|++|+.||...+.......+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLL-GSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred cccCCcccccccChHHhc-CCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 23345788999999873 334578899999999999999999999976544322211100
Q ss_pred ---------CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 440 ---------GELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 440 ---------~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
.........+++++.++|.+||+.||.+|||+.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00011123578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=333.61 Aligned_cols=256 Identities=36% Similarity=0.636 Sum_probs=219.0
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||++.+. ++..+|+|.+... .......+.+|+.++++++||||+++++.+..+...++
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI 79 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence 46889999999999999999875 6899999998643 23344678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 304 FLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
||||+++++|.+++... .+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 99999999999998653 58999999999999999999999999999999999999999999999999876543222
Q ss_pred cccCCCCCcccCchhhcc---ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC--CCCcccHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNL---KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP--VPNSLSRDAQ 454 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~---~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~ 454 (488)
.....+++.|+|||.+.. ....++.++|+||||+++|+|++|+.||...+.......+.....+. .+..++.++.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence 234568999999998732 23446789999999999999999999998877666666665554332 3456889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
+++.+||+.+|.+||++.++++||||.+..+
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (280)
T cd06611 240 DFLKSCLVKDPDDRPTAAELLKHPFVSDQSD 270 (280)
T ss_pred HHHHHHhccChhhCcCHHHHhcChhhcccch
Confidence 9999999999999999999999999988643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=333.98 Aligned_cols=242 Identities=20% Similarity=0.255 Sum_probs=205.5
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC----CCceEEEEe
Q 011326 231 ELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD----EKRLCIFLE 306 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~lV~E 306 (488)
..||+|++|.||+|.. +|..||+|.+..... ........+.+|+.+|.+++||||+++++++.+ ...+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHK--GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEecccccc--ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 5699999999999987 688999999875432 223345678899999999999999999998866 457899999
Q ss_pred eccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHH-CCCccccCCcccEEECCCCcEEEeecCCcccccCCCcccCC
Q 011326 307 LVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK 384 (488)
Q Consensus 307 ~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 384 (488)
|+++|+|.+++... .+++.....++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++...... ....
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-~~~~ 181 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-FKNV 181 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-cccc
Confidence 99999999998654 58899999999999999999998 499999999999999999999999999987654322 3456
Q ss_pred CCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhc-CCCCCCCCCcccHHHHHHHHHhhhh
Q 011326 385 GTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIG-GGELPPVPNSLSRDAQDFILKCLQV 463 (488)
Q Consensus 385 gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~l~~Li~~cL~~ 463 (488)
|+..|+|||++......++.++||||||+++|||++|+.||...+..+....+. .....+.+..+++++.+|+.+||+.
T Consensus 182 ~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~ 261 (283)
T PHA02988 182 NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSH 261 (283)
T ss_pred CcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcC
Confidence 889999999974333568999999999999999999999999887766665553 3334456667899999999999999
Q ss_pred CCCCCCCHHHHHh
Q 011326 464 NPNDRPTAAQLME 476 (488)
Q Consensus 464 dP~~Rps~~eil~ 476 (488)
||++|||+.++++
T Consensus 262 dp~~Rps~~ell~ 274 (283)
T PHA02988 262 DSIKRPNIKEILY 274 (283)
T ss_pred CcccCcCHHHHHH
Confidence 9999999999985
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=329.23 Aligned_cols=247 Identities=24% Similarity=0.437 Sum_probs=211.7
Q ss_pred cCceeeeeeecccCceEEEEEEec----CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD----DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
..+|++.+.||+|+||.||+|.+. .+..||+|.+.... .......+.+|+.++.+++||||+++++++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC----SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC----CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 457899999999999999999753 46789999987532 2233457889999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 300 RLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
..++||||+++|+|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++++|||.+.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999988653 589999999999999999999999999999999999999999999999998754332
Q ss_pred CCc---ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHH
Q 011326 378 NDV---KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDA 453 (488)
Q Consensus 378 ~~~---~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l 453 (488)
... ....++..|+|||.+ ....++.++||||||+++||+++ |..||...+..+....+..+...+.+..++..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAI--QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLL 237 (266)
T ss_pred cchhcccCCCCceeecCHHHH--hhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 221 123356789999987 44568999999999999999775 999998888777777777666667788899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHh
Q 011326 454 QDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
.+++.+||+.+|.+||++++|++
T Consensus 238 ~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 238 HQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHcCCCchhCCCHHHHHH
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=333.37 Aligned_cols=253 Identities=30% Similarity=0.463 Sum_probs=218.6
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||++.+. +++.+|+|.+..... ........+.+|+.++++++||||+++++++.+++..++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI--VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence 46899999999999999999885 689999999875432 122334678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCccc
Q 011326 304 FLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS 382 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 382 (488)
+|||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||+|.||+++.++.++|+|||++...... ...
T Consensus 79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-~~~ 157 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-TYT 157 (290)
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-CCC
Confidence 99999999999988654 5899999999999999999999999999999999999999999999999998765443 334
Q ss_pred CCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhh
Q 011326 383 CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQ 462 (488)
Q Consensus 383 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~ 462 (488)
..+++.|+|||.+ .....+.++|+||||+++|+|++|..||...+.......+..+. ..++..++..+.+++.+||+
T Consensus 158 ~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 158 LCGTPEYLAPEII--LSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK-VRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCccccChhhh--cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-ccCCccCCHHHHHHHHHHcc
Confidence 5689999999987 34467889999999999999999999998777655555555433 45677789999999999999
Q ss_pred hCCCCCC-----CHHHHHhCccCCCC
Q 011326 463 VNPNDRP-----TAAQLMEHPFIKRP 483 (488)
Q Consensus 463 ~dP~~Rp-----s~~eil~hp~f~~~ 483 (488)
.||.+|+ +++|+++||||+..
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred CCHHHccCcccCCHHHHHcCcccccC
Confidence 9999999 89999999999754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=336.58 Aligned_cols=255 Identities=31% Similarity=0.524 Sum_probs=211.4
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||++.+. ++..+|+|.+.... ......++.+|++++++++||||+++++++.+++..++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI----KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI 76 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence 36899999999999999999875 68889999886432 23344568899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHH-CCCccccCCcccEEECCCCcEEEeecCCcccccCCCcc
Q 011326 304 FLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK 381 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 381 (488)
+|||+++++|.+++... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 77 v~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (308)
T cd06615 77 CMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 156 (308)
T ss_pred EeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccc
Confidence 99999999999998654 58999999999999999999997 69999999999999999999999999998765444445
Q ss_pred cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC----------------------
Q 011326 382 SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG---------------------- 439 (488)
Q Consensus 382 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~---------------------- 439 (488)
...|+..|+|||.+ .+..++.++|+||||+++|+|++|+.||...+.......+..
T Consensus 157 ~~~~~~~~~aPE~~--~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 157 SFVGTRSYMSPERL--QGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cCCCCcCccChhHh--cCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 56789999999987 345588999999999999999999999865443322211110
Q ss_pred --------------CCCCCCC-CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 440 --------------GELPPVP-NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 440 --------------~~~~~~~-~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
...+..+ ..++.++.+++.+||+.+|++||++.++++||||++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 295 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAEL 295 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccc
Confidence 0111111 136788999999999999999999999999999987643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=328.28 Aligned_cols=254 Identities=45% Similarity=0.819 Sum_probs=212.0
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC--CCce
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD--EKRL 301 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~ 301 (488)
.+|+..+.||+|+||.||++.+. ++..|++|.+...............+.+|+.++++++||||+++++++.+ +..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999885 68999999987655433334455678899999999999999999998765 4678
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-- 378 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-- 378 (488)
+++|||+++++|.+++... .+++...+.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 9999999999999988654 5899999999999999999999999999999999999999999999999998654321
Q ss_pred ---CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhc-CCCCCCCCCcccHHHH
Q 011326 379 ---DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIG-GGELPPVPNSLSRDAQ 454 (488)
Q Consensus 379 ---~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~l~ 454 (488)
......++..|+|||.+ .+..++.++|+||+|+++|||++|+.||............. ....+..+..+++.+.
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVI--SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHAR 239 (266)
T ss_pred cCCccccCCccccccCHHHh--CCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHH
Confidence 12335588899999997 34568899999999999999999999998765554444333 2233455667889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCccCC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPFIK 481 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~f~ 481 (488)
+++ +||..+|++||+++|+++||||+
T Consensus 240 ~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 240 DFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 999 68888999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=335.26 Aligned_cols=252 Identities=37% Similarity=0.650 Sum_probs=217.8
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
.|+..+.||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc----chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence 4667788999999999999875 68899999986432 123446788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--ccc
Q 011326 305 LELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKS 382 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~~~ 382 (488)
|||+++++|.+++....+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 81 MEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred EEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence 999999999999988889999999999999999999999999999999999999999999999999987654332 223
Q ss_pred CCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhh
Q 011326 383 CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQ 462 (488)
Q Consensus 383 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~ 462 (488)
..++..|+|||.+ ....++.++|+||||+++|||++|..||...........+.....+..+..++.++.+++.+||+
T Consensus 161 ~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 161 FVGTPFWMAPEVI--KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred ccCcccccCHHHh--CcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 4588899999997 34568899999999999999999999998766666555555555555666788999999999999
Q ss_pred hCCCCCCCHHHHHhCccCCCC
Q 011326 463 VNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 463 ~dP~~Rps~~eil~hp~f~~~ 483 (488)
.+|++||++.+++.||||++-
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 239 KDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred CCcccCcCHHHHHHhHHHHHH
Confidence 999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=323.51 Aligned_cols=250 Identities=28% Similarity=0.499 Sum_probs=219.8
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|+..+.||+|+||.||.+... ++..+++|.+...... .....++.+|+.++++++|+||+++++++.+.+..+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc---hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence 5889999999999999998874 6899999998755422 23445778999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 305 LELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
|||+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence 9999999999998664 48999999999999999999999999999999999999999999999999987554332
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILK 459 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~ 459 (488)
.....+++.|+|||.+ .+..++.++|+||||+++|+|++|..||...+..+....+..+...+.+..++.++.+++.+
T Consensus 158 ~~~~~~~~~y~ape~~--~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08221 158 AETVVGTPYYMSPELC--QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHS 235 (256)
T ss_pred ccccCCCccccCHhhc--CCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHH
Confidence 2345689999999987 34457889999999999999999999998877777777777777777777889999999999
Q ss_pred hhhhCCCCCCCHHHHHhCccC
Q 011326 460 CLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 460 cL~~dP~~Rps~~eil~hp~f 480 (488)
||+.+|.+||++.++++|||+
T Consensus 236 ~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 236 LLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=355.43 Aligned_cols=246 Identities=31% Similarity=0.490 Sum_probs=209.0
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-C-----CCcceeeccccCC
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-H-----DNIVQYLGTDRDE 298 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-H-----pnIv~l~~~~~~~ 298 (488)
+|++.++||+|+||.|.+|.+. +++.||||+++.. .....+...|+.+|..|+ | -|+|+++++|...
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK------KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC------hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 7999999999999999999885 7999999999843 344456678999999987 3 4899999999999
Q ss_pred CceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC--CCcEEEeecCCcc
Q 011326 299 KRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA--SGSVKLADFGLAK 373 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~--~~~vkL~DFGla~ 373 (488)
+++|||+|++.. +|.++++.+ +++...+..++.||+.||..||+.||||+||||+|||+.. ...+||+|||.|.
T Consensus 261 ~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 261 NHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred cceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence 999999999977 999999876 4889999999999999999999999999999999999975 3479999999997
Q ss_pred cccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC------------
Q 011326 374 ATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE------------ 441 (488)
Q Consensus 374 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~------------ 441 (488)
.....-. ++..+..|+|||++ .+..|+.+.||||||||++||++|.+.|.+.+..+.+..|....
T Consensus 340 ~~~q~vy-tYiQSRfYRAPEVI--LGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 340 FESQRVY-TYIQSRFYRAPEVI--LGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred ccCCcce-eeeeccccccchhh--ccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 7664444 77889999999998 67789999999999999999999998898877766555442100
Q ss_pred -----------CC----------------------------CCC-----------CcccHHHHHHHHHhhhhCCCCCCCH
Q 011326 442 -----------LP----------------------------PVP-----------NSLSRDAQDFILKCLQVNPNDRPTA 471 (488)
Q Consensus 442 -----------~~----------------------------~~~-----------~~~s~~l~~Li~~cL~~dP~~Rps~ 471 (488)
.+ ..| ..-...+.+++++||.+||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 00 001 0122467899999999999999999
Q ss_pred HHHHhCccCC
Q 011326 472 AQLMEHPFIK 481 (488)
Q Consensus 472 ~eil~hp~f~ 481 (488)
.|+++||||.
T Consensus 497 ~qal~Hpfl~ 506 (586)
T KOG0667|consen 497 AQALNHPFLT 506 (586)
T ss_pred HHHhcCcccc
Confidence 9999999998
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=323.65 Aligned_cols=250 Identities=33% Similarity=0.538 Sum_probs=218.1
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecccc--CCCceE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR--DEKRLC 302 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--~~~~~~ 302 (488)
+|++.+.||.|+||.||++.+. ++..+|+|.+..... .......+.+|+.++++++||||+++++++. .+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM---TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC---CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence 5888999999999999999875 788999999875432 2344567889999999999999999999764 345689
Q ss_pred EEEeeccCCChHHHHhh-----hccChhhhhHHHHHHHHHHHHHH-----HCCCccccCCcccEEECCCCcEEEeecCCc
Q 011326 303 IFLELVTKGSLASLYQK-----YHLSDSQVSSYTRQILNGLKYLH-----EQNVVHRDIKCANILVDASGSVKLADFGLA 372 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~-----~~ls~~~~~~i~~qi~~aL~yLH-----~~giiHrDLkp~NILl~~~~~vkL~DFGla 372 (488)
++|||+++++|.+++.. ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 99999999999998864 35899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCC--cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCccc
Q 011326 373 KATTMND--VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLS 450 (488)
Q Consensus 373 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s 450 (488)
....... .....+++.|+|||.+ ....++.++|+||||+++++|++|..||...+..+....+..+..+..+..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQL--NHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYS 235 (265)
T ss_pred ccccCCcccccccccCCCccChhhh--cCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccC
Confidence 8765443 3345689999999997 34558899999999999999999999999887777777777777777888899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 451 RDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 451 ~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
.++.+++.+||+.+|.+||++.+|++|||+
T Consensus 236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 236 SELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=330.51 Aligned_cols=255 Identities=36% Similarity=0.642 Sum_probs=221.5
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
-|+..+.||.|+||.||+|.+. ++..+|+|.+.... .......+.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence 3667888999999999999875 78999999876432 123346788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--ccc
Q 011326 305 LELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKS 382 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~~~ 382 (488)
|||+++++|.+++....+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 81 MEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred EEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcc
Confidence 999999999999988889999999999999999999999999999999999999999999999999986554332 223
Q ss_pred CCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhh
Q 011326 383 CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQ 462 (488)
Q Consensus 383 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~ 462 (488)
..++..|+|||.+ ....++.++|+||+|+++|+|++|..||...........+.....+..+..++.++.+++.+||+
T Consensus 161 ~~~~~~y~~PE~~--~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (277)
T cd06641 161 FVGTPFWMAPEVI--KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 238 (277)
T ss_pred ccCCccccChhhh--ccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 4688899999987 34557889999999999999999999998777666666665565666777889999999999999
Q ss_pred hCCCCCCCHHHHHhCccCCCCCCC
Q 011326 463 VNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 463 ~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
.+|.+||++.+++.||||.+...+
T Consensus 239 ~~p~~Rp~~~~~l~~~~~~~~~~~ 262 (277)
T cd06641 239 KEPSFRPTAKELLKHKFIVRFAKK 262 (277)
T ss_pred CChhhCcCHHHHHhCHHHhhhhhc
Confidence 999999999999999999877654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=327.34 Aligned_cols=251 Identities=29% Similarity=0.452 Sum_probs=216.2
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|++.+.||+|+||.||++.+. ++..||+|.+..... ........+.+|+.++++++||||+++++++.+++..++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC--VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh--cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence 4889999999999999999886 699999999976432 1223456788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC-Cccc
Q 011326 305 LELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DVKS 382 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~ 382 (488)
+||+++++|.+.+... .+++..+..++.|+++||.|||++|++|+||+|+||+++.++.++|+|||.+...... ....
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccc
Confidence 9999999999999766 7999999999999999999999999999999999999999999999999998765443 2345
Q ss_pred CCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCch--hhhHHHhcCCCCCCCCCcccHHHHHHHHHh
Q 011326 383 CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG--GQAMFKIGGGELPPVPNSLSRDAQDFILKC 460 (488)
Q Consensus 383 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~s~~l~~Li~~c 460 (488)
..|+..|+|||.+. ...++.++|+||+|+++|+|++|..||...+. .+.............+..++.++.++|.+|
T Consensus 159 ~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 159 TSGTPGYMAPEVLC--RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred cCCChhhcCHHHHc--ccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 56888999999973 34488999999999999999999999987664 222222233244566778899999999999
Q ss_pred hhhCCCCCCCH--HHHHhCccC
Q 011326 461 LQVNPNDRPTA--AQLMEHPFI 480 (488)
Q Consensus 461 L~~dP~~Rps~--~eil~hp~f 480 (488)
|+.||.+||++ .|+++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=332.21 Aligned_cols=253 Identities=25% Similarity=0.427 Sum_probs=211.7
Q ss_pred eeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEE
Q 011326 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFL 305 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 305 (488)
|+..+.||+|+||.||++.+. +++.+|+|.+...... .......+.+|+.++++++|+||+++.+.+.+++..+++|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK--KRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh--hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence 677889999999999999885 7899999998754321 1223345678999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC-Ccc
Q 011326 306 ELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DVK 381 (488)
Q Consensus 306 E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~ 381 (488)
||+++++|..++... ++++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...... ...
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR 159 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCccc
Confidence 999999998877532 5899999999999999999999999999999999999999999999999998654332 234
Q ss_pred cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhc---CCCCCCCCCcccHHHHHHHH
Q 011326 382 SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIG---GGELPPVPNSLSRDAQDFIL 458 (488)
Q Consensus 382 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~---~~~~~~~~~~~s~~l~~Li~ 458 (488)
...|+..|+|||.+ .+..++.++|+||+|+++|+|++|..||...........+. .......+..++.++.+|+.
T Consensus 160 ~~~g~~~~~aPE~~--~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05632 160 GRVGTVGYMAPEVL--NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK 237 (285)
T ss_pred CCCCCcCccChHHh--cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence 55789999999997 34568899999999999999999999998765543322222 11123445678899999999
Q ss_pred HhhhhCCCCCCC-----HHHHHhCccCCCC
Q 011326 459 KCLQVNPNDRPT-----AAQLMEHPFIKRP 483 (488)
Q Consensus 459 ~cL~~dP~~Rps-----~~eil~hp~f~~~ 483 (488)
+||+.||++||+ +.++++||||+..
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 238 MLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 999999999999 8999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=343.61 Aligned_cols=256 Identities=23% Similarity=0.359 Sum_probs=212.2
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||++.+. ++..||+|.+..... ........+.+|..++..++|+||+++++++.+++..|+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM--LKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH--HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 47899999999999999999875 688999999865321 112234457789999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCc-
Q 011326 304 FLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV- 380 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~- 380 (488)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999999999999965 3589999999999999999999999999999999999999999999999999876543321
Q ss_pred --ccCCCCCcccCchhhcccc---CCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC----CCCCCCcccH
Q 011326 381 --KSCKGTAFWMAPEVVNLKK---DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE----LPPVPNSLSR 451 (488)
Q Consensus 381 --~~~~gt~~y~aPE~~~~~~---~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~s~ 451 (488)
....||+.|+|||++.... ..++.++|+||||+++|+|++|+.||...+..+....+.... .+.....+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 2356999999999974311 357889999999999999999999998877666665554322 2222345789
Q ss_pred HHHHHHHHhhhhCCCC--CCCHHHHHhCccCCC
Q 011326 452 DAQDFILKCLQVNPND--RPTAAQLMEHPFIKR 482 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~--Rps~~eil~hp~f~~ 482 (488)
++.+++.+||..++.+ |++++++++||||+.
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 9999999999876554 578999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=329.93 Aligned_cols=256 Identities=37% Similarity=0.634 Sum_probs=217.1
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC---CCCcceeeccccCCCce
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE---HDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~ 301 (488)
.|+..+.||+|+||.||+|.+. ++..+|+|.+..... .....++.+|+.++++++ |||++++++++..+...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~ 77 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL 77 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence 4777889999999999999874 789999999865422 223456778999999886 99999999999999999
Q ss_pred EEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 302 CIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
+++|||+++++|.+++....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK 157 (277)
T ss_pred EEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence 999999999999999988789999999999999999999999999999999999999999999999999987654432
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCC-cccHHHHHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPN-SLSRDAQDFIL 458 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~s~~l~~Li~ 458 (488)
.....|+..|+|||.+. .+..++.++|+||||+++|+|++|..||...+.......+.....+..+. ..+.++.+++.
T Consensus 158 ~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (277)
T cd06917 158 RSTFVGTPYWMAPEVIT-EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA 236 (277)
T ss_pred cccccCCcceeCHHHhc-cCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHH
Confidence 23456889999999873 34457889999999999999999999998776655554444333334443 37889999999
Q ss_pred HhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 459 KCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 459 ~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
+||+.||++||++.+++.||||++....
T Consensus 237 ~~l~~~p~~R~~~~~il~~~~~~~~~~~ 264 (277)
T cd06917 237 ACLDEEPKERLSAEELLKSKWIKAHSKT 264 (277)
T ss_pred HHcCCCcccCcCHHHHhhChHhhccccC
Confidence 9999999999999999999999887653
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=322.87 Aligned_cols=250 Identities=28% Similarity=0.528 Sum_probs=217.6
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|+..+.||+|+||.||++... ++..+|+|.+..... .......+.+|+.++++++||||+++++.+..++..++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM---TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc---ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence 5889999999999999999875 789999999976542 223456788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC-CcEEEeecCCcccccCCC-
Q 011326 305 LELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS-GSVKLADFGLAKATTMND- 379 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~-~~vkL~DFGla~~~~~~~- 379 (488)
|||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999998653 38899999999999999999999999999999999999865 468999999987654432
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILK 459 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~ 459 (488)
.....++..|+|||.+ ....++.++|+||+|+++|+|++|..||...+.......+......+.+..++.++.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 158 AYTVVGTPCYISPELC--EGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred ccccccCCcccCchhc--cCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 2345688999999997 34557889999999999999999999998877777776666666667777899999999999
Q ss_pred hhhhCCCCCCCHHHHHhCccC
Q 011326 460 CLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 460 cL~~dP~~Rps~~eil~hp~f 480 (488)
||+.+|.+|||+.|++.||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=331.06 Aligned_cols=248 Identities=26% Similarity=0.466 Sum_probs=213.9
Q ss_pred cCceeeeeeecccCceEEEEEEecC------CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTDD------GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
+.+|++.+.||+|+||.||+|.... ...|++|.+.... .......+.+|+.++.+++||||+++++++.+
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA----EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC----CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 5678999999999999999998642 2579999886432 23345678899999999999999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhh-----------------hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC
Q 011326 298 EKRLCIFLELVTKGSLASLYQK-----------------YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA 360 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~-----------------~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~ 360 (488)
.+..+++|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 9999999999999999998864 23677889999999999999999999999999999999999
Q ss_pred CCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHH
Q 011326 361 SGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMF 435 (488)
Q Consensus 361 ~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~ 435 (488)
++.++|+|||++......+ .....+++.|+|||.+ ....++.++|+||||+++|||++ |..||.+....+...
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAI--LYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHh--ccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999987543222 2234567889999987 34568999999999999999998 999999888888877
Q ss_pred HhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 436 KIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 436 ~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.+.....++.+..+++++.+|+.+||+.||.+||++.||+++
T Consensus 238 ~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 238 MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 777777777788899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=332.50 Aligned_cols=260 Identities=30% Similarity=0.503 Sum_probs=213.2
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|++.+.||+|++|.||+|.+. +|..|++|.+...............+..|+.++++++|+||+++++++.+++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999875 689999999986554322233445677899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhhc--cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--c
Q 011326 305 LELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--V 380 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~~--ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~ 380 (488)
|||+ +++|.+++.... +++..+..++.||++||.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 889999987654 8999999999999999999999999999999999999999999999999987654432 2
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC-------------------
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE------------------- 441 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~------------------- 441 (488)
....+++.|+|||.+. ....++.++|+||||+++|+|++|.+||...+..+....+....
T Consensus 160 ~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T cd07841 160 THQVVTRWYRAPELLF-GARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE 238 (298)
T ss_pred cccccceeeeCHHHHh-CCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc
Confidence 3345788899999873 34457899999999999999999988887655433322221100
Q ss_pred ---CC-----CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCCC
Q 011326 442 ---LP-----PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTS 487 (488)
Q Consensus 442 ---~~-----~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~~ 487 (488)
.+ ......+.++.++|.+||++||++|||+.|++.||||++..+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 00 11234578899999999999999999999999999999876653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=324.64 Aligned_cols=245 Identities=26% Similarity=0.428 Sum_probs=211.9
Q ss_pred cCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
.++|++.+.||+|+||.||++...++..+|+|.+.... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA------MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC------ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence 35788999999999999999998888899999876332 123567889999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCc-
Q 011326 304 FLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV- 380 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~- 380 (488)
+|||+++|+|.+++... .+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.++.......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 99999999999988643 488999999999999999999999999999999999999999999999999875433222
Q ss_pred --ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHH
Q 011326 381 --KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFI 457 (488)
Q Consensus 381 --~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li 457 (488)
....++..|+|||.+ ....++.++|+||||+++|+|++ |+.||...+..+....+..+.....+...+.++.+++
T Consensus 157 ~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li 234 (256)
T cd05114 157 SSSGAKFPVKWSPPEVF--NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVM 234 (256)
T ss_pred ccCCCCCchhhCChhhc--ccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence 122355679999997 34568899999999999999999 9999988887777777777666666777889999999
Q ss_pred HHhhhhCCCCCCCHHHHHh
Q 011326 458 LKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 458 ~~cL~~dP~~Rps~~eil~ 476 (488)
.+||+.+|.+||++.++++
T Consensus 235 ~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 235 YSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 9999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=330.81 Aligned_cols=254 Identities=35% Similarity=0.596 Sum_probs=214.2
Q ss_pred eeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEE
Q 011326 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFL 305 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 305 (488)
|++.+.||+|+||.||++.+. ++..+++|.+... .......+.+|+.+++.++||||+++++++..++..++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEE
Confidence 677888999999999999886 5888999998543 2334567888999999999999999999999999999999
Q ss_pred eeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--Ccc
Q 011326 306 ELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVK 381 (488)
Q Consensus 306 E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~ 381 (488)
||+++++|..++.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... ...
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 99999999887754 45899999999999999999999999999999999999999999999999998654322 123
Q ss_pred cCCCCCcccCchhhcc---ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC--CCCCCcccHHHHHH
Q 011326 382 SCKGTAFWMAPEVVNL---KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL--PPVPNSLSRDAQDF 456 (488)
Q Consensus 382 ~~~gt~~y~aPE~~~~---~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~l~~L 456 (488)
...++..|+|||.+.. ....++.++|+||+|+++|+|++|+.||...+..+....+..... ...+..++.++.++
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence 4568899999998731 234577899999999999999999999987766655555443322 23455688999999
Q ss_pred HHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 457 ILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 457 i~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
|.+||+.||.+||++.++++||||+....
T Consensus 242 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 242 LKKCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred HHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence 99999999999999999999999987654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=329.59 Aligned_cols=252 Identities=27% Similarity=0.506 Sum_probs=208.2
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||+|.+. +|..||+|.+...... ......+.+|+.++++++|||++++++++......++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 77 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD---PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL 77 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC---ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence 36899999999999999999886 6899999998754321 1223457789999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--c
Q 011326 304 FLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--V 380 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~ 380 (488)
||||+++++|..++... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....... .
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 99999999888877543 58999999999999999999999999999999999999999999999999987654432 2
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC--------------------
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG-------------------- 440 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~-------------------- 440 (488)
....++..|+|||.+. ....++.++|+||+|+++|+|++|+.||.+.+..+....+...
T Consensus 158 ~~~~~~~~~~aPE~~~-~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 158 TDYVATRWYRAPELLV-GDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred cCcccccccCCHHHHh-CCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 3455788999999873 3345788999999999999999999999876654433222110
Q ss_pred -CCCC---------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 441 -ELPP---------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 441 -~~~~---------~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
..+. ....++..+.+|+.+||+.+|++||++.|++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000 013467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=365.39 Aligned_cols=252 Identities=28% Similarity=0.497 Sum_probs=223.4
Q ss_pred cccccccCceeeeeeecccCceEEEEEEe------cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCccee
Q 011326 218 GKFRRRITSWQKGELLGSGSYGFVYEGLT------DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291 (488)
Q Consensus 218 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l 291 (488)
...+....+.+..+.||+|+||.||+|.. .+...||||.++... ..+..++|++|++++..++|||||+|
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a----~~~~~~dF~REaeLla~l~H~nIVrL 554 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA----ENQARQDFRREAELLAELQHPNIVRL 554 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc----cHHHHHHHHHHHHHHHhccCCCeEEE
Confidence 34455667788899999999999999874 246789999997542 34467899999999999999999999
Q ss_pred eccccCCCceEEEEeeccCCChHHHHhhh---------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccE
Q 011326 292 LGTDRDEKRLCIFLELVTKGSLASLYQKY---------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANI 356 (488)
Q Consensus 292 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~---------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NI 356 (488)
+|+|.+++.+|+|+|||..|+|.++|... .++..+.+.|+.||+.||+||-++.++||||.+.|+
T Consensus 555 lGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNC 634 (774)
T KOG1026|consen 555 LGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNC 634 (774)
T ss_pred EEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhc
Confidence 99999999999999999999999998532 167888999999999999999999999999999999
Q ss_pred EECCCCcEEEeecCCcccccCCCcccCC----CCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchh
Q 011326 357 LVDASGSVKLADFGLAKATTMNDVKSCK----GTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGG 431 (488)
Q Consensus 357 Ll~~~~~vkL~DFGla~~~~~~~~~~~~----gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~ 431 (488)
||+++..|||+|||+++..-..+..... -..+|||||.+ ..+.+|.++||||+||+|||+++ |+.||.+..+.
T Consensus 635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsI--ly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~ 712 (774)
T KOG1026|consen 635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESI--LYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ 712 (774)
T ss_pred eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHh--hcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence 9999999999999999866555543322 34579999998 45669999999999999999999 99999999999
Q ss_pred hhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHH
Q 011326 432 QAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLM 475 (488)
Q Consensus 432 ~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil 475 (488)
+++..+..+..-+.|..+|.++++|+..||+.+|.+||++.||-
T Consensus 713 EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 713 EVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 99999999999999999999999999999999999999999984
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=323.49 Aligned_cols=254 Identities=43% Similarity=0.768 Sum_probs=212.5
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC--Cce
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE--KRL 301 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~ 301 (488)
++|++++.||+|+||.||.+.+. ++..||+|.+...............+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47899999999999999999885 689999999875443333344567888999999999999999999987663 468
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-- 378 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-- 378 (488)
+++|||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 8999999999999988654 5788999999999999999999999999999999999999999999999988654321
Q ss_pred ---CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC-CCCCCCCcccHHHH
Q 011326 379 ---DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG-ELPPVPNSLSRDAQ 454 (488)
Q Consensus 379 ---~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~l~ 454 (488)
......|+..|+|||.+ .+..++.++|+||||+++|+|++|+.||...+........... ..+..+..++..+.
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVI--SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCR 239 (265)
T ss_pred cccccccCCCCccccChhhh--cCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 22334588899999987 3456889999999999999999999999876555544444332 23445667888999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCccCC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPFIK 481 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~f~ 481 (488)
+++.+||. +|.+||++++++.|||+.
T Consensus 240 ~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 240 DFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 99999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=332.28 Aligned_cols=247 Identities=26% Similarity=0.425 Sum_probs=201.4
Q ss_pred cCceeeeeeecccCceEEEEEEec-----------------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-----------------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-----------------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp 286 (488)
.++|++.+.||+|+||.||+|.+. ++..||+|.+.... ......++.+|+.++.+++||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA----NKNARNDFLKEVKILSRLKDP 79 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC----CHHHHHHHHHHHHHHhhcCCC
Confidence 357899999999999999999753 23479999986532 233456788999999999999
Q ss_pred CcceeeccccCCCceEEEEeeccCCChHHHHhhh--------------------ccChhhhhHHHHHHHHHHHHHHHCCC
Q 011326 287 NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--------------------HLSDSQVSSYTRQILNGLKYLHEQNV 346 (488)
Q Consensus 287 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~--------------------~ls~~~~~~i~~qi~~aL~yLH~~gi 346 (488)
||+++++++.+.+..+++|||+++|+|.+++... .+++..++.++.||+.||.|||++||
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 9999999999999999999999999999988543 25667789999999999999999999
Q ss_pred ccccCCcccEEECCCCcEEEeecCCcccccCCCc----ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc--
Q 011326 347 VHRDIKCANILVDASGSVKLADFGLAKATTMNDV----KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-- 420 (488)
Q Consensus 347 iHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-- 420 (488)
+||||||+|||++.++.+||+|||+++....... ....++..|+|||++ ....++.++||||||+++|||++
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI--LMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHH--hcCCCCchhhhHHHHHHHHHHHHcc
Confidence 9999999999999999999999999875533321 233457789999987 34568999999999999999986
Q ss_pred CCCCCCCCchhhhHHHhc-------CCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 421 RRHPYSHLEGGQAMFKIG-------GGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 421 G~~Pf~~~~~~~~~~~i~-------~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+..||...+..+....+. .......+..++..+.+|+.+||+.||.+|||+.+|..
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 677887766555443321 11112334568899999999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=330.41 Aligned_cols=255 Identities=35% Similarity=0.608 Sum_probs=214.8
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
+.|++.+.||+|+||.||+|.+. ++..+++|.+... .......+.+|+.+++.++||||+++++.+..++..++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 46889999999999999999886 6899999998643 23445678889999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--C
Q 011326 304 FLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--D 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~ 379 (488)
||||+++++|..++.+ ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... .
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 9999999999887753 35899999999999999999999999999999999999999999999999987643222 2
Q ss_pred cccCCCCCcccCchhhcc---ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC--CCCCcccHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNL---KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP--PVPNSLSRDAQ 454 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~---~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~ 454 (488)
.....+++.|+|||.+.. ....++.++|+||||+++|+|++|..||...+.......+.....+ ..+..++.++.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence 234568889999998732 2344688999999999999999999999876665555555443332 23456788999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
+++.+||+.+|++||+++++++||||....
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 247 DFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred HHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 999999999999999999999999997643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=326.98 Aligned_cols=251 Identities=34% Similarity=0.600 Sum_probs=207.1
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccC----
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRD---- 297 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~---- 297 (488)
.+.|++.+.||+|+||.||+|... ++..||+|.+.... .....+.+|+.++.++ +||||+++++++..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG------DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 356888899999999999999875 68999999987532 1224677899999998 79999999998764
Q ss_pred --CCceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCc
Q 011326 298 --EKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLA 372 (488)
Q Consensus 298 --~~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla 372 (488)
+..++++|||+++++|.+++... .+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 24689999999999999988753 4889999999999999999999999999999999999999999999999998
Q ss_pred ccccCC--CcccCCCCCcccCchhhccc---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC-CCCCC
Q 011326 373 KATTMN--DVKSCKGTAFWMAPEVVNLK---KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE-LPPVP 446 (488)
Q Consensus 373 ~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~~~ 446 (488)
...... ......|+..|+|||++... ...++.++|+||+|+++|||++|+.||................ ....+
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 238 (272)
T ss_pred eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCC
Confidence 754322 23345689999999997422 3457889999999999999999999997655444443333222 22234
Q ss_pred CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 447 NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 447 ~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
..++.++.+|+.+||+.||.+|||+.++++||||
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 5678999999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=332.75 Aligned_cols=255 Identities=30% Similarity=0.489 Sum_probs=215.7
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
.+|++.+.||+|++|.||+|.+. ++..+|+|.+...... .......+.+|+.++..++||||+++++.+.+++..++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI--KRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc--hHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence 36899999999999999999886 5999999999765332 12345678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-
Q 011326 304 FLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND- 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~- 379 (488)
+|||+.+++|.+++... .+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999999988653 58999999999999999999999999999999999999999999999999876432211
Q ss_pred ------------------------------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 011326 380 ------------------------------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE 429 (488)
Q Consensus 380 ------------------------------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~ 429 (488)
.....||..|+|||.+ .+..++.++||||||+++|+|++|..||.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVI--SGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHH--cCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1123578899999997 44567899999999999999999999998877
Q ss_pred hhhhHHHhcCCCCC-CCCCcccHHHHHHHHHhhhhCCCCCCC----HHHHHhCccCCCC
Q 011326 430 GGQAMFKIGGGELP-PVPNSLSRDAQDFILKCLQVNPNDRPT----AAQLMEHPFIKRP 483 (488)
Q Consensus 430 ~~~~~~~i~~~~~~-~~~~~~s~~l~~Li~~cL~~dP~~Rps----~~eil~hp~f~~~ 483 (488)
.......+...... +....+++++.+++.+||+.||++||| +++++.||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 237 RDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred hHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 76666555433321 122237999999999999999999999 9999999999874
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=330.38 Aligned_cols=258 Identities=28% Similarity=0.486 Sum_probs=216.2
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||++.+. +|..||+|.+.... .......+.+|+.+++.++||||+++++.+...+.++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA----KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC----cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 457889999999999999999875 68899999886532 2233567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHH-CCCccccCCcccEEECCCCcEEEeecCCcccccCCCc
Q 011326 303 IFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV 380 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 380 (488)
+||||+++++|.+++... .+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~ 159 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA 159 (284)
T ss_pred EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc
Confidence 999999999999988664 58999999999999999999997 6999999999999999999999999999865543334
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh-----------hhHHHhcCCCCCCCCCc-
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-----------QAMFKIGGGELPPVPNS- 448 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~-----------~~~~~i~~~~~~~~~~~- 448 (488)
....|+..|+|||.+ ....++.++|+||||+++|+|++|..||...... +....+.....+..+..
T Consensus 160 ~~~~~~~~~~aPE~~--~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd06620 160 DTFVGTSTYMSPERI--QGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237 (284)
T ss_pred CccccCcccCCHHHH--ccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchh
Confidence 456789999999987 3456889999999999999999999999765432 22223333333333333
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCCC
Q 011326 449 LSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTS 487 (488)
Q Consensus 449 ~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~~ 487 (488)
++.++.+|+.+||+.||.+|||+.|+++||||.++.+.+
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~ 276 (284)
T cd06620 238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRAS 276 (284)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccccc
Confidence 788999999999999999999999999999998876653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=341.38 Aligned_cols=259 Identities=25% Similarity=0.381 Sum_probs=230.2
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.+-|.+.+.||+|.|++|-++++- +|..||||++.+.... ......+.+|+..|+.++|||||+||++..+...+|
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD---~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD---TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc---hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 345888899999999999999875 8999999999877643 233356789999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEEC-CCCcEEEeecCCcccccCC-
Q 011326 303 IFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVD-ASGSVKLADFGLAKATTMN- 378 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~-~~~~vkL~DFGla~~~~~~- 378 (488)
+|+|+-.+|+|.++|.+ .+++++.+.+++.||+.|+.|+|+..++||||||+|+.+- .-|-+||.|||++......
T Consensus 94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 99999999999999854 4799999999999999999999999999999999998775 6789999999999665544
Q ss_pred CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHH
Q 011326 379 DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFIL 458 (488)
Q Consensus 379 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~ 458 (488)
...+.+|+..|.|||++ ++.....+++||||||++||-|++|++||...++.+++-.|...++ ..|..++.++++||.
T Consensus 174 kL~TsCGSLAYSAPEIL-LGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY-tvPshvS~eCrdLI~ 251 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEIL-LGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY-TVPSHVSKECRDLIQ 251 (864)
T ss_pred hhhcccchhhccCchhh-hcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc-cCchhhhHHHHHHHH
Confidence 46788999999999997 4444456889999999999999999999999999999999988887 678899999999999
Q ss_pred HhhhhCCCCCCCHHHHHhCccCCCCCCCC
Q 011326 459 KCLQVNPNDRPTAAQLMEHPFIKRPLQTS 487 (488)
Q Consensus 459 ~cL~~dP~~Rps~~eil~hp~f~~~~~~~ 487 (488)
.||..||.+|.++++|..|+|+|..=++.
T Consensus 252 sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 252 SMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred HHHhcCchhhccHHHHhccccccCCCCCc
Confidence 99999999999999999999998765543
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=326.85 Aligned_cols=251 Identities=33% Similarity=0.564 Sum_probs=213.9
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|+..+.||.|++|.||++.+. +++.+++|.+..... .....++.+|+.++++++||||+++++.+..++..+++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN----EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC----hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence 5778889999999999999886 689999999876432 24456788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHH-CCCccccCCcccEEECCCCcEEEeecCCcccccCCCcc
Q 011326 305 LELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK 381 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 381 (488)
+||+++++|.+++.. ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 999999999999875 458899999999999999999999 99999999999999999999999999998655433333
Q ss_pred cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCc-----hhhhHHHhcCCCCCCCCCc-ccHHHHH
Q 011326 382 SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE-----GGQAMFKIGGGELPPVPNS-LSRDAQD 455 (488)
Q Consensus 382 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~-~s~~l~~ 455 (488)
...++..|+|||.+ .+..++.++|+||+|+++|+|++|..||.... ..+....+.....+..+.. +++++.+
T Consensus 158 ~~~~~~~y~~PE~~--~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06605 158 TFVGTSSYMAPERI--QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD 235 (265)
T ss_pred cccCChhccCHHHH--cCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 36788999999997 34568899999999999999999999996542 2233333444444444444 8999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 456 FILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
+|.+||..||++|||+.+++.||||++
T Consensus 236 li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 236 FVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=326.14 Aligned_cols=251 Identities=37% Similarity=0.593 Sum_probs=207.7
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
..+|++.+.||+|+||.||+|.+. ++..||+|++..... .....+.+|+.++++++||||+++++++..++..+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-----~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-----DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-----chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence 457999999999999999999974 788999999875321 22345778999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 303 IFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 99999999999998854 458999999999999999999999999999999999999999999999999987553322
Q ss_pred cccCCCCCcccCchhhcc-ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC-C---CCCcccHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNL-KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP-P---VPNSLSRDAQ 454 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~-~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~-~---~~~~~s~~l~ 454 (488)
.....|++.|+|||.+.. ....++.++|+||+|+++|||++|+.||......+....+...... + ....++.++.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence 234568899999998732 2344788999999999999999999999665444333222222211 1 1234688999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCcc
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPF 479 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~ 479 (488)
+++.+||+.+|++|||++++++|+|
T Consensus 243 ~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 243 NFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHhhCChhhCcCHHHHhcCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=345.83 Aligned_cols=254 Identities=29% Similarity=0.493 Sum_probs=203.7
Q ss_pred CcccccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecccc
Q 011326 217 NGKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR 296 (488)
Q Consensus 217 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 296 (488)
...++..+++|.....||+|+||.||+|...+|..||||.+...... . ..+|.+|+.++.+++|||+|+|+|||.
T Consensus 67 ~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~----~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 67 YDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQ----G-EREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred HHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCc----c-hhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 34456677888888999999999999999999999999977643321 1 356999999999999999999999999
Q ss_pred CCC-ceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCC---CccccCCcccEEECCCCcEEEeec
Q 011326 297 DEK-RLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQN---VVHRDIKCANILVDASGSVKLADF 369 (488)
Q Consensus 297 ~~~-~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~NILl~~~~~vkL~DF 369 (488)
+.+ ..+||+|||++|+|.+.+... .++|....+|+.++|.||+|||+.. |+||||||+|||+|++++.||+||
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF 221 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF 221 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence 998 499999999999999998643 6899999999999999999999853 999999999999999999999999
Q ss_pred CCcccccC-CCcc-cC-CCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCc--hh----hhH-HHhcC
Q 011326 370 GLAKATTM-NDVK-SC-KGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE--GG----QAM-FKIGG 439 (488)
Q Consensus 370 Gla~~~~~-~~~~-~~-~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~--~~----~~~-~~i~~ 439 (488)
|+|+.... .... .. .||.+|+|||++. .+..+.++||||||++|+||++|+.|.+... .. +.. ..+..
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~--~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYAS--TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhc--cCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 99976654 3222 22 8999999999983 3668999999999999999999998876432 11 111 11111
Q ss_pred CCC-----CCCC-Cccc-----HHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 440 GEL-----PPVP-NSLS-----RDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 440 ~~~-----~~~~-~~~s-----~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
+.. +.+. ...+ ..+..+..+|++.+|.+||++.|+++.
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE 348 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence 111 1111 2222 236678999999999999999998643
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=327.45 Aligned_cols=251 Identities=26% Similarity=0.453 Sum_probs=208.4
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|++.+.||+|+||.||+|.+. +|..|++|.+...... ......+.+|+.++++++||||+++++++..+...++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE---GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc---chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence 5889999999999999999885 7899999998765422 22345788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC---
Q 011326 305 LELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--- 379 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--- 379 (488)
|||+ +++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9999 9999998854 358999999999999999999999999999999999999999999999999987654433
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC-------------------
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG------------------- 440 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~------------------- 440 (488)
.....|+..|+|||.+. ....++.++||||+|+++|+|++|.+||......+....+...
T Consensus 157 ~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 157 YSHQVATRWYRAPELLY-GARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred cccccCcccccCceeee-ccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 33456899999999873 3445689999999999999999998888765544332222110
Q ss_pred --CCC--------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCC
Q 011326 441 --ELP--------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481 (488)
Q Consensus 441 --~~~--------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~ 481 (488)
..+ ......+.++.+|+.+||+.+|.+|||++++++||||.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 000 11134678999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=347.05 Aligned_cols=255 Identities=27% Similarity=0.520 Sum_probs=219.1
Q ss_pred CCcccccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc
Q 011326 216 PNGKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD 295 (488)
Q Consensus 216 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 295 (488)
+...|.+..++..++..||+|+||+||+|.+.+ .||||++..... ..+..+.|++|+.++++-+|.||+-+.|+|
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~p---t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~ 457 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDP---TPEQLQAFKNEVAVLKKTRHENILLFMGAC 457 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCC---CHHHHHHHHHHHHHHhhcchhhheeeehhh
Confidence 346678888899999999999999999999864 599999987764 344778999999999999999999999999
Q ss_pred cCCCceEEEEeeccCCChHHHHh--hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 296 RDEKRLCIFLELVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 296 ~~~~~~~lV~E~~~~gsL~~~l~--~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
..+.. .||+-+|+|.+|..+++ +..|.......|++||++||.|||.++|||||||..||++.+++.|||+|||++.
T Consensus 458 ~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 458 MNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred cCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEeccccee
Confidence 98877 99999999999999885 4468999999999999999999999999999999999999999999999999985
Q ss_pred ccc----CCCcccCCCCCcccCchhhcc-ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC----
Q 011326 374 ATT----MNDVKSCKGTAFWMAPEVVNL-KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP---- 444 (488)
Q Consensus 374 ~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~---- 444 (488)
... ........|...|||||++.. ....|++.+||||||+++|||++|..||...+.+..+..+-.++..+
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~ 616 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSK 616 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchh
Confidence 432 233445567888999999842 34568999999999999999999999999666666666666664432
Q ss_pred CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 445 VPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 445 ~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
....++.++++|+..||..++++||.+.+|+.
T Consensus 617 ~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 617 IRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 33568889999999999999999999999987
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=323.28 Aligned_cols=251 Identities=32% Similarity=0.579 Sum_probs=212.7
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||.|+||.||+|... ++..+++|.+..... ......+.+|+.+++.++|+||+++++.+..++..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 76 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC----QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL 76 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc----chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence 47899999999999999999875 688999999864332 1245678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh----ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 304 FLELVTKGSLASLYQKY----HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~----~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
+||++++++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999999998653 47999999999999999999999999999999999999999999999999986554332
Q ss_pred c------ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCC-----Cc
Q 011326 380 V------KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVP-----NS 448 (488)
Q Consensus 380 ~------~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~-----~~ 448 (488)
. ....|+..|+|||.+.. ...++.++|+||||+++|+|++|+.||...+..+..........+..+ ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQ-VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK 235 (267)
T ss_pred cccccccccccCChhhcChHHHcc-ccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccc
Confidence 1 23458899999999742 236889999999999999999999999877665555554443332222 25
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 449 LSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 449 ~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
+++++.+++.+||+.||++||++.+++.||||
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 78899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=335.54 Aligned_cols=242 Identities=29% Similarity=0.482 Sum_probs=188.8
Q ss_pred eeeecccCceEEEEEEec---CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC--CCceEEE
Q 011326 230 GELLGSGSYGFVYEGLTD---DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD--EKRLCIF 304 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~lV 304 (488)
++.||+|+||.||+|.+. ++..+|+|.+..... ...+.+|+.++++++||||+++++++.. +...+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence 357999999999999864 568899999864321 1346789999999999999999998743 5568999
Q ss_pred EeeccCCChHHHHhhh----------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEE----CCCCcEEEeecC
Q 011326 305 LELVTKGSLASLYQKY----------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILV----DASGSVKLADFG 370 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~----------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl----~~~~~vkL~DFG 370 (488)
|||+.+ +|.+++... .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 999876 787776421 48888999999999999999999999999999999999 456789999999
Q ss_pred CcccccCC-----CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh---------hhHHH
Q 011326 371 LAKATTMN-----DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG---------QAMFK 436 (488)
Q Consensus 371 la~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~---------~~~~~ 436 (488)
+++..... ......||+.|+|||++. ....++.++||||+||++|+|++|++||...... .....
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLL-GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHc-CCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 99765432 223567899999999873 3345889999999999999999999999643321 00000
Q ss_pred hcC--C-----------CCC------------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCcc
Q 011326 437 IGG--G-----------ELP------------------------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479 (488)
Q Consensus 437 i~~--~-----------~~~------------------------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~ 479 (488)
+.. + ..+ ......+.++.+||.+||++||.+|||++|+++|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 316 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 000 0 000 001123567889999999999999999999999999
Q ss_pred C
Q 011326 480 I 480 (488)
Q Consensus 480 f 480 (488)
|
T Consensus 317 f 317 (317)
T cd07868 317 F 317 (317)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=322.78 Aligned_cols=247 Identities=27% Similarity=0.464 Sum_probs=212.2
Q ss_pred cccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
...++|++.+.||+|+||.||+|...++..||+|.+.... .....+.+|+.++++++|+||+++++.+.+.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT------MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc------hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 3457899999999999999999998888899999876422 2245788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 302 CIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
+++|||+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999999988643 4788899999999999999999999999999999999999999999999999765432
Q ss_pred Cc---ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHH
Q 011326 379 DV---KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQ 454 (488)
Q Consensus 379 ~~---~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~ 454 (488)
.. ....++..|+|||.+ ....++.++|+||||+++|+|++ |..||......+....+......+....++.++.
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELY 234 (261)
T ss_pred ceeccCCCccceecCCHHHh--ccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 21 223456789999987 34557889999999999999998 9999988777777666666555555667899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHh
Q 011326 455 DFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+++.+||+.+|++||+++++.+
T Consensus 235 ~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 235 DIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=369.64 Aligned_cols=261 Identities=26% Similarity=0.461 Sum_probs=213.7
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC--C
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD--E 298 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~ 298 (488)
..+.+|++.+.||+|+||.||++.+. ++..+|+|.+..... .......+..|+.++.+++||||+++++++.+ .
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l---~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL---KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc---CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 35679999999999999999999885 688999999876532 23345678899999999999999999998743 4
Q ss_pred CceEEEEeeccCCChHHHHhh-----hccChhhhhHHHHHHHHHHHHHHHC-------CCccccCCcccEEECC------
Q 011326 299 KRLCIFLELVTKGSLASLYQK-----YHLSDSQVSSYTRQILNGLKYLHEQ-------NVVHRDIKCANILVDA------ 360 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~-----~~ls~~~~~~i~~qi~~aL~yLH~~-------giiHrDLkp~NILl~~------ 360 (488)
..+||||||+++|+|.+++.. ..+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 579999999999999998864 3589999999999999999999984 4999999999999964
Q ss_pred -----------CCcEEEeecCCcccccCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 011326 361 -----------SGSVKLADFGLAKATTMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHL 428 (488)
Q Consensus 361 -----------~~~vkL~DFGla~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~ 428 (488)
.+.+||+|||++....... .....||+.|+|||++......++.++|||||||+||+|++|..||...
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2358999999997654332 3456799999999997444456889999999999999999999999766
Q ss_pred chhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 429 EGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 429 ~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
+....+...............+.++.+||..||+.+|.+||++.|+|.|||++...+
T Consensus 247 ~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 247 NNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred CcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 554443333322222222457899999999999999999999999999999975543
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=323.22 Aligned_cols=249 Identities=42% Similarity=0.712 Sum_probs=205.8
Q ss_pred eeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEE
Q 011326 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFL 305 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 305 (488)
+.....||+|+||.||+|.+. ++..|++|.+.... ......+.+|+.++++++|+||+++++++..++..++++
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-----SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 333457999999999999875 68889999886432 334467889999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhh--cc--ChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC-CCcEEEeecCCcccccCCC-
Q 011326 306 ELVTKGSLASLYQKY--HL--SDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMND- 379 (488)
Q Consensus 306 E~~~~gsL~~~l~~~--~l--s~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~~- 379 (488)
||+++++|.+++... .+ ++..+..++.|++.||.|||++||+|+||||+||+++. ++.++|+|||++......+
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 999999999988653 34 78888999999999999999999999999999999976 6799999999986543322
Q ss_pred -cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhH-H-HhcCCCCCCCCCcccHHHHHH
Q 011326 380 -VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAM-F-KIGGGELPPVPNSLSRDAQDF 456 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~-~-~i~~~~~~~~~~~~s~~l~~L 456 (488)
.....|++.|+|||.+......++.++|+||+|+++|+|++|..||......... . .......+.++..+++++.++
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF 244 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHH
Confidence 2334588999999997544455789999999999999999999999764432211 1 111233345677889999999
Q ss_pred HHHhhhhCCCCCCCHHHHHhCccC
Q 011326 457 ILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 457 i~~cL~~dP~~Rps~~eil~hp~f 480 (488)
+.+||+.+|.+|||+.|++.||||
T Consensus 245 i~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 245 ILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHcCCCchhCCCHHHHHhCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=322.67 Aligned_cols=246 Identities=29% Similarity=0.464 Sum_probs=211.7
Q ss_pred ccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
..++|++.+.||+|++|.||+|.+.++..||+|.+..... ....+.+|+.++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM------DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc------cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 3467999999999999999999987788899999864321 2356788999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 303 IFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
++|||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999999999998654 48999999999999999999999999999999999999999999999999987665332
Q ss_pred cccCC---CCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHH
Q 011326 380 VKSCK---GTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455 (488)
Q Consensus 380 ~~~~~---gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~ 455 (488)
..... .+..|+|||.+ ....++.++|+||||+++|||++ |+.||.+.+.......+......+.+..++..+.+
T Consensus 158 ~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAA--LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYD 235 (261)
T ss_pred ccccCCCcCceeccCcccc--ccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 22222 33579999986 44568899999999999999999 99999887777777666665555566778999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHh
Q 011326 456 FILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~eil~ 476 (488)
++.+||+.+|.+||++.++++
T Consensus 236 li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 236 IMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHhhcCcccCCCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=326.92 Aligned_cols=254 Identities=34% Similarity=0.583 Sum_probs=210.1
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCC-
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDE- 298 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~- 298 (488)
...++|++.+.||+|+||.||++... ++..+|+|.+.... .....+.+|+.++.++ +|||++++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 34678999999999999999999885 78999999986432 1234567889999988 899999999987643
Q ss_pred ----CceEEEEeeccCCChHHHHhh-----hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeec
Q 011326 299 ----KRLCIFLELVTKGSLASLYQK-----YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADF 369 (488)
Q Consensus 299 ----~~~~lV~E~~~~gsL~~~l~~-----~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DF 369 (488)
+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~df 172 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDF 172 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeec
Confidence 368999999999999988752 35899999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCC--cccCCCCCcccCchhhcccc---CCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC
Q 011326 370 GLAKATTMND--VKSCKGTAFWMAPEVVNLKK---DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP 444 (488)
Q Consensus 370 Gla~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~ 444 (488)
|++....... .....|+..|+|||.+.... ..++.++|+||||+++|+|++|+.||...+..+....+.....+.
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 252 (291)
T cd06639 173 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPT 252 (291)
T ss_pred ccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCC
Confidence 9987544322 23456889999999873221 236889999999999999999999998876666555554443322
Q ss_pred --CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCC
Q 011326 445 --VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481 (488)
Q Consensus 445 --~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~ 481 (488)
.+...+.++.+||.+||+.+|++||++.++++||||+
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 253 LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 2445778999999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=322.68 Aligned_cols=254 Identities=34% Similarity=0.716 Sum_probs=211.0
Q ss_pred ceeeeeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcc-hhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRG-KQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
+|+.++.||+|++|.||++.+ .++..+|+|.+......... ......+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999987 47899999998754432221 2345788999999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC-cEEEeecCCcccccCCC--
Q 011326 304 FLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG-SVKLADFGLAKATTMND-- 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~~-- 379 (488)
||||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 99999999999988654 589999999999999999999999999999999999998776 59999999986554321
Q ss_pred ----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHH---Hh-cCCCCCCCCCcccH
Q 011326 380 ----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF---KI-GGGELPPVPNSLSR 451 (488)
Q Consensus 380 ----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~---~i-~~~~~~~~~~~~s~ 451 (488)
.....++..|+|||.+ .+..++.++|+||+|+++++|++|..||...+...... .+ .....+..+..+++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~--~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVL--RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred CCccccccccccceeCHhHh--ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence 1234578899999997 44567899999999999999999999996544322211 11 12333456677899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHhCccCC
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~hp~f~ 481 (488)
++.+++.+||+.+|.+||++.++++||||+
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 999999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=351.98 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=195.1
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC------CCCcceeeccc
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE------HDNIVQYLGTD 295 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~------HpnIv~l~~~~ 295 (488)
...+|++.+.||+|+||.||+|.+. ++..||||++.... ........|+.+++.++ |++++.+++++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP------KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch------hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3578999999999999999999885 68899999986422 11223445666665554 45688888887
Q ss_pred cCC-CceEEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHH-CCCccccCCcccEEECCCC----------
Q 011326 296 RDE-KRLCIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHE-QNVVHRDIKCANILVDASG---------- 362 (488)
Q Consensus 296 ~~~-~~~~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~NILl~~~~---------- 362 (488)
..+ ..+|+|||++ +++|.+++.+ ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 654 5789999988 5578777654 469999999999999999999998 5999999999999998765
Q ss_pred ------cEEEeecCCcccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHH
Q 011326 363 ------SVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFK 436 (488)
Q Consensus 363 ------~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~ 436 (488)
.+||+|||.+.... .......||+.|+|||++ .+..++.++|||||||++|||++|+.||.+.+..+....
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~-~~~~~~~gt~~Y~APE~~--~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDER-HSRTAIVSTRHYRSPEVV--LGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred cCCCCceEEECCCCccccCc-cccccccCCccccCcHHh--hcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 49999999875432 223456799999999997 455689999999999999999999999987665443332
Q ss_pred hcCCC--C------------------------CCC---------------CCcccHHHHHHHHHhhhhCCCCCCCHHHHH
Q 011326 437 IGGGE--L------------------------PPV---------------PNSLSRDAQDFILKCLQVNPNDRPTAAQLM 475 (488)
Q Consensus 437 i~~~~--~------------------------~~~---------------~~~~s~~l~~Li~~cL~~dP~~Rps~~eil 475 (488)
+.... . +.. ....++.+.+||.+||++||++|||++|++
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 21100 0 000 001245678999999999999999999999
Q ss_pred hCccCCCCC
Q 011326 476 EHPFIKRPL 484 (488)
Q Consensus 476 ~hp~f~~~~ 484 (488)
+||||++..
T Consensus 437 ~Hp~~~~~~ 445 (467)
T PTZ00284 437 THPYVLKYY 445 (467)
T ss_pred cCccccccC
Confidence 999998743
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=319.76 Aligned_cols=250 Identities=31% Similarity=0.596 Sum_probs=215.9
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|++.+.||+|+||.||++.+. +|..+|+|.+....... .....+.+|+.++++++|+||+++++.+.+++..+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV---KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc---hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence 4788999999999999999886 68899999987643221 2335677899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC-cEEEeecCCcccccCCC-
Q 011326 305 LELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG-SVKLADFGLAKATTMND- 379 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~~- 379 (488)
+||+++++|.+++... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999999988653 378999999999999999999999999999999999999876 46999999987654332
Q ss_pred -cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHH
Q 011326 380 -VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFIL 458 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~ 458 (488)
.....|++.|+|||.+ ....++.++|+||||+++++|++|..||...+..+....+.....++.+..++.++.+++.
T Consensus 158 ~~~~~~~~~~~~ape~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 235 (257)
T cd08225 158 LAYTCVGTPYYLSPEIC--QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLIS 235 (257)
T ss_pred cccccCCCccccCHHHH--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Confidence 2234688999999986 3455889999999999999999999999877777766666666666667788999999999
Q ss_pred HhhhhCCCCCCCHHHHHhCccC
Q 011326 459 KCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 459 ~cL~~dP~~Rps~~eil~hp~f 480 (488)
+||+.+|++|||+.+++.||||
T Consensus 236 ~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 236 QLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHhccChhhCcCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=320.65 Aligned_cols=253 Identities=36% Similarity=0.614 Sum_probs=219.2
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|++|.||++.+. ++..|++|.+...... .....+.+|+..+.+++|+||+++++++..++..++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE----EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI 76 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEE
Confidence 36889999999999999999886 5999999998764321 445678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHH-CCCccccCCcccEEECCCCcEEEeecCCcccccCCCcc
Q 011326 304 FLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK 381 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 381 (488)
+|||+++++|.+++.. ..+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 77 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 77 VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999999865 568999999999999999999999 99999999999999999999999999998765443322
Q ss_pred --cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCc---hhhhHHHhcCCCCCCCCCc-ccHHHHH
Q 011326 382 --SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE---GGQAMFKIGGGELPPVPNS-LSRDAQD 455 (488)
Q Consensus 382 --~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~---~~~~~~~i~~~~~~~~~~~-~s~~l~~ 455 (488)
...++..|+|||.+ ....++.++|+||||+++|+|++|..||.... ..+....+.....+..+.. ++..+.+
T Consensus 157 ~~~~~~~~~y~~pE~~--~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 234 (264)
T cd06623 157 CNTFVGTVTYMSPERI--QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD 234 (264)
T ss_pred ccceeecccccCHhhh--CCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence 45688899999997 44568899999999999999999999997763 3444555555555566666 8999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 456 FILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
++.+||+.+|++||++.++++||||+..
T Consensus 235 li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 235 FISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 9999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=321.73 Aligned_cols=246 Identities=24% Similarity=0.433 Sum_probs=212.1
Q ss_pred cCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
..+|++.+.||+|+||.||.+...++..+|+|.+..... ....+.+|+.++++++||||+++++++.+.+..++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc------cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence 357899999999999999999887777899999864321 23567899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCcc
Q 011326 304 FLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK 381 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 381 (488)
+|||+++|+|.+++... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||.++........
T Consensus 77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999999999998653 5899999999999999999999999999999999999999999999999998754333221
Q ss_pred ---cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHH
Q 011326 382 ---SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFI 457 (488)
Q Consensus 382 ---~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li 457 (488)
...++..|+|||.+ ....++.++|+||||+++|+|++ |..||...+..+....+........+...+..+.+++
T Consensus 157 ~~~~~~~~~~y~~pe~~--~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 234 (256)
T cd05113 157 SSVGSKFPVRWSPPEVL--LYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIM 234 (256)
T ss_pred ecCCCccChhhCCHHHH--hcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 23355679999997 34558899999999999999998 9999988777777777776666666777899999999
Q ss_pred HHhhhhCCCCCCCHHHHHhC
Q 011326 458 LKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 458 ~~cL~~dP~~Rps~~eil~h 477 (488)
.+||+.+|.+||++.+++.+
T Consensus 235 ~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 235 YSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHcCCCcccCCCHHHHHHh
Confidence 99999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=319.14 Aligned_cols=252 Identities=43% Similarity=0.808 Sum_probs=212.5
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|++.+.||+|+||.||++.+. ++..|++|.+...... ......+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc---hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence 5888999999999999999875 7899999999765432 34567889999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCc---
Q 011326 305 LELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--- 380 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~--- 380 (488)
+||+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 9999999999998765 488999999999999999999999999999999999999999999999999876543321
Q ss_pred ---ccCCCCCcccCchhhcccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCch-hhhHHHhcCCCCCCCCCc--ccHHH
Q 011326 381 ---KSCKGTAFWMAPEVVNLKK-DGYGLTADIWSLGCTVLEMLTRRHPYSHLEG-GQAMFKIGGGELPPVPNS--LSRDA 453 (488)
Q Consensus 381 ---~~~~gt~~y~aPE~~~~~~-~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~--~s~~l 453 (488)
....++..|+|||.+.... ..++.++||||||+++|+|++|+.||..... ......+.....+..+.. +++.+
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHH
Confidence 1345788999999974322 3378899999999999999999999976533 233333333434444444 48999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 454 QDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
.+++.+||+.+|.+||++.+++.|||+
T Consensus 238 ~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 238 KDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=328.94 Aligned_cols=250 Identities=28% Similarity=0.479 Sum_probs=201.7
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|++.+.||+|+||.||+|.+. +|..+|+|.+...... ......+.+|+.++++++||||+++++++.+....+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~---~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc---ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence 4888999999999999999885 7999999999754321 12224567899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--Cc
Q 011326 305 LELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DV 380 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~ 380 (488)
+||+++ +|.+++.. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...... ..
T Consensus 78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 78 FEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence 999975 77776643 35899999999999999999999999999999999999999999999999998754432 22
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCC-CchhhhHHHhcC-------------------C
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSH-LEGGQAMFKIGG-------------------G 440 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~-~~~~~~~~~i~~-------------------~ 440 (488)
....+++.|+|||.+. ....++.++|+||||+++|+|++|..|+.. .+..+....+.. .
T Consensus 157 ~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 157 SAEVVTLWYRPPDVLF-GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred CCCccccCCcChHHHh-CCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence 3456788999999873 334578899999999999999999888643 222222111100 0
Q ss_pred CC---------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 441 EL---------PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 441 ~~---------~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
.. ......+++++.++|.+||+.||.+|||++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00 01123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=342.92 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=209.6
Q ss_pred CCcccccccCceeeeeeecccCceEEEEEEe------cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCc
Q 011326 216 PNGKFRRRITSWQKGELLGSGSYGFVYEGLT------DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNI 288 (488)
Q Consensus 216 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnI 288 (488)
...++....++|++++.||+|+||.||+|.+ .++..||+|++..... ......+.+|+.++..+ +||||
T Consensus 26 ~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~Ei~il~~l~~HpnI 101 (375)
T cd05104 26 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH----LTEREALMSELKVLSYLGNHINI 101 (375)
T ss_pred CccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC----cHHHHHHHHHHHHHHHhcCCcce
Confidence 3445666677899999999999999999964 2467899999864321 22345788999999999 89999
Q ss_pred ceeeccccCCCceEEEEeeccCCChHHHHhhh------------------------------------------------
Q 011326 289 VQYLGTDRDEKRLCIFLELVTKGSLASLYQKY------------------------------------------------ 320 (488)
Q Consensus 289 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~------------------------------------------------ 320 (488)
+++++++.+.+..++||||+++|+|.+++...
T Consensus 102 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 181 (375)
T cd05104 102 VNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPT 181 (375)
T ss_pred eeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccc
Confidence 99999999999999999999999999888532
Q ss_pred ----------------------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCc
Q 011326 321 ----------------------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLA 372 (488)
Q Consensus 321 ----------------------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla 372 (488)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 261 (375)
T cd05104 182 KADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA 261 (375)
T ss_pred ccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccc
Confidence 2577788999999999999999999999999999999999999999999998
Q ss_pred ccccCCCc----ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhh-hHHHhcCCCCCCCC
Q 011326 373 KATTMNDV----KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQ-AMFKIGGGELPPVP 446 (488)
Q Consensus 373 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~-~~~~i~~~~~~~~~ 446 (488)
+....... ....++..|+|||.+ ....++.++||||||+++|||++ |..||....... ....+..+.....+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 339 (375)
T cd05104 262 RDIRNDSNYVVKGNARLPVKWMAPESI--FNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSP 339 (375)
T ss_pred eeccCcccccccCCCCCCcceeChhHh--cCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCC
Confidence 75543321 123345679999997 45568999999999999999998 899997765433 33334444444556
Q ss_pred CcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 447 NSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 447 ~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
...+.++.+|+.+||+.||++|||+.|+++.
T Consensus 340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 6778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=320.12 Aligned_cols=246 Identities=28% Similarity=0.498 Sum_probs=214.6
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|++.+.||+|+||.||++.+. ++..+|+|.+..... ......+.+|+.+++.++||||+++++.+.+++.++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS----SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV 76 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc----hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 5889999999999999999885 789999999865431 23345778899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhh---hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 305 LELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~---~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 999999999888754 247899999999999999999999999999999999999999999999999987554322
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILK 459 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~ 459 (488)
.....|++.|+|||++ ....++.++|+||||+++|+|++|..||...+.......+..+...+.+..++.++.+|+.+
T Consensus 157 ~~~~~~~~~~~aPE~~--~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 234 (255)
T cd08219 157 ACTYVGTPYYVPPEIW--ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQ 234 (255)
T ss_pred cccccCCccccCHHHH--ccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence 2345688999999997 44558899999999999999999999998877766677777777777788899999999999
Q ss_pred hhhhCCCCCCCHHHHHhC
Q 011326 460 CLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 460 cL~~dP~~Rps~~eil~h 477 (488)
||+.||++||++.+++.-
T Consensus 235 ~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 235 MFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHhCCcccCCCHHHHhhc
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=325.46 Aligned_cols=248 Identities=25% Similarity=0.453 Sum_probs=211.6
Q ss_pred cCceeeeeeecccCceEEEEEEe-----cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLT-----DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
+.+|++.+.||+|+||.||+|.. .++..+++|.+.... .......+.+|+.++++++||||+++++++..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN----NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC----CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 56789999999999999999974 256789999986432 234456788999999999999999999999999
Q ss_pred CceEEEEeeccCCChHHHHhh------------------hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC
Q 011326 299 KRLCIFLELVTKGSLASLYQK------------------YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA 360 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~------------------~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~ 360 (488)
+..+++|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 999999999999999998842 13678888999999999999999999999999999999999
Q ss_pred CCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHH
Q 011326 361 SGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMF 435 (488)
Q Consensus 361 ~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~ 435 (488)
++.++|+|||+++...... .....++..|+|||.+ ....++.++|+||||+++|||++ |..||.+........
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAI--MYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHh--ccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999987543322 2234456779999987 34558999999999999999998 999998877766666
Q ss_pred HhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 436 KIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 436 ~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.+......+.+..+++++.+++.+||+.||.+||++.+|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 238 MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 666666667778899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=324.78 Aligned_cols=251 Identities=37% Similarity=0.635 Sum_probs=207.9
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+.+++.++||||+++++.+...+..+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence 357889999999999999999875 68999999987542 122345778999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--C
Q 011326 303 IFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--D 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~ 379 (488)
++|||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...... .
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 999999999999988654 5899999999999999999999999999999999999999999999999998654322 1
Q ss_pred cccCCCCCcccCchhhcc-ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC-C-C--CCcccHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNL-KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP-P-V--PNSLSRDAQ 454 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~-~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~-~-~--~~~~s~~l~ 454 (488)
.....|+..|+|||.+.. ....++.++|+||||+++|+|++|..||.................. + . ...++..+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 234568999999998632 2445788999999999999999999998665443333322222211 1 1 124778999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCcc
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPF 479 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~ 479 (488)
+++.+||+.+|++||+++++++|||
T Consensus 243 ~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 243 HFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhcCCC
Confidence 9999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=325.66 Aligned_cols=247 Identities=27% Similarity=0.453 Sum_probs=213.0
Q ss_pred cCceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
..+|.+.+.||+|+||.||+|... ++..||+|.+.... .......+.+|++++++++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 79 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA----SNDARKDFEREAELLTNFQHENIVKFYGVCTE 79 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC----CHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence 457888999999999999999763 35789999986432 23345688899999999999999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhhh---------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY---------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG 362 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~---------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~ 362 (488)
....+++|||+++++|.+++... .+++..+..++.|++.|+.|||++|++|+||||+||+++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence 99999999999999999998643 367888999999999999999999999999999999999999
Q ss_pred cEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHh
Q 011326 363 SVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKI 437 (488)
Q Consensus 363 ~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i 437 (488)
.++|+|||++....... .....+++.|+|||.+ ....++.++||||||+++|||++ |..||...+..+....+
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhh--ccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 99999999986543222 1233457789999997 45568999999999999999998 99999888888777777
Q ss_pred cCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 438 GGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 438 ~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
..+.....+..++.++.+++.+||+.||++||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 238 TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 777776777789999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=339.86 Aligned_cols=245 Identities=27% Similarity=0.376 Sum_probs=195.4
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
..+|++.+.||+|+||.||+|.+. ++..||+|..... ....|+.++++++||||+++++++...+..+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----------ccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 457999999999999999999886 6789999975321 1246889999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC-C
Q 011326 303 IFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-D 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~ 379 (488)
+|||++.+ +|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... .
T Consensus 134 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 134 MVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred EEEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcc
Confidence 99999965 77777754 35899999999999999999999999999999999999999999999999998653322 2
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCC-CCCchh---------hhHHHhcC------CCCC
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY-SHLEGG---------QAMFKIGG------GELP 443 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf-~~~~~~---------~~~~~i~~------~~~~ 443 (488)
.....||+.|+|||++ .+..++.++|||||||++|||+++..|+ ...... ..+..+.. ...+
T Consensus 213 ~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 213 FLGLAGTVETNAPEVL--ARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred cccccccccccCCeec--CCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 3456799999999997 4456899999999999999999855444 322111 00000000 0000
Q ss_pred --------------------C-------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 444 --------------------P-------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 444 --------------------~-------~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
+ ....++.++.+||.+||+.||.+|||+.|+++||||++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0 01235667888999999999999999999999999986
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=319.71 Aligned_cols=247 Identities=39% Similarity=0.681 Sum_probs=211.0
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||+|... ++..+++|.+.... ....+.+|+.++++++||||+++++++.++...++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-------DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-------HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence 57888999999999999999986 48999999986432 15678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 304 FLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
++||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 9999999999999864 358999999999999999999999999999999999999999999999999987654432
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC--CCCCcccHHHHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP--PVPNSLSRDAQDFI 457 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~Li 457 (488)
.....++..|+|||.+ .+..++.++||||||+++|+|++|+.||...........+.....+ ..+..++.++.+++
T Consensus 156 ~~~~~~~~~y~~PE~~--~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (256)
T cd06612 156 RNTVIGTPFWMAPEVI--QEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV 233 (256)
T ss_pred cccccCCccccCHHHH--hcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHH
Confidence 2344588899999997 3456889999999999999999999999876555444333322221 23345788999999
Q ss_pred HHhhhhCCCCCCCHHHHHhCccC
Q 011326 458 LKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 458 ~~cL~~dP~~Rps~~eil~hp~f 480 (488)
.+||+.||.+|||+.|++.||||
T Consensus 234 ~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 234 KKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=321.18 Aligned_cols=247 Identities=28% Similarity=0.460 Sum_probs=212.1
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
...+|++.+.||+|+||.||+|.+. ++..||+|.+... ......+.+|+.+++.++||||+++++++..++.+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC------chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 3467899999999999999999875 6889999998632 22345688999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 302 CIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
+++|||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999999988643 4888999999999999999999999999999999999999999999999998765433
Q ss_pred Ccc---cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHH
Q 011326 379 DVK---SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQ 454 (488)
Q Consensus 379 ~~~---~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~ 454 (488)
... ...++..|+|||.+ ....++.++||||||+++|||++ |..||.+.+..+....+.....+..+..++.++.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVY 235 (263)
T ss_pred eeeccCCCCCccccCCHHHh--ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 221 22345679999987 44568899999999999999998 9999988777776666666656667788999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~h 477 (488)
+++.+||+.||++||++.++++.
T Consensus 236 ~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 236 ELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHHHHccCCcccCCCHHHHHHH
Confidence 99999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=320.22 Aligned_cols=250 Identities=40% Similarity=0.659 Sum_probs=211.3
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||+|.+. ++..+++|.+..... .....+.+|+.++++++||||+++++++.+++.+++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-----DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-----hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEE
Confidence 57999999999999999999875 688999999975432 244678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 304 FLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
+|||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 99999999999988654 69999999999999999999999999999999999999999999999999986544322
Q ss_pred cccCCCCCcccCchhhccc-cCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC----CCCCcccHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNLK-KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP----PVPNSLSRDAQ 454 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~-~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~----~~~~~~s~~l~ 454 (488)
.....++..|+|||.+... ...++.++|+||||+++|+|++|..||...+..+....+...... ..+..++.++.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence 2345688899999997322 126788999999999999999999999876655544444333211 12334678899
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCcc
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPF 479 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~ 479 (488)
+++.+||+.+|.+|||+.+++.|+|
T Consensus 238 ~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 238 DFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHhcCCC
Confidence 9999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=325.32 Aligned_cols=258 Identities=26% Similarity=0.445 Sum_probs=214.9
Q ss_pred cccccCceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeec
Q 011326 220 FRRRITSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLG 293 (488)
Q Consensus 220 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~ 293 (488)
|....++|++.+.||+|+||.||+|..+ .+..||+|.+.... .......+.+|+.+++.++||||+++++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 76 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA----SLRERIEFLNEASVMKGFTCHHVVRLLG 76 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC----CHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 3445678999999999999999998643 25589999875432 1223346788999999999999999999
Q ss_pred cccCCCceEEEEeeccCCChHHHHhhhc-----------cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC
Q 011326 294 TDRDEKRLCIFLELVTKGSLASLYQKYH-----------LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG 362 (488)
Q Consensus 294 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~ 362 (488)
++.+.+..++||||+++|+|.+++.... ++...+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 77 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~ 156 (288)
T cd05061 77 VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF 156 (288)
T ss_pred EEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC
Confidence 9999999999999999999999986421 35567888999999999999999999999999999999999
Q ss_pred cEEEeecCCcccccCCCc----ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHh
Q 011326 363 SVKLADFGLAKATTMNDV----KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKI 437 (488)
Q Consensus 363 ~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i 437 (488)
.++|+|||+++....... ....++..|+|||.+ ....++.++|+||||+++|||++ |..||......+....+
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~--~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHh--ccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999875433221 122356779999987 34568999999999999999998 78999887777777766
Q ss_pred cCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh------CccCCCC
Q 011326 438 GGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME------HPFIKRP 483 (488)
Q Consensus 438 ~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~------hp~f~~~ 483 (488)
..+.....+..+++++.+++.+||+.||.+|||+.++++ ||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 235 MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 666666667788999999999999999999999999987 9999753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=321.50 Aligned_cols=245 Identities=23% Similarity=0.412 Sum_probs=210.3
Q ss_pred CceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
.+|++.+.||+|+||.||++.++++..+|+|.+..... ....+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM------SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 46888999999999999999888778899999864321 224677899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCccc
Q 011326 305 LELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS 382 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 382 (488)
|||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999999999988653 48899999999999999999999999999999999999999999999999987554332222
Q ss_pred C---CCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHH
Q 011326 383 C---KGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFIL 458 (488)
Q Consensus 383 ~---~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~ 458 (488)
. .++..|+|||.+ .+..++.++|+||||+++|+|++ |..||...+..+....+........+..++.++.+++.
T Consensus 158 ~~~~~~~~~y~~Pe~~--~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05059 158 SQGTKFPVKWAPPEVF--DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMY 235 (256)
T ss_pred cCCCCCCccccCHHHh--ccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 2 234579999987 34568899999999999999999 89999887777777777666556667788999999999
Q ss_pred HhhhhCCCCCCCHHHHHhC
Q 011326 459 KCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 459 ~cL~~dP~~Rps~~eil~h 477 (488)
+||+.+|++|||+.|+++.
T Consensus 236 ~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 236 SCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHhcCChhhCcCHHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=324.62 Aligned_cols=254 Identities=33% Similarity=0.576 Sum_probs=207.7
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccc---
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTD--- 295 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~--- 295 (488)
....++|++.+.||+|+||.||++.+. ++..+|+|.+.... .....+.+|+.++..+ +||||+++++++
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH------DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc------chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 345678999999999999999999885 68899999875421 1224577899999998 699999999987
Q ss_pred --cCCCceEEEEeeccCCChHHHHhh-----hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEee
Q 011326 296 --RDEKRLCIFLELVTKGSLASLYQK-----YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLAD 368 (488)
Q Consensus 296 --~~~~~~~lV~E~~~~gsL~~~l~~-----~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~D 368 (488)
..++..+++|||+++++|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEcc
Confidence 345679999999999999987742 3478889999999999999999999999999999999999999999999
Q ss_pred cCCcccccCCC--cccCCCCCcccCchhhcc---ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC
Q 011326 369 FGLAKATTMND--VKSCKGTAFWMAPEVVNL---KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP 443 (488)
Q Consensus 369 FGla~~~~~~~--~~~~~gt~~y~aPE~~~~---~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~ 443 (488)
||++....... .....|++.|+|||.+.. ....++.++|+||+|+++|+|++|+.||.................+
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (286)
T cd06638 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP 247 (286)
T ss_pred CCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence 99987554322 234568999999998732 1344788999999999999999999999876554444333322211
Q ss_pred --CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 444 --PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 444 --~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
..+..++.++.+|+.+||+.||++|||+.|+++|+||
T Consensus 248 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 1344568899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=330.45 Aligned_cols=254 Identities=32% Similarity=0.524 Sum_probs=213.4
Q ss_pred eeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEE
Q 011326 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFL 305 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 305 (488)
|.....||+|+||.||++.+. ++..||+|.+... .......+.+|+.+++.++||||+++++.+..++..++||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 344566999999999999875 6889999998642 2334456889999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--cccC
Q 011326 306 ELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSC 383 (488)
Q Consensus 306 E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~ 383 (488)
||+++++|.+++....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... ....
T Consensus 99 e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 178 (292)
T cd06658 99 EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL 178 (292)
T ss_pred eCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence 99999999999877789999999999999999999999999999999999999999999999999986443222 2345
Q ss_pred CCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC--CCCcccHHHHHHHHHhh
Q 011326 384 KGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP--VPNSLSRDAQDFILKCL 461 (488)
Q Consensus 384 ~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~Li~~cL 461 (488)
.|+..|+|||.+ ....++.++|+||+|+++|||++|+.||...+.......+.....+. ....++..+.+++.+||
T Consensus 179 ~~~~~y~aPE~~--~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 256 (292)
T cd06658 179 VGTPYWMAPEVI--SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLML 256 (292)
T ss_pred ecCccccCHHHH--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHc
Confidence 688999999987 44568899999999999999999999998766555444443322222 22357889999999999
Q ss_pred hhCCCCCCCHHHHHhCccCCCCCCCC
Q 011326 462 QVNPNDRPTAAQLMEHPFIKRPLQTS 487 (488)
Q Consensus 462 ~~dP~~Rps~~eil~hp~f~~~~~~~ 487 (488)
..||.+|||++++++||||+..-.++
T Consensus 257 ~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 257 VREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred cCChhHCcCHHHHhhChhhhccCCcc
Confidence 99999999999999999998766554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=323.53 Aligned_cols=256 Identities=32% Similarity=0.535 Sum_probs=210.2
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC--CCce
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD--EKRL 301 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~ 301 (488)
++|+..+.||.|++|.||++.+. ++..+|+|.+..... .....++.+|++++++++||||+++++++.+ .+.+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN----PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc----hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence 36889999999999999999985 689999999875422 2345678899999999999999999998754 4478
Q ss_pred EEEEeeccCCChHHHHhh-----hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 302 CIFLELVTKGSLASLYQK-----YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~-----~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999999887643 347889999999999999999999999999999999999999999999999987654
Q ss_pred CCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCc-----hhhhHHHhcCCCCCCCC-----
Q 011326 377 MNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE-----GGQAMFKIGGGELPPVP----- 446 (488)
Q Consensus 377 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~-----~~~~~~~i~~~~~~~~~----- 446 (488)
........++..|+|||.+ ....++.++|+||||+++|+|++|..||.... ..+....+.....+..+
T Consensus 157 ~~~~~~~~~~~~y~~pE~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd06621 157 NSLAGTFTGTSFYMAPERI--QGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234 (287)
T ss_pred ccccccccCCccccCHHHh--cCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence 4444455688899999987 44568899999999999999999999997652 12223332222221111
Q ss_pred -CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 447 -NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 447 -~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
...++++.+++.+||+.+|.+|||+.|++.||||++...+
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 2356789999999999999999999999999999877664
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=321.38 Aligned_cols=252 Identities=33% Similarity=0.620 Sum_probs=210.0
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCC-
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEK- 299 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~- 299 (488)
..++|++.+.||+|++|.||+|.+. ++..+++|.+.... .....+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE------DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc------hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 3578999999999999999999985 68899999987532 2335788999999998 7999999999986544
Q ss_pred -----ceEEEEeeccCCChHHHHhh-----hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeec
Q 011326 300 -----RLCIFLELVTKGSLASLYQK-----YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADF 369 (488)
Q Consensus 300 -----~~~lV~E~~~~gsL~~~l~~-----~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DF 369 (488)
.+++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCC
Confidence 58999999999999988754 35899999999999999999999999999999999999999999999999
Q ss_pred CCcccccCC--CcccCCCCCcccCchhhccc---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC
Q 011326 370 GLAKATTMN--DVKSCKGTAFWMAPEVVNLK---KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP 444 (488)
Q Consensus 370 Gla~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~ 444 (488)
|++...... ......|+..|+|||.+... ...++.++||||||+++|+|++|..||...........+.....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence 998654322 22345689999999987322 2346789999999999999999999998766555555555443322
Q ss_pred C--CCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 445 V--PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 445 ~--~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
. +..+++++.+|+.+||..||++|||+.|+++|||+
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2 23477899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=340.45 Aligned_cols=246 Identities=24% Similarity=0.336 Sum_probs=200.5
Q ss_pred cCceeeeeeecccCceEEEEEEec---CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD---DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 300 (488)
..+|++.+.||+|+||.||++... .+..||+|.+... ....+|+.+|++++||||+++++++.....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----------KTPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 457999999999999999999753 4678999987532 124579999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 301 LCIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
.+++||++.+ +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 161 ~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 161 VCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEEEehhcCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9999999975 77777743 468999999999999999999999999999999999999999999999999986544332
Q ss_pred ----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhh---hHHHhc--------------
Q 011326 380 ----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ---AMFKIG-------------- 438 (488)
Q Consensus 380 ----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~---~~~~i~-------------- 438 (488)
.....||+.|+|||++ ....++.++|||||||++|||++|+.||.+..... .+..+.
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELL--ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccCccCHhHh--cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 2245699999999997 44568999999999999999999999997643221 111100
Q ss_pred ------------CCCCCC--C-----CCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 439 ------------GGELPP--V-----PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 439 ------------~~~~~~--~-----~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
....++ . ...++.++.++|.+||+.||++|||+.|++.||||++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 000000 0 1235678899999999999999999999999999975
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=327.56 Aligned_cols=254 Identities=30% Similarity=0.461 Sum_probs=213.0
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||++.+. ++..|++|.+..... ........+.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL--ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh--hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence 36889999999999999999886 688999999875432 122334577899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC---
Q 011326 304 FLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--- 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--- 379 (488)
+|||++|++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 99999999999998654 48999999999999999999999999999999999999999999999999886321110
Q ss_pred --------------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC--C
Q 011326 380 --------------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL--P 443 (488)
Q Consensus 380 --------------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~--~ 443 (488)
.....++..|+|||.+ ....++.++|+||||+++|||++|..||.+....+....+..... +
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVI--LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 236 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhc--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence 1123578889999986 445689999999999999999999999988776666665544432 2
Q ss_pred CCCCcccHHHHHHHHHhhhhCCCCCCC---HHHHHhCccCCC
Q 011326 444 PVPNSLSRDAQDFILKCLQVNPNDRPT---AAQLMEHPFIKR 482 (488)
Q Consensus 444 ~~~~~~s~~l~~Li~~cL~~dP~~Rps---~~eil~hp~f~~ 482 (488)
.....++.++.++|.+||+.||++||+ +.++++||||..
T Consensus 237 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 237 EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 233467899999999999999999998 799999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=325.85 Aligned_cols=252 Identities=34% Similarity=0.562 Sum_probs=207.3
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||+|.+. ++..||+|.+...... ......+.+|+.+++.++||||+++++++..++..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD---KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL 77 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc---chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence 36889999999999999999986 6899999998654322 1234567889999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--c
Q 011326 304 FLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--V 380 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~ 380 (488)
||||+++++|..+.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 99999999998877543 58999999999999999999999999999999999999999999999999987543322 2
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC---------------------
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG--------------------- 439 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~--------------------- 439 (488)
....++..|+|||++. ....++.++||||||+++|||++|++||......+....+..
T Consensus 158 ~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 158 TDYVATRWYRAPELLV-GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred CcccceeeccCcHHhc-cccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 3456888999999873 334578899999999999999999999976543322111110
Q ss_pred CCCC---------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 440 GELP---------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 440 ~~~~---------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
...+ .....++..+.+|+.+||+.+|++||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000 1123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=322.83 Aligned_cols=250 Identities=26% Similarity=0.449 Sum_probs=210.4
Q ss_pred cccCceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD 295 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 295 (488)
...++|++.+.||+|+||.||+|.+. ++..||+|.+.... ......++.+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~ 78 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 34567999999999999999998753 35679999875322 223345688999999999999999999999
Q ss_pred cCCCceEEEEeeccCCChHHHHhhh-----------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcE
Q 011326 296 RDEKRLCIFLELVTKGSLASLYQKY-----------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSV 364 (488)
Q Consensus 296 ~~~~~~~lV~E~~~~gsL~~~l~~~-----------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~v 364 (488)
.++...++||||+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCE
Confidence 9999999999999999999988642 24667888999999999999999999999999999999999999
Q ss_pred EEeecCCcccccCCCc----ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcC
Q 011326 365 KLADFGLAKATTMNDV----KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGG 439 (488)
Q Consensus 365 kL~DFGla~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~ 439 (488)
+|+|||++........ ....++..|+|||.+ ....++.++|+||||+++|||++ |..||.+.+..+....+..
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHh--hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999865432221 123457789999997 34568999999999999999999 7899988877777766666
Q ss_pred CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 440 GELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 440 ~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
......+..+++.+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 237 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 66666778899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=325.11 Aligned_cols=243 Identities=29% Similarity=0.501 Sum_probs=205.1
Q ss_pred eeeeeecccCceEEEEEEec-----CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 228 QKGELLGSGSYGFVYEGLTD-----DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 228 ~~~~~LG~G~fg~Vy~~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
++.+.||.|+||.||+|.+. .+..|+||.+... ........+.+|++.+++++||||+++++++...+..+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS----SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT----SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc----cccccceeeeeccccccccccccccccccccccccccc
Confidence 46788999999999999876 3678999999532 23445678999999999999999999999999888899
Q ss_pred EEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 303 IFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
+||||+++|+|.+++... .+++..+..++.|++.||.|||+++++|+||+++||+++.++.+||+|||++.......
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999775 69999999999999999999999999999999999999999999999999987652221
Q ss_pred ----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHH
Q 011326 380 ----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQ 454 (488)
Q Consensus 380 ----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~ 454 (488)
.....+...|+|||.+. ...++.++||||||+++|||++ |+.||...+..+....+..+...+.+..++..+.
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~--~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLK--DGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIY 235 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHH--HSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHH
T ss_pred ccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHH
Confidence 22344677899999973 3448999999999999999999 7899998888888888877777777888999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHh
Q 011326 455 DFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+++.+||+.||++|||+.++++
T Consensus 236 ~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 236 SLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHh
Confidence 9999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=315.94 Aligned_cols=250 Identities=36% Similarity=0.589 Sum_probs=220.6
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|++.+.||+|+||.||++.+. ++..+++|.+...... ......+.+|+.++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS---QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc---HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence 4788999999999999999875 7889999998764432 23345677899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhh-----hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 305 LELVTKGSLASLYQK-----YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~-----~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
|||+++++|..++.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 999999999998865 458899999999999999999999999999999999999999999999999997765554
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILK 459 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~ 459 (488)
.....+++.|++||.+ ....++.++|+||+|+++|+|++|+.||...+..+....+.....++.+..++.++.+++.+
T Consensus 158 ~~~~~~~~~~~~Pe~~--~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08530 158 AKTQIGTPHYMAPEVW--KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRS 235 (256)
T ss_pred cccccCCccccCHHHH--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHH
Confidence 4455688999999997 44567889999999999999999999999888777777777777777777899999999999
Q ss_pred hhhhCCCCCCCHHHHHhCccC
Q 011326 460 CLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 460 cL~~dP~~Rps~~eil~hp~f 480 (488)
||+.+|++||++.++++||++
T Consensus 236 ~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 236 MLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HcCCCcccCCCHHHHhcCCCC
Confidence 999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=320.09 Aligned_cols=246 Identities=27% Similarity=0.431 Sum_probs=211.0
Q ss_pred ecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeeccCC
Q 011326 233 LGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKG 311 (488)
Q Consensus 233 LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 311 (488)
||.|++|.||++.+. ++..+++|.+...... .......+.+|+.+++.++||||+++++.+.++...+++|||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV--ETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcch--hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence 699999999999986 5899999999754321 2234467889999999999999999999999999999999999999
Q ss_pred ChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-cccCCCCCcc
Q 011326 312 SLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VKSCKGTAFW 389 (488)
Q Consensus 312 sL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~gt~~y 389 (488)
+|.+++.+. .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....... .....+++.|
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 158 (262)
T cd05572 79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEY 158 (262)
T ss_pred cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCc
Confidence 999998765 58999999999999999999999999999999999999999999999999987665432 2345688999
Q ss_pred cCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCc--hhhhHHHhcC-CCCCCCCCcccHHHHHHHHHhhhhCCC
Q 011326 390 MAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE--GGQAMFKIGG-GELPPVPNSLSRDAQDFILKCLQVNPN 466 (488)
Q Consensus 390 ~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~--~~~~~~~i~~-~~~~~~~~~~s~~l~~Li~~cL~~dP~ 466 (488)
++||.+ ....++.++|+||+|+++|+|++|..||.... ..+....+.. ......+...++++.++|.+||+.+|.
T Consensus 159 ~~PE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 159 VAPEII--LNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred cChhHh--cCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 999987 34557899999999999999999999998766 4444444442 334456667799999999999999999
Q ss_pred CCCC-----HHHHHhCccCCC
Q 011326 467 DRPT-----AAQLMEHPFIKR 482 (488)
Q Consensus 467 ~Rps-----~~eil~hp~f~~ 482 (488)
+||+ +.|+++||||++
T Consensus 237 ~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hCcCCcccCHHHHhcChhhhC
Confidence 9999 999999999986
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=323.89 Aligned_cols=248 Identities=27% Similarity=0.413 Sum_probs=200.9
Q ss_pred eecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHH---HHhcCCCCCcceeeccccCCCceEEEEee
Q 011326 232 LLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEIS---LLGQFEHDNIVQYLGTDRDEKRLCIFLEL 307 (488)
Q Consensus 232 ~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~---iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 307 (488)
.||+|+||.||++.+. ++..+|+|.+.......... ...+.+|.. ++...+||||+.+++.+..++..++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH--HHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence 3899999999999885 68999999987654322211 122333433 34445799999999999999999999999
Q ss_pred ccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCcccCCCC
Q 011326 308 VTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT 386 (488)
Q Consensus 308 ~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~gt 386 (488)
+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++............||
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 158 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCC
Confidence 9999999888654 589999999999999999999999999999999999999999999999999875544444455799
Q ss_pred CcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh--hhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhC
Q 011326 387 AFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG--QAMFKIGGGELPPVPNSLSRDAQDFILKCLQVN 464 (488)
Q Consensus 387 ~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~d 464 (488)
..|+|||.+. .+..++.++|+||+|+++|+|++|..||...... ..............+..++.++.++|.+||+.|
T Consensus 159 ~~y~aPE~~~-~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 237 (279)
T cd05633 159 HGYMAPEVLQ-KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRD 237 (279)
T ss_pred cCccCHHHhc-CCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCC
Confidence 9999999873 3455789999999999999999999999754322 222222222233556778999999999999999
Q ss_pred CCCCC-----CHHHHHhCccCCC
Q 011326 465 PNDRP-----TAAQLMEHPFIKR 482 (488)
Q Consensus 465 P~~Rp-----s~~eil~hp~f~~ 482 (488)
|.+|| ++.++++||||+.
T Consensus 238 p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 238 VSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred HHHhcCCCCCCHHHHHhCccccC
Confidence 99999 6999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=321.56 Aligned_cols=248 Identities=29% Similarity=0.477 Sum_probs=215.3
Q ss_pred cccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
....+|++.+.||.|+||.||+|.+.++..+++|.+.... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 77 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPV 77 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-----hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCe
Confidence 3456799999999999999999999889999999987532 22345678899999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhh---hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 302 CIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~---~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
++||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 999999999999999864 34899999999999999999999999999999999999999999999999998755432
Q ss_pred C--cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHH
Q 011326 379 D--VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455 (488)
Q Consensus 379 ~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~ 455 (488)
. .....++..|+|||.+ ....++.++|+||||+++|+|++ |..||...+..+....+......+.+..+++++.+
T Consensus 158 ~~~~~~~~~~~~~~~PE~~--~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05148 158 VYLSSDKKIPYKWTAPEAA--SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYK 235 (261)
T ss_pred cccccCCCCceEecCHHHH--ccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHH
Confidence 2 1233456789999987 34568899999999999999998 89999888777777777766666777889999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHh
Q 011326 456 FILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~eil~ 476 (488)
++.+||+.||.+|||+.++++
T Consensus 236 ~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 236 IMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=323.39 Aligned_cols=251 Identities=33% Similarity=0.576 Sum_probs=206.5
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeecccc-----
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDR----- 296 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~----- 296 (488)
.+.|++.+.||+|+||.||+|.+. ++..+|+|.+.... .....+..|+.++.++ +||||+++++++.
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE------DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh------HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 457888899999999999999885 68999999986432 2335677899999988 7999999999875
Q ss_pred -CCCceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCc
Q 011326 297 -DEKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLA 372 (488)
Q Consensus 297 -~~~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla 372 (488)
..+..+++|||+++|+|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 346789999999999999988653 3788889999999999999999999999999999999999999999999998
Q ss_pred ccccCC--CcccCCCCCcccCchhhccc---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC-CCCC
Q 011326 373 KATTMN--DVKSCKGTAFWMAPEVVNLK---KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL-PPVP 446 (488)
Q Consensus 373 ~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~~~ 446 (488)
...... ......|++.|+|||.+... ...++.++|+||||+++|||++|..||...........+..... ....
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 248 (282)
T cd06636 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKS 248 (282)
T ss_pred hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcc
Confidence 654322 23345689999999987321 34578899999999999999999999976654444333332222 2233
Q ss_pred CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 447 NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 447 ~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
..++.++.+||.+||+.||.+||++.|+++||||
T Consensus 249 ~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 4688999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=324.31 Aligned_cols=253 Identities=32% Similarity=0.538 Sum_probs=214.2
Q ss_pred eeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEE
Q 011326 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFL 305 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 305 (488)
|...+.||+|++|.||++.+. ++..+++|.+.... ......+.+|+.+++.++||||+++++++...+..++++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 344568999999999999874 78999999886432 223456789999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--cccC
Q 011326 306 ELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSC 383 (488)
Q Consensus 306 E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~ 383 (488)
||+++++|.+++....+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+....... ....
T Consensus 96 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 96 EFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred eccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence 99999999999988789999999999999999999999999999999999999999999999999876443221 2334
Q ss_pred CCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCC--CCcccHHHHHHHHHhh
Q 011326 384 KGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV--PNSLSRDAQDFILKCL 461 (488)
Q Consensus 384 ~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~Li~~cL 461 (488)
.|++.|+|||.+ ....++.++|+||+|+++|+|++|+.||...+.......+.....+.. +..++..+.+++.+||
T Consensus 176 ~~~~~y~aPE~~--~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 176 VGTPYWMAPEVI--SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred cCCccccCHHHh--cCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 689999999997 345588999999999999999999999987666655555554432222 2347899999999999
Q ss_pred hhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 462 QVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 462 ~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
+.+|++||++.++++||||+++...
T Consensus 254 ~~~p~~Rpt~~~il~~~~~~~~~~~ 278 (285)
T cd06648 254 VRDPAQRATAAELLNHPFLAKAGPP 278 (285)
T ss_pred ccChhhCcCHHHHccCcccccCCCc
Confidence 9999999999999999999887654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=315.39 Aligned_cols=250 Identities=32% Similarity=0.631 Sum_probs=220.9
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|++.+.||.|+||.||++.+. ++..+++|.+..... .......+.+|+++++.++|||++++.+.+...+..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM---SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC---ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence 5788999999999999999886 689999999876442 234456788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhh-----hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 305 LELVTKGSLASLYQK-----YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~-----~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
+|++++++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999998865 458999999999999999999999999999999999999999999999999987654432
Q ss_pred --cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHH
Q 011326 380 --VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFI 457 (488)
Q Consensus 380 --~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li 457 (488)
.....|++.|+|||.+ ....++.++|+||+|+++++|++|..||...+..+..........++.+..++.++.+++
T Consensus 158 ~~~~~~~~~~~y~~pe~~--~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (258)
T cd08215 158 DLAKTVVGTPYYLSPELC--QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLV 235 (258)
T ss_pred ceecceeeeecccChhHh--ccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 2335688899999986 345578899999999999999999999988877777777777777778888999999999
Q ss_pred HHhhhhCCCCCCCHHHHHhCccC
Q 011326 458 LKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 458 ~~cL~~dP~~Rps~~eil~hp~f 480 (488)
.+||..+|++|||+.++++||||
T Consensus 236 ~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 236 SSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=324.47 Aligned_cols=250 Identities=33% Similarity=0.550 Sum_probs=204.2
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|++.+.||.|++|.||+|.+. +|..||+|.+...... ......+.+|++++++++||||+++++++.+++..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc---cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence 4788999999999999999885 7899999998654322 22234678899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhh---hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--C
Q 011326 305 LELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--D 379 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~---~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~ 379 (488)
|||+. ++|..++.. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 99996 588887754 35889999999999999999999999999999999999999999999999998654332 2
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC-------------------
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG------------------- 440 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~------------------- 440 (488)
.....+++.|+|||.+. ....++.++|+||||+++|+|++|+.||...+..+....+...
T Consensus 157 ~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 157 YTHEVVTLWYRAPEILL-GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred cccccccccccCCeEEe-cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 23445788999999863 3344688999999999999999999999776544332221110
Q ss_pred ---------CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 441 ---------ELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 441 ---------~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
........++++++++|.+||+.||.+|||++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0001123467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=340.74 Aligned_cols=254 Identities=25% Similarity=0.451 Sum_probs=208.4
Q ss_pred CcccccccCceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcc
Q 011326 217 NGKFRRRITSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIV 289 (488)
Q Consensus 217 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv 289 (488)
.+.|....++|++++.||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.+++.+ +|+||+
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~~h~nIv 105 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA----HTDEREALMSELKILSHLGQHKNIV 105 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC----CHHHHHHHHHHHHHHHhhccCCcee
Confidence 4556667789999999999999999998752 34579999996542 223345688999999999 899999
Q ss_pred eeeccccCCCceEEEEeeccCCChHHHHhhh-------------------------------------------------
Q 011326 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKY------------------------------------------------- 320 (488)
Q Consensus 290 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~------------------------------------------------- 320 (488)
+++++|...+..++||||+++|+|.+++...
T Consensus 106 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (374)
T cd05106 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMR 185 (374)
T ss_pred eEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccC
Confidence 9999999999999999999999999887432
Q ss_pred ----------------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 321 ----------------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 321 ----------------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
++++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~ 265 (374)
T cd05106 186 PVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265 (374)
T ss_pred CccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCC
Confidence 2677788999999999999999999999999999999999999999999998754332
Q ss_pred Cc----ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHH-hcCCCCCCCCCcccHH
Q 011326 379 DV----KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFK-IGGGELPPVPNSLSRD 452 (488)
Q Consensus 379 ~~----~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~-i~~~~~~~~~~~~s~~ 452 (488)
.. ....++..|+|||++ ....++.++||||||+++|||++ |+.||........... +..+..+..+..++++
T Consensus 266 ~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (374)
T cd05106 266 SNYVVKGNARLPVKWMAPESI--FDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPE 343 (374)
T ss_pred cceeeccCCCCccceeCHHHh--cCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHH
Confidence 21 123355679999997 45568999999999999999997 9999977655443333 3333334455667999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 453 AQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 453 l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+.+++.+||+.||.+|||+.++++
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=347.03 Aligned_cols=247 Identities=30% Similarity=0.548 Sum_probs=210.8
Q ss_pred ccccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
.|+..++...-++-||.|+.|.||+|+.. ++.||||.++-. -..++.-|++|+||||+.+.|+|...
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el------------kETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL------------KETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhh------------hhhhHHHHHhccCcceeeEeeeecCC
Confidence 34444444455566999999999999876 568999987521 12467779999999999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 299 KRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
..+|||||||..|.|..+++.. .++...+..|..+|+.||.|||.+.|||||||.-||||+.+..+||+|||.++....
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred ceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 9999999999999999999765 589999999999999999999999999999999999999999999999999986654
Q ss_pred CC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC-CCCCCcccHHHHH
Q 011326 378 ND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL-PPVPNSLSRDAQD 455 (488)
Q Consensus 378 ~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~l~~ 455 (488)
.. .-.++||..|||||++ .+...+.|+|||||||+|||||||..||...+.--++.-+-.+.+ .+.|..+|+.++-
T Consensus 265 ~STkMSFaGTVaWMAPEvI--rnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gfkl 342 (904)
T KOG4721|consen 265 KSTKMSFAGTVAWMAPEVI--RNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKL 342 (904)
T ss_pred hhhhhhhhhhHhhhCHHHh--hcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHH
Confidence 43 3468899999999998 667789999999999999999999999987665544443333322 3678899999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 456 FILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
|++.||+..|..||+|.+|+.|-=+
T Consensus 343 L~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 343 LLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred HHHHHHhcCCCCCccHHHHHHHHhh
Confidence 9999999999999999999998433
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=319.81 Aligned_cols=255 Identities=45% Similarity=0.804 Sum_probs=209.3
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCc-----chhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPR-----GKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~-----~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
+|.+.+.||+|+||.||+|.+. +|..+|+|.+........ .....+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5788899999999999999875 689999999864322111 1223456788999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 300 RLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
..++||||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 999999999999999988664 5889999999999999999999999999999999999999999999999998654321
Q ss_pred ----CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC-CCCCC----CCcc
Q 011326 379 ----DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG-ELPPV----PNSL 449 (488)
Q Consensus 379 ----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~-~~~~~----~~~~ 449 (488)
......|+..|+|||.+......++.++|+||||+++|+|++|..||...+..+....+... ..... ...+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 12234588899999997433335789999999999999999999999765554443333222 12222 2356
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
+.++.+++.+||+++|.+||++.+++.||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=322.70 Aligned_cols=257 Identities=30% Similarity=0.532 Sum_probs=206.9
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHH-HhcCCCCCcceeeccccCCCceE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISL-LGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~i-L~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
++|++.+.||+|+||.||++.+. +|..||+|.+...... ....++..|+.+ ++.++||||+++++++..++..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~ 76 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS----QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW 76 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc----HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence 36899999999999999999886 7999999998754321 122345556654 56678999999999999999999
Q ss_pred EEEeeccCCChHHHHhh-----hccChhhhhHHHHHHHHHHHHHHHC-CCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 303 IFLELVTKGSLASLYQK-----YHLSDSQVSSYTRQILNGLKYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~-----~~ls~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
++|||+++ +|.+++.. ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 77 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 77 ICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred EEhhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 99999974 88777643 2489999999999999999999997 99999999999999999999999999987554
Q ss_pred CCCc-ccCCCCCcccCchhhccc--cCCCChhhhHHHHHHHHHHHHcCCCCCCCCc-hhhhHHHhcCCCCCCCC-CcccH
Q 011326 377 MNDV-KSCKGTAFWMAPEVVNLK--KDGYGLTADIWSLGCTVLEMLTRRHPYSHLE-GGQAMFKIGGGELPPVP-NSLSR 451 (488)
Q Consensus 377 ~~~~-~~~~gt~~y~aPE~~~~~--~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~-~~~~~~~i~~~~~~~~~-~~~s~ 451 (488)
.... ....++..|+|||.+... ...++.++|+||+|+++|+|++|+.||.... ..+..........+..+ ..+|.
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd06617 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSP 235 (283)
T ss_pred cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCH
Confidence 3322 235688899999987421 2456889999999999999999999996532 22333333333333333 35789
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
++.++|.+||+.+|.+||++.++++||||++....
T Consensus 236 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 236 EFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270 (283)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence 99999999999999999999999999999886544
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=312.71 Aligned_cols=250 Identities=52% Similarity=0.932 Sum_probs=215.3
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC--CceE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE--KRLC 302 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~ 302 (488)
+|.+.+.||+|++|.||+|.+. ++..+++|.+...... ......+.+|+.++++++||||+++++.+... ...+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS---EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence 4778899999999999999986 7999999998765432 34567888999999999999999999999888 8999
Q ss_pred EEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 303 IFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
+++||+++++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 999999999999998765 68999999999999999999999999999999999999999999999999987665543
Q ss_pred --cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh-hhHHHhc-CCCCCCCCCcccHHHHH
Q 011326 380 --VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-QAMFKIG-GGELPPVPNSLSRDAQD 455 (488)
Q Consensus 380 --~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~-~~~~~i~-~~~~~~~~~~~s~~l~~ 455 (488)
.....++..|+|||.+ .....+.++|+||||+++++|++|..||...... .....+. ....+..+..++.++.+
T Consensus 158 ~~~~~~~~~~~y~~pE~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVI--RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKD 235 (260)
T ss_pred ccccCCCCCccccCHhhh--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHH
Confidence 3455688899999987 3444889999999999999999999999876522 2222222 13445667788999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 456 FILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
++.+||+.+|.+||++.+++.||||
T Consensus 236 ~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 236 FLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=326.88 Aligned_cols=254 Identities=34% Similarity=0.597 Sum_probs=214.5
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
..+|++.+.||+|+||.||++.+. ++..|++|.+..... .....+.+|+.+++.++||||+++++.+...+..+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-----PKKELIINEILVMRENKHPNIVNYLDSYLVGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-----hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence 468999999999999999999875 788999999864321 22356788999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--c
Q 011326 303 IFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--V 380 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~ 380 (488)
+|+||+++++|.+++.+..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 93 lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 93 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred EEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999876543332 2
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC--CCCcccHHHHHHHH
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP--VPNSLSRDAQDFIL 458 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~Li~ 458 (488)
....+++.|++||.+ ....++.++|+||||+++|+|++|..||...+.......+.....+. .+..++..+.+++.
T Consensus 173 ~~~~~~~~y~~PE~~--~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 250 (293)
T cd06647 173 STMVGTPYWMAPEVV--TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 250 (293)
T ss_pred ccccCChhhcCchhh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHH
Confidence 344688899999987 34557899999999999999999999998765544333322222222 23456889999999
Q ss_pred HhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 459 KCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 459 ~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
+||+.+|++||++.+++.||||+...
T Consensus 251 ~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 251 RCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHccCChhhCcCHHHHhcCHHHhcCc
Confidence 99999999999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=323.85 Aligned_cols=245 Identities=26% Similarity=0.463 Sum_probs=210.2
Q ss_pred CceeeeeeecccCceEEEEEEe------cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 225 TSWQKGELLGSGSYGFVYEGLT------DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
.+|.+.+.||+|+||.||++.. .++..+|+|.+... .......+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4788999999999999999974 23566899988642 233456788999999999999999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhh--------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcE
Q 011326 299 KRLCIFLELVTKGSLASLYQKY--------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSV 364 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~--------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~v 364 (488)
+..+++|||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 9999999999999999988643 28999999999999999999999999999999999999999999
Q ss_pred EEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcC
Q 011326 365 KLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGG 439 (488)
Q Consensus 365 kL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~ 439 (488)
+|+|||++....... .....++..|+|||.+ ....++.++|+||||+++|+|++ |..||......+....+..
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999987543322 1233457789999987 44568999999999999999998 9999988877777777777
Q ss_pred CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 440 GELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 440 ~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+.....+..++.++.+|+.+||+.||.+|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 238 GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 7666667788999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=328.06 Aligned_cols=256 Identities=29% Similarity=0.459 Sum_probs=207.7
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC--C
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE--K 299 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~ 299 (488)
...+|++.+.||+|+||.||+|.+. +|..||+|.+....... .....+.+|+.++++++|+||+++++++... +
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD---GIPISSLREITLLLNLRHPNIVELKEVVVGKHLD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC---CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence 4678999999999999999999985 69999999987544221 1123456799999999999999999988654 5
Q ss_pred ceEEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 300 RLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
..++||||+.+ +|.+++.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.....
T Consensus 82 ~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 82 SIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred eEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 68999999976 78887764 3589999999999999999999999999999999999999999999999999876543
Q ss_pred C--CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC--------------
Q 011326 378 N--DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE-------------- 441 (488)
Q Consensus 378 ~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~-------------- 441 (488)
. ......+++.|+|||.+. ....++.++|+||+|+++|+|++|..||...+..+....+....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 161 PAKPMTPKVVTLWYRAPELLL-GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred ccCCCCcccccccccChhhhc-CCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 3 223344678899999873 33457899999999999999999999998776655444332110
Q ss_pred -------CCCC--------CCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 442 -------LPPV--------PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 442 -------~~~~--------~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
.+.. ....++++.++|.+||++||++|||+.|++.||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 0000 01257889999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=315.86 Aligned_cols=239 Identities=25% Similarity=0.456 Sum_probs=202.8
Q ss_pred eecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeeccC
Q 011326 232 LLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTK 310 (488)
Q Consensus 232 ~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 310 (488)
.||+|+||.||+|.+. ++..+|+|.+... ........+.+|+.++++++||||+++++++......++||||+++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRET----LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCcc----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 5899999999999885 7899999987532 2234456788999999999999999999999999999999999999
Q ss_pred CChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCccc----CC
Q 011326 311 GSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS----CK 384 (488)
Q Consensus 311 gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~----~~ 384 (488)
++|.+++... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......... ..
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999998653 48899999999999999999999999999999999999999999999999986543222111 12
Q ss_pred CCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhh
Q 011326 385 GTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQV 463 (488)
Q Consensus 385 gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~ 463 (488)
++..|+|||.+ ....++.++|+||||+++|||++ |..||...........+......+.+..++.++.+|+.+||+.
T Consensus 158 ~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 235 (252)
T cd05084 158 IPVKWTAPEAL--NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEY 235 (252)
T ss_pred CceeecCchhh--cCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCC
Confidence 34569999987 34558899999999999999997 9999987776666666655555567778899999999999999
Q ss_pred CCCCCCCHHHHHh
Q 011326 464 NPNDRPTAAQLME 476 (488)
Q Consensus 464 dP~~Rps~~eil~ 476 (488)
+|++|||+.++++
T Consensus 236 ~p~~Rps~~~~~~ 248 (252)
T cd05084 236 DPGQRPSFSTVHQ 248 (252)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=327.89 Aligned_cols=251 Identities=33% Similarity=0.551 Sum_probs=212.7
Q ss_pred eeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEee
Q 011326 229 KGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLEL 307 (488)
Q Consensus 229 ~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 307 (488)
....||+|+||.||++.+. ++..||+|.+..... .....+.+|+.++..++||||+++++++..++..+++|||
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-----chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 3446999999999999875 789999999865332 2235678899999999999999999999999999999999
Q ss_pred ccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--cccCCC
Q 011326 308 VTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKG 385 (488)
Q Consensus 308 ~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~g 385 (488)
+++++|..++....+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .....|
T Consensus 100 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 179 (297)
T cd06659 100 LQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 179 (297)
T ss_pred CCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceec
Confidence 999999998888789999999999999999999999999999999999999999999999999986543322 234568
Q ss_pred CCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC--CCCCcccHHHHHHHHHhhhh
Q 011326 386 TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP--PVPNSLSRDAQDFILKCLQV 463 (488)
Q Consensus 386 t~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~Li~~cL~~ 463 (488)
+..|+|||.+ ....++.++|+||||+++|||++|+.||......+....+.....+ .....++..+.+++.+||+.
T Consensus 180 ~~~y~aPE~~--~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~ 257 (297)
T cd06659 180 TPYWMAPEVI--SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR 257 (297)
T ss_pred CccccCHHHH--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcC
Confidence 9999999997 3455889999999999999999999999876665555544332221 22346788999999999999
Q ss_pred CCCCCCCHHHHHhCccCCCCCCC
Q 011326 464 NPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 464 dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
+|.+||++.++++||||.++-.+
T Consensus 258 ~P~~Rps~~~ll~~~~~~~~~~~ 280 (297)
T cd06659 258 EPQERATAQELLDHPFLLQTGLP 280 (297)
T ss_pred CcccCcCHHHHhhChhhccCCCc
Confidence 99999999999999999887543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=312.92 Aligned_cols=250 Identities=45% Similarity=0.804 Sum_probs=219.2
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|++.+.||+|++|.||++.+. ++..+++|.+...... ......+.+|++++++++|||++++++++.+++..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK---EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC---HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence 4788999999999999999876 6889999999765432 34556889999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCc--c
Q 011326 305 LELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--K 381 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~--~ 381 (488)
|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 999999999998865 4689999999999999999999999999999999999999999999999999876554432 3
Q ss_pred cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhh
Q 011326 382 SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCL 461 (488)
Q Consensus 382 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL 461 (488)
...++..|+|||.+. ...++.++|+|++|+++|+|++|..||...+.............+..+..+++++.+++.+||
T Consensus 158 ~~~~~~~y~~pe~~~--~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 235 (254)
T cd06627 158 SVVGTPYWMAPEVIE--MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCF 235 (254)
T ss_pred ccccchhhcCHhhhc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHH
Confidence 456888999999873 344789999999999999999999999877666655555556666777889999999999999
Q ss_pred hhCCCCCCCHHHHHhCccC
Q 011326 462 QVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 462 ~~dP~~Rps~~eil~hp~f 480 (488)
+.+|++|||+.+++.||||
T Consensus 236 ~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 236 QKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred hCChhhCcCHHHHhcCCCC
Confidence 9999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=338.57 Aligned_cols=260 Identities=27% Similarity=0.476 Sum_probs=210.9
Q ss_pred ccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDEK 299 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~ 299 (488)
...-..|++.+.||.||.+.||++...+...+|+|.+.... ...+...-+.+|+.+|.+++ |.+||+|++|-..++
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~---~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE---ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh---cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 33445799999999999999999998888888888876443 45677889999999999995 999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhhc--cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 300 RLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~~--ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
.+|+||||-+. +|..+|++.. ++...+..+..||+.|+.++|++||||.||||.|+|+ -.|.+||+|||+|.....
T Consensus 434 ~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 434 YLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQP 511 (677)
T ss_pred eEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCc
Confidence 99999998766 9999998765 3334888999999999999999999999999999999 789999999999987665
Q ss_pred CCc----ccCCCCCcccCchhhccccCC---------CChhhhHHHHHHHHHHHHcCCCCCCCCchhhh-HHHhcCCCC-
Q 011326 378 NDV----KSCKGTAFWMAPEVVNLKKDG---------YGLTADIWSLGCTVLEMLTRRHPYSHLEGGQA-MFKIGGGEL- 442 (488)
Q Consensus 378 ~~~----~~~~gt~~y~aPE~~~~~~~~---------~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~-~~~i~~~~~- 442 (488)
... ...+||+.||+||.+...... .++++|||||||+||+|+.|++||....+.-. +..|.....
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE 591 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence 432 356799999999998422211 67899999999999999999999976553322 222222211
Q ss_pred CCCCCccc-HHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC-CCC
Q 011326 443 PPVPNSLS-RDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR-PLQ 485 (488)
Q Consensus 443 ~~~~~~~s-~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~-~~~ 485 (488)
.++|..-+ .++.++++.||+.||.+||+..++|+|||++- +++
T Consensus 592 Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~ 636 (677)
T KOG0596|consen 592 IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIP 636 (677)
T ss_pred ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccccc
Confidence 12332222 24999999999999999999999999999986 443
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=317.80 Aligned_cols=248 Identities=27% Similarity=0.485 Sum_probs=211.8
Q ss_pred cCceeeeeeecccCceEEEEEEec----CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD----DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
.++|++.+.||+|+||.||+|.+. +...||+|.+.... .......+.+|+.++++++||||+++++++...+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS----SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR 78 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC----ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC
Confidence 357889999999999999999874 24579999886432 2334467889999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 300 RLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
..+++|||+++++|.+++... .+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999999998653 589999999999999999999999999999999999999999999999999876642
Q ss_pred CC--c--ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHH
Q 011326 378 ND--V--KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRD 452 (488)
Q Consensus 378 ~~--~--~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 452 (488)
.. . ....++..|+|||.+ ....++.++|+||||+++|+|++ |..||......+....+......+.+..+++.
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~--~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAI--AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSA 236 (266)
T ss_pred cccceeccCCCCCccccChhhh--ccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 11 1 122345679999987 44568899999999999999998 99999887777777777666555667788999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 453 AQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 453 l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
+.+++.+||+.+|++||++.+++++
T Consensus 237 l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 237 LYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=323.14 Aligned_cols=248 Identities=23% Similarity=0.398 Sum_probs=212.4
Q ss_pred cCceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
+.+|++.+.||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.++..++||||+++++++.+
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA----EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC----CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 456888899999999999999763 35789999987432 22334568899999999999999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhh-----------------hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC
Q 011326 298 EKRLCIFLELVTKGSLASLYQK-----------------YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA 360 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~-----------------~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~ 360 (488)
.+..++++||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 9999999999999999988742 23777888999999999999999999999999999999999
Q ss_pred CCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHH
Q 011326 361 SGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMF 435 (488)
Q Consensus 361 ~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~ 435 (488)
++.+||+|||+++...... .....+++.|+|||.+ ....++.++||||||+++|||++ |..||.+....+...
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAI--MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE 237 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHH--hcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999987543322 1233467789999987 34558899999999999999998 889998888888888
Q ss_pred HhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 436 KIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 436 ~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.+......+.+..++..+.+|+.+||+.+|.+||++.+|+..
T Consensus 238 ~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 238 MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 888777777788899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=317.58 Aligned_cols=246 Identities=26% Similarity=0.460 Sum_probs=210.6
Q ss_pred cccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
...++|++.+.||+|+||.||+|...++..||+|.+..... ...++.+|+.++++++|+||+++++++. .+..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM------SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPI 75 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC------cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCc
Confidence 34568999999999999999999988899999999864332 2356889999999999999999999874 4568
Q ss_pred EEEEeeccCCChHHHHhh---hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 302 CIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~---~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
+++|||+++++|.+++.. ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999999998854 24888999999999999999999999999999999999999999999999998765422
Q ss_pred Cc---ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHH
Q 011326 379 DV---KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQ 454 (488)
Q Consensus 379 ~~---~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~ 454 (488)
.. ....++..|+|||.+ ....++.++|+||||+++|||++ |+.||...+..+....+......+.+...+.++.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~--~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELY 233 (260)
T ss_pred CcccccCCcccccccCHHHh--ccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 21 233456789999987 44557889999999999999998 9999988877777776666666667778899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHh
Q 011326 455 DFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+++.+||+.+|++||+++++++
T Consensus 234 ~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 234 ELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=315.65 Aligned_cols=247 Identities=29% Similarity=0.469 Sum_probs=213.6
Q ss_pred cccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
...++|++.+.||+|+||.||++.+.++..+|+|.+..... ...++.+|+.++++++||||+++++++..+...
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM------SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc------CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 44678999999999999999999988888999999874332 235688999999999999999999999998999
Q ss_pred EEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 302 CIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
+++|||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+......
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999999999998653 4899999999999999999999999999999999999999999999999998765432
Q ss_pred Cc---ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHH
Q 011326 379 DV---KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQ 454 (488)
Q Consensus 379 ~~---~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~ 454 (488)
.. ....++..|+|||.+ .+..++.++|+||+|+++|+|++ |+.||.+.+.......+......+.+...+.++.
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAA--NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELY 234 (261)
T ss_pred hhhhhhccCCCccccCHHHh--ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 21 122345679999987 45568899999999999999998 9999988877777777776655566777899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHh
Q 011326 455 DFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+++.+||+.+|.+||+++++.+
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 235 DLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHcccCcccCCCHHHHHH
Confidence 9999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=314.36 Aligned_cols=241 Identities=30% Similarity=0.517 Sum_probs=212.0
Q ss_pred eeecccCceEEEEEEecC----CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEe
Q 011326 231 ELLGSGSYGFVYEGLTDD----GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLE 306 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~~----g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 306 (488)
+.||+|+||.||+|.+.. +..+++|.+...... .....+.+|+.++..++|+||+++++++.+....+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE----EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch----hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence 359999999999998853 889999998754322 145678899999999999999999999999999999999
Q ss_pred eccCCChHHHHhh----------hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 307 LVTKGSLASLYQK----------YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 307 ~~~~gsL~~~l~~----------~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
|+++++|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 9999999999865 458999999999999999999999999999999999999999999999999997665
Q ss_pred CCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccH
Q 011326 377 MND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSR 451 (488)
Q Consensus 377 ~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 451 (488)
... .....++..|+|||.+. ...++.++|+||+|+++|+|++ |..||......+....+..+.....+..++.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLK--DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD 234 (262)
T ss_pred cccccccccCCCcCccccCHHHhc--cCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCCh
Confidence 432 33455788999999873 3468999999999999999999 6999998888777777777666677888899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
++.+++.+||+.+|.+|||+.|++++
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 235 ELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=321.21 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=202.8
Q ss_pred eecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchh-HHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeecc
Q 011326 232 LLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQ-SILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVT 309 (488)
Q Consensus 232 ~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 309 (488)
+||+|+||.||++.+. +++.||+|.+........... ........+..++...||||+.+++++..++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999875 689999999876543211111 11111223344555689999999999999999999999999
Q ss_pred CCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCcccCCCCCc
Q 011326 310 KGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF 388 (488)
Q Consensus 310 ~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~gt~~ 388 (488)
|++|..++... .+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++............|+..
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 160 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG 160 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCcC
Confidence 99999888554 58999999999999999999999999999999999999999999999999987655444445679999
Q ss_pred ccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh--hhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCC
Q 011326 389 WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG--QAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPN 466 (488)
Q Consensus 389 y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~ 466 (488)
|+|||.+. .+..++.++|+||+|+++|+|++|+.||...... ..............+..++.++.+++.+||..+|.
T Consensus 161 y~aPE~~~-~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~ 239 (278)
T cd05606 161 YMAPEVLQ-KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 239 (278)
T ss_pred CcCcHHhc-CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHH
Confidence 99999973 3345789999999999999999999999765322 22222222333456667899999999999999999
Q ss_pred CCC-----CHHHHHhCccCCCC
Q 011326 467 DRP-----TAAQLMEHPFIKRP 483 (488)
Q Consensus 467 ~Rp-----s~~eil~hp~f~~~ 483 (488)
+|| ++.++++||||+..
T Consensus 240 ~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 240 RRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred hccCCCCCCHHHHHhCccccCC
Confidence 999 99999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=327.88 Aligned_cols=247 Identities=28% Similarity=0.474 Sum_probs=206.9
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCc----EEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGF----FFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
..+|++.+.||+|+||.||+|.+. ++. .||+|.+... .......++.+|+.+++.++||||+++++++..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 457999999999999999999864 333 4899998642 2233446788999999999999999999998775
Q ss_pred CceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 299 KRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
..++++||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 578999999999999988754 48888999999999999999999999999999999999999999999999997654
Q ss_pred CCCc----ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccH
Q 011326 377 MNDV----KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSR 451 (488)
Q Consensus 377 ~~~~----~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 451 (488)
.... ....++..|+|||.+ ....++.++||||||+++|||++ |..||.+....+....+......+.+..++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~--~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI 238 (316)
T ss_pred CCCcceeccCCccceeecChHHh--ccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCH
Confidence 3221 122346679999997 45668999999999999999997 9999988766665555555555566778899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
++.+++.+||+.+|.+||++.+++.+
T Consensus 239 ~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 239 DVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=311.32 Aligned_cols=247 Identities=40% Similarity=0.702 Sum_probs=213.1
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|+..+.||+|++|.||++.+. ++..+++|.+..... .....+.+|+.++++++|+|++++++++..+...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 4788899999999999999986 789999999975432 3456788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-cc
Q 011326 305 LELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VK 381 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~ 381 (488)
+||+++++|.+++... .+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 155 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN 155 (253)
T ss_pred EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccc
Confidence 9999999999998765 68999999999999999999999999999999999999999999999999987655443 34
Q ss_pred cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCc--ccHHHHHHHHH
Q 011326 382 SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNS--LSRDAQDFILK 459 (488)
Q Consensus 382 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~s~~l~~Li~~ 459 (488)
...++..|++||.+. ...++.++|+||||+++|+|++|..||...+.............+..+.. ++.++.+++.+
T Consensus 156 ~~~~~~~~~~PE~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 156 TMVGTPYWMAPEVIN--GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred ceecCCcccCHHHHc--CCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 566889999999973 34478899999999999999999999987755554444444444344333 38999999999
Q ss_pred hhhhCCCCCCCHHHHHhCcc
Q 011326 460 CLQVNPNDRPTAAQLMEHPF 479 (488)
Q Consensus 460 cL~~dP~~Rps~~eil~hp~ 479 (488)
||+.||++|||+.|+++|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=316.17 Aligned_cols=239 Identities=27% Similarity=0.465 Sum_probs=204.0
Q ss_pred eecccCceEEEEEEe---cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeec
Q 011326 232 LLGSGSYGFVYEGLT---DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 232 ~LG~G~fg~Vy~~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
.||+|+||.||+|.+ .++..+|+|.+.... ........+.+|+.+++.++||||+++++++.. +..++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN---NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC---CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecC
Confidence 589999999999965 367899999986443 223445678899999999999999999998864 4678999999
Q ss_pred cCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCc-----cc
Q 011326 309 TKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KS 382 (488)
Q Consensus 309 ~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-----~~ 382 (488)
++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||.||+++.++.++|+|||++........ ..
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 99999998865 3589999999999999999999999999999999999999999999999999876543321 12
Q ss_pred CCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhh
Q 011326 383 CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCL 461 (488)
Q Consensus 383 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL 461 (488)
..++..|+|||.+ ....++.++|+||||+++|||++ |..||...+..+....+..+..++.+..+++++.++|.+||
T Consensus 158 ~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~ 235 (257)
T cd05116 158 GKWPVKWYAPECM--NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCW 235 (257)
T ss_pred CCCCccccCHhHh--ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHh
Confidence 2345789999987 34558889999999999999998 99999887777777777777777788889999999999999
Q ss_pred hhCCCCCCCHHHHHh
Q 011326 462 QVNPNDRPTAAQLME 476 (488)
Q Consensus 462 ~~dP~~Rps~~eil~ 476 (488)
+.||.+||++.+|..
T Consensus 236 ~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 236 TYGVDERPGFAVVEL 250 (257)
T ss_pred ccCchhCcCHHHHHH
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=328.64 Aligned_cols=241 Identities=27% Similarity=0.445 Sum_probs=187.6
Q ss_pred eeecccCceEEEEEEec---CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecccc--CCCceEEEE
Q 011326 231 ELLGSGSYGFVYEGLTD---DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR--DEKRLCIFL 305 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--~~~~~~lV~ 305 (488)
..||+|+||.||+|... ++..||+|.+..... ...+.+|+.++++++||||+++++++. .+...+++|
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence 57999999999999864 467899998864321 135678999999999999999999874 456789999
Q ss_pred eeccCCChHHHHhh----------hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEE----CCCCcEEEeecCC
Q 011326 306 ELVTKGSLASLYQK----------YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILV----DASGSVKLADFGL 371 (488)
Q Consensus 306 E~~~~gsL~~~l~~----------~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl----~~~~~vkL~DFGl 371 (488)
||+++ +|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 99876 67666532 137888899999999999999999999999999999999 4667999999999
Q ss_pred cccccCC-----CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhh---------hHHHh
Q 011326 372 AKATTMN-----DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ---------AMFKI 437 (488)
Q Consensus 372 a~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~---------~~~~i 437 (488)
++..... ......||+.|+|||.+. ....++.++||||||+++|||++|++||....... ....+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLL-GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhc-CCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 9755432 123456899999999873 33457899999999999999999999996533210 00000
Q ss_pred cC----------------------------CC---------CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 438 GG----------------------------GE---------LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 438 ~~----------------------------~~---------~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
.. .. ........+..+.+|+.+||+.||.+|||+.|+++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 00 000111245678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=330.94 Aligned_cols=255 Identities=30% Similarity=0.515 Sum_probs=206.0
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC-----
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE----- 298 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~----- 298 (488)
.+|++.+.||+|+||.||+|.+. +|..||+|.+.... .......+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE----HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc----cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 57999999999999999999875 78999999986422 123345677899999999999999999876543
Q ss_pred CceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 299 KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
...++++||+.+ +|..++....+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 358999999976 8888888778999999999999999999999999999999999999999999999999998654332
Q ss_pred C-----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhc---------------
Q 011326 379 D-----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIG--------------- 438 (488)
Q Consensus 379 ~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~--------------- 438 (488)
. .....||+.|+|||.+. ....++.++|+||+|+++|+|++|+.||.+.+.......+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIML-NSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 1 12346889999999862 34557899999999999999999999997654322211110
Q ss_pred CCC----------CCC-----CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 439 GGE----------LPP-----VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 439 ~~~----------~~~-----~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
... .+. .....++++.+++.+||+.||++|||+.|+++||||+...-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 000 000 11345788999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=345.67 Aligned_cols=253 Identities=35% Similarity=0.649 Sum_probs=222.7
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
.|+|+..||.|+||.||++..+ ++...|.|++.. ...+.+.++.-|+.||...+||+||.|++.|..++.++|+
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet-----kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET-----KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc-----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 4678888999999999999886 566678888764 3456677899999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC--CCc
Q 011326 305 LELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDV 380 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~--~~~ 380 (488)
.|||.||-.+.++-. ..+++.++.-++.|++.||.|||+++|||||||..|||++-+|.++|+|||.+..... ...
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 999999999887743 4699999999999999999999999999999999999999999999999998743222 224
Q ss_pred ccCCCCCcccCchhhc---cccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCC--CCcccHHHHH
Q 011326 381 KSCKGTAFWMAPEVVN---LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV--PNSLSRDAQD 455 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~---~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~ 455 (488)
.++.|||+|||||++. ....+|+.++||||||++|.||..+.+|....+.-.++.++.....|.+ |..++..+.+
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D 267 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD 267 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence 5788999999999973 4566799999999999999999999999998888888888887766543 5678999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 456 FILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
++.+||.+||..||++.++++||||+.+
T Consensus 268 fLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 268 FLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 9999999999999999999999999854
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=316.08 Aligned_cols=249 Identities=29% Similarity=0.526 Sum_probs=208.2
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||+|... ++..||+|.+..... ........+.+|+.+++.++||||+++++++.+.+..++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM--MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc--CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence 57999999999999999999875 789999998865432 223445678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhh-----hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 304 FLELVTKGSLASLYQK-----YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~-----~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
+|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999999988742 23788999999999999999999999999999999999999999999999998765432
Q ss_pred C--cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCc--hhhhHHHhcCCCCCCCC-CcccHHH
Q 011326 379 D--VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE--GGQAMFKIGGGELPPVP-NSLSRDA 453 (488)
Q Consensus 379 ~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~--~~~~~~~i~~~~~~~~~-~~~s~~l 453 (488)
. .....|++.|+|||.+ ....++.++|+||+|+++|+|++|+.||.... .......+.....++.+ ..++..+
T Consensus 160 ~~~~~~~~~~~~~~aPE~~--~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERI--HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237 (267)
T ss_pred hHHHhcCCCCccccChhhh--ccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 2 2245688899999987 34557889999999999999999999996543 23344444444444433 4578899
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 454 QDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.+++.+||+.+|++||++.++++.
T Consensus 238 ~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 238 RELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHCCCCcccCcCHHHHHHH
Confidence 999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=318.96 Aligned_cols=251 Identities=31% Similarity=0.511 Sum_probs=215.4
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCCCceE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~ 302 (488)
++|++.+.||+|+||.||++.+. +|..|++|++...... .......+.+|+.++++++ ||||+++++++..++..+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI--KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc--chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence 47899999999999999999886 7999999998764321 2233467788999999998 999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 303 IFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
+|||++++++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 999999999999988766 68999999999999999999999999999999999999999999999999986543322
Q ss_pred --------------------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC
Q 011326 380 --------------------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG 439 (488)
Q Consensus 380 --------------------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~ 439 (488)
.....++..|+|||.+ ....++.++|+||||++++++++|..||...........+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~--~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL--NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK 236 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHh--CCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 1234578899999987 345588999999999999999999999987776555555443
Q ss_pred CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCH----HHHHhCccC
Q 011326 440 GELPPVPNSLSRDAQDFILKCLQVNPNDRPTA----AQLMEHPFI 480 (488)
Q Consensus 440 ~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~----~eil~hp~f 480 (488)
.. ...+..+++.+.+++.+||+.+|.+||++ +++++||||
T Consensus 237 ~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 237 LE-YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred cC-CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 33 24567789999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=316.91 Aligned_cols=245 Identities=28% Similarity=0.447 Sum_probs=207.4
Q ss_pred ccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
..++|++.+.||+|+||.||+|.+.++..||+|.+..... ....+.+|+.++++++||||+++++.+.. +..+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc------CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 3467999999999999999999887767899999874321 22467899999999999999999998754 5689
Q ss_pred EEEeeccCCChHHHHhh---hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 303 IFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~---~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999999999865 247889999999999999999999999999999999999999999999999987554332
Q ss_pred c---ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHH
Q 011326 380 V---KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455 (488)
Q Consensus 380 ~---~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~ 455 (488)
. ....++..|+|||.. ....++.++|+||||+++|+|++ |..||......+....+......+.+..++..+.+
T Consensus 157 ~~~~~~~~~~~~y~~PE~~--~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 234 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAA--LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 234 (262)
T ss_pred cccccCCcccceecCHhHh--ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHH
Confidence 2 123456779999986 45568999999999999999999 88899887777766666555545556778999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHh
Q 011326 456 FILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~eil~ 476 (488)
++.+||+.||++||++.++++
T Consensus 235 li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 235 LMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHccCCcccCCCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=343.53 Aligned_cols=257 Identities=30% Similarity=0.541 Sum_probs=223.9
Q ss_pred CCcccccccCceeeeeeecccCceEEEEEEec--CC--cE-EEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcce
Q 011326 216 PNGKFRRRITSWQKGELLGSGSYGFVYEGLTD--DG--FF-FAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQ 290 (488)
Q Consensus 216 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~--~g--~~-vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~ 290 (488)
+...|+...++..+.+.||+|+||.||+|... ++ .. ||+|....... .......++.+|++++++++|||||+
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~--~~~~~~~e~m~EArvMr~l~H~NVVr 225 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE--LTKEQIKEFMKEARVMRQLNHPNVVR 225 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc--ccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 44557777888888899999999999999874 22 23 89999875222 34667789999999999999999999
Q ss_pred eeccccCCCceEEEEeeccCCChHHHHhhhc--cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEee
Q 011326 291 YLGTDRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLAD 368 (488)
Q Consensus 291 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~D 368 (488)
++|++..+..+++|||+|+||+|.+++.+++ ++..+...++.+.+.||+|||+++++||||..+|+|++.++.+||+|
T Consensus 226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred EEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCc
Confidence 9999999999999999999999999998875 99999999999999999999999999999999999999999999999
Q ss_pred cCCcccccCCCc-c-cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHh-cCCCCCC
Q 011326 369 FGLAKATTMNDV-K-SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKI-GGGELPP 444 (488)
Q Consensus 369 FGla~~~~~~~~-~-~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i-~~~~~~~ 444 (488)
||+++....... . ...-...|+|||.++ ...++.++||||||+++||+++ |..||.+....+....+ ..+.+.+
T Consensus 306 FGLs~~~~~~~~~~~~~klPirWLAPEtl~--~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~ 383 (474)
T KOG0194|consen 306 FGLSRAGSQYVMKKFLKKLPIRWLAPETLN--TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP 383 (474)
T ss_pred cccccCCcceeeccccccCcceecChhhhc--cCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC
Confidence 999876542211 1 223456799999984 4479999999999999999999 89999999999999999 6677778
Q ss_pred CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 445 VPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 445 ~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
.+...|.++..++.+||..+|+.||++.++.+
T Consensus 384 ~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 384 IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 88899999999999999999999999998864
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=318.24 Aligned_cols=250 Identities=26% Similarity=0.439 Sum_probs=212.0
Q ss_pred cccCceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD 295 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 295 (488)
...++|++.+.||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.++..++||||+++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 78 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA----SMRERIEFLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc----CHHHHHHHHHHHHHHHhCCCCceeEEEEEE
Confidence 34568999999999999999999864 24789999975432 223345678999999999999999999999
Q ss_pred cCCCceEEEEeeccCCChHHHHhhh-----------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcE
Q 011326 296 RDEKRLCIFLELVTKGSLASLYQKY-----------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSV 364 (488)
Q Consensus 296 ~~~~~~~lV~E~~~~gsL~~~l~~~-----------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~v 364 (488)
......++||||+++|+|.+++... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+
T Consensus 79 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 79 STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence 9999999999999999999988542 25777899999999999999999999999999999999999999
Q ss_pred EEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcC
Q 011326 365 KLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGG 439 (488)
Q Consensus 365 kL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~ 439 (488)
+|+|||+++...... .....++..|+|||.+ ....++.++||||||+++|||++ |..||...+..+....+..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL--KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHH--hcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 999999987544332 1233467789999987 44558899999999999999998 9999988777777666666
Q ss_pred CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 440 GELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 440 ~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
......+..++.++.+++.+||+.+|++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 66667778889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=316.89 Aligned_cols=246 Identities=28% Similarity=0.461 Sum_probs=210.1
Q ss_pred cccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
...++|++.+.||+|+||.||+|.+.++..+|+|.+..... ....+.+|+.++++++|+|++++++++.. +..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM------SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPI 75 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC------CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCc
Confidence 34567899999999999999999888888899999875332 12468899999999999999999998754 568
Q ss_pred EEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 302 CIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
+++|||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 8999999999999988643 4899999999999999999999999999999999999999999999999998755433
Q ss_pred Cc---ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHH
Q 011326 379 DV---KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQ 454 (488)
Q Consensus 379 ~~---~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~ 454 (488)
.. ....++..|+|||.+ ....++.++|+||||+++|+|++ |..||...+..+....+......+.+...+..+.
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAA--LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLH 233 (260)
T ss_pred ccccccCCCCCccccChHHH--hcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 21 123355679999986 44568899999999999999999 8999988877777777766656667778899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHh
Q 011326 455 DFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+|+.+||+++|.+|||+.++.+
T Consensus 234 ~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 234 ELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=322.76 Aligned_cols=247 Identities=24% Similarity=0.453 Sum_probs=206.5
Q ss_pred CceeeeeeecccCceEEEEEEec-CCc--EEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCc
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGF--FFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~--~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 300 (488)
++|++.+.||+|+||.||+|.+. ++. .+++|.+... ........+.+|+.++.++ +||||+++++++...+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF----ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc----CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence 57899999999999999999875 343 4688876532 1223345788999999999 79999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhh-----------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCc
Q 011326 301 LCIFLELVTKGSLASLYQKY-----------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS 363 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~-----------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~ 363 (488)
.+++|||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+|||++.++.
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe
Confidence 99999999999999998643 3778889999999999999999999999999999999999999
Q ss_pred EEEeecCCcccccCCCc-ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCC
Q 011326 364 VKLADFGLAKATTMNDV-KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGE 441 (488)
Q Consensus 364 vkL~DFGla~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~ 441 (488)
+||+|||++........ .....+..|+|||.+ ....++.++||||||+++|||++ |..||......+....+..+.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESL--NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred EEECCcCCCccccceeccCCCCcCccccCchhh--ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 99999999864322111 112234579999987 44568899999999999999997 999998887777777776665
Q ss_pred CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 442 LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 442 ~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
....+..++.++.+|+.+||+.+|.+|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 556677899999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=320.72 Aligned_cols=246 Identities=28% Similarity=0.460 Sum_probs=204.2
Q ss_pred ecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeeccCC
Q 011326 233 LGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKG 311 (488)
Q Consensus 233 LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 311 (488)
||+|+||.||++.+. +|..+|+|.+...... .......+.+|+.++++++||||+++++.+...+..|+||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK--KRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh--hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence 699999999999875 7899999998754321 1223445678999999999999999999999999999999999999
Q ss_pred ChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC-CcccCCCCC
Q 011326 312 SLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DVKSCKGTA 387 (488)
Q Consensus 312 sL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~gt~ 387 (488)
+|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... ......++.
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTP 158 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCC
Confidence 999888553 4899999999999999999999999999999999999999999999999988654432 233456788
Q ss_pred cccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh---hhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhC
Q 011326 388 FWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG---QAMFKIGGGELPPVPNSLSRDAQDFILKCLQVN 464 (488)
Q Consensus 388 ~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~d 464 (488)
.|+|||.+. +..++.++|+||+|+++|+|++|+.||...... ..............+..+++++.++|.+||+.|
T Consensus 159 ~y~~PE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 159 GYMAPEVLQ--GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CcCCHHHhc--CCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 999999973 444889999999999999999999999765432 112222222233456678999999999999999
Q ss_pred CCCCC-----CHHHHHhCccCCC
Q 011326 465 PNDRP-----TAAQLMEHPFIKR 482 (488)
Q Consensus 465 P~~Rp-----s~~eil~hp~f~~ 482 (488)
|.+|| ++.++++||||.+
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhc
Confidence 99999 8888999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=321.11 Aligned_cols=252 Identities=32% Similarity=0.533 Sum_probs=202.4
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
.+++|++.+.||+|++|.||+|.+. ++..||+|.+....... ....+.+|+.++++++||||+++++++.+++..
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG----APFTAIREASLLKDLKHANIVTLHDIIHTKKTL 78 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC----CchhHHHHHHHHhhCCCcceeeEEEEEecCCeE
Confidence 3578999999999999999999886 78999999987543221 112456899999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC-
Q 011326 302 CIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN- 378 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~- 378 (488)
++||||+++ +|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 79 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 999999986 898887643 5789999999999999999999999999999999999999999999999998654322
Q ss_pred -CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCch-hhhHHHhcC---C-------------
Q 011326 379 -DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG-GQAMFKIGG---G------------- 440 (488)
Q Consensus 379 -~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~-~~~~~~i~~---~------------- 440 (488)
......++..|+|||.+. ....++.++||||+|+++|+|++|..||..... .+....+.. .
T Consensus 158 ~~~~~~~~~~~~~aPE~~~-~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLL-GSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred ccccccccccccCCcHHhh-cCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 122334688899999873 334578899999999999999999999976541 111111100 0
Q ss_pred -----C---CC-----CCCCccc--HHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 441 -----E---LP-----PVPNSLS--RDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 441 -----~---~~-----~~~~~~s--~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
. .. .....++ .++.+++.+||+.+|++|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 00 0001233 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=324.99 Aligned_cols=249 Identities=25% Similarity=0.448 Sum_probs=207.0
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCc--EEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCC
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGF--FFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDE 298 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~--~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 298 (488)
..++|++.+.||+|+||.||+|.+. ++. .+++|.+... ........+.+|+.++.++ +||||+++++++.++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~ 80 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 80 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc----CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence 4678999999999999999999875 454 4566665421 2234456788999999999 899999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhh-----------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC
Q 011326 299 KRLCIFLELVTKGSLASLYQKY-----------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS 361 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~-----------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~ 361 (488)
+..+++|||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 9999999999999999988643 36788999999999999999999999999999999999999
Q ss_pred CcEEEeecCCcccccCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcC
Q 011326 362 GSVKLADFGLAKATTMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGG 439 (488)
Q Consensus 362 ~~vkL~DFGla~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~ 439 (488)
+.++|+|||++....... .....++..|+|||.+ ....++.++||||||+++|||++ |..||...+..+....+..
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 238 (303)
T cd05088 161 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238 (303)
T ss_pred CcEEeCccccCcccchhhhcccCCCcccccCHHHH--hccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 999999999986432211 1122345679999987 44557899999999999999998 9999987777766666655
Q ss_pred CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 440 GELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 440 ~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
......+..+++++.+|+.+||+.+|++||++++++.+
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 54445566788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=346.53 Aligned_cols=248 Identities=43% Similarity=0.744 Sum_probs=215.5
Q ss_pred eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeecc
Q 011326 231 ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVT 309 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 309 (488)
-+||+|.||+||-|++. +...+|||.+.... ....+-+..|+.+-++++|.|||+.+|.+.+++.+-|.||-+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-----sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-----SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc-----chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCC
Confidence 36999999999999986 57789999997533 2334567889999999999999999999999999999999999
Q ss_pred CCChHHHHhhh--cc--ChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEEC-CCCcEEEeecCCcccccCCC--ccc
Q 011326 310 KGSLASLYQKY--HL--SDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVD-ASGSVKLADFGLAKATTMND--VKS 382 (488)
Q Consensus 310 ~gsL~~~l~~~--~l--s~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~-~~~~vkL~DFGla~~~~~~~--~~~ 382 (488)
||+|..+++.. ++ ++..+..+.+||++||.|||++.|+|||||-+|+|++ -.|.+||+|||.++.+..-+ ..+
T Consensus 656 GGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 656 GGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred CCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 99999999653 45 8889999999999999999999999999999999997 48999999999998665433 446
Q ss_pred CCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC--CCCCCCCCcccHHHHHHHHHh
Q 011326 383 CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG--GELPPVPNSLSRDAQDFILKC 460 (488)
Q Consensus 383 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~s~~l~~Li~~c 460 (488)
..||..|||||++..+..+|+.++|||||||++.||.||++||...-.......... ...|++|..++.+++++|.+|
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc 815 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC 815 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence 779999999999988888999999999999999999999999977655543332221 234789999999999999999
Q ss_pred hhhCCCCCCCHHHHHhCccCCCC
Q 011326 461 LQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 461 L~~dP~~Rps~~eil~hp~f~~~ 483 (488)
+.+||..||++.++|.+||++-.
T Consensus 816 Fepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 816 FEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred cCCCcccCccHHHhccCcccccC
Confidence 99999999999999999999765
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=316.66 Aligned_cols=245 Identities=25% Similarity=0.431 Sum_probs=202.9
Q ss_pred eeeeeecccCceEEEEEEecC-Cc--EEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC------C
Q 011326 228 QKGELLGSGSYGFVYEGLTDD-GF--FFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD------E 298 (488)
Q Consensus 228 ~~~~~LG~G~fg~Vy~~~~~~-g~--~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------~ 298 (488)
.+++.||+|+||.||+|.+.+ +. .+|+|.+.... ........+.+|+.+++.++||||+++++++.. .
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI---CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence 467889999999999998753 33 68999886543 223445678899999999999999999987642 2
Q ss_pred CceEEEEeeccCCChHHHHhh-------hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCC
Q 011326 299 KRLCIFLELVTKGSLASLYQK-------YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGL 371 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~-------~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGl 371 (488)
...+++|||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCc
Confidence 257899999999999887732 2378899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCc----ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCC
Q 011326 372 AKATTMNDV----KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVP 446 (488)
Q Consensus 372 a~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~ 446 (488)
++....... ....+++.|++||.+ ....++.++|+||||+++|||++ |..||......+....+..+...+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~--~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESL--ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP 236 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHc--cCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 876543221 223456789999987 45668999999999999999999 89999887777766666666655666
Q ss_pred CcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 447 NSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 447 ~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
..++..+.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=323.75 Aligned_cols=253 Identities=26% Similarity=0.436 Sum_probs=211.7
Q ss_pred ccccccCceeeeeeecccCceEEEEEEec--------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcc
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLTD--------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIV 289 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv 289 (488)
.+....++|.+++.||+|+||.||++.+. ++..+|+|.+.... ......++.+|+.++..+ +||||+
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~~h~~i~ 87 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNII 87 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC----ChHHHHHHHHHHHHHHHhcCCCCEe
Confidence 34555678999999999999999998752 23579999986432 223345688899999999 799999
Q ss_pred eeeccccCCCceEEEEeeccCCChHHHHhhh-----------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCC
Q 011326 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKY-----------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIK 352 (488)
Q Consensus 290 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-----------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLk 352 (488)
++++++...+..++||||+++|+|.+++... .+++..+..++.|++.||+|||++|++|+|||
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk 167 (307)
T cd05098 88 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLA 167 (307)
T ss_pred eEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 9999999999999999999999999998643 37788899999999999999999999999999
Q ss_pred cccEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 011326 353 CANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSH 427 (488)
Q Consensus 353 p~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~ 427 (488)
|+||+++.++.++|+|||.+....... .....++..|+|||.+ .+..++.++|+||||+++|||++ |..||..
T Consensus 168 p~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwslG~~l~el~~~g~~p~~~ 245 (307)
T cd05098 168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL--FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245 (307)
T ss_pred HHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHh--ccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 999999999999999999986543221 1122345689999987 44568899999999999999998 8899988
Q ss_pred CchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 428 LEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 428 ~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.+..+....+........+..++.++.+|+.+||+.+|.+|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 246 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 77766666666665556777889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=319.24 Aligned_cols=248 Identities=29% Similarity=0.459 Sum_probs=208.7
Q ss_pred cCceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
.++|++.+.||+|++|.||+|.+. .+..|++|.+.... .......+.+|+.+++.++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC----SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 457899999999999999999874 46788999875432 23334568899999999999999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhhh--------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC---cEEE
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY--------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG---SVKL 366 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~--------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~---~vkL 366 (488)
.+..+++|||+++++|.+++... .+++..+..++.||+.||.|||+++++|+||||+||+++.++ .++|
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 89999999999999999998654 378889999999999999999999999999999999998654 6999
Q ss_pred eecCCcccccCCCcc----cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCC
Q 011326 367 ADFGLAKATTMNDVK----SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGE 441 (488)
Q Consensus 367 ~DFGla~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~ 441 (488)
+|||+++........ ....+..|+|||++ ....++.++|||||||++|||++ |..||...+..+....+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~ 238 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAF--LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG 238 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHH--hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999998765322211 22235679999997 44558999999999999999997 999998877777666666555
Q ss_pred CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 442 LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 442 ~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
....+..++.++.+++.+||+.+|++|||+.++++|
T Consensus 239 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 556677889999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=316.73 Aligned_cols=246 Identities=26% Similarity=0.460 Sum_probs=207.6
Q ss_pred eeeeeeecccCceEEEEEEec----CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc--
Q 011326 227 WQKGELLGSGSYGFVYEGLTD----DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR-- 300 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~-- 300 (488)
|++++.||+|+||.||+|... .+..||+|.+.... ........+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI---HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ 77 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc---CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence 567889999999999999864 24789999987533 223345678899999999999999999998766544
Q ss_pred ----eEEEEeeccCCChHHHHhhh-------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeec
Q 011326 301 ----LCIFLELVTKGSLASLYQKY-------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADF 369 (488)
Q Consensus 301 ----~~lV~E~~~~gsL~~~l~~~-------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DF 369 (488)
.+++|||+++|+|..++... .+++..+..++.|++.||.|||++|++||||||+||++++++.+||+||
T Consensus 78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCc
Confidence 79999999999999887432 4788899999999999999999999999999999999999999999999
Q ss_pred CCcccccCCCc----ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCC
Q 011326 370 GLAKATTMNDV----KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPP 444 (488)
Q Consensus 370 Gla~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~ 444 (488)
|+++....... ....++..|+|||.+ ....++.++||||||+++|||++ |..||...+..+....+..+....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~--~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESL--ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK 235 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhc--ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99875543321 122346679999986 45568899999999999999999 999998887777777777776667
Q ss_pred CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 445 VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 445 ~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.+..++.++.+++.+||+.||.+|||+.|++++
T Consensus 236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=321.46 Aligned_cols=252 Identities=29% Similarity=0.469 Sum_probs=202.2
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCCCc--
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDEKR-- 300 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~-- 300 (488)
++|++.+.||+|+||.||+|.+. ++..||+|.+...... ......+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 77 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE---EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG 77 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc---cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence 36889999999999999999885 7899999998654321 122346778999999995 6999999999877665
Q ss_pred ---eEEEEeeccCCChHHHHhh------hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC-CCcEEEeecC
Q 011326 301 ---LCIFLELVTKGSLASLYQK------YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA-SGSVKLADFG 370 (488)
Q Consensus 301 ---~~lV~E~~~~gsL~~~l~~------~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~-~~~vkL~DFG 370 (488)
.+++|||+++ +|.+++.. ..+++..++.++.||+.||.|||++|++||||+|+||+++. ++.++|+|||
T Consensus 78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 78777643 24799999999999999999999999999999999999998 8999999999
Q ss_pred CcccccCC--CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC----C---
Q 011326 371 LAKATTMN--DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG----E--- 441 (488)
Q Consensus 371 la~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~----~--- 441 (488)
++...... ......+++.|+|||.+. ....++.++|+||||+++|+|++|..||.+.+..+....+... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLL-GSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhh-CCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 98754322 223345788899999873 3345789999999999999999999999876544433222110 0
Q ss_pred ------------CC--------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCC
Q 011326 442 ------------LP--------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481 (488)
Q Consensus 442 ------------~~--------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~ 481 (488)
.+ .....+++++.++|.+||+.||.+||++.|++.||||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00 01134788999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=331.01 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=205.3
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC---
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE--- 298 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--- 298 (488)
...+|++.+.||+|+||.||+|.+. +|..||+|.+..... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ---NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc---ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence 3568999999999999999999885 799999999864321 223345677899999999999999999987543
Q ss_pred ---CceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 299 ---KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 299 ---~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
...|+||||+.+ +|.+.+... +++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...
T Consensus 91 ~~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 91 EEFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cccCcEEEEEeccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 357999999975 888777654 899999999999999999999999999999999999999999999999999765
Q ss_pred cCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC-------------
Q 011326 376 TMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE------------- 441 (488)
Q Consensus 376 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~------------- 441 (488)
.... .....+++.|+|||.+ .+..++.++||||||+++|+|++|+.||...+.......+....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred CCCCCCCCCcccccccCHHHH--hCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 4332 2345688999999997 45568999999999999999999999997655433222211000
Q ss_pred --------CC---------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 442 --------LP---------------------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 442 --------~~---------------------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
.+ ..+...++++.++|.+||+.||.+|||+.|++.||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~ 318 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY 318 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence 00 00123466789999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=312.61 Aligned_cols=244 Identities=28% Similarity=0.467 Sum_probs=210.7
Q ss_pred ccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
...+|++.+.||.|+||.||+|... |+.||+|.+.... ....++.+|+.+++.++|+||+++++++.+.+..+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDS------TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccch------hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 3567899999999999999999765 7889999986432 14567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 303 IFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
+||||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 999999999999998654 48999999999999999999999999999999999999999999999999987663322
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFIL 458 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~ 458 (488)
....++..|+|||.+ ....++.++|+||||+++|+|++ |..||...+..+....+........+..+++++.+++.
T Consensus 157 -~~~~~~~~~~ape~~--~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 233 (256)
T cd05039 157 -DSGKLPVKWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMK 233 (256)
T ss_pred -ccCCCcccccCchhh--cCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHH
Confidence 233456679999987 34567889999999999999997 99999887766666665555555566778999999999
Q ss_pred HhhhhCCCCCCCHHHHHh
Q 011326 459 KCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 459 ~cL~~dP~~Rps~~eil~ 476 (488)
+||..+|++|||+.++++
T Consensus 234 ~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 234 DCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHhccChhhCcCHHHHHH
Confidence 999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=336.59 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=209.5
Q ss_pred CCcccccccCceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCc
Q 011326 216 PNGKFRRRITSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNI 288 (488)
Q Consensus 216 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnI 288 (488)
..+.+....++|++++.||+|+||.||+|.+. .+..||+|.+.... .......+.+|+.++.++. ||||
T Consensus 28 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~~Ei~~l~~l~~HpnI 103 (400)
T cd05105 28 YDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA----RSSEKQALMSELKIMTHLGPHLNI 103 (400)
T ss_pred CCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC----ChHHHHHHHHHHHHHHhcCCCCCe
Confidence 34566777889999999999999999999752 24579999986432 2233467889999999996 9999
Q ss_pred ceeeccccCCCceEEEEeeccCCChHHHHhhh------------------------------------------------
Q 011326 289 VQYLGTDRDEKRLCIFLELVTKGSLASLYQKY------------------------------------------------ 320 (488)
Q Consensus 289 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~------------------------------------------------ 320 (488)
+++++++.+.+..++||||+++|+|.+++...
T Consensus 104 v~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (400)
T cd05105 104 VNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQA 183 (400)
T ss_pred eeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccc
Confidence 99999999999999999999999999887532
Q ss_pred -------------------------------------------------ccChhhhhHHHHHHHHHHHHHHHCCCccccC
Q 011326 321 -------------------------------------------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDI 351 (488)
Q Consensus 321 -------------------------------------------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDL 351 (488)
.+++..+..++.|++.||.|||++|++|+||
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~di 263 (400)
T cd05105 184 DTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDL 263 (400)
T ss_pred cccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 2566778899999999999999999999999
Q ss_pred CcccEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCC
Q 011326 352 KCANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYS 426 (488)
Q Consensus 352 kp~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~ 426 (488)
||+|||++.++.+||+|||+++...... .....+++.|+|||.+ .+..++.++||||||+++|||++ |..||.
T Consensus 264 kp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DiwSlGvil~ellt~g~~P~~ 341 (400)
T cd05105 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI--FDNLYTTLSDVWSYGILLWEIFSLGGTPYP 341 (400)
T ss_pred ChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhh--cCCCCCchhhHHHHHHHHHHHHHCCCCCCc
Confidence 9999999999999999999987543322 1233467789999987 44568999999999999999997 999997
Q ss_pred CCchhh-hHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 427 HLEGGQ-AMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 427 ~~~~~~-~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
...... ....+..+...+.+..++.++.+++.+||+.||++||++.++.+
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 342 GMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred ccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 654433 33344444445566788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=319.81 Aligned_cols=249 Identities=33% Similarity=0.554 Sum_probs=204.0
Q ss_pred eeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEE
Q 011326 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFL 305 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 305 (488)
|++.+.||.|++|.||+|.+. +|..||+|.+...... ......+.+|+.+++.++|||++++++++.+++..+++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED---EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc---ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence 567889999999999999875 7999999998765322 222345778999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--Cc
Q 011326 306 ELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DV 380 (488)
Q Consensus 306 E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~ 380 (488)
||++ ++|.+++... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 9995 5899888654 4899999999999999999999999999999999999999999999999998654322 22
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC---------------------
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG--------------------- 439 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~--------------------- 439 (488)
....++..|+|||.+. ....++.++|+||||+++|+|++|+.||...+.......+..
T Consensus 157 ~~~~~~~~~~aPE~~~-~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 157 THEVVTLWYRAPEILL-GSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred CccccccCCCCCceee-cCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 3345688999999863 334568899999999999999999999976654332222110
Q ss_pred -------CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 440 -------GELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 440 -------~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
.........++.++.++|.+||+.||.+|||+.|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00011234577899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=314.52 Aligned_cols=245 Identities=27% Similarity=0.448 Sum_probs=207.4
Q ss_pred ccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
..++|++.+.||+|++|.||++.+.++..+|+|.+..... ....+.+|+.++++++|||++++++++.. +..+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM------MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIY 76 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc------cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcE
Confidence 3457899999999999999999887777899998764321 23467889999999999999999998754 5688
Q ss_pred EEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 303 IFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
++|||+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999999988653 37888999999999999999999999999999999999999999999999987554332
Q ss_pred c---ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHH
Q 011326 380 V---KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455 (488)
Q Consensus 380 ~---~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~ 455 (488)
. ....++..|+|||.. ....++.++|+||||+++|+|++ |..||......+....+......+.+...+..+.+
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~--~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAA--LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHE 234 (260)
T ss_pred ccccCCCccchhhCCHHHh--ccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 1 223456779999986 44568999999999999999999 99999887777766666665555667788999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHh
Q 011326 456 FILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~eil~ 476 (488)
++.+||++||.+||+++++++
T Consensus 235 li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 235 LMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=320.61 Aligned_cols=252 Identities=31% Similarity=0.559 Sum_probs=207.4
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||+|.+. ++..|++|.+..... .......+.+|+.++++++|+||+++++++..++..++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 77 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED---DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL 77 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc---cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence 36899999999999999999886 688999999865432 22334678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC---
Q 011326 304 FLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--- 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--- 379 (488)
+|||++++.+..+... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9999999777766644 458999999999999999999999999999999999999999999999999987654432
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC--------------------
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG-------------------- 439 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~-------------------- 439 (488)
.....++..|+|||++. ....++.++|+||||+++|+|++|+.||...+..+....+..
T Consensus 158 ~~~~~~~~~~~~PE~~~-~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 158 LTDYVATRWYRAPELLV-GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred ccCcccccCCcCCchhc-CCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 23456788999999973 222688999999999999999999999976554332222110
Q ss_pred C-CCC----------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 440 G-ELP----------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 440 ~-~~~----------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
+ ..+ ..+..++.++.+||.+||..+|++||+++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 000 1223458899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=343.23 Aligned_cols=245 Identities=26% Similarity=0.346 Sum_probs=197.4
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
...|.+.+.||+|+||.||++.+. ++..||+|.... ..+.+|+.+|++++|+||+++++++..++..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 347999999999999999999886 688999996421 23468999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-
Q 011326 303 IFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND- 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~- 379 (488)
+|||++. ++|..++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 237 lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 9999996 5887777543 58999999999999999999999999999999999999999999999999987553322
Q ss_pred ---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCc--------hhhhHHHhcCCC-----CC
Q 011326 380 ---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE--------GGQAMFKIGGGE-----LP 443 (488)
Q Consensus 380 ---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~--------~~~~~~~i~~~~-----~~ 443 (488)
.....||..|+|||++ .+..++.++|||||||+||||++|..|+.... .......+.... .+
T Consensus 316 ~~~~~~~~GT~~Y~APE~~--~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVL--AGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccCCCcCCcCHHHH--cCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 1235699999999997 44568999999999999999999876553221 111111111110 00
Q ss_pred C---------------------C-------CCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 444 P---------------------V-------PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 444 ~---------------------~-------~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
. . ...++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0 0 0134568999999999999999999999999999975
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=320.36 Aligned_cols=246 Identities=26% Similarity=0.442 Sum_probs=210.5
Q ss_pred cCceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
..+|.+.+.||+|+||.||+|... ++..+++|.+... .......+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-----TLAARKDFQREAELLTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc-----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 357889999999999999999742 3566888887532 22334578899999999999999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhhh-----------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY-----------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA 360 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~-----------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~ 360 (488)
.+..++||||+++++|.+++... .+++..+..++.||+.||+|||++|++||||||+||+++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 99999999999999999998643 2788899999999999999999999999999999999999
Q ss_pred CCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHH
Q 011326 361 SGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMF 435 (488)
Q Consensus 361 ~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~ 435 (488)
++.++|+|||++....... .....++..|+|||.+ ....++.++||||||+++|||++ |..||...+..+...
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999987543322 2234467889999987 44568899999999999999998 999998877777777
Q ss_pred HhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 436 KIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 436 ~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
.+..+..+..+..++.++.+++.+||+.||.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 237 CITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 77777666667778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=319.30 Aligned_cols=249 Identities=32% Similarity=0.534 Sum_probs=204.7
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|++.+.||+|++|.||+|.+. +|..||+|.+...... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE----GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV 76 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc----cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence 4889999999999999999986 6899999999765322 1224566899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhh----ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--
Q 011326 305 LELVTKGSLASLYQKY----HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-- 378 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~----~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-- 378 (488)
|||+++ +|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 999986 888877543 4899999999999999999999999999999999999999999999999998654322
Q ss_pred CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC------------------
Q 011326 379 DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG------------------ 440 (488)
Q Consensus 379 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~------------------ 440 (488)
......++..|++||.+. ....++.++|+||||+++|+|++|+.||...+..+....+...
T Consensus 156 ~~~~~~~~~~y~~PE~~~-~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLL-GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred ccccccccccccChHHhc-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 123455788999999873 3345788999999999999999999999876654433322110
Q ss_pred --CCC--------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 441 --ELP--------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 441 --~~~--------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
..+ .....++.++.+++.+||+.||.+||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 000 0112457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=313.62 Aligned_cols=253 Identities=43% Similarity=0.755 Sum_probs=212.8
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC--Cce
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE--KRL 301 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~ 301 (488)
.+|++.+.||+|+||.||+|.+. ++..+|+|.+...............+.+|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46899999999999999999875 699999999865433223344567889999999999999999999988654 468
Q ss_pred EEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--
Q 011326 302 CIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-- 378 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-- 378 (488)
+++|||+++++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 899999999999998865 45889999999999999999999999999999999999999999999999998754321
Q ss_pred ---CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC-CCCCCCCCcccHHHH
Q 011326 379 ---DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG-GELPPVPNSLSRDAQ 454 (488)
Q Consensus 379 ---~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l~ 454 (488)
......++..|+|||.+ .+..++.++|+||||+++|+|++|+.||...........+.. ...+..+..+++++.
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 239 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVI--SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACR 239 (264)
T ss_pred cCccccccCCcccccCHhhh--cCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHH
Confidence 12234688999999987 345578999999999999999999999987665555544443 334557788999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
+++.+||+ +|.+||+..+++.|||+
T Consensus 240 ~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 240 DFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHhc-CcccCccHHHHhcCCCC
Confidence 99999999 57999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=323.17 Aligned_cols=252 Identities=27% Similarity=0.458 Sum_probs=205.9
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC--Cc
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE--KR 300 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~ 300 (488)
+.+|++.+.||+|+||.||+|.+. ++..+++|.+...... ......+.+|+.++++++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK---EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc---ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCc
Confidence 467899999999999999999986 6899999999765432 12224567899999999999999999988776 89
Q ss_pred eEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 301 LCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
.++||||+++ +|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 81 IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9999999985 898887653 4899999999999999999999999999999999999999999999999998765443
Q ss_pred --CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC----------------
Q 011326 379 --DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG---------------- 440 (488)
Q Consensus 379 --~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~---------------- 440 (488)
......+++.|+|||.+. ....++.++|+||+|+++|+|++|..||...+..+....+...
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~-~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLL-GAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred ccccccccccccccCchhhc-CCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 223455788999999873 3334688999999999999999999999766544333221100
Q ss_pred -----C---------CCCCCCc-ccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 441 -----E---------LPPVPNS-LSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 441 -----~---------~~~~~~~-~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
. ...++.. +++.+.++|.+||+.||++|||+.|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0 0112222 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=354.05 Aligned_cols=251 Identities=27% Similarity=0.452 Sum_probs=223.9
Q ss_pred ccccCceeeeeeecccCceEEEEEEec----CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecccc
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD----DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR 296 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 296 (488)
+...+...+.++||.|.||.||+|..+ ....||||.++.. ..+....+|+.|+.||.+.+||||++|.|+..
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G----ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG----YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC----ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 344567889999999999999999874 3578999999754 34556678999999999999999999999999
Q ss_pred CCCceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccc
Q 011326 297 DEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 374 (488)
Q Consensus 297 ~~~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~ 374 (488)
.....+||+|||++|+|+.+|+.+ .++..++..+++.|+.||.||-++|++||||...|||++.+-.+|++|||+++.
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence 999999999999999999999765 599999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCcc--cCC---CCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCc
Q 011326 375 TTMNDVK--SCK---GTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNS 448 (488)
Q Consensus 375 ~~~~~~~--~~~---gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 448 (488)
+...... +.. -..+|.|||.+. ...++.++||||+|++|||.++ |..||..+.+.+++..+..+.+.+-|..
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa--~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmD 858 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMD 858 (996)
T ss_pred cccCCCccccccCCccceeecChhHhh--hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCC
Confidence 7654311 111 235699999984 4559999999999999999777 9999999999999999999999999999
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 449 LSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 449 ~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
||..+.+|+..||++|-.+||.|.||+.+
T Consensus 859 CP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 859 CPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred CcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 99999999999999999999999999864
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=314.71 Aligned_cols=245 Identities=32% Similarity=0.529 Sum_probs=209.2
Q ss_pred ecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeeccCC
Q 011326 233 LGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKG 311 (488)
Q Consensus 233 LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 311 (488)
||.|+||.||++.+. +|..+++|.+..... ........+.+|+.++.+++||||+++++.+..+...+++|||++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM--IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh--hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence 689999999999986 599999999865432 12344567889999999999999999999999999999999999999
Q ss_pred ChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC----------Cc
Q 011326 312 SLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----------DV 380 (488)
Q Consensus 312 sL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~----------~~ 380 (488)
+|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence 99998876 45899999999999999999999999999999999999999999999999998654332 12
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcc--cHHHHHHHH
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSL--SRDAQDFIL 458 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--s~~l~~Li~ 458 (488)
....++..|++||.+ .....+.++|+||||+++|+|++|..||......+....+..+.. ..+..+ +.++.+++.
T Consensus 159 ~~~~~~~~~~~Pe~~--~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~ 235 (265)
T cd05579 159 KRIVGTPDYIAPEVI--LGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI-EWPEDVEVSDEAIDLIS 235 (265)
T ss_pred cCcccCccccCHHHh--cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc-CCCccccCCHHHHHHHH
Confidence 234578889999997 344478899999999999999999999988777766666555333 333344 899999999
Q ss_pred HhhhhCCCCCCCH---HHHHhCccCCC
Q 011326 459 KCLQVNPNDRPTA---AQLMEHPFIKR 482 (488)
Q Consensus 459 ~cL~~dP~~Rps~---~eil~hp~f~~ 482 (488)
+||+.+|.+|||+ .++++||||++
T Consensus 236 ~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 236 KLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred HHhcCCHhhcCCCccHHHHhcCccccC
Confidence 9999999999999 99999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=322.89 Aligned_cols=255 Identities=31% Similarity=0.560 Sum_probs=213.5
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
..|++.+.||+|+||.||+|... ++..||+|.+..... ........+.+|+.+++.++||||+++++++.+++..++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEecccc--CcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 45888899999999999999875 689999999865432 223445678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHh--hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCcc
Q 011326 304 FLELVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK 381 (488)
Q Consensus 304 V~E~~~~gsL~~~l~--~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 381 (488)
||||+++ +|.+++. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 93 v~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--~ 169 (307)
T cd06607 93 VMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--N 169 (307)
T ss_pred EHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--C
Confidence 9999985 6766654 345899999999999999999999999999999999999999999999999998654322 3
Q ss_pred cCCCCCcccCchhhcc-ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCC-CCcccHHHHHHHHH
Q 011326 382 SCKGTAFWMAPEVVNL-KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV-PNSLSRDAQDFILK 459 (488)
Q Consensus 382 ~~~gt~~y~aPE~~~~-~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~s~~l~~Li~~ 459 (488)
...+++.|+|||.+.. ....++.++||||||+++|||++|+.||...+.......+.....+.. +..++.++.+++.+
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 249 (307)
T cd06607 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDS 249 (307)
T ss_pred CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHH
Confidence 4568889999998632 235578899999999999999999999988776665555544433333 34578899999999
Q ss_pred hhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 460 CLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 460 cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
||+.+|.+||++.+++.||||.+..
T Consensus 250 ~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 250 CLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HhcCChhhCcCHHHHhcChhhcccC
Confidence 9999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=341.82 Aligned_cols=255 Identities=33% Similarity=0.576 Sum_probs=226.6
Q ss_pred eeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEE
Q 011326 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFL 305 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 305 (488)
|.-++.||.|+||.||-+++. +...||||.+..... ...+-..++..|+..|++++|||++.+.||+-.+...++||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK--Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeecccccc--ccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 556788999999999999985 789999999987654 34456778999999999999999999999999999999999
Q ss_pred eeccCCChHHHHh--hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCcccC
Q 011326 306 ELVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC 383 (488)
Q Consensus 306 E~~~~gsL~~~l~--~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 383 (488)
|||-| +-.+++. +.++-+.++..|..+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|.... ...++
T Consensus 106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--PAnsF 182 (948)
T KOG0577|consen 106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA--PANSF 182 (948)
T ss_pred HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC--chhcc
Confidence 99977 7777774 5579999999999999999999999999999999999999999999999999986654 45678
Q ss_pred CCCCcccCchhhc-cccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCC-CcccHHHHHHHHHhh
Q 011326 384 KGTAFWMAPEVVN-LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVP-NSLSRDAQDFILKCL 461 (488)
Q Consensus 384 ~gt~~y~aPE~~~-~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~s~~l~~Li~~cL 461 (488)
+|||+|||||++- ...+.|+-++||||||++-.||.-.++|+.+++.-..+..|..+..|.++ +.++..+++++..||
T Consensus 183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CL 262 (948)
T KOG0577|consen 183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCL 262 (948)
T ss_pred cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHH
Confidence 9999999999972 34567999999999999999999999999999988888888887777665 468999999999999
Q ss_pred hhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 462 QVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 462 ~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
++-|.+|||.++++.|+|+......
T Consensus 263 qKipqeRptse~ll~H~fv~R~Rp~ 287 (948)
T KOG0577|consen 263 QKIPQERPTSEELLKHRFVLRERPP 287 (948)
T ss_pred hhCcccCCcHHHHhhcchhccCCCc
Confidence 9999999999999999999876543
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=317.62 Aligned_cols=246 Identities=30% Similarity=0.469 Sum_probs=205.0
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCc----EEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGF----FFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
..+|++.+.||+|+||.||+|.+. ++. .+++|.+... .......++..|+.++++++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~- 80 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR----SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG- 80 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc----cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-
Confidence 467889999999999999999874 454 4666766421 223445677888889999999999999998764
Q ss_pred CceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 299 KRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
...++++||+++|+|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++...
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 4578899999999999998653 58999999999999999999999999999999999999999999999999997543
Q ss_pred CCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccH
Q 011326 377 MND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSR 451 (488)
Q Consensus 377 ~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 451 (488)
... .....++..|+|||.+ ....++.++||||||+++|||++ |..||.+.........+..+..++.+..++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~--~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESI--LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTI 238 (279)
T ss_pred CCCcccccCCCCCcccccCHHHh--ccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCH
Confidence 222 2234467789999987 34568999999999999999998 9999988776666565666666666777889
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
++.+++.+||..||.+|||+.|+++
T Consensus 239 ~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 239 DVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=314.28 Aligned_cols=252 Identities=29% Similarity=0.522 Sum_probs=210.6
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
+|.+.+.||+|+||.||++.+. .+..+++|.+..............++..|+.++++++||||+++++++.+.+..+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888999999999999999875 455566666544332222222334567889999999999999999999999999999
Q ss_pred EeeccCCChHHHHhh-----hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 305 LELVTKGSLASLYQK-----YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~-----~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
|||+++++|..++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||.+.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988753 34899999999999999999999999999999999999974 679999999886543322
Q ss_pred --cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHH
Q 011326 380 --VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFI 457 (488)
Q Consensus 380 --~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li 457 (488)
.....|++.|+|||.+ ....++.++|+||+|+++|+|++|..||...........+..+..+..+..++.++.++|
T Consensus 160 ~~~~~~~~~~~~~~pe~~--~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (260)
T cd08222 160 DLATTFTGTPYYMSPEAL--KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIM 237 (260)
T ss_pred ccccCCCCCcCccCHHHH--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHH
Confidence 2345588899999987 345578899999999999999999999987776666666666666677778999999999
Q ss_pred HHhhhhCCCCCCCHHHHHhCccC
Q 011326 458 LKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 458 ~~cL~~dP~~Rps~~eil~hp~f 480 (488)
.+||+.+|++||++.++++||||
T Consensus 238 ~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 238 QSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHhcCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=320.31 Aligned_cols=251 Identities=32% Similarity=0.484 Sum_probs=199.9
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||+|.+. +|..||+|.+...... .....+.+|+.+++.++|+||+++++++.+++..+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 79 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE----GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC----CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence 578999999999999999999875 6899999998654321 12235568999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-
Q 011326 303 IFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND- 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~- 379 (488)
+||||+. ++|...+.. ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++......
T Consensus 80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 80 FVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred EEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9999996 566655543 347888899999999999999999999999999999999999999999999986543322
Q ss_pred -cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh-hhHHHhcC-----------------C
Q 011326 380 -VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-QAMFKIGG-----------------G 440 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~-~~~~~i~~-----------------~ 440 (488)
.....+++.|+|||.+. ....++.++|+||||+++|+|++|..||...+.. +....+.. .
T Consensus 159 ~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLL-GATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCccccccccCCceee-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 23445788999999873 3345788999999999999999999999765432 11111100 0
Q ss_pred CCCC------------CC--CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 441 ELPP------------VP--NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 441 ~~~~------------~~--~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
..+. .. ...+.++.+++.+||+.||.+|||+.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0000 00 1135789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=336.36 Aligned_cols=294 Identities=26% Similarity=0.426 Sum_probs=251.8
Q ss_pred ehhhHHHHHHHHHHHHHHHHHhhhhcCCCCCcccccccCCCCCCCCCCccccCCCCCCCC-CcccccccCceeeeeeecc
Q 011326 157 VRHKFQYYMSLCNYIVTEAAKVRRRQDCPNNVEYVSYHDDDDSKGHPISEIMEPGNNVSP-NGKFRRRITSWQKGELLGS 235 (488)
Q Consensus 157 ~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~-~~~~~~~~~~y~~~~~LG~ 235 (488)
-..+|.++.+|+.+....++++-+....|-... .++ . +.. ++| ..+|+-.-++..+..+||-
T Consensus 215 ~EsrF~TLaELVHHHStvADGLittLhYPApK~---------nKp--t--vyg----vSPn~DkWEmeRtdItMkhKLGG 277 (1157)
T KOG4278|consen 215 QESRFRTLAELVHHHSTVADGLITTLHYPAPKK---------NKP--T--VYG----VSPNADKWEMERTDITMKHKLGG 277 (1157)
T ss_pred ehhhhhHHHHHHhhccccccceeEeeeccCccC---------CCC--c--eee----ecCCcchhhccchheeeeeccCC
Confidence 467899999999999888888766544333211 011 0 111 122 2567777788889999999
Q ss_pred cCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeeccCCChH
Q 011326 236 GSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLA 314 (488)
Q Consensus 236 G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 314 (488)
|.||.||.|.|+ -.-.||||.++ .....+.+|+.|+.+|+.++|||+|+|+|+|..+..+|||+|||..|+|.
T Consensus 278 GQYGeVYeGvWKkyslTvAVKtLK------EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLL 351 (1157)
T KOG4278|consen 278 GQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLL 351 (1157)
T ss_pred Ccccceeeeeeeccceeeehhhhh------hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHH
Confidence 999999999997 47789999987 45667789999999999999999999999999999999999999999999
Q ss_pred HHHhhhc---cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCcccCCCCC---c
Q 011326 315 SLYQKYH---LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTA---F 388 (488)
Q Consensus 315 ~~l~~~~---ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~gt~---~ 388 (488)
+++++.. ++.-.++.++.||.+||+||..+++|||||...|+|+.++..+|++|||+++.+.....+...|.. -
T Consensus 352 dYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIK 431 (1157)
T KOG4278|consen 352 DYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIK 431 (1157)
T ss_pred HHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCccc
Confidence 9997653 677778899999999999999999999999999999999999999999999988766655555543 4
Q ss_pred ccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCC
Q 011326 389 WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPND 467 (488)
Q Consensus 389 y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~ 467 (488)
|.|||-+ .-..++.++|||+||++|||+.| |..||.+.+..+++..+..+.+..-|+.|++.+++|++.||++.|..
T Consensus 432 WTAPEsL--AyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsD 509 (1157)
T KOG4278|consen 432 WTAPESL--AYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSD 509 (1157)
T ss_pred ccCcccc--cccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCccc
Confidence 9999987 34558999999999999999998 99999999999999999999999999999999999999999999999
Q ss_pred CCCHHHHH
Q 011326 468 RPTAAQLM 475 (488)
Q Consensus 468 Rps~~eil 475 (488)
||++.||-
T Consensus 510 RPsFaeiH 517 (1157)
T KOG4278|consen 510 RPSFAEIH 517 (1157)
T ss_pred CccHHHHH
Confidence 99999874
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=319.97 Aligned_cols=253 Identities=25% Similarity=0.455 Sum_probs=214.3
Q ss_pred ccccccCceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCccee
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQY 291 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l 291 (488)
.+....++|++.+.||+|+||.||++... +...+|+|.+.... .......+.+|+.++.++ +||||+++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i~~~ 81 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINL 81 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC----CHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 45556678999999999999999999763 23679999986432 223445688999999999 79999999
Q ss_pred eccccCCCceEEEEeeccCCChHHHHhhh-----------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcc
Q 011326 292 LGTDRDEKRLCIFLELVTKGSLASLYQKY-----------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCA 354 (488)
Q Consensus 292 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-----------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~ 354 (488)
++++..++..+++|||+++|+|..++... .+++..+..++.|++.||.|||++||+|+||||+
T Consensus 82 ~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~ 161 (293)
T cd05053 82 LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAAR 161 (293)
T ss_pred EEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccccee
Confidence 99999999999999999999999988532 3788889999999999999999999999999999
Q ss_pred cEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCc
Q 011326 355 NILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLE 429 (488)
Q Consensus 355 NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~ 429 (488)
||+++.++.++|+|||+++...... .....++..|+|||.+ ....++.++||||||+++|||++ |..||...+
T Consensus 162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHh--ccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 9999999999999999987654322 1223355679999986 44568899999999999999997 999998887
Q ss_pred hhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 430 GGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 430 ~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
..+....+........+..++.++.+|+.+||..||++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 240 VEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 777777776666666777889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=313.05 Aligned_cols=244 Identities=26% Similarity=0.452 Sum_probs=207.2
Q ss_pred cccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc-cCCCc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD-RDEKR 300 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-~~~~~ 300 (488)
....+|++.+.||+|+||.||++... |..+++|.+... .....+.+|+.++++++|+|++++++++ .+++.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 74 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC-------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence 34568999999999999999999665 778999987532 1235688999999999999999999875 45667
Q ss_pred eEEEEeeccCCChHHHHhhhc---cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 301 LCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~~---ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
.+++|||+++++|.+++.... +++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 999999999999999886543 78899999999999999999999999999999999999999999999999875433
Q ss_pred CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHH
Q 011326 378 NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDF 456 (488)
Q Consensus 378 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L 456 (488)
.. ....++..|+|||++ ....++.++||||||+++|+|++ |+.||...+..+....+..+..+..+..+++.+.++
T Consensus 155 ~~-~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (256)
T cd05082 155 TQ-DTGKLPVKWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDV 231 (256)
T ss_pred cC-CCCccceeecCHHHH--ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 22 233456689999987 44568899999999999999997 999998777766666666665556677899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHh
Q 011326 457 ILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 457 i~~cL~~dP~~Rps~~eil~ 476 (488)
+.+||+.+|++|||+.++++
T Consensus 232 i~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 232 MKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=318.89 Aligned_cols=245 Identities=27% Similarity=0.452 Sum_probs=206.6
Q ss_pred ceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
+|++.+.||+|+||.||+|.+. ....+++|.+.... .......+.+|+.+++.++||||+++++.+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA----SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC----CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 4778899999999999999763 23568888876432 2334467889999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhh-------------------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcc
Q 011326 300 RLCIFLELVTKGSLASLYQKY-------------------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCA 354 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~-------------------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~ 354 (488)
..+++|||+++++|.+++... .+++..++.++.|++.||.|||++|++||||||+
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ 156 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR 156 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence 999999999999999987532 3678889999999999999999999999999999
Q ss_pred cEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCc
Q 011326 355 NILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLE 429 (488)
Q Consensus 355 NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~ 429 (488)
||+++.++.++|+|||+++...... .....++..|+|||.+ ....++.++||||||+++|||++ |..||.+..
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~--~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL--FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH--ccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999987543222 1223456789999987 44568999999999999999998 999998877
Q ss_pred hhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 430 GGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 430 ~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
..+....+......+.+..++.++.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 235 PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 77766666655555667788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=317.64 Aligned_cols=247 Identities=28% Similarity=0.459 Sum_probs=198.9
Q ss_pred eeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCC--CceE
Q 011326 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDE--KRLC 302 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~--~~~~ 302 (488)
|++.+.||+|+||.||+|.+. ++..+|+|.+...... .. .....+|+.++.++. |+|++++++++.++ +..+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~---~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS---LE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC---ch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence 577889999999999999875 7899999998654321 11 123457888888885 99999999999887 8999
Q ss_pred EEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-
Q 011326 303 IFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND- 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~- 379 (488)
+||||+++ +|.+.+.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++.......
T Consensus 77 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 77 LVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred EEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 99999985 77776654 35899999999999999999999999999999999999999 999999999987654332
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC-------------------
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG------------------- 440 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~------------------- 440 (488)
.....++..|+|||.+. ....++.++|+||+|+++|||++|..||...+..+....+...
T Consensus 155 ~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 155 YTEYISTRWYRAPECLL-TDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred cCCCCCCcccCChhHhh-cCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 23456889999999762 3445788999999999999999999999876554432222110
Q ss_pred -CCC--------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 441 -ELP--------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 441 -~~~--------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
..+ .....++.++.++|.+||+++|++||++++++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 000 0113568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=321.45 Aligned_cols=255 Identities=28% Similarity=0.496 Sum_probs=201.6
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
...+++|++.+.||+|+||.||+|.+. ++..||+|.+....... .....+.+|+.++++++||||+++++++...+
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC---CchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 445778999999999999999999885 79999999987543221 12234567999999999999999999876543
Q ss_pred --------ceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeec
Q 011326 300 --------RLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADF 369 (488)
Q Consensus 300 --------~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DF 369 (488)
..++||||+.+ +|.+.+... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred ccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcC
Confidence 45999999976 787777654 5899999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCC------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC--CC
Q 011326 370 GLAKATTMND------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG--GE 441 (488)
Q Consensus 370 Gla~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~--~~ 441 (488)
|++....... .....++..|+|||.+. ....++.++|+||||+++|+|++|..||...+.......+.. +.
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLL-GERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhc-CCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9986543322 12345778899999873 333468899999999999999999999976654332221111 00
Q ss_pred C-------------------CC----------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 442 L-------------------PP----------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 442 ~-------------------~~----------~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
. +. .+...+..+.+||.+||+.||.+|||++++++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0 00 011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=317.30 Aligned_cols=250 Identities=31% Similarity=0.499 Sum_probs=210.7
Q ss_pred eeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCCCceEEEEee
Q 011326 230 GELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDEKRLCIFLEL 307 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~ 307 (488)
.+.||+|+++.|-.+.. .+|..||||++.+.. .....++.+|++++.+.+ |+||++|+++|+++..+|+|||.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-----gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK 157 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-----GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK 157 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC-----chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence 36799999999999876 689999999998763 234567889999999985 99999999999999999999999
Q ss_pred ccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC---cEEEeecCCccccc-------
Q 011326 308 VTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG---SVKLADFGLAKATT------- 376 (488)
Q Consensus 308 ~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~---~vkL~DFGla~~~~------- 376 (488)
|.||+|...|.+ ..+++.++.+++..|+.||.+||.+||.||||||+|||-.+.+ -+|||||.+.....
T Consensus 158 m~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 158 MRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred ccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 999999777654 4699999999999999999999999999999999999997654 48999998864221
Q ss_pred --CCCcccCCCCCcccCchhhc---cccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh---------------hhHHH
Q 011326 377 --MNDVKSCKGTAFWMAPEVVN---LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG---------------QAMFK 436 (488)
Q Consensus 377 --~~~~~~~~gt~~y~aPE~~~---~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~---------------~~~~~ 436 (488)
..+..+.+|+..|||||++. .....|+.++|.||||++||-|++|.+||.+.-.. .....
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 22344667999999999973 23445889999999999999999999999764322 34556
Q ss_pred hcCCCCCCCC----CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 437 IGGGELPPVP----NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 437 i~~~~~~~~~----~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
|..+.+. +| ..+|.+.++|++.+|..|+..|.++.++++|||++...+
T Consensus 318 IQEGkYe-FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 318 IQEGKYE-FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred HhccCCc-CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 7777763 33 358999999999999999999999999999999987654
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=320.16 Aligned_cols=255 Identities=37% Similarity=0.648 Sum_probs=217.3
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
...|+..+.||+|++|.||++.+. ++..+++|.+..... ....+.+|+.+++.++|+|++++++.+..++..+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 445778889999999999999886 789999999975432 3457789999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-
Q 011326 303 IFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND- 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~- 379 (488)
+++||+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999999999877 69999999999999999999999999999999999999999999999999876543321
Q ss_pred -cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCC--CcccHHHHHH
Q 011326 380 -VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVP--NSLSRDAQDF 456 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~s~~l~~L 456 (488)
.....++..|++||.+ .+..++.++|+||||+++|+|++|..||...+.......+.....+... ..++.++.++
T Consensus 172 ~~~~~~~~~~y~~PE~~--~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (286)
T cd06614 172 KRNSVVGTPYWMAPEVI--KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF 249 (286)
T ss_pred hhccccCCcccCCHhHh--cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHH
Confidence 2334578899999987 3455789999999999999999999999877665555554443333322 3378999999
Q ss_pred HHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 457 ILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 457 i~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
|.+||+.+|.+||++.++++||||+++-.+
T Consensus 250 i~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 279 (286)
T cd06614 250 LNKCLVKDPEKRPSAEELLQHPFLKKACPK 279 (286)
T ss_pred HHHHhccChhhCcCHHHHhhChHhhccCch
Confidence 999999999999999999999999985443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=311.43 Aligned_cols=248 Identities=29% Similarity=0.574 Sum_probs=209.7
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||+|... +|..||+|.+...... .......+.+|+.++++++|+|++++++++..++..++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM--DAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc--chhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 57999999999999999999986 8999999998754332 22335678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhh-----hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 304 FLELVTKGSLASLYQK-----YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~-----~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
+|||+++++|..++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999999988853 24789999999999999999999999999999999999999999999999998654432
Q ss_pred C--cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCc--hhhhHHHhcCCCCCCCCC-cccHHH
Q 011326 379 D--VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE--GGQAMFKIGGGELPPVPN-SLSRDA 453 (488)
Q Consensus 379 ~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~-~~s~~l 453 (488)
. .....++..|+|||.+ .+..++.++|+||||+++|+|++|+.||.... ..+....+..+..++.+. .++.++
T Consensus 160 ~~~~~~~~~~~~y~apE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERI--HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL 237 (267)
T ss_pred CcccceecCCccccCHHHh--ccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHH
Confidence 2 2345688899999987 35568899999999999999999999996543 223444444555555555 788899
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHh
Q 011326 454 QDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
.++|.+||..+|++|||+.+|++
T Consensus 238 ~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 238 RDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=372.53 Aligned_cols=259 Identities=41% Similarity=0.736 Sum_probs=227.1
Q ss_pred cCceeeeeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.-+|+.+..||.|.||.||.|.+ .+|...|+|.+...+.. ......+.+|..++..++|||+|+.+|+-.+.+..+
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~---~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD---HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc---cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 34688889999999999999987 47999999999877643 445567789999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhhc-cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 303 IFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~~-ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
|.||||.+|+|.+++...+ .++.....+..|++.|+.|||++||+||||||.||+++.+|.+|++|||.|.....+.
T Consensus 1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 9999999999999998776 5555666788999999999999999999999999999999999999999997554332
Q ss_pred ----cccCCCCCcccCchhhcccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCchh-hhHHHhcCCCCCCCCCcccHHH
Q 011326 380 ----VKSCKGTAFWMAPEVVNLKK-DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-QAMFKIGGGELPPVPNSLSRDA 453 (488)
Q Consensus 380 ----~~~~~gt~~y~aPE~~~~~~-~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~l 453 (488)
.....||+.|||||++.... .+...+.|||||||++.||+||+.||...+++ ..+..+..+..|++|..++++.
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g 1470 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEG 1470 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhH
Confidence 34678999999999996544 56778999999999999999999999887655 5556677788899999999999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 454 QDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
+++|.+||+.||++|+++.|+++|.|-+....
T Consensus 1471 ~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1471 RDFLEHCLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred HHHHHHHHhcCchhhhHHHHHHHhhccccccc
Confidence 99999999999999999999999999876543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=362.92 Aligned_cols=259 Identities=27% Similarity=0.386 Sum_probs=222.6
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
+-...+|+++++||+|+||.|..++.+ ++..||+|++.+-...... ....|..|-.+|..-+.+=|++++..|+++.
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~--~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRA--ETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhch--hHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 445678999999999999999999875 7999999999864332222 2246788889999889999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhhc-cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 300 RLCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~~-ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
++|+|||||+||+|..++.+.. +++..+..++..|+.||.-||+.|+|||||||+|||||..|++||+|||.+-.+...
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 9999999999999999998887 999999999999999999999999999999999999999999999999987655433
Q ss_pred C---cccCCCCCcccCchhhccc--c-CCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC-CCCCC--Ccc
Q 011326 379 D---VKSCKGTAFWMAPEVVNLK--K-DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE-LPPVP--NSL 449 (488)
Q Consensus 379 ~---~~~~~gt~~y~aPE~~~~~--~-~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~~~--~~~ 449 (488)
. ....+|||.|.+||+++.. + +.|++.+|+||+||++|||++|.+||...+-.+++.+|..-. .-.+| ..+
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~V 308 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDV 308 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccccc
Confidence 2 3467899999999998532 2 568999999999999999999999999888888888876542 11233 569
Q ss_pred cHHHHHHHHHhhhhCCCCCCC---HHHHHhCccCCC
Q 011326 450 SRDAQDFILKCLQVNPNDRPT---AAQLMEHPFIKR 482 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps---~~eil~hp~f~~ 482 (488)
|+++++||.+++. +|+.|.. ++++..||||..
T Consensus 309 SeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 309 SEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred CHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence 9999999999997 4888888 999999999975
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=321.53 Aligned_cols=251 Identities=32% Similarity=0.530 Sum_probs=212.2
Q ss_pred eeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeec
Q 011326 230 GELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
...||+|+||.||++... ++..||+|.+.... ......+.+|+.+++.++|+||+++++.+..++..+++|||+
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-----hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 366999999999999885 79999999875322 234466889999999999999999999999999999999999
Q ss_pred cCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--CcccCCCC
Q 011326 309 TKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGT 386 (488)
Q Consensus 309 ~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~gt 386 (488)
++++|.+++....+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++...... ......|+
T Consensus 100 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 179 (292)
T cd06657 100 EGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT 179 (292)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence 9999999988778999999999999999999999999999999999999999999999999987654332 22345688
Q ss_pred CcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC--CCCcccHHHHHHHHHhhhhC
Q 011326 387 AFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP--VPNSLSRDAQDFILKCLQVN 464 (488)
Q Consensus 387 ~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~Li~~cL~~d 464 (488)
+.|++||.+ ....++.++|+||+|+++|+|++|..||......+....+.....+. ....++.++.+++.+||+.+
T Consensus 180 ~~y~~pE~~--~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 257 (292)
T cd06657 180 PYWMAPELI--SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257 (292)
T ss_pred ccccCHHHh--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCC
Confidence 999999987 34557889999999999999999999998766555444443222211 23457899999999999999
Q ss_pred CCCCCCHHHHHhCccCCCCCCCC
Q 011326 465 PNDRPTAAQLMEHPFIKRPLQTS 487 (488)
Q Consensus 465 P~~Rps~~eil~hp~f~~~~~~~ 487 (488)
|.+||++.+++.||||.+.-.++
T Consensus 258 P~~R~~~~~ll~~~~~~~~~~~~ 280 (292)
T cd06657 258 PAQRATAAELLKHPFLAKAGPPS 280 (292)
T ss_pred cccCcCHHHHhcChHHhccCCCc
Confidence 99999999999999998876544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=347.51 Aligned_cols=250 Identities=25% Similarity=0.440 Sum_probs=206.7
Q ss_pred ccccccCceeeeeeecccCceEEEEEEecCC-cEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeecc-c
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLTDDG-FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGT-D 295 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g-~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~-~ 295 (488)
.+...-.++++.+.|.+|||+.||.|.+..+ ..||+|++... .+.....+.+|+.+|++|+ |+|||.+++. .
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~ 105 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSA 105 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-----CHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Confidence 3455566789999999999999999998755 99999998764 4566788999999999997 9999999993 2
Q ss_pred cC------CCceEEEEeeccCCChHHHHhh---hccChhhhhHHHHHHHHHHHHHHHCC--CccccCCcccEEECCCCcE
Q 011326 296 RD------EKRLCIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQN--VVHRDIKCANILVDASGSV 364 (488)
Q Consensus 296 ~~------~~~~~lV~E~~~~gsL~~~l~~---~~ls~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~NILl~~~~~v 364 (488)
.. .-+++|+||||.||.|-+++.. .+|++.++++|+.++++|+.+||... |||||||-+||||+.+|+.
T Consensus 106 ~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~ 185 (738)
T KOG1989|consen 106 INRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNY 185 (738)
T ss_pred ccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCE
Confidence 21 2368999999999999999864 36999999999999999999999987 9999999999999999999
Q ss_pred EEeecCCcccccCCC-----------cccCCCCCcccCchhhcc-ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhh
Q 011326 365 KLADFGLAKATTMND-----------VKSCKGTAFWMAPEVVNL-KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ 432 (488)
Q Consensus 365 kL~DFGla~~~~~~~-----------~~~~~gt~~y~aPE~~~~-~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~ 432 (488)
||||||.+....... ......|+.|+|||+++. .+...++|+|||+|||+||-|++..+||+..-.
T Consensus 186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-- 263 (738)
T KOG1989|consen 186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-- 263 (738)
T ss_pred EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--
Confidence 999999985332221 012237999999999864 455689999999999999999999999976422
Q ss_pred hHHHhcCCCCC-CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 433 AMFKIGGGELP-PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 433 ~~~~i~~~~~~-~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
..|..+.+. +....++..+.+||+.||+.||.+||++-|++++
T Consensus 264 --laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 264 --LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred --eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 223334432 2235799999999999999999999999999865
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=319.27 Aligned_cols=257 Identities=27% Similarity=0.444 Sum_probs=211.0
Q ss_pred ceeeeeeecccCceEEEEEEe----cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCc
Q 011326 226 SWQKGELLGSGSYGFVYEGLT----DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 300 (488)
+|++.+.||+|+||.||.+.+ .+|..||+|.+...... ........+.+|+.+++++ +|+||+++++++..+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIV-QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhh-hcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence 478899999999999999986 36899999998753221 1222345677899999999 59999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 301 LCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
.++||||+++++|.+++... .+++..+..++.|++.||.|||+.|++||||+|+|||++.++.++|+|||++.......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 99999999999999988654 58899999999999999999999999999999999999999999999999987654322
Q ss_pred ---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh----hhHHHhcCCCCCCCCCcccHH
Q 011326 380 ---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG----QAMFKIGGGELPPVPNSLSRD 452 (488)
Q Consensus 380 ---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~s~~ 452 (488)
.....|+..|+|||.+......++.++|+||||+++|+|++|..||...... +....+. ...++.+..+++.
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KSEPPYPQEMSAL 238 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhh-ccCCCCCccCCHH
Confidence 2235588999999997433345788999999999999999999999643322 2222222 2234566778999
Q ss_pred HHHHHHHhhhhCCCCCC-----CHHHHHhCccCCCCC
Q 011326 453 AQDFILKCLQVNPNDRP-----TAAQLMEHPFIKRPL 484 (488)
Q Consensus 453 l~~Li~~cL~~dP~~Rp-----s~~eil~hp~f~~~~ 484 (488)
+.+++.+||+.||++|| +.++++.||||++.-
T Consensus 239 ~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 99999999999999997 899999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=310.43 Aligned_cols=246 Identities=24% Similarity=0.446 Sum_probs=209.9
Q ss_pred cCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
..+|++.+.||+|+||.||++.+.++..+|+|.+..... ....+.+|+.++++++|||++++++++......++
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM------SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL 76 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC------CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence 457889999999999999999887788999998864322 12467889999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCcc
Q 011326 304 FLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK 381 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 381 (488)
+|||+++++|.+++... .++++.+..++.|++.|++|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999999988643 4889999999999999999999999999999999999999999999999998654333221
Q ss_pred ---cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHH
Q 011326 382 ---SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFI 457 (488)
Q Consensus 382 ---~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li 457 (488)
...++..|+|||.+ ....++.++|+||||+++|||++ |..||......+....+..+.....+...+.++.+|+
T Consensus 157 ~~~~~~~~~~~~aPe~~--~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (256)
T cd05112 157 SSTGTKFPVKWSSPEVF--SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELM 234 (256)
T ss_pred ccCCCccchhhcCHhHh--ccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence 22345689999987 34568899999999999999998 9999988777776766665555455666899999999
Q ss_pred HHhhhhCCCCCCCHHHHHhC
Q 011326 458 LKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 458 ~~cL~~dP~~Rps~~eil~h 477 (488)
.+||+.+|++|||+.+++++
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 235 QHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHcccChhhCCCHHHHHHh
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=314.66 Aligned_cols=248 Identities=30% Similarity=0.559 Sum_probs=206.2
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
.+|++.+.||+|+||.||++... ++..+++|.+..... .......++.+|+.+++.++||||+++++++.+++..++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL--MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh--hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence 57888999999999999999874 799999998875432 223344678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhh-----hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 304 FLELVTKGSLASLYQK-----YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~-----~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
+|||+++++|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999999998853 34789999999999999999999999999999999999999999999999998755433
Q ss_pred C--cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh--hhHHHhcCCCCCCCC-CcccHHH
Q 011326 379 D--VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG--QAMFKIGGGELPPVP-NSLSRDA 453 (488)
Q Consensus 379 ~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~--~~~~~i~~~~~~~~~-~~~s~~l 453 (488)
. .....|+..|+|||.+ ....++.++|+||||+++|+|++|..||.+.... .....+.....++.+ ...++++
T Consensus 160 ~~~~~~~~~~~~~~ape~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERI--HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237 (267)
T ss_pred CcccccccCCcCccCHHHh--cCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence 2 2345688999999997 3455888999999999999999999999754332 223333333333333 4578899
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHh
Q 011326 454 QDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
.+++.+||+.||++|||+.+|++
T Consensus 238 ~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 238 RQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=308.94 Aligned_cols=240 Identities=27% Similarity=0.479 Sum_probs=205.0
Q ss_pred eecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeeccCC
Q 011326 232 LLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKG 311 (488)
Q Consensus 232 ~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 311 (488)
+||+|+||.||+|...++..+|+|.+.... .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL----PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC----CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 589999999999988888999999876432 2333456889999999999999999999999999999999999999
Q ss_pred ChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCc---ccCCCC
Q 011326 312 SLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV---KSCKGT 386 (488)
Q Consensus 312 sL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~gt 386 (488)
+|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ ....++
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 999988643 478999999999999999999999999999999999999999999999999865432221 122345
Q ss_pred CcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCC
Q 011326 387 AFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465 (488)
Q Consensus 387 ~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP 465 (488)
..|+|||++ ....++.++|+||||+++|++++ |..||...........+........+..++.++.+++.+||+.+|
T Consensus 158 ~~y~aPE~~--~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 158 IKWTAPEAL--NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred ccccCHHHh--ccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 679999997 34558899999999999999998 999998877777666666665556677889999999999999999
Q ss_pred CCCCCHHHHHhC
Q 011326 466 NDRPTAAQLMEH 477 (488)
Q Consensus 466 ~~Rps~~eil~h 477 (488)
++||++.++++.
T Consensus 236 ~~Rp~~~~l~~~ 247 (250)
T cd05085 236 ENRPKFSELQKE 247 (250)
T ss_pred ccCCCHHHHHHH
Confidence 999999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=329.08 Aligned_cols=251 Identities=26% Similarity=0.431 Sum_probs=204.4
Q ss_pred ccccCceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeec
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLG 293 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~ 293 (488)
...-.+|++.+.||+|+||.||+|... +++.||+|.+.... .......+.+|+.++.++ +|+||+++++
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~E~~~~~~l~~h~niv~~~~ 78 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA----TASEYKALMTELKILIHIGHHLNVVNLLG 78 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC----CHHHHHHHHHHHHHHHhhccCcchhheee
Confidence 333457999999999999999999642 35789999986432 223345678899999999 8999999999
Q ss_pred cccC-CCceEEEEeeccCCChHHHHhh-----------------------------------------------------
Q 011326 294 TDRD-EKRLCIFLELVTKGSLASLYQK----------------------------------------------------- 319 (488)
Q Consensus 294 ~~~~-~~~~~lV~E~~~~gsL~~~l~~----------------------------------------------------- 319 (488)
+|.. +..++++|||+++++|.+++..
T Consensus 79 ~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (337)
T cd05054 79 ACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEE 158 (337)
T ss_pred eEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhccc
Confidence 8754 5678999999999999988743
Q ss_pred ---------hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC----cccCCCC
Q 011326 320 ---------YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGT 386 (488)
Q Consensus 320 ---------~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt 386 (488)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... .....++
T Consensus 159 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 159 DEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred chhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 147888899999999999999999999999999999999999999999999997653322 1234466
Q ss_pred CcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhh-HHHhcCCCCCCCCCcccHHHHHHHHHhhhhC
Q 011326 387 AFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQA-MFKIGGGELPPVPNSLSRDAQDFILKCLQVN 464 (488)
Q Consensus 387 ~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~d 464 (488)
..|+|||++ .+..++.++|||||||++|||++ |..||.+....+. ...+..+.....+...++++.+++.+||+.+
T Consensus 239 ~~y~aPE~~--~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~ 316 (337)
T cd05054 239 LKWMAPESI--FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNN 316 (337)
T ss_pred ccccCcHHh--cCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCC
Confidence 789999987 45668999999999999999997 9999977544333 2333444444556778899999999999999
Q ss_pred CCCCCCHHHHHhC
Q 011326 465 PNDRPTAAQLMEH 477 (488)
Q Consensus 465 P~~Rps~~eil~h 477 (488)
|++||++.|+++|
T Consensus 317 p~~RPs~~ell~~ 329 (337)
T cd05054 317 PEDRPTFSELVEI 329 (337)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=314.60 Aligned_cols=247 Identities=26% Similarity=0.455 Sum_probs=207.5
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCc----EEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGF----FFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
..+|++.+.||+|+||.||+|.+. +|. .||+|.+.... .......+.+|+.++..++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT----SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC----CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 467999999999999999999863 444 48999986432 233456788999999999999999999998764
Q ss_pred CceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 299 KRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
..+++|||+++|+|.+++... .+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++...
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 578999999999999988653 48999999999999999999999999999999999999999999999999987654
Q ss_pred CCCc----ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccH
Q 011326 377 MNDV----KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSR 451 (488)
Q Consensus 377 ~~~~----~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 451 (488)
.... ....++..|+|||.+ ....++.++||||||+++|||++ |..||...........+..+...+.+..++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESI--LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTI 238 (279)
T ss_pred cccceeecCCCccchhhCCHHHh--ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCH
Confidence 3221 122346779999997 44568999999999999999998 9999987776666666666666666778899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
++.+++.+||+.||++||++.++++.
T Consensus 239 ~~~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 239 DVYMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=310.66 Aligned_cols=247 Identities=26% Similarity=0.476 Sum_probs=209.7
Q ss_pred ccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 300 (488)
.....+|++.+.||+|+||.||++.+.++..+++|.+... ......+.+|+.++++++|+||+++++++.+ ..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 74 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG------SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EP 74 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC------hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CC
Confidence 3446789999999999999999998877888999987632 2234578899999999999999999999887 77
Q ss_pred eEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 301 LCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
.+++|||+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 89999999999999998653 378888999999999999999999999999999999999999999999999865443
Q ss_pred CCc---ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHH
Q 011326 378 NDV---KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDA 453 (488)
Q Consensus 378 ~~~---~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l 453 (488)
... ....++..|+|||.+ ....++.++|+||||+++|++++ |..||...+.......+..+...+.+...+.++
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL 232 (260)
T ss_pred CCcccccCCcccccccCHhHh--ccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHH
Confidence 221 223356679999997 34558889999999999999998 999998877776666666665556667889999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHh
Q 011326 454 QDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
.+++.+||+.+|++||++.++++
T Consensus 233 ~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 233 YNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHH
Confidence 99999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=316.91 Aligned_cols=245 Identities=25% Similarity=0.425 Sum_probs=207.9
Q ss_pred CceeeeeeecccCceEEEEEEe------cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 225 TSWQKGELLGSGSYGFVYEGLT------DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
.+|+..+.||+|+||.||++.. .++..+++|.+... .......+.+|+.+++.++|+||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 4678889999999999999863 24668899987542 233456789999999999999999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhh----------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC
Q 011326 299 KRLCIFLELVTKGSLASLYQKY----------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG 362 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~----------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~ 362 (488)
+..+++|||+++++|.+++... .+++..+..++.|++.||+|||+.|++|+||||+|||++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 9999999999999999988643 378889999999999999999999999999999999999999
Q ss_pred cEEEeecCCcccccCCCc----ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHh
Q 011326 363 SVKLADFGLAKATTMNDV----KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKI 437 (488)
Q Consensus 363 ~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i 437 (488)
.++|+|||++........ ....+++.|+|||.+ ....++.++||||||+++|||++ |..||......+....+
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI--LYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHh--ccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 999999999865433221 223356789999987 44568999999999999999998 99999877777766666
Q ss_pred cCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 438 GGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 438 ~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
..+.....+..+++.+.+++.+||+.||.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 238 TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 666555667789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=319.29 Aligned_cols=252 Identities=26% Similarity=0.456 Sum_probs=212.3
Q ss_pred cccccCceeeeeeecccCceEEEEEEe--------cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcce
Q 011326 220 FRRRITSWQKGELLGSGSYGFVYEGLT--------DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQ 290 (488)
Q Consensus 220 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~--------~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~ 290 (488)
+.....+|++.+.||+|+||.||++.. .++..+|+|.+.... .......+.+|+.+++.+ +||||++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i~~ 85 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIIN 85 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc----chHHHHHHHHHHHHHHhhccCCCchh
Confidence 445577899999999999999999863 134579999876331 233456788999999999 8999999
Q ss_pred eeccccCCCceEEEEeeccCCChHHHHhhh-----------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCc
Q 011326 291 YLGTDRDEKRLCIFLELVTKGSLASLYQKY-----------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKC 353 (488)
Q Consensus 291 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-----------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp 353 (488)
+++++......+++|||+++|+|.+++... .+++..+..++.|++.||.|||++|++||||||
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp 165 (304)
T cd05101 86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165 (304)
T ss_pred eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 999999999999999999999999988642 366778899999999999999999999999999
Q ss_pred ccEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 011326 354 ANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHL 428 (488)
Q Consensus 354 ~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~ 428 (488)
+||+++.++.++|+|||+++...... .....++..|+|||++ .+..++.++||||||+++|+|++ |..||...
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhh--ccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999987654322 1223456789999987 34568899999999999999998 88999888
Q ss_pred chhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 429 EGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 429 ~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
+..+....+........+..++.++.+|+.+||+.+|.+|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 244 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 7777777776666656677889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=312.75 Aligned_cols=247 Identities=28% Similarity=0.448 Sum_probs=202.6
Q ss_pred eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHH-HhcCCCCCcceeeccccCCCceEEEEeec
Q 011326 231 ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISL-LGQFEHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~i-L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
+.||+|+||.||+|.+. +|..||+|.+...... .......+..|..+ ....+|+|++++++++..++..+++|||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI--AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh--HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence 46899999999999885 6899999998654321 11222334445444 44568999999999999999999999999
Q ss_pred cCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCcccCCCCC
Q 011326 309 TKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTA 387 (488)
Q Consensus 309 ~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~gt~ 387 (488)
++++|..++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .....++.
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~ 157 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--NKKFVGTP 157 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc--cccCCCCc
Confidence 999999998654 589999999999999999999999999999999999999999999999998865433 23456888
Q ss_pred cccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC---CCCCCcccHHHHHHHHHhhhhC
Q 011326 388 FWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL---PPVPNSLSRDAQDFILKCLQVN 464 (488)
Q Consensus 388 ~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~l~~Li~~cL~~d 464 (488)
.|++||.+. +..++.++|+||+|+++|+|++|..||...+.......+..... ......+++++.+++.+||+.+
T Consensus 158 ~y~~pe~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 158 DYLAPETIL--GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred CccChhhhc--CCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 999999973 34478999999999999999999999988776665555443322 2233468999999999999999
Q ss_pred CCCCC---CHHHHHhCccCCCC
Q 011326 465 PNDRP---TAAQLMEHPFIKRP 483 (488)
Q Consensus 465 P~~Rp---s~~eil~hp~f~~~ 483 (488)
|++|| ++.|++.||||++.
T Consensus 236 p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 236 PAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred HHHccCCCcHHHHHcChHhhcC
Confidence 99999 55899999999763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=319.07 Aligned_cols=255 Identities=31% Similarity=0.511 Sum_probs=205.3
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
+++|++.+.||+|++|.||+|.+. +|+.||+|.+...... ......+.+|+.++++++||||+++++++.++...+
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED---EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLY 77 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc---ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEE
Confidence 357999999999999999999886 7899999998654321 223346778999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC-CCcEEEeecCCcccccCC
Q 011326 303 IFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMN 378 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~ 378 (488)
+||||+++ +|.+.+... .+++..+..++.||+.||+|||++|++|+||+|+||+++. ++.+||+|||++......
T Consensus 78 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 78 LVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 99999975 777766433 2578888999999999999999999999999999999985 567999999998654322
Q ss_pred --CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC---CC------------
Q 011326 379 --DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG---GE------------ 441 (488)
Q Consensus 379 --~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~---~~------------ 441 (488)
......+++.|+|||.+. ....++.++|+||+|+++|+|++|..||...+..+....+.. ..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~-~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILL-GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred ccccccCceeecccCHHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 223446788999999873 334578899999999999999999999976654433332210 00
Q ss_pred -----CC--------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 442 -----LP--------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 442 -----~~--------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
.+ .....+++++.+++.+||+.+|++||++.++++||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 00 0123568899999999999999999999999999999864
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=311.94 Aligned_cols=237 Identities=27% Similarity=0.473 Sum_probs=201.3
Q ss_pred ecccCceEEEEEEec---CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeecc
Q 011326 233 LGSGSYGFVYEGLTD---DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVT 309 (488)
Q Consensus 233 LG~G~fg~Vy~~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 309 (488)
||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.++++++||||+++++++.. +..++||||++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~ 77 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN----EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMAS 77 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccccc----ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCC
Confidence 899999999999763 45679999986432 23344578899999999999999999998864 47899999999
Q ss_pred CCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCc-----cc
Q 011326 310 KGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KS 382 (488)
Q Consensus 310 ~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-----~~ 382 (488)
+++|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........ ..
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 9999998854 3589999999999999999999999999999999999999999999999999875433221 11
Q ss_pred CCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhh
Q 011326 383 CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCL 461 (488)
Q Consensus 383 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL 461 (488)
..++..|+|||.+ ....++.++|+||||+++|+|++ |..||......+....+..+..+..+..+++++.+++.+||
T Consensus 158 ~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~ 235 (257)
T cd05115 158 GKWPLKWYAPECI--NFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCW 235 (257)
T ss_pred CCCCcccCCHHHH--ccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence 2235689999987 34558899999999999999996 99999988877777777777777778889999999999999
Q ss_pred hhCCCCCCCHHHHHh
Q 011326 462 QVNPNDRPTAAQLME 476 (488)
Q Consensus 462 ~~dP~~Rps~~eil~ 476 (488)
+.+|++||++.+|.+
T Consensus 236 ~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 236 IYKWEDRPNFAKVEE 250 (257)
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=357.81 Aligned_cols=247 Identities=28% Similarity=0.485 Sum_probs=217.3
Q ss_pred cCceeeeeeecccCceEEEEEEec--CCc----EEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD--DGF----FFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~--~g~----~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
-...+..+.||+|.||.||.|... +|. .||+|.+... ...+...+|.+|..+|+.++|||||+++|+|.+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~----~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL----SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc----CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 446778899999999999999864 343 4888887643 346677899999999999999999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhhh--------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeec
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY--------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADF 369 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~--------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DF 369 (488)
....+|++|||+||+|..+|++. .++...++.++.||++|+.||+++++|||||..+|+|++....+||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999765 3888999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCCcccC----CCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCC
Q 011326 370 GLAKATTMNDVKSC----KGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPP 444 (488)
Q Consensus 370 Gla~~~~~~~~~~~----~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~ 444 (488)
|+|+.....+.... .-...|||||.+ ..+.++.++|||||||+|||+++ |..||...++.++......+.+.+
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl--~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~ 924 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESL--KDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLD 924 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHH--hhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccC
Confidence 99985544443222 223569999997 45779999999999999999999 999999999999988666666778
Q ss_pred CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 445 VPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 445 ~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
.|..||+.+.++|..||+.+|++||++..|++
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 89999999999999999999999999999986
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=320.74 Aligned_cols=251 Identities=27% Similarity=0.451 Sum_probs=209.9
Q ss_pred cccccCceeeeeeecccCceEEEEEEec--------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcce
Q 011326 220 FRRRITSWQKGELLGSGSYGFVYEGLTD--------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQ 290 (488)
Q Consensus 220 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~ 290 (488)
|.....+|.+++.||+|+||.||++... .+..+|+|.+.... .......+.+|+.+++++ +||||++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA----TDKDLADLISEMELMKLIGKHKNIIN 82 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC----ChHHHHHHHHHHHHHHhccCCCCeee
Confidence 3444568999999999999999998642 35579999876432 233456788999999999 6999999
Q ss_pred eeccccCCCceEEEEeeccCCChHHHHhhh-----------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCc
Q 011326 291 YLGTDRDEKRLCIFLELVTKGSLASLYQKY-----------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKC 353 (488)
Q Consensus 291 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-----------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp 353 (488)
+++++..++..+++|||+++|+|.+++... .+++..+..++.|++.||.|||++|++|+||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 162 (314)
T cd05099 83 LLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAA 162 (314)
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 999999999999999999999999988542 377888899999999999999999999999999
Q ss_pred ccEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 011326 354 ANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHL 428 (488)
Q Consensus 354 ~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~ 428 (488)
+|||++.++.+||+|||+++...... .....++..|+|||.+ ....++.++|+||||+++|+|++ |..||...
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHH--ccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999997554322 1122344679999987 34568899999999999999999 89999887
Q ss_pred chhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 429 EGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 429 ~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+..+....+........+..++.++.+++.+||+.+|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 241 PVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 777777766666555667788999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=312.32 Aligned_cols=247 Identities=27% Similarity=0.471 Sum_probs=208.2
Q ss_pred cCceeeeeeecccCceEEEEEEec-C---CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-D---GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~---g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
..+|++.+.||+|+||.||+|.+. + +..+|+|.+.... .......+.+|+.++.+++||||+++++++.+++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY----TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK 78 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 357889999999999999999864 2 3479999886432 2334567889999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 300 RLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
..+++|||+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999999998654 478999999999999999999999999999999999999999999999999875543
Q ss_pred CCc-----ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccH
Q 011326 378 NDV-----KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSR 451 (488)
Q Consensus 378 ~~~-----~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 451 (488)
... ....++..|++||.+ ....++.++|+||||+++||+++ |..||......+....+......+.+..+++
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~--~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAI--AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPA 236 (267)
T ss_pred ccceeeecCCCccceeecCHhHh--ccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCH
Confidence 221 112235679999997 34568999999999999999886 9999987776666666666555566667899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
.+.+++.+||+.+|.+||++.++++
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 237 ALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=314.82 Aligned_cols=249 Identities=29% Similarity=0.516 Sum_probs=205.0
Q ss_pred eeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC--CceEE
Q 011326 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE--KRLCI 303 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~l 303 (488)
|++.+.||+|++|.||+|.+. ++..+|+|.+..... .......+.+|+.+++.++|||++++++++.+. +..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE---KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccc---cccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence 678899999999999999886 589999999986541 122335677899999999999999999999887 89999
Q ss_pred EEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 304 FLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
||||+++ +|..++... .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 78 VFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred Eeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9999986 888887654 69999999999999999999999999999999999999999999999999987655433
Q ss_pred -cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC-------CC--------
Q 011326 380 -VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE-------LP-------- 443 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~-------~~-------- 443 (488)
.....++..|+|||.+. ....++.++||||||+++|+|++|+.||...+.......+.... .+
T Consensus 157 ~~~~~~~~~~y~~PE~~~-~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 157 DYTNRVITLWYRPPELLL-GATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred cccccccccccCCceeeE-ccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 33445788899999763 33457899999999999999999999998766544333222100 00
Q ss_pred ---------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 444 ---------------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 444 ---------------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
.....+++++.+++.+||+.+|.+||++.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0011138899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=315.63 Aligned_cols=247 Identities=25% Similarity=0.470 Sum_probs=209.8
Q ss_pred cCceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
.++|++.+.||+|+||.||++.+. ++..+|+|.+.... .......+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc----CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 457889999999999999999863 46789999986432 23344678899999999999999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhhh-----------------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcc
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY-----------------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCA 354 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~-----------------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~ 354 (488)
++..+++|||+++|+|.+++... .+++..++.++.|++.||.|||++|++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 99999999999999999988632 3677888999999999999999999999999999
Q ss_pred cEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCc
Q 011326 355 NILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLE 429 (488)
Q Consensus 355 NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~ 429 (488)
||+++.++.++|+|||++....... .....++..|+|||.+ ....++.++|+||||+++|+|++ |..||.+.+
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESI--FYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHH--hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999986543221 1223356679999987 34568999999999999999997 888998877
Q ss_pred hhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 430 GGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 430 ~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
..+....+..+...+.+..++.++.+|+.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 238 HEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 77777777766666667788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=319.78 Aligned_cols=251 Identities=29% Similarity=0.461 Sum_probs=199.1
Q ss_pred ceeeeeeecccCceEEEEEEec---CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC--Cc
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD---DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE--KR 300 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~ 300 (488)
+|++.+.||+|+||.||+|.+. ++..||+|.+...... .......+.+|+.++.+++||||+++++++.+. +.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ--YTGISQSACREIALLRELKHENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc--ccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence 4788999999999999999874 4899999999864321 112234567899999999999999999999888 78
Q ss_pred eEEEEeeccCCChHHHHhh------hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC----CCcEEEeecC
Q 011326 301 LCIFLELVTKGSLASLYQK------YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA----SGSVKLADFG 370 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~------~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~----~~~vkL~DFG 370 (488)
+++||||+++ +|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++. ++.+||+|||
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999999986 66665532 24789999999999999999999999999999999999999 8999999999
Q ss_pred CcccccCCC-----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhh---------hHHH
Q 011326 371 LAKATTMND-----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ---------AMFK 436 (488)
Q Consensus 371 la~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~---------~~~~ 436 (488)
++....... .....+++.|+|||.+. ....++.++|+||||+++|+|++|+.||.+.+... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLL-GARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHh-CCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 987543221 23446788999999872 33457899999999999999999999997654322 0000
Q ss_pred h-------------------------cCCCCCCCC-----------CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 437 I-------------------------GGGELPPVP-----------NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 437 i-------------------------~~~~~~~~~-----------~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
+ ........+ ...+.++.+++.+||++||++|||+.|+++||||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0 000000111 1467789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=315.93 Aligned_cols=248 Identities=29% Similarity=0.451 Sum_probs=208.6
Q ss_pred ccCceeee-eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhc-CCCCCcceeeccccC--
Q 011326 223 RITSWQKG-ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQ-FEHDNIVQYLGTDRD-- 297 (488)
Q Consensus 223 ~~~~y~~~-~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~-- 297 (488)
.+++|.+. ++||-|-.|.|..|..+ +|+.+|+|++... ...++|+++--. -.|||||.+++++++
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----------~KARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----------PKARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----------HHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 45677765 67999999999999875 8999999998632 234577776443 369999999998765
Q ss_pred --CCceEEEEeeccCCChHHHHhhhc---cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC---CCcEEEeec
Q 011326 298 --EKRLCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA---SGSVKLADF 369 (488)
Q Consensus 298 --~~~~~lV~E~~~~gsL~~~l~~~~---ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~---~~~vkL~DF 369 (488)
...+.+|||.|+||.|...++..+ ++|.++..|++||+.|+.|||+.+|.||||||+|+|... +..+||+||
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence 457899999999999999887653 999999999999999999999999999999999999964 557999999
Q ss_pred CCcccccC-CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCch----hhhHHHhcCCCCC-
Q 011326 370 GLAKATTM-NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG----GQAMFKIGGGELP- 443 (488)
Q Consensus 370 Gla~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~----~~~~~~i~~~~~~- 443 (488)
|+|+.... ....+.+.||.|.|||++ +...|+.++|+||+|+++|-|++|.+||..... ..+..+|..+.+.
T Consensus 209 GFAK~t~~~~~L~TPc~TPyYvaPevl--g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 209 GFAKETQEPGDLMTPCFTPYYVAPEVL--GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred ccccccCCCccccCCcccccccCHHHh--CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 99987663 456778899999999997 555699999999999999999999999976443 3456666666653
Q ss_pred --CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 444 --PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 444 --~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
+....+|++.+++|+.+|..+|++|.|++++++|||+.+
T Consensus 287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 233468999999999999999999999999999999964
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=315.04 Aligned_cols=245 Identities=30% Similarity=0.496 Sum_probs=198.9
Q ss_pred ce-eeeeeecccCceEEEEEEe-----cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC--
Q 011326 226 SW-QKGELLGSGSYGFVYEGLT-----DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD-- 297 (488)
Q Consensus 226 ~y-~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-- 297 (488)
+| ++.+.||+|+||.||.+.. .++..||+|.+.... .......+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC----GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 44 8889999999999987642 367899999986532 12334567889999999999999999998765
Q ss_pred CCceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 298 EKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
....+++|||+++++|.+++....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 34689999999999999999888899999999999999999999999999999999999999999999999999876543
Q ss_pred CCc-----ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh---------------hhHHHh
Q 011326 378 NDV-----KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG---------------QAMFKI 437 (488)
Q Consensus 378 ~~~-----~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~---------------~~~~~i 437 (488)
... ....++..|+|||.+ ....++.++||||||+++|||++|..||...... .....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~--~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECL--KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHh--cccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 221 223356679999987 3456889999999999999999999998543211 011111
Q ss_pred cCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 438 GGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 438 ~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
......+.+..++.++.+++.+||+.+|++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 122233456678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=324.92 Aligned_cols=257 Identities=28% Similarity=0.433 Sum_probs=211.2
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc--
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR-- 300 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~-- 300 (488)
.++|++.+.||+|++|.||+|.+. ++..||+|.+..... .......+.+|+.++++++||||+++++++..++.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ---SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc---hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 457999999999999999999886 688999998864321 12233567789999999999999999998876654
Q ss_pred ----eEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 301 ----LCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 301 ----~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
.++|+||+ +++|.+++....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999998 5599999988889999999999999999999999999999999999999999999999999987654
Q ss_pred CCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC--------------
Q 011326 377 MNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL-------------- 442 (488)
Q Consensus 377 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~-------------- 442 (488)
.. .....++..|+|||.+. ....++.++|+||||+++|+|++|+.||...+..+....+.....
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~-~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 170 DE-MTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred cc-ccCCcccccccCHHHHh-CCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 32 34456888999999873 333578999999999999999999999976655443333221100
Q ss_pred ----------------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 443 ----------------PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 443 ----------------~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
......+++++.++|.+||+.||.+|||+.+++.||||++...+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 01112468899999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=309.13 Aligned_cols=239 Identities=26% Similarity=0.505 Sum_probs=202.2
Q ss_pred eeecccCceEEEEEEec-C---CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEe
Q 011326 231 ELLGSGSYGFVYEGLTD-D---GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLE 306 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~-~---g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 306 (488)
+.||+|+||.||+|.+. . +..+|+|.+...... ....++.+|+.+++.++||||+++++++.. +..+++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA----AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVME 75 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEE
Confidence 36999999999999763 2 378999998754321 344678899999999999999999998764 46899999
Q ss_pred eccCCChHHHHhhhc-cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCc-----
Q 011326 307 LVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV----- 380 (488)
Q Consensus 307 ~~~~gsL~~~l~~~~-ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~----- 380 (488)
|+++|+|.+++.... +++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++.......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 999999999997655 99999999999999999999999999999999999999999999999999875543321
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHH
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILK 459 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~ 459 (488)
....++..|+|||.+ ....++.++|+||||+++|+|++ |..||...+..+....+......+.+..++..+.+++.+
T Consensus 156 ~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05060 156 TAGRWPLKWYAPECI--NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLS 233 (257)
T ss_pred cCccccccccCHHHh--cCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 112234679999987 44558999999999999999998 999998877777767776666667778899999999999
Q ss_pred hhhhCCCCCCCHHHHHh
Q 011326 460 CLQVNPNDRPTAAQLME 476 (488)
Q Consensus 460 cL~~dP~~Rps~~eil~ 476 (488)
||+.+|++||++.++++
T Consensus 234 cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 234 CWKYRPEDRPTFSELES 250 (257)
T ss_pred HhcCChhhCcCHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=313.09 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=208.4
Q ss_pred cCceeeeeeecccCceEEEEEEecC-----CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC-
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTDD-----GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD- 297 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~- 297 (488)
.++|++.+.||+|+||.||+|.+.. +..|++|.+... ........+.+|+.++++++||||+++++++..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH----ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 4679999999999999999998754 788999987532 233445678899999999999999999998765
Q ss_pred CCceEEEEeeccCCChHHHHhh---------hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEee
Q 011326 298 EKRLCIFLELVTKGSLASLYQK---------YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLAD 368 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~---------~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~D 368 (488)
+...++++||+++++|.+++.. ..+++..+..++.|++.||+|||+++++|+||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 5678999999999999998854 3478999999999999999999999999999999999999999999999
Q ss_pred cCCcccccCCCc----ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCC
Q 011326 369 FGLAKATTMNDV----KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELP 443 (488)
Q Consensus 369 FGla~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~ 443 (488)
||+++.....+. ....++..|+|||.+ ....++.++||||||+++||+++ |+.||...+..+....+..+...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~--~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESL--VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRL 238 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHH--hcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCC
Confidence 999975533321 223456779999987 44568999999999999999998 99999887766666655555554
Q ss_pred CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 444 PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 444 ~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
..+..+++++.+++.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 239 AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 556678999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=324.38 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=210.1
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC--
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK-- 299 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-- 299 (488)
..++|++.+.||+|+||.||++.+. +|..||+|.+.... ........+.+|+.+++.++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3567999999999999999999875 79999999986432 12233456789999999999999999999887654
Q ss_pred ----ceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 300 ----RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 300 ----~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
.+++||||+ +++|..++....+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 358999998 679999888778999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC--------------
Q 011326 376 TMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE-------------- 441 (488)
Q Consensus 376 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~-------------- 441 (488)
.. ......+++.|+|||.+. ....++.++|+||||+++|+|++|..||...+.......+....
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07880 169 DS-EMTGYVVTRWYRAPEVIL-NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246 (343)
T ss_pred cc-CccccccCCcccCHHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence 43 233456789999999873 22457899999999999999999999998765433322211100
Q ss_pred ----------------CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 442 ----------------LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 442 ----------------~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
.......+++++.++|.+||+.||.+|||+.+++.||||+....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 00122457888999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=316.97 Aligned_cols=255 Identities=29% Similarity=0.486 Sum_probs=204.5
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCCCceE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~ 302 (488)
.+|+..+.||+|+||.||++.+. ++..+|+|.+..... ......+.+|+.++.++. ||||+++++++..++..+
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~ 79 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD----EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW 79 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC----hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence 45667788999999999999885 689999999875432 234567889999999996 999999999999999999
Q ss_pred EEEeeccCCChHHHH---h---hhccChhhhhHHHHHHHHHHHHHHHC-CCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 303 IFLELVTKGSLASLY---Q---KYHLSDSQVSSYTRQILNGLKYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 303 lV~E~~~~gsL~~~l---~---~~~ls~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
++|||+.. +|.++. . ...+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++...
T Consensus 80 ~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 80 ICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred EEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 99999875 554432 1 23589999999999999999999975 9999999999999999999999999998654
Q ss_pred cCCC-cccCCCCCcccCchhhcccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCch-hhhHHHhcCCCCCCC----CCc
Q 011326 376 TMND-VKSCKGTAFWMAPEVVNLKK-DGYGLTADIWSLGCTVLEMLTRRHPYSHLEG-GQAMFKIGGGELPPV----PNS 448 (488)
Q Consensus 376 ~~~~-~~~~~gt~~y~aPE~~~~~~-~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~-~~~~~~i~~~~~~~~----~~~ 448 (488)
.... .....|+..|+|||.+.... ..++.++|+||+|+++|+|++|+.||..... .+....+.....+.. +..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence 3322 23446889999999974221 3688999999999999999999999976542 122222222222222 234
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 449 LSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 449 ~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
++.++.+|+.+||+.||.+|||+++++.||||+...
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 789999999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=329.33 Aligned_cols=255 Identities=26% Similarity=0.419 Sum_probs=216.1
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.+.|..-++||+||||.||-+.-+ +|+.+|.|.+.+........ ..-.++|-.+|++++.+.||.+-..+++.+.+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~g--e~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKG--ETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhh--hHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 345677789999999999999765 89999999987655433322 334578999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 303 IFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
+||..|+||+|.-+|.+. ++++..+..++.+|+.||++||+.+|++|||||+|||+|+.|+++|+|+|+|.......
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 999999999998777443 59999999999999999999999999999999999999999999999999998777665
Q ss_pred -cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhh---HHHhcCCCCCCCCCcccHHHHH
Q 011326 380 -VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQA---MFKIGGGELPPVPNSLSRDAQD 455 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~s~~l~~ 455 (488)
....+||.+|||||++ .+..|+.+.|+|||||+||||+.|+.||........ +..........++...|+++++
T Consensus 342 ~~~~rvGT~GYMAPEvl--~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaks 419 (591)
T KOG0986|consen 342 PIRGRVGTVGYMAPEVL--QNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKS 419 (591)
T ss_pred ccccccCcccccCHHHH--cCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHH
Confidence 4455899999999998 444599999999999999999999999976443322 2222223334667889999999
Q ss_pred HHHHhhhhCCCCCCC-----HHHHHhCccCCC
Q 011326 456 FILKCLQVNPNDRPT-----AAQLMEHPFIKR 482 (488)
Q Consensus 456 Li~~cL~~dP~~Rps-----~~eil~hp~f~~ 482 (488)
|.+.+|++||.+|.. ++++.+||||+.
T Consensus 420 lc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 420 LCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred HHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 999999999999964 789999999986
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=309.13 Aligned_cols=247 Identities=27% Similarity=0.478 Sum_probs=208.6
Q ss_pred cCceeeeeeecccCceEEEEEEec-CC---cEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DG---FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g---~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
.++|+..+.||+|+||.||+|.+. ++ ..+++|.+.... .......+.+|+.++++++||||+++.+++.+.+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY----TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC----CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 346888899999999999999875 33 379999886432 2233467889999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 300 RLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
..++||||+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999999998653 489999999999999999999999999999999999999999999999999865543
Q ss_pred CCcc-----cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccH
Q 011326 378 NDVK-----SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSR 451 (488)
Q Consensus 378 ~~~~-----~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 451 (488)
.... ....+..|+|||.+ ....++.++|+||||+++|||++ |..||...+..+....+......+.+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 237 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAI--AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPS 237 (268)
T ss_pred ccccceeccCCCcCceecCHHHh--hcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCH
Confidence 2211 12234579999987 34557899999999999999997 9999988777777777766655566677899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
++.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 238 AVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=317.33 Aligned_cols=254 Identities=30% Similarity=0.530 Sum_probs=204.8
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC-
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK- 299 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~- 299 (488)
...++|++.+.||+|+||.||+|.+. +|..||+|.+....... .....+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE---GFPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc---CchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 34678999999999999999999986 68999999997654321 22345678999999999999999999887654
Q ss_pred ---------ceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEee
Q 011326 300 ---------RLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLAD 368 (488)
Q Consensus 300 ---------~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~D 368 (488)
.+++++||+++ +|...+... .+++..+..++.|++.||.|||++||+|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 79999999987 666666543 589999999999999999999999999999999999999999999999
Q ss_pred cCCcccccCCCc---ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC---CCC
Q 011326 369 FGLAKATTMNDV---KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG---GEL 442 (488)
Q Consensus 369 FGla~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~---~~~ 442 (488)
||.+........ ....++..|+|||.+. ....++.++||||||+++|+|++|++||...+..+....+.. ...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLL-GEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999875543321 2234677899999873 334468899999999999999999999976554443322211 100
Q ss_pred C--------------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 443 P--------------------------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 443 ~--------------------------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
+ .....++..+.+++.+||+.||.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0 0122468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=316.28 Aligned_cols=255 Identities=25% Similarity=0.448 Sum_probs=209.7
Q ss_pred CCcccccccCceeeeeeecccCceEEEEEEe------cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCc
Q 011326 216 PNGKFRRRITSWQKGELLGSGSYGFVYEGLT------DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNI 288 (488)
Q Consensus 216 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnI 288 (488)
.+.++....++|++.+.||+|+||.||++.. .++..+|+|.+.... .......+.+|+.+++++ +||||
T Consensus 26 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i 101 (302)
T cd05055 26 YDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA----HSSEREALMSELKIMSHLGNHENI 101 (302)
T ss_pred ccccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC----ChHHHHHHHHHHHHHHhccCCCCc
Confidence 3344556667899999999999999999874 235689999886432 123345788999999999 79999
Q ss_pred ceeeccccCCCceEEEEeeccCCChHHHHhhhc---cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEE
Q 011326 289 VQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVK 365 (488)
Q Consensus 289 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vk 365 (488)
+++++++...+..+++|||+++|+|.+++.... +++..+..++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 102 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~ 181 (302)
T cd05055 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVK 181 (302)
T ss_pred ceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEE
Confidence 999999999999999999999999999986532 89999999999999999999999999999999999999999999
Q ss_pred EeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHH-hcC
Q 011326 366 LADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFK-IGG 439 (488)
Q Consensus 366 L~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~-i~~ 439 (488)
|+|||++....... .....++..|+|||.+ ....++.++||||+|+++|+|++ |..||......+.... +..
T Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~ 259 (302)
T cd05055 182 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI--FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259 (302)
T ss_pred ECCCcccccccCCCceeecCCCCcccccCCHhhh--ccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc
Confidence 99999987554322 1123456789999987 44558899999999999999998 9999977665443333 333
Q ss_pred CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 440 GELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 440 ~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+.....+...++++.+++.+||+++|++|||+.|++.
T Consensus 260 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 260 GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 3333445667899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=323.36 Aligned_cols=251 Identities=29% Similarity=0.478 Sum_probs=203.8
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC-----
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE----- 298 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~----- 298 (488)
.+|++.+.||.|+||.||+|.+. +|..||+|.+..... .....+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-----chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 57999999999999999999885 689999999865432 3345678899999999999999999876543
Q ss_pred ---------CceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC-CCcEEEee
Q 011326 299 ---------KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA-SGSVKLAD 368 (488)
Q Consensus 299 ---------~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~-~~~vkL~D 368 (488)
...+++|||+++ +|.+++....+++..+..++.||++||.|||+.|++||||||+||+++. ++.++|+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 357999999975 8988888778999999999999999999999999999999999999974 56789999
Q ss_pred cCCcccccCCC-----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC---
Q 011326 369 FGLAKATTMND-----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG--- 440 (488)
Q Consensus 369 FGla~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~--- 440 (488)
||.+....... .....++..|+|||.+. ....++.++|+|||||++|+|++|+.||...+..+....+...
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHh-CccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99986543211 12345788999999862 3455788999999999999999999999766543332222110
Q ss_pred ---------------------CCC-----CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 441 ---------------------ELP-----PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 441 ---------------------~~~-----~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
..+ .....++.++.+|+.+||+.||.+|||+.+++.||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 000 112357889999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=321.60 Aligned_cols=253 Identities=27% Similarity=0.452 Sum_probs=211.6
Q ss_pred ccccccCceeeeeeecccCceEEEEEEec--------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcc
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLTD--------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIV 289 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv 289 (488)
+|+....+|++++.||+|+||.||++.+. .+..+|+|.+.... .......+.+|+.++.++ +||||+
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv 81 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA----TDKDLSDLVSEMEMMKMIGKHKNII 81 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc----CHHHHHHHHHHHHHHHhhcCCCCee
Confidence 34455568999999999999999999752 12368999876421 233456788999999999 799999
Q ss_pred eeeccccCCCceEEEEeeccCCChHHHHhhh-----------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCC
Q 011326 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKY-----------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIK 352 (488)
Q Consensus 290 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-----------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLk 352 (488)
++++++..++..+++|||+++|+|.+++... .+++..+..++.|++.||.|||++|++|||||
T Consensus 82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlk 161 (334)
T cd05100 82 NLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLA 161 (334)
T ss_pred eeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 9999999999999999999999999988642 26677788899999999999999999999999
Q ss_pred cccEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 011326 353 CANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSH 427 (488)
Q Consensus 353 p~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~ 427 (488)
|+||+++.++.++|+|||+++...... .....++..|+|||.+ ....++.++||||||+++|||++ |..||..
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHh--ccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999987543322 1222345679999987 45568899999999999999998 8999988
Q ss_pred CchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 428 LEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 428 ~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.+..+....+........+..++.++.+++.+||+.+|.+||++.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 240 IPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 87777777776666666677889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=309.88 Aligned_cols=248 Identities=28% Similarity=0.491 Sum_probs=208.1
Q ss_pred cCceeeeeeecccCceEEEEEEec-CC---cEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DG---FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g---~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
..+|++.+.||+|+||.||+|... ++ ..||+|.+... ........+..|+.++++++||||+++++++.++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 78 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG----YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR 78 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence 457899999999999999999875 33 36999998643 12344567899999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 300 RLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
..++||||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999999999988653 489999999999999999999999999999999999999999999999999865433
Q ss_pred CCc----cc-C--CCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcc
Q 011326 378 NDV----KS-C--KGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSL 449 (488)
Q Consensus 378 ~~~----~~-~--~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 449 (488)
... .. . ..+..|+|||.+ ....++.++||||+|+++|||++ |..||...+..+....+......+.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 236 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAI--AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDC 236 (269)
T ss_pred CccccccccccCCCcceeecCHhHh--ccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccC
Confidence 221 11 1 124579999997 44568899999999999999886 99999887777666666555444556778
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
+.++.+++.+||+.+|.+||++.+++..
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 237 PTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=312.27 Aligned_cols=244 Identities=26% Similarity=0.426 Sum_probs=197.7
Q ss_pred cCceeeeeee--cccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhc-CCCCCcceeeccccCCC
Q 011326 224 ITSWQKGELL--GSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQ-FEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 224 ~~~y~~~~~L--G~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~~~ 299 (488)
.++|++.+.+ |+|+||.||++... ++..+|+|.+...... . .|+..... .+||||+++++.+..++
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~-------~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---A-------IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---h-------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 3455565555 99999999999875 7889999998753211 0 01112221 26999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC-cEEEeecCCcccccC
Q 011326 300 RLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG-SVKLADFGLAKATTM 377 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~-~vkL~DFGla~~~~~ 377 (488)
..++||||+++++|.+++... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++.....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 999999999999999998765 689999999999999999999999999999999999999988 999999999865542
Q ss_pred CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhh----HHHhcCCCCCCCCCcccHHH
Q 011326 378 NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQA----MFKIGGGELPPVPNSLSRDA 453 (488)
Q Consensus 378 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~s~~l 453 (488)
. ....++..|+|||++ .+..++.++|+||+|+++|+|++|..||........ ..... ....+.+..+++.+
T Consensus 163 ~--~~~~~~~~y~aPE~~--~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 237 (267)
T PHA03390 163 P--SCYDGTLDYFSPEKI--KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNA 237 (267)
T ss_pred C--ccCCCCCcccChhhh--cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHH
Confidence 2 345689999999997 445688999999999999999999999975543321 11111 22234556789999
Q ss_pred HHHHHHhhhhCCCCCCC-HHHHHhCccCCC
Q 011326 454 QDFILKCLQVNPNDRPT-AAQLMEHPFIKR 482 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps-~~eil~hp~f~~ 482 (488)
.++|.+||+.+|.+||+ ++++++||||+.
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 99999999999999996 699999999973
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=304.87 Aligned_cols=243 Identities=33% Similarity=0.505 Sum_probs=211.3
Q ss_pred ecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeeccCC
Q 011326 233 LGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKG 311 (488)
Q Consensus 233 LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 311 (488)
||+|+||.||++.+. ++..+++|.+..... ........+..|+.++++++||||+++++.+..++..+++|||++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI--IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh--cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence 699999999999886 689999999876543 22234567889999999999999999999999999999999999999
Q ss_pred ChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--CcccCCCCCc
Q 011326 312 SLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGTAF 388 (488)
Q Consensus 312 sL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~gt~~ 388 (488)
+|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... ......++..
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05123 79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE 158 (250)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcc
Confidence 999998765 5899999999999999999999999999999999999999999999999998765443 2345568889
Q ss_pred ccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCC
Q 011326 389 WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDR 468 (488)
Q Consensus 389 y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~R 468 (488)
|++||.. .....+.++|+||||+++|+|++|..||...+.......+.. ...+.+...+.++.+++.+||..||++|
T Consensus 159 ~~~Pe~~--~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~R 235 (250)
T cd05123 159 YLAPEVL--LGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPTKR 235 (250)
T ss_pred ccChHHh--CCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence 9999987 344578899999999999999999999987776665555554 3346777789999999999999999999
Q ss_pred CCH---HHHHhCccC
Q 011326 469 PTA---AQLMEHPFI 480 (488)
Q Consensus 469 ps~---~eil~hp~f 480 (488)
|++ .++++||||
T Consensus 236 ~~~~~~~~l~~~~~f 250 (250)
T cd05123 236 LGSGGAEEIKAHPFF 250 (250)
T ss_pred CCcccHHHHHhCCCC
Confidence 999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=320.37 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=222.4
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDE 298 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 298 (488)
+.+..+|..+.+||+|+||.|.++..+ +.+.+|||++++...-... ..+--..|-.+|... +.|.+++++.+|++-
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdD--Dvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDD--DVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecC--cccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 567889999999999999999999886 6788999999876432221 122223455666655 578999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 299 KRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
+++|+||||+.||+|.-.+++. ++.+..+..++..|+.||-+||++||++||||.+|||+|.+|++||+|||+++..-.
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999999999998877665 599999999999999999999999999999999999999999999999999975433
Q ss_pred --CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHH
Q 011326 378 --NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455 (488)
Q Consensus 378 --~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~ 455 (488)
....+.+|||.|+|||++ .-..|+.++|+||+|++||||+.|++||++.+..+....|..... .+|..+|.++.+
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi--~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv-syPKslSkEAv~ 579 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV-SYPKSLSKEAVA 579 (683)
T ss_pred CCcceeeecCCCcccccceE--EecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC-cCcccccHHHHH
Confidence 345688999999999998 456799999999999999999999999999999988888876554 789999999999
Q ss_pred HHHHhhhhCCCCCCC-----HHHHHhCccCCC
Q 011326 456 FILKCLQVNPNDRPT-----AAQLMEHPFIKR 482 (488)
Q Consensus 456 Li~~cL~~dP~~Rps-----~~eil~hp~f~~ 482 (488)
+++..|.+.|.+|.. -.+|-+||||+.
T Consensus 580 ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 580 ICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 999999999999964 468999999975
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=307.71 Aligned_cols=242 Identities=29% Similarity=0.528 Sum_probs=205.7
Q ss_pred ccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.+++|++.+.||+|+||.||++.. ++..+|+|.+.... ....+.+|+.++++++|||++++++++..+ ..+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 74 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-------TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLY 74 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcE
Confidence 457899999999999999999864 67889999985421 234678899999999999999999998765 479
Q ss_pred EEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 303 IFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
++|||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG- 153 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence 999999999999998653 3788899999999999999999999999999999999999999999999998654322
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFIL 458 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~ 458 (488)
......+..|+|||.+ ....++.++|+||||+++|+|++ |..||...+..+....+..+..+..+..+++++.+++.
T Consensus 154 ~~~~~~~~~y~~pe~~--~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 231 (254)
T cd05083 154 VDNSKLPVKWTAPEAL--KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMT 231 (254)
T ss_pred CCCCCCCceecCHHHh--ccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHH
Confidence 2233345679999987 44568899999999999999997 99999887777766666666555556778999999999
Q ss_pred HhhhhCCCCCCCHHHHHh
Q 011326 459 KCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 459 ~cL~~dP~~Rps~~eil~ 476 (488)
+||+.+|.+||++.++++
T Consensus 232 ~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 232 SCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=318.41 Aligned_cols=254 Identities=26% Similarity=0.439 Sum_probs=201.2
Q ss_pred eeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEe
Q 011326 227 WQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLE 306 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 306 (488)
+.+++.+|.|+++.||++.. ++..||+|.+..... .......+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e 79 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSC---SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSP 79 (314)
T ss_pred hhhhHhhcCCceEEEEEecC-CCCEEEEEEEecccc---chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEe
Confidence 34445566666666666544 799999999976432 23455678999999999999999999999999999999999
Q ss_pred eccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC----
Q 011326 307 LVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---- 379 (488)
Q Consensus 307 ~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~---- 379 (488)
|+++|+|.+++... .+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999999998753 58899999999999999999999999999999999999999999999999875442211
Q ss_pred -----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC------------
Q 011326 380 -----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL------------ 442 (488)
Q Consensus 380 -----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~------------ 442 (488)
.....++..|+|||++......++.++|+||+|+++|||++|..||..............+..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 123447778999999844334588999999999999999999999986554332221111000
Q ss_pred ---------------------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 443 ---------------------PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 443 ---------------------~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
......++.++.+|+.+||+.||++|||++++++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 011123456889999999999999999999999999998763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=309.04 Aligned_cols=247 Identities=28% Similarity=0.472 Sum_probs=208.7
Q ss_pred cCceeeeeeecccCceEEEEEEecC----CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTDD----GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
..+|.+.+.||+|+||.||+|.+.+ ...|++|...... .....+.+.+|+.++++++||||+++++++.++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~- 79 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT----SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN- 79 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC----CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-
Confidence 4568899999999999999998642 3568999876432 133456788999999999999999999988764
Q ss_pred ceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 300 RLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
..+++|||+++|+|.+++... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 578999999999999998754 489999999999999999999999999999999999999999999999999875543
Q ss_pred CCc---ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHH
Q 011326 378 NDV---KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDA 453 (488)
Q Consensus 378 ~~~---~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l 453 (488)
... ....++..|+|||.+ ....++.++|+||||+++|||++ |..||......+....+..+...+.+..++.++
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 237 (270)
T ss_pred ccceecCCCCccccccChhhh--ccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHH
Confidence 321 122344679999987 44568899999999999999986 999998887777777777777667788899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 454 QDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.+++.+||..+|.+|||+.+++..
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=314.39 Aligned_cols=247 Identities=30% Similarity=0.466 Sum_probs=204.4
Q ss_pred cCceeeeeeecccCceEEEEEEecC-----------------CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTDD-----------------GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp 286 (488)
.++|++.+.||+|+||.||++.+.. +..||+|.+.... .......+.+|+.++++++||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~l~~~ 79 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA----SDNAREDFLKEVKILSRLSDP 79 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc----CHHHHHHHHHHHHHHHhcCCC
Confidence 4678999999999999999987642 3568999987542 224456788999999999999
Q ss_pred CcceeeccccCCCceEEEEeeccCCChHHHHhhh------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcc
Q 011326 287 NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCA 354 (488)
Q Consensus 287 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~ 354 (488)
||+++++++..++..+++||++++++|.+++... .+++..++.++.|++.||.|||++|++|+||||+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 9999999999999999999999999999988654 3789999999999999999999999999999999
Q ss_pred cEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc--CCCCCCCC
Q 011326 355 NILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT--RRHPYSHL 428 (488)
Q Consensus 355 NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt--G~~Pf~~~ 428 (488)
||+++.++.++|+|||+++...... .....++..|+|||.+ ....++.++||||||+++|||++ |..||...
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV--LLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHh--hcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999999987543332 2234467789999987 34458999999999999999998 78888876
Q ss_pred chhhhHHHhcCC-------CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 429 EGGQAMFKIGGG-------ELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 429 ~~~~~~~~i~~~-------~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+..+........ ...+.+..++.++.+++.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 665554444322 112334567899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.48 Aligned_cols=249 Identities=33% Similarity=0.588 Sum_probs=216.7
Q ss_pred eeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc--eEEEEe
Q 011326 230 GELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR--LCIFLE 306 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~--~~lV~E 306 (488)
..+||+|+|-+||+|.+. +|..||.-.+...+.. .......+|..|+.+|+.|+||||++++.++.+... +-+|+|
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~-q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVT-QSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhh-cChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 467999999999999985 7888887776554433 344556789999999999999999999998877554 889999
Q ss_pred eccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHC--CCccccCCcccEEEC-CCCcEEEeecCCcccccCCCccc
Q 011326 307 LVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQ--NVVHRDIKCANILVD-ASGSVKLADFGLAKATTMNDVKS 382 (488)
Q Consensus 307 ~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~--giiHrDLkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~ 382 (488)
++..|+|..++.+. ..+...+..|++||++||.|||++ .|||||||.+||+|+ ..|.|||+|+|+|..........
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aks 203 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKS 203 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccce
Confidence 99999999999776 489999999999999999999988 599999999999997 57899999999999988888888
Q ss_pred CCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCC-chhhhHHHhcCCCCCCCC-CcccHHHHHHHHHh
Q 011326 383 CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHL-EGGQAMFKIGGGELPPVP-NSLSRDAQDFILKC 460 (488)
Q Consensus 383 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~-~~~~~~~~i~~~~~~~~~-~~~s~~l~~Li~~c 460 (488)
..|||.|||||++ ...|+..+||||||++|+||+|+..||... +..+++.++.++..|... .--.++++++|.+|
T Consensus 204 vIGTPEFMAPEmY---EE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekC 280 (632)
T KOG0584|consen 204 VIGTPEFMAPEMY---EENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKC 280 (632)
T ss_pred eccCccccChHHH---hhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHH
Confidence 9999999999987 366999999999999999999999999764 566777777777665433 33478999999999
Q ss_pred hhhCCCCCCCHHHHHhCccCCCC
Q 011326 461 LQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 461 L~~dP~~Rps~~eil~hp~f~~~ 483 (488)
|.. ..+|||+.|+|.||||..-
T Consensus 281 l~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 281 LAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred hcC-chhccCHHHHhhChhhccc
Confidence 999 8999999999999999873
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=323.12 Aligned_cols=255 Identities=28% Similarity=0.491 Sum_probs=205.0
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC----CC
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD----EK 299 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~ 299 (488)
.+|++.+.||+|+||.||+|.+. +|..||+|.+...... ......+.+|+.+|++++||||+++++++.. ..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV---PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc---ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 57899999999999999999875 6999999998754321 2234567789999999999999999998753 34
Q ss_pred ceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 300 RLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
..++||||+. ++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 6899999996 4888887543 5899999999999999999999999999999999999999999999999998654332
Q ss_pred C------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC-------------
Q 011326 379 D------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG------------- 439 (488)
Q Consensus 379 ~------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~------------- 439 (488)
. .....|+..|+|||.+. ....++.++|+||||+++|+|++|+.||...+.......+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLL-SLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred CcCCCcccccccccccccChHHhc-CCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 2 12346889999999873 334578999999999999999999999976543222111000
Q ss_pred ------------CCCCC-----CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 440 ------------GELPP-----VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 440 ------------~~~~~-----~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
..... .....++++.++|.+||+.+|.+||++.+++.||||.+.-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 00011 1134689999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=323.89 Aligned_cols=252 Identities=27% Similarity=0.455 Sum_probs=201.0
Q ss_pred eeeccc--CceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEee
Q 011326 231 ELLGSG--SYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLEL 307 (488)
Q Consensus 231 ~~LG~G--~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 307 (488)
..||+| +||+||.+.+. +|+.||+|.+..... .....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC---TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence 346666 99999999885 799999999875432 233456788999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-----
Q 011326 308 VTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----- 379 (488)
Q Consensus 308 ~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~----- 379 (488)
+.+++|.+++.+. .+++..+..++.|++.||+|||++|++||||||+||+++.++.++++||+.+.......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999999988753 48899999999999999999999999999999999999999999999998543221110
Q ss_pred ----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC--------------
Q 011326 380 ----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE-------------- 441 (488)
Q Consensus 380 ----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~-------------- 441 (488)
.....++..|+|||++......++.++||||+|+++|+|++|..||................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 11123456799999984333457899999999999999999999997665433332221110
Q ss_pred --------------------------------CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 442 --------------------------------LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 442 --------------------------------~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
..+.+..+++++.+|+++||+.||++|||+.|+++||||+...+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 00112346778999999999999999999999999999976543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=305.06 Aligned_cols=243 Identities=32% Similarity=0.550 Sum_probs=210.6
Q ss_pred eeeeeecccCceEEEEEEecC-----CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 228 QKGELLGSGSYGFVYEGLTDD-----GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 228 ~~~~~LG~G~fg~Vy~~~~~~-----g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
++.+.||.|+||.||++.+.. +..+|+|.+.... .......+.+|+.++..++|+||+++++++.+.+..+
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA----DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC----ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence 567889999999999998753 4889999986432 1224567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhhc---cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 303 IFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~~---ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
++|||+++++|.+++.... +++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999999986543 8999999999999999999999999999999999999999999999999987654432
Q ss_pred cc---cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHH
Q 011326 380 VK---SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455 (488)
Q Consensus 380 ~~---~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~ 455 (488)
.. ...+++.|+|||.+ ....++.++|+||+|+++++|++ |..||...+..+....+........+..++.++.+
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~--~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESL--KDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYK 235 (258)
T ss_pred ccccccCCCcccccChHHh--ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHH
Confidence 21 22367889999987 45568999999999999999998 88999887777777777777777777789999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHh
Q 011326 456 FILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~eil~ 476 (488)
++.+||..||++|||+.|+++
T Consensus 236 ~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 236 LMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHCcCChhhCcCHHHHHh
Confidence 999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=311.52 Aligned_cols=249 Identities=33% Similarity=0.546 Sum_probs=205.4
Q ss_pred eeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEE
Q 011326 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFL 305 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 305 (488)
|++.+.||+|++|.||++... ++..+++|.+...... ......+.+|+.++++++|+||+++++++.+++..+++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES---EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc---chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence 566788999999999999885 7899999998754322 123457788999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--cc
Q 011326 306 ELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VK 381 (488)
Q Consensus 306 E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~~ 381 (488)
||+++ +|.+.+... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence 99986 888777654 68999999999999999999999999999999999999999999999999986654432 23
Q ss_pred cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC--------------------
Q 011326 382 SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE-------------------- 441 (488)
Q Consensus 382 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~-------------------- 441 (488)
...++..|+|||.+. ....++.++|+||+|+++|+|++|+.||...+..+....+....
T Consensus 157 ~~~~~~~~~~PE~~~-~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 157 HYVVTRWYRAPELLL-GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred CccCcccccCcHHHh-cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence 355888899999973 33368999999999999999999999997766544332221100
Q ss_pred ---------CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 442 ---------LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 442 ---------~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
.......++.++.++|.+||++||.+||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 001123467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=306.52 Aligned_cols=239 Identities=33% Similarity=0.554 Sum_probs=200.6
Q ss_pred eeecccCceEEEEEEecC--C--cEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEe
Q 011326 231 ELLGSGSYGFVYEGLTDD--G--FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLE 306 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~~--g--~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 306 (488)
+.||+|++|.||+|.+.+ + ..||+|.+...... .....+.+|+.++++++||||+++++.+.. ...+++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS----DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE 75 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH----HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence 358999999999998742 3 36899998754321 556788999999999999999999999888 88999999
Q ss_pred eccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC----
Q 011326 307 LVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---- 379 (488)
Q Consensus 307 ~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~---- 379 (488)
|+++++|.+.+... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 99999999988664 48999999999999999999999999999999999999999999999999987654321
Q ss_pred -cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhc-CCCCCCCCCcccHHHHHH
Q 011326 380 -VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIG-GGELPPVPNSLSRDAQDF 456 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~l~~L 456 (488)
.....++..|+|||.+ ....++.++||||||+++|+|++ |..||...+..+....+. .......+..++..+.++
T Consensus 156 ~~~~~~~~~~y~~pE~~--~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (257)
T cd05040 156 MEEHLKVPFAWCAPESL--RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNV 233 (257)
T ss_pred cccCCCCCceecCHHHh--cccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHH
Confidence 1234467789999987 44558999999999999999998 999998776666554444 223334556788999999
Q ss_pred HHHhhhhCCCCCCCHHHHHh
Q 011326 457 ILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 457 i~~cL~~dP~~Rps~~eil~ 476 (488)
+.+||+.+|++|||+.++++
T Consensus 234 i~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 234 MLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHCCCCcccCCCHHHHHH
Confidence 99999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=314.98 Aligned_cols=247 Identities=26% Similarity=0.417 Sum_probs=200.9
Q ss_pred cCceeeeeeecccCceEEEEEEecC---------------CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCc
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTDD---------------GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~~---------------g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI 288 (488)
..+|++.+.||+|+||.||++...+ ...||+|.+.... .......+.+|++++++++|||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~i 79 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV----TKTARNDFLKEIKIMSRLKNPNI 79 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4589999999999999999987632 2358999986432 23344578899999999999999
Q ss_pred ceeeccccCCCceEEEEeeccCCChHHHHhhh-------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCccc
Q 011326 289 VQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCAN 355 (488)
Q Consensus 289 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~N 355 (488)
+++++++...+..++||||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+|
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N 159 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence 99999999999999999999999999988543 25778889999999999999999999999999999
Q ss_pred EEECCCCcEEEeecCCcccccCCCc----ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc--CCCCCCCCc
Q 011326 356 ILVDASGSVKLADFGLAKATTMNDV----KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT--RRHPYSHLE 429 (488)
Q Consensus 356 ILl~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt--G~~Pf~~~~ 429 (488)
|+++.++.+||+|||++........ ....++..|+|||.+ ....++.++|+||||+++|+|++ |..||...+
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESI--LLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhh--ccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 9999999999999999865433221 123356789999987 34558999999999999999988 677887766
Q ss_pred hhhhHHHhc-------CCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 430 GGQAMFKIG-------GGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 430 ~~~~~~~i~-------~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
..+....+. .......+..+++.+.+|+.+||+.||++|||+++|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 555443321 11122345567899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=323.21 Aligned_cols=258 Identities=28% Similarity=0.430 Sum_probs=207.8
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC---
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE--- 298 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--- 298 (488)
..++|++.+.||+|+||.||++.+. ++..||+|.+..... .......+.+|+.++++++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 3478999999999999999999874 789999999865321 122345677899999999999999999987532
Q ss_pred ---CceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 299 ---KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 299 ---~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
...+++++++ +++|.+++....+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 3478888877 679999888778999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC---------------
Q 011326 376 TMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG--------------- 440 (488)
Q Consensus 376 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~--------------- 440 (488)
.. ......++..|+|||.+. ....++.++|+||+|+++|+|++|+.||...+.......+...
T Consensus 171 ~~-~~~~~~~~~~y~aPE~~~-~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (345)
T cd07877 171 DD-EMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 248 (345)
T ss_pred cc-cccccccCCCccCHHHHh-CccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence 32 233456889999999873 3345788999999999999999999999765543322221100
Q ss_pred ----------CCC-----CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 441 ----------ELP-----PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 441 ----------~~~-----~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
..+ ......++++.++|.+||+.||.+||++.+++.||||++...+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~ 309 (345)
T cd07877 249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309 (345)
T ss_pred hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence 000 0112357889999999999999999999999999999875543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=309.90 Aligned_cols=239 Identities=26% Similarity=0.471 Sum_probs=199.1
Q ss_pred eecccCceEEEEEEec-CCc--EEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCceEEEEee
Q 011326 232 LLGSGSYGFVYEGLTD-DGF--FFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKRLCIFLEL 307 (488)
Q Consensus 232 ~LG~G~fg~Vy~~~~~-~g~--~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~ 307 (488)
.||+|+||.||+|.+. ++. .+++|.+... ........+.+|+.++.++ +||||+++++++...+..+++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 77 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc----CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence 5899999999999875 444 4688877532 1233445788999999999 899999999999999999999999
Q ss_pred ccCCChHHHHhhh-----------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecC
Q 011326 308 VTKGSLASLYQKY-----------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFG 370 (488)
Q Consensus 308 ~~~gsL~~~l~~~-----------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFG 370 (488)
+++|+|.+++... .+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCC
Confidence 9999999998643 26788999999999999999999999999999999999999999999999
Q ss_pred CcccccCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCc
Q 011326 371 LAKATTMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNS 448 (488)
Q Consensus 371 la~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 448 (488)
++....... ......+..|+|||++ ....++.++|+||||+++|||++ |..||...+..+....+........+..
T Consensus 158 l~~~~~~~~~~~~~~~~~~y~apE~~--~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 235 (270)
T cd05047 158 LSRGQEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 235 (270)
T ss_pred CccccchhhhccCCCCccccCChHHH--ccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCc
Confidence 985332111 1122345679999987 44568899999999999999997 9999988777776666666555556677
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 449 LSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 449 ~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
++.++.+|+.+||+.||.+|||+.+++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 236 CDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 8899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=320.97 Aligned_cols=256 Identities=30% Similarity=0.470 Sum_probs=210.9
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC-----
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK----- 299 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----- 299 (488)
+|++.+.||.|++|.||+|.+. ++..+|+|.+..... .......+.+|+.+++.++||||+++++++...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD---DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc---cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence 5888999999999999999986 589999999875432 1233457889999999999999999999988775
Q ss_pred ceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 300 RLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
..|++|||+++ +|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 78 ~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 78 DVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred ceEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 78999999985 788887654 6899999999999999999999999999999999999999999999999998765543
Q ss_pred C-----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC-----------
Q 011326 379 D-----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL----------- 442 (488)
Q Consensus 379 ~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~----------- 442 (488)
. .....++..|+|||.+.. ...++.++|+||+|+++|+|++|..||...+..+....+.....
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLS-SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred ccccccccccccccCcCCceeeec-ccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence 2 334568889999999742 22688999999999999999999999987665443333221100
Q ss_pred -------------------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 443 -------------------PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 443 -------------------~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
......++.++.++|.+||+++|.+||++.+++.||||++.-..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 01123468899999999999999999999999999999875543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=331.73 Aligned_cols=246 Identities=30% Similarity=0.458 Sum_probs=211.6
Q ss_pred eeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeec
Q 011326 230 GELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
.++||.|.||+||-|..+ +|+.||||++.+-..... ...++++|+.||++++||.||.+.-.|++.+++++|||.+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k---qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK---QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL 645 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCc---hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh
Confidence 478999999999999875 899999999987654332 2367889999999999999999999999999999999999
Q ss_pred cCCChHHHHh--hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC---CCcEEEeecCCcccccCCCc-cc
Q 011326 309 TKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA---SGSVKLADFGLAKATTMNDV-KS 382 (488)
Q Consensus 309 ~~gsL~~~l~--~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~---~~~vkL~DFGla~~~~~~~~-~~ 382 (488)
.|.-|.-++. +.++++.....++.||+.||.|||.+||+|+||||+|||+.. -.++||||||+|+....... ++
T Consensus 646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrs 725 (888)
T KOG4236|consen 646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRS 725 (888)
T ss_pred cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhh
Confidence 8866666664 456999999999999999999999999999999999999964 35899999999999887764 57
Q ss_pred CCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC---CCCCCCcccHHHHHHHHH
Q 011326 383 CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE---LPPVPNSLSRDAQDFILK 459 (488)
Q Consensus 383 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~l~~Li~~ 459 (488)
.+|||.|+|||++ ...+|..+.||||+|+++|--++|..||...++. ..+|.... .+.-...+++++.+||..
T Consensus 726 VVGTPAYLaPEVL--rnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQNAaFMyPp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 726 VVGTPAYLAPEVL--RNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQNAAFMYPPNPWSEISPEAIDLINN 801 (888)
T ss_pred hcCCccccCHHHH--hhccccccccceeeeEEEEEEecccccCCCccch--hHHhhccccccCCCchhhcCHHHHHHHHH
Confidence 7899999999997 5567999999999999999999999999764433 33333322 233346789999999999
Q ss_pred hhhhCCCCCCCHHHHHhCccCCC
Q 011326 460 CLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 460 cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
+|+..-.+|.|.++.+.|||+|.
T Consensus 802 LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred HHHHHHHHhcchHhhccchhhhc
Confidence 99999999999999999999985
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=322.33 Aligned_cols=254 Identities=26% Similarity=0.440 Sum_probs=204.4
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC-----
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE----- 298 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~----- 298 (488)
.+|.+.+.||+|+||.||++.+. ++..||+|.+..... .......+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD---NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 47999999999999999999875 799999999875432 122334667899999999999999999987644
Q ss_pred CceEEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 299 KRLCIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
...+++|||+. ++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 34899999996 588887754 4589999999999999999999999999999999999999999999999999876543
Q ss_pred CC--cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhc-----------------
Q 011326 378 ND--VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIG----------------- 438 (488)
Q Consensus 378 ~~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~----------------- 438 (488)
.. .....++..|+|||.+. ....++.++|+||||+++|+|++|..||.+.+..+....+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLL-NCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred CcccccccccccCccChHHHh-cCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 31 23456888999999873 22348899999999999999999999997654322111110
Q ss_pred ----------CCC---CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 439 ----------GGE---LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 439 ----------~~~---~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
... .......+++++.++|.+||+.+|++|||+.++++||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000 001124578999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=318.02 Aligned_cols=249 Identities=39% Similarity=0.658 Sum_probs=219.2
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
-|.+++.||+|+||.||++.++ +|..+|||.+... ..++++..|+.++++.+.|++|++||.+.....++||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-------chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence 3677889999999999999876 7999999998653 3456788999999999999999999998888889999
Q ss_pred EeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--Cc
Q 011326 305 LELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DV 380 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~ 380 (488)
||||..|+..++++. ..+++.++..+++..+.||+|||...-+|||||..|||++.+|..||+|||.|..+... ..
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 999999999999854 45999999999999999999999999999999999999999999999999999765543 24
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCC--CCcccHHHHHHHH
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV--PNSLSRDAQDFIL 458 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~Li~ 458 (488)
.+..|||.|||||+++ .-+|+.++||||||++..||..|++||....+-..+..+.....|.+ |...|.++.++++
T Consensus 187 NTVIGTPFWMAPEVI~--EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~ 264 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIE--EIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIR 264 (502)
T ss_pred CccccCcccccHHHHH--HhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHH
Confidence 5677999999999984 45589999999999999999999999988777666666655544433 4568999999999
Q ss_pred HhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 459 KCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 459 ~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
.||.++|++|-|+.++++|||++.+
T Consensus 265 ~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 265 SCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred HHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 9999999999999999999999875
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=314.73 Aligned_cols=252 Identities=33% Similarity=0.589 Sum_probs=209.4
Q ss_pred eeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEE
Q 011326 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFL 305 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 305 (488)
|...+.||+|+||.||+|.+. ++..|++|.+..... ........+.+|+.+++.++|||++++++++.+.+..++||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK--QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc--CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 555677999999999999875 689999999875433 22334457888999999999999999999999999999999
Q ss_pred eeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCcccC
Q 011326 306 ELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC 383 (488)
Q Consensus 306 E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 383 (488)
||+.+ +|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.... .....
T Consensus 101 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~--~~~~~ 177 (313)
T cd06633 101 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS--PANSF 177 (313)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC--CCCCc
Confidence 99975 77666643 358899999999999999999999999999999999999999999999999885432 22345
Q ss_pred CCCCcccCchhhcc-ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCC-CCcccHHHHHHHHHhh
Q 011326 384 KGTAFWMAPEVVNL-KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV-PNSLSRDAQDFILKCL 461 (488)
Q Consensus 384 ~gt~~y~aPE~~~~-~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~s~~l~~Li~~cL 461 (488)
.|+..|+|||.+.. ....++.++|+||||+++|+|++|..||...+.......+.....+.. ...++..+.+|+.+||
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 257 (313)
T cd06633 178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCL 257 (313)
T ss_pred cccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHc
Confidence 68899999998732 234578899999999999999999999987766555555444333332 3457788999999999
Q ss_pred hhCCCCCCCHHHHHhCccCCCC
Q 011326 462 QVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 462 ~~dP~~Rps~~eil~hp~f~~~ 483 (488)
+.+|.+||++.+++.||||+..
T Consensus 258 ~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 258 QKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred cCChhhCcCHHHHhcCcccCCC
Confidence 9999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=305.48 Aligned_cols=241 Identities=25% Similarity=0.446 Sum_probs=197.5
Q ss_pred eeecccCceEEEEEEec----CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecccc-CCCceEEEE
Q 011326 231 ELLGSGSYGFVYEGLTD----DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR-DEKRLCIFL 305 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-~~~~~~lV~ 305 (488)
+.||+|+||.||+|.+. ++..+|+|.+.... .......+.+|+.+++.++||||+++++++. .++..+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT----DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC----CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence 35899999999999863 34579999875321 2334567889999999999999999999765 456789999
Q ss_pred eeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC----
Q 011326 306 ELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---- 379 (488)
Q Consensus 306 E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~---- 379 (488)
||+++|+|.+++... .+++..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||++.......
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999999998654 35777788999999999999999999999999999999999999999999986543211
Q ss_pred --cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHH
Q 011326 380 --VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDF 456 (488)
Q Consensus 380 --~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L 456 (488)
.....++..|+|||.+ ....++.++||||||+++|||++ |.+||...+..+....+..+..+..+..+++.+.++
T Consensus 157 ~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (262)
T cd05058 157 HNHTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEV 234 (262)
T ss_pred cccccCcCCccccChhHh--ccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 1233467789999987 34568999999999999999999 566777766666666666555555666789999999
Q ss_pred HHHhhhhCCCCCCCHHHHHhC
Q 011326 457 ILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 457 i~~cL~~dP~~Rps~~eil~h 477 (488)
+.+||+.+|++||++.++++.
T Consensus 235 i~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 235 MLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=315.45 Aligned_cols=255 Identities=33% Similarity=0.563 Sum_probs=213.1
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
.|+..+.||+|+||.||++.+. ++..+|+|.+...... .......+.+|+.++++++|||++++++++.+++..++|
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ--SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC--chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 3777889999999999999875 6899999998754332 234456788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHh--hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCccc
Q 011326 305 LELVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS 382 (488)
Q Consensus 305 ~E~~~~gsL~~~l~--~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 382 (488)
|||+++ +|.+++. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--~~~ 180 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--ANS 180 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--ccc
Confidence 999976 7776664 34589999999999999999999999999999999999999999999999998865432 234
Q ss_pred CCCCCcccCchhhcc-ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC-CCCcccHHHHHHHHHh
Q 011326 383 CKGTAFWMAPEVVNL-KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP-VPNSLSRDAQDFILKC 460 (488)
Q Consensus 383 ~~gt~~y~aPE~~~~-~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~l~~Li~~c 460 (488)
..|++.|+|||.+.. ....++.++|+||+|+++|+|++|..||...+.......+.....+. ....+++.+.+++.+|
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 260 (317)
T cd06635 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC 260 (317)
T ss_pred ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHH
Confidence 568889999998632 23457889999999999999999999998776666555555444332 3346788999999999
Q ss_pred hhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 461 LQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 461 L~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
|+.+|.+||++.++++|+|+.....
T Consensus 261 l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 261 LQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred ccCCcccCcCHHHHHhChhhhccCc
Confidence 9999999999999999999976544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=327.47 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=209.5
Q ss_pred CcccccccCceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcc
Q 011326 217 NGKFRRRITSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIV 289 (488)
Q Consensus 217 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv 289 (488)
+..|+....+|.+++.||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.+|.++. ||||+
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~~E~~~l~~l~~H~niv 104 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA----RSSEKQALMSELKIMSHLGPHLNIV 104 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC----ChhHHHHHHHHHHHHHhcCCCCCeE
Confidence 3456777788999999999999999999853 35689999997532 1223356889999999997 99999
Q ss_pred eeeccccCCCceEEEEeeccCCChHHHHhhh-------------------------------------------------
Q 011326 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKY------------------------------------------------- 320 (488)
Q Consensus 290 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~------------------------------------------------- 320 (488)
++++++..++..++||||+++|+|.+++...
T Consensus 105 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (401)
T cd05107 105 NLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKD 184 (401)
T ss_pred EEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCc
Confidence 9999999999999999999999999988542
Q ss_pred --------------------------------------------------ccChhhhhHHHHHHHHHHHHHHHCCCcccc
Q 011326 321 --------------------------------------------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRD 350 (488)
Q Consensus 321 --------------------------------------------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrD 350 (488)
.+++..+..++.|++.||.|||+.|++|||
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrd 264 (401)
T cd05107 185 ESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRD 264 (401)
T ss_pred cccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCccc
Confidence 145566788999999999999999999999
Q ss_pred CCcccEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCC
Q 011326 351 IKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPY 425 (488)
Q Consensus 351 Lkp~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf 425 (488)
|||+|||++.++.++|+|||+++...... .....++..|+|||.+ ....++.++|+||||+++|||++ |..||
T Consensus 265 lkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwslGvil~e~l~~g~~P~ 342 (401)
T cd05107 265 LAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI--FNNLYTTLSDVWSFGILLWEIFTLGGTPY 342 (401)
T ss_pred CCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHh--cCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999987543221 1233467889999997 34558899999999999999998 89999
Q ss_pred CCCchhhhH-HHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 426 SHLEGGQAM-FKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 426 ~~~~~~~~~-~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
......+.. ..+..+..++.+..++.++.+|+.+||+.+|.+||++.||++.
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 343 PELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 775544433 3334444455677789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=322.33 Aligned_cols=257 Identities=30% Similarity=0.456 Sum_probs=207.2
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCC--C
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDE--K 299 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~--~ 299 (488)
.++|++.+.||+|+||.||+|.+. ++..+|+|.+..... .......+.+|+.+++++ +||||+++++++... .
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR---NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC---cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 467899999999999999999886 688999999864321 122234567899999999 999999999987643 3
Q ss_pred ceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 300 RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
..++||||+++ +|..++....+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 83 DIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred eEEEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 68999999985 99988877778999999999999999999999999999999999999999999999999986543221
Q ss_pred -------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC------------
Q 011326 380 -------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG------------ 440 (488)
Q Consensus 380 -------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~------------ 440 (488)
.....||..|+|||.+. ....++.++|+||||+++|+|++|+.||......+....+...
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILL-GSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred ccccCcchhcccccccccCceeee-ccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 22345889999999863 3455788999999999999999999999765543322221100
Q ss_pred ---------------CC---CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 441 ---------------EL---PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 441 ---------------~~---~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
.. ......++.++.++|.+||+.||.+|||+.++++||||++..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 00 1112337889999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=348.55 Aligned_cols=248 Identities=23% Similarity=0.288 Sum_probs=200.8
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
+++|++.+.||+|+||.||+|.+. +|+.||+|.+..... .......++.+|+.++++++||||+++++++.+++..+
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~--~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~ly 78 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS--ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVY 78 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc--cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEE
Confidence 468999999999999999999885 689999999875332 22334567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecC
Q 011326 303 IFLELVTKGSLASLYQKY------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFG 370 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFG 370 (488)
++|||++||+|.+++... ..+...+..++.||+.||+|||++||+||||||+||+++.++.++|+|||
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999999988531 24556788999999999999999999999999999999999999999999
Q ss_pred CcccccCCC--------------------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCch
Q 011326 371 LAKATTMND--------------------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG 430 (488)
Q Consensus 371 la~~~~~~~--------------------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~ 430 (488)
+++...... .....||+.|+|||.+ .+..++.++||||+||++|||++|..||.....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l--~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHh--cCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 987541110 1124699999999987 455689999999999999999999999977544
Q ss_pred hhhHHHhcCCCCC--CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHH
Q 011326 431 GQAMFKIGGGELP--PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLM 475 (488)
Q Consensus 431 ~~~~~~i~~~~~~--~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil 475 (488)
............. .....+++.+.+++.+||+.||++||+..+.+
T Consensus 237 ~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 237 RKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred hhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 3332221111111 11236789999999999999999998755544
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=321.10 Aligned_cols=254 Identities=28% Similarity=0.445 Sum_probs=204.1
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC----
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK---- 299 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~---- 299 (488)
.+|.+.+.||+|+||.||+|.+. +|..||+|.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ---SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc---cccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 57999999999999999999875 799999999865321 1222345778999999999999999999876543
Q ss_pred --ceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 300 --RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 300 --~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
.+++|+||+.. +|..++. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++....
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIMG-HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred CceEEEEeccccc-CHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 46999999975 7766653 4689999999999999999999999999999999999999999999999999875432
Q ss_pred CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC-----------------
Q 011326 378 NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG----------------- 440 (488)
Q Consensus 378 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~----------------- 440 (488)
......+++.|+|||.+. ....++.++|+||||+++|||++|+.||...+.......+...
T Consensus 170 -~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (342)
T cd07879 170 -EMTGYVVTRWYRAPEVIL-NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA 247 (342)
T ss_pred -CCCCceeeecccChhhhc-CccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence 233456788999999873 3345788999999999999999999999876543322221110
Q ss_pred -----CCCC--------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 441 -----ELPP--------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 441 -----~~~~--------~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
..+. .....++++.+||.+||+.||.+||++.+++.||||+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0000 11246788999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=312.74 Aligned_cols=261 Identities=30% Similarity=0.505 Sum_probs=208.8
Q ss_pred cccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccC
Q 011326 220 FRRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRD 297 (488)
Q Consensus 220 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~ 297 (488)
+....++|++.+.||+|+||.||+|.+. ++..||+|.+..... ......+..|+.++.+. .||||+++++++.+
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 85 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN----KEENKRILMDLDVVLKSHDCPYIVKCYGYFIT 85 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC----hHHHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence 4456788999999999999999999986 599999999975432 12234556677666666 49999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHH-CCCccccCCcccEEECCCCcEEEeecCCccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKA 374 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~NILl~~~~~vkL~DFGla~~ 374 (488)
+...+++|||+++ +|..++.. ..+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.++|+|||++..
T Consensus 86 ~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 86 DSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred CCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence 9999999999865 77776654 358899999999999999999997 5999999999999999999999999999865
Q ss_pred ccCCC-cccCCCCCcccCchhhcccc--CCCChhhhHHHHHHHHHHHHcCCCCCCCCch-hhhHHHhcCCCCCCCC--Cc
Q 011326 375 TTMND-VKSCKGTAFWMAPEVVNLKK--DGYGLTADIWSLGCTVLEMLTRRHPYSHLEG-GQAMFKIGGGELPPVP--NS 448 (488)
Q Consensus 375 ~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~-~~~~~~i~~~~~~~~~--~~ 448 (488)
..... .....++..|+|||.+.... ..++.++|+||||+++|+|++|+.||..... .+....+.....+..+ ..
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T cd06618 165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEG 244 (296)
T ss_pred ccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCC
Confidence 43322 23345788899999974332 4478899999999999999999999976433 2334443333332222 34
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 449 LSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 449 ~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
++.++.+|+.+||+.||.+||++++++.||||+....
T Consensus 245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 7899999999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=314.25 Aligned_cols=252 Identities=29% Similarity=0.496 Sum_probs=199.9
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC----
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE---- 298 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~---- 298 (488)
+++|++.+.||+|+||.||+|.+. ++..+|+|.+........ ....+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC---cchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 679999999999999999999875 689999999876443221 123456899999999999999999986443
Q ss_pred ----CceEEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCc
Q 011326 299 ----KRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLA 372 (488)
Q Consensus 299 ----~~~~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla 372 (488)
..+++||||+.+ +|...+.. ..+++..+..++.|+++||.|||++|++|+||||+||+++.++.++|+|||++
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 357999999976 66666543 35999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCC-------------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC
Q 011326 373 KATTMND-------------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG 439 (488)
Q Consensus 373 ~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~ 439 (488)
....... .....+++.|+|||.+. ....++.++||||||+++|+|++|++||.+.+.......+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL-GERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhh-CCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 6543221 12335688899999873 334578899999999999999999999976655433222211
Q ss_pred CC----------------------CCCC-------CCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 440 GE----------------------LPPV-------PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 440 ~~----------------------~~~~-------~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
.. .... ....++++.+++.+||+.||.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 00 0000 12345788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=303.68 Aligned_cols=240 Identities=27% Similarity=0.481 Sum_probs=204.0
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeeccC
Q 011326 231 ELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTK 310 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 310 (488)
+.||+|+||.||++.+.++..|++|.+..... ......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP----PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC----HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 35899999999999987799999998865432 23456788999999999999999999999999999999999999
Q ss_pred CChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCc----ccCC
Q 011326 311 GSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV----KSCK 384 (488)
Q Consensus 311 gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~----~~~~ 384 (488)
++|.+++... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........ ....
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9999988543 478889999999999999999999999999999999999999999999999875442211 1122
Q ss_pred CCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhh
Q 011326 385 GTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQV 463 (488)
Q Consensus 385 gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~ 463 (488)
++..|+|||.+ ....++.++|+||||+++|+|++ |..||...........+........+..++.++.+++.+||+.
T Consensus 157 ~~~~y~~PE~~--~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 234 (251)
T cd05041 157 IPIKWTAPEAL--NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAY 234 (251)
T ss_pred ceeccCChHhh--ccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhcc
Confidence 35669999987 34568899999999999999998 8999988776666666655544456677899999999999999
Q ss_pred CCCCCCCHHHHHh
Q 011326 464 NPNDRPTAAQLME 476 (488)
Q Consensus 464 dP~~Rps~~eil~ 476 (488)
+|.+|||+.|+++
T Consensus 235 ~p~~Rp~~~ell~ 247 (251)
T cd05041 235 DPENRPSFSEIYN 247 (251)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=331.81 Aligned_cols=260 Identities=25% Similarity=0.406 Sum_probs=229.7
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
......|.+.+.||+|.|+.|..+++. ++..||||.+.+.... ......+.+|+++|..++|||||+++.+.+...
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln---~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN---PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC---hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 345778999999999999999999885 7999999999876642 334455889999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 300 RLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
.+|+||||+.+|.+.+++.++ ++.+..+..++.|+++|++|||+++|+|||||++|||++.+.++||+|||++......
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence 999999999999999998766 4778899999999999999999999999999999999999999999999999877655
Q ss_pred C-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHH
Q 011326 379 D-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFI 457 (488)
Q Consensus 379 ~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li 457 (488)
. ..+.+|++.|.|||+++. ....++.+|+||+|++||-|+.|..||++.+-.+.......+.+ .++..++.++.+||
T Consensus 209 ~~lqt~cgsppyAaPEl~~g-~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~-rIp~~ms~dce~lL 286 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNG-KKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY-RIPFYMSCDCEDLL 286 (596)
T ss_pred ccccccCCCCCccChHhhcC-cccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee-cccceeechhHHHH
Confidence 4 568899999999999853 34568999999999999999999999998877766666665555 56778899999999
Q ss_pred HHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 458 LKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 458 ~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
+++|..+|.+|++.+++++|.|....++
T Consensus 287 rk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 287 RKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred HHhhccCccccCCHHHhhhhcccchhhh
Confidence 9999999999999999999999865543
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=308.05 Aligned_cols=246 Identities=28% Similarity=0.477 Sum_probs=208.5
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCc----EEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGF----FFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
..+|++.+.||+|+||.||+|.+. +|. .+|+|...... .......+.+|+.++++++||||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET----SPKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 357899999999999999999864 333 58999876442 23445678899999999999999999999887
Q ss_pred CceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 299 KRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
...+++|||+++|+|.+++... .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.++...
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 7899999999999999988654 48999999999999999999999999999999999999999999999999987654
Q ss_pred CCCc----ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccH
Q 011326 377 MNDV----KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSR 451 (488)
Q Consensus 377 ~~~~----~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 451 (488)
.... ....++..|+|||.+ ....++.++|+||||+++||+++ |..||......+....+..+...+.+..++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESI--LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTI 238 (279)
T ss_pred CcccceecCCCcccccccCHHHh--hcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCH
Confidence 3221 112235679999987 44568899999999999999998 9999998877777777766666666777899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
++.+++.+||..||.+||++.++++
T Consensus 239 ~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 239 DVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=321.32 Aligned_cols=251 Identities=25% Similarity=0.437 Sum_probs=202.7
Q ss_pred ccccCceeeeeeecccCceEEEEEEe------cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeec
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLT------DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLG 293 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~ 293 (488)
....++|++.+.||+|+||.||+|.+ .+++.||||.+.... .......+.+|+.++.++ +||||+++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 78 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLG 78 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC----ChHHHHHHHHHHHHHHhccCCccHhhhcc
Confidence 33456899999999999999999974 357899999986432 223345688999999999 6899999999
Q ss_pred cccC-CCceEEEEeeccCCChHHHHhhh----------------------------------------------------
Q 011326 294 TDRD-EKRLCIFLELVTKGSLASLYQKY---------------------------------------------------- 320 (488)
Q Consensus 294 ~~~~-~~~~~lV~E~~~~gsL~~~l~~~---------------------------------------------------- 320 (488)
++.. +...+++|||+++|+|.+++...
T Consensus 79 ~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (343)
T cd05103 79 ACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSL 158 (343)
T ss_pred eeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcc
Confidence 8754 45689999999999999887532
Q ss_pred ----------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC----c
Q 011326 321 ----------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----V 380 (488)
Q Consensus 321 ----------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~----~ 380 (488)
.+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++....... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 159 SDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred ccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 25677788899999999999999999999999999999999999999999987543221 1
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchh-hhHHHhcCCCCCCCCCcccHHHHHHHH
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGG-QAMFKIGGGELPPVPNSLSRDAQDFIL 458 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~l~~Li~ 458 (488)
....++..|+|||.+ ....++.++|+||||+++|+|++ |..||...... .....+..+.....+..+++++.+++.
T Consensus 239 ~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (343)
T cd05103 239 GDARLPLKWMAPETI--FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 316 (343)
T ss_pred CCCCCCcceECcHHh--cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence 223456779999987 34568999999999999999997 99999765433 233334444444556668899999999
Q ss_pred HhhhhCCCCCCCHHHHHhC
Q 011326 459 KCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 459 ~cL~~dP~~Rps~~eil~h 477 (488)
+||+.||.+|||+.++++|
T Consensus 317 ~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 317 DCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHccCChhhCcCHHHHHHH
Confidence 9999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=312.33 Aligned_cols=246 Identities=26% Similarity=0.445 Sum_probs=199.8
Q ss_pred CceeeeeeecccCceEEEEEEec-----------------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCC
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-----------------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-----------------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn 287 (488)
++|++.+.||+|+||.||++.+. ++..+|+|.+.... ......++.+|+.+++.++|+|
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA----NKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCC
Confidence 46899999999999999998532 24568999886432 2334567889999999999999
Q ss_pred cceeeccccCCCceEEEEeeccCCChHHHHhhhc------------cChhhhhHHHHHHHHHHHHHHHCCCccccCCccc
Q 011326 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH------------LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCAN 355 (488)
Q Consensus 288 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~N 355 (488)
|+++++++..++..+++|||+++++|.+++.... +++..+..++.|++.||+|||+.|++|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999999886532 5567899999999999999999999999999999
Q ss_pred EEECCCCcEEEeecCCcccccCCCc----ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc--CCCCCCCCc
Q 011326 356 ILVDASGSVKLADFGLAKATTMNDV----KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT--RRHPYSHLE 429 (488)
Q Consensus 356 ILl~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt--G~~Pf~~~~ 429 (488)
|+++.++.++|+|||++........ ....++..|++||.. ....++.++|+||||+++|||++ |..||...+
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~--~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESI--LLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHH--hcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 9999999999999999875433221 122345779999986 34558999999999999999998 788997766
Q ss_pred hhhhHHHhc-------CCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 430 GGQAMFKIG-------GGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 430 ~~~~~~~i~-------~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
..+...... .....+.+..+++.+.+|+.+||+.||.+||++.+|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 554433221 11222345668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=349.38 Aligned_cols=253 Identities=30% Similarity=0.544 Sum_probs=208.4
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC---
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD--- 297 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--- 297 (488)
+..++|+.+++||+||||.||+++++ ||..||||.+.... .......+.+|+.+|++|+|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~----s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA----SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA 551 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch----HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence 45788999999999999999999998 99999999998653 34455678999999999999999975431000
Q ss_pred --------------------------------------------------------------C-----------------
Q 011326 298 --------------------------------------------------------------E----------------- 298 (488)
Q Consensus 298 --------------------------------------------------------------~----------------- 298 (488)
+
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence 0
Q ss_pred -------------------------------------CceEEEEeeccCCChHHHHhhhccC--hhhhhHHHHHHHHHHH
Q 011326 299 -------------------------------------KRLCIFLELVTKGSLASLYQKYHLS--DSQVSSYTRQILNGLK 339 (488)
Q Consensus 299 -------------------------------------~~~~lV~E~~~~gsL~~~l~~~~ls--~~~~~~i~~qi~~aL~ 339 (488)
-.+||=||||+..+|.+++..+.+. ...+|++++||++||.
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHH
Confidence 1268889999998889999888775 8889999999999999
Q ss_pred HHHHCCCccccCCcccEEECCCCcEEEeecCCccccc--------------------CCCcccCCCCCcccCchhhcccc
Q 011326 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--------------------MNDVKSCKGTAFWMAPEVVNLKK 399 (488)
Q Consensus 340 yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~--------------------~~~~~~~~gt~~y~aPE~~~~~~ 399 (488)
|+|++|||||||||.||++++++.|||+|||+|+... ..+.+...||.-|+|||++....
T Consensus 712 YIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 712 YIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred HHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9999999999999999999999999999999996511 01235667999999999984333
Q ss_pred -CCCChhhhHHHHHHHHHHHHcCCCCCC-CCchhhhHHHhcCCCCCCC---CCcccHHHHHHHHHhhhhCCCCCCCHHHH
Q 011326 400 -DGYGLTADIWSLGCTVLEMLTRRHPYS-HLEGGQAMFKIGGGELPPV---PNSLSRDAQDFILKCLQVNPNDRPTAAQL 474 (488)
Q Consensus 400 -~~~s~k~DvwSlGvlL~eLltG~~Pf~-~~~~~~~~~~i~~~~~~~~---~~~~s~~l~~Li~~cL~~dP~~Rps~~ei 474 (488)
..|+.|+||||||++|+||+. ||. .++...++..+..+..|.. ...--+.-..+|.+|++.||.+|||+.|+
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eL 868 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATEL 868 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHH
Confidence 269999999999999999986 564 4566667777776666543 22333456789999999999999999999
Q ss_pred HhCccCC
Q 011326 475 MEHPFIK 481 (488)
Q Consensus 475 l~hp~f~ 481 (488)
|++.||.
T Consensus 869 L~s~llp 875 (1351)
T KOG1035|consen 869 LNSELLP 875 (1351)
T ss_pred hhccCCC
Confidence 9999987
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=319.66 Aligned_cols=257 Identities=27% Similarity=0.452 Sum_probs=205.3
Q ss_pred Ccee-eeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcch---------hHHHHHHHHHHHHhcCCCCCcceeec
Q 011326 225 TSWQ-KGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGK---------QSILQLEQEISLLGQFEHDNIVQYLG 293 (488)
Q Consensus 225 ~~y~-~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~---------~~~~~~~~Ei~iL~~l~HpnIv~l~~ 293 (488)
++|. +.+.||+|+||.||+|.+. ++..||+|.+.......... .....+.+|+.++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 4577999999999999875 79999999987543221110 01124678999999999999999999
Q ss_pred cccCCCceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCc
Q 011326 294 TDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLA 372 (488)
Q Consensus 294 ~~~~~~~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla 372 (488)
++..++..+++|||+.+ +|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 99999999999999975 888887553 5899999999999999999999999999999999999999999999999998
Q ss_pred ccccC----------------CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHH
Q 011326 373 KATTM----------------NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFK 436 (488)
Q Consensus 373 ~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~ 436 (488)
..... .......+++.|+|||.+. ....++.++|+||||+++|+|++|..||...+..+....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 245 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLM-GAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcc-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 65441 1122334688899999873 334478999999999999999999999987766544333
Q ss_pred hcCC---C----C--------------------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 437 IGGG---E----L--------------------PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 437 i~~~---~----~--------------------~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
+... . . .......+.++.++|.+||+.+|++|||++|++.||||+..
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 2110 0 0 00113457889999999999999999999999999999864
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=310.69 Aligned_cols=256 Identities=30% Similarity=0.468 Sum_probs=208.3
Q ss_pred ceeeeeeecccCceEEEEEEe----cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCc
Q 011326 226 SWQKGELLGSGSYGFVYEGLT----DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 300 (488)
+|++.+.||+|++|.||++.+ .++..+|+|.+...... ........+.+|+.++.++ +||||+++++.+..++.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~-~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV-QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH-hhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence 478899999999999999875 35788999998753221 1223345678899999999 59999999999999999
Q ss_pred eEEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 301 LCIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
.++||||+++|+|.+.+.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 9999999999999988765 458999999999999999999999999999999999999999999999999986543322
Q ss_pred ---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCch----hhhHHHhcCCCCCCCCCcccHH
Q 011326 380 ---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG----GQAMFKIGGGELPPVPNSLSRD 452 (488)
Q Consensus 380 ---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~ 452 (488)
.....|+..|++||.+.......+.++|+||||+++|+|++|..||..... .+....+.. ..++.+..++.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-SKPPFPKTMSAE 238 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-cCCCCCcccCHH
Confidence 123458899999999743333478899999999999999999999964321 122222222 234566778999
Q ss_pred HHHHHHHhhhhCCCCCCC---HHHHHhCccCCCC
Q 011326 453 AQDFILKCLQVNPNDRPT---AAQLMEHPFIKRP 483 (488)
Q Consensus 453 l~~Li~~cL~~dP~~Rps---~~eil~hp~f~~~ 483 (488)
+.+++.+||+.||++||| +.++++||||+..
T Consensus 239 l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 239 ARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred HHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 999999999999999998 5677999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.48 Aligned_cols=258 Identities=26% Similarity=0.402 Sum_probs=208.8
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC-CCc
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD-EKR 300 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~ 300 (488)
..++|++.+.||.|+||.||++.+. ++..||+|.+..... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS---TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 4568999999999999999999875 799999999865322 12233567789999999999999999998865 567
Q ss_pred eEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCc
Q 011326 301 LCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV 380 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 380 (488)
.+++|||+. ++|..++....+++..+..++.|+++||.|||+.|++|+||+|+||+++.++.++|+|||.+..... ..
T Consensus 85 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-~~ 162 (328)
T cd07856 85 IYFVTELLG-TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-QM 162 (328)
T ss_pred EEEEeehhc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-Cc
Confidence 899999984 5899998877889999999999999999999999999999999999999999999999999875432 22
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhc----------------------
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIG---------------------- 438 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~---------------------- 438 (488)
....++..|+|||.+. ....++.++|+||||+++|+|++|+.||...+.......+.
T Consensus 163 ~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 163 TGYVSTRYYRAPEIML-TWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred CCCcccccccCceeee-ccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 3456788999999862 33568899999999999999999999997654322111000
Q ss_pred -----CCCCC---CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 439 -----GGELP---PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 439 -----~~~~~---~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
..... .....+++++.++|.+||+.+|++||++++++.||||...-.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 00000 1113578899999999999999999999999999999765443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=309.14 Aligned_cols=248 Identities=30% Similarity=0.485 Sum_probs=201.8
Q ss_pred eeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCCCceEEE
Q 011326 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV 304 (488)
|++.+.||+|++|.||+|... ++..|++|.+...... .......+|+..+++++ ||||+++++++.+++..++|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 76 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS----WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV 76 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc----hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence 677889999999999999986 5889999998654321 12233457889999999 99999999999999999999
Q ss_pred EeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-c
Q 011326 305 LELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-V 380 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~ 380 (488)
|||+ +|+|.+.+... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 9999 77898877553 58999999999999999999999999999999999999999999999999987654332 3
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC--------------------
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG-------------------- 440 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~-------------------- 440 (488)
....++..|+|||.+. ....++.++|+||||+++++|++|+.||...+..+....+...
T Consensus 156 ~~~~~~~~~~aPE~~~-~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 156 TDYVSTRWYRAPEILL-RSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred CCCCCcccccCceeee-cCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 3456888999999873 3445788999999999999999999999766544333221110
Q ss_pred -CC--------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 441 -EL--------PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 441 -~~--------~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
.. .......+.++.+++.+||+.||++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 00111236889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=310.00 Aligned_cols=246 Identities=29% Similarity=0.493 Sum_probs=199.2
Q ss_pred ceeeeeeecccCceEEEEEEe-----cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC--
Q 011326 226 SWQKGELLGSGSYGFVYEGLT-----DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE-- 298 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-- 298 (488)
-|++.+.||+|+||.||.+.. .++..||+|.+.... .......+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc----cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 367889999999999999973 358899999986432 233346788999999999999999999988765
Q ss_pred CceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 299 KRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
...++||||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 5789999999999999998654 48999999999999999999999999999999999999999999999999987554
Q ss_pred CCC-----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCc---------------hhhhHHH
Q 011326 377 MND-----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE---------------GGQAMFK 436 (488)
Q Consensus 377 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~---------------~~~~~~~ 436 (488)
... .....++..|+|||.+ .+..++.++|+||||+++|+|+++..|..... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~--~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECL--IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cCccceeecCCCCCCccccCHHHh--ccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 322 1234567789999987 34568899999999999999999776542210 0111222
Q ss_pred hcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 437 IGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 437 i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
+..+...+.+..++.++.+|+.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 22333445566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=306.16 Aligned_cols=246 Identities=27% Similarity=0.488 Sum_probs=197.1
Q ss_pred CceeeeeeecccCceEEEEEEe-----cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC--
Q 011326 225 TSWQKGELLGSGSYGFVYEGLT-----DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD-- 297 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-- 297 (488)
.+|++.+.||+|+||.||++.. .++..||+|.+... .......+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 4788999999999999999873 36889999998643 23345678899999999999999999997643
Q ss_pred CCceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
...+++||||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 45689999999999999998653 4899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCc-----ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh----------------hhH
Q 011326 376 TMNDV-----KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG----------------QAM 434 (488)
Q Consensus 376 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~----------------~~~ 434 (488)
..... ....++..|+|||.+ .+..++.++|+||||+++|||++|..|+...... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESL--TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHh--ccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 43321 112234569999987 4456889999999999999999987765432211 011
Q ss_pred HHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 435 FKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 435 ~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
..+......+.+..++.++.+|+.+||+.+|++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1122222334556788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=312.82 Aligned_cols=255 Identities=32% Similarity=0.551 Sum_probs=211.4
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
.|+..+.||+|+||.||+|.+. ++..+++|.+...... ......++.+|+.+++.++|+|++++++++......++|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ--SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 4677788999999999999985 6889999998753321 233445778899999999999999999999999999999
Q ss_pred EeeccCCChHHHHh--hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCccc
Q 011326 305 LELVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS 382 (488)
Q Consensus 305 ~E~~~~gsL~~~l~--~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 382 (488)
|||+.+ +|.+.+. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 94 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~~ 170 (308)
T cd06634 94 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--NX 170 (308)
T ss_pred EEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--cc
Confidence 999975 7776653 335899999999999999999999999999999999999999999999999998654432 34
Q ss_pred CCCCCcccCchhhcc-ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC-CCCcccHHHHHHHHHh
Q 011326 383 CKGTAFWMAPEVVNL-KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP-VPNSLSRDAQDFILKC 460 (488)
Q Consensus 383 ~~gt~~y~aPE~~~~-~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~l~~Li~~c 460 (488)
..+++.|+|||.+.. ....++.++||||||+++|+|++|..||...+..+....+.....+. ....++..+.+||.+|
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 250 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHH
Confidence 568889999998732 23457889999999999999999999998766655555444444333 2346888999999999
Q ss_pred hhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 461 LQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 461 L~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
|+.+|.+||++.++++|||+.....
T Consensus 251 l~~~P~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 251 LQKIPQDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred hhCCcccCCCHHHHhhCccccccCC
Confidence 9999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=304.45 Aligned_cols=241 Identities=26% Similarity=0.413 Sum_probs=193.1
Q ss_pred eecccCceEEEEEEec---CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeec
Q 011326 232 LLGSGSYGFVYEGLTD---DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 232 ~LG~G~fg~Vy~~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
.||+|+||.||+|... ....+++|.+.... .......+.+|+.+++.++||||+++++.+.+....++||||+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA----TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC 77 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC----ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence 5899999999999754 34568888765322 2334456788999999999999999999999999999999999
Q ss_pred cCCChHHHHhhhc------cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC---
Q 011326 309 TKGSLASLYQKYH------LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--- 379 (488)
Q Consensus 309 ~~gsL~~~l~~~~------ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--- 379 (488)
++|+|.+++.... .++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999999986542 3567788999999999999999999999999999999999999999999986432221
Q ss_pred -cccCCCCCcccCchhhcc-----ccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCC-----CCCCC
Q 011326 380 -VKSCKGTAFWMAPEVVNL-----KKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGEL-----PPVPN 447 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~-----~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~-----~~~~~ 447 (488)
.....++..|+|||++.. ....++.++||||||+++|||++ |..||....+.+.......... +..+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL 237 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccc
Confidence 123345677999999742 13356889999999999999999 8889987766555444333221 23445
Q ss_pred cccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 448 SLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 448 ~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.++..+.+++..|| .||++|||+++|++-
T Consensus 238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 238 KYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred cCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 68899999999999 599999999999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=307.28 Aligned_cols=249 Identities=34% Similarity=0.542 Sum_probs=204.6
Q ss_pred eeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEE
Q 011326 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFL 305 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 305 (488)
|+..+.||+|++|.||+|... +++.+++|.+..... .......+..|+.++++++|+|++++++++.+.+..++||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE---EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc---cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence 566788999999999999886 699999999986541 1222346678999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--cc
Q 011326 306 ELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VK 381 (488)
Q Consensus 306 E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~~ 381 (488)
||+++ +|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (282)
T cd07829 78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT 156 (282)
T ss_pred cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence 99985 899999765 69999999999999999999999999999999999999999999999999987554332 23
Q ss_pred cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC--------------------CC
Q 011326 382 SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG--------------------GE 441 (488)
Q Consensus 382 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~--------------------~~ 441 (488)
...++..|+|||.+. ....++.++|+||||+++|||++|..||...+..+....+.. ..
T Consensus 157 ~~~~~~~~~aPE~~~-~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 157 HEVVTLWYRAPEILL-GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred ccccCcCcCChHHhc-CCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 345677899999973 333678999999999999999999999977654433322211 00
Q ss_pred CCC--------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 442 LPP--------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 442 ~~~--------~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
.+. .....+.++.+++.+||+.||++||++.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 000 112347889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=304.88 Aligned_cols=247 Identities=26% Similarity=0.475 Sum_probs=206.2
Q ss_pred CceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
++|++.+.||+|+||.||+|... +...+++|.+.... .......+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK----DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc----chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 57889999999999999999863 35679999875432 223456788999999999999999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhh----------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEee
Q 011326 299 KRLCIFLELVTKGSLASLYQKY----------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLAD 368 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~----------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~D 368 (488)
+..++||||+++|+|.+++... .+++..+..++.|++.||.|||++||+|+||||+||+++.++.++++|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999999998643 388999999999999999999999999999999999999999999999
Q ss_pred cCCcccccCCC---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCC-C
Q 011326 369 FGLAKATTMND---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGEL-P 443 (488)
Q Consensus 369 FGla~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~-~ 443 (488)
||++....... .....++..|+|||.+. ....+.++|+||||+++|+|++ |..||...........+..+.. .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQ--EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 99986433221 23345677899999873 4457889999999999999998 8889987666666555554332 2
Q ss_pred CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 444 PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 444 ~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
+.+..++..+.+++.+||+.+|.+|||+.|++.+
T Consensus 239 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 239 PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 3456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=304.45 Aligned_cols=250 Identities=29% Similarity=0.534 Sum_probs=208.3
Q ss_pred ceeeeeeecccCceEEEEEEecC--CcEEEEEEeecCCCCC-----cchhHHHHHHHHHHHHhc-CCCCCcceeeccccC
Q 011326 226 SWQKGELLGSGSYGFVYEGLTDD--GFFFAVKEVSLQDEGP-----RGKQSILQLEQEISLLGQ-FEHDNIVQYLGTDRD 297 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~~--g~~vAvK~i~~~~~~~-----~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~ 297 (488)
+|++.+.||+|+||.||++.+.. +..+|+|.+....... .......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999998854 7889999986543221 233455667788888865 799999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhh-----hccChhhhhHHHHHHHHHHHHHHH-CCCccccCCcccEEECCCCcEEEeecCC
Q 011326 298 EKRLCIFLELVTKGSLASLYQK-----YHLSDSQVSSYTRQILNGLKYLHE-QNVVHRDIKCANILVDASGSVKLADFGL 371 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~-----~~ls~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~NILl~~~~~vkL~DFGl 371 (488)
++..+++|||+++++|.+++.. ..+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999887732 348899999999999999999996 7899999999999999999999999999
Q ss_pred cccccCC-CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCC-cc
Q 011326 372 AKATTMN-DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPN-SL 449 (488)
Q Consensus 372 a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~ 449 (488)
+...... ......|+..|++||.+. ...++.++|+||||+++|+|++|+.||...+.......+......+.+. .+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~--~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVK--NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238 (269)
T ss_pred eeecccccccccccCcccCcChhhhc--CCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccC
Confidence 8765544 234556889999999973 4558999999999999999999999998776666555555554444333 67
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
++++.+++.+||+.||++||++.|+..+
T Consensus 239 ~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 239 SEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 8999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=338.40 Aligned_cols=258 Identities=26% Similarity=0.377 Sum_probs=192.8
Q ss_pred cCceeeeeeecccCceEEEEEEec--CCcEEEEEEeecCCC------------CCcchhHHHHHHHHHHHHhcCCCCCcc
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD--DGFFFAVKEVSLQDE------------GPRGKQSILQLEQEISLLGQFEHDNIV 289 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~--~g~~vAvK~i~~~~~------------~~~~~~~~~~~~~Ei~iL~~l~HpnIv 289 (488)
..+|++.+.||+|+||.||+|..+ ++...+.|.+..... ..........+.+|+.+|++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 578999999999999999998653 233333332211100 001122345678999999999999999
Q ss_pred eeeccccCCCceEEEEeeccCCChHHHHhhhc------cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCc
Q 011326 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKYH------LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS 363 (488)
Q Consensus 290 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~ 363 (488)
++++++.+.+..|+++|++.+ +|..++.... .....+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 999999999999999999865 6666654332 345667889999999999999999999999999999999999
Q ss_pred EEEeecCCcccccCCC---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCC-CCCCc--hhhhHHHh
Q 011326 364 VKLADFGLAKATTMND---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHP-YSHLE--GGQAMFKI 437 (488)
Q Consensus 364 vkL~DFGla~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~P-f~~~~--~~~~~~~i 437 (488)
+||+|||+++...... .....||..|+|||++ .+..++.++|||||||++|||++|..+ +.... ....+..+
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEIL--AGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhh--cCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 9999999997654332 2245799999999997 455689999999999999999998754 43221 11111111
Q ss_pred cC------CCCC----------------CC---------CCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 438 GG------GELP----------------PV---------PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 438 ~~------~~~~----------------~~---------~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
.. ...+ .. ...++.++.++|.+||+.||.+|||+.|++.||||....
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 10 0000 00 013566788899999999999999999999999997643
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=297.44 Aligned_cols=255 Identities=28% Similarity=0.455 Sum_probs=206.9
Q ss_pred cccccccCceeeeeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecccc
Q 011326 218 GKFRRRITSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR 296 (488)
Q Consensus 218 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 296 (488)
+.....-++|.+.+.||+|||+.||.+.. .++..+|+|++.... .+..+..++|++.-++++|||+++++++..
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-----QEDIEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-----hHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 34455667899999999999999999985 589999999998743 345677889999999999999999999875
Q ss_pred CCC-----ceEEEEeeccCCChHHHHhhh-----ccChhhhhHHHHHHHHHHHHHHHCC--CccccCCcccEEECCCCcE
Q 011326 297 DEK-----RLCIFLELVTKGSLASLYQKY-----HLSDSQVSSYTRQILNGLKYLHEQN--VVHRDIKCANILVDASGSV 364 (488)
Q Consensus 297 ~~~-----~~~lV~E~~~~gsL~~~l~~~-----~ls~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~NILl~~~~~v 364 (488)
.+. ..||++.|...|+|.+.++.. -+++.++++|+.++++||++||+.. ++||||||.|||++.++.+
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~ 168 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLP 168 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCce
Confidence 443 499999999999999887543 4999999999999999999999998 9999999999999999999
Q ss_pred EEeecCCcccccCC-----------CcccCCCCCcccCchhhccc-cCCCChhhhHHHHHHHHHHHHcCCCCCCCCch--
Q 011326 365 KLADFGLAKATTMN-----------DVKSCKGTAFWMAPEVVNLK-KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG-- 430 (488)
Q Consensus 365 kL~DFGla~~~~~~-----------~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~-- 430 (488)
+|.|||.+...... ++.....|..|+|||.++.. +...+.++|||||||+||+|+.|..||+..-.
T Consensus 169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G 248 (302)
T KOG2345|consen 169 VLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG 248 (302)
T ss_pred EEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC
Confidence 99999988643211 13345688999999998533 34468999999999999999999999964221
Q ss_pred hhhHHHhcCCCC-CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 431 GQAMFKIGGGEL-PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 431 ~~~~~~i~~~~~-~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
+.....+..+.+ -+....+|+.+.+||++||+.||.+||+..+++.+
T Consensus 249 gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 249 GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 111111222221 12234589999999999999999999999999875
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=305.26 Aligned_cols=239 Identities=30% Similarity=0.507 Sum_probs=200.7
Q ss_pred eecccCceEEEEEEecC-------CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 232 LLGSGSYGFVYEGLTDD-------GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 232 ~LG~G~fg~Vy~~~~~~-------g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
.||+|+||.||+|...+ +..+++|.+.... .......+.+|+.+++.++||||+++++++...+..+++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA----TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc----chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 58999999999998642 3579999886432 123345788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhh--------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC-----cEEEeecCC
Q 011326 305 LELVTKGSLASLYQKY--------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG-----SVKLADFGL 371 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~--------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~-----~vkL~DFGl 371 (488)
|||+++++|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999988542 377888999999999999999999999999999999999877 899999999
Q ss_pred cccccCCCc----ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCC
Q 011326 372 AKATTMNDV----KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVP 446 (488)
Q Consensus 372 a~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~ 446 (488)
+........ ....++..|+|||.+ ....++.++||||||+++|+|++ |..||...+..+....+..+.....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESL--LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKP 235 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHH--ccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCc
Confidence 865433221 123456789999987 44568999999999999999998 99999887777766666655555667
Q ss_pred CcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 447 NSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 447 ~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
..++..+.+++.+||+.+|.+||++.++++
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 788999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=303.50 Aligned_cols=240 Identities=25% Similarity=0.400 Sum_probs=191.5
Q ss_pred eecccCceEEEEEEec---CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeec
Q 011326 232 LLGSGSYGFVYEGLTD---DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 232 ~LG~G~fg~Vy~~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
.||+|+||.||+|... ++..+|+|.+.... .......+.+|+.++++++||||+++++++.+....++||||+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA----SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECC
Confidence 5899999999999764 35679999876543 1233457888999999999999999999999999999999999
Q ss_pred cCCChHHHHhhh------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC---
Q 011326 309 TKGSLASLYQKY------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--- 379 (488)
Q Consensus 309 ~~gsL~~~l~~~------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--- 379 (488)
++|+|.+++... ..++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999999988643 24566778899999999999999999999999999999999999999999986543322
Q ss_pred -cccCCCCCcccCchhhcccc-----CCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCC-----CCCCC
Q 011326 380 -VKSCKGTAFWMAPEVVNLKK-----DGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGEL-----PPVPN 447 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~~-----~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~-----~~~~~ 447 (488)
.....++..|+|||++.... ..++.++|+||||+++|||++ |..||......+.......... +....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence 12345678899999974221 235789999999999999996 9999987665554333222111 12233
Q ss_pred cccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 448 SLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 448 ~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
..++.+.+++.+|| .+|++|||+++|+.
T Consensus 238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 56889999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=304.70 Aligned_cols=248 Identities=33% Similarity=0.551 Sum_probs=200.1
Q ss_pred eeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC---CCCCcceeeccccCCCc--
Q 011326 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF---EHDNIVQYLGTDRDEKR-- 300 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~~~~-- 300 (488)
|++.+.||+|+||.||+|.+. ++..+|+|.+...... ......+.+|+.++.++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE---EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc---chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence 678899999999999999986 5899999999754331 11223455677766655 69999999999988776
Q ss_pred ---eEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccc
Q 011326 301 ---LCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 374 (488)
Q Consensus 301 ---~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~ 374 (488)
.+++|||+++ +|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus 78 ~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 78 ELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred CceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 9999999986 788877553 489999999999999999999999999999999999999999999999999876
Q ss_pred ccCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC------------
Q 011326 375 TTMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE------------ 441 (488)
Q Consensus 375 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~------------ 441 (488)
..... .....++..|+|||.+ .+..++.++|+||+|+++|+|++|.+||...+..+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~--~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVL--LQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred ccCCcccccccccccccChHHh--ccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 54332 2344578889999997 34557889999999999999999999998766555443332110
Q ss_pred ------CC--------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 442 ------LP--------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 442 ------~~--------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
.+ .....+++.+.+++.+||+.||.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00 0012356788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=300.91 Aligned_cols=257 Identities=31% Similarity=0.500 Sum_probs=215.9
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDE 298 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~ 298 (488)
...+++.+.+..||.|+.|+|+++..+ +|...|||.+.... +.+..++++..+.++..-+ +|.||+.+|+|..+
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~----Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n 163 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG----NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN 163 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC----CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence 345777888899999999999999875 69999999998764 4556677888888776654 99999999999999
Q ss_pred CceEEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHH-CCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 299 KRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
....|.||.|.. .++.++.+ .+++|..+-++...++.||.||.+ +||+|||+||+|||+|..|++||||||++..+
T Consensus 164 ~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 164 TDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred chHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee
Confidence 999999999855 56666654 358999999999999999999975 58999999999999999999999999998655
Q ss_pred cCC-CcccCCCCCcccCchhhccc-cCCCChhhhHHHHHHHHHHHHcCCCCCCCCch-hhhHHHhcCCCCCCCC--Cccc
Q 011326 376 TMN-DVKSCKGTAFWMAPEVVNLK-KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG-GQAMFKIGGGELPPVP--NSLS 450 (488)
Q Consensus 376 ~~~-~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~-~~~~~~i~~~~~~~~~--~~~s 450 (488)
... ..+...|-+.|||||.+... ...|+.++||||||++++||.||..||.+.+. .+++-++.....|.++ ...|
T Consensus 243 vdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFS 322 (391)
T KOG0983|consen 243 VDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFS 322 (391)
T ss_pred ecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcC
Confidence 443 45567799999999998654 45689999999999999999999999988544 4566666665544444 3479
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 451 RDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 451 ~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
+++.+++..||++|+.+||...++|+|||++.
T Consensus 323 p~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 323 PDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred HHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 99999999999999999999999999999864
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=303.92 Aligned_cols=236 Identities=23% Similarity=0.385 Sum_probs=189.8
Q ss_pred eecccCceEEEEEEecC-------------CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 232 LLGSGSYGFVYEGLTDD-------------GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 232 ~LG~G~fg~Vy~~~~~~-------------g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
.||+|+||.||+|...+ ...+++|.+... .......+.+|+.++..++||||+++++++..+
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~ 76 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-----HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD 76 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 58999999999997531 235888886542 223345678899999999999999999999999
Q ss_pred CceEEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCc-------EEEeec
Q 011326 299 KRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS-------VKLADF 369 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~-------vkL~DF 369 (488)
...+++|||+++|+|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999999988864 34899999999999999999999999999999999999987664 899999
Q ss_pred CCcccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHH-cCCCCCCCCchhhhHHHhcCCCCCCCCCc
Q 011326 370 GLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEML-TRRHPYSHLEGGQAMFKIGGGELPPVPNS 448 (488)
Q Consensus 370 Gla~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLl-tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 448 (488)
|++..... .....++..|+|||.+. ....++.++||||||+++|||+ .|..||......+.... ..... .....
T Consensus 157 g~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-~~~~~-~~~~~ 231 (262)
T cd05077 157 GIPITVLS--RQECVERIPWIAPECVE-DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF-YEGQC-MLVTP 231 (262)
T ss_pred CCCccccC--cccccccccccChhhhc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-HhcCc-cCCCC
Confidence 98865432 23456788899999862 3456889999999999999998 58888876554433222 22222 22334
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 449 LSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 449 ~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.++++.+|+.+||+.||.+||++.+|+++
T Consensus 232 ~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 232 SCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 56789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=314.31 Aligned_cols=256 Identities=28% Similarity=0.445 Sum_probs=201.6
Q ss_pred ceeeeeeecccCceEEEEEEec-C--CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccC----
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-D--GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRD---- 297 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~--g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~---- 297 (488)
+|++.+.||+|+||.||++.+. + +..||+|.+..... .......+.+|+.+++++ +||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 77 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS---KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN 77 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc---cchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence 4788999999999999999875 4 78999999864321 122345677899999999 59999999986432
Q ss_pred CCceEEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
....++++|++. ++|.+.+.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 78 ~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 78 FNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred CCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 245788999986 488887754 468999999999999999999999999999999999999999999999999987543
Q ss_pred CCC------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhc------------
Q 011326 377 MND------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIG------------ 438 (488)
Q Consensus 377 ~~~------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~------------ 438 (488)
... .....||..|+|||.+. ....++.++|+||+|+++|+|++|.+||...+.......+.
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIML-SFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred cccccccccccCcccCccccCcHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 221 22346899999999862 33457899999999999999999999997654322211110
Q ss_pred ---C---------------CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 439 ---G---------------GELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 439 ---~---------------~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
. .........++.++.+++.+||+.||.+|||+.+++.||||++..++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~ 301 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP 301 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence 0 00011123467899999999999999999999999999999866543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=301.13 Aligned_cols=235 Identities=23% Similarity=0.390 Sum_probs=189.7
Q ss_pred eeecccCceEEEEEEecC-C----------cEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 231 ELLGSGSYGFVYEGLTDD-G----------FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~~-g----------~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
+.||+|+||.||+|.+.+ + ..+++|.+.... .....+.+|+.++++++||||+++++++.. +
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH------RDSLAFFETASLMSQLSHKHLVKLYGVCVR-D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch------hhHHHHHHHHHHHHcCCCcchhheeeEEec-C
Confidence 358999999999998863 3 257777765322 114678899999999999999999999888 7
Q ss_pred ceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC-------cEEEeecC
Q 011326 300 RLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG-------SVKLADFG 370 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~-------~vkL~DFG 370 (488)
..++||||+++|+|.+++... .+++..+..++.||+.||.|||++||+|+||||+||+++.++ .++|+|||
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 789999999999999998654 488999999999999999999999999999999999999887 79999999
Q ss_pred CcccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcc
Q 011326 371 LAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSL 449 (488)
Q Consensus 371 la~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 449 (488)
++..... .....++..|+|||.+......++.++|+||||+++|+|++ |..||...+..+.......... .+...
T Consensus 154 ~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~ 229 (259)
T cd05037 154 IPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR--LPMPD 229 (259)
T ss_pred ccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCC--CCCCC
Confidence 9876543 22345677899999974332468999999999999999999 6888876644333333222221 22223
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
...+.+++.+||..+|.+|||+.++++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 230 CAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred chHHHHHHHHHhccChhhCCCHHHHHH
Confidence 489999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=309.42 Aligned_cols=247 Identities=26% Similarity=0.484 Sum_probs=203.9
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCc----EEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGF----FFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
.++|+..+.||+|+||.||+|.+. +|. .+|+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT----GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 467888999999999999999874 444 47888875432 223344688999999999999999999998764
Q ss_pred CceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 299 KRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
..++++||+++|+|.+++... .+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++...
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 467999999999999988654 47899999999999999999999999999999999999999999999999997554
Q ss_pred CCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccH
Q 011326 377 MND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSR 451 (488)
Q Consensus 377 ~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 451 (488)
... .....++..|+|||.+ ....++.++||||||+++|||++ |..||.+....+....+..+...+.+..++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECI--HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTI 238 (303)
T ss_pred CcccccccCCCccccccCCHHHh--ccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH
Confidence 322 1223356789999987 45568999999999999999997 9999987665555555555555555667889
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.+.+++.+||..+|++||++.++++.
T Consensus 239 ~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 239 DVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=305.62 Aligned_cols=236 Identities=22% Similarity=0.350 Sum_probs=189.8
Q ss_pred eecccCceEEEEEEec-------------------------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCC
Q 011326 232 LLGSGSYGFVYEGLTD-------------------------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286 (488)
Q Consensus 232 ~LG~G~fg~Vy~~~~~-------------------------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp 286 (488)
.||+|+||.||+|... ....|++|.+... .......+.+|+.+++.++||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----~~~~~~~~~~~~~~~~~l~h~ 76 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS-----HRDIALAFFETASLMSQVSHI 76 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH-----HHHHHHHHHHHHHHHhcCCCC
Confidence 5999999999998642 1245888887532 223345678899999999999
Q ss_pred CcceeeccccCCCceEEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC--
Q 011326 287 NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG-- 362 (488)
Q Consensus 287 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~-- 362 (488)
||+++++++.+++..++||||+++|+|..++.. ..+++..+..++.|++.||+|||++||+||||||+|||++..+
T Consensus 77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999999998854 3589999999999999999999999999999999999997644
Q ss_pred -----cEEEeecCCcccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHH-cCCCCCCCCchhhhHHH
Q 011326 363 -----SVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEML-TRRHPYSHLEGGQAMFK 436 (488)
Q Consensus 363 -----~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLl-tG~~Pf~~~~~~~~~~~ 436 (488)
.++++|||.+...... ....++..|+|||.+. ....++.++|+||||+++|||+ +|..||......+....
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~-~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVP-GGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred cCccceeeecCCccccccccc--cccccCCcccCchhhc-CCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 4899999987543221 2335778899999873 3356899999999999999985 69999987655443332
Q ss_pred hcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 437 IGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 437 i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.... ...+...++++.++|.+||+.+|++|||+.+++++
T Consensus 234 ~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 234 YEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2221 23344567789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=322.12 Aligned_cols=249 Identities=29% Similarity=0.485 Sum_probs=215.1
Q ss_pred ccccCceeeeeeecccCceEEEEEEec---C--CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD---D--GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD 295 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~---~--g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 295 (488)
+.+-...+..++||+|-||.||+|... . .-.||||..+..... ...+.|++|+.+|++++||||++++|+|
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~----d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP----DDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh----hhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 334445666788999999999999752 2 345888887654432 2356899999999999999999999999
Q ss_pred cCCCceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 296 RDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 296 ~~~~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
.+. ..+||||+++-|.|..+++.+ .++...+..++.||+.||.|||+..++||||...|||+.....+||+|||+++
T Consensus 461 ~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 461 VEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred ecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhh
Confidence 875 589999999999999999765 48888999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccc---CCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcc
Q 011326 374 ATTMNDVKS---CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSL 449 (488)
Q Consensus 374 ~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 449 (488)
......... ..-..-|||||.++. ..++.++|||.||+++||++. |..||.+..+.+++..+..+.+.+.|+.|
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nC 617 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNC 617 (974)
T ss_pred hccccchhhccccccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCC
Confidence 877655321 122335999999844 559999999999999999877 99999999999999999999999999999
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
|+.++.|+.+||+++|.+||++.+|..
T Consensus 618 Pp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 618 PPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred ChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 999999999999999999999998753
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=303.54 Aligned_cols=246 Identities=30% Similarity=0.514 Sum_probs=202.0
Q ss_pred CceeeeeeecccCceEEEEEEec-----CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC--
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-----DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD-- 297 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-- 297 (488)
.+|++.+.||+|+||.||++... ++..+|+|.+...... .....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~ 79 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE----QHRSDFEREIEILRTLDHENIVKYKGVCEKPG 79 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch----HHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence 46778899999999999999753 4789999998754321 345678999999999999999999999877
Q ss_pred CCceEEEEeeccCCChHHHHhhhc--cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~~--ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
....+++|||+++++|.+++.... +++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+...
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 567999999999999999997655 999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCc-----ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhh---------------hHH
Q 011326 376 TMNDV-----KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ---------------AMF 435 (488)
Q Consensus 376 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~---------------~~~ 435 (488)
..... ....++..|++||.+ ....++.++|+||||+++|||++|..|+....... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~--~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECL--RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHH--ccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 42211 122345669999987 34568889999999999999999999986532221 122
Q ss_pred HhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 436 KIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 436 ~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
.+......+.+..++.++.+|+.+||+.+|.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22333333445678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=304.02 Aligned_cols=236 Identities=20% Similarity=0.345 Sum_probs=191.6
Q ss_pred eecccCceEEEEEEec-C-------CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 232 LLGSGSYGFVYEGLTD-D-------GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 232 ~LG~G~fg~Vy~~~~~-~-------g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
.||+|+||.||+|.+. . ...+++|.+... .......+.+|+.+++.++||||+++++++..++..++
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch-----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEE
Confidence 5899999999999864 2 234788877532 23344577889999999999999999999999899999
Q ss_pred EEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCc--------EEEeecCCcc
Q 011326 304 FLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS--------VKLADFGLAK 373 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~--------vkL~DFGla~ 373 (488)
||||+++|+|..++... .+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||.+.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999999998654 4789999999999999999999999999999999999987664 6999999886
Q ss_pred cccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcC-CCCCCCCchhhhHHHhcCCCCCCCCCcccHH
Q 011326 374 ATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRD 452 (488)
Q Consensus 374 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 452 (488)
.... .....++..|+|||.+. ....++.++|+||||+++|+|++| ..||...+......... .....+...+.+
T Consensus 157 ~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 231 (258)
T cd05078 157 TVLP--KEILLERIPWVPPECIE-NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE--DRHQLPAPKWTE 231 (258)
T ss_pred ccCC--chhccccCCccCchhcc-CCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH--ccccCCCCCcHH
Confidence 5432 23356788999999973 334578899999999999999998 46666555444333222 223456667789
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 453 AQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 453 l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
+.+|+.+||+.||++|||++++++.
T Consensus 232 ~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 232 LANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHhccChhhCCCHHHHHHh
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=300.50 Aligned_cols=246 Identities=24% Similarity=0.433 Sum_probs=201.4
Q ss_pred eeeeeeecccCceEEEEEEec----CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC---
Q 011326 227 WQKGELLGSGSYGFVYEGLTD----DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK--- 299 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--- 299 (488)
|.+.+.||+|+||.||+|.+. ++..+|+|.+.... .......++.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI---FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG 77 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc---CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence 567788999999999999753 47899999986543 22334567889999999999999999999875432
Q ss_pred ---ceEEEEeeccCCChHHHHhhh-------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeec
Q 011326 300 ---RLCIFLELVTKGSLASLYQKY-------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADF 369 (488)
Q Consensus 300 ---~~~lV~E~~~~gsL~~~l~~~-------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DF 369 (488)
..++++||+++|+|..++... .+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+||
T Consensus 78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcc
Confidence 347899999999998876422 3688889999999999999999999999999999999999999999999
Q ss_pred CCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCC
Q 011326 370 GLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPP 444 (488)
Q Consensus 370 Gla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~ 444 (488)
|.++...... .....+++.|++||.+ ....++.++||||||+++|+|++ |.+||...+..+....+.......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~--~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESL--ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHH--hcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 9987553322 1223356779999986 45567889999999999999999 899998777666666555554445
Q ss_pred CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 445 VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 445 ~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.+...+..+.+++.+||+.+|++|||+.+++.+
T Consensus 236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 556788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=326.28 Aligned_cols=253 Identities=30% Similarity=0.463 Sum_probs=220.8
Q ss_pred cCceeeeeeecccCceEEEEEEec--CC--cEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD--DG--FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~--~g--~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
.++....++||+|+||+|++|.|. +| ..||||.+...... ....+|++|+.+|.+|+|||+++|||+..+ .
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~----~~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN----AIMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc----hhHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 445667788999999999999984 34 46899999865432 266899999999999999999999999887 6
Q ss_pred ceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 300 RLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
...+|||+++.|+|.+.+++. .|....+..++.||+.||.||..+++|||||...|+|+-....+||+|||+.+.+.
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 789999999999999988762 37788899999999999999999999999999999999999999999999998877
Q ss_pred CCCcccC-----CCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCccc
Q 011326 377 MNDVKSC-----KGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLS 450 (488)
Q Consensus 377 ~~~~~~~-----~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s 450 (488)
.++.... .-...|+|||.+ ....++.++|+|++|++||||++ |+.||.+.....++..+..+.+.+.|+.|+
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsL--rh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~cs 341 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESL--RHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCS 341 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHh--ccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCCh
Confidence 6543222 234459999997 55669999999999999999999 899999999999999999999889999999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 451 RDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 451 ~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
++++++++.||..+|.+||||..|.+.-+.+++
T Consensus 342 edIY~imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 342 EDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred HHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence 999999999999999999999999766555443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=325.90 Aligned_cols=247 Identities=30% Similarity=0.412 Sum_probs=208.3
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHh-cCCCCCcceeeccccCCCc
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLG-QFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~-~l~HpnIv~l~~~~~~~~~ 300 (488)
...+|++...+|.|+|+.|-.+... +++..++|++..... +..+|+.++. .-+||||+++.+++.++..
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---------DNQDEIPISLLVRDHPNIVKSHDVYEDGKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc---------ccccccchhhhhcCCCcceeecceecCCce
Confidence 4678999999999999999999875 789999999986521 1224554444 4479999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEE-CCCCcEEEeecCCcccccCCC
Q 011326 301 LCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILV-DASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl-~~~~~vkL~DFGla~~~~~~~ 379 (488)
.|+|||.+.|+.|.+.+...+.....+..|+.+|+.|+.|||++|++||||||+|||+ +..++++|+|||.++.....
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999999999988776665554447888999999999999999999999999999999 69999999999999776644
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh-hhHHHhcCCCCCCCCCcccHHHHHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-QAMFKIGGGELPPVPNSLSRDAQDFIL 458 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~l~~Li~ 458 (488)
....+-|..|.|||+. ...+|++++|+||||++||+||+|..||...... +....+..+ .+...+|+++++|+.
T Consensus 470 ~~tp~~t~~y~APEvl--~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~---~~s~~vS~~AKdLl~ 544 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVL--AIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP---KFSECVSDEAKDLLQ 544 (612)
T ss_pred hcccchhhcccChhhh--ccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC---ccccccCHHHHHHHH
Confidence 3445678889999997 4778999999999999999999999999877666 444444433 344789999999999
Q ss_pred HhhhhCCCCCCCHHHHHhCccC-CCCC
Q 011326 459 KCLQVNPNDRPTAAQLMEHPFI-KRPL 484 (488)
Q Consensus 459 ~cL~~dP~~Rps~~eil~hp~f-~~~~ 484 (488)
+||+.||.+||++.++..|||| ..+.
T Consensus 545 ~LL~~dP~~Rl~~~~i~~h~w~~~~~t 571 (612)
T KOG0603|consen 545 QLLQVDPALRLGADEIGAHPWFLSHPT 571 (612)
T ss_pred HhccCChhhCcChhhhccCcchhcCCC
Confidence 9999999999999999999999 4443
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=299.09 Aligned_cols=240 Identities=21% Similarity=0.331 Sum_probs=190.0
Q ss_pred eecccCceEEEEEEecCC---cEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeec
Q 011326 232 LLGSGSYGFVYEGLTDDG---FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 232 ~LG~G~fg~Vy~~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
.||+|+||.||++...++ ..+++|.+.... .......+.+|+.+++.++||||+++++.+.+....++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA----SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC 77 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC----ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence 599999999999976433 345666654322 2234567889999999999999999999999999999999999
Q ss_pred cCCChHHHHhhh-----ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC----C
Q 011326 309 TKGSLASLYQKY-----HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----D 379 (488)
Q Consensus 309 ~~gsL~~~l~~~-----~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~----~ 379 (488)
++|+|.+++.+. ..++..+..++.||+.||.|||+.+++|+||||+|||++.++.++|+|||++...... .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999999988653 2556677899999999999999999999999999999999999999999987543221 1
Q ss_pred cccCCCCCcccCchhhccc-----cCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCC-----CCCCCCc
Q 011326 380 VKSCKGTAFWMAPEVVNLK-----KDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGE-----LPPVPNS 448 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~-----~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~-----~~~~~~~ 448 (488)
.....++..|+|||++... ...++.++||||||+++|||++ |..||...+..+....+.... .+..+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP 237 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence 2244578899999987321 2235789999999999999997 677887766655555433222 1334456
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 449 LSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 449 ~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+++.+.+++..|| .+|++||+++++++
T Consensus 238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 238 YSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 7899999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=333.86 Aligned_cols=148 Identities=28% Similarity=0.470 Sum_probs=133.5
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
+.+|++.+.||+|+||.||+|.+. ++..||+|++..... ........+.+|+.++..++||||+++++++...+.+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM--INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc--cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence 578999999999999999999986 789999999975433 22344567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 303 IFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
+||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999998654 47899999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=294.46 Aligned_cols=227 Identities=24% Similarity=0.327 Sum_probs=187.4
Q ss_pred cCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeeccCCChH
Q 011326 236 GSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLA 314 (488)
Q Consensus 236 G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 314 (488)
|.+|.||++.+. +++.+|+|.+..... +.+|...+....||||+++++++.+.+..+++|||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence 899999999985 789999999975421 223444455567999999999999999999999999999999
Q ss_pred HHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCcccCCCCCcccCch
Q 011326 315 SLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPE 393 (488)
Q Consensus 315 ~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE 393 (488)
+++... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++++|||.+...... .....++..|+|||
T Consensus 74 ~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~y~aPE 152 (237)
T cd05576 74 SHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-CDGEAVENMYCAPE 152 (237)
T ss_pred HHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-cccCCcCccccCCc
Confidence 887544 6899999999999999999999999999999999999999999999999987654432 23345677899999
Q ss_pred hhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCH--
Q 011326 394 VVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTA-- 471 (488)
Q Consensus 394 ~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~-- 471 (488)
.+ ....++.++|+||+|+++|||++|..|+...... +........+..++++++++|.+||+.||.+||++
T Consensus 153 ~~--~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 153 VG--GISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred cc--CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 86 4455788999999999999999999887643221 11111123556789999999999999999999985
Q ss_pred ---HHHHhCccC
Q 011326 472 ---AQLMEHPFI 480 (488)
Q Consensus 472 ---~eil~hp~f 480 (488)
+++++||||
T Consensus 226 ~~~~~~~~h~~~ 237 (237)
T cd05576 226 AGVEDIKSHPFF 237 (237)
T ss_pred cchHHHHcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=297.81 Aligned_cols=247 Identities=19% Similarity=0.332 Sum_probs=185.4
Q ss_pred CceeeeeeecccCceEEEEEEecC----CcEEEEEEeecCCCCCcchhH------HHHHHHHHHHHhcCCCCCcceeecc
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTDD----GFFFAVKEVSLQDEGPRGKQS------ILQLEQEISLLGQFEHDNIVQYLGT 294 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~i~~~~~~~~~~~~------~~~~~~Ei~iL~~l~HpnIv~l~~~ 294 (488)
.+|++.+.||+|+||.||+|.+.+ +..+|+|...........+.. ......+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 579999999999999999998753 456777764433221111100 0112234445667789999999987
Q ss_pred ccCCC----ceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeec
Q 011326 295 DRDEK----RLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADF 369 (488)
Q Consensus 295 ~~~~~----~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DF 369 (488)
+.... ..++++|++.. ++.+.+... ..++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 65543 34678887754 666666544 3688889999999999999999999999999999999999999999999
Q ss_pred CCcccccCC---------CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh-hh------
Q 011326 370 GLAKATTMN---------DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-QA------ 433 (488)
Q Consensus 370 Gla~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~-~~------ 433 (488)
|+++..... ......||+.|+|||++ .+..++.++|||||||++|||++|..||...... +.
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~--~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAH--NGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHh--CCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 998754321 11234699999999987 4566899999999999999999999999876332 21
Q ss_pred --HHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 434 --MFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 434 --~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
...+..+.. ....+++++.+++..||+.+|++||+++++++
T Consensus 249 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 249 DFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 122222221 23456899999999999999999999999875
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=314.60 Aligned_cols=247 Identities=28% Similarity=0.438 Sum_probs=211.5
Q ss_pred cCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
-+...+++.||+|.||.|.+|....+..||+|.++... ......+|.+|+++|.+++||||++++++|..++.+++
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a----~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA----TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCccc----chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 34567889999999999999999889999999998654 33446789999999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhhcc---ChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCc
Q 011326 304 FLELVTKGSLASLYQKYHL---SDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV 380 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~~l---s~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 380 (488)
++|||++|+|.+++.++.. .......|+.||++||+||.+.+++||||.+.|+|++.++++||+|||+++.+-..+.
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 9999999999999987632 4456677999999999999999999999999999999999999999999986655543
Q ss_pred cc----CCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc--CCCCCCCCchhhhHHHhcCC-------CCCCCCC
Q 011326 381 KS----CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT--RRHPYSHLEGGQAMFKIGGG-------ELPPVPN 447 (488)
Q Consensus 381 ~~----~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt--G~~Pf~~~~~~~~~~~i~~~-------~~~~~~~ 447 (488)
.. .+-..+|||||.+ ..+.++.++|+|+||+++||+++ ...||....+++.......- .....|.
T Consensus 693 y~vqgr~vlpiRwmawEsi--llgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~ 770 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESI--LLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPP 770 (807)
T ss_pred eeeecceeeeeeehhHHHH--HhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCC
Confidence 32 2345679999998 44569999999999999999765 88999998888776654321 2245677
Q ss_pred cccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 448 SLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 448 ~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
-++.++.+++.+||..|-++||+++++..
T Consensus 771 ~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 771 ACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred cCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 89999999999999999999999999854
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=295.62 Aligned_cols=256 Identities=29% Similarity=0.482 Sum_probs=203.8
Q ss_pred ccCceeeeeeecccCceEEEEEEec---C--CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD---D--GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~---~--g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
.+..|+..+.||+|.||.||+|... + ...+|+|.+.-......-. ...-+|+.+++.++|||++.+..++.+
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS---~SAcREiaL~REl~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS---MSACREIALLRELKHPNVISLVKVFLS 98 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC---HHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence 4668999999999999999999653 2 3378999997654432222 234589999999999999999999877
Q ss_pred -CCceEEEEeeccCCChHHHHhhh------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC----CcEEE
Q 011326 298 -EKRLCIFLELVTKGSLASLYQKY------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS----GSVKL 366 (488)
Q Consensus 298 -~~~~~lV~E~~~~gsL~~~l~~~------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~----~~vkL 366 (488)
+..+++++||.+. +|.++|+-. .++...+..|+.||+.|+.|||++-|+||||||.|||+..+ |.+||
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEe
Confidence 8899999999998 888888432 48899999999999999999999999999999999999877 89999
Q ss_pred eecCCcccccCC-----CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh---------h
Q 011326 367 ADFGLAKATTMN-----DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG---------Q 432 (488)
Q Consensus 367 ~DFGla~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~---------~ 432 (488)
+|||+++..... .....+-|.+|+|||.+ ++...||.+.|||++||++.||++-++.|.+.+.. +
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELL-LGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELL-LGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHh-cccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 999999866533 23456688999999998 67788999999999999999999998888653321 1
Q ss_pred hHH---HhcC----CCC------CCC------------C-----------CcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 433 AMF---KIGG----GEL------PPV------------P-----------NSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 433 ~~~---~i~~----~~~------~~~------------~-----------~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
.+. .+.. ..+ |.. . ..-++...+|+.+||+.||.+|.|+++.++
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 111 1110 000 000 0 112445789999999999999999999999
Q ss_pred CccCCCC
Q 011326 477 HPFIKRP 483 (488)
Q Consensus 477 hp~f~~~ 483 (488)
|+||.+-
T Consensus 337 h~yF~~d 343 (438)
T KOG0666|consen 337 HPYFTED 343 (438)
T ss_pred ccccccC
Confidence 9999875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=313.97 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=226.1
Q ss_pred ccCceeeeeeecccCceEEEEEEecCC-cEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTDDG-FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g-~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
.+++++++..||-||||.|-++..+.. ..+|+|.+++.-... ....+.+..|-++|...+.|.||++|..|.++..+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd--tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD--TKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc--hhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 467788888999999999998876543 358999987655432 33345677899999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND- 379 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~- 379 (488)
|++||-|-||.|..+++.. .+++..+..++.-+++|++|||++|||+|||||+|.+++.+|.+||.|||+|+....+.
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 9999999999999998765 59999999999999999999999999999999999999999999999999999877664
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC-CCCCCCcccHHHHHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE-LPPVPNSLSRDAQDFIL 458 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~s~~l~~Li~ 458 (488)
..+.+|||.|.|||++ ...+.+.++|.||||+++|||++|.+||.+.++-.++..|..+- ...+|..++....+||+
T Consensus 576 TwTFcGTpEYVAPEII--LnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik 653 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEII--LNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIK 653 (732)
T ss_pred eeeecCCcccccchhh--hccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHH
Confidence 5578999999999998 55668999999999999999999999999999988888877653 34678899999999999
Q ss_pred HhhhhCCCCCCC-----HHHHHhCccCCC
Q 011326 459 KCLQVNPNDRPT-----AAQLMEHPFIKR 482 (488)
Q Consensus 459 ~cL~~dP~~Rps-----~~eil~hp~f~~ 482 (488)
++...+|.+|.. ..+|.+|.||..
T Consensus 654 ~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 654 KLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred HHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 999999999976 899999999953
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=292.70 Aligned_cols=260 Identities=29% Similarity=0.445 Sum_probs=215.4
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhc-CCCCCcceeeccccCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQ-FEHDNIVQYLGTDRDE 298 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~~ 298 (488)
.....+.+-+..||.|+||+|++...+ +|+..|||.++.... ....++++.|.+...+ -++||||+++|.+-.+
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~----~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E 135 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI----EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE 135 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc----hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence 334455666788999999999998875 799999999987653 3445677788777554 5799999999999999
Q ss_pred CceEEEEeeccCCChHHHH------hhhccChhhhhHHHHHHHHHHHHHHH-CCCccccCCcccEEECCCCcEEEeecCC
Q 011326 299 KRLCIFLELVTKGSLASLY------QKYHLSDSQVSSYTRQILNGLKYLHE-QNVVHRDIKCANILVDASGSVKLADFGL 371 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l------~~~~ls~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~NILl~~~~~vkL~DFGl 371 (488)
+-.+|-||+|.- ||+.+. .+..++|..+-.|....+.||.||.+ .+|||||+||+|||++..|.+||||||+
T Consensus 136 GdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGI 214 (361)
T KOG1006|consen 136 GDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGI 214 (361)
T ss_pred CceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccc
Confidence 999999999976 777654 34469999999999999999999975 5899999999999999999999999999
Q ss_pred cccccCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCch-hhhHHHhcCCCCCCCC---
Q 011326 372 AKATTMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG-GQAMFKIGGGELPPVP--- 446 (488)
Q Consensus 372 a~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~-~~~~~~i~~~~~~~~~--- 446 (488)
+..+..+- .+...|-..|||||.+.....+|+.++|+||||++|||+.||+.|+...++ .+.+..+..+..|.+.
T Consensus 215 cGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~ 294 (361)
T KOG1006|consen 215 CGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDK 294 (361)
T ss_pred hHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcc
Confidence 86554332 344568888999999987777899999999999999999999999987654 3555566666654432
Q ss_pred --CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 447 --NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 447 --~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
...+..+..+|..||.+|-..||++.+++++||++--.+
T Consensus 295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 237889999999999999999999999999999976544
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=291.54 Aligned_cols=256 Identities=29% Similarity=0.518 Sum_probs=209.5
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC---
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE--- 298 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--- 298 (488)
..+.|+...+||+|.||.||+|+.+ +|+.||+|.+....+..... ....+|+.+|..++|+|++.+++.|...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfp---italreikiL~~lkHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFP---ITALREIKILQLLKHENVVNLIEICRTKATP 91 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCc---HHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence 4567888889999999999999875 68889999887655443333 2446899999999999999999987542
Q ss_pred -----CceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCC
Q 011326 299 -----KRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGL 371 (488)
Q Consensus 299 -----~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGl 371 (488)
..+|+||.+|+. +|.-++... +++..++..++.++..||.|+|++.|+|||+||.|+||+.+|.++|+|||+
T Consensus 92 ~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred cccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccc
Confidence 358999999988 888888654 599999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC------
Q 011326 372 AKATTMND------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG------ 439 (488)
Q Consensus 372 a~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~------ 439 (488)
++...... .++.+-|..|++||.+ ++...|+++.|||+-||++.||+++.+-+.+......+..|..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEll-LG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELL-LGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHh-hcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 97654432 3345569999999998 6778899999999999999999999988887666555444321
Q ss_pred ---------------CCCCCCCC-------------cccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 440 ---------------GELPPVPN-------------SLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 440 ---------------~~~~~~~~-------------~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
...++++. .-+++..+|+..+|..||.+|++++++++|.||.+-
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 01111221 124578899999999999999999999999999653
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=270.23 Aligned_cols=253 Identities=29% Similarity=0.503 Sum_probs=209.3
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
.|...+.||+|.||+||+|++. +++.||+|.+...+...... ....+|+.+|+.++|.|||+++++...+..+.+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvp---ssalreicllkelkhknivrl~dvlhsdkkltlv 79 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCc---HHHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence 4566678999999999999875 78999999998876543333 3457899999999999999999999999999999
Q ss_pred EeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--c
Q 011326 305 LELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--V 380 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~ 380 (488)
+|||.. .|..+... ..++.+.+..++.|+++||.++|++++.||||||.|.||+.+|.+|++|||+++.....- .
T Consensus 80 fe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 80 FEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence 999977 77776643 348899999999999999999999999999999999999999999999999998665432 3
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcC-------CCCC---------
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGG-------GELP--------- 443 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~-------~~~~--------- 443 (488)
....-|.+|++|.++ .+..-|+.+.|+||-||++.|+.. |++.|.+.+-.+....|-. ..+|
T Consensus 159 saevvtlwyrppdvl-fgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVL-FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eceeeeeeccCccee-eeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 456689999999997 455668999999999999999998 7777888776665554421 1111
Q ss_pred ---CCC---------CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 444 ---PVP---------NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 444 ---~~~---------~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
.++ +.++..-++|+.++|.-+|.+|.++++.++||||..-
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 111 2345567899999999999999999999999999764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=279.29 Aligned_cols=238 Identities=37% Similarity=0.595 Sum_probs=202.9
Q ss_pred CceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeeccCCChHH
Q 011326 237 SYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLAS 315 (488)
Q Consensus 237 ~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 315 (488)
+||.||+|... +|..+++|.+....... ....+.+|+..+++++|+||+++++++......++++|++++++|..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK----KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc----HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence 68999999986 58999999987544321 15688899999999999999999999999999999999999999999
Q ss_pred HHhhhc-cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC-CcccCCCCCcccCch
Q 011326 316 LYQKYH-LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DVKSCKGTAFWMAPE 393 (488)
Q Consensus 316 ~l~~~~-ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~gt~~y~aPE 393 (488)
++.... +++..++.++.+++.++.+||+.|++|+||+|.||+++.++.++|+|||.+...... ......++..|++||
T Consensus 77 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE 156 (244)
T smart00220 77 LLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE 156 (244)
T ss_pred HHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHH
Confidence 987655 899999999999999999999999999999999999999999999999998766544 344566888999999
Q ss_pred hhccccCCCChhhhHHHHHHHHHHHHcCCCCCCC-CchhhhHHHhcCCCCCCCCCc--ccHHHHHHHHHhhhhCCCCCCC
Q 011326 394 VVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSH-LEGGQAMFKIGGGELPPVPNS--LSRDAQDFILKCLQVNPNDRPT 470 (488)
Q Consensus 394 ~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~--~s~~l~~Li~~cL~~dP~~Rps 470 (488)
.+ ....++.++|+|++|+++++|++|..||.. .+.......+........... ++.++.+++.+||..+|++||+
T Consensus 157 ~~--~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 157 VL--LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HH--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 87 345678899999999999999999999987 444444444444433332222 8899999999999999999999
Q ss_pred HHHHHhCccC
Q 011326 471 AAQLMEHPFI 480 (488)
Q Consensus 471 ~~eil~hp~f 480 (488)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=300.45 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=204.5
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCC--C----Ccceeecccc
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH--D----NIVQYLGTDR 296 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H--p----nIv~l~~~~~ 296 (488)
.++|++...+|+|.||.|-.+.+. ++..||+|+++. -....+..+-|+++|.++.+ | -+|++.+||.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~------V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN------VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH------HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 568999999999999999999885 589999999863 33344566779999999942 2 3788999999
Q ss_pred CCCceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC-------------
Q 011326 297 DEKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA------------- 360 (488)
Q Consensus 297 ~~~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~------------- 360 (488)
..++.|||+|.+ |.|+.+++.++ +++...+..++.|+++++++||+.+++|-||||+|||+.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence 999999999998 44899999876 4899999999999999999999999999999999999932
Q ss_pred -------CCcEEEeecCCcccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhh
Q 011326 361 -------SGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQA 433 (488)
Q Consensus 361 -------~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~ 433 (488)
+..++|+|||.|.... ......+.|..|+|||++ .+-+++..+||||+||+|.|+.+|...|.+.++.+.
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~-e~hs~iVsTRHYRAPEVi--LgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDH-EHHSTIVSTRHYRAPEVI--LGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred ceeccCCCcceEEEecCCcceec-cCcceeeeccccCCchhe--eccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 2258999999986544 334677899999999998 667799999999999999999999999988876663
Q ss_pred H---HHhcCCCCCC------------------CC-------------------------CcccHHHHHHHHHhhhhCCCC
Q 011326 434 M---FKIGGGELPP------------------VP-------------------------NSLSRDAQDFILKCLQVNPND 467 (488)
Q Consensus 434 ~---~~i~~~~~~~------------------~~-------------------------~~~s~~l~~Li~~cL~~dP~~ 467 (488)
+ ..+.. ..|. .+ ...-.++.+|+.+||..||.+
T Consensus 318 LaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 318 LAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 2 22221 1110 00 001125779999999999999
Q ss_pred CCCHHHHHhCccCCCCCC
Q 011326 468 RPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 468 Rps~~eil~hp~f~~~~~ 485 (488)
|+|+.|++.||||+...+
T Consensus 397 RiTl~EAL~HpFF~~~~~ 414 (415)
T KOG0671|consen 397 RITLREALSHPFFARLTP 414 (415)
T ss_pred cccHHHHhcCHHhhcCCC
Confidence 999999999999987654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=307.23 Aligned_cols=254 Identities=27% Similarity=0.449 Sum_probs=208.3
Q ss_pred cCceeeeeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
..-|..++.||-|+||.|.++.. ++...||+|.+.+.+--. .......+.|-.||..-+.+=||+|+..|++.+.+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~--rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM--RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHh--hhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 45689999999999999999865 467889999998765432 333456778999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhhc-cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc------
Q 011326 303 IFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT------ 375 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~~-ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~------ 375 (488)
+||+|++||++..+|-+.+ |.|..+..++.++..|+++.|..|+|||||||+|||||.+|++||+|||++.-.
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999999999988775554 888889999999999999999999999999999999999999999999997411
Q ss_pred ---cCCC-----------------------------------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHH
Q 011326 376 ---TMND-----------------------------------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLE 417 (488)
Q Consensus 376 ---~~~~-----------------------------------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~e 417 (488)
..++ ....+||+.|+|||++ ...+++..+|+||.|++|||
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl--~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVL--ARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHh--cccCccccchhhHhhHHHHH
Confidence 1000 0134599999999997 56679999999999999999
Q ss_pred HHcCCCCCCCCchhhhHHHhc---CCCCCCCCCcccHHHHHHHHHhhhhCCCCCCC---HHHHHhCccCCC
Q 011326 418 MLTRRHPYSHLEGGQAMFKIG---GGELPPVPNSLSRDAQDFILKCLQVNPNDRPT---AAQLMEHPFIKR 482 (488)
Q Consensus 418 LltG~~Pf~~~~~~~~~~~i~---~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps---~~eil~hp~f~~ 482 (488)
|+.|+.||-.....++..++. .....+...+++.++.+||.++.. +++.|.. .+||..||||+.
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence 999999997766665544332 111223456799999999988664 4677754 778999999985
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=289.01 Aligned_cols=259 Identities=25% Similarity=0.433 Sum_probs=217.0
Q ss_pred cccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccC
Q 011326 220 FRRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRD 297 (488)
Q Consensus 220 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~ 297 (488)
+.-.+++|.++++||+|+|+.|..++.. +.+.+|+|++++...... +.+.-...|-.+..+- +||.+|-++.+|++
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndd--edidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDD--EDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCc--ccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 3445789999999999999999999875 789999999987654322 2333445565565554 79999999999999
Q ss_pred CCceEEEEeeccCCChHHHHh-hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQ-KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~-~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
+.++++|.||++||+|.-.++ +..++++.+..+...|+.||.|||+.|||+||||.+|+|+|..|++||+|+|+.+..-
T Consensus 323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999999999976664 4579999999999999999999999999999999999999999999999999987432
Q ss_pred -CC-CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCC-------CchhhhHHHhcCCCCCCCCC
Q 011326 377 -MN-DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSH-------LEGGQAMFKIGGGELPPVPN 447 (488)
Q Consensus 377 -~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~-------~~~~~~~~~i~~~~~~~~~~ 447 (488)
.. ...+.+|||.|.|||++ .+..|+.++|+|+||++++||+.|+.||+- .+.++.+.++.-.....+|.
T Consensus 403 ~~gd~tstfcgtpnyiapeil--rgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr 480 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEIL--RGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR 480 (593)
T ss_pred CCCcccccccCCCcccchhhh--cccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc
Confidence 22 35578999999999997 667799999999999999999999999952 23334444444444557888
Q ss_pred cccHHHHHHHHHhhhhCCCCCC------CHHHHHhCccCCC
Q 011326 448 SLSRDAQDFILKCLQVNPNDRP------TAAQLMEHPFIKR 482 (488)
Q Consensus 448 ~~s~~l~~Li~~cL~~dP~~Rp------s~~eil~hp~f~~ 482 (488)
.+|-.+..+++..|++||.+|. .+.++..|+||+.
T Consensus 481 slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 481 SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 8999999999999999999994 4899999999973
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.40 Aligned_cols=240 Identities=30% Similarity=0.520 Sum_probs=192.5
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC----
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK---- 299 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~---- 299 (488)
.-|...+.||+|+||.||+|+++ +|+.||||.+..... ....+..-+|+++|++++|||||+++++-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~----~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS----LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcc----cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 34666788999999999999964 899999999976542 223456678999999999999999999866543
Q ss_pred --ceEEEEeeccCCChHHHHhh----hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEEC--CCC--cEEEeec
Q 011326 300 --RLCIFLELVTKGSLASLYQK----YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVD--ASG--SVKLADF 369 (488)
Q Consensus 300 --~~~lV~E~~~~gsL~~~l~~----~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~--~~~--~vkL~DF 369 (488)
...+|||||.||+|...++. .++++.+++.++..++.||.|||++||+||||||.||++- .+| ..||+||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 56899999999999999954 4799999999999999999999999999999999999984 344 4799999
Q ss_pred CCcccccCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh----hhHHHhcCCCC--
Q 011326 370 GLAKATTMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG----QAMFKIGGGEL-- 442 (488)
Q Consensus 370 Gla~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~----~~~~~i~~~~~-- 442 (488)
|.|+.++.+. ..+..||+.|.+||.+. ....|+..+|.|||||++|+.+||..||...... +....+.....
T Consensus 169 G~Arel~d~s~~~S~vGT~~YLhPel~E-~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 169 GAARELDDNSLFTSLVGTEEYLHPELYE-RQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccccCCCCCeeeeecCchhhcChHHHh-hccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 9999887664 56788999999999983 2567899999999999999999999999543222 23333222111
Q ss_pred ------------------CCCCCcccHH----HHHHHHHhhhhCCCCCC
Q 011326 443 ------------------PPVPNSLSRD----AQDFILKCLQVNPNDRP 469 (488)
Q Consensus 443 ------------------~~~~~~~s~~----l~~Li~~cL~~dP~~Rp 469 (488)
-+.|..++.. +-.++..+|..+|.+|.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1234444443 44678889999999998
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=310.98 Aligned_cols=252 Identities=21% Similarity=0.265 Sum_probs=174.9
Q ss_pred cccCceeeeeeecccCceEEEEEEec-C----CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecc--
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-D----GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGT-- 294 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~----g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~-- 294 (488)
...++|++.+.||+|+||.||+|.+. + +..||+|.+..... . .....+ .+....+.++..+...
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~---e~~~~e--~l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----V---EIWMNE--RVRRACPNSCADFVYGFL 199 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----h---HHHHHH--HHHhhchhhHHHHHHhhh
Confidence 35678999999999999999999885 5 78999998753221 0 111111 1222223333322221
Q ss_pred ----ccCCCceEEEEeeccCCChHHHHhhhcc---------------------ChhhhhHHHHHHHHHHHHHHHCCCccc
Q 011326 295 ----DRDEKRLCIFLELVTKGSLASLYQKYHL---------------------SDSQVSSYTRQILNGLKYLHEQNVVHR 349 (488)
Q Consensus 295 ----~~~~~~~~lV~E~~~~gsL~~~l~~~~l---------------------s~~~~~~i~~qi~~aL~yLH~~giiHr 349 (488)
+..+...++||||+++++|.+++....+ .+..+..++.||+.||.|||++||+||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 2456789999999999999998864321 123466799999999999999999999
Q ss_pred cCCcccEEECC-CCcEEEeecCCcccccCC---CcccCCCCCcccCchhhccccC--------------------CCChh
Q 011326 350 DIKCANILVDA-SGSVKLADFGLAKATTMN---DVKSCKGTAFWMAPEVVNLKKD--------------------GYGLT 405 (488)
Q Consensus 350 DLkp~NILl~~-~~~vkL~DFGla~~~~~~---~~~~~~gt~~y~aPE~~~~~~~--------------------~~s~k 405 (488)
||||+|||++. ++.+||+|||+++..... ......+|+.|+|||.+..... .++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999985 689999999999754322 2345678999999997522211 23456
Q ss_pred hhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC----------CC----------CCCcccHHHHHHHHHhhhhCC
Q 011326 406 ADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL----------PP----------VPNSLSRDAQDFILKCLQVNP 465 (488)
Q Consensus 406 ~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~----------~~----------~~~~~s~~l~~Li~~cL~~dP 465 (488)
+||||+||+||||+++..|+.... ......+..... +. .....+....+||.+||++||
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 799999999999999776643211 010000100000 00 001123345689999999999
Q ss_pred CCCCCHHHHHhCccCCCC
Q 011326 466 NDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 466 ~~Rps~~eil~hp~f~~~ 483 (488)
.+|||+.|+++||||+..
T Consensus 439 ~kR~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 439 RQRISAKAALAHPYFDRE 456 (566)
T ss_pred ccCCCHHHHhCCcCcCCC
Confidence 999999999999999864
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=312.72 Aligned_cols=252 Identities=29% Similarity=0.489 Sum_probs=217.8
Q ss_pred ccccccCceeeeeeecccCceEEEEEEec----C----CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcc
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLTD----D----GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIV 289 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~----~----g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv 289 (488)
.|+..-++.++.+.||+|.||.|++|... . ...||||....... ....+.+..|+++|..+ +|+||+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~----~~~~~~~~~El~~m~~~g~H~niv 365 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS----SSEKKDLMSELNVLKELGKHPNIV 365 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC----cHHHHHHHHHHHHHHHhcCCcchh
Confidence 56666677778889999999999998742 1 45799999875432 24567889999999998 599999
Q ss_pred eeeccccCCCceEEEEeeccCCChHHHHhhhc-----------------cChhhhhHHHHHHHHHHHHHHHCCCccccCC
Q 011326 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-----------------LSDSQVSSYTRQILNGLKYLHEQNVVHRDIK 352 (488)
Q Consensus 290 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------ls~~~~~~i~~qi~~aL~yLH~~giiHrDLk 352 (488)
.++|+|...+..++|+||+..|+|.++++..+ ++...++.++.||+.||+||++.+++||||.
T Consensus 366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLA 445 (609)
T KOG0200|consen 366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLA 445 (609)
T ss_pred hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhh
Confidence 99999999999999999999999999998777 8889999999999999999999999999999
Q ss_pred cccEEECCCCcEEEeecCCcccccCCCccc---CCC--CCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCC
Q 011326 353 CANILVDASGSVKLADFGLAKATTMNDVKS---CKG--TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYS 426 (488)
Q Consensus 353 p~NILl~~~~~vkL~DFGla~~~~~~~~~~---~~g--t~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~ 426 (488)
..|||++.+..+||+|||+++......... ..| ...|||||.+ ....++.++||||+|++|||+++ |..||.
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl--~~~~ft~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESL--FDRVFTSKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHh--ccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence 999999999999999999998655444322 222 2349999997 44679999999999999999999 999998
Q ss_pred CCc-hhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 427 HLE-GGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 427 ~~~-~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+.. ..+....+..+.+...|..++++++++++.||+.+|++||++.++.+
T Consensus 524 ~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 524 GIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 865 56666778889999999999999999999999999999999999874
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=303.25 Aligned_cols=243 Identities=29% Similarity=0.498 Sum_probs=211.5
Q ss_pred eeeeeeecccCceEEEEEEe-cC----CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 227 WQKGELLGSGSYGFVYEGLT-DD----GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~-~~----g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
....++||+|+||+||+|.+ .. ..+||+|++.... ..+.-.++++|+-+|.+++|||+++|+++|.... +
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t----~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT----SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC----CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 45568899999999999987 22 4578999886443 2333467889999999999999999999999876 8
Q ss_pred EEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 302 CIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
.||++|+++|+|.++++.. .+-....+.|..||++||.|||+++++||||...|||+.....+||.|||+++.+....
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 8999999999999998654 48888999999999999999999999999999999999999999999999998776543
Q ss_pred cc----cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHH
Q 011326 380 VK----SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQ 454 (488)
Q Consensus 380 ~~----~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~ 454 (488)
.. ...-..-|+|-|.+ ....++.++|||||||++||++| |..|+.+....++...+..+.+.+.|+.++-++.
T Consensus 853 ~ey~~~~gK~pikwmale~i--~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy 930 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESI--RIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVY 930 (1177)
T ss_pred ccccccccccCcHHHHHHHh--hccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHH
Confidence 21 12234459999987 56679999999999999999999 9999999999999999999999899999999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHh
Q 011326 455 DFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~ 476 (488)
-++.+||..|+..||+++++..
T Consensus 931 ~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 931 MVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHhccCcccCccHHHHHH
Confidence 9999999999999999998763
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=305.20 Aligned_cols=253 Identities=32% Similarity=0.589 Sum_probs=219.2
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeecccc-----
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDR----- 296 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~----- 296 (488)
...|++.++||.|.+|.||++... +++.+|+|+....... .++++.|.++|+.. +|||++.+++++.
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~------deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE------EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc------cHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 456889999999999999999874 7999999998764432 24567788899887 6999999999874
Q ss_pred CCCceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 297 DEKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 297 ~~~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
.+++++||||||.|||..+++++. ++.|+.+..|++.++.|+.+||++.++|||||-.|||++.++.|||+|||.+.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 467899999999999999998654 59999999999999999999999999999999999999999999999999987
Q ss_pred cccCC--CcccCCCCCcccCchhhcc---ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCC--C
Q 011326 374 ATTMN--DVKSCKGTAFWMAPEVVNL---KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV--P 446 (488)
Q Consensus 374 ~~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~--~ 446 (488)
.+... ...+..|||.|||||++.. ....|+..+|+||||++..||.-|.+|+..+.+-..+..|.....|.+ |
T Consensus 172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp 251 (953)
T KOG0587|consen 172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRP 251 (953)
T ss_pred eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccch
Confidence 65543 3456789999999999843 234477889999999999999999999999888888888877665443 4
Q ss_pred CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 447 NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 447 ~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
...+.++.++|..||.+|.++||+..++++|||+++
T Consensus 252 ~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 252 KKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred hhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 678999999999999999999999999999999984
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=297.48 Aligned_cols=261 Identities=22% Similarity=0.303 Sum_probs=186.0
Q ss_pred cccCceeeeeeecccCceEEEEEEe-----------------cCCcEEEEEEeecCCCCCcc---------hhHHHHHHH
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLT-----------------DDGFFFAVKEVSLQDEGPRG---------KQSILQLEQ 275 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~-----------------~~g~~vAvK~i~~~~~~~~~---------~~~~~~~~~ 275 (488)
...++|++.++||+|+||.||+|.+ ..+..||||.+......... .........
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3577899999999999999999864 24568999998653221000 001112334
Q ss_pred HHHHHhcCCCCCc-----ceeeccccC--------CCceEEEEeeccCCChHHHHhhh----------------------
Q 011326 276 EISLLGQFEHDNI-----VQYLGTDRD--------EKRLCIFLELVTKGSLASLYQKY---------------------- 320 (488)
Q Consensus 276 Ei~iL~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~---------------------- 320 (488)
|+.++.+++|.++ ++++++|.. .+..++||||+++++|.+++...
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6667777766554 567776643 35689999999999999887531
Q ss_pred ---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-cc--cCCCCCcccCchh
Q 011326 321 ---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VK--SCKGTAFWMAPEV 394 (488)
Q Consensus 321 ---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-~~--~~~gt~~y~aPE~ 394 (488)
.+++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++....... .. ...+|+.|+|||.
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 13456788899999999999999999999999999999999999999999986543221 11 2235789999998
Q ss_pred hccccC--------------------CCChhhhHHHHHHHHHHHHcCCC-CCCCCchhhh-----------HHHhcCCCC
Q 011326 395 VNLKKD--------------------GYGLTADIWSLGCTVLEMLTRRH-PYSHLEGGQA-----------MFKIGGGEL 442 (488)
Q Consensus 395 ~~~~~~--------------------~~s~k~DvwSlGvlL~eLltG~~-Pf~~~~~~~~-----------~~~i~~~~~ 442 (488)
+..... ....+.|+||+||++|+|++|.. |+........ .........
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~ 461 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY 461 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence 732211 11234799999999999999875 6653221111 111111111
Q ss_pred -CCCCCcccHHHHHHHHHhhhhCC---CCCCCHHHHHhCccCCC
Q 011326 443 -PPVPNSLSRDAQDFILKCLQVNP---NDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 443 -~~~~~~~s~~l~~Li~~cL~~dP---~~Rps~~eil~hp~f~~ 482 (488)
-+.....++...+|+.+||..+| .+|+|+.|+|+||||..
T Consensus 462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 12234578999999999999876 68999999999999964
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=291.47 Aligned_cols=262 Identities=27% Similarity=0.450 Sum_probs=212.1
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCc--chhHHHHHHHHHHHHhcCCCCCcceeecccc-CCCc
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPR--GKQSILQLEQEISLLGQFEHDNIVQYLGTDR-DEKR 300 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-~~~~ 300 (488)
.+|-++.+||+|||+.||++.+- ..+.||+|+-........ .....+..-+|..|-+.|+||.||++|+++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 46888999999999999999874 578899998765543221 1223455678999999999999999999985 5678
Q ss_pred eEEEEeeccCCChHHHHhhhc-cChhhhhHHHHHHHHHHHHHHHC--CCccccCCcccEEEC---CCCcEEEeecCCccc
Q 011326 301 LCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQ--NVVHRDIKCANILVD---ASGSVKLADFGLAKA 374 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~~-ls~~~~~~i~~qi~~aL~yLH~~--giiHrDLkp~NILl~---~~~~vkL~DFGla~~ 374 (488)
+|-|+|||+|.+|+.+++.+. +++.++..|+.||+.||.||.+. .|||-||||.|||+- ..|.+||.|||+++.
T Consensus 543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 999999999999999998775 89999999999999999999976 599999999999994 467899999999987
Q ss_pred ccCCC---------cccCCCCCcccCchhhccc--cCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHH------Hh
Q 011326 375 TTMND---------VKSCKGTAFWMAPEVVNLK--KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF------KI 437 (488)
Q Consensus 375 ~~~~~---------~~~~~gt~~y~aPE~~~~~--~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~------~i 437 (488)
..... .....||.+|++||.+... ....+.++||||+|+++|..+.|+.||........+. +.
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA 702 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA 702 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence 65432 2345699999999997544 2346889999999999999999999997644332222 22
Q ss_pred cCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCCC
Q 011326 438 GGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTS 487 (488)
Q Consensus 438 ~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~~ 487 (488)
..-.+|+ .+.++++++++|++||++--+.|....++..||||.-+...+
T Consensus 703 tEVqFP~-KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rrs 751 (775)
T KOG1151|consen 703 TEVQFPP-KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRRS 751 (775)
T ss_pred eeccCCC-CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhhc
Confidence 2222322 346899999999999999999999999999999998766543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=293.87 Aligned_cols=249 Identities=27% Similarity=0.448 Sum_probs=210.7
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC------CCCcceeeccccC
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE------HDNIVQYLGTDRD 297 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~------HpnIv~l~~~~~~ 297 (488)
++|.+....|+|-|++|..|.+. .|..||||+|.. ++...+.=+.|+++|++|+ -.|+++++..|..
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn------NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN------NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeec------chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 46999999999999999999886 588999999984 3344455678999999995 3589999999999
Q ss_pred CCceEEEEeeccCCChHHHHhhh----ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC-CCcEEEeecCCc
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY----HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLA 372 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~----~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~-~~~vkL~DFGla 372 (488)
.+++|+|+|.+.. +|.+++++. ++....+..++.|++.||..|...||+|.||||+|||+++ ...+||||||.|
T Consensus 506 knHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 506 KNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred cceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence 9999999998865 899999776 4888999999999999999999999999999999999986 457899999999
Q ss_pred ccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhc--CCCCCC------
Q 011326 373 KATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIG--GGELPP------ 444 (488)
Q Consensus 373 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~--~~~~~~------ 444 (488)
.....+..+++.-+..|.|||++ .+..|+...|+||+||+||||.||+..|.+..+.+++.... .+.+|.
T Consensus 585 ~~~~eneitPYLVSRFYRaPEIi--LG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg 662 (752)
T KOG0670|consen 585 SFASENEITPYLVSRFYRAPEII--LGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG 662 (752)
T ss_pred cccccccccHHHHHHhccCccee--ecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence 88888888888888999999998 66779999999999999999999999999887776544321 111110
Q ss_pred ---------------------------------CC-----------Ccc-------cHHHHHHHHHhhhhCCCCCCCHHH
Q 011326 445 ---------------------------------VP-----------NSL-------SRDAQDFILKCLQVNPNDRPTAAQ 473 (488)
Q Consensus 445 ---------------------------------~~-----------~~~-------s~~l~~Li~~cL~~dP~~Rps~~e 473 (488)
-| +.+ -..+.+|+.+||..||++|.|..|
T Consensus 663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq 742 (752)
T KOG0670|consen 663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ 742 (752)
T ss_pred chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence 00 012 236789999999999999999999
Q ss_pred HHhCccCCC
Q 011326 474 LMEHPFIKR 482 (488)
Q Consensus 474 il~hp~f~~ 482 (488)
+|.||||++
T Consensus 743 AL~HpFi~~ 751 (752)
T KOG0670|consen 743 ALKHPFITE 751 (752)
T ss_pred HhcCCcccC
Confidence 999999985
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=318.80 Aligned_cols=237 Identities=23% Similarity=0.378 Sum_probs=185.7
Q ss_pred CceeeeeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
..+...++||+|+||.||+|.+ .++..||+|.+..... ....|+.++++++|||||+++++|.+++..++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence 4566678899999999999988 4799999999864321 11245788999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHH---HCCCccccCCcccEEECCCCcEEEeecCCcccccCCCc
Q 011326 304 FLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLH---EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV 380 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 380 (488)
||||+++|+|.+++. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||....... .
T Consensus 761 v~Ey~~~g~L~~~l~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--~ 835 (968)
T PLN00113 761 IHEYIEGKNLSEVLR--NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--D 835 (968)
T ss_pred EEeCCCCCcHHHHHh--cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--C
Confidence 999999999999986 4899999999999999999999 6699999999999999998888776 665533221 2
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh--hh---HHHhc---------CCCCC---
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG--QA---MFKIG---------GGELP--- 443 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~--~~---~~~i~---------~~~~~--- 443 (488)
....+|+.|+|||++ ....++.++||||||+++|||++|+.||...... .. ..... .....
T Consensus 836 ~~~~~t~~y~aPE~~--~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 836 TKCFISSAYVAPETR--ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred CCccccccccCcccc--cCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 234688999999997 4566899999999999999999999998532211 11 00000 00000
Q ss_pred CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 444 PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 444 ~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
..+.....++.+++.+||+.||++|||+.|+++.
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 1111223467789999999999999999999865
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=272.35 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=203.7
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC---
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK--- 299 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--- 299 (488)
..+|..++.+|.|.- .|..+.+. .++.||+|.+...- ......++..+|..++..++|+||+.++.++.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf---~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF---QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc---ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 457888888999998 66666664 79999999987652 22445567789999999999999999999886443
Q ss_pred ---ceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 300 ---RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 300 ---~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
..|+|||+|.. +|.+.+. ..++-+.+..+..|++.|+.|||+.||+||||||+||++..++.+||+|||+|+...
T Consensus 92 ~~~e~y~v~e~m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 92 EFQEVYLVMELMDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHhHHHHHHhhhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 57999999977 8887776 568889999999999999999999999999999999999999999999999997665
Q ss_pred CC-CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC-------------
Q 011326 377 MN-DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL------------- 442 (488)
Q Consensus 377 ~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~------------- 442 (488)
.. ..+.+..|..|.|||++ .+.++...+||||+||++.||++|+..|.+.+..+...++....-
T Consensus 170 ~~~~mtpyVvtRyyrapevi--l~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 170 TDFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred cccccCchhheeeccCchhe--eccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 55 45678899999999998 344499999999999999999999999887665443333321100
Q ss_pred --------CC---------C-----------CCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCC
Q 011326 443 --------PP---------V-----------PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481 (488)
Q Consensus 443 --------~~---------~-----------~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~ 481 (488)
+. + +..-+..+++|+.+||..||++|.|++++|.||||+
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 00 0 112245688999999999999999999999999997
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=296.69 Aligned_cols=243 Identities=34% Similarity=0.500 Sum_probs=191.0
Q ss_pred eeeeeeecccCceE-EEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCceEEE
Q 011326 227 WQKGELLGSGSYGF-VYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 227 y~~~~~LG~G~fg~-Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV 304 (488)
|.-.+++|.|+-|+ ||+|... |+.||||++.. .......+|+..|+.- +|||||++++.-.++...||.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~--------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa 581 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE--------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA 581 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh--------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence 44456789999985 5788664 77999999853 2234567899999876 699999999999999999999
Q ss_pred EeeccCCChHHHHhhhc-----cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC---C--CcEEEeecCCccc
Q 011326 305 LELVTKGSLASLYQKYH-----LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA---S--GSVKLADFGLAKA 374 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~~-----ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~---~--~~vkL~DFGla~~ 374 (488)
.|.|.. +|.++++... ........+..|+++||+|||+.+|+||||||.||||+. + ..++|+|||+++.
T Consensus 582 lELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 582 LELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred ehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 999987 9999997732 122445788999999999999999999999999999975 3 4689999999987
Q ss_pred ccCCC-----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCC--CCCC
Q 011326 375 TTMND-----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGEL--PPVP 446 (488)
Q Consensus 375 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~--~~~~ 446 (488)
..... .....||.+|+|||++. ...-+.++||||+||++|+.++ |.+||...-..+. .|..+.. ..+.
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~--~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~ 736 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLR--EDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLE 736 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHh--ccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeec
Confidence 76543 34567999999999984 3335679999999999999998 5999975433332 2222222 1111
Q ss_pred CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 447 NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 447 ~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
.....++.+||.+|+.++|..||++.++|.||+|..-
T Consensus 737 ~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 737 PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 1112289999999999999999999999999999754
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=255.63 Aligned_cols=250 Identities=25% Similarity=0.465 Sum_probs=202.3
Q ss_pred ccCceeeeeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCC--
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDE-- 298 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~-- 298 (488)
..++|++.+.+|+|.++.||.|.. .+.+.++||++++- -.+.+.+|+.||..+. ||||+.++++..+.
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S 107 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPES 107 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence 467899999999999999999986 46888999998642 2367889999999997 99999999997664
Q ss_pred CceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC-CcEEEeecCCcccccC
Q 011326 299 KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS-GSVKLADFGLAKATTM 377 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~-~~vkL~DFGla~~~~~ 377 (488)
....+++||+.+.+...+.. .++...+..++.+++.||.|+|++||.|||+||.|++||+. -.++|+|+|+|..+..
T Consensus 108 ktpaLiFE~v~n~Dfk~ly~--tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 108 KTPSLIFEYVNNTDFKQLYP--TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred cCchhHhhhhccccHHHHhh--hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 46789999999977766543 37888999999999999999999999999999999999965 4799999999987766
Q ss_pred CCcc-cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCC-CCCchhhhHHHhcC---------------C
Q 011326 378 NDVK-SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY-SHLEGGQAMFKIGG---------------G 440 (488)
Q Consensus 378 ~~~~-~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf-~~~~~~~~~~~i~~---------------~ 440 (488)
.... ..+.+..|--||.+. .-..|+.+.|+|||||+|..|+..+.|| .+.++.+.+.+|.. .
T Consensus 186 ~~eYnVRVASRyfKGPELLV-dy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred CceeeeeeehhhcCCchhee-echhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 5433 345677789999973 4455888999999999999999988886 45555544333321 0
Q ss_pred CCC--------------------CC-CCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 441 ELP--------------------PV-PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 441 ~~~--------------------~~-~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
.++ +- ..-.++++.+|+.++|..|-.+|+|+.|.+.||||...
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 000 00 11256899999999999999999999999999999754
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=272.75 Aligned_cols=239 Identities=26% Similarity=0.401 Sum_probs=186.0
Q ss_pred cCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHh--cCCCCCcceeeccccCCC--
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLG--QFEHDNIVQYLGTDRDEK-- 299 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~--~l~HpnIv~l~~~~~~~~-- 299 (488)
....+..++||+|.||.||+|...+ +.||||++.. +....+.+|-+|.+ .++|+||+++++.-...+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~--------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE--------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccC-ceeEEEecCH--------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 3445667889999999999998764 8999999863 33456677777755 468999999999866555
Q ss_pred --ceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHC---------CCccccCCcccEEECCCCcEEEee
Q 011326 300 --RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQ---------NVVHRDIKCANILVDASGSVKLAD 368 (488)
Q Consensus 300 --~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~---------giiHrDLkp~NILl~~~~~vkL~D 368 (488)
.++||+||.+.|+|.++++.+-+++....+++..+++||+|||+. .|+|||||..|||+..|++.-|+|
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 899999999999999999999999999999999999999999963 599999999999999999999999
Q ss_pred cCCcccccCC----CcccCCCCCcccCchhhccccCCCC-----hhhhHHHHHHHHHHHHcCCC------------CCCC
Q 011326 369 FGLAKATTMN----DVKSCKGTAFWMAPEVVNLKKDGYG-----LTADIWSLGCTVLEMLTRRH------------PYSH 427 (488)
Q Consensus 369 FGla~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~s-----~k~DvwSlGvlL~eLltG~~------------Pf~~ 427 (488)
||+|..+... +....+||.+|||||++... -++. .+.||||+|.+||||++.-. ||..
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEga-inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGA-INLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhh-cccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 9999765533 34467899999999998422 2222 35899999999999998532 2220
Q ss_pred -----CchhhhHHHhc-CCCCCCCCC-----cccHHHHHHHHHhhhhCCCCCCCHH
Q 011326 428 -----LEGGQAMFKIG-GGELPPVPN-----SLSRDAQDFILKCLQVNPNDRPTAA 472 (488)
Q Consensus 428 -----~~~~~~~~~i~-~~~~~~~~~-----~~s~~l~~Li~~cL~~dP~~Rps~~ 472 (488)
..-+++...+. ...+|.++. ....-+++.+..||..||+-|.|+.
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 11112222222 233344442 2345788999999999999999965
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=270.92 Aligned_cols=243 Identities=28% Similarity=0.430 Sum_probs=189.1
Q ss_pred cCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhc--CCCCCcceeeccccCCC--
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQ--FEHDNIVQYLGTDRDEK-- 299 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~~-- 299 (488)
-.+.++.+.||+|.||.||+|.++ |+.||||++...++ ....+|.+|.+. |+|+||+.+++.-..+.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE--------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE--------RSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEecccch--------hhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 457889999999999999999887 78899999975443 345677777765 59999999999765443
Q ss_pred --ceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHC--------CCccccCCcccEEECCCCcEEEeec
Q 011326 300 --RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQ--------NVVHRDIKCANILVDASGSVKLADF 369 (488)
Q Consensus 300 --~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~--------giiHrDLkp~NILl~~~~~vkL~DF 369 (488)
++++|++|.+.|||.+++.++.++.+.+++++..+++||+|||.. .|.|||||..|||+..+|.+-|+|+
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 789999999999999999999999999999999999999999953 4999999999999999999999999
Q ss_pred CCcccccCC------CcccCCCCCcccCchhhccccC--CC--ChhhhHHHHHHHHHHHHcC----------CCCCCCCc
Q 011326 370 GLAKATTMN------DVKSCKGTAFWMAPEVVNLKKD--GY--GLTADIWSLGCTVLEMLTR----------RHPYSHLE 429 (488)
Q Consensus 370 Gla~~~~~~------~~~~~~gt~~y~aPE~~~~~~~--~~--s~k~DvwSlGvlL~eLltG----------~~Pf~~~~ 429 (488)
|+|-..... .....+||.+|||||++...-. .+ =..+||||||.++||++.. ++||...-
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 999544332 1345679999999999842211 11 1358999999999998752 47775432
Q ss_pred h----hhhHHHhc--CCCCCCCCCccc-----HHHHHHHHHhhhhCCCCCCCHHHHH
Q 011326 430 G----GQAMFKIG--GGELPPVPNSLS-----RDAQDFILKCLQVNPNDRPTAAQLM 475 (488)
Q Consensus 430 ~----~~~~~~i~--~~~~~~~~~~~s-----~~l~~Li~~cL~~dP~~Rps~~eil 475 (488)
+ .+.+.++. +..+|.+|+... ..+..|++.||..+|.-|.|+--|.
T Consensus 441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 2 22222221 233455555443 2567899999999999999865443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-33 Score=263.00 Aligned_cols=250 Identities=28% Similarity=0.487 Sum_probs=200.6
Q ss_pred eeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC-----ceEE
Q 011326 230 GELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK-----RLCI 303 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-----~~~l 303 (488)
.+.||-|+||+||.+++. +|+.||+|.+..-- .+-...+.+.+|+.+|...+|.|++..++.-+-.. ++|+
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf---q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF---QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHH---HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 356999999999999885 89999999885322 12334567889999999999999999888765432 5788
Q ss_pred EEeeccCCChHHHHh-hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC---
Q 011326 304 FLELVTKGSLASLYQ-KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--- 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~-~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--- 379 (488)
++|.|.. +|..++- ...++...++-+..||++||+|||+.||.||||||.|.|++.+..+||||||+++..+..+
T Consensus 135 ~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 9999876 7877764 4469999999999999999999999999999999999999999999999999998765543
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC--------------------
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG-------------------- 439 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~-------------------- 439 (488)
.+...-|-+|+|||++ .+...|+.+.||||+||++.||+..+..|...+..+.+..|..
T Consensus 214 MTqEVVTQYYRAPEiL-MGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELL-MGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hHHHHHHHHhccHHHh-hcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 3455678899999998 4566799999999999999999999888876665544433321
Q ss_pred ---C-C-CCC--------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 440 ---G-E-LPP--------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 440 ---~-~-~~~--------~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
+ . .+. .+..-..+...++..++..||++|.+.++.+.|++..+..
T Consensus 293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 0 0 011 1112344778899999999999999999999999987653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=237.70 Aligned_cols=209 Identities=40% Similarity=0.657 Sum_probs=184.9
Q ss_pred ecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeeccCC
Q 011326 233 LGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKG 311 (488)
Q Consensus 233 LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 311 (488)
||+|++|.||++... ++..+++|.+....... ....+.+|+..++.+.|++++++++++......+++||+++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence 689999999999886 48999999987543221 3467889999999999999999999999999999999999999
Q ss_pred ChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC-CCcEEEeecCCcccccCCC--cccCCCC
Q 011326 312 SLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMND--VKSCKGT 386 (488)
Q Consensus 312 sL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~~--~~~~~gt 386 (488)
+|.+++... .+++..+..++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+....... .....+.
T Consensus 77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (215)
T cd00180 77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT 156 (215)
T ss_pred cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence 999999775 6899999999999999999999999999999999999999 8999999999987665443 4456688
Q ss_pred CcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCC
Q 011326 387 AFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPN 466 (488)
Q Consensus 387 ~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~ 466 (488)
..|++||..... ...+.+.|+|++|+++++| ..+.+++.+|++.+|.
T Consensus 157 ~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l--------------------------------~~~~~~l~~~l~~~p~ 203 (215)
T cd00180 157 PAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL--------------------------------PELKDLIRKMLQKDPE 203 (215)
T ss_pred CCccChhHhccc-CCCCchhhhHHHHHHHHHH--------------------------------HHHHHHHHHHhhCCcc
Confidence 899999987322 2678899999999999998 6889999999999999
Q ss_pred CCCCHHHHHhCc
Q 011326 467 DRPTAAQLMEHP 478 (488)
Q Consensus 467 ~Rps~~eil~hp 478 (488)
+||++.++++|+
T Consensus 204 ~R~~~~~l~~~~ 215 (215)
T cd00180 204 KRPSAKEILEHL 215 (215)
T ss_pred cCcCHHHHhhCC
Confidence 999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=259.61 Aligned_cols=247 Identities=24% Similarity=0.363 Sum_probs=211.1
Q ss_pred cCceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
-.+++...++-+|.||.||.|.+. +.+.|.+|.+... ..+.....++.|..++..+.|||+.++.+++.+
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~----AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH----ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc----ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 345777888999999999999663 3455677776533 344566778899999999999999999998765
Q ss_pred -CCceEEEEeeccCCChHHHHhhh---------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEe
Q 011326 298 -EKRLCIFLELVTKGSLASLYQKY---------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLA 367 (488)
Q Consensus 298 -~~~~~lV~E~~~~gsL~~~l~~~---------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~ 367 (488)
.+..+.++.++.-|+|..++... .++..++..++.|++.|++|||+.|++|.||...|.+||+.-++||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 45678889999999999998622 26677788999999999999999999999999999999999999999
Q ss_pred ecCCcccccCCCcc----cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCC
Q 011326 368 DFGLAKATTMNDVK----SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGEL 442 (488)
Q Consensus 368 DFGla~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~ 442 (488)
|=.+++.+-..+.. +......||+||.+ .+..|+.++|+||||++||||+| |+.|+...++.++...+..+++
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal--~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR 516 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEAL--QNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR 516 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHH--hhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce
Confidence 99999876555432 22234469999997 45669999999999999999999 9999999999999999999999
Q ss_pred CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 443 PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 443 ~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
...|.+||+++..++..||..+|++||+++|+..
T Consensus 517 laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 517 LAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 9999999999999999999999999999999864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=240.69 Aligned_cols=221 Identities=29% Similarity=0.467 Sum_probs=180.1
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhc-CCCCCcceeeccccCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQ-FEHDNIVQYLGTDRDE 298 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~~ 298 (488)
+..-++...+..||+|++|.|-+.++. +|...|+|.+..... .+..++.++|+++.++ ..+|.+|+++|....+
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn----~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re 117 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN----SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE 117 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC----hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence 334455666788999999999888774 899999999987643 4556778889988765 4799999999998888
Q ss_pred CceEEEEeeccCCChHHHHhh-----hccChhhhhHHHHHHHHHHHHHHHC-CCccccCCcccEEECCCCcEEEeecCCc
Q 011326 299 KRLCIFLELVTKGSLASLYQK-----YHLSDSQVSSYTRQILNGLKYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLA 372 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~-----~~ls~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~NILl~~~~~vkL~DFGla 372 (488)
...+|.||.|.. ||+.+..+ ..++|..+-+|+..++.||.|||++ .++|||+||+||||+.+|++|+||||++
T Consensus 118 gdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 118 GDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred ccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccc
Confidence 999999999977 88776532 2489999999999999999999976 8999999999999999999999999999
Q ss_pred ccccCCCccc-CCCCCcccCchhhcc--ccCCCChhhhHHHHHHHHHHHHcCCCCCCCC-chhhhHHHhcCCCCCCCC
Q 011326 373 KATTMNDVKS-CKGTAFWMAPEVVNL--KKDGYGLTADIWSLGCTVLEMLTRRHPYSHL-EGGQAMFKIGGGELPPVP 446 (488)
Q Consensus 373 ~~~~~~~~~~-~~gt~~y~aPE~~~~--~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~-~~~~~~~~i~~~~~~~~~ 446 (488)
..+..+-..+ ..|-..|+|||.++. +..+|+.++||||||+++.||.+++.||... ++.+.+.++.....|.+|
T Consensus 197 G~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp 274 (282)
T KOG0984|consen 197 GYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLP 274 (282)
T ss_pred eeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCc
Confidence 7776554443 567888999999842 3447999999999999999999999999653 455566666555444433
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=267.89 Aligned_cols=205 Identities=27% Similarity=0.425 Sum_probs=175.9
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchh---HHHHHHHHHHHHhcCC---CCCcceeecc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQ---SILQLEQEISLLGQFE---HDNIVQYLGT 294 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~---~~~~~~~Ei~iL~~l~---HpnIv~l~~~ 294 (488)
..+.+|...+.+|+|+||.|++|.++ +...|+||.+.+...-..... ..-.+-.|++||..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 35778999999999999999999986 577899999976542211110 0112346999999997 9999999999
Q ss_pred ccCCCceEEEEeecc-CCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCc
Q 011326 295 DRDEKRLCIFLELVT-KGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLA 372 (488)
Q Consensus 295 ~~~~~~~~lV~E~~~-~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla 372 (488)
|++++.+||+||-.. |-+|.+++... .++|.++..|++|++.|+++||++||+|||||-+|+.++.+|.+||+|||.|
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence 999999999999764 45899999755 5999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 011326 373 KATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSH 427 (488)
Q Consensus 373 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~ 427 (488)
...........+||..|.|||++ .+....+...|||++|++||-++....||.+
T Consensus 718 a~~ksgpfd~f~gtv~~aapevl-~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKSGPFDVFVGTVDYAAPEVL-GGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcCCCcceeeeeccccchhhh-CCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 88888888899999999999998 3444557889999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=234.81 Aligned_cols=210 Identities=37% Similarity=0.560 Sum_probs=179.1
Q ss_pred eeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEE
Q 011326 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFL 305 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 305 (488)
|.+.+.||+|++|.||++... ++..+++|.+...... .....+.+|+..+++++|+|++++++++...+..++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 76 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM 76 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence 456788999999999999886 4899999999764322 24568889999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhhc--cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC---Cc
Q 011326 306 ELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN---DV 380 (488)
Q Consensus 306 E~~~~gsL~~~l~~~~--ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~---~~ 380 (488)
|++++++|.+++.... +++..+..++.+++.++.+||+++++|+||+|.||+++.++.++|+|||.+...... ..
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999999999987654 899999999999999999999999999999999999999999999999998766543 22
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCC-Cchh-hhHHHhcCCC
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSH-LEGG-QAMFKIGGGE 441 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~-~~~~-~~~~~i~~~~ 441 (488)
....++..|++||.+. ....++.++|+|+||+++++|++|+.||.. .+.. .....+..+.
T Consensus 157 ~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 157 KTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred cceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 3456788899999974 556677899999999999999999999977 4444 5555555444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-31 Score=273.31 Aligned_cols=256 Identities=39% Similarity=0.636 Sum_probs=216.4
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
-.+|+....+|.|++|.||++++. ++...|+|+++.... ....-+.+|+-+++..+||||+.+++.+...+.++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-----dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-----DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC-----ccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 467999999999999999999985 799999999987543 23345668999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--C
Q 011326 303 IFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--D 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~ 379 (488)
|.||||.+|+|.++..-. .+++.++..+.+..++|++|||++|-+|||||-.|||+++.|.+|+.|||.+-.+... .
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence 999999999999987654 5999999999999999999999999999999999999999999999999988654432 3
Q ss_pred cccCCCCCcccCchhhc-cccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC-CC---CCCcccHHHH
Q 011326 380 VKSCKGTAFWMAPEVVN-LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL-PP---VPNSLSRDAQ 454 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~-~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~---~~~~~s~~l~ 454 (488)
.....||+.|||||+.. ...++|...+|+|++|+...|+---++|......-.....+.+..+ ++ -+...++.+.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh 248 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFH 248 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHH
Confidence 45788999999999963 3456799999999999999999887777655554444444433332 21 2346789999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
+|++.+|.++|.+||+++.+|.|||+...+
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~l 278 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQTL 278 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccch
Confidence 999999999999999999999999998764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=255.90 Aligned_cols=250 Identities=29% Similarity=0.477 Sum_probs=197.3
Q ss_pred cCceeeeeeecccCceEEEEEEec----CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD----DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDE 298 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 298 (488)
.+.|..++.||+|+|++||++.+. ..+.||+|.+..... ...+.+|+++|..+ .+.||+++.+++..+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-------p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-------PSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-------chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 456888899999999999999763 478899999975432 24578999999998 589999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEEC-CCCcEEEeecCCcccc--
Q 011326 299 KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVD-ASGSVKLADFGLAKAT-- 375 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~-~~~~vkL~DFGla~~~-- 375 (488)
+...+|+||++..+..++... ++...+..+++.++.||.++|.+||+||||||.|+|.+ ..+.-.|+|||+|...
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred CeeEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 999999999999888888764 67888999999999999999999999999999999998 4678899999998510
Q ss_pred ---------------cC--C---------------C------------cccCCCCCcccCchhhccccCCCChhhhHHHH
Q 011326 376 ---------------TM--N---------------D------------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSL 411 (488)
Q Consensus 376 ---------------~~--~---------------~------------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSl 411 (488)
.. . . .-+..||++|+|||++ ..-...++++||||.
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL-~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVL-FRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHH-hhccCcCCccceeec
Confidence 00 0 0 0123499999999998 344556889999999
Q ss_pred HHHHHHHHcCCCCCCCCchh-hhHHHh---------------------cC-CCCC----------C--------------
Q 011326 412 GCTVLEMLTRRHPYSHLEGG-QAMFKI---------------------GG-GELP----------P-------------- 444 (488)
Q Consensus 412 GvlL~eLltG~~Pf~~~~~~-~~~~~i---------------------~~-~~~~----------~-------------- 444 (488)
|++++-++++..||....++ +.+..+ .. ...+ .
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 99999999999998543221 111100 00 0000 0
Q ss_pred ----CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 445 ----VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 445 ----~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
.....+..+.+|+.+||..||.+|.|+++.|+||||..+
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 001234578999999999999999999999999999854
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=246.35 Aligned_cols=128 Identities=27% Similarity=0.421 Sum_probs=109.5
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-----C---CCcceeeccc
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-----H---DNIVQYLGTD 295 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-----H---pnIv~l~~~~ 295 (488)
.+|.+.++||-|-|++||+|.+. +.+.||+|+++ ..+...+....|+.+|++++ | .+||+|++.|
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK------SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK------SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEe------hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 68999999999999999999885 78899999987 34555567788999999883 2 4799999987
Q ss_pred c----CCCceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHH-CCCccccCCcccEEEC
Q 011326 296 R----DEKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHE-QNVVHRDIKCANILVD 359 (488)
Q Consensus 296 ~----~~~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~NILl~ 359 (488)
. ++.++|+|+|++.. +|..+|... +++...+.+|++||+.||.|||+ .||||-||||+|||+.
T Consensus 152 khsGpNG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eecCCCCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 5 45689999999944 777777543 69999999999999999999996 5999999999999994
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=237.71 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=199.1
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeecc-ccCCCc
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGT-DRDEKR 300 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~-~~~~~~ 300 (488)
.+.|.+.+.||+|.||.+-++.++ +...+++|.+.. ......+|.+|...--.| .|.||+.-|++ |++.+.
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~------p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR------PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc------chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 356899999999999999999886 678899999874 344567889998765555 59999998875 788889
Q ss_pred eEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEEC-C-CCcEEEeecCCcccccCC
Q 011326 301 LCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVD-A-SGSVKLADFGLAKATTMN 378 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~-~-~~~vkL~DFGla~~~~~~ 378 (488)
+.+++||+|.|+|..-+...++-|..-..++.|+++||.|+|+++++|||||.+||||- . .-.+||||||+.+..+..
T Consensus 97 YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred EEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 99999999999999999999999999999999999999999999999999999999994 2 347999999998655432
Q ss_pred CcccCCCCCcccCchhhccc---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh----hhHHHhcCCCCCCCC---Cc
Q 011326 379 DVKSCKGTAFWMAPEVVNLK---KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG----QAMFKIGGGELPPVP---NS 448 (488)
Q Consensus 379 ~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~----~~~~~i~~~~~~~~~---~~ 448 (488)
- ....-+..|.+||.+... .....+.+|+|.||++++.+++|.+||...... -.......+..+..| ..
T Consensus 177 V-~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~ 255 (378)
T KOG1345|consen 177 V-KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNP 255 (378)
T ss_pred e-hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcc
Confidence 2 222345568999987322 222467899999999999999999999632211 122233344443333 56
Q ss_pred ccHHHHHHHHHhhhhCCCCC---CCHHHHHhCccCCCCC
Q 011326 449 LSRDAQDFILKCLQVNPNDR---PTAAQLMEHPFIKRPL 484 (488)
Q Consensus 449 ~s~~l~~Li~~cL~~dP~~R---ps~~eil~hp~f~~~~ 484 (488)
.++.+..+.++-|..+|++| .+........|.-+.+
T Consensus 256 fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i 294 (378)
T KOG1345|consen 256 FSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLI 294 (378)
T ss_pred cCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhh
Confidence 78999999999999999999 6666666666654443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=283.49 Aligned_cols=197 Identities=19% Similarity=0.288 Sum_probs=146.1
Q ss_pred cCCC-CCcceeeccc-------cCCCceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccC
Q 011326 282 QFEH-DNIVQYLGTD-------RDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDI 351 (488)
Q Consensus 282 ~l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDL 351 (488)
.++| +||.+++++| ...+.++.++|++. ++|.+++... .+++.++..++.||++||.|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3445 5788888876 23346788899874 4999999643 4899999999999999999999999999999
Q ss_pred CcccEEECCC-------------------CcEEEeecCCcccccCC------------------CcccCCCCCcccCchh
Q 011326 352 KCANILVDAS-------------------GSVKLADFGLAKATTMN------------------DVKSCKGTAFWMAPEV 394 (488)
Q Consensus 352 kp~NILl~~~-------------------~~vkL~DFGla~~~~~~------------------~~~~~~gt~~y~aPE~ 394 (488)
||+||||+.. +.+|++|||+++..... ......||+.|+|||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 9999999654 44566666665432110 0012358889999999
Q ss_pred hccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHH
Q 011326 395 VNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQL 474 (488)
Q Consensus 395 ~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~ei 474 (488)
+ .+..++.++|||||||+||||++|.+|+.... .....+.....++......++..+++.+||+++|.+||++.|+
T Consensus 187 ~--~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ei 262 (793)
T PLN00181 187 D--NGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSEL 262 (793)
T ss_pred h--ccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence 7 45568999999999999999999988875322 1222222222222222234567789999999999999999999
Q ss_pred HhCccCCCC
Q 011326 475 MEHPFIKRP 483 (488)
Q Consensus 475 l~hp~f~~~ 483 (488)
++||||.++
T Consensus 263 l~h~~~~~~ 271 (793)
T PLN00181 263 LQSEFINEP 271 (793)
T ss_pred hhchhhhhh
Confidence 999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-27 Score=215.37 Aligned_cols=159 Identities=29% Similarity=0.356 Sum_probs=126.9
Q ss_pred CChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCcccCCCCCc
Q 011326 311 GSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF 388 (488)
Q Consensus 311 gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~gt~~ 388 (488)
|+|.+++.. .++++..++.++.|++.||.|||+++ ||+|||++.++.+++ ||++...... ...||+.
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~---~~~g~~~ 69 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE---QSRVDPY 69 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc---cCCCccc
Confidence 689999874 35999999999999999999999998 999999999999999 9998765432 2368999
Q ss_pred ccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh-hhHHHhcCCCCCC------CCCcccH--HHHHHHHH
Q 011326 389 WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-QAMFKIGGGELPP------VPNSLSR--DAQDFILK 459 (488)
Q Consensus 389 y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~-~~~~~i~~~~~~~------~~~~~s~--~l~~Li~~ 459 (488)
|+|||++ .+..++.++|||||||++|||++|+.||...... .....+.....+. .+..++. ++.+++.+
T Consensus 70 y~aPE~~--~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 147 (176)
T smart00750 70 FMAPEVI--QGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV 147 (176)
T ss_pred ccChHHh--cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence 9999997 4556899999999999999999999999764432 2222222111111 1223344 69999999
Q ss_pred hhhhCCCCCCCHHHHHhCccCCC
Q 011326 460 CLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 460 cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
||+.+|.+||++.|+++|+|+..
T Consensus 148 cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 148 CASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999999753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-24 Score=208.52 Aligned_cols=254 Identities=34% Similarity=0.476 Sum_probs=205.7
Q ss_pred eeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCC-CcceeeccccCCCceEEEE
Q 011326 227 WQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD-NIVQYLGTDRDEKRLCIFL 305 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp-nIv~l~~~~~~~~~~~lV~ 305 (488)
|.+.+.||.|+||.||.+.+. ..+++|.+........ .....+.+|+.++..+.|+ +++++.+.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS--KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccch--hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence 678889999999999999887 7889999876554321 3456788999999999988 7999999997777789999
Q ss_pred eeccCCChHHHHhhh----ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC-cEEEeecCCcccccCCC-
Q 011326 306 ELVTKGSLASLYQKY----HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG-SVKLADFGLAKATTMND- 379 (488)
Q Consensus 306 E~~~~gsL~~~l~~~----~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~~- 379 (488)
+++.++++.+++... .++......++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||.+.......
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 999999999777665 589999999999999999999999999999999999999988 79999999987544332
Q ss_pred -------cccCCCCCcccCchhhcccc-CCCChhhhHHHHHHHHHHHHcCCCCCCCCch----hhhHHHhcCCCCC----
Q 011326 380 -------VKSCKGTAFWMAPEVVNLKK-DGYGLTADIWSLGCTVLEMLTRRHPYSHLEG----GQAMFKIGGGELP---- 443 (488)
Q Consensus 380 -------~~~~~gt~~y~aPE~~~~~~-~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~----~~~~~~i~~~~~~---- 443 (488)
.....||..|++||.+.... ...+...|+|++|++++++++|..||..... ......+.....+
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 35667999999999974321 5688899999999999999999999876653 3333333333322
Q ss_pred CCCCcc----cHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 444 PVPNSL----SRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 444 ~~~~~~----s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
...... ...+.+++..++..+|..|.+..+...+++.....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 111111 25789999999999999999999998887665443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-24 Score=218.67 Aligned_cols=244 Identities=25% Similarity=0.275 Sum_probs=189.5
Q ss_pred ceeeeeeecccCceEEEEEEecCC--cEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC----CCCcceeeccc-cCC
Q 011326 226 SWQKGELLGSGSYGFVYEGLTDDG--FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE----HDNIVQYLGTD-RDE 298 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~~g--~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~----HpnIv~l~~~~-~~~ 298 (488)
+|.+.+.||+|+||.||.+.+... ..+|+|.......... ..+..|..++..+. .+++..+++.+ ..+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-----ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence 899999999999999999998653 5789998875432211 13456777777776 36899999999 578
Q ss_pred CceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC-----CcEEEeecC
Q 011326 299 KRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS-----GSVKLADFG 370 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~-----~~vkL~DFG 370 (488)
...++||+.+ |.+|.++.... .++..++..++.|++.+|++||+.|++||||||.|+++... ..+.|.|||
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 8899999988 55999887433 59999999999999999999999999999999999999864 469999999
Q ss_pred Ccc--cccCC---------C-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhc
Q 011326 371 LAK--ATTMN---------D-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIG 438 (488)
Q Consensus 371 la~--~~~~~---------~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~ 438 (488)
+++ ..... . .....||..|++++.+ .+...+++.|+||++.++.+++.|..||...+.........
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H--~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVH--LGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHh--CCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 998 32111 1 1235599999999986 56678999999999999999999999997766433222222
Q ss_pred C---CCCCC-CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 439 G---GELPP-VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 439 ~---~~~~~-~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
. ..... .....+.++..+...+-..+...+|....+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 251 KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 1 11111 234456788888888888999999998877543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-26 Score=245.22 Aligned_cols=252 Identities=26% Similarity=0.404 Sum_probs=194.1
Q ss_pred eeeeecccCceEEEEEEec-CCcEEEEEEeecCC-CCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEe
Q 011326 229 KGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQD-EGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLE 306 (488)
Q Consensus 229 ~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~-~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 306 (488)
...++|.|++|.|+.+... ....++.|...... ...........+..|+.+-..++|||++..+....+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4577999999988877653 34445555443210 111112222336778888889999999998888777766666699
Q ss_pred eccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC------C
Q 011326 307 LVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN------D 379 (488)
Q Consensus 307 ~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~------~ 379 (488)
||++ +|..++... .++..++..++.|++.|+.|+|..||.||||||+|++++.+|.+||+|||.+...... .
T Consensus 402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~ 480 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHE 480 (601)
T ss_pred cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhh
Confidence 9999 999999877 7999999999999999999999999999999999999999999999999998644322 1
Q ss_pred cccCCCCCcccCchhhccccCCC-ChhhhHHHHHHHHHHHHcCCCCCCCCchhhhH-HHhcC-------CCCCCCCCccc
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGY-GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAM-FKIGG-------GELPPVPNSLS 450 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~-s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~-~~i~~-------~~~~~~~~~~s 450 (488)
....+|+..|+|||.+ ....| ....||||.|+++..|.+|+.||......+.. ..... .....+...++
T Consensus 481 ~~g~~gS~pY~apE~~--~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp 558 (601)
T KOG0590|consen 481 SSGIVGSDPYLAPEVL--TGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLP 558 (601)
T ss_pred hcCcccCCcCcCcccc--cccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhch
Confidence 3466799999999997 33445 45689999999999999999999765444332 11110 01112334578
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 451 RDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 451 ~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
.+.+.+|.+||++||.+|.|+++|++.+||++.
T Consensus 559 ~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 559 RETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred hhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 899999999999999999999999999999874
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=219.69 Aligned_cols=167 Identities=17% Similarity=0.145 Sum_probs=130.3
Q ss_pred cccccCceeeeeeecccCceEEEEEEec--CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcce-eecccc
Q 011326 220 FRRRITSWQKGELLGSGSYGFVYEGLTD--DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQ-YLGTDR 296 (488)
Q Consensus 220 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~-l~~~~~ 296 (488)
.+....+|++.+.||+|+||+||+|.+. ++..+|||.+...............+.+|+.+|++++|+|+++ ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 3445678999999999999999999874 5778899987532111112234567899999999999999985 5442
Q ss_pred CCCceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccC-CcccEEECCCCcEEEeecCCcccc
Q 011326 297 DEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDI-KCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 297 ~~~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDL-kp~NILl~~~~~vkL~DFGla~~~ 375 (488)
+..++||||++|++|... .. . ....++.|+++||.|||++||+|||| ||+|||++.++.++|+|||+|+..
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~~--~---~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-RP--H---GDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-Cc--c---chHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 357999999999999632 11 1 12568899999999999999999999 999999999999999999999754
Q ss_pred cCCC----------cccCCCCCcccCchhhc
Q 011326 376 TMND----------VKSCKGTAFWMAPEVVN 396 (488)
Q Consensus 376 ~~~~----------~~~~~gt~~y~aPE~~~ 396 (488)
.... ..+..+++.|.+||.+.
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 3322 23456888899999974
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=193.75 Aligned_cols=239 Identities=22% Similarity=0.299 Sum_probs=189.2
Q ss_pred ccCceeeeeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCCCc
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDEKR 300 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~ 300 (488)
..+.|.+++.||.|+||.+|.|.. .+|..||||.-......+ ++..|..+.+.++ ...|..+..++.+...
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp-------qL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP-------QLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc-------chhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 467899999999999999999987 579999999976544221 3456777777776 5678888888899999
Q ss_pred eEEEEeeccCCChHHHHh--hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEEC---CCCcEEEeecCCcccc
Q 011326 301 LCIFLELVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVD---ASGSVKLADFGLAKAT 375 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~--~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~---~~~~vkL~DFGla~~~ 375 (488)
-.+||+.+ |.||.++.. ...++..+++-++-|++.-++|+|..+++||||||+|+|+. ....+.++|||+|+..
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999998 459988874 44699999999999999999999999999999999999996 4567999999999755
Q ss_pred cCC---------CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhh---hHHHhcCCCCC
Q 011326 376 TMN---------DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ---AMFKIGGGELP 443 (488)
Q Consensus 376 ~~~---------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~---~~~~i~~~~~~ 443 (488)
... ..+...||.+|.+-..+ .+...+...|+-|+|.+|.++.-|..||.+..... ...+|...+..
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh--~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s 242 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAH--LGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS 242 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhh--hhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence 432 23456699999997765 34456888999999999999999999998865432 23333333322
Q ss_pred ----CCCCcccHHHHHHHHHhhhhCCCCCCCH
Q 011326 444 ----PVPNSLSRDAQDFILKCLQVNPNDRPTA 471 (488)
Q Consensus 444 ----~~~~~~s~~l~~Li~~cL~~dP~~Rps~ 471 (488)
.+-...|.|+.-.+..|-..-=++-|..
T Consensus 243 ~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 243 TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 2335678888888888887776777764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-25 Score=231.24 Aligned_cols=238 Identities=28% Similarity=0.449 Sum_probs=201.8
Q ss_pred eecccCceEEEEEEe----cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCCCceEEEEe
Q 011326 232 LLGSGSYGFVYEGLT----DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDEKRLCIFLE 306 (488)
Q Consensus 232 ~LG~G~fg~Vy~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E 306 (488)
++|+|+||.|+.+.. +.|..+|+|+..+......... ....|..++...+ ||.++.+...++.+...+++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~---~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld 77 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT---HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD 77 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc---ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence 379999999997643 3588899999887665443333 3446777888887 9999999999999999999999
Q ss_pred eccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCcccCCC
Q 011326 307 LVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG 385 (488)
Q Consensus 307 ~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~g 385 (488)
+..||.|...+... .+++.....+...++.+++++|+.||+|||+|++||+++.+|++++.|||+++..-..... +|
T Consensus 78 ~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--cg 155 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--CG 155 (612)
T ss_pred hcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--cc
Confidence 99999998776554 4788888999999999999999999999999999999999999999999999765444333 89
Q ss_pred CCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCC
Q 011326 386 TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465 (488)
Q Consensus 386 t~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP 465 (488)
|..|||||+++ +...+.|.||+|++++||++|..||.. ++...|.... ..+|..++.++.+++..++..+|
T Consensus 156 t~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~-~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 156 TYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE-LEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred chhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-cCCchhhhHHHHHHHHHHHhhCH
Confidence 99999999984 468899999999999999999999987 5555555444 36788999999999999999999
Q ss_pred CCCCC-----HHHHHhCccCCCC
Q 011326 466 NDRPT-----AAQLMEHPFIKRP 483 (488)
Q Consensus 466 ~~Rps-----~~eil~hp~f~~~ 483 (488)
..|.. ..|+++|+||+..
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred HHHhccCcchhHHHhccchheee
Confidence 99965 5899999999864
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.2e-23 Score=198.89 Aligned_cols=238 Identities=22% Similarity=0.344 Sum_probs=188.2
Q ss_pred CceeeeeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCceE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~ 302 (488)
-.|.++++||+|+||+.+.|.+ -++++||||.-......+ ++..|....+.| ..++|.+.+.+.+++..-.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP-------QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP-------QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcc-------hHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 3689999999999999999986 489999999876544322 455666666665 5899999999999999999
Q ss_pred EEEeeccCCChHHHHh--hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC-----CcEEEeecCCcccc
Q 011326 303 IFLELVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS-----GSVKLADFGLAKAT 375 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~--~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~-----~~vkL~DFGla~~~ 375 (488)
+|+|++ |.+|.++.. ...++...+..++.|++.-++|+|++.+|+|||||+|+||... ..+.++|||+|+.+
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 999998 459999875 3469999999999999999999999999999999999999754 35999999999866
Q ss_pred cCCC---------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCch---hhhHHHhcCCCCC
Q 011326 376 TMND---------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG---GQAMFKIGGGELP 443 (488)
Q Consensus 376 ~~~~---------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~---~~~~~~i~~~~~~ 443 (488)
.... ..+..||.+||+-..+ .+.+.+...|+-|||-++++.|-|..||.+... .+...+|-..+..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTH--lGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred cCccccccCccccccccccceeeeEeecc--ccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 5433 3456699999998875 566789999999999999999999999987653 3445555443332
Q ss_pred C----CCCcccHHHHHHHHHhhhhCCCCCCCHH
Q 011326 444 P----VPNSLSRDAQDFILKCLQVNPNDRPTAA 472 (488)
Q Consensus 444 ~----~~~~~s~~l~~Li~~cL~~dP~~Rps~~ 472 (488)
. +-..+|.++..-+...-..+=.+-|..+
T Consensus 258 T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 258 TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence 1 2245677777766666666666666643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=197.94 Aligned_cols=234 Identities=24% Similarity=0.303 Sum_probs=154.8
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCC-----------CCccee--
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH-----------DNIVQY-- 291 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-----------pnIv~l-- 291 (488)
.+..++.||.|+++.||.+++. +|+.+|+|+...... ......+++++|.-....+.+ .-++++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~--~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPAD--ASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESST--THTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccc--cchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 4677899999999999999996 799999999987763 344556777777655555332 112211
Q ss_pred ---ec---cccCC---C-----ceEEEEeeccCCChHHHHhh---h-----ccChhhhhHHHHHHHHHHHHHHHCCCccc
Q 011326 292 ---LG---TDRDE---K-----RLCIFLELVTKGSLASLYQK---Y-----HLSDSQVSSYTRQILNGLKYLHEQNVVHR 349 (488)
Q Consensus 292 ---~~---~~~~~---~-----~~~lV~E~~~~gsL~~~l~~---~-----~ls~~~~~~i~~qi~~aL~yLH~~giiHr 349 (488)
-+ ++... . ..+++|+-+.+ +|.+++.. . ++.......+..|+++.+++||..|++|+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg 169 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG 169 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence 11 01111 1 23667777755 88776532 1 13333456677999999999999999999
Q ss_pred cCCcccEEECCCCcEEEeecCCcccccCCCcccCCCCCcccCchhhccc------cCCCChhhhHHHHHHHHHHHHcCCC
Q 011326 350 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLK------KDGYGLTADIWSLGCTVLEMLTRRH 423 (488)
Q Consensus 350 DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~k~DvwSlGvlL~eLltG~~ 423 (488)
||+|+|++++.+|.++|+||+.....+..... ...+..|.+||..... ...++.+.|.|+||+++|.|++|..
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999999999999876544332222 4456779999986332 2347889999999999999999999
Q ss_pred CCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCC
Q 011326 424 PYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDR 468 (488)
Q Consensus 424 Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~R 468 (488)
||........... .+.... .+|+.++.||..+|++||.+|
T Consensus 249 Pf~~~~~~~~~~~----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9987654433221 222344 789999999999999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-23 Score=226.85 Aligned_cols=244 Identities=22% Similarity=0.250 Sum_probs=184.2
Q ss_pred ceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFL 305 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 305 (488)
++...+.||.+.|=.|.+|.++.|. |+||++.+.+....-.. ..+...|++ ...+++||++++.-+-..+...|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~-~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRP-FKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchH-HHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 6788889999999999999998887 99999987764433222 233334444 56678999999999988888899999
Q ss_pred eeccCCChHHHHhhhc-cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc--CCC---
Q 011326 306 ELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--MND--- 379 (488)
Q Consensus 306 E~~~~gsL~~~l~~~~-ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~--~~~--- 379 (488)
+|..+ +|.+.+..++ +...+...|+.|++.||..+|+.||+|||||.+||||+.-+-+.|+||..-+..- ..+
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 99988 8888887665 6788899999999999999999999999999999999999999999998776432 221
Q ss_pred cccCCCC----CcccCchhhcccc--------CC-CChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCC-C-C
Q 011326 380 VKSCKGT----AFWMAPEVVNLKK--------DG-YGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGE-L-P 443 (488)
Q Consensus 380 ~~~~~gt----~~y~aPE~~~~~~--------~~-~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~-~-~ 443 (488)
..-+..| ..|.|||.+.... .. .+++.||||+||+++||++ |++||....- .....+. . +
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL----~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL----LAYRSGNADDP 255 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH----HhHhccCccCH
Confidence 1112222 3499999974311 11 5789999999999999998 7888843110 0001110 0 0
Q ss_pred -C-CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 444 -P-VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 444 -~-~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
. +...-+..+++||..|++.||.+|.++++.|+.
T Consensus 256 e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 256 EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0 001124478999999999999999999999875
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=187.18 Aligned_cols=143 Identities=18% Similarity=0.170 Sum_probs=111.1
Q ss_pred eeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcch---------------------hHHHHHHHHHHHHhcCCCCCc
Q 011326 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGK---------------------QSILQLEQEISLLGQFEHDNI 288 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~---------------------~~~~~~~~Ei~iL~~l~HpnI 288 (488)
...||+|+||.||+|.+.+|+.||+|++.......... ........|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35699999999999998889999999997653211110 011233459999999988776
Q ss_pred ceeeccccCCCceEEEEeeccCCChHHH-HhhhccChhhhhHHHHHHHHHHHHH-HHCCCccccCCcccEEECCCCcEEE
Q 011326 289 VQYLGTDRDEKRLCIFLELVTKGSLASL-YQKYHLSDSQVSSYTRQILNGLKYL-HEQNVVHRDIKCANILVDASGSVKL 366 (488)
Q Consensus 289 v~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~ls~~~~~~i~~qi~~aL~yL-H~~giiHrDLkp~NILl~~~~~vkL 366 (488)
.....+.. ...+|||||++|+++... +...++++..+..++.|++.+|.+| |+.||+||||||+|||++ ++.++|
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~L 158 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYI 158 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEE
Confidence 43332222 223899999999877654 4556789999999999999999999 799999999999999998 588999
Q ss_pred eecCCcccc
Q 011326 367 ADFGLAKAT 375 (488)
Q Consensus 367 ~DFGla~~~ 375 (488)
+|||+|...
T Consensus 159 iDFG~a~~~ 167 (190)
T cd05147 159 IDVSQSVEH 167 (190)
T ss_pred EEccccccC
Confidence 999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.5e-22 Score=190.20 Aligned_cols=173 Identities=15% Similarity=0.155 Sum_probs=133.0
Q ss_pred cCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHH------HHHHHHHHhcCCCCCcceeeccccC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQ------LEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~------~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
-++|...++||.|+||.||.... ++..+|+|.+...... ....... +.+|+..+.++.||+|..+.+++..
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~--~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKR--TERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCc--hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 46799999999999999999655 5778999999754432 2222222 6799999999999999998887553
Q ss_pred C--------CceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeec
Q 011326 298 E--------KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADF 369 (488)
Q Consensus 298 ~--------~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DF 369 (488)
. ...+++|||++|.+|.++.. +++ ....+++.+|..||+.|++|||+||.||+++.+| ++|+||
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 2 35899999999999987732 233 3466999999999999999999999999999988 999999
Q ss_pred CCcccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHH
Q 011326 370 GLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEML 419 (488)
Q Consensus 370 Gla~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLl 419 (488)
|........... +.+ .....+..+.|+|+||+++..+.
T Consensus 179 g~~~~~~e~~a~-----------d~~-vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK-----------DRI-DLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH-----------HHH-HHHhHhcccccccceeEeehHHH
Confidence 987654322211 112 12334667899999999988654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=181.90 Aligned_cols=144 Identities=18% Similarity=0.190 Sum_probs=113.9
Q ss_pred eeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcc---------------------hhHHHHHHHHHHHHhcCCCCCc
Q 011326 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRG---------------------KQSILQLEQEISLLGQFEHDNI 288 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~---------------------~~~~~~~~~Ei~iL~~l~HpnI 288 (488)
.+.||+|+||.||+|.+.+|+.||||++......... ......+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999888999999999876321111 0112234678999999999987
Q ss_pred ceeeccccCCCceEEEEeeccCCChH-HHHhhhccChhhhhHHHHHHHHHHHHHHH-CCCccccCCcccEEECCCCcEEE
Q 011326 289 VQYLGTDRDEKRLCIFLELVTKGSLA-SLYQKYHLSDSQVSSYTRQILNGLKYLHE-QNVVHRDIKCANILVDASGSVKL 366 (488)
Q Consensus 289 v~l~~~~~~~~~~~lV~E~~~~gsL~-~~l~~~~ls~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~NILl~~~~~vkL 366 (488)
.....+... ..++||||++|+++. ..+....++...+..++.|++.++.+||. .||+||||||+||+++ ++.++|
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~l 158 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYI 158 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEE
Confidence 543333222 248999999998553 34566678889999999999999999999 9999999999999998 899999
Q ss_pred eecCCccccc
Q 011326 367 ADFGLAKATT 376 (488)
Q Consensus 367 ~DFGla~~~~ 376 (488)
+|||++....
T Consensus 159 iDFG~a~~~~ 168 (190)
T cd05145 159 IDVSQAVELD 168 (190)
T ss_pred EEcccceecC
Confidence 9999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-22 Score=188.76 Aligned_cols=247 Identities=21% Similarity=0.349 Sum_probs=194.8
Q ss_pred cccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
....+..+..+|.+...|..|+|++. |..+++|++.......+ .-.+|..|.-.|+-..||||+++++.|.....+
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~r---isrdfneefp~lrifshpnilpvlgacnsppnl 262 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTAR---ISRDFNEEFPALRIFSHPNILPVLGACNSPPNL 262 (448)
T ss_pred cchhhhhhhhhhccCCCccccccccc-Ccchhhhhhhhhhcchh---hcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence 34556667778999999999999987 44566688776553222 235678888889999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhhc---cChhhhhHHHHHHHHHHHHHHHCC--CccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 302 CIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILNGLKYLHEQN--VVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~~---ls~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
.++..||+.|+|...+.... .+..++.+++..++.|++|||+.. |.--.|+...++||++.+.+|. .+-.+..
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfs- 340 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS- 340 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceee-
Confidence 99999999999999997653 788899999999999999999864 4445688999999998877664 1111111
Q ss_pred CCCcccCCCCCcccCchhhccccCCC-ChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHh-cCCCCCCCCCcccHHHH
Q 011326 377 MNDVKSCKGTAFWMAPEVVNLKKDGY-GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKI-GGGELPPVPNSLSRDAQ 454 (488)
Q Consensus 377 ~~~~~~~~gt~~y~aPE~~~~~~~~~-s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i-~~~~~~~~~~~~s~~l~ 454 (488)
-+.....-.|.|++||.++...... -.++|+|||.+++|||.|...||....+-+.-.++ ..+.+..+|+.++..+.
T Consensus 341 -fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~ 419 (448)
T KOG0195|consen 341 -FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMN 419 (448)
T ss_pred -eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHH
Confidence 1122334578899999986444333 35799999999999999999999887765544433 45667789999999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHH
Q 011326 455 DFILKCLQVNPNDRPTAAQLM 475 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil 475 (488)
.|++-|+..||.+||.++.|+
T Consensus 420 klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 420 KLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHhcCCCCcCCCcceeh
Confidence 999999999999999998765
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=194.94 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=180.5
Q ss_pred ccccCceeeeeeecccCceEEEEEEecC-C-----------------------------------cEEEEEEeecCCCCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTDD-G-----------------------------------FFFAVKEVSLQDEGP 264 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-g-----------------------------------~~vAvK~i~~~~~~~ 264 (488)
+..+++|+++..||+|.-..||.+...+ | -+.|||.+..-+...
T Consensus 153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s 232 (598)
T KOG4158|consen 153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS 232 (598)
T ss_pred ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence 3458899999999999999999775321 1 134555554333332
Q ss_pred cchhHHHHHHHHH------HHH--------hc--------CCCCCcceeeccccCC------------------------
Q 011326 265 RGKQSILQLEQEI------SLL--------GQ--------FEHDNIVQYLGTDRDE------------------------ 298 (488)
Q Consensus 265 ~~~~~~~~~~~Ei------~iL--------~~--------l~HpnIv~l~~~~~~~------------------------ 298 (488)
......+.+-+|. ..+ +. -+|||||++.+.|.++
T Consensus 233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~ 312 (598)
T KOG4158|consen 233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA 312 (598)
T ss_pred chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence 3333333333321 111 11 2599999988865432
Q ss_pred ---CceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEEC--CC--CcEEEeecCC
Q 011326 299 ---KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVD--AS--GSVKLADFGL 371 (488)
Q Consensus 299 ---~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~--~~--~~vkL~DFGl 371 (488)
..+|+||.-++. +|.+++..+..+.....-++.|+++|+.|||++|+.|||+|.+|||+. +| ..+.|+|||.
T Consensus 313 g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC 391 (598)
T KOG4158|consen 313 GEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC 391 (598)
T ss_pred CCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence 247999998877 999999888889999999999999999999999999999999999993 33 3689999998
Q ss_pred cccccC--------CCcccCCCCCcccCchhhccccCCC----ChhhhHHHHHHHHHHHHcCCCCCCCCchh-hhHHHhc
Q 011326 372 AKATTM--------NDVKSCKGTAFWMAPEVVNLKKDGY----GLTADIWSLGCTVLEMLTRRHPYSHLEGG-QAMFKIG 438 (488)
Q Consensus 372 a~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~----s~k~DvwSlGvlL~eLltG~~Pf~~~~~~-~~~~~i~ 438 (488)
+-.... +......|...-||||+.+...+.. -.+.|.|+.|.+-||++....||...-.- -......
T Consensus 392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq 471 (598)
T KOG4158|consen 392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ 471 (598)
T ss_pred eeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh
Confidence 643221 1122445778899999974333221 24799999999999999999999762111 1111234
Q ss_pred CCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCH
Q 011326 439 GGELPPVPNSLSRDAQDFILKCLQVNPNDRPTA 471 (488)
Q Consensus 439 ~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~ 471 (488)
....|.++..+++.+++|+..+|+.||.+|++.
T Consensus 472 e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 472 ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred hhhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 456788999999999999999999999999983
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.6e-21 Score=179.50 Aligned_cols=188 Identities=20% Similarity=0.109 Sum_probs=140.9
Q ss_pred eeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCCCceEEEEee
Q 011326 229 KGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDEKRLCIFLEL 307 (488)
Q Consensus 229 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~ 307 (488)
....|+.|+||+||.+.. .+.+++.+.+........ ......+.+|+++|++++ |+++++++++ +..+++|||
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~-~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLR-GVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhh-hHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 346799999999997755 678888777754332111 111225789999999995 5889999886 347999999
Q ss_pred ccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccC-CcccEEECCCCcEEEeecCCcccccCCCc------
Q 011326 308 VTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDI-KCANILVDASGSVKLADFGLAKATTMNDV------ 380 (488)
Q Consensus 308 ~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDL-kp~NILl~~~~~vkL~DFGla~~~~~~~~------ 380 (488)
+.|.+|.+.+.. . ...++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||++........
T Consensus 80 I~G~~L~~~~~~-----~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~ 153 (218)
T PRK12274 80 LAGAAMYQRPPR-----G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLA 153 (218)
T ss_pred ecCccHHhhhhh-----h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHH
Confidence 999998754322 1 2457889999999999999999999 79999999999999999999975443221
Q ss_pred ---------ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 011326 381 ---------KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHL 428 (488)
Q Consensus 381 ---------~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~ 428 (488)
.-...++.|++|+........--...++++.|+-+|.++|+..|..+.
T Consensus 154 ~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 154 REDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 011268889999875333222225679999999999999999887554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.5e-21 Score=209.57 Aligned_cols=216 Identities=30% Similarity=0.457 Sum_probs=165.1
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
-.+|+.+++|..|++|.||...++ +.+.+|+|. .++.. +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l----------ilRn--ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----------ILRN--ILTFAGNPFVV------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch----------hhhc--cccccCCccee-------------
Confidence 357999999999999999999886 577888844 32111 1110 23333444443
Q ss_pred EEEeeccCCChHHHHhhhc-cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 303 IFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~~-ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
|+-..+++..+ ++.. ++.+++|||+.||+|||+||+|.+|+.-|++|+.|||+++..-...
T Consensus 136 --------gDc~tllk~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --------GDCATLLKNIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --------chhhhhcccCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 33333333322 2322 2889999999999999999999999999999999999986432211
Q ss_pred ---------------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC--C
Q 011326 380 ---------------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE--L 442 (488)
Q Consensus 380 ---------------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~--~ 442 (488)
....+|||.|.|||++ ...+|+..+|+|++|+++||.+.|..||.+...++.+..+.... +
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi--lrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w 277 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI--LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 277 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhh--hhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence 2355799999999998 55669999999999999999999999999998888877766544 3
Q ss_pred CCCCCcccHHHHHHHHHhhhhCCCCC---CCHHHHHhCccCCCC
Q 011326 443 PPVPNSLSRDAQDFILKCLQVNPNDR---PTAAQLMEHPFIKRP 483 (488)
Q Consensus 443 ~~~~~~~s~~l~~Li~~cL~~dP~~R---ps~~eil~hp~f~~~ 483 (488)
++-...+++++++++.++|+.+|..| +..-++.+|+||+..
T Consensus 278 pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 278 PEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred cccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 44456789999999999999999999 467889999999853
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=172.14 Aligned_cols=132 Identities=19% Similarity=0.263 Sum_probs=105.0
Q ss_pred eeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-----CCCCcceeeccccCCC---c
Q 011326 230 GELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-----EHDNIVQYLGTDRDEK---R 300 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-----~HpnIv~l~~~~~~~~---~ 300 (488)
.+.||+|+||.||. +. ++.. +||++..... .....+.+|+.+++.+ +||||++++++++++. .
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc-----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 46799999999996 43 4444 6998875432 1235688999999999 5799999999998864 3
Q ss_pred -eEEEEee--ccCCChHHHHhhhccChhhhhHHHHHHHHHH-HHHHHCCCccccCCcccEEECC----CCcEEEeecCC
Q 011326 301 -LCIFLEL--VTKGSLASLYQKYHLSDSQVSSYTRQILNGL-KYLHEQNVVHRDIKCANILVDA----SGSVKLADFGL 371 (488)
Q Consensus 301 -~~lV~E~--~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL-~yLH~~giiHrDLkp~NILl~~----~~~vkL~DFGl 371 (488)
+.+|||| +++|+|.+++.+..+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||+-
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 3378999 668999999987666666 36678888777 9999999999999999999974 34899999543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.2e-18 Score=191.72 Aligned_cols=195 Identities=21% Similarity=0.256 Sum_probs=155.5
Q ss_pred ccccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC---CCCcceeeccc
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE---HDNIVQYLGTD 295 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~ 295 (488)
.....-..|.|.+.||+|+||.||.|...+|+.||+|+-........ .--.+++.+|+ -+.|+++....
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf--------YI~~q~~~RLk~~~~~~~~~~~~a~ 763 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF--------YICLQVMERLKPQMLPSIMHISSAH 763 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee--------eehHHHHHhhchhhhcchHHHHHHH
Confidence 33444567999999999999999999998899999999765543211 11122334444 34566677766
Q ss_pred cCCCceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC-------CCcEEEe
Q 011326 296 RDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA-------SGSVKLA 367 (488)
Q Consensus 296 ~~~~~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~-------~~~vkL~ 367 (488)
...+.-++|+||.+.|||.+++... .+++..+..++.|++..+++||.++|||+||||+|+||.. ..-++|+
T Consensus 764 ~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 764 VFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred ccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence 7777889999999999999999755 4899999999999999999999999999999999999942 2359999
Q ss_pred ecCCccccc---CC-CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCC
Q 011326 368 DFGLAKATT---MN-DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRH 423 (488)
Q Consensus 368 DFGla~~~~---~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~ 423 (488)
|||-+-.+. .. .....++|-.+--+|+. .+..++..+|.|+++.+++-||.|+.
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~--~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMR--EGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHh--cCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999874322 22 24456788899999996 67789999999999999999999973
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=163.69 Aligned_cols=139 Identities=19% Similarity=0.237 Sum_probs=114.3
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeecCCCCCc---chhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEee
Q 011326 231 ELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPR---GKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLEL 307 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 307 (488)
+.||+|++|.||+|.. +|..+++|.......... .......+.+|+.++..+.|+++.....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5699999999999977 677899998654332111 111234678899999999999988777776677788999999
Q ss_pred ccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccc
Q 011326 308 VTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 374 (488)
Q Consensus 308 ~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~ 374 (488)
++|++|.+++..... ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999998865322 7889999999999999999999999999999998 88999999998754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-18 Score=169.85 Aligned_cols=145 Identities=21% Similarity=0.220 Sum_probs=112.9
Q ss_pred ceeeeeeecccCceEEEEEE--ecCCcEEEEEEeecCCCCCcc-------------------hhHHHHHHHHHHHHhcCC
Q 011326 226 SWQKGELLGSGSYGFVYEGL--TDDGFFFAVKEVSLQDEGPRG-------------------KQSILQLEQEISLLGQFE 284 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~--~~~g~~vAvK~i~~~~~~~~~-------------------~~~~~~~~~Ei~iL~~l~ 284 (488)
.|.+.+.||+|+||.||+|. ..+|..||+|.+......... ......+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 458999999999764321100 011234678999999997
Q ss_pred CCC--cceeeccccCCCceEEEEeeccCCChHHHH-hhhccChhhhhHHHHHHHHHHHHHHHCC-CccccCCcccEEECC
Q 011326 285 HDN--IVQYLGTDRDEKRLCIFLELVTKGSLASLY-QKYHLSDSQVSSYTRQILNGLKYLHEQN-VVHRDIKCANILVDA 360 (488)
Q Consensus 285 Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l-~~~~ls~~~~~~i~~qi~~aL~yLH~~g-iiHrDLkp~NILl~~ 360 (488)
+.+ +...+++ ...++||||++|++|.... ....+....+..++.|++.++.+||+.| ++||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 533 3444443 2358999999998886654 4445666677899999999999999999 99999999999999
Q ss_pred CCcEEEeecCCcccc
Q 011326 361 SGSVKLADFGLAKAT 375 (488)
Q Consensus 361 ~~~vkL~DFGla~~~ 375 (488)
++.++|+|||.+...
T Consensus 184 ~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCCEEEEEChhhhcc
Confidence 889999999987543
|
|
| >PF12515 CaATP_NAI: Ca2+-ATPase N terminal autoinhibitory domain; InterPro: IPR024750 This entry represents the N-terminal autoinhibitory calmodulin-binding domain characteristic of certain calcium-transporting ATPases [] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.7e-20 Score=126.85 Aligned_cols=47 Identities=34% Similarity=0.781 Sum_probs=42.9
Q ss_pred CCCCCCCCCCCCCCCCCcHHHHHHHHhhchhcccccccchhhhhhhhhHHH
Q 011326 2 FIDPELFGVAPWISGQPPEDTLKRWKSACNIVNNRRRKFRMVANLANQAET 52 (488)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 52 (488)
|++ ++|++++ ||||+|+|+|||+||++||||+|||||++||+||.|+
T Consensus 1 yl~-~~Fdi~~---Kn~s~e~l~rWR~a~~lv~N~~RRFR~~~dL~k~~e~ 47 (47)
T PF12515_consen 1 YLD-DNFDIPA---KNSSEEALRRWRQAVGLVKNARRRFRYTADLKKREEA 47 (47)
T ss_pred CCc-cccCCCC---CCCCHHHHHHHHHHhHHhccccceeeecccHhhHhcC
Confidence 444 4569999 9999999999999999999999999999999999874
|
This domain binds calmodulin in a calcium-dependent fashion and has a conserved RRFR sequence motif. There are two completely conserved residues (F and W) that may be functionally important.; GO: 0005516 calmodulin binding |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.8e-18 Score=161.04 Aligned_cols=142 Identities=21% Similarity=0.224 Sum_probs=110.8
Q ss_pred eeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcc-----------------hhHHHHHHHHHHHHhcCCCCC--
Q 011326 227 WQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRG-----------------KQSILQLEQEISLLGQFEHDN-- 287 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~-----------------~~~~~~~~~Ei~iL~~l~Hpn-- 287 (488)
|.+.+.||+|+||.||++...+|..||||++......... .........|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 6667889999999999998888999999998754311100 011123667888999988774
Q ss_pred cceeeccccCCCceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEe
Q 011326 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLA 367 (488)
Q Consensus 288 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~ 367 (488)
++..++. ...+++|||++|++|..+.. ......++.+++.++.++|+.|++|+||+|+||+++.++.++|+
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~-----~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~li 167 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRV-----LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYII 167 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhccc-----cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEE
Confidence 4444432 34589999999999976543 14567889999999999999999999999999999999999999
Q ss_pred ecCCcccccC
Q 011326 368 DFGLAKATTM 377 (488)
Q Consensus 368 DFGla~~~~~ 377 (488)
|||++.....
T Consensus 168 Dfg~~~~~~~ 177 (198)
T cd05144 168 DWPQMVSTDH 177 (198)
T ss_pred ECCccccCCC
Confidence 9999855443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.3e-18 Score=159.13 Aligned_cols=135 Identities=23% Similarity=0.282 Sum_probs=107.6
Q ss_pred eecccCceEEEEEEecCCcEEEEEEeecCCCCCc---chhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeec
Q 011326 232 LLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPR---GKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 232 ~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
.||+|+||.||+|.. +|..+++|.......... ......++.+|+.++..+.|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999984 577899998654322111 1223456788999999999887655444455566779999999
Q ss_pred cCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccc
Q 011326 309 TKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 374 (488)
Q Consensus 309 ~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~ 374 (488)
+|++|.+++..... .++.|++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988754322 8899999999999999999999999999999 89999999998755
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.1e-18 Score=178.27 Aligned_cols=197 Identities=27% Similarity=0.506 Sum_probs=155.5
Q ss_pred HhcCCCCCcceeeccccCCCceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCC-ccccCCcccE
Q 011326 280 LGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNV-VHRDIKCANI 356 (488)
Q Consensus 280 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~gi-iHrDLkp~NI 356 (488)
|+.+.|.|+.+++|.+.++...++|.+||.-|+|.+.+... .+++.-...+++.++.||.|||...| .|+.|++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 46788999999999999999999999999999999999764 47777888899999999999998866 9999999999
Q ss_pred EECCCCcEEEeecCCcccccC----CCcccCCCCCcccCchhhccc--cC---CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 011326 357 LVDASGSVKLADFGLAKATTM----NDVKSCKGTAFWMAPEVVNLK--KD---GYGLTADIWSLGCTVLEMLTRRHPYSH 427 (488)
Q Consensus 357 Ll~~~~~vkL~DFGla~~~~~----~~~~~~~gt~~y~aPE~~~~~--~~---~~s~k~DvwSlGvlL~eLltG~~Pf~~ 427 (488)
++|....+||+|||+...... .......-...|.|||.+... .. ..+.+.|+||+|++++|+++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999866532 112222244559999998432 11 146789999999999999999999976
Q ss_pred Cch----hhhHHHhcCCCC----CCCC--CcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 428 LEG----GQAMFKIGGGEL----PPVP--NSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 428 ~~~----~~~~~~i~~~~~----~~~~--~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
... .+.+..+..+.. |.+. ...++++..++..||..+|.+||+++++-.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 322 244555444122 2211 135567999999999999999999998853
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.7e-19 Score=180.28 Aligned_cols=174 Identities=26% Similarity=0.449 Sum_probs=139.6
Q ss_pred ceEEEEeeccCCChHHHHhhhc----cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 300 RLCIFLELVTKGSLASLYQKYH----LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~~----ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
.+||.|++|...+|.+++.... .+....+.++.|++.|++| +|.+|+|+||.||+...+..+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 5899999999999999996543 6777889999999999999 99999999999999999999999999997644
Q ss_pred cCCC--------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCC
Q 011326 376 TMND--------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVP 446 (488)
Q Consensus 376 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~ 446 (488)
.... .+...||..||+||.+ .+..|+.++|||+||++|+||+. -..++ ....+...+..+.+|+..
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi--~g~~y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r~g~ip~~~ 481 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQI--RGQQYSEKVDIYALGLILAELLIQFSTQF---ERIATLTDIRDGIIPPEF 481 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHH--hhhhhhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhhcCCCChHH
Confidence 3322 3456799999999998 66779999999999999999987 33332 223344455556655333
Q ss_pred CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCC
Q 011326 447 NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481 (488)
Q Consensus 447 ~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~ 481 (488)
..--++-..|+.+++.+.|.+||++.+.-.|+|.+
T Consensus 482 ~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 482 LQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred hhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 33334556899999999999999888888888764
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-17 Score=178.92 Aligned_cols=141 Identities=20% Similarity=0.231 Sum_probs=111.8
Q ss_pred ceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCC---cchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGP---RGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.|...+.||+|+||.||++.+.+.. +++|......... ........+.+|+.++..++|++++....++.+....+
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 3456788999999999999875443 4444332221111 11123456889999999999999988777777777789
Q ss_pred EEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 303 IFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
+||||++|++|.+++. ....++.|++.+|.+||+.|++||||||+|||+ .++.++|+|||+++..
T Consensus 413 lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999998875 356789999999999999999999999999999 6789999999998653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-18 Score=189.92 Aligned_cols=255 Identities=29% Similarity=0.404 Sum_probs=201.9
Q ss_pred cCceeeeeeecccCceEEEEEEec--CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCCCc
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD--DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDEKR 300 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~ 300 (488)
...|.+.+.||+|+|+.|-..... ....+|+|.+.... ...........|..+-..+. |+|++.+++...+.+.
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~ 95 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS 95 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC---CccchhhhcCccccccccccccccccccCCccCCCcc
Confidence 345667777999999999887663 35566767665443 12223344555777666676 9999999999999999
Q ss_pred eEEEEeeccCCChHHHH-hhh--ccChhhhhHHHHHHHHHHHHHH-HCCCccccCCcccEEECCCC-cEEEeecCCcccc
Q 011326 301 LCIFLELVTKGSLASLY-QKY--HLSDSQVSSYTRQILNGLKYLH-EQNVVHRDIKCANILVDASG-SVKLADFGLAKAT 375 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l-~~~--~ls~~~~~~i~~qi~~aL~yLH-~~giiHrDLkp~NILl~~~~-~vkL~DFGla~~~ 375 (488)
.++.+||..|+++...+ ... +.+...+..++.|+..++.|+| ..++.|+|+||+|.+++..+ .+++.|||+|...
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999999998877 433 5788889999999999999999 99999999999999999999 9999999999766
Q ss_pred cC-CC----cccCCC-CCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHH-HhcCC-C--CCCC
Q 011326 376 TM-ND----VKSCKG-TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGG-E--LPPV 445 (488)
Q Consensus 376 ~~-~~----~~~~~g-t~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~-~i~~~-~--~~~~ 445 (488)
.. .. .....| ++.|.|||... ......+..|+||.|+++.-+++|..||.......... ..... . ....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~-~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLS-GKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP 254 (601)
T ss_pred cccCCcceeeecccCCCCCCCCccccc-chhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence 65 22 234557 99999999873 22455788999999999999999999997655443221 11111 1 1334
Q ss_pred CCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 446 PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 446 ~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
...++....+++.+++..+|..|.+.+++..+||+..
T Consensus 255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 255 WNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccCChhhhhcccccccCCchhccccccccccccccc
Confidence 5678889999999999999999999999999999977
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.9e-16 Score=147.38 Aligned_cols=141 Identities=24% Similarity=0.289 Sum_probs=99.6
Q ss_pred eeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhH-------------------HHHHHHHHHHHhcCCCCC--c
Q 011326 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQS-------------------ILQLEQEISLLGQFEHDN--I 288 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~-------------------~~~~~~Ei~iL~~l~Hpn--I 288 (488)
.+.||+|+||.||+|.+.+|..||||++............ ......|...+.++.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998754322111110 011134555565554332 3
Q ss_pred ceeeccccCCCceEEEEeeccCCChH-HHHhhhccChhhhhHHHHHHHHHHHHHHH-CCCccccCCcccEEECCCCcEEE
Q 011326 289 VQYLGTDRDEKRLCIFLELVTKGSLA-SLYQKYHLSDSQVSSYTRQILNGLKYLHE-QNVVHRDIKCANILVDASGSVKL 366 (488)
Q Consensus 289 v~l~~~~~~~~~~~lV~E~~~~gsL~-~~l~~~~ls~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~NILl~~~~~vkL 366 (488)
.+.+++ ...+++|||++++++. ..+...... ..+..++.+++.++.++|. .||+|+||||+||+++ ++.++|
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~l 155 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYI 155 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEE
Confidence 444433 2358999999995432 112211111 6788999999999999999 9999999999999999 999999
Q ss_pred eecCCccccc
Q 011326 367 ADFGLAKATT 376 (488)
Q Consensus 367 ~DFGla~~~~ 376 (488)
+|||.+....
T Consensus 156 iDfg~a~~~~ 165 (187)
T cd05119 156 IDVPQAVEID 165 (187)
T ss_pred EECccccccc
Confidence 9999885443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.4e-16 Score=151.60 Aligned_cols=139 Identities=21% Similarity=0.230 Sum_probs=105.5
Q ss_pred eeec-ccCceEEEEEEecCCcEEEEEEeecCCC--------CCcchhHHHHHHHHHHHHhcCCCCCc--ceeeccccCCC
Q 011326 231 ELLG-SGSYGFVYEGLTDDGFFFAVKEVSLQDE--------GPRGKQSILQLEQEISLLGQFEHDNI--VQYLGTDRDEK 299 (488)
Q Consensus 231 ~~LG-~G~fg~Vy~~~~~~g~~vAvK~i~~~~~--------~~~~~~~~~~~~~Ei~iL~~l~HpnI--v~l~~~~~~~~ 299 (488)
..|| .||.|+||.+... +..+++|.+..... ..........+.+|+.++.++.|++| +..+++...+.
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4577 7888888888664 77899998864221 00111233567889999999998875 56666543322
Q ss_pred ----ceEEEEeeccC-CChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccc
Q 011326 300 ----RLCIFLELVTK-GSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 374 (488)
Q Consensus 300 ----~~~lV~E~~~~-gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~ 374 (488)
..++|||+++| .+|.+++....+++. .+.|++.+|.+||++||+|+||||+|||++.++.++|+|||.+..
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 23599999997 689988876555554 367899999999999999999999999999999999999998754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=2e-15 Score=133.42 Aligned_cols=131 Identities=21% Similarity=0.260 Sum_probs=110.9
Q ss_pred eeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCC--CCcceeeccccCCCceEEEEe
Q 011326 229 KGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH--DNIVQYLGTDRDEKRLCIFLE 306 (488)
Q Consensus 229 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~lV~E 306 (488)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++++++.+....+..+++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEE
Confidence 34679999999999998755 7899998764321 3467889999999976 589999998888889999999
Q ss_pred eccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHC---CCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 307 LVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQ---NVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 307 ~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
|++++++..+ +......++.+++.++++||.. +++|+|++|+||+++.++.++++|||.+.
T Consensus 74 ~~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 74 WIEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred ecCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 9999877654 5566678899999999999985 79999999999999998999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.7e-14 Score=148.92 Aligned_cols=144 Identities=17% Similarity=0.137 Sum_probs=100.7
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeecCCCCCcc-------------------------h----------hHHHHHHH
Q 011326 231 ELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRG-------------------------K----------QSILQLEQ 275 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~-------------------------~----------~~~~~~~~ 275 (488)
+.||.|++|.||+|+..+|+.||||+..+....... . ....++.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 569999999999999999999999998654211000 0 00113555
Q ss_pred HHHHHhcCC-----CCCcceeecc-ccCCCceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHH-HHHHHHHCCCcc
Q 011326 276 EISLLGQFE-----HDNIVQYLGT-DRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILN-GLKYLHEQNVVH 348 (488)
Q Consensus 276 Ei~iL~~l~-----HpnIv~l~~~-~~~~~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~-aL~yLH~~giiH 348 (488)
|+..+.++. ++++ .+-.+ .......++||||++|++|.++........ ....++.+++. .+..+|..|++|
T Consensus 203 Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~g~~H 280 (437)
T TIGR01982 203 EAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRDGFFH 280 (437)
T ss_pred HHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhCCcee
Confidence 666665552 3332 22222 222345799999999999988764322111 33456666666 478899999999
Q ss_pred ccCCcccEEECCCCcEEEeecCCccccc
Q 011326 349 RDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 349 rDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
+|+||.||+++.++.++++|||++....
T Consensus 281 ~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 281 ADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=4.2e-14 Score=148.58 Aligned_cols=250 Identities=26% Similarity=0.288 Sum_probs=188.1
Q ss_pred ceeeeeeecc--cCceEEEEEEe---cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCCC
Q 011326 226 SWQKGELLGS--GSYGFVYEGLT---DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDEK 299 (488)
Q Consensus 226 ~y~~~~~LG~--G~fg~Vy~~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~ 299 (488)
.+.+.+.+|. |.+|.||.+.. .++..+|+|.-......+... ..=.+|+...+.++ |+|.++.+..++..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~---~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS---KRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc---ccccchhhcccccCccccccccCcccccCC
Confidence 4566677999 99999998865 368889999843322211111 11234555555554 999999888999999
Q ss_pred ceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHH----HHHHHHHCCCccccCCcccEEECCC-CcEEEeecCCc
Q 011326 300 RLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILN----GLKYLHEQNVVHRDIKCANILVDAS-GSVKLADFGLA 372 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~----aL~yLH~~giiHrDLkp~NILl~~~-~~vkL~DFGla 372 (488)
..++-+|++. .+|..+.... .+++..++....+... ||.++|..+++|-|+||.||++..+ ...+++|||+.
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 9999999996 4776666433 3888899999999999 9999999999999999999999998 88999999998
Q ss_pred ccccCCCc-------ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC-CC
Q 011326 373 KATTMNDV-------KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL-PP 444 (488)
Q Consensus 373 ~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~ 444 (488)
......+. ....|...|++||.. +.-++.+.|+|++|.++.+..++..+......... ..+..... ..
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~---~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-~~~r~~~ip~e 346 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELL---NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW-SQLRQGYIPLE 346 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhh---ccccchHhhhcchhhhhHhhHhhcccccCCCCCCc-cccccccCchh
Confidence 76655442 233577889999985 45578999999999999999888766543311111 11111111 12
Q ss_pred CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 445 VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 445 ~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
+....+.++...+..|+..+|..|++.+.+++|+++.+.
T Consensus 347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred hhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 334567778889999999999999999999999998754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.1e-13 Score=152.45 Aligned_cols=260 Identities=23% Similarity=0.288 Sum_probs=202.6
Q ss_pred cccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 220 FRRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 220 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
.+....++.+.+-+-.|+++.++.+.-. .|...++|.......-.. ........+-+++-..++|-++....-+...
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~--~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r 876 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT--NDYESIRSKSNILITPRSPAVVRSFPSFPCR 876 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhcc--ccccccCCccCccccCCCCceecccCCCCCC
Confidence 5677889999999999999999987654 465566666544332111 1122233444444445567777666666677
Q ss_pred CceEEEEeeccCCChHHHHhhhc-cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc-
Q 011326 299 KRLCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT- 376 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~~-ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~- 376 (488)
...+++++|..+++|...++..+ .+.+.+...+..+..++++||...+.|+|++|.|+++..+|+.++.|||......
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence 88999999999999998887766 7888888899999999999999999999999999999999999999998332100
Q ss_pred ------C------------------CC--------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCC
Q 011326 377 ------M------------------ND--------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHP 424 (488)
Q Consensus 377 ------~------------------~~--------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~P 424 (488)
. .. .....||+.|.+||.. .+.......|+|+.|++++|.++|.+|
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~--lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEIL--LGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccc--ccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 0 00 1234589999999986 555577889999999999999999999
Q ss_pred CCCCchhhhHHHhcCCCCC--CCCCcccHHHHHHHHHhhhhCCCCCCCHH---HHHhCccCCCC
Q 011326 425 YSHLEGGQAMFKIGGGELP--PVPNSLSRDAQDFILKCLQVNPNDRPTAA---QLMEHPFIKRP 483 (488)
Q Consensus 425 f~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~Li~~cL~~dP~~Rps~~---eil~hp~f~~~ 483 (488)
|...........+..+..+ .-+...++++.+++..++..+|.+|..+. ++..||||+..
T Consensus 1035 ~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred CCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 9998888888877766543 34567899999999999999999998877 99999999864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.2e-13 Score=133.45 Aligned_cols=201 Identities=24% Similarity=0.350 Sum_probs=142.8
Q ss_pred HHHHHhcCCCCCcceeeccccCC-----CceEEEEeeccCCChHHHHhhh-----ccChhhhhHHHHHHHHHHHHHHHC-
Q 011326 276 EISLLGQFEHDNIVQYLGTDRDE-----KRLCIFLELVTKGSLASLYQKY-----HLSDSQVSSYTRQILNGLKYLHEQ- 344 (488)
Q Consensus 276 Ei~iL~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~-----~ls~~~~~~i~~qi~~aL~yLH~~- 344 (488)
-...|-++-|.|||+++.+..+. .+..+++|||..|+|..+|++. .+......+|..||+.||.|||+.
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 34445566799999999987543 4688999999999999998654 388888999999999999999987
Q ss_pred -CCccccCCcccEEECCCCcEEEeecCCccc------ccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHH
Q 011326 345 -NVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLE 417 (488)
Q Consensus 345 -giiHrDLkp~NILl~~~~~vkL~DFGla~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~e 417 (488)
-|+|+++..+.|++.++|-+|+.--.-... ..........+-++|.+||. ......+.++|||++|+..++
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~s--g~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPES--GTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCc--CcccccccchhhhhhhHHHHH
Confidence 599999999999999999888763321111 00111223457788999997 344556778999999999999
Q ss_pred HHcCCCCCCCCchh-hhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 418 MLTRRHPYSHLEGG-QAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 418 LltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
|..+..--.+.+.. +.-..+.. .. ...-...-+.++.+|++..|..||++.+++.||..-+
T Consensus 275 mailEiq~tnseS~~~~ee~ia~-~i---~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 275 MAILEIQSTNSESKVEVEENIAN-VI---IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred HHHheeccCCCcceeehhhhhhh-he---eeccCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 98876442222111 11111110 00 0011122346899999999999999999999997643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.2e-12 Score=119.55 Aligned_cols=126 Identities=21% Similarity=0.173 Sum_probs=94.8
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcce-eeccccCCCceEEEEeecc
Q 011326 231 ELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQ-YLGTDRDEKRLCIFLELVT 309 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~-l~~~~~~~~~~~lV~E~~~ 309 (488)
+.|+.|.++.||++... +..+++|....... ....+..|+.++..+.+.++++ ++.+.. ...++|||+++
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE------LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc------cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 56899999999998765 77899998754321 1124567888888886655544 444433 34579999999
Q ss_pred CCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCC-----ccccCCcccEEECCCCcEEEeecCCcc
Q 011326 310 KGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNV-----VHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 310 ~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~gi-----iHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
|.++... ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE-------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc-------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887643 11223467899999999999885 9999999999998 6789999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=5.6e-13 Score=142.91 Aligned_cols=146 Identities=17% Similarity=0.165 Sum_probs=94.4
Q ss_pred cCceeeeeeecccCceEEEEEEecC-CcEEEEEEeecCCCCC-------------------------cch----hHH---
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTDD-GFFFAVKEVSLQDEGP-------------------------RGK----QSI--- 270 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~i~~~~~~~-------------------------~~~----~~~--- 270 (488)
+.+|+. +.||.|++|.||+|+.++ |+.||||+..+..... ... +..
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 455665 789999999999999976 9999999997542100 000 111
Q ss_pred ---HHHHHHHHHHhcCC----CCCcceeeccccC-CCceEEEEeeccCCChHHH--Hhhhc-----cChhhhhHHHHHHH
Q 011326 271 ---LQLEQEISLLGQFE----HDNIVQYLGTDRD-EKRLCIFLELVTKGSLASL--YQKYH-----LSDSQVSSYTRQIL 335 (488)
Q Consensus 271 ---~~~~~Ei~iL~~l~----HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~--l~~~~-----ls~~~~~~i~~qi~ 335 (488)
.++.+|+..+.++. +.+.+.+-.++.+ ....++||||++|+.+.++ +...+ +.+..+..++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-- 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-- 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence 12344544444442 2222222222211 3456799999999999764 33333 233333333344
Q ss_pred HHHHHHHHCCCccccCCcccEEECCCC----cEEEeecCCcccccC
Q 011326 336 NGLKYLHEQNVVHRDIKCANILVDASG----SVKLADFGLAKATTM 377 (488)
Q Consensus 336 ~aL~yLH~~giiHrDLkp~NILl~~~~----~vkL~DFGla~~~~~ 377 (488)
+...|++|+|+||.||+++.+| .++++|||++...+.
T Consensus 276 -----if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 -----VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4569999999999999999888 999999999865543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.8e-12 Score=117.96 Aligned_cols=142 Identities=20% Similarity=0.210 Sum_probs=102.9
Q ss_pred eeeecccCceEEEEEEecC-------CcEEEEEEeecCCCC----------C-c----------chhHHHHHHHHHHHHh
Q 011326 230 GELLGSGSYGFVYEGLTDD-------GFFFAVKEVSLQDEG----------P-R----------GKQSILQLEQEISLLG 281 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~~-------g~~vAvK~i~~~~~~----------~-~----------~~~~~~~~~~Ei~iL~ 281 (488)
...||.|--+.||.|...+ +..+|||........ . . ........++|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3569999999999997653 579999988643210 0 0 0011122347999999
Q ss_pred cCCC--CCcceeeccccCCCceEEEEeeccCCCh-HHHHhhhccChhhhhHHHHHHHHHHHHH-HHCCCccccCCcccEE
Q 011326 282 QFEH--DNIVQYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQVSSYTRQILNGLKYL-HEQNVVHRDIKCANIL 357 (488)
Q Consensus 282 ~l~H--pnIv~l~~~~~~~~~~~lV~E~~~~gsL-~~~l~~~~ls~~~~~~i~~qi~~aL~yL-H~~giiHrDLkp~NIL 357 (488)
++.. -++...+++ ...+|||||+.+..+ ...+....+++.....+..+++.+|..| |+.|++|+||+|.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8853 456666654 457899999987544 2234444456667778899999999999 8999999999999999
Q ss_pred ECCCCcEEEeecCCccccc
Q 011326 358 VDASGSVKLADFGLAKATT 376 (488)
Q Consensus 358 l~~~~~vkL~DFGla~~~~ 376 (488)
++ ++.+.|+|||.+-...
T Consensus 158 ~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE-CCcEEEEECCCceeCC
Confidence 96 5789999999875443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.5e-11 Score=128.03 Aligned_cols=162 Identities=25% Similarity=0.366 Sum_probs=124.0
Q ss_pred cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeeccCCChHHHHhhhccChhh
Q 011326 247 DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQ 326 (488)
Q Consensus 247 ~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~ls~~~ 326 (488)
.++.+|.|........ .......+-+.-|+.++||||+.+++..+.++..|||+|-+.. |...+++ ++...
T Consensus 35 ~~~~~vsVF~~~~~~~-----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~--l~~~~ 105 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNG-----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE--LGKEE 105 (690)
T ss_pred ccCCceEEEEEeCCCc-----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH--hHHHH
Confidence 4688888888765432 2234456778889999999999999999999999999998854 5555554 34777
Q ss_pred hhHHHHHHHHHHHHHH-HCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--cccCCCCCcccCchhhccccCCCC
Q 011326 327 VSSYTRQILNGLKYLH-EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTAFWMAPEVVNLKKDGYG 403 (488)
Q Consensus 327 ~~~i~~qi~~aL~yLH-~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~s 403 (488)
+..-+.||+.||.+|| +.+++|++|....|+++..|..||++|..+......+ .....---.|..|+.+... +
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s----~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS----E 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc----c
Confidence 8888999999999997 6789999999999999999999999998764333222 1122222346777765211 2
Q ss_pred hhhhHHHHHHHHHHHHcC
Q 011326 404 LTADIWSLGCTVLEMLTR 421 (488)
Q Consensus 404 ~k~DvwSlGvlL~eLltG 421 (488)
-..|.|.||+++++++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 457999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.4e-12 Score=135.43 Aligned_cols=258 Identities=23% Similarity=0.236 Sum_probs=187.5
Q ss_pred ccccCceeeeeeecccCceEEEEEEe--cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLT--DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRD 297 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~ 297 (488)
.....+|..+..||.|.|+.|+.+.. .++..|++|.+........ .. ..-..|+.+...+ .|.+++.....+..
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~--~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~ 337 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA--SD-IFSLGEVILEAILGSHLPSVGKNSSWSQ 337 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH--hh-hcchhhhhHhhHhhcccccCCCCCCccc
Confidence 44578899999999999999998754 3688899998875543221 11 1223455555554 48888888777777
Q ss_pred CCceEEEEeeccCCChHHHH-hhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC-CcEEEeecCCcccc
Q 011326 298 EKRLCIFLELVTKGSLASLY-QKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS-GSVKLADFGLAKAT 375 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l-~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~-~~vkL~DFGla~~~ 375 (488)
....|+=-|||.++++...+ ....+.+...+.+..|++.++.++|+..++|+|++|+||++..+ +..++.|||.....
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence 77788999999999876544 22348888999999999999999999999999999999999876 78899999988653
Q ss_pred cCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHH
Q 011326 376 TMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455 (488)
Q Consensus 376 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~ 455 (488)
.........++..|-.+|++ .....+..+.|++|||..+.+.+++...- ........+..+..+..+. ...++..
T Consensus 418 ~~~~~~~~~~~r~~p~~~~~-~e~~~~~~~~~~~sl~~~~~e~~~~~~ls---~~~~~~~~i~~~~~p~~~~-~~~~~q~ 492 (524)
T KOG0601|consen 418 AFSSGVFHHIDRLYPIAEIL-LEDYPHLSKADIFSLGLSVDEAITGSPLS---ESGVQSLTIRSGDTPNLPG-LKLQLQV 492 (524)
T ss_pred ceecccccccccccccchhh-ccccccccccccccccccccccccCcccC---cccccceeeecccccCCCc-hHHhhhh
Confidence 33222222233334224444 35556788999999999999999876332 1222333344454444443 3488889
Q ss_pred HHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 456 FILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
+.+.++.+++..||.+.++..|+=|-....+
T Consensus 493 ~~kv~~~~~~~~~~l~~~l~~~~~~~~~~~~ 523 (524)
T KOG0601|consen 493 LLKVMINPDRKRRPSAVELSLHSEFYRDSRP 523 (524)
T ss_pred hhhhhcCCccccchhhhhhcccchhhhhccC
Confidence 9999999999999999999988877655443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=9.6e-11 Score=107.46 Aligned_cols=136 Identities=20% Similarity=0.235 Sum_probs=99.9
Q ss_pred eecccCceEEEEEEecCCcEEEEEEeecCCCCC---cchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeec
Q 011326 232 LLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGP---RGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 232 ~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 308 (488)
.+++|+-+.+|.+.+. |..+++|.=.+..-.. ...-...+..+|+.++.++.--.|.-..-+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999998664 3346666543322211 11223445678999999886555544444445666778999999
Q ss_pred cCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 309 TKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 309 ~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
+|..|.+.+... ...++..+-.-+.-||.+||+|+||.++||+++.++ +.++|||++...
T Consensus 82 ~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999998888765 256778888888999999999999999999996555 999999998643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.20 E-value=8.2e-11 Score=111.75 Aligned_cols=139 Identities=19% Similarity=0.222 Sum_probs=105.1
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCC--CcceeeccccCC---CceEEEE
Q 011326 231 ELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD--NIVQYLGTDRDE---KRLCIFL 305 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~~~~~---~~~~lV~ 305 (488)
+.||.|.++.||++...+|..+++|........ .....+..|+.++..+.+. ++.+++.+.... +..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~----~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL----PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC----cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 568999999999998877789999997644321 1234677899999998763 456677776654 3678999
Q ss_pred eeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHH------------------------------------------
Q 011326 306 ELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHE------------------------------------------ 343 (488)
Q Consensus 306 E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~------------------------------------------ 343 (488)
||++|.++...+....+++.....++.+++.+|..||+
T Consensus 80 e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 80 ERVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99999888765433346666777777777777777773
Q ss_pred --------------CCCccccCCcccEEECC--CCcEEEeecCCcc
Q 011326 344 --------------QNVVHRDIKCANILVDA--SGSVKLADFGLAK 373 (488)
Q Consensus 344 --------------~giiHrDLkp~NILl~~--~~~vkL~DFGla~ 373 (488)
..++|+|++|.||+++. ++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23589999999999998 6678999999764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.7e-10 Score=102.09 Aligned_cols=146 Identities=23% Similarity=0.248 Sum_probs=104.2
Q ss_pred eeeeecccCceEEEEEEecCCcEEEEEEeecCCCCC---cchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEE
Q 011326 229 KGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGP---RGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFL 305 (488)
Q Consensus 229 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 305 (488)
....|-||+-+.|+++.+. |+...||.=....... ..+-...+.++|+.+|.++.--.|.-..-++.+...-+|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4567899999999999765 6666666543322211 12234556788999999876444443333455556678999
Q ss_pred eeccC-CChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC---cEEEeecCCcccc
Q 011326 306 ELVTK-GSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG---SVKLADFGLAKAT 375 (488)
Q Consensus 306 E~~~~-gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~---~vkL~DFGla~~~ 375 (488)
||++| .++.+++... ....+....++.+|-+.+.-||.++|+|+||.++||++..++ .+.++|||++...
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99988 4677776443 233333478899999999999999999999999999997655 4689999998543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.2e-10 Score=103.76 Aligned_cols=130 Identities=25% Similarity=0.265 Sum_probs=88.8
Q ss_pred EEEEEEecCCcEEEEEEeecCCCC---------------------CcchhHHHHHHHHHHHHhcCCCC--Ccceeecccc
Q 011326 240 FVYEGLTDDGFFFAVKEVSLQDEG---------------------PRGKQSILQLEQEISLLGQFEHD--NIVQYLGTDR 296 (488)
Q Consensus 240 ~Vy~~~~~~g~~vAvK~i~~~~~~---------------------~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~~~ 296 (488)
.||.|...+|..+|+|........ ...........+|...|.++..- ++..++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999999999999998754210 11122345677899999999765 456666553
Q ss_pred CCCceEEEEeecc--CCChHHHHhhhccChhhhhHHHHHHHHHHHH-HHHCCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 297 DEKRLCIFLELVT--KGSLASLYQKYHLSDSQVSSYTRQILNGLKY-LHEQNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 297 ~~~~~~lV~E~~~--~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~y-LH~~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
..+|||||++ |..+.. +....++.+....++.+++..+.. +|+.||+|+||++.||+++.+ .+.|+|||.+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~-l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav 154 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPR-LKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAV 154 (188)
T ss_dssp ---TTEEEEE--EETTEEGGC-HHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEE
T ss_pred ---CCEEEEEecCCCccchhh-HHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcce
Confidence 4579999999 545544 333344467778888999986666 579999999999999999877 99999999875
Q ss_pred cc
Q 011326 374 AT 375 (488)
Q Consensus 374 ~~ 375 (488)
..
T Consensus 155 ~~ 156 (188)
T PF01163_consen 155 DS 156 (188)
T ss_dssp ET
T ss_pred ec
Confidence 44
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.3e-09 Score=111.26 Aligned_cols=211 Identities=16% Similarity=0.239 Sum_probs=151.3
Q ss_pred ceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC----CCceEEEEeeccC-C
Q 011326 238 YGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD----EKRLCIFLELVTK-G 311 (488)
Q Consensus 238 fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~~-g 311 (488)
-.+.|++... +|..|++|+++-........ ...-++.++++.|+|+|++.+++.+ +..+++|++|.|+ +
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk-----~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNK-----DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCccc-----chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 3467888765 89999999994332211111 1234677999999999999998873 4478999999987 4
Q ss_pred ChHHHHh----------------hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 312 SLASLYQ----------------KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 312 sL~~~l~----------------~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
+|.++.- ..+.+|+.+|.++.|+..||.++|+.|+.-+-|.|.+|+++.+.+++|.-.|.....
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeee
Confidence 7766441 123778999999999999999999999999999999999999989999888876554
Q ss_pred cCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHH
Q 011326 376 TMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455 (488)
Q Consensus 376 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~ 455 (488)
..+. . |-++ --.+-|.=.||.+++.|.||..--...+..... ....+...++.++++
T Consensus 444 ~~d~----------~--~~le-----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s------~~~~I~~~yS~D~rn 500 (655)
T KOG3741|consen 444 QEDP----------T--EPLE-----SQQQNDLRDLGLLLLALATGTENSNRTDSTQSS------HLTRITTTYSTDLRN 500 (655)
T ss_pred cCCC----------C--cchh-----HHhhhhHHHHHHHHHHHhhcccccccccchHHH------HHHHhhhhhhHHHHH
Confidence 4332 1 1111 123568889999999999986331111111110 012344568899999
Q ss_pred HHHHhhhhCCCCCCCHHHHHhC
Q 011326 456 FILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~eil~h 477 (488)
++..+...++++ -++.+++.+
T Consensus 501 ~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 501 VVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHhcCccc-ccHHHHHHH
Confidence 999999999987 677777654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1e-08 Score=104.19 Aligned_cols=233 Identities=19% Similarity=0.190 Sum_probs=152.4
Q ss_pred eeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhc-CCCCCcceeecc------ccCCC-ce
Q 011326 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQ-FEHDNIVQYLGT------DRDEK-RL 301 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~------~~~~~-~~ 301 (488)
++.||+|+-+.+|..-.- + .-+.|++....... . . +.+..|.. -.||-+-.-+.| ..++. .+
T Consensus 16 gr~LgqGgea~ly~l~e~-~-d~VAKIYh~Pppa~--~---a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV-R-DQVAKIYHAPPPAA--Q---A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CccccCCccceeeecchh-h-chhheeecCCCchH--H---H---HHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 355999999999964221 1 12457776543221 1 1 12222333 356644331221 22333 47
Q ss_pred EEEEeeccCCC-hHHHHhh---h----ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 302 CIFLELVTKGS-LASLYQK---Y----HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 302 ~lV~E~~~~gs-L~~~l~~---~----~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
.++|..++|.. ...+++. . ..+|.-+++.++.++.+.+.||+.|..-+|++++|+|+++++.+.|.|-..-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 88999988853 2333321 1 27888999999999999999999999999999999999999999999876543
Q ss_pred cccCC-CcccCCCCCcccCchhhcc---ccCCCChhhhHHHHHHHHHHHHcC-CCCCCCCch-------hhhHH------
Q 011326 374 ATTMN-DVKSCKGTAFWMAPEVVNL---KKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEG-------GQAMF------ 435 (488)
Q Consensus 374 ~~~~~-~~~~~~gt~~y~aPE~~~~---~~~~~s~k~DvwSlGvlL~eLltG-~~Pf~~~~~-------~~~~~------ 435 (488)
..... .....+|.+.|++||..+. .+.+-+...|.|.||+++++++.| ++||.+... .++..
T Consensus 166 i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 166 INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 33222 2345679999999998642 233456779999999999999885 999976432 12110
Q ss_pred --HhcCCCCCCCC-----CcccHHHHHHHHHhhhhC--CCCCCCHH
Q 011326 436 --KIGGGELPPVP-----NSLSRDAQDFILKCLQVN--PNDRPTAA 472 (488)
Q Consensus 436 --~i~~~~~~~~~-----~~~s~~l~~Li~~cL~~d--P~~Rps~~ 472 (488)
......+.+-| ..+++++..|..+|+... +.-|||++
T Consensus 246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 00011111111 347889999999999853 56899965
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.7e-09 Score=103.45 Aligned_cols=140 Identities=23% Similarity=0.254 Sum_probs=105.6
Q ss_pred eeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCC-----------------CcchhHHHHHHHHHHHHhcCCCC--C
Q 011326 227 WQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEG-----------------PRGKQSILQLEQEISLLGQFEHD--N 287 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~-----------------~~~~~~~~~~~~Ei~iL~~l~Hp--n 287 (488)
..++..||.|--+.||.|.+..|.++|||.-...... ..-........+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3456789999999999999999999999976543211 01122345567899999998655 6
Q ss_pred cceeeccccCCCceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEe
Q 011326 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLA 367 (488)
Q Consensus 288 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~ 367 (488)
+...+++ ++..+|||+++|-.|... +++.+....++..|++-+.-+-..||+|+|+++-||+++++|.+.++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vI 244 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRL----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVI 244 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecc----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEE
Confidence 6666655 567899999999777543 22455566666666666666668999999999999999999999999
Q ss_pred ecCCccc
Q 011326 368 DFGLAKA 374 (488)
Q Consensus 368 DFGla~~ 374 (488)
||--+..
T Consensus 245 DwPQ~v~ 251 (304)
T COG0478 245 DWPQAVP 251 (304)
T ss_pred eCccccc
Confidence 9986543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.4e-08 Score=100.53 Aligned_cols=132 Identities=12% Similarity=0.096 Sum_probs=91.2
Q ss_pred EEEEEecCCcEEEEEEeecCCCCCcc------hhHHHHHHHHHHHHhcCCCCCc--ceeeccccC-----CCceEEEEee
Q 011326 241 VYEGLTDDGFFFAVKEVSLQDEGPRG------KQSILQLEQEISLLGQFEHDNI--VQYLGTDRD-----EKRLCIFLEL 307 (488)
Q Consensus 241 Vy~~~~~~g~~vAvK~i~~~~~~~~~------~~~~~~~~~Ei~iL~~l~HpnI--v~l~~~~~~-----~~~~~lV~E~ 307 (488)
|++... +|+.|.||........... ......+.+|...+.++..-+| ++.+++++. ....++|||+
T Consensus 38 vvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~ 116 (268)
T PRK15123 38 TLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITED 116 (268)
T ss_pred EEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEee
Confidence 555533 4678888976432210000 0111236688888877743333 334444332 2357899999
Q ss_pred ccCC-ChHHHHhh---hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC-------CCcEEEeecCCcc
Q 011326 308 VTKG-SLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA-------SGSVKLADFGLAK 373 (488)
Q Consensus 308 ~~~g-sL~~~l~~---~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~-------~~~vkL~DFGla~ 373 (488)
+++- +|.+++.. ...+......++.+++..+..||+.||+|+|+++.|||++. ++.+.|+||+.+.
T Consensus 117 l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 117 LAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred CCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9986 89888753 33556677899999999999999999999999999999975 4689999999774
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.7e-08 Score=107.97 Aligned_cols=145 Identities=18% Similarity=0.154 Sum_probs=97.6
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeecCCCCC--------------------c-----ch----------hHHHHHHH
Q 011326 231 ELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGP--------------------R-----GK----------QSILQLEQ 275 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~--------------------~-----~~----------~~~~~~~~ 275 (488)
+.|+.++-|.||+|+.++|+.||||+.++.-... . -. ..+.++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5689999999999999999999999987653210 0 00 11223455
Q ss_pred HHHHHhcCC-----CCCcceeeccccCCCceEEEEeeccCCChHHH--HhhhccChhhhhHHHHHHHHHHHHHHHCCCcc
Q 011326 276 EISLLGQFE-----HDNIVQYLGTDRDEKRLCIFLELVTKGSLASL--YQKYHLSDSQVSSYTRQILNGLKYLHEQNVVH 348 (488)
Q Consensus 276 Ei~iL~~l~-----HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~--l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiH 348 (488)
|+..+.++. .+++.=-.-+.+-...-.++|||++|-.+.++ ++..+++...+.....++ -+..+=..|++|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgffH 288 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGFFH 288 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCccc
Confidence 666555542 33322111122234567899999999888776 455566644443333332 234444589999
Q ss_pred ccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 349 RDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 349 rDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
+|.+|.||+++.+|.+.+.|||+....+.
T Consensus 289 aDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 289 ADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999865543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.1e-09 Score=113.84 Aligned_cols=151 Identities=23% Similarity=0.336 Sum_probs=110.1
Q ss_pred HHHHHHHHHHHHC-CCccccCCcccEEECCCCcEEEeecCCcccccCC------Ccc-----cCCCCCcccCchhhcccc
Q 011326 332 RQILNGLKYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKATTMN------DVK-----SCKGTAFWMAPEVVNLKK 399 (488)
Q Consensus 332 ~qi~~aL~yLH~~-giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~------~~~-----~~~gt~~y~aPE~~~~~~ 399 (488)
.+++.|+.++|+. +++|+.|.|++|.++..+..||+-|+.+-..... .+. ...-...|.|||++ ..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~--~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL--LG 183 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh--cc
Confidence 3455999999965 8999999999999999999999999976432221 111 12245569999997 34
Q ss_pred CCCChhhhHHHHHHHHHHHHcCCCC-CCCCchhhhHH---HhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHH
Q 011326 400 DGYGLTADIWSLGCTVLEMLTRRHP-YSHLEGGQAMF---KIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLM 475 (488)
Q Consensus 400 ~~~s~k~DvwSlGvlL~eLltG~~P-f~~~~~~~~~~---~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil 475 (488)
...+.++|+||+|+++|.+..|..+ +.......... .......--+...+++++++=+.+++..++..||++.++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 5578899999999999998854444 33221111111 1111111234477899999999999999999999999999
Q ss_pred hCccCCCCC
Q 011326 476 EHPFIKRPL 484 (488)
Q Consensus 476 ~hp~f~~~~ 484 (488)
.-|||+.+.
T Consensus 264 ~~~ff~D~~ 272 (700)
T KOG2137|consen 264 SIPFFSDPG 272 (700)
T ss_pred cccccCCch
Confidence 999998764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=8.1e-08 Score=91.39 Aligned_cols=103 Identities=21% Similarity=0.294 Sum_probs=80.3
Q ss_pred HHHHHHHHHhcCCCCC--cceeeccccCC----CceEEEEeeccCC-ChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHH
Q 011326 272 QLEQEISLLGQFEHDN--IVQYLGTDRDE----KRLCIFLELVTKG-SLASLYQKY-HLSDSQVSSYTRQILNGLKYLHE 343 (488)
Q Consensus 272 ~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~~----~~~~lV~E~~~~g-sL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~ 343 (488)
...+|...+..+..-+ ....+++.+.. ...++|+|++++. +|.+++... ..+......++.+++..+.-||+
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~ 136 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD 136 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH
Confidence 5667777777764332 34445544332 3468999999984 799888752 36777788999999999999999
Q ss_pred CCCccccCCcccEEECCCC---cEEEeecCCccc
Q 011326 344 QNVVHRDIKCANILVDASG---SVKLADFGLAKA 374 (488)
Q Consensus 344 ~giiHrDLkp~NILl~~~~---~vkL~DFGla~~ 374 (488)
+||+|+|++|.|||++.++ .+.++||+-++.
T Consensus 137 ~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 137 AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999887 899999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=2e-07 Score=88.34 Aligned_cols=139 Identities=16% Similarity=0.119 Sum_probs=99.5
Q ss_pred cccCceEEEEEEecCCcEEEEEEeecCCCCCcc-hhHHHHHHHHHHHHhcCCCCC--cceeeccccC----CCceEEEEe
Q 011326 234 GSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRG-KQSILQLEQEISLLGQFEHDN--IVQYLGTDRD----EKRLCIFLE 306 (488)
Q Consensus 234 G~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~-~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~----~~~~~lV~E 306 (488)
|.||-+.|+..... |..+-+|.-......... ......|.+|...|.++..-+ +.+....... ..+.+||+|
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 66899999986554 346888876522111111 223457889999998885333 4444422111 235789999
Q ss_pred eccC-CChHHHHhhhc---cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCc--EEEeecCCcc
Q 011326 307 LVTK-GSLASLYQKYH---LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS--VKLADFGLAK 373 (488)
Q Consensus 307 ~~~~-gsL~~~l~~~~---ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~--vkL~DFGla~ 373 (488)
-+.| -+|.+++.... .+......++.+++.++.-||+.|+.|+|+.+.||+++.+|. +.++||.-++
T Consensus 106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 8765 48988886644 466677899999999999999999999999999999987777 9999998654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.1e-06 Score=84.65 Aligned_cols=141 Identities=18% Similarity=0.194 Sum_probs=98.5
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeecCCCCCc-------------------chhHHHHHHHHHHHHhcCC--CCCcc
Q 011326 231 ELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPR-------------------GKQSILQLEQEISLLGQFE--HDNIV 289 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~-------------------~~~~~~~~~~Ei~iL~~l~--HpnIv 289 (488)
..|++|--+.||+|...++..+|+|+......... ......-...|...|.++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 46888999999999998999999999875431100 0111222345666666653 33344
Q ss_pred eeeccccCCCceEEEEeeccCCC-hHHHHhhhccChhhhhHHHHHHHHHHHHHHH-CCCccccCCcccEEECCCCcEEEe
Q 011326 290 QYLGTDRDEKRLCIFLELVTKGS-LASLYQKYHLSDSQVSSYTRQILNGLKYLHE-QNVVHRDIKCANILVDASGSVKLA 367 (488)
Q Consensus 290 ~l~~~~~~~~~~~lV~E~~~~gs-L~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~NILl~~~~~vkL~ 367 (488)
+-+.+. .-.+||||+.... -.-.|+..++..+.+..+..++++.+.-|-. .|++|+||+.-|||+. ++.+.++
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iI 208 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYII 208 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEE
Confidence 444443 3479999996642 1223344455555788888999999998866 9999999999999998 8999999
Q ss_pred ecCCccccc
Q 011326 368 DFGLAKATT 376 (488)
Q Consensus 368 DFGla~~~~ 376 (488)
|+|-|....
T Consensus 209 D~~QaV~~~ 217 (268)
T COG1718 209 DVSQAVTID 217 (268)
T ss_pred ECccccccC
Confidence 999875443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.6e-06 Score=82.60 Aligned_cols=140 Identities=15% Similarity=0.210 Sum_probs=89.1
Q ss_pred cCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHH------HHHHHHHHhcCC---CCCcceeecc
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQ------LEQEISLLGQFE---HDNIVQYLGT 294 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~------~~~Ei~iL~~l~---HpnIv~l~~~ 294 (488)
-++|.+.+++-......|.+... +|..+++|....... ..+..... ..+.+..+.++. -.....++.+
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~--r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENR--RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhh--hHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 45678888888887777776544 468899998764332 11111111 123333333332 2222222222
Q ss_pred -----ccCCCceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeec
Q 011326 295 -----DRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADF 369 (488)
Q Consensus 295 -----~~~~~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DF 369 (488)
+.-....+++|||++|..|.++.. +++ .+...+.+++..||+.|++|+|.+|.|++++.++ ++++||
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~ 178 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDT 178 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEEC
Confidence 222345678999999988765432 222 3556778889999999999999999999998554 999999
Q ss_pred CCccc
Q 011326 370 GLAKA 374 (488)
Q Consensus 370 Gla~~ 374 (488)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 86543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=7.1e-07 Score=95.44 Aligned_cols=144 Identities=17% Similarity=0.124 Sum_probs=97.1
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeecCCCCCc--------------------------------chhHHHHHHHHHH
Q 011326 231 ELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPR--------------------------------GKQSILQLEQEIS 278 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~--------------------------------~~~~~~~~~~Ei~ 278 (488)
+.||.-+.|.||+|+.++|+.||||+-++.-.... .-..+.+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 55999999999999999999999999775532100 0011223555655
Q ss_pred HHhcC----CCCC------cceeeccccCCCceEEEEeeccCCChHH--HHhhhccChhhhhHHHHHHHHHHHHHHHCCC
Q 011326 279 LLGQF----EHDN------IVQYLGTDRDEKRLCIFLELVTKGSLAS--LYQKYHLSDSQVSSYTRQILNGLKYLHEQNV 346 (488)
Q Consensus 279 iL~~l----~Hpn------Iv~l~~~~~~~~~~~lV~E~~~~gsL~~--~l~~~~ls~~~~~~i~~qi~~aL~yLH~~gi 346 (488)
...+. .|-+ |.+++-.+ .....++||||+|..+.+ .+.+.+++...+..-+.+... +.+=..|+
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~Gf 322 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGF 322 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCC
Confidence 54443 3444 33333222 335789999999987754 556777887755544444322 33345789
Q ss_pred ccccCCcccEEECC----CCcEEEeecCCcccccCC
Q 011326 347 VHRDIKCANILVDA----SGSVKLADFGLAKATTMN 378 (488)
Q Consensus 347 iHrDLkp~NILl~~----~~~vkL~DFGla~~~~~~ 378 (488)
+|+|-+|.||+++. ++.+.+.|||+.......
T Consensus 323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred ccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 99999999999984 678999999998665443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.2e-06 Score=82.78 Aligned_cols=132 Identities=13% Similarity=0.146 Sum_probs=81.6
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCC--cceeeccccCCCceEEEEeec
Q 011326 231 ELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN--IVQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~ 308 (488)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-+ +.+.++++...+...++||++
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence 45899999999984 25567788875321 1234578998988886443 356777777777889999999
Q ss_pred cCCC-hHHHH---------------------hhhccCh---hh-hhHHHHH----------HHH-HHHHHH----HCCCc
Q 011326 309 TKGS-LASLY---------------------QKYHLSD---SQ-VSSYTRQ----------ILN-GLKYLH----EQNVV 347 (488)
Q Consensus 309 ~~gs-L~~~l---------------------~~~~ls~---~~-~~~i~~q----------i~~-aL~yLH----~~gii 347 (488)
+|.+ +...+ +....+. .. ...+..+ +.. ...+|. ...++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 9963 22111 0000000 00 0001000 111 112222 12468
Q ss_pred cccCCcccEEECCCCcEEEeecCCcc
Q 011326 348 HRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 348 HrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
|+|++|.||+++.++ +.|+||+.+.
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcC
Confidence 999999999999888 9999999763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.30 E-value=8e-06 Score=77.67 Aligned_cols=135 Identities=23% Similarity=0.268 Sum_probs=80.6
Q ss_pred eeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCC--cceeeccc---cCCCceEEE
Q 011326 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN--IVQYLGTD---RDEKRLCIF 304 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~---~~~~~~~lV 304 (488)
++.|+.|..+.||+....+ ..+++|.... ......+.+|..+++.+.... +..++..+ ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~-------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRP-------PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESS-------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCC-------CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence 4679999999999998877 5999999642 234456778888888875333 44555533 223357899
Q ss_pred EeeccCCChHH----------------HHh---hh-----ccChhh---------hhH------------HHHHHHH-HH
Q 011326 305 LELVTKGSLAS----------------LYQ---KY-----HLSDSQ---------VSS------------YTRQILN-GL 338 (488)
Q Consensus 305 ~E~~~~gsL~~----------------~l~---~~-----~ls~~~---------~~~------------i~~qi~~-aL 338 (488)
|++++|.++.. .+. .. ++.... ... ....+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 99999987766 110 00 000000 000 0111222 33
Q ss_pred HHHHH-------CCCccccCCcccEEEC-CCCcEEEeecCCc
Q 011326 339 KYLHE-------QNVVHRDIKCANILVD-ASGSVKLADFGLA 372 (488)
Q Consensus 339 ~yLH~-------~giiHrDLkp~NILl~-~~~~vkL~DFGla 372 (488)
..+++ ..++|+|+.|.||+++ .++.+-|+||+.+
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence 34432 3599999999999999 6676789999865
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.5e-05 Score=77.36 Aligned_cols=131 Identities=18% Similarity=0.158 Sum_probs=79.5
Q ss_pred ecccCc-eEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCCCceEEEEeeccC
Q 011326 233 LGSGSY-GFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDEKRLCIFLELVTK 310 (488)
Q Consensus 233 LG~G~f-g~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~ 310 (488)
|..|.. +.||+.... +..+.+|...... ...+.+|+.+++.+. +--+.+++++...++..++|||+++|
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 444444 788988654 4678888875332 124557888877774 33355677777666778999999999
Q ss_pred CChHHHHh----------------h-hccChh------hhhHHHHH-----------------------HHHHHHHHH--
Q 011326 311 GSLASLYQ----------------K-YHLSDS------QVSSYTRQ-----------------------ILNGLKYLH-- 342 (488)
Q Consensus 311 gsL~~~l~----------------~-~~ls~~------~~~~i~~q-----------------------i~~aL~yLH-- 342 (488)
.+|..... + ..++.. .......+ +......|-
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 87754310 0 001110 00000000 111122221
Q ss_pred -----HCCCccccCCcccEEECCCCcEEEeecCCc
Q 011326 343 -----EQNVVHRDIKCANILVDASGSVKLADFGLA 372 (488)
Q Consensus 343 -----~~giiHrDLkp~NILl~~~~~vkL~DFGla 372 (488)
...++|+|+.|.|||++.++.+.|+||+.+
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a 191 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRL 191 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccc
Confidence 124899999999999999877889999976
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.4e-05 Score=73.94 Aligned_cols=133 Identities=21% Similarity=0.302 Sum_probs=94.2
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeecCCCCCc-----------chhHHHHHHHHHHHHhcCC------CCCcceeec
Q 011326 231 ELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPR-----------GKQSILQLEQEISLLGQFE------HDNIVQYLG 293 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~-----------~~~~~~~~~~Ei~iL~~l~------HpnIv~l~~ 293 (488)
..||+|+.-.||. +++.....||+......... ......+..+|+.....+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 4599999999997 45566678888876550000 0112234455555544444 889999999
Q ss_pred cccCCCceEEEEeeccC------CChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC--C--c
Q 011326 294 TDRDEKRLCIFLELVTK------GSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS--G--S 363 (488)
Q Consensus 294 ~~~~~~~~~lV~E~~~~------gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~--~--~ 363 (488)
+.+++--..+|+|.+.+ .||.+++....+++ . +...+-+-..||-+++|+.+|++|.||++... + .
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~ 160 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFR 160 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceE
Confidence 99999999999998743 27888887777776 3 34444455678889999999999999999632 2 4
Q ss_pred EEEeec
Q 011326 364 VKLADF 369 (488)
Q Consensus 364 vkL~DF 369 (488)
+.|+|-
T Consensus 161 lvlIDG 166 (199)
T PF10707_consen 161 LVLIDG 166 (199)
T ss_pred EEEEeC
Confidence 777764
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.2e-05 Score=73.65 Aligned_cols=129 Identities=19% Similarity=0.170 Sum_probs=92.5
Q ss_pred eeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcce-eeccccCCCceEEEE
Q 011326 227 WQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQ-YLGTDRDEKRLCIFL 305 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~-l~~~~~~~~~~~lV~ 305 (488)
.+..+.||+|.+|.||+|.+.++ .+|+|+-.... ....+..|+++|..++..++.+ ++.+..+ .+.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds-------~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~m 91 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGG-EVALKVRRRDS-------PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRM 91 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCc-eEEEEEecCCc-------chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhh
Confidence 34457799999999999988744 78888765332 2356788999999998777765 5555433 3459
Q ss_pred eeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCC-cccEEECCCCcEEEeecCCcc
Q 011326 306 ELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIK-CANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 306 E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLk-p~NILl~~~~~vkL~DFGla~ 373 (488)
||+.|..|.+.-... + .+-+..+++.-.-|-..||-|+.|+ |..+++..++.+.|+||..|+
T Consensus 92 e~i~G~~L~~~~~~~--~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 92 EYIDGRPLGKLEIGG--D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhcCcchhhhhhcc--c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 999998887653321 1 2334556666667788899999996 555555566699999999886
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.14 E-value=9.8e-06 Score=91.76 Aligned_cols=208 Identities=24% Similarity=0.333 Sum_probs=144.6
Q ss_pred hHHHHHHHHHHHHhcCCCCCcceeeccccCCCc----eEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHH
Q 011326 268 QSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR----LCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLH 342 (488)
Q Consensus 268 ~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~----~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH 342 (488)
........|...+.++.|+|++.++.+...... ..+..|++..-++...+... ..+...+..+..++.+|+.|+|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 344455567788888999999999988654433 33456788888887777554 4888899999999999999999
Q ss_pred HCCCccccCCcc---cEEECCCCcEEEe--ecCCcccccCCCc-ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHH
Q 011326 343 EQNVVHRDIKCA---NILVDASGSVKLA--DFGLAKATTMNDV-KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVL 416 (488)
Q Consensus 343 ~~giiHrDLkp~---NILl~~~~~vkL~--DFGla~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~ 416 (488)
+....|.-|... +-..+..+.+.+. ||+.++.+..... .....+..+.+||.........+...|+|.+|.++.
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 996666555544 4444556667777 8988876654432 233455667888875333333445579999999999
Q ss_pred HHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 417 EMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 417 eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
.+..|..+-... ..... -.+.....+..+...+|+.-++++|++..+++.|+|.+.+-.
T Consensus 384 ~~~~~~~i~~~~---~~~~~-------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~ 442 (1351)
T KOG1035|consen 384 QLSQGEDISEKS---AVPVS-------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTD 442 (1351)
T ss_pred hhhhcCcccccc---cchhh-------hhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccccc
Confidence 998876442111 01110 111122227788999999999999999999999999876543
|
|
| >KOG0204 consensus Calcium transporting ATPase [Inorganic ion transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.5e-06 Score=94.77 Aligned_cols=90 Identities=26% Similarity=0.287 Sum_probs=79.7
Q ss_pred CCCCCCCCCCCCcHHHHHHHHhhchhcccccccchhhhhhhhhHHHHHhHHhhhh-----hhhhhhccCCCchHHHHHhh
Q 011326 7 LFGVAPWISGQPPEDTLKRWKSACNIVNNRRRKFRMVANLANQAETRVNTFKIQN-----KAYKEFYDDDPSSEYLAKAG 81 (488)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 81 (488)
.|.+.+ +|+|.++++||| .+.+++|+.||||+.++|+++++...+|+++.. +|+.+|.++.-.+||..
T Consensus 6 ~~~~~~---~n~~~~~~~~~~-~a~~~~~~~~~~~~~~~l~~~~~~~~~r~~~r~~~~~~~a~~~~~~~~~~~e~~~--- 78 (1034)
T KOG0204|consen 6 DFVVSM---KNSSIEALQRWR-LAYIVLEASRRFRFGASLKKLRELMEPRRKIRSAVLVSKAAALFIDAGSRTEYTL--- 78 (1034)
T ss_pred cccccc---ccchhhhhhhhh-hhhhhcccchhhccccCHHHHHHHHHHHhhhhhhhcccchhhhhhcccccccccc---
Confidence 347777 999999999999 889999999999999999999999999988776 89999999998899988
Q ss_pred hhHHHHhhhhhhcccceeeeeccc
Q 011326 82 IFQEFYDDIEYACKGRYVELLKRK 105 (488)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~ 105 (488)
-++.|++....+.||+++|++.
T Consensus 79 --~i~~e~l~~i~~~~~~~~L~~~ 100 (1034)
T KOG0204|consen 79 --GIGAEELVKIVKEHDLKALNAY 100 (1034)
T ss_pred --ccCHHHHHHHhhccchhhhhhc
Confidence 4567888999999988877653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.04 E-value=9.5e-07 Score=94.19 Aligned_cols=238 Identities=24% Similarity=0.210 Sum_probs=161.7
Q ss_pred CceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCC-cceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN-IVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~l 303 (488)
.-++...-+++|+.+.+++.+....+....+.+... ....-++++|.+++||| .+..++-++.++...+
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~----------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc----------hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 334455567999999999987654444446665432 23445788899999999 7777777888889999
Q ss_pred EEeeccCC-ChHHHH--hhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC-C
Q 011326 304 FLELVTKG-SLASLY--QKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-D 379 (488)
Q Consensus 304 V~E~~~~g-sL~~~l--~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~ 379 (488)
.++++.++ +-...+ ....+.+.+...+.+.-++++++||+.--+|+| ||+.. ++..+..||+....+... .
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~~ 386 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTMK 386 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCcccc
Confidence 99999887 222211 122344455566667778999999998778998 77764 477899999988666544 3
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCc-----ccHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNS-----LSRDAQ 454 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-----~s~~l~ 454 (488)
.+...+|+.++|||+. ....+....|.|++|.--.+|.-|-+|-...... ...+..+. ..+.- .+....
T Consensus 387 ~~t~~~~~~~~~pev~--~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~~~~g~~p--~s~~L~~~~aw~~~~~ 460 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVI--QENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAV--LPMIGNGP--NSPMLTDKSAWSPVFH 460 (829)
T ss_pred cccCCCCCCCCCchhh--cccccccCCCccCCCcchhhcCCCCCCCCCCccc--cCCCCCCC--CccccchhhhcCcccc
Confidence 4567799999999986 4555788899999998777777777775431110 00000000 01111 111111
Q ss_pred -HHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 455 -DFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 455 -~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
++...|+...|..|+..-..+.|.+|...
T Consensus 461 ~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 461 RDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred cCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 46778999999999999888888888653
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.95 E-value=6.4e-05 Score=85.97 Aligned_cols=79 Identities=14% Similarity=0.125 Sum_probs=55.8
Q ss_pred eeeecccCceEEEEEEecCC---cEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCc--ceeeccccCC---Cc
Q 011326 230 GELLGSGSYGFVYEGLTDDG---FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNI--VQYLGTDRDE---KR 300 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnI--v~l~~~~~~~---~~ 300 (488)
.+.++.|.++.+|+....++ ..+++|+....... .....+.+|+.+|+.+. |+++ .+++.+|.+. +.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~----~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL----QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC----ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence 46689999999999876543 46777775432211 11235778999999985 6665 6777777664 46
Q ss_pred eEEEEeeccCCC
Q 011326 301 LCIFLELVTKGS 312 (488)
Q Consensus 301 ~~lV~E~~~~gs 312 (488)
.++||||++|..
T Consensus 119 ~flVME~v~G~~ 130 (822)
T PLN02876 119 AFYIMEYLEGRI 130 (822)
T ss_pred ceEEEEecCCcc
Confidence 789999999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.91 E-value=7.4e-05 Score=72.32 Aligned_cols=73 Identities=15% Similarity=0.085 Sum_probs=44.1
Q ss_pred eeecccCce-EEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCC---CcceeeccccCC---CceEE
Q 011326 231 ELLGSGSYG-FVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD---NIVQYLGTDRDE---KRLCI 303 (488)
Q Consensus 231 ~~LG~G~fg-~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp---nIv~l~~~~~~~---~~~~l 303 (488)
+.|+.|+.. .||+. +..+++|..... .....+.+|..++..+... -+...++..... ...++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~-------~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA-------GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc-------chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 346766666 48875 234677764321 1234677898888877532 334445444332 23588
Q ss_pred EEeeccCCChH
Q 011326 304 FLELVTKGSLA 314 (488)
Q Consensus 304 V~E~~~~gsL~ 314 (488)
+||+++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999997663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.84 E-value=4.4e-05 Score=71.62 Aligned_cols=95 Identities=25% Similarity=0.208 Sum_probs=78.7
Q ss_pred HHHHHHhcCCC-CCcceeeccccCCCceEEEEeeccCCChHH----HHhhhccChhhhhHHHHHHHHHHHHHHH---CCC
Q 011326 275 QEISLLGQFEH-DNIVQYLGTDRDEKRLCIFLELVTKGSLAS----LYQKYHLSDSQVSSYTRQILNGLKYLHE---QNV 346 (488)
Q Consensus 275 ~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~----~l~~~~ls~~~~~~i~~qi~~aL~yLH~---~gi 346 (488)
.|.-+++.+++ +++++++|.|.. ++++||.+.+++.. +.+-...+|..+.+|+.++++.+++|+. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 57778888876 699999999953 67999998776642 2222347899999999999999999987 358
Q ss_pred ccccCCcccEEECCCCcEEEeecCCcc
Q 011326 347 VHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 347 iHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
.-.|++|+|+-++++|.+|++|...+.
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcc
Confidence 889999999999999999999998764
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00013 Score=70.19 Aligned_cols=74 Identities=12% Similarity=0.117 Sum_probs=47.7
Q ss_pred eeeecccCceEEEEEEecC--CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcc-eeeccccCCCceEEEEe
Q 011326 230 GELLGSGSYGFVYEGLTDD--GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV-QYLGTDRDEKRLCIFLE 306 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~~--g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~~~~~~~~~~~lV~E 306 (488)
.+.|..|-...+|+....+ +..|++|........ .....+|+.++..+...+++ ++++.+. + .++||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~------~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e 72 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL------IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYE 72 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc------eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEE
Confidence 3568889999999987664 678899976532111 11234677788877544443 3444332 1 47999
Q ss_pred eccCCCh
Q 011326 307 LVTKGSL 313 (488)
Q Consensus 307 ~~~~gsL 313 (488)
|++|.++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9999765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.74 E-value=3.7e-05 Score=76.76 Aligned_cols=137 Identities=18% Similarity=0.245 Sum_probs=96.0
Q ss_pred eeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCC-----------------CcchhHHHHHHHHHHHHhcCCC-C-C
Q 011326 227 WQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEG-----------------PRGKQSILQLEQEISLLGQFEH-D-N 287 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~-----------------~~~~~~~~~~~~Ei~iL~~l~H-p-n 287 (488)
+.+++.||-|--+.||.+-+.+|++.++|.-...... ..-.-+.....+|...|+.+.. . -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 4567889999999999999999999999965433211 1111223345567777877743 2 2
Q ss_pred cceeeccccCCCceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEe
Q 011326 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLA 367 (488)
Q Consensus 288 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~ 367 (488)
+...++ .++.++|||++.|-.|.+.-+ ......+...+..-+--|-++|+||+|.+--||++++++.++++
T Consensus 174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~-----v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vI 244 (465)
T KOG2268|consen 174 VPKPID----HNRHCVVMELVDGYPLRQVRH-----VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVI 244 (465)
T ss_pred CCCccc----ccceeeHHHhhcccceeeeee-----cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEe
Confidence 333333 356899999999987765421 12233445555566677889999999999999999999999999
Q ss_pred ecCCc
Q 011326 368 DFGLA 372 (488)
Q Consensus 368 DFGla 372 (488)
||--.
T Consensus 245 DFPQm 249 (465)
T KOG2268|consen 245 DFPQM 249 (465)
T ss_pred echHh
Confidence 99743
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00033 Score=71.19 Aligned_cols=144 Identities=19% Similarity=0.184 Sum_probs=100.2
Q ss_pred eeeeeecccCceEEEEEEecCCcEEEEEEeecCCCC---------------------CcchhHHHHHHHHHHHHhcCCCC
Q 011326 228 QKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEG---------------------PRGKQSILQLEQEISLLGQFEHD 286 (488)
Q Consensus 228 ~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~---------------------~~~~~~~~~~~~Ei~iL~~l~Hp 286 (488)
++-.+|..|--+.||.++..+|..+|||++.-+-.. ............|+..|.+|+..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 345779999999999999999999999987533110 00111222344567777776544
Q ss_pred CcceeeccccCCCceEEEEeeccCC-ChHHHHhhhccChhhhhHHHHHHHHHHHHH-HHCCCccccCCcccEEECCCCcE
Q 011326 287 NIVQYLGTDRDEKRLCIFLELVTKG-SLASLYQKYHLSDSQVSSYTRQILNGLKYL-HEQNVVHRDIKCANILVDASGSV 364 (488)
Q Consensus 287 nIv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~ls~~~~~~i~~qi~~aL~yL-H~~giiHrDLkp~NILl~~~~~v 364 (488)
.|.-.--+.. ....|||+++... --.-.|+...++...+..+-.|++.-|.-| |.++++|.||.--|+|+ ++|.+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l 303 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL 303 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence 4321110000 1357899998642 223345556788888999999999988888 67899999999999999 88999
Q ss_pred EEeecCCccc
Q 011326 365 KLADFGLAKA 374 (488)
Q Consensus 365 kL~DFGla~~ 374 (488)
.|+|.+-+-.
T Consensus 304 yiIDVSQSVE 313 (520)
T KOG2270|consen 304 YIIDVSQSVE 313 (520)
T ss_pred EEEEcccccc
Confidence 9999997743
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00074 Score=70.54 Aligned_cols=80 Identities=14% Similarity=0.080 Sum_probs=54.0
Q ss_pred eeecccCceEEEEEEecCC-cEEEEEEeecCCCC--CcchhHHHHHHHHHHHHhcCC---CCCcceeeccccCCCceEEE
Q 011326 231 ELLGSGSYGFVYEGLTDDG-FFFAVKEVSLQDEG--PRGKQSILQLEQEISLLGQFE---HDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~~g-~~vAvK~i~~~~~~--~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~lV 304 (488)
+.||.|.++.||++.+.+| +.++||.-...... ..-.....+...|.+.|..+. ..++++++.+.. +..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence 4689999999999998776 58999986422111 000123345667777777752 345677777743 557899
Q ss_pred EeeccCCC
Q 011326 305 LELVTKGS 312 (488)
Q Consensus 305 ~E~~~~gs 312 (488)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00061 Score=64.30 Aligned_cols=130 Identities=25% Similarity=0.313 Sum_probs=89.4
Q ss_pred CceeeeeeecccCc-eEEEEEEecCCcEEEEEEeec---CCCC------Ccc-------hhHHHHHHHHHHHHhcC---C
Q 011326 225 TSWQKGELLGSGSY-GFVYEGLTDDGFFFAVKEVSL---QDEG------PRG-------KQSILQLEQEISLLGQF---E 284 (488)
Q Consensus 225 ~~y~~~~~LG~G~f-g~Vy~~~~~~g~~vAvK~i~~---~~~~------~~~-------~~~~~~~~~Ei~iL~~l---~ 284 (488)
.+++.++.||.|.- |.||++... |..+|+|.+.. .... ... .....-|..|.....+| .
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 68999999999999 999998665 67999999321 1110 000 01223466777776665 4
Q ss_pred CCCc--ceeeccccC------------------CCceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHC
Q 011326 285 HDNI--VQYLGTDRD------------------EKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQ 344 (488)
Q Consensus 285 HpnI--v~l~~~~~~------------------~~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~ 344 (488)
+.++ |+.+||..- .....||.||++... .++ ..-+.+|.+-|..+|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~----~~~~~~~~~dl~~~~k~ 183 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQ----IRDIPQMLRDLKILHKL 183 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccc----hhHHHHHHHHHHHHHHC
Confidence 5566 888887521 123577888877643 122 23356777888999999
Q ss_pred CCccccCCcccEEECCCCcEEEeecCCc
Q 011326 345 NVVHRDIKCANILVDASGSVKLADFGLA 372 (488)
Q Consensus 345 giiHrDLkp~NILl~~~~~vkL~DFGla 372 (488)
||+-+|+++.|.. .-+|+|||.+
T Consensus 184 gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 184 GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred CeeeccCcccccc-----CCEEEecccC
Confidence 9999999999987 3488999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00018 Score=70.44 Aligned_cols=131 Identities=18% Similarity=0.227 Sum_probs=74.9
Q ss_pred ecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcc-eeeccccCCCceEEEEeeccCC
Q 011326 233 LGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV-QYLGTDRDEKRLCIFLELVTKG 311 (488)
Q Consensus 233 LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~~~~~~~~~~~lV~E~~~~g 311 (488)
+..|-.+.+|+.. .++..+++|......... . ....+|..+++.+...+++ +++..+. -++||||++|.
T Consensus 4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~----~-~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKAL----G-VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEE-eCCccEEEeeCCcccccc----c-CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 5668888999886 456678888754322111 0 1235677888877544343 3444332 36899999987
Q ss_pred ChHH-----------H---Hh---hhcc-----Ch-hhhhHHHHHH---------HHHHHHHHH--------CCCccccC
Q 011326 312 SLAS-----------L---YQ---KYHL-----SD-SQVSSYTRQI---------LNGLKYLHE--------QNVVHRDI 351 (488)
Q Consensus 312 sL~~-----------~---l~---~~~l-----s~-~~~~~i~~qi---------~~aL~yLH~--------~giiHrDL 351 (488)
++.. + +. .... +. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 6532 1 11 1111 11 1111221111 111222222 24899999
Q ss_pred CcccEEECCCCcEEEeecCCccc
Q 011326 352 KCANILVDASGSVKLADFGLAKA 374 (488)
Q Consensus 352 kp~NILl~~~~~vkL~DFGla~~ 374 (488)
.|.||+++.++ +.|+||..+..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999997743
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00052 Score=69.10 Aligned_cols=76 Identities=13% Similarity=0.023 Sum_probs=53.3
Q ss_pred eeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCC---CCcceeeccccC---CCceEE
Q 011326 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH---DNIVQYLGTDRD---EKRLCI 303 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H---pnIv~l~~~~~~---~~~~~l 303 (488)
.+.||.|..+.||.....++ .+.+|...... ....+..|+..|+.+.. -.+.++++++.. .+..+|
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~-------~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARSFS-------TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEecccc-------cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 35699999999999876655 46667743210 11356788888887743 356777876654 467899
Q ss_pred EEeeccCCCh
Q 011326 304 FLELVTKGSL 313 (488)
Q Consensus 304 V~E~~~~gsL 313 (488)
|||+++|+++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998764
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00034 Score=69.87 Aligned_cols=135 Identities=16% Similarity=0.129 Sum_probs=80.6
Q ss_pred eeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCC--cceeecc------ccCCCce
Q 011326 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN--IVQYLGT------DRDEKRL 301 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~------~~~~~~~ 301 (488)
.+.|..|....+|+....+ ..+++|..... ....+..|+.++..+.+.+ +.+++.. ...++..
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~--------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV--------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCC--------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 4567888889999986654 46888886531 1134556777777764332 3444332 1223467
Q ss_pred EEEEeeccCCChHH----HH----------hhh--ccChh----hhh----------------HHHHHHHHHHHHHHH--
Q 011326 302 CIFLELVTKGSLAS----LY----------QKY--HLSDS----QVS----------------SYTRQILNGLKYLHE-- 343 (488)
Q Consensus 302 ~lV~E~~~~gsL~~----~l----------~~~--~ls~~----~~~----------------~i~~qi~~aL~yLH~-- 343 (488)
++++++++|..+.. .. +.. .+... ... .....+..++.++.+
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999999876421 11 000 01100 000 011123344555543
Q ss_pred -----CCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 344 -----QNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 344 -----~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
.+++|+|++|.||+++.++.+.|+||+.+.
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999988778899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.56 E-value=2.5e-05 Score=90.34 Aligned_cols=209 Identities=14% Similarity=-0.001 Sum_probs=146.3
Q ss_pred HHHHHHHHhcCCCCCcceeeccc--cCCCceEEEEeeccCCChHHHHhhh-----ccChhhhhHHHHHHHHHHHHHHHC-
Q 011326 273 LEQEISLLGQFEHDNIVQYLGTD--RDEKRLCIFLELVTKGSLASLYQKY-----HLSDSQVSSYTRQILNGLKYLHEQ- 344 (488)
Q Consensus 273 ~~~Ei~iL~~l~HpnIv~l~~~~--~~~~~~~lV~E~~~~gsL~~~l~~~-----~ls~~~~~~i~~qi~~aL~yLH~~- 344 (488)
...|...++...|+++.....-. .+....+..++|+.+|.+...+.++ .+++..+.....+.+.+..-+|..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 34455556667898887755533 2345678999999999999988543 244555555555557777777753
Q ss_pred ----CCccccCCcccEEECCCCcEEEeecCCcccccCC--CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHH
Q 011326 345 ----NVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEM 418 (488)
Q Consensus 345 ----giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eL 418 (488)
--+|++||+-|.+|..+-++++.++|+.+..... -.....+++.|+.|++. ..-.++.++|+|..|+.+|+.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~--N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIK--NEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHH--HHHhhhhHHHHHHHHHHHHHH
Confidence 2689999999999999999999999999833222 13456688899999986 344478789999999999999
Q ss_pred HcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 419 LTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 419 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
-.|..+|...........+..+..-.++...|.+.......+|-+.-..||.-..++.-+.|.-.
T Consensus 1434 s~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~~ 1498 (2724)
T KOG1826|consen 1434 SDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAVG 1498 (2724)
T ss_pred hcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccccc
Confidence 88888875433333333333444444555556666666666666777788888887777666433
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0011 Score=66.73 Aligned_cols=136 Identities=16% Similarity=0.185 Sum_probs=78.9
Q ss_pred eeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCC--cceeecc------ccCCCc
Q 011326 229 KGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN--IVQYLGT------DRDEKR 300 (488)
Q Consensus 229 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~------~~~~~~ 300 (488)
..+.++.|....+|+....+| .+++|...... .. ..+..|.+++..|...+ +.+++.. ....+.
T Consensus 26 ~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~----~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV----KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred eccccCCccccceEEEEeCCC-cEEEEEecCCC----CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 345678888889999876555 57788765321 11 23345566666663222 3333332 122456
Q ss_pred eEEEEeeccCCChH----H-------HH---hh--hccChh-------hhh----------------HHHHHHHHHHHHH
Q 011326 301 LCIFLELVTKGSLA----S-------LY---QK--YHLSDS-------QVS----------------SYTRQILNGLKYL 341 (488)
Q Consensus 301 ~~lV~E~~~~gsL~----~-------~l---~~--~~ls~~-------~~~----------------~i~~qi~~aL~yL 341 (488)
.++++||++|..+. . .+ +. .+++.. ..+ .....+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 78999999986431 1 11 10 011100 000 0111233455555
Q ss_pred HH-------CCCccccCCcccEEECCCCcEEEeecCCc
Q 011326 342 HE-------QNVVHRDIKCANILVDASGSVKLADFGLA 372 (488)
Q Consensus 342 H~-------~giiHrDLkp~NILl~~~~~vkL~DFGla 372 (488)
.. .+++|+|+++.||+++.++...|+||+.+
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 43 58999999999999998887789999976
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00071 Score=67.88 Aligned_cols=74 Identities=15% Similarity=0.173 Sum_probs=47.0
Q ss_pred eeecccCceEEEEEEecC-------CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcc-eeeccccCCCceE
Q 011326 231 ELLGSGSYGFVYEGLTDD-------GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV-QYLGTDRDEKRLC 302 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~~-------g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~~~~~~~~~~~ 302 (488)
+.|..|-...+|+....+ +..+++|........ .....+|..++..+...++. ++++++.. .
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~------~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~ 73 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL------LIDRERELVVFARLSERNLGPKLYGIFPN----G 73 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc------eechHHHHHHHHHHHhCCCCCceEEEeCC----C
Confidence 457778888999987654 578999996543211 12345677777777533333 45555432 3
Q ss_pred EEEeeccCCChH
Q 011326 303 IFLELVTKGSLA 314 (488)
Q Consensus 303 lV~E~~~~gsL~ 314 (488)
+|+||++|.++.
T Consensus 74 ~v~e~i~G~~l~ 85 (302)
T cd05156 74 RIEEFIPSRTLT 85 (302)
T ss_pred chhheeCCCcCC
Confidence 589999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0023 Score=65.77 Aligned_cols=78 Identities=14% Similarity=0.064 Sum_probs=49.1
Q ss_pred eecccCceEEEEEEecCC-cEEEEEEeecCCCC--CcchhHHHHHHHHHHHHhcCC--CC-CcceeeccccCCCceEEEE
Q 011326 232 LLGSGSYGFVYEGLTDDG-FFFAVKEVSLQDEG--PRGKQSILQLEQEISLLGQFE--HD-NIVQYLGTDRDEKRLCIFL 305 (488)
Q Consensus 232 ~LG~G~fg~Vy~~~~~~g-~~vAvK~i~~~~~~--~~~~~~~~~~~~Ei~iL~~l~--Hp-nIv~l~~~~~~~~~~~lV~ 305 (488)
.||.|....||++.+.+| ..++||.-..-... ..-.....+..-|...|+... .| .+.+++.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999988654 68999976432221 111233344556667776653 34 44455544 444567999
Q ss_pred eeccCC
Q 011326 306 ELVTKG 311 (488)
Q Consensus 306 E~~~~g 311 (488)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.007 Score=60.28 Aligned_cols=30 Identities=33% Similarity=0.484 Sum_probs=24.8
Q ss_pred CCccccCCcccEEECCCCc-EEEeecCCccc
Q 011326 345 NVVHRDIKCANILVDASGS-VKLADFGLAKA 374 (488)
Q Consensus 345 giiHrDLkp~NILl~~~~~-vkL~DFGla~~ 374 (488)
.++|+|++|.||+++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3799999999999987565 56999997743
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.014 Score=58.96 Aligned_cols=30 Identities=27% Similarity=0.396 Sum_probs=25.7
Q ss_pred CCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 344 QNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 344 ~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
.++||+|++|.||+++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 379999999999999866556899999774
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0019 Score=68.19 Aligned_cols=162 Identities=24% Similarity=0.373 Sum_probs=104.3
Q ss_pred HHHHHHHHHHhcCCCCCcceeeccccC-CCceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccc
Q 011326 271 LQLEQEISLLGQFEHDNIVQYLGTDRD-EKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHR 349 (488)
Q Consensus 271 ~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHr 349 (488)
.++.....+++.+.|+|....+++... ..+..+|||++.. +|.+++..+.+-..... .+|+.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~l~~~s~~--------------~~~~~~- 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGNLKDESLL--------------AHGVLH- 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcccchhhhc--------------ccccce-
Confidence 356677788999999999999988654 3457889999865 89888765432211111 122222
Q ss_pred cCCcccEEECCCCcEEEeecCCcccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 011326 350 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE 429 (488)
Q Consensus 350 DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~ 429 (488)
-|++ +.+| .++ |. | |-. ..+++||||+|.++.++..|...+....
T Consensus 91 ----~~~~-------~~td-~~~-------------t~-~--~~~-------~~pKsdVwsl~~i~~el~L~~~l~~~~~ 135 (725)
T KOG1093|consen 91 ----LNII-------YITD-HFL-------------TK-Y--PSP-------IGPKSDVWSLGFIILELYLGISLEAELT 135 (725)
T ss_pred ----ehhh-------hccc-ccc-------------cc-C--CCC-------CCcchhhhhHHHHHHHHHHhhHHHHHHH
Confidence 1222 2222 000 00 0 111 1259999999999999999987776655
Q ss_pred hhhhHHHhcCCCCCC-----------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 430 GGQAMFKIGGGELPP-----------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 430 ~~~~~~~i~~~~~~~-----------~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
..+....+..-...+ +...++....++...|+-..|..||...++.+++-|.+.
T Consensus 136 ~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 136 ESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 555544443322211 112356677889999999999999999999999877654
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.016 Score=60.57 Aligned_cols=78 Identities=17% Similarity=0.115 Sum_probs=50.4
Q ss_pred eeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcc--hhHHHHHHHHHHHHhcCC---CCCcceeeccccCCCceEEE
Q 011326 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRG--KQSILQLEQEISLLGQFE---HDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~--~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~lV 304 (488)
.+.||.|....||+..+. +..++||.-......... .....+...|+..|+.+. ..++.+++.++.+ ..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence 456899999999998764 456889987632221111 012233344566666553 3577888888874 46788
Q ss_pred EeeccC
Q 011326 305 LELVTK 310 (488)
Q Consensus 305 ~E~~~~ 310 (488)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.019 Score=58.14 Aligned_cols=140 Identities=14% Similarity=0.154 Sum_probs=79.8
Q ss_pred eecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCC--CCcceeeccccCCC--ceEEEEee
Q 011326 232 LLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH--DNIVQYLGTDRDEK--RLCIFLEL 307 (488)
Q Consensus 232 ~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~--~~~lV~E~ 307 (488)
.+..|-...+|..... ++.+++. ..... .......+..+|..+++.+.- --+...++.|.++. ..+.||++
T Consensus 32 ~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~---~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 32 EISGGWSNDTFRLGDT-GQKYVLR-KPPRG---DPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eccCCcccceEEEecC-CceEEEe-cCCcc---ccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 3433444444544333 7778877 32111 223344566788888887643 22344666777666 67999999
Q ss_pred ccCCChHHHHhhhc---------------------------------cChhhhhHHHHH--------------HHHHHHH
Q 011326 308 VTKGSLASLYQKYH---------------------------------LSDSQVSSYTRQ--------------ILNGLKY 340 (488)
Q Consensus 308 ~~~gsL~~~l~~~~---------------------------------ls~~~~~~i~~q--------------i~~aL~y 340 (488)
++|..+...+.... ....++..+..+ ......+
T Consensus 107 veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 107 VEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred ecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 98842211110000 011111111111 1233444
Q ss_pred HHHC--------CCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 341 LHEQ--------NVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 341 LH~~--------giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
|+.+ .++|+|+++.|++++.++-+-|+||+++....
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 4432 37999999999999998889999999986543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.0078 Score=62.63 Aligned_cols=80 Identities=16% Similarity=0.140 Sum_probs=51.4
Q ss_pred eeeecccCceEEEEEEecC-CcEEEEEEeecCCCC-CcchhHHHHHHHHHHHHhcCC--CC-CcceeeccccCCCceEEE
Q 011326 230 GELLGSGSYGFVYEGLTDD-GFFFAVKEVSLQDEG-PRGKQSILQLEQEISLLGQFE--HD-NIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~~-g~~vAvK~i~~~~~~-~~~~~~~~~~~~Ei~iL~~l~--Hp-nIv~l~~~~~~~~~~~lV 304 (488)
.+.||.|.-..||++.+.+ +..|+||.-..-... ..-.-...+..-|...|+... .| ++.+++.+ +++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 3568999999999998753 667999976432221 111334455666777777653 34 45556654 44456789
Q ss_pred EeeccCC
Q 011326 305 LELVTKG 311 (488)
Q Consensus 305 ~E~~~~g 311 (488)
||+++..
T Consensus 112 MEdL~~~ 118 (409)
T PRK12396 112 MEDLSDH 118 (409)
T ss_pred HHhCccc
Confidence 9998653
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.018 Score=57.70 Aligned_cols=28 Identities=29% Similarity=0.487 Sum_probs=24.9
Q ss_pred CCCccccCCcccEEECCCCcEEEeecCCc
Q 011326 344 QNVVHRDIKCANILVDASGSVKLADFGLA 372 (488)
Q Consensus 344 ~giiHrDLkp~NILl~~~~~vkL~DFGla 372 (488)
.+++|+|+++.||+++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 47899999999999987 67899999965
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.0089 Score=61.46 Aligned_cols=133 Identities=15% Similarity=0.183 Sum_probs=77.2
Q ss_pred eeecccCceEEEEEEec-----CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcc-eeeccccCCCceEEE
Q 011326 231 ELLGSGSYGFVYEGLTD-----DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV-QYLGTDRDEKRLCIF 304 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~~~~~~~~~~~lV 304 (488)
+.|-.|-...+|++... .+..|++|....... .. -.-.+|..++..+..-++. ++++.+..+ .|
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-----~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-----LF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-----ee-echHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 44666888999998643 236788888754321 11 1225677787777654444 455555432 58
Q ss_pred EeeccCCChHHH-------H----------hhhcc-------ChhhhhHHHHHH-----------------HHHHHHHH-
Q 011326 305 LELVTKGSLASL-------Y----------QKYHL-------SDSQVSSYTRQI-----------------LNGLKYLH- 342 (488)
Q Consensus 305 ~E~~~~gsL~~~-------l----------~~~~l-------s~~~~~~i~~qi-----------------~~aL~yLH- 342 (488)
+||+++.+|... + +...+ ....+..+..++ ...+..|.
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 999988766321 1 11011 112222332211 11122221
Q ss_pred -------HCCCccccCCcccEEECC-CCcEEEeecCCcc
Q 011326 343 -------EQNVVHRDIKCANILVDA-SGSVKLADFGLAK 373 (488)
Q Consensus 343 -------~~giiHrDLkp~NILl~~-~~~vkL~DFGla~ 373 (488)
...++|+|+++.|||++. ++.+.++||..+.
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 125899999999999986 5789999998764
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.015 Score=59.36 Aligned_cols=133 Identities=11% Similarity=0.238 Sum_probs=76.3
Q ss_pred eeecccCceEEEEEEecC----CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcc-eeeccccCCCceEEEE
Q 011326 231 ELLGSGSYGFVYEGLTDD----GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV-QYLGTDRDEKRLCIFL 305 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~~----g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~~~~~~~~~~~lV~ 305 (488)
+.|..|=...+|+....+ +..|++|........ .-.-.+|..+++.+..-++- ++++++..+ ++.
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~------~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~ 89 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY------VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQ 89 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe------EechHHHHHHHHHHHhcCCCCceeEEeCCc----Eee
Confidence 445568888999886542 347888887543221 11234677888877655554 455555322 589
Q ss_pred eeccCCChHH-------HH----------hhhccC-------hhhhhHHHHHH----------------------HHHHH
Q 011326 306 ELVTKGSLAS-------LY----------QKYHLS-------DSQVSSYTRQI----------------------LNGLK 339 (488)
Q Consensus 306 E~~~~gsL~~-------~l----------~~~~ls-------~~~~~~i~~qi----------------------~~aL~ 339 (488)
+|+++.+|.. .+ +...++ +..+..+..++ ..-+.
T Consensus 90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 169 (330)
T PLN02421 90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV 169 (330)
T ss_pred hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence 9998766521 11 111111 11222222221 11122
Q ss_pred HHH----HC----CCccccCCcccEEECC-CCcEEEeecCCcc
Q 011326 340 YLH----EQ----NVVHRDIKCANILVDA-SGSVKLADFGLAK 373 (488)
Q Consensus 340 yLH----~~----giiHrDLkp~NILl~~-~~~vkL~DFGla~ 373 (488)
.+. .. -++|.|+.+.|||+++ ++.++++||..|.
T Consensus 170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 221 11 2799999999999975 5789999999774
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.037 Score=55.81 Aligned_cols=29 Identities=21% Similarity=0.304 Sum_probs=26.7
Q ss_pred CCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 345 NVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 345 giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
+++|+|+.++|+|++.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999998763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.02 Score=57.30 Aligned_cols=74 Identities=19% Similarity=0.132 Sum_probs=45.9
Q ss_pred eeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC---CCCCcceeeccccCCCceEEEE
Q 011326 229 KGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF---EHDNIVQYLGTDRDEKRLCIFL 305 (488)
Q Consensus 229 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~~~~~~lV~ 305 (488)
..+.++.|....+|+.. .++..+.+|.-.... ...|..|+.-|+.| ..-.+.+.+++....+..+++|
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~--------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSESG--------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGGG--------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecChhh--------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 34668999999999976 667889999976221 12456677767666 3456778888887777789999
Q ss_pred eeccCC
Q 011326 306 ELVTKG 311 (488)
Q Consensus 306 E~~~~g 311 (488)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.014 Score=55.37 Aligned_cols=29 Identities=41% Similarity=0.643 Sum_probs=20.7
Q ss_pred CCccccCCcccEEE-CCCCcEEEeecCCcc
Q 011326 345 NVVHRDIKCANILV-DASGSVKLADFGLAK 373 (488)
Q Consensus 345 giiHrDLkp~NILl-~~~~~vkL~DFGla~ 373 (488)
.++|+|+.|.|||+ +.++.++++||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 48999999999999 889999999998763
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.13 Score=60.31 Aligned_cols=30 Identities=47% Similarity=0.630 Sum_probs=25.7
Q ss_pred CCCccccCCcccEEECCCC--cEE-EeecCCcc
Q 011326 344 QNVVHRDIKCANILVDASG--SVK-LADFGLAK 373 (488)
Q Consensus 344 ~giiHrDLkp~NILl~~~~--~vk-L~DFGla~ 373 (488)
.++||+|+++.|||++.++ .+. |+|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4799999999999999775 555 99999874
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.063 Score=56.02 Aligned_cols=80 Identities=15% Similarity=0.234 Sum_probs=45.3
Q ss_pred eeeecccCceEEEEEEecCC--cEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcce-eeccccCCCceEEEEe
Q 011326 230 GELLGSGSYGFVYEGLTDDG--FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQ-YLGTDRDEKRLCIFLE 306 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~~g--~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~-l~~~~~~~~~~~lV~E 306 (488)
.+.|..|-.+.+|++...++ ..+.+|.+.....+.. ....-+-.+|+.+++.+...++-+ +++.+.. +++.|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 34566699999999875432 2332222111111111 111123356888888887655544 6666543 58999
Q ss_pred eccCCChH
Q 011326 307 LVTKGSLA 314 (488)
Q Consensus 307 ~~~~gsL~ 314 (488)
|++|.+|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99997663
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.046 Score=56.67 Aligned_cols=60 Identities=18% Similarity=0.176 Sum_probs=48.2
Q ss_pred eEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHH-HHCCCccccCCcccEEECC
Q 011326 301 LCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYL-HEQNVVHRDIKCANILVDA 360 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yL-H~~giiHrDLkp~NILl~~ 360 (488)
..++-+|.+|-++..++.....+++....++.-.+.|+..+ --.+++|.|++|.||++..
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 45666788888999999887788877777877777776655 4568999999999999954
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.12 Score=52.79 Aligned_cols=132 Identities=20% Similarity=0.237 Sum_probs=79.4
Q ss_pred ecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCc---ce---eec----cccCCCceE
Q 011326 233 LGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI---VQ---YLG----TDRDEKRLC 302 (488)
Q Consensus 233 LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI---v~---l~~----~~~~~~~~~ 302 (488)
|.. .-..+|+....+|.. ++|..... . ...++..|...|..+.-.+| ++ +-| ......+.+
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~------~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a 104 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-W------TRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA 104 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC-C------CHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence 555 677889988887777 88888754 2 12344556666666632221 11 111 112224788
Q ss_pred EEEeeccCCChHH-----H-------H---h----hhc---------cChh----h---------hhHHHHHHHHHHHHH
Q 011326 303 IFLELVTKGSLAS-----L-------Y---Q----KYH---------LSDS----Q---------VSSYTRQILNGLKYL 341 (488)
Q Consensus 303 lV~E~~~~gsL~~-----~-------l---~----~~~---------ls~~----~---------~~~i~~qi~~aL~yL 341 (488)
-+++|++|..+.. . + + ..+ ..+. . -.....++...+..+
T Consensus 105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~ 184 (331)
T COG2334 105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL 184 (331)
T ss_pred EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence 8999999987762 1 1 0 000 1111 0 011334455556665
Q ss_pred HH-------CC---CccccCCcccEEECCCCc-EEEeecCCcc
Q 011326 342 HE-------QN---VVHRDIKCANILVDASGS-VKLADFGLAK 373 (488)
Q Consensus 342 H~-------~g---iiHrDLkp~NILl~~~~~-vkL~DFGla~ 373 (488)
.+ .+ +||+|+.|.||+++.+.. .-++||+.+.
T Consensus 185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 54 23 999999999999998885 8999999763
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.73 E-value=0.54 Score=47.84 Aligned_cols=72 Identities=15% Similarity=0.050 Sum_probs=42.1
Q ss_pred ccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCC--cceee---c--cccCCCceEEEEee
Q 011326 235 SGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN--IVQYL---G--TDRDEKRLCIFLEL 307 (488)
Q Consensus 235 ~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~---~--~~~~~~~~~lV~E~ 307 (488)
.+.-..||+....+|..+++|...... . ...++..|+..+..+.... ++... | ....++..+.++++
T Consensus 35 ~s~eN~vy~v~~~~~~~~vlKv~r~~~---~---~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~ 108 (325)
T PRK11768 35 NSYENRVYQFGDEDGRRVVAKFYRPER---W---SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPR 108 (325)
T ss_pred ccccceEEEEecCCCCEEEEEEcCccc---C---CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEee
Confidence 355677899888888889999875322 1 1234555666666553211 22211 1 11224567889999
Q ss_pred ccCCC
Q 011326 308 VTKGS 312 (488)
Q Consensus 308 ~~~gs 312 (488)
++|..
T Consensus 109 ~~G~~ 113 (325)
T PRK11768 109 RGGRA 113 (325)
T ss_pred eCCCC
Confidence 98764
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=94.19 E-value=0.15 Score=50.81 Aligned_cols=28 Identities=43% Similarity=0.604 Sum_probs=23.6
Q ss_pred CccccCCcccEEECCC--C---cEEEeecCCcc
Q 011326 346 VVHRDIKCANILVDAS--G---SVKLADFGLAK 373 (488)
Q Consensus 346 iiHrDLkp~NILl~~~--~---~vkL~DFGla~ 373 (488)
++|||+++.|||+..+ | .++++||-.++
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeecccccc
Confidence 8999999999999754 3 58999998663
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 488 | ||||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-44 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-44 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-40 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-40 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-40 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-40 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-39 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-39 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-37 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-36 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-36 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-36 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-36 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-36 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-36 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-35 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-35 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-35 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-35 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-34 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-32 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-32 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-32 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-31 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-31 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-30 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-30 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-30 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-30 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-30 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-30 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-30 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-29 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-29 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-28 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-28 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-27 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-27 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-27 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-27 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-27 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-26 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-26 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-26 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-26 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-26 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-26 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-25 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-25 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-25 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-25 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-25 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-25 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-25 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-25 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-25 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-25 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-25 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-25 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-25 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-25 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-25 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-25 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-25 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-25 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-25 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-25 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-25 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-25 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-25 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-25 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-25 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-25 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-25 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-25 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-25 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-25 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-25 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-25 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-25 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-25 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-25 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-25 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-25 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-25 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-25 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-25 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-25 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-25 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-25 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-25 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-25 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-25 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-25 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-25 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-25 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-25 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-25 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-25 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-25 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-25 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-25 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-25 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-25 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-25 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-25 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-25 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-25 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-25 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-25 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-25 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-25 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-25 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-25 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-25 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-25 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-25 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-25 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-25 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-25 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-25 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-25 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-25 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-25 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-25 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-25 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-25 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-25 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-25 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-25 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-25 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-25 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-25 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-25 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-25 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-25 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-25 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-24 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-24 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-24 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-24 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-24 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-24 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-24 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-24 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-24 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-24 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-24 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-24 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-24 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-24 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-24 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-24 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-24 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-24 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-24 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-24 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-24 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-24 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-24 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-23 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-23 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-23 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-23 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-23 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-23 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-23 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-23 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-23 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-23 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-23 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-23 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-23 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-23 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-23 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-23 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-23 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-23 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-23 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-23 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-23 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-23 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-23 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-23 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-23 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-23 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-23 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-23 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-23 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-23 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-23 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-23 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-23 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-23 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-23 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-23 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-23 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-23 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-23 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-23 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-23 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-23 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-23 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-23 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-23 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-23 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-23 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-23 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-23 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-23 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-23 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-23 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-23 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-23 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-23 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-23 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-23 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-23 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-23 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-23 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-23 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-23 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-22 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-22 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-22 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-22 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-22 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-22 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-22 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-22 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-22 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-22 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-22 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-22 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-22 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-22 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-22 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-22 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-22 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-22 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-22 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-22 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-22 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-22 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-22 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-22 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-22 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-22 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-22 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-22 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-22 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-22 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-22 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-22 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-22 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-22 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-22 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-22 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-22 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-22 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-22 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-22 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-22 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-22 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-22 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-22 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-22 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-22 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-22 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-22 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-22 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-22 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-22 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-22 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-22 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-22 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-22 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-22 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-22 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-22 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-22 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-22 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-22 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-22 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-22 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-22 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-22 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-22 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-22 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-22 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-22 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-22 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-22 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-22 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-22 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-22 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-22 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-22 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-22 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-22 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-22 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-22 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-22 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-21 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-21 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-21 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-21 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-21 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-21 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-21 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-21 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-21 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-21 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-21 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-21 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-21 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-21 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-21 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-21 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-21 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-21 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-21 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-21 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-21 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-21 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-21 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-21 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-21 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-21 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-21 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-21 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-21 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-21 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-21 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-21 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-21 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-21 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-21 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-21 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-21 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-21 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-21 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-21 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-21 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-21 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-21 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-21 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-21 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-21 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-21 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-21 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-21 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-21 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-21 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-21 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-21 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-21 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-21 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-21 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-21 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-21 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-21 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-21 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-21 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-21 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-21 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-21 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-21 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-21 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-21 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-21 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-21 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-21 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-21 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-21 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-21 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-21 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-21 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-21 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-21 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-21 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-21 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-21 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-21 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-21 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-21 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-21 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-20 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-20 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-20 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-20 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-20 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-20 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-20 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-20 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-20 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-20 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-20 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-20 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-20 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-20 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-20 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-20 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-20 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-20 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-20 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-20 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-20 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-20 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-20 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-20 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-20 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-20 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-20 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-20 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-20 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-20 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-20 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-20 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-20 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-20 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-20 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-20 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-20 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-20 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-20 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-20 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-20 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-20 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-20 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-20 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-20 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-20 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-19 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-19 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-19 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-19 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-19 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-19 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-19 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-19 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-19 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-19 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-19 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-19 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-19 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-19 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-19 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-19 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-19 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-19 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-19 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-19 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-19 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-19 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-19 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-19 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-19 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-19 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-19 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-19 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-19 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-19 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-19 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-19 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-19 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-19 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-19 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-19 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-19 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-19 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-19 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-19 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-18 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-18 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-18 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-18 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-18 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-18 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-18 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-18 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-18 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-18 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-18 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-18 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-18 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-18 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-18 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-18 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-18 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-18 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-18 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-18 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-18 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-18 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-18 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-18 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-18 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-18 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-18 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-18 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-18 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-18 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-18 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-18 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-18 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-18 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-18 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-18 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-18 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-18 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-18 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-18 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-18 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-18 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-18 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-18 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-18 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-18 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-18 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-18 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-18 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-18 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-18 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-18 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-18 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-18 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-18 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-18 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-18 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-18 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-18 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-18 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-18 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-18 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-18 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-18 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-18 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-18 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-17 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-17 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-17 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-17 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-17 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-17 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-17 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-17 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-17 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-17 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-17 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-17 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-17 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-17 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-17 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-17 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-17 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-17 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-17 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-17 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-17 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-17 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-17 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-17 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-17 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-17 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-17 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-17 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-17 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-17 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-17 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-17 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-17 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-17 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-17 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-17 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-17 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-17 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-17 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-17 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-17 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-17 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-17 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-17 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-17 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-17 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-17 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-17 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-17 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-17 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-17 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-17 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-17 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-17 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-17 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-17 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-17 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-17 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-17 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-17 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-17 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-17 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-17 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-16 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-16 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-16 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-16 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-16 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-16 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-16 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-16 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-16 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-16 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-16 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-16 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-16 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-16 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-16 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-16 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-16 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-16 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-16 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-16 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-16 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-16 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-16 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-16 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-16 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-16 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-16 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-16 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-16 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-16 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-16 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-16 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-16 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-16 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-15 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-15 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-15 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-15 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-15 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-15 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-15 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-15 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-15 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-15 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-15 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-15 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-15 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-15 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-15 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-15 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-15 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-15 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-15 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 6e-15 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 6e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-15 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 7e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-15 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-15 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-15 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-14 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-14 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-14 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-14 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-14 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-14 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-14 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 9e-14 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-13 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-13 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-13 |
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 406 bits (1045), Expect = e-141
Identities = 107/290 (36%), Positives = 163/290 (56%), Gaps = 15/290 (5%)
Query: 209 EPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGK 267
E G+ S ++ +LG G+YG VY G + A+KE+ +D
Sbjct: 6 EEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-----S 60
Query: 268 QSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH----LS 323
+ L +EI+L +H NIVQYLG+ + + IF+E V GSL++L + +
Sbjct: 61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120
Query: 324 DSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAK--ATTMNDV 380
+ + YT+QIL GLKYLH+ +VHRDIK N+L++ SG +K++DFG +K A
Sbjct: 121 EQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180
Query: 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHL-EGGQAMFKIGG 439
++ GT +MAPE+++ GYG ADIWSLGCT++EM T + P+ L E AMFK+G
Sbjct: 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM 240
Query: 440 GEL-PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
++ P +P S+S +A+ FILKC + +P+ R A L+ F+K +
Sbjct: 241 FKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKK 290
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 357 bits (919), Expect = e-121
Identities = 80/302 (26%), Positives = 127/302 (42%), Gaps = 29/302 (9%)
Query: 194 HDDDDSKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFF 252
+ +D++G ++E ++P + ++R + +G GS+G V+ GF
Sbjct: 32 PETEDNEGVLLTEKLKP-----VDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQC 86
Query: 253 AVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGS 312
AVK+V L+ +E+ IV G R+ + IF+EL+ GS
Sbjct: 87 AVKKVRLEV----------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136
Query: 313 LASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS-VKLADFG 370
L L ++ L + + Y Q L GL+YLH + ++H D+K N+L+ + GS L DFG
Sbjct: 137 LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG 196
Query: 371 LAK-------ATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRH 423
A ++ GT MAPEVV DIWS C +L ML H
Sbjct: 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVV--MGKPCDAKVDIWSSCCMMLHMLNGCH 254
Query: 424 PYSHLEGGQAMFKIGGGE--LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
P++ G KI + +P S + I + L+ P R +A +L
Sbjct: 255 PWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314
Query: 482 RP 483
Sbjct: 315 LQ 316
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 353 bits (907), Expect = e-120
Identities = 78/299 (26%), Positives = 149/299 (49%), Gaps = 23/299 (7%)
Query: 195 DDDDSKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFA 253
++ + + I E+ +S +G+F + +G GS+ VY+GL T+ A
Sbjct: 2 EERNQQQDDIEELETKAVGMSNDGRF------LKFDIEIGRGSFKTVYKGLDTETTVEVA 55
Query: 254 VKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLG----TDRDEKRLCIFLELVT 309
E+ + K + ++E +L +H NIV++ T + +K + + EL+T
Sbjct: 56 WCELQDRK---LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 112
Query: 310 KGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQN--VVHRDIKCANILVDA-SGSVK 365
G+L + +++ + + S+ RQIL GL++LH + ++HRD+KC NI + +GSVK
Sbjct: 113 SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVK 172
Query: 366 LADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY 425
+ D GLA + K+ GT +MAPE+ ++ Y + D+++ G +LEM T +PY
Sbjct: 173 IGDLGLATLKRASFAKAVIGTPEFMAPEMY---EEKYDESVDVYAFGMCMLEMATSEYPY 229
Query: 426 SHLEGGQAMFKIGGGELPP--VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
S + +++ + P + ++ I C++ N ++R + L+ H F +
Sbjct: 230 SECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 311 bits (798), Expect = e-104
Identities = 62/294 (21%), Positives = 125/294 (42%), Gaps = 36/294 (12%)
Query: 214 VSPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQ 272
+ ++ + + E +GSG +G V++ + DG +A+K G +Q+ L+
Sbjct: 3 MGMKSRYTTE---FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR 59
Query: 273 LEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-----HLSDSQV 327
+ + +H ++V+Y ++ + I E GSLA + + ++++
Sbjct: 60 --EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117
Query: 328 SSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS-------------------VKLAD 368
Q+ GL+Y+H ++VH DIK +NI + + K+ D
Sbjct: 118 KDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 369 FGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHL 428
G T ++ + +G + ++A EV+ + ADI++L TV+
Sbjct: 178 LGH--VTRISSPQVEEGDSRFLANEVLQENY-THLPKADIFALALTVVCAAGAEPLPR-- 232
Query: 429 EGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
G +I G LP +P LS++ + + + +P RP+A L++H +
Sbjct: 233 -NGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 306 bits (787), Expect = e-102
Identities = 85/289 (29%), Positives = 132/289 (45%), Gaps = 16/289 (5%)
Query: 200 KGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVS 258
+G + PG + P+ S+Q+ LG GSYG V++ +DG +AVK
Sbjct: 34 RGEASETLQSPGYD--PSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSM 91
Query: 259 LQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQ 318
GP+ + L + S +H V+ + L + EL SL +
Sbjct: 92 SPFRGPKDRARKLA--EVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCE 148
Query: 319 KY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA-T 375
+ L ++QV Y R L L +LH Q +VH D+K ANI + G KL DFGL
Sbjct: 149 AWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208
Query: 376 TMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF 435
T + +G +MAPE++ YG AD++SLG T+LE+ GG+
Sbjct: 209 TAGAGEVQEGDPRYMAPELLQ---GSYGTAADVFSLGLTILEVACNMELPH---GGEGWQ 262
Query: 436 KIGGGELPP-VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483
++ G LPP LS + + ++ L+ +P R TA L+ P +++P
Sbjct: 263 QLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP 311
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 293 bits (752), Expect = 1e-95
Identities = 68/304 (22%), Positives = 130/304 (42%), Gaps = 23/304 (7%)
Query: 203 PISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDE 262
+ + + S N + + + +GSG V++ L + +A+K V+L++
Sbjct: 34 DLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE- 92
Query: 263 GPRGKQSILQLEQEISLLGQFEH--DNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQK 319
Q++ EI+ L + + D I++ + ++ + + +E L S L +K
Sbjct: 93 --ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK 149
Query: 320 YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA----T 375
+ + SY + +L + +H+ +VH D+K AN L+ G +KL DFG+A T
Sbjct: 150 KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208
Query: 376 TMNDVKSCKGTAFWMAPEVVNLK---------KDGYGLTADIWSLGCTVLEMLTRRHPYS 426
T S G +M PE + K +D+WSLGC + M + P+
Sbjct: 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268
Query: 427 HLEGG-QAMFKIG-GGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484
+ + I P+ +D QD + CL+ +P R + +L+ HP+++
Sbjct: 269 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328
Query: 485 QTSS 488
+
Sbjct: 329 HPVN 332
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 7e-92
Identities = 76/273 (27%), Positives = 131/273 (47%), Gaps = 15/273 (5%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++ + +G G + VY DG A+K+V + D ++ +EI LL Q H
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD--AKARADCIKEIDLLKQLNH 91
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-----HLSDSQVSSYTRQILNGLKY 340
N+++Y + ++ L I LEL G L+ + + + + + V Y Q+ + L++
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTAFWMAPEVVNLK 398
+H + V+HRDIK AN+ + A+G VKL D GL + + S GT ++M+PE ++
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 211
Query: 399 KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQA--MFKIGGGELPPVP-NSLSRDAQD 455
GY +DIWSLGC + EM + P+ + KI + PP+P + S + +
Sbjct: 212 --GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269
Query: 456 FILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
+ C+ +P RP + + SS
Sbjct: 270 LVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 1e-91
Identities = 71/307 (23%), Positives = 132/307 (42%), Gaps = 29/307 (9%)
Query: 194 HDDDDSKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFA 253
H S G + ++S G+ + + +GSG V++ L + +A
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSVKGR------IYSILKQIGSGGSSKVFQVLNEKKQIYA 56
Query: 254 VKEVSLQDEGPRGKQSILQLEQEISLLGQFEH--DNIVQYLGTDRDEKRLCIFLELVTKG 311
+K V+L++ Q++ EI+ L + + D I++ + ++ + + +E
Sbjct: 57 IKYVNLEE---ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NI 112
Query: 312 SLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFG 370
L S +K + + SY + +L + +H+ +VH D+K AN L+ G +KL DFG
Sbjct: 113 DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFG 171
Query: 371 LAKA----TTMNDVKSCKGTAFWMAPEVVNLK---------KDGYGLTADIWSLGCTVLE 417
+A TT S GT +M PE + K +D+WSLGC +
Sbjct: 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231
Query: 418 MLTRRHPYSHLEGG-QAMFKIGGGELP-PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLM 475
M + P+ + + I P+ +D QD + CL+ +P R + +L+
Sbjct: 232 MTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291
Query: 476 EHPFIKR 482
HP+++
Sbjct: 292 AHPYVQI 298
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 3e-91
Identities = 68/295 (23%), Positives = 128/295 (43%), Gaps = 29/295 (9%)
Query: 212 NNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSIL 271
+S G+ + + +GSG V++ L + +A+K V+L++ Q++
Sbjct: 2 ECISVKGR------IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE---ADNQTLD 52
Query: 272 QLEQEISLLGQFEH--DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVS 328
EI+ L + + D I++ + ++ + + +E L S +K + +
Sbjct: 53 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERK 111
Query: 329 SYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA----TTMNDVKSCK 384
SY + +L + +H+ +VH D+K AN L+ G +KL DFG+A TT S
Sbjct: 112 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV 170
Query: 385 GTAFWMAPEVVNLK---------KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-QAM 434
GT +M PE + K +D+WSLGC + M + P+ + +
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 230
Query: 435 FKIG-GGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
I P+ +D QD + CL+ +P R + +L+ HP+++ +
Sbjct: 231 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 285
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 1e-89
Identities = 75/282 (26%), Positives = 143/282 (50%), Gaps = 11/282 (3%)
Query: 210 PGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQ 268
G ++ + + + + + + +G GS+G T+DG + +KE+++ + ++
Sbjct: 9 SGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE 68
Query: 269 SILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY---HLSDS 325
+ E+++L +H NIVQY + + L I ++ G L +
Sbjct: 69 ESRR---EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQED 125
Query: 326 QVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSC 383
Q+ + QI LK++H++ ++HRDIK NI + G+V+L DFG+A+ +T+ ++C
Sbjct: 126 QILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC 185
Query: 384 KGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP 443
GT ++++PE+ K Y +DIW+LGC + E+ T +H + + KI G P
Sbjct: 186 IGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP 243
Query: 444 PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485
PV S D + + + + NP DRP+ ++E FI + ++
Sbjct: 244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIE 285
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 9e-81
Identities = 93/259 (35%), Positives = 145/259 (55%), Gaps = 9/259 (3%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+ K E +G GS+G V++G+ A+K + L++ I ++QEI++L Q +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE----IEDIQQEITVLSQCDS 79
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQN 345
+ +Y G+ + +L I +E + GS L + L ++Q+++ R+IL GL YLH +
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTAFWMAPEVVNLKKDGYG 403
+HRDIK AN+L+ G VKLADFG+A T + GT FWMAPEV+ K+ Y
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--KQSAYD 197
Query: 404 LTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQV 463
ADIWSLG T +E+ P+S L + +F I P + + S+ ++F+ CL
Sbjct: 198 SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 257
Query: 464 NPNDRPTAAQLMEHPFIKR 482
P+ RPTA +L++H FI R
Sbjct: 258 EPSFRPTAKELLKHKFILR 276
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 3e-80
Identities = 89/279 (31%), Positives = 139/279 (49%), Gaps = 29/279 (10%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
W+ LG G++G VY+ + G A K + + E + + EI +L +H
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-----EELEDYIVEIEILATCDH 75
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHE 343
IV+ LG + +L I +E G++ ++ + L++ Q+ RQ+L L +LH
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 344 QNVVHRDIKCANILVDASGSVKLADFG--------LAKATTMNDVKSCKGTAFWMAPEVV 395
+ ++HRD+K N+L+ G ++LADFG L K + GT +WMAPEVV
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF------IGTPYWMAPEVV 189
Query: 396 ---NLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV---PNSL 449
+K Y ADIWSLG T++EM P+ L + + KI + PP P+
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD-PPTLLTPSKW 248
Query: 450 SRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
S + +DF+ L NP RP+AAQL+EHPF+ +
Sbjct: 249 SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKA 287
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 1e-79
Identities = 71/293 (24%), Positives = 129/293 (44%), Gaps = 26/293 (8%)
Query: 208 MEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGK 267
+E + S+ ++LG G+ G + D AVK +
Sbjct: 7 LEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL--------P 58
Query: 268 QSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQK--YHLSD 324
+ ++E+ LL + EH N+++Y T++D + I +EL +L ++ +
Sbjct: 59 ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLG 117
Query: 325 SQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS-----VKLADFGLAK-----A 374
+ + +Q +GL +LH N+VHRD+K NIL+ + ++DFGL K
Sbjct: 118 LEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177
Query: 375 TTMNDVKSCKGTAFWMAPEVVNLK-KDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQ 432
+ + GT W+APE+++ K+ T DI+S GC +++ HP+ Q
Sbjct: 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ 237
Query: 433 AMFKIGGGELPPV--PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483
A +G L + A++ I K + ++P RP+A +++HPF
Sbjct: 238 ANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 8e-79
Identities = 94/270 (34%), Positives = 150/270 (55%), Gaps = 18/270 (6%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+ E LG GSYG VY+ + + G A+K+V ++ + + ++ +EIS++ Q +
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQCDS 83
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHE 343
++V+Y G+ L I +E GS++ + + + L++ ++++ + L GL+YLH
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTAFWMAPEVVNLKKDG 401
+HRDIK NIL++ G KLADFG+A TM + GT FWMAPEV+ ++ G
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI--QEIG 201
Query: 402 YGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV---PNSLSRDAQDFIL 458
Y ADIWSLG T +EM + PY+ + +A+F I PP P S + DF+
Sbjct: 202 YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP-PPTFRKPELWSDNFTDFVK 260
Query: 459 KCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
+CL +P R TA QL++HPF++ S
Sbjct: 261 QCLVKSPEQRATATQLLQHPFVRSAKGVSI 290
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 1e-78
Identities = 86/294 (29%), Positives = 136/294 (46%), Gaps = 27/294 (9%)
Query: 205 SEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEG 263
++ E P F +G GS+G VY + A+K++S +
Sbjct: 41 PDVAELFFKDDPEKLF-------SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ 93
Query: 264 PRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-- 321
K + +E+ L + H N +QY G E + +E GS + L + +
Sbjct: 94 SNEKWQDII--KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP 150
Query: 322 LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFG----LAKATTM 377
L + ++++ T L GL YLH N++HRD+K NIL+ G VKL DFG +A A +
Sbjct: 151 LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF 210
Query: 378 NDVKSCKGTAFWMAPEVV-NLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFK 436
GT +WMAPEV+ + + Y D+WSLG T +E+ R+ P ++ A++
Sbjct: 211 ------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 264
Query: 437 IGGGELPPV--PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
I E P S ++F+ CLQ P DRPT+ L++H F+ R +
Sbjct: 265 IAQNE-SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV 317
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 2e-78
Identities = 80/273 (29%), Positives = 128/273 (46%), Gaps = 20/273 (7%)
Query: 228 QKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286
+ +G+GSYG + DG KE+ KQ ++ E++LL + +H
Sbjct: 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS---EVNLLRELKHP 65
Query: 287 NIVQYLGT--DRDEKRLCIFLELVTKGSLASLYQKY-----HLSDSQVSSYTRQILNGLK 339
NIV+Y DR L I +E G LAS+ K +L + V Q+ LK
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 340 YLHEQN-----VVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTAFWMAP 392
H ++ V+HRD+K AN+ +D +VKL DFGLA+ + K+ GT ++M+P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 393 EVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRD 452
E +N Y +DIWSLGC + E+ P++ + KI G+ +P S +
Sbjct: 186 EQMNRMS--YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 243
Query: 453 AQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485
+ I + L + RP+ +++E+P I
Sbjct: 244 LNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 3e-78
Identities = 87/267 (32%), Positives = 144/267 (53%), Gaps = 12/267 (4%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+ + E +G G+ G VY + G A+++++LQ + P+ K+ I+ EI ++ + ++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PK-KELIIN---EILVMRENKN 76
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQN 345
NIV YL + L + +E + GSL + + + + Q+++ R+ L L++LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTAFWMAPEVVNLKKDGYG 403
V+HRDIK NIL+ GSVKL DFG + + GT +WMAPEVV + YG
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV--TRKAYG 194
Query: 404 LTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV--PNSLSRDAQDFILKCL 461
DIWSLG +EM+ PY + +A++ I P + P LS +DF+ +CL
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254
Query: 462 QVNPNDRPTAAQLMEHPFIKRPLQTSS 488
+++ R +A +L++H F+K SS
Sbjct: 255 EMDVEKRGSAKELLQHQFLKIAKPLSS 281
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 8e-78
Identities = 67/276 (24%), Positives = 117/276 (42%), Gaps = 37/276 (13%)
Query: 228 QKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286
++ EL+GSG +G V++ DG + +K V +E + E+E+ L + +H
Sbjct: 14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---------KAEREVKALAKLDHV 64
Query: 287 NIVQYLG----------------TDRDEKRLCIFLELVTKGSLASLYQKY---HLSDSQV 327
NIV Y G + K L I +E KG+L +K L
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 328 SSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA-TTMNDVKSCKGT 386
QI G+ Y+H + +++RD+K +NI + + VK+ DFGL + KGT
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGT 184
Query: 387 AFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVP 446
+M+PE + YG D+++LG + E+L E + + G +
Sbjct: 185 LRYMSPEQ--ISSQDYGKEVDLYALGLILAELLHVCDTAF--ETSKFFTDLRDGIISD-- 238
Query: 447 NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
+ + + K L P DRP ++++ + +
Sbjct: 239 -IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 1e-77
Identities = 81/267 (30%), Positives = 132/267 (49%), Gaps = 12/267 (4%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+G GS G V G AVK + L+ + Q L E+ ++ ++H
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQH 101
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQN 345
N+V+ + + L + +E + G+L + + L++ Q+++ +L L YLH Q
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG 161
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTAFWMAPEVVNLKKDGYG 403
V+HRDIK +IL+ G VKL+DFG + + KS GT +WMAPEV+ + Y
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI--SRSLYA 219
Query: 404 LTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV--PNSLSRDAQDFILKCL 461
DIWSLG V+EM+ PY QAM ++ P + + +S +DF+ + L
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279
Query: 462 QVNPNDRPTAAQLMEHPFIKRPLQTSS 488
+P +R TA +L++HPF+ +
Sbjct: 280 VRDPQERATAQELLDHPFLLQTGLPEC 306
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 2e-77
Identities = 87/280 (31%), Positives = 136/280 (48%), Gaps = 25/280 (8%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-E 284
++ EL+G+G+YG VY+G G A+K + + + +++QEI++L ++
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSH 79
Query: 285 HDNIVQYLG------TDRDEKRLCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQIL 335
H NI Y G + +L + +E GS+ L + L + ++ R+IL
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 336 NGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTAFWMAPE 393
GL +LH+ V+HRDIK N+L+ + VKL DFG++ T+ + GT +WMAPE
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 199
Query: 394 VV---NLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV--PNS 448
V+ Y +D+WSLG T +EM P + +A+F I P
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-APRLKSKK 258
Query: 449 LSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
S+ Q FI CL N + RP QLM+HPFI+
Sbjct: 259 WSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQ 298
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 8e-76
Identities = 82/288 (28%), Positives = 138/288 (47%), Gaps = 31/288 (10%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++ E++GSG+ V A+K ++L+ S+ +L +EI + Q H
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT----SMDELLKEIQAMSQCHH 72
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH---------LSDSQVSSYTRQILN 336
NIV Y + + L + ++L++ GS+ + + L +S +++ R++L
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 337 GLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCK-----GTAFW 389
GL+YLH+ +HRD+K NIL+ GSV++ADFG++ AT + ++ GT W
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 390 MAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKI---------GGG 440
MAPEV+ + GY ADIWS G T +E+ T PY + + G
Sbjct: 193 MAPEVME-QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 251
Query: 441 ELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
+ + + + I CLQ +P RPTAA+L+ H F ++
Sbjct: 252 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEF 299
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 4e-74
Identities = 70/301 (23%), Positives = 129/301 (42%), Gaps = 44/301 (14%)
Query: 222 RRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLL 280
R + +++ +LG G++G V + D ++A+K++ ++ + + E+ LL
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT------EEKLSTILSEVMLL 56
Query: 281 GQFEHDNIVQYLGTDRDEKR-------------LCIFLELVTKGSLASL--YQKYHLSDS 325
H +V+Y + + L I +E G+L L + +
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 326 QVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK------------ 373
+ RQIL L Y+H Q ++HRD+K NI +D S +VK+ DFGLAK
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 374 ----ATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE 429
+ +++ S GTA ++A EV++ Y D++SLG EM+ + +E
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLD-GTGHYNEKIDMYSLGIIFFEMIY--PFSTGME 233
Query: 430 GGQAMFKIGGGEL---PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486
+ K+ + P ++ + + I + +PN RP A L+ ++ Q
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD 293
Query: 487 S 487
Sbjct: 294 E 294
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 4e-73
Identities = 64/292 (21%), Positives = 116/292 (39%), Gaps = 39/292 (13%)
Query: 222 RRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLL 280
R +T ++ + LG G +G V+E D +A+K + L ++ +++ E+ L
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRL-PNRELAREKVMR---EVKAL 57
Query: 281 GQFEHDNIVQYLGTDRDEKR------------LCIFLELVTKGSLASLYQK----YHLSD 324
+ EH IV+Y ++ L I ++L K +L
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 325 SQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA---------- 374
S QI +++LH + ++HRD+K +NI VK+ DFGL A
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 375 ----TTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG 430
GT +M+PE + + Y DI+SLG + E+L + +E
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQ--IHGNSYSHKVDIFSLGLILFELLY--PFSTQMER 233
Query: 431 GQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
+ + + + PP+ + L +P +RP A ++E+ +
Sbjct: 234 VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 3e-71
Identities = 78/294 (26%), Positives = 133/294 (45%), Gaps = 36/294 (12%)
Query: 213 NVSPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSIL 271
+SP + + +G G+YG V + + G AVK + + ++
Sbjct: 10 KISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD----EKEQK 65
Query: 272 QLEQEIS-LLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH------LSD 324
QL ++ ++ + IVQ+ G E I +EL++ S Y+ + + +
Sbjct: 66 QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPE 124
Query: 325 SQVSSYTRQILNGLKYLHEQ-NVVHRDIKCANILVDASGSVKLADFG--------LAKAT 375
+ T + L +L E ++HRDIK +NIL+D SG++KL DFG +AK
Sbjct: 125 EILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR 184
Query: 376 TMNDVKSCKGTAFWMAPEVVN--LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG-GQ 432
G +MAPE ++ + GY + +D+WSLG T+ E+ T R PY
Sbjct: 185 DA-------GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237
Query: 433 AMFKIGGGELPPVPNSL----SRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
+ ++ G+ P + NS S +F+ CL + + RP +L++HPFI
Sbjct: 238 QLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 2e-70
Identities = 64/316 (20%), Positives = 118/316 (37%), Gaps = 63/316 (19%)
Query: 227 WQKGELLGSG--SYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF 283
++ ++G G V G + V+ ++L+ + + L+ E+ + F
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS---NEMVTFLQGELHVSKLF 83
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILNGLKY 340
H NIV Y T + L + + GS L + +++ ++ + +L L Y
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGLA--------KATTMNDVKSCK-GTAFWMA 391
+H VHR +K ++IL+ G V L+ + ++D W++
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 392 PEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP-------- 443
PEV+ GY +DI+S+G T E+ P+ + Q + + G +P
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI 263
Query: 444 -------------------------------------PVPNSLSRDAQDFILKCLQVNPN 466
P + S F+ +CLQ NP+
Sbjct: 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPD 323
Query: 467 DRPTAAQLMEHPFIKR 482
RP+A+ L+ H F K+
Sbjct: 324 ARPSASTLLNHSFFKQ 339
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 1e-69
Identities = 79/276 (28%), Positives = 129/276 (46%), Gaps = 32/276 (11%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEIS-LLGQFE 284
+ LG G+YG V + G AVK + Q +L ++ + +
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN----SQEQKRLLMDLDISMRTVD 64
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-----LSDSQVSSYTRQILNGLK 339
V + G E + I +EL+ SL Y++ + + + I+ L+
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 340 YLHEQ-NVVHRDIKCANILVDASGSVKLADFG--------LAKATTMNDVKSCKGTAFWM 390
+LH + +V+HRD+K +N+L++A G VK+ DFG +AK D G +M
Sbjct: 124 HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI---DA----GCKPYM 176
Query: 391 APEVVN--LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-QAMFKIGGGELPPVP- 446
APE +N L + GY + +DIWSLG T++E+ R PY Q + ++ P +P
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236
Query: 447 NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
+ S + DF +CL+ N +RPT +LM+HPF
Sbjct: 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 3e-68
Identities = 63/309 (20%), Positives = 117/309 (37%), Gaps = 35/309 (11%)
Query: 199 SKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEV 257
+ G+ V + K + + LG G + +V DG F+A+K +
Sbjct: 9 HHSSGRENLYFQGHMVIIDNK------HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI 62
Query: 258 SLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLG----TDRDEKRLCIFLELVTKGSL 313
+ +Q + ++E + F H NI++ + + + L +G+L
Sbjct: 63 LCHE-----QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTL 117
Query: 314 ASLYQKY-----HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLAD 368
+ ++ L++ Q+ I GL+ +H + HRD+K NIL+ G L D
Sbjct: 118 WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMD 177
Query: 369 FGLA-----------KATTMNDVKSCKGTAFWMAPEVVNLKK-DGYGLTADIWSLGCTVL 416
G +A T+ D + + T + APE+ +++ D+WSLGC +
Sbjct: 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLY 237
Query: 417 EMLTRRHPY--SHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQL 474
M+ PY +G + P S + + V+P+ RP L
Sbjct: 238 AMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297
Query: 475 MEHPFIKRP 483
+ +P
Sbjct: 298 LSQLEALQP 306
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 5e-67
Identities = 80/271 (29%), Positives = 130/271 (47%), Gaps = 31/271 (11%)
Query: 231 ELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEIS-LLGQFEHDNI 288
+GSG+ G V++ G AVK++ K+ ++ ++ +L + I
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN----KEENKRILMDLDVVLKSHDCPYI 86
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHEQ-N 345
VQ GT + I +EL+ L ++ + + + T I+ L YL E+
Sbjct: 87 VQCFGTFITNTDVFIAMELMG-TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG 145
Query: 346 VVHRDIKCANILVDASGSVKLADFG--------LAKATTMNDVKSCKGTAFWMAPEVVN- 396
V+HRD+K +NIL+D G +KL DFG AK + G A +MAPE ++
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA-------GCAAYMAPERIDP 198
Query: 397 --LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-QAMFKIGGGELPPVPNSL--SR 451
K Y + AD+WSLG +++E+ T + PY + + + + K+ E P +P + S
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSG 258
Query: 452 DAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
D Q F+ CL + RP +L+EH FIKR
Sbjct: 259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-64
Identities = 80/302 (26%), Positives = 133/302 (44%), Gaps = 52/302 (17%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++K LG+G+ G V++ G A K + L+ + Q+ +E+ +L +
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----PAIRNQIIRELQVLHECNS 90
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQ 344
IV + G + + I +E + GSL + +K + + + + ++ GL YL E+
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 345 -NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYG 403
++HRD+K +NILV++ G +KL DFG++ + S GT +M+PE L+ Y
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPER--LQGTHYS 208
Query: 404 LTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG----------------------- 440
+ +DIWS+G +++EM R+P + + G
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268
Query: 441 ------------------ELPPV--PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480
E PP S + QDF+ KCL NP +R QLM H FI
Sbjct: 269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328
Query: 481 KR 482
KR
Sbjct: 329 KR 330
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-63
Identities = 76/284 (26%), Positives = 140/284 (49%), Gaps = 26/284 (9%)
Query: 218 GKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSIL----- 271
+I ++ G LLG GS+ VY G A+K + K+++
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMID--------KKAMYKAGMV 55
Query: 272 -QLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVS 328
+++ E+ + Q +H +I++ D + + LE+ G + + S+++
Sbjct: 56 QRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR 115
Query: 329 SYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK---SCKG 385
+ QI+ G+ YLH ++HRD+ +N+L+ + ++K+ADFGLA M K C G
Sbjct: 116 HFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-G 174
Query: 386 TAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGELPP 444
T +++PE+ +GL +D+WSLGC +L R P+ + + K+ +
Sbjct: 175 TPNYISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPF-DTDTVKNTLNKVVLADY-E 230
Query: 445 VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
+P+ LS +A+D I + L+ NP DR + + +++HPF+ R T S
Sbjct: 231 MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKS 274
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 6e-63
Identities = 81/272 (29%), Positives = 126/272 (46%), Gaps = 21/272 (7%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEG-LTDDGFFFAVKEV---SLQDEGPRGKQSILQLEQE 276
R + +G LG G + +E D FA K V L R K + E
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-----MSME 65
Query: 277 ISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQIL 335
IS+ H ++V + G D + + LEL + SL L+++ L++ + Y RQI+
Sbjct: 66 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV 125
Query: 336 NGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK----SCKGTAFWMA 391
G +YLH V+HRD+K N+ ++ VK+ DFGLA D + C GT ++A
Sbjct: 126 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLC-GTPNYIA 183
Query: 392 PEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGELPPVPNSLS 450
PEV L K G+ D+WS+GC + +L + P+ + + +I E +P ++
Sbjct: 184 PEV--LSKKGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLRIKKNEY-SIPKHIN 239
Query: 451 RDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
A I K LQ +P RPT +L+ F
Sbjct: 240 PVAASLIQKMLQTDPTARPTINELLNDEFFTS 271
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 2e-62
Identities = 81/284 (28%), Positives = 129/284 (45%), Gaps = 21/284 (7%)
Query: 209 EPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEG-LTDDGFFFAVKEVS---LQDEGP 264
P + R + +G LG G + +E D FA K V L
Sbjct: 25 PPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ 84
Query: 265 RGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLS 323
R K + EIS+ H ++V + G D + + LEL + SL L+++ L+
Sbjct: 85 REK-----MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 139
Query: 324 DSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK-- 381
+ + Y RQI+ G +YLH V+HRD+K N+ ++ VK+ DFGLA D +
Sbjct: 140 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERK 198
Query: 382 --SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIG 438
C GT ++APEV++ K G+ D+WS+GC + +L + P+ + + +I
Sbjct: 199 KVLC-GTPNYIAPEVLS--KKGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLRIK 254
Query: 439 GGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
E +P ++ A I K LQ +P RPT +L+ F
Sbjct: 255 KNEY-SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 5e-62
Identities = 41/347 (11%), Positives = 91/347 (26%), Gaps = 45/347 (12%)
Query: 178 VRRRQDCPNNVEYVSYHDDDDSKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGS 237
++R ++ + + + + + + + + E L G
Sbjct: 15 LKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGD 74
Query: 238 YGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR 296
V+ + FA+K ++ E R + + +L + + ++ + R
Sbjct: 75 RSVVFLVRDVERLEDFALKVFTMGAENSRSE--LERLHEATFAAARLLGESPEEARDRRR 132
Query: 297 DEKRLCI-------------------------FLELVTKGSLASLY--------QKYHLS 323
L L L+ +
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEG 192
Query: 324 DSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC 383
+ T Q++ L + +VH N+ + G + L D S
Sbjct: 193 ILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASS 252
Query: 384 KGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQA-------MFK 436
+ E +N + + W LG ++ + P+ + G +
Sbjct: 253 -VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRV 311
Query: 437 IGGGELP-PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
G L L + I + L + R + ME P +
Sbjct: 312 PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 4e-61
Identities = 76/311 (24%), Positives = 135/311 (43%), Gaps = 48/311 (15%)
Query: 212 NNVSPNGKFRRRITS-WQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSI 270
+ ++ F + + + ++LG GS G V + G AVK +
Sbjct: 1 SRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML--------IDFC 52
Query: 271 LQLEQEISLLGQF-EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSS 329
EI LL + +H N+++Y ++ ++ L I LEL +L L + ++SD +
Sbjct: 53 DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKL 111
Query: 330 YT--------RQILNGLKYLHEQNVVHRDIKCANILVDASGS-------------VKLAD 368
RQI +G+ +LH ++HRD+K NILV S + ++D
Sbjct: 112 QKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171
Query: 369 FGLAK------ATTMNDVKSCKGTAFWMAPEVVN-----LKKDGYGLTADIWSLGCTVLE 417
FGL K ++ ++ + GT+ W APE++ K + DI+S+GC
Sbjct: 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY 231
Query: 418 MLTR-RHPYSHLEGGQAMFKIGGGELPPVP----NSLSRDAQDFILKCLQVNPNDRPTAA 472
+L++ +HP+ ++ G L + SL +A D I + + +P RPTA
Sbjct: 232 ILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAM 291
Query: 473 QLMEHPFIKRP 483
+++ HP
Sbjct: 292 KVLRHPLFWPK 302
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 4e-61
Identities = 79/258 (30%), Positives = 129/258 (50%), Gaps = 17/258 (6%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
E +G+GS+G V+ G AVK + QD + +E++++ + H NIV
Sbjct: 42 KEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVN---EFLREVAIMKRLRHPNIV 97
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASL----YQKYHLSDSQVSSYTRQILNGLKYLHEQN 345
++G L I E +++GSL L + L + + S + G+ YLH +N
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 346 --VVHRDIKCANILVDASGSVKLADFGLA--KATTMNDVKSCKGTAFWMAPEVVNLKKDG 401
+VHR++K N+LVD +VK+ DFGL+ KA+T KS GT WMAPEV L+ +
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV--LRDEP 215
Query: 402 YGLTADIWSLGCTVL-EMLTRRHPYSHLEGGQAMFKIG-GGELPPVPNSLSRDAQDFILK 459
+D++S G +L E+ T + P+ +L Q + +G + +P +L+ I
Sbjct: 216 SNEKSDVYSFG-VILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG 274
Query: 460 CLQVNPNDRPTAAQLMEH 477
C P RP+ A +M+
Sbjct: 275 CWTNEPWKRPSFATIMDL 292
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 1e-60
Identities = 48/341 (14%), Positives = 95/341 (27%), Gaps = 50/341 (14%)
Query: 185 PNNVEYVSYHDDDDSKGHPISE-IMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYE 243
P + + +S + G + R + +G +LG E
Sbjct: 32 PQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLE 91
Query: 244 GL-TDDGFFFAVKEVSLQDEGPRGKQSILQLE-----------------------QEISL 279
+ G F V + P ++ E L
Sbjct: 92 ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151
Query: 280 LGQFEHDNIVQYLGTDRDEKRLCIFLEL-VTKGSLASLY--------QKYHLSDSQVSSY 330
+ + +++ +RD L F + +L + L
Sbjct: 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 211
Query: 331 TRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWM 390
T Q++ L LH +VH ++ +I++D G V L F + +
Sbjct: 212 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR--DGARVVSSVSRGFE 269
Query: 391 APEVVN---------LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE 441
PE+ ++ + D W+LG + + P + I
Sbjct: 270 PPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS- 328
Query: 442 LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
++ + + + L+ DR Q ME P ++
Sbjct: 329 ----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 7e-60
Identities = 68/260 (26%), Positives = 116/260 (44%), Gaps = 16/260 (6%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
E++G G +G VY G AVK + D Q+I + QE L +H NI+
Sbjct: 12 EEIIGIGGFGKVYRAFWI-GDEVAVK-AARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQN---V 346
G E LC+ +E G L + + + ++ QI G+ YLH++ +
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 347 VHRDIKCANILVDASGS--------VKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLK 398
+HRD+K +NIL+ +K+ DFGLA+ S G WMAPEV ++
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEV--IR 187
Query: 399 KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIG-GGELPPVPNSLSRDAQDFI 457
+ +D+WS G + E+LT P+ ++G + + P+P++ +
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLM 247
Query: 458 LKCLQVNPNDRPTAAQLMEH 477
C +P+ RP+ +++
Sbjct: 248 EDCWNPDPHSRPSFTNILDQ 267
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 6e-59
Identities = 73/275 (26%), Positives = 129/275 (46%), Gaps = 21/275 (7%)
Query: 217 NGKFRRRITSWQKGELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSIL---- 271
+ K + + ++ G LG G +G VY F A+K + K +
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--------KAQLEKAGV 52
Query: 272 --QLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVS 328
QL +E+ + H NI++ G D R+ + LE G++ QK + + +
Sbjct: 53 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 112
Query: 329 SYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF 388
+Y ++ N L Y H + V+HRDIK N+L+ ++G +K+ADFG + + GT
Sbjct: 113 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLD 172
Query: 389 WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGELPPVPN 447
++ PE++ + + D+WSLG E L + P+ Q + +I E P+
Sbjct: 173 YLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF-TFPD 228
Query: 448 SLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
++ A+D I + L+ NP+ RP +++EHP+I
Sbjct: 229 FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 6e-58
Identities = 63/263 (23%), Positives = 113/263 (42%), Gaps = 18/263 (6%)
Query: 230 GELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQS--ILQLEQEISLLGQFEHD 286
+ +G G +G V++G L D A+K + L D + + ++E+ ++ H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 287 NIVQYLGTDRDEKRLCIFLELVTKGSLASLY--QKYHLSDSQVSSYTRQILNGLKYLHEQ 344
NIV+ G + +E V G L + + + S I G++Y+ Q
Sbjct: 84 NIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 345 N--VVHRDIKCANILVDASG-----SVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNL 397
N +VHRD++ NI + + K+ADFGL++ + + V G WMAPE +
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-HSVSGLLGNFQWMAPETIGA 200
Query: 398 KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIG---GGELPPVPNSLSRDAQ 454
+++ Y AD +S + +LT P+ G+ F G P +P +
Sbjct: 201 EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLR 260
Query: 455 DFILKCLQVNPNDRPTAAQLMEH 477
+ I C +P RP + +++
Sbjct: 261 NVIELCWSGDPKKRPHFSYIVKE 283
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 1e-57
Identities = 64/316 (20%), Positives = 120/316 (37%), Gaps = 45/316 (14%)
Query: 210 PGNNVSPNGKFRRR---ITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVS-------- 258
N + N + + I ++ L G + + D F+A+K+
Sbjct: 13 YSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILC-EKDNKFYALKKYEKSLLEKKR 71
Query: 259 ----LQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSL- 313
++ K + E+ ++ +++ + G + + I E + S+
Sbjct: 72 DFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSIL 131
Query: 314 --------ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQ-NVVHRDIKCANILVDASGSV 364
+ + + +LN Y+H + N+ HRD+K +NIL+D +G V
Sbjct: 132 KFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRV 191
Query: 365 KLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHP 424
KL+DFG ++ +K +GT +M PE + + G DIWSLG + M P
Sbjct: 192 KLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
Query: 425 YSHLEGGQAMF-KIGGGEL------------------PPVPNSLSRDAQDFILKCLQVNP 465
+S +F I + N LS + DF+ L+ NP
Sbjct: 252 FSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNP 311
Query: 466 NDRPTAAQLMEHPFIK 481
+R T+ ++H ++
Sbjct: 312 AERITSEDALKHEWLA 327
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 1e-56
Identities = 63/278 (22%), Positives = 124/278 (44%), Gaps = 27/278 (9%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
GEL+G G +G VY G + A++ + ++ + + ++E+ Q H+N+
Sbjct: 38 GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLK---AFKREVMAYRQTRHENV 91
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLASL--YQKYHLSDSQVSSYTRQILNGLKYLHEQNV 346
V ++G L I L +L S+ K L ++ ++I+ G+ YLH + +
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 347 VHRDIKCANILVDASGSVKLADFGLAKATTM-------NDVKSCKGTAFWMAPEVVNLKK 399
+H+D+K N+ D +G V + DFGL + + + ++ G +APE++
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 400 DG-------YGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPN-SLSR 451
+ +D+++LG E+ R P+ ++++G G P + + +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK 270
Query: 452 DAQDFILKCLQVNPNDRPTAAQLMEH--PFIKRPLQTS 487
+ D +L C +RPT +LM+ KR + S
Sbjct: 271 EISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLS 308
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-56
Identities = 75/269 (27%), Positives = 124/269 (46%), Gaps = 21/269 (7%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVS---LQDEGPRGKQSILQLEQEISLLGQFEH 285
+ LGSG+ G V A++ +S R L +E EI +L + H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYLHEQ 344
I++ D + I LEL+ G L + L ++ Y Q+L ++YLHE
Sbjct: 200 PCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 258
Query: 345 NVVHRDIKCANILV---DASGSVKLADFGLAK----ATTMNDVKSCKGTAFWMAPEVV-N 396
++HRD+K N+L+ + +K+ DFG +K + M + C GT ++APEV+ +
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL--C-GTPTYLAPEVLVS 315
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL---PPVPNSLSRD 452
+ GY D WSLG + L+ P+S ++ +I G+ P V +S
Sbjct: 316 VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK 375
Query: 453 AQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
A D + K L V+P R T + + HP+++
Sbjct: 376 ALDLVKKLLVVDPKARFTTEEALRHPWLQ 404
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-56
Identities = 48/257 (18%), Positives = 99/257 (38%), Gaps = 16/257 (6%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
L G +++G G VK + ++D R + +E L F H N++
Sbjct: 15 LTKLNENHSGELWKG-RWQGNDIVVKVLKVRDWSTRKSR---DFNEECPRLRIFSHPNVL 70
Query: 290 QYLG--TDRDEKRLCIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQ 344
LG + + GSL ++ + + + SQ + + G+ +LH
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 345 N--VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKK-DG 401
+ + ++++D + +++ + + W+APE + K D
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS---PGRMYAPAWVAPEALQKKPEDT 187
Query: 402 YGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIG-GGELPPVPNSLSRDAQDFILKC 460
+AD+WS + E++TR P++ L + K+ G P +P +S + C
Sbjct: 188 NRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKIC 247
Query: 461 LQVNPNDRPTAAQLMEH 477
+ +P RP ++
Sbjct: 248 MNEDPAKRPKFDMIVPI 264
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 5e-56
Identities = 73/263 (27%), Positives = 118/263 (44%), Gaps = 23/263 (8%)
Query: 230 GELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSIL------QLEQEISLLGQ 282
G LG G +G VY + F A+K + K + QL +EI +
Sbjct: 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLF--------KSQLEKEGVEHQLRREIEIQSH 70
Query: 283 FEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYL 341
H NI++ D KR+ + LE +G L QK+ + + +++ ++ + L Y
Sbjct: 71 LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC 130
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK-SCKGTAFWMAPEVVNLKKD 400
HE+ V+HRDIK N+L+ G +K+ADFG + + C GT ++ PE++ K
Sbjct: 131 HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC-GTLDYLPPEMIEGK-- 187
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGELPPVPNSLSRDAQDFILK 459
+ D+W G E L P+ +I +L P LS ++D I K
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFDS-PSHTETHRRIVNVDL-KFPPFLSDGSKDLISK 245
Query: 460 CLQVNPNDRPTAAQLMEHPFIKR 482
L+ +P R +MEHP++K
Sbjct: 246 LLRYHPPQRLPLKGVMEHPWVKA 268
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 7e-56
Identities = 66/268 (24%), Positives = 116/268 (43%), Gaps = 28/268 (10%)
Query: 230 GELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
GE+LG G +G + + G +KE+ DE ++ +E+ ++ EH N+
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE-----ETQRTFLKEVKVMRCLEHPNV 69
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLASL--YQKYHLSDSQVSSYTRQILNGLKYLHEQNV 346
++++G +KRL E + G+L + SQ S+ + I +G+ YLH N+
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 347 VHRDIKCANILVDASGSVKLADFGLA----------------KATTMNDVKSCKGTAFWM 390
+HRD+ N LV + +V +ADFGLA K + G +WM
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 391 APEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIG--GGELPPVPNS 448
APE++N + Y D++S G + E++ R + F + G P +
Sbjct: 190 APEMINGRS--YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPN 247
Query: 449 LSRDAQDFILKCLQVNPNDRPTAAQLME 476
++C ++P RP+ +L
Sbjct: 248 CPPSFFPITVRCCDLDPEKRPSFVKLEH 275
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 8e-56
Identities = 70/261 (26%), Positives = 130/261 (49%), Gaps = 20/261 (7%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
G+ +GSGS+G VY+G AVK +++ P+ Q + E+ +L + H NI+
Sbjct: 29 GQRIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQ---AFKNEVGVLRKTRHVNIL 83
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASL--YQKYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
++G +L I + SL + ++ RQ G+ YLH ++++
Sbjct: 84 LFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSII 142
Query: 348 HRDIKCANILVDASGSVKLADFGLAKATTM----NDVKSCKGTAFWMAPEVVNLKKDG-Y 402
HRD+K NI + +VK+ DFGLA + + + G+ WMAPEV+ ++ Y
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 403 GLTADIWSLGCTVL-EMLTRRHPYSHLEG-GQAMFKIGGGELPP----VPNSLSRDAQDF 456
+D+++ G VL E++T + PYS++ Q + +G G L P V ++ + +
Sbjct: 203 SFQSDVYAFG-IVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 261
Query: 457 ILKCLQVNPNDRPTAAQLMEH 477
+ +CL+ ++RP+ +++
Sbjct: 262 MAECLKKKRDERPSFPRILAE 282
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-55
Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 27/260 (10%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
E++G G++G V + A+K++ + E E+ L + H NIV
Sbjct: 13 EEVVGRGAFGVVCKA-KWRAKDVAIKQIESESE-------RKAFIVELRQLSRVNHPNIV 64
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQK----YHLSDSQVSSYTRQILNGLKYLHEQN 345
+ G + +C+ +E GSL ++ + + + S+ Q G+ YLH
Sbjct: 65 KLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 346 ---VVHRDIKCANILVDASGSV-KLADFGLAK--ATTMNDVKSCKGTAFWMAPEVVNLKK 399
++HRD+K N+L+ A G+V K+ DFG A T M + KG+A WMAPEV +
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---TNNKGSAAWMAPEV--FEG 177
Query: 400 DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG--QAMFKIGGGELPPVPNSLSRDAQDFI 457
Y D++S G + E++TRR P+ + G + M+ + G PP+ +L + + +
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLM 237
Query: 458 LKCLQVNPNDRPTAAQLMEH 477
+C +P+ RP+ ++++
Sbjct: 238 TRCWSKDPSQRPSMEEIVKI 257
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 3e-55
Identities = 73/307 (23%), Positives = 121/307 (39%), Gaps = 55/307 (17%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
+G GSYG V + A+K ++ + + +++ E+ L+ + H NI
Sbjct: 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSL----------------------------------- 313
+ DE+ +C+ +EL G L
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 314 ------ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILV--DASGSVK 365
+ + +S+ RQI + L YLH Q + HRDIK N L + S +K
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIK 210
Query: 366 LADFGLAKATTMNDVKSCK------GTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEML 419
L DFGL+K + GT +++APEV+N + YG D WS G + +L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 420 TRRHPYSHLEGGQAMF-KIGGGEL---PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLM 475
P+ ++ +L P N LS A+D + L N ++R A + +
Sbjct: 271 MGAVPFPG-VNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329
Query: 476 EHPFIKR 482
+HP+I +
Sbjct: 330 QHPWISQ 336
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 5e-55
Identities = 67/289 (23%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 228 QKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQ-FEH 285
+ +L G + FVYE G +A+K + + ++ + QE+ + + H
Sbjct: 31 RVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-----EEKNRAIIQEVCFMKKLSGH 85
Query: 286 DNIVQYLGTDRDEKR-------LCIFLELVTKGSLASLYQKY----HLSDSQVSSYTRQI 334
NIVQ+ K + L + KG L +K LS V Q
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 335 LNGLKYLHEQN--VVHRDIKCANILVDASGSVKLADFGLA--------------KATTMN 378
++++H Q ++HRD+K N+L+ G++KL DFG A + +
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 379 DVKSCKGTAFWMAPEVVNL-KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKI 437
+ + T + PE+++L G DIW+LGC + + R+HP+ A +I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDGAKLRI 261
Query: 438 GGGELP-PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485
G+ P ++ I LQVNP +R + A+++ +
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-54
Identities = 49/226 (21%), Positives = 90/226 (39%), Gaps = 24/226 (10%)
Query: 275 QEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASL--YQKYH--LSDSQVSSY 330
+I + F N V L + L I ++L K +L +
Sbjct: 110 VKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHI 169
Query: 331 TRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK--------ATTMNDVKS 382
QI +++LH + ++HRD+K +NI VK+ DFGL T + + +
Sbjct: 170 FIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229
Query: 383 CK------GTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYS-HLEGGQAMF 435
GT +M+PE + + Y DI+SLG + E+L + +S +E + +
Sbjct: 230 YATHTGQVGTKLYMSPEQ--IHGNNYSHKVDIFSLGLILFELL---YSFSTQMERVRIIT 284
Query: 436 KIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
+ + P + + L +P +RP A ++E+ +
Sbjct: 285 DVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 6e-05
Identities = 16/69 (23%), Positives = 33/69 (47%), Gaps = 5/69 (7%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++ + +G G +G V+E D +A+K + L + + ++ +E+ L + EH
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE----KVMREVKALAKLEH 63
Query: 286 DNIVQYLGT 294
IV+Y
Sbjct: 64 PGIVRYFNA 72
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-54
Identities = 78/298 (26%), Positives = 141/298 (47%), Gaps = 32/298 (10%)
Query: 215 SPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVS--------------- 258
S + ++ + + +G GSYG V +D ++A+K +S
Sbjct: 3 SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 259 ------LQDEGPRGKQSILQLEQEISLLGQFEHDNIVQ-Y-LGTDRDEKRLCIFLELVTK 310
+ + I Q+ QEI++L + +H N+V+ + D +E L + ELV +
Sbjct: 63 PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ 122
Query: 311 GSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFG 370
G + + LS+ Q Y + ++ G++YLH Q ++HRDIK +N+LV G +K+ADFG
Sbjct: 123 GPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 371 LAKATTMNDV---KSCKGTAFWMAPEVVNLKKDGY-GLTADIWSLGCTVLEMLTRRHPYS 426
++ +D + GT +MAPE ++ + + G D+W++G T+ + + P+
Sbjct: 183 VSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
Query: 427 HLEGGQAMF-KIGGGELP-PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
E + KI L P ++ D +D I + L NP R ++ HP++ R
Sbjct: 242 D-ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 8e-54
Identities = 70/298 (23%), Positives = 115/298 (38%), Gaps = 50/298 (16%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
W ++LG G+ V+ G G FA+K + + + +E +L + H
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI----SFLRPVDVQMREFEVLKKLNH 66
Query: 286 DNIVQYLGT--DRDEKRLCIFLELVTKGSLASLYQK----YHLSDSQVSSYTRQILNGLK 339
NIV+ + + + +E GSL ++ ++ Y L +S+ R ++ G+
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 340 YLHEQNVVHRDIKCANILV----DASGSVKLADFGLAKATTMNDV-KSCKGTAFWMAPEV 394
+L E +VHR+IK NI+ D KL DFG A+ ++ S GT ++ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 395 VNLKKD------GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQA----MFKIGGGELP- 443
YG T D+WS+G T T P+ EG + M+KI G+
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 444 -------------------PVPNSLSRDAQD----FILKCLQVNPNDRPTAAQLMEHP 478
PV SLSR Q + L+ + Q
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-53
Identities = 76/267 (28%), Positives = 122/267 (45%), Gaps = 17/267 (6%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVS---LQDEGPRGKQSILQLEQEISLLGQFEH 285
+ LGSG+ G V A+K +S R L +E EI +L + H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQ 344
I++ D + I LEL+ G L + L ++ Y Q+L ++YLHE
Sbjct: 75 PCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 133
Query: 345 NVVHRDIKCANILVDASG---SVKLADFGLAKATTMNDV--KSCKGTAFWMAPEV-VNLK 398
++HRD+K N+L+ + +K+ DFG +K + C GT ++APEV V++
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-GTPTYLAPEVLVSVG 192
Query: 399 KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL---PPVPNSLSRDAQ 454
GY D WSLG + L+ P+S ++ +I G+ P V +S A
Sbjct: 193 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 252
Query: 455 DFILKCLQVNPNDRPTAAQLMEHPFIK 481
D + K L V+P R T + + HP+++
Sbjct: 253 DLVKKLLVVDPKARFTTEEALRHPWLQ 279
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 6e-53
Identities = 46/351 (13%), Positives = 89/351 (25%), Gaps = 49/351 (13%)
Query: 174 EAAKVRRRQDCPNNVEYVSYHDDDDSKGHPISE-IMEPGNNVSPNGKFRRRITSWQKGEL 232
+ P + + +S + G + R + +G +
Sbjct: 26 DVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTV 85
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEI-------------- 277
LG E + G F V + P ++ E
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 278 ------SLLGQFEHDNIVQYLGTDRDEKRLCIFLELV----TKGSLASLYQ--------K 319
+ + + DE+ + + + +L + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 320 YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379
L T Q++ L LH +VH ++ +I++D G V L F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR--DGA 263
Query: 380 VKSCKGTAFWMAPEVV--------NLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG 431
+ PE D W+LG + + P +
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL 323
Query: 432 QAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
I N + + + + L+ DR Q ME P ++
Sbjct: 324 GGSEWI----FRSCKN-IPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-52
Identities = 73/269 (27%), Positives = 128/269 (47%), Gaps = 17/269 (6%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
+ LGSG+YG V A+K + +L +E+++L +H NI
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNS---KLLEEVAVLKLLDHPNI 98
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
++ D++ + +E G L + + ++ + +Q+L+G+ YLH+ N+V
Sbjct: 99 MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIV 158
Query: 348 HRDIKCANILV---DASGSVKLADFGLAKATTMNDV-KSCKGTAFWMAPEVVNLKKDGYG 403
HRD+K N+L+ + +K+ DFGL+ K GTA+++APEV L+K Y
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV--LRKK-YD 215
Query: 404 LTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL---PPVPNSLSRDAQDFILK 459
D+WS+G + +L P+ + Q + K+ G+ P ++S A+D I +
Sbjct: 216 EKCDVWSIGVILFILLAGYPPF-GGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274
Query: 460 CLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
LQ + R +A Q +EHP+IK
Sbjct: 275 MLQFDSQRRISAQQALEHPWIKEMCSKKE 303
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 4e-52
Identities = 75/277 (27%), Positives = 132/277 (47%), Gaps = 22/277 (7%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVS--------LQDEGPRGKQSILQLEQEISLL 280
LGSG+YG V + A+K + D+ ++ ++ EISLL
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 281 GQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLK 339
+H NI++ D+K + E G L + ++ + ++ +QIL+G+
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGIC 160
Query: 340 YLHEQNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDV-KSCKGTAFWMAPEVV 395
YLH+ N+VHRDIK NIL+ ++ ++K+ DFGL+ + + + GTA+++APEV
Sbjct: 161 YLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEV- 219
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL---PPVPNSLSR 451
LKK Y D+WS G + +L P+ + Q + K+ G+ ++S
Sbjct: 220 -LKKK-YNEKCDVWSCGVIMYILLCGYPPF-GGQNDQDIIKKVEKGKYYFDFNDWKNISD 276
Query: 452 DAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
+A++ I L + N R TA + + +IK+ +
Sbjct: 277 EAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNIN 313
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 5e-52
Identities = 74/270 (27%), Positives = 126/270 (46%), Gaps = 25/270 (9%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
E++G G + V + + G FAVK V + S L++E S+ +H +I
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSL-----ASLYQKYHLSDSQVSSYTRQILNGLKYLHE 343
V+ L T + L + E + L + S++ S Y RQIL L+Y H+
Sbjct: 89 VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 344 QNVVHRDIKCANILV---DASGSVKLADFGLAK-----ATTMNDVKSCKGTAFWMAPEVV 395
N++HRD+K +L+ + S VKL FG+A GT +MAPEV
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--V-GTPHFMAPEV- 204
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL---PPVPNSLSR 451
+K++ YG D+W G + +L+ P+ + + +F I G+ P + +S
Sbjct: 205 -VKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKMNPRQWSHISE 261
Query: 452 DAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
A+D + + L ++P +R T + + HP++K
Sbjct: 262 SAKDLVRRMLMLDPAERITVYEALNHPWLK 291
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 9e-52
Identities = 73/269 (27%), Positives = 125/269 (46%), Gaps = 18/269 (6%)
Query: 230 GELLGSGSYGFVYEGLTD--DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
+LG GS+G V D G AVK + + K L +E+ LL Q +H N
Sbjct: 31 QRVLGKGSFGEVILC-KDKITGQECAVK--VISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYLHEQNV 346
I++ D+ + E+ T G L + + S+ + RQ+L+G+ Y+H+ +
Sbjct: 88 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKI 147
Query: 347 VHRDIKCANILV---DASGSVKLADFGLAKATTMNDV-KSCKGTAFWMAPEVVNLKKDGY 402
VHRD+K N+L+ ++++ DFGL+ + K GTA+++APEV L Y
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV--LHGT-Y 204
Query: 403 GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL---PPVPNSLSRDAQDFIL 458
D+WS G + +L+ P+ + + K+ G+ P +S A+D I
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 263
Query: 459 KCLQVNPNDRPTAAQLMEHPFIKRPLQTS 487
K L P+ R +A ++H +I+ +
Sbjct: 264 KMLTYVPSMRISARDALDHEWIQTYTKEQ 292
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 1e-51
Identities = 84/275 (30%), Positives = 131/275 (47%), Gaps = 28/275 (10%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDN 287
E +G GSY + FAVK + P +EI +L ++ +H N
Sbjct: 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT---------EEIEILLRYGQHPN 77
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNV 346
I+ D K + + EL+ G L + ++ S+ + S+ I ++YLH Q V
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 347 VHRDIKCANILV----DASGSVKLADFGLAKATTMNDVK---SCKGTAFWMAPEVVNLKK 399
VHRD+K +NIL S+++ DFG AK + C TA ++APEV L++
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEV--LER 194
Query: 400 DGYGLTADIWSLGCTVLEMLTRRHPYSH--LEGGQAMF-KIGGGEL---PPVPNSLSRDA 453
GY DIWSLG + MLT P+++ + + + +IG G+ NS+S A
Sbjct: 195 QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA 254
Query: 454 QDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
+D + K L V+P+ R TAA ++ HP+I Q
Sbjct: 255 KDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQ 289
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-51
Identities = 77/263 (29%), Positives = 132/263 (50%), Gaps = 19/263 (7%)
Query: 230 GELLGSGSYGFVYEGLTD--DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
+LG GS+G V + D +AVK ++ + + +E+ LL + +H N
Sbjct: 27 VCMLGKGSFGEVLKC-KDRITQQEYAVKVINKASAKNKDTS---TILREVELLKKLDHPN 82
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYLHEQNV 346
I++ D I EL T G L + ++ S+ + +Q+ +G+ Y+H+ N+
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 347 VHRDIKCANILV---DASGSVKLADFGLAKATTMNDV-KSCKGTAFWMAPEVVNLKKDGY 402
VHRD+K NIL+ + +K+ DFGL+ N K GTA+++APEV L+ Y
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV--LRGT-Y 199
Query: 403 GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL---PPVPNSLSRDAQDFIL 458
D+WS G + +L+ P+ + + + ++ G+ P ++S DA+D I
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPF-YGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 459 KCLQVNPNDRPTAAQLMEHPFIK 481
K L +P+ R TA Q +EHP+I+
Sbjct: 259 KMLTFHPSLRITATQCLEHPWIQ 281
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-51
Identities = 76/272 (27%), Positives = 121/272 (44%), Gaps = 23/272 (8%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSI----LQLEQEISLLGQ-F 283
E+LG G V + +AVK + + G + + +E+ +L +
Sbjct: 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQVSSYTRQILNGLKYLH 342
H NI+Q T + +L+ KG L L +K LS+ + R +L + LH
Sbjct: 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 141
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAK----ATTMNDVKSCKGTAFWMAPEV---- 394
+ N+VHRD+K NIL+D ++KL DFG + + +V C GT ++APE+
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV--C-GTPSYLAPEIIECS 198
Query: 395 VNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL---PPVPNSLS 450
+N GYG D+WS G + +L P+ H M I G P + S
Sbjct: 199 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYS 257
Query: 451 RDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
+D + + L V P R TA + + HPF ++
Sbjct: 258 DTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-51
Identities = 77/265 (29%), Positives = 124/265 (46%), Gaps = 21/265 (7%)
Query: 230 GELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
LGSG++G V+ G +K ++ R + + Q+E EI +L +H NI
Sbjct: 27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKD----RSQVPMEQIEAEIEVLKSLDHPNI 82
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSL-----ASLYQKYHLSDSQVSSYTRQILNGLKYLHE 343
++ D + I +E G L ++ + LS+ V+ +Q++N L Y H
Sbjct: 83 IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142
Query: 344 QNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDV-KSCKGTAFWMAPEVVNLKK 399
Q+VVH+D+K NIL +K+ DFGLA+ ++ + GTA +MAPEV K+
Sbjct: 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV--FKR 200
Query: 400 DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL--PPVPNSLSRDAQDF 456
D DIWS G + +LT P+ + + K E L+ A D
Sbjct: 201 D-VTFKCDIWSAGVVMYFLLTGCLPF-TGTSLEEVQQKATYKEPNYAVECRPLTPQAVDL 258
Query: 457 ILKCLQVNPNDRPTAAQLMEHPFIK 481
+ + L +P RP+AAQ++ H + K
Sbjct: 259 LKQMLTKDPERRPSAAQVLHHEWFK 283
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 4e-51
Identities = 77/298 (25%), Positives = 137/298 (45%), Gaps = 37/298 (12%)
Query: 217 NGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQ 275
+ F + K + LG GS+ + + FAVK +S K+ ++
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS--------KRMEANTQK 54
Query: 276 EISLLGQF-EHDNIVQYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQVSSYTRQ 333
EI+ L H NIV+ D+ + +EL+ G L + +K H S+++ S R+
Sbjct: 55 EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRK 114
Query: 334 ILNGLKYLHEQNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDVK---SCKGTA 387
+++ + ++H+ VVHRD+K N+L + + +K+ DFG A+ ++ C T
Sbjct: 115 LVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTL 173
Query: 388 FWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHP-YSHLEGG-----QAMF-KIGGG 440
+ APE+ L ++GY + D+WSLG + ML+ + P SH + KI G
Sbjct: 174 HYAAPEL--LNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG 231
Query: 441 EL---PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK-------RPLQTSS 488
+ ++S++A+D I L V+PN R + L + +++ PL T
Sbjct: 232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPD 289
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 5e-51
Identities = 74/271 (27%), Positives = 128/271 (47%), Gaps = 22/271 (8%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVS---LQDEGPRGKQSILQLEQEISLLGQ-FE 284
+++G G V + G FAVK + + + ++ +E +L Q
Sbjct: 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQVSSYTRQILNGLKYLHE 343
H +I+ + + + + +L+ KG L L +K LS+ + S R +L + +LH
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA 218
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAK----ATTMNDVKSCKGTAFWMAPEV----V 395
N+VHRD+K NIL+D + ++L+DFG + + ++ C GT ++APE+ +
Sbjct: 219 NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLREL--C-GTPGYLAPEILKCSM 275
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL---PPVPNSLSR 451
+ GYG D+W+ G + +L P+ H M I G+ P + S
Sbjct: 276 DETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSSPEWDDRSS 334
Query: 452 DAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
+D I + LQV+P R TA Q ++HPF +R
Sbjct: 335 TVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 6e-51
Identities = 76/261 (29%), Positives = 126/261 (48%), Gaps = 17/261 (6%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
E+LGSG++ V+ G FA+K + LE EI++L + +H+NI
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKK-----SPAFRDSSLENEIAVLKKIKHENI 68
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
V + ++LV+ G L + ++ ++ S +Q+L+ +KYLHE +V
Sbjct: 69 VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIV 128
Query: 348 HRDIKCANILV---DASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGL 404
HRD+K N+L + + + + DFGL+K + + GT ++APEV L + Y
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEV--LAQKPYSK 186
Query: 405 TADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL---PPVPNSLSRDAQDFILKC 460
D WS+G +L P+ E +F KI G P + +S A+DFI
Sbjct: 187 AVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDISESAKDFICHL 245
Query: 461 LQVNPNDRPTAAQLMEHPFIK 481
L+ +PN+R T + + HP+I
Sbjct: 246 LEKDPNERYTCEKALSHPWID 266
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-50
Identities = 78/265 (29%), Positives = 127/265 (47%), Gaps = 22/265 (8%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
E LG G++ V + G FA K ++ + R Q LE+E + + +H NI
Sbjct: 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK---LEREARICRKLQHPNI 67
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLA-SLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
V+ + ++E + +LVT G L + + S++ S +QIL + Y H +V
Sbjct: 68 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIV 127
Query: 348 HRDIKCANILV---DASGSVKLADFGLAK----ATTMNDVKSCKGTAFWMAPEVVNLKKD 400
HR++K N+L+ +VKLADFGLA + + GT +++PEV LKKD
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--A-GTPGYLSPEV--LKKD 182
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL---PPVPNSLSRDAQDF 456
Y DIW+ G + +L P+ E ++ +I G P ++++ +A+
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241
Query: 457 ILKCLQVNPNDRPTAAQLMEHPFIK 481
I L VNP R TA Q ++ P+I
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWIC 266
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 2e-50
Identities = 70/297 (23%), Positives = 116/297 (39%), Gaps = 50/297 (16%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
W ++LG G+ V+ G G FA+K + + + +E +L + H
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI----SFLRPVDVQMREFEVLKKLNH 66
Query: 286 DNIVQYLGT--DRDEKRLCIFLELVTKGSLASLYQK----YHLSDSQVSSYTRQILNGLK 339
NIV+ + + + +E GSL ++ ++ Y L +S+ R ++ G+
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 340 YLHEQNVVHRDIKCANILV----DASGSVKLADFGLAKATTMNDV-KSCKGTAFWMAPEV 394
+L E +VHR+IK NI+ D KL DFG A+ ++ S GT ++ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 395 V------NLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQA----MFKIGGGELP- 443
+ YG T D+WS+G T T P+ EG + M+KI G+
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 444 -------------------PVPNSLSRDAQD----FILKCLQVNPNDRPTAAQLMEH 477
PV SLSR Q + L+ + Q
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-50
Identities = 76/293 (25%), Positives = 115/293 (39%), Gaps = 52/293 (17%)
Query: 228 QKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
E +G G YG V+ G G AVK S +DE +S + E E+ H+N
Sbjct: 11 TLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDE-----KSWFR-ETELYNTVMLRHEN 63
Query: 288 IVQYLGTDRDEK----RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHE 343
I+ ++ +D + +L + GSL Q L I +GL +LH
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 344 Q--------NVVHRDIKCANILVDASGSVKLADFGLAK----ATTMNDV--KSCKGTAFW 389
+ + HRD+K NILV +G +AD GLA +T DV GT +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 390 MAPEV----VNLKKDGYGLTADIWSLGCTVL-EMLTR----------RHPYSHLEGGQAM 434
MAPEV + + DIW+ G VL E+ R + P+ +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFG-LVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242
Query: 435 FK------IGGGELPPVPNSLSRDA-----QDFILKCLQVNPNDRPTAAQLME 476
F+ + P +PN D + +C NP+ R TA ++ +
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 171 bits (437), Expect = 3e-50
Identities = 79/265 (29%), Positives = 131/265 (49%), Gaps = 17/265 (6%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQD-EGPRGKQSILQLEQEISLLGQFEHDN 287
GE LGSG + V + G +A K + + R S ++E+E+++L + H N
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNV 346
I+ ++ + + LELV+ G L L +K L++ + + + +QIL+G+ YLH + +
Sbjct: 70 IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRI 129
Query: 347 VHRDIKCANILV----DASGSVKLADFGLAKATTMNDV-KSCKGTAFWMAPEVVNLKKDG 401
H D+K NI++ + +KL DFG+A + K+ GT ++APE+ + +
Sbjct: 130 AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI--VNYEP 187
Query: 402 YGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL----PPVPNSLSRDAQDF 456
GL AD+WS+G +L+ P+ E Q I N S A+DF
Sbjct: 188 LGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFDEEYFSN-TSELAKDF 245
Query: 457 ILKCLQVNPNDRPTAAQLMEHPFIK 481
I + L +P R T AQ +EH +IK
Sbjct: 246 IRRLLVKDPKRRMTIAQSLEHSWIK 270
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 6e-50
Identities = 78/266 (29%), Positives = 125/266 (46%), Gaps = 24/266 (9%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
E LG G++ V + G FA K ++ + R Q LE+E + + +H NI
Sbjct: 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK---LEREARICRKLQHPNI 90
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLA-SLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
V+ + ++E + +LVT G L + + S++ S +QIL + Y H +V
Sbjct: 91 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIV 150
Query: 348 HRDIKCANILV---DASGSVKLADFGLAK----ATTMNDVKSCKGTAFWMAPEVVNLKKD 400
HR++K N+L+ +VKLADFGLA + + GT +++PEV LKKD
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--A-GTPGYLSPEV--LKKD 205
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL----PPVPNSLSRDAQD 455
Y DIW+ G + +L P+ E ++ +I G P ++ +A+
Sbjct: 206 PYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDT-VTPEAKS 263
Query: 456 FILKCLQVNPNDRPTAAQLMEHPFIK 481
I L VNP R TA Q ++ P+I
Sbjct: 264 LIDSMLTVNPKKRITADQALKVPWIC 289
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 7e-50
Identities = 75/263 (28%), Positives = 120/263 (45%), Gaps = 21/263 (7%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
LG G+ VY +A+K + + EI +L + H NI
Sbjct: 58 ESELGRGATSIVYRCKQKGTQKPYALKVLK-------KTVDKKIVRTEIGVLLRLSHPNI 110
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
++ + + LELVT G L + +K + S+ + +QIL + YLHE +V
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 348 HRDIKCANILV---DASGSVKLADFGLAKATTMNDV-KSCKGTAFWMAPEVVNLKKDGYG 403
HRD+K N+L +K+ADFGL+K + K+ GT + APE+ L+ YG
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEI--LRGCAYG 228
Query: 404 LTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL----PPVPNSLSRDAQDFIL 458
D+WS+G +L P+ G Q MF +I E P +S +A+D +
Sbjct: 229 PEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDE-VSLNAKDLVR 287
Query: 459 KCLQVNPNDRPTAAQLMEHPFIK 481
K + ++P R T Q ++HP++
Sbjct: 288 KLIVLDPKKRLTTFQALQHPWVT 310
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-49
Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 40/285 (14%)
Query: 231 ELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
++LG G G V E G A+K + + E + +IV
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLY--------DSPKARQEVDH-HWQASGGPHIV 85
Query: 290 QYLGT--DRDEKRLCIFL--ELVTKGSL-----ASLYQKYHLSDSQVSSYTRQILNGLKY 340
L + + C+ + E + G L Q + ++ + + R I +++
Sbjct: 86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF--TEREAAEIMRDIGTAIQF 143
Query: 341 LHEQNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNL 397
LH N+ HRD+K N+L + +KL DFG AK TT N +++ T +++APEV L
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEV--L 201
Query: 398 KKDGYGLTADIWSLGCTVLEMLTRRHPY---SHLEGGQAMF-KIGGG--ELPPVP-NSLS 450
+ Y + D+WSLG + +L P+ + M +I G P + +S
Sbjct: 202 GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS 261
Query: 451 RDAQDFILKCLQVNPNDRPTAAQLMEHPFIK-------RPLQTSS 488
DA+ I L+ +P +R T Q M HP+I PL T+
Sbjct: 262 EDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTAR 306
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-49
Identities = 80/264 (30%), Positives = 124/264 (46%), Gaps = 15/264 (5%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVS-LQDEGPRGKQSILQLEQEISLLGQFEHDN 287
GE LGSG + V + G +A K + Q R ++E+E+S+L Q H N
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNV 346
I+ + + + LELV+ G L L QK LS+ + +S+ +QIL+G+ YLH + +
Sbjct: 77 IITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 347 VHRDIKCANILV----DASGSVKLADFGLAKATTMNDV-KSCKGTAFWMAPEVVNLKKDG 401
H D+K NI++ +KL DFGLA K+ GT ++APE+ + +
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI--VNYEP 194
Query: 402 YGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL---PPVPNSLSRDAQDFI 457
GL AD+WS+G +L+ P+ + Q I + S A+DFI
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFDEEFFSQTSELAKDFI 253
Query: 458 LKCLQVNPNDRPTAAQLMEHPFIK 481
K L R T + + HP+I
Sbjct: 254 RKLLVKETRKRLTIQEALRHPWIT 277
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 4e-49
Identities = 66/270 (24%), Positives = 122/270 (45%), Gaps = 21/270 (7%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
E LG G +G V+ + T + K V ++ + +++EIS+L H NI
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNI 63
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSL--ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNV 346
+ + + L + E ++ + + L++ ++ SY Q+ L++LH N+
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 347 VHRDIKCANILV--DASGSVKLADFGLAKATTMNDV-KSCKGTAFWMAPEVVNLKKDGYG 403
H DI+ NI+ S ++K+ +FG A+ D + + APEV + D
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV--HQHDVVS 181
Query: 404 LTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL----PPVPNSLSRDAQDFIL 458
D+WSLG V +L+ +P+ E Q + I E +S +A DF+
Sbjct: 182 TATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMNAEYTFDEEAFKE-ISIEAMDFVD 239
Query: 459 KCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
+ L R TA++ ++HP++K+ ++ S
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIERVS 269
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 5e-49
Identities = 79/264 (29%), Positives = 125/264 (47%), Gaps = 15/264 (5%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQD-EGPRGKQSILQLEQEISLLGQFEHDN 287
GE LGSG + V + G +A K + + R S ++E+E+S+L Q H N
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNV 346
++ + + + LELV+ G L L QK LS+ + +S+ +QIL+G+ YLH + +
Sbjct: 77 VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 347 VHRDIKCANILV----DASGSVKLADFGLAKATTMNDV-KSCKGTAFWMAPEVVNLKKDG 401
H D+K NI++ +KL DFGLA K+ GT ++APE+ + +
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI--VNYEP 194
Query: 402 YGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL---PPVPNSLSRDAQDFI 457
GL AD+WS+G +L+ P+ + Q I + S A+DFI
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITSVSYDFDEEFFSHTSELAKDFI 253
Query: 458 LKCLQVNPNDRPTAAQLMEHPFIK 481
K L R T + + HP+I
Sbjct: 254 RKLLVKETRKRLTIQEALRHPWIT 277
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 8e-49
Identities = 85/319 (26%), Positives = 149/319 (46%), Gaps = 30/319 (9%)
Query: 174 EAAKVRRRQDCPNNVEYVSYHDDDDSKGHPISEIMEPGNNVSPNGKFRRRITSW-QKGEL 232
+KVR + D P +Y +++D K P ++ G+ + + E
Sbjct: 10 HGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGS-----------VYDYYDILEE 58
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291
LGSG++G V+ + G F K ++ ++ EIS++ Q H ++
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINT-----PYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 292 LGTDRDEKRLCIFLELVTKGSL--ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHR 349
D+ + + LE ++ G L + Y +S+++V +Y RQ GLK++HE ++VH
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHL 173
Query: 350 DIKCANILV--DASGSVKLADFGLAKATTMNDV-KSCKGTAFWMAPEVVNLKKDGYGLTA 406
DIK NI+ + SVK+ DFGLA +++ K TA + APE+V+ ++ G
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD--REPVGFYT 231
Query: 407 DIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL---PPVPNSLSRDAQDFILKCLQ 462
D+W++G +L+ P+ E + + +S+S +A+DFI LQ
Sbjct: 232 DMWAIGVLGYVLLSGLSPF-AGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQ 290
Query: 463 VNPNDRPTAAQLMEHPFIK 481
P R T +EHP++K
Sbjct: 291 KEPRKRLTVHDALEHPWLK 309
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 9e-49
Identities = 77/265 (29%), Positives = 132/265 (49%), Gaps = 23/265 (8%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
+LG GS+G V + +AVK ++ + + + +E+ LL + +H NI
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST---ILREVELLKKLDHPNI 83
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
++ D I EL T G L + ++ S+ + +Q+ +G+ Y+H+ N+V
Sbjct: 84 MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIV 143
Query: 348 HRDIKCANILV---DASGSVKLADFGLAK----ATTMNDVKSCKGTAFWMAPEVVNLKKD 400
HRD+K NIL+ + +K+ DFGL+ T M D GTA+++APEV L+
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--I-GTAYYIAPEV--LRG- 197
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL---PPVPNSLSRDAQDF 456
Y D+WS G + +L+ P+ + + ++ G+ P ++S DA+D
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 457 ILKCLQVNPNDRPTAAQLMEHPFIK 481
I K L +P+ R TA Q +EHP+I+
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQ 281
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 1e-48
Identities = 76/265 (28%), Positives = 128/265 (48%), Gaps = 17/265 (6%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQD-EGPRGKQSILQLEQEISLLGQFEHDN 287
GE LGSG + V + G +A K + + + R S +E+E+S+L + +H N
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNV 346
++ ++ + + LELV G L L +K L++ + + + +QILNG+ YLH +
Sbjct: 76 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 135
Query: 347 VHRDIKCANILV----DASGSVKLADFGLAKATTMNDV-KSCKGTAFWMAPEVVNLKKDG 401
H D+K NI++ +K+ DFGLA + K+ GT ++APE+ + +
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI--VNYEP 193
Query: 402 YGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL----PPVPNSLSRDAQDF 456
GL AD+WS+G +L+ P+ + Q + N S A+DF
Sbjct: 194 LGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSAVNYEFEDEYFSN-TSALAKDF 251
Query: 457 ILKCLQVNPNDRPTAAQLMEHPFIK 481
I + L +P R T ++HP+IK
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPWIK 276
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-48
Identities = 75/267 (28%), Positives = 127/267 (47%), Gaps = 25/267 (9%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
E LG G++ V + G +A + + + +LE+E + +H NI
Sbjct: 16 FEELGKGAFSVVRRCVKVLAGQEYAAMII---NTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLA-SLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
V+ + +E + +LVT G L + + + S++ S +QIL + + H+ VV
Sbjct: 73 VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVV 132
Query: 348 HRDIKCANILV---DASGSVKLADFGLAK-----ATTMNDVKSCKGTAFWMAPEVVNLKK 399
HR++K N+L+ +VKLADFGLA GT +++PEV L+K
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF--A-GTPGYLSPEV--LRK 187
Query: 400 DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL----PPVPNSLSRDAQ 454
D YG D+W+ G + +L P+ E ++ +I G P ++ +A+
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDT-VTPEAK 245
Query: 455 DFILKCLQVNPNDRPTAAQLMEHPFIK 481
D I K L +NP+ R TAA+ ++HP+I
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWIS 272
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 5e-48
Identities = 71/293 (24%), Positives = 109/293 (37%), Gaps = 52/293 (17%)
Query: 228 QKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
Q + +G G YG V+ G G AVK +E S + E EI H+N
Sbjct: 40 QMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE-----ASWFR-ETEIYQTVLMRHEN 92
Query: 288 IVQYLGTDRDEK----RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHE 343
I+ ++ D +L + + GSL + L + ++GL +LH
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 344 QN--------VVHRDIKCANILVDASGSVKLADFGLA------KATTMNDVKSCKGTAFW 389
+ + HRD+K NILV +G+ +AD GLA + GT +
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 390 MAPEV----VNLKKDGYGLTADIWSLGCTVL-EMLTR----------RHPYSHLEGGQAM 434
M PEV +N + AD++S G +L E+ R + PY L
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGL-ILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 435 FKI------GGGELPPVPNSLSRDAQDFILK-----CLQVNPNDRPTAAQLME 476
++ P PN S D + C NP R TA ++ +
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 5e-48
Identities = 71/292 (24%), Positives = 113/292 (38%), Gaps = 50/292 (17%)
Query: 228 QKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
E +G G +G V+ G G AVK S ++E +S + E EI H+N
Sbjct: 45 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-----RSWFR-EAEIYQTVMLRHEN 97
Query: 288 IVQYLGTDRDEK----RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHE 343
I+ ++ D + +L + + GSL +Y ++ + +GL +LH
Sbjct: 98 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 344 Q--------NVVHRDIKCANILVDASGSVKLADFGLAK----ATTMNDVKSC--KGTAFW 389
+ + HRD+K NILV +G+ +AD GLA AT D+ GT +
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 390 MAPEV----VNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFK--------- 436
MAPEV +N+K ADI+++G E+ R E Q +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 437 -------IGGGELPPVPNSLSRDAQDFILK-----CLQVNPNDRPTAAQLME 476
P +PN ++ C N R TA ++ +
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 5e-48
Identities = 69/271 (25%), Positives = 120/271 (44%), Gaps = 25/271 (9%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVS---LQDEGPRGKQSILQLEQEISLLGQFEH 285
+G GS+G V + A K++ ++D + +QEI ++ +H
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD--------RFKQEIEIMKSLDH 65
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQ 344
NI++ T D + + +EL T G L + K +S + + +L+ + Y H+
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 345 NVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDV-KSCKGTAFWMAPEVVNLKKD 400
NV HRD+K N L +KL DFGLA + ++ GT ++++P+V L+
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV--LEG- 182
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL---PPVPNSLSRDAQDF 456
YG D WS G + +L P+ + KI G ++S A+
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGYPPF-SAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241
Query: 457 ILKCLQVNPNDRPTAAQLMEHPFIKRPLQTS 487
I + L +P R T+ Q +EH + ++ L +S
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-47
Identities = 70/303 (23%), Positives = 132/303 (43%), Gaps = 33/303 (10%)
Query: 197 DDSKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEG-LTDDGFFFAVK 255
D + P + P ++R ++ G++LG GS+ V +A+K
Sbjct: 2 DGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIK 61
Query: 256 EVSLQDEGPRGKQSILQLEQ------EISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVT 309
+ K+ I++ + E ++ + +H V+ T +D+++L L
Sbjct: 62 ILE--------KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 113
Query: 310 KGSLASLYQKYHLSDSQVSS-YTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLAD 368
G L +K D + YT +I++ L+YLH + ++HRD+K NIL++ +++ D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 369 FGLAKATTMNDVKS-----CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRH 423
FG AK + ++ GTA +++PE+ L + ++D+W+LGC + +++
Sbjct: 174 FGTAKVLSPESKQARANSFV-GTAQYVSPEL--LTEKSACKSSDLWALGCIIYQLVAGLP 230
Query: 424 PYSHLEGGQAMF-KIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPT------AAQLME 476
P+ +F KI E P A+D + K L ++ R L
Sbjct: 231 PFRA-GNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 288
Query: 477 HPF 479
HPF
Sbjct: 289 HPF 291
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-47
Identities = 73/263 (27%), Positives = 111/263 (42%), Gaps = 20/263 (7%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
E LG+G++G V+ G FA K V + + +EI + H +
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMT-----PHESDKETVRKEIQTMSVLRHPTL 216
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSL--ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNV 346
V D+ + + E ++ G L + +S+ + Y RQ+ GL ++HE N
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 276
Query: 347 VHRDIKCANILV--DASGSVKLADFGLAKATTMND-VKSCKGTAFWMAPEVVNLKKDGYG 403
VH D+K NI+ S +KL DFGL VK GTA + APEV G
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE--GKPVG 334
Query: 404 LTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL----PPVPNSLSRDAQDFIL 458
D+WS+G +L+ P+ E + + +S D +DFI
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWNMDDSAFSG-ISEDGKDFIR 392
Query: 459 KCLQVNPNDRPTAAQLMEHPFIK 481
K L +PN R T Q +EHP++
Sbjct: 393 KLLLADPNTRMTIHQALEHPWLT 415
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-47
Identities = 68/293 (23%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 228 QKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
Q E+ G +G V++ + AVK +QD+ QS E E+ L +H+N
Sbjct: 27 QLLEVKARGRFGCVWKA-QLLNEYVAVKIFPIQDK-----QSWQN-EYEVYSLPGMKHEN 79
Query: 288 IVQYLGTDR----DEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHE 343
I+Q++G ++ + L + KGSL+ + +S +++ + GL YLHE
Sbjct: 80 ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHE 139
Query: 344 Q----------NVVHRDIKCANILVDASGSVKLADFGLAK----ATTMNDVKSCKGTAFW 389
+ HRDIK N+L+ + + +ADFGLA + D GT +
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY 199
Query: 390 MAPEV----VNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-------------- 431
MAPEV +N ++D + L D++++G + E+ +R
Sbjct: 200 MAPEVLEGAINFQRDAF-LRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258
Query: 432 -QAMFKIGGGEL--PPVPNSLSRDAQ-----DFILKCLQVNPNDRPTAAQLME 476
+ M ++ + P + + + A + I +C + R +A + E
Sbjct: 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-47
Identities = 74/303 (24%), Positives = 129/303 (42%), Gaps = 50/303 (16%)
Query: 229 KGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HD 286
+ ++LG G++ V + +AVK + Q R + + +E+ +L Q + H
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR-----VFREVEMLYQCQGHR 71
Query: 287 NIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYLHEQN 345
N+++ + +E R + E + GS+ S ++++ H ++ + S + + + L +LH +
Sbjct: 72 NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131
Query: 346 VVHRDIKCANILV---DASGSVKLADFGLAKATTMNDVKSCK---------GTAFWMAPE 393
+ HRD+K NIL + VK+ DF L +N S G+A +MAPE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 394 VVN---LKKDGYGLTADIWSLG----------------CTVLEMLTRRHPYSHLEGGQAM 434
VV + Y D+WSLG C R + +
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ--NML 249
Query: 435 F-KIGGG--ELPPVP-NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK-----RPLQ 485
F I G E P +S A+D I K L + R +AAQ+++HP+++ L
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLP 309
Query: 486 TSS 488
T
Sbjct: 310 TPM 312
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-47
Identities = 76/294 (25%), Positives = 126/294 (42%), Gaps = 17/294 (5%)
Query: 199 SKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEV 257
H ++P + + +Q G LLGSG +G VY G+ D A+K V
Sbjct: 17 RGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV 76
Query: 258 SLQDEGPRGKQSIL-QLEQEISLLGQFEHD--NIVQYLGTDRDEKRLCIFLELVT-KGSL 313
G+ ++ E+ LL + +++ L + LE L
Sbjct: 77 EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDL 136
Query: 314 AS-LYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA-SGSVKLADFGL 371
+ ++ L + S+ Q+L +++ H V+HRDIK NIL+D G +KL DFG
Sbjct: 137 FDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196
Query: 372 AKATTMNDVKSCKGTAFWMAPEVVNLKKDGY-GLTADIWSLGCTVLEMLTRRHPYSHLEG 430
GT + PE + + Y G +A +WSLG + +M+ P+ H E
Sbjct: 197 GALLKDTVYTDFDGTRVYSPPEWIRYHR--YHGRSAAVWSLGILLYDMVCGDIPFEHDE- 253
Query: 431 GQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484
+I G++ +S + Q I CL + P+DRPT ++ HP+++ L
Sbjct: 254 -----EIIRGQVF-FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 6e-47
Identities = 69/265 (26%), Positives = 128/265 (48%), Gaps = 22/265 (8%)
Query: 229 KGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
K E+LG G +G V++ T G A K + RG + +++ EIS++ Q +H N
Sbjct: 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKT-----RGMKDKEEVKNEISVMNQLDHAN 147
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSL--ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQN 345
++Q + + + +E V G L + + Y+L++ + +QI G++++H+
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY 207
Query: 346 VVHRDIKCANILV--DASGSVKLADFGLAKATTMNDVKSCK-GTAFWMAPEVVNLKKDGY 402
++H D+K NIL + +K+ DFGLA+ + GT ++APEVVN D
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN--YDFV 265
Query: 403 GLTADIWSLGCTVLE--MLTRRHPYSHLEGGQAMF-KIGGGEL---PPVPNSLSRDAQDF 456
D+WS+G V+ +L+ P+ + I +S +A++F
Sbjct: 266 SFPTDMWSVG--VIAYMLLSGLSPF-LGDNDAETLNNILACRWDLEDEEFQDISEEAKEF 322
Query: 457 ILKCLQVNPNDRPTAAQLMEHPFIK 481
I K L + R +A++ ++HP++
Sbjct: 323 ISKLLIKEKSWRISASEALKHPWLS 347
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-46
Identities = 68/274 (24%), Positives = 117/274 (42%), Gaps = 17/274 (6%)
Query: 222 RRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLL 280
+ W + LG G+YG V + AVK V ++ R +++EI +
Sbjct: 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK----RAVDCPENIKKEICIN 59
Query: 281 GQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQVSSYTRQILNGLK 339
H+N+V++ G R+ +FLE + G L + + + + Q++ G+
Sbjct: 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTAFWMAPEV 394
YLH + HRDIK N+L+D ++K++DFGLA N+ K C GT ++APE+
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178
Query: 395 VNLKKDGY-GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF--KIGGGELPPVPNSLSR 451
LK+ + D+WS G + ML P+ + +
Sbjct: 179 --LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236
Query: 452 DAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485
+ K L NP+ R T + + + +PL+
Sbjct: 237 APLALLHKILVENPSARITIPDIKKDRWYNKPLK 270
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-46
Identities = 68/275 (24%), Positives = 123/275 (44%), Gaps = 35/275 (12%)
Query: 229 KGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD- 286
+ LG G + V + + G +A K + + G + I EI++L +
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEI---LHEIAVLELAKSCP 89
Query: 287 NIVQYLGTDRDEKRLCIFLELVTKGSL-----ASLYQKYHLSDSQVSSYTRQILNGLKYL 341
++ + + + LE G + L + +S++ V +QIL G+ YL
Sbjct: 90 RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE--MVSENDVIRLIKQILEGVYYL 147
Query: 342 HEQNVVHRDIKCANILV---DASGSVKLADFGLAK----ATTMNDVKSCKGTAFWMAPEV 394
H+ N+VH D+K NIL+ G +K+ DFG+++ A + ++ GT ++APE+
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI--M-GTPEYLAPEI 204
Query: 395 VNLKKDGYGLTADIWSLGCTVLE--MLTRRHPYSHLEGGQAMF-KIGGGEL----PPVPN 447
L D D+W++G ++ +LT P+ E Q + I + +
Sbjct: 205 --LNYDPITTATDMWNIG--IIAYMLLTHTSPFVG-EDNQETYLNISQVNVDYSEETFSS 259
Query: 448 SLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
+S+ A DFI L NP RPTA + H ++++
Sbjct: 260 -VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-46
Identities = 72/288 (25%), Positives = 119/288 (41%), Gaps = 21/288 (7%)
Query: 210 PGNNVSPNGKFRR--RITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRG 266
PG P G R ++ G LLG G +G V+ G D A+K +
Sbjct: 14 PGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWS 73
Query: 267 KQSILQ-LEQEISLL----GQFEHDNIVQYLGTDRDEKRLCIFLELVTKGS--LASLYQK 319
S E++LL H +++ L ++ + LE + +K
Sbjct: 74 PLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK 133
Query: 320 YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMN 378
L + + Q++ +++ H + VVHRDIK NIL+D G KL DFG
Sbjct: 134 GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE 193
Query: 379 DVKSCKGTAFWMAPEVVNLKKDGY-GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKI 437
GT + PE ++ + Y L A +WSLG + +M+ P+ + +I
Sbjct: 194 PYTDFDGTRVYSPPEWISRHQ--YHALPATVWSLGILLYDMVCGDIPFERDQ------EI 245
Query: 438 GGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485
EL P +S D I +CL P+ RP+ +++ P+++ P +
Sbjct: 246 LEAELH-FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-46
Identities = 73/286 (25%), Positives = 120/286 (41%), Gaps = 41/286 (14%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
++LG G G V + FA+K + + E E+ + +I
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVEL-HWRASQCPHI 117
Query: 289 VQYLGT--DRDEKRLCIFL--ELVTKGSL-----ASLYQKYHLSDSQVSSYTRQILNGLK 339
V+ + + R C+ + E + G L Q + ++ + S + I ++
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF--TEREASEIMKSIGEAIQ 175
Query: 340 YLHEQNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDV-KSCKGTAFWMAPEVV 395
YLH N+ HRD+K N+L + +KL DFG AK TT ++ + T +++APEV
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV- 234
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTRRHPY---SHLEGGQAMF-KIGGG--ELPPVP-NS 448
L + Y + D+WSLG + +L P+ L M +I G E P +
Sbjct: 235 -LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293
Query: 449 LSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK-------RPLQTS 487
+S + + I L+ P R T + M HP+I PL TS
Sbjct: 294 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 339
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-46
Identities = 75/277 (27%), Positives = 128/277 (46%), Gaps = 25/277 (9%)
Query: 222 RRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLL 280
+ I + G+LLG GSYG V E L ++ AVK + + + R +++EI LL
Sbjct: 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILK-KKKLRRIPNGEANVKKEIQLL 60
Query: 281 GQFEHDNIVQ-----YLGTDRDEKRLCIFLELVTKGS---LASLYQKYHLSDSQVSSYTR 332
+ H N++Q Y + + + +E G L S+ +K Q Y
Sbjct: 61 RRLRHKNVIQLVDVLYNEEKQK---MYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFC 116
Query: 333 QILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK-----SCKGTA 387
Q+++GL+YLH Q +VH+DIK N+L+ G++K++ G+A+A S G+
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-GSP 175
Query: 388 FWMAPEVVNLKKDGY-GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGELPPV 445
+ PE+ N + G DIWS G T+ + T +P+ + +F IG G +
Sbjct: 176 AFQPPEIANGLD-TFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSY-AI 232
Query: 446 PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
P D + L+ P R + Q+ +H + ++
Sbjct: 233 PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-46
Identities = 87/316 (27%), Positives = 133/316 (42%), Gaps = 62/316 (19%)
Query: 210 PGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQ 268
G ++ + + + ++ L+G GSYG V + D G A+K+ D+ K+
Sbjct: 10 SGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKK 69
Query: 269 SILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI---FLELVTKGSLASLYQKYHLSDS 325
++ EI LL Q H+N+V L + +KR + F++ L L
Sbjct: 70 IAMR---EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQ 124
Query: 326 QVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG 385
V Y QI+NG+ + H N++HRDIK NILV SG VKL DFG A+ + G
Sbjct: 125 VVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART------LAAPG 178
Query: 386 TAF-------WM-APEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY----SHLEGGQA 433
+ W APE++ + YG D+W++GC V EM P S ++ Q
Sbjct: 179 EVYDDEVATRWYRAPELL-VGDVKYGKAVDVWAIGCLVTEMFMGE-PLFPGDSDID--Q- 233
Query: 434 MFKI-------------GGGELP-------PVPN----------SLSRDAQDFILKCLQV 463
++ I + P P LS D KCL +
Sbjct: 234 LYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHI 293
Query: 464 NPNDRPTAAQLMEHPF 479
+P+ RP A+L+ H F
Sbjct: 294 DPDKRPFCAELLHHDF 309
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 7e-46
Identities = 80/332 (24%), Positives = 141/332 (42%), Gaps = 59/332 (17%)
Query: 194 HDDDDSKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFF 252
H G ++ PG+ I +++ LG G+YG VY+ + T
Sbjct: 3 HHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETV 62
Query: 253 AVKEVSLQ--DEG-PRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVT 309
A+K + L+ +EG P +I +E+SLL + +H NI++ RL + E
Sbjct: 63 AIKRIRLEHEEEGVPG--TAI----REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE 116
Query: 310 KGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS-----GS 363
L K +S + S+ Q++NG+ + H + +HRD+K N+L+ S
Sbjct: 117 N-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPV 175
Query: 364 VKLADFGLAKATTM------NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLE 417
+K+ DFGLA+A + +++ T ++ PE++ L Y + DIWS+ C E
Sbjct: 176 LKIGDFGLARAFGIPIRQFTHEII----TLWYRPPEIL-LGSRHYSTSVDIWSIACIWAE 230
Query: 418 MLTRRHPY----SHLEGGQAMFKIGG----------GELP----------------PVPN 447
ML + P S ++ +F++ G LP +
Sbjct: 231 MLMKT-PLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGA 289
Query: 448 SLSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
L + D + L+++P R +A +EHP+
Sbjct: 290 LLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 8e-46
Identities = 70/287 (24%), Positives = 112/287 (39%), Gaps = 40/287 (13%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEGL-----TDDGFFFAVKEVSLQDEGPRGKQSILQLEQ 275
R + + LG G++G V + G AVK LQ + +
Sbjct: 9 ERHLK---FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFER--- 60
Query: 276 EISLLGQFEHDNIVQYLG--TDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYT 331
EI +L +HDNIV+Y G + L + +E + GSL QK+ + ++ YT
Sbjct: 61 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 332 RQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKGTAF- 388
QI G++YL + +HRD+ NILV+ VK+ DFGL K + K +
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 389 --WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR----------------RHPYSHLEG 430
W APE + K + + +D+WS G + E+ T +
Sbjct: 181 IFWYAPESLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 431 GQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
+ + P P+ + + +C N N RP+ L
Sbjct: 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 9e-46
Identities = 76/283 (26%), Positives = 119/283 (42%), Gaps = 36/283 (12%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEGLTDD-----GFFFAVKEVSLQDEGPRGKQSILQLEQ 275
+R + K LG G +G V D G AVK +L+ + G Q +Q
Sbjct: 30 KRYLK---KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK--ALKADA--GPQHRSGWKQ 82
Query: 276 EISLLGQFEHDNIVQYLG--TDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQ 333
EI +L H++I++Y G D L + +E V GSL ++ + +Q+ + +Q
Sbjct: 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ 142
Query: 334 ILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTA-----F 388
I G+ YLH Q+ +HRD+ N+L+D VK+ DFGLAKA F
Sbjct: 143 ICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202
Query: 389 WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT---------------RRHPYSHLEGGQA 433
W APE + K + +D+WS G T+ E+LT + +
Sbjct: 203 WYAPECLKEYK--FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260
Query: 434 MFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476
+ GE P P+ + + C + + RPT L+
Sbjct: 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-45
Identities = 66/271 (24%), Positives = 126/271 (46%), Gaps = 17/271 (6%)
Query: 222 RRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVS---LQDEGPRGKQSILQLEQEI 277
+ LGSG++GFV+ + + VK + + ++ + ++ EI
Sbjct: 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 278 SLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGS--LASLYQKYHLSDSQVSSYTRQIL 335
++L + EH NI++ L ++ + +E G A + + L + S RQ++
Sbjct: 81 AILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV 140
Query: 336 NGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-KSCKGTAFWMAPEV 394
+ + YL ++++HRDIK NI++ ++KL DFG A + + GT + APEV
Sbjct: 141 SAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200
Query: 395 VNLKKDGY-GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDA 453
L + Y G ++WSLG T+ ++ +P+ LE + + P +S++
Sbjct: 201 --LMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAI-HPPYLVSKEL 251
Query: 454 QDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484
+ LQ P R T +L+ P++ +P+
Sbjct: 252 MSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-45
Identities = 68/273 (24%), Positives = 116/273 (42%), Gaps = 17/273 (6%)
Query: 222 RRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLL 280
+ W + LG G+YG V + AVK V ++ R +++EI +
Sbjct: 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK----RAVDCPENIKKEICIN 59
Query: 281 GQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQVSSYTRQILNGLK 339
H+N+V++ G R+ +FLE + G L + + + + Q++ G+
Sbjct: 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTAFWMAPEV 394
YLH + HRDIK N+L+D ++K++DFGLA N+ K C GT ++APE+
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178
Query: 395 VNLKKDGY-GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF--KIGGGELPPVPNSLSR 451
LK+ + D+WS G + ML P+ + +
Sbjct: 179 --LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236
Query: 452 DAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484
+ K L NP+ R T + + + +PL
Sbjct: 237 APLALLHKILVENPSARITIPDIKKDRWYNKPL 269
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-45
Identities = 75/325 (23%), Positives = 120/325 (36%), Gaps = 46/325 (14%)
Query: 188 VEYVSYHDDDDSKGHPISEIMEPGNNVSPNGKF------RRRITSWQKGELLGSGSYGFV 241
+ Y +H D + G S R + + LG G++G V
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLK---FLQQLGKGNFGSV 57
Query: 242 YEGL-----TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLG--T 294
+ G AVK LQ + + EI +L +HDNIV+Y G
Sbjct: 58 EMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFER---EIEILKSLQHDNIVKYKGVCY 112
Query: 295 DRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIK 352
+ L + +E + GSL QK+ + ++ YT QI G++YL + +HRD+
Sbjct: 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 172
Query: 353 CANILVDASGSVKLADFGLAKATTMNDV--KSCKGTAF---WMAPEVVNLKKDGYGLTAD 407
NILV+ VK+ DFGL K + K + W APE + K + + +D
Sbjct: 173 TRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK--FSVASD 230
Query: 408 IWSLGCTVLEMLTR----------------RHPYSHLEGGQAMFKIGGGELPPVPNSLSR 451
+WS G + E+ T + + + P P+
Sbjct: 231 VWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD 290
Query: 452 DAQDFILKCLQVNPNDRPTAAQLME 476
+ + +C N N RP+ L
Sbjct: 291 EIYMIMTECWNNNVNQRPSFRDLAL 315
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-45
Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 27/279 (9%)
Query: 216 PNGKFRRRI--TSWQKGELLGSGSYGFVYEG-LTDDGFFF----AVKEVSLQDE-GPRGK 267
PN R + T ++K ++LGSG++G VY+G +G A+K L++ P+
Sbjct: 4 PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKAN 61
Query: 268 QSILQLEQEISLLGQFEHDNIVQYLG--TDRDEKRLCIFLELVTKGSLAS--LYQKYHLS 323
+ IL E ++ ++ ++ + LG + + +L+ G L K ++
Sbjct: 62 KEILD---EAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIG 115
Query: 324 DSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VKS 382
+ ++ QI G+ YL ++ +VHRD+ N+LV VK+ DFGLAK +
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 383 CKGTAF---WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIG 438
+G WMA E + + Y +D+WS G TV E++T PY + + +
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
Query: 439 GGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
GE P P + D + KC ++ + RP +L+
Sbjct: 234 KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 4e-45
Identities = 80/295 (27%), Positives = 135/295 (45%), Gaps = 55/295 (18%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQ--DEG-PRGKQSILQLEQEISLLGQ 282
++K E +G G+YG V++ + A+K V L DEG P ++ +EI LL +
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS--SAL----REICLLKE 57
Query: 283 FEHDNIVQYLGTDRDEKRLCI---FLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLK 339
+H NIV+ +K+L + F + K S L V S+ Q+L GL
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLG 115
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM------NDVKSCKGTAFWMAPE 393
+ H +NV+HRD+K N+L++ +G +KLA+FGLA+A + +V T ++ P+
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV----TLWYRPPD 171
Query: 394 VVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY----SHLEGGQAMFKIGG---------- 439
V+ Y + D+WS GC E+ P + + +F++ G
Sbjct: 172 VL-FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 440 GELP--------PVPNSL-------SRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
+LP P SL + +D + L+ NP R +A + ++HP+
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 4e-45
Identities = 60/291 (20%), Positives = 105/291 (36%), Gaps = 22/291 (7%)
Query: 211 GNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQS 269
G SP+ + W+ E LG+G +G+V + D G A+K+ + ++
Sbjct: 1 GGGRSPSLP-TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE----LSPKN 55
Query: 270 ILQLEQEISLLGQFEHDNIVQ------YLGTDRDEKRLCIFLELVTKGSLASLYQK---- 319
+ EI ++ + H N+V L + +E G L +
Sbjct: 56 RERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC 115
Query: 320 YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS---VKLADFGLAKATT 376
L + + + I + L+YLHE ++HRD+K NI++ K+ D G AK
Sbjct: 116 CGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD 175
Query: 377 MNDV-KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF 435
++ GT ++APE++ KK Y +T D WS G E +T P+
Sbjct: 176 QGELCTEFVGTLQYLAPELLEQKK--YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWH 233
Query: 436 KIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486
+ + PN +++ L
Sbjct: 234 GKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMW 284
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 9e-45
Identities = 75/298 (25%), Positives = 127/298 (42%), Gaps = 60/298 (20%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++K +G GSYG V++ D G A+K+ ++ P K+ L+ EI +L Q +H
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR---EIRMLKQLKH 61
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHE 343
N+V L R ++RL + E ++ +Y + + V S T Q L + + H+
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF-------WM-APEVV 395
N +HRD+K NIL+ +KL DFG A+ + + W +PE++
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARL------LTGPSDYYDDEVATRWYRSPELL 174
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTRRHPY----SHLEGGQAMFKI-------------G 438
+ YG D+W++GC E+L+ P S ++ Q ++ I
Sbjct: 175 -VGDTQYGPPVDVWAIGCVFAELLSGV-PLWPGKSDVD--Q-LYLIRKTLGDLIPRHQQV 229
Query: 439 GGELP-------PVPNS----------LSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
P P +S A + CL ++P +R T QL+ HP+
Sbjct: 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 9e-45
Identities = 73/284 (25%), Positives = 139/284 (48%), Gaps = 26/284 (9%)
Query: 211 GNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEG---LTDDGFFFAVKEVSLQDEGPRGK 267
GN+++ + I +++ + +G G++ V LT G A+K + D+
Sbjct: 1 GNSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILT--GREVAIKII---DKTQLNP 55
Query: 268 QSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQ 326
S+ +L +E+ ++ H NIV+ EK L + +E + G + L + + +
Sbjct: 56 TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE 115
Query: 327 VSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK----S 382
S RQI++ ++Y H++ +VHRD+K N+L+DA ++K+ADFG +
Sbjct: 116 ARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGF--SNEFTVGGKLDAF 173
Query: 383 CKGTAFWMAPEVVNLKKDGY-GLTADIWSLGCTVLEMLTRRHPY--SHLEGGQAMF-KIG 438
C G + APE+ KK Y G D+WSLG + +++ P+ +L + + ++
Sbjct: 174 C-GAPPYAAPELFQGKK--YDGPEVDVWSLGVILYTLVSGSLPFDGQNL---KELRERVL 227
Query: 439 GGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
G+ +P +S D ++ + + L +NP R T Q+M+ +I
Sbjct: 228 RGKY-RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 9e-45
Identities = 91/302 (30%), Positives = 142/302 (47%), Gaps = 56/302 (18%)
Query: 220 FRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQ--DEG-PRGKQSILQLEQE 276
F+ + +QK E +G G+YG VY+ G A+K + L DEG P +I +E
Sbjct: 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPS--TAI----RE 69
Query: 277 ISLLGQFEHDNIVQYLGTDRDEKRLCI---FLELVTKGSLASLYQKYHLSDSQVSSYTRQ 333
ISLL + H NIV + E+ L + F+E K L K L DSQ+ Y Q
Sbjct: 70 ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQ 127
Query: 334 ILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM------NDVKSCKGTA 387
+L G+ + H+ ++HRD+K N+L+++ G++KLADFGLA+A + ++V T
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TL 183
Query: 388 FWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY----SHLEGGQAMFKIGG---- 439
++ AP+V+ + Y + DIWS+GC EM+T + P + + +F I G
Sbjct: 184 WYRAPDVL-MGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSILGTPNP 241
Query: 440 ------GELP---------PVPNSL-------SRDAQDFILKCLQVNPNDRPTAAQLMEH 477
ELP ++ D + L +PN R +A M H
Sbjct: 242 REWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301
Query: 478 PF 479
P+
Sbjct: 302 PY 303
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-44
Identities = 73/285 (25%), Positives = 114/285 (40%), Gaps = 39/285 (13%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEGL-----TDDGFFFAVKEVSLQDEGPRGKQSILQLEQ 275
R + LG G++G V + G AVK LQ GP ++ +
Sbjct: 22 ERHLK---YISQLGKGNFGSVELCRYDPLGDNTGALVAVK--QLQHSGPDQQRDFQR--- 73
Query: 276 EISLLGQFEHDNIVQYLG--TDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYT 331
EI +L D IV+Y G + L + +E + G L Q++ L S++ Y+
Sbjct: 74 EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133
Query: 332 RQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTA---- 387
QI G++YL + VHRD+ NILV++ VK+ADFGLAK ++
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 388 -FWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELP-- 443
FW APE ++ + +D+WS G + E+ T S M
Sbjct: 194 IFWYAPESLSDNI--FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251
Query: 444 ------------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476
P P + + + + C +P DRP+ + L
Sbjct: 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-44
Identities = 66/256 (25%), Positives = 109/256 (42%), Gaps = 16/256 (6%)
Query: 230 GELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
GE +G G++G V+ G L D AVK + P K LQ E +L Q+ H NI
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQ---EARILKQYSHPNI 174
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLASLY---QKYHLSDSQVSSYTRQILNGLKYLHEQN 345
V+ +G ++ + I +ELV G + + + L + G++YL +
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF----WMAPEVVNLKKDG 401
+HRD+ N LV +K++DFG+++ + G W APE +N +
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR-- 291
Query: 402 YGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460
Y +D+WS G + E + PY +L Q + G P P + +C
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQC 351
Query: 461 LQVNPNDRPTAAQLME 476
P RP+ + + +
Sbjct: 352 WAYEPGQRPSFSTIYQ 367
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-44
Identities = 81/284 (28%), Positives = 132/284 (46%), Gaps = 31/284 (10%)
Query: 216 PNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSIL--- 271
R +I + G+ LG G++G V G G AVK ++ +Q I
Sbjct: 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN--------RQKIRSLD 53
Query: 272 ---QLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQV 327
++++EI L F H +I++ + +E V+ G L + + + + +
Sbjct: 54 VVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA 113
Query: 328 SSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK---SCK 384
+QIL+ + Y H VVHRD+K N+L+DA + K+ADFGL+ + SC
Sbjct: 114 RRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC- 171
Query: 385 GTAFWMAPEVVNLKKDGY-GLTADIWSLGCTVLEMLTRRHPY--SHLEGGQAMF-KIGGG 440
G+ + APEV++ + Y G DIWS G + +L P+ H+ +F KI GG
Sbjct: 172 GSPNYAAPEVISGR--LYAGPEVDIWSCGVILYALLCGTLPFDDEHV---PTLFKKIRGG 226
Query: 441 ELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484
+P L+R ++ LQV+P R T + EH + K+ L
Sbjct: 227 VF-YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 5e-44
Identities = 73/280 (26%), Positives = 117/280 (41%), Gaps = 26/280 (9%)
Query: 215 SPNGKFRRRI--TSWQKGELLGSGSYGFVYEGL----TDDGFFFAVKEVSLQDEGPRGKQ 268
P I + E LG GS+G V G + AVK L+ + +
Sbjct: 6 GPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVK--CLKPDVLSQPE 63
Query: 269 SILQLEQEISLLGQFEHDNIVQYLG--TDRDEKRLCIFLELVTKGSLAS--LYQKYHLSD 324
++ +E++ + +H N+++ G + + EL GSL + H
Sbjct: 64 AMDDFIREVNAMHSLDHRNLIRLYGVVL---TPPMKMVTELAPLGSLLDRLRKHQGHFLL 120
Query: 325 SQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKS 382
+S Y Q+ G+ YL + +HRD+ N+L+ VK+ DFGL +A ND
Sbjct: 121 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 180
Query: 383 CKGTAF---WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKI- 437
+ W APE + + + +D W G T+ EM T + P+ L G Q + KI
Sbjct: 181 QEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
Query: 438 -GGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476
G LP P +D + +++C P DRPT L +
Sbjct: 239 KEGERLPR-PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 79/304 (25%), Positives = 127/304 (41%), Gaps = 38/304 (12%)
Query: 203 PISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGL-----TDDGFFFAVKEV 257
I +P V P +R + + LG G +G V + G AVK
Sbjct: 2 DIVSEKKPATEVDPTHFEKRFLK---RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK-- 56
Query: 258 SLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLG--TDRDEKRLCIFLELVTKGSLAS 315
SL+ E G I L++EI +L H+NIV+Y G T+ + + +E + GSL
Sbjct: 57 SLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE 114
Query: 316 LYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 373
K ++ Q Y QI G+ YL + VHRD+ N+LV++ VK+ DFGL K
Sbjct: 115 YLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174
Query: 374 ATTMNDV--KSCKGTAF---WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR------- 421
A + W APE + K + + +D+WS G T+ E+LT
Sbjct: 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSK--FYIASDVWSFGVTLHELLTYCDSDSSP 232
Query: 422 --------RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQ 473
+ + + + + G+ P P + + + KC + P++R +
Sbjct: 233 MALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQN 292
Query: 474 LMEH 477
L+E
Sbjct: 293 LIEG 296
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 69/263 (26%), Positives = 120/263 (45%), Gaps = 25/263 (9%)
Query: 232 LLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQ------EISLLGQFE 284
+G GS+G V D +A+K ++ KQ ++ + E+ ++ E
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMN--------KQKCVERNEVRNVFKELQIMQGLE 73
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYLHE 343
H +V + +DE+ + + ++L+ G L L Q H + V + +++ L YL
Sbjct: 74 HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN 133
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS--CKGTAFWMAPEVVNLKK-D 400
Q ++HRD+K NIL+D G V + DF +A + GT +MAPE+ + +K
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA-GTKPYMAPEMFSSRKGA 192
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPY---SHLEGGQAMFKIGGGELPPVPNSLSRDAQDFI 457
GY D WSLG T E+L R PY S + + + P++ S++ +
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV-TYPSAWSQEMVSLL 251
Query: 458 LKCLQVNPNDR-PTAAQLMEHPF 479
K L+ NP+ R + + P+
Sbjct: 252 KKLLEPNPDQRFSQLSDVQNFPY 274
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-43
Identities = 86/294 (29%), Positives = 138/294 (46%), Gaps = 55/294 (18%)
Query: 227 WQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQ--DEG-PRGKQSILQLEQEISLLGQF 283
+ E +G G+YG VY+ + G FA+K++ L+ DEG P +I +EIS+L +
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS--TTI----REISILKEL 57
Query: 284 EHDNIVQYLGTDRDEKRLCI---FLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKY 340
+H NIV+ +KRL + L+ K L + L S+ Q+LNG+ Y
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAY 115
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM------NDVKSCKGTAFWMAPEV 394
H++ V+HRD+K N+L++ G +K+ADFGLA+A + +++ T ++ AP+V
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDV 171
Query: 395 VNLKKDGYGLTADIWSLGCTVLEMLTRRHPY----SHLEGGQAMFKIGG----------- 439
+ + Y T DIWS+GC EM+ P S + +F+I G
Sbjct: 172 L-MGSKKYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 440 ------GELPPVP--------NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
L D + K L+++PN R TA Q +EH +
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-43
Identities = 72/301 (23%), Positives = 109/301 (36%), Gaps = 61/301 (20%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
EL+G G YG VY+G + D AVK S + Q+ + E+ I + EHDNI
Sbjct: 18 LELIGRGRYGAVYKG-SLDERPVAVKVFSFANR-----QNFIN-EKNIYRVPLMEHDNIA 70
Query: 290 QYLGTDR-----DEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQ 344
+++ D + +E GSL + + GL YLH +
Sbjct: 71 RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTE 130
Query: 345 ---------NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK----------G 385
+ HRD+ N+LV G+ ++DFGL+ T N + G
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190
Query: 386 TAFWMAPEV----VNLKK-DGYGLTADIWSLGCTVLEMLTR---RHPYSHLEGGQAMFKI 437
T +MAPEV VNL+ + D+++LG E+ R P + Q F+
Sbjct: 191 TIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQT 250
Query: 438 GGGEL----------------PPVPNSLSRDAQDF------ILKCLQVNPNDRPTAAQLM 475
G P P + ++ I C + R TA
Sbjct: 251 EVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE 310
Query: 476 E 476
E
Sbjct: 311 E 311
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-43
Identities = 70/262 (26%), Positives = 111/262 (42%), Gaps = 17/262 (6%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLL 280
R IT + LGSG +G V G + AVK + EG + Q E +
Sbjct: 7 REEIT---LLKELGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMSEDEFFQ---EAQTM 57
Query: 281 GQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGL 338
+ H +V++ G E + I E ++ G L + + + L SQ+ + G+
Sbjct: 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117
Query: 339 KYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVV 395
+L +HRD+ N LVD VK++DFG+ + + S GT F W APEV
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVF 177
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQ 454
+ K Y +D+W+ G + E+ + + PY + + K+ G P+ S
Sbjct: 178 HYFK--YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIY 235
Query: 455 DFILKCLQVNPNDRPTAAQLME 476
+ C P RPT QL+
Sbjct: 236 QIMYSCWHELPEKRPTFQQLLS 257
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 6e-43
Identities = 85/294 (28%), Positives = 129/294 (43%), Gaps = 52/294 (17%)
Query: 226 SWQKGELLGSGSYGFVYEGLTDD-GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE 284
++ K + LG G+Y VY+G + A+KE+ L+ E +I +E+SLL +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI----REVSLLKDLK 58
Query: 285 HDNIVQYLGTDRDEKRLCI---FLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYL 341
H NIV EK L + +L+ K L ++ V + Q+L GL Y
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYC 116
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM------NDVKSCKGTAFWMAPEVV 395
H Q V+HRD+K N+L++ G +KLADFGLA+A ++ N+V T ++ P+++
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV----TLWYRPPDIL 172
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTRRHPY----SHLEGGQAMFKIGG------------ 439
L Y D+W +GC EM T R P + E +F+I G
Sbjct: 173 -LGSTDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230
Query: 440 ------GELPPVP--------NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
P L D D + K LQ +R +A M+HPF
Sbjct: 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 7e-43
Identities = 51/284 (17%), Positives = 92/284 (32%), Gaps = 41/284 (14%)
Query: 230 GELLGSGSYGFVYEGLTDD------GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF 283
LLG G++ VYE D F +K P Q + L
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-----PANPWEFYIGTQLMERLKPS 124
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH------LSDSQVSSYTRQILNG 337
+++ + + EL + G+L + Y + V S+ ++L
Sbjct: 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYM 184
Query: 338 LKYLHEQNVVHRDIKCANILV-----------DASGSVKLADFGLAKATTMND-----VK 381
++ +H+ ++H DIK N ++ D S + L D G + +
Sbjct: 185 IEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244
Query: 382 SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE 441
C T+ + E+ L + D + + TV ML + EGG+ +
Sbjct: 245 KC-ETSGFQCVEM--LSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
Query: 442 LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485
LP + +F L + + L+ K Q
Sbjct: 302 LPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 7e-43
Identities = 69/260 (26%), Positives = 118/260 (45%), Gaps = 20/260 (7%)
Query: 229 KGELLGSGSYGFVYEG-LTDDGFFF--AVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+ + LGSG++G V +G AVK + + P K +L E +++ Q ++
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA---EANVMQQLDN 77
Query: 286 DNIVQYLG--TDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYLH 342
IV+ +G + + +E+ G L L Q H+ D + Q+ G+KYL
Sbjct: 78 PYIVRMIGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 134
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTAF---WMAPEVVNL 397
E N VHRD+ N+L+ K++DFGL+KA ++ K+ + W APE +N
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 398 KKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDF 456
K + +D+WS G + E + + PY ++G + + GE P R+ D
Sbjct: 195 YK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL 252
Query: 457 ILKCLQVNPNDRPTAAQLME 476
+ C + +RP A +
Sbjct: 253 MNLCWTYDVENRPGFAAVEL 272
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-43
Identities = 72/279 (25%), Positives = 124/279 (44%), Gaps = 27/279 (9%)
Query: 216 PNGKFRRRI--TSWQKGELLGSGSYGFVYEG-LTDDGFFF----AVKEVSLQDE-GPRGK 267
R T +K ++LGSG +G V++G +G +K ++D+ G +
Sbjct: 2 AMKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIK--VIEDKSGRQSF 59
Query: 268 QSILQLEQEISLLGQFEHDNIVQYLG--TDRDEKRLCIFLELVTKGSLAS--LYQKYHLS 323
Q++ + +G +H +IV+ LG L + + + GSL + L
Sbjct: 60 QAVTD---HMLAIGSLDHAHIVRLLGLCP---GSSLQLVTQYLPLGSLLDHVRQHRGALG 113
Query: 324 DSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-KS 382
+ ++ QI G+ YL E +VHR++ N+L+ + V++ADFG+A +D
Sbjct: 114 PQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 173
Query: 383 CKGTAF---WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIG 438
WMA E ++ K Y +D+WS G TV E++T PY+ L + +
Sbjct: 174 YSEAKTPIKWMALESIHFGK--YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
Query: 439 GGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
GE P + D ++KC ++ N RPT +L
Sbjct: 232 KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-42
Identities = 89/306 (29%), Positives = 145/306 (47%), Gaps = 61/306 (19%)
Query: 223 RITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSL-QDEG-PRGKQSILQLEQEISL 279
+ +++ E LG+G+Y VY+GL G + A+KEV L +EG P +I +EISL
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPS--TAI----REISL 56
Query: 280 LGQFEHDNIVQYLGTDRDEKRLCI---FLELVTKG---SLASLYQKYHLSDSQVSSYTRQ 333
+ + +H+NIV+ E +L + F++ K S L + V + Q
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 334 ILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM------NDVKSCKGTA 387
+L GL + HE ++HRD+K N+L++ G +KL DFGLA+A + ++V T
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV----TL 172
Query: 388 FWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY----SHLEGGQAMFKIGG---- 439
++ AP+V+ + Y + DIWS GC + EM+T + P + E + +F I G
Sbjct: 173 WYRAPDVL-MGSRTYSTSIDIWSCGCILAEMITGK-PLFPGTNDEEQLKLIFDIMGTPNE 230
Query: 440 ------GELP--------------------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQ 473
+LP L + DF+ LQ+NP+ R +A Q
Sbjct: 231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQ 290
Query: 474 LMEHPF 479
+ HP+
Sbjct: 291 ALHHPW 296
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-42
Identities = 62/272 (22%), Positives = 116/272 (42%), Gaps = 19/272 (6%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLL 280
+T + +GSG +G V+ G + A+K + EG ++ ++ E ++
Sbjct: 7 PSELT---FVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIE---EAEVM 57
Query: 281 GQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGL 338
+ H +VQ G ++ +C+ E + G L+ + + + + G+
Sbjct: 58 MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 117
Query: 339 KYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVV 395
YL E V+HRD+ N LV + +K++DFG+ + + S GT F W +PEV
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 177
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQ 454
+ + Y +D+WS G + E+ + + PY + + + I G P S
Sbjct: 178 SFSR--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY 235
Query: 455 DFILKCLQVNPNDRPTAAQLMEH--PFIKRPL 484
+ C + P DRP ++L+ + L
Sbjct: 236 QIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 59/254 (23%), Positives = 111/254 (43%), Gaps = 14/254 (5%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
+ LG+G +G V G + A+K + EG + ++ E ++ H+ +V
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIE---EAKVMMNLSHEKLV 82
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVV 347
Q G ++ + I E + G L + ++ + Q+ + + ++YL + +
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 348 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKKDGYGL 404
HRD+ N LV+ G VK++DFGL++ ++ S G+ F W PEV+ K +
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--FSS 200
Query: 405 TADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQV 463
+DIW+ G + E+ + + PY + I G P+ S + C
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHE 260
Query: 464 NPNDRPTAAQLMEH 477
++RPT L+ +
Sbjct: 261 KADERPTFKILLSN 274
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-42
Identities = 66/256 (25%), Positives = 115/256 (44%), Gaps = 20/256 (7%)
Query: 233 LGSGSYGFVYEGL---TDDGFFFAVKEVSL-QDEGPRGKQSILQLEQEISLLGQFEHDNI 288
LG G++G V +G+ A+K L Q + +++ E ++ Q ++ I
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIK--VLKQGTEKADTEEMMR---EAQIMHQLDNPYI 72
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNV 346
V+ +G + L + +E+ G L + S V+ Q+ G+KYL E+N
Sbjct: 73 VRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 347 VHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKGTAF---WMAPEVVNLKKDG 401
VHRD+ N+L+ K++DFGL+KA +D + + W APE +N +K
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK-- 189
Query: 402 YGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460
+ +D+WS G T+ E L+ + PY ++G + M I G+ P + + C
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDC 249
Query: 461 LQVNPNDRPTAAQLME 476
DRP + +
Sbjct: 250 WIYKWEDRPDFLTVEQ 265
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 72/259 (27%), Positives = 119/259 (45%), Gaps = 21/259 (8%)
Query: 230 GELLGSGSYGFVYEGL--TDDGFFF--AVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
G +G G +G V++G+ + + A+K ++ LQ E + QF+H
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQ---EALTMRQFDH 75
Query: 286 DNIVQYLG--TDRDEKRLCIFLELVTKGSLAS--LYQKYHLSDSQVSSYTRQILNGLKYL 341
+IV+ +G T E + I +EL T G L S +KY L + + Y Q+ L YL
Sbjct: 76 PHIVKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLK 398
+ VHRDI N+LV ++ VKL DFGL++ + WMAPE +N +
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 192
Query: 399 KDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFI 457
+ + +D+W G + E+L P+ ++ + +I GE P+P + +
Sbjct: 193 R--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 250
Query: 458 LKCLQVNPNDRPTAAQLME 476
KC +P+ RP +L
Sbjct: 251 TKCWAYDPSRRPRFTELKA 269
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-42
Identities = 75/324 (23%), Positives = 130/324 (40%), Gaps = 75/324 (23%)
Query: 215 SPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSL--QDEG-P----RG 266
S F ++ ++K +G G++G V++ G A+K+V + + EG P R
Sbjct: 7 SVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR- 65
Query: 267 KQSILQLEQEISLLGQFEHDNIVQYLG------TDRDEKRLCIFL-----ELVTKGSLAS 315
EI +L +H+N+V + + + + I+L E G L++
Sbjct: 66 ---------EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN 116
Query: 316 LYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375
+ S++ + +LNGL Y+H ++HRD+K AN+L+ G +KLADFGLA+A
Sbjct: 117 --VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA- 173
Query: 376 TMNDVKSCKGTAF-------WM-APEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY-- 425
+ K+ + + W PE++ L + YG D+W GC + EM TR P
Sbjct: 174 -FSLAKNSQPNRYTNRVVTLWYRPPELL-LGERDYGPPIDLWGAGCIMAEMWTRS-PIMQ 230
Query: 426 --SHLEGGQAMFKI----------GGGELP---------PVPNSL---------SRDAQD 455
+ + ++ + A D
Sbjct: 231 GNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD 290
Query: 456 FILKCLQVNPNDRPTAAQLMEHPF 479
I K L ++P R + + H F
Sbjct: 291 LIDKLLVLDPAQRIDSDDALNHDF 314
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-42
Identities = 73/280 (26%), Positives = 130/280 (46%), Gaps = 27/280 (9%)
Query: 215 SPNGKFRRRI--TSWQKGELLGSGSYGFVYEG-LTDDGFFF----AVKEVSLQDE-GPRG 266
+PN R + T ++K ++LGSG++G VY+G +G A+K L++ P+
Sbjct: 3 APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKA 60
Query: 267 KQSILQLEQEISLLGQFEHDNIVQYLG--TDRDEKRLCIFLELVTKGSLAS--LYQKYHL 322
+ IL E ++ ++ ++ + LG + + +L+ G L K ++
Sbjct: 61 NKEILD---EAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNI 114
Query: 323 SDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VK 381
+ ++ QI G+ YL ++ +VHRD+ N+LV VK+ DFGLAK +
Sbjct: 115 GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 382 SCKGTAF---WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKI 437
+G WMA E + + Y +D+WS G TV E++T PY + + +
Sbjct: 175 HAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
Query: 438 GGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
GE P P + D ++KC ++ + RP +L+
Sbjct: 233 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-42
Identities = 71/268 (26%), Positives = 117/268 (43%), Gaps = 24/268 (8%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEGL----TDDGFFFAVKEVSLQDEGPRGKQSILQLEQE 276
R + +LG G +G VYEG+ + AVK +D K+ + E
Sbjct: 11 REDVV---LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFMS---E 63
Query: 277 ISLLGQFEHDNIVQYLG--TDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTR 332
++ +H +IV+ +G E+ I +EL G L ++ L + Y+
Sbjct: 64 AVIMKNLDHPHIVKLIGIIE---EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 333 QILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---W 389
QI + YL N VHRDI NILV + VKL DFGL++ D T W
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 180
Query: 390 MAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNS 448
M+PE +N ++ + +D+W + E+L+ + P+ LE + + G+ P P+
Sbjct: 181 MSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDL 238
Query: 449 LSRDAQDFILKCLQVNPNDRPTAAQLME 476
+ +C +P+DRP +L+
Sbjct: 239 CPPVLYTLMTRCWDYDPSDRPRFTELVC 266
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-42
Identities = 82/302 (27%), Positives = 128/302 (42%), Gaps = 52/302 (17%)
Query: 222 RRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSL--QDEGPRG--KQSILQLEQE 276
+ ++ +G G+YG VY+ G F A+K V + G G ++ +E
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV----RE 61
Query: 277 ISLL---GQFEHDNIVQYLG---TDRDEKRLCIFL--ELVT---KGSLASLYQKYHLSDS 325
++LL FEH N+V+ + T R ++ + + L E V + L L
Sbjct: 62 VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA-PPPGLPAE 120
Query: 326 QVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG 385
+ RQ L GL +LH +VHRD+K NILV + G+VKLADFGLA+ + +
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV 180
Query: 386 TAFWM-APEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY----SHLEGGQAMFKI--- 437
W APEV L + Y D+WS+GC EM R+ P S + +F +
Sbjct: 181 VTLWYRAPEV--LLQSTYATPVDMWSVGCIFAEMFRRK-PLFCGNSEADQLGKIFDLIGL 237
Query: 438 -------GGGELP------PVPNSL-------SRDAQDFILKCLQVNPNDRPTAAQLMEH 477
LP P + +L+ L NP+ R +A + ++H
Sbjct: 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297
Query: 478 PF 479
+
Sbjct: 298 SY 299
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 71/256 (27%), Positives = 119/256 (46%), Gaps = 20/256 (7%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
LG G +G V+ G + A+K + G ++ LQ E ++ + H+ +V
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLV 242
Query: 290 QYLG--TDRDEKRLCIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQ 344
Q + E+ + I E ++KGSL + +L Q+ QI +G+ Y+
Sbjct: 243 QLYAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKKDG 401
N VHRD++ ANILV + K+ADFGLA+ N+ + +G F W APE +
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-- 357
Query: 402 YGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460
+ + +D+WS G + E+ T+ R PY + + + ++ G P P D + +C
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 417
Query: 461 LQVNPNDRPTAAQLME 476
+ P +RPT L
Sbjct: 418 WRKEPEERPTFEYLQA 433
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-41
Identities = 71/256 (27%), Positives = 116/256 (45%), Gaps = 16/256 (6%)
Query: 230 GELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
LG G YG VYEG AVK + E + L+ E +++ + +H N+
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLK---EAAVMKEIKHPNL 71
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLASL---YQKYHLSDSQVSSYTRQILNGLKYLHEQN 345
VQ LG E I E +T G+L + +S + QI + ++YL ++N
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKKDGY 402
+HRD+ N LV + VK+ADFGL++ T + + G F W APE + K +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--F 189
Query: 403 GLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCL 461
+ +D+W+ G + E+ T PY ++ Q + P + + C
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 249
Query: 462 QVNPNDRPTAAQLMEH 477
Q NP+DRP+ A++ +
Sbjct: 250 QWNPSDRPSFAEIHQA 265
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-41
Identities = 74/276 (26%), Positives = 127/276 (46%), Gaps = 32/276 (11%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSIL------QL 273
+R I + E LG GS+G V A+K +S +Q + ++
Sbjct: 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFIS--------RQLLKKSDMHMRV 56
Query: 274 EQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQVSSYTR 332
E+EIS L H +I++ + + +E G L + +K +++ + + +
Sbjct: 57 EREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQ 115
Query: 333 QILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK---SCKGTAFW 389
QI+ ++Y H +VHRD+K N+L+D + +VK+ADFGL+ + SC G+ +
Sbjct: 116 QIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTSC-GSPNY 173
Query: 390 MAPEVVNLKKDGY-GLTADIWSLGCTVLEMLTRRHPY--SHLEGGQAMF-KIGGGELPPV 445
APEV+N K Y G D+WS G + ML R P+ + +F K+ +
Sbjct: 174 AAPEVINGK--LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI---PNLFKKVNSCVY-VM 227
Query: 446 PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
P+ LS AQ I + + +P R T ++ P+
Sbjct: 228 PDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 78/336 (23%), Positives = 137/336 (40%), Gaps = 66/336 (19%)
Query: 192 SYHDDDDSKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEG-LTDDGF 250
++ S+ S++ + + S+ +++G+GS+G VY+ L D G
Sbjct: 22 AFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEV-SYTDTKVIGNGSFGVVYQAKLCDSGE 80
Query: 251 FFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYL------GTDRDEKRLCIF 304
A+K+V LQD K+ + E+ ++ + +H NIV+ G +DE L +
Sbjct: 81 LVAIKKV-LQD-----KRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131
Query: 305 LELVTKGSLASLYQ--------KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANI 356
L+ V + ++Y+ K L V Y Q+ L Y+H + HRDIK N+
Sbjct: 132 LDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 187
Query: 357 LVDA-SGSVKLADFGLAKATTMNDVKS---CKGTAFWMAPEVVNLKKDGYGLTADIWSLG 412
L+D + +KL DFG AK + C + ++ APE++ Y + D+WS G
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAPELI-FGATDYTSSIDVWSAG 244
Query: 413 CTVLEMLTRRHPY----SHLEGGQAMFKIGG----------------GELPPVP------ 446
C + E+L + P S ++ + K+ G + P +
Sbjct: 245 CVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 303
Query: 447 ---NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
+A + L+ P R T + H F
Sbjct: 304 VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-41
Identities = 71/256 (27%), Positives = 119/256 (46%), Gaps = 20/256 (7%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
LG G +G V+ G + A+K + G ++ LQ E ++ + H+ +V
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLV 325
Query: 290 QYLG--TDRDEKRLCIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQ 344
Q + E+ + I E ++KGSL + +L Q+ QI +G+ Y+
Sbjct: 326 QLYAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKKDG 401
N VHRD++ ANILV + K+ADFGLA+ N+ + +G F W APE +
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-- 440
Query: 402 YGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460
+ + +D+WS G + E+ T+ R PY + + + ++ G P P D + +C
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 500
Query: 461 LQVNPNDRPTAAQLME 476
+ P +RPT L
Sbjct: 501 WRKEPEERPTFEYLQA 516
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-41
Identities = 62/259 (23%), Positives = 112/259 (43%), Gaps = 18/259 (6%)
Query: 230 GELLGSGSYGFVYEGL----TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+++GSG G V G A+K +L+ ++ E S++GQF+H
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIK--ALKAGYT--ERQRRDFLSEASIMGQFDH 109
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHE 343
NI++ G + I E + GSL + + + + Q+ R + G++YL +
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTAF---WMAPEVVNLK 398
VHRD+ N+LVD++ K++DFGL++ + + G W APE + +
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 399 KDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFI 457
+ +D+WS G + E+L PY ++ + + G P P +
Sbjct: 230 T--FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLM 287
Query: 458 LKCLQVNPNDRPTAAQLME 476
L C + RP +Q++
Sbjct: 288 LDCWHKDRAQRPRFSQIVS 306
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-41
Identities = 76/309 (24%), Positives = 131/309 (42%), Gaps = 70/309 (22%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSL--QDEGPRG--KQSILQLEQ 275
+ R ++K + LG G + VY+ + A+K++ L + E G + ++ +
Sbjct: 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL----R 61
Query: 276 EISLLGQFEHDNIVQYLGTDRDEKRLCI---FLELVTKGSLASLYQKYHLSDSQVSSYTR 332
EI LL + H NI+ L + + + F+E + + L+ S + +Y
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYML 119
Query: 333 QILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAP 392
L GL+YLH+ ++HRD+K N+L+D +G +KLADFGLAK+ + ++
Sbjct: 120 MTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRA-------YTH 171
Query: 393 EVVNL-----------KKDGYGLTADIWSLGCTVLEMLTRRHPY----SHLEGGQAMFKI 437
+VV + YG+ D+W++GC + E+L R P+ S L+ Q + +I
Sbjct: 172 QVVTRWYRAPELLFGARM--YGVGVDMWAVGCILAELLLRV-PFLPGDSDLD--Q-LTRI 225
Query: 438 -------------GGGELP--------PVPN------SLSRDAQDFILKCLQVNPNDRPT 470
LP P + D D I NP R T
Sbjct: 226 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 285
Query: 471 AAQLMEHPF 479
A Q ++ +
Sbjct: 286 ATQALKMKY 294
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-41
Identities = 83/302 (27%), Positives = 131/302 (43%), Gaps = 54/302 (17%)
Query: 222 RRITSWQKGELLGSGSYGFVYEG--LTDDGFFFAVKEVSLQ--DEG-PRGKQSILQLEQE 276
R ++ +G G+YG V++ L + G F A+K V +Q +EG P +I +E
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL--STI----RE 61
Query: 277 ISLLGQ---FEHDNIVQ-----YLGTDRDEKRLCI---FLELVTKGSLASLYQKYHLSDS 325
+++L FEH N+V+ + E +L + ++ L + + +
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTE 120
Query: 326 QVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG 385
+ Q+L GL +LH VVHRD+K NILV +SG +KLADFGLA+ + +
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 180
Query: 386 TAFWM-APEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY----SHLEGGQAMFKI--- 437
W APEV L + Y D+WS+GC EM R+ P S ++ + +
Sbjct: 181 VTLWYRAPEV--LLQSSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILDVIGL 237
Query: 438 -------GGGELP------PVPNSL-------SRDAQDFILKCLQVNPNDRPTAAQLMEH 477
LP + +D +LKCL NP R +A + H
Sbjct: 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297
Query: 478 PF 479
P+
Sbjct: 298 PY 299
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-41
Identities = 84/288 (29%), Positives = 132/288 (45%), Gaps = 37/288 (12%)
Query: 215 SPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSIL-- 271
R +I + G+ LG G++G V G G AVK ++ +Q I
Sbjct: 6 KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILN--------RQKIRSL 57
Query: 272 ----QLEQEISLLGQFEHDNIV---QYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLS 323
++ +EI L F H +I+ Q + T D + + +E V+ G L + + L
Sbjct: 58 DVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD---IFMVMEYVSGGELFDYICKNGRLD 114
Query: 324 DSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK-- 381
+ + +QIL+G+ Y H VVHRD+K N+L+DA + K+ADFGL+ +
Sbjct: 115 EKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLR 173
Query: 382 -SCKGTAFWMAPEVVNLKKDGY-GLTADIWSLGCTVLEMLTRRHPY--SHLEGGQAMF-K 436
SC G+ + APEV++ + Y G DIWS G + +L P+ H+ +F K
Sbjct: 174 TSC-GSPNYAAPEVISGR--LYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTLFKK 227
Query: 437 IGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484
I G P L+ + LQV+P R T + EH + K+ L
Sbjct: 228 ICDGIF-YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL 274
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-41
Identities = 69/291 (23%), Positives = 121/291 (41%), Gaps = 27/291 (9%)
Query: 209 EPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGK 267
P + + + +GSG++G AVK + RG
Sbjct: 4 APVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYI------ERGA 57
Query: 268 QSILQLEQEISLLGQFEHDNIVQY---LGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLS 323
+++EI H NIV++ + T L I +E + G L + S
Sbjct: 58 AIDENVQREIINHRSLRHPNIVRFKEVILTPTH---LAIIMEYASGGELYERICNAGRFS 114
Query: 324 DSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS--GSVKLADFGLAKATTMNDV- 380
+ + + +Q+L+G+ Y H + HRD+K N L+D S +K+ DFG +K++ ++
Sbjct: 115 EDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174
Query: 381 KSCKGTAFWMAPEVVNLKKDGY-GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFK--- 436
KS GT ++APEV L + Y G AD+WS G T+ ML +P+ ++
Sbjct: 175 KSTVGTPAYIAPEV--LLRQEYDGKIADVWSCGVTLYVMLVGAYPFED-PEEPRDYRKTI 231
Query: 437 --IGGGELP-PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484
I + P +S + I + +P R + ++ H + + L
Sbjct: 232 QRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-41
Identities = 77/308 (25%), Positives = 130/308 (42%), Gaps = 25/308 (8%)
Query: 188 VEYVSYHDDDDSKG-HPISEIMEPGNNVSPN---GKFRRRI--TSWQKGELLGSGSYGFV 241
+ Y +H D + + PN KF I + + +++G+G +G V
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEV 60
Query: 242 YEGL-----TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR 296
Y+G+ A+K + + + L E ++GQF H NI++ G
Sbjct: 61 YKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLG---EAGIMGQFSHHNIIRLEGVIS 116
Query: 297 DEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCA 354
K + I E + G+L ++ S Q+ R I G+KYL N VHRD+
Sbjct: 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAAR 176
Query: 355 NILVDASGSVKLADFGLAKATTMND--VKSCKGTAF---WMAPEVVNLKKDGYGLTADIW 409
NILV+++ K++DFGL++ + + G W APE ++ +K + +D+W
Sbjct: 177 NILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK--FTSASDVW 234
Query: 410 SLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDR 468
S G + E++T PY L + M I G P P +++C Q R
Sbjct: 235 SFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARR 294
Query: 469 PTAAQLME 476
P A ++
Sbjct: 295 PKFADIVS 302
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 8e-41
Identities = 78/313 (24%), Positives = 134/313 (42%), Gaps = 64/313 (20%)
Query: 214 VSPNGKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQL 273
S +R ++ +++G+GS+G V++ + A+K+V LQD+ + +
Sbjct: 29 ASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-LQDKRFKNR------ 81
Query: 274 EQEISLLGQFEHDNIVQYL------GTDRDEKRLCIFLELVTKGSLASLYQ--------K 319
E+ ++ +H N+V G +DE L + LE V + ++Y+ K
Sbjct: 82 --ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE----TVYRASRHYAKLK 135
Query: 320 YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMN 378
+ + Y Q+L L Y+H + HRDIK N+L+D SG +KL DFG AK
Sbjct: 136 QTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195
Query: 379 DVKS---CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY----SHLEGG 431
+ C + ++ APE++ Y DIWS GC + E++ + P S ++
Sbjct: 196 EPNVSYIC--SRYYRAPELI-FGATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQL 251
Query: 432 QAMFKIGG----------------GELPPVP---------NSLSRDAQDFILKCLQVNPN 466
+ K+ G + P + DA D I + L+ P+
Sbjct: 252 VEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPS 311
Query: 467 DRPTAAQLMEHPF 479
R TA + + HPF
Sbjct: 312 ARLTAIEALCHPF 324
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 70/300 (23%), Positives = 129/300 (43%), Gaps = 27/300 (9%)
Query: 194 HDDDDSKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEG-LTDDGFFF 252
+ + K + + ++ + + + LG+GS+G V + G +
Sbjct: 10 SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 69
Query: 253 AVKEVSLQDEGPRGKQSILQLEQ------EISLLGQFEHDNIVQYLGTDRDEKRLCIFLE 306
A+K + KQ +++L+Q E +L +V+ + +D L + +E
Sbjct: 70 AMKILD--------KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121
Query: 307 LVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVK 365
V G + S ++ S+ Y QI+ +YLH ++++RD+K N+L+D G ++
Sbjct: 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181
Query: 366 LADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY 425
+ DFG AK C GT +APE++ K GY D W+LG + EM P+
Sbjct: 182 VTDFGFAKRVKGRTWTLC-GTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPF 238
Query: 426 SHLEGGQAMF-KIGGGELPPVPNSLSRDAQDFILKCLQVNPNDR-----PTAAQLMEHPF 479
+ ++ KI G++ P+ S D +D + LQV+ R + H +
Sbjct: 239 FA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 75/320 (23%), Positives = 128/320 (40%), Gaps = 68/320 (21%)
Query: 214 VSPNGKFRRRITSWQKGELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQ 272
+ + + R+ + +Q + G G++G V G G A+K+V +QD PR + LQ
Sbjct: 12 AAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQD--PRFRNRELQ 68
Query: 273 LEQEISLLGQFEHDNIVQ-------YLGTDRDEKRLCIFLELVTKGSLASLYQ------- 318
+ L H NIVQ DR + L + +E V +L++
Sbjct: 69 ---IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYR 121
Query: 319 -KYHLSDSQVSSYTRQILNGLKYLHEQ--NVVHRDIKCANILVD-ASGSVKLADFGLAKA 374
+ + + Q++ + LH NV HRDIK N+LV+ A G++KL DFG AK
Sbjct: 122 RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181
Query: 375 TTMNDVKS---CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY----SH 427
+ ++ C + ++ APE++ Y DIWS+GC EM+ P +
Sbjct: 182 LSPSEPNVAYIC--SRYYRAPELI-FGNQHYTTAVDIWSVGCIFAEMMLGE-PIFRGDNS 237
Query: 428 LEGGQAMFKIGG-------------------GELPPVP---------NSLSRDAQDFILK 459
+ ++ G +P +++A D +
Sbjct: 238 AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSA 297
Query: 460 CLQVNPNDRPTAAQLMEHPF 479
LQ P +R + + HP+
Sbjct: 298 LLQYLPEERMKPYEALCHPY 317
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 2e-40
Identities = 72/267 (26%), Positives = 128/267 (47%), Gaps = 37/267 (13%)
Query: 232 LLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQ------EISLLGQFE 284
LG+GS+G V+ +G ++A+K + K+ +++L+Q E +L
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLK--------KEIVVRLKQVEHTNDERLMLSIVT 64
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHE 343
H I++ GT +D +++ + ++ + G L SL +K + Y ++ L+YLH
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAK-----ATTMNDVKSCKGTAFWMAPEVVNLK 398
+++++RD+K NIL+D +G +K+ DFG AK T+ C GT ++APEVV+ K
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL-----C-GTPDYIAPEVVSTK 178
Query: 399 KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGELPPVPNSLSRDAQDFI 457
Y + D WS G + EML P+ + KI EL P + D +D +
Sbjct: 179 --PYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL-RFPPFFNEDVKDLL 234
Query: 458 LKCLQVNPNDR-----PTAAQLMEHPF 479
+ + + + R + HP+
Sbjct: 235 SRLITRDLSQRLGNLQNGTEDVKNHPW 261
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 66/259 (25%), Positives = 120/259 (46%), Gaps = 18/259 (6%)
Query: 230 GELLGSGSYGFVYEGL----TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+++G+G +G V G + A+K + + ++ L E S++GQF+H
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLG---EASIMGQFDH 105
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHE 343
NI++ G K + I E + GSL S +K+ + Q+ R I +G+KYL +
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTAF---WMAPEVVNLK 398
VHRD+ NIL++++ K++DFGL + + + +G W +PE + +
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 399 KDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFI 457
K + +D+WS G + E+++ PY + + + G P P +
Sbjct: 226 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 458 LKCLQVNPNDRPTAAQLME 476
L C Q + N+RP Q++
Sbjct: 284 LDCWQKDRNNRPKFEQIVS 302
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 71/257 (27%), Positives = 122/257 (47%), Gaps = 20/257 (7%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
E LG+G +G V+ G + AVK + +G + L E +L+ Q +H +V
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLA---EANLMKQLQHQRLV 71
Query: 290 QYLG--TDRDEKRLCIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQ 344
+ T ++ + I E + GSL + L+ +++ QI G+ ++ E+
Sbjct: 72 RLYAVVT---QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKKDG 401
N +HRD++ ANILV + S K+ADFGLA+ N+ + +G F W APE +N
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-- 186
Query: 402 YGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460
+ + +D+WS G + E++T R PY + + + + G P++ + + C
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246
Query: 461 LQVNPNDRPTAAQLMEH 477
+ P DRPT L
Sbjct: 247 WKERPEDRPTFDYLRSV 263
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 83/346 (23%), Positives = 139/346 (40%), Gaps = 35/346 (10%)
Query: 158 RHKFQYYMSLCN------YIVTEAAK----VRRRQDCPNNVEYVSYHDDDDSKG------ 201
Q +SL Y + A+ V E V +H + G
Sbjct: 136 SSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTV-ADGLITTLH 194
Query: 202 HPISEIMEPGNNVSPNGKFRRRI--TSWQKGELLGSGSYGFVYEG-LTDDGFFFAVKEVS 258
+P + +P + + T LG G YG VYEG AVK +
Sbjct: 195 YPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK 254
Query: 259 LQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASL-- 316
E + L+ E +++ + +H N+VQ LG E I E +T G+L
Sbjct: 255 ---EDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 308
Query: 317 -YQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375
+ +S + QI + ++YL ++N +HR++ N LV + VK+ADFGL++
Sbjct: 309 ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368
Query: 376 TMNDVKSCKGTAF---WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGG 431
T + + G F W APE + K + + +D+W+ G + E+ T PY ++
Sbjct: 369 TGDTYTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 426
Query: 432 QAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
Q + P + + C Q NP+DRP+ A++ +
Sbjct: 427 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 472
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 152 bits (384), Expect = 4e-40
Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 18/255 (7%)
Query: 233 LGSGSYGFVYEGL--TDDGFFF-AVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
LG G++G V +G+ A+K + Q + +++ E ++ Q ++ IV
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMR---EAQIMHQLDNPYIV 399
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLAS--LYQKYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
+ +G + L + +E+ G L + ++ + S V+ Q+ G+KYL E+N V
Sbjct: 400 RLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 348 HRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKGTAF---WMAPEVVNLKKDGY 402
HR++ N+L+ K++DFGL+KA +D + + W APE +N +K +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--F 516
Query: 403 GLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCL 461
+D+WS G T+ E L+ + PY ++G + M I G+ P + + C
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCW 576
Query: 462 QVNPNDRPTAAQLME 476
DRP + +
Sbjct: 577 IYKWEDRPDFLTVEQ 591
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 60/270 (22%), Positives = 112/270 (41%), Gaps = 27/270 (10%)
Query: 230 GELLGSGSYGFVYEG-LTDDGFFF---AVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
G +LG G +G V E L + F AVK + I + +E + + +F+H
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK---ADIIASSDIEEFLREAACMKEFDH 84
Query: 286 DNIVQYLG--TDRD----EKRLCIFLELVTKGSLAS-------LYQKYHLSDSQVSSYTR 332
++ + +G + L + G L + ++L + +
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 333 QILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---- 388
I G++YL +N +HRD+ N ++ +V +ADFGL++ D +
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 389 WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPN 447
W+A E + Y + +D+W+ G T+ E++TR + PY+ +E + + GG P
Sbjct: 205 WLALESLADNL--YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPP 262
Query: 448 SLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
+ D + +C +P RP+ L
Sbjct: 263 ECMEEVYDLMYQCWSADPKQRPSFTCLRME 292
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-39
Identities = 64/288 (22%), Positives = 106/288 (36%), Gaps = 64/288 (22%)
Query: 230 GELLGSGSYGFVYEGLTD--DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
++LG G G V + + FA+K + + E E+ + +
Sbjct: 23 SQVLGLGINGKVLQI-FNKRTQEKFALKMLQ--------DCPKARREVEL-HWRASQCPH 72
Query: 288 IVQYLGT--DRDEKRLCIFL--ELVTKGSL-----ASLYQKYHLSDSQVSSYTRQILNGL 338
IV+ + + R C+ + E + G L Q + ++ + S + I +
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF--TEREASEIMKSIGEAI 130
Query: 339 KYLHEQNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVV 395
+YLH N+ HRD+K N+L + +KL DFG A E
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-------------------AKETT 171
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTRRHPY---SHLEGGQAMF-KIGGGEL----PPVPN 447
+ Y + D+WSLG + +L P+ L M +I G+ P
Sbjct: 172 ---GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 228
Query: 448 SLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK-------RPLQTSS 488
+S + + I L+ P R T + M HP+I PL TS
Sbjct: 229 -VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 275
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-39
Identities = 86/371 (23%), Positives = 144/371 (38%), Gaps = 39/371 (10%)
Query: 122 LKATSYGVYILCHLVFKAFSSVRNIFSNLLLGVEFVRHKFQYYMSLCNYIVTEAAKVRRR 181
L T+ + I ++ R + + K + K R
Sbjct: 297 LTVTAPSLTIAENMADLIDGYCR-LVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVR 355
Query: 182 QDC---PNNVEYVSYHDDDDSKGHPISEIME-PGNNVSPNGKFRRRITSWQKGELLGSGS 237
+Y D++D+ P + E R RI G +G G
Sbjct: 356 SHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQ----------RERIE---LGRCIGEGQ 402
Query: 238 YGFVYEGL--TDDGFFF--AVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLG 293
+G V++G+ + + A+K ++ LQ E + QF+H +IV+ +G
Sbjct: 403 FGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQ---EALTMRQFDHPHIVKLIG 458
Query: 294 --TDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHR 349
T E + I +EL T G L S Q L + + Y Q+ L YL + VHR
Sbjct: 459 VIT---ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR 515
Query: 350 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKKDGYGLTA 406
DI N+LV ++ VKL DFGL++ + WMAPE +N ++ + +
Sbjct: 516 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR--FTSAS 573
Query: 407 DIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNP 465
D+W G + E+L P+ ++ + +I GE P+P + + KC +P
Sbjct: 574 DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDP 633
Query: 466 NDRPTAAQLME 476
+ RP +L
Sbjct: 634 SRRPRFTELKA 644
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-39
Identities = 73/267 (27%), Positives = 128/267 (47%), Gaps = 32/267 (11%)
Query: 232 LLGSGSYGFVY----EGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQ-----EISLLGQ 282
+LG GS+G V+ +D +A+K + K ++ ++ E +L +
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLK--------KATLKVRDRVRTKMERDILVE 82
Query: 283 FEHDNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYL 341
H IV+ + E +L + L+ + G L + L ++ ++ V Y ++ L +L
Sbjct: 83 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTAFWMAPEVVNLK 398
H +++RD+K NIL+D G +KL DFGL+K + ++ K+ C GT +MAPEV +
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEV--VN 199
Query: 399 KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGELPPVPNSLSRDAQDFI 457
+ G+ +AD WS G + EMLT P+ + + I +L +P LS +AQ +
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKL-GMPQFLSPEAQSLL 257
Query: 458 LKCLQVNPNDR-----PTAAQLMEHPF 479
+ NP +R ++ H F
Sbjct: 258 RMLFKRNPANRLGAGPDGVEEIKRHSF 284
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-39
Identities = 80/326 (24%), Positives = 144/326 (44%), Gaps = 34/326 (10%)
Query: 179 RRRQDCPNNVEYVSYHDDDDSKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSY 238
+ + + D D ++ E + I +++ ++LG+G+Y
Sbjct: 8 HEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAY 67
Query: 239 GFVY----EGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEI-------SLLGQFEHDN 287
G V+ D G +A+K + K +I+Q + +L
Sbjct: 68 GKVFLVRKISGHDTGKLYAMKVLK--------KATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 288 -IVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYLHEQN 345
+V + E +L + L+ + G L + L Q+ ++ +V Y +I+ L++LH+
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG 179
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTAFWMAPEVVNLKKDGY 402
+++RDIK NIL+D++G V L DFGL+K ++ + GT +MAP++V G+
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH 239
Query: 403 GLTADIWSLGCTVLEMLTRRHPYSHLEGGQA---MF-KIGGGELPPVPNSLSRDAQDFIL 458
D WSLG + E+LT P++ + + +I E P P +S A+D I
Sbjct: 240 DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-PYPQEMSALAKDLIQ 298
Query: 459 KCLQVNPNDR----PT-AAQLMEHPF 479
+ L +P R P A ++ EH F
Sbjct: 299 RLLMKDPKKRLGCGPRDADEIKEHLF 324
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 84/356 (23%), Positives = 153/356 (42%), Gaps = 42/356 (11%)
Query: 152 LGVEFVR----HKFQYYMSLCNYIVTEAAKVR---------------RRQDCPNNVEYVS 192
LG +R K Y +S+ +Y + V+ R E V
Sbjct: 93 LGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVD 152
Query: 193 YH-DDDDSKGHPISEIMEPGNNVSPNGKFRRRI--TSWQKGELLGSGSYGFVYEGLTDDG 249
++ +D +S P K I S + + LG+G +G V+ +
Sbjct: 153 HYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKH 212
Query: 250 FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLG--TDRDEKRLCIFLEL 307
AVK + G ++ L E +++ +HD +V+ T ++ + I E
Sbjct: 213 TKVAVKTMK---PGSMSVEAFLA---EANVMKTLQHDKLVKLHAVVT---KEPIYIITEF 263
Query: 308 VTKGSLASL---YQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSV 364
+ KGSL + ++ ++ QI G+ ++ ++N +HRD++ ANILV AS
Sbjct: 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVC 323
Query: 365 KLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR 421
K+ADFGLA+ N+ + +G F W APE +N + + +D+WS G ++E++T
Sbjct: 324 KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEIVTY 381
Query: 422 -RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476
R PY + + + + G P P + + + +++C + P +RPT +
Sbjct: 382 GRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 76/269 (28%), Positives = 131/269 (48%), Gaps = 34/269 (12%)
Query: 232 LLGSGSYGFVY----EGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEI-------SLL 280
+LG G YG V+ + G FA+K + K I++ ++ ++L
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLK--------KAMIVRNAKDTAHTKAERNIL 75
Query: 281 GQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLK 339
+ +H IV + + +L + LE ++ G L L ++ + Y +I L
Sbjct: 76 EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTAFWMAPEVVN 396
+LH++ +++RD+K NI+++ G VKL DFGL K + + + C GT +MAPE+
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPEI-- 192
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGELPPVPNSLSRDAQD 455
L + G+ D WSLG + +MLT P++ E + KI +L +P L+++A+D
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKL-NLPPYLTQEARD 250
Query: 456 FILKCLQVNPNDR----PT-AAQLMEHPF 479
+ K L+ N R P A ++ HPF
Sbjct: 251 LLKKLLKRNAASRLGAGPGDAGEVQAHPF 279
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-39
Identities = 73/269 (27%), Positives = 124/269 (46%), Gaps = 29/269 (10%)
Query: 232 LLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQE---------ISLLG 281
++G G +G VY D G +A+K + K+ I + E +SL+
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLD--------KKRIKMKQGETLALNERIMLSLVS 247
Query: 282 QFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKY 340
+ IV +L L+L+ G L L Q S++ + Y +I+ GL++
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKD 400
+H + VV+RD+K ANIL+D G V+++D GLA + + GT +MAPEV+ K
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGV 366
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPYSHLEGG--QAMF-KIGGGELPPVPNSLSRDAQDFI 457
Y +AD +SLGC + ++L P+ + + + +P+S S + + +
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-ELPDSFSPELRSLL 425
Query: 458 LKCLQVNPNDR-----PTAAQLMEHPFIK 481
LQ + N R A ++ E PF +
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFR 454
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 65/269 (24%), Positives = 108/269 (40%), Gaps = 33/269 (12%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVK----EVSLQDEGPRGKQSILQLEQE 276
+ + + +G G +G V G G AVK + + Q E
Sbjct: 20 MKELK---LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA-----------FLAE 64
Query: 277 ISLLGQFEHDNIVQYLGT-DRDEKRLCIFLELVTKGSLASLYQ---KYHLSDSQVSSYTR 332
S++ Q H N+VQ LG ++ L I E + KGSL + + L + ++
Sbjct: 65 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 124
Query: 333 QILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---W 389
+ ++YL N VHRD+ N+LV K++DFGL K + W
Sbjct: 125 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKW 180
Query: 390 MAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNS 448
APE + KK + +D+WS G + E+ + R PY + + ++ G P+
Sbjct: 181 TAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 238
Query: 449 LSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
+ + C ++ RP+ QL E
Sbjct: 239 CPPAVYEVMKNCWHLDAAMRPSFLQLREQ 267
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 53/275 (19%), Positives = 104/275 (37%), Gaps = 47/275 (17%)
Query: 230 GELLGSGSYGFVYEG-LTDDGFFF-------AVKEVSLQDEGPRGKQSILQLEQEISLLG 281
E LG G++ +++G + G + +K L +S + S++
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLK--VLDKAHRNYSESFFE---AASMMS 67
Query: 282 QFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLK 339
+ H ++V G + E V GSL + +K ++ +Q+ +
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 340 YLHEQNVVHRDIKCANILVDASGS--------VKLADFGLAKATTMND-----VKSCKGT 386
+L E ++H ++ NIL+ +KL+D G++ D +
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP----- 182
Query: 387 AFWMAPEVVNLKKDGYGLT--ADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKI-GGGEL 442
W+ PE + ++ L D WS G T+ E+ + P S L+ + + +L
Sbjct: 183 --WVPPECI---ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL 237
Query: 443 P-PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476
P P L + I C+ P+ RP+ ++
Sbjct: 238 PAPKAAEL----ANLINNCMDYEPDHRPSFRAIIR 268
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-38
Identities = 71/287 (24%), Positives = 114/287 (39%), Gaps = 44/287 (15%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEG----LTDDGFFFAV-----KEVSLQDEGPRGKQSIL 271
RR I LG G++G V+ L+ V K+ +L
Sbjct: 14 RRDIV---LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--------K 62
Query: 272 QLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSL-----------------A 314
++E LL +H++IV++ G D L + E + G L
Sbjct: 63 DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122
Query: 315 SLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 374
K L SQ+ QI +G+ YL Q+ VHRD+ N LV A+ VK+ DFG+++
Sbjct: 123 PRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD 182
Query: 375 TTMNDVKSCKGTAF----WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLE 429
D G WM PE + +K + +D+WS G + E+ T + P+ L
Sbjct: 183 VYSTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVILWEIFTYGKQPWFQLS 240
Query: 430 GGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476
+ + I G + P ++ D +L C Q P R ++ +
Sbjct: 241 NTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-38
Identities = 67/262 (25%), Positives = 110/262 (41%), Gaps = 20/262 (7%)
Query: 230 GELLGSGSYGFVYEGLTDDG----FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
E++G G +G VY G D AVK SL + Q E ++ F H
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK--SLNRITD--IGEVSQFLTEGIIMKDFSH 85
Query: 286 DNIVQYLGT-DRDEKRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLH 342
N++ LG R E + L + G L + + ++ + + + Q+ G+KYL
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF------WMAPEVVN 396
+ VHRD+ N ++D +VK+ADFGLA+ + S WMA E +
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455
+K + +D+WS G + E++TR PY + + G P +
Sbjct: 206 TQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 263
Query: 456 FILKCLQVNPNDRPTAAQLMEH 477
+LKC RP+ ++L+
Sbjct: 264 VMLKCWHPKAEMRPSFSELVSR 285
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 76/265 (28%), Positives = 129/265 (48%), Gaps = 30/265 (11%)
Query: 232 LLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQ------EISLLGQFE 284
LLG G++G V G ++A+K + K+ I+ ++ E +L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILR--------KEVIIAKDEVAHTVTESRVLQNTR 63
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYLHE 343
H + + RLC +E G L L ++ ++ + Y +I++ L+YLH
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTAFWMAPEVVNLKKD 400
++VV+RDIK N+++D G +K+ DFGL K + C GT ++APEV L+ +
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEV--LEDN 180
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGELPPVPNSLSRDAQDFILK 459
YG D W LG + EM+ R P+ + + + +F I E+ P +LS +A+ +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI-RFPRTLSPEAKSLLAG 238
Query: 460 CLQVNPNDR----PTAAQ-LMEHPF 479
L+ +P R P+ A+ +MEH F
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRF 263
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 72/301 (23%), Positives = 120/301 (39%), Gaps = 64/301 (21%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-E 284
+Q LG G Y V+E + + VK + K+ I + EI +L
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKR---EIKILENLRG 89
Query: 285 HDNIVQYLGT--DRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLH 342
NI+ D + + E V LYQ L+D + Y +IL L Y H
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCH 147
Query: 343 EQNVVHRDIKCANILVDAS-GSVKLADFGLAK----ATTMND-VKSCKGTAFWMAPEV-V 395
++HRD+K N+++D ++L D+GLA+ N V + ++ PE+ V
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV----ASRYFKGPELLV 203
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTRRHPY----SHLEGGQAMFKIGG------------ 439
+ + Y + D+WSLGC + M+ R+ P+ + + + K+ G
Sbjct: 204 DYQM--YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261
Query: 440 -----------GELPPVP----------NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHP 478
G + +S +A DF+ K L+ + R TA + MEHP
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321
Query: 479 F 479
+
Sbjct: 322 Y 322
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 64/287 (22%), Positives = 122/287 (42%), Gaps = 29/287 (10%)
Query: 212 NNVSPNGKFRRRITSWQKGELLGSGSYGFVYE-GLTDDGFFFAVKEVSLQDEGPRGKQSI 270
+ ++ R + ++ +++G G++G V +A+K +S K +
Sbjct: 56 DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS--------KFEM 107
Query: 271 LQLEQ------EISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSD 324
++ E ++ +VQ +D++ L + +E + G L +L Y + +
Sbjct: 108 IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE 167
Query: 325 SQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK 384
YT +++ L +H +HRD+K N+L+D SG +KLADFG + C
Sbjct: 168 KWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227
Query: 385 ---GTAFWMAPEVVNLK--KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIG 438
GT +++PEV+ + YG D WS+G + EML P+ + + KI
Sbjct: 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIM 286
Query: 439 GGELP---PVPNSLSRDAQDFILKCLQVNPNDR---PTAAQLMEHPF 479
+ P N +S++A++ I + R ++ H F
Sbjct: 287 NHKNSLTFPDDNDISKEAKNLI-CAFLTDREVRLGRNGVEEIKRHLF 332
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 66/265 (24%), Positives = 111/265 (41%), Gaps = 22/265 (8%)
Query: 228 QKGELLGSGSYGFVYEGLTDDGFFF----AVKEVSLQDEGPRGKQSILQLEQEISLLGQF 283
++G G +G VY G D A+K SL Q + +E L+
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK--SLSRITEM--QQVEAFLREGLLMRGL 79
Query: 284 EHDNIVQYLG--TDRDEKRLCIFLELVTKGSLAS--LYQKYHLSDSQVSSYTRQILNGLK 339
H N++ +G + + L + G L + + + + S+ Q+ G++
Sbjct: 80 NHPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGME 138
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---VKSCKGTAF---WMAPE 393
YL EQ VHRD+ N ++D S +VK+ADFGLA+ + V+ + W A E
Sbjct: 139 YLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 394 VVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRD 452
+ + + +D+WS G + E+LTR PY H++ + G P P
Sbjct: 199 SLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDS 256
Query: 453 AQDFILKCLQVNPNDRPTAAQLMEH 477
+ +C + +P RPT L+
Sbjct: 257 LYQVMQQCWEADPAVRPTFRVLVGE 281
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-37
Identities = 63/269 (23%), Positives = 115/269 (42%), Gaps = 26/269 (9%)
Query: 230 GELLGSGSYGFVYEG-LTDDGFFF---AVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
G++LG G +G V EG L + AVK +++ + ++ I + E + + F H
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVK--TMKLDNSSQRE-IEEFLSEAACMKDFSH 95
Query: 286 DNIVQYLG--TDRD---EKRLCIFLELVTKGSLAS-------LYQKYHLSDSQVSSYTRQ 333
N+++ LG + + + L + G L + H+ + +
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 334 ILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF----W 389
I G++YL +N +HRD+ N ++ +V +ADFGL+K D A W
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 390 MAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNS 448
+A E + + Y +D+W+ G T+ E+ TR PY ++ + + G P
Sbjct: 216 IAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPED 273
Query: 449 LSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
+ + + C + +P DRPT + L
Sbjct: 274 CLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 73/279 (26%), Positives = 106/279 (37%), Gaps = 31/279 (11%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEGLTDDGFFF------AVKEVSLQDEGPRGKQSILQLE 274
R+ IT LG G++G VYEG AVK +L + Q L
Sbjct: 29 RKNIT---LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK--TLPEVCSE--QDELDFL 81
Query: 275 QEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLAS--------LYQKYHLSDSQ 326
E ++ +F H NIV+ +G I +EL+ G L S Q L+
Sbjct: 82 MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 327 VSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS---VKLADFGLAKATTMNDVKSC 383
+ R I G +YL E + +HRDI N L+ G K+ DFG+A+
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201
Query: 384 KGTAF----WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIG 438
G A WM PE + D WS G + E+ + PY + + +
Sbjct: 202 GGCAMLPVKWMPPEAFMEGI--FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259
Query: 439 GGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
G P + + +C Q P DRP A ++E
Sbjct: 260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 298
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 62/275 (22%), Positives = 106/275 (38%), Gaps = 34/275 (12%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFF------AVKEVSLQDEGPRGKQSILQLEQEISLLGQF 283
LG G++G V+ + AVK +L++ +Q ++E LL
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQ---DFQREAELLTML 100
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSL----------------ASLYQKYHLSDSQV 327
+H +IV++ G + + L + E + G L L Q+
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 328 SSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTA 387
+ Q+ G+ YL + VHRD+ N LV VK+ DFG+++ D G
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 388 F----WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGEL 442
WM PE + +K + +D+WS G + E+ T + P+ L +A+ I G
Sbjct: 221 MLPIRWMPPESILYRK--FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE 278
Query: 443 PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
P + + + C Q P R + +
Sbjct: 279 LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-37
Identities = 68/274 (24%), Positives = 120/274 (43%), Gaps = 39/274 (14%)
Query: 232 LLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQ------EISLLGQFE 284
+LG G +G V + G +A K++ K+ I + + E +L +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLE--------KKRIKKRKGEAMALNEKQILEKVN 242
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHL--------SDSQVSSYTRQILN 336
+V + LC+ L L+ G L K+H+ +++ Y +I
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDL-----KFHIYHMGQAGFPEARAVFYAAEICC 297
Query: 337 GLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VKSCKGTAFWMAPEVV 395
GL+ LH + +V+RD+K NIL+D G ++++D GLA +K GT +MAPEV
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV- 356
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTRRHPY---SHLEGGQAMFKIGGGELPPVPNSLSRD 452
+K + Y + D W+LGC + EM+ + P+ + + ++ S
Sbjct: 357 -VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQ 415
Query: 453 AQDFILKCLQVNPNDR-----PTAAQLMEHPFIK 481
A+ + L +P +R +A ++ EHP K
Sbjct: 416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-37
Identities = 66/262 (25%), Positives = 110/262 (41%), Gaps = 20/262 (7%)
Query: 230 GELLGSGSYGFVYEGLTDDG----FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
E++G G +G VY G D AVK SL + Q E ++ F H
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK--SLNRITD--IGEVSQFLTEGIIMKDFSH 149
Query: 286 DNIVQYLGT-DRDEKRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLH 342
N++ LG R E + L + G L + + ++ + + + Q+ G+K+L
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF------WMAPEVVN 396
+ VHRD+ N ++D +VK+ADFGLA+ + S WMA E +
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455
+K + +D+WS G + E++TR PY + + G P +
Sbjct: 270 TQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 327
Query: 456 FILKCLQVNPNDRPTAAQLMEH 477
+LKC RP+ ++L+
Sbjct: 328 VMLKCWHPKAEMRPSFSELVSR 349
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 65/270 (24%), Positives = 116/270 (42%), Gaps = 31/270 (11%)
Query: 232 LLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQ------EISLLGQFE 284
++G G++G V L + FA+K ++ K +L+ + E +L +
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILN--------KWEMLKRAETACFREERDVLVNGD 132
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLH 342
I +D+ L + ++ G L +L K+ L + Y +++ + +H
Sbjct: 133 SKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH 192
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTAFWMAPEVVNLK- 398
+ + VHRDIK NIL+D +G ++LADFG + GT +++PE++
Sbjct: 193 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 399 --KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGE----LPPVPNSLSR 451
K YG D WSLG + EML P+ + E + KI + P +S
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHKERFQFPTQVTDVSE 311
Query: 452 DAQDFILKCLQVNPN--DRPTAAQLMEHPF 479
+A+D I + + + + +HPF
Sbjct: 312 NAKDLIRRLICSREHRLGQNGIEDFKKHPF 341
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-37
Identities = 76/280 (27%), Positives = 109/280 (38%), Gaps = 33/280 (11%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEGL------TDDGFFFAVKEVSLQDEGPRGKQSILQLE 274
R+ IT LG G++G VYEG AVK +L + Q L
Sbjct: 70 RKNIT---LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK--TLPEVCSE--QDELDFL 122
Query: 275 QEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLAS--------LYQKYHLSDSQ 326
E ++ +F H NIV+ +G I LEL+ G L S Q L+
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 327 VSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS---VKLADFGLAKATTMNDVKSC 383
+ R I G +YL E + +HRDI N L+ G K+ DFG+A+
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242
Query: 384 KGTAF----WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKI- 437
G A WM PE + D WS G + E+ + PY + + +
Sbjct: 243 GGCAMLPVKWMPPEAFMEGI--FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300
Query: 438 GGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
GG + P P + + +C Q P DRP A ++E
Sbjct: 301 SGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-37
Identities = 68/279 (24%), Positives = 129/279 (46%), Gaps = 46/279 (16%)
Query: 232 LLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQ------EISLLGQFE 284
+LG G +G V+ + G +A K+++ K+ + + + E +L +
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLN--------KKRLKKRKGYQGAMVEKKILAKVH 243
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHL----------SDSQVSSYTRQI 334
IV + LC+ + ++ G + +YH+ + + YT QI
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDI-----RYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 335 LNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTAFWMA 391
++GL++LH++N+++RD+K N+L+D G+V+++D GLA K+ GT +MA
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMA 357
Query: 392 PEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHP-YSHLEGGQA--MF-KIGGGELPPVPN 447
PE+ L + Y + D ++LG T+ EM+ R P + E + + ++ + P+
Sbjct: 358 PEL--LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV-TYPD 414
Query: 448 SLSRDAQDFILKCLQVNPNDR-----PTAAQLMEHPFIK 481
S ++DF LQ +P R + L HP +
Sbjct: 415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-37
Identities = 65/270 (24%), Positives = 114/270 (42%), Gaps = 28/270 (10%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFF------AVKEVSLQDEGPRGKQSILQLEQEISLLGQF 283
LG GS+G VYEG+ A+K ++ + + ++ E S++ +F
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIK--TVNEAASM--RERIEFLNEASVMKEF 85
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLAS-----------LYQKYHLSDSQVSSYTR 332
++V+ LG + + +EL+T+G L S S S++
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 333 QILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---- 388
+I +G+ YL+ VHRD+ N +V +VK+ DFG+ + D G
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 389 WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPN 447
WM+PE + + +D+WS G + E+ T PY L Q + + G L P+
Sbjct: 206 WMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 263
Query: 448 SLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
+ + + C Q NP RP+ +++
Sbjct: 264 NCPDMLFELMRMCWQYNPKMRPSFLEIISS 293
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-37
Identities = 80/294 (27%), Positives = 129/294 (43%), Gaps = 32/294 (10%)
Query: 205 SEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEG 263
E + GN + N R I +++ +LG GS+G V + + G +AVK +
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK----- 57
Query: 264 PRGKQSILQLEQEIS-------LLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSL-AS 315
K ILQ + L H + Q + RL +E V G L
Sbjct: 58 ---KDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFH 114
Query: 316 LYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375
+ + +++ Y +I++ L +LH++ +++RD+K N+L+D G KLADFG+ K
Sbjct: 115 IQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174
Query: 376 TMNDVKS---CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ 432
N V + C GT ++APE+ L++ YG D W++G + EML P+ E
Sbjct: 175 ICNGVTTATFC-GTPDYIAPEI--LQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENED 230
Query: 433 AMF-KIGGGELPPVPNSLSRDAQDFILKCLQVNPNDR----PTAA--QLMEHPF 479
+F I E+ P L DA + + NP R ++ HPF
Sbjct: 231 DLFEAILNDEV-VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-37
Identities = 79/309 (25%), Positives = 131/309 (42%), Gaps = 41/309 (13%)
Query: 194 HDDDDSKGHPISEIMEPGN-NVSPNGKFRRRITSWQKGELLGSGSYGFVYEG-LTDDGFF 251
+ + +P N+ P+ + + + +++G GS+G V + F
Sbjct: 6 QEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVF 65
Query: 252 FAVKEVSLQDEGPRGKQSILQLEQEIS-------LLGQFEHDNIVQYLGTDRDEKRLCIF 304
+AVK LQ K++IL+ ++E LL +H +V + + +L
Sbjct: 66 YAVK--VLQ------KKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117
Query: 305 LELVTKGSLASLYQKYHLSDSQVSS------YTRQILNGLKYLHEQNVVHRDIKCANILV 358
L+ + G L YHL + Y +I + L YLH N+V+RD+K NIL+
Sbjct: 118 LDYINGGELF-----YHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL 172
Query: 359 DASGSVKLADFGLAKATTMNDVKS---CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTV 415
D+ G + L DFGL K ++ + C GT ++APEV L K Y T D W LG +
Sbjct: 173 DSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPEV--LHKQPYDRTVDWWCLGAVL 229
Query: 416 LEMLTRRHPYSHLEGGQAMF-KIGGGELPPVPNSLSRDAQDFILKCLQVNPNDR----PT 470
EML P+ M+ I L + +++ A+ + LQ + R
Sbjct: 230 YEMLYGLPPFYS-RNTAEMYDNILNKPL-QLKPNITNSARHLLEGLLQKDRTKRLGAKDD 287
Query: 471 AAQLMEHPF 479
++ H F
Sbjct: 288 FMEIKSHVF 296
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 74/303 (24%), Positives = 115/303 (37%), Gaps = 61/303 (20%)
Query: 231 ELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLE------QEISLLGQFE 284
+ SGSYG V G+ +G A+K V R + +EI LL F
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 285 HDNIVQYL-----GTDRDEKRLCIFLELVTKGSLASLYQ-----KYHLSDSQVSSYTRQI 334
H NI+ + +L + EL+ L Q + +S + + I
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVIHDQRIVISPQHIQYFMYHI 143
Query: 335 LNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTAFW 389
L GL LHE VVHRD+ NIL+ + + + DF LA+ T + V ++
Sbjct: 144 LLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV----THRWY 199
Query: 390 MAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRR------HPYSHL--------------- 428
APE+V ++ G+ D+WS GC + EM R+ Y+ L
Sbjct: 200 RAPELV-MQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV 258
Query: 429 -----EGGQAMFKIGGGELPPVP-----NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHP 478
+ + +P + A D I K L+ NP R + Q + HP
Sbjct: 259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318
Query: 479 FIK 481
+ +
Sbjct: 319 YFE 321
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-36
Identities = 72/262 (27%), Positives = 121/262 (46%), Gaps = 27/262 (10%)
Query: 232 LLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEIS-------LLGQF 283
+LG GS+G V+ FFA+K + K +L + L +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALK--------KDVVLMDDDVECTMVEKRVLSLAW 75
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYLH 342
EH + T + ++ L +E + G L + + S+ + Y +I+ GL++LH
Sbjct: 76 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTAFWMAPEVVNLKK 399
+ +V+RD+K NIL+D G +K+ADFG+ K + D K+ C GT ++APE+ L
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEI--LLG 192
Query: 400 DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGELPPVPNSLSRDAQDFIL 458
Y + D WS G + EML + P+ H + + +F I P L ++A+D ++
Sbjct: 193 QKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNP-FYPRWLEKEAKDLLV 250
Query: 459 KCLQVNPNDRPTAAQ-LMEHPF 479
K P R + +HP
Sbjct: 251 KLFVREPEKRLGVRGDIRQHPL 272
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 2e-36
Identities = 75/330 (22%), Positives = 124/330 (37%), Gaps = 79/330 (23%)
Query: 221 RRRITSWQK--GELLGSGSYGFVYEGLTDD---GFFFAVKEVSLQDEGPRGKQSILQLEQ 275
R R+ + G +G G+YG VY+ D +A+K++ + G + +
Sbjct: 15 RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTG-ISMSAC----R 67
Query: 276 EISLLGQFEHDNIVQYLG--TDRDEKRLCI---FLE------LVTKGSLASLYQKYHLSD 324
EI+LL + +H N++ ++++ + + E + + + + L
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 325 SQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS----GSVKLADFGLAKATTMNDV 380
V S QIL+G+ YLH V+HRD+K ANILV G VK+AD G A+
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 381 KSCKGTA----FWM-APEVVNLKKDGYGLTADIWSLGCTVLEMLTRR---------HPYS 426
FW APE++ L Y DIW++GC E+LT S
Sbjct: 188 PLADLDPVVVTFWYRAPELL-LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 246
Query: 427 HLEGGQAMFKI-------------GGGELP------------PVPN------------SL 449
+ + +I ++P N
Sbjct: 247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP 306
Query: 450 SRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
A + K L ++P R T+ Q M+ P+
Sbjct: 307 DSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 69/257 (26%), Positives = 110/257 (42%), Gaps = 26/257 (10%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
+ +G G +G V G G AVK ++++ Q+ L E S++ Q H N+V
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVK--CIKNDATA--QAFLA---EASVMTQLRHSNLV 249
Query: 290 QYLG--TDRDEKRLCIFLELVTKGSLASLY----QKYHLSDSQVSSYTRQILNGLKYLHE 343
Q LG ++ L I E + KGSL Y + L + ++ + ++YL
Sbjct: 250 QLLGVIV-EEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKKD 400
N VHRD+ N+LV K++DFGL K + W APE + KK
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKK- 362
Query: 401 GYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILK 459
+ +D+WS G + E+ + R PY + + ++ G P+ D +
Sbjct: 363 -FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKN 421
Query: 460 CLQVNPNDRPTAAQLME 476
C ++ RPT QL E
Sbjct: 422 CWHLDAATRPTFLQLRE 438
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 67/273 (24%), Positives = 111/273 (40%), Gaps = 35/273 (12%)
Query: 232 LLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQ------EISLLGQFE 284
++G G++ V + G +A+K ++ K +L+ + E +L +
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMN--------KWDMLKRGEVSCFREERDVLVNGD 119
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLH 342
I Q +DE L + +E G L +L K+ + Y +I+ + +H
Sbjct: 120 RRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTAFWMAPEVV---- 395
VHRDIK NIL+D G ++LADFG + GT +++PE++
Sbjct: 180 RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVG 239
Query: 396 -NLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGEL----PPVPNSL 449
YG D W+LG EM + P+ + + + KI + P V +
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPF-YADSTAETYGKIVHYKEHLSLPLVDEGV 298
Query: 450 SRDAQDFILKCLQVNPNDR---PTAAQLMEHPF 479
+A+DFI + L P R A HPF
Sbjct: 299 PEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 82/295 (27%), Positives = 127/295 (43%), Gaps = 46/295 (15%)
Query: 225 TSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF 283
++ +GSG+YG V + G A+K++S + + + E+ LL
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR---ELLLLKHM 80
Query: 284 EHDNIVQYLGTDRDEKRLCIFLE--LVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLK 339
+H+N++ L L F + LV L + S+ ++ Q+L GLK
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLK 140
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT--TMND-VKSCKGTAFWMAPEVVN 396
Y+H VVHRD+K N+ V+ +K+ DFGLA+ M V T ++ APEV+
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV----VTRWYRAPEVI- 195
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTRR------HPYSHLE---------GGQAMFKIGGGE 441
L Y T DIWS+GC + EMLT + L G + + K+
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255
Query: 442 -------LPPVP--------NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
LP P S A D + K L+++ + R TAAQ + HPF +
Sbjct: 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-36
Identities = 71/277 (25%), Positives = 118/277 (42%), Gaps = 39/277 (14%)
Query: 232 LLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEIS-------LLGQF 283
++G GSY V L +A+K V K+ + E
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVK--------KELVNDDEDIDWVQTEKHVFEQAS 67
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYLH 342
H +V + E RL +E V G L + ++ L + Y+ +I L YLH
Sbjct: 68 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTAFWMAPEVVNLKK 399
E+ +++RD+K N+L+D+ G +KL D+G+ K + C GT ++APE+ L+
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEI--LRG 184
Query: 400 DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQA--------MF-KIGGGELPPVPNSLS 450
+ YG + D W+LG + EM+ R P+ + +F I ++ +P SLS
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLS 243
Query: 451 RDAQDFILKCLQVNPNDR------PTAAQLMEHPFIK 481
A + L +P +R A + HPF +
Sbjct: 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-36
Identities = 73/301 (24%), Positives = 128/301 (42%), Gaps = 55/301 (18%)
Query: 231 ELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
+ LG G G V+ + D A+K++ L D P+ + L+ EI ++ + +HDNIV
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALR---EIKIIRRLDHDNIV 71
Query: 290 QYL--------GTDRDEKRLCIFLE--LVTK---GSLASLYQKYHLSDSQVSSYTRQILN 336
+ D L +V + LA++ ++ L + + Q+L
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLR 131
Query: 337 GLKYLHEQNVVHRDIKCANILVDASG-SVKLADFGLAKATTMNDVKSCKGTAF----WM- 390
GLKY+H NV+HRD+K AN+ ++ +K+ DFGLA+ + + W
Sbjct: 132 GLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR 191
Query: 391 APEVVNLKKDGYGLTADIWSLGCTVLEMLTRR------HPYSHLE---------GGQAMF 435
+P ++ L + Y D+W+ GC EMLT + H ++ +
Sbjct: 192 SPRLL-LSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQ 250
Query: 436 KIGGG------ELPPVP--------NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
++ P +SR+A DF+ + L +P DR TA + + HP++
Sbjct: 251 ELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS 310
Query: 482 R 482
Sbjct: 311 I 311
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-36
Identities = 68/260 (26%), Positives = 119/260 (45%), Gaps = 23/260 (8%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
+ LG G VY T A+K ++ ++++ + E+E+ Q H NI
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIK--AIFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
V + D ++ + +E + +L+ + LS ++T QIL+G+K+ H+ +V
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIV 133
Query: 348 HRDIKCANILVDASGSVKLADFGLAKA---TTMNDVKSCKGTAFWMAPEVVNLKKDGYGL 404
HRDIK NIL+D++ ++K+ DFG+AKA T++ GT + +PE G
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK----GEAT 189
Query: 405 TA--DIWSLGCTVLEMLTRRHPYSHLEGGQAM---FKIGGGELPPVPN----SLSRDAQD 455
DI+S+G + EML P+ G A+ K +P V + + +
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPF---NGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN 246
Query: 456 FILKCLQVNPNDRPTAAQLM 475
IL+ + + +R Q M
Sbjct: 247 VILRATEKDKANRYKTIQEM 266
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-36
Identities = 63/276 (22%), Positives = 104/276 (37%), Gaps = 34/276 (12%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFF------AVKEVSLQDEGPRGKQSILQLEQEISLLGQF 283
E LG +G VY+G A+K +L+D+ + E L +
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK--TLKDKAE--GPLREEFRHEAMLRARL 69
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLAS-----------------LYQKYHLSDSQ 326
+H N+V LG ++ L + + G L K L
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 327 VSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT 386
QI G++YL +VVH+D+ N+LV +VK++D GL + D G
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 387 AF----WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGE 441
+ WMAPE + K + + +DIWS G + E+ + PY + I +
Sbjct: 190 SLLPIRWMAPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQ 247
Query: 442 LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
+ P P+ +++C P+ RP +
Sbjct: 248 VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 76/325 (23%), Positives = 129/325 (39%), Gaps = 40/325 (12%)
Query: 185 PNNVEYVSYHDDDDSKGHPISEIMEPGN-NVSPNGKFRRRITSWQKGELLGSGSYGFVYE 243
++ + G I E E N S + + ++G GSY V
Sbjct: 11 DYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLL 70
Query: 244 G-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEIS-------LLGQFEHDNIVQYLGTD 295
L +A++ V K+ + E H +V
Sbjct: 71 VRLKKTDRIYAMRVVK--------KELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 122
Query: 296 RDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCA 354
+ E RL +E V G L + ++ L + Y+ +I L YLHE+ +++RD+K
Sbjct: 123 QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 182
Query: 355 NILVDASGSVKLADFGLAKATTMNDVKS---CKGTAFWMAPEVVNLKKDGYGLTADIWSL 411
N+L+D+ G +KL D+G+ K + C GT ++APE+ L+ + YG + D W+L
Sbjct: 183 NVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEI--LRGEDYGFSVDWWAL 239
Query: 412 GCTVLEMLTRRHPYSHLEGGQA--------MF-KIGGGELPPVPNSLSRDAQDFILKCLQ 462
G + EM+ R P+ + +F I ++ +P SLS A + L
Sbjct: 240 GVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKAASVLKSFLN 298
Query: 463 VNPNDR------PTAAQLMEHPFIK 481
+P +R A + HPF +
Sbjct: 299 KDPKERLGCHPQTGFADIQGHPFFR 323
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 74/334 (22%), Positives = 130/334 (38%), Gaps = 97/334 (29%)
Query: 226 SWQKGELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE 284
+ G+ LG+GS+G V E + G FA+K+V LQD PR K +E+ ++ +
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV-LQD--PRYKN------RELDIMKVLD 58
Query: 285 HDNIVQ--------------------------------------YLGTDRDEKRLCIFLE 306
H NI++ + K L + +E
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 307 LVTKGSLASLYQ--------KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILV 358
V +L++ + + +S Y Q+ + ++H + HRDIK N+LV
Sbjct: 119 YVP----DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174
Query: 359 DA-SGSVKLADFGLAKATTMNDVKS---CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCT 414
++ ++KL DFG AK ++ C + F+ APE++ L Y + D+WS+GC
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELM-LGATEYTPSIDLWSIGCV 231
Query: 415 VLEMLTRRHPY----SHLEGGQAMFKIGG----------------GELPP---------V 445
E++ + P + ++ + +I G P +
Sbjct: 232 FGELILGK-PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKIL 290
Query: 446 PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
P A D + + L+ P+ R + M HPF
Sbjct: 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 83/318 (26%), Positives = 140/318 (44%), Gaps = 41/318 (12%)
Query: 185 PNNVEYVSYHDDDDSKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEG 244
+ + D S + E K R + ++ +LLG G++G V
Sbjct: 108 DGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILV 167
Query: 245 -LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQ------EISLLGQFEHDNIVQYLGTDRD 297
G ++A+K + K+ I+ ++ E +L H + + +
Sbjct: 168 KEKATGRYYAMKILK--------KEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT 219
Query: 298 EKRLCIFLELVTKGSLASLYQKYHLSDSQVSS------YTRQILNGLKYLH-EQNVVHRD 350
RLC +E G L +HLS +V S Y +I++ L YLH E+NVV+RD
Sbjct: 220 HDRLCFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 274
Query: 351 IKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTAFWMAPEVVNLKKDGYGLTAD 407
+K N+++D G +K+ DFGL K + C GT ++APEV L+ + YG D
Sbjct: 275 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEV--LEDNDYGRAVD 331
Query: 408 IWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGELPPVPNSLSRDAQDFILKCLQVNPN 466
W LG + EM+ R P+ + + + +F I E+ P +L +A+ + L+ +P
Sbjct: 332 WWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI-RFPRTLGPEAKSLLSGLLKKDPK 389
Query: 467 DR----PT-AAQLMEHPF 479
R A ++M+H F
Sbjct: 390 QRLGGGSEDAKEIMQHRF 407
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 67/269 (24%), Positives = 117/269 (43%), Gaps = 33/269 (12%)
Query: 232 LLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQ--------LEQEISLLGQ 282
+LG GS+G V +AVK + K ++Q +E+ + L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILK--------KDVVIQDDDVECTMVEKRV-LALP 77
Query: 283 FEHDNIVQYLGTDRDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQVSSYTRQILNGLKYL 341
+ + Q + RL +E V G L + Q + Y +I GL +L
Sbjct: 78 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTAFWMAPEVVNLK 398
+ +++RD+K N+++D+ G +K+ADFG+ K + V + C GT ++APE+ +
Sbjct: 138 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEI--IA 194
Query: 399 KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-KIGGGELPPVPNSLSRDAQDFI 457
YG + D W+ G + EML + P+ E +F I + P S+S++A
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNV-AYPKSMSKEAVAIC 252
Query: 458 LKCLQVNPNDR----PTAAQ-LMEHPFIK 481
+ +P R P + + EH F +
Sbjct: 253 KGLMTKHPGKRLGCGPEGERDIKEHAFFR 281
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-35
Identities = 62/286 (21%), Positives = 115/286 (40%), Gaps = 40/286 (13%)
Query: 201 GHPISEI--MEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGLTD---DGFFFAVK 255
G P S + + PG+ V+ + + + G G++Y D +G +K
Sbjct: 63 GSPYSFLPQLNPGDIVAG----QYEV-----KGCIAHGGLGWIYLA-LDRNVNGRPVVLK 112
Query: 256 EVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQ-Y-LGTDRDEKRLCI-FL--ELVTK 310
L G Q++ E++ L + H +IVQ + D + ++ E V
Sbjct: 113 G--LVHSGDAEAQAMAMAERQF--LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGG 168
Query: 311 GSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFG 370
SL + L ++ +Y +IL L YLH +V+ D+K NI++ +KL D G
Sbjct: 169 QSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLG 226
Query: 371 LAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG 430
GT + APE+V + G + DI+++G T+ + +
Sbjct: 227 AVSRIN--SFGYLYGTPGFQAPEIV---RTGPTVATDIYTVGRTLAALTLDLPTRN---- 277
Query: 431 GQAMFKIGGGE-LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLM 475
G+ + + + + +S R + + + +P R T A+ M
Sbjct: 278 GRYVDGLPEDDPVLKTYDSYGR----LLRRAIDPDPRQRFTTAEEM 319
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-35
Identities = 83/288 (28%), Positives = 130/288 (45%), Gaps = 47/288 (16%)
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291
+GSG+YG V T G AVK++S + + + E+ LL +H+N++
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR---ELRLLKHMKHENVIGL 93
Query: 292 LGTDRDEKRLCIFLE--LVTK---GSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNV 346
L + L F + LVT L ++ + L+D V QIL GLKY+H ++
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 153
Query: 347 VHRDIKCANILVDASGSVKLADFGLAKATT--MND-VKSCKGTAFWMAPEVVNLKKDGYG 403
+HRD+K +N+ V+ +K+ DFGLA+ T M V T ++ APE++ L Y
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV----ATRWYRAPEIM-LNWMHYN 208
Query: 404 LTADIWSLGCTVLEMLTRR------HPYSHLE---------GGQAMFKIGGGE------- 441
T DIWS+GC + E+LT R L+ G + + KI
Sbjct: 209 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 268
Query: 442 LPPVP--------NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
L +P + A D + K L ++ + R TAAQ + H +
Sbjct: 269 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 63/266 (23%), Positives = 105/266 (39%), Gaps = 37/266 (13%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
L+G G G VYE T A+K + + ++++E G+ + ++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALK--LMSETLSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
V + +L + + L+ LA+ L ++ L+ + + RQI + L H
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGAT 156
Query: 348 HRDIKCANILVDASGSVKLADFGLAKA---TTMNDVKSCKGTAFWMAPEVVNLKKDGYGL 404
HRD+K NILV A L DFG+A A + + + GT ++MAPE
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF----SESHA 212
Query: 405 TA--DIWSLGCTVLEMLTRRHPYS---------HLEGGQAMFKIGGGELPPVPNSLSRD- 452
T DI++L C + E LT PY H+ + P P+++
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN-----------QAIPRPSTVRPGI 261
Query: 453 ---AQDFILKCLQVNPNDRPTAAQLM 475
I + + NP DR +
Sbjct: 262 PVAFDAVIARGMAKNPEDRYVTCGDL 287
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 72/288 (25%), Positives = 126/288 (43%), Gaps = 47/288 (16%)
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291
+GSG+YG V + G A+K++ + + + E+ LL H+N++
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR---ELRLLKHMRHENVIGL 89
Query: 292 LGTDRDEKRLCIFLE--LVTK---GSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNV 346
L ++ L F + LV L L + L + ++ Q+L GL+Y+H +
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGI 149
Query: 347 VHRDIKCANILVDASGSVKLADFGLAK--ATTMND-VKSCKGTAFWMAPEVVNLKKDGYG 403
+HRD+K N+ V+ +K+ DFGLA+ + M V T ++ APEV+ L Y
Sbjct: 150 IHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV----VTRWYRAPEVI-LNWMRYT 204
Query: 404 LTADIWSLGCTVLEMLTRR------HPYSHLE---------GGQAMFKIGGGE------- 441
T DIWS+GC + EM+T + L+ + + ++ E
Sbjct: 205 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 264
Query: 442 LPPVP--------NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
LP + + S A + + K L ++ R TA + + HP+ +
Sbjct: 265 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 69/302 (22%), Positives = 125/302 (41%), Gaps = 52/302 (17%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+Q + +GSG+ G V A+K++S + + + E+ L+ H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR---ELVLMKCVNH 83
Query: 286 DNIVQYLGTDRDEKRLCIFLE--LVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYL 341
NI+ L +K L F + +V + A+L Q + L ++S Q+L G+K+L
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 143
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC-KGTAFWMAPEVVNLKKD 400
H ++HRD+K +NI+V + ++K+ DFGLA+ + + + T ++ APEV +
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV--ILGM 201
Query: 401 GYGLTADIWSLGCTVLEMLTRR------HPYSHLE---------GGQAMFKIGGG----- 440
GY DIWS+GC + EM+ + M K+
Sbjct: 202 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 261
Query: 441 -ELPPVP--------------------NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
P + A+D + K L ++ + R + + ++HP+
Sbjct: 262 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321
Query: 480 IK 481
I
Sbjct: 322 IN 323
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-34
Identities = 79/277 (28%), Positives = 124/277 (44%), Gaps = 58/277 (20%)
Query: 232 LLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291
L+G G +G VY+G+ DG A+K + P Q I + E EI L H ++V
Sbjct: 46 LIGHGVFGKVYKGVLRDGAKVALKRRT-----PESSQGIEEFETEIETLSFCRHPHLVSL 100
Query: 292 LG--TDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSY-----TR-QIL----NGLK 339
+G +R+E + I+ + + G+L HL S + + R +I GL
Sbjct: 101 IGFCDERNE-MILIY-KYMENGNLKR-----HLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-------VKSCKGTAFWMAP 392
YLH + ++HRD+K NIL+D + K+ DFG++K T D V KGT ++ P
Sbjct: 154 YLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV---KGTLGYIDP 210
Query: 393 EVVNLKKDGYGLT--ADIWSLGCTVLEMLTRRHPYSH-LEGGQ------AMFKIGGGELP 443
E + LT +D++S G + E+L R L A+ G+L
Sbjct: 211 EYFIKGR----LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266
Query: 444 PV----------PNSLSRDAQDFILKCLQVNPNDRPT 470
+ P SL + D +KCL ++ DRP+
Sbjct: 267 QIVDPNLADKIRPESLRK-FGDTAVKCLALSSEDRPS 302
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-34
Identities = 69/317 (21%), Positives = 126/317 (39%), Gaps = 33/317 (10%)
Query: 185 PNNVEYVSYHDDDDSKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEG 244
++ +K + + R ++T + +LG GS+G V
Sbjct: 301 ELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLS 360
Query: 245 -LTDDGFFFAVKEVSLQDEGPRGKQSILQ--------LEQEISLLGQFEHDNIVQYLGTD 295
+AVK + K ++Q +E+ + L + + Q
Sbjct: 361 ERKGTDELYAVKILK--------KDVVIQDDDVECTMVEKRV-LALPGKPPFLTQLHSCF 411
Query: 296 RDEKRLCIFLELVTKGSL-ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCA 354
+ RL +E V G L + Q + Y +I GL +L + +++RD+K
Sbjct: 412 QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD 471
Query: 355 NILVDASGSVKLADFGLAKATTMNDVKS---CKGTAFWMAPEVVNLKKDGYGLTADIWSL 411
N+++D+ G +K+ADFG+ K + V + C GT ++APE+ + YG + D W+
Sbjct: 472 NVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEI--IAYQPYGKSVDWWAF 528
Query: 412 GCTVLEMLTRRHPYSHLEGGQAMF-KIGGGELPPVPNSLSRDAQDFILKCLQVNPNDR-- 468
G + EML + P+ E +F I + P S+S++A + +P R
Sbjct: 529 GVLLYEMLAGQAPF-EGEDEDELFQSIMEHNV-AYPKSMSKEAVAICKGLMTKHPGKRLG 586
Query: 469 ---PTAAQLMEHPFIKR 482
+ EH F +
Sbjct: 587 CGPEGERDIKEHAFFRY 603
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 73/300 (24%), Positives = 123/300 (41%), Gaps = 55/300 (18%)
Query: 231 ELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
LLG G+YG V G A+K++ D+ +++ +EI +L F+H+NI+
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKHENII 72
Query: 290 QYL-----GTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQ 344
+ + + I EL+ L + LSD + + Q L +K LH
Sbjct: 73 TIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTAFWM----------AP 392
NV+HRD+K +N+L++++ +K+ DFGLA+ + + + G M AP
Sbjct: 132 NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAP 191
Query: 393 EVVNLKKDGYGLTADIWSLGCTVLEMLTRR------HPYSHLE---------GGQAMFKI 437
EV+ L Y D+WS GC + E+ RR L +
Sbjct: 192 EVM-LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC 250
Query: 438 GGGE--------LPPVP--------NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
LP P ++ D + + L +P R TA + +EHP+++
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 41/217 (18%)
Query: 285 HDNIVQ-Y-LGTDRDEKRLCIFL--ELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLK 339
H IV Y G ++ E V +L ++ + ++ + L
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA-----TTMNDVKSCKGTAFWMAPEV 394
+ H+ ++HRD+K ANI++ A+ +VK+ DFG+A+A ++ + GTA +++PE
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 395 VNLKKDGYGLTA--DIWSLGCTVLEMLTRRHPYS----------HLEGGQAMFKIGGGEL 442
G + A D++SLGC + E+LT P++ H+ E
Sbjct: 191 AR----GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-----------ED 235
Query: 443 PPVPNS----LSRDAQDFILKCLQVNPNDRPTAAQLM 475
P P++ LS D +LK L NP +R A M
Sbjct: 236 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 65/284 (22%), Positives = 114/284 (40%), Gaps = 42/284 (14%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFF------AVKEVSLQDEGPRGKQSILQLEQEISLLGQF 283
+G G++G V++ + AVK L++E ++E +L+ +F
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK--MLKEEAS--ADMQADFQREAALMAEF 107
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSL-------------------------ASLYQ 318
++ NIV+ LG K +C+ E + G L S
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 319 KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378
LS ++ RQ+ G+ YL E+ VHRD+ N LV + VK+ADFGL++
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 379 DVKSCKGTAF----WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQA 433
D G WM PE + + Y +D+W+ G + E+ + PY + +
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285
Query: 434 MFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
++ + G + P + + + + C P DRP+ +
Sbjct: 286 IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 79/290 (27%), Positives = 132/290 (45%), Gaps = 47/290 (16%)
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291
+G G+YG V + A+K++S + ++++ +EI +L +F H+NI+
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 292 L-----GTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNV 346
T K + I +L+ L L + HLS+ + + QIL GLKY+H NV
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 347 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF----WM-APEVVNLKKDG 401
+HRD+K +N+L++ + +K+ DFGLA+ + + T + W APE++ L G
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKG 208
Query: 402 YGLTADIWSLGCTVLEMLTRR------HPYSHLE---------GGQAMFKIGGGE----- 441
Y + DIWS+GC + EML+ R H L + + I +
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268
Query: 442 --LPPVP--------NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
LP + A D + K L NP+ R Q + HP+++
Sbjct: 269 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-33
Identities = 67/296 (22%), Positives = 115/296 (38%), Gaps = 51/296 (17%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEGLTDDGFFF------AVK---EVSLQDEGPRGKQSIL 271
R+ + G+ LG G +G V + AVK E + E +
Sbjct: 22 RKNLV---LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-------LR 71
Query: 272 QLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSL------------------ 313
L E ++L Q H ++++ G + L + +E GSL
Sbjct: 72 DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 314 -------ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKL 366
+ L+ + S+ QI G++YL E +VHRD+ NILV +K+
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKI 191
Query: 367 ADFGLAKATTMNDV-KSCKGTAF---WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR- 421
+DFGL++ D WMA E + Y +D+WS G + E++T
Sbjct: 192 SDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLG 249
Query: 422 RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
+PY + + + G P++ S + +L+C + P+ RP A + +
Sbjct: 250 GNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 72/293 (24%), Positives = 119/293 (40%), Gaps = 50/293 (17%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEG----LTDDGFFFAV-----KEVSLQDEGPRGKQSIL 271
R R+ G+ LG G++G V E + V KE + E
Sbjct: 26 RDRLK---LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-------HR 75
Query: 272 QLEQEISLLGQF-EHDNIVQYLG--TDRDEKRLCIFLELVTKGSL--------------- 313
L E+ +L H N+V LG T L + +E G+L
Sbjct: 76 ALMSELKILIHIGHHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 314 --ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGL 371
K L+ + Y+ Q+ G+++L + +HRD+ NIL+ VK+ DFGL
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 194
Query: 372 AKATTMNDVKSCKGTAF----WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYS 426
A+ + KG A WMAPE + + Y + +D+WS G + E+ + PY
Sbjct: 195 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYP 252
Query: 427 HLEGGQAMFK--IGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
++ + + G + P+ + + +L C P+ RPT ++L+EH
Sbjct: 253 GVKIDEEFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 67/282 (23%), Positives = 115/282 (40%), Gaps = 43/282 (15%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFF--------AVK---EVSLQDEGPRGKQSILQLEQEIS 278
G+ LG G++G V AVK + + + + + L E+
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-------LSDLVSEME 92
Query: 279 LLGQF-EHDNIVQYLGTDRDEKRLCIFLELVTKGSL-----------------ASLYQKY 320
++ +H NI+ LG + L + +E +KG+L + +
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 321 HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV 380
++ + S T Q+ G++YL Q +HRD+ N+LV + +K+ADFGLA+ D
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 212
Query: 381 -KSCKGTAF---WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMF 435
K WMAPE + + Y +D+WS G + E+ T PY + +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 436 KIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
+ G P + + + + C P+ RPT QL+E
Sbjct: 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 77/381 (20%), Positives = 134/381 (35%), Gaps = 116/381 (30%)
Query: 209 EPGNNVSPNGKFRRRITSW------QKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQD 261
+ ++ P R + W + L+G+GSYG V E + A+K++
Sbjct: 31 KQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF 90
Query: 262 EGPRGKQSILQLEQEISLLGQFEHDNIVQYL-----GTDRDEKRLCIFLELVTKGSLASL 316
E + IL+ EI++L + HD++V+ L L + LE+ +
Sbjct: 91 EDLIDCKRILR---EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD----SDF 143
Query: 317 YQ----KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLA 372
+ +L++ + + +L G+KY+H ++HRD+K AN LV+ SVK+ DFGLA
Sbjct: 144 KKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA 203
Query: 373 KATTMNDVKSCKGTAFWM-----------------------------APEVVNLKKDGYG 403
+ + + + APE++ L ++ Y
Sbjct: 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI-LLQENYT 262
Query: 404 LTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSL------------- 449
D+WS+GC E+L + ++ +F G P P+
Sbjct: 263 EAIDVWSIGCIFAELLNMIKENVAYHADRGPLFP-GSSCFPLSPDQKAGNDFKFHTRGNR 321
Query: 450 ----------------------SRDAQDFIL--------------------------KCL 461
DA+ +I + L
Sbjct: 322 DQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRML 381
Query: 462 QVNPNDRPTAAQLMEHPFIKR 482
NPN R T + + HPF K
Sbjct: 382 VFNPNKRITINECLAHPFFKE 402
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 69/291 (23%), Positives = 118/291 (40%), Gaps = 46/291 (15%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEGLTDDGFFF--------AVK---EVSLQDEGPRGKQS 269
R ++T G+ LG G +G V AVK + + + +
Sbjct: 80 RDKLT---LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD------- 129
Query: 270 ILQLEQEISLLGQF-EHDNIVQYLGTDRDEKRLCIFLELVTKGSL--------------- 313
+ L E+ ++ +H NI+ LG + L + +E +KG+L
Sbjct: 130 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 189
Query: 314 --ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGL 371
+ + ++ + S T Q+ G++YL Q +HRD+ N+LV + +K+ADFGL
Sbjct: 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 249
Query: 372 AKATTMNDV-KSCKGTAF---WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYS 426
A+ D K WMAPE + + Y +D+WS G + E+ T PY
Sbjct: 250 ARDINNIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYP 307
Query: 427 HLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
+ + + G P + + + + C P+ RPT QL+E
Sbjct: 308 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 75/345 (21%), Positives = 128/345 (37%), Gaps = 59/345 (17%)
Query: 178 VRRRQDCPNNVEYVSYHDDDDSKGHPISEIMEPGNNVSPNGKF-----------RRRITS 226
Y +H D P +E + ++ ++ R R+
Sbjct: 16 TTENLYFNGMGYYHHHHHHDYDI--PTTENLYFQGMLAGVSEYELPEDPRWELPRDRLV- 72
Query: 227 WQKGELLGSGSYGFVYEGLTDDGFFF--------AVK---EVSLQDEGPRGKQSILQLEQ 275
G+ LG G++G V AVK + + + + L
Sbjct: 73 --LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-------LSDLIS 123
Query: 276 EISLLGQF-EHDNIVQYLGTDRDEKRLCIFLELVTKGSL-----------------ASLY 317
E+ ++ +H NI+ LG + L + +E +KG+L S
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 318 QKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377
+ LS + S Q+ G++YL + +HRD+ N+LV +K+ADFGLA+
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 243
Query: 378 NDV-KSCKGTAF---WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQ 432
D K WMAPE + + Y +D+WS G + E+ T PY + +
Sbjct: 244 IDYYKKTTNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301
Query: 433 AMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
+ G P++ + + + C P+ RPT QL+E
Sbjct: 302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-32
Identities = 73/285 (25%), Positives = 127/285 (44%), Gaps = 52/285 (18%)
Query: 220 FRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISL 279
F R G +G G +G VY+G ++ AVK+++ + ++ Q +QEI +
Sbjct: 27 FDER-PISVGGNKMGEGGFGVVYKGYVNNTTV-AVKKLAAMVD-ITTEELKQQFDQEIKV 83
Query: 280 LGQFEHDNIVQYLG--TDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSS----YTRQ 333
+ + +H+N+V+ LG +D D+ ++ + GSL LS + + R
Sbjct: 84 MAKCQHENLVELLGFSSDGDD-LCLVY-VYMPNGSLLD-----RLSCLDGTPPLSWHMRC 136
Query: 334 -----ILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-------VK 381
NG+ +LHE + +HRDIK ANIL+D + + K++DFGLA+A+ +
Sbjct: 137 KIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRI- 195
Query: 382 SCKGTAFWMAPEVVNLKKDGYGLT--ADIWSLGCTVLEMLTRRHPYSHLEGGQAM----- 434
GT +MAPE + G +T +DI+S G +LE++T Q +
Sbjct: 196 --VGTTAYMAPEALR----GE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 248
Query: 435 -FKIGGGEL-----PPVPNSLSRDAQDFI---LKCLQVNPNDRPT 470
+ + + ++ S + +CL N RP
Sbjct: 249 EIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD 293
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-31
Identities = 71/300 (23%), Positives = 121/300 (40%), Gaps = 60/300 (20%)
Query: 233 LGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291
+GSG+ G V A+K++S + + + E+ L+ H NI+
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR---ELVLMKCVNHKNIISL 126
Query: 292 LGTDRDEKRLCIFLE--LVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
L +K L F + LV + A+L Q + L ++S Q+L G+K+LH ++
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGII 186
Query: 348 HRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTAFWMAPEVVNLKKDGY 402
HRD+K +NI+V + ++K+ DFGLA+ + V T ++ APEV + GY
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV----VTRYYRAPEV--ILGMGY 240
Query: 403 GLTADIWSLGCTVLEMLTRR------HPYSHLE---------GGQAMFKIGGG------E 441
DIWS+GC + EM+ + + M K+
Sbjct: 241 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 300
Query: 442 LPPVP--------------------NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
P + A+D + K L ++P R + ++HP+I
Sbjct: 301 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 64/286 (22%), Positives = 114/286 (39%), Gaps = 44/286 (15%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEG-LTDDGFFFAV-----KEVSLQDEGPRGKQSILQLE 274
I +++G G++G V + + DG KE + +D+
Sbjct: 24 WNDIK---FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-------HRDFA 73
Query: 275 QEISLLGQF-EHDNIVQYLGTDRDEKRLCIFLELVTKGSL-----------------ASL 316
E+ +L + H NI+ LG L + +E G+L +
Sbjct: 74 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133
Query: 317 YQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376
LS Q+ + + G+ YL ++ +HRD+ NILV + K+ADFGL++
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG-- 191
Query: 377 MNDV-KSCKGTAF---WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGG 431
+V WMA E +N Y +D+WS G + E+++ PY +
Sbjct: 192 -QEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 248
Query: 432 QAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
+ K+ G P + + D + +C + P +RP+ AQ++
Sbjct: 249 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 65/290 (22%), Positives = 104/290 (35%), Gaps = 43/290 (14%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEGLTDDGFFF------AVKEVSLQDEGPRGKQSILQLE 274
R R++ G+ LG+G++G V E AVK + L
Sbjct: 22 RNRLS---FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSA-HLTEREALM 74
Query: 275 QEISLLGQF-EHDNIVQYLGTDRDEKRLCIFLELVTKGSL-------------------A 314
E+ +L H NIV LG + E G L
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 315 SLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 374
+ L + S++ Q+ G+ +L +N +HRD+ NIL+ K+ DFGLA+
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 375 TTMNDV-KSCKGTAF---WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLE 429
+ WMAPE + Y +D+WS G + E+ + PY +
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 430 GGQAMFK--IGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
+K G + P + D + C +P RPT Q+++
Sbjct: 253 VDSKFYKMIKEGFRMLS-PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 71/325 (21%), Positives = 127/325 (39%), Gaps = 80/325 (24%)
Query: 231 ELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNI 288
+ LG G+YG V++ + G AVK++ + Q + EI +L + H+NI
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR---EIMILTELSGHENI 71
Query: 289 VQYLGTDRDE--KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNV 346
V L R + + + + + + + L ++ + L Q++ +KYLH +
Sbjct: 72 VNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGL 130
Query: 347 VHRDIKCANILVDASGSVKLADFGLA-------------KATTMNDVKSCKGTAFWM--- 390
+HRD+K +NIL++A VK+ADFGL+ + + ++ +
Sbjct: 131 LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDY 190
Query: 391 -------APEVVNLKKDGYGLTADIWSLGCTVLEMLTRR--------------------- 422
APE++ L Y D+WSLGC + E+L +
Sbjct: 191 VATRWYRAPEIL-LGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDF 249
Query: 423 --------------------------HPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDF 456
S+ +K ++ P + + +A D
Sbjct: 250 PSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC-NEEALDL 308
Query: 457 ILKCLQVNPNDRPTAAQLMEHPFIK 481
+ K LQ NPN R +A ++HPF+
Sbjct: 309 LDKLLQFNPNKRISANDALKHPFVS 333
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 3e-30
Identities = 72/345 (20%), Positives = 122/345 (35%), Gaps = 102/345 (29%)
Query: 231 ELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
L+G GSYG+VY + A+K+V+ E + IL+ EI++L + + D I+
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR---EITILNRLKSDYII 88
Query: 290 QYLGTDRDEKRLC-----IFLELVTKGSLASLYQ----KYHLSDSQVSSYTRQILNGLKY 340
+ + L I LE+ + L + L++ + + +L G +
Sbjct: 89 RLYDLIIPDDLLKFDELYIVLEIAD----SDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWM---------- 390
+HE ++HRD+K AN L++ SVK+ DFGLA+ +
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 391 --------------APEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMF 435
APE++ L ++ Y + DIWS GC E+L + + +F
Sbjct: 205 KKQLTSHVVTRWYRAPELI-LLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263
Query: 436 KIGGGELPPVPNSL--------------------------------SRDAQDFIL----- 458
G P P+ + +I
Sbjct: 264 P-GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHR 322
Query: 459 ---------------------KCLQVNPNDRPTAAQLMEHPFIKR 482
L+ NPN R T Q ++HP++K
Sbjct: 323 KPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 64/309 (20%), Positives = 111/309 (35%), Gaps = 56/309 (18%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEG----LTDDGFFFAV-----KEVSLQDEGPRGKQSIL 271
R + G++LGSG++G V ++ G V KE + E
Sbjct: 44 RENLE---FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE-------RE 93
Query: 272 QLEQEISLLGQF-EHDNIVQYLGTDRDEKRLCIFLELVTKGSL----------------- 313
L E+ ++ Q H+NIV LG + + E G L
Sbjct: 94 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 153
Query: 314 -------ASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKL 366
L+ + + Q+ G+++L ++ VHRD+ N+LV VK+
Sbjct: 154 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKI 213
Query: 367 ADFGLAKATTMNDV-KSCKGTAF---WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR- 421
DFGLA+ + WMAPE + Y + +D+WS G + E+ +
Sbjct: 214 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI--YTIKSDVWSYGILLWEIFSLG 271
Query: 422 RHPYSHLEGGQAMFK--IGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479
+PY + +K G ++ P + + + C + RP+ L
Sbjct: 272 VNPYPGIPVDANFYKLIQNGFKMDQ-PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF-- 328
Query: 480 IKRPLQTSS 488
+ L +
Sbjct: 329 LGCQLADAE 337
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 67/291 (23%), Positives = 111/291 (38%), Gaps = 49/291 (16%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEGLTDDGFFF------AVK---EVSLQDEGPRGKQSIL 271
R + G+ LG+G++G V E AVK + DE
Sbjct: 45 RNNLQ---FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE-------KE 94
Query: 272 QLEQEISLLGQF-EHDNIVQYLGTDRDEKRLCIFLELVTKGSL---------------AS 315
L E+ ++ +H+NIV LG + + E G L A
Sbjct: 95 ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAF 154
Query: 316 LYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375
S + ++ Q+ G+ +L +N +HRD+ N+L+ K+ DFGLA+
Sbjct: 155 AIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 376 TMNDVKSCKGTAF----WMAPEVVNLKKDGYGLTADIWSLGCTVL--EMLTR-RHPYSHL 428
+ KG A WMAPE + Y + +D+WS G +L E+ + +PY +
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDCV--YTVQSDVWSYG--ILLWEIFSLGLNPYPGI 270
Query: 429 EGGQAMFK--IGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
+K G ++ P ++ + C + P RPT Q+
Sbjct: 271 LVNSKFYKLVKDGYQMAQ-PAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 32/255 (12%), Positives = 60/255 (23%), Gaps = 39/255 (15%)
Query: 230 GELLGSGSYGFVYEGLTDD--GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
G ++ D A+ V Q P + L + +
Sbjct: 36 LIFHGGVPPLQFWQA-LDTALDRQVALTFVDPQGVLPDDVLQ--ETLSRTLRLSRIDKPG 92
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
+ + L + E + GSL + S + + H V
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-SPSPVGAIRAMQSLAAAADAAHRAGVA 151
Query: 348 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTAD 407
+ + V G V LA P+ D
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYPATMPDAN---------------PQ------------DD 184
Query: 408 IWSLGCTVLEMLTRRHPY---SHLEGGQAMFKIGGGELPP---VPNSLSRDAQDFILKCL 461
I +G ++ +L R P G + G+ + + + +
Sbjct: 185 IRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSV 244
Query: 462 QVNPNDRPTAAQLME 476
Q + R + L
Sbjct: 245 QGDGGIRSASTLLNL 259
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-28
Identities = 71/341 (20%), Positives = 120/341 (35%), Gaps = 105/341 (30%)
Query: 231 ELLGSGSYGFVYEGL-TDDGFFFAVK--------------EVSL---------QDEGPRG 266
LG G + V+ + A+K E+ L E G
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 267 KQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH---LS 323
IL+L L F H + + + E++ +L +L +KY +
Sbjct: 85 ANHILKL------LDHFNHKG--------PNGVHVVMVFEVL-GENLLALIKKYEHRGIP 129
Query: 324 DSQVSSYTRQILNGLKYLH-EQNVVHRDIKCANILVDAS------GSVKLADFGLA---K 373
V ++Q+L GL Y+H ++H DIK N+L++ +K+AD G A
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189
Query: 374 ATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRH---------- 423
N +++ + +PEV+ L +G ADIWS C + E++T
Sbjct: 190 EHYTNSIQTR----EYRSPEVL-LGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243
Query: 424 -----------------PYSHLEGGQ----------AMFKIGGGELPPVPNSLSRDAQ-- 454
P L G+ + I + P+ + L+ +
Sbjct: 244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS 303
Query: 455 --------DFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTS 487
DF+ LQ++P R A L+ HP++K L
Sbjct: 304 KDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 344
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 82/391 (20%), Positives = 142/391 (36%), Gaps = 108/391 (27%)
Query: 169 NYIVTEAAKVRRRQDCPNNVEYVSYHDDDDSKGHPISEIMEPGNNVSPNGKFRRRITSWQ 228
++ A K + PNN Y DD +G + P ++V+ +R +
Sbjct: 59 YFLGLNAKKRQGMTGGPNNGGY------DDDQGSYV---QVPHDHVA----YRYEVL--- 102
Query: 229 KGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSIL-QLEQEISLLGQF-EH 285
+++G GS+G V + A+K V R ++ Q +EI +L +
Sbjct: 103 --KVIGKGSFGQVVKAYDHKVHQHVALKMV-------RNEKRFHRQAAEEIRILEHLRKQ 153
Query: 286 D-----NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQ-----KYH-LSDSQVSSYTRQI 334
D N++ L +C+ EL++ +LY+ K+ S V + I
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSM----NLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 335 LNGLKYLHEQNVVHRDIKCANILV--DASGSVKLADFGLAKATTMNDVKSCKGTAFWMAP 392
L L LH+ ++H D+K NIL+ +K+ DFG + V + + F+ AP
Sbjct: 210 LQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-QRVYTYIQSRFYRAP 268
Query: 393 EVV-NLKKDGYGLTADIWSLGCTV---------------LEML----------------- 419
EV+ YG+ D+WSLGC + + L
Sbjct: 269 EVILGA---RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325
Query: 420 -TRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQ------------------------ 454
R + +G + V + R +
Sbjct: 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLF 385
Query: 455 -DFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484
DF+ +CL+ +P R T Q + HP+++R L
Sbjct: 386 LDFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 75/293 (25%), Positives = 116/293 (39%), Gaps = 79/293 (26%)
Query: 232 LLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291
+LG G +G VY+G DG AVK L++E +G + Q + E+ ++ H N+++
Sbjct: 37 ILGRGGFGKVYKGRLADGTLVAVK--RLKEERTQGGEL--QFQTEVEMISMAVHRNLLRL 92
Query: 292 LG--TDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSY-----TRQ-----ILNGLK 339
G E RL ++ + GS+AS L + S RQ GL
Sbjct: 93 RGFCMTPTE-RLLVY-PYMANGSVAS-----CLRERPESQPPLDWPKRQRIALGSARGLA 145
Query: 340 YLHEQ---NVVHRDIKCANILVDASGSVKLADFGLAKATTMND------VKSCKGTAFWM 390
YLH+ ++HRD+K ANIL+D + DFGLAK D V +GT +
Sbjct: 146 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV---RGTIGHI 202
Query: 391 APEVVNLKKDGYGLT------ADIWSLGCTVLEMLTRRHP--YSHLEGGQA--------- 433
APE Y T D++ G +LE++T + + L
Sbjct: 203 APE--------YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 434 MFKIG----------GGELPPVPNSLSRDAQDFI---LKCLQVNPNDRPTAAQ 473
+ K G + + I L C Q +P +RP ++
Sbjct: 255 LLKEKKLEALVDVDLQGNYKD------EEVEQLIQVALLCTQSSPMERPKMSE 301
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 48/177 (27%), Positives = 85/177 (48%), Gaps = 12/177 (6%)
Query: 319 KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378
K L+ + Y+ Q+ G+++L + +HRD+ NIL+ VK+ DFGLA+ +
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 379 DVKSCKGTAF----WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQA 433
KG A WMAPE + Y + +D+WS G + E+ + PY ++ +
Sbjct: 247 PDYVRKGDARLPLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304
Query: 434 MFK--IGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
+ G + P+ + + +L C P+ RPT ++L+EH + LQ ++
Sbjct: 305 FCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 358
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 31/161 (19%), Positives = 58/161 (36%), Gaps = 13/161 (8%)
Query: 230 GELLGSGSYGFVYE----GLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-E 284
G+ LG G++G V E G+ V L++ L E+ +L
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGH 84
Query: 285 HDNIVQYLG--TDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLH 342
H N+V LG T L + +E G+L++ + + + G Y+
Sbjct: 85 HLNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYV- 142
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC 383
+ D+K + +S S + F K+ + + +
Sbjct: 143 --GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 72/379 (18%), Positives = 125/379 (32%), Gaps = 129/379 (34%)
Query: 196 DDDSKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEG--LTDDGFFFA 253
+DD +GH + G+ + R I LG G++G V E A
Sbjct: 2 EDDKEGH---LVCRIGDWLQE----RYEIV-----GNLGEGTFGKVVECLDHARGKSQVA 49
Query: 254 VK--------------EVS----LQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD 295
+K E++ ++++ K + + F
Sbjct: 50 LKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLM------SDWFNFHG-------- 95
Query: 296 RDEKRLCIFLELVTKGSLASLYQ-----KYH-LSDSQVSSYTRQILNGLKYLHEQNVVHR 349
+CI EL+ K + ++ + V Q+ + L++LHE + H
Sbjct: 96 ----HMCIAFELLGK----NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHT 147
Query: 350 DIKCANILVDASG-------------------SVKLADFGLAKATTMND-VKSCKGTAFW 389
D+K NIL S S+++ADFG AT ++ + T +
Sbjct: 148 DLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHEHHTTIVATRHY 205
Query: 390 MAPEVV-NLKKDGYGLTADIWSLGCTVLEMLT----------RRH-----------PYSH 427
PEV+ L G+ D+WS+GC + E R H P
Sbjct: 206 RPPEVILEL---GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHM 262
Query: 428 LEGGQA--MFKIGGGELP--------------PVPNSLSRDAQ------DFILKCLQVNP 465
+ + F GG P+ + + +D+ D + + L+ +P
Sbjct: 263 IHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322
Query: 466 NDRPTAAQLMEHPFIKRPL 484
R T A+ + HPF
Sbjct: 323 AQRITLAEALLHPFFAGLT 341
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 8e-23
Identities = 71/343 (20%), Positives = 110/343 (32%), Gaps = 117/343 (34%)
Query: 231 ELLGSGSYGFVYEG--LTDDGFFFAVK--------------EVS----LQDEGPRGKQSI 270
+ LG G++G V E G AVK E+ L P
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 271 LQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQ-----KYH-LSD 324
+Q+ L FEH +CI EL+ S Y +
Sbjct: 80 VQM------LEWFEHHG------------HICIVFELLGL----STYDFIKENGFLPFRL 117
Query: 325 SQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG-------------------SVK 365
+ QI + +LH + H D+K NIL S +K
Sbjct: 118 DHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177
Query: 366 LADFGLAKATTMNDVKSC-KGTAFWMAPEVV-NLKKDGYGLTADIWSLGCTVLEMLT--- 420
+ DFG AT ++ S T + APEV+ L G+ D+WS+GC ++E
Sbjct: 178 VVDFG--SATYDDEHHSTLVSTRHYRAPEVILAL---GWSQPCDVWSIGCILIEYYLGFT 232
Query: 421 -------RRH-----------PYSHLEGGQA--MFKIGGGELPPVPNS------------ 448
+ H P ++ + F + ++
Sbjct: 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK 292
Query: 449 ---LSRDAQ-----DFILKCLQVNPNDRPTAAQLMEHPFIKRP 483
LS+D + D I K L+ +P R T + ++HPF
Sbjct: 293 EFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 77/373 (20%), Positives = 130/373 (34%), Gaps = 113/373 (30%)
Query: 194 HDDDDSKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFF 252
DD H + G ++ + +G G++G V D+ ++
Sbjct: 16 FQGDDEIVH---FSWKKGMLLNN----AFLVI-----RKMGDGTFGRVLLCQHIDNKKYY 63
Query: 253 AVKEVSLQDEGPRGKQSIL-QLEQEISLLGQF-EHD----NIVQYLGTDRDEKRLCIFLE 306
AVK V R + + E +L + D NIV+Y G +C+ E
Sbjct: 64 AVKVV-------RNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE 116
Query: 307 LVTKGSLASLYQ-----KYH-LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA 360
+ SLY+ Y+ + Y +IL L YL + ++ H D+K NIL+D
Sbjct: 117 PLGP----SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172
Query: 361 SG-------------------------SVKLADFGLAKATTMNDVKSC-KGTAFWMAPEV 394
+KL DFG AT +D T + APEV
Sbjct: 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG--CATFKSDYHGSIINTRQYRAPEV 230
Query: 395 V-NLKKDGYGLTADIWSLGCTVLEMLT--------------------------------- 420
+ NL G+ +++D+WS GC + E+ T
Sbjct: 231 ILNL---GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEAT 287
Query: 421 RRHPYSHLEGGQAMFKI-----GGGELPPVPNSLS-------RDAQDFILKCLQVNPNDR 468
+ + ++ + + V L DF+ LQ++P R
Sbjct: 288 KTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLR 347
Query: 469 PTAAQLMEHPFIK 481
P+ A+L++H F++
Sbjct: 348 PSPAELLKHKFLE 360
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 58/270 (21%), Positives = 101/270 (37%), Gaps = 64/270 (23%)
Query: 178 VRRRQDCPNNVEYVSYHDDDDSKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGS 237
Y +DDD+ I + E + R I S +G GS
Sbjct: 21 QSMSSHKKERKVYNDGYDDDN--YDYIVKNGEKWMD-------RYEIDSL-----IGKGS 66
Query: 238 YGFVYEGL-TDDGFFFAVK--------------EVS----LQDEGPRGKQSILQLEQEIS 278
+G V + + + A+K EV + K I+ L
Sbjct: 67 FGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHL----- 121
Query: 279 LLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQIL 335
F N LC+ E+++ +L L + + +S + + +Q+
Sbjct: 122 -KRHFMFRN------------HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 336 NGLKYLH--EQNVVHRDIKCANILV--DASGSVKLADFGLAKATTMNDVKSCKGTAFWMA 391
L +L E +++H D+K NIL+ ++K+ DFG + + + F+ +
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRIYQYIQSRFYRS 226
Query: 392 PEVV-NLKKDGYGLTADIWSLGCTVLEMLT 420
PEV+ + Y L D+WSLGC ++EM T
Sbjct: 227 PEVLLGM---PYDLAIDMWSLGCILVEMHT 253
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 9/28 (32%), Positives = 14/28 (50%)
Query: 455 DFILKCLQVNPNDRPTAAQLMEHPFIKR 482
D IL+ L +P R ++H F K+
Sbjct: 351 DLILRMLDYDPKTRIQPYYALQHSFFKK 378
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 58/304 (19%), Positives = 92/304 (30%), Gaps = 110/304 (36%)
Query: 277 ISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQ 333
+ LL F+ + +C+ E V L K + L V +Q
Sbjct: 104 VQLLDDFKISG--------VNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 334 ILNGLKYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK-------- 384
+L GL YLH + ++H DIK NIL+ + A +
Sbjct: 155 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 385 --------------------------GTAFWM--------------APEVVNLKKDGYGL 404
G A W+ + EV+ + GY
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVL-IGS-GYNT 272
Query: 405 TADIWSLGCTVLEMLTRRHPYSHLEGGQA---------MFKIGG---------------- 439
ADIWS C E+ T + + G + + ++ G
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332
Query: 440 ----GEL----PPVPNSLS-----------RDAQ---DFILKCLQVNPNDRPTAAQLMEH 477
G+L P L +A DF+L L++ P R TAA+ + H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392
Query: 478 PFIK 481
P++
Sbjct: 393 PWLN 396
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 8e-14
Identities = 53/240 (22%), Positives = 96/240 (40%), Gaps = 45/240 (18%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++ G +G GS+G ++EG + A+K + + P QL E
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-------QLRDEYRTYKLLAG 64
Query: 286 -DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLH 342
I ++ + ++L+ SL L S V+ +Q+L ++ +H
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 343 EQNVVHRDIKCANILVDASGS-----VKLADFGLAK----ATT-----MNDVKSCKGTAF 388
E+++V+RDIK N L+ S + + DFG+ K T + K+ GTA
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 389 WMAPEVVNL-------KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG---QAMFKIG 438
+M+ +N ++D D+ +LG + L P+ L+ Q +IG
Sbjct: 184 YMS---INTHLGREQSRRD------DLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 234
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 33/233 (14%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++ G +GSGS+G +Y G G A+K ++ + P QL E + +
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQG 63
Query: 286 -DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLH 342
I + + +EL+ SL L+ S V Q+++ ++Y+H
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 343 EQNVVHRDIKCANILV---DASGSVKLADFGLAKATTMN---------DVKSCKGTAFWM 390
+N +HRD+K N L+ V + DFGLAK + K+ GTA +
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 391 APEVVNLKKDGYGLT--ADIWSLGCTVLEMLTRRHPYSHLEGG---QAMFKIG 438
+ +N G + D+ SLG ++ P+ L+ Q +I
Sbjct: 183 S---INTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 51/266 (19%), Positives = 86/266 (32%), Gaps = 43/266 (16%)
Query: 227 WQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286
W+ G +G G +G +Y + + P L E+ +
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG---PLFTELKFYQRAAKP 93
Query: 287 NIVQYLGTDRDEKRLCI-----FLELVTKG-------------SLASLYQK--YHLSDSQ 326
+Q R K L + G L +Y+ S
Sbjct: 94 EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKT 153
Query: 327 VSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS--VKLADFGLAK---------AT 375
V + +IL+ L+Y+HE VH DIK +N+L++ V L D+GLA A
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY 213
Query: 376 TMNDVKSCKGTAFWMAPEVVNLKKDGYGLT--ADIWSLGCTVLEMLTRRHPYSHLEGG-- 431
+ + GT + + ++ G + D+ LG +++ LT P+
Sbjct: 214 AADPKRCHDGTIEFTS---IDAHN-GVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269
Query: 432 -QAMFKIGGGELPPVPNSLSRDAQDF 456
KI E A +
Sbjct: 270 YVRDSKIRYRENIASLMDKCFPAANA 295
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 57/238 (23%), Positives = 97/238 (40%), Gaps = 43/238 (18%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE- 284
++ G +GSGS+G +Y G A+K +++ + P QL E + +
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-------QLLYESKIYRILQG 61
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSLASL--YQKYHLSDSQVSSYTRQILNGLKYLH 342
I + + ++L+ SL L + LS V Q++N ++++H
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 343 EQNVVHRDIKCANILVDASGS---VKLADFGLAKATTMN---------DVKSCKGTAFWM 390
++ +HRDIK N L+ V + DFGLAK + K+ GTA +
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 391 APEVVNL-------KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG---QAMFKIG 438
+ VN ++D D+ SLG ++ L P+ L+ G Q KI
Sbjct: 181 S---VNTHLGIEQSRRD------DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 45/240 (18%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++ G+ +G G++G + G + A+K ++ P QL E Q
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-------QLHLEYRFYKQLGS 63
Query: 286 -DNIVQYLGTDRDEKRLCIFLELVTKGSLASL--YQKYHLSDSQVSSYTRQILNGLKYLH 342
D I Q K + LEL+ SL L S V Q+++ ++Y+H
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 343 EQNVVHRDIKCANILVDASGS-----VKLADFGLAK----ATT-----MNDVKSCKGTAF 388
+N+++RD+K N L+ G+ + + DF LAK T + KS GTA
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTAR 182
Query: 389 WMAPEVVNL-------KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG---QAMFKIG 438
+M+ +N ++D D+ +LG + L P+ L+ + KIG
Sbjct: 183 YMS---INTHLGKEQSRRD------DLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 51/243 (20%), Positives = 87/243 (35%), Gaps = 43/243 (17%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
W G+ +GSG +G +Y T+ A V ++ + L E+ +
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVE---YQENG---PLFSELKFYQRVAK 92
Query: 286 DNIVQYLGTDRDEKRLCI-----FLELVTKG-------------SLASLYQKY-HLSDSQ 326
+ ++ + L I KG L + + S
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKST 152
Query: 327 VSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS--VKLADFGLAK---------AT 375
V ++L+ L+Y+HE VH DIK AN+L+ V LAD+GL+
Sbjct: 153 VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212
Query: 376 TMNDVKSCKGTAFWMAPEVVNLKKDGYGLT--ADIWSLGCTVLEMLTRRHPYSHLEGGQA 433
N K GT + + ++ K G L+ +D+ LG +L L + P+
Sbjct: 213 QENPRKGHNGTIEFTS---LDAHK-GVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268
Query: 434 MFK 436
+
Sbjct: 269 AVQ 271
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 35/168 (20%), Positives = 59/168 (35%), Gaps = 23/168 (13%)
Query: 227 WQKGELLGSGSYGFVYEGL----TDDGFFFAVKEVSLQDEGPRGKQ-----------SIL 271
W+ + G +YE ++ SL+ + G+ L
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 272 QLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF-LELVTKGSLASLYQKYH---LSDSQV 327
Q+ + L I +G + + L + + SL S LS+ V
Sbjct: 104 QVNKWKKLYST-PLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSV 161
Query: 328 SSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS--VKLADFGLAK 373
++L+ L++LHE VH ++ NI VD V LA +G A
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 3e-11
Identities = 28/191 (14%), Positives = 52/191 (27%), Gaps = 44/191 (23%)
Query: 227 WQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQS------------ILQLE 274
Q+ E +G G +G V++ D A+K ++++ I +
Sbjct: 22 LQRCEKIGEGVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKEL 80
Query: 275 QEISLLGQFEHDNIVQYLG------------------------------TDRDEKRLCIF 304
+S + + + +L I
Sbjct: 81 SLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIV 140
Query: 305 LELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQ-NVVHRDIKCANILVDASGS 363
LE G + S + S Q+ L HRD+ N+L+ +
Sbjct: 141 LEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSL 200
Query: 364 VKLADFGLAKA 374
KL K+
Sbjct: 201 KKLHYTLNGKS 211
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 2e-07
Identities = 61/431 (14%), Positives = 116/431 (26%), Gaps = 130/431 (30%)
Query: 69 DDDPSSEYLAKAGIFQEFYDDI--EYACKGRYVELLKRKKAVVFPWEESSLSYPVLKATS 126
D + I F D + CK V+ + + +L
Sbjct: 8 DFETGEHQYQYKDILSVFEDAFVDNFDCK--DVQDMPK---------------SILSKEE 50
Query: 127 YG-VYILCHLVFKAFSSVRNIFSNLLL----GVE-FVRHKFQYYMSLCNY-IVTEAAKVR 179
+ + V S +F LL V+ FV + NY + K
Sbjct: 51 IDHIIMSKDAV----SGTLRLFWTLLSKQEEMVQKFVEEVLRI-----NYKFLMSPIKTE 101
Query: 180 RRQDCPNNVEYVSYHDDDDSKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYG 239
+RQ Y+ D + ++ NVS + + + + L
Sbjct: 102 QRQPSMMTRMYIEQRDRLYNDNQVFAKY-----NVSRLQPYLKLRQALLE---LRPAKNV 153
Query: 240 FVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299
+ G+ G GK + + L+ K
Sbjct: 154 LID-GVL--GS---------------GK-TWVALD-------------------VCLSYK 175
Query: 300 RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVD 359
C + + L+ +S +L L Q ++++ D
Sbjct: 176 VQCKMDFKI-----------FWLNLKNCNS-PETVLEML-----QKLLYQIDPNWTSRSD 218
Query: 360 ASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVN--LKKDGYGLTADIWS------- 410
S ++KL ++ +++ + + N L ++ +
Sbjct: 219 HSSNIKL---------RIHSIQA-ELRRLLKSKPYENCLLVLL------NVQNAKAWNAF 262
Query: 411 -LGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRD-AQDFILKCLQVNPNDR 468
L C +L + TR + I L +L+ D + +LK L P D
Sbjct: 263 NLSCKIL-LTTRFKQVTDFLSAATTTHI---SLDHHSMTLTPDEVKSLLLKYLDCRPQDL 318
Query: 469 PTAAQLMEHPF 479
P +P
Sbjct: 319 PREVLTT-NPR 328
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 1e-04
Identities = 67/531 (12%), Positives = 134/531 (25%), Gaps = 190/531 (35%)
Query: 8 FGVAPWIS-GQ--PPEDTLKRWKSAC-NIVNNRRRKFRMVANL---ANQAETRVNTFKIQ 60
F + W++ PE L+ + I N + +N+ + + + ++
Sbjct: 182 FKIF-WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL-LK 239
Query: 61 NKAYKEFYD--DDPSSEYLAKAGIFQEFYDDIEYACKGRYVELLKRKKAVVFPWEESSLS 118
+K Y+ + + A F ++ CK + L R K V
Sbjct: 240 SKPYENCLLVLLNVQNAKAWNA-----F--NLS--CK---ILLTTRFKQVTD-------- 279
Query: 119 YPVLKATSYGVYILCHLVFKAFSS--VRNIFSNLLLGVEFVRHKFQYYMSLCNYIVTEAA 176
L A + L H + V+++ ++ + Q L
Sbjct: 280 --FLSAATTTHISLDHHS-MTLTPDEVKSLLLK------YLDCRPQ---DL--------- 318
Query: 177 KVRRRQDCPNNVEYVSYHDDDDSKGHP-----ISEIMEPGNNVSPNGKFRRRITSWQKGE 231
R+ +P I+E + G +W+
Sbjct: 319 ---PREVL---------------TTNPRRLSIIAESIRDGLA---------TWDNWKH-- 349
Query: 232 LLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD-NIVQ 290
+ LT + E SL P + + L F +I
Sbjct: 350 --------VNCDKLTT------IIESSLNVLEPAEYRKMFDR------LSVFPPSAHI-- 387
Query: 291 YLGTDRDEKRLCIF------------LELVTKGSLASLYQK---YHLSDSQVSSYTRQIL 335
L + + + K SL K + + + L
Sbjct: 388 ------PTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLE--LKVKL 439
Query: 336 NGLKYLHEQNVVHRDIKCANILVDASGSVKLADFG-----LA---KATTMNDVKSCKGTA 387
LH V H +I D+ + + K + + T
Sbjct: 440 ENEYALHRSIVDHYNIPKT---FDSDDLIPPYLDQYFYSHIGHHLKNIEHPE----RMTL 492
Query: 388 F--------WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY-SHLEGGQAMFKIG 438
F ++ ++ D W+ ++L L + Y ++
Sbjct: 493 FRMVFLDFRFLE---QKIRHDSTA-----WNASGSILNTLQQLKFYKPYIC--------- 535
Query: 439 GGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPF---IKRPLQT 486
+ P L DF+ K L+ + ++ L
Sbjct: 536 --DNDPKYERLVNAILDFLPKI----------EENLICSKYTDLLRIALMA 574
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 6e-04
Identities = 34/267 (12%), Positives = 72/267 (26%), Gaps = 84/267 (31%)
Query: 6 ELFGVAPWISGQPPEDTLKRWKSACNI--------------VNNRRRKFRMVANLANQAE 51
L ++ P+D L R ++ V N
Sbjct: 305 SLL--LKYL-DCRPQD-LPR--EVLTTNPRRLSIIAESIRDGLATWDNWKHV-NCDKLTT 357
Query: 52 TRVNTFKIQNKA-YKEFYDDDPSSEYLAKAGIFQE-----------FYDDIEYACKGRYV 99
++ + A Y++ +D L+ +F + D+ + V
Sbjct: 358 IIESSLNVLEPAEYRKMFDR------LS---VFPPSAHIPTILLSLIWFDVIKSDVMVVV 408
Query: 100 ELLKRKKAVVFPWEESSLSYP----VLKAT-------------SYGV------------- 129
L + V +ES++S P LK Y +
Sbjct: 409 NKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPY 468
Query: 130 ---YILCHLVFKAFSSVR----NIFSNLLLGVEFVRHKFQYYMSLCNYIVTEAAKVRRRQ 182
Y H+ + +F + L F+ K ++ + N + + Q
Sbjct: 469 LDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTL---Q 525
Query: 183 DCPNNVEYVSYHDDDDSKGHPISEIME 209
Y+ +D + ++ I++
Sbjct: 526 QLKFYKPYICDNDPKYER--LVNAILD 550
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 7e-04
Identities = 45/379 (11%), Positives = 111/379 (29%), Gaps = 126/379 (33%)
Query: 60 QNKAYKEFYDD--DP---------SSEYLAKAGIFQEF-------YDDIEYACKG---RY 98
Q + ++F ++ +E + + + + Y+D + K R
Sbjct: 75 QEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRL 134
Query: 99 VELLKRKKA----------VVF-------PW--EESSLSYPVLKATSYGVY--------- 130
LK ++A ++ W + LSY V + ++
Sbjct: 135 QPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNS 194
Query: 131 ---------ILCHLVFKAFSSVRNIFSNLLLGVEFVRHKFQYYMSLCNYIVTEAAKVRRR 181
L + + ++S + SN+ L + ++ + + + Y
Sbjct: 195 PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY----------- 243
Query: 182 QDCPN------NVEYVSYHDDDDSKGHPISEIMEPGNNVSPNGKFRRRI--TSWQKG--E 231
N NV+ ++ N +I T+ K +
Sbjct: 244 ---ENCLLVLLNVQN--------------AKAWNAFN-------LSCKILLTTRFKQVTD 279
Query: 232 LLGSGSYGFVY-----EGLTDD---GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF 283
L + + + LT D + QD PR + +S++ +
Sbjct: 280 FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDL-PREVLTTNPR--RLSIIAES 336
Query: 284 EHDNIV-----QYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLS----DSQVSSYTRQI 334
D + +++ D+ + L ++ ++ + LS + + + +
Sbjct: 337 IRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDR--LSVFPPSAHIPTILLSL 394
Query: 335 L-NGLKYLHEQNVVHRDIK 352
+ + VV++ K
Sbjct: 395 IWFDVIKSDVMVVVNKLHK 413
|
| >2l1w_B Vacuolar calcium ATPase BCA1 peptide; calmodulin, calmodulin complex, soybean calmodulin, vacuolar ATPase, metal binding protein; NMR {Glycine max} Length = 26 | Back alignment and structure |
|---|
Score = 35.9 bits (82), Expect = 8e-04
Identities = 13/23 (56%), Positives = 20/23 (86%)
Query: 24 KRWKSACNIVNNRRRKFRMVANL 46
+RW+S+ +IV NR R+FRM++NL
Sbjct: 3 QRWRSSVSIVKNRARRFRMISNL 25
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 488 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 4aqr_D | 57 | Calcium-transporting ATPase 8, plasma membrane-TY; | 99.64 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.07 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.0 | |
| 2l1w_B | 26 | Vacuolar calcium ATPase BCA1 peptide; calmodulin, | 98.99 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.75 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.53 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.41 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.4 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.37 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.21 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.18 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.12 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.8 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.77 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.7 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.62 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.6 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.55 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.45 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.28 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.28 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.23 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.17 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.94 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.85 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.55 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.96 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.34 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.43 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.42 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-59 Score=479.05 Aligned_cols=259 Identities=27% Similarity=0.544 Sum_probs=228.8
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
.+++|++++.||+|+||.||+|.+. +|+.||||++.+... .......+.+|+.+|++++|||||++++++++++.+
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 98 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM---SSKEREESRREVAVLANMKHPNIVQYRESFEENGSL 98 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC---CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence 4689999999999999999999985 799999999986543 334567899999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 302 CIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
|||||||+||+|.+++... .+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999999998643 3789999999999999999999999999999999999999999999999999876543
Q ss_pred C--cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHH
Q 011326 379 D--VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDF 456 (488)
Q Consensus 379 ~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L 456 (488)
. ....+||+.|+|||++ .+..|+.++|||||||+||||++|+.||.+.+..+....+..+..++.+..+|+++.+|
T Consensus 179 ~~~~~~~~GT~~YmAPE~l--~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l 256 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEIC--ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSL 256 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred cccccccCCCccccCHHHH--CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 2 3456799999999998 45679999999999999999999999999999888888888888888888999999999
Q ss_pred HHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 457 ILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 457 i~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
|.+||++||++|||++|+++||||++.+++
T Consensus 257 i~~~L~~dP~~R~s~~e~l~hp~~~~~~~~ 286 (350)
T 4b9d_A 257 VSQLFKRNPRDRPSVNSILEKGFIAKRIEK 286 (350)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSHHHHTTGGG
T ss_pred HHHHccCChhHCcCHHHHhcCHHhhcCCCc
Confidence 999999999999999999999999876553
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-59 Score=468.49 Aligned_cols=256 Identities=25% Similarity=0.443 Sum_probs=228.0
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 300 (488)
...++|++++.||+|+||+||+|.+. +|+.||||++.+... ........+.+|+.+|++++|||||++++++++++.
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 106 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 106 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 45678999999999999999999985 799999999975421 112234678899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC-
Q 011326 301 LCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN- 378 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~- 378 (488)
+|||||||+||+|.+++.+. .+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 99999999999999998765 6999999999999999999999999999999999999999999999999999876432
Q ss_pred ---CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHH
Q 011326 379 ---DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455 (488)
Q Consensus 379 ---~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~ 455 (488)
...+.+||+.|+|||++ .+..|+.++||||+||++|||++|++||.+.+..+....+..... .+|..+++++++
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl--~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~d 263 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-DFPEKFFPKARD 263 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHH--HHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCTTCCHHHHH
T ss_pred CcccccCcccCcccCCHHHH--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCcccCHHHHH
Confidence 23467899999999998 456689999999999999999999999999888888888776654 567889999999
Q ss_pred HHHHhhhhCCCCCCCHHH------HHhCccCCC
Q 011326 456 FILKCLQVNPNDRPTAAQ------LMEHPFIKR 482 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~e------il~hp~f~~ 482 (488)
||.+||++||++|||++| |++||||+.
T Consensus 264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 999999999999999887 689999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-59 Score=473.76 Aligned_cols=255 Identities=31% Similarity=0.512 Sum_probs=227.7
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
..|++.+.||+|+||.||+|.+. +|+.||||++....... ...+.+|+.+|++++|||||++++++.+++.+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS-----GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56999999999999999999986 79999999997654321 2357799999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--Ccc
Q 011326 304 FLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVK 381 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~ 381 (488)
|||||+||+|.+++.+.++++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..... ...
T Consensus 149 vmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 149 VMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp EECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred EEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence 999999999999999889999999999999999999999999999999999999999999999999999876543 345
Q ss_pred cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC--CCCcccHHHHHHHHH
Q 011326 382 SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP--VPNSLSRDAQDFILK 459 (488)
Q Consensus 382 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~Li~~ 459 (488)
+.+||+.|+|||++ ....|+.++|||||||++|||++|++||.+.+..+....+.....+. .+..+|+++++||.+
T Consensus 229 ~~~GTp~YmAPEvl--~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 229 SLVGTPYWMAPELI--SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp CCCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred ccccCcCcCCHHHH--CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 67899999999997 45669999999999999999999999999988887777776544332 345789999999999
Q ss_pred hhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 460 CLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 460 cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
||++||++|||++|+++||||++...+
T Consensus 307 ~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 307 LLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 999999999999999999999986543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-58 Score=455.96 Aligned_cols=258 Identities=28% Similarity=0.437 Sum_probs=210.6
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
.+++|++++.||+|+||+||+|.+. +|+.||+|++.+.... .......+.+|+.+|++++|||||++++++.+++.+
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA--KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 4789999999999999999999985 7999999999865432 223346789999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-
Q 011326 302 CIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND- 379 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~- 379 (488)
|+||||+ +|+|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+......
T Consensus 89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 9999999 5688887754 469999999999999999999999999999999999999999999999999998655433
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILK 459 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~ 459 (488)
..+.+||+.|+|||++. ....++.++||||+||++|+|++|+.||.+.+..+....+..+.. .+|..+|+++++||.+
T Consensus 168 ~~~~~GT~~Y~APE~~~-~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 245 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY-TLPKFLSPGAAGLIKR 245 (275)
T ss_dssp -------CTTSCHHHHS-SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCTTSCHHHHHHHHH
T ss_pred cCCeeECcccCChhhhc-CCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHH
Confidence 45678999999999983 233357899999999999999999999998887777777765553 5678899999999999
Q ss_pred hhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 460 CLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 460 cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
||++||++|||++|+++||||+..+.
T Consensus 246 ~L~~dP~~R~s~~eil~hpw~k~~~p 271 (275)
T 3hyh_A 246 MLIVNPLNRISIHEIMQDDWFKVDLP 271 (275)
T ss_dssp HSCSSGGGSCCHHHHHHCHHHHTTCC
T ss_pred HccCChhHCcCHHHHHcCcccccCCC
Confidence 99999999999999999999987654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-57 Score=451.18 Aligned_cols=250 Identities=29% Similarity=0.528 Sum_probs=215.6
Q ss_pred eeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC----CCce
Q 011326 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD----EKRL 301 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~ 301 (488)
|++.++||+|+||.||+|.+. ++..||+|.+..... .......+.+|+.+|++++|||||++++++.+ ++.+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 367788999999999999985 799999999976542 34455789999999999999999999998864 4568
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCC--CccccCCcccEEECC-CCcEEEeecCCcccccC
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQN--VVHRDIKCANILVDA-SGSVKLADFGLAKATTM 377 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~NILl~~-~~~vkL~DFGla~~~~~ 377 (488)
|||||||+||+|.+++.+. .+++..+..++.||+.||+|||++| |+||||||+|||++. +|.+||+|||+|+....
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999999999765 5999999999999999999999998 999999999999984 89999999999987665
Q ss_pred CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhh-hHHHhcCCCCC-CCCCcccHHHHH
Q 011326 378 NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ-AMFKIGGGELP-PVPNSLSRDAQD 455 (488)
Q Consensus 378 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~-~~~~i~~~~~~-~~~~~~s~~l~~ 455 (488)
....+.+||+.|+|||++. ..|+.++|||||||+||||++|+.||.+.+... ....+..+..+ ..+..+++++.+
T Consensus 185 ~~~~~~~GTp~YmAPE~~~---~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261 (290)
T ss_dssp TSBEESCSSCCCCCGGGGG---TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred CccCCcccCccccCHHHcC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHH
Confidence 5666788999999999873 358999999999999999999999998765544 44444444333 345668899999
Q ss_pred HHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 456 FILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
||.+||++||++|||++|+++||||++
T Consensus 262 li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 262 IIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHccCChhHCcCHHHHhcCccccC
Confidence 999999999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-57 Score=474.04 Aligned_cols=255 Identities=31% Similarity=0.513 Sum_probs=228.2
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
..|++.+.||+|+||.||+|.+. +|+.||||++....... ...+.+|+.+|++++|||||++++++.+++.+||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS-----GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH-----HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence 56999999999999999999985 79999999998654322 2457899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--Ccc
Q 011326 304 FLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVK 381 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~ 381 (488)
|||||+||+|.+++...++++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... ...
T Consensus 226 VmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 305 (423)
T 4fie_A 226 VMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 305 (423)
T ss_dssp EEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred EEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence 999999999999999889999999999999999999999999999999999999999999999999999866443 245
Q ss_pred cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC--CCCCcccHHHHHHHHH
Q 011326 382 SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP--PVPNSLSRDAQDFILK 459 (488)
Q Consensus 382 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~Li~~ 459 (488)
..+||+.|||||++ .+..|+.++|||||||++|||++|+.||.+.+..+....+.....+ ..+..+|+++++||.+
T Consensus 306 ~~~GTp~YmAPEvl--~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 306 SLVGTPYWMAPELI--SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp CCEECTTTCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred ccccCcCcCCHHHH--CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence 67899999999997 4566999999999999999999999999998888777777655433 3345789999999999
Q ss_pred hhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 460 CLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 460 cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
||+.||++|||+.|+++||||++...+
T Consensus 384 ~L~~dP~~R~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 384 LLVRDPAQRATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence 999999999999999999999986543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-58 Score=457.45 Aligned_cols=254 Identities=28% Similarity=0.427 Sum_probs=218.1
Q ss_pred ccCceeeeeeecccCceEEEEEEec----CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD----DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
..++|++++.||+|+||+||+|.+. +++.||+|++.+..... .....+.+|+.+|++++|||||+++++++++
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 98 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV---RDRVRTKMERDILVEVNHPFIVKLHYAFQTE 98 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE---EECC------CCCCCCCCTTEECEEEEEEET
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh---HHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence 3468999999999999999999862 57899999997543211 1123577899999999999999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 299 KRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
+.+|||||||+||+|.+++.+. .+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 9999999999999999998765 599999999999999999999999999999999999999999999999999986533
Q ss_pred C--CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHH
Q 011326 378 N--DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455 (488)
Q Consensus 378 ~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~ 455 (488)
. ...+.+||+.|+|||++ .+..++.++||||+||++|||++|+.||.+.+..+....+..... ..|..+|+++.+
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~--~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~ 255 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVV--NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQS 255 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHH--HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHH
T ss_pred CCccccccccCcccCCHHHh--ccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCcCCHHHHH
Confidence 2 34567899999999997 456789999999999999999999999999888888887776554 567889999999
Q ss_pred HHHHhhhhCCCCCCC-----HHHHHhCccCCC
Q 011326 456 FILKCLQVNPNDRPT-----AAQLMEHPFIKR 482 (488)
Q Consensus 456 Li~~cL~~dP~~Rps-----~~eil~hp~f~~ 482 (488)
||.+||++||++||| ++|+++||||+.
T Consensus 256 li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 256 LLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 999999999999998 589999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-56 Score=450.78 Aligned_cols=256 Identities=30% Similarity=0.465 Sum_probs=222.5
Q ss_pred ccccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
.++...+.|++.+.||+|+||.||+|.+. +|+.||||++..... ..+|+.+|++++|||||++++++.+
T Consensus 52 ~~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----------~~~E~~il~~l~HpnIV~l~~~~~~ 121 (336)
T 4g3f_A 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----------RVEELVACAGLSSPRIVPLYGAVRE 121 (336)
T ss_dssp BCCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----------CTHHHHTTTTCCCTTBCCEEEEEEE
T ss_pred hhhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----------HHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 34556778999999999999999999985 799999999976432 1369999999999999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC-cEEEeecCCcccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG-SVKLADFGLAKAT 375 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~-~vkL~DFGla~~~ 375 (488)
++.+|||||||+||+|.+++.+. .+++..+..++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+..
T Consensus 122 ~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 122 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 201 (336)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred CCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence 99999999999999999999765 599999999999999999999999999999999999999988 6999999999865
Q ss_pred cCCC-------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC--CCC
Q 011326 376 TMND-------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP--PVP 446 (488)
Q Consensus 376 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~ 446 (488)
.... ....+||+.|||||++ .+..++.++|||||||++|||++|++||.+.+..+....+.....+ .++
T Consensus 202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~--~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 279 (336)
T 4g3f_A 202 QPDGLGKSLLTGDYIPGTETHMAPEVV--MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP 279 (336)
T ss_dssp ------------CCCCCCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSC
T ss_pred cCCCcccceecCCccccCccccCHHHH--CCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcC
Confidence 4332 1235799999999998 4567999999999999999999999999988777777666655432 467
Q ss_pred CcccHHHHHHHHHhhhhCCCCCCCHHHH-------------HhCccCCCCCCC
Q 011326 447 NSLSRDAQDFILKCLQVNPNDRPTAAQL-------------MEHPFIKRPLQT 486 (488)
Q Consensus 447 ~~~s~~l~~Li~~cL~~dP~~Rps~~ei-------------l~hp~f~~~~~~ 486 (488)
..+|+++.+||.+||++||.+|||+.|+ ++|||+++..++
T Consensus 280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 7899999999999999999999999998 579999876654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-55 Score=442.28 Aligned_cols=250 Identities=24% Similarity=0.404 Sum_probs=216.8
Q ss_pred ccccCceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecc
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGT 294 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 294 (488)
.....+|.+.++||+|+||.||+|.+. ++..||||++.. ......++|.+|+.+|++++|||||+++++
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-----~~~~~~~~f~~E~~il~~l~HpnIV~l~g~ 111 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-----ASESARQDFQREAELLTMLQHQHIVRFFGV 111 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC-----CSHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc-----CCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 344578999999999999999999863 578999999864 234556789999999999999999999999
Q ss_pred ccCCCceEEEEeeccCCChHHHHhhh----------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEE
Q 011326 295 DRDEKRLCIFLELVTKGSLASLYQKY----------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILV 358 (488)
Q Consensus 295 ~~~~~~~~lV~E~~~~gsL~~~l~~~----------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl 358 (488)
|.+++.++||||||++|+|.+++... .+++.++..++.||+.||.|||+++|+||||||+|||+
T Consensus 112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl 191 (329)
T 4aoj_A 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 191 (329)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence 99999999999999999999998642 48899999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhh
Q 011326 359 DASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQA 433 (488)
Q Consensus 359 ~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~ 433 (488)
+.++.+||+|||+|+.....+ .....||+.|+|||++ ....++.++|||||||+||||+| |+.||.+.+..+.
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~--~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~ 269 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI--LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269 (329)
T ss_dssp ETTTEEEECCCC----------------CCCCGGGCCHHHH--TTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH
T ss_pred CCCCcEEEcccccceeccCCCcceecCcccccccccChhhh--cCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999998654332 2346799999999997 45679999999999999999999 9999999998888
Q ss_pred HHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 434 MFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 434 ~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
...+..+..++.|..+|+++.+|+.+||+.||++|||+.||+++
T Consensus 270 ~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 270 IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 88888888788899999999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-55 Score=439.50 Aligned_cols=250 Identities=25% Similarity=0.452 Sum_probs=220.5
Q ss_pred ccCceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecccc
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR 296 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 296 (488)
..++|.+.+.||+|+||.||+|.+. ++..||||++... .....++|.+|+.+|++++|||||+++++|.
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----SDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 3468999999999999999999863 4788999998642 3445678999999999999999999999999
Q ss_pred CCCceEEEEeeccCCChHHHHhhh--------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC
Q 011326 297 DEKRLCIFLELVTKGSLASLYQKY--------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG 362 (488)
Q Consensus 297 ~~~~~~lV~E~~~~gsL~~~l~~~--------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~ 362 (488)
+++.++||||||++|+|.+++... .+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 999999999999999999999653 489999999999999999999999999999999999999999
Q ss_pred cEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHh
Q 011326 363 SVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKI 437 (488)
Q Consensus 363 ~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i 437 (488)
.+||+|||+|+.....+ .....||+.|+|||++ ....++.++|||||||+||||+| |+.||.+.+..+....+
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~--~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHH--cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999997654332 1234589999999998 45669999999999999999998 99999999998988888
Q ss_pred cCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCC
Q 011326 438 GGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481 (488)
Q Consensus 438 ~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~ 481 (488)
..+..++.|..+|+++.+|+.+||+.||++|||+.||. +|++
T Consensus 244 ~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 244 TQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred HcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 88888888999999999999999999999999999994 4544
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-55 Score=437.13 Aligned_cols=250 Identities=24% Similarity=0.416 Sum_probs=221.5
Q ss_pred cccCceeeeeeecccCceEEEEEEe------cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLT------DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD 295 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 295 (488)
....++++.+.||+|+||.||+|.+ .++..||||++..... ....++|.+|+.++++++|||||+++++|
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~----~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE----GPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC----C-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC----hHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 3467889999999999999999985 2578999999864432 23346799999999999999999999999
Q ss_pred cCCCceEEEEeeccCCChHHHHhh-----------------hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEE
Q 011326 296 RDEKRLCIFLELVTKGSLASLYQK-----------------YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILV 358 (488)
Q Consensus 296 ~~~~~~~lV~E~~~~gsL~~~l~~-----------------~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl 358 (488)
.+++.++||||||++|+|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 999999999999999999999853 248899999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhh
Q 011326 359 DASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQA 433 (488)
Q Consensus 359 ~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~ 433 (488)
+.++++||+|||+|+.....+ .....||+.|+|||++ ....++.++|||||||+||||+| |..||.+.+..+.
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l--~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~ 256 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAI--MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHH--hCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999998654332 3356799999999998 45669999999999999999998 8999999999999
Q ss_pred HHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 434 MFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 434 ~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
...+..+..++.|..+|+++.+|+.+||+.||++|||+.||+++
T Consensus 257 ~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 257 VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99998888888999999999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=434.59 Aligned_cols=256 Identities=26% Similarity=0.477 Sum_probs=212.2
Q ss_pred CCcccccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc
Q 011326 216 PNGKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD 295 (488)
Q Consensus 216 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 295 (488)
....|+...+++++++.||+|+||+||+|.+++ .||||+++... ......+.|.+|+.+|++++|||||++++++
T Consensus 27 ~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~---~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 101 (307)
T 3omv_A 27 SSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVD---PTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101 (307)
T ss_dssp --CCCBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecC---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 345677888899999999999999999998754 59999986543 3345567899999999999999999999998
Q ss_pred cCCCceEEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 296 RDEKRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 296 ~~~~~~~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
.+ +.++||||||++|+|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++++||+|||+|+
T Consensus 102 ~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 180 (307)
T 3omv_A 102 TK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLAT 180 (307)
T ss_dssp CS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCB
T ss_pred EC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCce
Confidence 65 568999999999999999854 359999999999999999999999999999999999999999999999999997
Q ss_pred cccCC----CcccCCCCCcccCchhhccc-cCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHh-cCCCC----C
Q 011326 374 ATTMN----DVKSCKGTAFWMAPEVVNLK-KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKI-GGGEL----P 443 (488)
Q Consensus 374 ~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i-~~~~~----~ 443 (488)
..... ......||+.|||||++... ...++.++|||||||+||||+||+.||.+.+.......+ ..+.. +
T Consensus 181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 260 (307)
T 3omv_A 181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLS 260 (307)
T ss_dssp C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCST
T ss_pred ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcc
Confidence 65432 23456799999999998432 345899999999999999999999999887665444333 33322 2
Q ss_pred CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 444 PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 444 ~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
..+..+|+++.+|+.+||+.||++|||+.||+++
T Consensus 261 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 261 KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 3556799999999999999999999999987543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=434.03 Aligned_cols=251 Identities=25% Similarity=0.442 Sum_probs=203.4
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC---
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK--- 299 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--- 299 (488)
+++|++++.||+|+||+||+|.+. +|+.||||.+.... .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence 568999999999999999999985 79999999997643 3344567899999999999999999999886543
Q ss_pred ---------ceEEEEeeccCCChHHHHhhhc----cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEE
Q 011326 300 ---------RLCIFLELVTKGSLASLYQKYH----LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKL 366 (488)
Q Consensus 300 ---------~~~lV~E~~~~gsL~~~l~~~~----ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL 366 (488)
.+|+|||||++|+|.+++.... .++..+..++.||++||+|||++||+||||||+|||++.+|.+||
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence 3799999999999999997653 334558899999999999999999999999999999999999999
Q ss_pred eecCCcccccCCC--------------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCc-hh
Q 011326 367 ADFGLAKATTMND--------------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE-GG 431 (488)
Q Consensus 367 ~DFGla~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~-~~ 431 (488)
+|||+|+...... ....+||+.|||||++ .+..|+.++|||||||++|||++ ||.... ..
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~--~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~ 234 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI--HGNSYSHKVDIFSLGLILFELLY---PFSTQMERV 234 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHH--TTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHH--cCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH
Confidence 9999997654322 1235799999999997 45679999999999999999996 776532 22
Q ss_pred hhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 432 QAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 432 ~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
.....+.....++.....++++.+||.+||++||.+|||+.|+++||||++.
T Consensus 235 ~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 235 RTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 3444555555555555667888999999999999999999999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=440.77 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=214.7
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC------
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD------ 297 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------ 297 (488)
++|++++.||+|+||+||+|.+. +|+.||||++.... ........+.+|+.+|++++|||||++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF---DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc---cchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 47999999999999999999985 79999999997543 233445678899999999999999999998653
Q ss_pred CCceEEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
.+.+|||||||+ |+|.+++.. .++++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 467899999997 578888855 469999999999999999999999999999999999999999999999999997653
Q ss_pred CC------CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC--------
Q 011326 377 MN------DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL-------- 442 (488)
Q Consensus 377 ~~------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~-------- 442 (488)
.. ...+.+||+.|+|||++ .....++.++||||+||++|||++|++||.+.+..+.+..+.....
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~-~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELM-LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHH-TTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred cCccccccccccceeChHhcCHHHh-cCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 22 23467899999999997 2445679999999999999999999999998877766555432110
Q ss_pred --------------C---C-----CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 443 --------------P---P-----VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 443 --------------~---~-----~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
+ + ....+++++.+||.+||++||.+|||+.|+|+||||++..
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 0 0 1134789999999999999999999999999999998753
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=428.37 Aligned_cols=250 Identities=26% Similarity=0.373 Sum_probs=205.2
Q ss_pred cCceeeeeeecccCceEEEEEEec----CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD----DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDE 298 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 298 (488)
.++|++.+.||+|+||+||+|.++ +++.||+|.+.... ...++.+|+.+|+.+ +||||+++++++.++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-------~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-------HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-------CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-------CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 357999999999999999999863 47889999986432 124677899999988 699999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC-CcEEEeecCCcccccC
Q 011326 299 KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS-GSVKLADFGLAKATTM 377 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~-~~vkL~DFGla~~~~~ 377 (488)
+.+|+||||+++|+|.+++. .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred CEEEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 99999999999999999985 59999999999999999999999999999999999999876 8999999999974432
Q ss_pred C------------------------------CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 011326 378 N------------------------------DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSH 427 (488)
Q Consensus 378 ~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~ 427 (488)
. ...+.+||+.|+|||++. ....++.++||||+||++|||++|+.||..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLT-KCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHT-TCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHc-CCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 1 123457999999999972 344689999999999999999999999954
Q ss_pred Cch-hhhHHHhcC--------------------------------------CC---------------CCCCCCcccHHH
Q 011326 428 LEG-GQAMFKIGG--------------------------------------GE---------------LPPVPNSLSRDA 453 (488)
Q Consensus 428 ~~~-~~~~~~i~~--------------------------------------~~---------------~~~~~~~~s~~l 453 (488)
.++ .+.+..+.. .. .......+|+++
T Consensus 250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a 329 (361)
T 4f9c_A 250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA 329 (361)
T ss_dssp CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence 432 222211100 00 001234578999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 454 QDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
.+||.+||++||.+|||++|+|+||||++.
T Consensus 330 ~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 330 YDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999863
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=456.37 Aligned_cols=258 Identities=27% Similarity=0.403 Sum_probs=221.0
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCC-cchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGP-RGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~-~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 300 (488)
.+++|+++++||+|+||.||+|.+. +|+.||||++.+..... ...........++.+++.++|||||++++++++++.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 3679999999999999999999986 79999999997543111 112223334456778888999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 301 LCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
+|||||||+||+|..++.+. .+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~ 346 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 346 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence 99999999999999998765 59999999999999999999999999999999999999999999999999998877666
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh---hhHHHhcCCCCCCCCCcccHHHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG---QAMFKIGGGELPPVPNSLSRDAQDF 456 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~s~~l~~L 456 (488)
..+.+||+.|+|||++. .+..|+.++|||||||+||||++|.+||.+.+.. +....+.... ..+|..+|+++++|
T Consensus 347 ~~t~~GTp~YmAPEvl~-~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~-~~~p~~~S~~a~dL 424 (689)
T 3v5w_A 347 PHASVGTHGYMAPEVLQ-KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-VELPDSFSPELRSL 424 (689)
T ss_dssp CCSCCSCGGGCCHHHHS-TTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC-CCCCTTSCHHHHHH
T ss_pred CCCccCCcCccCHHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC-CCCCccCCHHHHHH
Confidence 77789999999999983 3456899999999999999999999999764332 2333333333 46778899999999
Q ss_pred HHHhhhhCCCCCCC-----HHHHHhCccCCC
Q 011326 457 ILKCLQVNPNDRPT-----AAQLMEHPFIKR 482 (488)
Q Consensus 457 i~~cL~~dP~~Rps-----~~eil~hp~f~~ 482 (488)
|.+||++||.+|++ ++||++||||+.
T Consensus 425 I~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred HHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 99999999999998 799999999985
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=427.30 Aligned_cols=254 Identities=26% Similarity=0.437 Sum_probs=219.0
Q ss_pred cccccccCceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCC-CCcce
Q 011326 218 GKFRRRITSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH-DNIVQ 290 (488)
Q Consensus 218 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~ 290 (488)
.+|+...++|++++.||+|+||.||+|.+. +++.||||.+.... .....+.+.+|+.+|.+++| ||||+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~----~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----ChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 357778899999999999999999999863 24689999986532 23445679999999999965 89999
Q ss_pred eeccccC-CCceEEEEeeccCCChHHHHhhh-----------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCC
Q 011326 291 YLGTDRD-EKRLCIFLELVTKGSLASLYQKY-----------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIK 352 (488)
Q Consensus 291 l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~-----------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLk 352 (488)
++++|.+ ++.++||||||++|+|.+++... .+++..+..++.||+.||+|||+++|+|||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK 212 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 212 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccC
Confidence 9999865 46799999999999999999642 37899999999999999999999999999999
Q ss_pred cccEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 011326 353 CANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSH 427 (488)
Q Consensus 353 p~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~ 427 (488)
|+|||++.++.+||+|||+|+...... .....||+.|||||++ .+..++.++|||||||+||||+| |+.||.+
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l--~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI--FDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHH--hcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999998654332 2345689999999998 45679999999999999999998 9999988
Q ss_pred Cchh-hhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 428 LEGG-QAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 428 ~~~~-~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.+.. .....+..+..++.|..+++++.+|+.+||+.||++|||+.||++|
T Consensus 291 ~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 291 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 7644 4445566667778889999999999999999999999999999988
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=445.04 Aligned_cols=255 Identities=28% Similarity=0.442 Sum_probs=226.8
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
.+++|++++.||+|+||.||+|.++ +|+.||+|.+... .......+.+|+.+|+.++|||||++++++.+++.+
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 229 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 229 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc-----chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 4678999999999999999999985 7999999999753 233456788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC--CcEEEeecCCcccccC
Q 011326 302 CIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS--GSVKLADFGLAKATTM 377 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~--~~vkL~DFGla~~~~~ 377 (488)
|||||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999999999998853 469999999999999999999999999999999999999854 8999999999987654
Q ss_pred CC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC---CCCCcccHHH
Q 011326 378 ND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP---PVPNSLSRDA 453 (488)
Q Consensus 378 ~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l 453 (488)
.. ....+||+.|+|||++ .+..|+.++|||||||++|||++|..||.+.+..+....+...... ..+..+|+++
T Consensus 310 ~~~~~~~~GT~~y~APEv~--~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 310 KQSVKVTTGTAEFAAPEVA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 387 (573)
T ss_dssp TSEEEEECSSGGGCCHHHH--TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred CCceeeeEECccccCHHHh--CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 43 4566899999999998 4567899999999999999999999999999988888888766543 2235689999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 454 QDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
++||.+||+.||.+|||+.|+++||||+..-
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence 9999999999999999999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=399.83 Aligned_cols=259 Identities=25% Similarity=0.420 Sum_probs=228.2
Q ss_pred ccccCceeeeeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
...+++|++.+.||+|+||.||+|.+ .+|..||+|.+..... .......+.+|+.+++.++||||+++++++.+++
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 87 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL---NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK 87 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 34578999999999999999999998 4899999999976542 3445667889999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 300 RLCIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999999998855 46999999999999999999999999999999999999999999999999999765443
Q ss_pred -CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHH
Q 011326 379 -DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFI 457 (488)
Q Consensus 379 -~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li 457 (488)
......||+.|+|||++. .....+.++||||+|+++|+|++|+.||.+.+..+....+..+.. ..|..+++++.+|+
T Consensus 168 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 245 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLL 245 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHH-TCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHH
T ss_pred CccccccCCcceeCccccc-CCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHH
Confidence 345677999999999983 333346899999999999999999999999888877777766554 56778999999999
Q ss_pred HHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 458 LKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 458 ~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
.+||+.||.+|||++|+++||||+...
T Consensus 246 ~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 246 KRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 999999999999999999999998654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=401.75 Aligned_cols=246 Identities=26% Similarity=0.334 Sum_probs=194.6
Q ss_pred CceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC----c
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK----R 300 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----~ 300 (488)
.+|.+.+.||+|+||.||+|.+ +|+.||||++... ......+..|+..+.+++|||||+++++|.+++ .
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~------~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc------chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 3688999999999999999987 5889999998642 222233456777778899999999999987653 5
Q ss_pred eEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHC--------CCccccCCcccEEECCCCcEEEeecCCc
Q 011326 301 LCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQ--------NVVHRDIKCANILVDASGSVKLADFGLA 372 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~--------giiHrDLkp~NILl~~~~~vkL~DFGla 372 (488)
+|||||||++|+|.++++..+++++.+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+|
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 89999999999999999999999999999999999999999987 9999999999999999999999999999
Q ss_pred ccccCCC------cccCCCCCcccCchhhccc----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCch------------
Q 011326 373 KATTMND------VKSCKGTAFWMAPEVVNLK----KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG------------ 430 (488)
Q Consensus 373 ~~~~~~~------~~~~~gt~~y~aPE~~~~~----~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~------------ 430 (488)
+...... .....||+.|+|||++... ...++.++|||||||+||||+||.+||...+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 7654332 2245799999999998422 11367899999999999999999776532211
Q ss_pred ---hhhHHHhc-CCCCCCCCCc-----ccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 431 ---GQAMFKIG-GGELPPVPNS-----LSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 431 ---~~~~~~i~-~~~~~~~~~~-----~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
......+. ....+.+|.. ++..+.+|+.+||+.||++|||+.||++.
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 11222222 2233444433 34578999999999999999999999863
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=390.16 Aligned_cols=255 Identities=32% Similarity=0.563 Sum_probs=223.1
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
...+|++.+.||+|+||.||+|.+. +|..||+|.+...... ....+.+|+.++++++||||+++++++.+++..
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-----HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence 3567999999999999999999974 7999999999764322 235678999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 302 CIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
++||||+++|+|.+++....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp EEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 999999999999999998889999999999999999999999999999999999999999999999999987654432
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC--CCCCCcccHHHHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL--PPVPNSLSRDAQDFI 457 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~l~~Li 457 (488)
.....||+.|+|||.+ .+..++.++||||||+++|+|++|..||...+.......+..... ...+..+++.+.+||
T Consensus 173 ~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 250 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVV--TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250 (297)
T ss_dssp BCCCCSCGGGCCHHHH--HCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHH
T ss_pred cCCccCCcCccChhhh--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHH
Confidence 3456799999999997 455689999999999999999999999988776665554433222 234667899999999
Q ss_pred HHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 458 LKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 458 ~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
.+||+.||.+|||+.|+++||||+...
T Consensus 251 ~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 251 NRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHccCChhHCcCHHHHhhChhhcccC
Confidence 999999999999999999999998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=394.39 Aligned_cols=255 Identities=28% Similarity=0.475 Sum_probs=223.5
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
.+++|++.+.||+|+||.||+|.+. +|+.||+|.+.+... ........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 80 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEE
Confidence 4679999999999999999999886 799999999975321 0122345678999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC--C
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--N 378 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~--~ 378 (488)
++||||++||+|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... .
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 9999999999999888654 589999999999999999999999999999999999999999999999999975332 2
Q ss_pred CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHH
Q 011326 379 DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFIL 458 (488)
Q Consensus 379 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~ 458 (488)
......||+.|+|||++ .+..++.++|+||||+++|||++|..||...+..+....+..... .++..+++++.+||.
T Consensus 161 ~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~ 237 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLLA 237 (337)
T ss_dssp CBCCCEECGGGCCGGGG--SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHH
T ss_pred cccccccChhhCChhhh--cCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHH
Confidence 34567799999999997 455689999999999999999999999998877777666655443 567789999999999
Q ss_pred HhhhhCCCCCC-----CHHHHHhCccCCC
Q 011326 459 KCLQVNPNDRP-----TAAQLMEHPFIKR 482 (488)
Q Consensus 459 ~cL~~dP~~Rp-----s~~eil~hp~f~~ 482 (488)
+||+.||.+|| ++.|+++||||+.
T Consensus 238 ~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 99999999999 8999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=398.25 Aligned_cols=257 Identities=28% Similarity=0.443 Sum_probs=219.5
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDE 298 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 298 (488)
+..+++|++.+.||+|+||.||+|.+. +|..||+|++.+... ........+.+|..++..+ +||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~--~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh--cchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 345789999999999999999999886 699999999975321 1122345678899999988 799999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 299 KRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
+.+|+||||++||+|..++... .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 9999999999999999988654 699999999999999999999999999999999999999999999999999975432
Q ss_pred C--CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHH
Q 011326 378 N--DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455 (488)
Q Consensus 378 ~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~ 455 (488)
. .....+||+.|+|||++. +..++.++|||||||++|||++|..||...+..+....+..... ..+..+++++.+
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~ 253 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQ--EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLHEDATG 253 (353)
T ss_dssp ---------CCGGGCCHHHHH--HHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHH
T ss_pred CCccccccCCCcCeEChhhcC--CCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHH
Confidence 2 244567999999999973 44589999999999999999999999999888888877776554 567789999999
Q ss_pred HHHHhhhhCCCCCCCH------HHHHhCccCCC
Q 011326 456 FILKCLQVNPNDRPTA------AQLMEHPFIKR 482 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~------~eil~hp~f~~ 482 (488)
||.+||++||.+||++ .|+++||||+.
T Consensus 254 li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 254 ILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp HHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred HHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 9999999999999998 89999999986
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=391.39 Aligned_cols=258 Identities=29% Similarity=0.453 Sum_probs=225.0
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCc-chhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPR-GKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
.++|++++.||+|+||.||+|.+. +|..||+|.+........ .......+.+|+.+|++++||||+++++++.+.+.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 457999999999999999999986 799999999987553221 112346788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC----cEEEeecCCccccc
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG----SVKLADFGLAKATT 376 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~----~vkL~DFGla~~~~ 376 (488)
++||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 9999999999999998654 599999999999999999999999999999999999998777 79999999997665
Q ss_pred CC-CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC---CCCcccHH
Q 011326 377 MN-DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP---VPNSLSRD 452 (488)
Q Consensus 377 ~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~ 452 (488)
.. ......||+.|+|||++ ....++.++||||||+++|+|++|..||.+.+..+....+....... .+..++++
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 248 (361)
T 2yab_A 171 DGVEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248 (361)
T ss_dssp TTCCCCCCCSCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred CCCccccCCCCccEECchHH--cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHH
Confidence 43 24566799999999997 45568999999999999999999999999988888877777655432 22568999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 453 AQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 453 l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 249 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 9999999999999999999999999999853
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=382.66 Aligned_cols=260 Identities=31% Similarity=0.521 Sum_probs=215.2
Q ss_pred ccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 300 (488)
+...++|++.+.||+|+||.||+|.+.+|+.||+|.+..... .......+.+|+.++++++||||+++++++.+++.
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE---DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC---------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc---cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 345789999999999999999999998899999999975432 22334677899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 301 LCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
.++||||+++ +|.+.+... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9999999986 777776543 4999999999999999999999999999999999999999999999999999765432
Q ss_pred --CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC---CCCC----------
Q 011326 379 --DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG---GELP---------- 443 (488)
Q Consensus 379 --~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~---~~~~---------- 443 (488)
......||+.|+|||++. ....++.++||||||+++|+|++|+.||.+....+....+.. ...+
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLM-GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp CC---CCCCCCTTCCHHHHT-TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred cccccCCcccCCcCCHHHhc-CCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 234567899999999973 335689999999999999999999999987766655444321 0000
Q ss_pred ----------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 444 ----------------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 444 ----------------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
.....+++++.+||.+||++||.+|||+.|+++||||++.-.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 012346789999999999999999999999999999997643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=387.18 Aligned_cols=254 Identities=27% Similarity=0.445 Sum_probs=224.0
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
.+++|++.+.||+|+||.||+|.+. +|+.||+|++.+.... .......+.+|..+++.++||||+++++++.+.+.+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 81 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV--RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 81 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence 4678999999999999999999886 7999999999753210 112345678899999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCc
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV 380 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 380 (488)
|+||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... ..
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-~~ 160 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VT 160 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-CB
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC-cc
Confidence 9999999999999998754 589999999999999999999999999999999999999999999999999976543 33
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHh
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~c 460 (488)
....||+.|+|||++ .+..++.++|+||||+++|||++|..||...+..+....+..... ..+..+++++.+||.+|
T Consensus 161 ~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~l 237 (318)
T 1fot_A 161 YTLCGTPDYIAPEVV--STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVKDLLSRL 237 (318)
T ss_dssp CCCCSCTTTCCHHHH--TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHH
T ss_pred ccccCCccccCHhHh--cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHH
Confidence 456799999999997 455689999999999999999999999998887777777665543 56778999999999999
Q ss_pred hhhCCCCCC-----CHHHHHhCccCCC
Q 011326 461 LQVNPNDRP-----TAAQLMEHPFIKR 482 (488)
Q Consensus 461 L~~dP~~Rp-----s~~eil~hp~f~~ 482 (488)
|+.||.+|| +++|+++||||+.
T Consensus 238 L~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 238 ITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred hccCHHHcCCCcCCCHHHHhcCccccC
Confidence 999999999 8999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=382.20 Aligned_cols=260 Identities=29% Similarity=0.510 Sum_probs=214.9
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCc---------------------chhHHHHHHHHHHHH
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPR---------------------GKQSILQLEQEISLL 280 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~---------------------~~~~~~~~~~Ei~iL 280 (488)
.+++|++.+.||+|+||.||+|.+. ++..||+|++........ .......+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 4679999999999999999999885 789999999976542111 011235688999999
Q ss_pred hcCCCCCcceeeccccC--CCceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEE
Q 011326 281 GQFEHDNIVQYLGTDRD--EKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILV 358 (488)
Q Consensus 281 ~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl 358 (488)
++++||||+++++++.+ .+..++||||+++++|.+++....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 99999999999999876 5689999999999999988877789999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCCcccccCCC--cccCCCCCcccCchhhccccCC-CChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHH
Q 011326 359 DASGSVKLADFGLAKATTMND--VKSCKGTAFWMAPEVVNLKKDG-YGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF 435 (488)
Q Consensus 359 ~~~~~vkL~DFGla~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~ 435 (488)
+.++.+||+|||++....... .....||+.|+|||.+...... ++.++||||||+++|+|++|..||...+......
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 250 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS 250 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHH
Confidence 999999999999997655432 3456799999999997432221 4789999999999999999999998876665555
Q ss_pred HhcCCCCC-CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 436 KIGGGELP-PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 436 ~i~~~~~~-~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
.+...... +....+++++.+||.+||+.||.+|||+.|+++||||++
T Consensus 251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 251 KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 54433322 234578999999999999999999999999999999964
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=388.45 Aligned_cols=254 Identities=25% Similarity=0.398 Sum_probs=222.7
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||+|.+. ++..+|+|.+... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC------cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 568999999999999999999986 6899999998642 233456889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC--CCcEEEeecCCcccccCC
Q 011326 303 IFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA--SGSVKLADFGLAKATTMN 378 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~--~~~vkL~DFGla~~~~~~ 378 (488)
+||||+++|+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999999999764 4899999999999999999999999999999999999987 789999999999766543
Q ss_pred C-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCC---CCcccHHHH
Q 011326 379 D-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV---PNSLSRDAQ 454 (488)
Q Consensus 379 ~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~l~ 454 (488)
. .....||+.|+|||++ .+..++.++||||||+++|+|++|..||...+..+....+........ ...+++++.
T Consensus 158 ~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T 1tki_A 158 DNFRLLFTAPEYYAPEVH--QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp CEEEEEESCGGGSCHHHH--TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CccccccCChhhcCcHHh--cCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence 3 3456699999999997 345579999999999999999999999998888777777665554322 246899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
+||.+||+.||.+|||+.|+++||||++..+
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred HHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence 9999999999999999999999999987654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=377.91 Aligned_cols=255 Identities=31% Similarity=0.528 Sum_probs=211.7
Q ss_pred cCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
+++|++.+.||+|+||.||+|.+.+|..||+|.+..... .......+.+|+.++++++||||+++++++.+++..++
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG---GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred CccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc---ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEE
Confidence 468999999999999999999998899999999975432 12223567799999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--C
Q 011326 304 FLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--D 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~ 379 (488)
||||+++ +|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (288)
T 1ob3_A 78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (288)
T ss_dssp EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence 9999987 89888864 46999999999999999999999999999999999999999999999999998765432 2
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC----C--------------
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG----E-------------- 441 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~----~-------------- 441 (488)
.....||+.|+|||++. ....++.++||||||+++|+|++|..||.+.+..+....+... .
T Consensus 157 ~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLM-GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp -----CCCTTCCHHHHT-TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cccccccccccCchhee-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 34557899999999973 3345899999999999999999999999887765544433210 0
Q ss_pred --C--------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 442 --L--------PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 442 --~--------~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
. ......+++++.+||.+||+.||.+|||+.|+++||||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0 01224578999999999999999999999999999999863
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=392.41 Aligned_cols=258 Identities=26% Similarity=0.457 Sum_probs=222.9
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDE 298 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 298 (488)
...+++|++.+.||+|+||.||+|.+. +|+.||+|.+.+.... .......+..|..++..+ +||||+++++++.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~ 90 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 90 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh--hhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence 446789999999999999999999986 7999999999753210 112234567888888876 899999999999999
Q ss_pred CceEEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 299 KRLCIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
+.+|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 999999999999999999875 4699999999999999999999999999999999999999999999999999975432
Q ss_pred --CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHH
Q 011326 378 --NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455 (488)
Q Consensus 378 --~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~ 455 (488)
.......||+.|+|||++ .+..++.++|+||||+++|||++|..||.+.+..+....+.... +..+..+++++.+
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 247 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEIL--LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKD 247 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHH
T ss_pred CCCcccCCCCCcccCChhhh--cCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-CCCCcccCHHHHH
Confidence 234567899999999997 44568999999999999999999999999888877777766544 3567789999999
Q ss_pred HHHHhhhhCCCCCCCHH-HHHhCccCCCC
Q 011326 456 FILKCLQVNPNDRPTAA-QLMEHPFIKRP 483 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~-eil~hp~f~~~ 483 (488)
||.+||+.||.+||++. ++++||||+..
T Consensus 248 li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 248 LLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 99999999999999998 99999999763
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=395.31 Aligned_cols=256 Identities=27% Similarity=0.454 Sum_probs=216.2
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCC
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEK 299 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 299 (488)
..+++|+++++||+|+||.||+|.+. ++..||+|++.+..... ......+.+|..++.++ +||||+++++++.+++
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~--~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND--DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC------CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC--HHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 45789999999999999999999986 68899999998654321 22234567888898876 8999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC-
Q 011326 300 RLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM- 377 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~- 377 (488)
.+++||||+++|+|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 999999999999999888654 699999999999999999999999999999999999999999999999999975322
Q ss_pred -CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCch---------hhhHHHhcCCCCCCCCC
Q 011326 378 -NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG---------GQAMFKIGGGELPPVPN 447 (488)
Q Consensus 378 -~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~---------~~~~~~i~~~~~~~~~~ 447 (488)
......+||+.|+|||++ .+..++.++|||||||++|||++|+.||..... ......+.. ....+|.
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l--~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p~ 283 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEIL--RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPR 283 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH-CCCCCCT
T ss_pred CCccccccCCcccCCchhh--cCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc-cccCCCC
Confidence 234567899999999997 456689999999999999999999999964321 112233333 3346778
Q ss_pred cccHHHHHHHHHhhhhCCCCCCC------HHHHHhCccCCC
Q 011326 448 SLSRDAQDFILKCLQVNPNDRPT------AAQLMEHPFIKR 482 (488)
Q Consensus 448 ~~s~~l~~Li~~cL~~dP~~Rps------~~eil~hp~f~~ 482 (488)
.+++++.+||.+||+.||.+||+ ++|+++||||+.
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 89999999999999999999998 489999999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=383.95 Aligned_cols=259 Identities=24% Similarity=0.425 Sum_probs=216.5
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
..++|++.+.||+|+||.||+|.+. +++.||+|.+..... ......+.+|+.+++.++||||+++++++.+++..
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 80 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc----cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 3578999999999999999999986 799999999975432 12234678999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND- 379 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~- 379 (488)
++||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 9999999999999988755 69999999999999999999999999999999999999999999999999997553322
Q ss_pred ---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhh-HHHh-cCCCCCCCCCcccHHHH
Q 011326 380 ---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQA-MFKI-GGGELPPVPNSLSRDAQ 454 (488)
Q Consensus 380 ---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~-~~~i-~~~~~~~~~~~~s~~l~ 454 (488)
.....||+.|+|||++. ....++.++||||||+++|+|++|..||........ .... ...........+++++.
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHH-CSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred ccccCCCccCcCccCcHHhc-cCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHH
Confidence 34567999999999973 233347899999999999999999999987554322 2222 22222233467899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
+||.+||+.||.+|||+.|+++||||++.+.+
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 271 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKK 271 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred HHHHHHccCChhhCcCHHHHhhChhhcccccc
Confidence 99999999999999999999999999987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=374.16 Aligned_cols=257 Identities=28% Similarity=0.451 Sum_probs=211.1
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
+++|++.+.||+|+||.||+|.+. ++..||+|.+..... .......+.+|+.++++++||||+++++++.+++..+
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS---STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC---cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEE
Confidence 468999999999999999999986 799999999986553 2334467789999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHh-hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--C
Q 011326 303 IFLELVTKGSLASLYQ-KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--D 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~-~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~ 379 (488)
+||||++++.+..+.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 78 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 9999998744444443 346999999999999999999999999999999999999999999999999999765432 2
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCC-CCCchhhhHHHhcC-------------------
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY-SHLEGGQAMFKIGG------------------- 439 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf-~~~~~~~~~~~i~~------------------- 439 (488)
.....||+.|+|||++. ....++.++||||||+++|+|++|..|| .+.+..+....+..
T Consensus 158 ~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLF-GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCSCCSCGGGCCHHHHT-TCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred ccCCccccCCcChHHHc-CCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 34567899999999973 3344799999999999999999988775 44444433333211
Q ss_pred ---------CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 440 ---------GELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 440 ---------~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
.........+++++.+||.+||+.||++|||++|+++||||++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 001112245789999999999999999999999999999998754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=389.47 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=224.9
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
.+++|++.+.||+|+||.||+|.+. +|..||+|++..... ........+.+|+.+++.++||||+++++++.+++.+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh--ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 4678999999999999999999986 799999999975321 1112345788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCc
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV 380 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 380 (488)
|+||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... .
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-~ 195 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-T 195 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-B
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-c
Confidence 9999999999999998764 6999999999999999999999999999999999999999999999999999765433 3
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHh
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~c 460 (488)
....||+.|+|||++ .+..++.++||||||+++|||++|..||...+..+....+..+.. ..+..+++++.+||.+|
T Consensus 196 ~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~l 272 (350)
T 1rdq_E 196 WTLCGTPEALAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNL 272 (350)
T ss_dssp CCCEECGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTCCHHHHHHHHHH
T ss_pred ccccCCccccCHHHh--cCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHH
Confidence 456799999999997 455689999999999999999999999998888777777766543 56778999999999999
Q ss_pred hhhCCCCCCC-----HHHHHhCccCCC
Q 011326 461 LQVNPNDRPT-----AAQLMEHPFIKR 482 (488)
Q Consensus 461 L~~dP~~Rps-----~~eil~hp~f~~ 482 (488)
|+.||.+||+ ++|+++||||+.
T Consensus 273 L~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 273 LQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp SCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred hhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 9999999998 999999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=385.75 Aligned_cols=255 Identities=27% Similarity=0.460 Sum_probs=218.4
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCc
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 300 (488)
.+++|++.+.||+|+||.||+|.+. +++.||+|++.+... ........+.+|..++.++ +||||+++++++.+++.
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV--NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS--CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh--cchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 4678999999999999999999986 689999999986543 2334456788999999987 89999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC--
Q 011326 301 LCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM-- 377 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~-- 377 (488)
+|+||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 99999999999999988654 599999999999999999999999999999999999999999999999999975322
Q ss_pred CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCC---------chhhhHHHhcCCCCCCCCCc
Q 011326 378 NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHL---------EGGQAMFKIGGGELPPVPNS 448 (488)
Q Consensus 378 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~ 448 (488)
.......||+.|+|||++ .+..++.++|+|||||++|||++|+.||... ........+... ...++..
T Consensus 165 ~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p~~ 241 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEIL--RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRS 241 (345)
T ss_dssp CCBCCCCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-CCCCCTT
T ss_pred CcccccCCCccccCcccc--CCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-CCCCCCC
Confidence 234566899999999997 4456899999999999999999999999652 112223333333 3356778
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCH------HHHHhCccCCC
Q 011326 449 LSRDAQDFILKCLQVNPNDRPTA------AQLMEHPFIKR 482 (488)
Q Consensus 449 ~s~~l~~Li~~cL~~dP~~Rps~------~eil~hp~f~~ 482 (488)
++.++.+||.+||+.||.+||++ .|+++||||+.
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 99999999999999999999994 89999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=388.61 Aligned_cols=256 Identities=24% Similarity=0.387 Sum_probs=222.8
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCC
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEK 299 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 299 (488)
..+++|++.+.||+|+||.||+|.+. +|+.||+|++.+.... .......+..|..++..+ +||||+++++++.+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~--~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI--QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH--HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--cchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 45789999999999999999999986 5889999999753210 112345677899999987 7999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC-
Q 011326 300 RLCIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM- 377 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~- 377 (488)
.+|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999999999998875 4699999999999999999999999999999999999999999999999999975432
Q ss_pred -CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHH
Q 011326 378 -NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDF 456 (488)
Q Consensus 378 -~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L 456 (488)
.......||+.|+|||++ .+..++.++|+||||+++|||++|..||.+.+..+....+..... .++..+++++.+|
T Consensus 175 ~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l 251 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEAVAI 251 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHH--TTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHH
T ss_pred CcccccccCCccccChhhh--cCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHH
Confidence 234567799999999997 455689999999999999999999999998888777777765543 5677899999999
Q ss_pred HHHhhhhCCCCCCC-----HHHHHhCccCCC
Q 011326 457 ILKCLQVNPNDRPT-----AAQLMEHPFIKR 482 (488)
Q Consensus 457 i~~cL~~dP~~Rps-----~~eil~hp~f~~ 482 (488)
|.+||+.||.+||+ +.++++||||+.
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 99999999999994 799999999974
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=382.34 Aligned_cols=257 Identities=28% Similarity=0.449 Sum_probs=214.1
Q ss_pred cccCceeeeeeecccCceEEEEEEe----cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLT----DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
...++|++.+.||+|+||.||++.+ .+|..||+|++...... ........+.+|+.+++.++||||+++++++.+
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV-RNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 3467899999999999999999987 47899999999764322 122234567789999999999999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
++..++||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 99999999999999999988754 58999999999999999999999999999999999999999999999999987543
Q ss_pred CC--CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHH
Q 011326 377 MN--DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQ 454 (488)
Q Consensus 377 ~~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~ 454 (488)
.. ......||+.|+|||++ .+..++.++||||||+++|+|++|..||...+..+....+..... ..+..+++++.
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~ 249 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEIL--MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-NLPPYLTQEAR 249 (327)
T ss_dssp ------CTTSSCCTTSCHHHH--TTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCTTSCHHHH
T ss_pred cCCccccccCCCcCccCHhhC--cCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHH
Confidence 22 23456799999999997 445689999999999999999999999998887777766665443 56778999999
Q ss_pred HHHHHhhhhCCCCCC-----CHHHHHhCccCCC
Q 011326 455 DFILKCLQVNPNDRP-----TAAQLMEHPFIKR 482 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rp-----s~~eil~hp~f~~ 482 (488)
+||.+||+.||.+|| ++.|+++||||+.
T Consensus 250 ~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 999999999999999 8999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=375.83 Aligned_cols=260 Identities=27% Similarity=0.480 Sum_probs=221.8
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 300 (488)
..+++|++.+.||+|+||.||+|.+. ++..||+|++..... ........+.+|+.++++++||||+++++++.+.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc--chhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 45789999999999999999999886 688999999864321 112234568899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 301 LCIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
.++||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 9999999999999988865 468999999999999999999999999999999999999999999999999987665555
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILK 459 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~ 459 (488)
.....||+.|+|||.+ .+..++.++||||||+++|+|++|..||...+..+....+..... ..+..+++++.+||.+
T Consensus 164 ~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 240 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 240 (279)
T ss_dssp ----CCCCTTCCHHHH--TTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-CCCTTSCHHHHHHHHH
T ss_pred ccccCCCCCccCHhHh--ccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC-CCCCcCCHHHHHHHHH
Confidence 5667899999999997 455678999999999999999999999998877776666654443 5677899999999999
Q ss_pred hhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 460 CLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 460 cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
||+.||.+|||+.|+++||||+...++
T Consensus 241 ~l~~~p~~Rps~~e~l~h~~~~~~~~~ 267 (279)
T 3fdn_A 241 LLKHNPSQRPMLREVLEHPWITANSSK 267 (279)
T ss_dssp HCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred HhccChhhCCCHHHHhhCccccCCccC
Confidence 999999999999999999999865543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=380.48 Aligned_cols=258 Identities=28% Similarity=0.467 Sum_probs=222.5
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCc-chhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPR-GKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
.++|++.+.||+|+||.||+|.+. +|..||+|.+........ .......+.+|+.++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 357999999999999999999986 799999999987543321 122356788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC----cEEEeecCCccccc
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG----SVKLADFGLAKATT 376 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~----~vkL~DFGla~~~~ 376 (488)
++||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 9999999999999998654 589999999999999999999999999999999999999877 89999999997664
Q ss_pred CC-CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC---CCCcccHH
Q 011326 377 MN-DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP---VPNSLSRD 452 (488)
Q Consensus 377 ~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~ 452 (488)
.. ......||+.|+|||++ ....++.++||||||+++|+|++|..||.+....+....+....... ....++++
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (326)
T 2y0a_A 170 FGNEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247 (326)
T ss_dssp TTSCCCCCCSCTTTCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred CCCccccccCCcCcCCceee--cCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHH
Confidence 33 34456799999999997 45568999999999999999999999998887777666655443321 22468999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 453 AQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 453 l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 248 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 9999999999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=400.19 Aligned_cols=260 Identities=25% Similarity=0.372 Sum_probs=222.6
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
+...++|++.+.||+|+||.||+|.+. ++..||+|++.+.... .......+.+|+.+++.++||||+++++++.+++
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI--KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhh--hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 345678999999999999999999986 6899999999752110 0011124678999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 300 RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
.+|+||||++||+|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999997655443
Q ss_pred ---cccCCCCCcccCchhhccccC--CCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC---CCCCCCcccH
Q 011326 380 ---VKSCKGTAFWMAPEVVNLKKD--GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE---LPPVPNSLSR 451 (488)
Q Consensus 380 ---~~~~~gt~~y~aPE~~~~~~~--~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~s~ 451 (488)
.....||+.|+|||++..... .++.++||||||+++|||++|..||.+.+..+....+.... ..+....+++
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~ 302 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 302 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCH
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccH
Confidence 346779999999999843221 27889999999999999999999999888877777765432 1123347899
Q ss_pred HHHHHHHHhhhhCCCC--CCCHHHHHhCccCCC
Q 011326 452 DAQDFILKCLQVNPND--RPTAAQLMEHPFIKR 482 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~--Rps~~eil~hp~f~~ 482 (488)
++.+||.+||+.+|.+ ||+++||++||||+.
T Consensus 303 ~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 303 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp HHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred HHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 9999999999999988 999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=386.78 Aligned_cols=254 Identities=29% Similarity=0.453 Sum_probs=221.0
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||+|.+. +|..||+|.+..... .......+.+|+.++++++||||+++++++.+++..+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 467999999999999999999886 799999999986543 2344567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC---CcEEEeecCCcccccCC
Q 011326 303 IFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS---GSVKLADFGLAKATTMN 378 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~---~~vkL~DFGla~~~~~~ 378 (488)
+||||+++|+|.+.+... .+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 999999999998887544 58999999999999999999999999999999999999865 45999999999766543
Q ss_pred C-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC---CCCcccHHHH
Q 011326 379 D-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP---VPNSLSRDAQ 454 (488)
Q Consensus 379 ~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~l~ 454 (488)
. .....||+.|+|||++ .+..++.++||||||+++|+|++|..||...+..+....+..+.... ....+++++.
T Consensus 185 ~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 262 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVL--KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 262 (362)
T ss_dssp CSCCCSCSCTTTCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred cccccCCCCccccCHHHH--ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 3 3456799999999997 45568999999999999999999999999888777776665554322 2246899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
+||.+||+.||.+|||+.|+++||||+.
T Consensus 263 ~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 263 SLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 9999999999999999999999999964
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=390.52 Aligned_cols=258 Identities=28% Similarity=0.412 Sum_probs=218.4
Q ss_pred cccCceeeeeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 300 (488)
..+++|++.+.||+|+||.||+|.+ .++..||+|.+...... .......+.+|+.+++.++||||+++++++.+++.
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 83 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK--KSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD 83 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc--chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 4578999999999999999999998 47999999998743210 11123468899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHh-hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 301 LCIFLELVTKGSLASLYQ-KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~-~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
.++||||+ +|+|.+++. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99999999 568877664 4569999999999999999999999999999999999999999999999999997655433
Q ss_pred -cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHH
Q 011326 380 -VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFIL 458 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~ 458 (488)
.....||+.|+|||++. .....+.++||||||+++|+|++|..||......+....+.... ...+..+++++.+||.
T Consensus 163 ~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 240 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVIN-GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV-YVMPDFLSPGAQSLIR 240 (336)
T ss_dssp TTCCCTTSTTTSCGGGSC-CSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSC-CCCCTTSCHHHHHHHH
T ss_pred ccccccCCcCcCCHHHHc-CCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC-CCCcccCCHHHHHHHH
Confidence 45667999999999973 22223789999999999999999999998766555544444333 3567789999999999
Q ss_pred HhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 459 KCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 459 ~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
+||+.||.+|||+.|+++||||+..+
T Consensus 241 ~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 241 RMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp TTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred HHcCCChhHCcCHHHHHhChhhccCC
Confidence 99999999999999999999998654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=388.44 Aligned_cols=256 Identities=29% Similarity=0.454 Sum_probs=214.6
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||+|.+. +|+.||+|++...............+.+|+.+++.++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357999999999999999999885 7999999999653211111123467889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh-----ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCc---EEEeecCCccc
Q 011326 303 IFLELVTKGSLASLYQKY-----HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS---VKLADFGLAKA 374 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-----~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~---vkL~DFGla~~ 374 (488)
+||||+++++|.+.+... .+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999998877543 3899999999999999999999999999999999999986654 99999999976
Q ss_pred ccCCC--cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCC---CCcc
Q 011326 375 TTMND--VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV---PNSL 449 (488)
Q Consensus 375 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~ 449 (488)
..... .....||+.|+|||++ ....++.++||||||+++|+|++|..||.+.. .+....+..+..... ...+
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~ 259 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVV--KREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHI 259 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTS
T ss_pred ecCCCeeecCCcCCcCccCHHHH--cCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccC
Confidence 65433 3356799999999997 44568999999999999999999999998754 334444443333222 2468
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
++++.+||.+||+.||.+|||+.|+++||||++
T Consensus 260 s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 999999999999999999999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=385.11 Aligned_cols=267 Identities=27% Similarity=0.449 Sum_probs=221.7
Q ss_pred cccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 220 FRRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 220 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
.....++|++.+.||+|+||.||+|.+. ++..||+|++...............+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3445678999999999999999999885 789999999975432112234456889999999999999999999999999
Q ss_pred CceEEEEeeccCCChHHHHhh-----------------------------------------hccChhhhhHHHHHHHHH
Q 011326 299 KRLCIFLELVTKGSLASLYQK-----------------------------------------YHLSDSQVSSYTRQILNG 337 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~-----------------------------------------~~ls~~~~~~i~~qi~~a 337 (488)
+..++||||+++|+|.+++.. ..+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999998851 124677889999999999
Q ss_pred HHHHHHCCCccccCCcccEEECCCC--cEEEeecCCcccccCCC------cccCCCCCcccCchhhccccCCCChhhhHH
Q 011326 338 LKYLHEQNVVHRDIKCANILVDASG--SVKLADFGLAKATTMND------VKSCKGTAFWMAPEVVNLKKDGYGLTADIW 409 (488)
Q Consensus 338 L~yLH~~giiHrDLkp~NILl~~~~--~vkL~DFGla~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~s~k~Dvw 409 (488)
|.|||++||+||||||+|||++.++ .+||+|||++....... .....||+.|+|||.+......++.++|||
T Consensus 181 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 9999999999999999999998776 89999999997543221 245679999999999854456789999999
Q ss_pred HHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCC---CCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 410 SLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV---PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 410 SlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
|||+++|+|++|+.||.+.+..+....+........ ...+++++.+||.+||+.||.+|||+.|+++||||++...+
T Consensus 261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDK 340 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred HHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChHh
Confidence 999999999999999998887777666654443222 23479999999999999999999999999999999886654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=378.09 Aligned_cols=252 Identities=32% Similarity=0.537 Sum_probs=220.9
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
.|...+.||+|+||.||+|.+. +|..||||++..... .....+.+|+.++++++||||+++++++...+..++|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-----hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 3777889999999999999986 799999999975432 2235678999999999999999999999999999999
Q ss_pred EeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--Cccc
Q 011326 305 LELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKS 382 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~~ 382 (488)
|||+++++|.+++....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 121 ~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 200 (321)
T 2c30_A 121 MEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 200 (321)
T ss_dssp ECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999998765433 2345
Q ss_pred CCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC--CCCcccHHHHHHHHHh
Q 011326 383 CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP--VPNSLSRDAQDFILKC 460 (488)
Q Consensus 383 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~Li~~c 460 (488)
..||+.|+|||++ ....++.++||||||+++|+|++|+.||...+..+....+.....+. .+..+++++.+|+.+|
T Consensus 201 ~~gt~~y~aPE~~--~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 278 (321)
T 2c30_A 201 LVGTPYWMAPEVI--SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278 (321)
T ss_dssp CCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred ccCCccccCHhhh--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence 6799999999997 45568999999999999999999999998877766666555443332 2346899999999999
Q ss_pred hhhCCCCCCCHHHHHhCccCCCCC
Q 011326 461 LQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 461 L~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
|+.||++|||+.|+++||||++.-
T Consensus 279 l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 279 LVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp SCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred ccCChhhCcCHHHHhcChhhccCC
Confidence 999999999999999999997653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=395.08 Aligned_cols=254 Identities=29% Similarity=0.441 Sum_probs=220.3
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||+|.+. +|..+|+|.+..... .......+.+|+.++++++||||+++++++.+++..+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL---SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC---HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 467999999999999999999885 799999999986542 3344567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEEC---CCCcEEEeecCCcccccCC
Q 011326 303 IFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVD---ASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~---~~~~vkL~DFGla~~~~~~ 378 (488)
+||||+++|+|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 99999999999887754 4599999999999999999999999999999999999998 4678999999999765543
Q ss_pred C--cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC---CCCCcccHHH
Q 011326 379 D--VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP---PVPNSLSRDA 453 (488)
Q Consensus 379 ~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l 453 (488)
. .....||+.|+|||++ .+..++.++||||+|+++|+|++|..||.+.+..+....+..+... +....+++++
T Consensus 167 ~~~~~~~~gt~~Y~APE~l--~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVL--RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred CceeecccCCcccCCHHHh--cCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 2 3456799999999997 4556899999999999999999999999988887777776655442 2235789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 454 QDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
.+||.+||+.||.+|||+.|+++||||+.
T Consensus 245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 245 KDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 99999999999999999999999999964
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=386.47 Aligned_cols=261 Identities=25% Similarity=0.425 Sum_probs=217.8
Q ss_pred ccccCceeeeeeeccc--CceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 221 RRRITSWQKGELLGSG--SYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G--~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
....++|++++.||+| +||.||+|.+. +|..||+|.+..... .......+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 97 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC---SNEMVTFLQGELHVSKLFNHPNIVPYRATFIA 97 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc---ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence 3456789999999999 99999999986 799999999986542 34456778899999999999999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhh---hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 374 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~---~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~ 374 (488)
++..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||.+..
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999999999865 4599999999999999999999999999999999999999999999999998753
Q ss_pred ccCC---------CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC--
Q 011326 375 TTMN---------DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP-- 443 (488)
Q Consensus 375 ~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~-- 443 (488)
.... ......||+.|+|||++......++.++|||||||++|+|++|+.||.+.+..+....+..+..+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 3211 12234689999999998543356899999999999999999999999876665554443322211
Q ss_pred -------------------------------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 444 -------------------------------------------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 444 -------------------------------------------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
+.+..+++++.+||.+||+.||.+|||+.|+++||||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 2345678999999999999999999999999999999
Q ss_pred CCCC
Q 011326 481 KRPL 484 (488)
Q Consensus 481 ~~~~ 484 (488)
++..
T Consensus 338 ~~~~ 341 (389)
T 3gni_B 338 KQIK 341 (389)
T ss_dssp GGC-
T ss_pred HHHh
Confidence 8654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=386.75 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=216.3
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHH-HhcCCCCCcceeeccccCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISL-LGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~i-L~~l~HpnIv~l~~~~~~~ 298 (488)
....++|++.+.||+|+||.||+|.+. ++..||+|++.+..... ......+.+|..+ ++.++||||+++++++.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~--~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~ 111 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK--KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 111 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC---------------CCBCCCCCTTBCCEEEEEECS
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh--hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence 445789999999999999999999986 68999999998654321 2233455667776 5778999999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 299 KRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
+.+|+||||++||+|.+++.+. .+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 9999999999999999988764 589999999999999999999999999999999999999999999999999975332
Q ss_pred --CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHH
Q 011326 378 --NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455 (488)
Q Consensus 378 --~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~ 455 (488)
.......||+.|+|||++ .+..++.++|+|||||++|||++|..||...+..+....+..... ..+..+++++.+
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~ 268 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVL--HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QLKPNITNSARH 268 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC-CCCSSSCHHHHH
T ss_pred CCCccccccCCccccCHHHh--CCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-CCCCCCCHHHHH
Confidence 234567799999999997 456689999999999999999999999998888877777765543 466789999999
Q ss_pred HHHHhhhhCCCCCCCH----HHHHhCccCCC
Q 011326 456 FILKCLQVNPNDRPTA----AQLMEHPFIKR 482 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~----~eil~hp~f~~ 482 (488)
||.+||+.||.+||++ .++++||||+.
T Consensus 269 li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 269 LLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 9999999999999986 69999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=397.14 Aligned_cols=258 Identities=28% Similarity=0.468 Sum_probs=216.1
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
+...++|++.+.||+|+||.||+|.+. +|..||+|++...... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV--AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 221 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC---------------CCCCCSCTTSCCEEEEEEETT
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh--hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence 445789999999999999999999885 7999999999753211 1223456778999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHH-CCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 300 RLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
.+++||||+++|+|.+++... .+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999999888654 58999999999999999999998 9999999999999999999999999999975432
Q ss_pred C--CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHH
Q 011326 378 N--DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455 (488)
Q Consensus 378 ~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~ 455 (488)
. ......||+.|+|||++ .+..++.++||||||+++|||++|+.||.+.+..+....+..... ..+..+++++.+
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~ 378 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLGPEAKS 378 (446)
T ss_dssp -----CCSSSCGGGCCHHHH--HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHH
T ss_pred CCcccccccCCccccCHhhc--CCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHH
Confidence 2 24567799999999997 456689999999999999999999999998887777766655443 567789999999
Q ss_pred HHHHhhhhCCCCCC-----CHHHHHhCccCCCC
Q 011326 456 FILKCLQVNPNDRP-----TAAQLMEHPFIKRP 483 (488)
Q Consensus 456 Li~~cL~~dP~~Rp-----s~~eil~hp~f~~~ 483 (488)
||.+||+.||.+|| ++.|+++||||+..
T Consensus 379 li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 99999999999999 99999999999863
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=373.61 Aligned_cols=257 Identities=27% Similarity=0.462 Sum_probs=212.1
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
+++|++.+.||+|+||.||+|.+. +|..||+|.+.... ........+.+|+.++++++||||+++++++.+.+..+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH 78 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC---C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc---cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEE
Confidence 468999999999999999999986 69999999986543 23444567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 303 IFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
+||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 999999999999888644 59999999999999999999999999999999999999999999999999997654322
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC--------------------
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG-------------------- 439 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~-------------------- 439 (488)
.....||+.|+|||.+. ....++.++||||||+++|+|++|..||.+....+....+..
T Consensus 159 ~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 159 YDDEVATRWYRSPELLV-GDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp -------GGGCCHHHHH-TCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred cCCCcCCccccChHHHh-cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 34567999999999973 345689999999999999999999999988776554433211
Q ss_pred -CCCCC---------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 440 -GELPP---------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 440 -~~~~~---------~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
...+. ....+++++.+|+.+||+.||.+|||++|+++||||++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 00000 0135788999999999999999999999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=389.66 Aligned_cols=258 Identities=25% Similarity=0.461 Sum_probs=220.7
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 300 (488)
..+++|++.+.||+|+||.||++.+. ++..||+|.+..... ........+.+|+.+|+.++||||+++++++.+.+.
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC--VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc--ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34689999999999999999999886 689999999975321 112234578899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC-
Q 011326 301 LCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN- 378 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~- 378 (488)
.|+||||++||+|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 99999999999999998765 5999999999999999999999999999999999999999999999999999865443
Q ss_pred CcccCCCCCcccCchhhccc-cCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh---hhHHHhcCCCCCCCCCcccHHHH
Q 011326 379 DVKSCKGTAFWMAPEVVNLK-KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG---QAMFKIGGGELPPVPNSLSRDAQ 454 (488)
Q Consensus 379 ~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~s~~l~ 454 (488)
......||+.|+|||++... +..++.++|||||||++|+|++|..||...... +....+.. .....+..+++++.
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~p~~~s~~~~ 248 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET-TVVTYPSAWSQEMV 248 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH-CCCCCCTTSCHHHH
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh-cccCCCCcCCHHHH
Confidence 34567899999999998432 345899999999999999999999999754332 23333332 33466778999999
Q ss_pred HHHHHhhhhCCCCCCC-HHHHHhCccCCC
Q 011326 455 DFILKCLQVNPNDRPT-AAQLMEHPFIKR 482 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps-~~eil~hp~f~~ 482 (488)
+||.+||+.||.+||+ ++++++||||+.
T Consensus 249 ~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 249 SLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred HHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 9999999999999998 999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=365.84 Aligned_cols=257 Identities=29% Similarity=0.456 Sum_probs=222.0
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||+|.+. +|..||+|.+..... .......+.+|+.++++++||||+++++++.+++..+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC---CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 468999999999999999999885 699999999976542 3344567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCc---EEEeecCCcccccCC
Q 011326 303 IFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS---VKLADFGLAKATTMN 378 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~---vkL~DFGla~~~~~~ 378 (488)
+||||+++++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||++......
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 99999999999877754 45899999999999999999999999999999999999986655 999999999765543
Q ss_pred C-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC---CCCCcccHHHH
Q 011326 379 D-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP---PVPNSLSRDAQ 454 (488)
Q Consensus 379 ~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l~ 454 (488)
. .....||+.|+|||.+ ....++.++||||||+++|+|++|..||...+.......+..+... +....+++++.
T Consensus 162 ~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVL--KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239 (284)
T ss_dssp CBCCCSCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred ccccCCCCCcCCcCchhh--cCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence 3 3456799999999997 4556899999999999999999999999988877766665544332 22357899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
+|+.+||+.||.+|||+.|+++||||++..+
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 240 SLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 9999999999999999999999999977543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=367.58 Aligned_cols=253 Identities=29% Similarity=0.445 Sum_probs=211.9
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||++.+. ++..+|+|.+..... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS----QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC----CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc----chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 468999999999999999999885 789999999976532 223467889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhh-----hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEE---CCCCcEEEeecCCccc
Q 011326 303 IFLELVTKGSLASLYQK-----YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILV---DASGSVKLADFGLAKA 374 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~-----~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl---~~~~~vkL~DFGla~~ 374 (488)
+||||+++|+|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 99999999999988743 359999999999999999999999999999999999999 4568899999999976
Q ss_pred ccCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC--CCCCCCcccH
Q 011326 375 TTMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE--LPPVPNSLSR 451 (488)
Q Consensus 375 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~s~ 451 (488)
..... .....||+.|+|||.+. ..++.++||||||+++|+|++|..||.+.+..+......... .......+++
T Consensus 177 ~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (285)
T 3is5_A 177 FKSDEHSTNAAGTALYMAPEVFK---RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTP 253 (285)
T ss_dssp ----------CTTGGGCCHHHHT---TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCH
T ss_pred cCCcccCcCcccccCcCChHHhc---cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCH
Confidence 54332 34567999999999872 458999999999999999999999999877766555443322 2223345799
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
++.+|+.+||+.||.+|||+.|+++||||+++
T Consensus 254 ~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a 285 (285)
T 3is5_A 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285 (285)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence 99999999999999999999999999999874
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=376.26 Aligned_cols=257 Identities=31% Similarity=0.531 Sum_probs=201.9
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||+|.+. +|..||+|.+...... .....+.+|+.++++++||||+++++++.+++..+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 79 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE----GTPSTAIREISLMKELKHENIVRLYDVIHTENKLT 79 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT----CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc----ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence 468999999999999999999885 7999999999765422 12246778999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh-------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 303 IFLELVTKGSLASLYQKY-------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
+||||+++ +|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 80 LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp EEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 99999985 998888653 3889999999999999999999999999999999999999999999999999765
Q ss_pred cCC--CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC---C---------
Q 011326 376 TMN--DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG---E--------- 441 (488)
Q Consensus 376 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~---~--------- 441 (488)
... ......||+.|+|||++. ....++.++||||||+++|+|++|+.||.+.+..+....+... .
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLM-GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHT-TCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCCcccCCCCcccccccCchHhh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 432 234567999999999973 3345899999999999999999999999887766554443210 0
Q ss_pred --------C-------------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 442 --------L-------------PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 442 --------~-------------~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
. +..+..+++++.+||.+||+.||.+|||+.|+++||||++...+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 0 01123578899999999999999999999999999999876543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=364.54 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=214.4
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCc
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 300 (488)
..++|++.+.||+|+||.||+|.+. ++..||+|.+...... ......+.+|+..+..+ +||||+++++++.+++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~ 85 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG---SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH 85 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT---SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence 3568999999999999999999986 7999999999865432 23456778899999999 99999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhh-----ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC--------------
Q 011326 301 LCIFLELVTKGSLASLYQKY-----HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS-------------- 361 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~-----~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~-------------- 361 (488)
.++||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999998653 48999999999999999999999999999999999999844
Q ss_pred -----CcEEEeecCCcccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHH
Q 011326 362 -----GSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFK 436 (488)
Q Consensus 362 -----~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~ 436 (488)
..++|+|||.+...... ....||+.|+|||.+. ....++.++||||||+++|+|++|.+|+... .....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~ 239 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP--QVEEGDSRFLANEVLQ-ENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQWHE 239 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS--CCCCCCGGGCCHHHHT-TCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---HHHHH
T ss_pred ccCCceEEEEcccccccccCCc--cccCCCccccChhHhc-CCCCCCchhhHHHHHHHHHHHhcCCCCCcch---hHHHH
Confidence 47999999998765533 3346999999999983 3335678999999999999999998776543 33445
Q ss_pred hcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 437 IGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 437 i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
+..+..+..+..+++++.+||.+||+.||.+|||+.|+++||||++...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 288 (289)
T 1x8b_A 240 IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288 (289)
T ss_dssp HHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-----
T ss_pred HHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhcc
Confidence 5566677788899999999999999999999999999999999998754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=396.90 Aligned_cols=260 Identities=24% Similarity=0.358 Sum_probs=221.4
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
+...++|++.++||+|+||.||+|.+. +++.||+|++.+.... .......+.+|..++..++||||+++++++.+++
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML--KRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH--HTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhh--hHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 345678999999999999999999986 6889999999742210 0111223778999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 300 RLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
.+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 99999999999999999976 4699999999999999999999999999999999999999999999999999976543
Q ss_pred CC---cccCCCCCcccCchhhcc---ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC----CCCCCCC
Q 011326 378 ND---VKSCKGTAFWMAPEVVNL---KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG----ELPPVPN 447 (488)
Q Consensus 378 ~~---~~~~~gt~~y~aPE~~~~---~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~----~~~~~~~ 447 (488)
.. .....||+.|+|||++.. ....++.++|||||||++|||++|+.||.+.+..+....+... ..+....
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 307 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT 307 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCC
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccc
Confidence 32 234679999999999842 2456899999999999999999999999988877777666432 3344445
Q ss_pred cccHHHHHHHHHhhhhCCCC--CCCHHHHHhCccCCC
Q 011326 448 SLSRDAQDFILKCLQVNPND--RPTAAQLMEHPFIKR 482 (488)
Q Consensus 448 ~~s~~l~~Li~~cL~~dP~~--Rps~~eil~hp~f~~ 482 (488)
.+++++.+||.+||+.+|++ ||+++|+++||||+.
T Consensus 308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 68999999999999988888 999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=388.64 Aligned_cols=256 Identities=27% Similarity=0.441 Sum_probs=206.3
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCC--
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDE-- 298 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~-- 298 (488)
...+|++.+.||+|+||.||+|.+. +|..||+|.+.... ........+.+|+.++.++. ||||+++++++..+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF---QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC-----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc---cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 4678999999999999999999885 79999999986432 23445567889999999997 99999999998654
Q ss_pred CceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC-
Q 011326 299 KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM- 377 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~- 377 (488)
..+|+||||+++ +|..++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 84 RDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp SCEEEEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred CEEEEEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 378999999985 899999888899999999999999999999999999999999999999999999999999975422
Q ss_pred ----------------------CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHH
Q 011326 378 ----------------------NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF 435 (488)
Q Consensus 378 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~ 435 (488)
.......||+.|+|||++. ....++.++|||||||++|||++|++||.+.+..+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL-GSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHT-TCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhc-CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1123457999999999973 34568999999999999999999999998877665554
Q ss_pred HhcCCCC-C---------------------------------------------CCCCcccHHHHHHHHHhhhhCCCCCC
Q 011326 436 KIGGGEL-P---------------------------------------------PVPNSLSRDAQDFILKCLQVNPNDRP 469 (488)
Q Consensus 436 ~i~~~~~-~---------------------------------------------~~~~~~s~~l~~Li~~cL~~dP~~Rp 469 (488)
.+..... + ..+..+++++.+||.+||+.||.+||
T Consensus 242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 321 (388)
T 3oz6_A 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI 321 (388)
T ss_dssp HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence 4421000 0 01126789999999999999999999
Q ss_pred CHHHHHhCccCCCC
Q 011326 470 TAAQLMEHPFIKRP 483 (488)
Q Consensus 470 s~~eil~hp~f~~~ 483 (488)
|++|+++||||+.-
T Consensus 322 t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 322 SANDALKHPFVSIF 335 (388)
T ss_dssp CHHHHTTSTTTTTT
T ss_pred CHHHHhCCHHHHHh
Confidence 99999999998753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=370.08 Aligned_cols=259 Identities=27% Similarity=0.464 Sum_probs=226.0
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 300 (488)
..+++|++.+.||+|+||.||+|.+. ++..||+|.+..... ........+.+|+.++++++||||+++++++.+++.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL--EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc--chHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 35679999999999999999999886 688999999864321 011223578899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 301 LCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
.++||||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 99999999999999988654 58999999999999999999999999999999999999999999999999987665555
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILK 459 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~ 459 (488)
.....||+.|+|||.+ .+..++.++||||||+++|+|++|..||...+..+....+..... ..+..+++++.+||.+
T Consensus 169 ~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 245 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMI--EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL-KFPPFLSDGSKDLISK 245 (284)
T ss_dssp BCCCCSCGGGCCHHHH--TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-CCCTTSCHHHHHHHHH
T ss_pred cccccCCCCcCCHHHh--ccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc-CCCCcCCHHHHHHHHH
Confidence 5667799999999997 445688999999999999999999999998877777666665443 5667899999999999
Q ss_pred hhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 460 CLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 460 cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
||+.||.+|||+.++++||||+....
T Consensus 246 ~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 246 LLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp HSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred HhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 99999999999999999999976543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=367.56 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=222.3
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||+|.+. ++..+|+|.+..... .....+.+|+.++++++||||+++++++.+++..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-----EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 457999999999999999999986 688999999976432 22457889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEE---CCCCcEEEeecCCcccccCC
Q 011326 303 IFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILV---DASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl---~~~~~vkL~DFGla~~~~~~ 378 (488)
+||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+||++ +.++.++|+|||++......
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 999999999998887554 58999999999999999999999999999999999999 78899999999999765433
Q ss_pred -CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCC---CcccHHHH
Q 011326 379 -DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVP---NSLSRDAQ 454 (488)
Q Consensus 379 -~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~s~~l~ 454 (488)
......||+.|+|||.+. ..++.++||||||+++|+|++|..||...+..+....+..+...... ..+++++.
T Consensus 163 ~~~~~~~~t~~y~aPE~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLE---GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE 239 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHT---TCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred cchhccCCCCCccChHHhc---ccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence 344567999999999873 34899999999999999999999999988887777776665543222 26899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCccCCCCCCCC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTS 487 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~~ 487 (488)
+||.+||+.||.+|||+.|+++||||++..+.+
T Consensus 240 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~ 272 (277)
T 3f3z_A 240 SLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCS
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhcccccc
Confidence 999999999999999999999999998766543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=373.85 Aligned_cols=258 Identities=29% Similarity=0.526 Sum_probs=208.6
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC---CCCCcceeeccccCCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF---EHDNIVQYLGTDRDEK 299 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~~~ 299 (488)
.++|++.+.||+|+||.||+|.+. +++.||+|.+...............+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 568999999999999999999984 799999999976543222222223455677776666 4999999999987654
Q ss_pred -----ceEEEEeeccCCChHHHHhhhc---cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCC
Q 011326 300 -----RLCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGL 371 (488)
Q Consensus 300 -----~~~lV~E~~~~gsL~~~l~~~~---ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGl 371 (488)
..++||||+.+ +|.+++.... +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp SSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred CCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 58999999985 9999887653 89999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC-------CC
Q 011326 372 AKATTMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE-------LP 443 (488)
Q Consensus 372 a~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~-------~~ 443 (488)
+....... .....||+.|+|||++ .+..++.++||||||+++|+|++|+.||.+.+..+....+.... .+
T Consensus 167 a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 167 ARIYSYQMALTPVVVTLWYRAPEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp TTTSTTCCCSGGGGCCCSSCCHHHH--HTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred ccccCCCcccCCccccccccCchHH--cCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 97655433 3456799999999997 45568999999999999999999999998877766555442110 00
Q ss_pred -------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 444 -------------------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 444 -------------------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
.....+++++.+||.+||++||.+|||+.|+++||||++.-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 01135789999999999999999999999999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=376.12 Aligned_cols=252 Identities=23% Similarity=0.417 Sum_probs=208.2
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC--
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK-- 299 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-- 299 (488)
.+++|++.+.||+|+||.||+|.+. +|..||||++.... .......+.+|+.++++++||||+++++++.+.+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 79 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPE 79 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS----TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSC
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC----chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccc
Confidence 4578999999999999999999986 79999999997643 2334567899999999999999999999875433
Q ss_pred -------------------------------------------------------ceEEEEeeccCCChHHHHhhhc---
Q 011326 300 -------------------------------------------------------RLCIFLELVTKGSLASLYQKYH--- 321 (488)
Q Consensus 300 -------------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~--- 321 (488)
..++||||+++++|.+++....
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 159 (332)
T 3qd2_B 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159 (332)
T ss_dssp HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence 3899999999999999997643
Q ss_pred -cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--------------cccCCCC
Q 011326 322 -LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--------------VKSCKGT 386 (488)
Q Consensus 322 -ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--------------~~~~~gt 386 (488)
.++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .....||
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 4555689999999999999999999999999999999999999999999997654432 2345699
Q ss_pred CcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCC
Q 011326 387 AFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPN 466 (488)
Q Consensus 387 ~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~ 466 (488)
+.|+|||.+ .+..++.++||||||+++|+|++|..|+.. .......+.....+......++++.+||.+||+.||.
T Consensus 240 ~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 315 (332)
T 3qd2_B 240 KLYMSPEQI--HGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPT 315 (332)
T ss_dssp GGGSCHHHH--HCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGG
T ss_pred cCccChHHh--cCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCC
Confidence 999999997 455689999999999999999998766422 2233334444444444456788999999999999999
Q ss_pred CCCCHHHHHhCccCCC
Q 011326 467 DRPTAAQLMEHPFIKR 482 (488)
Q Consensus 467 ~Rps~~eil~hp~f~~ 482 (488)
+|||+.|+++||||++
T Consensus 316 ~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 316 ERPEATDIIENAIFEN 331 (332)
T ss_dssp GSCCHHHHHHSTTCCC
T ss_pred cCCCHHHHhhchhhhc
Confidence 9999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=368.74 Aligned_cols=261 Identities=28% Similarity=0.528 Sum_probs=199.3
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
...+++|++.+.||+|+||.||+|.+. +|..||+|.+..... ........+.+|+.++++++||||+++++++.+.+
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM--YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN 84 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhh--hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence 345778999999999999999999984 799999999964321 01122467889999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 300 RLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
..++||||+++++|.+++... .+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999999998763 589999999999999999999999999999999999999999999999999876543
Q ss_pred C--CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHH
Q 011326 378 N--DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455 (488)
Q Consensus 378 ~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~ 455 (488)
. ......||+.|+|||.+ ....++.++||||||+++|+|++|+.||......+....+..... ..+..++.++.+
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 241 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIA--TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY-EMPSFLSIEAKD 241 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCC-CCCTTSCHHHHH
T ss_pred CCCcceeccCCCCcCCcchh--cCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhccc-CCccccCHHHHH
Confidence 2 23346699999999987 445678899999999999999999999987666555554443332 456778999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 456 FILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
||.+||+.||.+|||+.++++||||++....
T Consensus 242 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 272 (278)
T 3cok_A 242 LIHQLLRRNPADRLSLSSVLDHPFMSRNSST 272 (278)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSTTTC-----
T ss_pred HHHHHcccCHhhCCCHHHHhcCccccCCCCc
Confidence 9999999999999999999999999876544
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=383.82 Aligned_cols=255 Identities=29% Similarity=0.477 Sum_probs=221.8
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
..++|++.+.||+|+||.||+|.+. +|..||+|.+.... ......+.+|+.+|++++||||+++++++.+.+..
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence 4578999999999999999999886 79999999997532 23345788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC--CCcEEEeecCCcccccC
Q 011326 302 CIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA--SGSVKLADFGLAKATTM 377 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~--~~~vkL~DFGla~~~~~ 377 (488)
++||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 9999999999999988654 5899999999999999999999999999999999999974 57899999999986654
Q ss_pred CC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC---CCCCcccHHH
Q 011326 378 ND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP---PVPNSLSRDA 453 (488)
Q Consensus 378 ~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l 453 (488)
.. .....||+.|+|||++ ....++.++|||||||++|+|++|..||.+.+..+....+...... .....+++++
T Consensus 204 ~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 281 (387)
T 1kob_A 204 DEIVKVTTATAEFAAPEIV--DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 281 (387)
T ss_dssp TSCEEEECSSGGGCCHHHH--TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred CcceeeeccCCCccCchhc--cCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 33 3345799999999997 4556899999999999999999999999988777766666544332 2345689999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 454 QDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
.+||.+||+.||.+|||+.|+++||||+...
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 9999999999999999999999999998653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=392.84 Aligned_cols=258 Identities=26% Similarity=0.386 Sum_probs=218.9
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 300 (488)
...++|++.+.||+|+||.||++.+. +|+.||+|++.+... ........+.+|..++..++||||+++++++.+++.
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~--~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM--LKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 45678999999999999999999985 799999999974221 011223357789999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 301 LCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
+|+||||++||+|.+++.+. .+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 99999999999999999764 5999999999999999999999999999999999999999999999999999765543
Q ss_pred C---cccCCCCCcccCchhhccc-----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC----CCCCCC
Q 011326 379 D---VKSCKGTAFWMAPEVVNLK-----KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG----ELPPVP 446 (488)
Q Consensus 379 ~---~~~~~gt~~y~aPE~~~~~-----~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~----~~~~~~ 446 (488)
. .....||+.|+|||++... ...++.++|||||||++|||++|+.||...+..+....+... ..+..+
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 295 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD 295 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence 3 2346799999999998421 345899999999999999999999999988877776666542 233445
Q ss_pred CcccHHHHHHHHHhhhhCCCCC---CCHHHHHhCccCCC
Q 011326 447 NSLSRDAQDFILKCLQVNPNDR---PTAAQLMEHPFIKR 482 (488)
Q Consensus 447 ~~~s~~l~~Li~~cL~~dP~~R---ps~~eil~hp~f~~ 482 (488)
..+|+++++||.+||+ +|.+| |+++|+++||||+.
T Consensus 296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 6799999999999999 99998 59999999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=398.14 Aligned_cols=260 Identities=29% Similarity=0.457 Sum_probs=226.8
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 300 (488)
..+++|++++.||+|+||.||+|.+. +|..||||.+..... ........+.+|+.+++.++||||+++++++.+.+.
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI--RSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD 90 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH--HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 35789999999999999999999986 799999999975321 111234578899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 301 LCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
.++||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 99999999999999998654 59999999999999999999999999999999999999999999999999998665433
Q ss_pred -cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHH
Q 011326 380 -VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFIL 458 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~ 458 (488)
.....||+.|+|||++. .....+.++||||||+++|+|++|..||...+.......+..+.. ..+..+++++.+||.
T Consensus 171 ~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~ 248 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVIS-GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-YTPQYLNPSVISLLK 248 (476)
T ss_dssp CBCCCCSCSTTCCHHHHT-TCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-CCCTTCCHHHHHHHH
T ss_pred cccccCCCcCeEChhhcc-CCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-CCCccCCHHHHHHHH
Confidence 44667999999999973 233347899999999999999999999998887777777776554 456779999999999
Q ss_pred HhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 459 KCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 459 ~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
+||+.||.+|||+.|+++||||++.+.
T Consensus 249 ~~L~~dP~~Rpt~~eil~hp~~~~~~~ 275 (476)
T 2y94_A 249 HMLQVDPMKRATIKDIREHEWFKQDLP 275 (476)
T ss_dssp HHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred HHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence 999999999999999999999987543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=380.92 Aligned_cols=255 Identities=25% Similarity=0.390 Sum_probs=203.8
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
..++|++.+.||+|+||.||++.+. ++..||+|.+...... ...+.+|+.+++.++||||+++++++.+.+..
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI------DENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS------CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc------cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 4578999999999999999999986 7999999999754321 14577999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCc--EEEeecCCcccccCC
Q 011326 302 CIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS--VKLADFGLAKATTMN 378 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~--vkL~DFGla~~~~~~ 378 (488)
++||||+++|+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999999999998855 46999999999999999999999999999999999999987765 999999998743322
Q ss_pred -CcccCCCCCcccCchhhccccCCCC-hhhhHHHHHHHHHHHHcCCCCCCCCchh----hhHHHhcCCCC-CCCCCcccH
Q 011326 379 -DVKSCKGTAFWMAPEVVNLKKDGYG-LTADIWSLGCTVLEMLTRRHPYSHLEGG----QAMFKIGGGEL-PPVPNSLSR 451 (488)
Q Consensus 379 -~~~~~~gt~~y~aPE~~~~~~~~~s-~k~DvwSlGvlL~eLltG~~Pf~~~~~~----~~~~~i~~~~~-~~~~~~~s~ 451 (488)
......||+.|+|||++. +..++ .++||||||+++|+|++|+.||.+.+.. .....+..... .+....+++
T Consensus 172 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLL--RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249 (361)
T ss_dssp ---------CTTSCHHHHH--CSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred CCCCCCcCCCCcCChhhhc--CCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence 234567999999999973 33454 4599999999999999999999875543 22233333222 223346899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
++.+||.+||+.||.+|||+.|+++||||++.+.
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 9999999999999999999999999999976543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=370.78 Aligned_cols=258 Identities=29% Similarity=0.448 Sum_probs=223.8
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCc-chhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPR-GKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
.++|++.+.||+|+||.||+|.+. +|..||+|.+........ .......+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999986 799999999986543321 112356788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC----cEEEeecCCccccc
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG----SVKLADFGLAKATT 376 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~----~vkL~DFGla~~~~ 376 (488)
++||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++ .++|+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 9999999999999998654 589999999999999999999999999999999999999887 79999999997655
Q ss_pred CCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC---CCCcccHH
Q 011326 377 MND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP---VPNSLSRD 452 (488)
Q Consensus 377 ~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~ 452 (488)
... .....||+.|+|||.+ ....++.++||||||+++|+|++|..||.+.+..+....+....... .+..++++
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (321)
T 2a2a_A 171 DGVEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248 (321)
T ss_dssp TTCCCCCCCSCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred ccccccccCCCCCccCcccc--cCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHH
Confidence 432 3456799999999997 45568999999999999999999999999888777777766554322 12568899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 453 AQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 453 l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 249 ~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp HHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 9999999999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=365.42 Aligned_cols=259 Identities=30% Similarity=0.499 Sum_probs=226.0
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc--cCCC
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD--RDEK 299 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~--~~~~ 299 (488)
..++|++.+.||+|+||.||++.+. +++.||+|.+..... .......+.+|+.++++++||||+++++++ ..+.
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM---TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC---CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence 4678999999999999999999886 799999999986542 334556789999999999999999999977 4567
Q ss_pred ceEEEEeeccCCChHHHHhhhc-----cChhhhhHHHHHHHHHHHHHHHCC-----CccccCCcccEEECCCCcEEEeec
Q 011326 300 RLCIFLELVTKGSLASLYQKYH-----LSDSQVSSYTRQILNGLKYLHEQN-----VVHRDIKCANILVDASGSVKLADF 369 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~~-----ls~~~~~~i~~qi~~aL~yLH~~g-----iiHrDLkp~NILl~~~~~vkL~DF 369 (488)
..++||||+++++|.+++.... +++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 8999999999999999986542 899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCC--cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCC
Q 011326 370 GLAKATTMND--VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPN 447 (488)
Q Consensus 370 Gla~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~ 447 (488)
|++....... .....||+.|+|||.+ ....++.++||||||+++|+|++|..||...+..+....+..+..+..+.
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 238 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQM--NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 238 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHH--HCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCT
T ss_pred chheeeccccccccccCCCccccChHHh--ccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCc
Confidence 9987654332 2245689999999997 44568999999999999999999999999888877777777777777888
Q ss_pred cccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 448 SLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 448 ~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
.+++++.++|.+||+.||.+|||+.|+++|+|+.++.++
T Consensus 239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 277 (279)
T 2w5a_A 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHH 277 (279)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGSC
T ss_pred ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhccc
Confidence 999999999999999999999999999999999988765
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=362.11 Aligned_cols=259 Identities=24% Similarity=0.430 Sum_probs=217.9
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||+|.+. ++..||+|.+..... ......+.+|+.+++.++||||+++++++.+++..+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC----TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc----hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence 568999999999999999999986 799999999975432 233467889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 303 IFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
+||||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 999999999999988654 69999999999999999999999999999999999999999999999999987543322
Q ss_pred --cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhh-hHHHhcC-CCCCCCCCcccHHHHH
Q 011326 380 --VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ-AMFKIGG-GELPPVPNSLSRDAQD 455 (488)
Q Consensus 380 --~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~-~~~~i~~-~~~~~~~~~~s~~l~~ 455 (488)
.....||+.|+|||.+. .....+.++||||||+++|+|++|..||....... ....+.. .........+++++.+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGT-CSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred hcccCCccccCccChHHHh-cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHH
Confidence 34567999999999973 22234789999999999999999999998765432 2222222 2222233578999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHhCccCCCCCCCC
Q 011326 456 FILKCLQVNPNDRPTAAQLMEHPFIKRPLQTS 487 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~~ 487 (488)
||.+||+.||.+|||+.|+++||||+++..+.
T Consensus 241 li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 272 (276)
T 2yex_A 241 LLHKILVENPSARITIPDIKKDRWYNKPLKKG 272 (276)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCCCC--
T ss_pred HHHHHCCCCchhCCCHHHHhcCccccChhhcc
Confidence 99999999999999999999999999988764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=370.41 Aligned_cols=257 Identities=36% Similarity=0.636 Sum_probs=228.5
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
-..|++.+.||+|+||.||+|.+. ++..||+|.+..... ......+.+|+.++++++||||+++++++.+++..+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 96 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA----EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 96 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC----STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 356999999999999999999875 799999999976542 223567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--c
Q 011326 303 IFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--V 380 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~ 380 (488)
+||||+++++|.+++....+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....... .
T Consensus 97 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp EEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred EEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999997654432 3
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHh
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~c 460 (488)
....||+.|+|||.+ ....++.++||||||+++|+|++|..||......+....+.....+..+..++.++.+|+.+|
T Consensus 177 ~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 254 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVI--KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 254 (303)
T ss_dssp CCCCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHH
T ss_pred CccCCCcCccCHHHH--hcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHH
Confidence 456799999999997 455688999999999999999999999998877777666666666677888999999999999
Q ss_pred hhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 461 LQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 461 L~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
|+.||.+|||+.|+++||||.+...+
T Consensus 255 l~~dp~~Rps~~~ll~~~~~~~~~~~ 280 (303)
T 3a7i_A 255 LNKEPSFRPTAKELLKHKFILRNAKK 280 (303)
T ss_dssp CCSSGGGSCCHHHHTTCHHHHHHCCC
T ss_pred cCCChhhCcCHHHHhhChhhhcCCCc
Confidence 99999999999999999999766544
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=361.15 Aligned_cols=252 Identities=23% Similarity=0.415 Sum_probs=222.9
Q ss_pred cccccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 218 GKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 218 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
+.|....++|++.+.||+|+||.||+|.+.++..||+|.+..... ...++.+|+.++++++||||+++++++.+
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 76 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM------SEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB------CHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc------CHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 345566789999999999999999999998899999999975432 22568899999999999999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
++..++||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 77 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 156 (269)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred CCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccc
Confidence 99999999999999999999654 4899999999999999999999999999999999999999999999999999755
Q ss_pred cCCC---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccH
Q 011326 376 TMND---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSR 451 (488)
Q Consensus 376 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 451 (488)
.... .....+|+.|+|||.+ ....++.++||||||+++|+|++ |..||......+....+........+..+++
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T 4hcu_A 157 LDDQYTSSTGTKFPVKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 234 (269)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred cccccccccCcccccccCCHHHh--cCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCH
Confidence 4332 2345577889999997 44568999999999999999999 9999999888888888887777777888999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
++.+++.+||+.||.+|||+.|+++|
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 235 HVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHH
Confidence 99999999999999999999999976
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=379.35 Aligned_cols=255 Identities=24% Similarity=0.433 Sum_probs=211.8
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC---
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK--- 299 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--- 299 (488)
..+|++.+.||+|+||.||+|.+. +|..||||.+.... ........+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 468999999999999999999985 79999999986543 23445567889999999999999999999987653
Q ss_pred ---ceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 300 ---RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 300 ---~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
.+|+||||+ +++|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 469999999 7799999988889999999999999999999999999999999999999999999999999997654
Q ss_pred CCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC-----------------
Q 011326 377 MNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG----------------- 439 (488)
Q Consensus 377 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~----------------- 439 (488)
. ......||+.|+|||++. ....++.++||||+||++|||++|+.||.+.+..+....+..
T Consensus 180 ~-~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 257 (367)
T 1cm8_A 180 S-EMTGYVVTRWYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257 (367)
T ss_dssp S-SCCSSCSCGGGCCTHHHH-TTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred c-ccCcCcCCCCcCCHHHHh-CCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence 3 345567999999999973 335689999999999999999999999988776554433321
Q ss_pred -------------CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 440 -------------GELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 440 -------------~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
.........+++++.+|+.+||+.||.+|||+.|+++||||++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 111123356789999999999999999999999999999998754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=377.12 Aligned_cols=257 Identities=26% Similarity=0.452 Sum_probs=206.2
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 300 (488)
..+++|++.+.||+|+||.||+|.+. ++..||+|.+..... .......+.+|+.++++++||||+++++++.+++.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE---EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc---ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 45779999999999999999999875 799999999975432 22334567789999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEEC-----CCCcEEEeecCCccc
Q 011326 301 LCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVD-----ASGSVKLADFGLAKA 374 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~-----~~~~vkL~DFGla~~ 374 (488)
.++||||+++ +|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999986 998888655 599999999999999999999999999999999999994 455699999999976
Q ss_pred ccCC--CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC----------
Q 011326 375 TTMN--DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL---------- 442 (488)
Q Consensus 375 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~---------- 442 (488)
.... ......||+.|+|||++. ....++.++||||||+++|+|++|..||.+.+..+....+.....
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILL-GSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp HC-----------CCTTCCHHHHT-TCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred cCCcccccCCCcCCccccCHHHhc-CCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 5432 234566899999999973 334589999999999999999999999988776655544321100
Q ss_pred ----------CC---------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 443 ----------PP---------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 443 ----------~~---------~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
+. .+..+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 00 011278999999999999999999999999999999875
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=364.01 Aligned_cols=259 Identities=29% Similarity=0.484 Sum_probs=226.5
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
...+|++.+.||+|+||.||++.+. ++..+|+|.+...... .......+.+|+.++++++||||+++++++.+++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL--KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc--CHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 3468999999999999999999986 6889999999765432 234556788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-- 378 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-- 378 (488)
++||||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 9999999999999988654 5899999999999999999999999999999999999999999999999999765432
Q ss_pred CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHH
Q 011326 379 DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFIL 458 (488)
Q Consensus 379 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~ 458 (488)
......||+.|+|||.+ ....++.++||||||+++|+|++|..||......+....+..... ..+..+++++.+|+.
T Consensus 171 ~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 247 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVL--SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVAASLIQ 247 (294)
T ss_dssp CBCCCCSCCSSCCHHHH--TTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-CCCTTSCHHHHHHHH
T ss_pred ccccccCCCCcCCcchh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC-CCccccCHHHHHHHH
Confidence 23456799999999997 445689999999999999999999999998877776666665543 567789999999999
Q ss_pred HhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 459 KCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 459 ~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
+||+.||++|||+.|+++||||++...+
T Consensus 248 ~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 248 KMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp HHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred HHcccChhhCcCHHHHhhChheecCCcC
Confidence 9999999999999999999999876543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=368.57 Aligned_cols=262 Identities=30% Similarity=0.503 Sum_probs=215.0
Q ss_pred ccccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
.+.....+|++.+.||+|+||.||+|.+ +|..||+|.+.... ........+.+|+.++++++||||+++++++.+.
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQD---FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCC---CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCC---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 3455677999999999999999999976 58889999987543 2345567789999999999999999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhhc----cChhhhhHHHHHHHHHHHHHHHCC--CccccCCcccEEECCCCcEEEeecCCc
Q 011326 299 KRLCIFLELVTKGSLASLYQKYH----LSDSQVSSYTRQILNGLKYLHEQN--VVHRDIKCANILVDASGSVKLADFGLA 372 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~~----ls~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~NILl~~~~~vkL~DFGla 372 (488)
+..++||||+++|+|.+++.... +++..++.++.|++.||+|||++| |+||||||+|||++.++.+||+|||++
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 99999999999999999997543 999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCC--cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhc-CCCCCCCCCcc
Q 011326 373 KATTMND--VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIG-GGELPPVPNSL 449 (488)
Q Consensus 373 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~ 449 (488)
+...... .....||+.|+|||++ .+..++.++||||||+++|+|++|..||...+..+....+. .......+..+
T Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (309)
T 3p86_A 187 RLKASTFLSSKSAAGTPEWMAPEVL--RDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNL 264 (309)
T ss_dssp ---------------CCTTSCHHHH--TTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTS
T ss_pred ccccccccccccCCCCccccChhhh--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 7544332 3456799999999997 45568999999999999999999999999887776665553 34445677889
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHh--CccCCCCCCC
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLME--HPFIKRPLQT 486 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~--hp~f~~~~~~ 486 (488)
++++.+||.+||+.||.+|||+.++++ .++++....+
T Consensus 265 ~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987 5776665443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=361.97 Aligned_cols=253 Identities=28% Similarity=0.499 Sum_probs=215.2
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC----CC
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD----EK 299 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~ 299 (488)
..|++.+.||+|+||.||+|.+. ++..||+|.+..... .......+.+|+.++++++||||+++++++.. ..
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh---CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 35889999999999999999885 788999999976442 34456778999999999999999999998754 45
Q ss_pred ceEEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCC--CccccCCcccEEEC-CCCcEEEeecCCcccc
Q 011326 300 RLCIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQN--VVHRDIKCANILVD-ASGSVKLADFGLAKAT 375 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~NILl~-~~~~vkL~DFGla~~~ 375 (488)
.+++||||+++++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.++|+|||++...
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 68999999999999999976 46899999999999999999999999 99999999999998 7899999999999766
Q ss_pred cCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhh-HHHhcCCCC-CCCCCcccHHH
Q 011326 376 TMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQA-MFKIGGGEL-PPVPNSLSRDA 453 (488)
Q Consensus 376 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~-~~~i~~~~~-~~~~~~~s~~l 453 (488)
.........||+.|+|||.+. ..++.++||||||+++|+|++|+.||........ ...+..+.. ...+...++++
T Consensus 183 ~~~~~~~~~~t~~y~aPE~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 259 (290)
T 1t4h_A 183 RASFAKAVIGTPEFMAPEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259 (290)
T ss_dssp CTTSBEESCSSCCCCCGGGGG---TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred cccccccccCCcCcCCHHHHh---ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHH
Confidence 655566678999999999863 4489999999999999999999999987555443 333333322 23445678999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 454 QDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
.+||.+||+.||.+|||+.|+++||||++.
T Consensus 260 ~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 999999999999999999999999999863
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=375.89 Aligned_cols=261 Identities=26% Similarity=0.435 Sum_probs=209.4
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 300 (488)
....+|++.+.||+|+||.||+|.+. +|..||+|.+...............+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34678999999999999999999986 69999999997543322222223467899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 301 LCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
.++||||+++ +|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 9999999987 888888654 4899999999999999999999999999999999999999999999999999765433
Q ss_pred C--cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC-------CC-------
Q 011326 379 D--VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG-------EL------- 442 (488)
Q Consensus 379 ~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~-------~~------- 442 (488)
. .....||+.|+|||++. ....++.++||||||+++|+|++|.+||.+.+..+....+... ..
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLF-GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHT-TCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred cccCCcccccccccCchHhh-CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 2 34567999999999973 3345899999999999999999999999887766554443211 00
Q ss_pred --------CCC-----CCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 443 --------PPV-----PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 443 --------~~~-----~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
+.. ...+++++.+||.+||+.||.+|||+.|+++||||++.-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 000 145678999999999999999999999999999998653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=361.71 Aligned_cols=253 Identities=22% Similarity=0.406 Sum_probs=222.2
Q ss_pred CcccccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecccc
Q 011326 217 NGKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR 296 (488)
Q Consensus 217 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 296 (488)
.+.|....++|++.+.||+|+||.||++.+.++..||+|.+..... ...++.+|+.++.+++||||+++++++.
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 89 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------SEDEFIEEAKVMMNLSHEKLVQLYGVCT 89 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB------CHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC------CHHHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence 4556677889999999999999999999998888999999975332 2256889999999999999999999999
Q ss_pred CCCceEEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccc
Q 011326 297 DEKRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 374 (488)
Q Consensus 297 ~~~~~~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~ 374 (488)
+++..++||||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 90 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169 (283)
T ss_dssp SSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred cCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccc
Confidence 99999999999999999999965 4699999999999999999999999999999999999999999999999999975
Q ss_pred ccCCC---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCccc
Q 011326 375 TTMND---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLS 450 (488)
Q Consensus 375 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s 450 (488)
..... .....+|+.|+|||.+ ....++.++||||||+++|+|++ |+.||...+..+....+........+..++
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 247 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHH--HHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccccccccccCCccCcccCCHHHh--ccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCC
Confidence 54332 2344577889999997 34568999999999999999998 999999988888888888777777788899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 451 RDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 451 ~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
+++.+|+.+||+.||.+|||+.++++|
T Consensus 248 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 248 EKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999999999976
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=363.33 Aligned_cols=260 Identities=29% Similarity=0.464 Sum_probs=215.8
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 300 (488)
...++|++++.||+|+||.||+|.+. +|+.||+|.+..... ........+.+|+.+++.++||||+++++++.+.+.
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI--RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc--cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 34678999999999999999999986 799999999874321 112234578899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 301 LCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
.++||||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 99999999999999998654 58999999999999999999999999999999999999999999999999987654433
Q ss_pred -cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHH
Q 011326 380 -VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFIL 458 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~ 458 (488)
.....||+.|+|||.+. .....+.++||||||+++|+|++|..||...+.......+.... ...+..++.++.++|.
T Consensus 166 ~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~ 243 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVIS-GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-FYIPEYLNRSVATLLM 243 (276)
T ss_dssp -----------CCTGGGT-TSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHH
T ss_pred ceecccCCccccCHHHHc-CCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-ccCchhcCHHHHHHHH
Confidence 33556899999999973 22234689999999999999999999998877766666655443 3567788999999999
Q ss_pred HhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 459 KCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 459 ~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
+||+.||.+|||+.|+++||||++.+.
T Consensus 244 ~~l~~~p~~Rps~~~~l~h~~~~~~~~ 270 (276)
T 2h6d_A 244 HMLQVDPLKRATIKDIREHEWFKQDLP 270 (276)
T ss_dssp HHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HHccCChhhCCCHHHHHhChhhccCch
Confidence 999999999999999999999988764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=376.36 Aligned_cols=253 Identities=26% Similarity=0.453 Sum_probs=222.1
Q ss_pred ccccccCceeeeeeecccCceEEEEEEec--------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcc
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLTD--------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIV 289 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv 289 (488)
.+....++|++++.||+|+||.||+|.+. ++..||+|.+... ........+.+|+.+++++ +||||+
T Consensus 75 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpnIv 150 (370)
T 2psq_A 75 KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNII 150 (370)
T ss_dssp TTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT----CBHHHHHHHHHHHHHHHHSCCCTTBC
T ss_pred cccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC----cCHHHHHHHHHHHHHHHHhcCCCCEe
Confidence 34556789999999999999999999752 4567999998643 2344567889999999999 899999
Q ss_pred eeeccccCCCceEEEEeeccCCChHHHHhhh-----------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCC
Q 011326 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQKY-----------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIK 352 (488)
Q Consensus 290 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-----------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLk 352 (488)
++++++.+++.+|+||||+++|+|.+++... .+++..+..++.||+.||.|||++||+|||||
T Consensus 151 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk 230 (370)
T 2psq_A 151 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 230 (370)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred eEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 9999999999999999999999999998754 37888999999999999999999999999999
Q ss_pred cccEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 011326 353 CANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSH 427 (488)
Q Consensus 353 p~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~ 427 (488)
|+|||++.++.+||+|||+++...... .....+|+.|+|||++ .+..++.++||||||+++|||++ |..||.+
T Consensus 231 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DvwslG~il~ellt~g~~p~~~ 308 (370)
T 2psq_A 231 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308 (370)
T ss_dssp GGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHH--HTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred hhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHh--cCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999997554322 2344578899999997 45668999999999999999999 9999999
Q ss_pred CchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 428 LEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 428 ~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.+..+....+..+..+..+..+++++.+||.+||+.||.+|||+.|++++
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 309 IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp CCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88888888888777778888999999999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=373.51 Aligned_cols=256 Identities=25% Similarity=0.464 Sum_probs=211.7
Q ss_pred ccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCC--CCcceeeccccCCCc
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH--DNIVQYLGTDRDEKR 300 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~ 300 (488)
.-.+|++.+.||+|+||.||++.+.++..||+|.+.... ........+.+|+.+|.+++| |||+++++++.+++.
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE---ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc---cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 345799999999999999999999889999999997654 234556788999999999976 999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 301 LCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
.++||| +.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 999999 5677999988664 589999999999999999999999999999999999996 6889999999997654332
Q ss_pred ----cccCCCCCcccCchhhcc---------ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh-hhHHHh-cCCCCCC
Q 011326 380 ----VKSCKGTAFWMAPEVVNL---------KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-QAMFKI-GGGELPP 444 (488)
Q Consensus 380 ----~~~~~gt~~y~aPE~~~~---------~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~-~~~~~i-~~~~~~~ 444 (488)
.....||+.|+|||++.. ....++.++||||||+++|+|++|+.||...... .....+ .......
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence 235679999999999742 1256899999999999999999999999764332 222332 2333445
Q ss_pred CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 445 VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 445 ~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
.+...++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 677788999999999999999999999999999999753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=375.20 Aligned_cols=254 Identities=28% Similarity=0.424 Sum_probs=203.6
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
..++|++.+.||+|+||.||+|.+. ++..||+|++.... ....+.+|+.++++++||||+++++++.+.+..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-------hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 3567999999999999999999986 68899999997532 224577899999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC---CCcEEEeecCCcccccC
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA---SGSVKLADFGLAKATTM 377 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~---~~~vkL~DFGla~~~~~ 377 (488)
++||||+++|+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 9999999999999988654 5899999999999999999999999999999999999975 88999999999976544
Q ss_pred CC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhh-hHHHhcCCCCC---CCCCcccHH
Q 011326 378 ND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ-AMFKIGGGELP---PVPNSLSRD 452 (488)
Q Consensus 378 ~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~-~~~~i~~~~~~---~~~~~~s~~ 452 (488)
.. .....||+.|+|||++ .+..++.++||||||+++|||++|..||....... ....+...... +....++.+
T Consensus 204 ~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 281 (349)
T 2w4o_A 204 QVLMKTVCGTPGYCAPEIL--RGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281 (349)
T ss_dssp ---------CGGGSCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred ccccccccCCCCccCHHHh--cCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence 32 3456799999999997 45568999999999999999999999997765544 44444443332 233578999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 453 AQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 453 l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
+.+||.+||+.||++|||+.|+++||||+....
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 999999999999999999999999999987654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=368.89 Aligned_cols=250 Identities=31% Similarity=0.434 Sum_probs=204.9
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCce
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 301 (488)
.++|++.+.||+|+||+||+|.+. +|..||||++..... ..........|+..+.++ +||||+++++++.+++..
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR---GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC---SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc---ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 367999999999999999999986 799999999865432 223334455565555554 899999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 302 CIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
++||||+ +++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999999 56898887654 49999999999999999999999999999999999999999999999999987654433
Q ss_pred -cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC-CCCCCcccHHHHHHH
Q 011326 380 -VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL-PPVPNSLSRDAQDFI 457 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~l~~Li 457 (488)
.....||+.|+|||++. +.++.++||||||+++|||++|..|+..... ...+..... +..+..+++++.+||
T Consensus 212 ~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li 285 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQ---GSYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVL 285 (311)
T ss_dssp ---CCCCCGGGCCGGGGG---TCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHH
T ss_pred CCcccCCCccccCHhHhc---CCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHH
Confidence 34456999999999873 3589999999999999999999776654322 223333222 223457899999999
Q ss_pred HHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 458 LKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 458 ~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
.+||++||++|||+.|+++||||+++
T Consensus 286 ~~~L~~dP~~Rpt~~ell~hp~~~~p 311 (311)
T 3p1a_A 286 VMMLEPDPKLRATAEALLALPVLRQP 311 (311)
T ss_dssp HHHSCSSTTTSCCHHHHHTSGGGSCC
T ss_pred HHHcCCChhhCcCHHHHHhCccccCC
Confidence 99999999999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=366.51 Aligned_cols=254 Identities=29% Similarity=0.457 Sum_probs=219.3
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||++.+. +|+.||+|.+..... .....+.+|+.++++++||||+++++++.+.+..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-----FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-----cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence 457999999999999999999986 799999999985432 12246789999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEE---CCCCcEEEeecCCcccccCC
Q 011326 303 IFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILV---DASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl---~~~~~vkL~DFGla~~~~~~ 378 (488)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 99999999999988764 458999999999999999999999999999999999999 78899999999998765544
Q ss_pred CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC---CCCCcccHHHHH
Q 011326 379 DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP---PVPNSLSRDAQD 455 (488)
Q Consensus 379 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l~~ 455 (488)
......||+.|+|||.+ .+..++.++||||||+++|+|++|..||...+..+....+..+... +.+..+++++.+
T Consensus 163 ~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 240 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVL--AQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD 240 (304)
T ss_dssp TTHHHHSCCCBCCTTTB--SSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred ccccccCCCCccChHHh--ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence 44456699999999997 4566899999999999999999999999887777666666554332 334678999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 456 FILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
||.+||+.||.+|||+.|+++||||+...
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 241 FICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 99999999999999999999999997643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=380.18 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=211.7
Q ss_pred eeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEE
Q 011326 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFL 305 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 305 (488)
+...+.||+|+||.||+|.+. +|..||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 165 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-----MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 344678999999999999885 79999999997532 244567899999999999999999999999999999999
Q ss_pred eeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEE--CCCCcEEEeecCCcccccCCC-c
Q 011326 306 ELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILV--DASGSVKLADFGLAKATTMND-V 380 (488)
Q Consensus 306 E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl--~~~~~vkL~DFGla~~~~~~~-~ 380 (488)
||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...... .
T Consensus 166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~ 245 (373)
T 2x4f_A 166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245 (373)
T ss_dssp ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence 999999998887543 59999999999999999999999999999999999999 567899999999998665433 3
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC---CCCcccHHHHHHH
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP---VPNSLSRDAQDFI 457 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~l~~Li 457 (488)
....||+.|+|||++ ....++.++||||||+++|||++|..||.+.+..+....+....... ....+++++.+||
T Consensus 246 ~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 323 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVV--NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI 323 (373)
T ss_dssp CCCCSSCTTCCHHHH--TTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred ccccCCCcEeChhhc--cCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence 455799999999997 45568999999999999999999999999888777776665544322 2246899999999
Q ss_pred HHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 458 LKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 458 ~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
.+||+.||.+|||+.|+++||||+..
T Consensus 324 ~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 324 SKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 99999999999999999999999763
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=376.61 Aligned_cols=257 Identities=30% Similarity=0.468 Sum_probs=207.4
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
+++|++.+.||+|+||.||+|.+. ++..||+|.+....... ....+.+|+.++++++||||+++++++.+++..+
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 76 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc----cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEE
Confidence 468999999999999999999986 79999999996543211 1113447899999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--
Q 011326 303 IFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-- 378 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-- 378 (488)
+||||+++ +|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 77 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 77 LVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp EEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred EEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 99999986 888877653 4899999999999999999999999999999999999999999999999998755432
Q ss_pred CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC---CCC------------
Q 011326 379 DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG---ELP------------ 443 (488)
Q Consensus 379 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~---~~~------------ 443 (488)
......||+.|+|||++. ....++.++||||||+++|+|++|+.||.+.+..+....+... ..+
T Consensus 156 ~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILL-GSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp -------CGGGCCHHHHT-TCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred ccccccCcccccChhhhc-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 234557899999999973 3456899999999999999999999999887766554443211 000
Q ss_pred --------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 444 --------------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 444 --------------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
.....+++++.+||.+||+.||.+|||+.|+++||||++..+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 0123578899999999999999999999999999999876543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=392.50 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=205.5
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC---
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE--- 298 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--- 298 (488)
..++|++++.||+|+||.||+|.+. +|+.||||++.... .......++.+|+.+|+.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG---GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc---cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc
Confidence 4678999999999999999999885 79999999997542 2344567788999999999999999999998654
Q ss_pred ---CceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 299 ---KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 299 ---~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
..+|+||||++++ |.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 137 ~~~~~~~lv~E~~~~~-l~~~~~~-~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 137 EEFQDVYLVMELMDAN-LCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp TTCCEEEEEEECCSEE-HHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred ccCCeEEEEEeCCCCC-HHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 3579999999875 6555543 5999999999999999999999999999999999999999999999999999866
Q ss_pred cCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC------------
Q 011326 376 TMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL------------ 442 (488)
Q Consensus 376 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~------------ 442 (488)
.... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||.+.+..+....+.....
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 215 GTSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp --CCCC----CCCTTCCHHHH--TTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred CCCcccCCCcccccccCHHHH--cCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence 5442 4557899999999998 445789999999999999999999999998776555444321100
Q ss_pred ---------CC---------CCC-----------cccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 443 ---------PP---------VPN-----------SLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 443 ---------~~---------~~~-----------~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
+. .+. ..++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 00 000 015689999999999999999999999999999753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=372.59 Aligned_cols=252 Identities=28% Similarity=0.458 Sum_probs=196.0
Q ss_pred Cceeee---eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCCC
Q 011326 225 TSWQKG---ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDEK 299 (488)
Q Consensus 225 ~~y~~~---~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~ 299 (488)
.+|++. +.||+|+||.||+|.+. ++..||+|.+... ....+.+|+.++..+. ||||+++++++.++.
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 345554 78999999999999986 7999999998642 2356778999999997 999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC---cEEEeecCCcccc
Q 011326 300 RLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG---SVKLADFGLAKAT 375 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~---~vkL~DFGla~~~ 375 (488)
..++||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 999999999999999988665 599999999999999999999999999999999999998765 8999999999755
Q ss_pred cCCC--cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCch-------hhhHHHhcCCCCCCCC
Q 011326 376 TMND--VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG-------GQAMFKIGGGELPPVP 446 (488)
Q Consensus 376 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~ 446 (488)
.... .....||+.|+|||++ ....++.++||||||+++|+|++|..||...+. .+....+..+......
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 237 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELL--NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237 (325)
T ss_dssp CC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS
T ss_pred CCCCCcccccCCCcCccCHHHh--cCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc
Confidence 4332 3456789999999997 456689999999999999999999999976433 3445555555443222
Q ss_pred ---CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 447 ---NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 447 ---~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
..+++++.+||.+||+.||.+|||+.|+++||||+...+.
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~ 280 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccC
Confidence 3589999999999999999999999999999999976543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=370.99 Aligned_cols=259 Identities=29% Similarity=0.487 Sum_probs=225.9
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
...+|++.+.||+|+||.||++.+. ++..||+|.+..... ........+.+|+.+++.++||||+++++++.+.+..
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL--LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 3568999999999999999999986 688999999976433 2234556788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-- 378 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-- 378 (488)
++||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 9999999999999988654 5899999999999999999999999999999999999999999999999999765432
Q ss_pred CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHH
Q 011326 379 DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFIL 458 (488)
Q Consensus 379 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~ 458 (488)
......||+.|+|||.+ .+..++.++||||||+++|+|++|..||......+....+..... ..+..+++++.+||.
T Consensus 197 ~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 273 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVL--SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVAASLIQ 273 (335)
T ss_dssp CBCCCCSCCSSCCHHHH--HTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-CCCTTSCHHHHHHHH
T ss_pred cccccCCCccccCHHHh--ccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC-CCCccCCHHHHHHHH
Confidence 23456799999999997 445689999999999999999999999988777666665554443 466789999999999
Q ss_pred HhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 459 KCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 459 ~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
+||+.||++|||+.|+++||||+....+
T Consensus 274 ~~l~~dp~~Rps~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 274 KMLQTDPTARPTINELLNDEFFTSGYIP 301 (335)
T ss_dssp HHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred HHccCChhHCcCHHHHhcCccccCCCcc
Confidence 9999999999999999999999876543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=374.77 Aligned_cols=256 Identities=29% Similarity=0.495 Sum_probs=216.6
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC----
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE---- 298 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~---- 298 (488)
..+|++.+.||+|+||.||+|.+. ++..||+|.+... ........+.+|+.++.+++||||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF----EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT----TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc----cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 458999999999999999999885 7889999998642 2344556788999999999999999999988654
Q ss_pred -CceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 299 -KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 299 -~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
...++||||+.+ +|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 102 ~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 102 MKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp CCCEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred cceEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 468999999986 999999888899999999999999999999999999999999999999999999999999976543
Q ss_pred CC-----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC-----------
Q 011326 378 ND-----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE----------- 441 (488)
Q Consensus 378 ~~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~----------- 441 (488)
.. .....||+.|+|||++ .....++.++||||||+++|+|++|+.||.+.+..+....+....
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHH-HTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccccccccccccCCCCCHHh-cCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 32 2345799999999986 244558999999999999999999999998877665544432100
Q ss_pred --------------C-----CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 442 --------------L-----PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 442 --------------~-----~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
. ......+++++.+||.+||+.||.+|||+.|+++||||++...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 0 0112457899999999999999999999999999999997643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=362.46 Aligned_cols=258 Identities=28% Similarity=0.450 Sum_probs=201.7
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 300 (488)
...++|++.+.||+|+||.||+|.+. +|+.||+|.+.... ........+.++...++.++||||+++++++.+++.
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~ 80 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV---NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD 80 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc---CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence 45678999999999999999999985 79999999997543 222333445555666888999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhh-----hccChhhhhHHHHHHHHHHHHHHHC-CCccccCCcccEEECCCCcEEEeecCCccc
Q 011326 301 LCIFLELVTKGSLASLYQK-----YHLSDSQVSSYTRQILNGLKYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKA 374 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~-----~~ls~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~NILl~~~~~vkL~DFGla~~ 374 (488)
.++||||+++ +|.+++.. ..+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++..
T Consensus 81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999999986 88776643 3599999999999999999999998 999999999999999999999999999976
Q ss_pred ccCCC-cccCCCCCcccCchhhc--cccCCCChhhhHHHHHHHHHHHHcCCCCCCCCc-hhhhHHH-hcCCCCCCCCCcc
Q 011326 375 TTMND-VKSCKGTAFWMAPEVVN--LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE-GGQAMFK-IGGGELPPVPNSL 449 (488)
Q Consensus 375 ~~~~~-~~~~~gt~~y~aPE~~~--~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~-~~~~~~~-i~~~~~~~~~~~~ 449 (488)
..... .....||+.|+|||.+. .....++.++||||||+++|+|++|..||.... ....... +........+..+
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T 3fme_A 160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF 239 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTS
T ss_pred ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccC
Confidence 54433 23457999999999963 234568999999999999999999999997533 2233333 3333333334578
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
++++.+|+.+||+.||.+|||+.|+++||||+..
T Consensus 240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 9999999999999999999999999999999754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=387.47 Aligned_cols=255 Identities=28% Similarity=0.474 Sum_probs=194.9
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecccc-----C
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR-----D 297 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-----~ 297 (488)
.++|++++.||+|+||.||+|.+. ++..||||.+.... ........+.+|+.+|++++||||+++++++. .
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF---EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh---cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 468999999999999999999886 79999999996532 23445678899999999999999999999984 3
Q ss_pred CCceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
...+|+||||+. ++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 129 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 129 FDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred CceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 457999999985 5898888665 49999999999999999999999999999999999999999999999999997653
Q ss_pred CC-----------------------------CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-------
Q 011326 377 MN-----------------------------DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT------- 420 (488)
Q Consensus 377 ~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt------- 420 (488)
.. ......||+.|+|||++ .....++.++|||||||+||||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI-LLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHH-TTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHh-hCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 21 12345689999999986 345668999999999999999998
Q ss_pred ----CCCCCCCCch--------------------hhhHHHh---c--------------------C-------CCCCCCC
Q 011326 421 ----RRHPYSHLEG--------------------GQAMFKI---G--------------------G-------GELPPVP 446 (488)
Q Consensus 421 ----G~~Pf~~~~~--------------------~~~~~~i---~--------------------~-------~~~~~~~ 446 (488)
|+++|.+... .+.+..+ . . .......
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF 366 (458)
T ss_dssp SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence 6666655331 0000000 0 0 0001112
Q ss_pred CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 447 NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 447 ~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
..+++++.+||.+||+.||.+|||++|+++||||++.
T Consensus 367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 367 PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 3568999999999999999999999999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=373.51 Aligned_cols=260 Identities=27% Similarity=0.458 Sum_probs=222.4
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcc---hhHHHHHHHHHHHHhcC-CCCCcceeeccccC
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRG---KQSILQLEQEISLLGQF-EHDNIVQYLGTDRD 297 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~ 297 (488)
..++|++.+.||+|+||.||+|.+. +|..||||++......... ......+.+|+.++.++ +||||+++++++..
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 3467999999999999999999986 7999999999865432211 22345678999999999 79999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
.+..++||||+++++|.+++... .+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++....
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 99999999999999999988654 69999999999999999999999999999999999999999999999999987655
Q ss_pred CC-CcccCCCCCcccCchhhccc----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCC---CCc
Q 011326 377 MN-DVKSCKGTAFWMAPEVVNLK----KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV---PNS 448 (488)
Q Consensus 377 ~~-~~~~~~gt~~y~aPE~~~~~----~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~ 448 (488)
.. ......||+.|+|||++... ...++.++||||||+++|+|++|..||...+.......+..+..... ...
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 331 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDD 331 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSS
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence 43 34556799999999997422 33578899999999999999999999988777766666554443221 246
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 449 LSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 449 ~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
+++++.+||.+||+.||.+|||+.|+++||||++
T Consensus 332 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 332 RSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 7899999999999999999999999999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=373.59 Aligned_cols=249 Identities=27% Similarity=0.405 Sum_probs=210.0
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-----CCCcceeecccc
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-----HDNIVQYLGTDR 296 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-----HpnIv~l~~~~~ 296 (488)
..++|++.+.||+|+||.||+|.+. ++..||+|++.. .......+..|+.+++.+. ||||+++++++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN------IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS------CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc------chhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 4578999999999999999999985 789999999863 2344456778999999886 999999999999
Q ss_pred CCCceEEEEeeccCCChHHHHhhhc---cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC-------------
Q 011326 297 DEKRLCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA------------- 360 (488)
Q Consensus 297 ~~~~~~lV~E~~~~gsL~~~l~~~~---ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~------------- 360 (488)
..+..++||||+ +++|.+++.... +++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence 999999999999 889999987654 899999999999999999999999999999999999975
Q ss_pred ------------CCcEEEeecCCcccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 011326 361 ------------SGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHL 428 (488)
Q Consensus 361 ------------~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~ 428 (488)
++.+||+|||++..... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||...
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVI--LNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTS-CCCSCCSCGGGCCHHHH--TTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccCCCCEEEEeccCceecCC-CCcCccCcccccCcHHH--cCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 78999999999976443 33456799999999997 4556899999999999999999999999887
Q ss_pred chhhhHHHhcCCCCCC---------------------------------------------CCCcccHHHHHHHHHhhhh
Q 011326 429 EGGQAMFKIGGGELPP---------------------------------------------VPNSLSRDAQDFILKCLQV 463 (488)
Q Consensus 429 ~~~~~~~~i~~~~~~~---------------------------------------------~~~~~s~~l~~Li~~cL~~ 463 (488)
+..+....+.....+. .+...++++.+||.+||+.
T Consensus 263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 342 (360)
T 3llt_A 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI 342 (360)
T ss_dssp SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence 6655444332211100 0011247788999999999
Q ss_pred CCCCCCCHHHHHhCccCC
Q 011326 464 NPNDRPTAAQLMEHPFIK 481 (488)
Q Consensus 464 dP~~Rps~~eil~hp~f~ 481 (488)
||.+|||+.|+++||||+
T Consensus 343 dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 343 DPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SGGGSCCHHHHTTSGGGC
T ss_pred ChhhCCCHHHHhcCcccC
Confidence 999999999999999996
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=372.97 Aligned_cols=256 Identities=32% Similarity=0.558 Sum_probs=219.5
Q ss_pred CceeeeeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
..|++.+.||+|+||.||+|.+ .+|..||||.+..... ........+.+|+.++++++||||+++++++.+++..++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc--cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 4599999999999999999987 4799999999976432 233445678999999999999999999999999999999
Q ss_pred EEeeccCCChHHHHh--hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCcc
Q 011326 304 FLELVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK 381 (488)
Q Consensus 304 V~E~~~~gsL~~~l~--~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 381 (488)
||||+.| +|.+++. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 132 v~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--~~ 208 (348)
T 1u5q_A 132 VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--AN 208 (348)
T ss_dssp EEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--BC
T ss_pred EEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--CC
Confidence 9999985 7877764 34599999999999999999999999999999999999999999999999999976543 34
Q ss_pred cCCCCCcccCchhhcc-ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC-CCCcccHHHHHHHHH
Q 011326 382 SCKGTAFWMAPEVVNL-KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP-VPNSLSRDAQDFILK 459 (488)
Q Consensus 382 ~~~gt~~y~aPE~~~~-~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~l~~Li~~ 459 (488)
...||+.|+|||++.. ....++.++||||||+++|||++|+.||...+.......+.....+. .+..+++++.+||.+
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 288 (348)
T 1u5q_A 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 288 (348)
T ss_dssp CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHH
T ss_pred cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 5679999999999732 24568999999999999999999999998877766655554444333 345789999999999
Q ss_pred hhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 460 CLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 460 cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
||+.||.+|||+.++++||||.....
T Consensus 289 ~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 289 CLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HcccChhhCcCHHHHhhChhhhccCC
Confidence 99999999999999999999976543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=373.34 Aligned_cols=254 Identities=30% Similarity=0.502 Sum_probs=215.4
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.++++++||||+++++++.+++..+
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC----CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc----CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 568999999999999999999986 79999999997642 3445577899999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHC-CCccccCCcccEEECCCCcEEEeecCCcccccCCCc
Q 011326 303 IFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV 380 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 380 (488)
+||||+++++|.+++... .+++..+..++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++........
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 187 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 187 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC-
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccc
Confidence 999999999999998765 699999999999999999999986 999999999999999999999999999876554445
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHH------------------------
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFK------------------------ 436 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~------------------------ 436 (488)
....||+.|+|||++ .+..++.++||||||+++|+|++|+.||...+..+....
T Consensus 188 ~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 188 NSFVGTRSYMSPERL--QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp ---CCCCTTCCHHHH--TTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred cCCCCCCCeECHHHH--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 567899999999997 455689999999999999999999999987654432211
Q ss_pred ------------------hcCCCCCCC-CCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 437 ------------------IGGGELPPV-PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 437 ------------------i~~~~~~~~-~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
+.....+.. ...++.++.+||.+||+.||.+|||+.|+++||||++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 111111222 23478999999999999999999999999999999753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=391.84 Aligned_cols=257 Identities=29% Similarity=0.473 Sum_probs=220.6
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
..++|++.+.||+|+||.||+|.+. ++..||+|++...... ......+.+|+.++++++||||+++++++.+.+.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK---NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB---CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence 4568999999999999999999986 7999999999753321 12245788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEEC---CCCcEEEeecCCcccccC
Q 011326 302 CIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVD---ASGSVKLADFGLAKATTM 377 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~---~~~~vkL~DFGla~~~~~ 377 (488)
++||||+++|+|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999999999999887754 5699999999999999999999999999999999999995 456899999999976544
Q ss_pred CC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC---CCCcccHHH
Q 011326 378 ND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP---VPNSLSRDA 453 (488)
Q Consensus 378 ~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~l 453 (488)
.. .....||+.|+|||++. +.++.++||||+||++|+|++|..||.+.+..+....+..+.... ....+++++
T Consensus 177 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 253 (486)
T 3mwu_A 177 NTKMKDRIGTAYYIAPEVLR---GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253 (486)
T ss_dssp C----CCTTGGGGCCGGGGG---SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHH
T ss_pred CCccCCCcCCCCCCCHHHhC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHH
Confidence 33 34567999999999973 348999999999999999999999999988887777776655432 235689999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 454 QDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
.+||.+||+.||.+|||+.|+++||||++...
T Consensus 254 ~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 99999999999999999999999999986543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=355.85 Aligned_cols=249 Identities=25% Similarity=0.398 Sum_probs=221.2
Q ss_pred ccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 300 (488)
....++|++.+.||+|+||.||+|.+.++..||+|.+..... ....+.+|+.++.+++||||+++++++.+++.
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM------SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP 77 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC------cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence 445678999999999999999999988888999999975332 23568899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 301 LCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
.++||||+++++|.+++... .+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999999999998654 4899999999999999999999999999999999999999999999999999765544
Q ss_pred Cc---ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHH
Q 011326 379 DV---KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQ 454 (488)
Q Consensus 379 ~~---~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~ 454 (488)
.. ....+|+.|+|||.+ ....++.++||||||+++|+|++ |..||...+..+....+........+..+++++.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVF--HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIY 235 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHH--HHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred hhhcccCCCcCcccCCHHHH--hccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHH
Confidence 32 234467789999997 34458899999999999999999 9999999888888888887777777888999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~h 477 (488)
+++.+||+.||.+|||+.|++++
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 236 QIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999976
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=365.30 Aligned_cols=259 Identities=23% Similarity=0.433 Sum_probs=204.9
Q ss_pred cccCceeeeeeecccCceEEEEEEecC-C---cEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTDD-G---FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-g---~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
...++|++++.||+|+||.||+|.+.. + ..||+|.+..... .......+.+|+.++++++||||+++++++..
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII---ASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc---CHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 345689999999999999999998753 3 3899999875432 23445788999999999999999999999887
Q ss_pred CCce------EEEEeeccCCChHHHHhhh-------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcE
Q 011326 298 EKRL------CIFLELVTKGSLASLYQKY-------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSV 364 (488)
Q Consensus 298 ~~~~------~lV~E~~~~gsL~~~l~~~-------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~v 364 (488)
.+.. ++||||+++|+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence 7655 9999999999999988644 38999999999999999999999999999999999999999999
Q ss_pred EEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcC
Q 011326 365 KLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGG 439 (488)
Q Consensus 365 kL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~ 439 (488)
||+|||++....... .....+|+.|+|||.+ .+..++.++||||||+++|+|++ |..||.+.+..+....+..
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 254 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESL--ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred EEeeccccccccccccccccccccCcccccCchhh--cCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence 999999997654332 2234577889999997 45568999999999999999999 9999999888888888887
Q ss_pred CCCCCCCCcccHHHHHHHHHhhhhCCCCCCC-------HHHHHhCccCCCCCC
Q 011326 440 GELPPVPNSLSRDAQDFILKCLQVNPNDRPT-------AAQLMEHPFIKRPLQ 485 (488)
Q Consensus 440 ~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps-------~~eil~hp~f~~~~~ 485 (488)
......+..+++++.+|+.+||+.||.+||| +++++.|||+....+
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence 7777788899999999999999999999999 889999999987654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=405.18 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=224.7
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDE 298 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 298 (488)
+..+++|++++.||+|+||.||+|.+. +++.||||++.+... ........+..|..++..+ +||||+++++++++.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH--HHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence 445789999999999999999999986 688999999975321 0112235677899999987 799999999999999
Q ss_pred CceEEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 299 KRLCIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
+.+|+||||+++|+|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 999999999999999998876 4699999999999999999999999999999999999999999999999999975332
Q ss_pred --CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHH
Q 011326 378 --NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455 (488)
Q Consensus 378 --~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~ 455 (488)
.......||+.|+|||++ ....++.++||||||++||||++|..||.+.+..+....+..... .+|..+++++.+
T Consensus 495 ~~~~~~~~~GT~~Y~APE~l--~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~ 571 (674)
T 3pfq_A 495 DGVTTKTFCGTPDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEAVA 571 (674)
T ss_dssp TTCCBCCCCSCSSSCCHHHH--TCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC-CCCTTSCHHHHH
T ss_pred CCcccccccCCCcccCHhhh--cCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHH
Confidence 234567899999999997 456789999999999999999999999999888888888876654 677889999999
Q ss_pred HHHHhhhhCCCCCCCH-----HHHHhCccCCC
Q 011326 456 FILKCLQVNPNDRPTA-----AQLMEHPFIKR 482 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~-----~eil~hp~f~~ 482 (488)
||.+||+.||.+||++ +||++||||+.
T Consensus 572 li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 572 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred HHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 9999999999999997 99999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=373.28 Aligned_cols=254 Identities=25% Similarity=0.404 Sum_probs=214.7
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCc---chhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPR---GKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
..++|++.+.||+|+||.||+|.+. ++..||+|.+........ .......+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3568999999999999999999875 799999999987543221 111223566899999999999999999999999
Q ss_pred CceEEEEeeccCC-ChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 299 KRLCIFLELVTKG-SLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 299 ~~~~lV~E~~~~g-sL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
+..++||||+.+| +|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 9999999999776 999988765 59999999999999999999999999999999999999999999999999997665
Q ss_pred CCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHH
Q 011326 377 MND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455 (488)
Q Consensus 377 ~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~ 455 (488)
... .....||+.|+|||++. .....+.++||||||+++|+|++|..||...... . ......+..+++++.+
T Consensus 182 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~-~~~~~~~~~~~~~l~~ 253 (335)
T 3dls_A 182 RGKLFYTFCGTIEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------V-EAAIHPPYLVSKELMS 253 (335)
T ss_dssp TTCCBCEECSCGGGCCHHHHT-TCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------T-TTCCCCSSCCCHHHHH
T ss_pred CCCceeccCCCccccChhhhc-CCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------H-hhccCCCcccCHHHHH
Confidence 433 34567999999999973 2333488999999999999999999999763321 1 1222445668999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 456 FILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
||.+||+.||.+|||+.|+++||||+++.
T Consensus 254 li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 254 LVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred HHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 99999999999999999999999998764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=359.95 Aligned_cols=265 Identities=26% Similarity=0.437 Sum_probs=224.3
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcc----hhHHHHHHHHHHHHhcCC-CCCcceeeccc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRG----KQSILQLEQEISLLGQFE-HDNIVQYLGTD 295 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~----~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~ 295 (488)
...++|++.+.||+|+||.||+|.+. +|..||+|.+......... ......+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34678999999999999999999986 7899999999865432211 233457789999999995 99999999999
Q ss_pred cCCCceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccc
Q 011326 296 RDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 374 (488)
Q Consensus 296 ~~~~~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~ 374 (488)
.+++..++||||+++++|.+++... .+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 9999999999999999999998765 689999999999999999999999999999999999999999999999999876
Q ss_pred ccCC-CcccCCCCCcccCchhhcc----ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC---CCC
Q 011326 375 TTMN-DVKSCKGTAFWMAPEVVNL----KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP---PVP 446 (488)
Q Consensus 375 ~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~ 446 (488)
.... ......||+.|+|||.+.. ....++.++||||||+++|+|++|..||...+.......+...... +..
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccc
Confidence 5443 2345679999999999732 2445789999999999999999999999887776666655544332 222
Q ss_pred CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 447 NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 447 ~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
..+++++.+|+.+||+.||.+|||+.|+++||||++....
T Consensus 254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (298)
T 1phk_A 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293 (298)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence 4689999999999999999999999999999999987543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=357.92 Aligned_cols=257 Identities=29% Similarity=0.468 Sum_probs=218.6
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCc-chhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPR-GKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
++|++.+.||+|+||.||+|.+. +|..||+|.+........ .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 47999999999999999999986 799999999986543322 1223567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC----cEEEeecCCcccccC
Q 011326 303 IFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG----SVKLADFGLAKATTM 377 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~----~vkL~DFGla~~~~~ 377 (488)
+||||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 999999999999998654 599999999999999999999999999999999999998877 899999999976543
Q ss_pred C-CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC---CCCcccHHH
Q 011326 378 N-DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP---VPNSLSRDA 453 (488)
Q Consensus 378 ~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~l 453 (488)
. ......||+.|+|||.+ ....++.++||||||+++|+|++|..||...+..+....+....... ....+++++
T Consensus 165 ~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T 3bhy_A 165 GNEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 242 (283)
T ss_dssp -------CCCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHH
T ss_pred CCcccccCCCcCccCccee--cCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHH
Confidence 3 23455699999999997 44568999999999999999999999999887777666665544322 224678999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 454 QDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
.+|+.+||+.||.+|||+.|+++||||+..
T Consensus 243 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 243 KDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 999999999999999999999999999754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=398.70 Aligned_cols=255 Identities=25% Similarity=0.442 Sum_probs=218.3
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
..++|++.+.||+|+||.||+|.+. +|..||+|.+.+.... .......+.+|+.+|++++||||+++++++.+.+.+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh--hhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 3568999999999999999999885 7999999999753211 112235678999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 302 CIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
|+||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 9999999999999988654 3999999999999999999999999999999999999999999999999999876543
Q ss_pred C-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCch----hhhHHHhcCCCCCCCCCcccHHH
Q 011326 379 D-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG----GQAMFKIGGGELPPVPNSLSRDA 453 (488)
Q Consensus 379 ~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~l 453 (488)
. .....||+.|+|||++ .+..++.++|||||||++|||++|..||..... .+....+.. ....++..+++++
T Consensus 340 ~~~~~~~GT~~Y~APEvl--~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~~~~~p~~~s~~~ 416 (576)
T 2acx_A 340 QTIKGRVGTVGYMAPEVV--KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VPEEYSERFSPQA 416 (576)
T ss_dssp CCEECCCSCGGGCCHHHH--TTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-CCCCCCTTSCHHH
T ss_pred ccccccCCCccccCHHHH--cCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-ccccCCccCCHHH
Confidence 3 3456899999999997 345689999999999999999999999987542 223333332 2335667899999
Q ss_pred HHHHHHhhhhCCCCCC-----CHHHHHhCccCCC
Q 011326 454 QDFILKCLQVNPNDRP-----TAAQLMEHPFIKR 482 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rp-----s~~eil~hp~f~~ 482 (488)
.+||.+||+.||.+|| ++.|+++||||+.
T Consensus 417 ~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 9999999999999999 7999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=390.07 Aligned_cols=253 Identities=28% Similarity=0.471 Sum_probs=215.4
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++++.||+|+||.||+|.+. ++..||+|++........ ....+.+|+.+++.++||||+++++++.+...++
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS---SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C---TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch---HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 457999999999999999999986 789999999986543222 2356789999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC---CCcEEEeecCCcccccCC
Q 011326 303 IFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA---SGSVKLADFGLAKATTMN 378 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~---~~~vkL~DFGla~~~~~~ 378 (488)
+||||+++|+|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 99999999999887754 46999999999999999999999999999999999999976 455999999999765543
Q ss_pred C-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC---CCCcccHHHH
Q 011326 379 D-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP---VPNSLSRDAQ 454 (488)
Q Consensus 379 ~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~l~ 454 (488)
. .....||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+....+..+.... ....+++++.
T Consensus 193 ~~~~~~~gt~~y~aPE~l~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 269 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLR---KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHT---TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred ccccccCCCcCeeCHHHHc---ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence 3 44567999999999873 458999999999999999999999999988888777776655432 2246899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
+||.+||+.||.+|||+.|+++||||++
T Consensus 270 ~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 270 DLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHHHHHCCCChhhCccHHHHhcCccccc
Confidence 9999999999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=372.37 Aligned_cols=259 Identities=32% Similarity=0.513 Sum_probs=214.3
Q ss_pred cccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 220 FRRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 220 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
....+++|++.+.||+|+||.||+|.+. +|..||+|.+.... ........+.+|+.++++++||||+++++++.+.
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 96 (331)
T 4aaa_A 20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD---DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK 96 (331)
T ss_dssp CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC---CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC
Confidence 3446789999999999999999999986 69999999987543 3344456778999999999999999999999999
Q ss_pred CceEEEEeeccCCChHHHHh-hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 299 KRLCIFLELVTKGSLASLYQ-KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~-~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
+..++||||+++++|.+++. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999999999988765 44699999999999999999999999999999999999999999999999999976543
Q ss_pred C--CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC----------------
Q 011326 378 N--DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG---------------- 439 (488)
Q Consensus 378 ~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~---------------- 439 (488)
. ......||+.|+|||.+. ....++.++||||||+++|+|++|+.||.+.+..+....+..
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLV-GDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp -------CCCCCTTCCHHHHT-TCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred CccccCCCcCCccccCccccc-CCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 2 234567999999999973 334689999999999999999999999988776554433211
Q ss_pred -----CCCCC---------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 440 -----GELPP---------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 440 -----~~~~~---------~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
...+. ....+++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 00111 11357899999999999999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=389.23 Aligned_cols=260 Identities=28% Similarity=0.408 Sum_probs=220.6
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCc--------chhHHHHHHHHHHHHhcCCCCCcceeec
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPR--------GKQSILQLEQEISLLGQFEHDNIVQYLG 293 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~--------~~~~~~~~~~Ei~iL~~l~HpnIv~l~~ 293 (488)
..++|++++.||+|+||.||+|.+. ++..||+|++........ .......+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3568999999999999999999986 689999999976542211 1133467889999999999999999999
Q ss_pred cccCCCceEEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC---cEEEeec
Q 011326 294 TDRDEKRLCIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG---SVKLADF 369 (488)
Q Consensus 294 ~~~~~~~~~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~---~vkL~DF 369 (488)
++.++..+++||||+++|+|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 99999999999999999999887754 4699999999999999999999999999999999999998776 6999999
Q ss_pred CCcccccCC-CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCC---
Q 011326 370 GLAKATTMN-DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV--- 445 (488)
Q Consensus 370 Gla~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~--- 445 (488)
|++...... ......||+.|+|||++. ..++.++||||+|+++|+|++|..||.+.+..+....+..+.....
T Consensus 194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (504)
T 3q5i_A 194 GLSSFFSKDYKLRDRLGTAYYIAPEVLK---KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270 (504)
T ss_dssp TTCEECCTTSCBCCCCSCTTTCCHHHHT---TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH
T ss_pred CCCEEcCCCCccccccCCcCCCCHHHhc---cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 999766543 345667999999999973 4589999999999999999999999999888888777776654321
Q ss_pred CCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 446 PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 446 ~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
...+++++.+||.+||++||.+|||+.|+++||||++...
T Consensus 271 ~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 271 WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 2568999999999999999999999999999999986554
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=376.55 Aligned_cols=256 Identities=25% Similarity=0.450 Sum_probs=212.5
Q ss_pred ccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC--CCCcceeeccccCCCc
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE--HDNIVQYLGTDRDEKR 300 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~~~ 300 (488)
.-.+|++.+.||+|+||.||++.+.++..||||.+..... .......+.+|+.+|++++ ||||+++++++..++.
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~ 130 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc---cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence 3456999999999999999999988899999999976542 3455678899999999996 5999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 301 LCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
+++||| +.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 999999 5677999988654 588889999999999999999999999999999999995 6899999999997654332
Q ss_pred ----cccCCCCCcccCchhhccc---------cCCCChhhhHHHHHHHHHHHHcCCCCCCCCch-hhhHHHhcC-CCCCC
Q 011326 380 ----VKSCKGTAFWMAPEVVNLK---------KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG-GQAMFKIGG-GELPP 444 (488)
Q Consensus 380 ----~~~~~gt~~y~aPE~~~~~---------~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~-~~~~~~i~~-~~~~~ 444 (488)
.....||+.|+|||++... ...++.++|||||||++|||++|..||..... ......+.. .....
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence 2356799999999997421 23589999999999999999999999976533 233333333 23335
Q ss_pred CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 445 VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 445 ~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
.+...+.++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 289 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 566778999999999999999999999999999999754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=364.32 Aligned_cols=255 Identities=28% Similarity=0.436 Sum_probs=205.6
Q ss_pred cCceeee-eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCc
Q 011326 224 ITSWQKG-ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 224 ~~~y~~~-~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 300 (488)
.+.|++. +.||+|+||.||+|.+. ++..||+|.+..... .....+.+|+.++.++ +||||+++++++.+++.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-----HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-----CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 4578884 78999999999999875 799999999975432 2235678999999885 79999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCc---EEEeecCCccccc
Q 011326 301 LCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS---VKLADFGLAKATT 376 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~---vkL~DFGla~~~~ 376 (488)
.++||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999999988654 5899999999999999999999999999999999999998776 9999999986543
Q ss_pred CC---------CcccCCCCCcccCchhhccc---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh-------------
Q 011326 377 MN---------DVKSCKGTAFWMAPEVVNLK---KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG------------- 431 (488)
Q Consensus 377 ~~---------~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~------------- 431 (488)
.. ......||+.|+|||++... ...++.++||||||+++|+|++|..||......
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 21 12244599999999997421 134788999999999999999999999765421
Q ss_pred --hhHHHhcCCCCCCCC----CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 432 --QAMFKIGGGELPPVP----NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 432 --~~~~~i~~~~~~~~~----~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
.....+..+.. ..+ ..+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 246 ~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 246 QNMLFESIQEGKY-EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHHHCCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHHHHhccCc-ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 22333333332 222 35889999999999999999999999999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=373.86 Aligned_cols=248 Identities=32% Similarity=0.512 Sum_probs=209.1
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCce
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 301 (488)
.++|++.+.||+|+||.||+|.+. +|..||+|.+...... ..+|+.++.++ +||||+++++++.+++..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---------PTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---------CHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 567999999999999999999986 7999999999764321 23577778777 799999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC----CcEEEeecCCccccc
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS----GSVKLADFGLAKATT 376 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~----~~vkL~DFGla~~~~ 376 (488)
|+||||+++|+|.+.+... .+++..+..++.||+.||.|||++||+||||||+|||+..+ +.+||+|||+++...
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999999999888654 58999999999999999999999999999999999998543 359999999997654
Q ss_pred CCC--cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCC---chhhhHHHhcCCCCC---CCCCc
Q 011326 377 MND--VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHL---EGGQAMFKIGGGELP---PVPNS 448 (488)
Q Consensus 377 ~~~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~---~~~~~~~~i~~~~~~---~~~~~ 448 (488)
... .....||+.|+|||++. +..++.++||||||+++|+|++|..||... ...+....+..+... ..+..
T Consensus 172 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 249 (342)
T 2qr7_A 172 AENGLLMTPCYTANFVAPEVLE--RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249 (342)
T ss_dssp CTTCCBCCSSCCSSCCCHHHHH--HHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred CCCCceeccCCCccccCHHHhc--CCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence 332 34567999999999973 344789999999999999999999999763 333445555444432 23357
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 449 LSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 449 ~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
+++++.+||.+||+.||.+|||+.|+++||||..
T Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 8999999999999999999999999999999954
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=376.52 Aligned_cols=256 Identities=28% Similarity=0.463 Sum_probs=205.7
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC----
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE---- 298 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~---- 298 (488)
.++|++.+.||+|+||.||+|.+. ++..||||.+.... ........+.+|+.+|++++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF---EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT---TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh---cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 568999999999999999999985 68999999997532 2344567889999999999999999999998766
Q ss_pred -CceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 299 -KRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 299 -~~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
+..|+||||+.+ +|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 102 FDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred CCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 579999999875 999988765 49999999999999999999999999999999999999999999999999997654
Q ss_pred CCC------------------------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCC--------
Q 011326 377 MND------------------------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHP-------- 424 (488)
Q Consensus 377 ~~~------------------------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~P-------- 424 (488)
... .....||+.|+|||++ .....++.++|||||||++|||++|..|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~-~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 259 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI-LLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHH-TTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHH-hcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence 321 2456799999999986 3455689999999999999999985444
Q ss_pred ---CCCCch-----------------hhh------------------------HHHhcCCC-CCC-----CCCcccHHHH
Q 011326 425 ---YSHLEG-----------------GQA------------------------MFKIGGGE-LPP-----VPNSLSRDAQ 454 (488)
Q Consensus 425 ---f~~~~~-----------------~~~------------------------~~~i~~~~-~~~-----~~~~~s~~l~ 454 (488)
|.+.+. .+. ...+.... ..+ ....+++++.
T Consensus 260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 339 (432)
T 3n9x_A 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI 339 (432)
T ss_dssp CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence 333220 000 00011000 001 1145899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
+||.+||+.||.+|||++|+++||||++..
T Consensus 340 dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 340 NLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 999999999999999999999999998753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=390.88 Aligned_cols=255 Identities=28% Similarity=0.439 Sum_probs=222.3
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||+|.+. +|..||+|++....... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ--KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB--SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc--chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 457999999999999999999986 79999999997654321 233467889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEE---CCCCcEEEeecCCcccccCC
Q 011326 303 IFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILV---DASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl---~~~~~vkL~DFGla~~~~~~ 378 (488)
+||||+.+|+|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 99999999999887754 469999999999999999999999999999999999999 46789999999999765443
Q ss_pred C-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC---CCCcccHHHH
Q 011326 379 D-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP---VPNSLSRDAQ 454 (488)
Q Consensus 379 ~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~l~ 454 (488)
. .....||+.|+|||++. +.++.++||||+|+++|+|++|.+||.+.+..+....+..+.... ....+++++.
T Consensus 183 ~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 259 (484)
T 3nyv_A 183 KKMKDKIGTAYYIAPEVLH---GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 259 (484)
T ss_dssp CSHHHHTTGGGTCCHHHHH---TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred cccccCCCCccccCceeec---CCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence 3 34567999999999973 258999999999999999999999999988888777776655432 2256899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
+||.+||+.||.+|||+.|+++||||+..
T Consensus 260 ~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 260 DLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred HHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 99999999999999999999999999754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=364.94 Aligned_cols=250 Identities=24% Similarity=0.432 Sum_probs=218.3
Q ss_pred ccccCceeeeeeecccCceEEEEEEec----CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecccc
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD----DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR 296 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 296 (488)
....++|++.+.||+|+||.||+|.+. .+..||||.+... ........+.+|+.++++++||||+++++++.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 120 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG----YTERQRRDFLSEASIMGQFDHPNIIRLEGVVT 120 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC----CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 345678999999999999999999884 3456999999743 23445567899999999999999999999999
Q ss_pred CCCceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccc
Q 011326 297 DEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 374 (488)
Q Consensus 297 ~~~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~ 374 (488)
+++..++||||+++|+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999999999999643 699999999999999999999999999999999999999999999999999976
Q ss_pred ccCCC-----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCc
Q 011326 375 TTMND-----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNS 448 (488)
Q Consensus 375 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 448 (488)
..... .....+|+.|+|||++ ....++.++||||||+++|+|++ |..||......+....+..+...+.+..
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAI--AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMG 278 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHH--HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred cccCccceeeccCCCCcccccCHhHh--cCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCC
Confidence 54332 2233467789999997 44568999999999999999999 9999999988888888888877788889
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 449 LSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 449 ~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+++++.+||.+||+.||.+|||+.++++
T Consensus 279 ~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 279 CPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999999999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=354.25 Aligned_cols=252 Identities=27% Similarity=0.517 Sum_probs=205.9
Q ss_pred cccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
....+|++.+.||+|+||.||+|.+. |..||+|.+...... ........+.+|+.+++.++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDE-DISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcc-cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 35678999999999999999999875 889999998754332 1233456788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCC---CccccCCcccEEECC--------CCcEEEeecC
Q 011326 302 CIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQN---VVHRDIKCANILVDA--------SGSVKLADFG 370 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~NILl~~--------~~~vkL~DFG 370 (488)
++||||+++++|.+++....+++..++.++.|++.||.|||++| |+||||||+||+++. ++.++|+|||
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 99999999999999998888999999999999999999999999 899999999999986 7789999999
Q ss_pred CcccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC-CCCCCCcc
Q 011326 371 LAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE-LPPVPNSL 449 (488)
Q Consensus 371 la~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~ 449 (488)
++............||+.|+|||.+ ....++.++||||||+++|+|++|+.||.+.+.......+.... ..+.+..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3dtc_A 162 LAREWHRTTKMSAAGAYAWMAPEVI--RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239 (271)
T ss_dssp C-------------CCGGGSCHHHH--HHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred cccccccccccCCCCccceeCHHHh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence 9987665555567799999999997 44568999999999999999999999999877766655554433 34567789
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
++++.+++.+||+.||.+|||+.|++++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 9999999999999999999999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=361.83 Aligned_cols=257 Identities=33% Similarity=0.604 Sum_probs=215.5
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+++..+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 92 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-----EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence 467999999999999999999986 68999999986542 223467889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC--C
Q 011326 303 IFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--N 378 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~--~ 378 (488)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... .
T Consensus 93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 99999999999998864 4599999999999999999999999999999999999999999999999998753221 1
Q ss_pred CcccCCCCCcccCchhhcc---ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC--CCCCcccHHH
Q 011326 379 DVKSCKGTAFWMAPEVVNL---KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP--PVPNSLSRDA 453 (488)
Q Consensus 379 ~~~~~~gt~~y~aPE~~~~---~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l 453 (488)
......||+.|+|||.+.. ....++.++||||||+++|+|++|..||...+.......+.....+ ..+..++.++
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF 252 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHH
Confidence 2334579999999998731 3456889999999999999999999999987776665555444433 2356789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 454 QDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
.+||.+||+.||.+|||+.++++||||+....
T Consensus 253 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 253 RDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred HHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence 99999999999999999999999999987653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=375.35 Aligned_cols=254 Identities=24% Similarity=0.434 Sum_probs=222.4
Q ss_pred CcccccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc
Q 011326 217 NGKFRRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD 295 (488)
Q Consensus 217 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 295 (488)
...|....++|++.+.||+|+||.||+|.+. ++..||+|.+... ........+.+|+.++++++||||+++++++
T Consensus 106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 181 (377)
T 3cbl_A 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET----LPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181 (377)
T ss_dssp CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT----SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc----CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3456667789999999999999999999986 7999999998643 2233445788999999999999999999999
Q ss_pred cCCCceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 296 RDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 296 ~~~~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
.+++..++||||+++|+|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 182 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSR 261 (377)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred ecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence 9999999999999999999998754 48999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCcc----cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCc
Q 011326 374 ATTMNDVK----SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNS 448 (488)
Q Consensus 374 ~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 448 (488)
........ ...++..|+|||.+. ...++.++||||||+++|||++ |..||...+..+....+..+...+.+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 339 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALN--YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPEL 339 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 64433221 223567799999973 4558999999999999999998 9999999888888888877777788889
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 449 LSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 449 ~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+++++.+||.+||+.||++|||+.++++
T Consensus 340 ~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=369.47 Aligned_cols=257 Identities=27% Similarity=0.458 Sum_probs=210.6
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC----
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD---- 297 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~---- 297 (488)
.+++|++.+.||+|+||.||+|.+. +|..||+|.+........ ....+.+|+.+++.++||||+++++++.+
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLLKHENVVNLIEICRTKASP 91 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSS---SCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccccc---chHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence 4689999999999999999999984 799999999876543322 22456789999999999999999998876
Q ss_pred ----CCceEEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCC
Q 011326 298 ----EKRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGL 371 (488)
Q Consensus 298 ----~~~~~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGl 371 (488)
.+..++||||+++ +|...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 92 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 92 YNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 4468999999987 67666644 3599999999999999999999999999999999999999999999999999
Q ss_pred cccccCC------CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC---CCC
Q 011326 372 AKATTMN------DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG---GEL 442 (488)
Q Consensus 372 a~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~---~~~ 442 (488)
+...... ......||+.|+|||++. ....++.++||||||+++|+|++|..||.+.+.......+.. ...
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLL-GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHT-TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccccccccccCCcccccCccCchhhc-CCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9754321 234566899999999872 345589999999999999999999999998776655444321 111
Q ss_pred CCCCCc----------------------------ccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 443 PPVPNS----------------------------LSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 443 ~~~~~~----------------------------~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
+..... .++++.+||.+||+.||.+|||+.|+++||||+..-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 111100 267899999999999999999999999999997644
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=381.57 Aligned_cols=259 Identities=27% Similarity=0.416 Sum_probs=205.3
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCC---cchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGP---RGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
.++|++.+.||+|+||.||+|.+. ++..||+|.+....... ........+.+|+.+|++++||||+++++++..+
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~- 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 578999999999999999999885 78999999997643211 1122233578999999999999999999998654
Q ss_pred ceEEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC---cEEEeecCCcccc
Q 011326 300 RLCIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG---SVKLADFGLAKAT 375 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~---~vkL~DFGla~~~ 375 (488)
..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 58999999999999888754 4599999999999999999999999999999999999997544 5999999999876
Q ss_pred cCCC-cccCCCCCcccCchhhcc-ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh-hhHHHhcCCCCCCC---CCcc
Q 011326 376 TMND-VKSCKGTAFWMAPEVVNL-KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-QAMFKIGGGELPPV---PNSL 449 (488)
Q Consensus 376 ~~~~-~~~~~gt~~y~aPE~~~~-~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~-~~~~~i~~~~~~~~---~~~~ 449 (488)
.... .....||+.|+|||++.. ....++.++||||||+++|+|++|..||...... .....+..+..... ...+
T Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 372 (419)
T 3i6u_A 293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 372 (419)
T ss_dssp C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTS
T ss_pred CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhccc
Confidence 5433 345679999999999732 2456889999999999999999999999765443 33334444433322 2468
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 373 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 9999999999999999999999999999999863
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=370.29 Aligned_cols=256 Identities=26% Similarity=0.438 Sum_probs=225.1
Q ss_pred CCcccccccCceeeeeeecccCceEEEEEEec--------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCC
Q 011326 216 PNGKFRRRITSWQKGELLGSGSYGFVYEGLTD--------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHD 286 (488)
Q Consensus 216 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~Hp 286 (488)
+...++...++|++++.||+|+||.||+|.+. ++..||+|++... ........+.+|+.+++++ +||
T Consensus 60 ~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp 135 (382)
T 3tt0_A 60 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHK 135 (382)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCT
T ss_pred cCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc----cCHHHHHHHHHHHHHHHHhcCCc
Confidence 33445666789999999999999999999862 3467999998754 2344557889999999999 999
Q ss_pred CcceeeccccCCCceEEEEeeccCCChHHHHhhhc-----------------cChhhhhHHHHHHHHHHHHHHHCCCccc
Q 011326 287 NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-----------------LSDSQVSSYTRQILNGLKYLHEQNVVHR 349 (488)
Q Consensus 287 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------ls~~~~~~i~~qi~~aL~yLH~~giiHr 349 (488)
||+++++++.+++..++||||+++|+|.+++.... +++..++.++.||+.||.|||++||+||
T Consensus 136 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 215 (382)
T 3tt0_A 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 215 (382)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred hhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 99999999999999999999999999999997643 8999999999999999999999999999
Q ss_pred cCCcccEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCC
Q 011326 350 DIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHP 424 (488)
Q Consensus 350 DLkp~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~P 424 (488)
||||+|||++.++.+||+|||+++...... .....+|+.|+|||++ .+..++.++||||||+++|+|++ |..|
T Consensus 216 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DiwslG~il~ellt~g~~p 293 (382)
T 3tt0_A 216 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL--FDRIYTHQSDVWSFGVLLWEIFTLGGSP 293 (382)
T ss_dssp CCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHH--HSCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHh--cCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999997654322 3345578899999997 45668999999999999999999 9999
Q ss_pred CCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 425 YSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 425 f~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
|.+.+..+....+..+.....+..+++++.+|+.+||+.||.+|||+.|++++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 294 YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp STTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99988888888888887778888999999999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=359.89 Aligned_cols=254 Identities=26% Similarity=0.437 Sum_probs=222.6
Q ss_pred cccccccCceeeeeeecccCceEEEEEEe------cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCccee
Q 011326 218 GKFRRRITSWQKGELLGSGSYGFVYEGLT------DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQY 291 (488)
Q Consensus 218 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l 291 (488)
..+.....+|++.+.||+|+||.||+|.+ .++..||+|.+.... .......+.+|+.++++++||||+++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~ 91 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA----SPSELRDLLSEFNVLKQVNHPHVIKL 91 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC----CHHHHHHHHHHHHHHhhCCCCceeeE
Confidence 34555678899999999999999999986 245889999986432 34456788999999999999999999
Q ss_pred eccccCCCceEEEEeeccCCChHHHHhhh-------------------------ccChhhhhHHHHHHHHHHHHHHHCCC
Q 011326 292 LGTDRDEKRLCIFLELVTKGSLASLYQKY-------------------------HLSDSQVSSYTRQILNGLKYLHEQNV 346 (488)
Q Consensus 292 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-------------------------~ls~~~~~~i~~qi~~aL~yLH~~gi 346 (488)
++++.+++..++||||+++++|.+++... .+++..++.++.||+.||.|||++||
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 171 (314)
T 2ivs_A 92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL 171 (314)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred EEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999998653 28899999999999999999999999
Q ss_pred ccccCCcccEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-C
Q 011326 347 VHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-R 421 (488)
Q Consensus 347 iHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G 421 (488)
+||||||+||+++.++.+||+|||++....... .....+|+.|+|||.+ .+..++.++||||||+++|+|++ |
T Consensus 172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL--FDHIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHH--HHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhh--cCCCcCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999997654332 2344578889999997 34568999999999999999999 9
Q ss_pred CCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 422 RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 422 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
..||.+.+..+....+........+..+++++.+|+.+||+.||.+|||+.+++++
T Consensus 250 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 250 GNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999988888888787777777888999999999999999999999999999875
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=373.73 Aligned_cols=254 Identities=27% Similarity=0.414 Sum_probs=204.5
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC--
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK-- 299 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-- 299 (488)
...+|++.+.||+|+||.||+|.+. ++..||+|.+.... ........+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc---CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccc
Confidence 4678999999999999999999885 78999999997543 23445567889999999999999999999987654
Q ss_pred ----ceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 300 ----RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 300 ----~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
..++||||+++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 100 ~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 100 EEFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ccccceEEEEEcCCC-CHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 78999999986 7877775 46899999999999999999999999999999999999999999999999999765
Q ss_pred cCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCC---------
Q 011326 376 TMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV--------- 445 (488)
Q Consensus 376 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~--------- 445 (488)
.... .....||+.|+|||++ .+..++.++||||||+++|+|++|+.||.+.+..+....+......+.
T Consensus 178 ~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 178 GTSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp ------------CTTCCHHHH--TTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred ccccccCCceecCCccCHHHh--cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 4432 3456799999999997 445689999999999999999999999998777665555443221110
Q ss_pred --------------------------C------CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 446 --------------------------P------NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 446 --------------------------~------~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
+ ...++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 0 0125789999999999999999999999999999754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=362.54 Aligned_cols=261 Identities=26% Similarity=0.447 Sum_probs=216.6
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc--cCCC
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD--RDEK 299 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~--~~~~ 299 (488)
..++|++++.||+|+||.||++.+. ++..||+|.+...... ........+.+|+.++++++||||+++++++ .+.+
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR-RIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHH-HSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccc-ccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 3578999999999999999999985 7899999999753211 1123356788999999999999999999988 5566
Q ss_pred ceEEEEeeccCCChHHHHhh---hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 300 RLCIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~---~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
..++||||++++ |.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 899999999986 6666643 459999999999999999999999999999999999999999999999999997654
Q ss_pred CC----CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHH
Q 011326 377 MN----DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRD 452 (488)
Q Consensus 377 ~~----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 452 (488)
.. ......||+.|+|||++......++.++||||||+++|+|++|..||...+..+....+..... ..+..++++
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~ 239 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY-AIPGDCGPP 239 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-CCCSSSCHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC-CCCCccCHH
Confidence 22 1235569999999999743333458899999999999999999999998877776666655443 567789999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 453 AQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 453 l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
+.+||.+||+.||.+|||+.|+++||||++....
T Consensus 240 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 240 LSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 9999999999999999999999999999876543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=392.77 Aligned_cols=255 Identities=25% Similarity=0.421 Sum_probs=218.2
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
..++|++.++||+|+||.||+|.+. +|+.||+|++.+.... .......+.+|+.++++++||||+++++++.+.+.+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK--KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhh--hhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 3568999999999999999999985 7999999999753211 112345678999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh-----ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 302 CIFLELVTKGSLASLYQKY-----HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-----~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
|+||||++||+|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999988643 49999999999999999999999999999999999999999999999999998655
Q ss_pred CCC--cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCch----hhhHHHhcCCCCCCCCCccc
Q 011326 377 MND--VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG----GQAMFKIGGGELPPVPNSLS 450 (488)
Q Consensus 377 ~~~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~s 450 (488)
... .....||+.|+|||++ .+..++.++|||||||++|||++|..||..... .+....+... ....+..++
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l--~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-~~~~p~~~s 417 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELL--LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-AVTYPDKFS 417 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-CCCCCTTSC
T ss_pred CCCcccccccCCccccChhhh--cCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-ccCCCcccC
Confidence 433 2345899999999998 456689999999999999999999999976532 3333333333 235677899
Q ss_pred HHHHHHHHHhhhhCCCCCCC-----HHHHHhCccCCC
Q 011326 451 RDAQDFILKCLQVNPNDRPT-----AAQLMEHPFIKR 482 (488)
Q Consensus 451 ~~l~~Li~~cL~~dP~~Rps-----~~eil~hp~f~~ 482 (488)
+++.+||.+||+.||.+||+ ++++++||||+.
T Consensus 418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 99999999999999999996 489999999986
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=358.78 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=212.2
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||+|.+. ++..||+|.+..... ........+.+|+.++++++||||+++++++.+++..+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR--EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc--ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 467999999999999999999975 799999999976443 33455678899999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 303 IFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
+||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 999999999999998765 58999999999999999999999999999999999999999999999999997654332
Q ss_pred -cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC----CCCcccHHHH
Q 011326 380 -VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP----VPNSLSRDAQ 454 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~----~~~~~s~~l~ 454 (488)
.....||+.|+|||.+ .+..++.++||||||+++|+|++|+.||.+.+.............+. .+..+++.+.
T Consensus 168 ~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 245 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQA--KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245 (294)
T ss_dssp -------CCSSCCHHHH--HTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred ccCccccCccccCHhHh--cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence 2345699999999997 45568999999999999999999999999887766655555444433 3467899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
++|.+||+.||.+||+..+.+.+.|.
T Consensus 246 ~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 246 NVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp HHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHhcCCHhHccccHHHHHHHHH
Confidence 99999999999999955555555543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=363.40 Aligned_cols=261 Identities=31% Similarity=0.553 Sum_probs=197.8
Q ss_pred cccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 220 FRRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 220 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
+....++|++.+.||+|+||.||+|.+. ++..||+|.+..... ......+.+|+.++++++||||+++++++...
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC----QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEESS
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc----chhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence 3445678999999999999999999875 789999999865421 22345678999999999999999999999999
Q ss_pred CceEEEEeeccCCChHHHHhh---------hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeec
Q 011326 299 KRLCIFLELVTKGSLASLYQK---------YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADF 369 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~---------~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DF 369 (488)
+..++||||+++++|.+++.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEec
Confidence 999999999999999998863 24899999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCC-------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC
Q 011326 370 GLAKATTMND-------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL 442 (488)
Q Consensus 370 Gla~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~ 442 (488)
|++....... .....||+.|+|||.+. ....++.++||||||+++|+|++|..||.................
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 244 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME-QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHH-HHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhc-cccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC
Confidence 9886543221 23456999999999973 224578999999999999999999999988766655444433322
Q ss_pred C---------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 443 P---------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 443 ~---------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
+ .....+++++.+|+.+||+.||.+|||+.++++||||++.-.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 2 233568899999999999999999999999999999987643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=357.70 Aligned_cols=261 Identities=38% Similarity=0.636 Sum_probs=213.7
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
.....+|....+||+|+||.||+|.+. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 18 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 92 (295)
T 2clq_A 18 DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG 92 (295)
T ss_dssp EECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-----C---HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC
Confidence 344555666678999999999999975 78999999997543 223457889999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhh----ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC-CCcEEEeecCCccc
Q 011326 300 RLCIFLELVTKGSLASLYQKY----HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAKA 374 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~----~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~-~~~vkL~DFGla~~ 374 (488)
..++||||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++. ++.++|+|||++..
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~ 172 (295)
T 2clq_A 93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR 172 (295)
T ss_dssp EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccc
Confidence 999999999999999998754 3668889999999999999999999999999999999987 89999999999976
Q ss_pred ccCCC--cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhh--HHHhcCCCCCCCCCccc
Q 011326 375 TTMND--VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQA--MFKIGGGELPPVPNSLS 450 (488)
Q Consensus 375 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~s 450 (488)
..... .....||+.|+|||.+......++.++||||||+++|+|++|+.||........ .........+..+..++
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (295)
T 2clq_A 173 LAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS 252 (295)
T ss_dssp SCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSC
T ss_pred cCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCC
Confidence 54322 345679999999999854334578999999999999999999999975433221 11122233456678899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 451 RDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 451 ~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
+++.+||.+||+.||++|||+.++++||||+...++
T Consensus 253 ~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 288 (295)
T 2clq_A 253 AEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK 288 (295)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC----
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcChhhhhcccc
Confidence 999999999999999999999999999999876543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=351.44 Aligned_cols=251 Identities=23% Similarity=0.404 Sum_probs=221.4
Q ss_pred ccccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
+|....++|++.+.||+|+||.||+|.+.++..||+|.+..... ....+.+|+.++++++||||+++++++.++
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 75 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB------CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34556679999999999999999999998889999999975432 225688999999999999999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 299 KRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
+..++||||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 76 APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp SSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccc
Confidence 9999999999999999999764 48999999999999999999999999999999999999999999999999987654
Q ss_pred CCC---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHH
Q 011326 377 MND---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRD 452 (488)
Q Consensus 377 ~~~---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 452 (488)
... .....+|+.|+|||.+ ....++.++||||||+++|+|++ |..||...+..+....+..+.....+..++++
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 233 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 233 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred cccccccccccccccccChhhh--cCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHH
Confidence 322 2345577889999997 44568999999999999999999 89999988888888888777666777889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 453 AQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 453 l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
+.+++.+||+.||.+|||+.+++++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 234 VYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999874
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=375.62 Aligned_cols=255 Identities=29% Similarity=0.437 Sum_probs=197.3
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC----
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE---- 298 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~---- 298 (488)
.++|++.+.||+|+||.||+|.+. +|..||||.+.... ........+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 478999999999999999999875 79999999986533 2344556788999999999999999999988654
Q ss_pred --CceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 299 --KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 299 --~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
...++|||++ +++|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp GCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred cCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 5689999999 6799999988889999999999999999999999999999999999999999999999999997654
Q ss_pred CCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC----------------
Q 011326 377 MNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG---------------- 440 (488)
Q Consensus 377 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~---------------- 440 (488)
. ......||+.|+|||++. ....++.++|||||||++|||++|+.||.+.+..+....+...
T Consensus 184 ~-~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 184 D-EMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp --------CCCTTCCHHHHT-TCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred c-cCCCcCcCcCccChHHHc-CCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 3 244567999999999973 3356899999999999999999999999887765544333210
Q ss_pred ---------CCC-----CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 441 ---------ELP-----PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 441 ---------~~~-----~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
..+ .....+++++.+||.+||+.||.+|||+.|+++||||++..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 000 01135688999999999999999999999999999998753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=382.32 Aligned_cols=250 Identities=26% Similarity=0.475 Sum_probs=220.9
Q ss_pred cccccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 218 GKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 218 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
..|+...++|++.+.||+|+||.||+|.+.++..||||.+.... .....+.+|+.+|++++||||+++++++.
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~l~~~~~- 253 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS------MSVEAFLAEANVMKTLQHDKLVKLHAVVT- 253 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS------BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC------ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-
Confidence 44667788999999999999999999999888999999997532 23467899999999999999999999987
Q ss_pred CCceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 374 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~ 374 (488)
.+..++||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 254 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 56789999999999999999653 588999999999999999999999999999999999999999999999999976
Q ss_pred ccCCC---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCccc
Q 011326 375 TTMND---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLS 450 (488)
Q Consensus 375 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s 450 (488)
..... .....+|..|+|||++ ....++.++||||||+++|||++ |+.||.+.+..+....+..+...+.+..++
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~ 411 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP 411 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSC
T ss_pred cCCCceeccCCCcccccccCHHHh--ccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 54322 2334567889999997 34568999999999999999999 999999988888888777777777788999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 451 RDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 451 ~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+++.+||.+||+.||++|||+.+|++
T Consensus 412 ~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 412 EELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHH
Confidence 99999999999999999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=377.89 Aligned_cols=250 Identities=28% Similarity=0.422 Sum_probs=202.4
Q ss_pred ccCceeee-eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHh-cCCCCCcceeeccccC--
Q 011326 223 RITSWQKG-ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLG-QFEHDNIVQYLGTDRD-- 297 (488)
Q Consensus 223 ~~~~y~~~-~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~-~l~HpnIv~l~~~~~~-- 297 (488)
.+++|.+. ++||+|+||.||+|.+. +|..||||++... ..+.+|+.++. ..+||||+++++++..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 46778887 78999999999999886 7999999998631 24567888764 4589999999998765
Q ss_pred --CCceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC---CCcEEEeec
Q 011326 298 --EKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA---SGSVKLADF 369 (488)
Q Consensus 298 --~~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~---~~~vkL~DF 369 (488)
.+.+|+||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 66799999999999999999754 4999999999999999999999999999999999999987 789999999
Q ss_pred CCcccccCC-CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhh----hHHHhcCCCCC-
Q 011326 370 GLAKATTMN-DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ----AMFKIGGGELP- 443 (488)
Q Consensus 370 Gla~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~----~~~~i~~~~~~- 443 (488)
|+++..... ......||+.|+|||++ ....++.++|||||||++|+|++|..||...+... ....+..+...
T Consensus 209 G~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~ 286 (400)
T 1nxk_A 209 GFAKETTSHNSLTTPCYTPYYVAPEVL--GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286 (400)
T ss_dssp TTCEECC-----------CTTCCGGGS--CCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred ccccccCCCCccccCCCCCCccCHhhc--CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence 999765433 23466799999999997 45668999999999999999999999997654322 22233222221
Q ss_pred --CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 444 --PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 444 --~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
+....+++++.+||.+||+.||.+|||+.|+++||||.+..
T Consensus 287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 22356899999999999999999999999999999997643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=364.93 Aligned_cols=256 Identities=28% Similarity=0.489 Sum_probs=213.0
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC---
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE--- 298 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--- 298 (488)
..++|++.+.||+|+||.||+|.+. +|..||||.+... ........+.+|+.++++++||||+++++++..+
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF----DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc----ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 3568999999999999999999986 7999999999642 2344456788999999999999999999987654
Q ss_pred --CceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 299 --KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 299 --~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
...++||||+.+ +|.+++....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 85 ~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 85 NFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp TCCCEEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 679999999985 89999988889999999999999999999999999999999999999999999999999997554
Q ss_pred CCC------------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC---C-
Q 011326 377 MND------------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG---G- 440 (488)
Q Consensus 377 ~~~------------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~---~- 440 (488)
... .....||+.|+|||++. ....++.++||||||+++|+|++|..||.+.+..+....+.. .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVML-TSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHH-SCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccccccCccccccchhhccccccccCCeeec-cCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 221 22346899999999872 346689999999999999999999999988765443322210 0
Q ss_pred ----------------------CCC-----CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 441 ----------------------ELP-----PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 441 ----------------------~~~-----~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
..+ .....+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 000 01246889999999999999999999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=374.55 Aligned_cols=261 Identities=28% Similarity=0.435 Sum_probs=214.3
Q ss_pred ccccCceeeeeeecccCceEEEEEEe----cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccc
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLT----DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTD 295 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~ 295 (488)
...+++|++.+.||+|+||.||++.+ .++..||||++...... ........+.+|+.+++++ +||||+++++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEE-EEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhh-hhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 34568999999999999999999987 37899999998643211 0111223456788999999 699999999999
Q ss_pred cCCCceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccc
Q 011326 296 RDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 374 (488)
Q Consensus 296 ~~~~~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~ 374 (488)
.+++..++||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 9999999999999999999988654 599999999999999999999999999999999999999999999999999875
Q ss_pred ccCC---CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh----hhHHHhcCCCCCCCCC
Q 011326 375 TTMN---DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG----QAMFKIGGGELPPVPN 447 (488)
Q Consensus 375 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~----~~~~~i~~~~~~~~~~ 447 (488)
.... ......||+.|+|||++......++.++||||||+++|||++|..||...... .....+. ...++.+.
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~ 287 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KSEPPYPQ 287 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-HCCCCCCT
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh-ccCCCCCc
Confidence 4322 22345799999999998533455789999999999999999999999754322 2222222 23346677
Q ss_pred cccHHHHHHHHHhhhhCCCCCC-----CHHHHHhCccCCCC
Q 011326 448 SLSRDAQDFILKCLQVNPNDRP-----TAAQLMEHPFIKRP 483 (488)
Q Consensus 448 ~~s~~l~~Li~~cL~~dP~~Rp-----s~~eil~hp~f~~~ 483 (488)
.++..+.+||.+||+.||.+|| ++.|+++||||++.
T Consensus 288 ~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 8999999999999999999999 99999999999863
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=373.42 Aligned_cols=249 Identities=26% Similarity=0.441 Sum_probs=205.9
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecccc-----
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR----- 296 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~----- 296 (488)
...+|++++.||+|+||.||+|.+. +|..||+|.+...... ..+|+.+++.++||||+++++++.
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---------~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---------KNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 4568999999999999999999884 7999999998754321 236999999999999999999873
Q ss_pred ---------------------------------CCCceEEEEeeccCCChHHHHhh-----hccChhhhhHHHHHHHHHH
Q 011326 297 ---------------------------------DEKRLCIFLELVTKGSLASLYQK-----YHLSDSQVSSYTRQILNGL 338 (488)
Q Consensus 297 ---------------------------------~~~~~~lV~E~~~~gsL~~~l~~-----~~ls~~~~~~i~~qi~~aL 338 (488)
.....++||||+++ +|.+.+.. ..+++..+..++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 33458999999996 77776643 3599999999999999999
Q ss_pred HHHHHCCCccccCCcccEEEC-CCCcEEEeecCCcccccCC-CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHH
Q 011326 339 KYLHEQNVVHRDIKCANILVD-ASGSVKLADFGLAKATTMN-DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVL 416 (488)
Q Consensus 339 ~yLH~~giiHrDLkp~NILl~-~~~~vkL~DFGla~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~ 416 (488)
.|||++||+||||||+|||++ .++.+||+|||+++..... ......||+.|+|||.+. ....++.++||||+||++|
T Consensus 155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELML-GATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHT-TCSSCCTHHHHHHHHHHHH
T ss_pred HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhc-CCCCCCcchhhhhHHHHHH
Confidence 999999999999999999998 6899999999999865433 344667899999999873 3445899999999999999
Q ss_pred HHHcCCCCCCCCchhhhHHHhcCC-------------------CCC---------CCCCcccHHHHHHHHHhhhhCCCCC
Q 011326 417 EMLTRRHPYSHLEGGQAMFKIGGG-------------------ELP---------PVPNSLSRDAQDFILKCLQVNPNDR 468 (488)
Q Consensus 417 eLltG~~Pf~~~~~~~~~~~i~~~-------------------~~~---------~~~~~~s~~l~~Li~~cL~~dP~~R 468 (488)
||++|+.||.+.+..+....+... ..+ ..+..+++++.+||.+||+.||.+|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999999987766555443210 011 1345688999999999999999999
Q ss_pred CCHHHHHhCccCCC
Q 011326 469 PTAAQLMEHPFIKR 482 (488)
Q Consensus 469 ps~~eil~hp~f~~ 482 (488)
||+.|+++||||++
T Consensus 314 ~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 314 INPYEAMAHPFFDH 327 (383)
T ss_dssp CCHHHHHTSGGGHH
T ss_pred CCHHHHhcCHHHHH
Confidence 99999999999964
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=364.79 Aligned_cols=252 Identities=24% Similarity=0.441 Sum_probs=221.4
Q ss_pred cccccCceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeec
Q 011326 220 FRRRITSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLG 293 (488)
Q Consensus 220 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~ 293 (488)
+....++|++.+.||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.++++++||||+++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 117 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDNPNIVKLLG 117 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 3445688999999999999999999874 34889999987432 3445567899999999999999999999
Q ss_pred cccCCCceEEEEeeccCCChHHHHhh-------------------------hccChhhhhHHHHHHHHHHHHHHHCCCcc
Q 011326 294 TDRDEKRLCIFLELVTKGSLASLYQK-------------------------YHLSDSQVSSYTRQILNGLKYLHEQNVVH 348 (488)
Q Consensus 294 ~~~~~~~~~lV~E~~~~gsL~~~l~~-------------------------~~ls~~~~~~i~~qi~~aL~yLH~~giiH 348 (488)
++.+++..++||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+|
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH 197 (343)
T 1luf_A 118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 197 (343)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 99999999999999999999999865 45889999999999999999999999999
Q ss_pred ccCCcccEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCC
Q 011326 349 RDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRH 423 (488)
Q Consensus 349 rDLkp~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~ 423 (488)
|||||+|||++.++.+||+|||++....... .....+|+.|+|||.+ ....++.++||||||+++|+|++ |..
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI--FYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhh--ccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999987543222 2345688999999997 34568999999999999999999 999
Q ss_pred CCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 424 PYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 424 Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
||.+.+..+....+..+.....+..+++++.+|+.+||+.||.+|||+.+++++
T Consensus 276 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 999988888888888888778888999999999999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=379.63 Aligned_cols=254 Identities=28% Similarity=0.440 Sum_probs=207.4
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC------CCCCcceeecccc
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF------EHDNIVQYLGTDR 296 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l------~HpnIv~l~~~~~ 296 (488)
..+|++.+.||+|+||.||+|.+. ++..||||++.. .......+.+|+.+++.+ +|+||+++++++.
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN------EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC------ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 467999999999999999999885 689999999963 233345667788777776 6789999999999
Q ss_pred CCCceEEEEeeccCCChHHHHhhhc---cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCc--EEEeecCC
Q 011326 297 DEKRLCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS--VKLADFGL 371 (488)
Q Consensus 297 ~~~~~~lV~E~~~~gsL~~~l~~~~---ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~--vkL~DFGl 371 (488)
..+..++||||+. ++|.+++.... +++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999999997 58988886543 899999999999999999999999999999999999999887 99999999
Q ss_pred cccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC-----------
Q 011326 372 AKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG----------- 440 (488)
Q Consensus 372 a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~----------- 440 (488)
+..... ......||+.|+|||++ .+..++.++|||||||++|||++|.+||.+.+..+....+...
T Consensus 249 a~~~~~-~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 249 SCYEHQ-RVYTYIQSRFYRAPEVI--LGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp CEETTC-CCCSSCSCGGGCCHHHH--HTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ceecCC-cccccCCCCCccChHHH--hCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 965442 34456799999999997 3456899999999999999999999999887765544332210
Q ss_pred -----------CCC------------------------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHH
Q 011326 441 -----------ELP------------------------------------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQ 473 (488)
Q Consensus 441 -----------~~~------------------------------------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~e 473 (488)
..+ .++...++++.+||.+||++||++|||+.|
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 000 011234788999999999999999999999
Q ss_pred HHhCccCCCCCCCC
Q 011326 474 LMEHPFIKRPLQTS 487 (488)
Q Consensus 474 il~hp~f~~~~~~~ 487 (488)
+++||||++...++
T Consensus 406 ~L~Hpw~~~~~~~~ 419 (429)
T 3kvw_A 406 ALRHPWLRRRLPKP 419 (429)
T ss_dssp HHTSTTTC------
T ss_pred HhCChhhccCCCCC
Confidence 99999999876543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=365.81 Aligned_cols=256 Identities=26% Similarity=0.382 Sum_probs=211.9
Q ss_pred ccCceeeeeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc-
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR- 300 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~- 300 (488)
..++|++.+.||+|+||.||+|.+ .+++.||+|++..... ........+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA--RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT--TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc--CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 356899999999999999999998 4799999999976433 234556678999999999999999999999876554
Q ss_pred ---eEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 301 ---LCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 301 ---~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
.++||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 49999999999999998654 59999999999999999999999999999999999999999999999999997554
Q ss_pred CCC-----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC---CCCc
Q 011326 377 MND-----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP---VPNS 448 (488)
Q Consensus 377 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~ 448 (488)
... .....||+.|+|||++ .+..++.++||||||+++|+|++|+.||.+.+..+...........+ ....
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQA--RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245 (311)
T ss_dssp --------------CCTTCCHHHH--HTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred ccccccccccccCcCcccCCHHHh--cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence 322 2345689999999997 45568999999999999999999999999887766655444333221 2346
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 449 LSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 449 ~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
+++++.+||.+||+.||.+||+..+++.|+|++.
T Consensus 246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 8999999999999999999999999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=367.53 Aligned_cols=258 Identities=24% Similarity=0.418 Sum_probs=220.0
Q ss_pred ccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcc------------hhHHHHHHHHHHHHhcCCCCCcce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRG------------KQSILQLEQEISLLGQFEHDNIVQ 290 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~------------~~~~~~~~~Ei~iL~~l~HpnIv~ 290 (488)
..++|++.+.||+|+||.||+|.+ +|..||+|.+......... ......+.+|+.++++++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 467999999999999999999998 8999999999754321110 112267889999999999999999
Q ss_pred eeccccCCCceEEEEeeccCCChHHH------Hhh---hccChhhhhHHHHHHHHHHHHHHH-CCCccccCCcccEEECC
Q 011326 291 YLGTDRDEKRLCIFLELVTKGSLASL------YQK---YHLSDSQVSSYTRQILNGLKYLHE-QNVVHRDIKCANILVDA 360 (488)
Q Consensus 291 l~~~~~~~~~~~lV~E~~~~gsL~~~------l~~---~~ls~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~NILl~~ 360 (488)
+++++.+++..++||||+++++|.++ +.. ..+++..++.++.|++.||.|||+ +||+||||||+||+++.
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 99999999999999999999999998 543 458999999999999999999999 99999999999999999
Q ss_pred CCcEEEeecCCcccccCCCcccCCCCCcccCchhhccccCCCCh-hhhHHHHHHHHHHHHcCCCCCCCCch-hhhHHHhc
Q 011326 361 SGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGL-TADIWSLGCTVLEMLTRRHPYSHLEG-GQAMFKIG 438 (488)
Q Consensus 361 ~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~-k~DvwSlGvlL~eLltG~~Pf~~~~~-~~~~~~i~ 438 (488)
++.++|+|||.+............||+.|+|||.+. ....++. ++||||||+++|+|++|..||..... .+....+.
T Consensus 188 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~ 266 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFS-NESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266 (348)
T ss_dssp TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGS-SCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHT
T ss_pred CCcEEEeccccccccccccccCCCCCcCccCchhhc-CCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Confidence 999999999999876555556678999999999973 2224555 99999999999999999999988766 55555555
Q ss_pred CCCCCCCC-------------------CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 439 GGELPPVP-------------------NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 439 ~~~~~~~~-------------------~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
.... ..+ ..+++++.+||.+||+.||.+|||+.|+++||||++.
T Consensus 267 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 267 TKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp SCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 4433 233 5689999999999999999999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=379.23 Aligned_cols=251 Identities=18% Similarity=0.206 Sum_probs=200.4
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHH---HHHhcCCCCCcceee------
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEI---SLLGQFEHDNIVQYL------ 292 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei---~iL~~l~HpnIv~l~------ 292 (488)
...+|++.+.||+|+||.||+|.+. +|..||||++...... .......+.+|+ .++++++||||++++
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP--PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-C--CTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecccc--chHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 4568999999999999999999974 7999999999865332 233456788999 556666899999998
Q ss_pred -ccccCCC-----------------ceEEEEeeccCCChHHHHhhh-ccCh-------hhhhHHHHHHHHHHHHHHHCCC
Q 011326 293 -GTDRDEK-----------------RLCIFLELVTKGSLASLYQKY-HLSD-------SQVSSYTRQILNGLKYLHEQNV 346 (488)
Q Consensus 293 -~~~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~-~ls~-------~~~~~i~~qi~~aL~yLH~~gi 346 (488)
+++.+++ ..++||||+ +|+|.+++... .+++ ..++.++.||+.||+|||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 227 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 227 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4444332 388999999 57999998653 3444 7888899999999999999999
Q ss_pred ccccCCcccEEECCCCcEEEeecCCcccccCCCcccCCCCCcccCchhhccc---------cCCCChhhhHHHHHHHHHH
Q 011326 347 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLK---------KDGYGLTADIWSLGCTVLE 417 (488)
Q Consensus 347 iHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~k~DvwSlGvlL~e 417 (488)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++... ...++.++||||||+++||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 9999999999999999999999999976432 3345567 999999998432 0158999999999999999
Q ss_pred HHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 418 MLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 418 LltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
|++|+.||...+.......+.. ....+++++.+||.+||+.||.+|||+.|+++||||++.
T Consensus 306 lltg~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 306 IWCADLPITKDAALGGSEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHSSCCC------CCSGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHCCCCCcccccccchhhhhh-----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 9999999987665544443332 235789999999999999999999999999999999753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=365.71 Aligned_cols=255 Identities=25% Similarity=0.432 Sum_probs=215.3
Q ss_pred cCceeee-eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCc
Q 011326 224 ITSWQKG-ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 224 ~~~y~~~-~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 300 (488)
.++|.+. +.||+|+||.||+|.+. ++..||+|.+...... ......+.+|+.++..+ +||||+++++++.+.+.
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG---QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT---EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc---hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 4567777 89999999999999886 7999999999765432 22345788999999998 56999999999999999
Q ss_pred eEEEEeeccCCChHHHHhh---hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC---CCcEEEeecCCccc
Q 011326 301 LCIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA---SGSVKLADFGLAKA 374 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~---~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~---~~~vkL~DFGla~~ 374 (488)
.++||||+++|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 9999999999999998854 45899999999999999999999999999999999999987 78999999999976
Q ss_pred ccCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC---CCCCCCccc
Q 011326 375 TTMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE---LPPVPNSLS 450 (488)
Q Consensus 375 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~s 450 (488)
..... .....||+.|+|||++ ....++.++||||||+++|+|++|..||...+..+....+.... .......++
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 261 (327)
T 3lm5_A 184 IGHACELREIMGTPEYLAPEIL--NYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVS 261 (327)
T ss_dssp C---------CCCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred cCCccccccccCCcCccCCeee--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccC
Confidence 55432 3456799999999997 45568999999999999999999999998887776655544332 233445789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 451 RDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 451 ~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
+++.+||.+||+.||.+|||++|+++||||++.
T Consensus 262 ~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 262 QLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 999999999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=371.76 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=220.7
Q ss_pred cccCceeeeeeecccCceEEEEEEe------cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLT------DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD 295 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 295 (488)
....+|++.+.||+|+||.||+|.+ .++..||||.+... ........+.+|+.++++++||||+++++++
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----CSEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc----cChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3457899999999999999999984 25778999998632 2344556788999999999999999999999
Q ss_pred cCCCceEEEEeeccCCChHHHHhhh--------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC---cE
Q 011326 296 RDEKRLCIFLELVTKGSLASLYQKY--------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG---SV 364 (488)
Q Consensus 296 ~~~~~~~lV~E~~~~gsL~~~l~~~--------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~---~v 364 (488)
.+....++||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 9999999999999999999999764 388999999999999999999999999999999999999555 59
Q ss_pred EEeecCCcccccCC----CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcC
Q 011326 365 KLADFGLAKATTMN----DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGG 439 (488)
Q Consensus 365 kL~DFGla~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~ 439 (488)
||+|||+++..... ......||+.|+|||++ .+..++.++|||||||++|||++ |..||...+..+....+..
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~ 301 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHh--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999999743221 22345688999999997 45568999999999999999998 9999999888888888888
Q ss_pred CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 440 GELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 440 ~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
+.....+..+++++.+|+.+||+.||.+|||+.+++++.++
T Consensus 302 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 87777888999999999999999999999999999998764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=358.89 Aligned_cols=253 Identities=36% Similarity=0.655 Sum_probs=212.9
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
..++|++.+.||+|+||.||+|.+. +|..||+|.+..... ...+.+|+.++.+++||||+++++++.+++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-------CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-------HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 4567999999999999999999886 699999999975431 24678999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHh--hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC-
Q 011326 302 CIFLELVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN- 378 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~--~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~- 378 (488)
++||||+++++|.+++. ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999999999986 346999999999999999999999999999999999999999999999999999765433
Q ss_pred -CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC--CCCCcccHHHHH
Q 011326 379 -DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP--PVPNSLSRDAQD 455 (488)
Q Consensus 379 -~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~ 455 (488)
......||+.|+|||.+ ....++.++||||||+++|+|++|..||...+.......+.....+ ..+..+++++.+
T Consensus 180 ~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 257 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVI--QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257 (314)
T ss_dssp SCBCCCCSCGGGCCHHHH--SSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred cccCccCCCCCccChhhc--CCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence 23456799999999997 4456899999999999999999999999887766555444333222 234568999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 456 FILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
||.+||+.||.+|||+.++++||||+..-
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred HHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 99999999999999999999999998753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=353.39 Aligned_cols=251 Identities=27% Similarity=0.465 Sum_probs=208.8
Q ss_pred cccccCceeeeeeecccCceEEEEEEec----CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc
Q 011326 220 FRRRITSWQKGELLGSGSYGFVYEGLTD----DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD 295 (488)
Q Consensus 220 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 295 (488)
+....++|++.+.||+|+||.||+|.+. .+..||+|.+... ........+.+|+.++++++||||+++++++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVI 85 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence 4455678999999999999999999874 2567999997643 2344556789999999999999999999998
Q ss_pred cCCCceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 296 RDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 296 ~~~~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
. ++..++||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 86 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 86 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred c-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence 5 45789999999999999998754 48999999999999999999999999999999999999999999999999997
Q ss_pred cccCCC---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcc
Q 011326 374 ATTMND---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSL 449 (488)
Q Consensus 374 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 449 (488)
...... .....+|+.|+|||.+ ....++.++||||||+++|||++ |..||.+.+..+....+......+.+..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 242 (281)
T ss_dssp --------------CCGGGCCHHHH--HHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred ccCcccccccccCCCcccccChhhc--ccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCC
Confidence 654332 2234577889999997 44568999999999999999997 99999988888888888877777788899
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
++++.+++.+||+.||.+|||+.|++++
T Consensus 243 ~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 243 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=369.34 Aligned_cols=253 Identities=28% Similarity=0.442 Sum_probs=209.9
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce-
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL- 301 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~- 301 (488)
.++|++.+.||+|+||.||+|.+. +|..||+|.+.... ........+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc---cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence 468999999999999999999885 79999999997543 2344567788999999999999999999999877655
Q ss_pred -----EEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 302 -----CIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 302 -----~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
++||||+.+ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 118 NFYDFYLVMPFMQT-DLQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp TCCCCEEEEECCCE-EHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred cceeEEEEEccccc-cHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 999999985 88877743 59999999999999999999999999999999999999999999999999997654
Q ss_pred CCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC----------------
Q 011326 377 MNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG---------------- 440 (488)
Q Consensus 377 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~---------------- 440 (488)
. ......||+.|+|||++. ....++.++||||||+++|+|++|+.||.+.+..+....+...
T Consensus 196 ~-~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 196 A-EMTGYVVTRWYRAPEVIL-SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp -----CTTCCCTTSCHHHHS-CCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred c-CcCCcccCccccCHHHhc-CCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 3 334567899999999973 3356899999999999999999999999887755544433210
Q ss_pred -----------C---CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 441 -----------E---LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 441 -----------~---~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
. ....+..+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0 001124578999999999999999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=359.19 Aligned_cols=251 Identities=26% Similarity=0.456 Sum_probs=207.9
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccC--CC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRD--EK 299 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~--~~ 299 (488)
.++|++.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+|+.++++++ ||||+++++++.+ ..
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 106 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence 578999999999999999999874 79999999986321 256789999999997 9999999999887 66
Q ss_pred ceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC-cEEEeecCCcccccCC
Q 011326 300 RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG-SVKLADFGLAKATTMN 378 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~ 378 (488)
..++||||+++++|.+++. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 107 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQ--TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp CEEEEEECCCCCCHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ceEEEEeccCchhHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 7899999999999999875 489999999999999999999999999999999999999777 8999999999765433
Q ss_pred -CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCch-hhhHHHh-------------cCCC--
Q 011326 379 -DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG-GQAMFKI-------------GGGE-- 441 (488)
Q Consensus 379 -~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~-~~~~~~i-------------~~~~-- 441 (488)
......||+.|+|||.+. ....++.++||||||+++|+|++|..||..... .+....+ ....
T Consensus 185 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 185 QEYNVRVASRYFKGPELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp CCCCSCCSCGGGCCHHHHT-TCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CccccccccccccChhhhc-CCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 344567999999999973 335689999999999999999999999954322 1111110 0000
Q ss_pred ---------------------CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 442 ---------------------LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 442 ---------------------~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
....+..+++++.+||.+||+.||.+|||++|+++||||+...+
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 01112337999999999999999999999999999999998654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=358.94 Aligned_cols=254 Identities=27% Similarity=0.454 Sum_probs=207.6
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc-------
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD------- 295 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~------- 295 (488)
.++|++.+.||+|+||.||+|.+. +++.||+|.+... .......+.+|+.++++++||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-----ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 468999999999999999999986 5999999998753 344567788999999999999999999876
Q ss_pred -------cCCCceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEEC-CCCcEEEe
Q 011326 296 -------RDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVD-ASGSVKLA 367 (488)
Q Consensus 296 -------~~~~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~-~~~~vkL~ 367 (488)
.+....++||||+++ +|.+++....+++..++.++.|++.||.|||++||+||||||+||+++ .++.+||+
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp CC----CCSCSEEEEEEECCSE-EHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccccccccccCceeEEeeccCC-CHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 345678999999985 999999888899999999999999999999999999999999999997 56799999
Q ss_pred ecCCcccccCC-----CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC
Q 011326 368 DFGLAKATTMN-----DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL 442 (488)
Q Consensus 368 DFGla~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~ 442 (488)
|||++...... ......+|+.|+|||.+. ....++.++||||||+++|+|++|+.||.+.+..+....+.....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHH-CTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhc-CcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999765422 223455799999999873 345689999999999999999999999988776554443321110
Q ss_pred -----------------------------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 443 -----------------------------PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 443 -----------------------------~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
......+++++.+||.+||+.||.+|||+.|+++||||+..-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 011245899999999999999999999999999999998643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=366.28 Aligned_cols=262 Identities=28% Similarity=0.444 Sum_probs=208.2
Q ss_pred cccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCc------chhHHHHHHHHHHHHhcCCCCCcceeeccc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPR------GKQSILQLEQEISLLGQFEHDNIVQYLGTD 295 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~------~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 295 (488)
...++|++.+.||+|+||.||+|.+.+|..||+|.+........ .......+.+|+.++++++||||+++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 34678999999999999999999998899999999966443221 223346789999999999999999999988
Q ss_pred -----cCCCceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEee
Q 011326 296 -----RDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLAD 368 (488)
Q Consensus 296 -----~~~~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~D 368 (488)
.....+++||||+++ +|.+.+... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 344578999999985 777777544 589999999999999999999999999999999999999999999999
Q ss_pred cCCcccccCC-CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC--------
Q 011326 369 FGLAKATTMN-DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG-------- 439 (488)
Q Consensus 369 FGla~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~-------- 439 (488)
||++...... ......||+.|+|||.+. ....++.++||||||+++|+|++|+.||.+.+..+....+..
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 256 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVM-QFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256 (362)
T ss_dssp TTC---------------CGGGCCHHHHT-TCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cCcccccccccccceecccceecCcHHhc-CCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence 9999754433 234567999999999873 335689999999999999999999999988765544433321
Q ss_pred ---------------CCCC--------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 440 ---------------GELP--------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 440 ---------------~~~~--------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
.... .....+++.+.+||.+||+.||.+|||+.|+++||||++...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp HHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 0111 112456889999999999999999999999999999997643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=361.22 Aligned_cols=257 Identities=34% Similarity=0.606 Sum_probs=211.7
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccC-
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRD- 297 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~- 297 (488)
....++|++.+.||+|+||.||+|.+. +|..||+|.+..... ....+.+|+.++.++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc------cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 345678999999999999999999985 799999999975432 224678899999998 79999999999866
Q ss_pred -----CCceEEEEeeccCCChHHHHhh---hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeec
Q 011326 298 -----EKRLCIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADF 369 (488)
Q Consensus 298 -----~~~~~lV~E~~~~gsL~~~l~~---~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DF 369 (488)
.+..++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeC
Confidence 5689999999999999999865 35899999999999999999999999999999999999999999999999
Q ss_pred CCcccccCC--CcccCCCCCcccCchhhccc---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC-
Q 011326 370 GLAKATTMN--DVKSCKGTAFWMAPEVVNLK---KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP- 443 (488)
Q Consensus 370 Gla~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~- 443 (488)
|++...... ......||+.|+|||.+... ...++.++||||||+++|+|++|..||...+.......+.....+
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 253 (326)
T 2x7f_A 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR 253 (326)
T ss_dssp TTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred cCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc
Confidence 998765432 23355799999999997321 455889999999999999999999999887766655554433332
Q ss_pred CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 444 PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 444 ~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
..+..+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus 254 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 2346789999999999999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=363.10 Aligned_cols=259 Identities=28% Similarity=0.422 Sum_probs=209.0
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCC---cchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGP---RGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
.++|++.+.||+|+||.||+|.+. ++..||||.+....... ........+.+|+.++++++||||+++++++..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 468999999999999999999885 68999999997543211 11223345789999999999999999999987665
Q ss_pred ceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCc---EEEeecCCcccc
Q 011326 300 RLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS---VKLADFGLAKAT 375 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~---vkL~DFGla~~~ 375 (488)
.++||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 89999999999999887654 5999999999999999999999999999999999999987654 999999999765
Q ss_pred cCCC-cccCCCCCcccCchhhcc-ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh-hhHHHhcCCCCCC---CCCcc
Q 011326 376 TMND-VKSCKGTAFWMAPEVVNL-KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-QAMFKIGGGELPP---VPNSL 449 (488)
Q Consensus 376 ~~~~-~~~~~gt~~y~aPE~~~~-~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~-~~~~~i~~~~~~~---~~~~~ 449 (488)
.... .....||+.|+|||++.. ....++.++||||||+++|+|++|..||...... .....+..+.... .+..+
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 247 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTS
T ss_pred ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhc
Confidence 4332 234569999999998732 3456889999999999999999999999765443 2223333333222 22568
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 248 ~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 248 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred CHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 9999999999999999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=371.97 Aligned_cols=252 Identities=27% Similarity=0.417 Sum_probs=206.2
Q ss_pred ccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC----
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE---- 298 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~---- 298 (488)
...+|++.+.||+|+||.||+|.+..+..+|+|.+...... ..+|+.+++.++||||+++++++...
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---------~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 108 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---------KNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---------CCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---------HHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence 34579999999999999999999977777999998754321 12689999999999999999998433
Q ss_pred --CceEEEEeeccCCChHHHHh----hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEEC-CCCcEEEeecCC
Q 011326 299 --KRLCIFLELVTKGSLASLYQ----KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVD-ASGSVKLADFGL 371 (488)
Q Consensus 299 --~~~~lV~E~~~~gsL~~~l~----~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~-~~~~vkL~DFGl 371 (488)
..+++||||++++.+..+.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 34889999999854443332 34589999999999999999999999999999999999999 799999999999
Q ss_pred cccccCC-CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC-----------
Q 011326 372 AKATTMN-DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG----------- 439 (488)
Q Consensus 372 a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~----------- 439 (488)
++..... ......||+.|+|||++. ....++.++||||+||++|||++|+.||.+.+..+....+..
T Consensus 189 a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 189 AKILIAGEPNVSYICSRYYRAPELIF-GATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp CEECCTTCCCCSSCSCGGGCCHHHHT-TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccccCCCCCcccccCcCccCHHHHc-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9765433 344667999999999972 344589999999999999999999999998776554443321
Q ss_pred --------CCCCC---------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 440 --------GELPP---------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 440 --------~~~~~---------~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
...+. ++..+++++.+||.+||+.||.+|||+.|+++||||++..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 11111 2345889999999999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=366.20 Aligned_cols=254 Identities=26% Similarity=0.445 Sum_probs=214.9
Q ss_pred cccccccCceeeeeeecccCceEEEEEEe------cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcce
Q 011326 218 GKFRRRITSWQKGELLGSGSYGFVYEGLT------DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQ 290 (488)
Q Consensus 218 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~ 290 (488)
..|....++|++++.||+|+||.||+|.+ .++..||||.+.... .......+.+|+.++.++ +||||++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC----CHHHHHHHHHHHHHHHhhcCCcceee
Confidence 34666778999999999999999999973 357899999996432 334456789999999999 7999999
Q ss_pred eeccccCCC-ceEEEEeeccCCChHHHHhhhc------------------------------------------------
Q 011326 291 YLGTDRDEK-RLCIFLELVTKGSLASLYQKYH------------------------------------------------ 321 (488)
Q Consensus 291 l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~------------------------------------------------ 321 (488)
+++++.+.+ ..++||||+++|+|.+++....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999987754 5999999999999999986542
Q ss_pred -------------------cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC---
Q 011326 322 -------------------LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--- 379 (488)
Q Consensus 322 -------------------ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--- 379 (488)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence 8899999999999999999999999999999999999999999999999997553322
Q ss_pred -cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhh-hHHHhcCCCCCCCCCcccHHHHHH
Q 011326 380 -VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQ-AMFKIGGGELPPVPNSLSRDAQDF 456 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~s~~l~~L 456 (488)
.....||+.|+|||++ .+..++.++||||||+++|||++ |..||.+....+ ....+........+..+++++.++
T Consensus 251 ~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 328 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETI--FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 328 (359)
T ss_dssp EC--CEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred hccccCCCceeEChhhh--cCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 2345688899999997 35668999999999999999998 999998766443 334444455566778899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHhC
Q 011326 457 ILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 457 i~~cL~~dP~~Rps~~eil~h 477 (488)
+.+||+.||.+|||+.|+++|
T Consensus 329 i~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 329 MLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCCCHHHHHHH
Confidence 999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=379.17 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=218.9
Q ss_pred cccccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 218 GKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 218 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
..|....++|++.+.||+|+||.||+|.+.++..||||.+..... ....+.+|+.+|++++||||+++++++.+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 250 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 346667789999999999999999999998888899999875331 23578899999999999999999999876
Q ss_pred CCceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 374 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~ 374 (488)
+..++||||+++|+|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 251 -~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 251 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred -CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCcccee
Confidence 6789999999999999999643 489999999999999999999999999999999999999999999999999976
Q ss_pred ccCCC---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCccc
Q 011326 375 TTMND---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLS 450 (488)
Q Consensus 375 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s 450 (488)
..... .....++..|+|||.+ ....++.++||||||+++|||++ |..||.+....+....+..+...+.+..++
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~ 407 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAA--LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 407 (452)
T ss_dssp -------------CCGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSC
T ss_pred cCCCceecccCCcccccccCHhHH--hcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 54332 2234567889999997 34568999999999999999999 999999988888888888887778888999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHhC--ccCC
Q 011326 451 RDAQDFILKCLQVNPNDRPTAAQLMEH--PFIK 481 (488)
Q Consensus 451 ~~l~~Li~~cL~~dP~~Rps~~eil~h--p~f~ 481 (488)
+++.+||.+||+.||++|||++++++. .++.
T Consensus 408 ~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 408 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 999999999999999999999999863 4544
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=361.60 Aligned_cols=254 Identities=28% Similarity=0.441 Sum_probs=210.0
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc--
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR-- 300 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~-- 300 (488)
..+|.+.+.||+|+||.||+|.+. +|..||||.+.... ........+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 468999999999999999999985 79999999997543 234455678899999999999999999999887654
Q ss_pred ----eEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 301 ----LCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 301 ----~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
+++||||+.+ +|.+++.. .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 100 NFYDFYLVMPFMQT-DLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp GCCCCEEEEECCSE-EGGGTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred cceeEEEEeccccC-CHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 4999999985 88877754 59999999999999999999999999999999999999999999999999997654
Q ss_pred CCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC-----------------
Q 011326 377 MNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG----------------- 439 (488)
Q Consensus 377 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~----------------- 439 (488)
. ......||+.|+|||.+. ....++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus 178 ~-~~~~~~~t~~y~aPE~~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 178 A-EMTGYVVTRWYRAPEVIL-SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp -------CCSBCCSCHHHHS-CCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred C-CccccccCcCcCCHHHHh-CcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 3 234567899999999973 335689999999999999999999999987665443332211
Q ss_pred -------------CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 440 -------------GELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 440 -------------~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
.........+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 112233456899999999999999999999999999999998643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=355.31 Aligned_cols=256 Identities=30% Similarity=0.518 Sum_probs=210.2
Q ss_pred ccCceeeeeeecccCceEEEEEEe--cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC---CCCCcceeecccc-
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLT--DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF---EHDNIVQYLGTDR- 296 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~- 296 (488)
..++|++.+.||+|+||.||+|.+ .+|..||+|.+.......... ..+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB---CTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCC---chhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 457899999999999999999998 368899999997644322211 2344566666555 8999999999986
Q ss_pred ----CCCceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeec
Q 011326 297 ----DEKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADF 369 (488)
Q Consensus 297 ----~~~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DF 369 (488)
.....++||||++ |+|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence 5678999999998 5999988654 3899999999999999999999999999999999999999999999999
Q ss_pred CCcccccCC-CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC--------
Q 011326 370 GLAKATTMN-DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG-------- 440 (488)
Q Consensus 370 Gla~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~-------- 440 (488)
|++...... ......||+.|+|||.+ .+..++.++||||||+++|+|++|+.||.+.+..+....+...
T Consensus 165 g~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 165 GLARIYSFQMALTSVVVTLWYRAPEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccccccCCCCccccccccceeCHHHH--hcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 999765433 23456799999999997 4456899999999999999999999999887765554433210
Q ss_pred ------------------CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 441 ------------------ELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 441 ------------------~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
........+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 00112356899999999999999999999999999999998653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=372.83 Aligned_cols=255 Identities=14% Similarity=0.115 Sum_probs=192.1
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHH---HHHhcCCCCCcceeeccc----
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEI---SLLGQFEHDNIVQYLGTD---- 295 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei---~iL~~l~HpnIv~l~~~~---- 295 (488)
..+|++.+.||+|+||.||+|.+. +|..||+|++...... .......+.+|+ .+|+. +||||++++..+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN--SRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPS 137 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT--HHHHHHHHHHHHHHHHHHHC-----------CBCCCC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc--cccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeee
Confidence 456999999999999999999985 7999999999875432 334455677784 45555 799988855322
Q ss_pred ---cCC-----------------CceEEEEeeccCCChHHHHhhh--ccChhhh------hHHHHHHHHHHHHHHHCCCc
Q 011326 296 ---RDE-----------------KRLCIFLELVTKGSLASLYQKY--HLSDSQV------SSYTRQILNGLKYLHEQNVV 347 (488)
Q Consensus 296 ---~~~-----------------~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~------~~i~~qi~~aL~yLH~~gii 347 (488)
..+ ..+++||||++ |+|.+++... .+++..+ ..++.||+.||+|||++||+
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~iv 216 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLV 216 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCc
Confidence 211 34899999999 7999999754 3555555 67789999999999999999
Q ss_pred cccCCcccEEECCCCcEEEeecCCcccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 011326 348 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSH 427 (488)
Q Consensus 348 HrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~ 427 (488)
||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++......++.++||||||+++|||++|+.||..
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCEE-EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCCc-cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999997654322 24557799999999843335689999999999999999999999977
Q ss_pred CchhhhH--HH---hc---CCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 428 LEGGQAM--FK---IG---GGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 428 ~~~~~~~--~~---i~---~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
....... .. .. .....+....+++++.+||.+||+.||++|||+.|+++||||++.
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 6432111 00 00 011112235789999999999999999999999999999999753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=359.59 Aligned_cols=251 Identities=25% Similarity=0.425 Sum_probs=206.9
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC--c
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK--R 300 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--~ 300 (488)
-++|++.+.||+|+||.||+|.+. +|..||+|++..... ......+.+|+.++++++||||+++++++...+ .
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF----LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG----GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc----cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 457999999999999999999986 699999999975322 223456789999999999999999999887655 7
Q ss_pred eEEEEeeccCCChHHHHhhhc----cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEE----CCCCcEEEeecCCc
Q 011326 301 LCIFLELVTKGSLASLYQKYH----LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILV----DASGSVKLADFGLA 372 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~~----ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl----~~~~~vkL~DFGla 372 (488)
.++||||+++++|.+++.... +++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 899999999999999997543 8999999999999999999999999999999999999 77888999999999
Q ss_pred ccccCCC-cccCCCCCcccCchhhcc------ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh----hhHHHhcCCC
Q 011326 373 KATTMND-VKSCKGTAFWMAPEVVNL------KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG----QAMFKIGGGE 441 (488)
Q Consensus 373 ~~~~~~~-~~~~~gt~~y~aPE~~~~------~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~----~~~~~i~~~~ 441 (488)
+...... .....||+.|+|||++.. ....++.++||||||+++|||++|..||...... +....+..+.
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred eecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 7655433 345679999999999732 1466899999999999999999999999654332 2222222111
Q ss_pred C------------------------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCc
Q 011326 442 L------------------------PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHP 478 (488)
Q Consensus 442 ~------------------------~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp 478 (488)
. ......+++.+.+|+.+||+.||++|||++|+++||
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 1 012234567899999999999999999999999997
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=359.10 Aligned_cols=247 Identities=26% Similarity=0.462 Sum_probs=207.5
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
..++|++++.||+|+||.||+|.+. ++..||+|.+.. ........+.+|+.++++++||||+++++++.+++..
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 4678999999999999999999985 799999999853 2345567899999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 302 CIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
++||||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999999976 469999999999999999999999999999999999999999999999999997553322
Q ss_pred c----------------ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHH--hcCCC
Q 011326 380 V----------------KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFK--IGGGE 441 (488)
Q Consensus 380 ~----------------~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~--i~~~~ 441 (488)
. ....||+.|+|||.+ .+..++.++||||||+++|+|++|..||........... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~ 240 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI--NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHh--cCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc
Confidence 1 145799999999997 456689999999999999999999999865332211000 00000
Q ss_pred CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 442 LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 442 ~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
....+..+++++.+|+.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 241 DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 01235678899999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=352.35 Aligned_cols=251 Identities=28% Similarity=0.479 Sum_probs=203.8
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC-----
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD----- 297 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----- 297 (488)
.++|++.+.||+|+||.||+|.+. +|..||+|.+.. .......+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH------TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE------EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec------cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence 467999999999999999999985 799999999963 34455778899999999999999999987643
Q ss_pred --------CCceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEe
Q 011326 298 --------EKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLA 367 (488)
Q Consensus 298 --------~~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~ 367 (488)
.+..++||||+++|+|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEe
Confidence 45789999999999999999654 47888999999999999999999999999999999999999999999
Q ss_pred ecCCcccccCC----------------CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCC-ch
Q 011326 368 DFGLAKATTMN----------------DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHL-EG 430 (488)
Q Consensus 368 DFGla~~~~~~----------------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~-~~ 430 (488)
|||++...... ......||+.|+|||.+. ....++.++||||||+++|+|++ ||... +.
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~ 234 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD-GTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHT-SCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCccccc-CCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence 99998754321 123456899999999973 33468999999999999999998 55432 22
Q ss_pred hhhHHHhcCCC---CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 431 GQAMFKIGGGE---LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 431 ~~~~~~i~~~~---~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
.+....+.... .+..+...++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291 (303)
T ss_dssp HHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred HHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence 33333333322 2234566788999999999999999999999999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=355.41 Aligned_cols=253 Identities=26% Similarity=0.450 Sum_probs=221.8
Q ss_pred ccccccCceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceee
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYL 292 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~ 292 (488)
.++...++|++.+.||+|+||.||+|.+. ++..||+|.+... ........+.+|+.++++++||||++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA----ASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT----SCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc----cCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 45666789999999999999999999764 4788999998643 2234456788999999999999999999
Q ss_pred ccccCCCceEEEEeeccCCChHHHHhhh-----------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC
Q 011326 293 GTDRDEKRLCIFLELVTKGSLASLYQKY-----------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS 361 (488)
Q Consensus 293 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~-----------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~ 361 (488)
+++.+++..++||||+++|+|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC
Confidence 9999999999999999999999998652 35889999999999999999999999999999999999999
Q ss_pred CcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHH
Q 011326 362 GSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFK 436 (488)
Q Consensus 362 ~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~ 436 (488)
+.+||+|||++....... .....+|+.|+|||.+ .+..++.++||||||+++|+|++ |..||...+..+....
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 252 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhh--ccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence 999999999997554332 2234578899999997 44568999999999999999999 8999999888888888
Q ss_pred hcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 437 IGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 437 i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
+........+..+++++.+|+.+||+.||.+|||+.|++++
T Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 253 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 87777777888999999999999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=347.65 Aligned_cols=249 Identities=27% Similarity=0.453 Sum_probs=218.1
Q ss_pred ccccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
.|....++|++.+.||+|+||.||+|.+.++..||+|.+..... ....+.+|+.++++++||||+++++++.+
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 79 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM------SPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc------cHHHHHHHHHHHHhCCCcCcceEEEEEcC-
Confidence 35556678999999999999999999988888999999865331 23578899999999999999999999874
Q ss_pred CceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 299 KRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
+..++||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 4689999999999999998654 5999999999999999999999999999999999999999999999999999765
Q ss_pred cCCC---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccH
Q 011326 376 TMND---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSR 451 (488)
Q Consensus 376 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 451 (488)
.... .....++..|+|||.+ ....++.++||||||+++|+|++ |..||.+.+..+....+..+.....+..+++
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHH--HHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred cCcccccccCCCCccCccChhhh--ccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccH
Confidence 5433 2234577889999997 34558999999999999999999 9999998888888777777766677788999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
++.+|+.+||+.||++|||+.++++
T Consensus 238 ~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 238 ELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=368.47 Aligned_cols=261 Identities=25% Similarity=0.359 Sum_probs=200.9
Q ss_pred CcccccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc
Q 011326 217 NGKFRRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD 295 (488)
Q Consensus 217 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 295 (488)
.......+++|++.+.||+|+||.||+|.+. +|..||||.+....... ....+++..+..++||||+++++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~l~~l~h~niv~~~~~~ 88 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR------NRELQIMQDLAVLHHPNIVQLQSYF 88 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC------CHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc------HHHHHHHHHHHhcCCCCcccHHHhh
Confidence 3445667899999999999999999999985 79999999986543221 2445677888889999999999998
Q ss_pred cCCC-------ceEEEEeeccCCChHHHHh-----hhccChhhhhHHHHHHHHHHHHHH--HCCCccccCCcccEEECC-
Q 011326 296 RDEK-------RLCIFLELVTKGSLASLYQ-----KYHLSDSQVSSYTRQILNGLKYLH--EQNVVHRDIKCANILVDA- 360 (488)
Q Consensus 296 ~~~~-------~~~lV~E~~~~gsL~~~l~-----~~~ls~~~~~~i~~qi~~aL~yLH--~~giiHrDLkp~NILl~~- 360 (488)
...+ ..++||||+++ +|...+. ...+++..+..++.|++.||.||| ++||+||||||+|||++.
T Consensus 89 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 89 YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA 167 (360)
T ss_dssp EEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETT
T ss_pred hccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCC
Confidence 5433 38899999987 4443332 235889999999999999999999 999999999999999996
Q ss_pred CCcEEEeecCCcccccCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC
Q 011326 361 SGSVKLADFGLAKATTMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG 439 (488)
Q Consensus 361 ~~~vkL~DFGla~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~ 439 (488)
++.+||+|||++....... .....||+.|+|||++. ....++.++||||||+++|+|++|+.||.+.+.......+..
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 246 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIF-GNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246 (360)
T ss_dssp TTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHT-TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHc-CCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence 8999999999998665443 34567899999999972 344589999999999999999999999988776655444321
Q ss_pred CC-------------------------------CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 440 GE-------------------------------LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 440 ~~-------------------------------~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
.. .+..+..+++++.+||.+||+.||.+|||+.|+++||||++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 00 01122336789999999999999999999999999999987644
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=360.86 Aligned_cols=247 Identities=27% Similarity=0.474 Sum_probs=207.9
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcE----EEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFF----FAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~----vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
.++|++.+.||+|+||.||+|.+. ++.. ||+|.+... ........+.+|+.++++++||||+++++++.++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc----cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 467999999999999999999874 4544 577776532 2233446788999999999999999999999876
Q ss_pred CceEEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 299 KRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
. .++++||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 5 7899999999999998865 358999999999999999999999999999999999999999999999999997654
Q ss_pred CCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccH
Q 011326 377 MND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSR 451 (488)
Q Consensus 377 ~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 451 (488)
... .....+|+.|+|||.+ .+..++.++||||||+++|||++ |..||.+.+..+....+..+...+.+..++.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI 246 (327)
T ss_dssp TTCC-------CCCGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCH
T ss_pred CCcccccccCCCccccccChHHh--ccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCH
Confidence 332 2234568899999997 45668999999999999999999 9999999888887777777777778888999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
++.+++.+||+.||.+|||+.|++++
T Consensus 247 ~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 247 DVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999999999865
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=373.88 Aligned_cols=247 Identities=27% Similarity=0.454 Sum_probs=216.5
Q ss_pred ccccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
.|....++|++.+.||+|+||.||+|.+. |..||||.+.... ....+.+|+.+|++++||||+++++++.+.
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-------TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-------HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 35667889999999999999999999875 7799999996432 235788999999999999999999997665
Q ss_pred C-ceEEEEeeccCCChHHHHhhhc---cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccc
Q 011326 299 K-RLCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 374 (488)
Q Consensus 299 ~-~~~lV~E~~~~gsL~~~l~~~~---ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~ 374 (488)
+ ..++||||+++|+|.+++...+ +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 4 7999999999999999997653 68999999999999999999999999999999999999999999999999975
Q ss_pred ccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHH
Q 011326 375 TTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDA 453 (488)
Q Consensus 375 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l 453 (488)
.... .....++..|+|||.+ ....++.++||||||+++|||++ |..||...+..+....+..+...+.+..+++++
T Consensus 339 ~~~~-~~~~~~~~~y~aPE~~--~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l 415 (450)
T 1k9a_A 339 ASST-QDTGKLPVKWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 415 (450)
T ss_dssp CC-------CCCTTTSCHHHH--HSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccc-ccCCCCCcceeCHHHh--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence 4432 2234678899999997 45568999999999999999998 999999988888888888887778888999999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHh
Q 011326 454 QDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
.+||.+||+.||.+|||+.++++
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=371.35 Aligned_cols=251 Identities=27% Similarity=0.437 Sum_probs=189.6
Q ss_pred Cceee-eeeecccCceEEEEEEec---CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc--cCC
Q 011326 225 TSWQK-GELLGSGSYGFVYEGLTD---DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD--RDE 298 (488)
Q Consensus 225 ~~y~~-~~~LG~G~fg~Vy~~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~--~~~ 298 (488)
+.|++ +++||+|+||.||+|.+. ++..||+|.+..... ...+.+|+.+|++++||||+++++++ ..+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-------SMSACREIALLRELKHPNVISLQKVFLSHAD 92 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence 34666 568999999999999864 588999999864322 13577899999999999999999998 557
Q ss_pred CceEEEEeeccCCChHHHHhhh----------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEE----CCCCcE
Q 011326 299 KRLCIFLELVTKGSLASLYQKY----------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILV----DASGSV 364 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~----------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl----~~~~~v 364 (488)
...++||||+.+ +|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 93 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp TEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred CeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 789999999986 777776432 38999999999999999999999999999999999999 677899
Q ss_pred EEeecCCcccccCC-----CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh--------
Q 011326 365 KLADFGLAKATTMN-----DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-------- 431 (488)
Q Consensus 365 kL~DFGla~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~-------- 431 (488)
||+|||+++..... ......||+.|+|||++. ....++.++|||||||++|+|++|..||.+....
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL-GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHT-TCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhc-CCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 99999999765432 234567999999999973 3345899999999999999999999999754431
Q ss_pred -hhHHHhc---CCCCC----------------------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHH
Q 011326 432 -QAMFKIG---GGELP----------------------------------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQ 473 (488)
Q Consensus 432 -~~~~~i~---~~~~~----------------------------------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~e 473 (488)
+.+..+. ..... ......++++.+||.+||+.||.+|||++|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 1111110 00000 001123678999999999999999999999
Q ss_pred HHhCccCCCCC
Q 011326 474 LMEHPFIKRPL 484 (488)
Q Consensus 474 il~hp~f~~~~ 484 (488)
+++||||++.-
T Consensus 331 ~L~hp~f~~~~ 341 (405)
T 3rgf_A 331 AMQDPYFLEDP 341 (405)
T ss_dssp HHTSGGGTSSS
T ss_pred HhcChhhccCC
Confidence 99999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=349.77 Aligned_cols=251 Identities=27% Similarity=0.456 Sum_probs=221.8
Q ss_pred cccccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecccc
Q 011326 218 GKFRRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR 296 (488)
Q Consensus 218 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 296 (488)
..|.....+|++.+.||+|+||.||+|.+. ++..||+|.+... ......+.+|+.++++++||||+++++++.
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 79 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC------STHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 345667789999999999999999999986 5899999998642 223467889999999999999999999999
Q ss_pred CCCceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 297 DEKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 297 ~~~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
+++..++||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred cCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccce
Confidence 999999999999999999999653 48999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCc---ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcc
Q 011326 374 ATTMNDV---KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSL 449 (488)
Q Consensus 374 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 449 (488)
....... ....+|+.|+|||.+ ....++.++||||||+++|+|++ |..||...+.......+........+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC 237 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred eccCCccccccCCccccCcCChhhh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCC
Confidence 6554332 234467889999997 44568999999999999999999 99999988888877777777677778889
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
++++.+|+.+||+.||.+|||+.++++
T Consensus 238 ~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 238 PEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 999999999999999999999999975
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=352.35 Aligned_cols=256 Identities=26% Similarity=0.421 Sum_probs=217.3
Q ss_pred CCcccccccCceeeeeeecccCceEEEEEEe------cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCc
Q 011326 216 PNGKFRRRITSWQKGELLGSGSYGFVYEGLT------DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNI 288 (488)
Q Consensus 216 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnI 288 (488)
....+....++|++.+.||+|+||.||+|.+ .++..||+|.+.... .......+.+|+.+++++ +||||
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i 89 (313)
T 1t46_A 14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----HLTEREALMSELKVLSYLGNHMNI 89 (313)
T ss_dssp CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch----hHHHHHHHHHHHHHHhhcccCCCe
Confidence 4455667778999999999999999999985 357899999997542 234456789999999999 99999
Q ss_pred ceeeccccCCCceEEEEeeccCCChHHHHhhh-------------------ccChhhhhHHHHHHHHHHHHHHHCCCccc
Q 011326 289 VQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-------------------HLSDSQVSSYTRQILNGLKYLHEQNVVHR 349 (488)
Q Consensus 289 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-------------------~ls~~~~~~i~~qi~~aL~yLH~~giiHr 349 (488)
+++++++.+++..++||||+++|+|.+++... .+++..++.++.|++.||.|||++||+||
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~ 169 (313)
T 1t46_A 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 169 (313)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 99999999999999999999999999998654 28999999999999999999999999999
Q ss_pred cCCcccEEECCCCcEEEeecCCcccccCCCc----ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCC
Q 011326 350 DIKCANILVDASGSVKLADFGLAKATTMNDV----KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHP 424 (488)
Q Consensus 350 DLkp~NILl~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~P 424 (488)
||||+||+++.++.+||+|||++........ ....+|+.|+|||.+ ....++.++||||||+++|+|++ |..|
T Consensus 170 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~ellt~g~~p 247 (313)
T 1t46_A 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI--FNCVYTFESDVWSYGIFLWELFSLGSSP 247 (313)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred CCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHh--cCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999976554332 234577889999987 34568999999999999999999 9999
Q ss_pred CCCCchhhhHHH-hcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 425 YSHLEGGQAMFK-IGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 425 f~~~~~~~~~~~-i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
|........... +........+..+++++.+|+.+||+.||.+|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp STTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 987665443333 33333445567899999999999999999999999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=353.12 Aligned_cols=256 Identities=29% Similarity=0.476 Sum_probs=218.8
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
..++|++.+.||+|+||.||+|.+. +++.||+|.+...... ......+.+|+.++++++||||+++++++.+.+..
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK---NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS---SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 4568999999999999999999986 7999999999765432 22345788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC---CcEEEeecCCcccccC
Q 011326 302 CIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS---GSVKLADFGLAKATTM 377 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~---~~vkL~DFGla~~~~~ 377 (488)
++||||+++++|.+.+.. ..+++..++.++.||+.||.|||++|++|+||||+||+++.+ +.+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 999999999999887754 469999999999999999999999999999999999999754 4799999999876543
Q ss_pred CC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC---CCCcccHHH
Q 011326 378 ND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP---VPNSLSRDA 453 (488)
Q Consensus 378 ~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~l 453 (488)
.. .....||+.|+|||.+. ..++.++||||||+++|+|++|..||...+..+....+..+.... ....+++++
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (287)
T 2wei_A 177 NTKMKDRIGTAYYIAPEVLR---GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253 (287)
T ss_dssp CSSCSCHHHHHTTCCHHHHT---TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHH
T ss_pred CCccccccCcccccChHHhc---CCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHH
Confidence 32 33445889999999873 348999999999999999999999999888777666665554322 124689999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 454 QDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
.++|.+||+.||.+|||+.|+++||||++..
T Consensus 254 ~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 9999999999999999999999999997643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=366.06 Aligned_cols=249 Identities=26% Similarity=0.464 Sum_probs=207.6
Q ss_pred cccCceeeeeeecccCceEEEEEEec----CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD----DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
....+|++.+.||+|+||.||+|.+. ++..||||.+.... .......+.+|+.++++++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY----TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 34568999999999999999999874 57789999986532 34455689999999999999999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
++..++||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999999999764 5899999999999999999999999999999999999999999999999999765
Q ss_pred cCCC-----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcc
Q 011326 376 TMND-----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSL 449 (488)
Q Consensus 376 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 449 (488)
.... .....+|+.|+|||++ ....++.++||||||+++|||++ |+.||...+..+....+..+...+.+..+
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~ 275 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAI--AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275 (373)
T ss_dssp ----------------CTTSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTC
T ss_pred ccCCccceeccCCCcCCCccChhhh--ccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 4332 1123356789999997 44568999999999999999998 99999988888887777776666677789
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+.++.+|+.+||+.||.+||++.++++
T Consensus 276 ~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 276 PAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp BHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 999999999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=357.55 Aligned_cols=254 Identities=26% Similarity=0.450 Sum_probs=220.3
Q ss_pred cccccccCceeeeeeecccCceEEEEEEec--------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCc
Q 011326 218 GKFRRRITSWQKGELLGSGSYGFVYEGLTD--------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNI 288 (488)
Q Consensus 218 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnI 288 (488)
..|....++|++++.||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.+++++ +||||
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~i 103 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNI 103 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC----CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC----cHHHHHHHHHHHHHHHHhhcCCCE
Confidence 345556789999999999999999999863 57789999986432 344567789999999999 89999
Q ss_pred ceeeccccCCCceEEEEeeccCCChHHHHhhhc-----------------cChhhhhHHHHHHHHHHHHHHHCCCccccC
Q 011326 289 VQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-----------------LSDSQVSSYTRQILNGLKYLHEQNVVHRDI 351 (488)
Q Consensus 289 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------ls~~~~~~i~~qi~~aL~yLH~~giiHrDL 351 (488)
+++++++.+++..++||||+++|+|.+++.... +++..++.++.||+.||.|||++||+||||
T Consensus 104 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 183 (334)
T 2pvf_A 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL 183 (334)
T ss_dssp CCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred eeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 999999999999999999999999999987543 788999999999999999999999999999
Q ss_pred CcccEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCC
Q 011326 352 KCANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYS 426 (488)
Q Consensus 352 kp~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~ 426 (488)
||+||+++.++.+||+|||++....... .....+|+.|+|||++ ....++.++||||||+++|+|++ |..||.
T Consensus 184 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~ellt~g~~p~~ 261 (334)
T 2pvf_A 184 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261 (334)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHH--HHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHh--cCCCcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence 9999999999999999999997654332 2344578889999997 34558999999999999999999 999999
Q ss_pred CCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 427 HLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 427 ~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
+.+..+....+..+.....+..+++++.+++.+||+.||.+|||+.|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 262 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp TCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 888877777777666667788899999999999999999999999999865
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=372.58 Aligned_cols=249 Identities=26% Similarity=0.410 Sum_probs=203.4
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC-----
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD----- 297 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----- 297 (488)
..+|++.+.||+|+||.||+|.+. +|..||||.+..... ...+|+.+|+.++||||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence 457999999999999999999985 699999999875332 12368999999999999999998732
Q ss_pred -CCceEEEEeeccCCChHHHHh-----hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC-CcEEEeecC
Q 011326 298 -EKRLCIFLELVTKGSLASLYQ-----KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS-GSVKLADFG 370 (488)
Q Consensus 298 -~~~~~lV~E~~~~gsL~~~l~-----~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~-~~vkL~DFG 370 (488)
...+++||||+++ +|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence 2347799999987 5655553 2358999999999999999999999999999999999999965 578999999
Q ss_pred CcccccCC-CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC----------
Q 011326 371 LAKATTMN-DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG---------- 439 (488)
Q Consensus 371 la~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~---------- 439 (488)
+++..... ......||+.|+|||++. ....++.++|||||||++|||++|+.||.+.+..+.+..+..
T Consensus 203 ~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 203 SAKQLVRGEPNVSYICSRYYRAPELIF-GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp TCEECCTTCCCCSCCSCTTSCCHHHHT-TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhhhcccCCCceeeeeCCCcCCHHHHc-CCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99865433 234567999999999973 334689999999999999999999999988776554433321
Q ss_pred ---------CCCCC---------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 440 ---------GELPP---------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 440 ---------~~~~~---------~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
...+. ++..+++++.+||.+||+.||.+|||+.|+++||||++.
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 01111 234578999999999999999999999999999999764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=362.59 Aligned_cols=247 Identities=28% Similarity=0.446 Sum_probs=210.6
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcE----EEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFF----FAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~----vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
.++|++.+.||+|+||.||+|.+. ++.. ||+|.+...... .....+.+|+.++++++||||+++++++. +
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR----QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC----SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH----HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 468999999999999999999874 4544 777777543221 12234668999999999999999999986 4
Q ss_pred CceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 299 KRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
+..++||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 5689999999999999988653 69999999999999999999999999999999999999999999999999998654
Q ss_pred CCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccH
Q 011326 377 MND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSR 451 (488)
Q Consensus 377 ~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 451 (488)
... .....||..|+|||.+ ....++.++||||||+++|+|++ |..||.+....+....+........+..++.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESI--HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTI 244 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCT
T ss_pred cccccccccCCCCcccccChHHh--ccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcH
Confidence 332 2345678899999997 44568999999999999999999 9999998888888887877777777888999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
++.+++.+||+.||.+|||+.+++++
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 245 DVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999976
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=380.98 Aligned_cols=251 Identities=27% Similarity=0.449 Sum_probs=222.3
Q ss_pred cccccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecccc
Q 011326 218 GKFRRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR 296 (488)
Q Consensus 218 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 296 (488)
..|+....+|++.+.||+|+||.||+|.+. ++..||||.+.... .....+.+|+.+|++++||||+++++++.
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 286 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS------SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc------cchHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 456677889999999999999999999986 58999999987432 12467889999999999999999999999
Q ss_pred CCCceEEEEeeccCCChHHHHhh---hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 297 DEKRLCIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 297 ~~~~~~lV~E~~~~gsL~~~l~~---~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
+++.+++||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 287 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred cCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccce
Confidence 99999999999999999999965 348999999999999999999999999999999999999999999999999998
Q ss_pred cccCCC---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcc
Q 011326 374 ATTMND---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSL 449 (488)
Q Consensus 374 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 449 (488)
...... .....++..|+|||.+ ....++.++||||||+++|||++ |..||.+.+..+....+..+.....+..+
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC 444 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHH--HHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred eccCCceeecCCCcCCcceeCHhHH--hcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 654333 2234467789999997 34558999999999999999999 99999998888888777777777788899
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
++++.+||.+||+.||.+|||+.++++
T Consensus 445 ~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 445 PEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 999999999999999999999999975
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=351.95 Aligned_cols=247 Identities=27% Similarity=0.471 Sum_probs=205.8
Q ss_pred ccCceeeeeeecccCceEEEEEEe-----cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLT-----DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
...+|++.+.||+|+||.||+|.. .++..||+|.+... .......+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 356899999999999999999983 36899999998642 34555788999999999999999999998854
Q ss_pred --CCceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 298 --EKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 298 --~~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
...+++||||+++|+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 35689999999999999999764 39999999999999999999999999999999999999999999999999997
Q ss_pred cccCCC-----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh----------------h
Q 011326 374 ATTMND-----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG----------------Q 432 (488)
Q Consensus 374 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~----------------~ 432 (488)
...... .....+|..|+|||.+ .+..++.++||||||+++|+|++|..||...... .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESL--TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp -------------CTTCGGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHh--cCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 654332 2234577789999997 4456899999999999999999999998653221 2
Q ss_pred hHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 433 AMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 433 ~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
....+......+.+..+++++.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 23334445556678889999999999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=357.09 Aligned_cols=252 Identities=24% Similarity=0.357 Sum_probs=209.6
Q ss_pred cCceeeeeeecccCceEEEEEEe-c-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCC------cceeeccc
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLT-D-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN------IVQYLGTD 295 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~-~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn------Iv~l~~~~ 295 (488)
.++|++.+.||+|+||.||+|.+ . ++..||+|++.. .......+.+|+.+++.++|+| ++++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN------VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS------SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec------CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 46899999999999999999987 3 688999999863 2344567788999998887654 99999999
Q ss_pred cCCCceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC------------
Q 011326 296 RDEKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA------------ 360 (488)
Q Consensus 296 ~~~~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~------------ 360 (488)
.+.+..++||||+ +++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 9999999999999 78999988665 4889999999999999999999999999999999999987
Q ss_pred -------CCcEEEeecCCcccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhh
Q 011326 361 -------SGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQA 433 (488)
Q Consensus 361 -------~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~ 433 (488)
++.+||+|||++..... ......||+.|+|||++ .+..++.++||||||+++|||++|..||...+..+.
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDE-HHSTLVSTRHYRAPEVI--LALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTS-CCCSSCSCGGGCCHHHH--TTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccccCCCceEeeCcccccCcc-ccccccCCccccChHHh--hCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 66899999999976443 33456799999999997 455689999999999999999999999987766544
Q ss_pred HHHhcCC--CC-----------------------------------------CCCCCcccHHHHHHHHHhhhhCCCCCCC
Q 011326 434 MFKIGGG--EL-----------------------------------------PPVPNSLSRDAQDFILKCLQVNPNDRPT 470 (488)
Q Consensus 434 ~~~i~~~--~~-----------------------------------------~~~~~~~s~~l~~Li~~cL~~dP~~Rps 470 (488)
...+... .. ...+...++++.+||.+||+.||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 3322110 00 0112234678999999999999999999
Q ss_pred HHHHHhCccCCCCCC
Q 011326 471 AAQLMEHPFIKRPLQ 485 (488)
Q Consensus 471 ~~eil~hp~f~~~~~ 485 (488)
+.|+++||||++..+
T Consensus 323 ~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 323 LREALKHPFFDLLKK 337 (339)
T ss_dssp HHHHTTSGGGGGGGC
T ss_pred HHHHhcCHHHHHHhc
Confidence 999999999987554
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=349.13 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=217.6
Q ss_pred cccCceeeee-eecccCceEEEEEEec---CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 222 RRITSWQKGE-LLGSGSYGFVYEGLTD---DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 222 ~~~~~y~~~~-~LG~G~fg~Vy~~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
...++|.+.+ .||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.++++++||||+++++++ .
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----EKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc----chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 3456777776 9999999999999853 68889999997542 344567889999999999999999999999 4
Q ss_pred CCceEEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
.+..++||||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 5579999999999999999854 35999999999999999999999999999999999999999999999999999765
Q ss_pred cCCC-----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcc
Q 011326 376 TMND-----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSL 449 (488)
Q Consensus 376 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 449 (488)
.... .....+|+.|+|||.+ ....++.++||||||+++|+|++ |..||...+..+....+..+..+..+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 238 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 238 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHH--HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTC
T ss_pred ccCcceeeccccccccccccCHHHh--ccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCc
Confidence 4332 2234568899999997 34558999999999999999998 99999988888888888877777888899
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHhCc
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLMEHP 478 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~hp 478 (488)
++++.++|.+||+.||.+||++.+++++.
T Consensus 239 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 239 PPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99999999999999999999999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=343.07 Aligned_cols=249 Identities=19% Similarity=0.352 Sum_probs=213.6
Q ss_pred ccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC--
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE-- 298 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-- 298 (488)
....++|++.+.||+|+||.||+|.+. +..||+|.+.... ........+.+|+.++++++||||+++++++.+.
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRD---WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTT---CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccc---cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 345779999999999999999999885 8899999997653 2344556789999999999999999999999877
Q ss_pred CceEEEEeeccCCChHHHHhhhc---cChhhhhHHHHHHHHHHHHHHHCC--CccccCCcccEEECCCCcEEEeecCCcc
Q 011326 299 KRLCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILNGLKYLHEQN--VVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~~---ls~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
+..++||||+++|+|.+++.... +++..++.++.|++.||.|||++| ++||||||+||+++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 78899999999999999997653 899999999999999999999999 9999999999999999999999998865
Q ss_pred cccCCCcccCCCCCcccCchhhccc-cCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhc-CCCCCCCCCcccH
Q 011326 374 ATTMNDVKSCKGTAFWMAPEVVNLK-KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIG-GGELPPVPNSLSR 451 (488)
Q Consensus 374 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~s~ 451 (488)
... .....||+.|+|||.+... ...++.++||||||+++|+|++|+.||...+..+....+. ....+..+..+++
T Consensus 162 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3kmu_A 162 SFQ---SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238 (271)
T ss_dssp TTS---CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred eec---ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence 432 2345689999999997432 1224458999999999999999999998877766544443 4455677888999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
++.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 239 HVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=359.75 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=211.8
Q ss_pred CcccccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecccc
Q 011326 217 NGKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR 296 (488)
Q Consensus 217 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 296 (488)
........++|++.+.||+|+||.||+|.+.+|..||+|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-----SQGIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-----SSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 334556678999999999999999999998889999999876532 234567889999999999999999999999
Q ss_pred CCCceEEEEeeccCCChHHHHhhh-----ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCC
Q 011326 297 DEKRLCIFLELVTKGSLASLYQKY-----HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGL 371 (488)
Q Consensus 297 ~~~~~~lV~E~~~~gsL~~~l~~~-----~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGl 371 (488)
+++..++||||+++|+|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 999999999999999999988654 388999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHH-------HhcCC
Q 011326 372 AKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF-------KIGGG 440 (488)
Q Consensus 372 a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~-------~i~~~ 440 (488)
+....... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||......+... .....
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYF--IKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHH--HHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccCCCccccCHHHh--cCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 97543222 2344589999999997 34568999999999999999999999997654332111 11111
Q ss_pred C---------CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCcc
Q 011326 441 E---------LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479 (488)
Q Consensus 441 ~---------~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~ 479 (488)
. ....+..++.++.+++.+||+.||++|||+.|++++..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1 11233446778999999999999999999999998753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=352.63 Aligned_cols=262 Identities=24% Similarity=0.449 Sum_probs=212.2
Q ss_pred cccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC--CCCcceeeccccC
Q 011326 220 FRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE--HDNIVQYLGTDRD 297 (488)
Q Consensus 220 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~ 297 (488)
......+|++.+.||+|+||.||++.+.++..||+|.+.... ........+.+|+.++.+++ ||||+++++++.+
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE---ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccc---ccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 344556899999999999999999999889999999997654 23455678899999999997 5999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
++..++||| +.+++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred CCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence 999999999 5677999988654 589999999999999999999999999999999999996 5899999999997654
Q ss_pred CCC----cccCCCCCcccCchhhccc---------cCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh-hhHHHh-cCCC
Q 011326 377 MND----VKSCKGTAFWMAPEVVNLK---------KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-QAMFKI-GGGE 441 (488)
Q Consensus 377 ~~~----~~~~~gt~~y~aPE~~~~~---------~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~-~~~~~i-~~~~ 441 (488)
... .....||+.|+|||.+... ...++.++||||||+++|+|++|..||...... .....+ ....
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 257 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 257 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc
Confidence 332 2345689999999997421 246889999999999999999999999765332 222332 2333
Q ss_pred CCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 442 LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 442 ~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
....+...++++.+||.+||+.||.+|||+.|+++||||+....+
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~ 302 (313)
T 3cek_A 258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302 (313)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence 345667789999999999999999999999999999999875443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=357.84 Aligned_cols=255 Identities=24% Similarity=0.396 Sum_probs=214.7
Q ss_pred cccccccCceeeeeeecccCceEEEEEEe------cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcce
Q 011326 218 GKFRRRITSWQKGELLGSGSYGFVYEGLT------DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQ 290 (488)
Q Consensus 218 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~ 290 (488)
..++...++|++.+.||+|+||.||+|.+ .++..||+|.+.... .......+.+|+.++.++ +||||++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~ 113 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVN 113 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc----CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 34666778999999999999999999986 246789999997432 122345788999999999 8999999
Q ss_pred eeccccCCCceEEEEeeccCCChHHHHhhhc------------------------cChhhhhHHHHHHHHHHHHHHHCCC
Q 011326 291 YLGTDRDEKRLCIFLELVTKGSLASLYQKYH------------------------LSDSQVSSYTRQILNGLKYLHEQNV 346 (488)
Q Consensus 291 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------------------ls~~~~~~i~~qi~~aL~yLH~~gi 346 (488)
+++++..++..++||||+++|+|.+++.... +++..++.++.||+.||.|||++||
T Consensus 114 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 193 (344)
T 1rjb_A 114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC 193 (344)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred EEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 9999999999999999999999999986532 7889999999999999999999999
Q ss_pred ccccCCcccEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-C
Q 011326 347 VHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-R 421 (488)
Q Consensus 347 iHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G 421 (488)
+||||||+|||++.++.+||+|||++....... .....||+.|+|||.+ ....++.++||||||+++|+|++ |
T Consensus 194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~il~el~t~g 271 (344)
T 1rjb_A 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL--FEGIYTIKSDVWSYGILLWEIFSLG 271 (344)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred ccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHh--ccCCCChhHhHHHHHHHHHHHHcCC
Confidence 999999999999999999999999997654332 2234578889999997 44568999999999999999998 9
Q ss_pred CCCCCCCchhhhH-HHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCc
Q 011326 422 RHPYSHLEGGQAM-FKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHP 478 (488)
Q Consensus 422 ~~Pf~~~~~~~~~-~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp 478 (488)
..||.+....... ..+........+..+++++.+|+.+||+.||.+|||+.++++|.
T Consensus 272 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 272 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 9999877654433 33444445566778999999999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=344.13 Aligned_cols=251 Identities=24% Similarity=0.433 Sum_probs=210.3
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcch--hHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGK--QSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
..++|++.+.||+|+||.||+|.+. ++..||+|.+.......... .....+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3568999999999999999999985 79999999997654332211 11257889999999999999999999987765
Q ss_pred ceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCC--CccccCCcccEEECCCCc-----EEEeecC
Q 011326 300 RLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQN--VVHRDIKCANILVDASGS-----VKLADFG 370 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~NILl~~~~~-----vkL~DFG 370 (488)
++||||+++|+|.+.+... .+++..++.++.|++.||.|||++| |+||||||+|||++.++. +||+|||
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 7999999999998877443 5899999999999999999999999 999999999999988776 9999999
Q ss_pred CcccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhh--HH-HhcCCCCCCCCC
Q 011326 371 LAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQA--MF-KIGGGELPPVPN 447 (488)
Q Consensus 371 la~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~--~~-~i~~~~~~~~~~ 447 (488)
+++.... ......||+.|+|||.+......++.++||||||+++|+|++|+.||........ .. .......+..+.
T Consensus 175 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (287)
T 4f0f_A 175 LSQQSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253 (287)
T ss_dssp TCBCCSS-CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCT
T ss_pred ccccccc-cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCc
Confidence 9975433 3445679999999999744455678999999999999999999999987654433 22 223444556778
Q ss_pred cccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 448 SLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 448 ~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
.+++++.+|+.+||+.||.+|||+.|+++
T Consensus 254 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 254 DCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 89999999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=355.66 Aligned_cols=264 Identities=28% Similarity=0.481 Sum_probs=196.4
Q ss_pred CCCcccccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHH-HHhcCCCCCcceee
Q 011326 215 SPNGKFRRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEIS-LLGQFEHDNIVQYL 292 (488)
Q Consensus 215 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIv~l~ 292 (488)
.+...+....++|++.+.||+|+||.||+|.+. +|..||+|.+.... ......++..|+. +++.++||||++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~~~~h~niv~~~ 87 (327)
T 3aln_A 12 SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV----DEKEQKQLLMDLDVVMRSSDCPYIVQFY 87 (327)
T ss_dssp CCCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC----CHHHHHHHHHHHHHHHSSCCCTTBCCEE
T ss_pred ChHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc----CchHHHHHHHHHHHHHHcCCCCcEeeee
Confidence 455566777889999999999999999999985 79999999997542 2233345555655 77888999999999
Q ss_pred ccccCCCceEEEEeeccCCChHHHHh------hhccChhhhhHHHHHHHHHHHHHHHC-CCccccCCcccEEECCCCcEE
Q 011326 293 GTDRDEKRLCIFLELVTKGSLASLYQ------KYHLSDSQVSSYTRQILNGLKYLHEQ-NVVHRDIKCANILVDASGSVK 365 (488)
Q Consensus 293 ~~~~~~~~~~lV~E~~~~gsL~~~l~------~~~ls~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~NILl~~~~~vk 365 (488)
+++.+++..++||||+++ +|.+++. ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~k 166 (327)
T 3aln_A 88 GALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIK 166 (327)
T ss_dssp EEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEE
T ss_pred eEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEE
Confidence 999999999999999987 7877765 34689999999999999999999999 999999999999999999999
Q ss_pred EeecCCcccccCCC-cccCCCCCcccCchhhcc--ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh-hhHHHhcCCC
Q 011326 366 LADFGLAKATTMND-VKSCKGTAFWMAPEVVNL--KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG-QAMFKIGGGE 441 (488)
Q Consensus 366 L~DFGla~~~~~~~-~~~~~gt~~y~aPE~~~~--~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~-~~~~~i~~~~ 441 (488)
|+|||++....... .....||+.|+|||.+.. ....++.++||||||+++|+|++|+.||...... +....+..+.
T Consensus 167 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 246 (327)
T 3aln_A 167 LCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246 (327)
T ss_dssp ECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSC
T ss_pred EccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCC
Confidence 99999997654432 234479999999999732 2445889999999999999999999999765432 2222333333
Q ss_pred CCCCC----CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 442 LPPVP----NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 442 ~~~~~----~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
.+..+ ..+++++.+|+.+||+.||.+|||+.++++||||.+.
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 22222 4689999999999999999999999999999999754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=355.91 Aligned_cols=246 Identities=27% Similarity=0.471 Sum_probs=207.3
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcE----EEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFF----FAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~----vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
.++|++.+.||+|+||.||+|.+. ++.. ||+|.+.... .......+.+|+.++++++||||+++++++.++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT----SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS----SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 568999999999999999999874 4554 4666664322 223446788999999999999999999999876
Q ss_pred CceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 299 KRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
. .++++|++++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 5 88999999999999988653 58999999999999999999999999999999999999999999999999997654
Q ss_pred CCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccH
Q 011326 377 MND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSR 451 (488)
Q Consensus 377 ~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 451 (488)
... .....+|+.|+|||.+ .+..++.++||||||+++|+|++ |..||.+.+..+....+......+.+..++.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI 246 (327)
T ss_dssp -----------CCCGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCH
T ss_pred CccccccccCCCccccccCHHHH--cCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCH
Confidence 332 2234578889999997 45668999999999999999999 9999999888888888877777778888999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
++.+|+.+||+.||.+|||+.|+++
T Consensus 247 ~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 247 DVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=381.27 Aligned_cols=294 Identities=27% Similarity=0.433 Sum_probs=241.2
Q ss_pred hhhHHHHHHHHHHHHHHHHHhhhhcC--CCCCcccccccCCCCCCCCCCccccCCCCCCCCCcccccccCceeeeeeecc
Q 011326 158 RHKFQYYMSLCNYIVTEAAKVRRRQD--CPNNVEYVSYHDDDDSKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGS 235 (488)
Q Consensus 158 ~~~f~~~~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~ 235 (488)
...|.+...|+.++..+.+....+.. |+... +.........|+...++|++.+.||+
T Consensus 219 ~~~F~SL~eLv~~y~~~~~~~~~~l~~~~~~~~---------------------~~~~~~~~~~~~i~~~~~~~~~~lG~ 277 (535)
T 2h8h_A 219 RTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSK---------------------PQTQGLAKDAWEIPRESLRLEVKLGQ 277 (535)
T ss_dssp TEEESSHHHHHHHHHHCCTTSSSCCCEECCCCC---------------------CCCSSSSTTCSBCCGGGEEEEEEEEE
T ss_pred cccccChHHhheeeccccCcccccccccccccc---------------------ccccccCccceecchhhhhhheeccc
Confidence 35688889999888655444332211 11100 00011123446677789999999999
Q ss_pred cCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEeeccCCChHH
Q 011326 236 GSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLAS 315 (488)
Q Consensus 236 G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 315 (488)
|+||.||+|.+.++..||||.+..... ....+.+|+.+|++++||||+++++++.+ +..+|||||+++|+|.+
T Consensus 278 G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~ 350 (535)
T 2h8h_A 278 GCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD 350 (535)
T ss_dssp CSSEEEEEEEETTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHH
T ss_pred CCCeEEEEEEECCCceEEEEEeCCCCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHH
Confidence 999999999998888899999975431 23578899999999999999999999876 67899999999999999
Q ss_pred HHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC---cccCCCCCcc
Q 011326 316 LYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---VKSCKGTAFW 389 (488)
Q Consensus 316 ~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~---~~~~~gt~~y 389 (488)
++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .....++..|
T Consensus 351 ~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y 430 (535)
T 2h8h_A 351 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 430 (535)
T ss_dssp HHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGG
T ss_pred HHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccc
Confidence 99643 48999999999999999999999999999999999999999999999999997654322 2334567889
Q ss_pred cCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCC
Q 011326 390 MAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDR 468 (488)
Q Consensus 390 ~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~R 468 (488)
+|||.+ ....++.++||||||++||||++ |..||.+....+....+..+...+.+..+++++.+||.+||+.||++|
T Consensus 431 ~aPE~~--~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 508 (535)
T 2h8h_A 431 TAPEAA--LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 508 (535)
T ss_dssp SCHHHH--HHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred cCHHHh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHC
Confidence 999997 34568999999999999999999 999999988888888888777777888999999999999999999999
Q ss_pred CCHHHHHhC--ccCC
Q 011326 469 PTAAQLMEH--PFIK 481 (488)
Q Consensus 469 ps~~eil~h--p~f~ 481 (488)
||+.+|++. .+|.
T Consensus 509 Pt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 509 PTFEYLQAFLEDYFT 523 (535)
T ss_dssp CCHHHHHHHHHTSSC
T ss_pred cCHHHHHHHHHHHhh
Confidence 999999864 4443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=366.03 Aligned_cols=249 Identities=27% Similarity=0.398 Sum_probs=202.1
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC--------CCCcceeecc
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE--------HDNIVQYLGT 294 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~--------HpnIv~l~~~ 294 (488)
.++|++.+.||+|+||.||+|.+. ++..||+|++.. .......+.+|+.+++.++ |+||++++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS------AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec------CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 478999999999999999999875 789999999863 2344567889999999885 7889999999
Q ss_pred cc----CCCceEEEEeeccCCChHHHH-hh--hccChhhhhHHHHHHHHHHHHHHHC-CCccccCCcccEEECCCC----
Q 011326 295 DR----DEKRLCIFLELVTKGSLASLY-QK--YHLSDSQVSSYTRQILNGLKYLHEQ-NVVHRDIKCANILVDASG---- 362 (488)
Q Consensus 295 ~~----~~~~~~lV~E~~~~gsL~~~l-~~--~~ls~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~NILl~~~~---- 362 (488)
+. +....++||||+.+ +|.+.+ .. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 110 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EEEEETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHH
T ss_pred eeecCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhh
Confidence 87 66789999999955 555554 33 3599999999999999999999998 999999999999999775
Q ss_pred ---------------------------------------------cEEEeecCCcccccCCCcccCCCCCcccCchhhcc
Q 011326 363 ---------------------------------------------SVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNL 397 (488)
Q Consensus 363 ---------------------------------------------~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~~~~ 397 (488)
.+||+|||++..... ......||+.|+|||++
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-~~~~~~gt~~y~aPE~~-- 265 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-HFTEDIQTRQYRSLEVL-- 265 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-CSCSCCSCGGGCCHHHH--
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-cCccCCCCCcccCChhh--
Confidence 799999999976543 34456799999999997
Q ss_pred ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhh------hHHHh---cCC---------C-----------C------
Q 011326 398 KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ------AMFKI---GGG---------E-----------L------ 442 (488)
Q Consensus 398 ~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~------~~~~i---~~~---------~-----------~------ 442 (488)
.+..++.++|||||||++|||++|+.||...+..+ ....+ ... . .
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 44568999999999999999999999997654321 11111 000 0 0
Q ss_pred ------------CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 443 ------------PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 443 ------------~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
...+...++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0122345678899999999999999999999999999974
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=344.35 Aligned_cols=251 Identities=26% Similarity=0.451 Sum_probs=214.0
Q ss_pred cccccCceeeeeeecccCceEEEEEEecC----CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc
Q 011326 220 FRRRITSWQKGELLGSGSYGFVYEGLTDD----GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD 295 (488)
Q Consensus 220 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 295 (488)
+....++|++.+.||+|+||.||+|.+.+ +..||+|.+.... .......+.+|+.++++++||||+++++++
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 82 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC----TLDNKEKFMSEAVIMKNLDHPHIVKLIGII 82 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS----CHHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc----CchHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 34456789999999999999999998642 3469999987542 334557789999999999999999999998
Q ss_pred cCCCceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 296 RDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 296 ~~~~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
.++ ..++||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 83 ~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 83 EEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp CSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred cCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 754 568999999999999999654 48999999999999999999999999999999999999999999999999987
Q ss_pred cccCCC---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcc
Q 011326 374 ATTMND---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSL 449 (488)
Q Consensus 374 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 449 (488)
...... .....+|+.|+|||.+ ....++.++||||||+++|+|++ |+.||......+....+......+.+..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESI--NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLC 239 (281)
T ss_dssp CC---------CCCCCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTC
T ss_pred ccccccccccccCCCCcceeCchhh--ccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCC
Confidence 654432 2344578899999997 44568999999999999999998 99999887777777776666666778889
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
++++.+++.+||+.||.+|||+.|++++
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 240 PPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 9999999999999999999999999865
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=350.50 Aligned_cols=260 Identities=30% Similarity=0.493 Sum_probs=198.8
Q ss_pred ccccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
.+...+++|++.+.||+|+||.||+|.+. +|..||+|.+..... .......+.++..+++.++||||+++++++.+
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN---KEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC---HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc---chHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence 45567889999999999999999999986 799999999976432 22233344555567888899999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHC-CCccccCCcccEEECCCCcEEEeecCCccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKA 374 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~NILl~~~~~vkL~DFGla~~ 374 (488)
++..++||||+ ++.+..+... ..+++..+..++.|++.||.|||++ |++|+||||+||+++.++.+||+|||++..
T Consensus 96 ~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 96 NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 99999999999 4466666543 4699999999999999999999995 999999999999999999999999999865
Q ss_pred ccCCC-cccCCCCCcccCchhhcc---ccCCCChhhhHHHHHHHHHHHHcCCCCCCCC-chhhhHHHhcCCCCCCCC--C
Q 011326 375 TTMND-VKSCKGTAFWMAPEVVNL---KKDGYGLTADIWSLGCTVLEMLTRRHPYSHL-EGGQAMFKIGGGELPPVP--N 447 (488)
Q Consensus 375 ~~~~~-~~~~~gt~~y~aPE~~~~---~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~-~~~~~~~~i~~~~~~~~~--~ 447 (488)
..... .....||+.|+|||.+.. ....++.++||||||+++|+|++|+.||... ...+....+.....+..+ .
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (318)
T 2dyl_A 175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHM 254 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSS
T ss_pred ccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccC
Confidence 54332 334569999999999732 2445789999999999999999999999864 334444444444433333 4
Q ss_pred cccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 448 SLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 448 ~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
.+++++.+||.+||+.||.+|||+.|+++||||++
T Consensus 255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 58999999999999999999999999999999964
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=343.71 Aligned_cols=246 Identities=26% Similarity=0.440 Sum_probs=208.1
Q ss_pred cccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC-C
Q 011326 220 FRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD-E 298 (488)
Q Consensus 220 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~ 298 (488)
+....++|++.+.||+|+||.||++.+. |..||+|.+.... ....+.+|+.++++++||||+++++++.+ .
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 4556789999999999999999999764 8899999986432 23578899999999999999999998654 4
Q ss_pred CceEEEEeeccCCChHHHHhhhc---cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 299 KRLCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~~---ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
+..++||||+++++|.+++...+ +++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 57999999999999999987543 899999999999999999999999999999999999999999999999998755
Q ss_pred cCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHH
Q 011326 376 TMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQ 454 (488)
Q Consensus 376 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~ 454 (488)
... .....+++.|+|||.+ ....++.++||||||+++|+|++ |..||...+..+....+..+.....+..+++++.
T Consensus 168 ~~~-~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 244 (278)
T 1byg_A 168 SST-QDTGKLPVKWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 244 (278)
T ss_dssp ---------CCTTTSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHH
T ss_pred ccc-ccCCCccccccCHHHh--CCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHH
Confidence 432 2344678899999997 45568999999999999999998 9999998888777777777766777888999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHh
Q 011326 455 DFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+++.+||+.||.+|||+.|+++
T Consensus 245 ~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 245 EVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCChhhCCCHHHHHH
Confidence 9999999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=355.81 Aligned_cols=254 Identities=24% Similarity=0.327 Sum_probs=205.2
Q ss_pred CCcccccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc
Q 011326 216 PNGKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD 295 (488)
Q Consensus 216 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 295 (488)
+...+.....+|++.+.||+|+||.||+|.+. +..||||++... ........+|+.++++++||||+++++++
T Consensus 15 ~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 87 (322)
T 3soc_A 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ------DKQSWQNEYEVYSLPGMKHENILQFIGAE 87 (322)
T ss_dssp CCCCEEETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred CccccccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC------chHHHHHHHHHHHHhcCCCCCchhhccee
Confidence 33445566789999999999999999999776 789999998642 23334566799999999999999999998
Q ss_pred cCCC----ceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHC----------CCccccCCcccEEECCC
Q 011326 296 RDEK----RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQ----------NVVHRDIKCANILVDAS 361 (488)
Q Consensus 296 ~~~~----~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~----------giiHrDLkp~NILl~~~ 361 (488)
.+.. .+++||||+++|+|.+++....+++..++.++.|++.||.|||+. ||+||||||+|||++.+
T Consensus 88 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~ 167 (322)
T 3soc_A 88 KRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167 (322)
T ss_dssp EEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT
T ss_pred ccCCCCCceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC
Confidence 7744 479999999999999999988899999999999999999999999 99999999999999999
Q ss_pred CcEEEeecCCcccccCCC----cccCCCCCcccCchhhccc---cCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh---
Q 011326 362 GSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLK---KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG--- 431 (488)
Q Consensus 362 ~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~--- 431 (488)
+.+||+|||+++...... .....||+.|+|||++... ...++.++||||||+++|||++|+.||.+....
T Consensus 168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 247 (322)
T 3soc_A 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247 (322)
T ss_dssp CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence 999999999997654332 2346799999999997421 123567899999999999999999999754321
Q ss_pred -------------hhHHHhcCCC-CCCCCC-----cccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 432 -------------QAMFKIGGGE-LPPVPN-----SLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 432 -------------~~~~~i~~~~-~~~~~~-----~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
.....+.... .+..+. ..++++.+||.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1111222222 222222 23566999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=354.11 Aligned_cols=255 Identities=24% Similarity=0.421 Sum_probs=204.5
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcc-hhHHHHHHHHHHHHhcC----CCCCcceeecccc
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRG-KQSILQLEQEISLLGQF----EHDNIVQYLGTDR 296 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~-~~~~~~~~~Ei~iL~~l----~HpnIv~l~~~~~ 296 (488)
..++|++.+.||+|+||.||+|.+. ++..||+|.+......... ......+.+|+.++.++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 4568999999999999999999875 7899999999755432111 11223455788888888 8999999999999
Q ss_pred CCCceEEEEee-ccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEEC-CCCcEEEeecCCcc
Q 011326 297 DEKRLCIFLEL-VTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVD-ASGSVKLADFGLAK 373 (488)
Q Consensus 297 ~~~~~~lV~E~-~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~-~~~~vkL~DFGla~ 373 (488)
+.+..++|||+ +.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++ .++.++|+|||++.
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~ 188 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA 188 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCE
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhh
Confidence 99999999999 7899999998755 599999999999999999999999999999999999999 88999999999998
Q ss_pred cccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHH
Q 011326 374 ATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDA 453 (488)
Q Consensus 374 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l 453 (488)
...........||+.|+|||++. .....+.++||||||+++|+|++|+.||..... .. . .....+..++.++
T Consensus 189 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~----~-~~~~~~~~~~~~~ 260 (312)
T 2iwi_A 189 LLHDEPYTDFDGTRVYSPPEWIS-RHQYHALPATVWSLGILLYDMVCGDIPFERDQE--IL----E-AELHFPAHVSPDC 260 (312)
T ss_dssp ECCSSCBCCCCSCTTTSCHHHHH-HSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HH----H-TCCCCCTTSCHHH
T ss_pred hcccCcccccCCcccccCceeee-cCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--Hh----h-hccCCcccCCHHH
Confidence 77666666778999999999873 233345689999999999999999999975321 11 1 1224567789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 454 QDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
.+||.+||+.||++|||+.|+++||||+...+
T Consensus 261 ~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 261 CALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred HHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 99999999999999999999999999998654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=357.73 Aligned_cols=257 Identities=28% Similarity=0.444 Sum_probs=214.6
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcch-hHHHHHHHHHHHHhcCC--CCCcceeecccc
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGK-QSILQLEQEISLLGQFE--HDNIVQYLGTDR 296 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~-~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~ 296 (488)
....++|++.+.||+|+||.||+|.+. ++..||+|.+.......... .....+.+|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 344678999999999999999999875 78999999997654322110 11234567889999986 599999999999
Q ss_pred CCCceEEEEeeccC-CChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEEC-CCCcEEEeecCCcc
Q 011326 297 DEKRLCIFLELVTK-GSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVD-ASGSVKLADFGLAK 373 (488)
Q Consensus 297 ~~~~~~lV~E~~~~-gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~-~~~~vkL~DFGla~ 373 (488)
+++..++|||++.+ ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 99999999999976 8999988654 589999999999999999999999999999999999999 78999999999998
Q ss_pred cccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHH
Q 011326 374 ATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDA 453 (488)
Q Consensus 374 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l 453 (488)
...........||+.|+|||++. .....+.++||||||+++|||++|+.||...+. . ... ....+..+++++
T Consensus 199 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~----~~~-~~~~~~~~~~~~ 270 (320)
T 3a99_A 199 LLKDTVYTDFDGTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--I----IRG-QVFFRQRVSSEC 270 (320)
T ss_dssp ECCSSCBCCCCSCGGGSCHHHHH-HSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--H----HHC-CCCCSSCCCHHH
T ss_pred ccccccccCCCCCccCCChHHhc-cCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--h----hcc-cccccccCCHHH
Confidence 77666566678999999999973 333347889999999999999999999975321 1 111 124566789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 454 QDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
.+||.+||+.||.+|||+.|+++||||++...
T Consensus 271 ~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 271 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred HHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 99999999999999999999999999998753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=362.51 Aligned_cols=253 Identities=26% Similarity=0.398 Sum_probs=205.9
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CC-----Ccceeeccc
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HD-----NIVQYLGTD 295 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-Hp-----nIv~l~~~~ 295 (488)
..++|++.+.||+|+||.||+|.+. ++..||||++.. .......+..|+.+++.++ |+ +|+++++++
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN------KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS------SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec------cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 4679999999999999999999886 788999999963 2334456778888888774 55 489999999
Q ss_pred cCCCceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHH--HCCCccccCCcccEEEC--CCCcEEEee
Q 011326 296 RDEKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLH--EQNVVHRDIKCANILVD--ASGSVKLAD 368 (488)
Q Consensus 296 ~~~~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH--~~giiHrDLkp~NILl~--~~~~vkL~D 368 (488)
...+..++||||+++ +|.+++... ++++..+..++.|++.||.||| +.||+||||||+|||++ .++.+||+|
T Consensus 126 ~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 126 MFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 999999999999975 999988654 4899999999999999999999 57999999999999995 478899999
Q ss_pred cCCcccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC-----
Q 011326 369 FGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP----- 443 (488)
Q Consensus 369 FGla~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~----- 443 (488)
||++..... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.+.+..+....+......
T Consensus 205 FG~a~~~~~-~~~~~~~t~~y~aPE~~--~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (382)
T 2vx3_A 205 FGSSCQLGQ-RIYQYIQSRFYRSPEVL--LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281 (382)
T ss_dssp CTTCEETTC-CCCSSCSCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ccCceeccc-ccccccCCccccChHHH--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999976643 34456799999999997 4456899999999999999999999999987766554433211000
Q ss_pred ---------------------------------CCCC-------------------------cccHHHHHHHHHhhhhCC
Q 011326 444 ---------------------------------PVPN-------------------------SLSRDAQDFILKCLQVNP 465 (488)
Q Consensus 444 ---------------------------------~~~~-------------------------~~s~~l~~Li~~cL~~dP 465 (488)
+... ..++++.+||.+||++||
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 361 (382)
T 2vx3_A 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361 (382)
T ss_dssp HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence 0000 011478999999999999
Q ss_pred CCCCCHHHHHhCccCCCCCC
Q 011326 466 NDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 466 ~~Rps~~eil~hp~f~~~~~ 485 (488)
++|||+.|+++||||++...
T Consensus 362 ~~Rpta~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 362 KTRIQPYYALQHSFFKKTAD 381 (382)
T ss_dssp TTSCCHHHHTTSGGGCC---
T ss_pred hhCCCHHHHhcCcccccCCC
Confidence 99999999999999998653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=350.75 Aligned_cols=251 Identities=27% Similarity=0.466 Sum_probs=213.2
Q ss_pred ccccCceeeeeeecccCceEEEEEEecC-----CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTDD-----GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD 295 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-----g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 295 (488)
+....+|++.+.||+|+||.||+|.+.. +..||+|.+.... .......+.+|+.++++++||||+++++++
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3446789999999999999999998642 3469999986432 334456788999999999999999999999
Q ss_pred cCCCceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 296 RDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 296 ~~~~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
.+.+..++||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999999999998653 59999999999999999999999999999999999999999999999999997
Q ss_pred cccCCC-----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCC
Q 011326 374 ATTMND-----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPN 447 (488)
Q Consensus 374 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 447 (488)
...... .....+|+.|+|||.+ ....++.++||||||+++|||++ |..||...+..+....+..+...+.+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 273 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAI--SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM 273 (333)
T ss_dssp ---------------CCCGGGSCHHHH--HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred hhccccccccccCCCCccccccCchhc--ccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcc
Confidence 654332 1223467889999997 45568999999999999999999 999999888888888877776667788
Q ss_pred cccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 448 SLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 448 ~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.+++++.+|+.+||+.||.+||++.+++++
T Consensus 274 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 274 DCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 899999999999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=354.64 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=216.6
Q ss_pred cccCceeeeeeecccCceEEEEEEe------cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLT------DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD 295 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 295 (488)
....+|++.+.||+|+||.||+|.+ .++..||+|.+... .......++.+|+.++++++||||+++++++
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----CSEQDELDFLMEALIISKFNHQNIVRCIGVS 102 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc----cchhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence 3457899999999999999999983 35789999998633 2344556788999999999999999999999
Q ss_pred cCCCceEEEEeeccCCChHHHHhhh--------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC---CCcE
Q 011326 296 RDEKRLCIFLELVTKGSLASLYQKY--------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA---SGSV 364 (488)
Q Consensus 296 ~~~~~~~lV~E~~~~gsL~~~l~~~--------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~---~~~v 364 (488)
.+.+..++||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++. +..+
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 9999999999999999999999764 3888999999999999999999999999999999999984 4469
Q ss_pred EEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcC
Q 011326 365 KLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGG 439 (488)
Q Consensus 365 kL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~ 439 (488)
+|+|||++....... .....||+.|+|||.+ ....++.++||||||+++|+|++ |..||......+....+..
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 260 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHh--cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence 999999986443222 2345578999999997 34568999999999999999998 9999998888888777777
Q ss_pred CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 440 GELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 440 ~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
+.....+..+++++.+||.+||+.||.+|||+.++++|.|+
T Consensus 261 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 77777788899999999999999999999999999998775
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=353.60 Aligned_cols=250 Identities=25% Similarity=0.455 Sum_probs=213.4
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEE--EEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccC
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFF--AVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRD 297 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~v--AvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~ 297 (488)
...++|++.+.||+|+||.||+|.+. ++..+ |+|.+.... .......+.+|+.+++++ +||||+++++++.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 97 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 97 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc----chHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence 34678999999999999999999875 56654 999887432 223345688999999999 89999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhhh-----------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY-----------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA 360 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~-----------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~ 360 (488)
.+..++||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 177 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence 99999999999999999998654 4899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCCcccccCC-CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhc
Q 011326 361 SGSVKLADFGLAKATTMN-DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIG 438 (488)
Q Consensus 361 ~~~vkL~DFGla~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~ 438 (488)
++.+||+|||+++..... ......+++.|+|||.+ ....++.++||||||+++|+|++ |..||.+.+..+....+.
T Consensus 178 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp GGCEEECCTTCEESSCEECCC----CCTTTCCHHHH--HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred CCeEEEcccCcCccccccccccCCCCCccccChhhh--ccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 999999999998643322 22344578899999997 44558999999999999999998 999999988888877777
Q ss_pred CCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 439 GGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 439 ~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.+.....+..+++++.+||.+||+.||.+|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 776667778899999999999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=345.46 Aligned_cols=249 Identities=26% Similarity=0.421 Sum_probs=213.3
Q ss_pred cccCceeeee-eecccCceEEEEEEe---cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 222 RRITSWQKGE-LLGSGSYGFVYEGLT---DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 222 ~~~~~y~~~~-~LG~G~fg~Vy~~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
....+|++.+ .||+|+||.||+|.+ .++..||+|.+..... .......+.+|+.+++.++||||+++++++ .
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN---DPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 3456899988 999999999999964 2578999999975432 233456789999999999999999999999 5
Q ss_pred CCceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
.+..++||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 66789999999999999998765 49999999999999999999999999999999999999999999999999997654
Q ss_pred CCC-----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCccc
Q 011326 377 MND-----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLS 450 (488)
Q Consensus 377 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s 450 (488)
... .....+|+.|+|||.+ ....++.++||||||+++|+|++ |..||...+..+....+..+..+..+..++
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECI--NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP 246 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHH--HHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred cCCCcccccccCCCCceeeChHHh--ccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 332 1233467889999997 34457899999999999999999 999999988888888887777778888999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 451 RDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 451 ~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+++.+++.+||+.||.+|||+.++++
T Consensus 247 ~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 247 REMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=343.04 Aligned_cols=248 Identities=25% Similarity=0.417 Sum_probs=211.4
Q ss_pred ccCceeeeeeecccCceEEEEEEec----CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc-cC
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD----DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD-RD 297 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-~~ 297 (488)
...+|++.+.||+|+||.||+|.+. .+..+|+|.+... ........+.+|+.++++++||||+++++++ ..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC----CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC----CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 3457999999999999999999863 2346899988642 2344567789999999999999999999985 55
Q ss_pred CCceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
++..++||||+++|+|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 67889999999999999999653 4899999999999999999999999999999999999999999999999999755
Q ss_pred cCCC------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCc
Q 011326 376 TMND------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNS 448 (488)
Q Consensus 376 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 448 (488)
.... .....+|+.|+|||.+ .+..++.++||||||+++|+|++ |.+||...+..+....+........+..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 256 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTT
T ss_pred cccchhccccccCCCCCccccChHHh--cCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCcc
Confidence 3322 2345578899999997 44568999999999999999999 6778887777777777777777777888
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 449 LSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 449 ~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+++++.+++.+||+.||.+|||+.|+++
T Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 257 CPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=347.95 Aligned_cols=253 Identities=25% Similarity=0.414 Sum_probs=209.3
Q ss_pred cccccCceeeeeeecccCceEEEEEEec----CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc
Q 011326 220 FRRRITSWQKGELLGSGSYGFVYEGLTD----DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD 295 (488)
Q Consensus 220 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 295 (488)
+....++|++.+.||+|+||.||+|.+. ++..||+|.+.... ........+.+|+.++++++||||+++++++
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN---SSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc---cchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3445678999999999999999999764 35589999987543 2344556789999999999999999999998
Q ss_pred cCCC-----ceEEEEeeccCCChHHHHhh-------hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCc
Q 011326 296 RDEK-----RLCIFLELVTKGSLASLYQK-------YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS 363 (488)
Q Consensus 296 ~~~~-----~~~lV~E~~~~gsL~~~l~~-------~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~ 363 (488)
.+.+ ..++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence 7654 45999999999999998832 34899999999999999999999999999999999999999999
Q ss_pred EEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhc
Q 011326 364 VKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIG 438 (488)
Q Consensus 364 vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~ 438 (488)
+||+|||++....... .....+++.|+|||.+ ....++.++||||||+++|+|++ |..||......+....+.
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 263 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL--ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHH--HSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhh--cCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH
Confidence 9999999987654332 2334578899999997 45668999999999999999999 999999888888888777
Q ss_pred CCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 439 GGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 439 ~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.+..+..+..+++++.+++.+||+.||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 264 HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 777777888899999999999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=349.62 Aligned_cols=253 Identities=26% Similarity=0.447 Sum_probs=213.8
Q ss_pred ccccccCceeeeeeecccCceEEEEEEe------cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCccee
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLT------DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQY 291 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l 291 (488)
.+....++|++.+.||+|+||.||+|.+ .++..||+|.+.... .......+.+|+.++.++ +||||+++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC----CcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 4555678999999999999999999974 357899999997532 234456788999999999 79999999
Q ss_pred eccccCCC-ceEEEEeeccCCChHHHHhhhc-----------------cChhhhhHHHHHHHHHHHHHHHCCCccccCCc
Q 011326 292 LGTDRDEK-RLCIFLELVTKGSLASLYQKYH-----------------LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKC 353 (488)
Q Consensus 292 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~-----------------ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp 353 (488)
++++...+ .+++||||+++|+|.+++.... +++..++.++.|++.||.|||++||+||||||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp 176 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 176 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCcc
Confidence 99987654 5999999999999999996543 78999999999999999999999999999999
Q ss_pred ccEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 011326 354 ANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHL 428 (488)
Q Consensus 354 ~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~ 428 (488)
+||+++.++.+||+|||++....... .....||+.|+|||.+ ....++.++||||||+++|+|++ |..||...
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI--FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhh--ccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999997654332 2244578899999997 45668999999999999999998 99999876
Q ss_pred chhh-hHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 429 EGGQ-AMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 429 ~~~~-~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
...+ ....+..+.....+..+++++.+++.+||+.||.+|||+.|+++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5433 334444445556677899999999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=358.20 Aligned_cols=252 Identities=28% Similarity=0.426 Sum_probs=183.1
Q ss_pred cccCceeeee-eecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC--
Q 011326 222 RRITSWQKGE-LLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD-- 297 (488)
Q Consensus 222 ~~~~~y~~~~-~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-- 297 (488)
...++|++.+ +||+|+||.||+|.+. +|+.||+|++... .... .+....++.++||||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~ 95 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PKAR---QEVDHHWQASGGPHIVCILDVYENMH 95 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------HHHH---HHHHHHHHhcCCCChHHHHHHHhhcc
Confidence 3467899954 6999999999999986 7999999998642 2111 222334567799999999999865
Q ss_pred --CCceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC---CCcEEEeec
Q 011326 298 --EKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA---SGSVKLADF 369 (488)
Q Consensus 298 --~~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~---~~~vkL~DF 369 (488)
....++||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence 45689999999999999999765 4999999999999999999999999999999999999976 455999999
Q ss_pred CCcccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhH----HHhcCCC---C
Q 011326 370 GLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAM----FKIGGGE---L 442 (488)
Q Consensus 370 Gla~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~----~~i~~~~---~ 442 (488)
|++............||+.|+|||++ ....++.++||||||+++|+|++|..||......... ..+.... .
T Consensus 176 g~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (336)
T 3fhr_A 176 GFAKETTQNALQTPCYTPYYVAPEVL--GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP 253 (336)
T ss_dssp TTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCC
T ss_pred ccceeccccccccCCCCcCccChhhh--CCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccC
Confidence 99987665555667799999999997 4556789999999999999999999999765543321 1111111 1
Q ss_pred CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 443 PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 443 ~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
.+....+++++.+||.+||+.||.+|||+.|+++||||++..
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 122357899999999999999999999999999999997643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=346.31 Aligned_cols=245 Identities=20% Similarity=0.352 Sum_probs=205.9
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CC-------cEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecc
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DG-------FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGT 294 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g-------~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 294 (488)
..++|++.+.||+|+||.||+|.+. ++ ..||+|.+... .......+.+|+.++++++||||++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-----HRNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-----GGGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-----cHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 4578999999999999999999875 34 57999998642 23445678999999999999999999999
Q ss_pred ccCCCceEEEEeeccCCChHHHHhhhc--cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCc--------E
Q 011326 295 DRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS--------V 364 (488)
Q Consensus 295 ~~~~~~~~lV~E~~~~gsL~~~l~~~~--ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~--------v 364 (488)
+.+++..++||||+++|+|.+++...+ +++..++.++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 999999999999999999999997654 999999999999999999999999999999999999998887 9
Q ss_pred EEeecCCcccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcC-CCCCCCCchhhhHHHhcCCCCC
Q 011326 365 KLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELP 443 (488)
Q Consensus 365 kL~DFGla~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG-~~Pf~~~~~~~~~~~i~~~~~~ 443 (488)
||+|||++..... .....||+.|+|||.+. ....++.++||||||+++|+|++| .+||...+.......... ..
T Consensus 161 kl~Dfg~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~--~~ 235 (289)
T 4fvq_A 161 KLSDPGISITVLP--KDILQERIPWVPPECIE-NPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED--RH 235 (289)
T ss_dssp EECCCCSCTTTSC--HHHHHHTTTTSCHHHHH-CGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT--TC
T ss_pred eeccCcccccccC--ccccCCcCcccCHHHhC-CCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc--cC
Confidence 9999999865432 23345788999999973 235589999999999999999995 555555554444433332 23
Q ss_pred CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 444 PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 444 ~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
..+...++++.+|+.+||+.||.+|||+.|+++|
T Consensus 236 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 236 QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4566678899999999999999999999999976
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=340.56 Aligned_cols=247 Identities=26% Similarity=0.430 Sum_probs=210.7
Q ss_pred CceeeeeeecccCceEEEEEEec-C---CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-D---GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~---g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 300 (488)
..|.+.+.||+|+||.||+|.+. + +..+|+|.+... ........+.+|+.++++++||||+++++++.+.+.
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI----TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG 96 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC----CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc----ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC
Confidence 35778899999999999999863 2 337999998642 234456788999999999999999999999987665
Q ss_pred e-EEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 301 L-CIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 301 ~-~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
. +++|||+.+|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 5 999999999999999975 3589999999999999999999999999999999999999999999999999975432
Q ss_pred C------CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCccc
Q 011326 378 N------DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLS 450 (488)
Q Consensus 378 ~------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s 450 (488)
. ......+|+.|+|||.+ .+..++.++||||||+++|+|++ |.+||...+..+....+......+.+..++
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESL--QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCP 254 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHH--TTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCC
T ss_pred CcccccccCcCCCCCccccChhhh--ccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccch
Confidence 2 23345688899999997 45568999999999999999999 556666667777777777777777788899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 451 RDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 451 ~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
+++.+|+.+||+.||.+|||+.++++.
T Consensus 255 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 255 DSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999998853
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=353.86 Aligned_cols=250 Identities=23% Similarity=0.343 Sum_probs=204.7
Q ss_pred cCceeeeeeecccCceEEEEEEec-CC-cEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCC------cceeeccc
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DG-FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN------IVQYLGTD 295 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g-~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn------Iv~l~~~~ 295 (488)
.++|++.+.||+|+||.||+|.+. ++ ..||+|++.. .......+.+|+.+++.++|++ ++.+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN------VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc------cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 468999999999999999999885 44 7899999863 2344567788999999887665 88999999
Q ss_pred cCCCceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEE--------------
Q 011326 296 RDEKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILV-------------- 358 (488)
Q Consensus 296 ~~~~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl-------------- 358 (488)
...+..++||||+ +++|.+.+... .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence 9999999999999 45666655443 48999999999999999999999999999999999999
Q ss_pred -----CCCCcEEEeecCCcccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhh
Q 011326 359 -----DASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQA 433 (488)
Q Consensus 359 -----~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~ 433 (488)
+.++.+||+|||++..... ......||+.|+|||++ .+..++.++||||||+++|||++|..||...+..+.
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHE-HHTTIVATRHYRPPEVI--LELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTS-CCCSSCSCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccccCCCcEEEeecCccccccc-cccCCcCCCcccCCeee--ecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 5678999999999976443 33456799999999997 455689999999999999999999999988766544
Q ss_pred HHHhcCC--CCC-----------------------------------------CCCCcccHHHHHHHHHhhhhCCCCCCC
Q 011326 434 MFKIGGG--ELP-----------------------------------------PVPNSLSRDAQDFILKCLQVNPNDRPT 470 (488)
Q Consensus 434 ~~~i~~~--~~~-----------------------------------------~~~~~~s~~l~~Li~~cL~~dP~~Rps 470 (488)
...+... ..+ ......+.++.+||.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 3322110 000 011223568999999999999999999
Q ss_pred HHHHHhCccCCCC
Q 011326 471 AAQLMEHPFIKRP 483 (488)
Q Consensus 471 ~~eil~hp~f~~~ 483 (488)
+.|+++||||+..
T Consensus 328 ~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 328 LAEALLHPFFAGL 340 (355)
T ss_dssp HHHHTTSGGGGGC
T ss_pred HHHHhcChhhcCC
Confidence 9999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=350.14 Aligned_cols=256 Identities=25% Similarity=0.440 Sum_probs=215.5
Q ss_pred CCcccccccCceeeeeeecccCceEEEEEEec-CC-----cEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCc
Q 011326 216 PNGKFRRRITSWQKGELLGSGSYGFVYEGLTD-DG-----FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNI 288 (488)
Q Consensus 216 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g-----~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnI 288 (488)
....++...++|++.+.||+|+||.||+|.+. ++ ..||+|.+.... .......+.+|+.+++++ +||||
T Consensus 37 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i 112 (333)
T 2i1m_A 37 YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA----HADEKEALMSELKIMSHLGQHENI 112 (333)
T ss_dssp CCGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred ccccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc----ChHHHHHHHHHHHHHHhhcCCCCe
Confidence 34456777889999999999999999999874 23 479999987532 234556789999999999 89999
Q ss_pred ceeeccccCCCceEEEEeeccCCChHHHHhhh---------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCc
Q 011326 289 VQYLGTDRDEKRLCIFLELVTKGSLASLYQKY---------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKC 353 (488)
Q Consensus 289 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~---------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp 353 (488)
+++++++.+++..++||||+++|+|.+++... .+++..++.++.|++.||.|||++||+||||||
T Consensus 113 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 192 (333)
T 2i1m_A 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAA 192 (333)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred eeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCccc
Confidence 99999999999999999999999999988643 368999999999999999999999999999999
Q ss_pred ccEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 011326 354 ANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHL 428 (488)
Q Consensus 354 ~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~ 428 (488)
+|||++.++.+||+|||++....... .....+|+.|+|||.+ ....++.++||||||+++|+|++ |..||.+.
T Consensus 193 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 270 (333)
T 2i1m_A 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI--FDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270 (333)
T ss_dssp GGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHh--ccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence 99999999999999999997554332 2234577889999987 34568999999999999999998 99999876
Q ss_pred chhhhHHH-hcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 429 EGGQAMFK-IGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 429 ~~~~~~~~-i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
........ +........+..+++++.+|+.+||+.||.+|||+.|++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 271 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp CSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 65443333 23333445567789999999999999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=344.96 Aligned_cols=247 Identities=28% Similarity=0.485 Sum_probs=206.3
Q ss_pred cCceeeeeeecccCceEEEEEEe-----cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLT-----DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
...|++.+.||+|+||.||+|.. .++..||+|.+..... ......+.+|+.++++++||||+++++++.+.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG----GNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc----chhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 45699999999999999999983 4789999999975432 22346788999999999999999999998876
Q ss_pred --CceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccc
Q 011326 299 --KRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 374 (488)
Q Consensus 299 --~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~ 374 (488)
..+++||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 6789999999999999998543 599999999999999999999999999999999999999999999999999976
Q ss_pred ccCCC-----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCC---------------chhhhH
Q 011326 375 TTMND-----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHL---------------EGGQAM 434 (488)
Q Consensus 375 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~---------------~~~~~~ 434 (488)
..... .....||..|+|||.+ .+..++.++||||||+++|+|++|..|+... ......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECL--MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHH--HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeee--cCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 54432 2345688889999997 4455789999999999999999999876322 112233
Q ss_pred HHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 435 FKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 435 ~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
..+......+.+..+++++.+|+.+||+.||.+|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 444555566778889999999999999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=355.09 Aligned_cols=255 Identities=24% Similarity=0.391 Sum_probs=206.9
Q ss_pred ccccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
.+....++|++.+.||+|+||.||+|.+.+|..||+|.+....... ....+.+|+.+++.++||||+++++++.++
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG----GELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC---------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch----HHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 3455678899999999999999999988889999999987543221 112578999999999999999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhhc-----cChhhhhHHHHHHHHHHHHHHHC---CCccccCCcccEEECCCCcEEEeecC
Q 011326 299 KRLCIFLELVTKGSLASLYQKYH-----LSDSQVSSYTRQILNGLKYLHEQ---NVVHRDIKCANILVDASGSVKLADFG 370 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~~-----ls~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~NILl~~~~~vkL~DFG 370 (488)
+..++||||+++|+|.+++.... +++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 99999999999999999986542 89999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCC---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCc----hhhhHHHhcCC---
Q 011326 371 LAKATTMND---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE----GGQAMFKIGGG--- 440 (488)
Q Consensus 371 la~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~----~~~~~~~i~~~--- 440 (488)
++....... .....||+.|+|||.+ ....++.++||||||+++|+|++|..||.... ...........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYL--STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp SCEECCSSSSCEECCCCSCGGGCCHHHH--HHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred cccccCcccccccccccCCcCccCHHHh--ccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 997654332 2345599999999997 34558999999999999999999999995211 11011111000
Q ss_pred -----------CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCcc
Q 011326 441 -----------ELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPF 479 (488)
Q Consensus 441 -----------~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~ 479 (488)
.....+...+.++.+++.+||+.||.+|||+.|+++|-.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 011223345578999999999999999999999998854
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=358.85 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=204.1
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-----------CCCcce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-----------HDNIVQ 290 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-----------HpnIv~ 290 (488)
...+|++.+.||+|+||.||+|.+. ++..||+|.+.. .......+.+|+.++++++ ||||++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG------DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC------CccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 3568999999999999999999984 799999999863 2334466788999988886 899999
Q ss_pred eeccccCCC----ceEEEEeeccCCChHHHHhh---hccChhhhhHHHHHHHHHHHHHHHC-CCccccCCcccEEEC---
Q 011326 291 YLGTDRDEK----RLCIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQ-NVVHRDIKCANILVD--- 359 (488)
Q Consensus 291 l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~---~~ls~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~NILl~--- 359 (488)
+++++...+ .+++|||++ +++|.+++.. .++++..+..++.||+.||.|||++ ||+||||||+|||++
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999987644 789999999 7899998865 3499999999999999999999998 999999999999994
Q ss_pred ---CCCcEEEeecCCcccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh-----
Q 011326 360 ---ASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG----- 431 (488)
Q Consensus 360 ---~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~----- 431 (488)
..+.+||+|||++..... ......||+.|+|||++ .+..++.++||||||+++|||++|..||...+..
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDE-HYTNSIQTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTB-CCCSCCSCGGGCCHHHH--HTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CCcCcceEEEcccccccccCC-CCCCCCCCccccCcHHH--hCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 444899999999976543 33456799999999997 4456899999999999999999999999764421
Q ss_pred -hhHHHhcC--CC---------------------------------------CCCCCCcccHHHHHHHHHhhhhCCCCCC
Q 011326 432 -QAMFKIGG--GE---------------------------------------LPPVPNSLSRDAQDFILKCLQVNPNDRP 469 (488)
Q Consensus 432 -~~~~~i~~--~~---------------------------------------~~~~~~~~s~~l~~Li~~cL~~dP~~Rp 469 (488)
+....+.. +. ....+..+++++.+||.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 11111100 00 0123345678899999999999999999
Q ss_pred CHHHHHhCccCCCCCC
Q 011326 470 TAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 470 s~~eil~hp~f~~~~~ 485 (488)
|+.|+++||||++...
T Consensus 327 t~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 327 DAGGLVNHPWLKDTLG 342 (373)
T ss_dssp CHHHHHTCGGGTTCTT
T ss_pred CHHHHhhChhhhcccC
Confidence 9999999999998754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=342.24 Aligned_cols=251 Identities=29% Similarity=0.547 Sum_probs=201.8
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
.+.+|++.+.||+|+||.||+|.+. +|..||+|.+..... ........+.+|+.++++++||||+++++++.+++..
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL--MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 4678999999999999999999874 799999999975432 2344567788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhh-----hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 302 CIFLELVTKGSLASLYQK-----YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~-----~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
++||||+++++|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999998864 348999999999999999999999999999999999999999999999999987554
Q ss_pred CCC--cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCc--hhhhHHHhcCCCCCCCC-CcccH
Q 011326 377 MND--VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE--GGQAMFKIGGGELPPVP-NSLSR 451 (488)
Q Consensus 377 ~~~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~--~~~~~~~i~~~~~~~~~-~~~s~ 451 (488)
... .....||+.|+|||.+ ....++.++||||||+++|+|++|..||.+.. .......+.....++.+ ..+++
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERI--HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265 (310)
T ss_dssp -----------CCSSCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred CCCccccccCCCeeEeChHHh--CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence 332 2345689999999997 45568999999999999999999999997543 22344445554444443 67899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
++.+|+.+||+.||.+|||+.+++++
T Consensus 266 ~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 266 ELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=376.38 Aligned_cols=247 Identities=26% Similarity=0.436 Sum_probs=210.9
Q ss_pred ccCceeeee-eecccCceEEEEEEec---CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 223 RITSWQKGE-LLGSGSYGFVYEGLTD---DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 223 ~~~~y~~~~-~LG~G~fg~Vy~~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
...++.+.+ .||+|+||.||+|.+. ++..||||++.... .......+.+|+.+|++++||||+++++++..
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC----SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 345566666 8999999999999764 56789999997542 22345678999999999999999999999976
Q ss_pred CceEEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 299 KRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
+..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 569999999999999999854 358999999999999999999999999999999999999999999999999997654
Q ss_pred CCCc-----ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCccc
Q 011326 377 MNDV-----KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLS 450 (488)
Q Consensus 377 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s 450 (488)
.... ....+|+.|+|||++ ....++.++||||||+++|||++ |+.||.+.+..+....+..+...+.+..++
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~--~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~ 565 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP 565 (613)
T ss_dssp --------------CCTTSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCC
T ss_pred CCCceeeeccCCCCccceeCHhhh--cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCC
Confidence 3321 123356889999997 44568999999999999999998 999999998888888888888888888999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 451 RDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 451 ~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+++.+||.+||+.||++||++.++++
T Consensus 566 ~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 566 PELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999999853
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=340.11 Aligned_cols=250 Identities=26% Similarity=0.533 Sum_probs=198.6
Q ss_pred ccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 300 (488)
+..-++|++.+.||+|+||.||+|.+.. .+|+|.+.... ........+.+|+.++++++||||+++++++ ..+.
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTA---PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccC---CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 3445689999999999999999997653 59999997554 2345567889999999999999999999975 4556
Q ss_pred eEEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 301 LCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
.++||||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 8999999999999998854 35899999999999999999999999999999999999999999999999998754321
Q ss_pred ----CcccCCCCCcccCchhhcc-ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHh-cCCCC----CCCCCc
Q 011326 379 ----DVKSCKGTAFWMAPEVVNL-KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKI-GGGEL----PPVPNS 448 (488)
Q Consensus 379 ----~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i-~~~~~----~~~~~~ 448 (488)
......||+.|+|||.+.. ....++.++||||||+++|+|++|+.||......+..... ..... ......
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcccc
Confidence 2334569999999999742 2456789999999999999999999999876655443332 22222 234457
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 449 LSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 449 ~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+++++.+|+.+||+.||.+|||+.++++
T Consensus 254 ~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 254 CPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 8999999999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=344.02 Aligned_cols=241 Identities=27% Similarity=0.548 Sum_probs=200.4
Q ss_pred ccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
..++|++.+.||+|+||.||++.+. +..||+|.+.. ......+.+|+.++++++||||+++++++.+ ..+
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES-------ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS-------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC-------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 4568999999999999999999875 78899999853 2234678899999999999999999999874 489
Q ss_pred EEEeeccCCChHHHHhhhc----cChhhhhHHHHHHHHHHHHHHH---CCCccccCCcccEEECCCCc-EEEeecCCccc
Q 011326 303 IFLELVTKGSLASLYQKYH----LSDSQVSSYTRQILNGLKYLHE---QNVVHRDIKCANILVDASGS-VKLADFGLAKA 374 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~~----ls~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~NILl~~~~~-vkL~DFGla~~ 374 (488)
+||||+++|+|.+++.... +++..++.++.|++.||.|||+ +||+||||||+||+++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999999999999997543 6888999999999999999999 89999999999999998886 79999999865
Q ss_pred ccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh--hhHHHhcCCCCCCCCCcccHH
Q 011326 375 TTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG--QAMFKIGGGELPPVPNSLSRD 452 (488)
Q Consensus 375 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~s~~ 452 (488)
.... .....||+.|+|||.+ .+..++.++||||||+++|+|++|+.||...... .....+.....++.+..++++
T Consensus 156 ~~~~-~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (307)
T 2eva_A 156 IQTH-MTNNKGSAAWMAPEVF--EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP 232 (307)
T ss_dssp ----------CCTTSSCHHHH--TCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHH
T ss_pred cccc-cccCCCCCceEChhhh--CCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHH
Confidence 5432 3345699999999997 4556899999999999999999999999764332 334445556666777889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 453 AQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 453 l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+.+|+.+||+.||.+|||+.++++
T Consensus 233 l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 233 IESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=356.60 Aligned_cols=248 Identities=25% Similarity=0.411 Sum_probs=204.2
Q ss_pred cCceeeeeeecccCceEEEEEEec--C--CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecccc-CC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD--D--GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR-DE 298 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~--~--g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-~~ 298 (488)
...|++.+.||+|+||.||+|.+. + +..||+|.+... ........+.+|+.++++++||||+++++++. .+
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 163 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 163 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC----SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 346889999999999999999863 2 246899988642 22345678899999999999999999999864 45
Q ss_pred CceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 299 KRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
+..++||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 6889999999999999999754 48899999999999999999999999999999999999999999999999997543
Q ss_pred CCC------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcc
Q 011326 377 MND------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSL 449 (488)
Q Consensus 377 ~~~------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 449 (488)
... .....+|+.|+|||.+ ....++.++||||||+++|||++ |.+||...+..+....+..+.....+..+
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~ 321 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 321 (373)
T ss_dssp --------------CCGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTC
T ss_pred ccccccccccCCCCCcccccChHHh--cCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 322 2334578889999997 45668999999999999999999 78889887777777777777777778889
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
++++.+++.+||+.||++|||+.|++++
T Consensus 322 ~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 322 PDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=347.02 Aligned_cols=244 Identities=30% Similarity=0.479 Sum_probs=207.9
Q ss_pred eeeeeeecccCceEEEEEEe-----cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC--CC
Q 011326 227 WQKGELLGSGSYGFVYEGLT-----DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD--EK 299 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~ 299 (488)
|++++.||+|+||.||++.. .++..||+|++... ........+.+|+.++++++||||+++++++.+ ..
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD----AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc----cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 59999999999999998864 26889999999754 234456678999999999999999999999876 46
Q ss_pred ceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 300 RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
.+++||||+++|+|.+++...++++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred eEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 78999999999999999998889999999999999999999999999999999999999999999999999997665432
Q ss_pred -----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh---------------hhHHHhcC
Q 011326 380 -----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG---------------QAMFKIGG 439 (488)
Q Consensus 380 -----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~---------------~~~~~i~~ 439 (488)
.....+|+.|+|||.+ .+..++.++||||||+++|+|++|..||...... .....+..
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECL--KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHH--HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccCCCCCceeeChHHh--cCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 2345588889999997 3455789999999999999999999998653321 12333445
Q ss_pred CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 440 GELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 440 ~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
....+.+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 5556778889999999999999999999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=349.94 Aligned_cols=242 Identities=23% Similarity=0.315 Sum_probs=201.7
Q ss_pred cCceeeeeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCce
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 301 (488)
-.+|++.+.||+|+||.||+|.+ .+|..||||.+...... ..+.+|+.+++++ +||||+++++++.+++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-------PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-------CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-------HHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence 35799999999999999999997 47999999998754321 2467899999999 999999999999999999
Q ss_pred EEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCc-----EEEeecCCccc
Q 011326 302 CIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS-----VKLADFGLAKA 374 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~-----vkL~DFGla~~ 374 (488)
++||||+ +++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999999 8899999874 56999999999999999999999999999999999999998887 99999999976
Q ss_pred ccCCC---------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhh---HHHhcCCCC
Q 011326 375 TTMND---------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQA---MFKIGGGEL 442 (488)
Q Consensus 375 ~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~---~~~i~~~~~ 442 (488)
..... .....||+.|+|||++ .+..++.++||||||+++|||++|..||.+.+..+. ...+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTH--LGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHH--cCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 54322 2356799999999997 456689999999999999999999999987543322 222211111
Q ss_pred C----CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 443 P----PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 443 ~----~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+ .....+| ++.+++.+||+.||.+||++.+|.+
T Consensus 238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1 1122345 9999999999999999999998876
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=340.11 Aligned_cols=243 Identities=21% Similarity=0.287 Sum_probs=203.3
Q ss_pred cCceeeeeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCce
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 301 (488)
.++|++.+.||+|+||.||+|.+ .+|..||+|.+...... ..+.+|+.++..+ +|+|++++++++.++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-------HHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 45799999999999999999997 47999999998654321 2467899999999 799999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCc-----EEEeecCCccc
Q 011326 302 CIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS-----VKLADFGLAKA 374 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~-----vkL~DFGla~~ 374 (488)
++||||+ +++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999999 88999999753 5999999999999999999999999999999999999987776 99999999976
Q ss_pred ccCCC---------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh---hhHHHhcC---
Q 011326 375 TTMND---------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG---QAMFKIGG--- 439 (488)
Q Consensus 375 ~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~---~~~~~i~~--- 439 (488)
..... .....||+.|+|||.+ .+..++.++||||||+++|+|++|+.||...... +....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhh--cCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 54332 2345699999999997 4556899999999999999999999999875432 22222211
Q ss_pred -CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 440 -GELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 440 -~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
...+.....+++++.+|+.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 1112233568999999999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=348.01 Aligned_cols=247 Identities=28% Similarity=0.496 Sum_probs=209.9
Q ss_pred cCceeeeeeecccCceEEEEEEe-----cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecccc--
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLT-----DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR-- 296 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-- 296 (488)
..+|++.+.||+|+||.||+|.. .++..||+|.+... .......+.+|+.++++++||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-----GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 46899999999999999999983 46899999998743 3444567899999999999999999999875
Q ss_pred CCCceEEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccc
Q 011326 297 DEKRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 374 (488)
Q Consensus 297 ~~~~~~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~ 374 (488)
+....++||||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 55679999999999999999875 3599999999999999999999999999999999999999999999999999976
Q ss_pred ccCCC-----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCch---------------hhhH
Q 011326 375 TTMND-----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG---------------GQAM 434 (488)
Q Consensus 375 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~---------------~~~~ 434 (488)
..... .....||+.|+|||.+ .+..++.++||||||+++|+|++|..||..... ....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESL--SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHH--HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHh--ccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 54332 2345588889999997 445579999999999999999999999865332 1233
Q ss_pred HHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 435 FKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 435 ~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
..+..+...+.+..+++++.+|+.+||+.||.+|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3445555566778899999999999999999999999999754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=343.89 Aligned_cols=252 Identities=26% Similarity=0.341 Sum_probs=203.0
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
...+++|++.+.||+|+||.||+|.+. ++..||+|.+..... ........+.+|+.++++++||||+++++++.+++
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS--SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG--GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc--cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 345789999999999999999999986 789999999875432 22344567889999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 300 RLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
..++||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 999999999999999998764 5999999999999999999999999999999999999999999999999998765433
Q ss_pred C---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC--CCCCCcccHHH
Q 011326 379 D---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL--PPVPNSLSRDA 453 (488)
Q Consensus 379 ~---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~l 453 (488)
. .....||+.|+|||.+ .+..++.++||||||+++|+|++|+.||...+.......+..... ...+..+++++
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 265 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERF--SESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAF 265 (309)
T ss_dssp ---------CCGGGCCGGGT--CC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHH
T ss_pred ccccccccCCCcCccCHHHH--cCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHH
Confidence 2 2345699999999997 445688899999999999999999999988766544444433222 23456789999
Q ss_pred HHHHHHhhhhCCCCCC-CHHHHHh
Q 011326 454 QDFILKCLQVNPNDRP-TAAQLME 476 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rp-s~~eil~ 476 (488)
.++|.+||+.||++|| +++++++
T Consensus 266 ~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 266 DAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHhccCCHHHHHHhHHHHHH
Confidence 9999999999999999 8888775
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=340.51 Aligned_cols=245 Identities=27% Similarity=0.401 Sum_probs=196.0
Q ss_pred ccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhc--CCCCCcceeeccccC---
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQ--FEHDNIVQYLGTDRD--- 297 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~--- 297 (488)
..++|++.+.||+|+||.||+|.+ ++..||+|++... ....+.+|.+++.. ++||||+++++++.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--------DEKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 356899999999999999999987 6889999998642 12344556666655 899999999998543
Q ss_pred -CCceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHH--------HCCCccccCCcccEEECCCCcEEEee
Q 011326 298 -EKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLH--------EQNVVHRDIKCANILVDASGSVKLAD 368 (488)
Q Consensus 298 -~~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH--------~~giiHrDLkp~NILl~~~~~vkL~D 368 (488)
....++||||+++|+|.+++....+++..++.++.|++.||.||| ++||+||||||+|||++.++.+||+|
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred CCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 456899999999999999998888999999999999999999999 99999999999999999999999999
Q ss_pred cCCcccccCCC------cccCCCCCcccCchhhccccC----CCChhhhHHHHHHHHHHHHcC----------CCCCCCC
Q 011326 369 FGLAKATTMND------VKSCKGTAFWMAPEVVNLKKD----GYGLTADIWSLGCTVLEMLTR----------RHPYSHL 428 (488)
Q Consensus 369 FGla~~~~~~~------~~~~~gt~~y~aPE~~~~~~~----~~s~k~DvwSlGvlL~eLltG----------~~Pf~~~ 428 (488)
||++....... .....||+.|+|||++..... .++.++||||||+++|||++| ..||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997544332 223479999999999843211 345799999999999999999 8888653
Q ss_pred chh----hhHHHh--cCCCCCCCC-----CcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 429 EGG----QAMFKI--GGGELPPVP-----NSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 429 ~~~----~~~~~i--~~~~~~~~~-----~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
... ...... .....+..+ ..+++++.+|+.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 221 112221 122223333 235678999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=359.99 Aligned_cols=249 Identities=30% Similarity=0.424 Sum_probs=194.5
Q ss_pred ceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV 304 (488)
.|...+.||+|+||+||.+...+|..||||.+... ....+.+|+.++.++ +||||+++++++.+++..++|
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 45667899999999998776678999999998642 124567899999876 899999999999999999999
Q ss_pred EeeccCCChHHHHhhhcc--------ChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC-------------Cc
Q 011326 305 LELVTKGSLASLYQKYHL--------SDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS-------------GS 363 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~~l--------s~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~-------------~~ 363 (488)
|||+. |+|.+++..... ++..++.++.||+.||.|||++||+||||||+|||++.+ +.
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99996 599999976542 344567899999999999999999999999999999754 48
Q ss_pred EEEeecCCcccccCCC------cccCCCCCcccCchhhcc-----ccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchh
Q 011326 364 VKLADFGLAKATTMND------VKSCKGTAFWMAPEVVNL-----KKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGG 431 (488)
Q Consensus 364 vkL~DFGla~~~~~~~------~~~~~gt~~y~aPE~~~~-----~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~ 431 (488)
+||+|||+++...... .....||+.|+|||++.. ....++.++|||||||++|||++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 9999999998655432 224579999999999843 13568999999999999999999 99999765433
Q ss_pred hhHHHhcCCCCCCC----CCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 432 QAMFKIGGGELPPV----PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 432 ~~~~~i~~~~~~~~----~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
+..........+.. +..+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 247 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp HHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred HHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 32111111111111 22457899999999999999999999999999999753
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=343.37 Aligned_cols=253 Identities=22% Similarity=0.359 Sum_probs=204.7
Q ss_pred ccccCceeeeeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecccc---
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR--- 296 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--- 296 (488)
....++|++.+.||+|+||.||++.+ .++..||+|.+... .......+.+|+.+++.++||||+++++++.
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-----EQQDREEAQREADMHRLFNHPNILRLVAYCLRER 99 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence 34456899999999999999999998 47999999998653 3445567889999999999999999999986
Q ss_pred -CCCceEEEEeeccCCChHHHHhh-----hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecC
Q 011326 297 -DEKRLCIFLELVTKGSLASLYQK-----YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFG 370 (488)
Q Consensus 297 -~~~~~~lV~E~~~~gsL~~~l~~-----~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFG 370 (488)
.....++||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecC
Confidence 34578999999999999998865 358999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCC-----------cccCCCCCcccCchhhccc-cCCCChhhhHHHHHHHHHHHHcCCCCCCCCc--hhhhHHH
Q 011326 371 LAKATTMND-----------VKSCKGTAFWMAPEVVNLK-KDGYGLTADIWSLGCTVLEMLTRRHPYSHLE--GGQAMFK 436 (488)
Q Consensus 371 la~~~~~~~-----------~~~~~gt~~y~aPE~~~~~-~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~--~~~~~~~ 436 (488)
++....... .....||+.|+|||.+... ...++.++||||||+++|+|++|+.||.... .......
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 886543211 1234579999999987322 1236889999999999999999999995421 1122222
Q ss_pred hcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCc
Q 011326 437 IGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHP 478 (488)
Q Consensus 437 i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp 478 (488)
+......+.+..+++++.+||.+||+.||.+|||+.+++++-
T Consensus 260 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 260 VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 233333344567899999999999999999999999999863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=337.29 Aligned_cols=250 Identities=30% Similarity=0.485 Sum_probs=202.6
Q ss_pred ccCceeeeeeecccCceEEEEEEec--CCc--EEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD--DGF--FFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~--~g~--~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
..++|++.+.||+|+||.||+|.+. ++. .||+|.+..... ........+.+|+.++++++||||+++++++.++
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc--CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 3568999999999999999999863 333 689999875432 1234557889999999999999999999999876
Q ss_pred CceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 299 KRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
+ .++||||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++....
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 5 89999999999999988654 59999999999999999999999999999999999999999999999999987654
Q ss_pred CCC-----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCC-CCCCCCCcc
Q 011326 377 MND-----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGG-ELPPVPNSL 449 (488)
Q Consensus 377 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~ 449 (488)
... .....+|+.|+|||.+ ....++.++||||||+++|+|++ |..||...+..+....+... ...+.+..+
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESL--KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 250 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHH--HHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC
T ss_pred ccccchhhhccCCCCceeeCchhh--cCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCc
Confidence 432 2234578889999997 34557899999999999999999 99999988877776666543 334566789
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
++++.+++.+||+.||.+|||+.+++++
T Consensus 251 ~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 251 PQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999999999999999999999873
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=340.13 Aligned_cols=246 Identities=28% Similarity=0.443 Sum_probs=203.6
Q ss_pred eeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEe
Q 011326 227 WQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLE 306 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 306 (488)
|..++.||+|+||.||+|.. ++..||+|.+...... ........+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDI-TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTS-CTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE-CCceEEEEEEecccCc-chHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44458899999999999986 5889999998754322 223445678999999999999999999999999999999999
Q ss_pred eccCCChHHHHhhh----ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC---
Q 011326 307 LVTKGSLASLYQKY----HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--- 379 (488)
Q Consensus 307 ~~~~gsL~~~l~~~----~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--- 379 (488)
|+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 99999999988632 48999999999999999999999999999999999999999999999999987654322
Q ss_pred -cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHH--------------hcCCCCCC
Q 011326 380 -VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFK--------------IGGGELPP 444 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~--------------i~~~~~~~ 444 (488)
.....||+.|+|||.+. ..++.++||||||+++|+|++|..||........... ........
T Consensus 191 ~~~~~~g~~~y~aPE~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND 267 (307)
T ss_dssp ECSSCCSCGGGCCHHHHT---TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred cccccCCCcCcCChHHhc---CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence 23456999999999873 3478999999999999999999999987554332111 11122233
Q ss_pred CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 445 VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 445 ~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.+...++.+.+++.+||+.||.+|||+.+++++
T Consensus 268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 445567889999999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=371.81 Aligned_cols=240 Identities=27% Similarity=0.446 Sum_probs=208.1
Q ss_pred eeecccCceEEEEEEec---CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEee
Q 011326 231 ELLGSGSYGFVYEGLTD---DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLEL 307 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 307 (488)
+.||+|+||.||+|.+. ++..||||++.... .......++.+|+.+|++++||||+++++++.. +..++||||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~ 450 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEM 450 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG---GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEc
Confidence 58999999999999653 56889999997543 223345678999999999999999999999965 458999999
Q ss_pred ccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-----cc
Q 011326 308 VTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----VK 381 (488)
Q Consensus 308 ~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-----~~ 381 (488)
+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 451 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 451 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred cCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 9999999998765 59999999999999999999999999999999999999999999999999997654332 22
Q ss_pred cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHh
Q 011326 382 SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460 (488)
Q Consensus 382 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~c 460 (488)
...+|+.|+|||++ ....++.++||||||+++|||++ |..||.+.+..+....+..+.....+..+++++.+||.+|
T Consensus 531 ~~~~t~~y~APE~~--~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 608 (635)
T 4fl3_A 531 HGKWPVKWYAPECI--NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 608 (635)
T ss_dssp ----CGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred CCCCceeeeChhhh--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 34467889999998 45568999999999999999998 9999999998888888888888888899999999999999
Q ss_pred hhhCCCCCCCHHHHHh
Q 011326 461 LQVNPNDRPTAAQLME 476 (488)
Q Consensus 461 L~~dP~~Rps~~eil~ 476 (488)
|+.||++|||+.++++
T Consensus 609 l~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 609 WTYDVENRPGFAAVEL 624 (635)
T ss_dssp TCSSTTTSCCHHHHHH
T ss_pred cCCCHhHCcCHHHHHH
Confidence 9999999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=343.15 Aligned_cols=257 Identities=25% Similarity=0.348 Sum_probs=195.7
Q ss_pred ccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecc-----c
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGT-----D 295 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~-----~ 295 (488)
...+++|++.+.||+|+||.||+|.. ++..||+|++.... ........|+..+..++||||+++++. +
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTA 81 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred CcChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence 34578999999999999999999966 68999999986421 111222344444556899999999873 3
Q ss_pred cCCCceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHC---------CCccccCCcccEEECCCCcEEE
Q 011326 296 RDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQ---------NVVHRDIKCANILVDASGSVKL 366 (488)
Q Consensus 296 ~~~~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~---------giiHrDLkp~NILl~~~~~vkL 366 (488)
.....+++||||+++|+|.+++.....++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred CCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 4445789999999999999999988899999999999999999999999 9999999999999999999999
Q ss_pred eecCCcccccCCC----------cccCCCCCcccCchhhccc-----cCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh
Q 011326 367 ADFGLAKATTMND----------VKSCKGTAFWMAPEVVNLK-----KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG 431 (488)
Q Consensus 367 ~DFGla~~~~~~~----------~~~~~gt~~y~aPE~~~~~-----~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~ 431 (488)
+|||++....... .....||+.|+|||++... ...++.++||||||+++|||++|..||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 9999997554221 2245699999999997321 124567899999999999999997776332211
Q ss_pred ------------------hhHHHh-cCCCCCCCCCc------ccHHHHHHHHHhhhhCCCCCCCHHHH------HhCccC
Q 011326 432 ------------------QAMFKI-GGGELPPVPNS------LSRDAQDFILKCLQVNPNDRPTAAQL------MEHPFI 480 (488)
Q Consensus 432 ------------------~~~~~i-~~~~~~~~~~~------~s~~l~~Li~~cL~~dP~~Rps~~ei------l~hp~f 480 (488)
.....+ .....+..+.. +++++.+||.+||+.||++|||+.|+ +.++|-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 000111 11222233322 55689999999999999999999999 456777
Q ss_pred CCCC
Q 011326 481 KRPL 484 (488)
Q Consensus 481 ~~~~ 484 (488)
++.-
T Consensus 322 ~~~~ 325 (336)
T 3g2f_A 322 RNKS 325 (336)
T ss_dssp C---
T ss_pred hccc
Confidence 6543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=333.78 Aligned_cols=243 Identities=22% Similarity=0.302 Sum_probs=199.8
Q ss_pred cCceeeeeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc-cCCCce
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD-RDEKRL 301 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-~~~~~~ 301 (488)
.++|++.+.||+|+||.||+|.+ .+|+.||+|++...... ..+.+|+.+++.++|++++..+..+ .+++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-------CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-------hHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 46899999999999999999998 57999999998754321 2577899999999988877666554 567788
Q ss_pred EEEEeeccCCChHHHHh--hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEEC---CCCcEEEeecCCccccc
Q 011326 302 CIFLELVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVD---ASGSVKLADFGLAKATT 376 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~--~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~---~~~~vkL~DFGla~~~~ 376 (488)
++||||+ +++|.+++. ...+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999999 889999986 34699999999999999999999999999999999999994 78899999999997654
Q ss_pred CCC---------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh---hhHHHhcCC----
Q 011326 377 MND---------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG---QAMFKIGGG---- 440 (488)
Q Consensus 377 ~~~---------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~---~~~~~i~~~---- 440 (488)
... .....||+.|+|||.+ .+..++.++||||||+++|+|++|+.||...+.. +....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccCChhhh--cCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 432 2455799999999997 4556899999999999999999999999864322 222222111
Q ss_pred CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 441 ELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 441 ~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
..+..+..+|+++.+|+.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 111223568999999999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=344.36 Aligned_cols=254 Identities=24% Similarity=0.492 Sum_probs=211.0
Q ss_pred cccccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 218 GKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 218 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
..+....++|++.+.||+|+||.||+|.+.+ .+|+|.+........ ....+.+|+.++++++||||+++++++.+
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNED---QLKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCC---CCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHH---HHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 3455667899999999999999999998754 499999876543221 22346689999999999999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhhhc--cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~~--ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
++..++||||+++++|.+++...+ +++..++.++.|++.||.|||++|++||||||+||+++ ++.++|+|||++...
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 999999999999999999997654 89999999999999999999999999999999999998 789999999997654
Q ss_pred cC-------CCcccCCCCCcccCchhhccc-------cCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC
Q 011326 376 TM-------NDVKSCKGTAFWMAPEVVNLK-------KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE 441 (488)
Q Consensus 376 ~~-------~~~~~~~gt~~y~aPE~~~~~-------~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~ 441 (488)
.. .......||+.|+|||.+... ...++.++||||||+++|+|++|..||...........+..+.
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 259 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC
Confidence 22 122345589999999998431 3457999999999999999999999999888777777766665
Q ss_pred CCCCC-CcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 442 LPPVP-NSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 442 ~~~~~-~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.+... ..++.++.+++.+||+.||.+|||+.++++.
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 260 KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 54433 3688999999999999999999999999863
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=335.67 Aligned_cols=243 Identities=27% Similarity=0.483 Sum_probs=206.2
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC-----
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD----- 297 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----- 297 (488)
..+|++.+.||+|+||.||+|.+. ++..||+|.+.... ..+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 357999999999999999999986 79999999997532 245689999999999999999998753
Q ss_pred -----------CCceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCc
Q 011326 298 -----------EKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS 363 (488)
Q Consensus 298 -----------~~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~ 363 (488)
....++||||+++++|.+++... .+++..++.++.|++.||.|||++||+|+||||+||+++.++.
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC
Confidence 44589999999999999999643 5899999999999999999999999999999999999999999
Q ss_pred EEEeecCCcccccCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC
Q 011326 364 VKLADFGLAKATTMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL 442 (488)
Q Consensus 364 vkL~DFGla~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~ 442 (488)
++|+|||++....... .....||+.|+|||.+ ....++.++||||||+++|+|++|..|+... ......+...
T Consensus 161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~-- 234 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQI--SSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG-- 234 (284)
T ss_dssp EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHH--HCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--
T ss_pred EEECcchhheeccccccccccCCcccccChhhh--ccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--
Confidence 9999999987655432 3456799999999997 4456899999999999999999999887432 2222333332
Q ss_pred CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 443 PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 443 ~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
..+..++.++.+||.+||+.||.+|||+.|+++|.+..+
T Consensus 235 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 235 -IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred -cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 245678999999999999999999999999999987643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=341.38 Aligned_cols=244 Identities=26% Similarity=0.370 Sum_probs=194.1
Q ss_pred ccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhc--CCCCCcceeeccccCC--
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQ--FEHDNIVQYLGTDRDE-- 298 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~-- 298 (488)
..++|++.+.||+|+||.||+|.+. +..||+|++... . ......|.+++.. ++||||+++++++.+.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~------~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT------E--EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG------G--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc------c--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 3568999999999999999999876 899999998632 1 1233445555554 4899999999998776
Q ss_pred --CceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHC--------CCccccCCcccEEECCCCcEEEee
Q 011326 299 --KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQ--------NVVHRDIKCANILVDASGSVKLAD 368 (488)
Q Consensus 299 --~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~--------giiHrDLkp~NILl~~~~~vkL~D 368 (488)
...++||||+++|+|.+++....+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 6899999999999999999888999999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccCCCc------ccCCCCCcccCchhhccccCCCCh------hhhHHHHHHHHHHHHcC----------CCCCC
Q 011326 369 FGLAKATTMNDV------KSCKGTAFWMAPEVVNLKKDGYGL------TADIWSLGCTVLEMLTR----------RHPYS 426 (488)
Q Consensus 369 FGla~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~s~------k~DvwSlGvlL~eLltG----------~~Pf~ 426 (488)
||++........ ....||+.|+|||++.. ...+. ++||||||+++|||++| ..||.
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE--SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTT--CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhccc--ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 999965543321 24579999999999732 22333 49999999999999999 67775
Q ss_pred CCchh-----hhHHHhc-CCCCCCCCC-----cccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 427 HLEGG-----QAMFKIG-GGELPPVPN-----SLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 427 ~~~~~-----~~~~~i~-~~~~~~~~~-----~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
..... .....+. ....+..+. .+++++.+|+.+||+.||.+|||+.|+++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 43221 1111111 122233332 567789999999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=358.95 Aligned_cols=253 Identities=28% Similarity=0.408 Sum_probs=199.7
Q ss_pred ccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEK 299 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 299 (488)
.....+|++.+.||+|+||+||.....+|+.||||++..... ..+.+|+.+|+.+ +||||+++++++.+.+
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 91 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--------SFADREVQLLRESDEHPNVIRYFCTEKDRQ 91 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--------EECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--------HHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 334457999999999999997765566899999999864321 1245799999998 7999999999999999
Q ss_pred ceEEEEeeccCCChHHHHhhhc--cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC-----CCcEEEeecCCc
Q 011326 300 RLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA-----SGSVKLADFGLA 372 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~~--ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~-----~~~vkL~DFGla 372 (488)
..|+||||+.+ +|.+++.... +++..+..++.||+.||.|||++||+||||||+|||++. ...+||+|||++
T Consensus 92 ~~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 92 FQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 99999999975 9999987654 566678899999999999999999999999999999953 236889999999
Q ss_pred ccccCC-----CcccCCCCCcccCchhhccc-cCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCC--
Q 011326 373 KATTMN-----DVKSCKGTAFWMAPEVVNLK-KDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELP-- 443 (488)
Q Consensus 373 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~-- 443 (488)
+..... ......||+.|+|||++... ...++.++|||||||++|||++ |..||..................
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~ 250 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL 250 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc
Confidence 765432 23356799999999997422 4557889999999999999999 99999765544433333322222
Q ss_pred CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 444 PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 444 ~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
..+...+..+.+||.+||+.||.+|||+.|+++||||+.
T Consensus 251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 122345677899999999999999999999999999975
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=348.51 Aligned_cols=251 Identities=21% Similarity=0.274 Sum_probs=194.8
Q ss_pred cCceeeeeeecccCceEEEEEEec----CCcEEEEEEeecCCCCCcch------hHHHHHHHHHHHHhcCCCCCcceeec
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD----DGFFFAVKEVSLQDEGPRGK------QSILQLEQEISLLGQFEHDNIVQYLG 293 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~i~~~~~~~~~~------~~~~~~~~Ei~iL~~l~HpnIv~l~~ 293 (488)
.++|++.+.||+|+||.||+|.+. ++..+|+|.+.........+ .....+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999885 67899999997653211000 01123567888999999999999999
Q ss_pred cccC----CCceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC--cEEE
Q 011326 294 TDRD----EKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG--SVKL 366 (488)
Q Consensus 294 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~--~vkL 366 (488)
++.+ ....++||||+ +++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 9877 77899999999 88999998755 699999999999999999999999999999999999998877 9999
Q ss_pred eecCCcccccCCC---------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCc-hhhhHHH
Q 011326 367 ADFGLAKATTMND---------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE-GGQAMFK 436 (488)
Q Consensus 367 ~DFGla~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~-~~~~~~~ 436 (488)
+|||+++...... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||.... .......
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAH--KGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHH--HTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHh--cCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 9999997543221 2445799999999997 45568999999999999999999999995422 1111111
Q ss_pred hcCCCCCCCC---------CcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 437 IGGGELPPVP---------NSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 437 i~~~~~~~~~---------~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.........+ ..+++++.+++.+||+.||.+|||+.++++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 1111111111 2688999999999999999999999999853
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=340.67 Aligned_cols=247 Identities=27% Similarity=0.466 Sum_probs=206.3
Q ss_pred ccCceeeeeeecccCceEEEEEEe-----cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLT-----DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
...+|++.+.||+|+||.||+|.. .++..||+|.+... .......+.+|+.++++++||||+++++++..
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 356799999999999999999983 36899999998753 23445678999999999999999999998876
Q ss_pred CC--ceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 298 EK--RLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 298 ~~--~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
.+ ..++||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 54 789999999999999999764 48999999999999999999999999999999999999999999999999997
Q ss_pred cccCCC-----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchh----------------h
Q 011326 374 ATTMND-----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG----------------Q 432 (488)
Q Consensus 374 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~----------------~ 432 (488)
...... .....++..|+|||.+ .+..++.++||||||+++|+|++|..||...... .
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESL--TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHH--HHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhh--cCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 654432 2234577889999997 3445789999999999999999999988642110 1
Q ss_pred hHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 433 AMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 433 ~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
....+......+.+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 12233344445667889999999999999999999999999985
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=352.63 Aligned_cols=251 Identities=18% Similarity=0.264 Sum_probs=195.7
Q ss_pred ccCceeeeeeecccCceEEEEEEecC------CcEEEEEEeecCCCCCcch------hHHHHHHHHHHHHhcCCCCCcce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTDD------GFFFAVKEVSLQDEGPRGK------QSILQLEQEISLLGQFEHDNIVQ 290 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~i~~~~~~~~~~------~~~~~~~~Ei~iL~~l~HpnIv~ 290 (488)
..++|++++.||+|+||.||+|.+.+ +..||+|.+.........+ .....+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35589999999999999999998753 4789999987543100000 00112344666778889999999
Q ss_pred eeccccCC----CceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEEC--CCC
Q 011326 291 YLGTDRDE----KRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVD--ASG 362 (488)
Q Consensus 291 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~--~~~ 362 (488)
+++++... ...++||||+ +++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99998764 4589999999 89999999764 599999999999999999999999999999999999999 889
Q ss_pred cEEEeecCCcccccCCC---------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhh
Q 011326 363 SVKLADFGLAKATTMND---------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQA 433 (488)
Q Consensus 363 ~vkL~DFGla~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~ 433 (488)
.+||+|||+++...... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||.+......
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAH--NGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHh--CCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 99999999997543321 1334599999999997 455689999999999999999999999985332221
Q ss_pred HHH-hcCC---CCC------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 434 MFK-IGGG---ELP------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 434 ~~~-i~~~---~~~------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
... .... ..+ .....+++++.+++..||+.||.+||++.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 111 1100 000 012467999999999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=333.46 Aligned_cols=243 Identities=22% Similarity=0.299 Sum_probs=196.4
Q ss_pred cCceeeeeeecccCceEEEEEEe-cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc-cCCCce
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLT-DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD-RDEKRL 301 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-~~~~~~ 301 (488)
.++|++.+.||+|+||.||+|.+ .++..||+|.+...... ..+.+|+.+++.++|++++..+..+ .+++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-------CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-------hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 36799999999999999999997 47999999987654322 2467899999999988877766654 667788
Q ss_pred EEEEeeccCCChHHHHh--hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEE---CCCCcEEEeecCCccccc
Q 011326 302 CIFLELVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILV---DASGSVKLADFGLAKATT 376 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~--~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl---~~~~~vkL~DFGla~~~~ 376 (488)
++||||+ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999999 889999987 3469999999999999999999999999999999999999 788999999999997654
Q ss_pred CCC---------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhh---hHHHhcCC----
Q 011326 377 MND---------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ---AMFKIGGG---- 440 (488)
Q Consensus 377 ~~~---------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~---~~~~i~~~---- 440 (488)
... .....||+.|+|||.+ .+..++.++||||||+++|+|++|+.||.+.+... ....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred CcccCccCCCCcccccCCCccccchHHh--cCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 332 2345799999999997 45568999999999999999999999997654321 11111111
Q ss_pred CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 441 ELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 441 ~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
..+.....+++++.+|+.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 111123567999999999999999999999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=334.29 Aligned_cols=232 Identities=27% Similarity=0.403 Sum_probs=189.6
Q ss_pred cccCceeee-eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHH-hcCCCCCcceeeccccC-
Q 011326 222 RRITSWQKG-ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLL-GQFEHDNIVQYLGTDRD- 297 (488)
Q Consensus 222 ~~~~~y~~~-~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL-~~l~HpnIv~l~~~~~~- 297 (488)
..+++|.+. +.||+|+||.||+|.+. ++..||+|.+... ..+.+|+.++ +..+||||+++++++.+
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 346788887 78999999999999885 7999999998631 2456788887 56699999999998876
Q ss_pred ---CCceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC---CCcEEEee
Q 011326 298 ---EKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA---SGSVKLAD 368 (488)
Q Consensus 298 ---~~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~---~~~vkL~D 368 (488)
+...++||||+++|+|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++. ++.++|+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 67899999999999999999765 4999999999999999999999999999999999999998 78999999
Q ss_pred cCCcccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCC---CCCC
Q 011326 369 FGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE---LPPV 445 (488)
Q Consensus 369 FGla~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~---~~~~ 445 (488)
||++.... ...++.++||||||+++|+|++|..||...+............ ....
T Consensus 164 fg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 221 (299)
T 3m2w_A 164 FGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 221 (299)
T ss_dssp CTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSS
T ss_pred cccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccC
Confidence 99885432 2336789999999999999999999997655443222111111 1112
Q ss_pred C----CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 446 P----NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 446 ~----~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
+ ..+++++.+||.+||+.||.+|||+.|+++||||++...
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 2 468999999999999999999999999999999987643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=354.88 Aligned_cols=250 Identities=25% Similarity=0.430 Sum_probs=203.5
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC--c
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK--R 300 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--~ 300 (488)
-.+|++.+.||+|+||.||+|.+. +|..||+|++..... ......+.+|+.++++++||||+++++++.+.+ .
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF----LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG----GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc----cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 457999999999999999999986 699999999975321 223456779999999999999999999987655 7
Q ss_pred eEEEEeeccCCChHHHHhhhc----cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEE----CCCCcEEEeecCCc
Q 011326 301 LCIFLELVTKGSLASLYQKYH----LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILV----DASGSVKLADFGLA 372 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~~----ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl----~~~~~vkL~DFGla 372 (488)
.++||||+++|+|.+++.... +++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 899999999999999996543 8999999999999999999999999999999999999 77888999999999
Q ss_pred ccccCCC-cccCCCCCcccCchhhccc------cCCCChhhhHHHHHHHHHHHHcCCCCCCCCch----hhhHHHhcCCC
Q 011326 373 KATTMND-VKSCKGTAFWMAPEVVNLK------KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEG----GQAMFKIGGGE 441 (488)
Q Consensus 373 ~~~~~~~-~~~~~gt~~y~aPE~~~~~------~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~----~~~~~~i~~~~ 441 (488)
+...... .....||+.|+|||++... ...++.++||||||+++|||++|+.||..... .+....+..+.
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp EECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred eEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 7654433 3456799999999997321 13467899999999999999999999964332 23333333222
Q ss_pred CC------------------------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 442 LP------------------------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 442 ~~------------------------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.+ .+...++..+.+++.+||+.||++|||+.|++++
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 11 1223456788999999999999999999998653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=337.92 Aligned_cols=249 Identities=25% Similarity=0.409 Sum_probs=187.9
Q ss_pred ccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccc---
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTD--- 295 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~--- 295 (488)
...-.+|++.+.||+|+||.||+|.+. ++..||+|.+... .......+.+|+.++.++. ||||+++++++
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-----chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 334458999999999999999999985 7999999998643 3444567889999999996 99999999987
Q ss_pred -----cCCCceEEEEeeccCCChHHHHhh----hccChhhhhHHHHHHHHHHHHHHHCC--CccccCCcccEEECCCCcE
Q 011326 296 -----RDEKRLCIFLELVTKGSLASLYQK----YHLSDSQVSSYTRQILNGLKYLHEQN--VVHRDIKCANILVDASGSV 364 (488)
Q Consensus 296 -----~~~~~~~lV~E~~~~gsL~~~l~~----~~ls~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~NILl~~~~~v 364 (488)
.....++++|||+. |+|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 44556899999997 588887754 35999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCcccccCCCc--------------ccCCCCCcccCchhhcc-ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 011326 365 KLADFGLAKATTMNDV--------------KSCKGTAFWMAPEVVNL-KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLE 429 (488)
Q Consensus 365 kL~DFGla~~~~~~~~--------------~~~~gt~~y~aPE~~~~-~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~ 429 (488)
||+|||++........ ....||+.|+|||++.. ....++.++||||||+++|+|++|..||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 9999999976543221 13458999999998732 34567899999999999999999999997654
Q ss_pred hhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCc
Q 011326 430 GGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHP 478 (488)
Q Consensus 430 ~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp 478 (488)
....... ....+.+...+..+.+|+.+||+.||.+|||+.|+++|-
T Consensus 258 ~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 258 KLRIVNG---KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp -----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHhhcC---cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 4333222 122234456788899999999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=366.81 Aligned_cols=252 Identities=27% Similarity=0.462 Sum_probs=216.0
Q ss_pred ccccccCceeeeeeecccCceEEEEEEec----CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecc
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLTD----DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGT 294 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 294 (488)
.+.....+|++++.||+|+||.||+|.+. .+..||+|.+... ........+.+|+.++++++||||++++++
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 459 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGV 459 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST----TCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 44556778999999999999999999874 3567999987643 234455678999999999999999999999
Q ss_pred ccCCCceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCc
Q 011326 295 DRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLA 372 (488)
Q Consensus 295 ~~~~~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla 372 (488)
+.+ +..++||||+++|+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 460 ~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 460 ITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred Eec-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCC
Confidence 854 5689999999999999999754 4899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCc
Q 011326 373 KATTMND---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNS 448 (488)
Q Consensus 373 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 448 (488)
+...... .....+|+.|+|||.+ ....++.++||||||+++|||++ |..||.+.+..+....+..+...+.+..
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 616 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 616 (656)
T ss_dssp CSCCC----------CCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTT
T ss_pred eecCCCcceeccCCCCCcceeCHHHh--cCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 7654332 2234577899999997 44568999999999999999997 9999999888888888877777788889
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 449 LSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 449 ~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
+++++.+||.+||+.||.+|||+.++++.
T Consensus 617 ~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 617 CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=345.97 Aligned_cols=240 Identities=21% Similarity=0.279 Sum_probs=195.6
Q ss_pred cCceeeeeeecccCceEEEEEEecC---------CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcce----
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTDD---------GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQ---- 290 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~~---------g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~---- 290 (488)
.++|++.+.||+|+||.||+|.+.. +..||+|.+... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~ 110 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----------GRLFNEQNFFQRAAKPLQVNKWKK 110 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----------chHHHHHHHHHHhcccchhhhhhh
Confidence 4689999999999999999998863 889999998743 24678999999999999998
Q ss_pred -----------eeccccC-CCceEEEEeeccCCChHHHHhh---hccChhhhhHHHHHHHHHHHHHHHCCCccccCCccc
Q 011326 291 -----------YLGTDRD-EKRLCIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCAN 355 (488)
Q Consensus 291 -----------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~---~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~N 355 (488)
+++++.. ++..++||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 189 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189 (352)
T ss_dssp HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 4445544 67899999999 8999999976 469999999999999999999999999999999999
Q ss_pred EEECCCC--cEEEeecCCcccccCCC---------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCC
Q 011326 356 ILVDASG--SVKLADFGLAKATTMND---------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHP 424 (488)
Q Consensus 356 ILl~~~~--~vkL~DFGla~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~P 424 (488)
||++.++ .+||+|||+++...... .....||+.|+|||.+ .+..++.++||||||+++|+|++|+.|
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLH--KGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHH--ccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999998 99999999997544321 1345799999999997 445689999999999999999999999
Q ss_pred CCCCc-hhhhHHHhc---CCCCCCCC------CcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 425 YSHLE-GGQAMFKIG---GGELPPVP------NSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 425 f~~~~-~~~~~~~i~---~~~~~~~~------~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
|.... ......... ........ ..+++++.+|+.+||+.||.+|||+.++++
T Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 97653 222221111 11111111 256899999999999999999999999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=337.48 Aligned_cols=246 Identities=26% Similarity=0.369 Sum_probs=201.2
Q ss_pred ccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhc--CCCCCcceeeccccCCC-
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQ--FEHDNIVQYLGTDRDEK- 299 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~~- 299 (488)
...+|++.+.||+|+||.||+|.+ +|+.||+|.+... ....+.+|.+++.. ++||||+++++++...+
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--------EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred ccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 346899999999999999999987 5899999998532 23456778888877 78999999999988776
Q ss_pred ---ceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHH--------HCCCccccCCcccEEECCCCcEEEee
Q 011326 300 ---RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLH--------EQNVVHRDIKCANILVDASGSVKLAD 368 (488)
Q Consensus 300 ---~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH--------~~giiHrDLkp~NILl~~~~~vkL~D 368 (488)
..++||||+++|+|.+++....+++..++.++.|++.||.||| +.||+||||||+|||++.++.+||+|
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred ccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 8999999999999999999888999999999999999999999 89999999999999999999999999
Q ss_pred cCCcccccCCC------cccCCCCCcccCchhhccccC----CCChhhhHHHHHHHHHHHHcC----------CCCCCCC
Q 011326 369 FGLAKATTMND------VKSCKGTAFWMAPEVVNLKKD----GYGLTADIWSLGCTVLEMLTR----------RHPYSHL 428 (488)
Q Consensus 369 FGla~~~~~~~------~~~~~gt~~y~aPE~~~~~~~----~~s~k~DvwSlGvlL~eLltG----------~~Pf~~~ 428 (488)
||++....... .....||+.|+|||.+..... .++.++||||||+++|||++| ..||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 99997654432 234579999999999742211 233789999999999999999 7888654
Q ss_pred ch-----hhhHHHhcCC-CCCCCCC-----cccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 429 EG-----GQAMFKIGGG-ELPPVPN-----SLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 429 ~~-----~~~~~~i~~~-~~~~~~~-----~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.. ......+... ..+..+. .+++.+.+|+.+||+.||.+|||+.|+++|
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 32 2222223222 2233332 345689999999999999999999999876
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=344.45 Aligned_cols=244 Identities=18% Similarity=0.234 Sum_probs=197.3
Q ss_pred CCcccccccCceeeeeeecccCceEEEEEE------ecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC---CC
Q 011326 216 PNGKFRRRITSWQKGELLGSGSYGFVYEGL------TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE---HD 286 (488)
Q Consensus 216 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~------~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~---Hp 286 (488)
+...+.....+|++.+.||+|+||.||+|. ..++..||+|++.... ..++..|+.++..++ |+
T Consensus 56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~e~~~~~~l~~~~~~ 127 (365)
T 3e7e_A 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--------PWEFYIGTQLMERLKPSMQH 127 (365)
T ss_dssp SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--------HHHHHHHHHHHHHSCGGGGG
T ss_pred cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--------hhHHHHHHHHHHHhhhhhhh
Confidence 344455567789999999999999999994 3478999999986421 235667777777776 99
Q ss_pred CcceeeccccCCCceEEEEeeccCCChHHHHhh------hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC
Q 011326 287 NIVQYLGTDRDEKRLCIFLELVTKGSLASLYQK------YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA 360 (488)
Q Consensus 287 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~------~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~ 360 (488)
||+.+++++..++..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 128 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~ 207 (365)
T 3e7e_A 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGN 207 (365)
T ss_dssp GBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECG
T ss_pred hhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecc
Confidence 999999999999999999999999999999963 35999999999999999999999999999999999999998
Q ss_pred -----------CCcEEEeecCCcccccC----CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCC
Q 011326 361 -----------SGSVKLADFGLAKATTM----NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY 425 (488)
Q Consensus 361 -----------~~~vkL~DFGla~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf 425 (488)
++.+||+|||+++.... .......||+.|+|||++ .+..++.++|||||||++|||++|+.||
T Consensus 208 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~elltg~~pf 285 (365)
T 3e7e_A 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML--SNKPWNYQIDYFGVAATVYCMLFGTYMK 285 (365)
T ss_dssp GGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHH--TTCCBSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred cccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHh--cCCCCCccccHHHHHHHHHHHHhCCCcc
Confidence 89999999999965431 123456799999999997 4455899999999999999999999999
Q ss_pred CCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCC-HHHH
Q 011326 426 SHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPT-AAQL 474 (488)
Q Consensus 426 ~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps-~~ei 474 (488)
......... ........ ..++.+.+++..||+.+|.+|++ +.++
T Consensus 286 ~~~~~~~~~---~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l 330 (365)
T 3e7e_A 286 VKNEGGECK---PEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLL 330 (365)
T ss_dssp EEEETTEEE---ECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHH
T ss_pred ccCCCCcee---echhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHH
Confidence 654332211 11111122 34778999999999999999965 4444
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.53 Aligned_cols=251 Identities=19% Similarity=0.179 Sum_probs=196.2
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCC-CCcceeec-------
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH-DNIVQYLG------- 293 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~------- 293 (488)
....|..++.||+|+||.||+|.+. +|+.||||++...... .....+.+.+|+.+++.++| +|......
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~--~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP--PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCc--cHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 4456889999999999999999975 7999999998744332 22335678899999999987 33221111
Q ss_pred --------------cccC-----CCceEEEEeeccCCChHHHHh--------hhccChhhhhHHHHHHHHHHHHHHHCCC
Q 011326 294 --------------TDRD-----EKRLCIFLELVTKGSLASLYQ--------KYHLSDSQVSSYTRQILNGLKYLHEQNV 346 (488)
Q Consensus 294 --------------~~~~-----~~~~~lV~E~~~~gsL~~~l~--------~~~ls~~~~~~i~~qi~~aL~yLH~~gi 346 (488)
++.. ...++++|+++ +++|.+++. ...+++..+..++.||+.||.|||++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 232 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 232 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 1111 22467777766 469988884 3348888999999999999999999999
Q ss_pred ccccCCcccEEECCCCcEEEeecCCcccccCCCcccCCCCCcccCchhhcc--------ccCCCChhhhHHHHHHHHHHH
Q 011326 347 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNL--------KKDGYGLTADIWSLGCTVLEM 418 (488)
Q Consensus 347 iHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~s~k~DvwSlGvlL~eL 418 (488)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++.. ....++.++|||||||++|||
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999999998765433 445567 99999999731 233478899999999999999
Q ss_pred HcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 419 LTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 419 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
++|+.||...+..+....+... ...+|+++.+||.+||+.||++||++.++++||||++.
T Consensus 311 ltg~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 311 WCADLPNTDDAALGGSEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HHSSCCCCTTGGGSCSGGGGSS-----CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHCCCCCCCcchhhhHHHHHhh-----cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 9999999877665544444322 23678999999999999999999999999999999753
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=342.93 Aligned_cols=246 Identities=19% Similarity=0.243 Sum_probs=192.6
Q ss_pred cCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCC---cchhHHHHHHHHHHHHhcCC----------------
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGP---RGKQSILQLEQEISLLGQFE---------------- 284 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~iL~~l~---------------- 284 (488)
.++|++.+.||+|+||.||+|.+ +|..||||++....... ........+.+|+.+++.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 56899999999999999999987 68999999998764321 12233456788888888876
Q ss_pred ----------CCCcceeeccccC-------------CCceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHH
Q 011326 285 ----------HDNIVQYLGTDRD-------------EKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYL 341 (488)
Q Consensus 285 ----------HpnIv~l~~~~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yL 341 (488)
||||+++++++.+ ++..++||||+++|++.+.+.+..+++..+..++.||+.||.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 5555555665554 78899999999999776666667799999999999999999999
Q ss_pred H-HCCCccccCCcccEEECCCC--------------------cEEEeecCCcccccCCCcccCCCCCcccCchhhccccC
Q 011326 342 H-EQNVVHRDIKCANILVDASG--------------------SVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKD 400 (488)
Q Consensus 342 H-~~giiHrDLkp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 400 (488)
| ++||+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|||++. +.
T Consensus 178 H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y~aPE~~~--g~ 252 (336)
T 2vuw_A 178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVSMDEDLFT--GD 252 (336)
T ss_dssp HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---EEECCCCTTCSGGGC--CC
T ss_pred HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---cEEEeecccChhhhc--CC
Confidence 9 99999999999999999887 8999999999866532 347999999999973 33
Q ss_pred CCChhhhHHHHHHH-HHHHHcCCCCCCCCch-hhhHHHhc-CCCC-----CCCCCcccHHHHHHHHHhhhhCCCCCCCHH
Q 011326 401 GYGLTADIWSLGCT-VLEMLTRRHPYSHLEG-GQAMFKIG-GGEL-----PPVPNSLSRDAQDFILKCLQVNPNDRPTAA 472 (488)
Q Consensus 401 ~~s~k~DvwSlGvl-L~eLltG~~Pf~~~~~-~~~~~~i~-~~~~-----~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~ 472 (488)
.+.++||||+|++ .+++++|..||..... ......+. .... ...+..+++++.+||.+||+.| |+.
T Consensus 253 -~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~ 326 (336)
T 2vuw_A 253 -GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT 326 (336)
T ss_dssp -SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred -CccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence 3889999998777 6778889999854211 11111111 1111 1122357899999999999976 999
Q ss_pred HHH-hCccCC
Q 011326 473 QLM-EHPFIK 481 (488)
Q Consensus 473 eil-~hp~f~ 481 (488)
|++ +||||+
T Consensus 327 e~l~~Hp~f~ 336 (336)
T 2vuw_A 327 DLLCQHSLFK 336 (336)
T ss_dssp HHHHHCGGGC
T ss_pred HHHhcCCCcC
Confidence 999 999996
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=348.91 Aligned_cols=243 Identities=23% Similarity=0.313 Sum_probs=199.9
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCC-CCcceeeccccCCCce
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH-DNIVQYLGTDRDEKRL 301 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~ 301 (488)
.++|++++.||+|+||.||+|.+. ++..||||++...... .++.+|+.+++.++| +++..+..++.+.+..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-------CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 468999999999999999999974 7999999998754432 236789999999987 5555666677778889
Q ss_pred EEEEeeccCCChHHHHh--hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEE---CCCCcEEEeecCCccccc
Q 011326 302 CIFLELVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILV---DASGSVKLADFGLAKATT 376 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~--~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl---~~~~~vkL~DFGla~~~~ 376 (488)
++||||+ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999 889999997 4469999999999999999999999999999999999999 588999999999997654
Q ss_pred CCC---------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhh---hHHHhcC----C
Q 011326 377 MND---------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ---AMFKIGG----G 440 (488)
Q Consensus 377 ~~~---------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~---~~~~i~~----~ 440 (488)
... .....||+.|+|||.+ .+..++.++|||||||+||||++|+.||.+..... .+..+.. .
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~--~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTH--LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred CCccccccccccccccCCCccccCHHHh--cCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence 432 1256799999999997 45668999999999999999999999998755432 2222111 1
Q ss_pred CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 441 ELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 441 ~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
........+++++.+|+.+||+.||++||++.+|++
T Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111233568999999999999999999999998874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=366.71 Aligned_cols=254 Identities=22% Similarity=0.365 Sum_probs=204.1
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC----
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD---- 297 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~---- 297 (488)
..++|++.+.||+|+||.||+|.+. +|..||+|.+... ........+.+|+.++++++||||+++++++..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~----~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~ 87 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE----LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC----CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc----CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence 3578999999999999999999885 7999999998643 234455678999999999999999999998765
Q ss_pred --CCceEEEEeeccCCChHHHHhhh----ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCc---EEEee
Q 011326 298 --EKRLCIFLELVTKGSLASLYQKY----HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGS---VKLAD 368 (488)
Q Consensus 298 --~~~~~lV~E~~~~gsL~~~l~~~----~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~---vkL~D 368 (488)
++..++||||+++|+|.+++... ++++..++.++.|++.||.|||++||+||||||+||+++.++. ++|+|
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 67889999999999999999754 4899999999999999999999999999999999999997765 99999
Q ss_pred cCCcccccCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHH-----------
Q 011326 369 FGLAKATTMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFK----------- 436 (488)
Q Consensus 369 FGla~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~----------- 436 (488)
||++....... .....||+.|+|||.+ .+..++.++||||||+++|+|++|..||...........
T Consensus 168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l--~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 168 LGYAKELDQGELCTEFVGTLQYLAPELL--EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245 (676)
T ss_dssp CCCCCBTTSCCCCCCCCSCCTTCSSCSS--CCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred cccccccccccccccccCCcccCChHHh--ccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence 99998665443 3456799999999997 456689999999999999999999999965422211000
Q ss_pred ---hcCC-----CC----CCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 437 ---IGGG-----EL----PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 437 ---i~~~-----~~----~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
...+ .. ......+++++.+||.+||++||.+|||+.|+++||||+.
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0000 00 1123347889999999999999999999999999999864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=316.13 Aligned_cols=222 Identities=14% Similarity=0.102 Sum_probs=187.1
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
++|++.+.||+|+||.||+|.+. +|+.||+|.+..... ........+.+|+.++.+++||||+++++++.+++..|+
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV--LPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCC--SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccc--cCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 67999999999999999999986 699999999976543 234456788999999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCcccC
Q 011326 304 FLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC 383 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 383 (488)
||||++|++|.+++... .....+..++.|++.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred EEEecCCCCHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------------
Confidence 99999999999999654 5666789999999999999999999999999999999999999998554
Q ss_pred CCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHH---HhcCCCCC---CCCCcccHHHHHHH
Q 011326 384 KGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF---KIGGGELP---PVPNSLSRDAQDFI 457 (488)
Q Consensus 384 ~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~---~i~~~~~~---~~~~~~s~~l~~Li 457 (488)
|++ .++.++||||||+++|||++|+.||.+.+..+... .......+ .....+++++.+||
T Consensus 175 -----~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 240 (286)
T 3uqc_A 175 -----TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVA 240 (286)
T ss_dssp -----CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHH
T ss_pred -----ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHH
Confidence 222 26889999999999999999999998766543221 11111111 12356899999999
Q ss_pred HHhhhhCCCCCCCHHHHHhC
Q 011326 458 LKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 458 ~~cL~~dP~~Rps~~eil~h 477 (488)
.+||+.||.+| |+.|+++.
T Consensus 241 ~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 241 ARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHCTTSSCC-CHHHHHHH
T ss_pred HHHcccCCccC-CHHHHHHH
Confidence 99999999999 99999863
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=357.89 Aligned_cols=239 Identities=21% Similarity=0.263 Sum_probs=197.6
Q ss_pred cCceeeeeeecccCceEEEEEEec--CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc-
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD--DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR- 300 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~- 300 (488)
.++|++.+.||+|+||.||+|.+. +|+.||||.+... ........+.+|+.++.+++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS----GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS----CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc----CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 478999999999999999999985 6899999998643 234455678899999999999999999999887665
Q ss_pred ----eEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 301 ----LCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 301 ----~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
.|+||||++|++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++...
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred CCceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 7999999999999988766 79999999999999999999999999999999999999875 89999999997654
Q ss_pred CCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHH
Q 011326 377 MNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDF 456 (488)
Q Consensus 377 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L 456 (488)
.. ....||+.|+|||++. . .++.++||||||+++|+|++|..||.+...... .........++.+.+|
T Consensus 233 ~~--~~~~gt~~y~aPE~~~--~-~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-------~~~~~~~~~~~~l~~l 300 (681)
T 2pzi_A 233 SF--GYLYGTPGFQAPEIVR--T-GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-------PEDDPVLKTYDSYGRL 300 (681)
T ss_dssp CC--SCCCCCTTTSCTTHHH--H-CSCHHHHHHHHHHHHHHHHSCCCEETTEECSSC-------CTTCHHHHHCHHHHHH
T ss_pred cC--CccCCCccccCHHHHc--C-CCCCceehhhhHHHHHHHHhCCCCCcccccccc-------cccccccccCHHHHHH
Confidence 33 4567999999999973 2 248999999999999999999988865321110 0000112346789999
Q ss_pred HHHhhhhCCCCCCCHHHHHhCccC
Q 011326 457 ILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 457 i~~cL~~dP~~Rps~~eil~hp~f 480 (488)
|.+||+.||.+||+..+.+.|+|+
T Consensus 301 i~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 301 LRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred HhhhccCChhhCCCHHHHHHHHHH
Confidence 999999999999998888888776
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-32 Score=292.23 Aligned_cols=185 Identities=16% Similarity=0.105 Sum_probs=132.2
Q ss_pred eecccCceEEEEEEec-CCcEEEEEEeecCCCCC-----cchhHHHHHHHHHHHHhcC-CCCCcceeeccccCCCceEEE
Q 011326 232 LLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGP-----RGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 232 ~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~-----~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV 304 (488)
..+.|+.|.+..+... .|..+++|.+.+..... ..+...+++.+|+++|+++ +|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4677888877766543 69999999998764322 1234456799999999999 799999999999999999999
Q ss_pred EeeccCCChHHHHhhhc-cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--Ccc
Q 011326 305 LELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVK 381 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~~-ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~ 381 (488)
|||++|++|.+++...+ +++ .+|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..... ...
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~---~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~ 397 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDR---EKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPT 397 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCH---HHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSH
T ss_pred EecCCCCcHHHHHHhCCCCCH---HHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcccc
Confidence 99999999999997764 544 358999999999999999999999999999999999999999999866543 234
Q ss_pred cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCC
Q 011326 382 SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRR 422 (488)
Q Consensus 382 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~ 422 (488)
+.+||+.|+|||++. +.+..++|+||+|+++++|.++.
T Consensus 398 t~vGTp~YmAPE~l~---g~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 398 NLVQSFFVFVNELFA---ENKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp HHHHHHHHHHHHHC--------------------CCCCTTH
T ss_pred CceechhhccHHHhC---CCCCCcccccccccchhhhcccc
Confidence 567999999999973 34677899999999988776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=256.52 Aligned_cols=188 Identities=19% Similarity=0.223 Sum_probs=146.7
Q ss_pred eeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcc---hhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 228 QKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRG---KQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 228 ~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
...+.||+|+||.||+| ...+..+++|........... ....+++.+|+.++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~-~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD-SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEE-ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEE-EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 34578999999999999 445788999987653322111 12245689999999999999999666555567778999
Q ss_pred EeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-----
Q 011326 305 LELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----- 379 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~----- 379 (488)
|||+++++|.+++.. +..++.|+++||.|||++||+||||||+|||++. .+||+|||+++......
T Consensus 418 mE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~ 488 (540)
T 3en9_A 418 MSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVD 488 (540)
T ss_dssp EECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHH
T ss_pred EECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccc
Confidence 999999999999876 7799999999999999999999999999999998 99999999998765432
Q ss_pred ----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCC
Q 011326 380 ----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY 425 (488)
Q Consensus 380 ----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf 425 (488)
.....||+.|+|||+++.....|+..+|+|+..+-..+.+.++.+|
T Consensus 489 ~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 489 LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1356799999999998543455788899999999988888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=208.33 Aligned_cols=148 Identities=16% Similarity=0.151 Sum_probs=118.5
Q ss_pred ceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCc----ch---------hHHHHHHHHHHHHhcCCCCCcceee
Q 011326 226 SWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPR----GK---------QSILQLEQEISLLGQFEHDNIVQYL 292 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~----~~---------~~~~~~~~Ei~iL~~l~HpnIv~l~ 292 (488)
.|.+++.||+|+||.||+|.+.+|..||+|.+........ .. .....+.+|+.++++++ | +++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 4566699999999999999997799999999965332111 00 24567889999999998 5 6666
Q ss_pred ccccCCCceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCc
Q 011326 293 GTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLA 372 (488)
Q Consensus 293 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla 372 (488)
+++.. +..++||||++|++|.+ + .......++.|++.||.|||++||+||||||+|||++ ++.++|+|||++
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l-----~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a 239 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-V-----RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS 239 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-C-----CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTC
T ss_pred eEEec-cceEEEEEecCCCcHHH-c-----chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCC
Confidence 65433 56799999999999987 3 2345668999999999999999999999999999999 999999999998
Q ss_pred ccccCCCcccCCCCCcccCchhh
Q 011326 373 KATTMNDVKSCKGTAFWMAPEVV 395 (488)
Q Consensus 373 ~~~~~~~~~~~~gt~~y~aPE~~ 395 (488)
.. +..+.|||.+
T Consensus 240 ~~-----------~~~~~a~e~l 251 (282)
T 1zar_A 240 VE-----------VGEEGWREIL 251 (282)
T ss_dssp EE-----------TTSTTHHHHH
T ss_pred eE-----------CCCCCHHHHH
Confidence 53 3457889986
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.1e-20 Score=182.34 Aligned_cols=142 Identities=20% Similarity=0.239 Sum_probs=110.1
Q ss_pred ceeeeeeecccCceEEEEEEe-cCCcE--EEEEEeecCCCCCc-------------------chhHHHHHHHHHHHHhcC
Q 011326 226 SWQKGELLGSGSYGFVYEGLT-DDGFF--FAVKEVSLQDEGPR-------------------GKQSILQLEQEISLLGQF 283 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~--vAvK~i~~~~~~~~-------------------~~~~~~~~~~Ei~iL~~l 283 (488)
-|++.+.||+|+||.||+|.+ .+|.. ||||++........ .......+.+|+.+|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 377889999999999999998 68988 99999754321100 112234678999999999
Q ss_pred CCCCc--ceeeccccCCCceEEEEeeccC-C----ChHHHHhhhccChhhhhHHHHHHHHHHHHHH-HCCCccccCCccc
Q 011326 284 EHDNI--VQYLGTDRDEKRLCIFLELVTK-G----SLASLYQKYHLSDSQVSSYTRQILNGLKYLH-EQNVVHRDIKCAN 355 (488)
Q Consensus 284 ~HpnI--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH-~~giiHrDLkp~N 355 (488)
.|+++ +.++++ +..++||||+.+ | +|.++... .++..+..++.|++.||.||| ++||+||||||+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 88764 334432 357899999943 4 66665432 356788999999999999999 9999999999999
Q ss_pred EEECCCCcEEEeecCCcccc
Q 011326 356 ILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 356 ILl~~~~~vkL~DFGla~~~ 375 (488)
||++. .++|+|||+|...
T Consensus 202 ILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EEESS--SEEECCCTTCEET
T ss_pred EEEcC--cEEEEECcccccC
Confidence 99988 9999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.7e-18 Score=177.81 Aligned_cols=144 Identities=16% Similarity=0.101 Sum_probs=99.6
Q ss_pred ceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCc---------chhHHHHHHHHHHHHhcCCCCCcceeecccc
Q 011326 226 SWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPR---------GKQSILQLEQEISLLGQFEHDNIVQYLGTDR 296 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~---------~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 296 (488)
-|++++.||+|+||.||+|.+.+|+.||||+++....... ..........++.++....|+|+.+++....
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3889999999999999999999999999998764311100 0000111122222222223444444333222
Q ss_pred CC------CceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC--------
Q 011326 297 DE------KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG-------- 362 (488)
Q Consensus 297 ~~------~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~-------- 362 (488)
.- ...+|||||++|++|.++. ..+....++.|++.+|.+||++||+||||||.|||++.+|
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~-----~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~ 250 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVS-----SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSI 250 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCC-----CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSE
T ss_pred CCCeeeeccCceEEEEecCCccHhhhc-----ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccccccc
Confidence 11 2347999999998886543 3345677899999999999999999999999999998776
Q ss_pred --cEEEeecCCccc
Q 011326 363 --SVKLADFGLAKA 374 (488)
Q Consensus 363 --~vkL~DFGla~~ 374 (488)
.+.|+||+-+-.
T Consensus 251 ~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 251 TLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEEECCCTTCEE
T ss_pred ccceEEEEeCCccc
Confidence 389999997643
|
| >4aqr_D Calcium-transporting ATPase 8, plasma membrane-TY; Ca-binding protein-hydrolase complex, plasma-membrane calciu; 1.95A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.64 E-value=5.8e-17 Score=115.84 Aligned_cols=43 Identities=33% Similarity=0.560 Sum_probs=40.1
Q ss_pred CcHHHHHHHHhhchhcccccccchhhhhhhhhHHHHHhHHhhhh
Q 011326 18 PPEDTLKRWKSACNIVNNRRRKFRMVANLANQAETRVNTFKIQN 61 (488)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 61 (488)
.|+|+|+|||+| ++|+||+||||+++||.|+.|++++++++..
T Consensus 1 ~s~e~L~rWR~a-~lVlNa~RRFR~t~dL~K~~e~~~~~rkiR~ 43 (57)
T 4aqr_D 1 SSIERLQQWRKA-ALVLNASRRFRYTLDLKKEQETREMRQKIRS 43 (57)
T ss_dssp CHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcHHHHHHHHHH-HHHhchHhhhhhhcchhhHHHHHHHHHHHHH
Confidence 489999999999 6999999999999999999999999987765
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=2.5e-12 Score=124.39 Aligned_cols=142 Identities=14% Similarity=0.145 Sum_probs=112.8
Q ss_pred ccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDEK 299 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~ 299 (488)
+..+..|++...+|.|+.+.||++... +..+++|......... ...+.+|+.+++.+. +..+.++++++.+.+
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~ 83 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC-----HHHHHHHHHHHHHHhcCCCCCeEEEEEecCC
Confidence 345678999999999999999998754 6889999986432111 124678888988884 667888999888888
Q ss_pred ceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHH------------------------------------
Q 011326 300 RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHE------------------------------------ 343 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~------------------------------------ 343 (488)
..++|||+++|.+|.+.+ .+......++.+++.+|..||+
T Consensus 84 ~~~lv~e~i~G~~l~~~~----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 84 WSNLLMSEADGVLCSEEY----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEEECCSSEEHHHHC----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred ceEEEEEecCCeehhhcc----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 999999999999987652 1334455789999999999998
Q ss_pred -----------------------CCCccccCCcccEEECCCCcEEEeecCCc
Q 011326 344 -----------------------QNVVHRDIKCANILVDASGSVKLADFGLA 372 (488)
Q Consensus 344 -----------------------~giiHrDLkp~NILl~~~~~vkL~DFGla 372 (488)
..++|+|++|.||+++.++.+.|+||+.+
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 44899999999999987656679999976
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.29 E-value=6.2e-12 Score=120.56 Aligned_cols=138 Identities=17% Similarity=0.131 Sum_probs=101.4
Q ss_pred ccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCC--cceeeccccCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN--IVQYLGTDRDE 298 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~~ 298 (488)
...+.++.+..+.+.|..+.||++...+|..+++|...... ...+.+|+.+++.+.+.+ +.+++++...+
T Consensus 16 ~~~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~--------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 16 VERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--------LNELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp TTTTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT--------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred HHhcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc--------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 34455666655555677799999977778889999975421 124567888888886545 45588888877
Q ss_pred CceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCC---------------------------------
Q 011326 299 KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQN--------------------------------- 345 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~g--------------------------------- 345 (488)
+..++||||++|.+|. .. ......++.+++..|..||+..
T Consensus 88 ~~~~~v~e~i~G~~l~--~~-----~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--SS-----HLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp SCEEEEEECCSSEETT--TS-----CCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred CCCEEEEEecCCcccC--cC-----cCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 8899999999998884 11 1122356777777888887643
Q ss_pred -------------------------CccccCCcccEEECCCCcEEEeecCCcc
Q 011326 346 -------------------------VVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 346 -------------------------iiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
++|+|++|.||+++.++.+.|+|||.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.07 E-value=2.9e-10 Score=115.17 Aligned_cols=140 Identities=14% Similarity=0.200 Sum_probs=103.5
Q ss_pred eeeeecccCceEEEEEEecCCcEEEEEEee--cCCCCCcchhHHHHHHHHHHHHhcCC--CCCcceeeccccCC---Cce
Q 011326 229 KGELLGSGSYGFVYEGLTDDGFFFAVKEVS--LQDEGPRGKQSILQLEQEISLLGQFE--HDNIVQYLGTDRDE---KRL 301 (488)
Q Consensus 229 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~--~~~~~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~---~~~ 301 (488)
..+.|+.|.++.||+....+ ..+++|... .... ......+.+|+.+++.+. +..+.+++.++.+. +..
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~----~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKL----LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC--------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCC----CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 35678999999999987654 578888765 2211 112245678999998886 44577888888766 458
Q ss_pred EEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHH--------------------------------------
Q 011326 302 CIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHE-------------------------------------- 343 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~-------------------------------------- 343 (488)
++||||++|.++.+.. ...++......++.+++.+|..||+
T Consensus 117 ~~vme~v~G~~l~~~~-~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS-LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEEECCCCBCCCCTT-CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEEecCCeecCCCc-cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999999998774311 1236778888999999999999997
Q ss_pred --------------------CCCccccCCcccEEECCCCc--EEEeecCCccc
Q 011326 344 --------------------QNVVHRDIKCANILVDASGS--VKLADFGLAKA 374 (488)
Q Consensus 344 --------------------~giiHrDLkp~NILl~~~~~--vkL~DFGla~~ 374 (488)
.+++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997753 68999998853
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.00 E-value=5.6e-10 Score=110.55 Aligned_cols=183 Identities=19% Similarity=0.177 Sum_probs=119.5
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCC--cceeeccccCCC---ceEEE
Q 011326 231 ELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDN--IVQYLGTDRDEK---RLCIF 304 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-Hpn--Iv~l~~~~~~~~---~~~lV 304 (488)
+.++.|..+.||+.. ..+++|.... ......+.+|+.+|+.+. +.. +..++......+ ..|+|
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~-------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKH-------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESS-------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred EecCCCCcceEEEEC----CEEEEEecCC-------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 448999999999863 5688888531 234467889999998873 332 344555544333 35889
Q ss_pred EeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHH-----------------------------------------
Q 011326 305 LELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHE----------------------------------------- 343 (488)
Q Consensus 305 ~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~----------------------------------------- 343 (488)
||+++|.+|..... ..++.++...++.|++..+..||+
T Consensus 95 m~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred EcccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99999988864322 346777788888888888888886
Q ss_pred -----------------CCCccccCCcccEEECC--CCcEEEeecCCcccccCCC-cccCCCCCcccCchhhcc----cc
Q 011326 344 -----------------QNVVHRDIKCANILVDA--SGSVKLADFGLAKATTMND-VKSCKGTAFWMAPEVVNL----KK 399 (488)
Q Consensus 344 -----------------~giiHrDLkp~NILl~~--~~~vkL~DFGla~~~~~~~-~~~~~gt~~y~aPE~~~~----~~ 399 (488)
..++|+|++|.||+++. ++.+.|+||+.+....... .........-..|+.... -+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 13699999999999988 4568899999875432210 000000000012222100 00
Q ss_pred C--------CCChhhhHHHHHHHHHHHHcCCCCC
Q 011326 400 D--------GYGLTADIWSLGCTVLEMLTRRHPY 425 (488)
Q Consensus 400 ~--------~~s~k~DvwSlGvlL~eLltG~~Pf 425 (488)
. ......+.|++|.++|.+.+|..+|
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 0122368999999999999998775
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=9.5e-07 Score=87.53 Aligned_cols=132 Identities=20% Similarity=0.179 Sum_probs=91.1
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCC---Ccceeecccc-CCCceEEEEe
Q 011326 231 ELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD---NIVQYLGTDR-DEKRLCIFLE 306 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp---nIv~l~~~~~-~~~~~~lV~E 306 (488)
+.++.|....||+. |..+++|.-. .......+.+|+.+|+.+.+. .+.+.+.++. ..+..+++||
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~-------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK-------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES-------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC-------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 45788999999987 5678888742 223446788999999998653 2455665553 4556789999
Q ss_pred eccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHC------------------------------------------
Q 011326 307 LVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQ------------------------------------------ 344 (488)
Q Consensus 307 ~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~------------------------------------------ 344 (488)
+++|.+|....- ..++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~-~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 94 KVQGQILGEDGM-AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCCSEECHHHHH-TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ccCCeECchhhh-hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 999988865311 1234444445555555555555532
Q ss_pred ------------------CCccccCCcccEEECC---CCc-EEEeecCCccc
Q 011326 345 ------------------NVVHRDIKCANILVDA---SGS-VKLADFGLAKA 374 (488)
Q Consensus 345 ------------------giiHrDLkp~NILl~~---~~~-vkL~DFGla~~ 374 (488)
.++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3589999999999987 455 48999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=2.6e-06 Score=82.07 Aligned_cols=130 Identities=13% Similarity=0.093 Sum_probs=93.5
Q ss_pred ecccCce-EEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCCCceEEEEeecc
Q 011326 233 LGSGSYG-FVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDEKRLCIFLELVT 309 (488)
Q Consensus 233 LG~G~fg-~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ 309 (488)
+..|..| .||+.... ++..+++|.-.. .....+.+|...|+.+. +--+.+++.++.+++..++|||+++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~--------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~ 103 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG--------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP 103 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET--------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC--------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence 4445554 68987765 567899998642 12346778988888774 2235678888888889999999999
Q ss_pred CCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHC---------------------------------------------
Q 011326 310 KGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQ--------------------------------------------- 344 (488)
Q Consensus 310 ~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~--------------------------------------------- 344 (488)
|.++.+.... .......+..++...|..||+.
T Consensus 104 G~~~~~~~~~---~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 104 GKTAFQVLEE---YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp SEEHHHHHHH---CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred CccccccccC---CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 9888765432 2233445666677777777741
Q ss_pred -------------CCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 345 -------------NVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 345 -------------giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
.++|+|++|.|||++.++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 15899999999999987777899999763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=1.2e-06 Score=88.09 Aligned_cols=82 Identities=4% Similarity=-0.070 Sum_probs=52.5
Q ss_pred eeee-cccCceEEEEEEec-------CCcEEEEEEeecCCC-CCcchhHHHHHHHHHHHHhcCC-C--CCcceeeccccC
Q 011326 230 GELL-GSGSYGFVYEGLTD-------DGFFFAVKEVSLQDE-GPRGKQSILQLEQEISLLGQFE-H--DNIVQYLGTDRD 297 (488)
Q Consensus 230 ~~~L-G~G~fg~Vy~~~~~-------~g~~vAvK~i~~~~~-~~~~~~~~~~~~~Ei~iL~~l~-H--pnIv~l~~~~~~ 297 (488)
.+.| +.|..+.+|+.... ++..+++|....... .... ...+.+|+.+++.+. + -.+.+++.++.+
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4668 88999999987654 266788887643220 0000 123556777777764 2 346667777665
Q ss_pred C---CceEEEEeeccCCChH
Q 011326 298 E---KRLCIFLELVTKGSLA 314 (488)
Q Consensus 298 ~---~~~~lV~E~~~~gsL~ 314 (488)
. +..++|||+++|.++.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 4 3568999999986653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=4e-06 Score=85.85 Aligned_cols=80 Identities=14% Similarity=0.135 Sum_probs=48.2
Q ss_pred eeeecccCceEEEEEEec-CCcEEEEEEeecCCC--CCcchhHHHHHHHHHHHHhcCCC--CCc-ceeeccccCCCceEE
Q 011326 230 GELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDE--GPRGKQSILQLEQEISLLGQFEH--DNI-VQYLGTDRDEKRLCI 303 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~--~~~~~~~~~~~~~Ei~iL~~l~H--pnI-v~l~~~~~~~~~~~l 303 (488)
.+.||.|.++.||++... ++..+++|....... .........++..|..+++.+.. |.. ..++.+. .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 356899999999999764 578899998753221 00000112345678888877632 333 3455443 345689
Q ss_pred EEeeccCC
Q 011326 304 FLELVTKG 311 (488)
Q Consensus 304 V~E~~~~g 311 (488)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.12 E-value=1.5e-05 Score=79.00 Aligned_cols=30 Identities=20% Similarity=0.351 Sum_probs=27.2
Q ss_pred CCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 344 QNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 344 ~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999763
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00026 Score=66.32 Aligned_cols=134 Identities=20% Similarity=0.130 Sum_probs=92.2
Q ss_pred CChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHH-CCCccccCCcccEEECCCCcEEEeecCCcccccCCCcccCCCCC
Q 011326 311 GSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTA 387 (488)
Q Consensus 311 gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~gt~ 387 (488)
-+|.+++... +++++++|.++.|.+.+|.-+-. ..-..+=+.|..|++..+|+|-+.+ +.+. ....
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------~~~~ 101 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------AGEP 101 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc----------cccc
Confidence 3899988654 69999999999999999887732 2222344567999999999987764 2110 1223
Q ss_pred cccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhh----
Q 011326 388 FWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQV---- 463 (488)
Q Consensus 388 ~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~---- 463 (488)
.+.|||.. ....+.+.-|||||+++|..+--..| +..+..+|+++.+||..|..-
T Consensus 102 ~~~~pe~~---~~~~te~~~IysLG~tLY~ALDygL~------------------e~eE~eLS~~LE~LL~~Mt~~~~d~ 160 (229)
T 2yle_A 102 PPVAGKLG---YSQCMETEVIESLGIIIYKALDYGLK------------------ENEERELSPPLEQLIDHMANTVEAD 160 (229)
T ss_dssp -----CCS---SSSSCHHHHHHHHHHHHHHHHTTTCC------------------TTEEECCCHHHHHHHHHHTTCCC--
T ss_pred CCCChhhc---cccchHHHHHHHHHHHHHHHhhcCCC------------------cccchhhCHHHHHHHHHHHhccccc
Confidence 46788864 23467899999999999998863332 233456899999999999866
Q ss_pred ---------------------CCCCCCCHHHHHh
Q 011326 464 ---------------------NPNDRPTAAQLME 476 (488)
Q Consensus 464 ---------------------dP~~Rps~~eil~ 476 (488)
.+..|+++++|++
T Consensus 161 ~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 161 GSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp ------------------CCSCCCCCCSHHHHHH
T ss_pred ccccccccccccccccccccccccCcCCHHHHHH
Confidence 2457889999885
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00011 Score=75.82 Aligned_cols=78 Identities=13% Similarity=0.191 Sum_probs=45.1
Q ss_pred HCCCccccCCcccEEECCCCcEEEeecCCcccccCC-CcccCCC--CCcccCchhhccccC-CCChhhhHHHHHHHHHHH
Q 011326 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DVKSCKG--TAFWMAPEVVNLKKD-GYGLTADIWSLGCTVLEM 418 (488)
Q Consensus 343 ~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~g--t~~y~aPE~~~~~~~-~~s~k~DvwSlGvlL~eL 418 (488)
...++|+|++|.|||++.++ +.|+||+.+...... +...... ...|++|+....... .-....++..+...+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 45799999999999998776 999999987543211 1100000 123555554311000 112234455677777776
Q ss_pred HcC
Q 011326 419 LTR 421 (488)
Q Consensus 419 ltG 421 (488)
+.+
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00018 Score=71.44 Aligned_cols=74 Identities=18% Similarity=0.071 Sum_probs=57.4
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC---CCCcceeeccccCCCceEEEEee
Q 011326 231 ELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE---HDNIVQYLGTDRDEKRLCIFLEL 307 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~lV~E~ 307 (488)
+.|+.|....+|+... ++..+++|..... ....+..|+..|+.+. ...+.+++.++...+..++|||+
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG--------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc--------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 5589999999999876 4678888987532 2346778888888774 35677888888777889999999
Q ss_pred ccCCCh
Q 011326 308 VTKGSL 313 (488)
Q Consensus 308 ~~~gsL 313 (488)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00018 Score=71.40 Aligned_cols=32 Identities=34% Similarity=0.373 Sum_probs=27.3
Q ss_pred CCCccccCCcccEEECCC----CcEEEeecCCcccc
Q 011326 344 QNVVHRDIKCANILVDAS----GSVKLADFGLAKAT 375 (488)
Q Consensus 344 ~giiHrDLkp~NILl~~~----~~vkL~DFGla~~~ 375 (488)
..++|+|+++.|||++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 469999999999999874 68999999987543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.60 E-value=7e-05 Score=73.51 Aligned_cols=71 Identities=8% Similarity=0.008 Sum_probs=42.8
Q ss_pred eeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCc-ceeeccccCCCceEEEEeec
Q 011326 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI-VQYLGTDRDEKRLCIFLELV 308 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~E~~ 308 (488)
.+.|+.|....+|+. ..+++|......... ....+|+.+++.+...++ .++++++. +.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~------~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY------INRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C------CCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce------eCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeec
Confidence 567999999999998 568888875432111 112356666666542233 34555443 3346899999
Q ss_pred -cCCCh
Q 011326 309 -TKGSL 313 (488)
Q Consensus 309 -~~gsL 313 (488)
+|.+|
T Consensus 90 ~~g~~l 95 (301)
T 3dxq_A 90 AGAQTM 95 (301)
T ss_dssp TTCEEC
T ss_pred CCCccC
Confidence 66544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00065 Score=66.06 Aligned_cols=78 Identities=17% Similarity=0.026 Sum_probs=53.4
Q ss_pred eeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCC---CCcceeeccccCCCceEE
Q 011326 227 WQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH---DNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H---pnIv~l~~~~~~~~~~~l 303 (488)
..-.+.+|.|..+.||+.+..+|+.|++|+........ ...+..|+..|+.+.- --+.+++.+. .-++
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~-----~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL-----DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC-----TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch-----hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 34457799999999999999999999999865332211 1246678888877742 1244455443 2478
Q ss_pred EEeeccCCCh
Q 011326 304 FLELVTKGSL 313 (488)
Q Consensus 304 V~E~~~~gsL 313 (488)
|||+++++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00048 Score=67.81 Aligned_cols=137 Identities=15% Similarity=0.078 Sum_probs=76.8
Q ss_pred eeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCC--cceeeccc------cCCCc
Q 011326 229 KGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN--IVQYLGTD------RDEKR 300 (488)
Q Consensus 229 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~------~~~~~ 300 (488)
-.+.|+.|....+|+....+| .+++|....... . ..+..|+.++..+...+ +.+++... ...+.
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~----~---~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE----K---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEECC---EEEEEEEESSC-CEEEEEECC-------C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred EeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC----H---HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 346688899999999877655 688898764211 1 23445666666653222 23333221 12356
Q ss_pred eEEEEeeccCCChHH-----------H---Hhhh--ccC-----------hhh--------hh----HHHHHHHHHHHHH
Q 011326 301 LCIFLELVTKGSLAS-----------L---YQKY--HLS-----------DSQ--------VS----SYTRQILNGLKYL 341 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~-----------~---l~~~--~ls-----------~~~--------~~----~i~~qi~~aL~yL 341 (488)
.+++|++++|..+.. . ++.. .++ +.. +. .+...+...+..+
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 789999999864311 0 1110 111 000 00 0111244455666
Q ss_pred HH-------CCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 342 HE-------QNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 342 H~-------~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
++ .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 53 368999999999999877666899999774
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0011 Score=65.29 Aligned_cols=75 Identities=16% Similarity=0.027 Sum_probs=47.2
Q ss_pred eeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCC--cceeecc-----ccCCCceEE
Q 011326 231 ELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN--IVQYLGT-----DRDEKRLCI 303 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~-----~~~~~~~~l 303 (488)
..|+ |....||+....+|..+++|....... ....+..|..++..+.... +++++.. ...++..++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~------~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW------TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS------CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC------CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 3466 888899998777777899999863211 1234556777777664222 3444433 112345678
Q ss_pred EEeeccCCC
Q 011326 304 FLELVTKGS 312 (488)
Q Consensus 304 V~E~~~~gs 312 (488)
+||+++|.+
T Consensus 105 l~~~i~G~~ 113 (328)
T 1zyl_A 105 VFPSVGGRQ 113 (328)
T ss_dssp EEECCCCEE
T ss_pred EEEecCCCC
Confidence 999998854
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00067 Score=70.33 Aligned_cols=73 Identities=8% Similarity=0.012 Sum_probs=48.4
Q ss_pred eeeecccCceEEEEEEecC--------CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCc-ceeeccccCCCc
Q 011326 230 GELLGSGSYGFVYEGLTDD--------GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI-VQYLGTDRDEKR 300 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~~--------g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~ 300 (488)
.+.|+.|....+|++...+ +..+++|+.... .. ...+.+|..++..+...++ .++++.+.+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~--- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG--- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC---
Confidence 3568889999999997653 578999987421 11 1234468888887753344 456666543
Q ss_pred eEEEEeeccCCCh
Q 011326 301 LCIFLELVTKGSL 313 (488)
Q Consensus 301 ~~lV~E~~~~gsL 313 (488)
.+|+||++|.+|
T Consensus 148 -g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 -GRLEEYIPSRPL 159 (429)
T ss_dssp -EEEECCCCEEEC
T ss_pred -CEEEEEeCCccc
Confidence 389999987443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00075 Score=68.85 Aligned_cols=133 Identities=16% Similarity=0.181 Sum_probs=78.7
Q ss_pred eeecccCceEEEEEEec--------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCc-ceeeccccCCCce
Q 011326 231 ELLGSGSYGFVYEGLTD--------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI-VQYLGTDRDEKRL 301 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~--------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~ 301 (488)
+.|..|-...+|++... ++..+++|+.... ......+.+|..+++.+...++ .++++.+.+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~------~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~---- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI------LQGVDSLVLESVMFAILAERSLGPQLYGVFPE---- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc------cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----
Confidence 45777888999998764 3578999985321 1122345688888877743333 456666654
Q ss_pred EEEEeeccCCChHH-----------H---H---hhhc------c--ChhhhhHHHHHHHH-------------------H
Q 011326 302 CIFLELVTKGSLAS-----------L---Y---QKYH------L--SDSQVSSYTRQILN-------------------G 337 (488)
Q Consensus 302 ~lV~E~~~~gsL~~-----------~---l---~~~~------l--s~~~~~~i~~qi~~-------------------a 337 (488)
.+||||++|.+|.. + + +... . -+.++.++..++-. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 28999999865531 1 1 1110 1 12344555544422 2
Q ss_pred HHHHH----H----CCCccccCCcccEEECCC----CcEEEeecCCcc
Q 011326 338 LKYLH----E----QNVVHRDIKCANILVDAS----GSVKLADFGLAK 373 (488)
Q Consensus 338 L~yLH----~----~giiHrDLkp~NILl~~~----~~vkL~DFGla~ 373 (488)
+..|. . ..++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 33333 2 248999999999999876 789999999874
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00055 Score=69.06 Aligned_cols=74 Identities=14% Similarity=0.011 Sum_probs=42.2
Q ss_pred eeeecccCceEEEEEEecC---------CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCc-ceeeccccCCC
Q 011326 230 GELLGSGSYGFVYEGLTDD---------GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI-VQYLGTDRDEK 299 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~~---------g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~ 299 (488)
.+.|+.|....+|+....+ +..+++|....... .......|..+++.+...++ .++++...
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~------~~~~~~~E~~~l~~L~~~g~~P~~~~~~~--- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD------ELYNTISEFEVYKTMSKYKIAPQLLNTFN--- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG------GTSCHHHHHHHHHHHHHTTSSCCEEEEET---
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc------ceecHHHHHHHHHHHHhcCCCCceEEecC---
Confidence 3557889999999987653 26888888643211 11123467777776643333 35554432
Q ss_pred ceEEEEeeccCCCh
Q 011326 300 RLCIFLELVTKGSL 313 (488)
Q Consensus 300 ~~~lV~E~~~~gsL 313 (488)
-++||||++|.++
T Consensus 109 -~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 -GGRIEEWLYGDPL 121 (369)
T ss_dssp -TEEEEECCCSEEC
T ss_pred -CcEEEEEecCCcC
Confidence 2689999988543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0068 Score=63.28 Aligned_cols=74 Identities=9% Similarity=0.027 Sum_probs=47.0
Q ss_pred eeeecccCceEEEEEEecC-CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCc-ceeeccccCCCceEEEEee
Q 011326 230 GELLGSGSYGFVYEGLTDD-GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI-VQYLGTDRDEKRLCIFLEL 307 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~~-g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~E~ 307 (488)
.+.|+.|-...+|++...+ +..+++|+........ ....+|..++..+...++ .++++.+.. .+||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~------idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI------INREREKKISCILYNKNIAKKIYVFFTN----GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC------SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh------cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEe
Confidence 3568889999999998765 5788898874322111 112468888888765555 456666632 359999
Q ss_pred ccCCCh
Q 011326 308 VTKGSL 313 (488)
Q Consensus 308 ~~~gsL 313 (488)
++|.+|
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0075 Score=60.17 Aligned_cols=31 Identities=26% Similarity=0.388 Sum_probs=27.2
Q ss_pred CCCccccCCcccEEECCCCcEEEeecCCccc
Q 011326 344 QNVVHRDIKCANILVDASGSVKLADFGLAKA 374 (488)
Q Consensus 344 ~giiHrDLkp~NILl~~~~~vkL~DFGla~~ 374 (488)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3589999999999999888899999987653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.96 E-value=0.0098 Score=61.44 Aligned_cols=74 Identities=9% Similarity=-0.050 Sum_probs=46.5
Q ss_pred eeeecccCceEEEEEEecC--------CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCc-ceeeccccCCCc
Q 011326 230 GELLGSGSYGFVYEGLTDD--------GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI-VQYLGTDRDEKR 300 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~~--------g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~ 300 (488)
.+.|..|-...+|+....+ +..+++++........ -+..+|..+++.+...++ .++++.+.
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~------idR~~E~~~l~~L~~~gi~P~l~~~~~---- 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF------YDSKVELDVFRYLSNINIAPNIIADFP---- 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC------CCHHHHHHHHHHHHHTTSSCCEEEEET----
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh------cCHHHHHHHHHHHHhcCCCCCEEEEcC----
Confidence 4667889999999987653 5789999864322111 122467777776643233 44554332
Q ss_pred eEEEEeeccCCCh
Q 011326 301 LCIFLELVTKGSL 313 (488)
Q Consensus 301 ~~lV~E~~~~gsL 313 (488)
-++||||++|.+|
T Consensus 145 ~~~I~efI~G~~l 157 (424)
T 3mes_A 145 EGRIEEFIDGEPL 157 (424)
T ss_dssp TEEEEECCCSEEC
T ss_pred CCEEEEEeCCccC
Confidence 2789999998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.34 E-value=0.09 Score=53.54 Aligned_cols=28 Identities=29% Similarity=0.453 Sum_probs=24.4
Q ss_pred CccccCCcccEEE------CCCCcEEEeecCCcc
Q 011326 346 VVHRDIKCANILV------DASGSVKLADFGLAK 373 (488)
Q Consensus 346 iiHrDLkp~NILl------~~~~~vkL~DFGla~ 373 (488)
++|+|+.+.|||+ +.+..+.++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6899999999999 456789999999874
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.43 E-value=1.6 Score=40.35 Aligned_cols=115 Identities=8% Similarity=0.054 Sum_probs=78.6
Q ss_pred CCCCcceeeccccCCCceEEEEeeccCC-ChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC
Q 011326 284 EHDNIVQYLGTDRDEKRLCIFLELVTKG-SLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG 362 (488)
Q Consensus 284 ~HpnIv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~ 362 (488)
.||++++. .+-.+++.+.+.++.-+.+ ++.. -..++....++++.+|+....++ ..-+|--|+|+|++++.++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~---ik~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~ 116 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN---IKSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDG 116 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG---GGGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTS
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH---HHhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCC
Confidence 68888877 4666667776666654432 3332 23478888899999998877444 3457778999999999999
Q ss_pred cEEEeecCCcccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 011326 363 SVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYS 426 (488)
Q Consensus 363 ~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~ 426 (488)
.+++.=.|+-.. ++|. ..+...=.-.+=+++..+++++..|.
T Consensus 117 ~p~i~~RGik~~---------------l~P~-------~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 117 LPIAKTRGLQNV---------------VDPL-------PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CEEESCCEETTT---------------BSCC-------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CEEEEEccCccC---------------CCCC-------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999997775321 1222 12333334457888899999988874
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.42 E-value=2.4 Score=39.39 Aligned_cols=114 Identities=10% Similarity=0.074 Sum_probs=76.7
Q ss_pred CCCCcceeeccccCCCceEEEEeeccCC-ChHHHHhhhccChhhhhHHHHHHHHHHH-HHHHCCCccccCCcccEEECCC
Q 011326 284 EHDNIVQYLGTDRDEKRLCIFLELVTKG-SLASLYQKYHLSDSQVSSYTRQILNGLK-YLHEQNVVHRDIKCANILVDAS 361 (488)
Q Consensus 284 ~HpnIv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~ls~~~~~~i~~qi~~aL~-yLH~~giiHrDLkp~NILl~~~ 361 (488)
.||++ -..+-.+++.+.+.++.-+++ ++..+ ..++....++++.+|+.... ++ ..-+|--|+|+||+++.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence 68888 334446777777777765443 33332 45788888998888887655 44 455778899999999999
Q ss_pred CcEEEeecCCcccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 011326 362 GSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYS 426 (488)
Q Consensus 362 ~~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~ 426 (488)
+.+++.-.|+-. -++|.. .+...=.-.+=+++..++.++..|.
T Consensus 121 ~~p~i~hRGi~~---------------~lpP~e-------~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 121 LEPFFLHVGVKE---------------SLPPDE-------WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CCEEESCCEETT---------------TBSSCS-------CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred CcEEEEEcCCcc---------------cCCCCC-------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999777532 223322 2222333457788888888877663
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 488 | ||||
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-77 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-77 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-77 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-76 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-74 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-72 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-71 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-70 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-70 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-69 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-69 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-68 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-68 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-67 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-65 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-63 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-63 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-61 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-61 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-59 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-59 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-59 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-58 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-57 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-57 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-57 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-56 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-56 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-55 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-55 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-54 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-54 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-53 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-52 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-50 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-49 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-48 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-46 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-43 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-34 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-22 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (619), Expect = 1e-77
Identities = 88/288 (30%), Positives = 149/288 (51%), Gaps = 15/288 (5%)
Query: 206 EIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGP 264
EI+E ++ G +++ + + E +G G+ G VY + G A+++++LQ +
Sbjct: 4 EILEKLRSIVSVGDPKKK---YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK 60
Query: 265 RGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSD 324
+ + EI ++ + ++ NIV YL + L + +E + GSL + + + +
Sbjct: 61 KE-----LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE 115
Query: 325 SQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--S 382
Q+++ R+ L L++LH V+HRDIK NIL+ GSVKL DFG T K +
Sbjct: 116 GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175
Query: 383 CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL 442
GT +WMAPE + + YG DIWSLG +EM+ PY + +A++ I
Sbjct: 176 MVGTPYWMAPE--VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 233
Query: 443 PPV--PNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
P + P LS +DF+ +CL ++ R +A +L++H F+K SS
Sbjct: 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSS 281
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (617), Expect = 3e-77
Identities = 89/266 (33%), Positives = 138/266 (51%), Gaps = 15/266 (5%)
Query: 227 WQKGELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
W+ LG G++G VY+ + A K + + E + + EI +L +H
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-----EELEDYMVEIDILASCDH 68
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHE 343
NIV+ L E L I +E G++ ++ + L++SQ+ +Q L+ L YLH+
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTAFWMAPEVV---NLK 398
++HRD+K NIL G +KLADFG++ T+ S GT +WMAPEVV K
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 399 KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPV--PNSLSRDAQDF 456
Y AD+WSLG T++EM P+ L + + KI E P + P+ S + +DF
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248
Query: 457 ILKCLQVNPNDRPTAAQLMEHPFIKR 482
+ KCL+ N + R T +QL++HPF+
Sbjct: 249 LKKCLEKNVDARWTTSQLLQHPFVTV 274
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (613), Expect = 4e-77
Identities = 71/257 (27%), Positives = 125/257 (48%), Gaps = 7/257 (2%)
Query: 227 WQKGELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++ G LG G +G VY F A+K + G + QL +E+ + H
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSHLRH 65
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQ 344
NI++ G D R+ + LE G++ QK + + ++Y ++ N L Y H +
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGL 404
V+HRDIK N+L+ ++G +K+ADFG + + + GT ++ PE+ ++ +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM--IEGRMHDE 183
Query: 405 TADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVN 464
D+WSLG E L + P+ + +I E P+ ++ A+D I + L+ N
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHN 242
Query: 465 PNDRPTAAQLMEHPFIK 481
P+ RP +++EHP+I
Sbjct: 243 PSQRPMLREVLEHPWIT 259
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 239 bits (611), Expect = 4e-76
Identities = 83/266 (31%), Positives = 130/266 (48%), Gaps = 8/266 (3%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+ +G GS+G VY + A+K++S G + + + +E+ L + H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLA-SLYQKYHLSDSQVSSYTRQILNGLKYLHEQ 344
N +QY G E + +E + K L + ++++ T L GL YLH
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDG-YG 403
N++HRD+K NIL+ G VKL DFG A M S GT +WMAPEV+ +G Y
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSAS--IMAPANSFVGTPYWMAPEVILAMDEGQYD 192
Query: 404 LTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNS-LSRDAQDFILKCLQ 462
D+WSLG T +E+ R+ P ++ A++ I E P + + S ++F+ CLQ
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 252
Query: 463 VNPNDRPTAAQLMEHPFIKRPLQTSS 488
P DRPT+ L++H F+ R +
Sbjct: 253 KIPQDRPTSEVLLKHRFVLRERPPTV 278
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 8e-74
Identities = 80/273 (29%), Positives = 130/273 (47%), Gaps = 20/273 (7%)
Query: 223 RITSWQKGELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLG 281
R ++ +G+GSYG + DG KE+ KQ ++ E++LL
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS---EVNLLR 58
Query: 282 QFEHDNIVQYL--GTDRDEKRLCIFLELVTKGSLASLYQKY-----HLSDSQVSSYTRQI 334
+ +H NIV+Y DR L I +E G LAS+ K +L + V Q+
Sbjct: 59 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118
Query: 335 LNGLKYLHEQN-----VVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTA 387
LK H ++ V+HRD+K AN+ +D +VKL DFGLA+ + K+ GT
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTP 178
Query: 388 FWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPN 447
++M+PE + + Y +DIWSLGC + E+ P++ + KI G+ +P
Sbjct: 179 YYMSPEQ--MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 236
Query: 448 SLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480
S + + I + L + RP+ +++E+P I
Sbjct: 237 RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 2e-72
Identities = 64/270 (23%), Positives = 116/270 (42%), Gaps = 13/270 (4%)
Query: 227 WQKGELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
W + LG G+YG V AVK V ++ R +++EI + H
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK----RAVDCPENIKKEICINKMLNH 62
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYLHEQ 344
+N+V++ G R+ +FLE + G L + + + + Q++ G+ YLH
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKD 400
+ HRDIK N+L+D ++K++DFGLA N+ + GT ++APE++ +++
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RRE 181
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKI--GGGELPPVPNSLSRDAQDFIL 458
+ D+WS G + ML P+ + + +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 459 KCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
K L NP+ R T + + + +PL+ +
Sbjct: 242 KILVENPSARITIPDIKKDRWYNKPLKKGA 271
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 2e-71
Identities = 75/279 (26%), Positives = 141/279 (50%), Gaps = 23/279 (8%)
Query: 214 VSPNGKFRRRITSWQKGELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQ 272
+S +G+F + +G GS+ VY+G T+ A E+ + +Q +
Sbjct: 4 MSNDGRFLKF------DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---R 54
Query: 273 LEQEISLLGQFEHDNIVQYLG----TDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQV 327
++E +L +H NIV++ T + +K + + EL+T G+L + +++ + +
Sbjct: 55 FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVL 114
Query: 328 SSYTRQILNGLKYLHEQN--VVHRDIKCANILVDA-SGSVKLADFGLAKATTMNDVKSCK 384
S+ RQIL GL++LH + ++HRD+KC NI + +GSVK+ D GLA + K+
Sbjct: 115 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI 174
Query: 385 GTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKI--GGGEL 442
GT +MAPE+ + Y + D+++ G +LEM T +PYS + +++ G +
Sbjct: 175 GTPEFMAPEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 231
Query: 443 PPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
+ ++ I C++ N ++R + L+ H F +
Sbjct: 232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 225 bits (575), Expect = 3e-70
Identities = 72/264 (27%), Positives = 130/264 (49%), Gaps = 16/264 (6%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+ E LGSG++G V+ + G F K ++ ++ EIS++ Q H
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-----LDKYTVKNEISIMNQLHH 85
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHE 343
++ D+ + + LE ++ G L Y +S+++V +Y RQ GLK++HE
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 344 QNVVHRDIKCANILVDA--SGSVKLADFGLAKATTMNDVKSC-KGTAFWMAPEVVNLKKD 400
++VH DIK NI+ + + SVK+ DFGLA +++ TA + APE+ + ++
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI--VDRE 203
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL---PPVPNSLSRDAQDFI 457
G D+W++G +L+ P++ + + + + + +S+S +A+DFI
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263
Query: 458 LKCLQVNPNDRPTAAQLMEHPFIK 481
LQ P R T +EHP++K
Sbjct: 264 KNLLQKEPRKRLTVHDALEHPWLK 287
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (568), Expect = 3e-70
Identities = 66/264 (25%), Positives = 124/264 (46%), Gaps = 18/264 (6%)
Query: 226 SWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
G+ +GSGS+G VY+G AVK +++ P+ Q + E+ +L + H
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQ---AFKNEVGVLRKTRH 63
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHE 343
NI+ ++G +L I + SL ++ RQ G+ YLH
Sbjct: 64 VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKK 399
++++HRD+K NI + +VK+ DFGLA + + G+ WMAPEV+ ++
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 400 DG-YGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG-----ELPPVPNSLSRDA 453
Y +D+++ G + E++T + PYS++ + + G +L V ++ +
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 454 QDFILKCLQVNPNDRPTAAQLMEH 477
+ + +CL+ ++RP Q++
Sbjct: 243 KRLMAECLKKKRDERPLFPQILAS 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 224 bits (571), Expect = 1e-69
Identities = 74/265 (27%), Positives = 115/265 (43%), Gaps = 16/265 (6%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+ E LG+G++G V+ G FA K V E + +EI + H
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-----SDKETVRKEIQTMSVLRH 82
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHE 343
+V D+ + + E ++ G L H +S+ + Y RQ+ GL ++HE
Sbjct: 83 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 344 QNVVHRDIKCANILV--DASGSVKLADFGLAK-ATTMNDVKSCKGTAFWMAPEVVNLKKD 400
N VH D+K NI+ S +KL DFGL VK GTA + APEV +
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV--AEGK 200
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL---PPVPNSLSRDAQDFI 457
G D+WS+G +L+ P+ + + + + + +S D +DFI
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260
Query: 458 LKCLQVNPNDRPTAAQLMEHPFIKR 482
K L +PN R T Q +EHP++
Sbjct: 261 RKLLLADPNTRMTIHQALEHPWLTP 285
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 219 bits (559), Expect = 8e-69
Identities = 74/271 (27%), Positives = 125/271 (46%), Gaps = 15/271 (5%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQ----EISLLG 281
++ E+LG G V + +AVK + + G + + +L + E+ +L
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 282 QF-EHDNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLK 339
+ H NI+Q T + +L+ KG L L +K LS+ + R +L +
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124
Query: 340 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VKSCKGTAFWMAPEVV--- 395
LH+ N+VHRD+K NIL+D ++KL DFG + + ++ GT ++APE++
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 184
Query: 396 -NLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL---PPVPNSLSR 451
N GYG D+WS G + +L P+ H + + I G P + S
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 244
Query: 452 DAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
+D + + L V P R TA + + HPF ++
Sbjct: 245 TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 1e-68
Identities = 79/302 (26%), Positives = 136/302 (45%), Gaps = 52/302 (17%)
Query: 227 WQKGELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++K LG+G+ G V++ G A K + L+ + Q+ +E+ +L +
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----PAIRNQIIRELQVLHECNS 63
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQ 344
IV + G + + I +E + GSL + +K + + + + ++ GL YL E+
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 345 N-VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYG 403
+ ++HRD+K +NILV++ G +KL DFG++ + S GT +M+PE L+ Y
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPER--LQGTHYS 181
Query: 404 LTADIWSLGCTVLEMLTRRHPYSH------------------------------------ 427
+ +DIWS+G +++EM R+P
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 428 ------LEGGQAMFKIGGGELPPVPNS-LSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480
+ + + I P +P+ S + QDF+ KCL NP +R QLM H FI
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
Query: 481 KR 482
KR
Sbjct: 302 KR 303
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 3e-68
Identities = 65/271 (23%), Positives = 120/271 (44%), Gaps = 17/271 (6%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+ E LG G +G V+ + T + K V ++ +++EIS+L H
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV------LVKKEISILNIARH 60
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHE 343
NI+ + + L + E ++ + + L++ ++ SY Q+ L++LH
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 344 QNVVHRDIKCANILVDASGS--VKLADFGLAKATTMND-VKSCKGTAFWMAPEVVNLKKD 400
N+ H DI+ NI+ S +K+ +FG A+ D + + APEV + D
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV--HQHD 178
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL---PPVPNSLSRDAQDFI 457
D+WSLG V +L+ +P+ Q + I E +S +A DF+
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238
Query: 458 LKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
+ L R TA++ ++HP++K+ ++ S
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLKQKIERVS 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 2e-67
Identities = 61/268 (22%), Positives = 124/268 (46%), Gaps = 11/268 (4%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISL 279
++R ++ G++LG GS+ V +A+K + + + + + +E +
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDV 61
Query: 280 LGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGL 338
+ + +H V+ T +D+++L L G L +K ++ YT +I++ L
Sbjct: 62 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 121
Query: 339 KYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEV 394
+YLH + ++HRD+K NIL++ +++ DFG AK + S GTA +++PE+
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 395 VNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQ 454
L + ++D+W+LGC + +++ P+ KI E P A+
Sbjct: 182 --LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKAR 238
Query: 455 DFILKCLQVNPNDRPTAAQLMEHPFIKR 482
D + K L ++ R ++ + +K
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 209 bits (534), Expect = 8e-65
Identities = 70/264 (26%), Positives = 123/264 (46%), Gaps = 15/264 (5%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+ ++LG+G++ V A+K ++ + + +E EI++L + +H
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL----EGKEGSMENEIAVLHKIKH 66
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYLHEQ 344
NIV L + ++LV+ G L + +K ++ S Q+L+ +KYLH+
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 345 NVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDV-KSCKGTAFWMAPEVVNLKKD 400
+VHRD+K N+L D + ++DFGL+K V + GT ++APEV L +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV--LAQK 184
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL---PPVPNSLSRDAQDFI 457
Y D WS+G +L P+ + +I E P + +S A+DFI
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 244
Query: 458 LKCLQVNPNDRPTAAQLMEHPFIK 481
++ +P R T Q ++HP+I
Sbjct: 245 RHLMEKDPEKRFTCEQALQHPWIA 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 3e-64
Identities = 69/260 (26%), Positives = 121/260 (46%), Gaps = 9/260 (3%)
Query: 227 WQKGELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+ ++LG GS+G V+ FFA+K + +E+ + L +EH
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV-LSLAWEH 62
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYLHEQ 344
+ T + ++ L +E + G L + + S+ + Y +I+ GL++LH +
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTAFWMAPEVVNLKKDGY 402
+V+RD+K NIL+D G +K+ADFG+ K + D K + GT ++APE+ L Y
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI--LLGQKY 180
Query: 403 GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQ 462
+ D WS G + EML + P+ + + I P P L ++A+D ++K
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVKLFV 239
Query: 463 VNPNDRPTAA-QLMEHPFIK 481
P R + +HP +
Sbjct: 240 REPEKRLGVRGDIRQHPLFR 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 2e-63
Identities = 58/254 (22%), Positives = 107/254 (42%), Gaps = 14/254 (5%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
+ LG+G +G V G + A+K + G S + +E ++ H+ +V
Sbjct: 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIK------EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASL--YQKYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
Q G ++ + I E + G L + ++ Q+ + + ++YL + +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122
Query: 348 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTAFWMAPEVVNLKKDGYGL 404
HRD+ N LV+ G VK++DFGL++ ++ S K W PEV+ K +
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--FSS 180
Query: 405 TADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQV 463
+DIW+ G + E+ + + PY + I G P+ S + C
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHE 240
Query: 464 NPNDRPTAAQLMEH 477
++RPT L+ +
Sbjct: 241 KADERPTFKILLSN 254
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 206 bits (526), Expect = 6e-63
Identities = 71/268 (26%), Positives = 128/268 (47%), Gaps = 11/268 (4%)
Query: 224 ITSWQKGELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLE-QEISLLG 281
+ + ++G G +G VY D G +A+K + + + +++ E +SL+
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 282 QFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKY 340
+ IV +L L+L+ G L L Q S++ + Y +I+ GL++
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKD 400
+H + VV+RD+K ANIL+D G V+++D GLA + + GT +MAPEV+ K
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL-QKGV 181
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPYSH--LEGGQAMFKIGGGELPPVPNSLSRDAQDFIL 458
Y +AD +SLGC + ++L P+ + + ++ +P+S S + + +
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241
Query: 459 KCLQVNPNDRPT-----AAQLMEHPFIK 481
LQ + N R A ++ E PF +
Sbjct: 242 GLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 3e-62
Identities = 71/262 (27%), Positives = 120/262 (45%), Gaps = 15/262 (5%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGK-QSILQLEQEISLLGQF- 283
+Q G LLGSG +G VY G+ D A+K V G+ + ++ E+ LL +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 284 -EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLY--QKYHLSDSQVSSYTRQILNGLKY 340
+++ L + LE + ++ L + S+ Q+L +++
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 341 LHEQNVVHRDIKCANILVDAS-GSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKK 399
H V+HRDIK NIL+D + G +KL DFG GT + PE + +
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 185
Query: 400 DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILK 459
+G +A +WSLG + +M+ P+ H E +I G++ +S + Q I
Sbjct: 186 -YHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF-FRQRVSSECQHLIRW 237
Query: 460 CLQVNPNDRPTAAQLMEHPFIK 481
CL + P+DRPT ++ HP+++
Sbjct: 238 CLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 3e-62
Identities = 66/255 (25%), Positives = 110/255 (43%), Gaps = 16/255 (6%)
Query: 228 QKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
+ + +G G +G V G G AVK + + + E S++ Q H N
Sbjct: 10 KLLQTIGKGEFGDVMLG-DYRGNKVAVKCI-------KNDATAQAFLAEASVMTQLRHSN 61
Query: 288 IVQYLGTDRDEK-RLCIFLELVTKGSLASLYQKYH---LSDSQVSSYTRQILNGLKYLHE 343
+VQ LG +EK L I E + KGSL + L + ++ + ++YL
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYG 403
N VHRD+ N+LV K++DFGL K + + + K W APE L++ +
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-STQDTGKLPVKWTAPEA--LREKKFS 178
Query: 404 LTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQ 462
+D+WS G + E+ + R PY + + ++ G P+ + + C
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWH 238
Query: 463 VNPNDRPTAAQLMEH 477
++ RP+ QL E
Sbjct: 239 LDAAMRPSFLQLREQ 253
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 1e-61
Identities = 57/254 (22%), Positives = 105/254 (41%), Gaps = 14/254 (5%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
+ +GSG +G V+ G + A+K + G S +E ++ + H +V
Sbjct: 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIR------EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVV 347
Q G ++ +C+ E + G L+ + + + + G+ YL E V+
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123
Query: 348 HRDIKCANILVDASGSVKLADFGLAKA---TTMNDVKSCKGTAFWMAPEVVNLKKDGYGL 404
HRD+ N LV + +K++DFG+ + K W +PEV + + Y
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSS 181
Query: 405 TADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQV 463
+D+WS G + E+ + + PY + + + I G P S + C +
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKE 241
Query: 464 NPNDRPTAAQLMEH 477
P DRP ++L+
Sbjct: 242 RPEDRPAFSRLLRQ 255
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-61
Identities = 73/266 (27%), Positives = 129/266 (48%), Gaps = 13/266 (4%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQD-EGPRGKQSILQLEQEISLLGQFE 284
+ GE LGSG + V + G +A K + + + R S +E+E+S+L + +
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 285 HDNIVQYLGTDRDEKRLCIFLELVTKGSLASLY-QKYHLSDSQVSSYTRQILNGLKYLHE 343
H N++ ++ + + LELV G L +K L++ + + + +QILNG+ YLH
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 344 QNVVHRDIKCANILVDASGS----VKLADFGLAKATTMND-VKSCKGTAFWMAPEVVNLK 398
+ H D+K NI++ +K+ DFGLA + K+ GT ++APE+ +
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI--VN 189
Query: 399 KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL---PPVPNSLSRDAQD 455
+ GL AD+WS+G +L+ P+ + + + ++ S A+D
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 249
Query: 456 FILKCLQVNPNDRPTAAQLMEHPFIK 481
FI + L +P R T ++HP+IK
Sbjct: 250 FIRRLLVKDPKKRMTIQDSLQHPWIK 275
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 3e-61
Identities = 68/262 (25%), Positives = 113/262 (43%), Gaps = 19/262 (7%)
Query: 233 LGSGSYGFVYEGL---TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
LGSG++G V +G AVK + + P K +L E +++ Q ++ IV
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA---EANVMQQLDNPYIV 71
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVH 348
+ +G E + +E+ G L L Q H+ D + Q+ G+KYL E N VH
Sbjct: 72 RMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 349 RDIKCANILVDASGSVKLADFGLAKA-----TTMNDVKSCKGTAFWMAPEVVNLKKDGYG 403
RD+ N+L+ K++DFGL+KA K W APE + +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC--INYYKFS 188
Query: 404 LTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQ 462
+D+WS G + E + + PY ++G + + GE P R+ D + C
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWT 248
Query: 463 VNPNDRPTAAQL---MEHPFIK 481
+ +RP A + + + +
Sbjct: 249 YDVENRPGFAAVELRLRNYYYD 270
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 5e-61
Identities = 69/263 (26%), Positives = 119/263 (45%), Gaps = 21/263 (7%)
Query: 233 LGSGSYGFVYEG---LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
LG G++G V +G + A+K + E K ++ +E ++ Q ++ IV
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE----KADTEEMMREAQIMHQLDNPYIV 72
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLY--QKYHLSDSQVSSYTRQILNGLKYLHEQNVV 347
+ +G + E L + +E+ G L ++ + S V+ Q+ G+KYL E+N V
Sbjct: 73 RLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 348 HRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTAFWMAPEVVNLKKDGY 402
HRD+ N+L+ K++DFGL+KA +D + K W APE +N +K +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--F 189
Query: 403 GLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCL 461
+D+WS G T+ E L+ + PY ++G + M I G+ P + + C
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCW 249
Query: 462 QVNPNDRPTAAQL---MEHPFIK 481
DRP + M +
Sbjct: 250 IYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 5e-60
Identities = 70/262 (26%), Positives = 114/262 (43%), Gaps = 19/262 (7%)
Query: 228 QKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
+ E LG+G +G V+ G + AVK + P E +L+ Q +H
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD------AFLAEANLMKQLQHQR 69
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQ 344
+V+ E + I E + GSL + L+ +++ QI G+ ++ E+
Sbjct: 70 LVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAK---ATTMNDVKSCKGTAFWMAPEVVNLKKDG 401
N +HRD++ ANILV + S K+ADFGLA+ + K W APE +N
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 402 YGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460
+D+WS G + E++T R PY + + + + G P++ + + C
Sbjct: 189 I--KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246
Query: 461 LQVNPNDRPTAAQLM---EHPF 479
+ P DRPT L E F
Sbjct: 247 WKERPEDRPTFDYLRSVLEDFF 268
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-59
Identities = 69/263 (26%), Positives = 114/263 (43%), Gaps = 18/263 (6%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
LG G +G V+ G + A+K + P QE ++ + H+ +V
Sbjct: 22 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE------AFLQEAQVMKKLRHEKLV 75
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQNV 346
Q +E + I E ++KGSL + +L Q+ QI +G+ Y+ N
Sbjct: 76 QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134
Query: 347 VHRDIKCANILVDASGSVKLADFGLAKATTMNDV---KSCKGTAFWMAPEVVNLKKDGYG 403
VHRD++ ANILV + K+ADFGLA+ N+ + K W APE + +
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FT 192
Query: 404 LTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQ 462
+ +D+WS G + E+ T+ R PY + + + ++ G P P D + +C +
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR 252
Query: 463 VNPNDRPTAAQLME--HPFIKRP 483
P +RPT L +
Sbjct: 253 KEPEERPTFEYLQAFLEDYFTST 275
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 3e-59
Identities = 75/264 (28%), Positives = 118/264 (44%), Gaps = 18/264 (6%)
Query: 227 WQKGELLGSGSYGFVYEG----LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQ 282
+ E LG GS+G V G + AVK L+ + +++ +E++ +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKC--LKPDVLSQPEAMDDFIREVNAMHS 67
Query: 283 FEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKY 340
+H N+++ G + + EL GSL +K+ H +S Y Q+ G+ Y
Sbjct: 68 LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTAFWMAPEVV 395
L + +HRD+ N+L+ VK+ DFGL +A ND + K W APE
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES- 185
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIG-GGELPPVPNSLSRDA 453
LK + +D W G T+ EM T + P+ L G Q + KI GE P P +D
Sbjct: 186 -LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244
Query: 454 QDFILKCLQVNPNDRPTAAQLMEH 477
+ +++C P DRPT L +
Sbjct: 245 YNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 195 bits (496), Expect = 5e-59
Identities = 66/262 (25%), Positives = 122/262 (46%), Gaps = 13/262 (4%)
Query: 227 WQKGELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+Q LG+GS+G V+ +G ++A+K + + + + E +L H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTH 63
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQ-KYHLSDSQVSSYTRQILNGLKYLHEQ 344
I++ GT +D +++ + ++ + G L SL + + Y ++ L+YLH +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGL 404
++++RD+K NIL+D +G +K+ DFG AK + + GT ++APEV + Y
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTYTLCGTPDYIAPEV--VSTKPYNK 180
Query: 405 TADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVN 464
+ D WS G + EML P+ + KI EL P + D +D + + + +
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF-PPFFNEDVKDLLSRLITRD 239
Query: 465 PNDR-----PTAAQLMEHPFIK 481
+ R + HP+ K
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFK 261
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 5e-59
Identities = 66/282 (23%), Positives = 114/282 (40%), Gaps = 32/282 (11%)
Query: 231 ELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
+ LG G + VY+ + A+K++ L +EI LL + H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 290 QYLGTDRDEKRLCIFLELVTKGSLASLYQ-KYHLSDSQVSSYTRQILNGLKYLHEQNVVH 348
L + + + + + + L+ S + +Y L GL+YLH+ ++H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123
Query: 349 RDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTA 406
RD+K N+L+D +G +KLADFGLAK+ + T ++ APE++ YG+
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF-GARMYGVGV 182
Query: 407 DIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP---------------------- 444
D+W++GC + E+L R + +I P
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242
Query: 445 -----VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
+ ++ D D I NP R TA Q ++ +
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-58
Identities = 70/258 (27%), Positives = 114/258 (44%), Gaps = 17/258 (6%)
Query: 230 GELLGSGSYGFVYEGL----TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
G +G G +G V++G+ + A+K + QE + QF+H
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS----DSVREKFLQEALTMRQFDH 67
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHE 343
+IV+ +G E + I +EL T G L S Q L + + Y Q+ L YL
Sbjct: 68 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK---SCKGTAFWMAPEVVNLKKD 400
+ VHRDI N+LV ++ VKL DFGL++ + K WMAPE +N ++
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 185
Query: 401 GYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILK 459
+ +D+W G + E+L P+ ++ + +I GE P+P + + K
Sbjct: 186 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 244
Query: 460 CLQVNPNDRPTAAQLMEH 477
C +P+ RP +L
Sbjct: 245 CWAYDPSRRPRFTELKAQ 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (486), Expect = 8e-58
Identities = 68/270 (25%), Positives = 114/270 (42%), Gaps = 22/270 (8%)
Query: 230 GELLGSGSYGFVYEG----LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+++G+G +G V G F A+K + ++ E S++GQF+H
Sbjct: 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT----EKQRRDFLSEASIMGQFDH 86
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHE 343
N++ G + I E + GSL S ++ + Q+ R I G+KYL +
Sbjct: 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD 146
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAKA-------TTMNDVKSCKGTAFWMAPEVVN 396
N VHRD+ NILV+++ K++DFGL++ T K W APE
Sbjct: 147 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA-- 204
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455
++ + +D+WS G + E+++ PY + + I P P
Sbjct: 205 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 264
Query: 456 FILKCLQVNPNDRPTAAQLMEH--PFIKRP 483
+L C Q + N RP Q++ I+ P
Sbjct: 265 LMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-57
Identities = 73/264 (27%), Positives = 123/264 (46%), Gaps = 14/264 (5%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+ +LLG G++G V G ++A+K + E K + E +L H
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK--EVIIAKDEVAHTVTESRVLQNTRH 64
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSSYTRQILNGLKYLHEQ 344
+ + RLC +E G L L ++ ++ + Y +I++ L+YLH +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTAFWMAPEVVNLKKDGY 402
+VV+RDIK N+++D G +K+ DFGL K + GT ++APEV L+ + Y
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV--LEDNDY 182
Query: 403 GLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQ 462
G D W LG + EM+ R P+ + + + I E+ P +LS +A+ + L+
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF-PRTLSPEAKSLLAGLLK 241
Query: 463 VNPNDRP-----TAAQLMEHPFIK 481
+P R A ++MEH F
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 3e-57
Identities = 79/291 (27%), Positives = 123/291 (42%), Gaps = 38/291 (13%)
Query: 227 WQKGELLGSGSYGFVYEG--LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE 284
++ +G G+YG V++ L + G F A+K V +Q S ++ + L FE
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 285 HDNIVQYLG-----TDRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNG 337
H N+V+ E +L + E V + L + + + Q+L G
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 128
Query: 338 LKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA-TTMNDVKSCKGTAFWMAPEVVN 396
L +LH VVHRD+K NILV +SG +KLADFGLA+ + + S T ++ APEV
Sbjct: 129 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV-- 186
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKI------------------- 437
L + Y D+WS+GC EM R+ + + KI
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 438 -------GGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
+ + +D +LKCL NP R +A + HP+ +
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 3e-57
Identities = 70/275 (25%), Positives = 120/275 (43%), Gaps = 30/275 (10%)
Query: 230 GELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
++LG G G V + FA+K + + E E+ + +I
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVEL-HWRASQCPHI 67
Query: 289 VQYLGT----DRDEKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYL 341
V+ + K L I +E + G L S Q ++ + S + I ++YL
Sbjct: 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127
Query: 342 HEQNVVHRDIKCANILVDA---SGSVKLADFGLAK-ATTMNDVKSCKGTAFWMAPEVVNL 397
H N+ HRD+K N+L + + +KL DFG AK T+ N + + T +++APEV L
Sbjct: 128 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--L 185
Query: 398 KKDGYGLTADIWSLGCTVLEMLTRRHPY------SHLEGGQAMFKIGGGELP-PVPNSLS 450
+ Y + D+WSLG + +L P+ + G + ++G E P P + +S
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245
Query: 451 RDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485
+ + I L+ P R T + M HP+I + +
Sbjct: 246 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 187 bits (475), Expect = 2e-56
Identities = 64/269 (23%), Positives = 110/269 (40%), Gaps = 18/269 (6%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++ GE+LG G V+ AVK + R L+ +E H
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA--RDPSFYLRFRREAQNAAALNH 66
Query: 286 DNIVQYLGTDRDE----KRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKY 340
IV T E I +E V +L + ++ + L +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGLAK-----ATTMNDVKSCKGTAFWMAPEVV 395
H+ ++HRD+K ANI++ A+ +VK+ DFG+A+ ++ + GTA +++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ- 185
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP---VPNSLSRD 452
+ D +D++SLGC + E+LT P++ ++ + P LS D
Sbjct: 186 -ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244
Query: 453 AQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
+LK L NP +R A M ++
Sbjct: 245 LDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 3e-56
Identities = 77/286 (26%), Positives = 135/286 (47%), Gaps = 19/286 (6%)
Query: 213 NVSPNGKFRRRITSWQKGELLGSGSYGFVYEG----LTDDGFFFAVKEVSLQDEGPRGKQ 268
N++ + + + I +++ ++LG+G+YG V+ D G +A+K + + K
Sbjct: 13 NLTGHAE-KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT 71
Query: 269 SILQLEQEISLLGQFEH-DNIVQYLGTDRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQ 326
E +L +V + E +L + L+ + G L + L Q+ ++ +
Sbjct: 72 -TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE 130
Query: 327 VSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLA---KATTMNDVKSC 383
V Y +I+ L++LH+ +++RDIK NIL+D++G V L DFGL+ A
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 190
Query: 384 KGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL- 442
GT +MAP++V G+ D WSLG + E+LT P++ + +I L
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 250
Query: 443 --PPVPNSLSRDAQDFILKCLQVNPNDRP-----TAAQLMEHPFIK 481
PP P +S A+D I + L +P R A ++ EH F +
Sbjct: 251 SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 186 bits (472), Expect = 5e-56
Identities = 80/285 (28%), Positives = 131/285 (45%), Gaps = 35/285 (12%)
Query: 228 QKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDN 287
E +G G+YG VY+ + G FA+K++ L+ E + ++ EIS+L + +H N
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSN 61
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSLASL-YQKYHLSDSQVSSYTRQILNGLKYLHEQNV 346
IV+ +KRL + E + + L + L S+ Q+LNG+ Y H++ V
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 347 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTAFWMAPEVVNLKKDGYGL 404
+HRD+K N+L++ G +K+ADFGLA+A + K T ++ AP+V+ + Y
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL-MGSKKYST 180
Query: 405 TADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP-------------------- 444
T DIWS+GC EM+ + + + +I P
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 445 --------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
L D + K L+++PN R TA Q +EH + K
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (473), Expect = 6e-56
Identities = 61/285 (21%), Positives = 113/285 (39%), Gaps = 42/285 (14%)
Query: 228 QKGELLGSGSYGFVYEG------LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLG 281
+ +G G++G V++ + AVK + + ++E +L+
Sbjct: 16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS----ADMQADFQREAALMA 71
Query: 282 QFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-------------------- 321
+F++ NIV+ LG K +C+ E + G L +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 322 -----LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376
LS ++ RQ+ G+ YL E+ VHRD+ N LV + VK+ADFGL++
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 377 MNDVK----SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGG 431
D + WM PE + + Y +D+W+ G + E+ + PY +
Sbjct: 192 SADYYKADGNDAIPIRWMPPES--IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 432 QAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476
+ ++ + G + P + + + + C P DRP+ +
Sbjct: 250 EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 8e-56
Identities = 68/271 (25%), Positives = 117/271 (43%), Gaps = 21/271 (7%)
Query: 228 QKGELLGSGSYGFVYEGLTDDG-----FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQ 282
+ +++G+G +G VY+G+ A+K + ++ + E ++GQ
Sbjct: 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG----YTEKQRVDFLGEAGIMGQ 65
Query: 283 FEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKY 340
F H NI++ G K + I E + G+L ++ S Q+ R I G+KY
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS-----CKGTAFWMAPEVV 395
L N VHRD+ NILV+++ K++DFGL++ + + K W APE +
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 396 NLKKDGYGLTADIWSLGCTVLEMLTRRHPYSH-LEGGQAMFKIGGGELPPVPNSLSRDAQ 454
+ +K +D+WS G + E++T L + M I G P P
Sbjct: 186 SYRKFTS--ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY 243
Query: 455 DFILKCLQVNPNDRPTAAQLME--HPFIKRP 483
+++C Q RP A ++ I+ P
Sbjct: 244 QLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 8e-56
Identities = 62/285 (21%), Positives = 110/285 (38%), Gaps = 43/285 (15%)
Query: 230 GELLGSGSYGFVYEGL------TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF 283
G++LGSG++G V T AVK + + + L E+ ++ Q
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD----SSEREALMSELKMMTQL 97
Query: 284 E-HDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH--------------------- 321
H+NIV LG + + E G L + +
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 322 ---LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378
L+ + + Q+ G+++L ++ VHRD+ N+LV VK+ DFGLA+ +
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 379 D----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQA 433
+ + WMAPE +L + Y + +D+WS G + E+ + +PY +
Sbjct: 218 SNYVVRGNARLPVKWMAPE--SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 434 MFKI-GGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
+K+ G P + + + C + RP+ L
Sbjct: 276 FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 185 bits (470), Expect = 1e-55
Identities = 72/267 (26%), Positives = 120/267 (44%), Gaps = 18/267 (6%)
Query: 230 GELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI 288
LG G YG VYEG AVK + + + +E +++ + +H N+
Sbjct: 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNL 75
Query: 289 VQYLGTDRDEKRLCIFLELVTKGSLASLYQ---KYHLSDSQVSSYTRQILNGLKYLHEQN 345
VQ LG E I E +T G+L + + +S + QI + ++YL ++N
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135
Query: 346 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAF---WMAPEVVNLKKDGY 402
+HRD+ N LV + VK+ADFGL++ T + + G F W APE L + +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES--LAYNKF 193
Query: 403 GLTADIWSLGCTVLEMLTRRH-PYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCL 461
+ +D+W+ G + E+ T PY ++ Q + P + + C
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 253
Query: 462 QVNPNDRPTAAQLMEHPFIKRPLQTSS 488
Q NP+DRP+ A++ + + Q SS
Sbjct: 254 QWNPSDRPSFAEIHQ--AFETMFQESS 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-55
Identities = 83/288 (28%), Positives = 128/288 (44%), Gaps = 37/288 (12%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+QK E +G G+YG VY+ G A+K++ L E + ++ EISLL + H
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNH 60
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHE 343
NIV+ L E +L + E + + + + + SY Q+L GL + H
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 344 QNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTAFWMAPEVVNLKKDG 401
V+HRD+K N+L++ G++KLADFGLA+A + T ++ APE++ L
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL-LGCKY 179
Query: 402 YGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP----------------- 444
Y DIWSLGC EM+TRR + +F+I P
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 445 -----------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
V L D + + + L +PN R +A + HPF +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 4e-55
Identities = 66/267 (24%), Positives = 125/267 (46%), Gaps = 19/267 (7%)
Query: 223 RITSWQKGELLGSGSYGFVYEGL-----TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEI 277
+ T ++K ++LGSG++G VY+GL A+KE+ ++ ++ E
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS----PKANKEILDEA 62
Query: 278 SLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQIL 335
++ ++ ++ + LG + + +L+ G L +++ ++ + ++ QI
Sbjct: 63 YVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 336 NGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMA 391
G+ YL ++ +VHRD+ N+LV VK+ DFGLAK + + K WMA
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 392 PEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLS 450
E + + Y +D+WS G TV E++T PY + + + GE P P +
Sbjct: 182 LESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 239
Query: 451 RDAQDFILKCLQVNPNDRPTAAQLMEH 477
D ++KC ++ + RP +L+
Sbjct: 240 IDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 4e-55
Identities = 61/269 (22%), Positives = 112/269 (41%), Gaps = 25/269 (9%)
Query: 230 GELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDN 287
+++G G++G V + + DG +++ K E+ +L + H N
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPN 72
Query: 288 IVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-----------------LSDSQVSSY 330
I+ LG L + +E G+L +K LS Q+ +
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 331 TRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK-SCKGTAFW 389
+ G+ YL ++ +HRD+ NILV + K+ADFGL++ + K + W
Sbjct: 133 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 192
Query: 390 MAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRH-PYSHLEGGQAMFKIGGGELPPVPNS 448
MA E +N +D+WS G + E+++ PY + + K+ G P +
Sbjct: 193 MAIESLNYSVYTT--NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 250
Query: 449 LSRDAQDFILKCLQVNPNDRPTAAQLMEH 477
+ D + +C + P +RP+ AQ++
Sbjct: 251 CDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 8e-55
Identities = 65/262 (24%), Positives = 111/262 (42%), Gaps = 20/262 (7%)
Query: 230 GELLGSGSYGFVYEGLTDD----GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
E++G G +G VY G D AVK ++ + + Q E ++ F H
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD----IGEVSQFLTEGIIMKDFSH 87
Query: 286 DNIVQYLGTD-RDEKRLCIFLELVTKGSLASLY--QKYHLSDSQVSSYTRQILNGLKYLH 342
N++ LG R E + L + G L + + ++ + + + Q+ G+K+L
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 343 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS------CKGTAFWMAPEVVN 396
+ VHRD+ N ++D +VK+ADFGLA+ + S K WMA E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES-- 205
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTRRH-PYSHLEGGQAMFKIGGGELPPVPNSLSRDAQD 455
L+ + +D+WS G + E++TR PY + + G P +
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 265
Query: 456 FILKCLQVNPNDRPTAAQLMEH 477
+LKC RP+ ++L+
Sbjct: 266 VMLKCWHPKAEMRPSFSELVSR 287
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-54
Identities = 67/301 (22%), Positives = 110/301 (36%), Gaps = 49/301 (16%)
Query: 221 RRRITSWQKGELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISL 279
R + S+ +++G+GS+G VY+ L D G A+K+V +E+ +
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQI 66
Query: 280 LGQFEHDNIVQYL------GTDRDEKRLCIFLELVTKGSLASLYQ----KYHLSDSQVSS 329
+ + +H NIV+ G +DE L + L+ V + K L V
Sbjct: 67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 330 YTRQILNGLKYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVKSCKGTAF 388
Y Q+ L Y+H + HRDIK N+L+D +V KL DFG AK + +
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186
Query: 389 WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPN- 447
+ + Y + D+WS GC + E+L + + G + +I P
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 448 ---------------------------SLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480
+A + L+ P R T + H F
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 481 K 481
Sbjct: 307 D 307
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 4e-54
Identities = 69/309 (22%), Positives = 122/309 (39%), Gaps = 51/309 (16%)
Query: 220 FRRRITSWQKGELLGSGSYGFVYEG-LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEIS 278
F ++ ++K +G G++G V++ G A+K+V +++E + L+ EI
Sbjct: 5 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIK 61
Query: 279 LLGQFEHDNIVQYLGT--------DRDEKRLCIFLELVTKGSLAS-LYQKYHLSDSQVSS 329
+L +H+N+V + +R + + + + + S++
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121
Query: 330 YTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSC 383
+ +LNGL Y+H ++HRD+K AN+L+ G +KLADFGLA+A + N +
Sbjct: 122 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 384 KGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP 443
T ++ PE++ L + YG D+W GC + EM TR + I
Sbjct: 182 VVTLWYRPPELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 444 PVPN-------------------------------SLSRDAQDFILKCLQVNPNDRPTAA 472
P A D I K L ++P R +
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 473 QLMEHPFIK 481
+ H F
Sbjct: 301 DALNHDFFW 309
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 180 bits (457), Expect = 5e-53
Identities = 68/294 (23%), Positives = 122/294 (41%), Gaps = 13/294 (4%)
Query: 195 DDDDSKGHPISEIMEPGNNVSPNGKFRRRITSWQKGELLGSGSYGFVYEGL-TDDGFFFA 253
+ + K + + ++ + + + LG+GS+G V + G +A
Sbjct: 11 EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYA 70
Query: 254 VKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSL 313
+K + Q + I E +L +V+ + +D L + +E V G +
Sbjct: 71 MKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 314 AS-LYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLA 372
S L + S+ Y QI+ +YLH ++++RD+K N+L+D G +++ DFG A
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 373 KATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ 432
K + GT +APE+ + GY D W+LG + EM P+ + Q
Sbjct: 189 KR-VKGRTWTLCGTPEALAPEI--ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
Query: 433 AMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDR-----PTAAQLMEHPFIK 481
KI G++ P+ S D +D + LQV+ R + H +
Sbjct: 246 IYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 6e-53
Identities = 72/296 (24%), Positives = 125/296 (42%), Gaps = 45/296 (15%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
+ +G G+YG V + A+K++S + + + +EI +L +F H
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH----QTYCQRTLREIKILLRFRH 65
Query: 286 DNIVQYLGTDRDE----KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYL 341
+NI+ R + + + L L + HLS+ + + QIL GLKY+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKA-----TTMNDVKSCKGTAFWMAPEVVN 396
H NV+HRD+K +N+L++ + +K+ DFGLA+ + T ++ APE++
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 397 LKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP------------ 444
GY + DIWS+GC + EML+ R + + I G P
Sbjct: 186 -NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 445 ------------------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
+ + A D + K L NP+ R Q + HP++++
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 9e-52
Identities = 69/290 (23%), Positives = 108/290 (37%), Gaps = 50/290 (17%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIV 289
E +G G +G V+ G G AVK S ++E E EI H+NI+
Sbjct: 8 QESIGKGRFGEVWRG-KWRGEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENIL 60
Query: 290 QYLGTDRDE----KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQ- 344
++ D + +L + + GSL +Y ++ + +GL +LH +
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 345 -------NVVHRDIKCANILVDASGSVKLADFGL------AKATTMNDVKSCKGTAFWMA 391
+ HRD+K NILV +G+ +AD GL A T GT +MA
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 392 PEV----VNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFK----------- 436
PEV +N+K ADI+++G E+ R E Q +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 437 -----IGGGELPPVPNSLS-----RDAQDFILKCLQVNPNDRPTAAQLME 476
P +PN R + +C N R TA ++ +
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-51
Identities = 75/287 (26%), Positives = 124/287 (43%), Gaps = 35/287 (12%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++K E +G G+YG V++ + A+K V L D+ S L+ EI LL + +H
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKH 60
Query: 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQ-KYHLSDSQVSSYTRQILNGLKYLHEQ 344
NIV+ +K+L + E + L V S+ Q+L GL + H +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTAFWMAPEVVNLKKDGYG 403
NV+HRD+K N+L++ +G +KLA+FGLA+A + S + W P V Y
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 404 LTADIWSLGCTVLEMLTRRHPY----SHLEGGQAMFKIGG-------------------- 439
+ D+WS GC E+ P + + +F++ G
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 440 -----GELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
L V L+ +D + L+ NP R +A + ++HP+
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-51
Identities = 65/291 (22%), Positives = 108/291 (37%), Gaps = 40/291 (13%)
Query: 230 GELLGSGSYGFVYEGL------TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF 283
G+ LG+G++G V E +D AVK + L E+ +L
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH----LTEREALMSELKVLSYL 83
Query: 284 E-HDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-------------------LS 323
H NIV LG + E G L + ++ L
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 324 DSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS- 382
+ S++ Q+ G+ +L +N +HRD+ NIL+ K+ DFGLA+ +
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 383 ---CKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFK--I 437
+ WMAPE + Y +D+WS G + E+ + + F I
Sbjct: 204 KGNARLPVKWMAPES--IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
Query: 438 GGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
G P + D + C +P RPT Q+++ I++ + S+
Sbjct: 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ--LIEKQISEST 310
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-51
Identities = 68/282 (24%), Positives = 117/282 (41%), Gaps = 34/282 (12%)
Query: 230 GELLGSGSYGFVYEGL------TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF 283
LG GS+G VYEG+ + A+K V+ + ++ E S++ +F
Sbjct: 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS----MRERIEFLNEASVMKEF 80
Query: 284 EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-----------LSDSQVSSYTR 332
++V+ LG + + +EL+T+G L S + S S++
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 333 QILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC----KGTAF 388
+I +G+ YL+ VHRD+ N +V +VK+ DFG+ + D
Sbjct: 141 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 389 WMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPN 447
WM+PE LK + +D+WS G + E+ T PY L Q + + G L P+
Sbjct: 201 WMSPES--LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 258
Query: 448 SLSRDAQDFILKCLQVNPNDRPTAAQLME------HPFIKRP 483
+ + + C Q NP RP+ +++ P +
Sbjct: 259 NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 6e-50
Identities = 70/290 (24%), Positives = 118/290 (40%), Gaps = 39/290 (13%)
Query: 230 GELLGSGSYGFVYEG--------LTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLG 281
G+ LG G++G V + AVK + ++ + L E+ ++
Sbjct: 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMK 73
Query: 282 QF-EHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-----------------HLS 323
+H NI+ LG + L + +E +KG+L Q LS
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 324 DSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--- 380
+ S Q+ G++YL + +HRD+ N+LV +K+ADFGLA+ D
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 381 -KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIG 438
+ + WMAPE L Y +D+WS G + E+ T PY + + +
Sbjct: 194 TTNGRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251
Query: 439 GGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
G P++ + + + C P+ RPT QL+E + R + +S
Sbjct: 252 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTS 299
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 170 bits (431), Expect = 2e-49
Identities = 67/298 (22%), Positives = 118/298 (39%), Gaps = 54/298 (18%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-E 284
+Q LG G Y V+E + + VK + ++++EI +L
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--------PVKKKKIKREIKILENLRG 88
Query: 285 HDNIVQYLGT--DRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLH 342
NI+ D + + E V LYQ L+D + Y +IL L Y H
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCH 146
Query: 343 EQNVVHRDIKCANILVDASG-SVKLADFGLAKATTMNDVKSCK-GTAFWMAPEVVNLKKD 400
++HRD+K N+++D ++L D+GLA+ + + + ++ PE + +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE-LLVDYQ 205
Query: 401 GYGLTADIWSLGCTVLEMLTRRHPY----SHLEGGQAMFKIGGGE--------------- 441
Y + D+WSLGC + M+ R+ P+ + + + K+ G E
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265
Query: 442 ------------------LPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
+ +S +A DF+ K L+ + R TA + MEHP+
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 6e-49
Identities = 66/290 (22%), Positives = 124/290 (42%), Gaps = 41/290 (14%)
Query: 228 QKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286
+ + +GSG+YG V + G A+K++ + + + +E+ LL H+
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK---RAYRELRLLKHMRHE 77
Query: 287 NIVQYLGTDRDEKRLCIFLELVT-----KGSLASLYQKYHLSDSQVSSYTRQILNGLKYL 341
N++ L ++ L F + L L + L + ++ Q+L GL+Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDG 401
H ++HRD+K N+ V+ +K+ DFGLA+ +++ T ++ APEV+ L
Sbjct: 138 HAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEMTGYVVTRWYRAPEVI-LNWMR 195
Query: 402 YGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP----------------- 444
Y T DIWS+GC + EM+T + + + + +I P
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 445 -------------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIK 481
+ + S A + + K L ++ R TA + + HP+ +
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (422), Expect = 1e-48
Identities = 52/284 (18%), Positives = 100/284 (35%), Gaps = 34/284 (11%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++ G +GSGS+G +Y G G A+K ++ + P QL E + +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQG 61
Query: 286 DNIVQYLG-TDRDEKRLCIFLELVTKGSLA-SLYQKYHLSDSQVSSYTRQILNGLKYLHE 343
+ + + + +EL+ + S V Q+++ ++Y+H
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 344 QNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDVKSC---------KGTAFWMA 391
+N +HRD+K N L+ V + DFGLAK GTA + +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 392 PEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGE-------LPP 444
D+ SLG ++ P+ L+ K +
Sbjct: 182 INT--HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 445 VPNSLSRDAQDFILKCLQVNPNDRPTAA---QLMEHPFIKRPLQ 485
+ + ++ C + +D+P + QL + F ++
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-47
Identities = 75/291 (25%), Positives = 128/291 (43%), Gaps = 41/291 (14%)
Query: 228 QKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286
Q +GSG+YG V T G AVK++S + + + +E+ LL +H+
Sbjct: 21 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHE 77
Query: 287 NIVQYLG-----TDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYL 341
N++ L +E + + L ++ + L+D V QIL GLKY+
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 342 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDG 401
H +++HRD+K +N+ V+ +K+ DFGLA+ T T ++ APE++ L
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-TGYVATRWYRAPEIM-LNWMH 195
Query: 402 YGLTADIWSLGCTVLEMLTRRHPY---SHLEGGQAMFKIGGG------------------ 440
Y T DIWS+GC + E+LT R + H++ + + ++ G
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 441 ---------ELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482
V + A D + K L ++ + R TAAQ + H + +
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-46
Identities = 65/293 (22%), Positives = 117/293 (39%), Gaps = 39/293 (13%)
Query: 227 WQKGELLGSGSYGFVYEGL------TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLL 280
+ G+ LG G++G V E T AVK + L E+ +L
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT----HSEHRALMSELKIL 70
Query: 281 GQFEHDNIVQYLG--TDRDEKRLCIFLELVTKGSLASLYQKY-----------------H 321
H V L + L + +E G+L++ +
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 322 LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379
L+ + Y+ Q+ G+++L + +HRD+ NIL+ VK+ DFGLA+ +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 380 --VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFK 436
+ WMAPE + Y + +D+WS G + E+ + PY ++ + +
Sbjct: 191 VRKGDARLPLKWMAPET--IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248
Query: 437 -IGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488
+ G P+ + + +L C P+ RPT ++L+EH + LQ ++
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 299
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 5e-44
Identities = 64/303 (21%), Positives = 122/303 (40%), Gaps = 56/303 (18%)
Query: 228 QKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHD 286
Q + +GSG+ G V A+K++S + + + +E+ L+ H
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKCVNHK 76
Query: 287 NIVQYLG------TDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKY 340
NI+ L T + + + + +EL+ + + ++S Q+L G+K+
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--DHERMSYLLYQMLCGIKH 134
Query: 341 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK-GTAFWMAPEVVNLKK 399
LH ++HRD+K +NI+V + ++K+ DFGLA+ + + + T ++ APE +
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE--VILG 192
Query: 400 DGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVP------------- 446
GY DIWS+GC + EM+ + + + K+ P P
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 447 ----------------------------NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHP 478
+ A+D + K L ++P R + ++HP
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312
Query: 479 FIK 481
+I
Sbjct: 313 YIN 315
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (387), Expect = 2e-43
Identities = 49/274 (17%), Positives = 95/274 (34%), Gaps = 33/274 (12%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH 285
++ G +G GS+G ++EG + A+K + + P QL E
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-------QLRDEYRTYKLLAG 59
Query: 286 -DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYH-LSDSQVSSYTRQILNGLKYLHE 343
I ++ + ++L+ L S V+ +Q+L ++ +HE
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 344 QNVVHRDIKCANILVDA-----SGSVKLADFGLAKA---------TTMNDVKSCKGTAFW 389
+++V+RDIK N L+ + + + DFG+ K + K+ GTA +
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 390 MAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPY---SHLEGGQAMFKIGGGELPPVP 446
M+ D+ +LG + L P+ Q +IG +
Sbjct: 180 MSINT--HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 447 NSL----SRDAQDFILKCLQVNPNDRPTAAQLME 476
L + ++ + + P L
Sbjct: 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 129 bits (325), Expect = 4e-34
Identities = 63/324 (19%), Positives = 115/324 (35%), Gaps = 69/324 (21%)
Query: 227 WQKGELLGSGSYGFVYEGL-TDDGFFFAVKEVSLQDEGPRGKQSILQLEQEIS-----LL 280
+ LG G + V+ + A+K V + ++L Q ++
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 281 GQFEHDNIVQYLGTDRDEKRLCIFLELVT------KGSLASLYQKYHLSDSQVSSYTRQI 334
++I++ L + + + +V +L Y+ + V ++Q+
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 335 LNGLKYLH-EQNVVHRDIKCANILVDASG------SVKLADFGLAKATTMNDVKSCKGTA 387
L GL Y+H ++H DIK N+L++ +K+AD G A + S T
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI-QTR 193
Query: 388 FWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGG---------QAMFKIG 438
+ +PEV L +G ADIWS C + E++T + EG + ++
Sbjct: 194 EYRSPEV--LLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
Query: 439 G--------------------------------------GELPPVPNSLSRDAQDFILKC 460
G E +++ DF+
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311
Query: 461 LQVNPNDRPTAAQLMEHPFIKRPL 484
LQ++P R A L+ HP++K L
Sbjct: 312 LQLDPRKRADAGGLVNHPWLKDTL 335
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.8 bits (227), Expect = 4e-22
Identities = 29/203 (14%), Positives = 62/203 (30%), Gaps = 31/203 (15%)
Query: 230 GELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRG-------------KQSILQLEQE 276
G+L+G G V+ ++ VK + + +I E
Sbjct: 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 277 ISLLGQFEHDNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILN 336
L + + + + + + + +EL+ L + + IL
Sbjct: 65 FRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRVRVENPDE------VLDMILE 114
Query: 337 GLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVN 396
+ + + +VH D+ N+LV G + + DF + + +
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWR----EILERDVRNII 169
Query: 397 --LKKDGYGLTADIWSLGCTVLE 417
+ Y DI S +L+
Sbjct: 170 TYFSRT-YRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 488 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.36 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.25 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.85 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.3 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.11 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.76 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-58 Score=451.40 Aligned_cols=260 Identities=24% Similarity=0.426 Sum_probs=220.3
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
+++|++++.||+|+||+||+|.+. +|+.||||++..... ....+.+.+|+.+|++++||||+++++++.+++.+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ 79 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 79 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc----chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeE
Confidence 568999999999999999999985 799999999976432 222356889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 303 IFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
+||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....+
T Consensus 80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999999999988654 69999999999999999999999999999999999999999999999999998654332
Q ss_pred --cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhH-HHhc-CCCCCCCCCcccHHHHH
Q 011326 380 --VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAM-FKIG-GGELPPVPNSLSRDAQD 455 (488)
Q Consensus 380 --~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~-~~i~-~~~~~~~~~~~s~~l~~ 455 (488)
.....||+.|+|||++. ....++.++||||+||++|||++|+.||......... ..+. ..........+|+++.+
T Consensus 160 ~~~~~~~GT~~Y~APE~~~-~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHH-CSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred ccccceeeCcCccCHhHhc-CCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHH
Confidence 34567999999999973 2333478899999999999999999999765543322 2222 22223334678999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHhCccCCCCCCCCC
Q 011326 456 FILKCLQVNPNDRPTAAQLMEHPFIKRPLQTSS 488 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~~~ 488 (488)
||.+||+.||++|||++|+++||||+++++++|
T Consensus 239 li~~~L~~dP~~R~t~~eil~hpwf~~~l~kg~ 271 (271)
T d1nvra_ 239 LLHKILVENPSARITIPDIKKDRWYNKPLKKGA 271 (271)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCCCCCCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhCcCCCCCC
Confidence 999999999999999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-58 Score=449.42 Aligned_cols=256 Identities=27% Similarity=0.496 Sum_probs=229.3
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
.+++|++++.||+|+||.||+|.+. +|+.||+|++.+... ........+.+|+.++++++||||+++++++.+++.+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 81 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 81 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHc--cChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEE
Confidence 4789999999999999999999985 799999999975321 1122345788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCc
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV 380 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 380 (488)
|+||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 161 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 161 (263)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC
T ss_pred EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCcc
Confidence 9999999999999988754 699999999999999999999999999999999999999999999999999987766666
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHh
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~c 460 (488)
....||+.|+|||++ .+..++.++|||||||++|||++|+.||.+.+..+....+..... ..|..+|+++.+||.+|
T Consensus 162 ~~~~Gt~~Y~APE~~--~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~ 238 (263)
T d2j4za1 162 TTLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRL 238 (263)
T ss_dssp EETTEEGGGCCHHHH--TTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-CCCTTSCHHHHHHHHHH
T ss_pred cccCCCCcccCHHHH--cCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCccCCHHHHHHHHHH
Confidence 677899999999998 455689999999999999999999999998888888777776654 56788999999999999
Q ss_pred hhhCCCCCCCHHHHHhCccCCCC
Q 011326 461 LQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 461 L~~dP~~Rps~~eil~hp~f~~~ 483 (488)
|++||++|||++|+++||||++.
T Consensus 239 L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 239 LKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp TCSSGGGSCCHHHHHTCHHHHHH
T ss_pred ccCCHhHCcCHHHHHcCcCcCCc
Confidence 99999999999999999999753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-57 Score=447.09 Aligned_cols=252 Identities=33% Similarity=0.575 Sum_probs=223.2
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
.+|++.+.||+|+||.||+|.+. +|+.||||.+...... ..+.+.+|+.+|++++|||||++++++.+++.+|+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-----HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEE
Confidence 36999999999999999999985 7999999999865432 23568899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--Ccc
Q 011326 304 FLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVK 381 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~ 381 (488)
||||++||+|.+++.+.++++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+..... ...
T Consensus 95 vmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred EEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence 999999999999998889999999999999999999999999999999999999999999999999999866433 245
Q ss_pred cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC--CCCCCcccHHHHHHHHH
Q 011326 382 SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL--PPVPNSLSRDAQDFILK 459 (488)
Q Consensus 382 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~l~~Li~~ 459 (488)
...||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+..+....+..... ...+..+|+++++||.+
T Consensus 175 ~~~gt~~Y~aPE~~--~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 175 TMVGTPYWMAPEVV--TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp CCCSCGGGCCHHHH--SSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred ccccCCCccChhhh--cCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 66799999999998 456689999999999999999999999988777666655543332 23456799999999999
Q ss_pred hhhhCCCCCCCHHHHHhCccCCCC
Q 011326 460 CLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 460 cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
||++||.+|||+.|+++||||+..
T Consensus 253 ~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HccCChhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999743
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=440.30 Aligned_cols=253 Identities=31% Similarity=0.509 Sum_probs=215.5
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC--CC
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD--EK 299 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~ 299 (488)
+.++|++.+.||+|+||.||+|.+. +|+.||+|.+..... .......+.+|+.+|++++|||||++++++.+ ++
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 78 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM---TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS---CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC---CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCC
Confidence 3578999999999999999999885 799999999976543 34445678999999999999999999998854 56
Q ss_pred ceEEEEeeccCCChHHHHhhh-----ccChhhhhHHHHHHHHHHHHHHHCC-----CccccCCcccEEECCCCcEEEeec
Q 011326 300 RLCIFLELVTKGSLASLYQKY-----HLSDSQVSSYTRQILNGLKYLHEQN-----VVHRDIKCANILVDASGSVKLADF 369 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~-----~ls~~~~~~i~~qi~~aL~yLH~~g-----iiHrDLkp~NILl~~~~~vkL~DF 369 (488)
.+|+|||||++|+|.+++.+. .+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+||
T Consensus 79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF 158 (269)
T d2java1 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158 (269)
T ss_dssp CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence 789999999999999988542 4999999999999999999999876 999999999999999999999999
Q ss_pred CCcccccCCC--cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCC
Q 011326 370 GLAKATTMND--VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPN 447 (488)
Q Consensus 370 Gla~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~ 447 (488)
|+|+...... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||.+.+..+....+..+..+..+.
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l--~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 236 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQM--NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 236 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCT
T ss_pred cceeecccCCCccccCCCCcccCCHHHH--cCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 9998765432 3457799999999997 45668999999999999999999999999988888888888888888888
Q ss_pred cccHHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 448 SLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 448 ~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
.+|+++.+||.+||+.||.+|||++|+++|||+
T Consensus 237 ~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 237 RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 999999999999999999999999999999996
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-56 Score=439.54 Aligned_cols=255 Identities=35% Similarity=0.597 Sum_probs=223.3
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
+.|++++.||+|+||.||+|.+. +|..||+|++.... ....+.+.+|+.+|++++|||||++++++.+++.+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-----EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence 35899999999999999999985 79999999997643 2234567899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--C
Q 011326 304 FLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--D 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~ 379 (488)
||||+++|+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..... .
T Consensus 87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence 9999999999998754 35999999999999999999999999999999999999999999999999999754432 2
Q ss_pred cccCCCCCcccCchhhcc---ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC--CCCCcccHHHH
Q 011326 380 VKSCKGTAFWMAPEVVNL---KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP--PVPNSLSRDAQ 454 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~---~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~ 454 (488)
.....||+.|+|||++.. ....++.++|||||||++|||++|+.||.+.+..+....+.....+ ..+..+|+++.
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 246 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 246 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence 346779999999999732 3455899999999999999999999999998888877777665543 33567899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
+||.+||++||.+|||+.|+++||||+...
T Consensus 247 ~li~~~L~~dp~~R~t~~ell~hp~~~~~~ 276 (288)
T d2jfla1 247 DFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276 (288)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred HHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999999998653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-56 Score=438.48 Aligned_cols=255 Identities=25% Similarity=0.429 Sum_probs=222.8
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
..++|++++.||+|+||+||+|.+. +|+.||||++.+... ........+.+|+.+|++++||||+++++++.+++.+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc--cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 3468999999999999999999985 799999999975321 1122345788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND- 379 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~- 379 (488)
|+||||++||+|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 9999999999999987654 69999999999999999999999999999999999999999999999999998664332
Q ss_pred ---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHH
Q 011326 380 ---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDF 456 (488)
Q Consensus 380 ---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L 456 (488)
.....||+.|+|||++ .+..++.++|||||||++|||++|..||.+.+..+....+..... .+|..+++++.+|
T Consensus 164 ~~~~~~~~GT~~Y~APE~~--~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l 240 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDL 240 (288)
T ss_dssp ------CCCCGGGCCHHHH--HTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-CCCTTCCHHHHHH
T ss_pred ccccccccCCccccCceee--ccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC-CCCccCCHHHHHH
Confidence 3456799999999997 456689999999999999999999999999888888877776654 5678899999999
Q ss_pred HHHhhhhCCCCCCCHHH------HHhCccCCC
Q 011326 457 ILKCLQVNPNDRPTAAQ------LMEHPFIKR 482 (488)
Q Consensus 457 i~~cL~~dP~~Rps~~e------il~hp~f~~ 482 (488)
|.+||+.||.+|||++| +++||||+.
T Consensus 241 i~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp HHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 99999999999999987 689999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-55 Score=427.97 Aligned_cols=249 Identities=29% Similarity=0.529 Sum_probs=214.4
Q ss_pred eeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC----CCce
Q 011326 227 WQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD----EKRL 301 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~ 301 (488)
|++.+.||+|+||+||+|.+. ++..||+|.+..... .......+.+|+++|++++|||||++++++.+ +..+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 467788999999999999986 789999999976542 23445678999999999999999999998754 4568
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCC--CccccCCcccEEEC-CCCcEEEeecCCcccccC
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQN--VVHRDIKCANILVD-ASGSVKLADFGLAKATTM 377 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~NILl~-~~~~vkL~DFGla~~~~~ 377 (488)
++||||+++|+|.+++.+. .+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+|+....
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999999998665 5999999999999999999999998 99999999999996 578999999999987666
Q ss_pred CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhh-hHHHhcCCCCC-CCCCcccHHHHH
Q 011326 378 NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ-AMFKIGGGELP-PVPNSLSRDAQD 455 (488)
Q Consensus 378 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~-~~~~i~~~~~~-~~~~~~s~~l~~ 455 (488)
.......||+.|+|||++. ..++.++|||||||++|||++|+.||.+..+.. ....+..+..+ ..+..+++++.+
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~---~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244 (270)
T ss_dssp TSBEESCSSCCCCCGGGGG---TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred CccCCcccCccccCHHHhC---CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHH
Confidence 6666788999999999873 358999999999999999999999998765444 44444444332 345668999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHhCccCC
Q 011326 456 FILKCLQVNPNDRPTAAQLMEHPFIK 481 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~eil~hp~f~ 481 (488)
||.+||++||++|||++|+++|||||
T Consensus 245 li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 245 IIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHccCCHhHCcCHHHHhCCcccC
Confidence 99999999999999999999999997
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-55 Score=442.12 Aligned_cols=255 Identities=31% Similarity=0.511 Sum_probs=215.5
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
.-++|++.+.||+|+||+||+|.+. +|..||+|++.... ......++.+|+.+|++++|||||+++++|.+++.+
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC----CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3568999999999999999999985 79999999997643 223346788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHH-CCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
|+||||++||+|.+++.+. .+++..+..++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||+|+......
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 9999999999999998654 69999999999999999999997 599999999999999999999999999998766555
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHH------------------------
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMF------------------------ 435 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~------------------------ 435 (488)
..+..||+.|+|||++ .+..++.++||||+||++|||++|+.||.+.+..+...
T Consensus 160 ~~~~~GT~~Y~APEvl--~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERL--QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp C---CCSSCCCCHHHH--HCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred cccccCCccccCchHH--cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 6678899999999998 45669999999999999999999999997654332211
Q ss_pred ------------------HhcCCCCCCCC-CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 436 ------------------KIGGGELPPVP-NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 436 ------------------~i~~~~~~~~~-~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
.+.....+..+ ..+|.++.+||.+||+.||++|||++|+++||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 01111111222 2368899999999999999999999999999999753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-55 Score=437.25 Aligned_cols=256 Identities=32% Similarity=0.537 Sum_probs=223.6
Q ss_pred ceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEE
Q 011326 226 SWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIF 304 (488)
Q Consensus 226 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 304 (488)
.|+..+.||+|+||+||+|.+. +|..||||++..... ........+.+|+.+|++++|||||++++++.+++.+|+|
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS--CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc--cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 4999999999999999999875 789999999986543 2344556789999999999999999999999999999999
Q ss_pred EeeccCCChHHHHh-hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCcccC
Q 011326 305 LELVTKGSLASLYQ-KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC 383 (488)
Q Consensus 305 ~E~~~~gsL~~~l~-~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 383 (488)
||||++|+|..++. ..++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.... ....
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--~~~~ 171 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANSF 171 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--BCCC
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--CCcc
Confidence 99999999977654 44699999999999999999999999999999999999999999999999999976543 3456
Q ss_pred CCCCcccCchhhccc-cCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC-CCCcccHHHHHHHHHhh
Q 011326 384 KGTAFWMAPEVVNLK-KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP-VPNSLSRDAQDFILKCL 461 (488)
Q Consensus 384 ~gt~~y~aPE~~~~~-~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~l~~Li~~cL 461 (488)
.||+.|+|||++... ...++.++|||||||++|||++|..||.+.+..+....+.....+. .+..+|+++.+||.+||
T Consensus 172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L 251 (309)
T d1u5ra_ 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251 (309)
T ss_dssp CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHT
T ss_pred ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHC
Confidence 799999999998432 3458999999999999999999999999888777766666555443 34568999999999999
Q ss_pred hhCCCCCCCHHHHHhCccCCCCCC
Q 011326 462 QVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 462 ~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
+.||.+|||++|+++||||++...
T Consensus 252 ~~dP~~Rpt~~ell~Hp~~~~~~~ 275 (309)
T d1u5ra_ 252 QKIPQDRPTSEVLLKHRFVLRERP 275 (309)
T ss_dssp CSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred cCChhHCcCHHHHHhCHHhcCCCC
Confidence 999999999999999999976543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-55 Score=440.89 Aligned_cols=256 Identities=28% Similarity=0.462 Sum_probs=227.3
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCc
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKR 300 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 300 (488)
..+++|++++.||+|+||.||+|.+. +|+.||||++.+.... .......+.+|+.+|++++||||+++++++++++.
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 79 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII--AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR 79 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhcc--CHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccc
Confidence 35789999999999999999999985 7999999999754211 12234678899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC-
Q 011326 301 LCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN- 378 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~- 378 (488)
+|+||||++||+|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 99999999999999988765 5899999999999999999999999999999999999999999999999999865432
Q ss_pred -CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHH
Q 011326 379 -DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFI 457 (488)
Q Consensus 379 -~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li 457 (488)
.....+||+.|+|||++ .+..++.++|||||||++|||++|++||.+.+..+....+.... ..+|..+|+++.+||
T Consensus 160 ~~~~~~~GT~~Y~aPE~~--~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli 236 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLL 236 (337)
T ss_dssp CCBCCCEECGGGCCGGGG--SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHH
T ss_pred cccccceeCHHHhhhhhc--cCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHHHHH
Confidence 34567899999999997 45668999999999999999999999999988888777777665 467888999999999
Q ss_pred HHhhhhCCCCCCC-----HHHHHhCccCCC
Q 011326 458 LKCLQVNPNDRPT-----AAQLMEHPFIKR 482 (488)
Q Consensus 458 ~~cL~~dP~~Rps-----~~eil~hp~f~~ 482 (488)
.+||++||.+||+ ++|+++||||++
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HhhccCCchhhcccccccHHHHHcCccccc
Confidence 9999999999994 999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.6e-55 Score=435.55 Aligned_cols=252 Identities=26% Similarity=0.428 Sum_probs=206.8
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
+.|++.+.||+|+||+||+|.+. +|+.||||++...... .....+.+|+.+|++++|||||++++++.+++.+|+
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE----GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45999999999999999999985 7999999999865432 123467899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEEC---CCCcEEEeecCCcccccCCC
Q 011326 304 FLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVD---ASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~---~~~~vkL~DFGla~~~~~~~ 379 (488)
|||||+||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||+. .++.+||+|||+|+......
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 99999999999988654 699999999999999999999999999999999999995 57899999999998665443
Q ss_pred -cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC---CCCCcccHHHHH
Q 011326 380 -VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP---PVPNSLSRDAQD 455 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l~~ 455 (488)
.....||+.|+|||++ .+..++.++|||||||++|||++|+.||.+.+..+....+...... +.+..+|+++.+
T Consensus 165 ~~~~~~GT~~y~APE~~--~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 242 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVL--AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242 (307)
T ss_dssp --------CTTSCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred eeeeeeeCccccCcHHH--cCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHH
Confidence 3456799999999998 4556899999999999999999999999988888777777665543 334678999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 456 FILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 456 Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
||.+||++||++|||++|+++||||+.
T Consensus 243 li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 243 FIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 999999999999999999999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-54 Score=427.87 Aligned_cols=256 Identities=28% Similarity=0.476 Sum_probs=225.6
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCc-chhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPR-GKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
++|++++.||+|+||+||+|.+. +|+.||||++.+...... .....+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 46999999999999999999985 799999999986543322 2234567899999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC----cEEEeecCCcccccC
Q 011326 303 IFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG----SVKLADFGLAKATTM 377 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~----~vkL~DFGla~~~~~ 377 (488)
+|||||++|+|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence 999999999999998665 699999999999999999999999999999999999998776 599999999987654
Q ss_pred C-CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC---CCCcccHHH
Q 011326 378 N-DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP---VPNSLSRDA 453 (488)
Q Consensus 378 ~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~l 453 (488)
. ......||+.|+|||++ .+..++.++||||+||++|||++|+.||.+.+..+....+....... .+..+|+++
T Consensus 170 ~~~~~~~~~t~~y~APE~~--~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 247 (293)
T d1jksa_ 170 GNEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA 247 (293)
T ss_dssp SCBCSCCCCCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHH
T ss_pred CccccccCCCCcccCHHHH--cCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHH
Confidence 4 34567799999999998 45568999999999999999999999999988888887777665432 235789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 454 QDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
.+||.+||+.||++|||++|+++||||+.
T Consensus 248 ~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 248 KDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.4e-54 Score=438.32 Aligned_cols=255 Identities=28% Similarity=0.441 Sum_probs=224.1
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
.+++|++++.||+|+||.||+|.+. +|..||||++... .....+.+.+|+.+|++++|||||++++++.+++.+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc-----chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3678999999999999999999985 7999999999653 233456788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC--CCcEEEeecCCcccccC
Q 011326 302 CIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA--SGSVKLADFGLAKATTM 377 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~--~~~vkL~DFGla~~~~~ 377 (488)
|+|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999999998843 35999999999999999999999999999999999999964 67899999999987654
Q ss_pred CC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC---CCCcccHHH
Q 011326 378 ND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP---VPNSLSRDA 453 (488)
Q Consensus 378 ~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~l 453 (488)
.. .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.+..+....+....... ....+|+++
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~--~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 256 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256 (350)
T ss_dssp TSCEEEECSCTTTCCHHHH--HTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHH
T ss_pred ccccceecCcccccCHHHH--cCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 43 4467899999999997 45668999999999999999999999999888888777776554422 235689999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 454 QDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
++||.+||+.||++|||++|+++||||+...
T Consensus 257 ~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 257 KDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999999999998653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-54 Score=433.64 Aligned_cols=254 Identities=27% Similarity=0.447 Sum_probs=225.4
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
.+++|++++.||+|+||+||+|.+. +|+.||||++.+... ........+.+|+.+|++++|||||++++++.+++.+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 79 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 79 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc--cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCee
Confidence 3678999999999999999999985 799999999975321 1122346788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCc
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV 380 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 380 (488)
|+||||++||+|..++... .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus 80 ~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-~~ 158 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VT 158 (316)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-CB
T ss_pred eeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-cc
Confidence 9999999999999888655 588999999999999999999999999999999999999999999999999987653 34
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHh
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~c 460 (488)
....||+.|+|||++ .+..++.++|||||||++|||++|+.||.+.+..+....+..+.. ..|..+++++.+++.+|
T Consensus 159 ~~~~Gt~~Y~APE~l--~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~ 235 (316)
T d1fota_ 159 YTLCGTPDYIAPEVV--STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVKDLLSRL 235 (316)
T ss_dssp CCCCSCTTTCCHHHH--TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHH
T ss_pred ccccCcccccCHHHH--cCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHH
Confidence 467899999999997 455689999999999999999999999999888888777766654 56778999999999999
Q ss_pred hhhCCCCCC-----CHHHHHhCccCCC
Q 011326 461 LQVNPNDRP-----TAAQLMEHPFIKR 482 (488)
Q Consensus 461 L~~dP~~Rp-----s~~eil~hp~f~~ 482 (488)
|++||.+|+ |++++++||||++
T Consensus 236 L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 236 ITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred hhhCHHhccccchhhHHHHHcCccccc
Confidence 999999996 9999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.6e-54 Score=436.08 Aligned_cols=254 Identities=29% Similarity=0.480 Sum_probs=224.3
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++++.||+|+||.||+|.+. +|+.||||++.... ......+.+|+.+|++++|||||++++++.+++.+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 567999999999999999999985 79999999997532 334467889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEEC--CCCcEEEeecCCcccccCC
Q 011326 303 IFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVD--ASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~--~~~~vkL~DFGla~~~~~~ 378 (488)
||||||+||+|.+.+... ++++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.....
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999999998877543 599999999999999999999999999999999999998 5789999999999876654
Q ss_pred C-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC---CCCCcccHHHH
Q 011326 379 D-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP---PVPNSLSRDAQ 454 (488)
Q Consensus 379 ~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l~ 454 (488)
. .....||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+..+....+...... ..+..+|+++.
T Consensus 183 ~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 260 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIV--DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260 (352)
T ss_dssp SCEEEECSSGGGCCHHHH--TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred CceeeccCcccccCHHHH--cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 3 4456799999999997 4566899999999999999999999999998888877777655432 23457899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
+||.+||++||.+|||+.|+++||||+...
T Consensus 261 ~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 999999999999999999999999998643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-53 Score=419.42 Aligned_cols=260 Identities=27% Similarity=0.448 Sum_probs=225.8
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcch----hHHHHHHHHHHHHhcCC-CCCcceeeccccC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGK----QSILQLEQEISLLGQFE-HDNIVQYLGTDRD 297 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~----~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~ 297 (488)
.++|++.+.||+|+||+||+|.+. +|+.||||++.+........ .....+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999885 79999999998765443322 23456889999999997 9999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
++.+||||||+++|+|.+++... ++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999654 69999999999999999999999999999999999999999999999999998765
Q ss_pred CC-CcccCCCCCcccCchhhcc----ccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC---CCCCc
Q 011326 377 MN-DVKSCKGTAFWMAPEVVNL----KKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP---PVPNS 448 (488)
Q Consensus 377 ~~-~~~~~~gt~~y~aPE~~~~----~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~ 448 (488)
.. ......||+.|+|||.+.. ....++.++||||+||++|+|++|+.||.+.+..+....+..+... +....
T Consensus 162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (277)
T d1phka_ 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241 (277)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence 43 3455779999999999842 2345788999999999999999999999998877776666544432 23347
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 449 LSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 449 ~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
+|+++++|+.+||++||++|||++|+++||||++-
T Consensus 242 ~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 99999999999999999999999999999999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-53 Score=435.90 Aligned_cols=258 Identities=27% Similarity=0.416 Sum_probs=219.8
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCC-cchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCce
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGP-RGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~-~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 301 (488)
+++|+++++||+|+||.||+|.+. +|+.||||++.+..... ..........+|+.+++.++|||||++++++.+++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 678999999999999999999985 79999999986432110 1112223334567888889999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCc
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV 380 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 380 (488)
|+||||++||+|.+++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~ 162 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 162 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSCC
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCcc
Confidence 9999999999999988654 589999999999999999999999999999999999999999999999999987776666
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhh--HHHhcCCCCCCCCCcccHHHHHHHH
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQA--MFKIGGGELPPVPNSLSRDAQDFIL 458 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~s~~l~~Li~ 458 (488)
....||+.|+|||++. .+..++.++|||||||++|||++|+.||...+..+. +...........+..+|+++.+||.
T Consensus 163 ~~~~GT~~y~APE~~~-~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 241 (364)
T d1omwa3 163 HASVGTHGYMAPEVLQ-KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241 (364)
T ss_dssp CSCCSCGGGCCHHHHS-TTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHH
T ss_pred cccccccccchhHHhh-cCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHH
Confidence 7788999999999973 345689999999999999999999999987554332 2223333445667789999999999
Q ss_pred HhhhhCCCCCCC-----HHHHHhCccCCC
Q 011326 459 KCLQVNPNDRPT-----AAQLMEHPFIKR 482 (488)
Q Consensus 459 ~cL~~dP~~Rps-----~~eil~hp~f~~ 482 (488)
+||++||.+||| ++|+++||||+.
T Consensus 242 ~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 242 GLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 999999999999 799999999985
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-53 Score=432.64 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=224.5
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
+++|++++.||+|+||.||+|.+. +|+.||||++.+... ........+.+|+.+|+.++|||||++++++.+.+..+
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc--cCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 578999999999999999999985 799999999975321 11223457889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCCcc
Q 011326 303 IFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK 381 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 381 (488)
+||||+.+|+|..++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.... ...
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~-~~~ 196 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RTW 196 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-CBC
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc-ccc
Confidence 999999999998888654 699999999999999999999999999999999999999999999999999987653 334
Q ss_pred cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhh
Q 011326 382 SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCL 461 (488)
Q Consensus 382 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL 461 (488)
...||+.|+|||++ .+..++.++|||||||++|||++|..||.+.+.......+..... ..+..+++++.+||.+||
T Consensus 197 ~~~Gt~~Y~APE~~--~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L 273 (350)
T d1rdqe_ 197 TLCGTPEALAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLL 273 (350)
T ss_dssp CCEECGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTCCHHHHHHHHHHS
T ss_pred cccCccccCCHHHH--cCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-CCCccCCHHHHHHHHHHh
Confidence 56799999999998 456689999999999999999999999998888777777766554 567789999999999999
Q ss_pred hhCCCCCC-----CHHHHHhCccCCC
Q 011326 462 QVNPNDRP-----TAAQLMEHPFIKR 482 (488)
Q Consensus 462 ~~dP~~Rp-----s~~eil~hp~f~~ 482 (488)
++||.+|+ |++|+++||||+.
T Consensus 274 ~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 274 QVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred hhCHHhccccccccHHHHHcCccccC
Confidence 99999994 9999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-53 Score=416.64 Aligned_cols=255 Identities=27% Similarity=0.456 Sum_probs=223.1
Q ss_pred cccccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 218 GKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 218 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
..|+...++|++++.||+|+||.||+|.++++..||||++.... ...+.+.+|+.++++++|||||++++++.+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 79 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS------MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc------CCHHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence 45666678999999999999999999999888999999986432 223578999999999999999999998865
Q ss_pred CCceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 374 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~ 374 (488)
+..++||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 80 -~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 158 (272)
T ss_dssp -SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred -CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEE
Confidence 4679999999999999877433 499999999999999999999999999999999999999999999999999987
Q ss_pred ccCCC---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcC-CCCCCCCchhhhHHHhcCCCCCCCCCccc
Q 011326 375 TTMND---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSLS 450 (488)
Q Consensus 375 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s 450 (488)
..... .....||+.|+|||++ ....++.++|||||||++|||+|| .+|+...+..+....+..+..+..|..++
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~~--~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~ 236 (272)
T d1qpca_ 159 IEDNEYTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP 236 (272)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHH--HHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccCCccccccccCCcccccChHHH--hCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccCh
Confidence 65443 3346689999999997 345689999999999999999995 56667777777888888888888889999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHh--CccCC
Q 011326 451 RDAQDFILKCLQVNPNDRPTAAQLME--HPFIK 481 (488)
Q Consensus 451 ~~l~~Li~~cL~~dP~~Rps~~eil~--hp~f~ 481 (488)
+++.+|+.+||+.||++|||++||++ |+||.
T Consensus 237 ~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 99999999999999999999999998 78874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=421.33 Aligned_cols=254 Identities=26% Similarity=0.423 Sum_probs=209.0
Q ss_pred eeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEee
Q 011326 229 KGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLEL 307 (488)
Q Consensus 229 ~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 307 (488)
.+++||+|+||+||+|.+. +|+.||||++...............+.+|+.+|++++|||||++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4678999999999999985 799999999976543322233345688999999999999999999999999999999999
Q ss_pred ccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--cccCC
Q 011326 308 VTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCK 384 (488)
Q Consensus 308 ~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~ 384 (488)
+.++++..+.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 161 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV 161 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence 9998877766543 59999999999999999999999999999999999999999999999999997655432 34567
Q ss_pred CCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC----------------------CC
Q 011326 385 GTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG----------------------EL 442 (488)
Q Consensus 385 gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~----------------------~~ 442 (488)
||+.|+|||++. ....++.++||||+||++|||++|.+||.+.+..+....+... ..
T Consensus 162 gt~~y~aPE~~~-~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ua2a_ 162 VTRWYRAPELLF-GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240 (299)
T ss_dssp CCCTTCCHHHHT-TCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC
T ss_pred cChhhccHHHHc-cCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccC
Confidence 999999999973 4456899999999999999999999999888776665544210 00
Q ss_pred CC-----CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 443 PP-----VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 443 ~~-----~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
+. ....+++++.+||.+||+.||++|||++|+++||||++.
T Consensus 241 ~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred CCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 00 113568899999999999999999999999999999853
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-53 Score=418.77 Aligned_cols=251 Identities=27% Similarity=0.444 Sum_probs=219.5
Q ss_pred cccccccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecccc
Q 011326 218 GKFRRRITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR 296 (488)
Q Consensus 218 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 296 (488)
.+|+...++|++.+.||+|+||+||+|.+. +|..||||++.... ...+++.+|+.+|++++|||||++++++.
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~------~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC------SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc------chHHHHHHHHHHHHhCCCCCEecCCccEe
Confidence 457777889999999999999999999986 68999999986432 22357889999999999999999999999
Q ss_pred CCCceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 297 DEKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 297 ~~~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
+++.+++||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 84 ~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 84 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred eCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEcccccee
Confidence 999999999999999999988653 58999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCc---ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCC-CCCCchhhhHHHhcCCCCCCCCCcc
Q 011326 374 ATTMNDV---KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHP-YSHLEGGQAMFKIGGGELPPVPNSL 449 (488)
Q Consensus 374 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~P-f~~~~~~~~~~~i~~~~~~~~~~~~ 449 (488)
....... ....||+.|+|||++ ....++.++|||||||++|||++|..| |.+.+..+....+..+..++.+..+
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~ 241 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC 241 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHH--HHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred ecCCCCceeeccccccccccChHHH--cCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccc
Confidence 7654432 234588899999997 445689999999999999999996555 5555666666666777777888899
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
|+++.+||.+||+.||++|||++|+++
T Consensus 242 ~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 242 PEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999999999976
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=426.05 Aligned_cols=254 Identities=24% Similarity=0.401 Sum_probs=222.8
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
.++|++++.||+|+||+||+|.+. +|+.||+|.+.... .....+.+|+.+|++++|||||++++++.+++.+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 578999999999999999999985 79999999997532 22346789999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC--CcEEEeecCCcccccCC
Q 011326 303 IFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS--GSVKLADFGLAKATTMN 378 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~--~~vkL~DFGla~~~~~~ 378 (488)
+|||||+||+|.+++... .+++.++..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999999999654 58999999999999999999999999999999999999854 58999999999876544
Q ss_pred C-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCC---CCCcccHHHH
Q 011326 379 D-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPP---VPNSLSRDAQ 454 (488)
Q Consensus 379 ~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~l~ 454 (488)
. .....||+.|+|||.+ .+..++.++||||+||++|+|++|..||.+.+..+....+....... .+..+|++++
T Consensus 158 ~~~~~~~~t~~y~ape~~--~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVH--QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp CEEEEEESCGGGSCHHHH--TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred Ccccccccccccccchhc--cCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence 3 3456799999999997 45568999999999999999999999999988888877776655422 1246899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
+||.+||++||.+|||++|+++||||++..+
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~hp~~~~~~~ 266 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhccCcc
Confidence 9999999999999999999999999987643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-53 Score=412.26 Aligned_cols=246 Identities=23% Similarity=0.414 Sum_probs=210.2
Q ss_pred cCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
.++|++++.||+|+||.||+|.+.++..||||++..... ..+++.+|+.++++++|||||+++++|.+++..++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC------cHHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence 357999999999999999999998889999999874322 23578999999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 304 FLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
||||+++|+|.+++... .+++..+..++.|++.||.|||+++|+||||||+|||++.++++||+|||+++......
T Consensus 78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 99999999999988653 48899999999999999999999999999999999999999999999999997654432
Q ss_pred -cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHH
Q 011326 380 -VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFI 457 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li 457 (488)
.....||+.|+|||++ ....++.++|||||||++|||+| |.+||...+..+....+..+..+..|..+++++.+|+
T Consensus 158 ~~~~~~gt~~y~aPE~l--~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 235 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM 235 (263)
T ss_dssp -------CTTSCCHHHH--TTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred eecceecCcccCChHHh--cCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHH
Confidence 2345689999999997 45569999999999999999999 5777777777777888877777788889999999999
Q ss_pred HHhhhhCCCCCCCHHHHHhC
Q 011326 458 LKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 458 ~~cL~~dP~~Rps~~eil~h 477 (488)
.+||+.||++|||++||++|
T Consensus 236 ~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 236 NHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-53 Score=425.25 Aligned_cols=254 Identities=27% Similarity=0.479 Sum_probs=221.2
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHh-cCCCCCcceeeccccCCCce
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLG-QFEHDNIVQYLGTDRDEKRL 301 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~-~l~HpnIv~l~~~~~~~~~~ 301 (488)
+++|++++.||+|+||+||+|.+. +|+.||||++.+... ........+..|..++. .++|||||++++++.+++.+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~--~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~ 78 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 78 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc--cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCce
Confidence 468999999999999999999985 799999999975321 01122345566666665 68999999999999999999
Q ss_pred EEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC--
Q 011326 302 CIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-- 378 (488)
Q Consensus 302 ~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-- 378 (488)
|+||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 9999999999999999665 5999999999999999999999999999999999999999999999999999765433
Q ss_pred CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHH
Q 011326 379 DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFIL 458 (488)
Q Consensus 379 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~ 458 (488)
......||+.|+|||++ .+..++.++||||+||++|||++|+.||.+.+..+....+..+. +..|..+|+++.+||.
T Consensus 159 ~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~ 235 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEIL--LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLV 235 (320)
T ss_dssp CBCCCCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHH
T ss_pred cccccCCCCCcCCHHHH--cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHH
Confidence 24456799999999998 45668999999999999999999999999988888777776554 4677889999999999
Q ss_pred HhhhhCCCCCCCHH-HHHhCccCCC
Q 011326 459 KCLQVNPNDRPTAA-QLMEHPFIKR 482 (488)
Q Consensus 459 ~cL~~dP~~Rps~~-eil~hp~f~~ 482 (488)
+||++||.+|||+. |+++||||++
T Consensus 236 ~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 236 KLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp HHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HhcccCCCCCcCHHHHHHhCchhcc
Confidence 99999999999995 8999999976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=406.83 Aligned_cols=246 Identities=22% Similarity=0.409 Sum_probs=222.2
Q ss_pred cCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
.++|++++.||+|+||+||+|..+++..||||.+..... ...++.+|+.++++++||||+++++++.+++.+++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~------~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS------CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC------CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 357889999999999999999998899999999985432 23578999999999999999999999999999999
Q ss_pred EEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 304 FLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 304 V~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
||||+++|+|.+++.. ..+++..+..++.|+++||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999999999888643 458999999999999999999999999999999999999999999999999997654332
Q ss_pred -cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHH
Q 011326 380 -VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFI 457 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li 457 (488)
.....||+.|+|||.+ ....++.++||||||+++|||+| |+.||.+.+..+....+..+..++.|..+++++.+||
T Consensus 157 ~~~~~~~t~~y~aPE~~--~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 234 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 234 (258)
T ss_dssp CCCCSCCCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eecccCCCCCcCCcHHh--cCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHH
Confidence 3346689999999998 44568999999999999999998 8999999999999988988888888999999999999
Q ss_pred HHhhhhCCCCCCCHHHHHhC
Q 011326 458 LKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 458 ~~cL~~dP~~Rps~~eil~h 477 (488)
.+||+.||++|||+++|++|
T Consensus 235 ~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 235 YSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHTTCSSGGGSCCHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999987
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=412.85 Aligned_cols=253 Identities=26% Similarity=0.516 Sum_probs=210.0
Q ss_pred ccccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
.|+...++|++++.||+|+||.||+|++++ .||||++..... .....+.|.+|+.+|++++|||||++++++.+
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~- 75 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAP---TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA- 75 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSC---CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-
Confidence 355667889999999999999999997653 599999976543 23456789999999999999999999998765
Q ss_pred CceEEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 299 KRLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
+.+++||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 76 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 76 PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 568999999999999999854 359999999999999999999999999999999999999999999999999997654
Q ss_pred CC----CcccCCCCCcccCchhhccc-cCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHH-hcCCCC----CCCC
Q 011326 377 MN----DVKSCKGTAFWMAPEVVNLK-KDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFK-IGGGEL----PPVP 446 (488)
Q Consensus 377 ~~----~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~-i~~~~~----~~~~ 446 (488)
.. ......||+.|+|||++... ...++.++|||||||++|||+||+.||.+.+....... +..+.. ...+
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 235 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSC
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcc
Confidence 32 23456799999999998533 34589999999999999999999999988765544333 222222 2356
Q ss_pred CcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 447 NSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 447 ~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
..+|+++.+|+.+||+.||++|||+.||+++
T Consensus 236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 236 SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 6789999999999999999999999999987
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-51 Score=411.21 Aligned_cols=249 Identities=27% Similarity=0.482 Sum_probs=209.9
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CC---cEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DG---FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE 298 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g---~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 298 (488)
..++|++.++||+|+||+||+|.++ ++ ..||||.+... ......+.|.+|+.+|++++|||||++++++.++
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG----YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc----cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 3568999999999999999999875 33 35888887643 2344566899999999999999999999999999
Q ss_pred CceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 299 KRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
+.+++|||||++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999999999988653 58999999999999999999999999999999999999999999999999997654
Q ss_pred CCC-------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCc
Q 011326 377 MND-------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNS 448 (488)
Q Consensus 377 ~~~-------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 448 (488)
... .....||+.|+|||.+ ....++.++|||||||++|||+| |+.||.+.+..+....+..+..++.+..
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAI--QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMD 257 (299)
T ss_dssp ----------------CGGGSCHHHH--HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred CCCCcceeeecccccCCccccCHHHH--hcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 332 1234578999999997 45678999999999999999998 8999999988888888888888888889
Q ss_pred ccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 449 LSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 449 ~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
+++++.+|+.+||+.||++|||+.||+++
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999999988765
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-53 Score=414.62 Aligned_cols=253 Identities=29% Similarity=0.465 Sum_probs=213.3
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcch-hHHHHHHHHHHHHhcCC--CCCcceeeccccCCCc
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGK-QSILQLEQEISLLGQFE--HDNIVQYLGTDRDEKR 300 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~-~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~~~ 300 (488)
++|++++.||+|+||.||+|.+. +|..||||++.+........ ....++.+|+.+|++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999985 79999999997654322111 11234568999999986 8999999999999999
Q ss_pred eEEEEeeccC-CChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC-CCcEEEeecCCcccccC
Q 011326 301 LCIFLELVTK-GSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAKATTM 377 (488)
Q Consensus 301 ~~lV~E~~~~-gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~-~~~vkL~DFGla~~~~~ 377 (488)
.++||||+.+ +++.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+....
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence 9999999976 577777754 46999999999999999999999999999999999999985 57999999999987766
Q ss_pred CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHH
Q 011326 378 NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFI 457 (488)
Q Consensus 378 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li 457 (488)
.......||+.|+|||++. ....++.++||||+||++|||++|+.||...+. +.... ...+..+|+++.+||
T Consensus 164 ~~~~~~~GT~~y~aPE~~~-~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~~~-~~~~~~~s~~~~~li 235 (273)
T d1xwsa_ 164 TVYTDFDGTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQ-VFFRQRVSSECQHLI 235 (273)
T ss_dssp SCBCCCCSCGGGSCHHHHH-HSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCC-CCCSSCCCHHHHHHH
T ss_pred ccccccccCCCcCCHHHHc-CCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhhcc-cCCCCCCCHHHHHHH
Confidence 6667788999999999983 333457889999999999999999999975321 11122 246678999999999
Q ss_pred HHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 458 LKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 458 ~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
.+||++||++|||++|+++||||++...
T Consensus 236 ~~~L~~dp~~R~s~~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 236 RWCLALRPSDRPTFEEIQNHPWMQDVLL 263 (273)
T ss_dssp HHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred HHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence 9999999999999999999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-52 Score=410.89 Aligned_cols=250 Identities=26% Similarity=0.448 Sum_probs=219.2
Q ss_pred cCceeeeee-ecccCceEEEEEEec---CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 224 ITSWQKGEL-LGSGSYGFVYEGLTD---DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 224 ~~~y~~~~~-LG~G~fg~Vy~~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
.++|.+.+. ||+|+||.||+|.++ ++..||||++.... .....+++.+|+.+|++++|||||++++++.++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~- 81 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE- 81 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc----CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-
Confidence 457888885 999999999999764 45689999986532 344567899999999999999999999998754
Q ss_pred ceEEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 300 RLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
.+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 68999999999999998754 3599999999999999999999999999999999999999999999999999986544
Q ss_pred CC-----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccH
Q 011326 378 ND-----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSR 451 (488)
Q Consensus 378 ~~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 451 (488)
.. .....||+.|+|||++ ....++.++|||||||++|||+| |+.||.+.+..+....+..+..++.|..+|+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~ 239 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP 239 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHH--HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCH
T ss_pred cccccccccccccCccccChHHH--hCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence 32 2345689999999997 34568999999999999999998 9999999888888888888888889999999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHH---HhCccC
Q 011326 452 DAQDFILKCLQVNPNDRPTAAQL---MEHPFI 480 (488)
Q Consensus 452 ~l~~Li~~cL~~dP~~Rps~~ei---l~hp~f 480 (488)
++.+||.+||+.||++|||+.+| |+|+|+
T Consensus 240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 99999999999999999999988 567776
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-52 Score=412.55 Aligned_cols=259 Identities=32% Similarity=0.506 Sum_probs=212.9
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
+++|++++.||+|+||+||+|.+. +|+.||||++...... ......+.+|+.+|++++|||||++++++.+++.+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~ 77 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 77 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC---hHHHHHHHHHHHHHHhCCCCcEEEecccccccccee
Confidence 468999999999999999999985 7999999999654321 223457889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHh--hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-
Q 011326 303 IFLELVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND- 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~--~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~- 379 (488)
+||||+.++.+..... ..++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||.|+......
T Consensus 78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 9999998765544433 3359999999999999999999999999999999999999999999999999997654432
Q ss_pred -cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC-----------------C
Q 011326 380 -VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG-----------------E 441 (488)
Q Consensus 380 -~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~-----------------~ 441 (488)
.....||+.|+|||.+. ....++.++|+||+||++|+|++|+.||.+.+..+....+... .
T Consensus 158 ~~~~~~gt~~y~apE~~~-~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILL-GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp CTTCCBCCCTTCCHHHHT-TCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cceeecccceeeehhhhc-cccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 34567999999999873 3445689999999999999999999999887765544433110 0
Q ss_pred CCC-----------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 442 LPP-----------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 442 ~~~-----------~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
... ....+++++.+|+.+||+.||++|||++|+++||||++.-++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 000 112567899999999999999999999999999999876554
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.3e-52 Score=409.36 Aligned_cols=255 Identities=31% Similarity=0.502 Sum_probs=214.1
Q ss_pred cCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 303 (488)
+++|++.+.||+|+||+||+|.+++|+.||||++..... .......+.+|+.+|++++||||+++++++.+++..++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 77 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG---GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc---ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeE
Confidence 468999999999999999999999999999999976432 22234678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHh-hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--c
Q 011326 304 FLELVTKGSLASLYQ-KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--V 380 (488)
Q Consensus 304 V~E~~~~gsL~~~l~-~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~--~ 380 (488)
+||++.++.+..+.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||.+....... .
T Consensus 78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 999999987777765 4459999999999999999999999999999999999999999999999999997654332 3
Q ss_pred ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC--------------------
Q 011326 381 KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG-------------------- 440 (488)
Q Consensus 381 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~-------------------- 440 (488)
....|++.|+|||.+. ....++.++||||+||++|||++|+.||.+.+..+....+...
T Consensus 158 ~~~~~~~~y~~pE~~~-~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLM-GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp ----CCCTTCCHHHHT-TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceecccchhhhHHHHh-CCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 4456999999999973 4456799999999999999999999999887665544432100
Q ss_pred --------CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCC
Q 011326 441 --------ELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKR 482 (488)
Q Consensus 441 --------~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~ 482 (488)
........+++++.+||.+||++||++|||++|+++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 001123457899999999999999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=410.29 Aligned_cols=244 Identities=27% Similarity=0.450 Sum_probs=210.3
Q ss_pred eeecccCceEEEEEEec---CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceEEEEee
Q 011326 231 ELLGSGSYGFVYEGLTD---DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLCIFLEL 307 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 307 (488)
+.||+|+||.||+|.++ +++.||||++..... .....+++.+|+.+|++++|||||+++++|.++ ..++||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~ 88 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN---DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEM 88 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEEC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC---CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEc
Confidence 57999999999999864 357899999865432 233456799999999999999999999999654 57899999
Q ss_pred ccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-----cc
Q 011326 308 VTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----VK 381 (488)
Q Consensus 308 ~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-----~~ 381 (488)
+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 89 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 89 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 9999999998764 59999999999999999999999999999999999999999999999999997654332 23
Q ss_pred cCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHh
Q 011326 382 SCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKC 460 (488)
Q Consensus 382 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~c 460 (488)
...||+.|+|||.+ ....++.++|||||||++|||++ |+.||.+.+..+....+..+..++.|..+|+++.+||.+|
T Consensus 169 ~~~gt~~y~APE~l--~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~c 246 (277)
T d1xbba_ 169 HGKWPVKWYAPECI--NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 246 (277)
T ss_dssp --CCCGGGCCHHHH--HHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred ccCCCceecCchhh--cCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHH
Confidence 45689999999997 34568999999999999999998 8999999888888888888888889999999999999999
Q ss_pred hhhCCCCCCCHHHHH---hCccC
Q 011326 461 LQVNPNDRPTAAQLM---EHPFI 480 (488)
Q Consensus 461 L~~dP~~Rps~~eil---~hp~f 480 (488)
|+.||++|||+++|+ +|+|+
T Consensus 247 l~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 247 WTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp TCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cCCCHhHCcCHHHHHHHhhCHHh
Confidence 999999999999984 56654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=406.93 Aligned_cols=261 Identities=26% Similarity=0.428 Sum_probs=221.3
Q ss_pred CCCcccccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecc
Q 011326 215 SPNGKFRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGT 294 (488)
Q Consensus 215 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 294 (488)
.+.+.|+...++|++++.||+|+||.||+|.++++..||||++..... ..+.|.+|+.++++++|||||+++++
T Consensus 7 ~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~g~ 80 (285)
T d1fmka3 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAV 80 (285)
T ss_dssp SSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC------CHHHHHHHHHHHHhcccCCEeEEEEE
Confidence 345567777889999999999999999999998888999999864332 23578999999999999999999999
Q ss_pred ccCCCceEEEEeeccCCChHHHHhh---hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCC
Q 011326 295 DRDEKRLCIFLELVTKGSLASLYQK---YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGL 371 (488)
Q Consensus 295 ~~~~~~~~lV~E~~~~gsL~~~l~~---~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGl 371 (488)
+.+ +.+++||||+++|+|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGl 159 (285)
T d1fmka3 81 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 159 (285)
T ss_dssp ECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred Eec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccch
Confidence 865 568999999999999988754 3599999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcC-CCCCCCCchhhhHHHhcCCCCCCCCC
Q 011326 372 AKATTMND---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPN 447 (488)
Q Consensus 372 a~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~ 447 (488)
++...... .....||+.|+|||++ ....++.++||||||+++|||++| .+|+......+....+..+..++.+.
T Consensus 160 a~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~ 237 (285)
T d1fmka3 160 ARLIEDNEYTARQGAKFPIKWTAPEAA--LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 237 (285)
T ss_dssp TC--------------CCGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred hhhccCCCceeeccccccccccChHHH--hCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCc
Confidence 97654332 2346699999999997 456689999999999999999995 55566667777777777777778899
Q ss_pred cccHHHHHHHHHhhhhCCCCCCCHHHHHh--CccCCCCC
Q 011326 448 SLSRDAQDFILKCLQVNPNDRPTAAQLME--HPFIKRPL 484 (488)
Q Consensus 448 ~~s~~l~~Li~~cL~~dP~~Rps~~eil~--hp~f~~~~ 484 (488)
.+++++.+||.+||+.||++|||+++|++ ++||....
T Consensus 238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 99999999999999999999999999988 89997643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=414.14 Aligned_cols=256 Identities=24% Similarity=0.414 Sum_probs=216.6
Q ss_pred CCcccccccCceeeeeeecccCceEEEEEEecC-C-----cEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCc
Q 011326 216 PNGKFRRRITSWQKGELLGSGSYGFVYEGLTDD-G-----FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNI 288 (488)
Q Consensus 216 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-g-----~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnI 288 (488)
.+.+|+...++|++++.||+|+||+||+|++.. + ..||+|.+..... ......+.+|+.+|.++ +||||
T Consensus 28 ~~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~~HpnI 103 (325)
T d1rjba_ 28 YDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD----SSEREALMSELKMMTQLGSHENI 103 (325)
T ss_dssp CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTB
T ss_pred CCccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC----HHHHHHHHHHHHHHHHhcCCCcE
Confidence 345677777899999999999999999998742 2 3699999865432 22335688999999998 89999
Q ss_pred ceeeccccCCCceEEEEeeccCCChHHHHhhh------------------------ccChhhhhHHHHHHHHHHHHHHHC
Q 011326 289 VQYLGTDRDEKRLCIFLELVTKGSLASLYQKY------------------------HLSDSQVSSYTRQILNGLKYLHEQ 344 (488)
Q Consensus 289 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~------------------------~ls~~~~~~i~~qi~~aL~yLH~~ 344 (488)
|++++++.+.+.+++|||||++|+|.+++... .+++..++.++.||+.||.|||++
T Consensus 104 v~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~ 183 (325)
T d1rjba_ 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK 183 (325)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999998643 378899999999999999999999
Q ss_pred CCccccCCcccEEECCCCcEEEeecCCcccccCCCc----ccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc
Q 011326 345 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV----KSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT 420 (488)
Q Consensus 345 giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt 420 (488)
||+||||||+|||++.++.+||+|||+|+....... ....||+.|+|||++ ....++.++|||||||++|||++
T Consensus 184 ~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l--~~~~~~~~~DiwS~Gvil~emlt 261 (325)
T d1rjba_ 184 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL--FEGIYTIKSDVWSYGILLWEIFS 261 (325)
T ss_dssp TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHTT
T ss_pred CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHH--cCCCCCcceeccchhHHHHHHHh
Confidence 999999999999999999999999999976544332 245589999999997 45668999999999999999998
Q ss_pred -CCCCCCCCchhhhHHH-hcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 421 -RRHPYSHLEGGQAMFK-IGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 421 -G~~Pf~~~~~~~~~~~-i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
|..||.+.+..+.... +..+..++.|..+|+++.+||.+||+.||++|||++||++|
T Consensus 262 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 262 LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8999988766554444 44555667788999999999999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=398.53 Aligned_cols=248 Identities=27% Similarity=0.477 Sum_probs=209.9
Q ss_pred ccCceeeeeeecccCceEEEEEEecC-C----cEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTDD-G----FFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD 297 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-g----~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 297 (488)
..++|++.++||+|+||.||+|.+++ + ..||||.+.... ......++.+|+.+|++++|||||++++++.+
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc----ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 34679999999999999999998753 2 479999986432 33445678999999999999999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
.+..++||||+.++++.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999999998877543 5999999999999999999999999999999999999999999999999999865
Q ss_pred cCCC-----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcC-CCCCCCCchhhhHHHhcCCCCCCCCCcc
Q 011326 376 TMND-----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFKIGGGELPPVPNSL 449 (488)
Q Consensus 376 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 449 (488)
.... .....||+.|+|||++ ....++.++|||||||++|||++| .+|+...+..+....+..+..++.+..+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l--~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 238 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAI--SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC 238 (283)
T ss_dssp -------------CCCGGGSCHHHH--HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred cCCCccceEeccCCCCccccCHHHH--ccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhh
Confidence 4332 2235689999999997 456799999999999999999995 5556666777778888888888888999
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
++++.+||.+||+.||++|||+.||++
T Consensus 239 ~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 239 PSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 999999999999999999999999976
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=415.68 Aligned_cols=250 Identities=27% Similarity=0.426 Sum_probs=206.8
Q ss_pred ccCceeee-eeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhc-CCCCCcceeeccccC--
Q 011326 223 RITSWQKG-ELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQ-FEHDNIVQYLGTDRD-- 297 (488)
Q Consensus 223 ~~~~y~~~-~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~-- 297 (488)
.+++|++. ++||+|+||.||+|.+. +|+.||||++... ..+.+|+.++.+ .+|||||++++++++
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~ 78 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLY 78 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence 36789887 46999999999999984 7999999998632 346689988655 589999999998865
Q ss_pred --CCceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC---CCcEEEeec
Q 011326 298 --EKRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA---SGSVKLADF 369 (488)
Q Consensus 298 --~~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~---~~~vkL~DF 369 (488)
+..+|+|||||+||+|.+++... ++++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence 46789999999999999999653 5999999999999999999999999999999999999985 567999999
Q ss_pred CCcccccCC-CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHh----cCCCCCC
Q 011326 370 GLAKATTMN-DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKI----GGGELPP 444 (488)
Q Consensus 370 Gla~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i----~~~~~~~ 444 (488)
|+|+..... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.+.......+ ..... .
T Consensus 159 G~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~-~ 235 (335)
T d2ozaa1 159 GFAKETTSHNSLTTPCYTPYYVAPEVL--GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-E 235 (335)
T ss_dssp TTCEECCCCCCCCCCSCCCSSCCCCCC--CGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS-S
T ss_pred ceeeeccCCCccccccCCcccCCcHHH--cCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC-C
Confidence 999865543 34567799999999997 4456899999999999999999999999776554433322 22221 1
Q ss_pred CC----CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 445 VP----NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 445 ~~----~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
.+ ..+|+++.+||.+||++||++|||+.|+++||||++..+
T Consensus 236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 280 (335)
T d2ozaa1 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280 (335)
T ss_dssp CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence 22 358999999999999999999999999999999976543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=401.97 Aligned_cols=256 Identities=30% Similarity=0.507 Sum_probs=208.5
Q ss_pred ccCceeeeeeecccCceEEEEEEec-C-CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhc---CCCCCcceeecccc-
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-D-GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQ---FEHDNIVQYLGTDR- 296 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~-g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~---l~HpnIv~l~~~~~- 296 (488)
..++|++++.||+|+||+||+|.+. + ++.||||++.......... ..+.+|+.+|+. .+||||+++++++.
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~---~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~ 81 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVLRHLETFEHPNVVRLFDVCTV 81 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB---CTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHH---HHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence 3468999999999999999999974 4 6679999997654322222 233456666555 48999999999874
Q ss_pred ----CCCceEEEEeeccCCChHHHH--hhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecC
Q 011326 297 ----DEKRLCIFLELVTKGSLASLY--QKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFG 370 (488)
Q Consensus 297 ----~~~~~~lV~E~~~~gsL~~~l--~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFG 370 (488)
....++++|||+.++.+.... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 82 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchh
Confidence 345789999999998765444 33469999999999999999999999999999999999999999999999999
Q ss_pred CcccccCC-CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC---------
Q 011326 371 LAKATTMN-DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG--------- 440 (488)
Q Consensus 371 la~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~--------- 440 (488)
+++..... ......||+.|+|||++ .+..++.++||||+||++|||++|++||.+.+..+....+...
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~--~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhcccccCCCcccChhhcCcchh--cCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 98765433 34567899999999997 4567899999999999999999999999988766655443210
Q ss_pred -----------------CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 441 -----------------ELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 441 -----------------~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
.....+..+++++.+||.+||++||++|||+.|+++||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 0112345678999999999999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=398.48 Aligned_cols=251 Identities=27% Similarity=0.463 Sum_probs=210.1
Q ss_pred cccccCceeeeeeecccCceEEEEEEec----CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccc
Q 011326 220 FRRRITSWQKGELLGSGSYGFVYEGLTD----DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTD 295 (488)
Q Consensus 220 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 295 (488)
|+...++|++++.||+|+||.||+|.+. .+..||||.+... ........+.+|+.+|++++||||+++++++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 77 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVI 77 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 4455678999999999999999999874 2456888887532 2344566799999999999999999999998
Q ss_pred cCCCceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 296 RDEKRLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 296 ~~~~~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
.+ +.+++||||+++|+|.+++... .+++..++.++.||++||.|||++||+||||||+||+++.++.+||+|||+|+
T Consensus 78 ~~-~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 78 TE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp CS-SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred ec-CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhe
Confidence 64 6789999999999999877543 58999999999999999999999999999999999999999999999999997
Q ss_pred cccCCC---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcc
Q 011326 374 ATTMND---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSL 449 (488)
Q Consensus 374 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 449 (488)
...... .....||+.|+|||.+ ....++.++|||||||++|||++ |.+||...+..+....+..+..++.+..+
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l--~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~ 234 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 234 (273)
T ss_dssp --------------CCGGGCCHHHH--HHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred eccCCcceeccceecCcccchhhHh--ccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 654332 3345689999999997 45668999999999999999998 89999999888888888888888899999
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 450 SRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 450 s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
|+++.+||.+||+.||++|||+.||++|
T Consensus 235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999999876
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=394.34 Aligned_cols=247 Identities=26% Similarity=0.436 Sum_probs=212.3
Q ss_pred cccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC-C
Q 011326 220 FRRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD-E 298 (488)
Q Consensus 220 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~ 298 (488)
|+...++|++++.||+|+||.||+|.++ |..||||++.... ..+.+.+|+.++++++||||++++++|.+ .
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 5677889999999999999999999885 7789999986432 23568899999999999999999998854 5
Q ss_pred CceEEEEeeccCCChHHHHhhh---ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccc
Q 011326 299 KRLCIFLELVTKGSLASLYQKY---HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 375 (488)
Q Consensus 299 ~~~~lV~E~~~~gsL~~~l~~~---~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~ 375 (488)
+.+++||||+++|+|.+++... .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceec
Confidence 6789999999999999998654 3899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHHHH
Q 011326 376 TMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRDAQ 454 (488)
Q Consensus 376 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~ 454 (488)
... .....+|+.|+|||++. +..++.++||||||+++|||++ |++||...+..+....+..+..++.+..+++++.
T Consensus 154 ~~~-~~~~~~~~~y~aPE~l~--~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (262)
T d1byga_ 154 SST-QDTGKLPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 230 (262)
T ss_dssp ---------CCTTTSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHH
T ss_pred CCC-CccccccccCCChHHHh--CCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence 433 34456899999999973 4568999999999999999998 7999999888888888888888899999999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHhC
Q 011326 455 DFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 455 ~Li~~cL~~dP~~Rps~~eil~h 477 (488)
+||.+||+.||.+|||+.+++++
T Consensus 231 ~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 231 EVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcccCHhHCcCHHHHHHH
Confidence 99999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-50 Score=406.71 Aligned_cols=255 Identities=24% Similarity=0.433 Sum_probs=211.1
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC---
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK--- 299 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--- 299 (488)
.++|++++.||+|+||+||+|.+. +|+.||||++.... ......+.+.+|+.+|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 93 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh---cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence 468999999999999999999985 79999999997543 23445678889999999999999999999987655
Q ss_pred ---ceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 300 ---RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 300 ---~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
.+|+||||+ +.+|..++...++++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+|+...
T Consensus 94 ~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 94 DFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 579999999 5588888888889999999999999999999999999999999999999999999999999997664
Q ss_pred CCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC-----------------
Q 011326 377 MNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG----------------- 439 (488)
Q Consensus 377 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~----------------- 439 (488)
. ......||+.|+|||++. ....++.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 173 ~-~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T d1cm8a_ 173 S-EMTGYVVTRWYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250 (346)
T ss_dssp S-SCCSSCSCGGGCCTHHHH-TTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred C-ccccccccccccCHHHHc-CCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence 3 345678999999999973 445679999999999999999999999987765544322211
Q ss_pred -------------CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 440 -------------GELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 440 -------------~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
.........+++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 111123356789999999999999999999999999999998743
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=390.68 Aligned_cols=258 Identities=28% Similarity=0.443 Sum_probs=216.5
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCCceE
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 302 (488)
+++|++++.||+|+||+||+|++. +|+.||||++..... ......++.+|+.+|++++||||+++++++.+.+..+
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 77 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS---STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC---ChHHHHHHHHHHHHHHhcCcCCEEeecccccccccee
Confidence 468999999999999999999985 799999999976542 2345578899999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC--
Q 011326 303 IFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-- 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-- 379 (488)
+|+|++.+++|..++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||.++......
T Consensus 78 iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred EEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 999999999998887655 58999999999999999999999999999999999999999999999999998665432
Q ss_pred cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCC-chhhhHHHhcC-------------------
Q 011326 380 VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHL-EGGQAMFKIGG------------------- 439 (488)
Q Consensus 380 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~-~~~~~~~~i~~------------------- 439 (488)
.....+++.|+|||.+. ....++.++||||+||++|||++|+.||... +..+....+..
T Consensus 158 ~~~~~~~~~~~~pe~~~-~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLF-GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCSCCSCGGGCCHHHHT-TCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred ceeeccccchhhhhHhc-cCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 34456888899999873 3445799999999999999999999986443 33333222210
Q ss_pred ---------CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 440 ---------GELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 440 ---------~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
.........+++++.+||.+||++||.+|||++|+++||||++-..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~ 291 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence 0111233467899999999999999999999999999999997654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-49 Score=395.99 Aligned_cols=250 Identities=24% Similarity=0.450 Sum_probs=219.6
Q ss_pred ccccCceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecc
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGT 294 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 294 (488)
+...++|++.+.||+|+||+||+|+.. ++..||||++.... ......++.+|+.+|++++||||++++++
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc----ChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 334568999999999999999999863 45789999986432 34456789999999999999999999999
Q ss_pred ccCCCceEEEEeeccCCChHHHHhhh-------------------------ccChhhhhHHHHHHHHHHHHHHHCCCccc
Q 011326 295 DRDEKRLCIFLELVTKGSLASLYQKY-------------------------HLSDSQVSSYTRQILNGLKYLHEQNVVHR 349 (488)
Q Consensus 295 ~~~~~~~~lV~E~~~~gsL~~~l~~~-------------------------~ls~~~~~~i~~qi~~aL~yLH~~giiHr 349 (488)
+.+.+..+++|||+++|+|.+++... .+++..+..++.|++.||+|||++||+||
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr 164 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence 99999999999999999999988542 27888999999999999999999999999
Q ss_pred cCCcccEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCC-CC
Q 011326 350 DIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRR-HP 424 (488)
Q Consensus 350 DLkp~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~-~P 424 (488)
||||+|||++.++.+||+|||+|+...... .....||+.|+|||.+ ....++.++|||||||++|||++|. +|
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI--FYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHH--ccCCCChhhhhccchhhHHHHHccCCCC
Confidence 999999999999999999999997543322 2345688999999998 4566999999999999999999985 78
Q ss_pred CCCCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 425 YSHLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 425 f~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
|.+.+..+....+..+..++.+..+++++.+||.+||+.||++|||+.||++
T Consensus 243 ~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 243 YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9998988998999999888899999999999999999999999999999965
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=402.04 Aligned_cols=246 Identities=27% Similarity=0.479 Sum_probs=210.0
Q ss_pred CceeeeeeecccCceEEEEEEec-CCc----EEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGF----FFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
++|+++++||+|+||+||+|.+. +|+ +||+|.+.... .....+.+.+|+.++++++|||||+++++|.++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT----SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 57999999999999999999874 444 58888875432 233456789999999999999999999999875
Q ss_pred ceEEEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 300 RLCIFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
..+++||++.+|+|.+.+... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 567889999999998877544 589999999999999999999999999999999999999999999999999986543
Q ss_pred CC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCCCCCCCCCcccHH
Q 011326 378 ND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGGELPPVPNSLSRD 452 (488)
Q Consensus 378 ~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 452 (488)
.. .....||+.|+|||++ .+..++.++|||||||++|||+| |.+||.+.+..+....+..+..++.|..++++
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l--~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~ 241 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 241 (317)
T ss_dssp TCC--------CCTTTSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHH
T ss_pred ccccccccccccCccccChHHH--hcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence 32 2334689999999997 44568999999999999999998 89999988888887778778878888999999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 453 AQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 453 l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
+.+|+.+||+.||.+|||+.||++|
T Consensus 242 ~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 242 VYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCCCChhhCcCHHHHHHH
Confidence 9999999999999999999999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.6e-50 Score=393.90 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=206.3
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC----
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK---- 299 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~---- 299 (488)
++|++.+.||+|+||.||+|.+. +|+.||||++..... ........+.+|+.++++++||||+++++++.+++
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA--RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT--TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc--cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 56999999999999999999985 799999999976543 23455668999999999999999999999987643
Q ss_pred ceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCC
Q 011326 300 RLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 378 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~ 378 (488)
.+|+||||++|++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++..+|+|||.+......
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 489999999999999888655 6999999999999999999999999999999999999999999999999988654332
Q ss_pred -----CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCCC---CCCCccc
Q 011326 379 -----DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGELP---PVPNSLS 450 (488)
Q Consensus 379 -----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s 450 (488)
......||+.|+|||++ .+..++.++||||+||++|||++|++||.+.+..+....+...... .....+|
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~--~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 242 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQA--RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242 (277)
T ss_dssp --------------TTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred cccccccccccCcccccCHHHH--cCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence 23456799999999997 4566899999999999999999999999988777766555443322 2346789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHhCccC
Q 011326 451 RDAQDFILKCLQVNPNDRPTAAQLMEHPFI 480 (488)
Q Consensus 451 ~~l~~Li~~cL~~dP~~Rps~~eil~hp~f 480 (488)
+++.+||.+||++||.+||+..+.+.|+|.
T Consensus 243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 999999999999999999944444456654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=398.16 Aligned_cols=260 Identities=26% Similarity=0.429 Sum_probs=208.4
Q ss_pred ccCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC----
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD---- 297 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~---- 297 (488)
.+++|++++.||+|+||+||+|.+. +|+.||||++...... .....++.+|+.+|++++||||+++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~ 84 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNLIEICRTKASP 84 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT---TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc---hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence 4789999999999999999999985 7999999998765432 2233567899999999999999999998754
Q ss_pred ----CCceEEEEeeccCCChHHHHhh-hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCc
Q 011326 298 ----EKRLCIFLELVTKGSLASLYQK-YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLA 372 (488)
Q Consensus 298 ----~~~~~lV~E~~~~gsL~~~l~~-~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla 372 (488)
++.+++||||+.++.+...... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 85 ~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp ------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeeccee
Confidence 4568999999998777655433 35899999999999999999999999999999999999999999999999999
Q ss_pred ccccCC------CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCC---CCC
Q 011326 373 KATTMN------DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGG---ELP 443 (488)
Q Consensus 373 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~---~~~ 443 (488)
+..... ......||+.|+|||++. ....++.++||||+||++|||++|+.||.+.+..+....+... ..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~-~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLL-GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHT-TCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eecccccccccccccceecCHHHhhHHHHc-CCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 654422 233457999999999973 3456899999999999999999999999887766554433211 000
Q ss_pred CC-------------------C---------CcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCCC
Q 011326 444 PV-------------------P---------NSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQT 486 (488)
Q Consensus 444 ~~-------------------~---------~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~~ 486 (488)
.. + ...++++.+||.+||++||++|||++|+++||||+..-.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p 314 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 314 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCC
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCC
Confidence 00 0 0136788899999999999999999999999999975433
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=402.60 Aligned_cols=256 Identities=28% Similarity=0.484 Sum_probs=209.5
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC----
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK---- 299 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~---- 299 (488)
.+|++++.||+|+||+||+|.+. +|+.||||++.+.. .....+.+.+|+.+|++++||||+++++++..+.
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE----HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT----CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc----ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 46999999999999999999875 89999999997532 3445567889999999999999999999986543
Q ss_pred ceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC
Q 011326 300 RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 379 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~ 379 (488)
..+++++++.+|+|.+++...++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred ceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 23555566778999999988899999999999999999999999999999999999999999999999999997543322
Q ss_pred -----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC---------------
Q 011326 380 -----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG--------------- 439 (488)
Q Consensus 380 -----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~--------------- 439 (488)
.....||+.|+|||++. ....++.++||||+||++|+|++|+.||.+.+..+.......
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTT-TBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred ccceeeccccccceechHHHhh-cCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 34566999999999973 445678999999999999999999999987665433322210
Q ss_pred ------------CCCC---CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 440 ------------GELP---PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 440 ------------~~~~---~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
.... .....+++++.+|+.+||+.||.+|||++|+++||||++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 0000 112457889999999999999999999999999999996544
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=393.22 Aligned_cols=258 Identities=26% Similarity=0.449 Sum_probs=227.0
Q ss_pred ccccccCceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceee
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYL 292 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~ 292 (488)
+|+...++|++++.||+|+||.||+|.+. ++..||||++... ........+.+|+.++++++||||++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~----~~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA----ASMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT----SCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc----cChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence 47777899999999999999999999763 3678999998643 2344556789999999999999999999
Q ss_pred ccccCCCceEEEEeeccCCChHHHHhhh-----------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCC
Q 011326 293 GTDRDEKRLCIFLELVTKGSLASLYQKY-----------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDAS 361 (488)
Q Consensus 293 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~-----------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~ 361 (488)
+++..++..++||||+++|+|.+++... .+++..+..++.|++.||.|||+++|+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 169 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCC
Confidence 9999999999999999999999988543 26788899999999999999999999999999999999999
Q ss_pred CcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcC-CCCCCCCchhhhHHH
Q 011326 362 GSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHLEGGQAMFK 436 (488)
Q Consensus 362 ~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG-~~Pf~~~~~~~~~~~ 436 (488)
+++||+|||+++...... .....||+.|+|||.+ .+..++.++||||||+++|||++| .+||.+.+..+....
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l--~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~ 247 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHH--ccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999997654332 2344689999999997 456689999999999999999997 588999888888888
Q ss_pred hcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh------CccCCC
Q 011326 437 IGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME------HPFIKR 482 (488)
Q Consensus 437 i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~------hp~f~~ 482 (488)
+..+..++.+..+++++.+||.+||+.||++|||+.||++ +|+|++
T Consensus 248 i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 248 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred HHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 8888888889999999999999999999999999999998 666653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=390.31 Aligned_cols=253 Identities=26% Similarity=0.442 Sum_probs=217.9
Q ss_pred cccccccCceeeeeeecccCceEEEEEEec--------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCc
Q 011326 218 GKFRRRITSWQKGELLGSGSYGFVYEGLTD--------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNI 288 (488)
Q Consensus 218 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnI 288 (488)
.+|....++|++++.||+|+||.||+|+.. ++..||||++.... ......++.+|...+.++ +||||
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~e~~~l~~~~~HpnI 81 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNI 81 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC----CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc----ChHHHHHHHHHHHHHHHhcCCCeE
Confidence 346677789999999999999999999753 23479999987532 344556788899999888 79999
Q ss_pred ceeeccccCCCceEEEEeeccCCChHHHHhhh-----------------ccChhhhhHHHHHHHHHHHHHHHCCCccccC
Q 011326 289 VQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-----------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDI 351 (488)
Q Consensus 289 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-----------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDL 351 (488)
|+++++|.+++..++||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||
T Consensus 82 v~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDi 161 (299)
T d1fgka_ 82 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDL 161 (299)
T ss_dssp CCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeee
Confidence 99999999999999999999999999998543 3899999999999999999999999999999
Q ss_pred CcccEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCC
Q 011326 352 KCANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYS 426 (488)
Q Consensus 352 kp~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~ 426 (488)
||+|||++.++.+||+|||+++...... .....||+.|+|||.+ .+..++.++||||||+++|||++ |.+||.
T Consensus 162 Kp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l--~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 162 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL--FDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp SGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHh--cCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence 9999999999999999999998654432 2345689999999997 44679999999999999999998 799999
Q ss_pred CCchhhhHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 427 HLEGGQAMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 427 ~~~~~~~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+.+..+....+..+..++.+..+++++.+||.+||+.||.+|||+.||++
T Consensus 240 ~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 240 GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp TCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 88888888888888888889999999999999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=391.72 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=204.8
Q ss_pred ccccccCceeeeeeecccCceEEEEEEec------CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCccee
Q 011326 219 KFRRRITSWQKGELLGSGSYGFVYEGLTD------DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQY 291 (488)
Q Consensus 219 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l 291 (488)
+|+...++|++++.||+|+||.||+|.+. +++.||||.+.... .......+.+|..++.++ +|+||+.+
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~----~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----CcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 45556688999999999999999999863 35689999986432 234456677888888776 68999999
Q ss_pred eccccC-CCceEEEEeeccCCChHHHHhhh-----------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCc
Q 011326 292 LGTDRD-EKRLCIFLELVTKGSLASLYQKY-----------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKC 353 (488)
Q Consensus 292 ~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~-----------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp 353 (488)
++++.+ ++.+++|||||++|+|.+++... .+++..+..++.||++||.|||++||+||||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp 162 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 162 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCc
Confidence 998765 45789999999999999998542 388999999999999999999999999999999
Q ss_pred ccEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcC-CCCCCCC
Q 011326 354 ANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTR-RHPYSHL 428 (488)
Q Consensus 354 ~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG-~~Pf~~~ 428 (488)
+|||++.++++||+|||+|+...... .....||+.|+|||++ .+..++.++|||||||++|||++| .+||.+.
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l--~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI--FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHh--hcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999997654332 2346799999999997 456689999999999999999986 5678776
Q ss_pred chhh-hHHHhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 429 EGGQ-AMFKIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 429 ~~~~-~~~~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
+..+ ....+..+..++.+..+++++.+||.+||+.||++|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5444 344455566677888999999999999999999999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-49 Score=398.24 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=205.4
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeecccc------C
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDR------D 297 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~------~ 297 (488)
.+|+..++||+|+||+||+|++. +|+.||||++...... ..+|+.+|++++||||+++++++. +
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~ 90 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---------HHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence 37999999999999999999985 7999999999764321 236999999999999999999874 3
Q ss_pred CCceEEEEeeccCCChHHHHh----hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC-cEEEeecCCc
Q 011326 298 EKRLCIFLELVTKGSLASLYQ----KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG-SVKLADFGLA 372 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~----~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~-~vkL~DFGla 372 (488)
...+++||||++++.+..+.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccch
Confidence 345799999998865444432 23599999999999999999999999999999999999999775 8999999999
Q ss_pred ccccCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC------------
Q 011326 373 KATTMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG------------ 439 (488)
Q Consensus 373 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~------------ 439 (488)
+...... .....||+.|+|||.+ .....++.++||||+||++|||++|+.||...+..+....+..
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 171 KQLVRGEPNVSYICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp EECCTTSCCCSCCSCTTSCCHHHH-TTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hhccCCcccccccccccccChHHh-hcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 7665433 4567899999999987 3455689999999999999999999999988776555443321
Q ss_pred -------CCCC---------CCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 440 -------GELP---------PVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 440 -------~~~~---------~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
...+ .....+++++.+||.+||++||++|||+.|+++||||++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0111 1123578999999999999999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-50 Score=401.43 Aligned_cols=259 Identities=28% Similarity=0.448 Sum_probs=216.0
Q ss_pred ccCceeeeeeecccCceEEEEEEe----cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCC-CCcceeeccccC
Q 011326 223 RITSWQKGELLGSGSYGFVYEGLT----DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH-DNIVQYLGTDRD 297 (488)
Q Consensus 223 ~~~~y~~~~~LG~G~fg~Vy~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~ 297 (488)
.+++|++++.||+|+||+||+|.. .+|+.||||.+.+..... .......+.+|+.++++++| |||+++++++.+
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE-EESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhcc-chHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 468899999999999999999986 258999999986532211 11123456789999999976 899999999999
Q ss_pred CCceEEEEeeccCCChHHHHhhh-ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY-HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~-~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
....+++|||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 99999999999999999988665 58899999999999999999999999999999999999999999999999997553
Q ss_pred CCC---cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC---CCCCCCCCccc
Q 011326 377 MND---VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG---GELPPVPNSLS 450 (488)
Q Consensus 377 ~~~---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~s 450 (488)
... .....|++.|++||.+......++.++|||||||+||+|++|+.||...+..+....+.. ...++.+..++
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s 260 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence 322 345679999999999865555688999999999999999999999977655443333322 23456677899
Q ss_pred HHHHHHHHHhhhhCCCCCC-----CHHHHHhCccCCC
Q 011326 451 RDAQDFILKCLQVNPNDRP-----TAAQLMEHPFIKR 482 (488)
Q Consensus 451 ~~l~~Li~~cL~~dP~~Rp-----s~~eil~hp~f~~ 482 (488)
+++.+||.+||++||.+|| |++|+++||||++
T Consensus 261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999999999999999 5899999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=399.70 Aligned_cols=257 Identities=28% Similarity=0.409 Sum_probs=211.5
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCC----
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDE---- 298 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~---- 298 (488)
.++|++.+.||+|+||+||+|.+. +|+.||||++.... .......++.+|+.+|++++|||||++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~ 93 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 93 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh---cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence 467999999999999999999975 79999999997543 2344556788999999999999999999987533
Q ss_pred -CceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 299 -KRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 299 -~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
...+++|+++.+|+|.+++...++++..+..++.||+.||+|||++||+||||||+|||++.++.+|++|||++....
T Consensus 94 ~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~- 172 (348)
T d2gfsa1 94 EFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD- 172 (348)
T ss_dssp TCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT-
T ss_pred cCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC-
Confidence 344666778889999999988899999999999999999999999999999999999999999999999999986554
Q ss_pred CCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcCCCC---------------
Q 011326 378 NDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGGGEL--------------- 442 (488)
Q Consensus 378 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~~~~--------------- 442 (488)
.......||+.|+|||.+ .....++.++||||+||++|+|++|+.||.+.+.......+.....
T Consensus 173 ~~~~~~~g~~~y~apE~~-~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 173 DEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp GGGSSSCHHHHTSCHHHH-TTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred cccccccccccccCchhh-cCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 234456799999999986 3445578999999999999999999999988765544433321100
Q ss_pred -------CC--------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCCC
Q 011326 443 -------PP--------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPLQ 485 (488)
Q Consensus 443 -------~~--------~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~~ 485 (488)
.. ....+++++.+||.+||+.||.+|||+.|+++||||++...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 00 12357899999999999999999999999999999997643
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=386.77 Aligned_cols=248 Identities=29% Similarity=0.483 Sum_probs=202.7
Q ss_pred cCceeeeeeecccCceEEEEEEec--C--CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD--D--GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK 299 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~--~--g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 299 (488)
..+|++.+.||+|+||.||+|... + +..||||++...... .....++|.+|+.+|++++||||+++++++.++
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~- 83 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS--QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP- 83 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-
Confidence 367999999999999999999863 2 347899998755432 234557899999999999999999999999764
Q ss_pred ceEEEEeeccCCChHHHHhh--hccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccC
Q 011326 300 RLCIFLELVTKGSLASLYQK--YHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM 377 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~--~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~ 377 (488)
..++||||+++|+|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 67899999999999887654 3599999999999999999999999999999999999999999999999999986644
Q ss_pred CC-----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-CCCCCCCCchhhhHHHhcCC-CCCCCCCccc
Q 011326 378 ND-----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-RRHPYSHLEGGQAMFKIGGG-ELPPVPNSLS 450 (488)
Q Consensus 378 ~~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~s 450 (488)
.. .....|+..|+|||.+ .+..++.++||||||+++|||++ |.+||.+.+..+....+... ..++.+..+|
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~--~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESL--KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHH--HHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred CCCcceecCccccCcccCCHHHH--hCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccccc
Confidence 32 2345578899999998 44568999999999999999998 89999998888887776544 4556778899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 451 RDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 451 ~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
+++.+||.+||+.||++|||+.||++
T Consensus 242 ~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 242 QDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999999974
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=387.54 Aligned_cols=258 Identities=25% Similarity=0.419 Sum_probs=220.7
Q ss_pred CCCCCcccccccCceeeeeeecccCceEEEEEEe------cCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CC
Q 011326 213 NVSPNGKFRRRITSWQKGELLGSGSYGFVYEGLT------DDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EH 285 (488)
Q Consensus 213 ~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~H 285 (488)
.++++.+|+...++|++++.||+|+||.||+|++ .++..||||++.... .......+.+|+.+++++ +|
T Consensus 11 ~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~E~~~~~~l~~H 86 (311)
T d1t46a_ 11 QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----HLTEREALMSELKVLSYLGNH 86 (311)
T ss_dssp TSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCC
T ss_pred cCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc----CHHHHHHHHHHHHHHHhccCC
Confidence 4455667888889999999999999999999975 256789999997542 344556789999999998 69
Q ss_pred CCcceeeccccCCCceEEEEeeccCCChHHHHhhh-------------------ccChhhhhHHHHHHHHHHHHHHHCCC
Q 011326 286 DNIVQYLGTDRDEKRLCIFLELVTKGSLASLYQKY-------------------HLSDSQVSSYTRQILNGLKYLHEQNV 346 (488)
Q Consensus 286 pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-------------------~ls~~~~~~i~~qi~~aL~yLH~~gi 346 (488)
||||++++++.+++..+++||||++|+|.+++... .+++..+..++.||+.||+|||++|+
T Consensus 87 pnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~i 166 (311)
T d1t46a_ 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC 166 (311)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 99999999999999999999999999999998643 38899999999999999999999999
Q ss_pred ccccCCcccEEECCCCcEEEeecCCcccccCCC----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHc-C
Q 011326 347 VHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLT-R 421 (488)
Q Consensus 347 iHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLlt-G 421 (488)
+||||||+||+++.++.++++|||.++...... .....||+.|+|||.+ ....++.++||||||+++|||++ |
T Consensus 167 vHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DIwS~G~~l~ellt~g 244 (311)
T d1t46a_ 167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI--FNCVYTFESDVWSYGIFLWELFSLG 244 (311)
T ss_dssp CCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred eecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHh--cCCCCCCcccccchHHHHHHHHhCC
Confidence 999999999999999999999999998655432 2346789999999997 45668999999999999999999 6
Q ss_pred CCCCCCCchhhhHH-HhcCCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 422 RHPYSHLEGGQAMF-KIGGGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 422 ~~Pf~~~~~~~~~~-~i~~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
.+||...+..+.+. .+..+..+..+..+++++.+||.+||+.||++|||++||++
T Consensus 245 ~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 245 SSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 66676665544433 34455666777889999999999999999999999999985
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=390.84 Aligned_cols=250 Identities=25% Similarity=0.441 Sum_probs=214.2
Q ss_pred cccCceeeeeeecccCceEEEEEEec-CCc--EEEEEEeecCCCCCcchhHHHHHHHHHHHHhcC-CCCCcceeeccccC
Q 011326 222 RRITSWQKGELLGSGSYGFVYEGLTD-DGF--FFAVKEVSLQDEGPRGKQSILQLEQEISLLGQF-EHDNIVQYLGTDRD 297 (488)
Q Consensus 222 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~--~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~ 297 (488)
...++|+++++||+|+||.||+|.+. +|. .||||.+..... ....+.+.+|+.+|+++ +|||||++++++.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 82 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS----KDDHRDFAGELEVLCKLGHHPNIINLLGACEH 82 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC----hHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence 34578999999999999999999885 454 477787754322 22345789999999998 79999999999999
Q ss_pred CCceEEEEeeccCCChHHHHhhh-----------------ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC
Q 011326 298 EKRLCIFLELVTKGSLASLYQKY-----------------HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA 360 (488)
Q Consensus 298 ~~~~~lV~E~~~~gsL~~~l~~~-----------------~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~ 360 (488)
++.+++||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 162 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC
Confidence 99999999999999999998542 4899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCCcccccCCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCC-CCCCCCchhhhHHHhc
Q 011326 361 SGSVKLADFGLAKATTMND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRR-HPYSHLEGGQAMFKIG 438 (488)
Q Consensus 361 ~~~vkL~DFGla~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~-~Pf~~~~~~~~~~~i~ 438 (488)
++.+||+|||+++...... .....||..|+|||.+ ....++.++||||||+++|||++|. +||...+..+....+.
T Consensus 163 ~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l--~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240 (309)
T ss_dssp GGCEEECCTTCEESSCEECCC----CCTTTCCHHHH--HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred CCceEEccccccccccccccccceecCCcccchHHh--ccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 9999999999997654433 2345689999999998 4556899999999999999999965 6788888888888888
Q ss_pred CCCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 439 GGELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 439 ~~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
.+..++.+..+++++.+||.+||+.||++|||+.||++|
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 888888889999999999999999999999999999976
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4e-48 Score=389.36 Aligned_cols=250 Identities=26% Similarity=0.456 Sum_probs=206.5
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccC--CC
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRD--EK 299 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~--~~ 299 (488)
.++|++++.||+|+||+||+|++. +|+.||||++.... ..++.+|+.+|++++ ||||+++++++.. ..
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~ 105 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 105 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence 468999999999999999999985 79999999986421 246789999999995 9999999999864 45
Q ss_pred ceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCC-cEEEeecCCcccccCC
Q 011326 300 RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASG-SVKLADFGLAKATTMN 378 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~-~vkL~DFGla~~~~~~ 378 (488)
.+++||||+.+++|..+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 106 ~~~~v~e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 106 TPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp SEEEEEECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred ceeEEEeecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 799999999999998764 3599999999999999999999999999999999999998655 6999999999866543
Q ss_pred -CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhh-hHHHhc---------------CC-
Q 011326 379 -DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ-AMFKIG---------------GG- 440 (488)
Q Consensus 379 -~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~-~~~~i~---------------~~- 440 (488)
......||+.|+|||.+ .....++.++||||+||++|+|++|+.||....... ....+. ..
T Consensus 184 ~~~~~~~~t~~y~aPE~~-~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp CCCCSCCSCGGGCCHHHH-TTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CcccccccCccccCcccc-cCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 34567799999999997 344557999999999999999999999997544321 111000 00
Q ss_pred --------------------CCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCCC
Q 011326 441 --------------------ELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRPL 484 (488)
Q Consensus 441 --------------------~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~~ 484 (488)
........+++++.+||.+||++||.+|||++|+|+||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 00112234789999999999999999999999999999998754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=392.80 Aligned_cols=253 Identities=25% Similarity=0.385 Sum_probs=199.7
Q ss_pred cCceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC-----
Q 011326 224 ITSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD----- 297 (488)
Q Consensus 224 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----- 297 (488)
+++|+++++||+|+||+||+|.+. +|..||||++..... ......++.+|+.+|++++||||+++++++..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc---CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccc
Confidence 468999999999999999999986 799999999976542 34455678899999999999999999999853
Q ss_pred -CCceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCccccc
Q 011326 298 -EKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 376 (488)
Q Consensus 298 -~~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~ 376 (488)
...+|+||||+.++.+..+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||+++...
T Consensus 93 ~~~~~~iv~Ey~~~~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 93 EFQDVYLVMELMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp TCCEEEEEEECCSEEHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred cCceeEEEEeccchHHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence 4678999999988655544 3468999999999999999999999999999999999999999999999999987655
Q ss_pred CCC-cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHhcC----------------
Q 011326 377 MND-VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKIGG---------------- 439 (488)
Q Consensus 377 ~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i~~---------------- 439 (488)
... .....||+.|+|||++ .+..++.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 171 ~~~~~~~~~~t~~y~aPE~l--~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 171 TSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp ----------CCTTCCHHHH--TTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred cccccccccccccccChhhh--cCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence 433 3456799999999997 446789999999999999999999999987765544332210
Q ss_pred ------CCCCC-------------------CCCcccHHHHHHHHHhhhhCCCCCCCHHHHHhCccCCCC
Q 011326 440 ------GELPP-------------------VPNSLSRDAQDFILKCLQVNPNDRPTAAQLMEHPFIKRP 483 (488)
Q Consensus 440 ------~~~~~-------------------~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~hp~f~~~ 483 (488)
..... .+...++++.+||++||++||++|||++|+|+||||++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 00000 001246789999999999999999999999999999863
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=380.65 Aligned_cols=251 Identities=25% Similarity=0.415 Sum_probs=209.4
Q ss_pred eeeeeecccCceEEEEEEecC----CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccC-CCceE
Q 011326 228 QKGELLGSGSYGFVYEGLTDD----GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRD-EKRLC 302 (488)
Q Consensus 228 ~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~~ 302 (488)
+..++||+|+||+||+|.+.+ +..||||.+... .......++.+|+++|++++||||+++++++.+ +...+
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC----CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc----cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 346789999999999998742 236899998642 245556789999999999999999999999764 56899
Q ss_pred EEEeeccCCChHHHHhhhc--cChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcccccCCC-
Q 011326 303 IFLELVTKGSLASLYQKYH--LSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND- 379 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~~--ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~- 379 (488)
+|||||++|+|.+++.... +++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999999999886553 7788899999999999999999999999999999999999999999999997654332
Q ss_pred -----cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCC-CCchhhhHHHhcCCCCCCCCCcccHHH
Q 011326 380 -----VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYS-HLEGGQAMFKIGGGELPPVPNSLSRDA 453 (488)
Q Consensus 380 -----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~s~~l 453 (488)
.....||+.|+|||.+ ....++.++||||||+++|||++|..||. ..+..+....+..+..+..|..+++++
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~--~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l 263 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 263 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHH
T ss_pred ccceecccccccccccChHHH--hcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHH
Confidence 2245689999999997 44568999999999999999999766664 444555666677777888888999999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHhC------ccCCCCC
Q 011326 454 QDFILKCLQVNPNDRPTAAQLMEH------PFIKRPL 484 (488)
Q Consensus 454 ~~Li~~cL~~dP~~Rps~~eil~h------p~f~~~~ 484 (488)
.+||.+||+.||++|||+.||++| +|..+..
T Consensus 264 ~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~~ 300 (311)
T d1r0pa_ 264 YEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 300 (311)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhhc
Confidence 999999999999999999999988 6666543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-46 Score=369.63 Aligned_cols=246 Identities=26% Similarity=0.333 Sum_probs=193.0
Q ss_pred CceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcceeeccccCCC----c
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQYLGTDRDEK----R 300 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----~ 300 (488)
.+|.+.+.||+|+||.||+|+. +|..||||++... .........|+..+.+++||||+++++++.+++ .
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc------chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 4688999999999999999986 5889999998632 122223345666667889999999999987643 6
Q ss_pred eEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHH--------CCCccccCCcccEEECCCCcEEEeecCCc
Q 011326 301 LCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHE--------QNVVHRDIKCANILVDASGSVKLADFGLA 372 (488)
Q Consensus 301 ~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~--------~giiHrDLkp~NILl~~~~~vkL~DFGla 372 (488)
+++||||+++|+|.+++++.++++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 8999999999999999999899999999999999999999996 59999999999999999999999999999
Q ss_pred ccccCCC------cccCCCCCcccCchhhccccC----CCChhhhHHHHHHHHHHHHcCCCCCCCCchh-----------
Q 011326 373 KATTMND------VKSCKGTAFWMAPEVVNLKKD----GYGLTADIWSLGCTVLEMLTRRHPYSHLEGG----------- 431 (488)
Q Consensus 373 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~----~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~----------- 431 (488)
+...... .....||+.|+|||++..... .++.++|||||||+||||+||..||......
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 7654332 235679999999999743211 2577899999999999999998876432211
Q ss_pred ----hhHHHhc-CCCCCCCCCc-----ccHHHHHHHHHhhhhCCCCCCCHHHHHhC
Q 011326 432 ----QAMFKIG-GGELPPVPNS-----LSRDAQDFILKCLQVNPNDRPTAAQLMEH 477 (488)
Q Consensus 432 ----~~~~~i~-~~~~~~~~~~-----~s~~l~~Li~~cL~~dP~~Rps~~eil~h 477 (488)
....... ....+..+.. .+..+.+|+.+||+.||++|||+.||+++
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1111112 2222333332 33568999999999999999999999763
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-44 Score=359.64 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=196.1
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCcce-eeccccCCCceE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNIVQ-YLGTDRDEKRLC 302 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~-l~~~~~~~~~~~ 302 (488)
++|++++.||+|+||.||+|.+. +|+.||||++...... .++..|+++++.++|+|++. +.+++.+++..+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-------HHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 46999999999999999999885 7999999998764322 23678999999998776555 555667788899
Q ss_pred EEEeeccCCChHHHHh--hhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC---CCcEEEeecCCcccccC
Q 011326 303 IFLELVTKGSLASLYQ--KYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA---SGSVKLADFGLAKATTM 377 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~--~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~---~~~vkL~DFGla~~~~~ 377 (488)
+||||+.+ +|...+. ...+++..+..++.|++.||+|||++||+||||||+|||++. +..++|+|||+|+....
T Consensus 80 ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 80 MVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 99999955 6655543 346999999999999999999999999999999999999864 55799999999986543
Q ss_pred CC---------cccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhhhHHHh---c----CCC
Q 011326 378 ND---------VKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQAMFKI---G----GGE 441 (488)
Q Consensus 378 ~~---------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~~~~~i---~----~~~ 441 (488)
.. .....||+.|+|||.+ .+..++.++|||||||++|||++|+.||...........+ . ...
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHH--TTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred cccccceeccccCCcCCCccccCHHHH--hCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 22 2345799999999997 4556899999999999999999999999775544322211 1 111
Q ss_pred CCCCCCcccHHHHHHHHHhhhhCCCCCCCHH---HHHhCccCCCCC
Q 011326 442 LPPVPNSLSRDAQDFILKCLQVNPNDRPTAA---QLMEHPFIKRPL 484 (488)
Q Consensus 442 ~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~---eil~hp~f~~~~ 484 (488)
.+.....+|+++.+++.+||+.||++||++. ++++|+|.++..
T Consensus 237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~ 282 (299)
T d1ckia_ 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282 (299)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence 1223457899999999999999999999987 457787765443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.6e-44 Score=352.27 Aligned_cols=242 Identities=21% Similarity=0.295 Sum_probs=198.1
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCC-CCcceeeccccCCCceE
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH-DNIVQYLGTDRDEKRLC 302 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~ 302 (488)
++|++++.||+|+||+||+|++. +|+.||||++...... ..+.+|+++++.++| +|++.+++++.++...+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 47999999999999999999985 7999999998654321 235678888888865 89999999999999999
Q ss_pred EEEeeccCCChHHHHhhh--ccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECC-----CCcEEEeecCCcccc
Q 011326 303 IFLELVTKGSLASLYQKY--HLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDA-----SGSVKLADFGLAKAT 375 (488)
Q Consensus 303 lV~E~~~~gsL~~~l~~~--~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~-----~~~vkL~DFGla~~~ 375 (488)
+||||+ +++|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+..
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 999999 57998888653 5999999999999999999999999999999999999974 578999999999765
Q ss_pred cCC---------CcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhh---hHHHhcC----
Q 011326 376 TMN---------DVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ---AMFKIGG---- 439 (488)
Q Consensus 376 ~~~---------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~---~~~~i~~---- 439 (488)
... ......||+.|+|||++ .+..++.++||||||+++|||++|..||.+..... ....+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~--~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccCccccceeecccCceEEchhhcCHHHh--cCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 432 13356799999999997 45669999999999999999999999997654332 2222211
Q ss_pred CCCCCCCCcccHHHHHHHHHhhhhCCCCCCCHHHHHh
Q 011326 440 GELPPVPNSLSRDAQDFILKCLQVNPNDRPTAAQLME 476 (488)
Q Consensus 440 ~~~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~eil~ 476 (488)
...+.....+|+++.+++..|++.+|++||+++.+.+
T Consensus 235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1112234568999999999999999999999776643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.5e-42 Score=346.97 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=190.9
Q ss_pred CceeeeeeecccCceEEEEEEec-CCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-----------CCCcceee
Q 011326 225 TSWQKGELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-----------HDNIVQYL 292 (488)
Q Consensus 225 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-----------HpnIv~l~ 292 (488)
++|+++++||+|+||+||+|++. +|+.||||++... ......+.+|+.+++.++ |+||++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~------~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc------ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 35999999999999999999985 7999999999742 223356678888888775 57888898
Q ss_pred ccccC--CCceEEEEeeccCCChHH-HH---hhhccChhhhhHHHHHHHHHHHHHHH-CCCccccCCcccEEECCCC---
Q 011326 293 GTDRD--EKRLCIFLELVTKGSLAS-LY---QKYHLSDSQVSSYTRQILNGLKYLHE-QNVVHRDIKCANILVDASG--- 362 (488)
Q Consensus 293 ~~~~~--~~~~~lV~E~~~~gsL~~-~l---~~~~ls~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~NILl~~~~--- 362 (488)
+++.. ....+++|+++..+.... .. ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 88754 345667777765553322 22 22358999999999999999999998 8999999999999998665
Q ss_pred ---cEEEeecCCcccccCCCcccCCCCCcccCchhhccccCCCChhhhHHHHHHHHHHHHcCCCCCCCCchhh------h
Q 011326 363 ---SVKLADFGLAKATTMNDVKSCKGTAFWMAPEVVNLKKDGYGLTADIWSLGCTVLEMLTRRHPYSHLEGGQ------A 433 (488)
Q Consensus 363 ---~vkL~DFGla~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvlL~eLltG~~Pf~~~~~~~------~ 433 (488)
.++++|||.+..... ......||+.|+|||++ ....++.++|+||+||++++|++|+.||...+... .
T Consensus 167 ~~~~~kl~dfg~s~~~~~-~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDE-HYTNSIQTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp TEEEEEECCCTTCEETTB-CCCSCCSCGGGCCHHHH--HTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ccceeeEeeccccccccc-ccccccccccccChhhc--cccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 399999999875543 33566799999999987 35568999999999999999999999996543211 0
Q ss_pred HHH---hcC-----------------------CC---------------CCCCCCcccHHHHHHHHHhhhhCCCCCCCHH
Q 011326 434 MFK---IGG-----------------------GE---------------LPPVPNSLSRDAQDFILKCLQVNPNDRPTAA 472 (488)
Q Consensus 434 ~~~---i~~-----------------------~~---------------~~~~~~~~s~~l~~Li~~cL~~dP~~Rps~~ 472 (488)
... ... .. ........++++.+||.+||++||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 000 000 00 0011233567899999999999999999999
Q ss_pred HHHhCccCCCCC
Q 011326 473 QLMEHPFIKRPL 484 (488)
Q Consensus 473 eil~hp~f~~~~ 484 (488)
|+|+||||++..
T Consensus 324 e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 324 GLVNHPWLKDTL 335 (362)
T ss_dssp HHHTCGGGTTCT
T ss_pred HHhcCcccCCCC
Confidence 999999999654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=2.4e-25 Score=205.27 Aligned_cols=172 Identities=16% Similarity=0.159 Sum_probs=125.2
Q ss_pred eeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCC-------------cchhHHHHHHHHHHHHhcCCCCCcceeec
Q 011326 227 WQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGP-------------RGKQSILQLEQEISLLGQFEHDNIVQYLG 293 (488)
Q Consensus 227 y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~-------------~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~ 293 (488)
+.+++.||+|+||+||+|.+.+|+.||||++....... ..........+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 35789999999999999999899999999876432110 00112334567889999999999998886
Q ss_pred cccCCCceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHCCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 294 TDRDEKRLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 294 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
+.. .+++|||++++.+. .+++..+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||+|.
T Consensus 82 ~~~----~~lvme~~~~~~~~------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~ 150 (191)
T d1zara2 82 WEG----NAVLMELIDAKELY------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSV 150 (191)
T ss_dssp EET----TEEEEECCCCEEGG------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCE
T ss_pred ecC----CEEEEEeecccccc------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcc
Confidence 632 37999999986553 36777888999999999999999999999999999999865 48999999986
Q ss_pred cccCCCcccCCCCCcccCchh--h-ccccCCCChhhhHHHHHHHH
Q 011326 374 ATTMNDVKSCKGTAFWMAPEV--V-NLKKDGYGLTADIWSLGCTV 415 (488)
Q Consensus 374 ~~~~~~~~~~~gt~~y~aPE~--~-~~~~~~~s~k~DvwSlGvlL 415 (488)
....+... .|....+ + ..-...|+.++|+||+.--+
T Consensus 151 ~~~~~~~~------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 151 EVGEEGWR------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ETTSTTHH------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred cCCCCCcH------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 65433221 1211110 0 01123467789999976544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.36 E-value=5.5e-07 Score=84.07 Aligned_cols=143 Identities=14% Similarity=0.152 Sum_probs=94.2
Q ss_pred ccccCceeeeeeecccCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCC-CCCcceeeccccCCC
Q 011326 221 RRRITSWQKGELLGSGSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFE-HDNIVQYLGTDRDEK 299 (488)
Q Consensus 221 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~ 299 (488)
+..+..|+..+..+.++.+.||+... ++..+++|......... ...+.+|...+..+. +--+.+++.++.+++
T Consensus 10 ~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~-----~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc-----hhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 34466777777666666679998754 45667788876443221 123556777776653 323566777777788
Q ss_pred ceEEEEeeccCCChHHHHhhhccChhhhhHHHHHHHHHHHHHHHC-----------------------------------
Q 011326 300 RLCIFLELVTKGSLASLYQKYHLSDSQVSSYTRQILNGLKYLHEQ----------------------------------- 344 (488)
Q Consensus 300 ~~~lV~E~~~~gsL~~~l~~~~ls~~~~~~i~~qi~~aL~yLH~~----------------------------------- 344 (488)
..++||++++|.++..... +......++.++...+..||+.
T Consensus 84 ~~~lv~~~l~G~~~~~~~~----~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEEECCSSEEHHHHTT----TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred ceEEEEEeccccccccccc----ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 8999999999987754321 2222333444555555555531
Q ss_pred ------------------------CCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 345 ------------------------NVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 345 ------------------------giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
.++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 16899999999999877666799999763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.25 E-value=2e-06 Score=79.66 Aligned_cols=132 Identities=17% Similarity=0.084 Sum_probs=80.5
Q ss_pred ecccC-ceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCC--CCcceeeccccCCCceEEEEeecc
Q 011326 233 LGSGS-YGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEH--DNIVQYLGTDRDEKRLCIFLELVT 309 (488)
Q Consensus 233 LG~G~-fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~ 309 (488)
+..|. -+.||+...+++..+++|....... ..+..|+..++.+.. -.+.+++.++.+++..++||++++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT--------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH--------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 34444 4689999888888899998654321 124566666666543 235567777788888999999998
Q ss_pred CCChHHH--------------Hhh-hccC-------hhhhhHH----------------------HHHHHHHHHHHHHC-
Q 011326 310 KGSLASL--------------YQK-YHLS-------DSQVSSY----------------------TRQILNGLKYLHEQ- 344 (488)
Q Consensus 310 ~gsL~~~--------------l~~-~~ls-------~~~~~~i----------------------~~qi~~aL~yLH~~- 344 (488)
|.++.+. +.+ ..++ ......+ .......+..+.+.
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 8655321 100 0000 0000000 00112233334332
Q ss_pred ------CCccccCCcccEEECCCCcEEEeecCCc
Q 011326 345 ------NVVHRDIKCANILVDASGSVKLADFGLA 372 (488)
Q Consensus 345 ------giiHrDLkp~NILl~~~~~vkL~DFGla 372 (488)
.++|+|+.|.|||++.+..+-|+||+.+
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~ 203 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL 203 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhc
Confidence 2799999999999988766789999976
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.85 E-value=2.4e-05 Score=77.75 Aligned_cols=81 Identities=14% Similarity=0.112 Sum_probs=47.5
Q ss_pred eeeecccCceEEEEEEec-CCcEEEEEEeecCCC--CCcchhHHHHHHHHHHHHhcCC--C-CCcceeeccccCCCceEE
Q 011326 230 GELLGSGSYGFVYEGLTD-DGFFFAVKEVSLQDE--GPRGKQSILQLEQEISLLGQFE--H-DNIVQYLGTDRDEKRLCI 303 (488)
Q Consensus 230 ~~~LG~G~fg~Vy~~~~~-~g~~vAvK~i~~~~~--~~~~~~~~~~~~~Ei~iL~~l~--H-pnIv~l~~~~~~~~~~~l 303 (488)
.+.||.|....||+..+. +++.+++|.-..... +........+...|...|+.+. - ..+.+++.+. ++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 356899999999999875 477899997543110 0011111223445777776552 2 3345566553 445688
Q ss_pred EEeeccCCC
Q 011326 304 FLELVTKGS 312 (488)
Q Consensus 304 V~E~~~~gs 312 (488)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.30 E-value=0.00035 Score=67.15 Aligned_cols=130 Identities=15% Similarity=0.106 Sum_probs=75.0
Q ss_pred cCceEEEEEEecCCcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCc--ceeec-----cccCCCceEEEEeec
Q 011326 236 GSYGFVYEGLTDDGFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI--VQYLG-----TDRDEKRLCIFLELV 308 (488)
Q Consensus 236 G~fg~Vy~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI--v~l~~-----~~~~~~~~~lV~E~~ 308 (488)
+--..||++...+|..|++|....... ...++..|...+..|...++ +..+. ....++..+.+++++
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~------s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~ 106 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERW------TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 106 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTS------CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCC------CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeec
Confidence 334689999999999999999864321 23456677777777642222 11111 123455678899998
Q ss_pred cCCChH-----HH------H---hh----h------c-------------------cChhhhhHHHHHHHHHHHHHHH--
Q 011326 309 TKGSLA-----SL------Y---QK----Y------H-------------------LSDSQVSSYTRQILNGLKYLHE-- 343 (488)
Q Consensus 309 ~~gsL~-----~~------l---~~----~------~-------------------ls~~~~~~i~~qi~~aL~yLH~-- 343 (488)
+|..+. .+ + +. . . ++......+...+-..+..+..
T Consensus 107 ~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~ 186 (325)
T d1zyla1 107 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 186 (325)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 774321 11 1 00 0 0 1111111222223333333332
Q ss_pred -----CCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 344 -----QNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 344 -----~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
.++||+|++|.|||++. + ..++||+.+.
T Consensus 187 ~~~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 187 REDFTVLRLHGDCHAGNILWRD-G-PMFVDLDDAR 219 (325)
T ss_dssp CSCSCCEECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred cccCCceeecCCCCcccEEEeC-C-ceEEechhcc
Confidence 36899999999999964 3 4589999774
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.11 E-value=0.00091 Score=65.88 Aligned_cols=72 Identities=8% Similarity=0.031 Sum_probs=47.9
Q ss_pred eeecccCceEEEEEEecC--------CcEEEEEEeecCCCCCcchhHHHHHHHHHHHHhcCCCCCc-ceeeccccCCCce
Q 011326 231 ELLGSGSYGFVYEGLTDD--------GFFFAVKEVSLQDEGPRGKQSILQLEQEISLLGQFEHDNI-VQYLGTDRDEKRL 301 (488)
Q Consensus 231 ~~LG~G~fg~Vy~~~~~~--------g~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~ 301 (488)
+.|+.|-.-.+|++...+ ...|.+++... . .. .....+|..+++.+.-.++ .++++++.+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~---~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P---ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C---CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c---ch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 568999999999987643 34566666542 1 11 1244578888887753444 467777654
Q ss_pred EEEEeeccCCCh
Q 011326 302 CIFLELVTKGSL 313 (488)
Q Consensus 302 ~lV~E~~~~gsL 313 (488)
.+||||++|.+|
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 689999988544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.76 E-value=0.0032 Score=59.47 Aligned_cols=30 Identities=27% Similarity=0.303 Sum_probs=26.8
Q ss_pred CCCccccCCcccEEECCCCcEEEeecCCcc
Q 011326 344 QNVVHRDIKCANILVDASGSVKLADFGLAK 373 (488)
Q Consensus 344 ~giiHrDLkp~NILl~~~~~vkL~DFGla~ 373 (488)
.|+||+|+.++||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988877899999873
|